PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhong, MC; Veillette, A				Zhong, Ming-Chao; Veillette, Andre			The Adaptor Molecule Signaling Lymphocytic Activation Molecule (SLAM)-associated Protein (SAP) Is Essential in Mechanisms Involving the Fyn Tyrosine Kinase for Induction and Progression of Collagen-induced Arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELPER T-CELLS; LINKED LYMPHOPROLIFERATIVE-DISEASE; HUMORAL IMMUNITY; GENE-PRODUCT; B-CELLS; SYSTEMIC AUTOIMMUNITY; CYTOKINE REGULATION; ANTIBODY-RESPONSES; SLAM RECEPTORS; MICE	Signaling lymphocytic activation molecule-associated protein (SAP) is an Src homology 2 domain-only adaptor involved in multiple immune cell functions. It has also been linked to immunodeficiencies and autoimmune diseases, such as systemic lupus erythematosus. Here, we examined the role and mechanism of action of SAP in autoimmunity using a mouse model of autoimmune arthritis, collagen-induced arthritis (CIA). We found that SAP was essential for development of CIA in response to collagen immunization. It was also required for production of collagen-specific antibodies, which play a key role in disease pathogenesis. These effects required SAP expression in T cells, not in B cells. In mice immunized with a high dose of collagen, the activity of SAP was nearly independent of its ability to bind the protein tyrosine kinase Fyn and correlated with the capacity of SAP to promote full differentiation of follicular T helper (T-FH) cells. However, with a lower dose of collagen, the role of SAP was more dependent on Fyn binding, suggesting that additional mechanisms other than T-FH cell differentiation were involved. Further studies suggested that this might be due to a role of the SAP-Fyn interaction in natural killer T cell development through the ability of SAP-Fyn to promote Vav-1 activation. We also found that removal of SAP expression during progression of CIA attenuated disease severity. However, it had no effect on disease when CIA was clinically established. Together, these results indicate that SAP plays an essential role in CIA because of Fyn-independent and Fyn-dependent effects on T-FH cells and, possibly, other T cell types.	[Zhong, Ming-Chao; Veillette, Andre] Clin Res Inst Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; [Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Zhong, MC (corresponding author), Clin Res Inst Montreal, Mol Oncol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	zhongmc@ircm.qc.ca; veillea@ircm.qc.ca						Barral P, 2008, P NATL ACAD SCI USA, V105, P8345, DOI 10.1073/pnas.0802968105; Brand DD, 2003, SPRINGER SEMIN IMMUN, V25, P3, DOI 10.1007/s00281-003-0127-1; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chan GD, 2001, EUR J IMMUNOL, V31, P2403, DOI 10.1002/1521-4141(200108)31:8<2403::AID-IMMU2403>3.0.CO;2-O; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Dong ZJ, 2009, NAT IMMUNOL, V10, P973, DOI 10.1038/ni.1763; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hron JD, 2004, J EXP MED, V200, P261, DOI 10.1084/jem.20040526; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Kim HY, 2005, J EXP MED, V201, P41, DOI 10.1084/jem.20041400; Komori H, 2006, J IMMUNOL, V176, P395, DOI 10.4049/jimmunol.176.1.395; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Leavenworth JW, 2013, J CLIN INVEST, V123, P1382, DOI 10.1172/JCI66938; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Ma CS, 2005, J CLIN INVEST, V115, P1049, DOI 10.1172/JCI23139; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Murphy K, 2012, IMMUNOBIOLOGY; MYERS LK, 1993, J IMMUNOL, V151, P500; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Nunez-Cruz S, 2008, J IMMUNOL, V181, P2311, DOI 10.4049/jimmunol.181.4.2311; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Platt AM, 2010, J IMMUNOL, V185, P1558, DOI 10.4049/jimmunol.1001311; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Rosloniec E. F., 2010, CURR PROTOC IMMUNOL, P11; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Simmons M, 2006, J VIROL, V80, P9577, DOI 10.1128/JVI.00284-06; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Tangye SG, 2012, ANN NY ACAD SCI, V1250, P1, DOI 10.1111/j.1749-6632.2011.06361.x; Teige A, 2010, J IMMUNOL, V185, P345, DOI 10.4049/jimmunol.0901693; Veillette A, 2008, P NATL ACAD SCI USA, V105, P1273, DOI 10.1073/pnas.0710698105; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Zhao F, 2012, IMMUNITY, V36, P1003, DOI 10.1016/j.immuni.2012.05.017; Zhong MC, 2013, MOL CELL BIOL, V33, P1223, DOI 10.1128/MCB.01591-12; Zhong MC, 2008, J BIOL CHEM, V283, P19255, DOI 10.1074/jbc.M800209200; Zhu CL, 2012, J CLIN ENDOCR METAB, V97, P943, DOI 10.1210/jc.2011-2003	60	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31423	31436		10.1074/jbc.M113.473736	http://dx.doi.org/10.1074/jbc.M113.473736			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045941	Green Published, hybrid			2022-12-28	WOS:000330596200002
J	Matsumura, Y; Sakai, J; Skach, WR				Matsumura, Yoshihiro; Sakai, Juro; Skach, William R.			Endoplasmic Reticulum Protein Quality Control Is Determined by Cooperative Interactions between Hsp/c70 Protein and the CHIP E3 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; HEAT-SHOCK PROTEINS; ER-ASSOCIATED DEGRADATION; UBIQUITIN-LIGASE; CYSTIC-FIBROSIS; MOLECULAR CHAPERONES; SODIUM 4-PHENYLBUTYRATE; PROTEASOMAL DEGRADATION; PARTIAL RESTORATION; TRIAGE DECISIONS	The C terminus of Hsp70 interacting protein (CHIP) E3 ligase functions as a key regulator of protein quality control by binding the C-terminal (M/I)EEVD peptide motif of Hsp/c70(90) with its N-terminal tetratricopeptide repeat (TPR) domain and facilitating polyubiquitination of misfolded client proteins via its C-terminal catalytic U-box. Using CFTR as a model client, we recently showed that the duration of the Hsc70-client binding cycle is a primary determinant of stability. However, molecular features that control CHIP recruitment to Hsp/c70, and hence the fate of the Hsp/c70 client, remain unknown. To understand how CHIP recognizes Hsp/c70, we utilized a dominant negative mutant in which loss of a conserved proline in the U-box domain (P269A) eliminates E3 ligaseactivity. In a cell-free reconstituted ER- associated degradation system, P269A CHIP inhibited Hsc70-dependent CFTR ubiquitination and degradation in a dose-dependent manner. Optimal inhibition required both the TPR and the U-box, indicating cooperativity between the two domains. Neither the wild type nor the P269A mutant changed the extent of Hsc70 association with CFTR nor the dissociation rate of the Hsc70-CFTR complex. However, the U-box mutation stimulated CHIP binding to Hsc70 while promoting CHIP oligomerization. CHIP binding to Hsc70 binding was also stimulated by the presence of an Hsc70 client with a preference for the ADP-bound state. Thus, the Hsp/c70 (M/I) EEVD motif is not a simple anchor for the TPR domain. Rather CHIP recruitment involves reciprocal allosteric interactions between its TPR and U-box domains and the substrate-binding and C-terminal domains of Hsp/c70.	[Matsumura, Yoshihiro; Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97231 USA; [Matsumura, Yoshihiro; Sakai, Juro] Univ Tokyo, Div Metab Med, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	Oregon Health & Science University; University of Tokyo	Skach, WR (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, MC L-224,3181 SW Sam Jackson Pk Rd, Portland, OR 97231 USA.	skachw@ohsu.edu		Sakai, Juro/0000-0003-4043-1035; Matsumura, Yoshihiro/0000-0002-3108-0440	National Institutes of Health [DK51818, GM53457]; American Cystic Fibrosis Foundation; Manpei Suzuki Diabetes Foundation; Translational Systems Biology and Medicine Initiative (TSBMI),Ministry of Education, Science, Sports and Culture (MEXT), Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053457] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24116507, 24650442] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cystic Fibrosis Foundation; Manpei Suzuki Diabetes Foundation; Translational Systems Biology and Medicine Initiative (TSBMI),Ministry of Education, Science, Sports and Culture (MEXT), Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants DK51818 and GM53457 (to W. R. S.). This work was also supported by grants from the American Cystic Fibrosis Foundation (to W. R. S.), the Manpei Suzuki Diabetes Foundation (to Y. M.), grants-in-aid for young scientists (to Y.M.), for scientific research (to J. S.), and for scientific research on innovative areas (to J.S.), and a grant from the Translational Systems Biology and Medicine Initiative (TSBMI) from the Ministry of Education, Science, Sports and Culture (MEXT), Japan.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; BROWN CR, 1993, J CELL BIOL, V120, P1101, DOI 10.1083/jcb.120.5.1101; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Carlson Eric, 2005, V301, P185; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Carraway KL, 2010, SEMIN CELL DEV BIOL, V21, P936, DOI 10.1016/j.semcdb.2010.09.006; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; Graf C, 2010, BIOCHEMISTRY-US, V49, P2121, DOI 10.1021/bi901829f; Hatakeyama S, 2004, GENES CELLS, V9, P533, DOI 10.1111/j.1356-9597.2004.00742.x; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Jiang CW, 1998, AM J PHYSIOL-CELL PH, V275, pC171, DOI 10.1152/ajpcell.1998.275.1.C171; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kampinga HH, 2003, MOL CELL BIOL, V23, P4948, DOI 10.1128/MCB.23.14.4948-4958.2003; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Matsumura Y., 2009, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0003430.pub2, DOI 10.1002/9780470015902.A0003430.PUB2]; Matsumura Y, 2006, J BIOL CHEM, V281, P34503, DOI 10.1074/jbc.M600071200; Matsumura Y, 2011, MOL BIOL CELL, V22, P2797, DOI 10.1091/mbc.E11-02-0137; Matsumura Y, 2011, METHODS MOL BIOL, V741, P233, DOI 10.1007/978-1-61779-117-8_16; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Oberdorf J, 2006, J CELL SCI, V119, P303, DOI 10.1242/jcs.02732; Oberdorf Jon, 2002, Methods Mol Med, V70, P295; Park HJ, 2009, CHEM BIOL, V16, P461, DOI 10.1016/j.chembiol.2009.02.014; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Ramsey AJ, 2009, BIOCHEM J, V423, P411, DOI 10.1042/BJ20090543; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shibatani T, 2006, MOL BIOL CELL, V17, P4962, DOI 10.1091/mbc.E06-04-0311; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Stankiewicz M, 2010, FEBS J, V277, P3353, DOI 10.1111/j.1742-4658.2010.07737.x; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Xiong XM, 1999, J BIOL CHEM, V274, P2616, DOI 10.1074/jbc.274.5.2616; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	66	43	45	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31069	31079		10.1074/jbc.M113.479345	http://dx.doi.org/10.1074/jbc.M113.479345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	23990462	Green Published, hybrid			2022-12-28	WOS:000330778900026
J	Cerofolini, L; Fields, GB; Fragai, M; Geraldes, CFGC; Luchinat, C; Parigi, G; Ravera, E; Svergun, DI; Teixeira, JMC				Cerofolini, Linda; Fields, Gregg B.; Fragai, Marco; Geraldes, Carlos F. G. C.; Luchinat, Claudio; Parigi, Giacomo; Ravera, Enrico; Svergun, Dmitri I.; Teixeira, Joao M. C.			Examination of Matrix Metalloproteinase-1 in Solution A PREFERENCE FOR THE PRE-COLLAGENOLYSIS STATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemical Biology; Collagen; Matrix Metalloproteinase (MMP); Metalloprotease; Structural Biology; Collagenolysis; Maximum Occurrence	PARAMAGNETIC RELAXATION ENHANCEMENT; BIOLOGICAL MACROMOLECULES; SUBSTRATE-SPECIFICITY; CONFORMATIONAL SPACE; SOLUTION SCATTERING; CATALYTIC DOMAIN; STRUCTURAL BASIS; CYTOCHROME-C; METAL-IONS; BINDING	Catalysis of collagen degradation by matrix metalloproteinase 1 (MMP-1) has been proposed to critically rely on flexibility between the catalytic (CAT) and hemopexin-like (HPX) domains. A rigorous assessment of the most readily accessed conformations in solution is required to explain the onset of substrate recognition and collagenolysis. The present study utilized paramagnetic NMR spectroscopy and small angle x-ray scattering (SAXS) to calculate the maximum occurrence (MO) of MMP-1 conformations. The MMP-1 conformations with large MO values (up to 47%) are restricted into a relatively small conformational region. All conformations with high MO values differ largely from the closed MMP-1 structures obtained by x-ray crystallography. The MO of the latter is approximate to 20%, which represents the upper limit for the presence of this conformation in the ensemble sampled by the protein in solution. In all the high MO conformations, the CAT and HPX domains are not in tight contact, and the residues of the HPX domain reported to be responsible for the binding to the collagen triple-helix are solvent exposed. Thus, overall analysis of the highest MO conformations indicated that MMP-1 in solution was poised to interact with collagen and then could readily proceed along the steps of collagenolysis.	[Cerofolini, Linda; Fragai, Marco; Luchinat, Claudio; Parigi, Giacomo; Ravera, Enrico; Teixeira, Joao M. C.] Univ Florence, CERM, I-50019 Sesto Fiorentino, FI, Italy; [Fragai, Marco; Luchinat, Claudio; Parigi, Giacomo; Ravera, Enrico] Univ Florence, Dept Chem U Schiff, I-50019 Sesto Fiorentino, FI, Italy; [Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Geraldes, Carlos F. G. C.; Teixeira, Joao M. C.] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3001401 Coimbra, Portugal; [Geraldes, Carlos F. G. C.; Teixeira, Joao M. C.] Univ Coimbra, Fac Sci & Technol, Dept Life Sci, P-3001401 Coimbra, Portugal; [Svergun, Dmitri I.] DESY, EMBL, D-22603 Hamburg, Germany	University of Florence; University of Florence; Torrey Pines Institute for Molecular Studies, Florida; Universidade de Coimbra; Universidade de Coimbra; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Fields, GB (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	gfields@tpims.org; claudioluchinat@cerm.unifi.it	Cerofolini, Linda/AAQ-2914-2020; Ravera, Enrico/E-9361-2012; Fragai, Marco/K-4732-2015; Parigi, Giacomo/A-4329-2018; Ravera, Enrico/N-1251-2019; Teixeira, João Miguel Correia/ABD-1037-2020; Parigi, Giacomo/ABF-5321-2020	Ravera, Enrico/0000-0001-7708-9208; Fragai, Marco/0000-0002-8440-1690; Parigi, Giacomo/0000-0002-1989-4644; Ravera, Enrico/0000-0001-7708-9208; Teixeira, João Miguel Correia/0000-0002-9113-0622; Parigi, Giacomo/0000-0002-1989-4644; Cerofolini, Linda/0000-0002-0795-9594; Geraldes, Carlos/0000-0002-0837-8329; Luchinat, Claudio/0000-0003-2271-8921; Svergun, Dmitri/0000-0003-0830-5696	National Institutes of Health [CA98799]; MIUR-FIRB [RBLA032ZM7, RBRN07BMCT]; European Commission [228461, 261572, 261863]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [SFRH/BD/45928/2008]; Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI); Ente Cassa di Risparmio; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIUR-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI); Ente Cassa di Risparmio; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA98799, Ente Cassa di Risparmio, MIUR-FIRB contracts RBLA032ZM7 and RBRN07BMCT, European Commission contracts East-NMR number 228461, WeNMR number 261572, and Bio-NMR number 261863, and Fundacao para a Ciencia e Tecnologia (FCT), Portugal, Grant SFRH/BD/45928/2008 (to J. M. C. T.), and Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI) and supported by national member subscriptions.	Anthis NJ, 2011, J AM CHEM SOC, V133, P18966, DOI 10.1021/ja2082813; Arnold LH, 2011, J BIOL CHEM, V286, P45073, DOI 10.1074/jbc.M111.285213; Bashir Q, 2010, J AM CHEM SOC, V132, P241, DOI 10.1021/ja9064574; Berlin K, 2009, J MAGN RESON, V201, P25, DOI 10.1016/j.jmr.2009.07.028; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bertini I, 2004, P NATL ACAD SCI USA, V101, P6841, DOI 10.1073/pnas.0308641101; Bertini I, 2003, BIOCHEMISTRY-US, V42, P8011, DOI 10.1021/bi034494z; Bertini I, 2002, PROG NUCL MAG RES SP, V40, P249, DOI 10.1016/S0079-6565(02)00002-X; Bertini I, 2005, J MED CHEM, V48, P7544, DOI 10.1021/jm050574k; Bertini I, 2004, ANGEW CHEM INT EDIT, V43, P2254, DOI 10.1002/anie.200353453; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; Bertini I, 2007, J AM CHEM SOC, V129, P12786, DOI 10.1021/ja0726613; Bertini I, 2012, J BIOMOL NMR, V53, P271, DOI 10.1007/s10858-012-9638-1; Bertini I, 2012, PHYS CHEM CHEM PHYS, V14, P9149, DOI 10.1039/c2cp40139h; Bertini I, 2012, FEBS LETT, V586, P557, DOI 10.1016/j.febslet.2011.09.020; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Bertini I, 2011, COORDIN CHEM REV, V255, P649, DOI 10.1016/j.ccr.2010.09.001; Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; Bertini I, 2010, J AM CHEM SOC, V132, P13553, DOI 10.1021/ja1063923; Bertini I, 2009, J BIOL CHEM, V284, P12821, DOI 10.1074/jbc.M809627200; Bode W, 2003, BIOCHEM SOC SYMP, V70, P1; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Dasgupta S, 2011, J BIOMOL NMR, V51, P253, DOI 10.1007/s10858-011-9532-2; Fasciglione GF, 2012, J BIOL INORG CHEM, V17, P663, DOI 10.1007/s00775-012-0886-z; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; Fragai M, 2013, COORDIN CHEM REV, V257, P2652, DOI 10.1016/j.ccr.2013.02.009; Ikegami T, 2004, J BIOMOL NMR, V29, P339, DOI 10.1023/B:JNMR.0000032611.72827.de; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Keizers PHJ, 2008, J AM CHEM SOC, V130, P14802, DOI 10.1021/ja8054832; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuffner JJ, 2004, IEEE INT CONF ROBOT, P3993, DOI 10.1109/ROBOT.2004.1308895; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Longinetti M, 2002, J PHYS A-MATH GEN, V35, P8153, DOI 10.1088/0305-4470/35/39/302; Longinetti M, 2006, INVERSE PROBL, V22, P1485, DOI 10.1088/0266-5611/22/4/019; Lu KG, 2013, J MOL BIOL, V425, P1815, DOI 10.1016/j.jmb.2013.02.002; Luchinat C, 2012, J MAGN RESON, V215, P85, DOI 10.1016/j.jmr.2011.12.016; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Nagulapalli M, 2012, STRUCTURE, V20, P522, DOI 10.1016/j.str.2012.01.021; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Ryabov YE, 2007, J AM CHEM SOC, V129, P3315, DOI 10.1021/ja067667r; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; Shealy P, 2010, J MAGN RESON, V207, P8, DOI 10.1016/j.jmr.2010.07.016; Su XC, 2008, J AM CHEM SOC, V130, P10486, DOI 10.1021/ja803741f; Sun HB, 2000, ANAL BIOCHEM, V283, P153, DOI 10.1006/abio.2000.4629; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Tolman JR, 2001, J AM CHEM SOC, V123, P1416, DOI 10.1021/ja002500y; Tsukada H, 2002, J BIOL CHEM, V277, P27378, DOI 10.1074/jbc.M201367200; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; Weiss DR, 2009, J MOL BIOL, V385, P665, DOI 10.1016/j.jmb.2008.10.064; Wohnert J, 2003, J AM CHEM SOC, V125, P13338, DOI 10.1021/ja036022d; Xu XF, 2008, J AM CHEM SOC, V130, P6395, DOI 10.1021/ja7101357; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yuwen T, 2011, J BIOMOL NMR, V51, P131, DOI 10.1007/s10858-011-9548-7	69	59	58	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30659	30671		10.1074/jbc.M113.477240	http://dx.doi.org/10.1074/jbc.M113.477240			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24025334	Green Published, hybrid			2022-12-28	WOS:000329868100066
J	Iqbal, J; Parks, JS; Hussain, MM				Iqbal, Jahangir; Parks, John S.; Hussain, M. Mahmood			Lipid Absorption Defects in Intestine-specific Microsomal Triglyceride Transfer Protein and ATP-binding Cassette Transporter A1-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol; Intestine; Lipids; Lipid Absorption; Lipid Metabolism; Lipoprotein Secretion; Lipoprotein Structure; Triglyceride; ABCA1; MTP	CHOLESTEROL ABSORPTION; ACYL-COENZYME; ABETALIPOPROTEINEMIA GENE; ENDOPLASMIC-RETICULUM; LIPOPROTEIN SECRETION; FATTY-ACIDS; IN-VIVO; ABCA1; HOMEOSTASIS; MULTIPLE	We have previously described apolipoprotein B (apoB)-dependent and -independent cholesterol absorption pathways and the role of microsomal triglyceride transfer protein (MTP) and ATP-binding cassette transporter A1 (ABCA1) in these pathways. To assess the contribution of these pathways to cholesterol absorption and to determine whether there are other pathways, we generated mice that lack MTP and ABCA1, individually and in combination, in the intestine. Intestinal deletions of Mttp and Abca1 decreased plasma cholesterol concentrations by 45 and 24%, respectively, whereas their combined deletion reduced it by 59%. Acute cholesterol absorption was reduced by 28% in the absence of ABCA1, and it was reduced by 92-95% when MTP was deleted in the intestine alone or together with ABCA1. MTP deficiency significantly reduced triglyceride absorption, although ABCA1 deficiency had no effect. ABCA1 deficiency did not affect cellular lipids, but Mttp deficiency significantly increased intestinal levels of triglycerides and free fatty acids. Accumulation of intestinal free fatty acids, but not triglycerides, in Mttp-deficient intestines was prevented when mice were also deficient in intestinal ABCA1. Combined deficiency of these genes increased intestinal fatty acid oxidation as a consequence of increased expression of peroxisome proliferator-activated receptor- (PPAR) and carnitine palmitoyltransferase 1 (CPT1). These studies show that intestinal MTP and ABCA1 are critical for lipid absorption and are the main determinants of plasma and intestinal lipid levels. Reducing their activities might lower plasma lipid concentrations.	[Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Parks, John S.] Wake Forest Sch Med, Sect Lipid Sci & Biochem, Dept Pathol, Winston Salem, NC 27157 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Wake Forest University	Hussain, MM (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol & Pediat, 450 Clarkson Ave, Brooklyn, NY 11230 USA.	Mahmood.Hussain@downstate.edu	Iqbal, Jahangir/B-3903-2014	Iqbal, Jahangir/0000-0002-9021-2271	National Institutes of Health [DK-46900, HL049373, HL119962]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373, R01HL119962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046900, R56DK046900, R29DK046900, R01DK081879] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-46900 (to M. M. H.), HL049373, and HL119962 (to J. S. P.). This work was also supported by a grant-in-aid from the American Heart Association (to J. L).	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Anwar K, 2007, J LIPID RES, V48, P2028, DOI 10.1194/jlr.M700207-JLR200; Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Chang TY, 2001, CURR OPIN LIPIDOL, V12, P289, DOI 10.1097/00041433-200106000-00008; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dawson PA, 1999, CURR OPIN LIPIDOL, V10, P315, DOI 10.1097/00041433-199908000-00005; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Hussain MM, 2005, CURR OPIN LIPIDOL, V16, P281, DOI 10.1097/01.mol.0000169347.53568.5a; Hussain MM, 1996, BBA-LIPID LIPID MET, V1300, P151, DOI 10.1016/0005-2760(96)00041-0; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P572, DOI 10.1097/MOL.0b013e328312707c; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Iqbal J, 2005, J LIPID RES, V46, P1491, DOI 10.1194/jlr.M500023-JLR200; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; Iqbal J, 2008, J BIOL CHEM, V283, P19967, DOI 10.1074/jbc.M800398200; Iqbal J, 2010, J LIPID RES, V51, P1929, DOI 10.1194/jlr.M005744; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; Josekutty J, 2013, J BIOL CHEM, V288, P14372, DOI 10.1074/jbc.M113.459602; KESANIEMI YA, 1987, EUR J CLIN INVEST, V17, P391, DOI 10.1111/j.1365-2362.1987.tb01132.x; Khatun I, 2012, HEPATOLOGY, V55, P1356, DOI 10.1002/hep.25504; Klappe K, 2009, CHEM PHYS LIPIDS, V161, P57, DOI 10.1016/j.chemphyslip.2009.07.004; Lagakos WS, 2011, AM J PHYSIOL-GASTR L, V300, pG803, DOI 10.1152/ajpgi.00229.2010; Lee RG, 2004, CIRC RES, V95, P998, DOI 10.1161/01.RES.0000147558.15554.67; Liu YH, 2012, BBA-MOL CELL BIOL L, V1821, P522, DOI 10.1016/j.bbalip.2011.08.015; MCGILL HC, 1979, AM J CLIN NUTR, V32, P2664, DOI 10.1093/ajcn/32.12.2664; Parks JS, 2012, CURR OPIN LIPIDOL, V23, P196, DOI 10.1097/MOL.0b013e328352dd1a; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; Rava P, 2005, J LIPID RES, V46, P1779, DOI 10.1194/jlr.D400043-JLR200; Repa JJ, 2004, HEPATOLOGY, V40, P1088, DOI 10.1002/hep.20439; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Soh J, 2013, NAT MED, V19, P892, DOI 10.1038/nm.3200; Sturley SL, 2012, J LIPID RES, V53, P1800, DOI 10.1194/jlr.R028290; Temel RE, 2005, J LIPID RES, V46, P2423, DOI 10.1194/jlr.M500232-JLR200; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Wang J, 2006, J BIOL CHEM, V281, P27894, DOI 10.1074/jbc.M605603200; Wierzbicki AS, 2009, CURR VASC PHARMACOL, V7, P277, DOI 10.2174/157016109788340703; WILSON MD, 1994, J LIPID RES, V35, P943; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200	45	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30432	30444		10.1074/jbc.M113.501247	http://dx.doi.org/10.1074/jbc.M113.501247			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24019513	Green Published, hybrid			2022-12-28	WOS:000329868100039
J	Kodama, T; Hikita, H; Kawaguchi, T; Saito, Y; Tanaka, S; Shigekawa, M; Shimizu, S; Li, W; Miyagi, T; Kanto, T; Hiramatsu, N; Tatsumi, T; Takehara, T				Kodama, Takahiro; Hikita, Hayato; Kawaguchi, Tsukasa; Saito, Yoshinobu; Tanaka, Satoshi; Shigekawa, Minoru; Shimizu, Satoshi; Li, Wei; Miyagi, Takuya; Kanto, Tatsuya; Hiramatsu, Naoki; Tatsumi, Tomohide; Takehara, Tetsuo			The Bcl-2 Homology Domain 3 (BH3)-only Proteins Bim and Bid Are Functionally Active and Restrained by Anti-apoptotic Bcl-2 Family Proteins in Healthy Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bcl-2 Family Proteins; Cell Biology; Hepatocyte; Liver Injury; Mitochondrial Apoptosis; Bcl-xl; Mcl-1	HEPATOCYTE APOPTOSIS; BH3-ONLY PROTEINS; CELL-DEATH; EXPRESSION; MICE; LIPOAPOPTOSIS; DISRUPTION; INCREASES; RESPONSES; INJURY	Background: A fine balance between the anti- and pro-apoptotic multidomain Bcl-2 family proteins controls hepatocyte apoptosis in the healthy liver. Results: Disruption of the BH3-only proteins Bim and Bid prevents spontaneous hepatocyte apoptosis in the absence of anti-apoptotic Bcl-2 family proteins. Conclusion: Hepatocyte integrity is maintained by the well orchestrated Bcl-2 network. Significance: We demonstrated the novel involvement of BH3-only proteins in the healthy Bcl-2 network of the liver. An intrinsic pathway of apoptosis is regulated by the B-cell lymphoma-2 (Bcl-2) family proteins. We previously reported that a fine rheostatic balance between the anti- and pro-apoptotic multidomain Bcl-2 family proteins controls hepatocyte apoptosis in the healthy liver. The Bcl-2 homology domain 3 (BH3)-only proteins set this rheostatic balance toward apoptosis upon activation in the diseased liver. However, their involvement in healthy Bcl-2 rheostasis remains unknown. In the present study, we focused on two BH3-only proteins, Bim and Bid, and we clarified the Bcl-2 network that governs hepatocyte life and death in the healthy liver. We generated hepatocyte-specific Bcl-xL- or Mcl-1-knock-out mice, with or without disrupting Bim and/or Bid, and we examined hepatocyte apoptosis under physiological conditions. We also examined the effect of both Bid and Bim disruption on the hepatocyte apoptosis caused by the inhibition of Bcl-xL and Mcl-1. Spontaneous hepatocyte apoptosis in Bcl-xL- or Mcl-1-knock-out mice was significantly ameliorated by Bim deletion. The disruption of both Bim and Bid completely prevented hepatocyte apoptosis in Bcl-xL-knock-out mice and weakened massive hepatocyte apoptosis via the additional in vivo knockdown of mcl-1 in these mice. Finally, the hepatocyte apoptosis caused by ABT-737, which is a Bcl-xL/Bcl-2/Bcl-w inhibitor, was completely prevented in Bim/Bid double knock-out mice. The BH3-only proteins Bim and Bid are functionally active but are restrained by the anti-apoptotic Bcl-2 family proteins under physiological conditions. Hepatocyte integrity is maintained by the dynamic and well orchestrated Bcl-2 network in the healthy liver.	[Kodama, Takahiro; Hikita, Hayato; Kawaguchi, Tsukasa; Saito, Yoshinobu; Tanaka, Satoshi; Shigekawa, Minoru; Shimizu, Satoshi; Li, Wei; Miyagi, Takuya; Kanto, Tatsuya; Hiramatsu, Naoki; Tatsumi, Tomohide; Takehara, Tetsuo] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Suita, Osaka 5650871, Japan	Osaka University	Takehara, T (corresponding author), Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	takehara@gh.med.osaka-u.ac.jp	Kodama, Takahiro/AAW-9605-2021	Kodama, Takahiro/0000-0002-6250-1324; Saito, Yoshinobu/0000-0002-0624-0449; Tanaka, Satoshi/0000-0003-3950-783X	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. Takehara).	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Baskin-Bey ES, 2005, AM J PHYSIOL-GASTR L, V289, pG987, DOI 10.1152/ajpgi.00371.2005; Blom KG, 2009, CLIN EXP IMMUNOL, V155, P320, DOI 10.1111/j.1365-2249.2008.03815.x; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Garcia-Monzon C, 2011, J HEPATOL, V54, P142, DOI 10.1016/j.jhep.2010.06.021; Giam M, 2008, ONCOGENE, V27, pS128, DOI 10.1038/onc.2009.50; Higuchi H, 2001, J PHARMACOL EXP THER, V299, P866; Hikita H, 2009, HEPATOLOGY, V50, P1972, DOI 10.1002/hep.23207; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Ibrahim SH, 2011, J PEDIATR GASTR NUTR, V53, P131, DOI 10.1097/MPG.0b013e31822578db; Ishihara Y, 2011, FEBS J, V278, P1873, DOI 10.1111/j.1742-4658.2011.08105.x; Ishihara Y, 2011, J CELL PHYSIOL, V226, P1007, DOI 10.1002/jcp.22414; Iwata M, 2000, HUM PATHOL, V31, P179, DOI 10.1016/S0046-8177(00)80217-8; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957; Kodama T, 2010, GASTROENTEROLOGY, V138, P2487, DOI 10.1053/j.gastro.2010.02.054; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Maruyama C, 2002, EXP ANIM TOKYO, V51, P391, DOI 10.1538/expanim.51.391; Masuoka HC, 2009, J BIOL CHEM, V284, P30039, DOI 10.1074/jbc.M109.039545; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Wagner KU, 2000, DEVELOPMENT, V127, P4949; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	33	11	11	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30009	30018		10.1074/jbc.M112.443093	http://dx.doi.org/10.1074/jbc.M112.443093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986435	Green Published, hybrid			2022-12-28	WOS:000329868100002
J	Griffith, JD				Griffith, Jack D.			Many Ways to Loop DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRAND DNA; RECA PROTEIN; REPLICATION COMPLEX; HOLLIDAY JUNCTIONS; TELOMERIC CIRCLES; BINDING PROTEIN; IN-VITRO; VISUALIZATION; CHROMATIN; HELIX	In the 1960s, I developed methods for directly visualizing DNA and DNA-protein complexes using an electron microscope. This made it possible to examine the shape of DNA and to visualize proteins as they fold and loop DNA. Early applications included the first visualization of true nucleosomes and linkers and the demonstration that repeating tracts of adenines can cause a curvature in DNA. The binding of DNA repair proteins, including p53 and BRCA2, has been visualized at three-and four-way junctions in DNA. The trombone model of DNA replication was directly verified, and the looping of DNA at telomeres was discovered.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Griffith, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jdg@med.unc.edu			National Institutes of Health [GM31819]; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	There are many colleagues who I have not mentioned specifically, yet who have been a strong part of our work for many years, in particular Tom Broker and Louise Chow. Alexander Makhov and Smaranda Willcox have contributed greatly to my success. I thank many colleagues who have critically read this article and provided very helpful suggestions. Much of this work was supported by a long-standing grant from the National Institutes of Health (GM31819).	Alani E, 1997, J MOL BIOL, V265, P289, DOI 10.1006/jmbi.1996.0743; ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Cesare AJ, 2004, MOL CELL BIOL, V24, P9948, DOI 10.1128/MCB.24.22.9948-9957.2004; Cesare AJ, 2003, PLANT J, V36, P271, DOI 10.1046/j.1365-313X.2003.01882.x; CHASE JW, 1980, NUCLEIC ACIDS RES, V8, P3215, DOI 10.1093/nar/8.14.3215; Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6; Chastain PD, 2004, J BIOL CHEM, V279, P36354, DOI 10.1074/jbc.M403501200; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Chen SH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1343; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; CHRISTIANSEN G, 1986, P NATL ACAD SCI USA, V83, P2066, DOI 10.1073/pnas.83.7.2066; CLAYTON DA, 1967, NATURE, V216, P652, DOI 10.1038/216652a0; Davis R.W., 1971, METHODS ENZYMOL, V21, P413; Doksani Y., 2013, CELL IN PRESS, V155; Egelman EH, 2003, NAT REV MOL CELL BIO, V4, P621, DOI 10.1038/nrm1176; EISENBERG S, 1977, P NATL ACAD SCI USA, V74, P3198, DOI 10.1073/pnas.74.8.3198; FISHEL R, 1994, SCIENCE, V266, P1403, DOI 10.1126/science.7973733; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; GERMOND JE, 1975, P NATL ACAD SCI USA, V72, P1843, DOI 10.1073/pnas.72.5.1843; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Griffith J, 1998, J MOL BIOL, V278, P79, DOI 10.1006/jmbi.1998.1686; GRIFFITH J, 1986, CELL, V46, P717, DOI 10.1016/0092-8674(86)90347-8; GRIFFITH J, 1971, J MOL BIOL, V55, P209, DOI 10.1016/0022-2836(71)90192-6; GRIFFITH JD, 1995, J MOL BIOL, V246, P576, DOI 10.1016/S0022-2836(05)80107-X; GRIFFITH JD, 1975, SCIENCE, V187, P1202, DOI 10.1126/science.187.4182.1202; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; GRILLEY M, 1993, J BIOL CHEM, V268, P11830; HALL MR, 1973, J VIROL, V12, P901, DOI 10.1128/JVI.12.4.901-908.1973; Hamdan SM, 2010, J BIOL CHEM, V285, P18979, DOI 10.1074/jbc.R109.022939; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; HARRIS LD, 1987, J BIOL CHEM, V262, P9285; Heuser JE, 2011, J ELECTRON MICROSC, V60, pS3, DOI 10.1093/jmicro/dfr044; HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7; JACKSON DA, 1972, P NATL ACAD SCI USA, V69, P2904, DOI 10.1073/pnas.69.10.2904; KLEINSCHMIDT A, 1962, BIOCHIM BIOPHYS ACTA, V61, P857, DOI 10.1016/0926-6550(62)90001-4; Kornberg A., 1974, DNA REPLICATION; LAKE RS, 1973, BIOCHEM BIOPH RES CO, V54, P640, DOI 10.1016/0006-291X(73)91471-X; LAUNDON CH, 1988, CELL, V52, P545, DOI 10.1016/0092-8674(88)90467-9; LEE S, 1995, CELL, V81, P1013, DOI 10.1016/S0092-8674(05)80006-6; Lee SJ, 2011, CURR OPIN CHEM BIOL, V15, P580, DOI 10.1016/j.cbpa.2011.07.024; Lee SH, 2013, P NATL ACAD SCI USA, V110, pE3587, DOI 10.1073/pnas.1304103110; LOBBAN PE, 1973, J MOL BIOL, V78, P453, DOI 10.1016/0022-2836(73)90468-3; Makhov AM, 2003, P NATL ACAD SCI USA, V100, P898, DOI 10.1073/pnas.0237171100; Makhov AM, 1996, EMBO J, V15, P1742, DOI 10.1002/j.1460-2075.1996.tb00520.x; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; Marsischky GT, 1999, J BIOL CHEM, V274, P7200, DOI 10.1074/jbc.274.11.7200; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; NAKAMURA TM, 1995, EMBO J, V14, P4849, DOI 10.1002/j.1460-2075.1995.tb00166.x; Natarajan S, 2002, MOL CELL BIOL, V22, P4512, DOI 10.1128/MCB.22.13.4512-4521.2002; Nikitina T, 2004, J CELL BIOL, V166, P161, DOI 10.1083/jcb.200403118; NOSEK J, 1995, MOL GEN GENET, V247, P61, DOI 10.1007/BF00425822; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; OLINS AL, 1974, SCIENCE, V183, P330, DOI 10.1126/science.183.4122.330; Park K, 1998, J BIOL CHEM, V273, P5260, DOI 10.1074/jbc.273.9.5260; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; REGISTER JC, 1987, J BIOL CHEM, V262, P12812; SANCAR A, 1979, BIOCHEM BIOPH RES CO, V90, P123, DOI 10.1016/0006-291X(79)91598-5; Sar F, 2004, J BIOL CHEM, V279, P39289, DOI 10.1074/jbc.M405793200; SINHA NK, 1980, J BIOL CHEM, V255, P4290; STASIAK A, 1984, COLD SPRING HARB SYM, V49, P561, DOI 10.1101/SQB.1984.049.01.063; THOMAS JO, 1975, P NATL ACAD SCI USA, V72, P2626, DOI 10.1073/pnas.72.7.2626; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Tomaska L, 2000, NUCLEIC ACIDS RES, V28, P4479, DOI 10.1093/nar/28.22.4479; Tomaska L, 2009, NAT STRUCT MOL BIOL, V16, P1010, DOI 10.1038/nsmb.1660; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; VINOGRAD J, 1965, P NATL ACAD SCI USA, V53, P1104, DOI 10.1073/pnas.53.5.1104; WANG YH, 1994, J MOL BIOL, V236, P64, DOI 10.1006/jmbi.1994.1118; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; Wang YH, 1996, J BIOL CHEM, V271, P22937, DOI 10.1074/jbc.271.38.22937; Wang YH, 1996, J MOL BIOL, V263, P511, DOI 10.1006/jmbi.1996.0593; WANG YH, 1993, J BIOL CHEM, V268, P17571; WEINSTOCK GM, 1979, P NATL ACAD SCI USA, V76, P126, DOI 10.1073/pnas.76.1.126; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0	81	6	6	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29724	29735		10.1074/jbc.X113.515981	http://dx.doi.org/10.1074/jbc.X113.515981			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24005675	hybrid, Green Published			2022-12-28	WOS:000330615300048
J	Haynes, AC; Qian, J; Reisz, JA; Furdui, CM; Lowther, WT				Haynes, Alexina C.; Qian, Jiang; Reisz, Julie A.; Furdui, Cristina M.; Lowther, W. Todd			Molecular Basis for the Resistance of Human Mitochondrial 2-Cys Peroxiredoxin 3 to Hyperoxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX-SENSITIVE OLIGOMERIZATION; IONIZATION MASS-SPECTROMETRY; TYROSINE-PHOSPHATASE 1B; CYSTEINE-SULFINIC ACID; SULFENIC-ACID; HYDROGEN-PEROXIDE; TRYPAREDOXIN PEROXIDASE; CRYSTAL-STRUCTURE; ENZYME CATALYSIS; SITE CYSTEINE	Peroxiredoxins (Prxs) detoxify peroxides and modulate H2O2-mediated cell signaling in normal and numerous pathophysiological contexts. The typical 2-Cys subclass of Prxs (human Prx1-4) utilizes a Cys sulfenic acid (Cys-SOH) intermediate and disulfide bond formation across two subunits during catalysis. During oxidative stress, however, the Cys-SOH moiety can react with H2O2 to form Cys sulfinic acid (Cys-SO2H), resulting in inactivation. The propensity to hyperoxidize varies greatly among human Prxs. Mitochondrial Prx3 is the most resistant to inactivation, but the molecular basis for this property is unknown. A panel of chimeras and Cys variants of Prx2 and Prx3 were treated with H2O2 and analyzed by rapid chemical quench and time-resolved electrospray ionization-TOF mass spectrometry. The latter utilized an on-line rapid-mixing setup to collect data on the low seconds time scale. These approaches enabled the first direct observation of the Cys-SOH intermediate and a putative Cys sulfenamide (Cys-SN) for Prx2 and Prx3 during catalysis. The substitution of C-terminal residues in Prx3, residues adjacent to the resolving Cys residue, resulted in a Prx2-like protein with increased sensitivity to hyperoxidation and decreased ability to form the intermolecular disulfide bond between subunits. The corresponding Prx2 chimera became more resistant to hyperoxidation. Taken together, the results of this study support that the kinetics of the Cys-SOH intermediate is key to determine the probability of hyperoxidation or disulfide formation. Given the oxidizing environment of the mitochondrion, it makes sense that Prx3 would favor disulfide bond formation as a protection mechanism against hyperoxidation and inactivation.	[Haynes, Alexina C.; Lowther, W. Todd] Wake Forest Sch Med, Struct Biol Ctr, Winston Salem, NC 27157 USA; [Haynes, Alexina C.; Lowther, W. Todd] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Qian, Jiang; Reisz, Julie A.; Furdui, Cristina M.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University	Furdui, CM (corresponding author), Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	cfurdui@wakehealth.edu; tlowther@wakehealth.edu		Furdui, Cristina M./0000-0003-3771-7999	National Institutes of Health from NIGMS [R01 GM072866]; National Institutes of Health from NCI [R01 CA136810]; NATIONAL CANCER INSTITUTE [R01CA136810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072866] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM072866 from NIGMS (to W. T. L.) and Grant R01 CA136810 from NCI (to C. M. F.).	Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; Cao Z, 2007, J MOL BIOL, V372, P1022, DOI 10.1016/j.jmb.2007.07.018; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Fu XY, 2002, BIOCHEMISTRY-US, V41, P1293, DOI 10.1021/bi015777z; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Halliwell B, 2000, FEBS LETT, V486, P10, DOI 10.1016/S0014-5793(00)02197-9; Jara M, 2007, MOL BIOL CELL, V18, P2288, DOI 10.1091/mbc.E06-11-1039; Jarvela S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-104; Jeong W, 2012, FREE RADICAL BIO MED, V53, P447, DOI 10.1016/j.freeradbiomed.2012.05.020; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Kil IS, 2012, MOL CELL, V46, P584, DOI 10.1016/j.molcel.2012.05.030; Klomsiri C, 2010, METHOD ENZYMOL, V473, P77, DOI 10.1016/S0076-6879(10)73003-2; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lee KW, 2011, J BIOL CHEM, V286, P8394, DOI 10.1074/jbc.M110.179416; Li ZL, 2005, ANAL BIOCHEM, V343, P35, DOI 10.1016/j.ab.2005.04.021; Li ZL, 2003, J AM CHEM SOC, V125, P9938, DOI 10.1021/ja0354768; Lowther WT, 2011, ANTIOXID REDOX SIGN, V15, P99, DOI 10.1089/ars.2010.3564; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Nonn L, 2003, MOL CANCER RES, V1, P682; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Qian J, 2012, CHEM COMMUN, V48, P4091, DOI 10.1039/c2cc17868k; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Salsbury FR, 2012, J PHYS CHEM B, V116, P6832, DOI 10.1021/jp212606k; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Song IS, 2011, INT J MOL SCI, V12, P7163, DOI 10.3390/ijms12107163; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Wang X, 2012, BIOCHEM J, V441, P113, DOI 10.1042/BJ20110380; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Yang J, 2007, BIOCHEMISTRY-US, V46, P709, DOI 10.1021/bi061546m; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Yuan Y, 2010, J BIOMOL STRUCT DYN, V28, P51, DOI 10.1080/07391102.2010.10507343	49	54	55	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29714	29723		10.1074/jbc.M113.473470	http://dx.doi.org/10.1074/jbc.M113.473470			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003226	Green Published, hybrid			2022-12-28	WOS:000330615300047
J	Combs, MD; Knutsen, RH; Broekelmann, TJ; Toennies, HM; Brett, TJ; Miller, CA; Kober, DL; Craft, CS; Atkinson, JJ; Shipley, JM; Trask, BC; Mecham, RP				Combs, Michelle D.; Knutsen, Russell H.; Broekelmann, Thomas J.; Toennies, Holly M.; Brett, Thomas J.; Miller, Chantel A.; Kober, Daniel L.; Craft, Clarissa S.; Atkinson, Jeffrey J.; Shipley, J. Michael; Trask, Barbara C.; Mecham, Robert P.			Microfibril-associated Glycoprotein 2 (MAGP2) Loss of Function Has Pleiotropic Effects in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone Morphogenetic Protein (BMP); Elastin; Extracellular Matrix; Hematopoiesis; Transforming Growth Factor (TGF); MAGP; Microfibril	FIBRILLIN-CONTAINING MICROFIBRILS; ELASTIN-ASSOCIATED MICROFIBRILS; MARFAN-SYNDROME; AORTIC-ANEURYSM; TGF-BETA; O-GLCNACYLATION; GENE-EXPRESSION; BONE-FORMATION; TIGHT-SKIN; MATRIX	Microfibril-associated glycoprotein (MAGP) 1 and 2 are evolutionarily related but structurally divergent proteins that are components of microfibrils of the extracellular matrix. Using mice with a targeted inactivation of Mfap5, the gene for MAGP2 protein, we demonstrate that MAGPs have shared as well as unique functions in vivo. Mfap5(-/-) mice appear grossly normal, are fertile, and have no reduction in life span. Cardiopulmonary development is typical. The animals are normotensive and have vascular compliance comparable with age-matched wild-type mice, which is indicative of normal, functional elastic fibers. Loss of MAGP2 alone does not significantly alter bone mass or architecture, and loss of MAGP2 in tandem with loss of MAGP1 does not exacerbate MAGP1-dependent osteopenia. MAGP2-deficient mice are neutropenic, which contrasts with monocytopenia described in MAGP1-deficient animals. This suggests that MAGP1 and MAGP2 have discrete functions in hematopoiesis. In the cardiovascular system, MAGP1;MAGP2 double knockout mice (Mfap2(-/-);Mfap5(-/-)) show age-dependent aortic dilation. These findings indicate that MAGPs have shared primary functions in maintaining large vessel integrity. In solid phase binding assays, MAGP2 binds active TGF1, TGF2, and BMP2. Together, these data demonstrate that loss of MAGP2 expression in vivo has pleiotropic effects potentially related to the ability of MAGP2 to regulate growth factors or participate in cell signaling.	[Combs, Michelle D.; Knutsen, Russell H.; Broekelmann, Thomas J.; Brett, Thomas J.; Craft, Clarissa S.; Mecham, Robert P.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Toennies, Holly M.; Brett, Thomas J.; Miller, Chantel A.; Kober, Daniel L.; Atkinson, Jeffrey J.; Shipley, J. Michael; Mecham, Robert P.] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA; [Brett, Thomas J.] Washington Univ, Sch Med, Dept Biochem, St Louis, MO 63110 USA; [Kober, Daniel L.] Washington Univ, Sch Med, Mol Biol & Microbial Pathogenesis Program, St Louis, MO 63110 USA; [Trask, Barbara C.] Weber State Univ, Dept Zool, Ogden, UT 84408 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Utah System of Higher Education; Weber State University	Mecham, RP (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Box 8228,660 S Euclid, St Louis, MO 63110 USA.	bmecham@wustl.edu	Brett, Thomas/AAC-9147-2019	Brett, Thomas/0000-0002-6871-6676; Kober, Daniel/0000-0001-8657-9348; Atkinson, Jeffrey/0000-0001-9125-7968	National Institutes of Health [HL53325, HL74138, HL105314, P30-AR057235]; National Institutes of Health Developmental Cardiology and Pulmonary Training Grant [T32 HL007873]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL053325, T32HL007873, R01HL105314, R01HL074138, R01HL053325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Developmental Cardiology and Pulmonary Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL53325, HL74138, and HL105314 (to R. P. M.), National Institutes of Health Developmental Cardiology and Pulmonary Training Grant T32 HL007873 (to M. D. C.), and National Institutes of Health Grant P30-AR057235 (to the Musculoskeletal and Morphology Cores).	Albig AR, 2008, MICROVASC RES, V76, P7, DOI 10.1016/j.mvr.2008.01.001; Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bigas A, 2012, BLOOD, V119, P3226, DOI 10.1182/blood-2011-10-355826; Blank U, 2011, LEUKEMIA, V25, P1379, DOI 10.1038/leu.2011.95; Booms P, 2005, HUM GENET, V116, P51, DOI 10.1007/s00439-004-1194-7; Carta L, 2009, ARTERIOSCL THROM VAS, V29, P2083, DOI 10.1161/ATVBAHA.109.193227; Chen E, 2006, BLOOD, V107, P4364, DOI 10.1182/blood-2005-02-0789; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Craft CS, 2012, J CELL BIOCHEM, V113, P93, DOI 10.1002/jcb.23331; Craft CS, 2010, J BIOL CHEM, V285, P23858, DOI 10.1074/jbc.M110.113019; DAVIS EC, 1994, J CELL SCI, V107, P727; Donovan LJ, 2013, MATRIX BIOL, V32, P117, DOI 10.1016/j.matbio.2012.11.009; Ehrman LA, 1999, DEV BIOL, V207, P163, DOI 10.1006/dbio.1998.9167; Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028; GIBSON MA, 1986, J BIOL CHEM, V261, P1429; Gibson MA, 1998, J HISTOCHEM CYTOCHEM, V46, P871, DOI 10.1177/002215549804600802; Gibson MA, 1999, J BIOL CHEM, V274, P13060, DOI 10.1074/jbc.274.19.13060; Gibson MA, 1996, J BIOL CHEM, V271, P1096, DOI 10.1074/jbc.271.2.1096; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hatzinikolas G, 1998, J BIOL CHEM, V273, P29309, DOI 10.1074/jbc.273.45.29309; Henderson M, 1996, J HISTOCHEM CYTOCHEM, V44, P1389, DOI 10.1177/44.12.8985131; Ito S, 2006, AM J RESP CELL MOL, V34, P688, DOI 10.1165/rcmb.2006-0002OC; Jensen SA, 2012, STRUCTURE, V20, P215, DOI 10.1016/j.str.2011.12.008; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; Kozel BA, 2011, BIOL EXTRACELL MATR, P267, DOI 10.1007/978-3-642-16555-9_8; KUMARATILAKE JS, 1989, EUR J CELL BIOL, V50, P117; Lemaire R, 2005, ARTHRITIS RHEUM-US, V52, P1812, DOI 10.1002/art.21059; Lemaire R, 2004, ARTHRITIS RHEUM-US, V50, P915, DOI 10.1002/art.20053; Lemaire R, 2007, J BIOL CHEM, V282, P800, DOI 10.1074/jbc.M609692200; Lincoln J, 2006, DEV BIOL, V294, P292, DOI 10.1016/j.ydbio.2006.03.027; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mariko B, 2011, J PATHOL, V224, P33, DOI 10.1002/path.2840; Massam-Wu T, 2010, J CELL SCI, V123, P3006, DOI 10.1242/jcs.073437; Mead TJ, 2012, ADV EXP MED BIOL, V727, P114, DOI 10.1007/978-1-4614-0899-4_9; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Mok SC, 2009, CANCER CELL, V16, P521, DOI 10.1016/j.ccr.2009.10.018; Munger J.S., 2011, COLD SPRING HARB PER, V3; Nehring LC, 2005, J BIOL CHEM, V280, P20349, DOI 10.1074/jbc.M500273200; Nistala H, 2010, HUM MOL GENET, V19, P4790, DOI 10.1093/hmg/ddq409; Nistala H, 2010, J CELL BIOL, V190, P1107, DOI 10.1083/jcb.201003089; Nistala H, 2010, J BIOL CHEM, V285, P34126, DOI 10.1074/jbc.M110.125328; Ramirez F, 2007, CELL MOL LIFE SCI, V64, P2437, DOI 10.1007/s00018-007-7166-z; Ramirez F, 2004, NAT CLIN PRACT CARD, V1, P31, DOI 10.1038/ncpcardio0020; Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x; Segade F, 2002, J BIOL CHEM, V277, P11050, DOI 10.1074/jbc.M110347200; Segade F, 2009, GENE, V439, P43, DOI 10.1016/j.gene.2009.03.013; Shelton EL, 2007, DEV BIOL, V302, P376, DOI 10.1016/j.ydbio.2006.09.047; Swiecki M, 2011, J BIOL CHEM, V286, P2987, DOI 10.1074/jbc.M110.190538; Trask BC, 2001, BIOCHEMISTRY-US, V40, P4372, DOI 10.1021/bi002738z; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wagenseil JE, 2005, AM J PHYSIOL-HEART C, V289, pH1209, DOI 10.1152/ajpheart.00046.2005; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Xiong WF, 2012, CIRC RES, V110, pE92, DOI 10.1161/CIRCRESAHA.112.268268; Yanagisawa H, 2010, INT J BIOCHEM CELL B, V42, P1084, DOI 10.1016/j.biocel.2010.03.009; ZEBDA N, 1994, J CELL BIOCHEM, V54, P161, DOI 10.1002/jcb.240540205	58	43	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28869	28880		10.1074/jbc.M113.497727	http://dx.doi.org/10.1074/jbc.M113.497727			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23963447	Green Published, hybrid			2022-12-28	WOS:000330298800039
J	Lee, DY; Wauquier, F; Eid, AA; Roman, LJ; Ghosh-Choudhury, G; Khazim, K; Block, K; Gorin, Y				Lee, Doug-Yoon; Wauquier, Fabien; Eid, Assaad A.; Roman, Linda J.; Ghosh-Choudhury, Goutam; Khazim, Khaled; Block, Karen; Gorin, Yves			Nox4 NADPH Oxidase Mediates Peroxynitrite-dependent Uncoupling of Endothelial Nitric-oxide Synthase and Fibronectin Expression in Response to Angiotensin II ROLE OF MITOCHONDRIAL REACTIVE OXYGEN SPECIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiotensin II; Extracellular Matrix Proteins; Kidney; Nitric-oxide Synthase; Nox; Oxidative Stress	RAT MESANGIAL CELLS; EXPERIMENTAL DIABETIC-NEPHROPATHY; NAD(P)H OXIDASE; MOLECULAR-MECHANISMS; GLOMERULAR INJURY; RECEPTOR BLOCKADE; VASCULAR-DISEASE; REDOX CONTROL; UP-REGULATION; SUPEROXIDE	Activation of glomerular mesangial cells (MCs) by angiotensin II (Ang II) leads to extracellular matrix accumulation. Here, we demonstrate that, in MCs, Ang II induces endothelial nitric-oxide synthase (eNOS) uncoupling with enhanced generation of reactive oxygen species (ROS) and decreased production of NO. Ang II promotes a rapid increase in 3-nitrotyrosine formation, and uric acid attenuates Ang II-induced decrease in NO bioavailability, demonstrating that peroxynitrite mediates the effects of Ang II on eNOS dysfunction. Ang II rapidly up-regulates Nox4 protein. Inhibition of Nox4 abolishes the increase in ROS and peroxynitrite generation as well as eNOS uncoupling triggered by Ang II, indicating that Nox4 is upstream of eNOS. This pathway contributes to Ang II-mediated fibronectin accumulation in MCs. Ang II also elicits an increase in mitochondrial abundance of Nox4 protein, and the oxidase contributes to ROS production in mitochondria. Overexpression of mitochondrial manganese superoxide dismutase prevents the stimulatory effects of Ang II on mitochondrial ROS production, loss of NO availability, and MC fibronectin accumulation, whereas manganese superoxide dismutase depletion increases mitochondrial ROS, NO deficiency, and fibronectin synthesis basally and in cells exposed to Ang II. This work provides the first evidence that uncoupled eNOS is responsible for Ang II-induced MC fibronectin accumulation and identifies Nox4 and mitochondrial ROS as mediators of eNOS dysfunction. These data shed light on molecular processes underlying the oxidative signaling cascade engaged by Ang II and identify potential targets for intervention to prevent renal fibrosis.	[Lee, Doug-Yoon; Wauquier, Fabien; Eid, Assaad A.; Ghosh-Choudhury, Goutam; Khazim, Khaled; Block, Karen; Gorin, Yves] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Roman, Linda J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Goutam] Vet Adm Res & Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Ghosh-Choudhury, Goutam; Block, Karen] South Texas Vet Hlth Care Syst, Audie Leon Murphy Mem Hosp Div, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Gorin, Y (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Nephrol MC 7882, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	gorin@uthscsa.edu			National Institutes of Health [RO1 DK 079996, RO1 CA 131272, RO1 DK 50190]; Juvenile Diabetes Research Foundation Multiproject Grant; Juvenile Diabetes Research Foundation Advanced Research Fellowship Grant; Veterans Administration Merit Awards; Veterans Administration Senior Research Career Scientist Award; NATIONAL CANCER INSTITUTE [R01CA131272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079996, R01DK050190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation Multiproject Grant(Juvenile Diabetes Research Foundation); Juvenile Diabetes Research Foundation Advanced Research Fellowship Grant(Juvenile Diabetes Research Foundation); Veterans Administration Merit Awards; Veterans Administration Senior Research Career Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK 079996 (to Y. G.), RO1 CA 131272 (to K. B.), and RO1 DK 50190 (to G. G. C.). This work was also supported in part by a Juvenile Diabetes Research Foundation Multiproject Grant (to Y. G. and K. B.), a Juvenile Diabetes Research Foundation Advanced Research Fellowship Grant (to A. A. E.), and Veterans Administration Merit Awards (to K. B. and G. G. C.).; Recipient of Veterans Administration Senior Research Career Scientist Award.	Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P413, DOI 10.1161/01.ATV.0000110785.96039.f6; Awad AS, 2004, J HYPERTENS, V22, P1571, DOI 10.1097/01.hjh.0000133718.86451.6a; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2008, J BIOL CHEM, V283, P24061, DOI 10.1074/jbc.M803964200; Block K, 2006, ANTIOXID REDOX SIGN, V8, P1497, DOI 10.1089/ars.2006.8.1497; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Brandes RP, 2011, ARTERIOSCL THROM VAS, V31, P1255, DOI 10.1161/ATVBAHA.111.226894; Chatziantoniou C, 2005, AM J PHYSIOL-RENAL, V289, pF227, DOI 10.1152/ajprenal.00453.2004; Craige SM, 2011, CIRCULATION, V124, P731, DOI 10.1161/CIRCULATIONAHA.111.030775; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V328, P208, DOI 10.1006/abbi.1996.0162; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Dikalov SI, 2013, ANTIOXID REDOX SIGN, V19, P1085, DOI 10.1089/ars.2012.4604; Dikalova AE, 2010, AM J PHYSIOL-HEART C, V299, pH673, DOI 10.1152/ajpheart.00242.2010; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Faria AM, 2012, DIABETES, V61, P1838, DOI 10.2337/db11-1241; Feliers D, 2005, KIDNEY INT, V68, P1648, DOI 10.1111/j.1523-1755.2005.00575.x; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Fogo AB, 1999, EXP NEPHROL, V7, P147; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Gao SJ, 2004, J BIOL CHEM, V279, P15968, DOI 10.1074/jbc.M308504200; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gomez-Guerrero Carmen, 2005, Current Drug Targets - Inflammation and Allergy, V4, P341, DOI 10.2174/1568010054022169; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Gorin Y, 2013, FREE RADICAL BIO MED, V61, P130, DOI 10.1016/j.freeradbiomed.2013.03.014; Gorin Y, 2013, CLIN SCI, V125, P361, DOI 10.1042/CS20130065; GUSKOVA RA, 1984, BIOCHIM BIOPHYS ACTA, V778, P579, DOI 10.1016/0005-2736(84)90409-7; Kagami S, 2012, CLIN EXP NEPHROL, V16, P214, DOI 10.1007/s10157-011-0568-0; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kashyap SR, 2005, J CLIN ENDOCR METAB, V90, P1100, DOI 10.1210/jc.2004-0745; Kietadisorn R, 2012, AM J PHYSIOL-ENDOC M, V302, pE481, DOI 10.1152/ajpendo.00540.2011; Kim S, 2000, PHARMACOL REV, V52, P11; Kim S, 2012, PLOS ONE; LAFAYETTE RA, 1992, J CLIN INVEST, V90, P766, DOI 10.1172/JCI115949; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Li YZ, 2010, BIOCHEM BIOPH RES CO, V397, P5, DOI 10.1016/j.bbrc.2010.04.084; Lustgarten MS, 2012, BIOCHEM BIOPH RES CO, V422, P515, DOI 10.1016/j.bbrc.2012.05.055; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Martinez-Ruiz A, 2011, FREE RADICAL BIO MED, V51, P17, DOI 10.1016/j.freeradbiomed.2011.04.010; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Miyata K, 2005, J AM SOC NEPHROL, V16, P2906, DOI 10.1681/ASN.2005040390; Mount PF, 2006, ACTA PHYSIOL, V187, P433, DOI 10.1111/j.1748-1716.2006.01582.x; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; New DD, 2012, AM J PHYSIOL-CELL PH, V302, pC122, DOI 10.1152/ajpcell.00141.2011; Nistala R, 2008, ANTIOXID REDOX SIGN, V10, P2047, DOI 10.1089/ars.2008.2034; Pleskova M, 2005, FASEB J, V19, P139, DOI 10.1096/fj.05-3791fje; RADEKE HH, 1991, J BIOL CHEM, V266, P21025; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; Rafikov R, 2013, J BIOL CHEM, V288, P6212, DOI 10.1074/jbc.M112.423269; Rincon-Choles H, 2002, KIDNEY INT, V62, pS8, DOI 10.1046/j.1523-1755.62.s82.3.x; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Satoh M, 2005, AM J PHYSIOL-RENAL, V288, pF1144, DOI 10.1152/ajprenal.00221.2004; Satoh M, 2008, NEPHROL DIAL TRANSPL, V23, P3806, DOI 10.1093/ndt/gfn357; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Shah A, 2013, J BIOL CHEM, V288, P6835, DOI 10.1074/jbc.M112.419101; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Thomas SR, 2008, ANTIOXID REDOX SIGN, V10, P1713, DOI 10.1089/ars.2008.2027; Wang SX, 2002, J BIOL CHEM, V277, P9880, DOI 10.1074/jbc.M108360200; Xia Y, 2007, ANTIOXID REDOX SIGN, V9, P1773, DOI 10.1089/ars.2007.1733; Xu J, 2006, ARTERIOSCL THROM VAS, V26, P2688, DOI 10.1161/01.ATV.0000249394.94588.82; Youn JY, 2012, DIABETOLOGIA, V55, P2069, DOI 10.1007/s00125-012-2557-6; Zhang MA, 2011, ARTERIOSCL THROM VAS, V31, P125, DOI 10.1161/ATVBAHA.110.207712; Zhang M, 2013, ANTIOXID REDOX SIGN, V18, P1024, DOI 10.1089/ars.2012.4550; Zhang WK, 2007, AM J PHYSIOL-RENAL, V292, pF1054, DOI 10.1152/ajprenal.00286.2006; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	78	98	104	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28668	28686		10.1074/jbc.M113.470971	http://dx.doi.org/10.1074/jbc.M113.470971			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940049	Green Published, hybrid			2022-12-28	WOS:000330298800022
J	Zucconi, BE; Wilson, GM				Zucconi, Beth E.; Wilson, Gerald M.			Assembly of Functional Ribonucleoprotein Complexes by AU-rich Element RNA-binding Protein 1 (AUF1) Requires Base-dependent and -independent RNA Contacts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGET MESSENGER-RNAS; RESONANCE ENERGY-TRANSFER; NUCLEIC ACID INTERACTIONS; HIGH-AFFINITY BINDING; GENE-EXPRESSION; POSTTRANSCRIPTIONAL CONTROL; FLUORESCENCE ANISOTROPY; THERMODYNAMIC ANALYSIS; CONFORMATIONAL-CHANGES; DNA-BINDING	AU-rich element RNA-binding protein 1 (AUF1) regulates the stability and/or translational efficiency of diverse mRNA targets, including many encoding products controlling the cell cycle, apoptosis, and inflammation by associating with AU-rich elements residing in their 3' -untranslated regions. Previous biochemical studies showed that optimal AUF1 binding requires 33-34 nucleotides with a strong preference for U-rich RNA despite observations that few AUF1-associated cellular mRNAs contain such extended U-rich domains. Using the smallest AUF1 isoform (p37(AUF1)) as a model, we employed fluorescence anisotropy-based approaches to define thermodynamic parameters describing AUF1 ribonucleoprotein (RNP) complex formation across a panel of RNA substrates. These data demonstrated that 15 nucleotides of AU-rich sequence were sufficient to nucleate high affinity p37(AUF1) RNP complexes within a larger RNA context. In particular, p37(AUF1) binding to short AU-rich RNA targets was significantly stabilized by interactions with a 3' -purine residue and largely base-independent but non-ionic contacts 5' of the AU-rich site. RNP stabilization by the upstream RNA domain was associated with an enhanced negative change in heat capacity consistent with conformational changes in protein and/or RNA components, and fluorescence resonance energy transfer-based assays demonstrated that these contacts were required for p37(AUF1) to remodel local RNA structure. Finally, reporter mRNAs containing minimal high affinity p37(AUF1) target sequences associated with AUF1 and were destabilized in a p37(AUF1) -dependent manner in cells. These findings provide a mechanistic explanation for the diverse population of AUF1 target mRNAs but also suggest how AUF1 binding could regulate protein and/or microRNA binding events at adjacent sites.	[Wilson, Gerald M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Wilson, GM (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	gwilson@som.umaryland.edu	Wilson, Gerald/AAF-3874-2019	Wilson, Gerald/0000-0002-1273-7507	National Institutes of Health [R01 CA102428, T32 GM066706]; American Heart Association [11PRE6900008]; NATIONAL CANCER INSTITUTE [R01CA102428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA102428 (NCI; to G.M.W.).; Supported by American Heart Association Grant 11PRE6900008 and National Institutes of Health Grant T32 GM066706.	Arao Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P228, DOI 10.1006/abbi.2000.1938; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Ballin JD, 2010, BIOCHEMISTRY-US, V49, P2018, DOI 10.1021/bi902027z; Barraud P, 2013, J BIOMOL NMR, V55, P119, DOI 10.1007/s10858-012-9696-4; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Baumann C, 1996, J BIOL CHEM, V271, P12269, DOI 10.1074/jbc.271.21.12269; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Chen TM, 2010, NUCLEIC ACIDS RES, V38, P8061, DOI 10.1093/nar/gkq717; DEHASETH PL, 1977, BIOCHEMISTRY-US, V16, P4783, DOI 10.1021/bi00641a004; DeMaria CT, 1996, J BIOL CHEM, V271, P12179, DOI 10.1074/jbc.271.21.12179; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; DRAPER DE, 1995, ANNU REV BIOCHEM, V64, P593, DOI 10.1146/annurev.bi.64.070195.003113; Enokizono Y, 2005, J BIOL CHEM, V280, P18862, DOI 10.1074/jbc.M411822200; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Fialcowitz-White EJ, 2007, J BIOL CHEM, V282, P20948, DOI 10.1074/jbc.M701751200; Fisher BM, 1998, BIOCHEMISTRY-US, V37, P12121, DOI 10.1021/bi980743l; FRIED MG, 1993, EUR J BIOCHEM, V218, P469, DOI 10.1111/j.1432-1033.1993.tb18398.x; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; HA JH, 1989, J MOL BIOL, V209, P801, DOI 10.1016/0022-2836(89)90608-6; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Hall KB, 1995, METHOD ENZYMOL, V259, P261; He C, 2006, EMBO J, V25, P3823, DOI 10.1038/sj.emboj.7601264; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; Katsamba PS, 2001, J BIOL CHEM, V276, P21476, DOI 10.1074/jbc.M101624200; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kim HS, 2011, NUCLEIC ACIDS RES, V39, P1117, DOI 10.1093/nar/gkq837; Kishor A, 2013, MOL CELL BIOL, V33, P71, DOI 10.1128/MCB.01275-12; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lamichhane R, 2010, P NATL ACAD SCI USA, V107, P4105, DOI 10.1073/pnas.0907072107; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lin SK, 2000, MOL CELL BIOL, V20, P7903, DOI 10.1128/MCB.20.21.7903-7913.2000; LOHMAN TM, 1980, BIOCHEMISTRY-US, V19, P3522, DOI 10.1021/bi00556a017; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P400; LOHMAN TM, 1986, CRIT REV BIOCHEM MOL, V19, P191, DOI 10.3109/10409238609084656; Lu JY, 2006, RNA, V12, P883, DOI 10.1261/rna.2308106; Lund N, 2012, NUCLEIC ACIDS RES, V40, P3663, DOI 10.1093/nar/gkr1238; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; MARTIN KJ, 1987, J MOL BIOL, V195, P741, DOI 10.1016/0022-2836(87)90193-8; Matsui H, 2007, MOL CELL, V25, P99, DOI 10.1016/j.molcel.2006.12.007; Mazan-Mamczarz K, 2009, NUCLEIC ACIDS RES, V37, P204, DOI 10.1093/nar/gkn929; Mili S, 2001, MOL CELL BIOL, V21, P7307, DOI 10.1128/MCB.21.21.7307-7319.2001; Norman DG, 2000, BIOCHEMISTRY-US, V39, P6317, DOI 10.1021/bi992944a; Raghavan A, 2001, J BIOL CHEM, V276, P47958, DOI 10.1074/jbc.M109511200; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RECORD MT, 1976, BIOPOLYMERS, V15, P893, DOI 10.1002/bip.1976.360150507; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Sarkar S, 2008, J INTERF CYTOK RES, V28, P679, DOI 10.1089/jir.2008.0028; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Sinsimer KS, 2008, MOL CELL BIOL, V28, P5223, DOI 10.1128/MCB.00431-08; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stickle DF, 2007, BIOPHYS CHEM, V126, P106, DOI 10.1016/j.bpc.2006.05.016; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wang H, 2013, ACTA CRYSTALLOGR D, V69, P373, DOI 10.1107/S0907444912047828; WEBER G, 1952, BIOCHEM J, V51, P145, DOI 10.1042/bj0510145; White EJF, 2013, BBA-GENE REGUL MECH, V1829, P680, DOI 10.1016/j.bbagrm.2012.12.002; Wilson GM, 1999, J BIOL CHEM, V274, P33374, DOI 10.1074/jbc.274.47.33374; Wilson GM, 2001, J BIOL CHEM, V276, P38400, DOI 10.1074/jbc.M106509200; Wilson GM, 2005, REV FLUORESCENCE, V2, P223; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200; Wilson GM, 1999, METHODS, V17, P74, DOI 10.1006/meth.1998.0709; Wilson GM, 2001, J BIOL CHEM, V276, P8695, DOI 10.1074/jbc.M009848200; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Wu XY, 2013, NUCLEIC ACIDS RES, V41, P2644, DOI 10.1093/nar/gks1453; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Ysla RM, 2008, METHOD ENZYMOL, V449, P47, DOI 10.1016/S0076-6879(08)02403-8; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zucconi BE, 2010, J BIOL CHEM, V285, P39127, DOI 10.1074/jbc.M110.180182	72	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28034	28048		10.1074/jbc.M113.489559	http://dx.doi.org/10.1074/jbc.M113.489559			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940053	Green Published, hybrid			2022-12-28	WOS:000330612800029
J	Adada, MM; Orr-Gandy, KA; Snider, AJ; Canals, D; Hannun, YA; Obeid, LM; Clarke, CJ				Adada, Mohamad M.; Orr-Gandy, K. Alexa; Snider, Ashley J.; Canals, Daniel; Hannun, Yusuf A.; Obeid, Lina M.; Clarke, Christopher J.			Sphingosine Kinase 1 Regulates Tumor Necrosis Factor-mediated RANTES Induction through p38 Mitogen-activated Protein Kinase but Independently of Nuclear Factor kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; HUMAN NK CELLS; TNF-ALPHA; EPITHELIAL-CELLS; MOLECULAR-MECHANISMS; INTERFERON-GAMMA; CCL5 EXPRESSION; PATHWAY; MAPK; SPHINGOSINE-1-PHOSPHATE	Sphingosine kinase 1 (SK1) produces the pro-survival sphingolipid sphingosine 1-phosphate and has been implicated in inflammation, proliferation, and angiogenesis. Recent studies identified TRAF2 as a sphingosine 1-phosphate target, implicating SK1 in activation of the NF-kappa B pathway, but the functional consequences of this connection on gene expression are unknown. Here, we find that loss of SK1 potentiates induction of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted; also known as CCL5) in HeLa cells stimulated with TNF-alpha despite RANTES induction being highly dependent on the NF-kappa B pathway. Additionally, we find that SK1 is not required for TNF-induced IKK phosphorylation, I kappa B degradation, nuclear translocation of NF-kappa B subunits, and transcriptional NF-kappa B activity. In contrast, loss of SK1 prevented TNF-induced phosphorylation of p38 MAPK, and inhibition of p38 MAPK, like SK1 knockdown, also potentiates RANTES induction. Finally, in addition to RANTES, loss of SK1 also potentiated the induction of multiple chemokines and cytokines in the TNF response. Taken together, these data identify a potential and novel anti-inflammatory function of SK1 in which chemokine levels are suppressed through SK1-mediated activation of p38 MAPK. Furthermore, in this system, activation of NF-kappa B is dissociated from SK1, suggesting that the interaction between these pathways may be more complex than currently thought.	[Adada, Mohamad M.; Snider, Ashley J.; Hannun, Yusuf A.; Obeid, Lina M.; Clarke, Christopher J.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Orr-Gandy, K. Alexa] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29209 USA; [Snider, Ashley J.; Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY 11768 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Obeid, LM (corresponding author), SUNY Stony Brook, Dept Med, Hlth Sci Ctr, Stony Brook, NY 11794 USA.	lina.obeid@stonybrookmedicine.edu	Canals, Daniel/AAJ-8176-2021; Canals, Daniel/AAW-1998-2021	Canals, Daniel/0000-0002-9293-5123; obeid, lina/0000-0002-0734-0847; Adada, Mohamad/0000-0002-2988-2081	National Institutes of Health [PO1-CA97132, R01-GM062887]; MERIT Award from the Office of Research and Development, Department of Veterans Affairs, Northport Veterans Affairs Medical Center (Northport, NY) [BX000156]; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA087584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887, R01GM097741, T32GM008444] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MERIT Award from the Office of Research and Development, Department of Veterans Affairs, Northport Veterans Affairs Medical Center (Northport, NY); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants PO1-CA97132 (to L. M. O.) and R01-GM062887 (to L. M. O.). This work was also supported by MERIT Award BX000156 (to L. M. O.) from the Office of Research and Development, Department of Veterans Affairs, Northport Veterans Affairs Medical Center (Northport, NY).	Aarthi JJ, 2011, J DENT RES, V90, P841, DOI 10.1177/0022034510389178; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Ammit AJ, 2002, AM J RESP CELL MOL, V26, P465, DOI 10.1165/ajrcmb.26.4.4681; Anelli V, 2010, FASEB J, V24, P2727, DOI 10.1096/fj.09-150540; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Billie Au PY, 2007, ADV EXP MED BIOL, V597, P32; Boiardi L, 1999, CLIN EXP RHEUMATOL, V17, P419; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Casola A, 2002, AM J PHYSIOL-LUNG C, V283, pL1280, DOI 10.1152/ajplung.00162.2002; Charni F, 2009, BBA-GEN SUBJECTS, V1790, P1314, DOI 10.1016/j.bbagen.2009.07.015; Cheon S, 2008, BIOCHEM BIOPH RES CO, V374, P74, DOI 10.1016/j.bbrc.2008.06.091; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2011, BIOCHEM J, V435, P381, DOI 10.1042/BJ20101752; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Deutschman DH, 2003, AM HEART J, V146, P62, DOI 10.1016/S0002-8703(03)00118-2; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; French KJ, 2003, CANCER RES, V63, P5962; Ghadjar P, 2009, INT J CANCER, V125, P741, DOI 10.1002/ijc.24468; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Heffernan-Stroud LA, 2012, ONCOGENE, V31, P1166, DOI 10.1038/onc.2011.302; Herder C, 2008, EUR J ENDOCRINOL, V158, pR1, DOI 10.1530/EJE-07-0686; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Homma T, 2010, INT ARCH ALLERGY IMM, V152, P9, DOI 10.1159/000312120; Iwano S, 2011, J APPL TOXICOL, V31, P671, DOI 10.1002/jat.1622; Jenkins RW, 2011, J BIOL CHEM, V286, P13292, DOI 10.1074/jbc.M110.163378; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kilpatrick LE, 2006, J LEUKOCYTE BIOL, V80, P1512, DOI 10.1189/jlb.0406284; Kim MO, 2004, J NEUROCHEM, V90, P297, DOI 10.1111/j.1471-4159.2004.02487.x; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Kozawa O, 1999, J BONE MINER RES, V14, P1761, DOI 10.1359/jbmr.1999.14.10.1761; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016; Kumar D, 2009, J IMMUNOL, V182, P1011, DOI 10.4049/jimmunol.182.2.1011; Levy JA, 2009, J IMMUNOL, V182, P3945, DOI 10.4049/jimmunol.0990015; Liu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030873; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Matsuzaki S, 2010, J IMMUNOL, V185, P4863, DOI 10.4049/jimmunol.1000904; Maune S., 1996, Rhinology (Utrecht), V34, P210; McLoughlin RM, 2005, P NATL ACAD SCI USA, V102, P9589, DOI 10.1073/pnas.0501794102; Melchjorsen J, 2003, J GEN VIROL, V84, P2491, DOI 10.1099/vir.0.19159-0; Neubauer H. A., 2013, FEBS J IN PRESS; Nijnik A, 2012, J IMMUNOL, V189, P102, DOI 10.4049/jimmunol.1200282; Osawa Y, 2001, J IMMUNOL, V167, P173, DOI 10.4049/jimmunol.167.1.173; Park SW, 2012, J AM SOC NEPHROL, V23, P266, DOI 10.1681/ASN.2011050503; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Sawada M, 2004, CELL DEATH DIFFER, V11, P997, DOI 10.1038/sj.cdd.4401438; Schenten V, 2011, J LEUKOCYTE BIOL, V89, P587, DOI 10.1189/jlb.0510304; Selvam Shanmugam Panneer, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-7091-1511-4_1; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Verhelst K, 2011, CYTOKINE GROWTH F R, V22, P277, DOI 10.1016/j.cytogfr.2011.11.002; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Werts C, 2007, EUR J IMMUNOL, V37, P2499, DOI 10.1002/eji.200737069; Wong CK, 2006, ALLERGY, V61, P289, DOI 10.1111/j.1398-9995.2006.00972.x; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Yagasaki Y, 2004, FEBS LETT, V575, P136, DOI 10.1016/j.febslet.2004.08.050; Yung LM, 2012, STROKE, V43, P199, DOI 10.1161/STROKEAHA.111.626911; Zhou FH, 2006, J BONE MINER RES, V21, P1075, DOI 10.1359/JBMR.060410	70	28	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27667	27679		10.1074/jbc.M113.489443	http://dx.doi.org/10.1074/jbc.M113.489443			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23935096	Green Published, hybrid			2022-12-28	WOS:000330597300060
J	Zhang, WL; Zhao, JW; Lee, JF; Gartung, A; Jawadi, H; Lambiv, WL; Honn, KV; Lee, MJ				Zhang, Wenliang; Zhao, Jiawei; Lee, Jen-Fu; Gartung, Allison; Jawadi, Hiba; Lambiv, Wanyu Louis; Honn, Kenneth V.; Lee, Menq-Jer			ETS-1-mediated Transcriptional Up-regulation of CD44 Is Required for Sphingosine-1-phosphate Receptor Subtype 3-stimulated Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD44; Chemotaxis; Ets Family Transcription Factor; Jun N-terminal Kinase (JNK); Lipids; Receptors; Signal Transduction	PROTEIN-COUPLED RECEPTOR; ENDOTHELIAL-CELL MIGRATION; SPHINGOSINE 1-PHOSPHATE; PROSTATE-CANCER; LYSOPHOSPHATIDIC ACID; SIGNALING PATHWAYS; LYMPHOCYTE EGRESS; B-CELLS; PROLIFERATION; EXPRESSION	Sphingosine-1-phosphate (S1P)-regulated chemotaxis plays critical roles in various physiological and pathophysiological conditions. S1P-regulated chemotaxis is mediated by the S1P family of G-protein-coupled receptors. However, molecular details of the S1P-regulated chemotaxis are incompletely understood. Cultured human lung adenocarcinoma cell lines abundantly express S1P receptor subtype 3 (S1P(3)), thus providing a tractable in vitro system to characterize molecular mechanism(s) underlying the S1P(3) receptor-regulated chemotactic response. S1P treatment enhances CD44 expression and induces membrane localization of CD44 polypeptides via the S1P(3)/Rho kinase (ROCK) signaling pathway. Knockdown of CD44 completely diminishes the S1P-stimulated chemotaxis. Promoter analysis suggests that the CD44 promoter contains binding sites of the ETS-1 (v-ets erythroblastosis virus E26 oncogene homolog 1) transcriptional factor. ChIP assay confirms that S1P treatment stimulates the binding of ETS-1 to the CD44 promoter region. Moreover, S1P induces the expression and nuclear translocation of ETS-1. Knockdown of S1P(3) or inhibition of ROCK abrogates the S1P-induced ETS-1 expression. Furthermore, knockdown of ETS-1 inhibits the S1P-induced CD44 expression and cell migration. In addition, we showed that S1P(3)/ROCK signaling up-regulates ETS-1 via the activity of JNK. Collectively, we characterized a novel signaling axis, i.e., ROCK-JNK-ETS-1-CD44 pathway, which plays an essential role in the S1P(3)-regulated chemotactic response.	[Zhang, Wenliang; Zhao, Jiawei; Lee, Jen-Fu; Gartung, Allison; Lambiv, Wanyu Louis; Honn, Kenneth V.; Lee, Menq-Jer] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Zhang, Wenliang; Zhao, Jiawei; Lee, Jen-Fu; Gartung, Allison; Jawadi, Hiba; Lambiv, Wanyu Louis; Honn, Kenneth V.; Lee, Menq-Jer] Wayne State Univ, Sch Med, Bioact Lipid Res Program, Detroit, MI 48201 USA; [Honn, Kenneth V.; Lee, Menq-Jer] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA; [Lee, Menq-Jer] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University	Lee, MJ (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Bioact Lipid Res Program, 540 East Canfield Ave,Rm 9215, Detroit, MI 48201 USA.	menqjer.lee@wayne.edu	LEE, JEN-FU/GRO-3670-2022		National Institutes of Health [R01 HL 071071]; Michigan Diabetes Research and Training Center through National Institutes of Health [5P600-DK020572]; Department of Defense [W81XWH-11-1-0519, W81XWH-12-1-0036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Diabetes Research and Training Center through National Institutes of Health; Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL 071071 (to M.-J. L.). This work was also supported by a pilot and feasibility grant from the Michigan Diabetes Research and Training Center through National Institutes of Health Grant 5P600-DK020572 (to M.-J. L.), and Department of Defense Grant W81XWH-11-1-0519 (to K. V. H.).; Supported by Department of Defense Postdoctoral Fellowship W81XWH-12-1-0036.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; An SZ, 1998, J CELL BIOCHEM, P147; An SZ, 2000, J BIOL CHEM, V275, P288, DOI 10.1074/jbc.275.1.288; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Berger A, 1996, MOL PHARMACOL, V50, P451; Blom T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-45; BORNFELDT KE, 1995, J CELL BIOL, V130, P193, DOI 10.1083/jcb.130.1.193; Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Brizuela L, 2007, J LIPID RES, V48, P2264, DOI 10.1194/jlr.M700291-JLR200; Chen ZQ, 1997, CANCER RES, V57, P2013; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Donovan EE, 2010, EUR J IMMUNOL, V40, P688, DOI 10.1002/eji.200939858; Estrada R, 2008, J BIOL CHEM, V283, P30363, DOI 10.1074/jbc.M804392200; Gallatin WM, 2006, J IMMUNOL, V177, P5; Garcia-Bernal D, 2013, J PATHOL, V229, P36, DOI 10.1002/path.4066; Goetzl EJ, 1999, J IMMUNOL, V162, P2049; GOODEMOTE KA, 1995, J BIOL CHEM, V270, P10272, DOI 10.1074/jbc.270.17.10272; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Guo YD, 2011, J BIOL CHEM, V286, P33832, DOI 10.1074/jbc.M110.216564; Hahne JC, 2005, ONCOGENE, V24, P5384, DOI 10.1038/sj.onc.1208761; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Han M, 2012, PLOS ONE, V7; Heringdorf DMZ, 2003, FEBS LETT, V554, P443, DOI 10.1016/S0014-5793(03)01219-5; Higuchi T, 2007, MOL CELL BIOL, V27, P3353, DOI 10.1128/MCB.01871-06; Hsu A, 2012, INT J ONCOL, V40, P1619, DOI 10.3892/ijo.2012.1379; Huang S, 2012, ONCOL REP, V28, P1831, DOI 10.3892/or.2012.2015; IDA K, 1995, INT J CANCER, V63, P500, DOI 10.1002/ijc.2910630407; Ilangumaran S, 1999, LEUKEMIA LYMPHOMA, V35, P455, DOI 10.1080/10428199909169610; Ivanova MM, 2009, MOL CELL ENDOCRINOL, V305, P12, DOI 10.1016/j.mce.2009.01.021; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kim ES, 2011, J CELL SCI, V124, P2220, DOI 10.1242/jcs.076794; Kimura T, 2003, ARTERIOSCL THROM VAS, V23, P1283, DOI 10.1161/01.ATV.0000079011.67194.5A; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kluk MJ, 2001, CIRC RES, V89, P496, DOI 10.1161/hh1801.096338; Krishnamachary B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044078; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; Lee JF, 2006, HISTOCHEM CELL BIOL, V126, P297, DOI 10.1007/s00418-006-0143-z; Lee JF, 2009, AM J PHYSIOL-HEART C, V296, pH33, DOI 10.1152/ajpheart.00097.2008; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Lefter LP, 2009, CANCER GENE THER, V16, P137, DOI 10.1038/cgt.2008.65; Li CY, 2009, AM J PATHOL, V175, P1464, DOI 10.2353/ajpath.2009.090037; Li YS, 2004, EXP CELL RES, V298, P107, DOI 10.1016/j.yexcr.2004.03.023; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Lou W, 1999, CANCER RES, V59, P2329; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Martens JHA, 2011, INT J BIOCHEM CELL B, V43, P1413, DOI 10.1016/j.biocel.2011.05.014; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Meriane M, 2006, STEM CELLS, V24, P2557, DOI 10.1634/stemcells.2006-0209; Morales-Ruiz M, 2001, J BIOL CHEM, V276, P19672, DOI 10.1074/jbc.M009993200; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Okuducu AF, 2006, HISTOPATHOLOGY, V48, P836, DOI 10.1111/j.1365-2559.2006.02432.x; Ongusaha PP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161938; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Park YH, 2008, BIOCHEM BIOPH RES CO, V377, P389, DOI 10.1016/j.bbrc.2008.09.135; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Rothhammer T, 2004, CELL MOL LIFE SCI, V61, P118, DOI 10.1007/s00018-003-3337-8; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; SADAHIRA Y, 1992, P NATL ACAD SCI USA, V89, P9686, DOI 10.1073/pnas.89.20.9686; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sekine Y, 2011, PROSTATE, V71, P690, DOI 10.1002/pros.21285; Shaikhibrahim Z, 2012, INT J ONCOL, V40, P1748, DOI 10.3892/ijo.2012.1380; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Skoura A, 2011, ARTERIOSCL THROM VAS, V31, P81, DOI 10.1161/ATVBAHA.110.213496; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; THOMAS L, 1992, J CELL BIOL, V118, P971, DOI 10.1083/jcb.118.4.971; Trochon V, 1996, INT J CANCER, V66, P664, DOI 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4; Tsai NP, 2010, CELL SIGNAL, V22, P668, DOI 10.1016/j.cellsig.2009.12.001; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Wang L, 2008, HISTOCHEM CELL BIOL, V129, P579, DOI 10.1007/s00418-008-0389-8; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wittig BM, 2000, J EXP MED, V191, P2053, DOI 10.1084/jem.191.12.2053; Young N, 2009, MOL CANCER RES, V7, P23, DOI 10.1158/1541-7786.MCR-08-0061; Zhang M, 2011, PLOS ONE, V6; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200; Zhu D, 2000, J CELL PHYSIOL, V183, P182, DOI 10.1002/(SICI)1097-4652(200005)183:2<182::AID-JCP5>3.0.CO;2-O; Zondag GCM, 1998, BIOCHEM J, V330, P605, DOI 10.1042/bj3300605	90	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32126	32137		10.1074/jbc.M113.495218	http://dx.doi.org/10.1074/jbc.M113.495218			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24064218	Green Published, hybrid			2022-12-28	WOS:000328681700003
J	Gomez-Herreros, F; Rodriguez-Galan, O; Morillo-Huesca, M; Maya, D; Arista-Romero, M; de la Cruz, J; Chavez, S; Munoz-Centeno, MC				Gomez-Herreros, Fernando; Rodriguez-Galan, Olga; Morillo-Huesca, Macarena; Maya, Douglas; Arista-Romero, Maria; de la Cruz, Jesus; Chavez, Sebastian; Cruz Munoz-Centeno, Mari			Balanced Production of Ribosome Components Is Required for Proper G(1)/S Transition in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT CELL-LINES; P-GLYCOPROTEIN-EGFP; HUMAN CANCER-CELLS; MULTIDRUG-RESISTANCE; SUBCELLULAR-LOCALIZATION; LYSOSOMOTROPIC AGENTS; ANTITUMOR-ACTIVITY; DRUG-RESISTANCE; IRON CHELATORS; TUMOR-CELLS	Cell cycle regulation is a very accurate process that ensures cell viability and the genomic integrity of daughter cells. A fundamental part of this regulation consists in the arrest of the cycle at particular points to ensure the completion of a previous event, to repair cellular damage, or to avoid progression in potentially risky situations. In this work, we demonstrate that a reduction in nucleotide levels or the depletion of RNA polymerase I or III subunits generates a cell cycle delay at the G(1)/S transition in Saccharomyces cerevisiae. This delay is concomitant with an imbalance between ribosomal RNAs and proteins which, among others, provokes an accumulation of free ribosomal protein L5. Consistently with a direct impact of free L5 on the G(1)/S transition, rrs1 mutants, which weaken the assembly of L5 and L11 on pre-60S ribosomal particles, enhance both the G(1)/S delay and the accumulation of free ribosomal protein L5. We propose the existence of a surveillance mechanism that couples the balanced production of yeast ribosomal components and cell cycle progression through the accumulation of free ribosomal proteins. This regulatory pathway resembles the p53-dependent nucleolar-stress checkpoint response described in human cells, which indicates that this is a general control strategy extended throughout eukaryotes.	Univ Seville, Dept Genet, E-41012 Seville, Spain; Univ Seville, CSIC, Inst Biomed Sevilla, Hosp Univ Virgen del Rocio, Seville 41012, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Munoz-Centeno, MC (corresponding author), Fac Biol, Dept Genet, Avda Reina Mercedes 6, Seville 41012, Spain.	mcmunoz@us.es	Morillo-Huesca, Macarena/H-5144-2015; de la Cruz Muñoz-Centeno, Maria/F-7539-2016; Chavez, Sebastian S/F-7574-2011; Herreros, Fernando Gomez/F-2674-2016; Chávez, Sebastián/GXF-7069-2022; Rodríguez-Galán, Olga/K-5580-2015; IBIS, GENICA/O-1906-2015; DE LA CRUZ, JESUS/A-7309-2013	Morillo-Huesca, Macarena/0000-0002-2914-4871; Chavez, Sebastian S/0000-0002-8064-4839; Herreros, Fernando Gomez/0000-0002-5693-3489; Rodríguez-Galán, Olga/0000-0002-3137-8554; DE LA CRUZ, JESUS/0000-0001-5870-659X; Munoz Centeno, Maria de la Cruz/0000-0002-9973-8931; Maya Miles, Douglas/0000-0002-0669-6526; Arista-Romero, Maria/0000-0002-1992-070X	Spanish Ministry of Economy and Competitiveness; European Regional Development Fund (ERDF) Grants [BFU2007-67575-C03-02, BFU2010-21975-C03-03, BFU2010-15690]; Andalusian Government [P07-CVI-02623, P08-CVI-03508, BIO-271]; Andalusian Government; Formacion de Personal Investigador (FPI) fellowship	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (ERDF) Grants; Andalusian Government; Andalusian Government; Formacion de Personal Investigador (FPI) fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Spanish Ministry of Economy and Competitiveness and European Regional Development Fund (ERDF) Grants BFU2007-67575-C03-02 and BFU2010-21975-C03-03 (to S. C.) and BFU2010-15690 (to J. d. l. C.) and the Andalusian Government Grants P07-CVI-02623 and P08-CVI-03508, and BIO-271.; Recipient of a Formacion de Personal Investigador (FPI) fellowship. Present address: Centro Andaluz de Biolog a Molecular y Medicina Regenerativa, CABIMER, Avda. Americo Vespucio s/n, Parque Cientifico y Tecnologico Cartuja 41092 Sevilla, Spain.; Recipient of a fellowship from the Andalusian Government. Present address: Centre de Recherche en Cancerologie de Marseille (CRCM), INSERM UMR 1068, CNRS UMR 7258, Marseille, France.	Abulrob ANG, 2000, J DRUG TARGET, V8, P247, DOI 10.3109/10611860008997903; Akhtar N, 2011, EXPERT OPIN THER PAT, V21, P561, DOI 10.1517/13543776.2011.561784; Altan N, 1998, J EXP MED, V187, P1583, DOI 10.1084/jem.187.10.1583; ANTOINE JC, 1985, BIOL CELL, V55, P41, DOI 10.1111/j.1768-322X.1985.tb00408.x; BALDINI N, 1995, EUR J CELL BIOL, V68, P226; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Barranco WT, 2006, BRIT J CANCER, V94, P884, DOI 10.1038/sj.bjc.6603009; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BRAUN M, 1989, EMBO J, V8, P3633, DOI 10.1002/j.1460-2075.1989.tb08537.x; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Fu D, 2004, INT J CANCER, V109, P174, DOI 10.1002/ijc.11659; Fu D, 2007, AM J PHYSIOL-CELL PH, V292, pC1543, DOI 10.1152/ajpcell.00068.2006; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Ivanova S, 2008, METHOD ENZYMOL, V442, P183, DOI 10.1016/S0076-6879(08)01409-2; JAFFREZOU JP, 1992, CANCER RES, V52, P6440; Kannan P, 2011, P NATL ACAD SCI USA, V108, P2593, DOI 10.1073/pnas.1014641108; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Mahoney BP, 2003, BIOCHEM PHARMACOL, V66, P1207, DOI 10.1016/S0006-2952(03)00467-2; Maraldi NM, 1999, BIOL CELL, V91, P17, DOI 10.1016/S0248-4900(99)80027-6; Molad Yair, 2002, Curr Rheumatol Rep, V4, P252, DOI 10.1007/s11926-002-0073-2; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Munteanu E, 2006, BIOCHEM PHARMACOL, V71, P1162, DOI 10.1016/j.bcp.2006.01.006; Paterson JK, 2007, EXP CELL RES, V313, P3100, DOI 10.1016/j.yexcr.2007.04.019; Pezzini F, 2011, BIOCHEM BIOPH RES CO, V416, P159, DOI 10.1016/j.bbrc.2011.11.016; Raghunand N, 2000, DRUG RESIST UPDATE, V3, P39, DOI 10.1054/drup.2000.0119; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Saparov SM, 2006, BIOPHYS J, V90, pL86, DOI 10.1529/biophysj.106.084343; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Seelig A, 2007, J MOL NEUROSCI, V33, P32, DOI 10.1007/s12031-007-0055-y; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; Shen F, 2008, J PHARMACOL EXP THER, V324, P95, DOI 10.1124/jpet.107.127704; SHIRAISHI N, 1986, CANCER LETT, V30, P251, DOI 10.1016/0304-3835(86)90049-2; Solazzo M, 2006, EXP CELL RES, V312, P4070, DOI 10.1016/j.yexcr.2006.09.005; Solazzo M, 2009, CANCER RES, V69, P7235, DOI 10.1158/0008-5472.CAN-08-4315; Stordal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040717; Straubinger RM, 1995, TAXOL SCI APPL, P237; STYRT B, 1986, BLOOD, V67, P334; Taatjes DJ, 2001, CURR MED CHEM, V8, P15, DOI 10.2174/0929867013374029; VANROSMALEN A, 1995, NUCLEIC ACIDS RES, V23, P42, DOI 10.1093/nar/23.1.42; Wang YH, 2005, J CHEM INF MODEL, V45, P750, DOI 10.1021/ci050041k; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868	45	32	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31689	31771		10.1074/jbc.M113.500488	http://dx.doi.org/10.1074/jbc.M113.500488			89	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043628	Green Published, hybrid			2022-12-28	WOS:000330596200027
J	Hall, BE; Wankhade, UD; Konkel, JE; Cherukuri, K; Nagineni, CN; Flanders, KC; Arany, PR; Chen, WJ; Rane, SG; Kulkarni, AB				Hall, Bradford E.; Wankhade, Umesh D.; Konkel, Joanne E.; Cherukuri, Karthik; Nagineni, Chandrasekharam N.; Flanders, Kathleen C.; Arany, Praveen R.; Chen, Wanjun; Rane, Sushil G.; Kulkarni, Ashok B.			Transforming Growth Factor-beta 3 (TGF-beta 3) Knock-in Ameliorates Inflammation Due to TGF-beta 1 Deficiency While Promoting Glucose Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BETA; TARGETED DISRUPTION; EXPRESSION PATTERNS; CRYSTAL-STRUCTURE; CLEFT-PALATE; MICE LACKING; GROWTH-FACTOR-BETA-1; ACTIVATION; CELLS; TRANSFORMING-GROWTH-FACTOR-BETA-3	Three homologues of TGF-beta exist in mammals as follows: TGF-beta 1, TGF-beta 2, and TGF-beta 3. All three proteins share high homology in their amino acid sequence, yet each TGF-beta isoform has unique heterologous motifs that are highly conserved during evolution. Although these TGF-beta proteins share similar properties in vitro, isoform-specific properties have been suggested through in vivo studies and by the unique phenotypes for each TGF-beta knock-out mouse. To test our hypothesis that each of these homologues has nonredundant functions, and to identify such isoform-specific roles, we genetically exchanged the coding sequence of the mature TGF-beta 1 ligand with a sequence from TGF-beta 3 using targeted recombination to create chimeric TGF-beta 1/3 knock-in mice (TGF-beta 1(L beta 3/L beta 3)). In the TGF-beta 1(L beta 3/L beta 3) mouse, localization and activation still occur through the TGF-beta 1 latent associated peptide, but cell signaling is triggered through the TGF-beta 3 ligand that binds to TGF-beta receptors. Unlike TGF-beta 1(-/-) mice, the TGF-beta 1(L beta 3/L beta 3) mice show neither embryonic lethality nor signs of multifocal inflammation, demonstrating that knock-in of the TGF-beta 3 ligand can prevent the vasculogenesis defects and autoimmunity associated with TGF-beta 1 deficiency. However, the TGF-beta 1(L beta 3/L beta 3) mice have a shortened life span and display tooth and bone defects, indicating that the TGF-beta homologues are not completely interchangeable. Remarkably, the TGF-beta 1(L beta 3/L beta 3) mice display an improved metabolic phenotype with reduced body weight gain and enhanced glucose tolerance by induction of beneficial changes to the white adipose tissue compartment. These findings reveal both redundant and unique nonoverlapping functional diversity in TGF-beta isoform signaling that has relevance to the design of therapeutics aimed at targeting the TGF-beta pathway in human disease.	[Hall, Bradford E.; Cherukuri, Karthik; Kulkarni, Ashok B.] NIDCR, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Konkel, Joanne E.; Chen, Wanjun] NIDCR, Mucosal Immunol Sect, NIH, Bethesda, MD 20892 USA; [Arany, Praveen R.] NIDCR, Cell Regulat & Control Unit, NIH, Bethesda, MD 20892 USA; [Wankhade, Umesh D.; Rane, Sushil G.] NIDDK, Cell Growth & Metab Sect, NIH, Bethesda, MD 20892 USA; [Nagineni, Chandrasekharam N.] NEI, NIH, Bethesda, MD 20892 USA; [Flanders, Kathleen C.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kulkarni, AB (corresponding author), NIDCR, Funct Genom Sect, Lab Cell & Dev Biol, NIH, 30 Convent Dr,Bldg 30,Rm 130, Bethesda, MD 20892 USA.	ak40m@nih.gov	Arany, Praveen/S-5329-2019; Wankhade, Umesh/J-8739-2015	Arany, Praveen/0000-0002-6116-2340; Wankhade, Umesh/0000-0003-4810-221X	National Institutes of Health [ZO1 DE000698-13]; Divisions of Intramural Research, NIDCR; Divisions of Intramural Research, NCI; Divisions of Intramural Research, NIDDK; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000741, ZIADE000101, ZIADE000664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Divisions of Intramural Research, NIDCR; Divisions of Intramural Research, NCI; Divisions of Intramural Research, NIDDK; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant ZO1 DE000698-13 and grants from Divisions of Intramural Research, NIDCR, NCI, and NIDDK.	Ask K, 2008, INT J BIOCHEM CELL B, V40, P484, DOI 10.1016/j.biocel.2007.08.016; Bandyopadhyay B, 2006, J CELL BIOL, V172, P1093, DOI 10.1083/jcb.200507111; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; Bottinger EP, 1996, P NATL ACAD SCI USA, V93, P5877, DOI 10.1073/pnas.93.12.5877; BRUNET CL, 1995, INT J DEV BIOL, V39, P345; ChimalMonroy J, 1997, INT J DEV BIOL, V41, P91; D'Souza RN, 1998, EUR J ORAL SCI, V106, P185, DOI 10.1111/j.1600-0722.1998.tb02174.x; Datto MB, 1999, MOL CELL BIOL, V19, P2495; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Doetschman T, 2012, GENESIS, V50, P59, DOI 10.1002/dvg.20789; Emanuelli M, 2008, GYNECOL OBSTET INVES, V65, P1, DOI 10.1159/000106497; Figueroa JD, 2010, BREAST CANCER RES TR, V121, P727, DOI 10.1007/s10549-009-0590-z; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; GEISER AG, 1991, MOL CELL BIOL, V11, P84, DOI 10.1128/MCB.11.1.84; GRAYCAR JL, 1989, MOL ENDOCRINOL, V3, P1977, DOI 10.1210/mend-3-12-1977; Hao JH, 2008, EXPERT OPIN BIOL TH, V8, P1485, DOI [10.1517/14712598.8.10.1485, 10.1517/14712598.8.10.1485 ]; Hart PJ, 2002, NAT STRUCT BIOL, V9, P203, DOI 10.1038/nsb766; Hu BC, 2010, CLIN CHIM ACTA, V411, P558, DOI 10.1016/j.cca.2010.01.014; Jakowlew SB, 1998, EXP LUNG RES, V24, P579, DOI 10.3109/01902149809087387; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kruit A, 2006, CHEST, V129, P1584, DOI 10.1378/chest.129.6.1584; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Laverty HG, 2009, CYTOKINE GROWTH F R, V20, P305, DOI 10.1016/j.cytogfr.2009.07.002; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Li J, 1999, J BIOL CHEM, V274, P4213, DOI 10.1074/jbc.274.7.4213; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; MASSAGUE J, 1987, CELL, V49, P437, DOI 10.1016/0092-8674(87)90443-0; MILLAN FA, 1991, DEVELOPMENT, V111, P131; MILLER DA, 1989, MOL ENDOCRINOL, V3, P1926, DOI 10.1210/mend-3-12-1926; Mittl PRE, 1996, PROTEIN SCI, V5, P1261, DOI 10.1002/pro.5560050705; Moioli EK, 2007, WOUND REPAIR REGEN, V15, P413, DOI 10.1111/j.1524-475X.2007.00244.x; Mu ZY, 2008, MECH DEVELOP, V125, P508, DOI 10.1016/j.mod.2008.01.003; Olsson N, 2000, J LEUKOCYTE BIOL, V67, P350, DOI 10.1002/jlb.67.3.350; Pellaud J, 1999, J BIOL CHEM, V274, P7699, DOI 10.1074/jbc.274.12.7699; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Roberts A. B., 1991, PEPTIDE GROWTH FACTO; ROBERTS AB, 1992, MOL REPROD DEV, V32, P91, DOI 10.1002/mrd.1080320203; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; SHAH M, 1995, J CELL SCI, V108, P985; Shah S, 2008, EUR J IMMUNOL, V38, P2488, DOI 10.1002/eji.200838201; Shaikh S, 2012, MED ORAL PATOL ORAL, V17, pE197, DOI 10.4317/medoral.17453; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; SPORN MB, 1987, J CELL BIOL, V105, P1039, DOI 10.1083/jcb.105.3.1039; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; TENDIJKE P, 1988, P NATL ACAD SCI USA, V85, P4715; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Vitsky A, 2009, AM J PATHOL, V174, P2137, DOI 10.2353/ajpath.2009.080723; WAKEFIELD LM, 1995, CLIN CANCER RES, V1, P129; Wolfraim LA, 2002, J IMMUNOL METHODS, V266, P7, DOI 10.1016/S0022-1759(02)00090-X; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yang LT, 2007, DEV BIOL, V312, P384, DOI 10.1016/j.ydbio.2007.09.034; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044	66	25	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					32074	32092		10.1074/jbc.M113.480764	http://dx.doi.org/10.1074/jbc.M113.480764			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24056369	Green Published, hybrid			2022-12-28	WOS:000330596200058
J	Hedrich, CM; Rauen, T; Crispin, JC; Koga, T; Ioannidis, C; Zajdel, M; Kyttaris, VC; Tsokos, GC				Hedrich, Christian M.; Rauen, Thomas; Crispin, Jose C.; Koga, Tomohiro; Ioannidis, Christina; Zajdel, Melissa; Kyttaris, Vasileios C.; Tsokos, George C.			cAMP-responsive Element Modulator alpha (CREM alpha) trans-Represses the Transmembrane Glycoprotein CD8 and Contributes to the Generation of CD3(+)CD4(-)CD8(-) T Cells in Health and Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; IL-2 PRODUCTION; THYMIC DIFFERENTIATION; LINEAGE COMMITMENT; GENE-EXPRESSION; MICE; LYMPHOCYTES; CD8-ALPHA; STAGE	T cell receptor-alpha beta(+) CD3(+)CD4(-)CD8(-) "double-negative" T cells are expanded in the peripheral blood of patients with systemic lupus erythematosus and autoimmune lymphoproliferative syndrome. In both disorders, double-negative T cells infiltrate tissues, induce immunoglobulin production, and secrete proinflammatory cytokines. Double-negative T cells derive from CD8(+) T cells through down-regulation of CD8 surface co-receptors. However, the molecular mechanisms orchestrating this process remain unclear. Here, we demonstrate that the transcription factor cAMP-responsive element modulator alpha (CREM alpha), which is expressed at increased levels in T cells from systemic lupus erythematosus patients, contributes to transcriptional silencing of CD8A and CD8B. We provide the first evidence that CREM alpha trans-represses a regulatory element 5' of the CD8B gene. Therefore, CREM alpha represents a promising candidate in the search for biomarkers and treatment options in diseases in which double-negative T cells contribute to the pathogenesis.	[Hedrich, Christian M.; Rauen, Thomas; Crispin, Jose C.; Koga, Tomohiro; Ioannidis, Christina; Zajdel, Melissa; Kyttaris, Vasileios C.; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, Boston, MA 02115 USA; [Hedrich, Christian M.] Univ Childrens Hosp Dresden, Dept Pediat Rheumatol & Immunol, D-01307 Dresden, Germany; [Rauen, Thomas] Rhein Westfal TH Aachen, Dept Nephrol & Clin Immunol, D-52062 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Technische Universitat Dresden; RWTH Aachen University	Tsokos, GC (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Rheumatol, Boston, MA 02115 USA.	gtsokos@bidmc.harvard.edu	Rauen, Thomas/GLR-8682-2022; Hedrich, Christian/AAD-6855-2019; Hedrich, Christian/AAW-3958-2020; Crispín, José/I-4919-2019; tsokos, george C/O-3360-2013; Koga, Tomohiro/V-9397-2019; Koga, Tomohiro/AAU-9697-2020	Crispín, José/0000-0002-7590-3621; tsokos, george C/0000-0001-9589-2360; Hedrich, Christian/0000-0002-1295-6179; Koga, Tomohiro/0000-0003-2077-4428	National Institutes of Health [R01 AI42269, R01 AI49954, R01 AI85567]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI049954, R01AI042269, R01AI049954, R01AI085567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI42269, R01 AI49954, and R01 AI85567 (to G. C. T.).	Anand A, 2002, LUPUS, V11, P493, DOI 10.1191/0961203302lu235oa; BENDER A, 1990, CELL IMMUNOL, V128, P542, DOI 10.1016/0008-8749(90)90047-U; Bristeau-Leprince A, 2008, J IMMUNOL, V181, P440, DOI 10.4049/jimmunol.181.1.440; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Crispin JC, 2009, J IMMUNOL, V183, P4675, DOI 10.4049/jimmunol.0901533; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Feik N, 2005, J IMMUNOL, V174, P1513, DOI 10.4049/jimmunol.174.3.1513; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Garefalaki A, 2002, IMMUNITY, V16, P635, DOI 10.1016/S1074-7613(02)00308-4; Gonzalez-Quintial R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027528; GORMAN SD, 1988, J IMMUNOL, V140, P3646; Hamad ARA, 2003, J IMMUNOL, V171, P2421, DOI 10.4049/jimmunol.171.5.2421; Hedrich CM, 2012, P NATL ACAD SCI USA, V109, P16606, DOI 10.1073/pnas.1210129109; Hedrich CM, 2012, J BIOL CHEM, V287, P4715, DOI 10.1074/jbc.M111.323261; Hedrich CM, 2011, J BIOL CHEM, V286, P43429, DOI 10.1074/jbc.M111.299339; Holzelova E, 2004, NEW ENGL J MED, V351, P1409, DOI 10.1056/NEJMoa040036; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Hostert A, 1997, J IMMUNOL, V158, P4270; JARRY A, 1990, EUR J IMMUNOL, V20, P1097, DOI 10.1002/eji.1830200523; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Kappes DJ, 2005, NAT IMMUNOL, V6, P761, DOI 10.1038/ni1230; Kawachi Y, 1996, IMMUNOGENETICS, V44, P358, DOI 10.1007/BF02602780; Kieffer LJ, 1996, INT IMMUNOL, V8, P1617, DOI 10.1093/intimm/8.10.1617; Kieffer LJ, 1997, J IMMUNOL, V159, P4907; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; LEFRANCOIS L, 1991, J IMMUNOL, V147, P1746; Notarangelo Luigi D, 2009, Hematology Am Soc Hematol Educ Program, P139, DOI 10.1182/asheducation-2009.1.139; Oliveira JB, 2010, BLOOD, V116, pE35, DOI 10.1182/blood-2010-04-280347; Rauen T, 2013, TRENDS MOL MED, V19, P262, DOI 10.1016/j.molmed.2013.02.001; Rauen T, 2011, J BIOL CHEM, V286, P43437, DOI 10.1074/jbc.M111.299313; SHIVAKUMAR S, 1989, J IMMUNOL, V143, P103; Sneller MC, 2003, CURR OPIN RHEUMATOL, V15, P417, DOI 10.1097/00002281-200307000-00008; Solomou EE, 2001, J IMMUNOL, V166, P4216, DOI 10.4049/jimmunol.166.6.4216; Teachey DT, 2010, BRIT J HAEMATOL, V148, P205, DOI 10.1111/j.1365-2141.2009.07991.x; Treiner E, 2006, CURR OPIN IMMUNOL, V18, P519, DOI 10.1016/j.coi.2006.07.001; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Zhang XL, 1998, J IMMUNOL, V161, P2254; Zhang XL, 2001, J EXP MED, V194, P685, DOI 10.1084/jem.194.5.685; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513	44	44	45	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31880	31887		10.1074/jbc.M113.508655	http://dx.doi.org/10.1074/jbc.M113.508655			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047902	Green Published, hybrid			2022-12-28	WOS:000330596200037
J	Tanida, S; Akita, K; Ishida, A; Mori, Y; Toda, M; Inoue, M; Ohta, M; Yashiro, M; Sawada, T; Hirakawa, K; Nakada, H				Tanida, Shuhei; Akita, Kaoru; Ishida, Akiko; Mori, Yugo; Toda, Munetoyo; Inoue, Mizue; Ohta, Mariko; Yashiro, Masakazu; Sawada, Tetsuji; Hirakawa, Kosei; Nakada, Hiroshi			Binding of the Sialic Acid-binding Lectin, Siglec-9, to the Membrane Mucin, MUC1, Induces Recruitment of beta-Catenin and Subsequent Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA-ASSOCIATED ANTIGEN; INTERCELLULAR-ADHESION MOLECULE-1; TUMOR-PRODUCED MUCINS; BREAST-CARCINOMA; FACTOR RECEPTOR; C-SRC; TYROSINE KINASE; CANCER; LIGATION; PHOSPHORYLATION	Because MUC1 carries a variety of sialoglycans that are possibly recognized by the siglec family, we examined MUC1-binding siglecs and found that Siglec-9 prominently bound to MUC1. An immunochemical study showed that Siglec-9-positive immune cells were associated with MUC1-positive cells in human colon, pancreas, and breast tumor tissues. We investigated whether or not this interaction has any functional implications for MUC1-expressing cells. When mouse 3T3 fibroblast cells and a human colon cancer cell line, HCT116, stably transfected with MUC1cDNA were ligated with recombinant soluble Siglec-9, beta-catenin was recruited to the MUC1 C-terminal domain, which was enhanced on stimulation with soluble Siglec-9 in dose-and time-dependent manners. A co-culture model of MUC1-expressing cells and Siglec-9-expressing cells mimicking the interaction between MUC1-expressing malignant cells, and Siglec-9-expressing immune cells in a tumor microenvironment was designed. Brief co-incubation of Siglec-9-expressing HEK293 cells, but not mock HEK293 cells, with MUC1-expressing cells similarly enhanced the recruitment of beta-catenin to the MUC1 C-terminal domain. In addition, treatment of MUC1-expressing cells with neuraminidase almost completely abolished the effect of Siglec-9 on MUC1-mediated signaling. The recruited beta-catenin was thereafter transported to the nucleus, leading to cell growth. These findings suggest that Siglec-9 expressed on immune cells may play a role as a potential counterreceptor for MUC1 and that this signaling may be another MUC1-mediated pathway and function in parallel with a growth factor-dependent pathway.	[Tanida, Shuhei; Akita, Kaoru; Ishida, Akiko; Mori, Yugo; Toda, Munetoyo; Inoue, Mizue; Ohta, Mariko; Nakada, Hiroshi] Kyoto Sangyo Univ, Dept Mol Biosci, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Yashiro, Masakazu; Sawada, Tetsuji; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 5458585, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Oncol Inst Geriatr & Med Sci, Osaka 5458585, Japan	Kyoto Sangyo University; Osaka Metropolitan University; Osaka Metropolitan University	Nakada, H (corresponding author), Kyoto Sangyo Univ, Dept Mol Biosci, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan.	hnakada@cc.kyoto-su.ac.jp						Al Masri A, 2005, ONCOGENE, V24, P5799, DOI 10.1038/sj.onc.1208738; Angata T, 2000, J BIOL CHEM, V275, P22127, DOI 10.1074/jbc.M002775200; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; Brabletz T, 2002, VIRCHOWS ARCH, V441, P1, DOI 10.1007/s00428-002-0642-9; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Halwani R, 2004, J VIROL, V78, P7553, DOI 10.1128/JVI.78.14.7553-7564.2004; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; KLUG TL, 1988, CANCER RES, V48, P1505; LAN MS, 1990, J BIOL CHEM, V265, P15294; Li Y, 2003, CANCER BIOL THER, V2, P187, DOI 10.4161/cbt.2.2.282; Li YQ, 1998, MOL CELL BIOL, V18, P7216, DOI 10.1128/MCB.18.12.7216; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lock K, 2004, IMMUNOBIOLOGY, V209, P199, DOI 10.1016/j.imbio.2004.04.007; Mukherjee P, 2005, J LEUKOCYTE BIOL, V77, P90, DOI 10.1189/jlb.0604333; Nath D, 1999, IMMUNOLOGY, V98, P213; Ohta M, 2010, BIOCHEM BIOPH RES CO, V402, P663, DOI 10.1016/j.bbrc.2010.10.079; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; OSULLIVAN C, 1994, J PATHOL, V172, P229, DOI 10.1002/path.1711720302; Parry S, 2001, BIOCHEM BIOPH RES CO, V283, P715, DOI 10.1006/bbrc.2001.4775; Pochampalli MR, 2007, ONCOGENE, V26, P1693, DOI 10.1038/sj.onc.1209976; Rahn JJ, 2004, J BIOL CHEM, V279, P29386, DOI 10.1074/jbc.C400010200; Ren J, 2002, J BIOL CHEM, V277, P17616, DOI 10.1074/jbc.M200436200; Ren J, 2006, MOL CANCER RES, V4, P873, DOI 10.1158/1541-7786.MCR-06-0204; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Shen Q, 2008, MOL CANCER RES, V6, P555, DOI 10.1158/1541-7786.MCR-07-2033; SIDDIQUI J, 1988, P NATL ACAD SCI USA, V85, P2320, DOI 10.1073/pnas.85.7.2320; Toda M, 2009, BIOCHEM J, V417, P673, DOI 10.1042/BJ20081241; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; Workman HC, 2009, CANCER RES, V69, P2845, DOI 10.1158/0008-5472.CAN-08-2089; Yamamoto M, 1997, J BIOL CHEM, V272, P12492, DOI 10.1074/jbc.272.19.12492; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154	38	53	54	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31842	31852		10.1074/jbc.M113.471318	http://dx.doi.org/10.1074/jbc.M113.471318			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045940	hybrid, Green Published			2022-12-28	WOS:000330596200034
J	Rosenhouse-Dantsker, A; Noskov, S; Durdagi, S; Logothetis, DE; Levitan, I				Rosenhouse-Dantsker, Avia; Noskov, Sergei; Durdagi, Serdar; Logothetis, Diomedes E.; Levitan, Irena			Identification of Novel Cholesterol-binding Regions in Kir2 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; ACETYLCHOLINE-RECEPTOR; FORCE-FIELD; FREE-ENERGY; MOLECULAR-DYNAMICS; MEMBRANE-PROTEINS; ION CHANNELS; K+ CHANNEL; SENSITIVITY; MODULATION	Inwardly rectifying potassium (Kir) channels play an important role in setting the resting membrane potential and modulating membrane excitability. We have recently shown that cholesterol regulates representative members of the Kir family and that in the majority of the cases, cholesterol suppresses channel function. Furthermore, recent data indicate that cholesterol regulates Kir channels by specific sterol-protein interactions, yet the location of the cholesterol binding site in Kir channels is unknown. Using a combined computational-experimental approach, we show that cholesterol may bind to two nonanular hydrophobic regions in the transmembrane domain of Kir2.1 located between adjacent subunits of the channel. The location of the binding regions suggests that cholesterol modulates channel function by affecting the hinging motion at the center of the pore-lining transmembrane helix that underlies channel gating either directly or through the interface between the N and C termini of the channel.	[Rosenhouse-Dantsker, Avia; Levitan, Irena] Univ Illinois, Dept Med, Pulm Sect, Chicago, IL 60612 USA; [Noskov, Sergei; Durdagi, Serdar] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada; [Noskov, Sergei; Durdagi, Serdar] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Logothetis, Diomedes E.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Calgary; University of Calgary; Virginia Commonwealth University	Rosenhouse-Dantsker, A (corresponding author), Univ Illinois, Dept Med, Pulm Sect, Chicago, IL 60612 USA.	dantsker@uic.edu	Durdagi, Serdar/B-6862-2009; Durdagi, Serdar/J-1904-2018	Durdagi, Serdar/0000-0002-0426-0905; Noskov, Sergei/0000-0001-7769-335X	National Institutes of Health [HL-073965, HL-083298, HL-059949]; American Heart Association [11SDG5190025]; Canadian Institutes of Health Research [MOP-186232]; Heart and Stroke Foundation of Alberta and Northwest Territories; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083298, R01HL073965, R01HL059949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta and Northwest Territories; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-073965 and HL-083298 (to I. L.) and HL-059949 (to D. E. L.). This work was also supported by Scientist Development Grant 11SDG5190025 from the American Heart Association (to A. R.-D.).; Supported by operating funds from Canadian Institutes of Health Research Grant MOP-186232 and the Heart and Stroke Foundation of Alberta and Northwest Territories. An Alberta Heritage Foundation for Medical Research Scholar.	Addona GH, 2003, BBA-BIOMEMBRANES, V1609, P177, DOI 10.1016/S0005-2736(02)00685-5; Addona GH, 1998, BBA-BIOMEMBRANES, V1370, P299, DOI 10.1016/S0005-2736(97)00280-0; [Anonymous], CHOLESTEROL REGULATI, DOI [10.1016/bs.ctm.2017.05.003, DOI 10.1016/BS.CTM.2017.05.003]; Baier CJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00069; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Covey DF, 2009, STEROIDS, V74, P577, DOI 10.1016/j.steroids.2008.11.019; D'Avanzo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019393; Deol SS, 2004, BIOPHYS J, V87, P3737, DOI 10.1529/biophysj.104.048397; Domene C, 2003, J AM CHEM SOC, V125, P14966, DOI 10.1021/ja0364874; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; Joy Saju, 2006, In Silico Biology, V6, P601; Klauda JB, 2008, CURR TOP MEMBR, V60, P1, DOI 10.1016/S1063-5823(08)00001-X; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Levitan I, 2009, IUBMB LIFE, V61, P781, DOI 10.1002/iub.192; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Lim JB, 2012, J PHYS CHEM B, V116, P203, DOI 10.1021/jp207925m; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Lopatin AN, 2001, J MOL CELL CARDIOL, V33, P625, DOI 10.1006/jmcc.2001.1344; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Luo Y, 2010, J PHYS CHEM LETT, V1, P183, DOI 10.1021/jz900079w; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; MARSH D, 1978, P NATL ACAD SCI USA, V75, P4329, DOI 10.1073/pnas.75.9.4329; Meng XY, 2012, BIOPHYS J, V102, P2049, DOI 10.1016/j.bpj.2012.03.050; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Nina M, 1997, J PHYS CHEM B, V101, P5239, DOI 10.1021/jp970736r; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Noskov SY, 2007, J GEN PHYSIOL, V129, P135, DOI 10.1085/jgp.200609633; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Picazo-Juarez G, 2011, J BIOL CHEM, V286, P24966, DOI 10.1074/jbc.M111.237537; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Rosenhouse-Dantsker A, 2007, PFLUG ARCH EUR J PHY, V455, P45, DOI 10.1007/s00424-007-0291-6; Rosenhouse-Dantsker A, 2013, CHANNELS, V7, P303, DOI 10.4161/chan.25437; Rosenhouse-Dantsker A, 2012, COMPR PHYSIOL, V2, P31, DOI 10.1002/cphy.c110001; Rosenhouse-Dantsker A, 2012, J BIOL CHEM, V287, P40266, DOI 10.1074/jbc.M111.336339; Rosenhouse-Dantsker A, 2011, BIOPHYS J, V100, P381, DOI 10.1016/j.bpj.2010.11.086; Rosenhouse-Dantsker A, 2010, CHANNELS, V4, P63, DOI 10.4161/chan.4.1.10366; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Roux B, 1997, BIOPHYS J, V73, P2980, DOI 10.1016/S0006-3495(97)78327-9; Santiago J, 2001, J BIOL CHEM, V276, P46523, DOI 10.1074/jbc.M104563200; Setny P, 2010, J CHEM THEORY COMPUT, V6, P2866, DOI 10.1021/ct1003077; Singh AK, 2012, J BIOL CHEM, V287, P20509, DOI 10.1074/jbc.M112.356261; Singh DK, 2011, BBA-BIOMEMBRANES, V1808, P2527, DOI 10.1016/j.bbamem.2011.07.006; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; Tai KH, 2009, BIOCHEMISTRY-US, V48, P8758, DOI 10.1021/bi9007808; Thompson M.A., 2004, ARGUSLAB VERSION 4 0; Tikku S, 2007, AM J PHYSIOL-CELL PH, V293, pC440, DOI 10.1152/ajpcell.00492.2006	65	67	67	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31154	31164		10.1074/jbc.M113.496117	http://dx.doi.org/10.1074/jbc.M113.496117			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24019518	Green Published, hybrid			2022-12-28	WOS:000330778900033
J	Yao, MD; Ohtsuka, J; Nagata, K; Miyazono, K; Zhi, Y; Ohnishi, Y; Tanokura, M				Yao, Ming Dong; Ohtsuka, Jun; Nagata, Koji; Miyazono, Ken-ichi; Zhi, Yuehua; Ohnishi, Yasuo; Tanokura, Masaru			Complex Structure of the DNA-binding Domain of AdpA, the Global Transcription Factor in Streptomyces griseus, and a Target Duplex DNA Reveals the Structural Basis of Its Tolerant DNA Sequence Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR REGULATORY CASCADE; AERIAL MYCELIUM FORMATION; A-FACTOR; SECONDARY METABOLISM; MORPHOLOGICAL DEVELOPMENT; ESCHERICHIA-COLI; ARAC/XYLS FAMILY; ACTIVATOR; GENE; REGULON	AdpA serves as the global transcription factor in the A-factor regulatory cascade, controlling the secondary metabolism and morphological differentiation of the filamentous bacterium Streptomyces griseus. AdpA binds to over 500 operator regions with the consensus sequence 5'-TGGCSNGWWY-3' (where S is G or C, W is A or T, Y is T or C, and N is any nucleotide). However, it is still obscure how AdpA can control hundreds of genes. To elucidate the structural basis of this tolerant DNA recognition by AdpA, we focused on the interaction between the DNA-binding domain of AdpA (AdpA-DBD), which consists of two helix-turn-helix motifs, and a target duplex DNA containing the consensus sequence 5'-TGGCGGGTTC-3'. The crystal structure of the AdpA-DBD-DNA complex and the mutant analysis of AdpA-DBD revealed its unique manner of DNA recognition, whereby only two arginine residues directly recognize the consensus sequence, explaining the strict recognition of G and C at positions 2 and 4, respectively, and the tolerant recognition of other positions of the consensus sequence. AdpA-DBD confers tolerant DNA sequence specificity to AdpA, allowing it to control hundreds of genes as a global transcription factor.	[Yao, Ming Dong; Ohtsuka, Jun; Nagata, Koji; Miyazono, Ken-ichi; Zhi, Yuehua; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Ohnishi, Yasuo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp	Miyazono, Kenichi/P-9654-2019; Yao, Ming-Dong/ABD-5694-2020	Miyazono, Kenichi/0000-0002-9354-2604; Ohnishi, Yasuo/0000-0001-7633-9236; Tanokura, Masaru/0000-0001-5072-2480; Nagata, Koji/0000-0002-4704-0603	Target Protein Research Project; Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan	Target Protein Research Project; Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan	This work was partly supported by the Target Protein Research Project and the Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a Funding Program for Next Generation World-Leading Researchers from the Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan.	Akanuma G, 2011, FEMS MICROBIOL LETT, V315, P54, DOI 10.1111/j.1574-6968.2010.02177.x; Akanuma G, 2009, MOL MICROBIOL, V73, P898, DOI 10.1111/j.1365-2958.2009.06814.x; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Crothers D. M., 1999, OXFORD HDB NUCL ACID; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Griffith KL, 2001, MOL MICROBIOL, V40, P1141, DOI 10.1046/j.1365-2958.2001.02456.x; Higo A, 2012, DNA RES, V19, P259, DOI 10.1093/dnares/dss010; Higo A, 2011, MOL MICROBIOL, V81, P1607, DOI 10.1111/j.1365-2958.2011.07795.x; Hirano S, 2006, J BACTERIOL, V188, P6207, DOI 10.1128/JB.00662-06; Horinouchi S, 2007, P JPN ACAD B-PHYS, V83, P277, DOI [10.2183/pjab.83.277, 10.2183/pjab/83.277]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato J, 2005, J MOL BIOL, V350, P12, DOI 10.1016/j.jmb.2005.04.058; Kato J, 2002, J BACTERIOL, V184, P6016, DOI 10.1128/JB.184.21.6016-6025.2002; Kato JY, 2005, J BACTERIOL, V187, P286, DOI 10.1128/JB.187.1.286-295.2005; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Martin RG, 2002, MOL MICROBIOL, V44, P1611, DOI 10.1046/j.1365-2958.2002.02985.x; Martin RG, 2011, J BACTERIOL, V193, P506, DOI 10.1128/JB.00360-10; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohnishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P431, DOI 10.1271/bbb.69.431; RETZLAFF L, 1995, MOL MICROBIOL, V18, P151, DOI 10.1111/j.1365-2958.1995.mmi_18010151.x; Rhee S, 1998, P NATL ACAD SCI USA, V95, P10413, DOI 10.1073/pnas.95.18.10413; Rohs R, 2005, STRUCTURE, V13, P1499, DOI 10.1016/j.str.2005.07.005; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Tezuka T., 2010, ACTINOMYCETOLOGICA, V24, P45; Tobes R, 2002, NUCLEIC ACIDS RES, V30, P318, DOI 10.1093/nar/30.1.318; Tomono A, 2005, J BACTERIOL, V187, P6341, DOI 10.1128/JB.187.18.6341-6353.2005; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Yamazaki H, 2004, MOL MICROBIOL, V53, P555, DOI 10.1111/j.1365-2958.2004.04153.x; Yamazaki H, 2000, J BACTERIOL, V182, P4596, DOI 10.1128/JB.182.16.4596-4605.2000; Yamazaki H, 2003, MOL MICROBIOL, V50, P1173, DOI 10.1046/j.1365-2958.2003.03760.x; Yamazaki H, 2003, J BACTERIOL, V185, P1273, DOI 10.1128/JB.185.4.1273-1283.2003; Yao MD, 2012, ACTA CRYSTALLOGR F, V68, P946, DOI 10.1107/S1744309112026899	36	14	15	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31019	31029		10.1074/jbc.M113.473611	http://dx.doi.org/10.1074/jbc.M113.473611			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24019524	hybrid, Green Published			2022-12-28	WOS:000330778900021
J	Kubo, M; Nakashima, S; Yamaguchi, S; Ogura, T; Mochizuki, M; Kang, J; Tateno, M; Shinzawa-Itoh, K; Kato, K; Yoshikawa, S				Kubo, Minoru; Nakashima, Satoru; Yamaguchi, Satoru; Ogura, Takashi; Mochizuki, Masao; Kang, Jiyoung; Tateno, Masaru; Shinzawa-Itoh, Kyoko; Kato, Koji; Yoshikawa, Shinya			Effective Pumping Proton Collection Facilitated by a Copper Site (CUB) of Bovine Heart Cytochrome c Oxidase, Revealed by a Newly Developed Time-resolved Infrared System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Biophysics; Infrared Spectroscopy; Membrane Proteins; Respiratory Chain	FTIR DIFFERENCE SPECTROSCOPY; PARACOCCUS-DENITRIFICANS; RHODOBACTER-SPHAEROIDES; SIDE-CHAINS; O-2 REDUCTION; WATER H2O; HEME; MECHANISM; STEP; IR	Background: Cytochrome c oxidase reduces O-2 coupled with proton pumping. Results: A newly developed time-resolved infrared system reveals transient conformational changes in the proton-pumping pathway upon CO binding to Cu-B in the O-2 reduction site. Conclusion: Cu-B promotes proton collection and effective blockage of back-leak of pumping protons. Significance: These critical findings in bioenergetics stimulate the new infrared approach for mechanistic investigation of any other protein function. X-ray structural and mutational analyses have shown that bovine heart cytochrome c oxidase (CcO) pumps protons electrostatically through a hydrogen bond network using net positive charges created upon oxidation of a heme iron (located near the hydrogen bond network) for O-2 reduction. Pumping protons are transferred by mobile water molecules from the negative side of the mitochondrial inner membrane through a water channel into the hydrogen bond network. For blockage of spontaneous proton back-leak, the water channel is closed upon O-2 binding to the second heme (heme a(3)) after complete collection of the pumping protons in the hydrogen bond network. For elucidation of the structural bases for the mechanism of the proton collection and timely closure of the water channel, conformational dynamics after photolysis of CO (an O-2 analog)-bound CcO was examined using a newly developed time-resolved infrared system feasible for accurate detection of a single C=O stretch band of -helices of CcO in H2O medium. The present results indicate that migration of CO from heme a(3) to Cu-B in the O-2 reduction site induces an intermediate state in which a bulge conformation at Ser-382 in a transmembrane helix is eliminated to open the water channel. The structural changes suggest that, using a conformational relay system, including Cu-B, O-2, heme a(3), and two helix turns extending to Ser-382, Cu-B induces the conformational changes of the water channel that stimulate the proton collection, and senses complete proton loading into the hydrogen bond network to trigger the timely channel closure by O-2 transfer from Cu-B to heme a(3).	[Kubo, Minoru; Nakashima, Satoru; Ogura, Takashi; Mochizuki, Masao; Kang, Jiyoung; Tateno, Masaru; Shinzawa-Itoh, Kyoko; Kato, Koji; Yoshikawa, Shinya] Univ Hyogo, Picobiol Inst, Akoh, Hyogo 6781297, Japan; [Yamaguchi, Satoru; Ogura, Takashi] Univ Hyogo, Dept Life Sci, Grad Sch Life Sci, Akoh, Hyogo 6781297, Japan; [Kubo, Minoru] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ogura, Takashi; Tateno, Masaru; Yoshikawa, Shinya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Hyogo; University of Hyogo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Yoshikawa, S (corresponding author), Univ Hyogo, Picobiol Inst, Grad Sch Life Sci, 3-2-1 Kouto, Akoh, Hyogo 6781297, Japan.	yoshi@sci.u-hyogo.ac.jp	Kato, Koji/H-8502-2017	Kato, Koji/0000-0001-9846-5903; Nakashima, Satoru/0000-0001-8378-1153	Global Center of Excellence Program; Targeted Protein Research Program; Scientific Research Grant [2247012]; Young Scientists Grants [23685040, 21750022, 22770154]; Japanese Ministry of Education, Culture, Sports, Science and Technology; PRESTO; CREST; Grants-in-Aid for Scientific Research [23685040] Funding Source: KAKEN	Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Protein Research Program; Scientific Research Grant; Young Scientists Grants; Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO; CREST(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid from the Global Center of Excellence Program (to S. Y.), the Targeted Protein Research Program (to S. Y. and T. O.), Scientific Research Grant (A) 2247012 (to S. Y.), Young Scientists Grants (A) 23685040 and (B) 21750022 (to M. K.) and (B) 22770154 (to S. Y.), the Japanese Ministry of Education, Culture, Sports, Science and Technology, the Japan Science and Technology Agency, PRESTO and CREST.	ALBEN JO, 1981, P NATL ACAD SCI-BIOL, V78, P234, DOI 10.1073/pnas.78.1.234; Aminaka R, 2012, BBA-BIOENERGETICS, V1817, pS104, DOI 10.1016/j.bbabio.2012.06.281; ANSARI A, 1993, BIOPHYS J, V64, P838, DOI 10.1016/S0006-3495(93)81445-0; ANSARI A, 1993, BIOPHYS J, V64, P852, DOI 10.1016/S0006-3495(93)81446-2; Aoyama H, 2009, P NATL ACAD SCI USA, V106, P2165, DOI 10.1073/pnas.0806391106; Babcock G. T., 1988, BIOL APPLICATIONS RA, V3, P293; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Behr J, 1998, BIOCHEMISTRY-US, V37, P7400, DOI 10.1021/bi9731697; Behr J, 2000, BIOCHEMISTRY-US, V39, P1356, DOI 10.1021/bi991504g; Bene P., 2010, CAVER 2 1; Bloch D, 2004, P NATL ACAD SCI USA, V101, P529, DOI 10.1073/pnas.0306036101; Braiman MS, 1999, J PHYS CHEM B, V103, P4744, DOI 10.1021/jp983011b; Brzezinski P, 2003, BBA-BIOENERGETICS, V1605, P1, DOI 10.1016/S0005-2728(03)00079-3; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang HY, 2009, P NATL ACAD SCI USA, V106, P16169, DOI 10.1073/pnas.0905264106; DYER RB, 1994, BIOCHEMISTRY-US, V33, P500, DOI 10.1021/bi00168a015; EINARSDOTTIR O, 1993, BIOCHEMISTRY-US, V32, P12013, DOI 10.1021/bi00096a011; FINDSEN EW, 1987, J AM CHEM SOC, V109, P5367, DOI 10.1021/ja00252a011; Groot ML, 2007, PHOTOCH PHOTOBIO SCI, V6, P501, DOI 10.1039/b613023b; HAMM P, 1995, P NATL ACAD SCI USA, V92, P1826, DOI 10.1073/pnas.92.6.1826; Hellwig P, 1999, BIOCHEMISTRY-US, V38, P1685, DOI 10.1021/bi982282+; Kandori H, 2000, BBA-BIOENERGETICS, V1460, P177, DOI 10.1016/S0005-2728(00)00138-9; Kang JY, 2011, BBA-BIOENERGETICS, V1807, P1314, DOI 10.1016/j.bbabio.2011.06.014; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; Kotting C, 2005, CHEMPHYSCHEM, V6, P881, DOI 10.1002/cphc.200400504; Koutsoupakis C, 2004, BBA-BIOENERGETICS, V1655, P347, DOI 10.1016/j.bbabio.2003.06.004; Lee HM, 2000, BIOCHEMISTRY-US, V39, P2989, DOI 10.1021/bi9924821; Locke B., 1993, ADV SPECTROSC, V21, P1; Magana D, 2011, APPL SPECTROSC, V65, P535, DOI 10.1366/10-06179; MATSUKAWA S, 1985, J AM CHEM SOC, V107, P1108, DOI 10.1021/ja00291a004; Mochizuki M, 1999, J BIOL CHEM, V274, P33403, DOI 10.1074/jbc.274.47.33403; Muramoto K, 2007, P NATL ACAD SCI USA, V104, P7881, DOI 10.1073/pnas.0610031104; Muramoto K, 2010, P NATL ACAD SCI USA, V107, P7740, DOI 10.1073/pnas.0910410107; NAGAI K, 1980, J MOL BIOL, V136, P271, DOI 10.1016/0022-2836(80)90374-5; Nagarajan S, 2011, J AM CHEM SOC, V133, P20335, DOI 10.1021/ja2071362; Okuno D, 2003, J AM CHEM SOC, V125, P7209, DOI 10.1021/ja021302z; PALMER RA, 1989, APPL SPECTROSC, V43, P193, DOI 10.1366/0003702894203101; Qin L, 2009, BIOCHEMISTRY-US, V48, P5121, DOI 10.1021/bi9001387; Radu I, 2009, PHOTOCH PHOTOBIO SCI, V8, P1517, DOI 10.1039/b9pp00050j; Salomonsson L, 2005, P NATL ACAD SCI USA, V102, P17624, DOI 10.1073/pnas.0505431102; Shimokata K, 2007, P NATL ACAD SCI USA, V104, P4200, DOI 10.1073/pnas.0611627104; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Siegbahn PEM, 2007, BBA-BIOENERGETICS, V1767, P1143, DOI 10.1016/j.bbabio.2007.06.009; Slayton RM, 1997, CURR OPIN STRUC BIOL, V7, P717, DOI 10.1016/S0959-440X(97)80083-8; TORII H, 1992, J CHEM PHYS, V97, P92, DOI 10.1063/1.463528; TORII H, 1992, J CHEM PHYS, V96, P3379, DOI 10.1063/1.461939; Treuffet J, 2007, P NATL ACAD SCI USA, V104, P15705, DOI 10.1073/pnas.0703279104; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; UHMANN W, 1991, APPL SPECTROSC, V45, P390, DOI 10.1366/0003702914337128; van Wilderen LJGW, 2006, P NATL ACAD SCI USA, V103, P15050, DOI 10.1073/pnas.0603476103; Venyaminov SY, 1997, ANAL BIOCHEM, V248, P234, DOI 10.1006/abio.1997.2136; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1259, DOI 10.1002/bip.360301310; Waegele MM, 2010, BIOCHEMISTRY-US, V49, P7659, DOI 10.1021/bi100851c; Wikstrom M, 2003, BBA-BIOENERGETICS, V1604, P61, DOI 10.1016/S0005-2728(03)00041-0; YOSHIKAWA S, 1977, J BIOL CHEM, V252, P5498; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Yoshikawa S, 2011, ANNU REV BIOPHYS, V40, P205, DOI 10.1146/annurev-biophys-042910-155341	58	26	27	1	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30259	30269		10.1074/jbc.M113.473983	http://dx.doi.org/10.1074/jbc.M113.473983			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23996000	Green Published, hybrid			2022-12-28	WOS:000329868100024
J	Lyons, PJ; Sapio, MR; Fricker, LD				Lyons, Peter J.; Sapio, Matthew R.; Fricker, Lloyd D.			Zebrafish Cytosolic Carboxypeptidases 1 and 5 Are Essential for Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carboxypeptidase; Metalloenzymes; Peptidases; Tubulin; Zebrafish	PURKINJE-CELL DEGENERATION; CEREBELLAR MUTANT MOUSE; TUBULIN DEGLUTAMYLASE; RETINAL DEGENERATION; TYROSINE; BRAIN; CILIA; IDENTIFICATION; MUTATIONS; PROTEIN	The cytosolic carboxypeptidases (CCPs) are a subfamily of metalloenzymes within the larger M14 family of carboxypeptidases that have been implicated in the post-translational modification of tubulin. It has been suggested that at least four of the six mammalian CCPs function as tubulin deglutamylases. However, it is not yet clear whether these enzymes play redundant or unique roles within the cell. To address this question, genes encoding CCPs were identified in the zebrafish genome. Analysis by quantitative polymerase chain reaction indicated that CCP1, CCP2, CCP5, and CCP6 mRNAs were detectable between 2 h and 8 days postfertilization with highest levels 5-8 days postfertilization. CCP1, CCP2, and CCP5 mRNAs were predominantly expressed in tissues such as the brain, olfactory placodes, and pronephric ducts. Morpholino oligonucleotide-mediated knockdown of CCP1 and CCP5 mRNA resulted in a common phenotype including ventral body curvature and hydrocephalus. Confocal microscopy of morphant zebrafish revealed olfactory placodes with defective morphology as well as pronephric ducts with increased polyglutamylation. These data suggest that CCP1 and CCP5 play important roles in developmental processes, particularly the development and functioning of cilia. The robust and similar defects upon knockdown suggest that each CCP may have a function in microtubule modification and ciliary function and that other CCPs are not able to compensate for the loss of one.	[Lyons, Peter J.; Fricker, Lloyd D.] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Sapio, Matthew R.] Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lloyd.fricker@einstein.yu.edu	Sapio, Matthew R/J-5096-2016	Sapio, Matthew R/0000-0002-8855-5419; Lyons, Peter/0000-0001-5214-5445	National Institutes of Health [1R01DA-004494]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01DA-004494 (to L D. F.).	ARCE CA, 1975, EUR J BIOCHEM, V59, P145, DOI 10.1111/j.1432-1033.1975.tb02435.x; ARGARANA CE, 1980, J NEUROCHEM, V34, P114, DOI 10.1111/j.1471-4159.1980.tb04628.x; ARGARANA CE, 1978, MOL CELL BIOCHEM, V19, P17; BARRA HS, 1973, J NEUROCHEM, V21, P1241, DOI 10.1111/j.1471-4159.1973.tb07578.x; Berezniuk I, 2013, J BIOL CHEM, V288, P30445, DOI 10.1074/jbc.M113.497917; Berezniuk I, 2012, J BIOL CHEM, V287, P6503, DOI 10.1074/jbc.M111.309138; BLANKS JC, 1982, J COMP NEUROL, V212, P231, DOI 10.1002/cne.902120303; Chakrabarti L, 2008, VISION RES, V48, P1999, DOI 10.1016/j.visres.2008.05.026; Chandrasekar G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063123; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Otazo MRD, 2013, FASEB J, V27, P424, DOI 10.1096/fj.12-209080; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Drummond I, 2009, METHOD CELL BIOL, V93, P197, DOI 10.1016/S0091-679X(08)93011-9; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; Gomis-Ruth FX, 1999, EMBO J, V18, P5817, DOI 10.1093/emboj/18.21.5817; GUNDERSEN GG, 1986, EUR J CELL BIOL, V42, P288; HALLAK ME, 1977, FEBS LETT, V73, P147, DOI 10.1016/0014-5793(77)80968-X; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; LAVAIL MM, 1982, J COMP NEUROL, V212, P217, DOI 10.1002/cne.902120302; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; O'Hagan R, 2011, CURR BIOL, V21, P1685, DOI 10.1016/j.cub.2011.08.049; Otero A, 2012, FASEB J, V26, P3754, DOI 10.1096/fj.12-209601; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Sahab ZJ, 2011, CANCER RES, V71, P1219, DOI 10.1158/0008-5472.CAN-10-2294; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; Teng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024596; Thakar K, 2013, MOL CELL PROTEOMICS, V12, P664, DOI 10.1074/mcp.M112.024877; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Ventura S, 1997, BIOL CHEM, V378, P161; Wang TY, 2007, BRAIN RES, V1140, P26, DOI 10.1016/j.brainres.2006.07.065; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF55, DOI 10.1152/ajprenal.00043.2010	45	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30454	30462		10.1074/jbc.M113.497933	http://dx.doi.org/10.1074/jbc.M113.497933			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24022483	Green Published, hybrid			2022-12-28	WOS:000329868100041
J	Nedielkov, R; Steffen, W; Steuber, J; Moller, HM				Nedielkov, Ruslan; Steffen, Wojtek; Steuber, Julia; Moeller, Heiko M.			NMR Reveals Double Occupancy of Quinone-type Ligands in the Catalytic Quinone Binding Site of the Na+-translocating NADH:Quinone Oxidoreductase from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Membrane Enzymes; NMR; Redox; Sodium Transport; Ubiquinone; DBMIB; Interligand NOE	CYTOCHROME B(6)F COMPLEX; BC(1) COMPLEX; SUBUNIT-B; UBIQUINONE; INHIBITOR; ELECTRON; DIBROMOTHYMOQUINONE; ALGINOLYTICUS; LOCALIZATION; SPECTROSCOPY	The sodium ion-translocating NADH:quinone oxidoreductase (Na+-NQR) from the pathogen Vibrio cholerae exploits the free energy liberated during oxidation of NADH with ubiquinone to pump sodium ions across the cytoplasmic membrane. The Na+-NQR consists of four membrane-bound subunits NqrBCDE and the peripheral NqrF and NqrA subunits. NqrA binds ubiquinone-8 as well as quinones with shorter prenyl chains (ubiquinone-1 and ubiquinone-2). Here we show that the quinone derivative 2,5-dibromo-3-methyl-6-isopropyl-p-benzoquinone (DBMIB), a known inhibitor of the bc(1) and b(6)f complexes found in mitochondria and chloroplasts, also inhibits quinone reduction by the Na+-NQR in a mixed inhibition mode. Tryptophan fluorescence quenching and saturation transfer difference NMR experiments in the presence of Na+-NQR inhibitor (DBMIB or 2-n-heptyl-4-hydroxyquinoline N-oxide) indicate that two quinone analog ligands are bound simultaneously by the NqrA subunit with very similar interaction constants as observed with the holoenzyme complex. We conclude that the catalytic site of quinone reduction is located on NqrA. The two ligands bind to an extended binding pocket in direct vicinity to each other as demonstrated by interligand Overhauser effects between ubiquinone-1 and DBMIB or 2-n-heptyl-4-hydroxyquinoline N-oxide, respectively. We propose that a similar spatially close arrangement of the native quinone substrates is also operational in vivo, enhancing the catalytic efficiency during the final electron transfer steps in the Na+-NQR.	[Nedielkov, Ruslan; Moeller, Heiko M.] Univ Konstanz, Dept Chem, D-78457 Constance, Germany; [Steffen, Wojtek; Steuber, Julia] Univ Stuttgart Hohenheim, Dept Microbiol, D-70599 Stuttgart, Germany	University of Konstanz; University Hohenheim	Steuber, J (corresponding author), Univ Stuttgart Hohenheim, Dept Microbiol, D-70599 Stuttgart, Germany.	julia.steuber@uni-hohenheim.de; heiko.moeller@uni-konstanz.de	Möller, Heiko/AAX-1075-2020	Möller, Heiko/0000-0002-5795-1195	Baden-Wurttemberg Stiftung [P-LS-Meth/4]; Deutsche Forschungsgemeinschaft [FR 1321/3-1]; Young Scholar Fund; Research School Chemical Biology of the University of Konstanz	Baden-Wurttemberg Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Young Scholar Fund; Research School Chemical Biology of the University of Konstanz	This work was supported in part by contract research of the Baden-Wurttemberg Stiftung, Forschungsprogramm P-LS-Meth/4 (to J. S. and H. M. M.), and Deutsche Forschungsgemeinschaft Grant FR 1321/3-1 (to J. S.).; Supported by the Young Scholar Fund and the Research School Chemical Biology of the University of Konstanz.	Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Bartoschek S, 2001, J BIOL CHEM, V276, P35231, DOI 10.1074/jbc.C100365200; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; Casutt MS, 2010, ACTA CRYSTALLOGR F, V66, P1677, DOI [10.1107/S1744309110043125, 10.1107/S17443091100431]; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; CHAIN RK, 1979, ARCH BIOCHEM BIOPHYS, V197, P52, DOI 10.1016/0003-9861(79)90217-0; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; ESPOSTI MD, 1984, BIOCHIM BIOPHYS ACTA, V767, P10, DOI 10.1016/0005-2728(84)90074-4; ESPOSTI MD, 1983, FEBS LETT, V156, P15, DOI 10.1016/0014-5793(83)80238-5; Feng Y, 2012, NATURE, V491, P478, DOI 10.1038/nature11541; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; HORE PJ, 1989, METHOD ENZYMOL, V176, P64; HOULT DI, 1976, J MAGN RESON, V21, P337, DOI 10.1016/0022-2364(76)90081-0; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Iwata M, 2012, P NATL ACAD SCI USA, V109, P15247, DOI 10.1073/pnas.1210059109; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Lenaz G, 1998, BBA-BIOENERGETICS, V1364, P207, DOI 10.1016/S0005-2728(98)00028-0; Li DW, 1999, J BIOMOL NMR, V15, P71, DOI 10.1023/A:1008360208627; Lin PC, 2007, J BACTERIOL, V189, P3902, DOI 10.1128/JB.01651-06; LOSCHEN G, 1974, FEBS LETT, V41, P115, DOI 10.1016/0014-5793(74)80967-1; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; Roberts AG, 2004, BIOCHEMISTRY-US, V43, P7707, DOI 10.1021/bi049521f; Roberts AG, 2001, BIOCHEMISTRY-US, V40, P13407, DOI 10.1021/bi015774m; Sanchez-Pedregal VM, 2005, ANGEW CHEM INT EDIT, V44, P4172, DOI 10.1002/anie.200500503; Simkovic M, 2004, BIOCHEM J, V378, P633, DOI 10.1042/BJ20031272; STONEHOUSE J, 1994, J AM CHEM SOC, V116, P6037, DOI 10.1021/ja00092a092; Tao ML, 2008, BBA-BIOENERGETICS, V1777, P696, DOI 10.1016/j.bbabio.2008.04.006; TREBST A, 1970, Z NATURFORSCH PT B, VB 25, P1157; Turk K, 2004, J BIOL CHEM, V279, P21349, DOI 10.1074/jbc.M311692200; Voet D, 2011, BIOCHEMISTRY-US, P482	38	26	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30597	30606		10.1074/jbc.M112.435750	http://dx.doi.org/10.1074/jbc.M112.435750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003222	hybrid, Green Published			2022-12-28	WOS:000329868100060
J	Taniguchi, T; Tanaka, S; Ishii, A; Watanabe, M; Fujitani, N; Sugeo, A; Gotoh, S; Ohta, T; Hiyoshi, M; Matsuzaki, H; Sakai, N; Konishi, H				Taniguchi, Tomonori; Tanaka, Shigeru; Ishii, Ayumi; Watanabe, Miyuki; Fujitani, Noriko; Sugeo, Ayusa; Gotoh, Shuhei; Ohta, Takeshi; Hiyoshi, Mineyoshi; Matsuzaki, Hideki; Sakai, Norio; Konishi, Hiroaki			A Brain-specific Grb2-associated Regulator of Extracellular Signal-regulated Kinase (Erk)/Mitogen-activated Protein Kinase (MAPK) (GAREM) Subtype, GAREM2, Contributes to Neurite Outgrowth of Neuroblastoma Cells by Regulating Erk Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASES; NERVE GROWTH-FACTOR; NUCLEAR-LOCALIZATION; IRS PROTEINS; IN-VIVO; ACTIVATION; NETWORKS; CANCER; PHOSPHORYLATION; DIFFERENTIATION	Grb2-associated regulator of Erk/MAPK1 (GAREM) is an adaptor molecule in the EGF-mediated signaling pathway. GAREM is expressed ubiquitously in human organs and cultured cells. Two GAREM homologues are encoded by the human genome. Therefore, previously identified GAREM is named GAREM1. Here we characterized a new subtype of GAREM, GAREM2, that is specifically expressed in the mouse, rat, and human brain. Three GAREM2 tyrosines (Tyr-102, Tyr-429, and Tyr-551) are phosphorylated upon EGF stimulation and are necessary for binding to Grb2. Furthermore, GAREM2 and Shp2 regulate Erk activity in EGF-stimulated cells. These characteristics are similar to those of GAREM1. GAREM2 is expressed in some neuroblastoma cell lines and is also tyrosine-phosphorylated and bound to Grb2 after treatment with EGF. Eventually, GAREM2 regulates Erk activation in the presence of EGF or insulin like growth factor 1. GAREM2 also regulates insulin-like growth factor 1-induced neuronal differentiation of the SH-SY5Y neuroblastoma cell line. Although the structure and function of both GAREM subtypes are similar, GAREM1 is recruited into the nucleus and GAREM2 is not. Nuclear localization of GAREM1 might be controlled by a GAREM1-specific nuclear localization sequence and 14-3-3 epsilon binding. The N-terminal 20 amino acids of GAREM1 make up its nuclear localization sequence that is also a 14-3-3 epsilon binding site. The GAREM family is a new class of adaptor molecules with subtype-specific biological functions.	[Taniguchi, Tomonori; Ishii, Ayumi; Watanabe, Miyuki; Fujitani, Noriko; Sugeo, Ayusa; Gotoh, Shuhei; Ohta, Takeshi; Konishi, Hiroaki] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Shobara, Hiroshima 7270023, Japan; [Tanaka, Shigeru; Sakai, Norio] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol & Pharmacol Neurosci, Hiroshima 7348553, Japan; [Hiyoshi, Mineyoshi] Shimane Univ, Fac Med Izumo, Dept Biochem, Matsue, Shimane 6938501, Japan; [Matsuzaki, Hideki] Natl Inst Adv Ind Sci & Technol, RCMG, Tsukuba, Ibaraki 3058568, Japan	Hiroshima University; Shimane University; National Institute of Advanced Industrial Science & Technology (AIST)	Konishi, H (corresponding author), Prefectural Univ Hiroshima, Fac Life & Environm Sci, 562 Nanatsuka, Shobara, Hiroshima 7270023, Japan.	hkonishi@pu-hiroshima.ac.jp	Tanaka, Shigeru/O-3908-2015; Sakai, Norio/AAM-5822-2021	Tanaka, Shigeru/0000-0003-3247-9098; Sakai, Norio/0000-0002-6648-8761	Satake Technical Foundation; Grants-in-Aid for Scientific Research [25293061] Funding Source: KAKEN	Satake Technical Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Satake Technical Foundation.	BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Carpenter G, 2003, CURR OPIN CELL BIOL, V15, P143, DOI 10.1016/S0955-0674(03)00015-2; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Dohi E, 2012, NEUROCHEM INT, V60, P431, DOI 10.1016/j.neuint.2012.01.020; Gibson SL, 2007, CELL CYCLE, V6, P631, DOI 10.4161/cc.6.6.3987; Grynspan F, 1997, J NEUROSCI RES, V48, P181; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; JALAVA A, 1992, FEBS LETT, V300, P114, DOI 10.1016/0014-5793(92)80176-H; Kim B, 1997, J BIOL CHEM, V272, P21268, DOI 10.1074/jbc.272.34.21268; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Konishi H, 2006, J BIOL CHEM, V281, P28919, DOI 10.1074/jbc.M605693200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; O'Bryan JP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3152re10; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; RECIOPINTO E, 1984, BRAIN RES, V302, P323, DOI 10.1016/0006-8993(84)90246-4; Riese DJ, 2007, BIOESSAYS, V29, P558, DOI 10.1002/bies.20582; ROGERS MV, 1994, NEUROSCIENCE, V60, P479, DOI 10.1016/0306-4522(94)90259-3; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Seiffert M, 2003, MOL CELL BIOL, V23, P2415, DOI 10.1128/MCB.23.7.2415-2424.2003; Shaw LM, 2011, CELL CYCLE, V10, P1750, DOI 10.4161/cc.10.11.15824; SPINELLI W, 1982, CANCER RES, V42, P5067; Tashiro K, 2009, J BIOL CHEM, V284, P20206, DOI 10.1074/jbc.M109.021139; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Tsyba L, 2011, GENE, V473, P67, DOI 10.1016/j.gene.2010.11.016; Tzouros M., 2013, MOL CELL PROTEOMICS, DOI [10.1074/mcp.O113.027342, DOI 10.1074/MCP.0113.027342]; Verma S, 2012, ADV HEMATOL, V2012, P380635; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang XZ, 2003, MOL CELL BIOL, V23, P6013, DOI 10.1128/MCB.23.17.6013-6026.2003; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Wong KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036023; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	39	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29934	29942		10.1074/jbc.M113.492520	http://dx.doi.org/10.1074/jbc.M113.492520			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003223	Green Published, hybrid			2022-12-28	WOS:000330615300066
J	Licciulli, S; Maksimoska, J; Zhou, C; Troutman, S; Kota, S; Liu, Q; Duron, S; Campbell, D; Chernoff, J; Field, J; Marmorstein, R; Kissil, JL				Licciulli, Silvia; Maksimoska, Jasna; Zhou, Chun; Troutman, Scott; Kota, Smitha; Liu, Qin; Duron, Sergio; Campbell, David; Chernoff, Jonathan; Field, Jeffrey; Marmorstein, Ronen; Kissil, Joseph L.			FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitors; Protein Kinases; Schwann Cells; Signal Transduction; Small Molecules; Merlin; nf2; p21-activated Kinase	TUMOR-SUPPRESSOR GENE; PAK PROTEIN-KINASES; MERLIN; GROWTH; PROGRESSION; ACTIVATION; NF1(+/-); RAS; REORGANIZATION; PROLIFERATION	The p21-activated kinases (PAKs) are immediate downstream effectors of the Rac/Cdc42 small G-proteins and implicated in promoting tumorigenesis in various types of cancer including breast and lung carcinomas. Recent studies have established a requirement for the PAKs in the pathogenesis of Neurofibromatosis type 2 (NF2), a dominantly inherited cancer disorder caused by mutations at the NF2 gene locus. Merlin, the protein product of the NF2 gene, has been shown to negatively regulate signaling through the PAKs and the tumor suppressive functions of Merlin are mediated, at least in part, through inhibition of the PAKs. Knockdown of PAK1 and PAK2 expression, through RNAi-based approaches, impairs the proliferation of NF2-null schwannoma cells in culture and inhibits their ability to form tumors in vivo. These data implicate the PAKs as potential therapeutic targets. High-throughput screening of a library of small molecules combined with a structure-activity relationship approach resulted in the identification of FRAX597, a small-molecule pyridopyrimidinone, as a potent inhibitor of the group I PAKs. Crystallographic characterization of the FRAX597/PAK1 complex identifies a phenyl ring that traverses the gatekeeper residue and positions the thiazole in the back cavity of the ATP binding site, a site rarely targeted by kinase inhibitors. FRAX597 inhibits the proliferation of NF2-deficient schwannoma cells in culture and displayed potent anti-tumor activity in vivo, impairing schwannoma development in an orthotopic model of NF2. These studies identify a novel class of orally available ATP-competitive Group I PAK inhibitors with significant potential for the treatment of NF2 and other cancers.	[Licciulli, Silvia; Troutman, Scott; Kota, Smitha; Kissil, Joseph L.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Maksimoska, Jasna; Marmorstein, Ronen] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA; [Zhou, Chun; Liu, Qin] Wistar Inst Anat & Biol, Mol Oncogenesis Program, Philadelphia, PA 19104 USA; [Duron, Sergio; Campbell, David] Afraxis Inc, San Diego, CA 92037 USA; [Chernoff, Jonathan] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Field, Jeffrey] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	Scripps Research Institute; The Wistar Institute; The Wistar Institute; Fox Chase Cancer Center; University of Pennsylvania; Pennsylvania Medicine	Kissil, JL (corresponding author), Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	jkissil@scripps.edu	Chernoff, Jonathan/I-7631-2014	Chernoff, Jonathan/0000-0002-4803-7836	National Institutes of Health [CA124495, CA114046, CA148805]; American Cancer Society [RSG-10-018-01-CDD]; Afraxis; Children's Tumor Foundation; NATIONAL CANCER INSTITUTE [R01CA148805, R01CA124495, P01CA114046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Afraxis; Children's Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA124495 (to J. K.), CA114046 (to R. M.), and CA148805 (to J. C.) and from the American Cancer Society RSG-10-018-01-CDD (to J. K.). Work in the J. L. K.'s laboratory was also supported by Afraxis and the Children's Tumor Foundation.	Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Arias-Romero LE, 2013, CANCER RES, V73, P3671, DOI 10.1158/0008-5472.CAN-12-4453; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; Barvian M, 2000, J MED CHEM, V43, P4606, DOI 10.1021/jm000271k; Blanck S, 2012, ANGEW CHEM INT EDIT, V51, P5244, DOI 10.1002/anie.201108865; Chow HY, 2012, CANCER RES, V72, P5966, DOI 10.1158/0008-5472.CAN-12-2246; Chow HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013791; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaran J, 2007, STRUCTURE, V15, P201, DOI 10.1016/j.str.2007.01.001; Flaiz C, 2007, J NEUROPATH EXP NEUR, V66, P608, DOI 10.1097/nen.0b013e318093e555; Flaiz C, 2009, EXP NEUROL, V218, P137, DOI 10.1016/j.expneurol.2009.04.019; Gerber PA, 2009, EUR J MED RES, V14, P102; Hirokawa Y, 2004, CANCER J, V10, P20, DOI 10.1097/00130404-200401000-00006; Kaempchen K, 2003, HUM MOL GENET, V12, P1211, DOI 10.1093/hmg/ddg146; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Li QW, 2008, NEOPLASIA, V10, P314, DOI 10.1593/neo.07970; Lu H, 2006, J MED CHEM, V49, P3826, DOI 10.1021/jm0600388; Maksimoska J, 2008, J AM CHEM SOC, V130, P15764, DOI 10.1021/ja805555a; McDaniel AS, 2008, BLOOD, V112, P4646, DOI 10.1182/blood-2008-04-155085; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai Y, 2006, J NEUROSCI, V26, P3390, DOI 10.1523/JNEUROSCI.4865-05.2006; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Saydam O, 2011, J NEUROSCI METH, V195, P75, DOI 10.1016/j.jneumeth.2010.10.021; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Stamenkovic I, 2010, CURR PROTEIN PEPT SC, V11, P471, DOI 10.2174/138920310791824011; Tang Y, 1998, P NATL ACAD SCI USA, V95, P5139, DOI 10.1073/pnas.95.9.5139; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; VanderWel SN, 2005, J MED CHEM, V48, P2371, DOI 10.1021/jm049355+; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Wilkes MC, 2009, DEV CELL, V16, P433, DOI 10.1016/j.devcel.2009.01.009; Wong HK, 2010, CANCER RES, V70, P3483, DOI 10.1158/0008-5472.CAN-09-3107; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Yang FC, 2003, J CLIN INVEST, V112, P1851, DOI 10.1172/JCI200319195; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Ye Diana Zi, 2012, Cell Logist, V2, P105; Yi CL, 2008, CANCER RES, V68, P7932, DOI 10.1158/0008-5472.CAN-08-0866; Zhao Zhuo-Shen, 2012, Cell Logist, V2, P59; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452; Zuccotto F, 2010, J MED CHEM, V53, P2681, DOI 10.1021/jm901443h	48	96	100	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29105	29114		10.1074/jbc.M113.510933	http://dx.doi.org/10.1074/jbc.M113.510933			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23960073	Green Published, hybrid			2022-12-28	WOS:000330298800063
J	Vannier, C; Pesty, A; San-Roman, MJ; Schmidt, AA				Vannier, Christian; Pesty, Arlette; San-Roman, Mabel Jouve; Schmidt, Anne A.			The Bin/Amphiphysin/Rvs (BAR) Domain Protein Endophilin B2 Interacts with Plectin and Controls Perinuclear Cytoskeletal Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; MEMBRANE CURVATURE; INTERMEDIATE-FILAMENTS; AMPHIPATHIC HELICES; STRUCTURAL BASIS; SH3 DOMAIN; REGULATES AUTOPHAGY; NUCLEAR-ENVELOPE; FISSION; RECRUITMENT	Proteins of the Bin/amphiphysin/Rvs (BAR) domain superfamily are essential in controlling the shape and dynamics of intracellular membranes. Here, we present evidence for the unconventional function of a member of the endophilin family of BAR and Src homology 3 domain-containing proteins, namely endophilin B2, in the perinuclear organization of intermediate filaments. Using mass spectrometry analysis based on capturing endophilin B2 partners in in situ pre-established complexes in cells, we unravel the interaction of endophilin B2 with plectin 1, a variant of the cytoskeleton linker protein plectin as well as with vimentin. Endophilin B2 directly binds the N-terminal region of plectin 1 via Src homology 3-mediated interaction and vimentin indirectly via plectin-mediated interaction. The relevance of these interactions is strengthened by the selective and drastic reorganization of vimentin around nuclei upon overexpression of endophilin B2 and by the extensive colocalization of both proteins in a meshwork of perinuclear filamentous structures. By generating mutants of the endophilin B2 BAR domain, we show that this phenotype requires the BAR-mediated membrane binding activity of endophilin B2. Plectin 1 or endophilin B2 knockdown using RNA interference disturbed the perinuclear organization of vimentin. Altogether, these data suggest that the endophilin B2-plectin 1 complex functions as a membrane-anchoring device organizing and stabilizing the perinuclear network of vimentin filaments. Finally, we present evidence for the involvement of endophilin B2 and plectin 1 in nuclear positioning in individual cells. This points to the potential importance of the endophilin B2-plectin complex in the biological functions depending on nuclear migration and positioning.	[Vannier, Christian; Pesty, Arlette; San-Roman, Mabel Jouve; Schmidt, Anne A.] Univ Paris Diderot, Inst Jacques Monod, Sorbonne Paris Cite, CNRS,UMR7592, F-75205 Paris 13, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Schmidt, AA (corresponding author), Univ Paris Diderot, Inst Jacques Monod, Sorbonne Paris Cite, CNRS,UMR7592, 15 Rue Helene Brion, F-75205 Paris 13, France.	schmidt.anne@ijm.univ-paris-diderot.fr		Schmidt, Anne/0000-0002-8326-0937; Jouve San Roman, Mabel Juana/0000-0002-3115-4681	CNRS; La Ligue National Contre le Cancer, Comite de Paris	CNRS(Centre National de la Recherche Scientifique (CNRS)); La Ligue National Contre le Cancer, Comite de Paris	This work was supported by CNRS and by a grant from La Ligue National Contre le Cancer, Comite de Paris.	Abrahamsberg C, 2005, P NATL ACAD SCI USA, V102, P18449, DOI 10.1073/pnas.0505380102; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Burgstaller G, 2010, MOL BIOL CELL, V21, P3362, DOI 10.1091/mbc.E10-02-0094; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036; deHeuvel E, 1997, J BIOL CHEM, V272, P8710, DOI 10.1074/jbc.272.13.8710; Dupin I, 2011, INT J BIOCHEM CELL B, V43, P1698, DOI 10.1016/j.biocel.2011.09.004; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Gortat A, 2012, J BIOL CHEM, V287, P4232, DOI 10.1074/jbc.M111.325837; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hijikata T, 2008, J CELL SCI, V121, P2062, DOI 10.1242/jcs.021634; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Kabeche R, 2011, MOL BIOL CELL, V22, P4059, DOI 10.1091/mbc.E11-07-0605; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Karotki L, 2011, J CELL BIOL, V195, P889, DOI 10.1083/jcb.201104040; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Kirmse R, 2010, METHOD CELL BIOL, V96, P565, DOI 10.1016/S0091-679X(10)96023-8; Kjaerulff O, 2011, CELL BIOCHEM BIOPHYS, V60, P137, DOI 10.1007/s12013-010-9137-5; Konieczny P, 2008, J CELL BIOL, V181, P667, DOI 10.1083/jcb.200711058; Loll PJ, 2008, ACTA CRYSTALLOGR F, V64, P243, DOI 10.1107/S1744309108007574; Madsen KL, 2010, FEBS LETT, V584, P1848, DOI 10.1016/j.febslet.2010.01.053; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Masuda M, 2010, SEMIN CELL DEV BIOL, V21, P391, DOI 10.1016/j.semcdb.2010.01.010; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Mim C, 2012, TRENDS BIOCHEM SCI, V37, P526, DOI 10.1016/j.tibs.2012.09.001; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Morgan JT, 2011, MOL BIOL CELL, V22, P4324, DOI 10.1091/mbc.E11-04-0287; Niwa T, 2009, CANCER SCI, V100, P2115, DOI 10.1111/j.1349-7006.2009.01282.x; Olivera-Couto A, 2011, MOL BIOL CELL, V22, P2360, DOI 10.1091/mbc.E10-12-1021; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; Postel R, 2011, J CELL SCI, V124, P755, DOI 10.1242/jcs.081174; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Ralser M, 2005, HUM MOL GENET, V14, P2893, DOI 10.1093/hmg/ddi321; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rezniczek GA, 2004, METHOD CELL BIOL, V78, P721; Rezniczek GA, 1998, J CELL BIOL, V141, P209, DOI 10.1083/jcb.141.1.209; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rostovtseva TK, 2009, J BIOL CHEM, V284, P34390, DOI 10.1074/jbc.M109.021873; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Suetsugu S, 2012, TRENDS CELL BIOL, V22, P141, DOI 10.1016/j.tcb.2012.01.001; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Takahashi Y, 2011, AUTOPHAGY, V7, P61, DOI 10.4161/auto.7.1.14015; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Valencia RG, 2013, MOL BIOL CELL, V24, P768, DOI 10.1091/mbc.E12-06-0488; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; VIKSTROM KL, 1992, J CELL BIOL, V118, P121, DOI 10.1083/jcb.118.1.121; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wiche Gerhard, 2011, Bioarchitecture, V1, P14; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Yang JS, 2006, NAT CELL BIOL, V8, P1376, DOI 10.1038/ncb1503; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	75	11	11	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27619	27637		10.1074/jbc.M113.485482	http://dx.doi.org/10.1074/jbc.M113.485482			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23921385	hybrid, Green Published			2022-12-28	WOS:000330597300056
J	Jia, HL; Li, JS; Zhu, JG; Fan, TT; Qian, D; Zhou, YL; Wang, JJ; Ren, HY; Xiang, Y; An, LZ				Jia, Honglei; Li, Jisheng; Zhu, Jingen; Fan, Tingting; Qian, Dong; Zhou, Yuelong; Wang, Jiaojiao; Ren, Haiyun; Xiang, Yun; An, Lizhe			Arabidopsis CROLIN1, a Novel Plant Actin-binding Protein, Functions in Cross-linking and Stabilizing Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Arabidopsis; Cell Polarity; Plant; Plant Biochemistry; CROLIN1; Actin-cross-linking Protein; Novel Actin-binding Protein	II FORMIN FH5; POLLEN GERMINATION; MICROTUBULES; ORGANIZATION; CYTOSKELETON; GROWTH; HISACTOPHILIN; INTERACTS; DYNAMICS; ENCODES	Higher order actin filament structures are necessary for cytoplasmic streaming, organelle movement, and other physiological processes. However, the mechanism by which the higher order cytoskeleton is formed in plants remains unknown. In this study, we identified a novel actin-cross-linking protein family (named CROLIN) that is well conserved only in the plant kingdom. There are six isovariants of CROLIN in the Arabidopsis genome, with CROLIN1 specifically expressed in pollen. In vitro biochemical analyses showed that CROLIN1 is a novel actin-cross-linking protein with binding and stabilizing activities. Remarkably, CROLIN1 can cross-link actin bundles into actin networks. CROLIN1 loss of function induces pollen germination and pollen tube growth hypersensitive to latrunculin B. All of these results demonstrate that CROLIN1 may play an important role in stabilizing and remodeling actin filaments by binding to and cross-linking actin filaments.	[Jia, Honglei; Li, Jisheng; Zhu, Jingen; Fan, Tingting; Qian, Dong; Zhou, Yuelong; Xiang, Yun; An, Lizhe] Lanzhou Univ, Sch Life Sci, Minist Educ, Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China; [Wang, Jiaojiao; Ren, Haiyun] Beijing Normal Univ, Key Lab Cell Proliferat & Regulat Biol, Minist Educ, Beijing 100875, Peoples R China; [Wang, Jiaojiao; Ren, Haiyun] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Lanzhou University; Beijing Normal University; Beijing Normal University	Xiang, Y (corresponding author), Lanzhou Univ, Sch Life Sci, Minist Educ, Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China.	xiangy@lzu.edu.cn; lizhean@lzu.edu.cn	; Yang, Xiaoming/GRJ-9483-2022	Xiang, Yun/0000-0002-5178-0700; Yang, Xiaoming/0000-0002-1792-6921	National Basic Research Program [2014CB954200]; National Natural Science Foundation of China [31270326, 30800079]; Fundamental Research Funds for the Central Universities [lzujbky-2013-94]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Program Grant 2014CB954200, National Natural Science Foundation of China Grants 31270326 and 30800079, and Fundamental Research Funds for the Central Universities Grant lzujbky-2013-94 (to Y. X.).	Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Deeks MJ, 2010, J CELL SCI, V123, P1209, DOI 10.1242/jcs.065557; Fan TT, 2013, PLANT CELL REP, V32, P149, DOI 10.1007/s00299-012-1349-2; Gibbon BC, 1999, PLANT CELL, V11, P2349, DOI 10.1105/tpc.11.12.2349; Grazi E, 1997, FEBS LETT, V405, P249, DOI 10.1016/S0014-5793(97)00214-7; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Huang S, 2005, PLANT CELL, V17, P486, DOI 10.1105/tpc.104.028555; Huang SL, 2007, PLANT J, V51, P406, DOI 10.1111/j.1365-313X.2007.03153.x; Hussey PJ, 2002, PHILOS T R SOC B, V357, P791, DOI 10.1098/rstb.2002.1086; Ikawa T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.018101; Jawhari AU, 2003, AM J PATHOL, V162, P69, DOI 10.1016/S0002-9440(10)63799-6; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khurana P, 2010, PLANT CELL, V22, P2727, DOI 10.1105/tpc.110.076240; Kovar DR, 2000, PLANT J, V24, P625, DOI 10.1046/j.1365-313x.2000.00907.x; Li YH, 2010, PLANT CELL, V22, P2710, DOI 10.1105/tpc.110.075507; Liu CS, 2002, PROTEIN SCI, V11, P669, DOI 10.1110/ps.31702; Ma BY, 2012, J BIOL CHEM, V287, P19008, DOI 10.1074/jbc.M111.281873; Marrocco K, 2003, PLANT MOL BIOL, V52, P715, DOI 10.1023/A:1025056008926; MEAGHER RB, 1994, ARABIDOPSIS, P1049; Michelot A, 2006, CURR BIOL, V16, P1924, DOI 10.1016/j.cub.2006.07.054; Moes D, 2013, MOL PLANT, V6, P483, DOI 10.1093/mp/sss075; Papuga J, 2010, PLANT CELL, V22, P3034, DOI 10.1105/tpc.110.075960; Pintsch T, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-10; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Ren HY, 2007, PROTOPLASMA, V230, P171, DOI 10.1007/s00709-006-0231-x; Snowman BN, 2002, PLANT CELL, V14, P2613, DOI 10.1105/tpc.002998; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Staiger CJ, 2010, J EXP BOT, V61, P1969, DOI 10.1093/jxb/erq012; Staiger CJ, 2000, ANNU REV PLANT PHYS, V51, P257, DOI 10.1146/annurev.arplant.51.1.257; Tholl S, 2011, FEBS LETT, V585, P1821, DOI 10.1016/j.febslet.2011.05.019; Thomas C, 2006, PLANT CELL, V18, P2194, DOI 10.1105/tpc.106.040956; Thomas C, 2009, CELL MOTIL CYTOSKEL, V66, P940, DOI 10.1002/cm.20389; Wang HJ, 2008, PLANT PHYSIOL, V147, P1619, DOI 10.1104/pp.108.118604; Whippo CW, 2011, CURR BIOL, V21, P59, DOI 10.1016/j.cub.2010.11.059; Wu YJ, 2010, PLANT CELL, V22, P3745, DOI 10.1105/tpc.110.080283; Xiang Y, 2007, PLANT CELL, V19, P1930, DOI 10.1105/tpc.106.048413; Xue XH, 2011, MOL PLANT, V4, P264, DOI 10.1093/mp/ssq085; Yang WB, 2011, PLANT CELL, V23, P661, DOI 10.1105/tpc.110.081802; Ye JR, 2009, PLANT CELL, V21, P3868, DOI 10.1105/tpc.109.068700; Zhang H, 2010, PLANT CELL, V22, P2749, DOI 10.1105/tpc.110.076257; Zhang Y, 2011, NEW PHYTOL, V190, P667, DOI 10.1111/j.1469-8137.2010.03632.x; Zhang Z, 2011, PLANT CELL, V23, P681, DOI 10.1105/tpc.110.081349; Zhao Y, 2011, PLANT CELL, V23, P2314, DOI 10.1105/tpc.111.086546	43	29	31	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32277	32288		10.1074/jbc.M113.483594	http://dx.doi.org/10.1074/jbc.M113.483594			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072702	hybrid, Green Published			2022-12-28	WOS:000328681700015
J	Sana, B; Johnson, E; Le Magueres, P; Criswell, A; Cascio, D; Lim, S				Sana, Barindra; Johnson, Eric; Le Magueres, Pierre; Criswell, Angela; Cascio, Duilio; Lim, Sierin			The Role of Nonconserved Residues of Archaeoglobus fulgidus Ferritin on Its Unique Structure and Biophysical Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Enzyme Kinetics; Ferritin; Mutant; Protein Engineering; Archaeoglobus fulgidus; Protein Nanocage	HYPERTHERMOPHILIC ARCHAEON; PROTEIN NANOCAGES; H-CHAIN; IRON; PORES; MECHANISM; CHANNELS; SYSTEM; SITE	Background:Archaeoglobus fulgidus ferritin (AfFtn) assembles with unique tetrahedral symmetry and four large pores. Results: The AfFtn K150A/R151A double mutant forms a closed octahedral assembly with reduced iron release rates relative to the tetrahedral assembly. Conclusion: The K150A/R151A substitution alters the symmetry type of the ferritin cage. Significance: The AfFtn can be modulated for tuning molecular release from the cavity. Archaeoglobus fulgidus ferritin (AfFtn) is the only tetracosameric ferritin known to form a tetrahedral cage, a structure that remains unique in structural biology. As a result of the tetrahedral (2-3) symmetry, four openings (approximate to 45 in diameter) are formed in the cage. This open tetrahedral assembly contradicts the paradigm of a typical ferritin cage: a closed assembly having octahedral (4-3-2) symmetry. To investigate the molecular mechanism affecting this atypical assembly, amino acid residues Lys-150 and Arg-151 were replaced by alanine. The data presented here shed light on the role that these residues play in shaping the unique structural features and biophysical properties of the AfFtn. The x-ray crystal structure of the K150A/R151A mutant, solved at 2.1 resolution, indicates that replacement of these key residues flips a symmetry switch. The engineered molecule no longer assembles with tetrahedral symmetry but forms a typical closed octahedral ferritin cage. Small angle x-ray scattering reveals that the overall shape and size of AfFtn and AfFtn-AA in solution are consistent with those observed in their respective crystal structures. Iron binding and release kinetics of the AfFtn and AfFtn-AA were investigated to assess the contribution of cage openings to the kinetics of iron oxidation, mineralization, or reductive iron release. Identical iron binding kinetics for AfFtn and AfFtn-AA suggest that Fe2+ ions do not utilize the triangular pores for access to the catalytic site. In contrast, relatively slow reductive iron release was observed for the closed AfFtn-AA, demonstrating involvement of the large pores in the pathway for iron release.	[Sana, Barindra; Lim, Sierin] Nanyang Technol Univ, Div Bioengn, Sch Chem & Biomed Engn, Singapore 637457, Singapore; [Johnson, Eric] CALTECH, Div Chem & Chem Engn, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Le Magueres, Pierre; Criswell, Angela] Rigaku Amer, The Woodlands, TX 77381 USA; [Cascio, Duilio] UCLA DOE, Inst Genom & Prote, Los Angeles, CA 90095 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; California Institute of Technology; Howard Hughes Medical Institute; Rigaku Corporation; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Cascio, D (corresponding author), UCLA DOE, Inst Genom & Prote, Los Angeles, CA 90095 USA.	cascio@mbi.ucla.edu; slim@ntu.sg	Lim, Sierin/G-6109-2010	Lim, Sierin/0000-0001-7455-6771; Johnson, Eric/0000-0002-2909-865X	DOE [DE-FC02-02ER63421]; National Center for Research Resources [5P41RR015301-10]; National Institute of General Medical Sciences from the National Institutes of Health [8 P41 GM103403-10]; Department of Energy [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Prof. Imke Schroeder (UCLA) and Prof. Wilfred R. Hagen (Delft University of Technology) for the generous gifts of AfFtn, AfFtn-AA, and PfFtn plasmids, respectively. We thank M. Sawaya and the UCLA-DOE X-ray Crystallography Core Facility, which is supported by DOE Grant DE-FC02-02ER63421. We thank M. Capel, K. Rajashankar, N. Sukumar, J. Schuermann, I. Kourinov, and F. Murphy (Northeastern Collaborative Access Team Beamline 24-ID at Advanced Photon Source, which is supported by National Center for Research Resources Grant 5P41RR015301-10 and National Institute of General Medical Sciences Grant 8 P41 GM103403-10 from the National Institutes of Health). Use of the Advanced Photon Source is supported by the Department of Energy under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPHICS S; Bertini I, 2012, J AM CHEM SOC, V134, P6169, DOI 10.1021/ja210084n; BONOMI F, 1986, EUR J BIOCHEM, V155, P295, DOI 10.1111/j.1432-1033.1986.tb09489.x; Butts CA, 2008, BIOCHEMISTRY-US, V47, P12729, DOI 10.1021/bi8016735; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Douglas T, 1998, PROTEIN SCI, V7, P1083, DOI 10.1002/pro.5560070502; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Haldar S, 2011, J BIOL CHEM, V286, P25620, DOI 10.1074/jbc.M110.205278; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; Johnson E, 2005, STRUCTURE, V13, P637, DOI 10.1016/j.str.2005.01.019; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEVI S, 1988, J BIOL CHEM, V263, P18086; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Matias PM, 2005, ACTA CRYSTALLOGR F, V61, P503, DOI 10.1107/S1744309105011516; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; Swift J, 2009, LANGMUIR, V25, P5219, DOI 10.1021/la8040743; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0; Tatur J, 2007, J BIOL INORG CHEM, V12, P615, DOI 10.1007/s00775-007-0212-3; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Theil EC, 2008, INORG CHIM ACTA, V361, P868, DOI 10.1016/j.ica.2007.08.025; Theil EC, 2011, CURR OPIN CHEM BIOL, V15, P304, DOI 10.1016/j.cbpa.2011.01.004; Tosha T, 2012, J BIOL CHEM, V287, P13016, DOI 10.1074/jbc.M111.332734; Tosha T, 2010, J AM CHEM SOC, V132, P14562, DOI 10.1021/ja105583d; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Voss NR, 2005, J MOL BIOL, V346, P477, DOI 10.1016/j.jmb.2004.11.072; WESSON L, 1992, PROTEIN SCI, V1, P227	37	33	33	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32663	32672		10.1074/jbc.M113.491191	http://dx.doi.org/10.1074/jbc.M113.491191			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24030827	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000328681700051
J	Dertli, E; Colquhoun, IJ; Gunning, AP; Bongaerts, RJ; Le Gall, G; Bonev, BB; Mayer, MJ; Narbad, A				Dertli, Enes; Colquhoun, Ian J.; Gunning, A. Patrick; Bongaerts, Roy J.; Le Gall, Gwenaelle; Bonev, Boyan B.; Mayer, Melinda J.; Narbad, Arjan			Structure and Biosynthesis of Two Exopolysaccharides Produced by Lactobacillus johnsonii FI9785	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-ANALYSIS; MOLECULAR CHARACTERIZATION; GENE-CLUSTER; GLUCAN; STREPTOCOCCUS; GLUCANSUCRASE; ENZYMES; GLYCOSYLTRANSFERASES; POLYSACCHARIDE; IDENTIFICATION	Exopolysaccharides were isolated and purified from Lactobacillus johnsonii FI9785, which has previously been shown to act as a competitive exclusion agent to control Clostridium perfringens in poultry. Structural analysis by NMR spectroscopy revealed that L. johnsonii FI9785 can produce two types of exopolysaccharide: EPS-1 is a branched dextran with the unusual feature that every backbone residue is substituted with a 2-linked glucose unit, and EPS-2 was shown to have a repeating unit with the following structure: -6)-alpha-Glcp-(1-3)-beta-Glcp-(1-5)-beta-Galf-(1-6)-alpha-Glcp-(1-4)-beta-Galp-(1-4)-beta-Glcp-(1-. Siteson both polysaccharides were partially occupied by substituent groups: 1-phosphoglycerol and O-acetyl groups in EPS-1 and a single O-acetyl group in EPS-2. Analysis of a deletion mutant (Delta epsE) lacking the putative priming glycosyltransferase gene located within a predicted eps gene cluster revealed that the mutant could produce EPS-1 but not EPS-2, indicating that epsE is essential for the biosynthesis of EPS-2. Atomic force microscopy confirmed the localization of galactose residues on the exterior of wild type cells and their absence in the Delta epsE mutant. EPS2 was found to adopt a random coil structural conformation. Deletion of the entire 14-kb eps cluster resulted in an acapsular mutant phenotype that was not able to produce either EPS-2 or EPS-1. Alterations in the cell surface properties of the EPS-specific mutants were demonstrated by differences in binding of an anti-wild type L. johnsonii antibody. These findings provide insights into the biosynthesis and structures of novel exopolysaccharides produced by L. johnsonii FI9785, which are likely to play an important role in biofilm formation, protection against harsh environment of the gut, and colonization of the host.	[Dertli, Enes; Mayer, Melinda J.; Narbad, Arjan] Inst Food Res, Gut Hlth & Food Safety Programme, Norwich NR4 7UA, Norfolk, England; [Dertli, Enes] Bayburt Univ, Dept Food Engn, Fac Engn, TR-69000 Bayburt, Turkey; [Colquhoun, Ian J.; Bongaerts, Roy J.; Le Gall, Gwenaelle] Univ Nottingham, Inst Food Res, Analyt Sci Unit, Nottingham NG7 2UH, England; [Gunning, A. Patrick] Univ Nottingham, Inst Food Res, Food & Hlth Programme, Nottingham NG7 2UH, England; [Bonev, Boyan B.] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2UH, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Bayburt University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of Nottingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of Nottingham; University of Nottingham	Mayer, MJ (corresponding author), Inst Food Res, Gut Hlth & Food Safety Programme, Norwich NR4 7UA, Norfolk, England.	Melinda.Mayer@ifr.ac.uk	Dertli, enes/AAZ-4384-2020; Le Gall, Gwenaelle/HDL-8283-2022	Le Gall, Gwenaelle/0000-0002-1379-2196; Bonev, Boyan/0000-0001-7156-2412	Biotechnology and Biological Science Research Council (BBSRC) [BB/J004529/1, BB/J004545/1]; European Union FP7 TORNADO program; Turkish Ministry of Education; BBSRC [BB/C510924]; BBSRC [BBS/E/F/00044453] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044453] Funding Source: researchfish	Biotechnology and Biological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union FP7 TORNADO program; Turkish Ministry of Education(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Biotechnology and Biological Science Research Council (BBSRC) Strategic Core Grants BB/J004529/1 and BB/J004545/1 and the European Union FP7 TORNADO program.; Supported by the Turkish Ministry of Education.; Recipient of instrument funding from BBSRC Grant BB/C510924 and a contribution from Varian Inc. (Agilent Technologies).	Alp G, 2010, MICROBIOL IMMUNOL, V54, P658, DOI 10.1111/j.1348-0421.2010.00227.x; Badel S, 2011, BIOTECHNOL ADV, V29, P54, DOI 10.1016/j.biotechadv.2010.08.011; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Cescutti P, 1998, EUR J BIOCHEM, V251, P971, DOI 10.1046/j.1432-1327.1998.2510971.x; Ciesielski F, 2009, CHEM PHYS LIPIDS, V161, P77, DOI 10.1016/j.chemphyslip.2009.07.001; Cieslewicz MJ, 2001, J BIOL CHEM, V276, P139, DOI 10.1074/jbc.M005702200; De Vuyst L, 1999, FEMS MICROBIOL REV, V23, P153, DOI 10.1016/S0168-6445(98)00042-4; Delcour J, 1999, ANTON LEEUW INT J G, V76, P159, DOI 10.1023/A:1002089722581; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; Deutsch SM, 2012, APPL ENVIRON MICROB, V78, P1765, DOI 10.1128/AEM.07027-11; Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769; Faber EJ, 2001, CARBOHYD RES, V331, P173, DOI 10.1016/S0008-6215(01)00013-1; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Flory P., 1998, STAT MECH CHAIN MOL; Gorska S, 2010, CARBOHYD RES, V345, P108, DOI 10.1016/j.carres.2009.09.015; Gunning AP, 2008, FASEB J, V22, P2331, DOI 10.1096/fj.07-100578; Haas A, 2011, GUT, V60, P1506, DOI 10.1136/gut.2010.224774; Hidalgo-Cantabrana C, 2012, PROBIOTICS ANTIMICRO, V4, P227, DOI 10.1007/s12602-012-9110-2; Horn N, 2005, PLASMID, V54, P176, DOI 10.1016/j.plasmid.2005.01.005; Horn N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059957; Iwamori M, 2009, J BIOCHEM, V146, P185, DOI 10.1093/jb/mvp058; Jolly L, 2002, GLYCOBIOLOGY, V12, P319, DOI 10.1093/glycob/12.5.319; Kitazawa H, 1998, INT J FOOD MICROBIOL, V40, P169, DOI 10.1016/S0168-1605(98)00030-0; Kralj S, 2002, APPL ENVIRON MICROB, V68, P4283, DOI 10.1128/AEM.68.9.4283-4291.2002; Kralj S, 2004, MICROBIOL-SGM, V150, P3681, DOI 10.1099/mic.0.27321-0; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; La Ragione RM, 2004, LETT APPL MICROBIOL, V38, P197, DOI 10.1111/j.1472-765X.2004.01474.x; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lin MH, 2011, J BIOL CHEM, V286, P17736, DOI 10.1074/jbc.M110.200113; Looijesteijn PJ, 2001, INT J FOOD MICROBIOL, V64, P71, DOI 10.1016/S0168-1605(00)00437-2; Luzhetskyy A, 2008, APPL MICROBIOL BIOT, V80, P945, DOI 10.1007/s00253-008-1672-2; MacKenzie DA, 2010, MICROBIOL-SGM, V156, P3368, DOI 10.1099/mic.0.043265-0; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Maina NH, 2008, CARBOHYD RES, V343, P1446, DOI 10.1016/j.carres.2008.04.012; Minic Z, 2007, J BACTERIOL, V189, P1351, DOI 10.1128/JB.01122-06; Morona JK, 2003, J BACTERIOL, V185, P3009, DOI 10.1128/JB.185.10.3009-3019.2003; Paulo EM, 2012, AN ACAD BRAS CIENC, V84, P495, DOI 10.1590/S0001-37652012000200018; Robijn GW, 1996, CARBOHYD RES, V285, P129, DOI 10.1016/0008-6215(96)00034-1; ROBIJN GW, 1995, CARBOHYD RES, V276, P117, DOI 10.1016/0008-6215(95)00172-P; Rodriguez-Carvajal MA, 2008, CARBOHYD RES, V343, P3066, DOI 10.1016/j.carres.2008.08.028; Sato T, 2004, J FOOD PROTECT, V67, P1719, DOI 10.4315/0362-028X-67.8.1719; Sims IM, 2011, ISME J, V5, P1115, DOI 10.1038/ismej.2010.201; Staaf M, 2000, CARBOHYD RES, V326, P113, DOI 10.1016/S0008-6215(00)00027-6; Suo ZY, 2007, LANGMUIR, V23, P1365, DOI 10.1021/la0621721; Suo ZY, 2009, LANGMUIR, V25, P4588, DOI 10.1021/la8033319; SUTHERLAND IW, 1970, EUR J BIOCHEM, V12, P285, DOI 10.1111/j.1432-1033.1970.tb00848.x; SUTHERLAND IW, 1968, BIOCHEM J, V110, P749, DOI 10.1042/bj1100749; Tallon R, 2003, RES MICROBIOL, V154, P705, DOI 10.1016/j.resmic.2003.09.006; van de Velde F, 2004, CARBOHYD RES, V339, P2309, DOI 10.1016/j.carres.2004.07.015; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; van Leeuwen SS, 2008, CARBOHYD RES, V343, P1237, DOI 10.1016/j.carres.2008.01.042; vanKranenburg R, 1997, MOL MICROBIOL, V24, P387, DOI 10.1046/j.1365-2958.1997.3521720.x; Wegmann U, 1999, APPL ENVIRON MICROB, V65, P4729	55	81	82	6	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31938	31951		10.1074/jbc.M113.507418	http://dx.doi.org/10.1074/jbc.M113.507418			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24019531	Green Published, hybrid			2022-12-28	WOS:000330596200046
J	West, MB; Chen, YY; Wickham, S; Heroux, A; Cahill, K; Hanigan, MH; Mooers, BHM				West, Matthew B.; Chen, Yunyu; Wickham, Stephanie; Heroux, Ann; Cahill, Kyle; Hanigan, Marie H.; Mooers, Blaine H. M.			Novel Insights into Eukaryotic gamma-Glutamyltranspeptidase 1 from the Crystal Structure of the Glutamate-bound Human Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; CATALYTIC MECHANISM; ESCHERICHIA-COLI; PHASE-I; TRANSFERASE; GLYCOSYLATION; GLUTATHIONE; ACIVICIN; SEQUENCE; PROTEIN	The enzyme gamma-glutamyltranspeptidase 1 (GGT1) is a conserved member of the N-terminal nucleophile hydrolase family that cleaves the gamma-glutamyl bond of glutathione and other gamma-glutamyl compounds. In animals, GGT1 is expressed on the surface of the cell and has critical roles in maintaining cysteine levels in the body and regulating intracellular redox status. Expression of GGT1 has been implicated as a potentiator of asthma, cardiovascular disease, and cancer. The rational design of effective inhibitors of human GGT1(hGGT1) has been delayed by the lack of a reliable structural model. The available crystal structures of several bacterial GGTs have been of limited use due to differences in the catalytic behavior of bacterial and mammalian GGTs. We report the high resolution (1.67 angstrom) crystal structure of glutamate-bound hGGT1, the first of any eukaryotic GGT. Comparisons of the active site architecture of hGGT1 with those of its bacterial orthologs highlight key differences in the residues responsible for substrate binding, including a bimodal switch in the orientation of the catalytic nucleophile (Thr-381) that is unique to the human enzyme. Compared with several bacterial counterparts, the lid loop in the crystal structure of hGGT1 adopts an open conformation that allows greater access to the active site. The hGGT1 structure also revealed tightly bound chlorides near the catalytic residue that may contribute to catalytic activity. These are absent in the bacterial GGTs. These differences between bacterial and mammalian GGTs and the new structural data will accelerate the development of new therapies for GGT1-dependent diseases.	[West, Matthew B.; Wickham, Stephanie; Hanigan, Marie H.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Chen, Yunyu; Cahill, Kyle; Mooers, Blaine H. M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Hanigan, Marie H.; Mooers, Blaine H. M.] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK 73104 USA; [Heroux, Ann] Brookhaven Natl Lab, Upton, NY 11973 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; United States Department of Energy (DOE); Brookhaven National Laboratory	Mooers, BHM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, 975 NE 10th St,BRC 466, Oklahoma City, OK 73104 USA.	blaine-mooers@ouhsc.edu	Mooers, Blaine/S-4383-2017	Mooers, Blaine/0000-0001-8181-8987	United States Department of Energy Offices of Biological and Environmental Research; Basic Energy Sciences; National Institutes of Health [P41RR012408, P41GM103473]; NATIONAL CANCER INSTITUTE [R56CA057530, F32CA128338] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473, P20GM103640] Funding Source: NIH RePORTER	United States Department of Energy Offices of Biological and Environmental Research(United States Department of Energy (DOE)); Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Donald Capra for a critical review of the manuscript. X-ray diffraction data were collected at the National Synchrotron Light Source, for which financial support comes principally from the United States Department of Energy Offices of Biological and Environmental Research and of Basic Energy Sciences and from National Institutes of Health Grants P41RR012408 and P41GM103473.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALLISON RD, 1985, METHOD ENZYMOL, V113, P419; Boanca G, 2007, J BIOL CHEM, V282, P534, DOI 10.1074/jbc.M607694200; Boanca G, 2006, J BIOL CHEM, V281, P19029, DOI 10.1074/jbc.M603381200; Castellano I, 2012, CELL MOL LIFE SCI, V69, P3381, DOI 10.1007/s00018-012-0988-3; Castonguay R, 2007, BIOCHEMISTRY-US, V46, P12253, DOI 10.1021/bi700956c; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cooper AJL, 2010, COMPREHENSIVE TOXICOLOGY, VOL 4: BIOTRANSFORMATION, 2ND EDITION, P323; CURTHOYS NP, 1979, ENZYME, V24, P383, DOI 10.1159/000458694; Diergaarde B, 2010, PANCREATOLOGY, V10, P194, DOI 10.1159/000236023; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; EARHART RH, 1983, CANCER TREAT REP, V67, P683; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; ELCE JS, 1976, BIOCHEM J, V153, P223, DOI 10.1042/bj1530223; Emdin M, 2005, CIRCULATION, V112, P2078, DOI 10.1161/CIRCULATIONAHA.105.571919; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FLEISHMAN G, 1983, CANCER TREAT REP, V67, P843; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; HANIGAN MH, 1993, BIOCHEMISTRY-US, V32, P6302, DOI 10.1021/bi00075a026; Hidalgo M, 1998, CLIN CANCER RES, V4, P2763; Hu X, 2012, BIOCHEMISTRY-US, V51, P1199, DOI 10.1021/bi200987b; IKEDA Y, 1993, J BIOL CHEM, V268, P3980; IKEDA Y, 1995, J BIOL CHEM, V270, P22223, DOI 10.1074/jbc.270.38.22223; Ikeda Y, 1996, J BIOCHEM-TOKYO, V119, P1166; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; King JB, 2009, J BIOL CHEM, V284, P9059, DOI 10.1074/jbc.M809608200; Kinlough CL, 2005, METHOD ENZYMOL, V401, P426, DOI 10.1016/S0076-6879(05)01026-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Lodola A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032397; Lowry MH, 2008, AM J RESP CELL MOL, V38, P509, DOI 10.1165/rcmb.2007-0128OC; Minami H, 2003, ENZYME MICROB TECH, V32, P431, DOI 10.1016/S0141-0229(02)00314-9; Morrow AL, 2007, BIOCHEMISTRY-US, V46, P13407, DOI 10.1021/bi701599e; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; Okada T, 2007, J BIOL CHEM, V282, P2433, DOI 10.1074/jbc.M607490200; RAJPERTDEMEYTS E, 1988, P NATL ACAD SCI USA, V85, P8840, DOI 10.1073/pnas.85.23.8840; Rojas E, 2000, MUTAT RES-FUND MOL M, V447, P305, DOI 10.1016/S0027-5107(99)00191-8; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; SIAN J, 1994, ANN NEUROL, V36, P356, DOI 10.1002/ana.410360306; Suzuki H, 2002, J BIOL CHEM, V277, P43536, DOI 10.1074/jbc.M207680200; SUZUKI H, 1986, J BACTERIOL, V168, P1325, DOI 10.1128/jb.168.3.1325-1331.1986; Taniguchi N, 1998, ADV ENZYMOL RAMB, V72, P239; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorn A, 2011, J APPL CRYSTALLOGR, V44, P1285, DOI [10.1107/S00218898110417681285, 10.1107/S0021889811041768]; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wada K, 2010, FEBS J, V277, P1000, DOI 10.1111/j.1742-4658.2009.07543.x; West MB, 2013, ANTIOXID REDOX SIGN, V19, P1877, DOI 10.1089/ars.2012.4997; West MB, 2011, J BIOL CHEM, V286, P28876, DOI 10.1074/jbc.M111.248823; West MB, 2010, J BIOL CHEM, V285, P29511, DOI 10.1074/jbc.M110.145938; Wickham S, 2013, BIOCHEM J, V450, P547, DOI 10.1042/BJ20121435; Wickham S, 2012, J ENZYM INHIB MED CH, V27, P476, DOI 10.3109/14756366.2011.597748; Wickham S, 2011, ANAL BIOCHEM, V414, P208, DOI 10.1016/j.ab.2011.03.026	55	54	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31902	31913		10.1074/jbc.M113.498139	http://dx.doi.org/10.1074/jbc.M113.498139			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047895	Green Published, hybrid			2022-12-28	WOS:000330596200039
J	Fahie, M; Romano, FB; Chisholm, C; Heuck, AP; Zbinden, M; Chen, M				Fahie, Monifa; Romano, Fabian B.; Chisholm, Christina; Heuck, Alejandro P.; Zbinden, Mark; Chen, Min			A Non-classical Assembly Pathway of Escherichia coli Pore-forming Toxin Cytolysin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE VESICLES; HEMOLYSIN-E HLYE; CHOLESTEROL-DEPENDENT CYTOLYSIN; HEPTAMERIC TRANSMEMBRANE PORE; CRYSTAL-STRUCTURE; ANTHRAX TOXIN; PROTECTIVE ANTIGEN; BACTERIAL TOXINS; CLYA; PROTEIN	Cytolysin A (ClyA) is an alpha-pore forming toxin from pathogenic Escherichia coli (E. coli) and Salmonella enterica. Here, we report that E. coli ClyA assembles into an oligomeric structure in solution in the absence of either bilayer membranes or detergents at physiological temperature. These oligomers can rearrange to create transmembrane pores when in contact with detergents or biological membranes. Intrinsic fluorescence measurements revealed that oligomers adopted an intermediate state found during the transition between monomer and transmembrane pore. These results indicate that the water-soluble oligomer represents a prepore intermediate state. Furthermore, we show that ClyA does not form transmembrane pores on E. coli lipid membranes. Because ClyA is delivered to the target host cell in an oligomeric conformation within outer membrane vesicles (OMVs), our findings suggest ClyA forms a prepore oligomeric structure independently of the lipid membrane within the OMV. The proposed model for ClyA represents a non-classical pathway to attack eukaryotic host cells.	[Fahie, Monifa; Chisholm, Christina; Zbinden, Mark; Chen, Min] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Romano, Fabian B.; Heuck, Alejandro P.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Chen, M (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.	mchen1@chem.umass.edu	Romano-Chernac, Fabian B./K-9396-2019	Fahie, Monifa/0000-0002-3747-9735	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008515] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008515] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atkins A, 2000, J BIOL CHEM, V275, P41150, DOI 10.1074/jbc.M005420200; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bradley KA, 2003, BIOCHEM PHARMACOL, V65, P309, DOI 10.1016/S0006-2952(02)01455-7; Chen DJ, 2010, P NATL ACAD SCI USA, V107, P3099, DOI 10.1073/pnas.0805532107; Chen M, 2008, P NATL ACAD SCI USA, V105, P6272, DOI 10.1073/pnas.0711561105; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; delCastillo FJ, 1997, MOL MICROBIOL, V25, P107, DOI 10.1046/j.1365-2958.1997.4391813.x; Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; Heuck AP, 2010, SUBCELL BIOCHEM, V51, P551, DOI 10.1007/978-90-481-8622-8_20; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Horstman AL, 2002, J BIOL CHEM, V277, P32538, DOI 10.1074/jbc.M203740200; Hunt S, 2008, MICROBIOL-SGM, V154, P633, DOI 10.1099/mic.0.2007/011700-0; Hunt S, 2010, ADV EXP MED BIOL, V677, P116; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lai XH, 2000, INFECT IMMUN, V68, P4363, DOI 10.1128/IAI.68.7.4363-4367.2000; Ludwig A, 1999, MOL MICROBIOL, V31, P557, DOI 10.1046/j.1365-2958.1999.01196.x; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Opota O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002259; Oscarsson J, 2002, INFECT IMMUN, V70, P5759, DOI 10.1128/IAI.70.10.5759-5769.2002; Oscarsson J, 1999, MOL MICROBIOL, V32, P1226, DOI 10.1046/j.1365-2958.1999.01435.x; Oscarsson J, 1996, MOL MICROBIOL, V20, P191, DOI 10.1111/j.1365-2958.1996.tb02500.x; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Reingold J, 1999, VET MICROBIOL, V66, P125, DOI 10.1016/S0378-1135(98)00310-1; ROWE GE, 1994, METHOD ENZYMOL, V235, P657; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Soderblom T, 2005, CELL MICROBIOL, V7, P779, DOI 10.1111/j.1462-5822.2005.00510.x; Soskine M, 2012, NANO LETT, V12, P4895, DOI 10.1021/nl3024438; Thompson JR, 2011, BIOPHYS J, V101, P2679, DOI 10.1016/j.bpj.2011.09.054; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Tzokov SB, 2006, J BIOL CHEM, V281, P23042, DOI 10.1074/jbc.M602421200; von Rhein C, 2009, INT J MED MICROBIOL, V299, P21, DOI 10.1016/j.ijmm.2008.06.004; WAI SN, 1995, MICROBIOL IMMUNOL, V39, P451, DOI 10.1111/j.1348-0421.1995.tb02228.x; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; WALKER B, 1995, CHEM BIOL, V2, P99, DOI 10.1016/1074-5521(95)90282-1; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	47	32	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31042	31051		10.1074/jbc.M113.475350	http://dx.doi.org/10.1074/jbc.M113.475350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24019520	Green Published, hybrid			2022-12-28	WOS:000330778900023
J	Vasudevan, D; Rao, SPS; Noble, CG				Vasudevan, Dileep; Rao, Srinivasa P. S.; Noble, Christian G.			Structural Basis of Mycobacterial Inhibition by Cyclomarin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPARATIVE GENOMICS; CRYSTAL-STRUCTURE; ADAPTER PROTEIN; AAA+ PROTEASES; TUBERCULOSIS; CLPP; CHAPERONE; ANTIBIOTICS; MECHANISM; MACHINES	Cyclomarin A (CymA) was identified as a mycobactericidal compound targeting ClpC1. However, the target was identified based on pulldown experiments and in vitro binding data, without direct functional evidence in mycobacteria. Here we show that CymA specifically binds to the N-terminal domain of ClpC1. In addition we have determined the co-crystal structure of CymA bound to the N-terminal domain of ClpC1 to high resolution. Based on the structure of the complex several mutations were engineered into ClpC1, which showed reduced CymA binding in vitro. The ClpC1 mutants were overexpressed in mycobacteria and two showed resistance to CymA, providing the first direct evidence that ClpC1 is the target of CymA. Phe(80) is important in vitro and in cells for the ClpC1-CymA interaction and this explains why other bacteria are resistant to CymA. A model for how CymA binding to the N-terminal domain of ClpC1 leads to uncontrolled proteolysis by the associated ClpP protease machinery is discussed.	[Vasudevan, Dileep; Rao, Srinivasa P. S.; Noble, Christian G.] Novartis Inst Trop Dis, Singapore 138670, Singapore	Novartis	Noble, CG (corresponding author), 10 Biopolis Rd,05-01 Chromos, Singapore 138670, Singapore.	christian.noble@novartis.com	Vasudevan, Dileep/AAR-4748-2021	Vasudevan, Dileep/0000-0001-5568-628X				Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chandu D, 2004, RES MICROBIOL, V155, P710, DOI 10.1016/j.resmic.2004.06.003; Dye C, 2008, LANCET INFECT DIS, V8, P233, DOI 10.1016/S1473-3099(07)70291-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Ferenczy GG, 2010, DRUG DISCOV TODAY, V15, P919, DOI 10.1016/j.drudis.2010.08.013; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Kar NP, 2008, FEBS J, V275, P6149, DOI 10.1111/j.1742-4658.2008.06738.x; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kirstein J, 2009, EMBO MOL MED, V1, P37, DOI 10.1002/emmm.200900002; Kress W, 2009, RES MICROBIOL, V160, P618, DOI 10.1016/j.resmic.2009.08.006; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Li JZ, 2003, STRUCTURE, V11, P323, DOI 10.1016/S0969-2126(03)00030-3; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Mogk A, 2004, J STRUCT BIOL, V146, P90, DOI 10.1016/j.jsb.2003.10.009; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Ribeiro-Guimaraes ML, 2007, MICROB PATHOGENESIS, V43, P173, DOI 10.1016/j.micpath.2007.05.010; Sass P, 2011, P NATL ACAD SCI USA, V108, P17474, DOI 10.1073/pnas.1110385108; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Villemagne B, 2012, EUR J MED CHEM, V51, P1, DOI 10.1016/j.ejmech.2012.02.033; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	33	73	74	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30883	30891		10.1074/jbc.M113.493767	http://dx.doi.org/10.1074/jbc.M113.493767			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24022489	Green Published, hybrid			2022-12-28	WOS:000330778900009
J	Yang, J; Hocking, DM; Cheng, C; Dogovski, C; Perugini, MA; Holien, JK; Parker, MW; Hartland, EL; Tauschek, M; Robins-Browne, RM				Yang, Ji; Hocking, Dianna M.; Cheng, Catherine; Dogovski, Con; Perugini, Matthew A.; Holien, Jessica K.; Parker, Michael W.; Hartland, Elizabeth L.; Tauschek, Marija; Robins-Browne, Roy M.			Disarming Bacterial Virulence through Chemical Inhibition of the DNA Binding Domain of an AraC-like Transcriptional Activator Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIBRIO-CHOLERAE VIRULENCE; CITROBACTER-RODENTIUM; REGULATORY PROTEIN; EXPRESSION; INTIMIN; TYRR; REGA; COLONIZATION; INFECTIONS; STRATEGIES	The misuse of antibiotics during past decades has led to pervasive antibiotic resistance in bacteria. Hence, there is an urgent need for the development of new and alternative approaches to combat bacterial infections. In most bacterial pathogens the expression of virulence is tightly regulated at the transcriptional level. Therefore, targeting pathogens with drugs that interfere with virulence gene expression offers an effective alternative to conventional antimicrobial chemotherapy. Many Gram-negative intestinal pathogens produce AraC-like proteins that control the expression of genes required for infection. In this study we investigated the prototypical AraC-like virulence regulator, RegA, from the mouse attaching and effacing pathogen, Citrobacter rodentium, as a potential drug target. By screening a small molecule chemical library and chemical optimization, we identified two compounds that specifically inhibited the ability of RegA to activate its target promoters and thus reduced expression of a number of proteins required for virulence. Biophysical, biochemical, genetic, and computational analyses indicated that the more potent of these two compounds, which we named regacin, disrupts the DNA binding capacity of RegA by interacting with amino acid residues within a conserved region of the DNA binding domain. Oral administration of regacin to mice, commencing 15 min before or 12 h after oral inoculation with C. rodentium, caused highly significant attenuation of intestinal colonization by the mouse pathogen comparable to that of an isogenic regA-deletion mutant. These findings demonstrate that chemical inhibition of the DNA binding domains of transcriptional regulators is a viable strategy for the development of antimicrobial agents that target bacterial pathogens.	[Yang, Ji; Hocking, Dianna M.; Cheng, Catherine; Hartland, Elizabeth L.; Tauschek, Marija; Robins-Browne, Roy M.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Dogovski, Con; Perugini, Matthew A.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Holien, Jessica K.; Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Holien, Jessica K.; Parker, Michael W.] St Vincents Inst Med Res, Australian Canc Res Fdn, Rat Drug Discovery Ctr, Fitzroy, Vic 3065, Australia; [Perugini, Matthew A.; Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Hartland, Elizabeth L.; Robins-Browne, Roy M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of Melbourne; La Trobe University; St. Vincent's Institute of Medical Research; St. Vincent's Institute of Medical Research; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Robins-Browne, RM (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.	r.browne@unimelb.edu.au	Parker, Michael W/F-9069-2013; Robinsbrowne, Roy/ABF-8434-2020; Holien, Jess/V-7005-2019; Hartland, Elizabeth/O-2569-2014	Parker, Michael W/0000-0002-3101-1138; Robinsbrowne, Roy/0000-0001-9179-7884; Holien, Jess/0000-0002-8735-2871; Hartland, Elizabeth/0000-0003-4254-2863; Perugini, Matthew/0000-0001-8052-5584	Australian National Health and Medical Research Council (NHMRC); NHMRC Independent Research Institutes Infrastructure Support Scheme; Victorian State Government Operational Infrastructure Support Program	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Independent Research Institutes Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support Program	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC), the NHMRC Independent Research Institutes Infrastructure Support Scheme, and the Victorian State Government Operational Infrastructure Support Program to St. Vincent's Institute and the Murdoch Childrens Research Institute.	ARGAET VP, 1994, J BIOL CHEM, V269, P5171; Bender JK, 2012, APPL ENVIRON MICROB, V78, P5083, DOI 10.1128/AEM.00617-12; Blaser M, 2011, NATURE, V476, P393, DOI 10.1038/476393a; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Childers BM, 2007, J MOL BIOL, V367, P1413, DOI 10.1016/j.jmb.2007.01.061; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Deng WY, 2003, MOL MICROBIOL, V48, P95, DOI 10.1046/j.1365-2958.2003.03429.x; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; EVANS DG, 1973, INFECT IMMUN, V7, P873, DOI 10.1128/IAI.7.6.873-880.1973; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Garrity-Ryan LK, 2010, INFECT IMMUN, V78, P4683, DOI 10.1128/IAI.01305-09; Gauthier A, 2003, INFECT IMMUN, V71, P3310, DOI 10.1128/IAI.71.6.3310-3319.2003; Ghaem-Maghami M, 2001, INFECT IMMUN, V69, P5597, DOI 10.1128/IAI.69.9.5597-5605.2001; GOMEZDUARTE OG, 1995, INFECT IMMUN, V63, P1767; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hart E, 2008, INFECT IMMUN, V76, P5247, DOI 10.1128/IAI.00770-08; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Kimura K, 2011, J ANTIBIOT, V64, P197, DOI 10.1038/ja.2010.155; Kollef MH, 2011, CLIN INFECT DIS, V53, pS33, DOI 10.1093/cid/cir475; KOYA GYOICHI, 1954, JAPANESE JOUR MED SCI AND BIOL, V7, P197; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEE JH, 1995, INFECT IMMUN, V63, P4143, DOI 10.1128/IAI.63.10.4143-4149.1995; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; Marches O, 2000, INFECT IMMUN, V68, P2171, DOI 10.1128/IAI.68.4.2171-2182.2000; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; Miller JH, 1974, EXPT MOL GENETICS; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Murphree D, 1997, J BACTERIOL, V179, P5736, DOI 10.1128/jb.179.18.5736-5743.1997; NATARO JP, 1994, J BACTERIOL, V176, P4691, DOI 10.1128/JB.176.15.4691-4699.1994; NATARO JP, 1995, J INFECT DIS, V171, P465, DOI 10.1093/infdis/171.2.465; Petri WA, 2008, J CLIN INVEST, V118, P1277, DOI 10.1172/JCI34005; Pittard J, 2005, MOL MICROBIOL, V55, P16, DOI 10.1111/j.1365-2958.2004.04385.x; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Salim A, 2005, EMERG INFECT DIS, V11, P1758, DOI 10.3201/eid1111.041170; Sambrook J., 2001, MOL CLONING LAB MANU; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shakhnovich EA, 2007, P NATL ACAD SCI USA, V104, P2372, DOI 10.1073/pnas.0611643104; Sheikh J, 2002, J CLIN INVEST, V110, P1329, DOI 10.1172/JCI200216172; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Srikhanta YN, 2013, INFECT IMMUN, V81, P1078, DOI 10.1128/IAI.01325-12; Stanton TB, 2013, TRENDS MICROBIOL, V21, P111, DOI 10.1016/j.tim.2012.11.002; Sun F, 2011, CHEM BIOL, V18, P1032, DOI 10.1016/j.chembiol.2011.05.014; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Tauschek M, 2010, J BACTERIOL, V192, P3722, DOI 10.1128/JB.01540-09; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Yang J, 1997, J BACTERIOL, V179, P6187, DOI 10.1128/jb.179.19.6187-6191.1997; YANG J, 1993, J BACTERIOL, V175, P1767, DOI 10.1128/JB.175.6.1767-1776.1993; Yang J, 2008, MOL MICROBIOL, V68, P314, DOI 10.1111/j.1365-2958.2008.06171.x; Yang J, 2011, TRENDS MICROBIOL, V19, P128, DOI 10.1016/j.tim.2010.12.001; Yang J, 2010, MICROB BIOTECHNOL, V3, P259, DOI 10.1111/j.1751-7915.2009.00114.x; Yang J, 2009, J MOL BIOL, V394, P591, DOI 10.1016/j.jmb.2009.10.033	62	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31115	31126		10.1074/jbc.M113.503912	http://dx.doi.org/10.1074/jbc.M113.503912			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24019519	Green Published, hybrid			2022-12-28	WOS:000330778900030
J	Cai, BS; Giridharan, SSP; Zhang, J; Saxena, S; Bahl, K; Schmidt, JA; Sorgen, PL; Guo, W; Naslavsky, N; Caplan, S				Cai, Bishuang; Giridharan, Sai Srinivas Panapakkam; Zhang, Jing; Saxena, Sugandha; Bahl, Kriti; Schmidt, John A.; Sorgen, Paul L.; Guo, Wei; Naslavsky, Naava; Caplan, Steve			Differential Roles of C-terminal Eps15 Homology Domain Proteins as Vesiculators and Tubulators of Recycling Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Endosomes; Liposomes; Membrane Biogenesis; Membrane Recycling; Membrane Trafficking; Protein Sorting; Receptor Recycling; Subcellular Organelles; Vesicles	EHD1 INTERACT; MEMBRANE; TRANSPORT; ASSOCIATION; CAVEOLAE; INSIGHTS	Background: Vesiculation of tubular recycling endosomes is essential for the recycling of receptors and lipids to the plasma membrane. Results: A novel vesiculation assay was used to demonstrate a role for endocytic regulatory proteins in vesiculation. Conclusion: EHD family proteins play significant roles in both the vesiculation and generation of tubular recycling endosomes. Significance: This provides the first direct evidence of differential EHD function in vesiculation and tubulation. Endocytic recycling involves the return of membranes and receptors to the plasma membrane following their internalization into the cell. Recycling generally occurs from a series of vesicular and tubular membranes localized to the perinuclear region, collectively known as the endocytic recycling compartment. Within this compartment, receptors are sorted into tubular extensions that later undergo vesiculation, allowing transport vesicles to move along microtubules and return to the cell surface where they ultimately undergo fusion with the plasma membrane. Recent studies have led to the hypothesis that the C-terminal Eps15 homology domain (EHD) ATPase proteins are involved in the vesiculation process. Here, we address the functional roles of the four EHD proteins. We developed a novel semipermeabilized cell system in which addition of purified EHD proteins to reconstitute vesiculation allows us to assess the ability of each protein to vesiculate MICAL-L1-decorated tubular recycling endosomes (TREs). Using this assay, we show that EHD1 vesiculates membranes, consistent with enhanced TRE generation observed upon EHD1 depletion. EHD4 serves a role similar to that of EHD1 in TRE vesiculation, whereas EHD2, despite being capable of vesiculating TREs in the semipermeabilized cells, fails to do so in vivo. Surprisingly, the addition of EHD3 causes tubulation of endocytic membranes in our semipermeabilized cell system, consistent with the lack of tubulation observed upon EHD3 depletion. Our novel vesiculation assay and in vitro electron microscopy analysis, combined with in vivo data, provide evidence that the functions of both EHD1 and EHD4 are primarily in TRE membrane vesiculation, whereas EHD3 is a membrane-tubulating protein.	[Cai, Bishuang; Giridharan, Sai Srinivas Panapakkam; Zhang, Jing; Saxena, Sugandha; Bahl, Kriti; Sorgen, Paul L.; Naslavsky, Naava; Caplan, Steve] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Cai, Bishuang; Giridharan, Sai Srinivas Panapakkam; Zhang, Jing; Saxena, Sugandha; Bahl, Kriti; Sorgen, Paul L.; Naslavsky, Naava; Caplan, Steve] Univ Nebraska Med Ctr, Eppley Canc Ctr, Omaha, NE 68198 USA; [Schmidt, John A.; Guo, Wei] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Pennsylvania	Caplan, S (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	scaplan@unmc.edu	giridharan, sai srinivas panapakkam/X-9083-2019; Saxena, Sugandha/AAX-6646-2020; Cai, Bishuang/AAE-4334-2020; Cai, Bishuang/ABG-4817-2020	Schmidt, John/0000-0002-1075-0425	National Institutes of Health [R01GM087455, R01GM074876, R01GM085146]; National Research Service Award Postdoctoral Fellowship [GM-095094]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074876, R01GM087455, F32GM095094, R01GM085146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM087455 (to S. C. and P. L S.), R01GM074876 (to S. C.), and R01GM085146 (to W. G.). This work was also supported by National Research Service Award Postdoctoral Fellowship GM-095094 (to J. A. S.).	Ayton GS, 2009, BIOPHYS J, V97, P1616, DOI 10.1016/j.bpj.2009.06.036; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Cai BS, 2012, MOL BIOL CELL, V23, P1874, DOI 10.1091/mbc.E11-10-0881; Cai BS, 2011, TRAFFIC, V12, P102, DOI 10.1111/j.1600-0854.2010.01135.x; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Giridharan SSP, 2013, MOL BIOL CELL, V24, P1776, DOI 10.1091/mbc.E13-01-0026; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Jakobsson J, 2011, J NEUROSCI, V31, P13972, DOI 10.1523/JNEUROSCI.1289-11.2011; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pucadyil TJ, 2010, BIOPHYS J, V99, P517, DOI 10.1016/j.bpj.2010.04.036; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Simone LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074519; Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98	26	40	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30172	30180		10.1074/jbc.M113.488627	http://dx.doi.org/10.1074/jbc.M113.488627			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24019528	hybrid, Green Published			2022-12-28	WOS:000329868100017
J	Hoshina, S; Yura, K; Teranishi, H; Kiyasu, N; Tominaga, A; Kadoma, H; Nakatsuka, A; Kunichika, T; Obuse, C; Waga, S				Hoshina, Shoko; Yura, Kei; Teranishi, Honami; Kiyasu, Noriko; Tominaga, Ayumi; Kadoma, Haruka; Nakatsuka, Ayaka; Kunichika, Tomoko; Obuse, Chikashi; Waga, Shou			Human Origin Recognition Complex Binds Preferentially to G-quadruplex-preferable RNA and Single-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; DNA Methyltransferase; DNA Replication; Protein Structure; RNA-binding Protein; G-quadruplex; ORC; Replication Origin	REPLICATION INITIATION; ORC6 PROTEIN; TRANSCRIPTION; REVEALS; RECRUITMENT; SEQUENCE; ORGANIZATION; CHROMATIN; HOMOLOGY; SITE	Background: ORC binds to replication origins, but human ORC does not exhibit apparent sequence-specificity. Results: G-quadruplex (G4)-preferable RNA or single-stranded DNA competes for DNA binding of ORC. Conclusion: Human ORC binds preferentially to RNA and single-stranded DNA that form G4, and the certain domain in ORC1 is involved in this binding. Significance: This ability may correlate with the G4-formable motif in human replication origins. Origin recognition complex (ORC), consisting of six subunits ORC1-6, is known to bind to replication origins and function in the initiation of DNA replication in eukaryotic cells. In contrast to the fact that Saccharomyces cerevisiae ORC recognizes the replication origin in a sequence-specific manner, metazoan ORC has not exhibited strict sequence-specificity for DNA binding. Here we report that human ORC binds preferentially to G-quadruplex (G4)-preferable G-rich RNA or single-stranded DNA (ssDNA). We mapped the G-rich RNA-binding domain in the ORC1 subunit, in a region adjacent to its ATPase domain. This domain itself has an ability to preferentially recognize G4-preferable sequences of ssDNA. Furthermore, we found, by structure modeling, that the G-rich RNA-binding domain is similar to the N-terminal portion of AdoMet_MTase domain of mammalian DNA methyltransferase 1. Therefore, in contrast with the binding to double-stranded DNA, human ORC has an apparent sequence preference with respect to its RNA/ssDNA binding. Interestingly, this specificity coincides with the common signature present in most of the human replication origins. We expect that our findings provide new insights into the regulations of function and chromatin binding of metazoan ORCs.	[Hoshina, Shoko; Teranishi, Honami; Kiyasu, Noriko; Tominaga, Ayumi; Kadoma, Haruka; Nakatsuka, Ayaka; Waga, Shou] Japan Womens Univ, Dept Chem & Biol Sci, Fac Sci, Tokyo 1128681, Japan; [Yura, Kei] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo 1128610, Japan; [Kunichika, Tomoko] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Obuse, Chikashi] Hokkaido Univ, Grad Sch Life Sci, Div Mol Life Sci, Sapporo, Hokkaido 0010021, Japan	Japan Womens University; Ochanomizu University; Osaka University; Hokkaido University	Waga, S (corresponding author), Japan Womens Univ, Dept Chem & Biol Sci, Fac Sci, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan.	swaga@fc.jwu.ac.jp	Yura, Kei/S-1030-2018	Yura, Kei/0000-0003-0197-5478; Waga, Shou/0000-0003-4986-8735	KAKENHI from the Japan Society for the Promotion of Science (JSPS) [21657045, 24570200]; Science Research Promotion Fund; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT)	KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Science Research Promotion Fund; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT)	This work was supported in part by KAKENHI Grants 21657045 and 24570200 from the Japan Society for the Promotion of Science (JSPS) (to S. W.), the Science Research Promotion Fund (to S. W.), and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology-Japan (MEXT) (to K. Y.).	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Balasov M, 2007, MOL CELL BIOL, V27, P3143, DOI 10.1128/MCB.02382-06; Bell S. D., 2013, DNA REPLICATION; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Cayrou C, 2012, CELL CYCLE, V11, P658, DOI 10.4161/cc.11.4.19097; Cayrou C, 2011, GENOME RES, V21, P1438, DOI 10.1101/gr.121830.111; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Chesnokov IN, 2003, P NATL ACAD SCI USA, V100, P9150, DOI 10.1073/pnas.1633580100; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; Dellino GI, 2013, GENOME RES, V23, P1, DOI 10.1101/gr.142331.112; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Farkash-Amar S, 2008, GENOME RES, V18, P1562, DOI 10.1101/gr.079566.108; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Kim OTP, 2006, NUCLEIC ACIDS RES, V34, P6450, DOI 10.1093/nar/gkl819; Kong DC, 2003, EMBO J, V22, P3441, DOI 10.1093/emboj/cdg319; Kusic J, 2010, MOL BIOL REP, V37, P2317, DOI 10.1007/s11033-009-9735-8; Lee DG, 2000, EMBO J, V19, P4774, DOI 10.1093/emboj/19.17.4774; Liu SX, 2011, P NATL ACAD SCI USA, V108, P7373, DOI 10.1073/pnas.1013676108; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Martin MM, 2011, GENOME RES, V21, P1822, DOI 10.1101/gr.124644.111; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Minami H, 2006, MOL CELL BIOL, V26, P8770, DOI 10.1128/MCB.00949-06; Mohammad MM, 2007, EMBO J, V26, P5048, DOI 10.1038/sj.emboj.7601919; Moriyama K, 2012, J BIOL CHEM, V287, P23977, DOI 10.1074/jbc.M112.368456; Norseen J, 2008, EMBO J, V27, P3024, DOI 10.1038/emboj.2008.221; Norseen J, 2009, J VIROL, V83, P10336, DOI 10.1128/JVI.00747-09; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; Remus D, 2004, EMBO J, V23, P897, DOI 10.1038/sj.emboj.7600077; Sequeira-Mendes J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000446; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Thomae AW, 2008, P NATL ACAD SCI USA, V105, P1692, DOI 10.1073/pnas.0707260105; Valenzuela MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017308; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Yabuki T, 2001, GENE, V264, P123, DOI 10.1016/S0378-1119(00)00592-8; Zheng KW, 2013, NUCLEIC ACIDS RES, V41, P5533, DOI 10.1093/nar/gkt264	44	64	65	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30161	30171		10.1074/jbc.M113.492504	http://dx.doi.org/10.1074/jbc.M113.492504			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003239	Green Published, hybrid			2022-12-28	WOS:000329868100016
J	Li, HL; Zuccolo, J; Kem, DC; Zillner, C; Lee, J; Smith, K; James, JA; Cunningham, MW; Yu, XC				Li, Hongliang; Zuccolo, Jonathan; Kem, David C.; Zillner, Caitlin; Lee, Jiyeon; Smith, Kenneth; James, Judith A.; Cunningham, Madeleine W.; Yu, Xichun			Implications of a Vasodilatory Human Monoclonal Autoantibody in Postural Hypotension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adrenergic Receptor; Autoimmunity; Cardiovascular Disease; Pathogenesis; Vascular; Human Monoclonal Autoantibody; Postural Hypotension; Vasodilatory	IDIOPATHIC DILATED CARDIOMYOPATHY; BETA-ADRENERGIC-RECEPTORS; MUSCARINIC RECEPTORS; ALPHA(1)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; ACTIVATING AUTOANTIBODIES; ORTHOSTATIC HYPOTENSION; ATRIAL-FIBRILLATION; EXTRACELLULAR LOOP; SEQUENCE-ANALYSIS	Functional autoantibodies to the autonomic receptors are increasingly recognized in the pathophysiology of cardiovascular diseases. To date, no human activating monoclonal autoantibodies to these receptors have been available. In this study, we describe for the first time a (2)-adrenergic receptor ((2)AR)-activating monoclonal autoantibody (C5F2) produced from the lymphocytes of a patient with idiopathic postural hypotension. C5F2, an IgG3 isotype, recognizes an epitope in the N terminus of the second extracellular loop (ECL2) of (2)AR. Surface plasmon resonance analysis revealed high binding affinity for the (2)AR ECL2 peptide. Immunoblotting and immunofluorescence demonstrated specific binding to (2)AR in H9c2 cardiomyocytes, CHO cells expressing human (2)AR, and rat aorta. C5F2 stimulated cyclic AMP production in (2)AR-transfected CHO cells and induced potent dilation of isolated rat cremaster arterioles, both of which were specifically blocked by the (2)AR-selective antagonist ICI-118551 and by the (2)AR ECL2 peptide. This monoclonal antibody demonstrated sufficient activity to produce postural hypotension in its host. Its availability provides a unique opportunity to identify previously unrecognized causes and new pharmacological management of postural hypotension and other cardiovascular diseases.	[Li, Hongliang; Kem, David C.; Zillner, Caitlin; Lee, Jiyeon; James, Judith A.; Yu, Xichun] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Zuccolo, Jonathan; James, Judith A.; Cunningham, Madeleine W.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; [Li, Hongliang; Kem, David C.; Zillner, Caitlin; Yu, Xichun] Oklahoma Med Res Fdn, Oklahoma City Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA; [Smith, Kenneth; James, Judith A.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Yu, XC (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, TCH 6E103,1200 Everett Dr, Oklahoma City, OK 73104 USA.	xichun-yu@ouhsc.edu	Li, Hongliang/AAV-1697-2020		National Institutes of Health [R01 HL056267, P30 GM103510]; Veterans Affairs Merit Review grant; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL056267, R01HL056267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review grant(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL056267 and P30 GM103510. This work was also supported by a Veterans Affairs Merit Review grant, an American Heart Association postdoctoral fellowship, and individual grant support from Will and Helen Webster.	Adderson EE, 1998, J IMMUNOL, V161, P2020; Baba A, 2004, EUR HEART J, V25, P1108, DOI 10.1016/j.ehj.2004.05.012; BENOVIC JL, 1984, BIOCHEMISTRY-US, V23, P4510, DOI 10.1021/bi00315a002; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Chiale PA, 2001, CIRCULATION, V103, P1765, DOI 10.1161/01.CIR.103.13.1765; Chiale PA, 2006, HEART RHYTHM, V3, P1182, DOI 10.1016/j.hrthm.2006.06.011; Dragun D, 2009, THROMB HAEMOSTASIS, V101, P643, DOI 10.1160/TH08-10-0710; FU MLX, 1994, LANCET, V344, P1660, DOI 10.1016/S0140-6736(94)90456-1; Fu MLX, 1996, CLIN IMMUNOL IMMUNOP, V78, P203, DOI 10.1006/clin.1996.0030; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Hill MA, 2000, AM J PHYSIOL-HEART C, V278, pH345, DOI 10.1152/ajpheart.2000.278.2.H345; Hoebeke J, 1996, INT J CARDIOL, V54, P103, DOI 10.1016/0167-5273(96)02586-7; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; Jahns R, 1999, CIRCULATION, V99, P649, DOI 10.1161/01.CIR.99.5.649; Lebesgue D, 1998, EUR J PHARMACOL, V348, P123, DOI 10.1016/S0014-2999(98)00136-8; Li HL, 2013, HEART RHYTHM, V10, P436, DOI 10.1016/j.hrthm.2012.11.010; Li HL, 2012, HYPERTENSION, V59, P402, DOI 10.1161/HYPERTENSIONAHA.111.184937; Luther HP, 1997, HYPERTENSION, V29, P678, DOI 10.1161/01.HYP.29.2.678; MAGNUSSON Y, 1994, CIRCULATION, V89, P2760, DOI 10.1161/01.CIR.89.6.2760; Mascaro-Blanco A, 2008, AUTOIMMUNITY, V41, P442, DOI 10.1080/08916930802031579; Matsui S, 1997, J MOL CELL CARDIOL, V29, P641, DOI 10.1006/jmcc.1996.0307; McLachlan SM, 2004, CLIN ENDOCRINOL, V61, P10, DOI 10.1111/j.1365-2265.2004.02028.x; Mijares A, 2000, MOL PHARMACOL, V58, P373, DOI 10.1124/mol.58.2.373; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; MURRAY KJ, 1990, PHARMACOL THERAPEUT, V47, P329, DOI 10.1016/0163-7258(90)90060-F; NODA K, 1994, J BIOL CHEM, V269, P6743; Peter JC, 2003, J BIOL CHEM, V278, P36740, DOI 10.1074/jbc.M306877200; Queen LR, 2006, CELL MOL LIFE SCI, V63, P1070, DOI 10.1007/s00018-005-5451-2; Sanders J, 2003, LANCET, V362, P126, DOI 10.1016/S0140-6736(03)13866-4; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Stavrakis S, 2009, J AM COLL CARDIOL, V54, P1309, DOI 10.1016/j.jacc.2009.07.015; WALLUKAT G, 1991, EUR HEART J, V12, P178, DOI 10.1093/eurheartj/12.suppl_D.178; Wallukat G, 1999, LIFE SCI, V64, P465, DOI 10.1016/S0024-3205(98)00589-X; Wallukat G, 2000, HERZ, V25, P261, DOI 10.1007/s000590050017; Wenzel K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009409; Wenzel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003742; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yu XC, 2012, J AM SOC HYPERTENS, V6, P40, DOI 10.1016/j.jash.2011.10.003; Zhou ZH, 2005, CLIN IMMUNOL, V114, P164, DOI 10.1016/j.clim.2004.09.011	39	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30734	30741		10.1074/jbc.M113.477869	http://dx.doi.org/10.1074/jbc.M113.477869			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24043632	hybrid, Green Published			2022-12-28	WOS:000329868100073
J	Li, XP; Kahn, PC; Kahn, JN; Grela, P; Tumer, NE				Li, Xiao-Ping; Kahn, Peter C.; Kahn, Jennifer Nielsen; Grela, Przemyslaw; Tumer, Nilgun E.			Arginine Residues on the Opposite Side of the Active Site Stimulate the Catalysis of Ribosome Depurination by Ricin A Chain by Interacting with the P-protein Stalk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein Synthesis; Ribosomal RNA (rRNA); Ribosomes; RIP; Toxins; Ribosome-inactivating Protein; Ricin	TOXIN-A-CHAIN; CIRCULAR-DICHROISM SPECTROSCOPY; N-GLYCOSIDASE ACTIVITY; SYNTHESIS IN-VITRO; SECONDARY STRUCTURE; ENZYMATIC INACTIVATION; GLUTAMIC ACID-177; SUBSTRATE-ANALOGS; AMINO-ACIDS; RNA	Background: Ricin A chain (RTA) uses the ribosomal stalk to access the sarcin/ricin loop (SRL). Results: Arginine residues at the interface of RTB are critical for RTA to bind to the stalk and to stimulate depurination of the SRL. Conclusion: Stalk binding stimulates depurination by orienting RTA toward the SRL. Significance: We propose a model that describes how RTA accesses the SRL. Ricin inhibits protein synthesis by depurinating the -sarcin/ricin loop (SRL). Ricin holotoxin does not inhibit translation unless the disulfide bond between the A (RTA) and B (RTB) subunits is reduced. Ricin holotoxin did not bind ribosomes or depurinate them but could depurinate free RNA. When RTA is separated from RTB, arginine residues located at the interface are exposed to the solvent. Because this positively charged region, but not the active site, is blocked by RTB, we mutated arginine residues at or near the interface of RTB to determine if they are critical for ribosome binding. These variants were structurally similar to wild type RTA but could not bind ribosomes. Their K-m values and catalytic rates (k(cat)) for an SRL mimic RNA were similar to those of wild type, indicating that their activity was not altered. However, they showed an up to 5-fold increase in K-m and up to 38-fold decrease in k(cat) toward ribosomes. These results suggest that the stalk binding stimulates the catalysis of ribosome depurination by RTA. The mutated arginines have side chains behind the active site cleft, indicating that the ribosome binding surface of RTA is on the opposite side of the surface that interacts with the SRL. We propose that stalk binding stimulates the catalysis of ribosome depurination by orienting the active site of RTA toward the SRL and thereby allows docking of the target adenine into the active site. This model may apply to the translation factors that interact with the stalk.	[Li, Xiao-Ping; Kahn, Jennifer Nielsen; Grela, Przemyslaw; Tumer, Nilgun E.] Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, New Brunswick, NJ 08901 USA; [Kahn, Peter C.] Rutgers State Univ, Dept Biochem & Microbiol, Sch Environm & Biol Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Tumer, NE (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, 59 Dudley Rd, New Brunswick, NJ 08901 USA.	tumer@aesop.rutgers.edu		Grela, Przemyslaw/0000-0002-5930-416X	National Institutes of Health [AI072425]; New Jersey Agriculture Experiment Station; FOGARTY INTERNATIONAL CENTER [R03TW008418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI072425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Agriculture Experiment Station; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI072425 (to N. E. T.). This work was also supported by a grant from the New Jersey Agriculture Experiment Station (to P. C. K.).	Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Battelli MG, 2004, MINI-REV MED CHEM, V4, P513, DOI 10.2174/1389557043403819; CAWLEY DB, 1979, BIOCHEMISTRY-US, V18, P2648, DOI 10.1021/bi00579a034; Chan DSB, 2007, NUCLEIC ACIDS RES, V35, P1660, DOI 10.1093/nar/gkm065; Chen XY, 1998, BIOCHEMISTRY-US, V37, P11605, DOI 10.1021/bi980990p; Chiou JC, 2008, MOL MICROBIOL, V70, P1441, DOI 10.1111/j.1365-2958.2008.06492.x; Clementi N, 2010, NAT CHEM BIOL, V6, P344, DOI 10.1038/nchembio.341; Dai JX, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.196584; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; ENDO Y, 1988, J BIOL CHEM, V263, P8735; ENDO Y, 1987, J BIOL CHEM, V262, P5908; FRANKEL A, 1990, MOL CELL BIOL, V10, P6257, DOI 10.1128/MCB.10.12.6257; Frigerio L, 1998, J BIOL CHEM, V273, P14194, DOI 10.1074/jbc.273.23.14194; Gonzalo P, 2003, BIOL CELL, V95, P179, DOI 10.1016/S0248-4900(03)00034-0; GOSS NH, 1980, BIOCHEMISTRY-US, V19, P5805, DOI 10.1021/bi00566a022; Grela P, 2010, BIOCHEMISTRY-US, V49, P924, DOI 10.1021/bi901811s; Guarinos E, 2003, MOL MICROBIOL, V50, P703, DOI 10.1046/j.1365-2958.2003.03733.x; HEDBLOM ML, 1976, ARCH BIOCHEM BIOPHYS, V177, P46, DOI 10.1016/0003-9861(76)90414-8; Honjo E, 2002, J BIOCHEM, V131, P267, DOI 10.1093/oxfordjournals.jbchem.a003098; Kahn P C, 1979, Methods Enzymol, V61, P339; KIM Y, 1992, PROTEIN ENG, V5, P775, DOI 10.1093/protein/5.8.775; Kitaoka Y, 1998, EUR J BIOCHEM, V257, P255, DOI 10.1046/j.1432-1327.1998.2570255.x; Korennykh AV, 2007, RNA, V13, P1391, DOI 10.1261/rna.619707; Korennykh AV, 2006, NAT STRUCT MOL BIOL, V13, P436, DOI 10.1038/nsmb1082; Lapadula WJ, 2012, TOXICON, V59, P427, DOI 10.1016/j.toxicon.2011.12.014; Lee K. M., 2013, NUCL ACIDS IN PRESS; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Li XP, 2007, INFECT IMMUN, V75, P417, DOI 10.1128/IAI.01295-06; Li XP, 2010, J BIOL CHEM, V285, P41463, DOI 10.1074/jbc.M110.171793; Li XP, 2009, BIOCHEMISTRY-US, V48, P3853, DOI 10.1021/bi802371h; LUGNIER AAJ, 1977, FEBS LETT, V76, P166, DOI 10.1016/0014-5793(77)80144-0; Marsden CJ, 2004, EUR J BIOCHEM, V271, P153, DOI 10.1046/j.1432-1033.2003.03914.x; May KL, 2012, FEBS J, V279, P3925, DOI 10.1111/j.1742-4658.2012.08752.x; McCluskey AJ, 2008, J MOL BIOL, V378, P375, DOI 10.1016/j.jmb.2008.02.014; McCluskey AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031191; MLSNA D, 1993, PROTEIN SCI, V2, P429; MONTANARO L, 1973, BIOCHEM J, V136, P677, DOI 10.1042/bj1360677; MONZINGO AF, 1992, J MOL BIOL, V227, P1136, DOI 10.1016/0022-2836(92)90526-P; MORRIS KN, 1992, P NATL ACAD SCI USA, V89, P4869, DOI 10.1073/pnas.89.11.4869; Nomura N, 2012, P NATL ACAD SCI USA, V109, P3748, DOI 10.1073/pnas.1112934109; O'Hara JM, 2012, CURR TOP MICROBIOL, V357, P209, DOI 10.1007/82_2011_193; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; OLSNES S, 1974, NATURE, V249, P627, DOI 10.1038/249627a0; Olson MA, 1997, PROTEINS, V27, P80, DOI 10.1002/(SICI)1097-0134(199701)27:1<80::AID-PROT9>3.0.CO;2-R; Olson MA, 1999, BIOPHYS J, V76, P28, DOI 10.1016/S0006-3495(99)77175-4; Pierce M, 2011, RNA, V17, P201, DOI 10.1261/rna.2375411; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; READY MP, 1991, PROTEINS, V10, P270, DOI 10.1002/prot.340100311; SANTOS C, 1995, J BIOL CHEM, V270, P20608, DOI 10.1074/jbc.270.35.20608; SCHLOSSMAN D, 1989, MOL CELL BIOL, V9, P5012, DOI 10.1128/MCB.9.11.5012; Shi WX, 2001, BIOCHEMISTRY-US, V40, P10800, DOI 10.1021/bi010465h; Shi XY, 2012, J MOL BIOL, V419, P125, DOI 10.1016/j.jmb.2012.03.016; SPERTI S, 1973, BIOCHEM J, V136, P813, DOI 10.1042/bj1360813; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Sturm MB, 2009, ANAL CHEM, V81, P2847, DOI 10.1021/ac8026433; Suh JK, 1998, BIOCHEMISTRY-US, V37, P9394, DOI 10.1021/bi980424u; Too PHM, 2009, NUCLEIC ACIDS RES, V37, P602, DOI 10.1093/nar/gkn922; Tumer NE, 2012, CURR TOP MICROBIOL, V357, P1, DOI 10.1007/82_2011_174; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Wahl MC, 2002, CURR PROTEIN PEPT SC, V3, P93, DOI 10.2174/1389203023380756; WANG HC, 1988, BIOCHEMISTRY-US, V27, P625, DOI 10.1021/bi00402a020; WATANABE K, 1994, BIOSCI BIOTECH BIOCH, V58, P716, DOI 10.1271/bbb.58.716; WATANABE K, 1986, FEBS LETT, V204, P219, DOI 10.1016/0014-5793(86)80815-8; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yan Q, 2012, TRAFFIC, V13, P1508, DOI 10.1111/j.1600-0854.2012.01404.x; Yang YH, 2010, J MOL BIOL, V395, P897, DOI 10.1016/j.jmb.2009.10.051; Zhang TT, 2011, YEAST, V28, P795, DOI 10.1002/yea.1905	69	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30270	30284		10.1074/jbc.M113.510966	http://dx.doi.org/10.1074/jbc.M113.510966			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003229	hybrid, Green Published			2022-12-28	WOS:000329868100025
J	Schweiger, R; Soll, J; Jung, K; Heermann, R; Schwenkert, S				Schweiger, Regina; Soll, Juergen; Jung, Kirsten; Heermann, Ralf; Schwenkert, Serena			Quantification of Interaction Strengths between Chaperones and Tetratricopeptide Repeat Domain-containing Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Chloroplast; Endoplasmic Reticulum(ER); Mitochondria; Surface Plasmon Resonance (SPR); Interaction Map Analysis; Microscale Thermophoresis	OUTER-MEMBRANE; SIGNAL PEPTIDES; TPR DOMAIN; MITOCHONDRIAL; IMPORT; HSP90; RECEPTOR; TRANSLOCATION; COMPLEX; RECOGNITION	The three tetratricopeptide repeat domain-containing docking proteins Toc64, OM64, and AtTPR7 reside in the chloroplast, mitochondrion, and endoplasmic reticulum of Arabidopsis thaliana, respectively. They are suggested to act during post-translational protein import by association with chaperone-bound preprotein complexes. Here, we performed a detailed biochemical, biophysical, and computational analysis of the interaction between Toc64, OM64, and AtTPR7 and the five cytosolic chaperones HSP70.1, HSP90.1, HSP90.2, HSP90.3, and HSP90.4. We used surface plasmon resonance spectroscopy in combination with Interaction Map (R) analysis to distinguish between chaperone oligomerization and docking protein-chaperone interactions and to calculate binding affinities for all tested interactions. Complementary to this, we applied pulldown assays as well as microscale thermophoresis as surface immobilization independent techniques. The data revealed that OM64 prefers HSP70 over HSP90, whereas Toc64 binds all chaperones with comparable affinities. We could further show that AtTPR7 is able to bind HSP90 in addition to HSP70. Moreover, differences between the HSP90 isoforms were detected and revealed a weaker binding for HSP90.1 to AtTPR7 and OM64, showing that slight differences in the amino acid composition or structure of the chaperones influence binding to the tetratricopeptide repeat domain. The combinatory approach of several methods provided a powerful toolkit to determine binding affinities of similar interaction partners in a highly quantitative manner.	[Schweiger, Regina; Soll, Juergen; Jung, Kirsten; Heermann, Ralf; Schwenkert, Serena] Univ Munich, Munich Ctr Integrated Prot Sci, Dept Biol 1, D-82152 Planegg Martinsried, Germany	University of Munich	Heermann, R (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci, Dept Biol 1, Grosshaderner Str 2-4, D-82152 Planegg Martinsried, Germany.	heermann@lmu.de; serena.schwenkert@lmu.de	Heermann, Ralf/CAF-8609-2022; Schwenkert, Serena/F-8564-2012; Heermann, Ralf/E-1793-2013	Heermann, Ralf/0000-0003-0631-6156	Deutsche Forschungsgemeinschaft [SFB 1035]; Fonds der Chemischen Industrie [Do 187/22];  [Exc114/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); 	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 1035, Project A04 (to J. S. and S. S.), Fonds der Chemischen Industrie Grant Do 187/22 (to R. S.), and the Exc114/1.	Altschuh D, 2012, BIOCHEM BIOPH RES CO, V428, P74, DOI 10.1016/j.bbrc.2012.10.008; Aprile FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067961; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Barta P, 2011, NUCL MED COMMUN, V32, P863, DOI 10.1097/MNM.0b013e3283483e1c; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Carrie C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-249; Carrigan PE, 2004, J BIOL CHEM, V279, P16185, DOI 10.1074/jbc.M314130200; Chan NC, 2006, J MOL BIOL, V358, P1010, DOI 10.1016/j.jmb.2006.02.062; Chew O, 2004, FEBS LETT, V557, P109, DOI 10.1016/S0014-5793(03)01457-1; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Faou P, 2012, BBA-MOL CELL RES, V1823, P348, DOI 10.1016/j.bbamcr.2011.12.001; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; Fellerer C, 2011, MOL PLANT, V4, P1133, DOI 10.1093/mp/ssr037; Kadota Y, 2012, BBA-MOL CELL RES, V1823, P689, DOI 10.1016/j.bbamcr.2011.09.016; Kriechbaumer V, 2011, BIOPHYS J, V101, P504, DOI 10.1016/j.bpj.2011.06.011; Krishna P, 2001, CELL STRESS CHAPERON, V6, P238, DOI 10.1379/1466-1268(2001)006<0238:THFOPI>2.0.CO;2; Lamberti G, 2011, PLANT PHYSIOL, V157, P70, DOI 10.1104/pp.111.182774; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; Nemoto T, 1998, BIOCHEM J, V330, P989, DOI 10.1042/bj3300989; Qbadou S, 2007, J MOL BIOL, V367, P1330, DOI 10.1016/j.jmb.2007.01.047; Qbadou S, 2006, EMBO J, V25, P1836, DOI 10.1038/sj.emboj.7601091; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schlegel T, 2007, MOL BIOL EVOL, V24, P2763, DOI 10.1093/molbev/msm211; Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Schweiger R, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25286; Schweiger R, 2012, J CELL SCI, V125, P5196, DOI 10.1242/jcs.111054; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Sohrt K, 2000, J CELL BIOL, V148, P1213, DOI 10.1083/jcb.148.6.1213; Sommer M, 2013, PLANT CELL ENVIRON, V36, P970, DOI 10.1111/pce.12030; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Thompson AD, 2012, CELL STRESS CHAPERON, V17, P313, DOI 10.1007/s12192-011-0307-1; von Loeffelholz O, 2011, BIOCHEM J, V438, P143, DOI 10.1042/BJ20110448; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	37	27	31	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30614	30625		10.1074/jbc.M113.493015	http://dx.doi.org/10.1074/jbc.M113.493015			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24036116	Green Published, hybrid			2022-12-28	WOS:000329868100062
J	ter Beek, J; Krause, N; Reimann, J; Lachmann, P; Adelroth, P				ter Beek, Josy; Krause, Nils; Reimann, Joachim; Lachmann, Peter; Adelroth, Pia			The Nitric-oxide Reductase from Paracoccus denitrificans Uses a Single Specific Proton Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transfer Complex; Electron Transfer; Enzyme Kinetics; Membrane Biophysics; Nitric Oxide; Proton Transport; Flow-Flash; Heme-Copper Oxidase; Kinetic Isotope Effect	CYTOCHROME-C-OXIDASE; STRUCTURAL BASIS; GENERATION; MECHANISM; RESIDUES	The NO reductase from Paracoccus denitrificans reduces NO to N2O (2NO + 2H(+) + 2e(-) N2O + H2O) with electrons donated by periplasmic cytochrome c (cytochrome c-dependent NO reductase; cNOR). cNORs are members of the heme-copper oxidase superfamily of integral membrane proteins, comprising the O-2-reducing, proton-pumping respiratory enzymes. In contrast, although NO reduction is as exergonic as O-2 reduction, there are no protons pumped in cNOR, and in addition, protons needed for NO reduction are derived from the periplasmic solution (no contribution to the electrochemical gradient is made). cNOR thus only needs to transport protons from the periplasm into the active site without the requirement to control the timing of opening and closing (gating) of proton pathways as is needed in a proton pump. Based on the crystal structure of a closely related cNOR and molecular dynamics simulations, several proton transfer pathways were suggested, and in principle, these could all be functional. In this work, we show that residues in one of the suggested pathways (denoted pathway 1) are sensitive to site-directed mutation, whereas residues in the other proposed pathways (pathways 2 and 3) could be exchanged without severe effects on turnover activity with either NO or O-2. We further show that electron transfer during single-turnover reduction of O-2 is limited by proton transfer and can thus be used to study alterations in proton transfer rates. The exchange of residues along pathway 1 showed specific slowing of this proton-coupled electron transfer as well as changes in its pH dependence. Our results indicate that only pathway 1 is used to transfer protons in cNOR.	[ter Beek, Josy; Krause, Nils; Reimann, Joachim; Lachmann, Peter; Adelroth, Pia] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Stockholm University	Adelroth, P (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	piaa@dbb.su.se	Beek, Josy ter/AAG-8291-2021	Beek, Josy ter/0000-0003-4165-9277	Faculty of Science at Stockholm University; Swedish Research Council; Carl Trygger Foundation; Stockholm University	Faculty of Science at Stockholm University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation; Stockholm University	This work was supported by grants from the Faculty of Science at Stockholm University and the Swedish Research Council (to P. A.).; Supported in part by a grant from the Carl Trygger Foundation and from Stockholm University.	BELL LC, 1992, J GEN MICROBIOL, V138, P437, DOI 10.1099/00221287-138-3-437; Bergaust L, 2010, APPL ENVIRON MICROB, V76, P6387, DOI 10.1128/AEM.00608-10; Branden M, 2001, P NATL ACAD SCI USA, V98, P5013, DOI 10.1073/pnas.081088398; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Butland G, 2001, J BACTERIOL, V183, P189, DOI 10.1128/JB.183.1.189-199.2001; Chang HY, 2012, P NATL ACAD SCI USA, V109, P5259, DOI 10.1073/pnas.1107345109; Flock U, 2005, BIOCHEMISTRY-US, V44, P10711, DOI 10.1021/bi050524h; Flock U, 2008, J BIOL CHEM, V283, P3839, DOI 10.1074/jbc.M704615200; Flock U, 2009, J INORG BIOCHEM, V103, P845, DOI 10.1016/j.jinorgbio.2009.02.008; Fujiwara T, 1996, J BACTERIOL, V178, P1866, DOI 10.1128/jb.178.7.1866-1871.1996; Gribaldo S, 2009, TRENDS BIOCHEM SCI, V34, P375, DOI 10.1016/j.tibs.2009.04.002; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; HARMS N, 1985, J BACTERIOL, V164, P1064, DOI 10.1128/JB.164.3.1064-1070.1985; Hendriks JHM, 2002, BIOCHEMISTRY-US, V41, P2331, DOI 10.1021/bi0121050; Hino T, 2010, SCIENCE, V330, P1666, DOI 10.1126/science.1195591; Kaila VRI, 2011, BBA-BIOENERGETICS, V1807, P80, DOI 10.1016/j.bbabio.2010.08.014; Karpefors M, 2000, BIOCHEMISTRY-US, V39, P6850, DOI 10.1021/bi992719t; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; Krishtalik LI, 2000, BBA-BIOENERGETICS, V1458, P6, DOI 10.1016/S0005-2728(00)00057-8; Lachmann P, 2010, J BIOL CHEM, V285, P25531, DOI 10.1074/jbc.M110.123984; Lee HJ, 2012, BBA-BIOENERGETICS, V1817, P537, DOI 10.1016/j.bbabio.2011.10.007; Pisliakov AV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002674; Reimann J, 2007, BBA-BIOENERGETICS, V1767, P362, DOI 10.1016/j.bbabio.2007.03.006; Schurig-Briccio LA, 2013, P NATL ACAD SCI USA, V110, P12613, DOI 10.1073/pnas.1301731110; SHAPLEIGH JP, 1985, J BACTERIOL, V163, P837, DOI 10.1128/JB.163.3.837-840.1985; Shiro Y, 2012, BBA-BIOENERGETICS, V1817, P1907, DOI 10.1016/j.bbabio.2012.03.001; Shiro Y, 2012, PHILOS T R SOC B, V367, P1195, DOI 10.1098/rstb.2011.0310; Thorndycroft FH, 2007, BIOCHEM J, V401, P111, DOI 10.1042/BJ20060856	28	19	19	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30626	30635		10.1074/jbc.M113.497347	http://dx.doi.org/10.1074/jbc.M113.497347			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014024	Green Published, hybrid			2022-12-28	WOS:000329868100063
J	Budd, ME; Campbell, JL				Budd, Martin E.; Campbell, Judith L.			Dna2 Is Involved in CA Strand Resection and Nascent Lagging Strand Completion at Native Yeast Telomeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; SACCHAROMYCES-CEREVISIAE; LEADING-STRAND; S-PHASE; ENDONUCLEASE ACTIVITY; EXONUCLEASE ACTIVITY; NUCLEASE ACTIVITY; POLYMERASE ALPHA; REPAIR PROTEINS; G-TAILS	Post-replicational telomere end processing involves both extension by telomerase and resection to produce 3 '-GT-overhangs that extend beyond the complementary 5 '-CA-rich strand. Resection must be carefully controlled to maintain telomere length. At short de novo telomeres generated artificially by HO endonuclease in the G(2) phase, we show that dna2-defective strains are impaired in both telomere elongation and sequential 5 '-CA resection. At native telomeres in dna2 mutants, GT-overhangs do clearly elongate during late S phase but are shorter than in wild type, suggesting a role for Dna2 in 5 '-CA resection but also indicating significant redundancy with other nucleases. Surprisingly, elimination of Mre11 nuclease or Exo1, which are complementary to Dna2 in resection of internal double strand breaks, does not lead to further shortening of GT-overhangs in dna2 mutants. A second step in end processing involves filling in of the CA-strand to maintain appropriate telomere length. Weshow that Dna2 is required for normal telomeric CA-strand fill-in. Yeast dna2 mutants, like mutants in DNA ligase 1 (cdc9), accumulate low molecular weight, nascent lagging strand DNA replication intermediates at telomeres. Based on this and other results, we propose that FEN1 is not sufficient and that either Dna2 or Exo1 is required to supplement FEN1 in maturing lagging strands at telomeres. Telomeres may be among the subset of genomic locations where Dna2 helicase/nuclease is essential for the two-nuclease pathway of primer processing on lagging strands.	[Budd, Martin E.; Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	California Institute of Technology	Campbell, JL (corresponding author), CALTECH, Braun Labs, 1200 E Calif Blvd,MC 147-75, Pasadena, CA 91125 USA.	jcampbel@caltech.edu			National Institutes of Health [GM078666]; Ellison Foundation [AG-SS-2143-08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078666. This work was also supported by Ellison Foundation Grant AG-SS-2143-08.	Adams AK, 1996, MOL CELL BIOL, V16, P4614; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae JB, 2008, ONCOGENE, V27, P5045, DOI 10.1038/onc.2008.139; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Balakrishnan L, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010173; Bertuch AA, 2004, GENETICS, V166, P1651, DOI 10.1534/genetics.166.4.1651; Bielinsky AK, 1999, MOL CELL, V3, P477, DOI 10.1016/S1097-2765(00)80475-X; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Bonetti D, 2009, MOL CELL, V35, P70, DOI 10.1016/j.molcel.2009.05.015; Bressan DA, 1998, GENETICS, V150, P591; Budd ME, 2011, CELL CYCLE, V10, P1690, DOI 10.4161/cc.10.10.15643; Budd ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004267; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; CARSON MJ, 1985, CELL, V42, P249, DOI 10.1016/S0092-8674(85)80120-3; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; Chai WH, 2006, MOL CELL, V21, P427, DOI 10.1016/j.molcel.2005.12.004; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Diede SJ, 2001, CURR BIOL, V11, P1336, DOI 10.1016/S0960-9822(01)00400-6; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Duch A, 2012, FEBS LETT, V586, P2925, DOI 10.1016/j.febslet.2012.07.034; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Faure V, 2010, MOL CELL, V38, P842, DOI 10.1016/j.molcel.2010.05.016; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Formosa T, 1999, GENETICS, V151, P1459; Fumagalli M, 2012, NAT CELL BIOL, V14, P555, DOI 10.1038/ncb0512-555b; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; Grandin N, 2001, EMBO J, V20, P1173, DOI 10.1093/emboj/20.5.1173; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; Kang HY, 2000, GENETICS, V155, P1055; Kironmai KM, 1997, GENES CELLS, V2, P443; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Kuntz K, 2013, EMBO J, V32, P290, DOI 10.1038/emboj.2012.322; Lam YC, 2010, EMBO J, V29, P2230, DOI 10.1038/emboj.2010.58; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Lendvay TS, 1996, GENETICS, V144, P1399; Lin WQ, 2013, EMBO J, V32, P1425, DOI 10.1038/emboj.2013.88; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Martin AD, 2000, MOL CELL BIOL, V20, P786, DOI 10.1128/MCB.20.3.786-796.2000; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moreau S, 1999, MOL CELL BIOL, V19, P556; Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Ohki R, 2001, MOL CELL BIOL, V21, P5753, DOI 10.1128/MCB.21.17.5753-5766.2001; Parenteau J, 2002, GENETICS, V162, P1583; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pike JE, 2009, J BIOL CHEM, V284, P25170, DOI 10.1074/jbc.M109.023325; Pokharel S, 2012, NUCLEIC ACIDS RES, V40, P7821, DOI 10.1093/nar/gks534; Ribeyre C, 2013, CHROMOSOMA, V122, P159, DOI 10.1007/s00412-013-0404-2; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Ueno M, 2010, BIOSCI BIOTECH BIOCH, V74, P1, DOI 10.1271/bbb.90682; Viscardi V, 2007, MOL BIOL CELL, V18, P3047, DOI 10.1091/mbc.E07-03-0285; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; WALMSLEY RM, 1984, NATURE, V310, P157, DOI 10.1038/310157a0; WALMSLEY RM, 1985, P NATL ACAD SCI USA, V82, P506, DOI 10.1073/pnas.82.2.506; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; WELLINGER RJ, 1993, MOL CELL BIOL, V13, P4057, DOI 10.1128/MCB.13.7.4057; WELLINGER RJ, 1989, P NATL ACAD SCI USA, V86, P973, DOI 10.1073/pnas.86.3.973; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026; Zhu XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006363; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou L, 2013, GENE DEV, V27, P227, DOI 10.1101/gad.213306.113; Zubko MK, 2004, GENETICS, V168, P103, DOI 10.1534/genetics.104.027904	105	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29414	29429		10.1074/jbc.M113.472456	http://dx.doi.org/10.1074/jbc.M113.472456			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23963457	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000330615300020
J	Wakai, S; Kidokoro, S; Masaki, K; Nakasone, K; Sambongi, Y				Wakai, Satoshi; Kidokoro, Shun-ichi; Masaki, Kazuo; Nakasone, Kaoru; Sambongi, Yoshihiro			Constant Enthalpy Change Value during Pyrophosphate Hydrolysis within the Physiological Limits of NaCl	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP-NOV; WATER; HALOBACTERIUM; ENVIRONMENTS; ENERGY; LIFE	A decrease in water activity was thought to result in smaller enthalpy change values during PPi hydrolysis, indicating the importance of solvation for the reaction. However, the physiological significance of this phenomenon is unknown. Here, we combined biochemistry and calorimetry to solve this problem using NaCl, a physiologically occurring water activity-reducing reagent. The pyrophosphatase activities of extremely halophilic Haloarcula japonica, which can grow at similar to 4 M NaCl, and non-halophilic Escherichia coli and Saccharomyces cerevisiae were maximal at 2.0 and 0.1 M NaCl, respectively. Thus, halophilic and non-halophilic pyrophosphatases exhibit distinct maximal activities at different NaCl concentration ranges. Upon calorimetry, the same exothermic enthalpy change of -35 kJ/mol was obtained for the halophile and non-halophiles at 1.5-4.0 and 0.1-2.0 M NaCl, respectively. These results show that solvation changes caused by up to 4.0 M NaCl (water activity of similar to 0.84) do not affect the enthalpy change in PPi hydrolysis. It has been postulated that PPi is an ATP analog, having a so-called high energy phosphate bond, and that the hydrolysis of both compounds is enthalpically driven. Therefore, our results indicate that the hydrolysis of high energy phosphate compounds, which are responsible for biological energy conversion, is enthalpically driven within the physiological limits of NaCl.	[Wakai, Satoshi; Sambongi, Yoshihiro] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima 7398528, Japan; [Kidokoro, Shun-ichi] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 9402188, Japan; [Masaki, Kazuo] Natl Res Inst Brewing, Applicat Res Div, Hiroshima 7390046, Japan; [Nakasone, Kaoru] Kinki Univ, Sch Engn, Dept Chem & Environm Technol, Hiroshima 7392116, Japan	Hiroshima University; Nagaoka University of Technology; Kindai University (Kinki University)	Wakai, S (corresponding author), Kobe Univ, Org Adv Sci & Technol, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	wakaists@pegasus.kobe-u.ac.jp; sambongi@hiroshima-u.ac.jp	Wakai, Satoshi/A-6458-2014	Wakai, Satoshi/0000-0002-9400-4058; Masaki, Kazuo/0000-0003-3809-1414	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20118005]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 20118005 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bianconi ML, 2003, J BIOL CHEM, V278, P18709, DOI 10.1074/jbc.M211103200; CHRISTIAN JHB, 1962, BIOCHIM BIOPHYS ACTA, V65, P506, DOI 10.1016/0006-3002(62)90453-5; DEMEIS L, 1989, BIOCHIM BIOPHYS ACTA, V973, P333, DOI 10.1016/S0005-2728(89)80440-2; Fiske CH, 1925, J BIOL CHEM, V66, P375; Franzetti B, 2001, J BIOL CHEM, V276, P29906, DOI 10.1074/jbc.M102098200; Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.0.CO;2-E; GEORGE P, 1970, BIOCHIM BIOPHYS ACTA, V223, P1, DOI 10.1016/0005-2728(70)90126-X; Hallsworth JE, 2007, ENVIRON MICROBIOL, V9, P801, DOI 10.1111/j.1462-2920.2006.01212.x; Holm NG, 2011, ORIGINS LIFE EVOL B, V41, P483, DOI 10.1007/s11084-011-9235-4; Hong J, 2012, J CHEM THEORY COMPUT, V8, P2239, DOI 10.1021/ct300099e; Karim N, 2005, THERMOCHIM ACTA, V431, P9, DOI 10.1016/j.tca.2005.01.025; LANYI JK, 1969, J BACTERIOL, V98, P611, DOI 10.1128/JB.98.2.611-616.1969; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MORIN PE, 1991, BIOCHEMISTRY-US, V30, P8494, DOI 10.1021/bi00098a030; Muller-Santos M, 2009, BBA-MOL CELL BIOL L, V1791, P719, DOI 10.1016/j.bbalip.2009.03.006; OREN A, 1983, INT J SYST BACTERIOL, V33, P381, DOI 10.1099/00207713-33-2-381; STMARTIN H, 1994, BBA-PROTEIN STRUCT M, V1207, P12, DOI 10.1016/0167-4838(94)90046-9; TAKASHINA T, 1990, SYST APPL MICROBIOL, V13, P177, DOI 10.1016/S0723-2020(11)80165-7; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569; Wolfenden R, 2006, CHEM REV, V106, P3379, DOI 10.1021/cr050311y	20	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29247	29251		10.1074/jbc.M113.502963	http://dx.doi.org/10.1074/jbc.M113.502963			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23965994	Green Published, hybrid			2022-12-28	WOS:000330615300004
J	Keenholtz, RA; Mouw, KW; Boocock, MR; Li, NS; Piccirilli, JA; Rice, PA				Keenholtz, Ross A.; Mouw, Kent W.; Boocock, Martin R.; Li, Nan-Sheng; Piccirilli, Joseph A.; Rice, Phoebe A.			Arginine as a General Acid Catalyst in Serine Recombinase-mediated DNA Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Recombination; Enzyme Catalysis; Enzyme Mechanisms; Nucleic Acid Enzymology; Protein-DNA Interaction; Arginine; General Acid; Phosphotransfer; Serine Recombinase; Site-specific Recombination	GAMMA-DELTA-RESOLVASE; PHOSPHORYL-TRANSFER; TN3 RESOLVASE; 2-METAL-ION MECHANISM; STRUCTURAL BASIS; MUTANTS; HYDROLYSIS; ACTIVATION; BASE; SIN	Members of the serine family of site-specific DNA recombinases use an unusual constellation of amino acids to catalyze the formation and resolution of a covalent protein-DNA intermediate. A recent high resolution structure of the catalytic domain of Sin, a particularly well characterized family member, provided a detailed view of the catalytic site. To determine how the enzyme might protonate and stabilize the 3O leaving group in the strand cleavage reaction, we examined how replacing this oxygen with a sulfur affected the cleavage rate by WT and mutant enzymes. To facilitate direct comparison of the cleavage rates, key experiments used suicide substrates that prevented religation after cleavage. The catalytic defect associated with mutation of one of six highly conserved arginine residues, Arg-69 in Sin, was partially rescued by a 3 phosphorothiolate substrate. We conclude that Arg-69 has an important role in stabilizing the 3O leaving group and is the prime candidate for the general acid that protonates the 3O, in good agreement with the position it occupies in the high resolution structure of the active site of Sin.	[Keenholtz, Ross A.; Mouw, Kent W.; Li, Nan-Sheng; Piccirilli, Joseph A.; Rice, Phoebe A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Piccirilli, Joseph A.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Boocock, Martin R.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Chicago; University of Chicago; University of Glasgow	Rice, PA (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St, Chicago, IL 60637 USA.	price@uchicago.edu		Mouw, Kent/0000-0001-7939-7343	National Institutes of Health [R01GM086826, R01GM088656, T32GM007183]; Medical Scientist National Research Service [T32 G07281]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086826, T32GM007183, R01GM088656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist National Research Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM086826 (to P. A. R.) and R01GM088656 (to J. A. P.).; Supported by National Institutes of Health Training Grant T32GM007183.; Supported by Medical Scientist National Research Service Award T32 G07281.	Arnold PH, 1999, EMBO J, V18, P1407, DOI 10.1093/emboj/18.5.1407; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; COSSTICK R, 1990, NUCLEIC ACIDS RES, V18, P829, DOI 10.1093/nar/18.4.829; Das SR, 2005, NAT CHEM BIOL, V1, P45, DOI 10.1038/nchembio703; DERBISE A, 1995, MOL MICROBIOL, V17, P769, DOI 10.1111/j.1365-2958.1995.mmi_17040769.x; Deweese JE, 2008, NUCLEIC ACIDS RES, V36, P4883, DOI 10.1093/nar/gkn466; Deweese JE, 2008, BIOCHEMISTRY-US, V47, P4129, DOI 10.1021/bi702194x; Deweese JE, 2009, BIOCHEMISTRY-US, V48, P1862, DOI 10.1021/bi8023256; Dhar G, 2009, NUCLEIC ACIDS RES, V37, P4743, DOI 10.1093/nar/gkp466; Gibb B, 2010, NUCLEIC ACIDS RES, V38, P5817, DOI 10.1093/nar/gkq384; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; HAFFTER P, 1988, EMBO J, V7, P3991, DOI 10.1002/j.1460-2075.1988.tb03287.x; HATFULL GF, 1986, P NATL ACAD SCI USA, V83, P5429, DOI 10.1073/pnas.83.15.5429; Haykinson MJ, 1996, CURR BIOL, V6, P163, DOI 10.1016/S0960-9822(02)00449-9; Highbarger LA, 1996, BIOCHEMISTRY-US, V35, P41, DOI 10.1021/bi9518306; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Ho MC, 2009, NATURE, V459, P393, DOI 10.1038/nature07938; Kamtekar S, 2006, P NATL ACAD SCI USA, V103, P10642, DOI 10.1073/pnas.0604062103; Keenholtz RA, 2011, STRUCTURE, V19, P799, DOI 10.1016/j.str.2011.03.017; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KLIPPEL A, 1988, EMBO J, V7, P3983, DOI 10.1002/j.1460-2075.1988.tb03286.x; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Krogh BO, 2002, J BIOL CHEM, V277, P5711, DOI 10.1074/jbc.C100681200; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; Li NS, 2011, ACCOUNTS CHEM RES, V44, P1257, DOI 10.1021/ar200131t; Li WK, 2005, SCIENCE, V309, P1210, DOI 10.1126/science.1112064; Mouw KW, 2010, J MOL BIOL, V404, P16, DOI 10.1016/j.jmb.2010.08.057; O'Brien PJ, 2008, BIOCHEMISTRY-US, V47, P7663, DOI 10.1021/bi800545n; O'Brien PJ, 2002, BIOCHEMISTRY-US, V41, P3207, DOI 10.1021/bi012166y; Olorunniji FJ, 2009, NUCLEIC ACIDS RES, V37, P7590, DOI 10.1093/nar/gkp797; Olorunniji FJ, 2008, NUCLEIC ACIDS RES, V36, P7181, DOI 10.1093/nar/gkn885; PAULSEN IT, 1994, GENE, V141, P109, DOI 10.1016/0378-1119(94)90136-8; Pinard R, 2001, EMBO J, V20, P6434, DOI 10.1093/emboj/20.22.6434; Rowland SJ, 2009, MOL MICROBIOL, V74, P282, DOI 10.1111/j.1365-2958.2009.06756.x; ROWLAND SJ, 1989, EMBO J, V8, P2761, DOI 10.1002/j.1460-2075.1989.tb08418.x; Schlippe YVG, 2005, BIOCHEMISTRY-US, V44, P11700, DOI 10.1021/bi048342v; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; STARK WM, 1989, CELL, V58, P779, DOI 10.1016/0092-8674(89)90111-6; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Sun SG, 1997, RNA, V3, P1352; VYLE JS, 1992, BIOCHEMISTRY-US, V31, P3012, DOI 10.1021/bi00126a024; WEBER DJ, 1992, PROTEINS, V13, P275, DOI 10.1002/prot.340130402; Whiteson KL, 2007, CHEM BIOL, V14, P121, DOI 10.1016/j.chembiol.2007.01.011; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0	44	23	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29206	29214		10.1074/jbc.M113.508028	http://dx.doi.org/10.1074/jbc.M113.508028			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23970547	Green Published, hybrid			2022-12-28	WOS:000330298800073
J	Kuroha, K; Ando, K; Nakagawa, R; Inada, T				Kuroha, Kazushige; Ando, Koji; Nakagawa, Reiko; Inada, Toshifumi			The Upf Factor Complex Interacts with Aberrant Products Derived from mRNAs Containing a Premature Termination Codon and Facilitates Their Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; mRNA Decay; Protein Folding; Protein Turnover; Ribosomes	E3 UBIQUITIN LIGASE; QUALITY-CONTROL; TRANSLATIONAL TERMINATION; NONSENSE; DECAY; YEAST; RIBOSOME; PATHWAYS; IDENTIFICATION; SURVEILLANCE	Up-frameshift (Upf) factors eliminate aberrant mRNAs containing a specific premature termination codon (PTC). Here, we show that Upf complex facilitates the ubiquitin-dependent degradation of products derived from mRNA containing specific PTCs in Saccharomyces cerevisiae. The efficiency of recruitment of the Upf complex to a PTC product was correlated with the decay of the PTC product. Upf factors promoted the degradation of the human von Hippel-Lindau (VHL) protein, which is an unfolded protein in yeast cells, in a manner that depends on the presence of a faux 3-UTR. Mass spectrometric analysis and Western blot analysis revealed that Hsp70 was associated with the PTC product. These findings suggest that the Upf complex may be recruited to ribosomes in a faux 3-UTR-dependent manner and then associates with aberrant products to facilitate their degradation by the proteasome.	[Kuroha, Kazushige; Ando, Koji; Inada, Toshifumi] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Nakagawa, Reiko] RIKEN Ctr Dev Biol, Kobe, Hyogo 6500047, Japan	Tohoku University; RIKEN	Inada, T (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan.	tinada@m.tohoku.ac.jp	Nakagawa, Reiko/C-4214-2017; Inada, Toshifumi/AAE-1517-2019	Nakagawa, Reiko/0000-0002-6178-2945; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [20112006]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for young scientists (to K. K.) and Grant-in-aid for Scientific Research on Innovative Areas "RNA regulation" 20112006 (to T. I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amrani N, 2006, BIOCHEM SOC T, V34, P39, DOI 10.1042/BST0340039; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; ARNOLD CE, 1994, J BIOL CHEM, V269, P30412; Behm-Ansmant I, 2007, FEBS LETT, V581, P2845, DOI 10.1016/j.febslet.2007.05.027; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Holbrook WP, 2004, ACTA ODONTOL SCAND, V62, P177, DOI 10.1080/00016350410001522; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Kaake RM, 2010, J PROTEOME RES, V9, P2016, DOI 10.1021/pr1000175; Kertesz S, 2006, NUCLEIC ACIDS RES, V34, P6147, DOI 10.1093/nar/gkl737; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Kuroha K, 2009, EMBO REP, V10, P1265, DOI 10.1038/embor.2009.200; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Longman D, 2007, GENE DEV, V21, P1075, DOI 10.1101/gad.417707; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; Muhlrad D, 1999, RNA, V5, P1299, DOI 10.1017/S1355838299990829; Singh G, 2012, CELL, V151, P750, DOI 10.1016/j.cell.2012.10.007; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Takahashi S, 2008, RNA, V14, P1950, DOI 10.1261/rna.536308; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013	35	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28630	28640		10.1074/jbc.M113.460691	http://dx.doi.org/10.1074/jbc.M113.460691			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23928302	Green Published, hybrid			2022-12-28	WOS:000330298800019
J	Baba, SP; Hoetker, JD; Merchant, M; Klein, JB; Cai, J; Barski, OA; Conklin, DJ; Bhatnagar, A				Baba, Shahid P.; Hoetker, Joseph David; Merchant, Michael; Klein, Jon B.; Cai, Jian; Barski, Oleg A.; Conklin, Daniel J.; Bhatnagar, Aruni			Role of Aldose Reductase in the Metabolism and Detoxification of Carnosine-Acrolein Conjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION PRODUCT; TANDEM MASS-SPECTROMETRY; ALPHA,BETA-UNSATURATED ALDEHYDES; STRUCTURAL-CHARACTERIZATION; ISCHEMIA-REPERFUSION; PARKINSONS-DISEASE; OXIDATIVE STRESS; CROSS-LINKING; RAT-HEART; ADDUCTS	Oxidation of unsaturated lipids generates reactive aldehydes that accumulate in tissues during inflammation, ischemia, or aging. These aldehydes form covalent adducts with histidine-containing dipeptides such as carnosine and anserine, which are present in high concentration in skeletal muscle, heart, and brain. The metabolic pathways involved in the detoxification and elimination of these conjugates are, however, poorly defined, and their significance in regulating oxidative stress is unclear. Here we report that conjugates of carnosine with aldehydes such as acrolein are produced during normal metabolism and excreted in the urine of mice and adult human non-smokers as carnosine-propanols. Our studies show that the reduction of carnosine-propanals is catalyzed by the enzyme aldose reductase (AR). Carnosine-propanals were converted to carnosine-propanols in the lysates of heart, skeletal muscle, and brain tissue from wild-type (WT) but not AR-null mice. In comparison with WT mice, the urinary excretion of carnosine-propanols was decreased in AR-null mice. Carnosine-propanals formed covalent adducts with nucleophilic amino acids leading to the generation of carnosinylated proteins. Deletion of AR increased the abundance of proteins bound to carnosine in skeletal muscle, brain, and heart of aged mice and promoted the accumulation of carnosinylated proteins in hearts subjected to global ischemia ex vivo. Perfusion with carnosine promoted post-ischemic functional recovery in WT but not in AR-null mouse hearts. Collectively, these findings reveal a previously unknown metabolic pathway for the removal of carnosine-propanal conjugates and suggest a new role of AR as a critical regulator of protein carnosinylation and carnosine-mediated tissue protection.	[Baba, Shahid P.; Hoetker, Joseph David; Barski, Oleg A.; Conklin, Daniel J.; Bhatnagar, Aruni] Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40202 USA; [Cai, Jian; Bhatnagar, Aruni] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA; [Baba, Shahid P.; Hoetker, Joseph David; Merchant, Michael; Klein, Jon B.; Barski, Oleg A.; Conklin, Daniel J.; Bhatnagar, Aruni] Univ Louisville, Dept Med, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville	Bhatnagar, A (corresponding author), Diabet & Obes Ctr, 580 S Preston St,Delia Baxter Bldg,Rm 421, Louisville, KY 40202 USA.	aruni@louisville.edu	Lorkiewicz, Pawel/A-2126-2011; Merchant, Michael L/N-7444-2013; Merchant, Michael/F-7109-2013	Lorkiewicz, Pawel/0000-0002-1755-9826; Merchant, Michael L/0000-0003-4128-4057; 	National Institutes of Health [HL55477, HL59378, HL89380, RR024489]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024489] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055477, R01HL089380, R01HL059378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL55477, HL59378, HL89380, and RR024489.	Abdillahi M, 2012, AM J PHYSIOL-HEART C, V303, pH297, DOI 10.1152/ajpheart.00999.2011; Aldini G, 2004, J MASS SPECTROM, V39, P1417, DOI 10.1002/jms.696; Aldini G, 2002, BIOCHEM BIOPH RES CO, V298, P699, DOI 10.1016/S0006-291X(02)02545-7; Ananthakrishnan R, 2009, AM J PHYSIOL-HEART C, V296, pH333, DOI 10.1152/ajpheart.01012.2008; Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Awasthi Y. C., 2007, TOXICOLOGY GLUTATHIO; BENEDETTI A, 1980, BIOCHIM BIOPHYS ACTA, V620, P281, DOI 10.1016/0005-2760(80)90209-X; Boldyrev A, 2008, REJUV RES, V11, P821, DOI 10.1089/rej.2008.0716; Brownson C, 2000, FREE RADICAL BIO MED, V28, P1564, DOI 10.1016/S0891-5849(00)00270-7; Butterfield DA, 2010, BBA-MOL CELL BIOL L, V1801, P924, DOI 10.1016/j.bbalip.2010.02.005; Carini M, 2003, J MASS SPECTROM, V38, P996, DOI 10.1002/jms.517; Carmella SG, 2007, CHEM RES TOXICOL, V20, P986, DOI 10.1021/tx700075y; Chung FL, 2003, MUTAT RES-FUND MOL M, V531, P25, DOI 10.1016/j.mrfmmm.2003.07.001; Dixit BL, 2000, J BIOL CHEM, V275, P21587, DOI 10.1074/jbc.M909235199; Dobrota D, 2005, NEUROCHEM RES, V30, P1283, DOI 10.1007/s11064-005-8799-7; Eaton P, 1999, AM J PHYSIOL-HEART C, V276, pH935, DOI 10.1152/ajpheart.1999.276.3.H935; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Hill BG, 2009, BIOCHEM J, V417, P513, DOI 10.1042/BJ20081615; Hipkiss AR, 2009, ADV FOOD NUTR RES, V57, P87, DOI 10.1016/S1043-4526(09)57003-9; Hsu DKW, 1997, BIOCHEM J, V328, P593, DOI 10.1042/bj3280593; Hwang YC, 2001, FASEB J, V15, P243, DOI 10.1096/fj.01-0368fje; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jensen O. N., 1997, PROTEIN ANAL MASS SP; Kaiserova K, 2006, J BIOL CHEM, V281, P15110, DOI 10.1074/jbc.M600837200; Kuiper HC, 2008, J BIOL CHEM, V283, P17131, DOI 10.1074/jbc.M802797200; Kurata H, 2006, J PHARMACOL EXP THER, V319, P640, DOI 10.1124/jpet.106.110122; Lee JW, 1999, J MOL CELL CARDIOL, V31, P113, DOI 10.1006/jmcc.1998.0850; Linhart I, 1996, TOXICOL APPL PHARM, V136, P155, DOI 10.1006/taap.1996.0019; Liu YH, 2003, CHEM RES TOXICOL, V16, P1589, DOI 10.1021/tx034160a; LoPachin RM, 2009, CHEM RES TOXICOL, V22, P1499, DOI 10.1021/tx900147g; MCFARLAND GA, 1994, EXP CELL RES, V212, P167, DOI 10.1006/excr.1994.1132; Minko IG, 2009, CHEM RES TOXICOL, V22, P759, DOI 10.1021/tx9000489; Nair J, 1999, MUTAT RES-FUND MOL M, V424, P59, DOI 10.1016/S0027-5107(99)00008-1; Oriolli M, 2007, ANAL CHEM, V79, P9174, DOI 10.1021/ac7016184; Parent RA, 1998, TOXICOL SCI, V43, P110, DOI 10.1006/toxs.1998.2462; Ramana KV, 2000, BIOCHEMISTRY-US, V39, P12172, DOI 10.1021/bi000796e; Ramasamy R, 1998, AM J PHYSIOL-HEART C, V275, pH195, DOI 10.1152/ajpheart.1998.275.1.H195; Riahi Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE879, DOI 10.1152/ajpendo.00508.2010; Rittner HL, 1999, J CLIN INVEST, V103, P1007, DOI 10.1172/JCI4711; Sauerhofer S, 2007, DIABETES, V56, P2425, DOI 10.2337/db07-0177; Shinmura K, 2002, CIRC RES, V91, P240, DOI 10.1161/01.RES.0000029970.97247.57; Srivastava S, 1998, BIOCHEMISTRY-US, V37, P12909, DOI 10.1021/bi9804333; Srivastava S, 1999, BIOCHEMISTRY-US, V38, P42, DOI 10.1021/bi981794l; Srivastava S, 2000, FREE RADICAL BIO MED, V29, P642, DOI 10.1016/S0891-5849(00)00351-8; Srivastava S, 1998, J BIOL CHEM, V273, P10893, DOI 10.1074/jbc.273.18.10893; Srivastava S, 2009, CIRC RES, V105, P793, DOI 10.1161/CIRCRESAHA.109.200568; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Toninello A, 2006, BBA-REV CANCER, V1765, P1, DOI 10.1016/j.bbcan.2005.09.001; Tsuruta Y, 2010, J CHROMATOGR B, V878, P327, DOI 10.1016/j.jchromb.2009.11.038; Vladykovskaya E, 2012, J BIOL CHEM, V287, P11398, DOI 10.1074/jbc.M111.320416; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Yuneva AO, 2002, B EXP BIOL MED+, V133, P559, DOI 10.1023/A:1020273506970; Zhang GF, 2009, J BIOL CHEM, V284, P33521, DOI 10.1074/jbc.M109.055665; Zhao Z, 2012, AUTOPHAGY, V8, P1392, DOI 10.4161/auto.21035; Zhao Z, 2012, DEV CELL, V22, P1001, DOI 10.1016/j.devcel.2011.12.027; Zhou SY, 1999, J AGR FOOD CHEM, V47, P51, DOI 10.1021/jf980780j; Zhu X, 2009, CHEM RES TOXICOL, V22, P1050, DOI 10.1021/tx9000144	58	64	65	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28163	28179		10.1074/jbc.M113.504753	http://dx.doi.org/10.1074/jbc.M113.504753			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23928303	Green Published, hybrid			2022-12-28	WOS:000330612800040
J	Cabodevilla, AG; Sanchez-Caballero, L; Nintou, E; Boiadjieva, VG; Picatoste, F; Gubern, A; Claro, E				Cabodevilla, Ainara G.; Sanchez-Caballero, Laura; Nintou, Eleni; Boiadjieva, Violeta G.; Picatoste, Fernando; Gubern, Albert; Claro, Enrique			Cell Survival during Complete Nutrient Deprivation Depends on Lipid Droplet-fueled beta-Oxidation of Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-IVA PHOSPHOLIPASE-A(2); NUCLEAR-MAGNETIC-RESONANCE; VISIBLE LIPIDS; INSULIN-RESISTANCE; PERILIPIN 5; INTRACELLULAR LIPIDS; MUSCLE MITOCHONDRIA; C6 CELLS; IN-VIVO; METABOLISM	Cells exposed to stress of different origins synthesize triacylglycerols and generate lipid droplets (LD), but the physiological relevance of this response is uncertain. Using complete nutrient deprivation of cells in culture as a simple model of stress, we have addressed whether LD biogenesis has a protective role in cells committed to die. Complete nutrient deprivation induced the biogenesis of LD in human LN18 glioblastoma and HeLa cells and also in CHO and rat primary astrocytes. In all cell types, death was associated with LD depletion and was accelerated by blocking LD biogenesis after pharmacological inhibition of Group IVA phospholipase A(2) (cPLA(2)alpha) or down-regulation of ceramide kinase. Nutrient deprivation also induced beta-oxidation of fatty acids that was sensitive to cPLA(2)alpha inhibition, and cell survival in these conditions became strictly dependent on fatty acid catabolism. These results show that, during nutrient deprivation, cell viability is sustained by beta-oxidation of fatty acids that requires biogenesis and mobilization of LD.	[Cabodevilla, Ainara G.; Sanchez-Caballero, Laura; Nintou, Eleni; Boiadjieva, Violeta G.; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Inst Neurosci, E-08193 Cerdanyola Del Valles, Spain; [Cabodevilla, Ainara G.; Sanchez-Caballero, Laura; Nintou, Eleni; Boiadjieva, Violeta G.; Picatoste, Fernando; Claro, Enrique] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Cerdanyola Del Valles, Spain; [Gubern, Albert] Univ Pompeu Fabra, Cell Signaling Res Grp, Dept Ciencies Expt & Salut, E-08003 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Pompeu Fabra University	Claro, E (corresponding author), Univ Autonoma Barcelona, Inst Neurosci, Edifici M2,Campus UAB, E-08193 Cerdanyola Del Valles, Spain.	enrique.claro@uab.es	Gubern, Albert/C-9902-2011; Claro, Enrique/D-5612-2009	Gubern, Albert/0000-0001-6458-1498; Claro, Enrique/0000-0002-7592-7906; Gonzalez Cabodevilla, Ainara/0000-0002-4026-7637	Spanish Ministry of Economy [BFU2009-07823, BFU2012-34987]	Spanish Ministry of Economy(Spanish Government)	This work was supported in part by Spanish Ministry of Economy Grants BFU2009-07823 and BFU2012-34987).	Barba I, 1999, CANCER RES, V59, P1861; Barba I, 2001, NMR BIOMED, V14, P33, DOI 10.1002/nbm.688; Barcelo-Torns M, 2011, FEBS LETT, V585, P2300, DOI 10.1016/j.febslet.2011.05.062; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boren J, 2012, CELL DEATH DIFFER, V19, P1561, DOI 10.1038/cdd.2012.34; Bosma M, 2012, HISTOCHEM CELL BIOL, V137, P205, DOI 10.1007/s00418-011-0888-x; Bozza PT, 2011, PROSTAG LEUKOTR ESS, V85, P205, DOI 10.1016/j.plefa.2011.04.020; Carman GM, 2012, J BIOL CHEM, V287, P2272, DOI 10.1074/jbc.R111.323931; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Coen PM, 2012, TRENDS ENDOCRIN MET, V23, P391, DOI 10.1016/j.tem.2012.05.009; Delikatny EJ, 2011, NMR BIOMED, V24, P592, DOI 10.1002/nbm.1661; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; FREITAS I, 1990, ANTICANCER RES, V10, P613; Freitas I, 1996, ANTICANCER RES, V16, P1491; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Greenberg AS, 2011, TRENDS ENDOCRIN MET, V22, P195, DOI 10.1016/j.tem.2011.04.002; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Gubern A, 2008, J BIOL CHEM, V283, P27369, DOI 10.1074/jbc.M800696200; Gubern A, 2009, J BIOL CHEM, V284, P32359, DOI 10.1074/jbc.M109.061515; Gubern A, 2009, J BIOL CHEM, V284, P5697, DOI 10.1074/jbc.M806173200; Guijas C, 2012, J LIPID RES, V53, P2343, DOI 10.1194/jlr.M028423; Hakumaki JM, 1999, NAT MED, V5, P1323, DOI 10.1038/15279; Hakumaki JM, 2003, TRENDS PHARMACOL SCI, V24, P146, DOI 10.1016/S0165-6147(03)00032-4; Hakumaki JM, 2000, TRENDS BIOCHEM SCI, V25, P357, DOI 10.1016/S0968-0004(00)01614-5; Hapala I, 2011, BIOL CELL, V103, P271, DOI 10.1042/BC20100144; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Ii H, 2008, PROSTAG OTH LIPID M, V86, P12, DOI 10.1016/j.prostaglandins.2007.12.002; Ii H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008089; Iorio E, 2003, BBA-MOL CELL BIOL L, V1634, P1, DOI 10.1016/j.bbalip.2003.07.001; Kaushik S, 2011, CELL METAB, V14, P173, DOI 10.1016/j.cmet.2011.06.008; Khatchadourian A, 2009, MOL PHARMACEUT, V6, P1125, DOI 10.1021/mp900098p; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Le Lay S, 2009, PROG LIPID RES, V48, P191, DOI 10.1016/j.plipres.2009.03.001; Lei P, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0323-z; Li LO, 2010, BBA-MOL CELL BIOL L, V1801, P246, DOI 10.1016/j.bbalip.2009.09.024; Menzel N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002829; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Quintero M, 2007, BBA-MOL CELL BIOL L, V1771, P31, DOI 10.1016/j.bbalip.2006.10.003; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Schmitz JE, 2005, MAGN RESON MED, V54, P43, DOI 10.1002/mrm.20529; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Wang H, 2011, J LIPID RES, V52, P2159, DOI 10.1194/jlr.M017939; Wang H, 2011, TRENDS ENDOCRIN MET, V22, P197, DOI 10.1016/j.tem.2011.03.008; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zoula S, 2003, BRIT J CANCER, V88, P1439, DOI 10.1038/sj.bjc.6600837	56	94	94	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27777	27788		10.1074/jbc.M113.466656	http://dx.doi.org/10.1074/jbc.M113.466656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940052	Green Published, hybrid			2022-12-28	WOS:000330612800007
J	Teixeira, FR; Manfiolli, AO; Soares, CS; Baqui, MMA; Koide, T; Gomes, MD				Teixeira, Felipe R.; Manfiolli, Adriana O.; Soares, Claudia S.; Baqui, Munira M. A.; Koide, Tie; Gomes, Marcelo D.			The F-box Protein FBXO25 Promotes the Proteasome-dependent Degradation of ELK-1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; UBIQUITIN LIGASE; CYCLIN D1; IDENTIFICATION; EXPRESSION; FAMILY; PHOSPHORYLATION; PROLIFERATION; ACTIVATION; INDUCTION	FBXO25 is one of the 69 known human F-box proteins that serve as specificity factors for a family of ubiquitin ligases composed of SKP1, Rbx1, Cullin1, and F-box protein (SCF1) that are involved in targeting proteins for degradation across the ubiquitin proteasome system. However, the substrates of most SCF E3 ligases remain unknown. Here, we applied an in chip ubiquitination screen using a human protein microarray to uncover putative substrates for the FBXO25 protein. Among several novel putative targets identified, the c-fos protooncogene regulator ELK-1 was characterized as the first endogenous substrate for SCF1(FBXO25) E3 ligase. FBXO25 interacted with and mediated the ubiquitination and proteasomal degradation of ELK-1 in HEK293T cells. In addition, FBXO25 overexpression suppressed induction of two ELK-1 target genes, c-fos and egr-1, in response to phorbol 12-myristate 13-acetate. Together, our findings show that FBXO25 mediates ELK-1 degradation through the ubiquitin proteasome system and thereby plays a role in regulating the activation of ELK-1 pathway in response to mitogens.	[Teixeira, Felipe R.; Manfiolli, Adriana O.; Soares, Claudia S.; Koide, Tie; Gomes, Marcelo D.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biochem & Immunol, BR-14049900 Ribeirao Preto, SP, Brazil; [Baqui, Munira M. A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cell Biol, BR-14049900 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Gomes, MD (corresponding author), Av Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.	mdamario@fmrp.usp.br	Teixeira, Felipe R/D-6235-2012; Baqui, Munira M. A/H-5243-2013; Koide, Tie/D-4406-2014; Teixeira, Felipe/ABB-4687-2020; Gomes, Marcelo/AAC-6041-2021	Teixeira, Felipe R/0000-0003-0251-2686; Baqui, Munira M. A/0000-0002-7945-2899; Koide, Tie/0000-0003-4760-2423; Teixeira, Felipe/0000-0003-0251-2686; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [201013045-4]; CNPq [GENOPROT 42/2009]; Fundacao de Apoio ao Ensino, Pequisa e Assistencia (FAEPA); University of Sao Paulo through the Nucleo de Apoio a Pesquisa na Interface Proteolise Sinalizacao Celular (NAPPS)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio ao Ensino, Pequisa e Assistencia (FAEPA); University of Sao Paulo through the Nucleo de Apoio a Pesquisa na Interface Proteolise Sinalizacao Celular (NAPPS)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant 201013045-4, CNPq Grant GENOPROT 42/2009, Fundacao de Apoio ao Ensino, Pequisa e Assistencia (FAEPA), and the University of Sao Paulo through the Nucleo de Apoio a Pesquisa na Interface Proteolise Sinalizacao Celular (NAPPS).	Andrews PS, 2010, ASSAY DRUG DEV TECHN, V8, P471, DOI 10.1089/adt.2009.0264; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Cleveland BM, 2010, COMP BIOCHEM PHYS B, V157, P248, DOI 10.1016/j.cbpb.2010.06.010; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; Evans EL, 2011, NUCLEIC ACIDS RES, V39, P6390, DOI 10.1093/nar/gkr266; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kanie T, 2012, MOL CELL BIOL, V32, P590, DOI 10.1128/MCB.06570-11; Laman H, 2005, EMBO J, V24, P3104, DOI 10.1038/sj.emboj.7600775; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomonosov M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021165; Lu JY, 2008, MOL CELL PROTEOMICS, V7, P35, DOI 10.1074/mcp.M700353-MCP200; Manfiolli AO, 2008, MOL BIOL CELL, V19, P1848, DOI 10.1091/mbc.E07-08-0815; Maragno ALGC, 2006, BBA-GEN SUBJECTS, V1760, P966, DOI 10.1016/j.bbagen.2006.03.020; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Meziane E, 2011, J CELL SCI, V124, P2175, DOI 10.1242/jcs.080465; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Phizicky E, 2003, NATURE, V422, P208, DOI 10.1038/nature01512; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shao NS, 1998, ONCOGENE, V17, P527, DOI 10.1038/sj.onc.1201931; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Teixeira FR, 2010, PROTEOMICS, V10, P2746, DOI 10.1002/pmic.200900419; Townsend KJ, 1999, J BIOL CHEM, V274, P1801, DOI 10.1074/jbc.274.3.1801; Uht RM, 2007, ONCOGENE, V26, P2885, DOI 10.1038/sj.onc.1210090; Vanhoutte P, 2001, J BIOL CHEM, V276, P5189, DOI 10.1074/jbc.M006678200; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Zhang JX, 2003, P NATL ACAD SCI USA, V100, P14127, DOI 10.1073/pnas.2233012100; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	41	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28152	28162		10.1074/jbc.M113.504308	http://dx.doi.org/10.1074/jbc.M113.504308			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940030	Green Published, hybrid			2022-12-28	WOS:000330612800039
J	Kang, HW; Ozdemir, C; Kawano, Y; LeClair, KB; Vernochet, C; Kahn, CR; Hagen, SJ; Cohen, DE				Kang, Hye Won; Ozdemir, Cafer; Kawano, Yuki; LeClair, Katherine B.; Vernochet, Cecile; Kahn, C. Ronald; Hagen, Susan J.; Cohen, David E.			Thioesterase Superfamily Member 2/Acyl-CoA Thioesterase 13 (Them2/Acot13) Regulates Adaptive Thermogenesis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Energy metabolism; Fatty acid; Fatty acid oxidation; Mitochondrial metabolism; Obesity; Brown adipose tissue; Fatty acyl-CoA	BROWN ADIPOSE-TISSUE; INSULIN-RESISTANCE; METABOLISM; OXIDATION; PROTECTS; DELETION; OBESITY	Members of the acyl-CoA thioesterase (Acot) gene family hydrolyze fatty acyl-CoAs, but their biological functions remain incompletely understood. Thioesterase superfamily member 2 (Them2; synonym Acot13) is enriched in oxidative tissues, associated with mitochondria, and relatively specific for long chain fatty acyl-CoA substrates. Using Them2(-/-) mice, we have demonstrated key roles for Them2 in regulating hepatic glucose and lipid metabolism. However, reduced body weights and decreased adiposity in Them2(-/-) mice observed despite increased food consumption were not well explained. To explore a role in thermogenesis, mice were exposed to ambient temperatures ranging from thermoneutrality (30 degrees C) to cold (4 degrees C). In response to short term (24-h) exposures to decreasing ambient temperatures, Them2(-/-) mice exhibited increased adaptive responses in physical activity, food consumption, and energy expenditure when compared with Them2(+/+) mice. By contrast, genotype-dependent differences were not observed in mice that were equilibrated (96 h) at each ambient temperature. In brown adipose tissue, the absence of Them2 was associated with reduced lipid droplets, alterations in the ultrastructure of mitochondria, and increased expression of thermogenic genes. Indicative of a direct regulatory role for Them2 in heat production, cultured primary brown adipocytes from Them2(-/-) mice exhibited increased norepinephrine-mediated triglyceride hydrolysis and increased rates of O-2 consumption, together with elevated expression of thermogenic genes. At least in part by regulating intracellular fatty acid channeling, Them2 functions in brown adipose tissue to suppress adaptive increases in energy expenditure.	[Kang, Hye Won; Ozdemir, Cafer; Kawano, Yuki; LeClair, Katherine B.; Cohen, David E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Gastroenterol, Boston, MA 02115 USA; [Vernochet, Cecile; Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [Hagen, Susan J.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Cohen, DE (corresponding author), Brigham & Womens Hosp, 77 Ave Louis Pasteur,HIM 941, Boston, MA 02115 USA.	dcohen@partners.org	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228; Ozdemir, Cafer/0000-0002-5546-983X	National Institutes of Health/National Center for Research Resources [S10-RR-023010]; NCI Cancer Center Support Grant, National Institutes of Health [P30 CA06516]; National Institutes of Health [U24 DK76169]; NATIONAL CANCER INSTITUTE [P30CA006516] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082659, U24DK076169, R01DK056626, P30DK034854, R37DK048873] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI Cancer Center Support Grant, National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The use of the Longwood Small Animal Imaging Facility at Beth Israel Deaconess Medical Center (Boston, MA) was supported in part by National Institutes of Health/National Center for Research Resources shared instrumentation Grant S10-RR-023010. The use of the Rodent Histopathology Core Facility of Dana-Farber/Harvard Cancer Center (Boston, MA) was supported in part by an NCI Cancer Center Support Grant, National Institutes of Health Grant P30 CA06516. The use of the Mouse Metabolic Phenotype Center at Yale University School of Medicine (New Haven, CT) was supported in part by National Institutes of Health Grant U24 DK76169.	Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Brocker Chad, 2010, Hum Genomics, V4, P411; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Cao J, 2009, BIOCHEMISTRY-US, V48, P1293, DOI 10.1021/bi801879z; Cheng ZJ, 2006, BIOCHEM BIOPH RES CO, V350, P850, DOI 10.1016/j.bbrc.2006.09.105; Clapham JC, 2012, NEUROPHARMACOLOGY, V63, P111, DOI 10.1016/j.neuropharm.2011.10.014; Cohen DE, 2013, ADIPOCYTE, V2, P3, DOI 10.4161/adip.21853; Ellis JM, 2013, MOL CELL BIOL, V33, P1869, DOI 10.1128/MCB.01548-12; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Kang HW, 2012, FASEB J, V26, P2209, DOI 10.1096/fj.11-202853; Kang HW, 2009, J LIPID RES, V50, P2212, DOI 10.1194/jlr.M900013-JLR200; Kanno K, 2007, J BIOL CHEM, V282, P30728, DOI 10.1074/jbc.M703745200; Kirkby B, 2010, PROG LIPID RES, V49, P366, DOI 10.1016/j.plipres.2010.04.001; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; McLean J., 1987, ANIMAL HUMAN CALORIM; Nagy TR, 2002, OBES RES, V10, P412, DOI 10.1038/oby.2002.57; Souza SC, 2007, J LIPID RES, V48, P1273, DOI 10.1194/jlr.M700047-JLR200; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Wei J, 2009, BIOCHEM J, V421, P311, DOI 10.1042/BJ20090039; Zhang YZ, 2012, P NATL ACAD SCI USA, V109, P5417, DOI 10.1073/pnas.1116011109	26	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33376	33386		10.1074/jbc.M113.481408	http://dx.doi.org/10.1074/jbc.M113.481408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24072708	Green Published, hybrid			2022-12-28	WOS:000328841700051
J	Brickley, DR; Agyeman, AS; Kopp, RF; Hall, BA; Harbeck, MC; Belova, L; Volden, PA; Wu, W; Roe, MW; Conzen, SD				Brickley, Deanna R.; Agyeman, Abena S.; Kopp, Richard F.; Hall, Ben A.; Harbeck, Mark C.; Belova, Larissa; Volden, Paul A.; Wu, Wei; Roe, Michael W.; Conzen, Suzanne D.			Serum- and Glucocorticoid-induced Protein Kinase 1 (SGK1) Is Regulated by Store-operated Ca2+ Entry and Mediates Cytoprotection against Necrotic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Calcium Signaling; Mitochondrial Apoptosis; Necrosis (Necrotic Death); Signal Transduction; SGK1; Cytoprotection; Mitochondrial Membrane Potential	EPITHELIAL SODIUM-CHANNEL; KAPPA-B KINASE; INTRACELLULAR CALCIUM; INDUCED GENE; ER STRESS; EXPRESSION; APOPTOSIS; SURVIVAL; ISCHEMIA; PHOSPHORYLATION	Background: Mechanisms underlying SGK1 activation are incompletely understood in epithelial cells. Results: Store-operated Ca2+ entry up-regulates SGK1, thereby modulating the lethal effects of Ca2+ overloading on mitochondrial membrane potential. Conclusion: Ca2+-induced SGK1 activates cytoprotective signaling and modifies mitochondrial function in epithelial cells. Significance: This work reveals a cytoprotective role for SGK1 in necrosis and has potential relevance for epithelial cell protection and cancer treatment. Serum and glucocorticoid-regulated kinase 1 (SGK1) encodes a phosphatidylinositol 3-kinase-dependent serine/threonine kinase that is rapidly induced in response to cellular stressors and is an important cell survival signal. Previous studies have suggested that an increase in cytoplasmic Ca2+ concentration ([Ca2+](c)) is required for increased SGK1 expression, but the subcellular source of Ca2+ regulating SGK1 transcription remains uncertain. Activation of endoplasmic reticulum stress (ERS) with thapsigargin (TG) increased SGK1 mRNA and protein expression in MDA-MB-231 cells. Intracellular Ca2+ imaging revealed that store-operated Ca2+ entry played a prominent role in SGK1 induction by TG. Neither ERS nor release of Ca2+ from the ER was sufficient to activate SGK1. Prolonged elevation of intracellular Ca2+ levels, however, triggered cell death with a much greater proportion of the cells undergoing necrosis rather than apoptosis. A relative increase in the percentage of cells undergoing necrosis was observed in cells expressing a short hairpin RNA targeted to the SGK1 gene. Necrotic cell death evoked by cytoplasmic Ca2+ overloading was associated with persistent hyperpolarization of the inner mitochondrial membrane and a modest increase in calpain activation, but did not involve detectable caspase 3 or caspase 7 activation. The effects of cytoplasmic Ca2+ overloading on mitochondrial membrane potential were significantly reduced in cells expressing SGK1 compared with SGK1-depleted cells. Our findings indicate that store-operated Ca2+ entry regulates SGK1 expression in epithelial cells and suggest that SGK1-dependent cytoprotective signaling involves effects on maintaining mitochondrial function.	[Brickley, Deanna R.; Agyeman, Abena S.; Hall, Ben A.; Belova, Larissa; Volden, Paul A.; Wu, Wei; Conzen, Suzanne D.] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA; [Harbeck, Mark C.] Univ Chicago, Dept Med, Endocrinol Sect, Chicago, IL 60637 USA; [Conzen, Suzanne D.] Univ Chicago, Ben May Dept Canc Biol, Chicago, IL 60637 USA; [Kopp, Richard F.; Roe, Michael W.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Roe, Michael W.] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	University of Chicago; University of Chicago; University of Chicago; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Roe, MW (corresponding author), SUNY Upstate Med Univ, Dept Med, 505 Irving Ave, Syracuse, NY 13210 USA.	roem@upstate.edu; sdconzen@uchicago.edu	wu, wei/J-2797-2019	wu, wei/0000-0002-6556-067X; Kopp, Richard/0000-0001-8190-1748	National Institutes of Health [R01 CA089208, R21 CA149472, R01 DK074966, R01 DK092616]; University of Chicago's Breast Cancer SPORE National Institutes of Health [P50 CA125183]; Comprehensive Cancer Center Support Grant for Core Facilities, National Institutes of Health [P30 CA014599]; NATIONAL CANCER INSTITUTE [R21CA149472, R01CA089208, P50CA125183, P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092616, T32DK087703, R01DK074966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago's Breast Cancer SPORE National Institutes of Health; Comprehensive Cancer Center Support Grant for Core Facilities, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 CA089208 and R21 CA149472 (to S. D. C.), R01 DK074966 and R01 DK092616 (to M. W. R.), as well as the University of Chicago's Breast Cancer SPORE National Institutes of Health Grant P50 CA125183 and Comprehensive Cancer Center Support Grant for Core Facilities, National Institutes of Health Grant P30 CA014599.	Aoyama T, 2005, CIRCULATION, V111, P1652, DOI 10.1161/01.CIR.0000160352.58142.06; Bell JR, 2011, CLIN EXP PHARMACOL P, V38, P717, DOI 10.1111/j.1440-1681.2011.05567.x; Belova L, 2008, J BIOL CHEM, V283, P18821, DOI 10.1074/jbc.M803289200; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Boini KM, 2006, DIABETES, V55, P2059, DOI 10.2337/db05-1038; Brickley DR, 2002, J BIOL CHEM, V277, P43064, DOI 10.1074/jbc.M207604200; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Catela C, 2010, DEV DYNAM, V239, P2149, DOI 10.1002/dvdy.22345; Chang WJ, 2010, J INVEST SURG, V23, P228, DOI 10.3109/08941939.2010.496036; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Choi K, 2009, CURR NEUROVASC RES, V6, P213, DOI 10.2174/156720209789630375; Fagerli UM, 2011, ONCOGENE, V30, P3198, DOI 10.1038/onc.2011.79; Fejes-Toth G, 2007, ENDOCRINOLOGY, V148, P1502, DOI 10.1210/en.2006-1438; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Frosali S, 2009, BBA-MOL CELL RES, V1793, P572, DOI 10.1016/j.bbamcr.2008.11.018; George TC, 2004, CYTOM PART A, V59A, P237, DOI 10.1002/cyto.a.20048; Gouriou Y, 2011, BIOCHIMIE, V93, P2060, DOI 10.1016/j.biochi.2011.08.001; Harbeck M. C., 2006, SCI STKE, P6; Imai S, 2003, LIFE SCI, V72, P2199, DOI 10.1016/S0024-3205(03)00092-4; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Moran TJ, 2000, CANCER RES, V60, P867; Naray-Fejes-Toth A, 2000, J STEROID BIOCHEM, V75, P51, DOI 10.1016/S0960-0760(00)00136-9; Naray-Fejes-Toth A, 2000, KIDNEY INT, V57, P1290, DOI 10.1046/j.1523-1755.2000.00964.x; Nilius B, 2001, CELL CALCIUM, V29, P417, DOI 10.1054/ceca.2001.0201; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Orrenius S, 2011, TOXICOL SCI, V119, P3, DOI 10.1093/toxsci/kfq268; Pang D, 2006, CANCER BIOL THER, V5, P933, DOI 10.4161/cbt.5.8.2875; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Paschen W, 2004, J NEUROCHEM, V88, P983, DOI 10.1046/j.1471-4159.2003.02218.x; Perez-Pinzon MA, 2012, J CEREBR BLOOD F MET, V32, P1362, DOI 10.1038/jcbfm.2012.32; Perl A, 2009, CURR OPIN RHEUMATOL, V21, P454, DOI 10.1097/BOR.0b013e32832e977c; Pradelli LA, 2010, CELL MOL LIFE SCI, V67, P1589, DOI 10.1007/s00018-010-0285-y; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Rusai K, 2009, CELL PHYSIOL BIOCHEM, V24, P577, DOI 10.1159/000257527; Sahoo S, 2005, EUR J CANCER, V41, P2754, DOI 10.1016/j.ejca.2005.07.018; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Sheng H, 2008, AM J PHYSIOL-ENDOC M, V295, pE938, DOI 10.1152/ajpendo.90462.2008; Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tai DJC, 2009, J BIOL CHEM, V284, P4073, DOI 10.1074/jbc.M805055200; Taruno A, 2008, AM J PHYSIOL-RENAL, V294, pF177, DOI 10.1152/ajprenal.00250.2007; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Vanlangenakker N, 2008, CURR MOL MED, V8, P207, DOI 10.2174/156652408784221306; Verkhratsky A., 2007, V45, P465; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yamashima T, 2012, J NEUROCHEM, V120, P477, DOI 10.1111/j.1471-4159.2011.07596.x; Yang YC, 2006, MOL CELL BIOL, V26, P8357, DOI 10.1128/MCB.01017-06; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Zhang BH, 2001, J BIOL CHEM, V276, P31620, DOI 10.1074/jbc.M102808200; Zhang LP, 2005, CANCER RES, V65, P457; Zhou YP, 1998, J CLIN INVEST, V101, P1623, DOI 10.1172/JCI1245; Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340, DOI 10.1152/ajpendo.2000.278.2.E340	66	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32708	32719		10.1074/jbc.M113.507210	http://dx.doi.org/10.1074/jbc.M113.507210			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24043625	hybrid, Green Published			2022-12-28	WOS:000328681700055
J	Ermert, D; Weckel, A; Agarwal, V; Frick, IM; Bjorck, L; Blom, AM				Ermert, David; Weckel, Antonin; Agarwal, Vaibhav; Frick, Inga-Maria; Bjorck, Lars; Blom, Anna M.			Binding of Complement Inhibitor C4b-binding Protein to a Highly Virulent Streptococcus pyogenes M1 Strain Is Mediated by Protein H and Enhances Adhesion to and Invasion of Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Complement; Host-pathogen Interactions; Peptide Arrays; Protein-protein Interactions; Streptococcus pyogenes; Virulence Factors	GROUP-A STREPTOCOCCI; I COFACTOR FUNCTION; SURFACE-PROTEINS; ALPHA-CHAIN; C4B BINDING; STRUCTURAL REQUIREMENTS; NEISSERIA-GONORRHOEAE; C4-BINDING PROTEIN; SERUM RESISTANCE; IGG	Streptococcus pyogenes AP1, a strain of the highly virulent M1 serotype, uses exclusively protein H to bind the complement inhibitor C4b-binding protein (C4BP). We found a strong correlation between the ability of AP1 and its isogenic mutants lacking protein H to inhibit opsonization with complement C3b and binding of C4BP. C4BP bound to immobilized protein H or AP1 bacteria retained its cofactor activity for degradation of I-125-C4b. Furthermore, C4b deposited from serum onto AP1 bacterial surfaces was processed into C4c/C4d fragments, which did not occur on strains unable to bind C4BP. Recombinant C4BP mutants, which (i) lack certain CCP domains or (ii) have mutations in single aa as well as (iii) mutants with additional aa between different CCP domains were used to determine that the binding is mainly mediated by a patch of positively charged amino acid residues at the interface of domains CCP1 and CCP2. Using recombinant protein H fragments, we narrowed down the binding site to the N-terminal domain A. With a peptide microarray, we identified one single 18-amino acid-long peptide comprising residues 92-109, which specifically bound C4BP. Biacore was used to determine K-D = 6 x 10(-7) m between protein H and a single subunit of C4BP. C4BP binding also correlated with elevated levels of adhesion and invasion to endothelial cells. Taken together, we identified the molecular basis of C4BP-protein H interaction and found that it is not only important for decreased opsonization but also for invasion of endothelial cells by S. pyogenes.	[Ermert, David; Weckel, Antonin; Agarwal, Vaibhav; Blom, Anna M.] Lund Univ, Dept Lab Med, SE-20502 Malmo, Sweden; [Frick, Inga-Maria; Bjorck, Lars] Lund Univ, Div Infect Med, Dept Clin Sci, SE-22100 Lund, Sweden	Lund University; Lund University	Blom, AM (corresponding author), Wallenberg Inst & Labs, Dept Lab Med, Fl 4,Inga Marie Nilsson St 53, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Ermert, David/I-5879-2013; Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022	Ermert, David/0000-0003-4600-9070; Blom, Anna/0000-0002-1348-1734; Weckel, Antonin/0000-0002-5085-0551	Swedish Research Council [K2012-66X-14928-09-5, 7480]; Swedish Government Funds for Clinical Research (ALF); Torsten Soderberg Foundation; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of Gustav V 80-years anniversary; Foundation of Craaford; Foundation of Knut and Alice Wallenberg; Foundation of Inga-Britt and Arne Lundberg; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Government Funds for Clinical Research (ALF); Torsten Soderberg Foundation; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of Gustav V 80-years anniversary; Foundation of Craaford; Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Inga-Britt and Arne Lundberg; Swedish Society for Medical Research	This work was supported by Swedish Research Council (Projects K2012-66X-14928-09-5 and 7480), the Swedish Government Funds for Clinical Research (ALF), the Torsten Soderberg Foundation, and the Foundations of Osterlund, Greta and Johan Kock, Gustav V 80-years anniversary, Craaford, Knut and Alice Wallenberg and Inga-Britt and Arne Lundberg.; Recipient of a postdoctoral stipend from the Swedish Society for Medical Research.	Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; AKESSON P, 1990, MOL IMMUNOL, V27, P523, DOI 10.1016/0161-5890(90)90071-7; AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; Andre I, 2006, BIOCHEMISTRY-US, V45, P4559, DOI 10.1021/bi052455c; Berge A, 1997, J BIOL CHEM, V272, P20774, DOI 10.1074/jbc.272.33.20774; Berggard K, 2001, EUR J IMMUNOL, V31, P2771, DOI 10.1002/1521-4141(200109)31:9<2771::AID-IMMU2771>3.0.CO;2-0; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Blom AM, 2000, J IMMUNOL, V164, P5328, DOI 10.4049/jimmunol.164.10.5328; Blom AM, 2004, ARCH IMMUNOL THER EX, V52, P83; Blom AM, 2003, J BIOL CHEM, V278, P43437, DOI 10.1074/jbc.M306620200; Blom AM, 1999, J BIOL CHEM, V274, P19237, DOI 10.1074/jbc.274.27.19237; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Collin M, 2000, MOL MICROBIOL, V36, P1306, DOI 10.1046/j.1365-2958.2000.01942.x; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; FRICK IM, 1994, MOL MICROBIOL, V12, P143, DOI 10.1111/j.1365-2958.1994.tb01003.x; FUJITA T, 1979, J EXP MED, V150, P267, DOI 10.1084/jem.150.2.267; GIGLI I, 1979, P NATL ACAD SCI USA, V76, P6596, DOI 10.1073/pnas.76.12.6596; GOMI H, 1990, J IMMUNOL, V144, P4046; GRECO R, 1995, RES MICROBIOL, V146, P551, DOI 10.1016/0923-2508(96)80561-4; Hallstrom T, 2007, J IMMUNOL, V178, P6359, DOI 10.4049/jimmunol.178.10.6359; Hardig Y, 1997, BIOCHEM J, V323, P469; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Jarva H, 2007, J IMMUNOL, V179, P540, DOI 10.4049/jimmunol.179.1.540; Jenkins HT, 2006, J BIOL CHEM, V281, P3690, DOI 10.1074/jbc.M511563200; Johnsson E, 1996, J IMMUNOL, V157, P3021; Kask L, 2002, BIOCHEMISTRY-US, V41, P9349, DOI 10.1021/bi025980+; Kihlberg BM, 1995, MICROB PATHOGENESIS, V19, P299, DOI 10.1016/S0882-4010(96)80003-9; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Meri T, 2006, INFECT IMMUN, V74, P4157, DOI 10.1128/IAI.00007-06; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Morfeldt E, 2001, J IMMUNOL, V167, P3870, DOI 10.4049/jimmunol.167.7.3870; NILSON BHK, 1995, BIOCHEMISTRY-US, V34, P13688, DOI 10.1021/bi00041a051; Nordstrom T, 2004, J IMMUNOL, V173, P4598, DOI 10.4049/jimmunol.173.7.4598; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; NOWAK R, 1994, SCIENCE, V264, P1665, DOI 10.1126/science.8209244; Persson Jenny, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020047; Ram S, 2001, J EXP MED, V193, P281, DOI 10.1084/jem.193.3.281; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; SCHARFSTEIN J, 1978, J EXP MED, V148, P207, DOI 10.1084/jem.148.1.207; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; THERN A, 1995, J IMMUNOL, V154, P375; WHITNACK E, 1982, J CLIN INVEST, V69, P1042, DOI 10.1172/JCI110508; ZICCARDI RJ, 1984, J BIOL CHEM, V259, P3674	50	29	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32172	32183		10.1074/jbc.M113.502955	http://dx.doi.org/10.1074/jbc.M113.502955			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24064215	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000328681700007
J	Ju, LN; Dong, JF; Cruz, MA; Zhu, C				Ju, Lining; Dong, Jing-fei; Cruz, Miguel A.; Zhu, Cheng			The N-terminal Flanking Region of the A1 Domain Regulates the Force-dependent Binding of von Willebrand Factor to Platelet Glycoprotein Ib alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Kinetics; Platelets; Single Molecule Biophysics; Thrombosis; von Willebrand Factor; Biomembrane Force Probe; Catch Bond; Glycoprotein Ib	VWF TETHER BOND; CATCH BONDS; GPIB-ALPHA; CRYSTAL-STRUCTURE; SHEAR-STRESS; CONFORMATIONAL-CHANGE; LIGAND INTERACTIONS; CELL-ADHESION; L-SELECTIN; DISEASE	Binding of platelet glycoprotein Ib (GPIb) to von Willebrand factor (VWF) initiates platelet adhesion to disrupted vascular surface under arterial blood flow. Flow exerts forces on the platelet that are transmitted to VWF-GPIb bonds, which regulate their dissociation. Mutations in VWF and/or GPIb may alter the mechanical regulation of platelet adhesion to cause hemostatic defects as found in patients with von Willebrand disease (VWD). Using a biomembrane force probe, we observed biphasic force-decelerated (catch) and force-accelerated (slip) dissociation of GPIb from VWF. The VWF A1 domain that contains the N-terminal flanking sequence Gln(1238)-Glu(1260) (1238-A1) formed triphasic slip-catch-slip bonds with GPIb. By comparison, using a short form of A1 that deletes this sequence (1261-A1) abolished the catch bond, destabilizing its binding to GPIb at high forces. Importantly, shear-dependent platelet rolling velocities on these VWF ligands in a flow chamber system mirrored the force-dependent single-bond lifetimes. Adding the Gln(1238)-Glu(1260) peptide, which interacted with GPIb and 1261-A1 but not 1238-A1, to whole blood decreased platelet attachment under shear stress. Soluble Gln(1238)-Glu(1260) reduced the lifetimes of GPIb bonds with VWF and 1238-A1 but rescued the catch bond of GPIb with 1261-A1. A type 2B VWD 1238-A1 mutation eliminated the catch bond by prolonging lifetimes at low forces, a type 2M VWD 1238-A1 mutation shifted the respective slip-catch and catch-slip transition points to higher forces, whereas a platelet type VWD GPIb mutation enhanced the bond lifetime in the entire force regime. These data reveal the structural determinants of VWF activation by hemodynamic force of the circulation.	[Ju, Lining; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Dong, Jing-fei] Univ Washington, Puget Sound Blood Res Inst, Seattle, WA 98104 USA; [Dong, Jing-fei] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Cruz, Miguel A.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Puget Sound Blood Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Baylor College of Medicine	Zhu, C (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu		Ju, Lining Arnold/0000-0002-7591-0864	National Institutes of Health [HL091020, HL072886, HL71895]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071895, R01HL072886, R01HL091020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL091020 (to C. Z.), HL072886 (to M. A. C.), and HL71895 (to J.-F. D.).	Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020; Arya M, 2002, BLOOD, V99, P3971, DOI 10.1182/blood-2001-11-0060; Auton M, 2012, J BIOL CHEM, V287, P14579, DOI 10.1074/jbc.M112.348573; Auton M, 2010, BIOPHYS J, V99, P1192, DOI 10.1016/j.bpj.2010.06.002; Auton M, 2010, J BIOL CHEM, V285, P22829, DOI 10.1074/jbc.M110.103358; Auton M, 2009, BIOPHYS J, V97, P618, DOI 10.1016/j.bpj.2009.05.009; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Chen W, 2008, BIOPHYS J, V94, P694, DOI 10.1529/biophysj.107.117895; Chen W, 2012, J CELL BIOL, V199, P497, DOI 10.1083/jcb.201201091; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Coburn LA, 2011, BIOPHYS J, V100, P304, DOI 10.1016/j.bpj.2010.11.084; CRUZ MA, 1993, J BIOL CHEM, V268, P21238; Cruz MA, 2000, J BIOL CHEM, V275, P19098, DOI 10.1074/jbc.M002292200; Cruz MA, 2005, BLOOD, V105, P1986, DOI 10.1182/blood-2004-04-1365; Doggett TA, 2003, BLOOD, V102, P152, DOI 10.1182/blood-2003-01-0072; Doggett TA, 2002, BIOPHYS J, V83, P194, DOI 10.1016/S0006-3495(02)75161-8; Dong JF, 2000, J BIOL CHEM, V275, P27663; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Jackson SP, 2009, J THROMB HAEMOST, V7, P17, DOI 10.1111/j.1538-7836.2009.03401.x; Kim J, 2010, NATURE, V466, P992, DOI 10.1038/nature09295; Kong F, 2013, MOL CELL, V49, P1060, DOI 10.1016/j.molcel.2013.01.015; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Kumar RA, 2003, BIOPHYS J, V85, P4099, DOI 10.1016/S0006-3495(03)74822-X; Lenting PJ, 2010, THROMB HAEMOSTASIS, V104, P449, DOI 10.1160/TH09-11-0777; Marchese P, 1999, P NATL ACAD SCI USA, V96, P7837, DOI 10.1073/pnas.96.14.7837; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Martin C, 2007, J THROMB HAEMOST, V5, P1363, DOI 10.1111/j.1538-7836.2007.02536.x; MATSUSHITA T, 1995, J BIOL CHEM, V270, P13406, DOI 10.1074/jbc.270.22.13406; Mazzucato Mario, 2007, Ann Ist Super Sanita, V43, P130; Miura S, 2000, J BIOL CHEM, V275, P7539, DOI 10.1074/jbc.275.11.7539; Miyata S, 1999, J BIOL CHEM, V274, P6586, DOI 10.1074/jbc.274.10.6586; MOHRI H, 1988, J BIOL CHEM, V263, P17901; Morales LD, 2006, J THROMB HAEMOST, V4, P417, DOI 10.1111/j.1538-7836.2006.01742.x; RABINOWITZ I, 1992, P NATL ACAD SCI USA, V89, P9846, DOI 10.1073/pnas.89.20.9846; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Ruggeri ZM, 2004, J THROMB HAEMOST, V2, P2, DOI 10.1111/j.1538-7836.2003.00523.x; Ruggeri ZM, 2003, J THROMB HAEMOST, V1, P1335, DOI 10.1046/j.1538-7836.2003.00260.x; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; Tischer A, 2013, PROTEIN SCI, V22, P1049, DOI 10.1002/pro.2294; Uff S, 2002, J BIOL CHEM, V277, P35657, DOI 10.1074/jbc.M205271200; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; Wayman AM, 2010, BIOPHYS J, V99, P1166, DOI 10.1016/j.bpj.2010.05.040; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Zhu C, 2008, ANN BIOMED ENG, V36, P604, DOI 10.1007/s10439-008-9464-5	53	66	68	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32289	32301		10.1074/jbc.M113.504001	http://dx.doi.org/10.1074/jbc.M113.504001			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24062306	Green Published, hybrid			2022-12-28	WOS:000328681700016
J	Sirbu, BM; McDonald, WH; Dungrawala, H; Badu-Nkansah, A; Kavanaugh, GM; Chen, YY; Tabb, DL; Cortez, D				Sirbu, Bianca M.; McDonald, W. Hayes; Dungrawala, Huzefa; Badu-Nkansah, Akosua; Kavanaugh, Gina M.; Chen, Yaoyi; Tabb, David L.; Cortez, David			Identification of Proteins at Active, Stalled, and Collapsed Replication Forks Using Isolation of Proteins on Nascent DNA (iPOND) Coupled with Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; PEPTIDE IDENTIFICATION; MMS22L-TONSL COMPLEX; GENE PRIORITIZATION; DAMAGE RESPONSE; MISMATCH REPAIR; ATR; PCNA; DYNAMICS; CHECKPOINT	Both DNA and chromatin need to be duplicated during each cell division cycle. Replication happens in the context of defects in the DNA template and other forms of replication stress that present challenges to both genetic and epigenetic inheritance. The replication machinery is highly regulated by replication stress responses to accomplish this goal. To identify important replication and stress response proteins, we combined isolation of proteins on nascent DNA (iPOND) with quantitative mass spectrometry. We identified 290 proteins enriched on newly replicated DNA at active, stalled, and collapsed replication forks. Approximately 16% of these proteins are known replication or DNA damage response proteins. Genetic analysis indicates that several of the newly identified proteins are needed to facilitate DNA replication, especially under stressed conditions. Our data provide a useful resource for investigators studying DNA replication and the replication stress response and validate the use of iPOND combined with mass spectrometry as a discovery tool.	[Sirbu, Bianca M.; McDonald, W. Hayes; Dungrawala, Huzefa; Badu-Nkansah, Akosua; Kavanaugh, Gina M.; Cortez, David] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Chen, Yaoyi; Tabb, David L.] Vanderbilt Univ, Dept Biomed Informat, Sch Med, Nashville, TN 37232 USA; [McDonald, W. Hayes] Vanderbilt Univ, Mass Spectrometry Res Ctr, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA.	david.cortez@vanderbilt.edu	Dungrawala, Huzefa/AAO-1931-2021; McDonald, W. Hayes/B-4109-2016	Dungrawala, Huzefa/0000-0003-1868-7923; McDonald, W. Hayes/0000-0002-3510-426X; Tabb, David/0000-0001-7223-578X	National Institutes of Health [R01 CA136933, R21 ES22319, P30 ES000267]; Department of Defense Breast Cancer Research Program Predoctoral Fellowship [W81XWH-10-1-0226]; Swim Across America; Center of Molecular Toxicology Grant for Vanderbilt Proteomics Core use; Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE [T32CA009582, R01CA136933] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, T32ES007028, R21ES022319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program Predoctoral Fellowship(United States Department of Defense); Swim Across America; Center of Molecular Toxicology Grant for Vanderbilt Proteomics Core use; Vanderbilt-Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA136933 and R21 ES22319 (to D. C.) and P30 ES000267. This work was also supported by Department of Defense Breast Cancer Research Program Predoctoral Fellowship W81XWH-10-1-0226 (to B. M. S.), by a grant from Swim Across America (to B. M. S.), by a Center of Molecular Toxicology Grant for Vanderbilt Proteomics Core use, and by the Vanderbilt-Ingram Cancer Center.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chaudhury I, 2013, NUCLEIC ACIDS RES, V41, P6444, DOI 10.1093/nar/gkt348; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen YY, 2012, ANAL BIOANAL CHEM, V404, P1115, DOI 10.1007/s00216-012-6011-x; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Duro E, 2010, MOL CELL, V40, P632, DOI 10.1016/j.molcel.2010.10.023; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Joo W, 2011, SCIENCE, V333, P312, DOI 10.1126/science.1205805; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Landsverk HB, 2010, EMBO REP, V11, P868, DOI 10.1038/embor.2010.134; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Li M, 2010, J PROTEOME RES, V9, P4295, DOI 10.1021/pr100527g; Lopez-Contreras AJ, 2013, CELL REP, V3, P1105, DOI 10.1016/j.celrep.2013.03.009; Lovejoy CA, 2009, P NATL ACAD SCI USA, V106, P19304, DOI 10.1073/pnas.0909345106; Lujan SA, 2013, MOL CELL, V50, P437, DOI 10.1016/j.molcel.2013.03.017; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; O'Connell BC, 2010, MOL CELL, V40, P645, DOI 10.1016/j.molcel.2010.10.022; O'Donnell L, 2010, MOL CELL, V40, P619, DOI 10.1016/j.molcel.2010.10.024; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sirbu BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012724; Sirbu BM, 2012, NAT PROTOC, V7, P594, DOI 10.1038/nprot.2012.010; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Toiber D, 2013, MOL CELL, V51, P454, DOI 10.1016/j.molcel.2013.06.018; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Yadon AN, 2011, CELL, V144, P454, DOI 10.1016/j.cell.2011.01.019; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Ye Y, 2009, MOL CANCER RES, V7, P1984, DOI 10.1158/1541-7786.MCR-09-0119; Yu DS, 2010, EMBO REP, V11, P876, DOI 10.1038/embor.2010.153; Yu YX, 2012, MOL CELL, V46, P7, DOI 10.1016/j.molcel.2012.01.019	47	134	134	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31458	31467		10.1074/jbc.M113.511337	http://dx.doi.org/10.1074/jbc.M113.511337			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047897	Green Published, hybrid			2022-12-28	WOS:000330596200005
J	Stuparevic, I; Mosrin-Huaman, C; Hervouet-Coste, N; Remenaric, M; Rahmouni, AR				Stuparevic, Igor; Mosrin-Huaman, Christine; Hervouet-Coste, Nadege; Remenaric, Mateja; Rahmouni, A. Rachid			Cotranscriptional Recruitment of RNA Exosome Cofactors Rrp47p and Mpp6p and Two Distinct Trf-Air-Mtr4 Polyadenylation (TRAMP) Complexes Assists the Exonuclease Rrp6p in the Targeting and Degradation of an Aberrant Messenger Ribonucleoprotein Particle (mRNP) in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-QUALITY CONTROL; IN-VIVO; SUBUNIT; DOMAIN; EXPORT; CORE; SURVEILLANCE; BINDING; TRANSCRIPTS; EXPRESSION	The cotranscriptional mRNA processing and packaging reactions that lead to the formation of export-competent messenger ribonucleoprotein particles (mRNPs) are under the surveillance of quality control steps. Aberrant mRNPs resulting from faulty events are retained in the nucleus with ensuing elimination of their mRNA component. The molecular mechanisms by which the surveillance system recognizes defective mRNPs and stimulates their destruction by the RNA degradation machinery are still not completely elucidated. Using an experimental approach in which mRNP formation in yeast is disturbed by the action of the bacterial Rho helicase, we have shown previously that the targeting of Rho-induced aberrant mRNPs is mediated by Rrp6p, which is recruited cotranscriptionally in association with Nrd1p following Rho action. Here we investigated the specific involvement in this quality control process of different cofactors associated with the nuclear RNA degradation machinery. We show that, in addition to the main hydrolytic action of the exonuclease Rrp6p, the cofactors Rrp47p, Mpp6p as well as the Trf-Air-Mtr4 polyadenylation (TRAMP) components Trf4p, Trf5p, and Air2p contribute significantly by stimulating the degradation process upon their cotranscriptional recruitment. Trf4p and Trf5p are apparently recruited in two distinct TRAMP complexes that both contain Air2p as component. Surprisingly, Rrp47p appears to play an important role in mutual protein stabilization with Rrp6p, which highlights a close association between the two partners. Together, our results provide an integrated view of how different cofactors of the RNA degradation machinery cooperate to target and eliminate aberrant mRNPs.	[Stuparevic, Igor; Mosrin-Huaman, Christine; Hervouet-Coste, Nadege; Remenaric, Mateja; Rahmouni, A. Rachid] CNRS, UPR 4301, Ctr Biophys Mol, F-45071 Orleans, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Rahmouni, AR (corresponding author), CNRS, UPR 4301, Ctr Biophys Mol, Rue Charles Sadron, F-45071 Orleans, France.	rahmouni@cnrs-orleans.fr	Stuparevic, Igor/M-8771-2015	Stuparevic, Igor/0000-0002-9878-5007	la Ligue contre le Cancer Grand Ouest (Comite du Loiret); CNRS; Ecole Doctorale Sante, Sciences Biologiques et Chimie du Vivant of the University of Orleans	la Ligue contre le Cancer Grand Ouest (Comite du Loiret); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole Doctorale Sante, Sciences Biologiques et Chimie du Vivant of the University of Orleans	This work was supported in part by la Ligue contre le Cancer Grand Ouest (Comite du Loiret) and by recurrent funding from the CNRS. This work was also supported by a postdoctoral fellowship from the CNRS (to I. S.) and by a doctoral fellowship from the Ecole Doctorale Sante, Sciences Biologiques et Chimie du Vivant of the University of Orleans (to M. R.).	Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; Assenholt J, 2008, RNA, V14, P2305, DOI 10.1261/rna.1108008; BaudinBaillieu A, 1997, YEAST, V13, P353, DOI 10.1002/(SICI)1097-0061(19970330)13:4<353::AID-YEA86>3.0.CO;2-P; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Costello JL, 2011, J BIOL CHEM, V286, P4535, DOI 10.1074/jbc.M110.162826; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Feigenbutz M, 2013, J BIOL CHEM, V288, P15959, DOI 10.1074/jbc.M112.445759; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Holub P, 2012, NUCLEIC ACIDS RES, V40, P5679, DOI 10.1093/nar/gks223; Honorine R, 2011, NUCLEIC ACIDS RES, V39, P2809, DOI 10.1093/nar/gkq1192; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Johnson SA, 2009, MOL CELL, V33, P215, DOI 10.1016/j.molcel.2008.12.007; Kiss DL, 2011, RNA, V17, P1, DOI 10.1261/rna.2364811; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mosrin-Huaman C, 2009, MOL CELL BIOL, V29, P4033, DOI 10.1128/MCB.00272-09; Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555; Phillips S, 2003, RNA, V9, P1098, DOI 10.1261/rna.5560903; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rougemaille M, 2008, CELL, V135, P308, DOI 10.1016/j.cell.2008.08.005; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; Saguez C, 2005, CURR OPIN CELL BIOL, V17, P287, DOI 10.1016/j.ceb.2005.04.009; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schmid M, 2008, CHROMOSOMA, V117, P419, DOI 10.1007/s00412-008-0166-4; Schmidt K, 2012, RNA, V18, P1934, DOI 10.1261/rna.033431.112; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schneider C, 2012, MOL CELL, V48, P422, DOI 10.1016/j.molcel.2012.08.013; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Villa T, 2008, BBA-GENE REGUL MECH, V1779, P524, DOI 10.1016/j.bbagrm.2008.06.009; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	48	22	22	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31816	31829		10.1074/jbc.M113.491290	http://dx.doi.org/10.1074/jbc.M113.491290			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047896	hybrid, Green Published			2022-12-28	WOS:000330596200032
J	Huang, GC; He, QY; Guo, JH; Cha, J; Liu, Y				Huang, Guocun; He, Qiyang; Guo, Jinhu; Cha, Joonseok; Liu, Yi			The Ccr4-Not Protein Complex Regulates the Phase of the Neurospora Circadian Clock by Controlling WHITE COLLAR Protein Stability and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE FEEDBACK LOOP; MESSENGER-RNA DEADENYLASE; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; DIFFERENTIALLY AFFECTS; PHOSPHORYLATION; FREQUENCY; LIGHT; GENE; FRQ	In the Neurospora circadian negative feedback loop, WHITE COLLAR 1 (WC-1) and WC-2 form the WC complex that activates frequency (frq) transcription. Here we show that Not1 is a WC-interacting protein and is important for maintaining WC levels. The not1 transcript displays a circadian oscillation with a similar phase as frq. Down-regulation of not1 leads to low levels of WC-1 and WC-2 and a delayed circadian phase as a result of increased protein degradation and increased WC activity. Protein purification of Not1 shows that it is part of the Neurospora Ccr4-Not complex. ccr4 is a clock-controlled gene and is regulated directly by the WC complex. Down-regulation of ccr4 results in a phase delay and period lengthening of the clock. Together, our findings suggest that the Ccr4-Not complex participates in the Neurospora clock function by interacting with and regulating the WC complex.	[Huang, Guocun] Soochow Univ, Ctr Circadian Clocks, Coll Med, Suzhou 215123, Peoples R China; [Huang, Guocun; He, Qiyang; Guo, Jinhu; Cha, Joonseok; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Huang, Guocun] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [He, Qiyang] Peking Union Med Coll, Inst Med Biotechnol, Beijing 100050, Peoples R China; [He, Qiyang] Chinese Acad Med Sci, Beijing 100050, Peoples R China; [Guo, Jinhu] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510006, Guangdong, Peoples R China	Soochow University - China; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Sun Yat Sen University	Huang, GC (corresponding author), Soochow Univ, Ctr Circadian Clocks, Coll Med, Suzhou 215123, Peoples R China.	gchuang@suda.edu.cn; Yi.Liu@UTsouthwestern.edu	He, qiyang/GQA-4070-2022; He, qiyang/AAT-5826-2021; Cha, Joonseok/AAE-9918-2020		National Institutes of Health [GM068496, GM062591]; Welch Foundation [I-1560]; National Natural Science Foundation of China [31271281]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068496, R01GM062591] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068496 and GM062591 (to Y. L.). This work was also supported by Welch Foundation Grant I-1560 (to Y. L.) and National Natural Science Foundation of China Grant 31271281 (to G. H.).	Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Baker CL, 2009, MOL CELL, V34, P354, DOI 10.1016/j.molcel.2009.04.023; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; COLLART MA, 1993, EMBO J, V12, P177, DOI 10.1002/j.1460-2075.1993.tb05643.x; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Dunlap JC, 2006, J BIOL CHEM, V281, P28489, DOI 10.1074/jbc.R600018200; Elvin M, 2005, GENE DEV, V19, P2593, DOI 10.1101/gad.349305; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884; Guo JH, 2010, J BIOL CHEM, V285, P11508, DOI 10.1074/jbc.M109.071688; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hong CI, 2008, GENE DEV, V22, P3196, DOI 10.1101/gad.1706908; Hunt SM, 2010, P NATL ACAD SCI USA, V107, P16709, DOI 10.1073/pnas.1009474107; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lenssen E, 2002, MOL MICROBIOL, V43, P1023, DOI 10.1046/j.1365-2958.2002.02799.x; Li R, 2008, MAR GEOD, V31, P1, DOI 10.1080/01490410701860856; Maillet L, 2000, J MOL BIOL, V303, P131, DOI 10.1006/jmbi.2000.4131; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schafmeier T, 2008, GENE DEV, V22, P3397, DOI 10.1101/gad.507408; Shi M, 2010, GENETICS, V184, P351, DOI 10.1534/genetics.109.111393; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Winkler GS, 2006, EMBO J, V25, P3089, DOI 10.1038/sj.emboj.7601194; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	49	6	7	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31002	31009		10.1074/jbc.M113.494120	http://dx.doi.org/10.1074/jbc.M113.494120			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24030828	Green Published, hybrid			2022-12-28	WOS:000330778900019
J	Mangialavori, IC; Ferreira-Gomes, MS; Saffioti, NA; Gonzalez-Lebrero, RM; Rossi, RC; Rossi, JPFC				Mangialavori, Irene C.; Ferreira-Gomes, Mariela S.; Saffioti, Nicolas A.; Gonzalez-Lebrero, Rodolfo M.; Rossi, Rolando C.; Rossi, Juan Pablo F. C.			Conformational Changes Produced by ATP Binding to the Plasma Membrane Calcium Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM ATPASE; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; ADENOSINE-TRIPHOSPHATASE; STRUCTURAL BASIS; ENERGY-TRANSFER; STEADY-STATE; CA2+; CA2+-ATPASE; MECHANISM	The aim of this work was to study the plasma membrane calcium pump (PMCA) reaction cycle by characterizing conformational changes associated with calcium, ATP, and vanadate binding to purified PMCA. This was accomplished by studying the exposure of PMCA to surrounding phospholipids by measuring the incorporation of the photoactivatable phosphatidylcholine analog 1-O-hexadecanoyl-2-O-[9-[[[2-[I-125] iodo-4-(trifluoromethyl-3H-diazirin-3-yl)benzyl]oxy]carbonyl]nonanoyl]-sn-glycero-3-phosphocholine to the protein. ATP could bind to the different vanadate-bound states of the enzyme either in the presence or in the absence of Ca2+ with high apparent affinity. Conformational movements of the ATP binding domain were determined using the fluorescent analog 2'(3')-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate. To assess the conformational behavior of the Ca2+ binding domain, we also studied the occlusion of Ca2+, both in the presence and in the absence of ATP and with or without vanadate. Results show the existence of occluded species in the presence of vanadate and/or ATP. This allowed the development of a model that describes the transport of Ca2+ and its relation with ATP hydrolysis. This is the first approach that uses a conformational study to describe the PMCA P-type ATPase reaction cycle, adding important features to the classical E-1-E-2 model devised using kinetics methodology only.	[Mangialavori, Irene C.; Ferreira-Gomes, Mariela S.; Saffioti, Nicolas A.; Gonzalez-Lebrero, Rodolfo M.; Rossi, Rolando C.; Rossi, Juan Pablo F. C.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, Consejo Nacl Invest Cient & Tecn, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Rossi, RC (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol, Consejo Nacl Invest Cient & Tecn, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	rcr@retina.ar; jprossi@qb.ffyb.uba.ar	Mangialavori, Irene/GLU-8182-2022	Rossi, Juan Pablo/0000-0001-7087-844X; Mangialavori, Irene/0000-0003-3187-3130; Saffioti, Nicolas Andres/0000-0002-5722-182X; Gonzalez Lebrero, Rodolfo M./0000-0002-3832-2270	Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad de Buenos Aires Ciencia y Tecnica (UBACYT; Argentina)	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires Ciencia y Tecnica (UBACYT; Argentina)	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Universidad de Buenos Aires Ciencia y Tecnica (UBACYT; Argentina).	ADAMO HP, 1990, J BIOL CHEM, V265, P3789; Akin BL, 2010, J BIOL CHEM, V285, P28540, DOI 10.1074/jbc.M110.151779; ANDERSEN JP, 1985, BIOCHIM BIOPHYS ACTA, V815, P9, DOI 10.1016/0005-2736(85)90467-5; ARIKI M, 1980, BIOCHEMISTRY-US, V19, P2001, DOI 10.1021/bi00550a042; BALL EH, 1986, ANAL BIOCHEM, V155, P23, DOI 10.1016/0003-2697(86)90218-6; BODLEY AL, 1987, J BIOL CHEM, V262, P13997; Burnham K.P., 2002, MODEL SELECTION MULT, P60; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; CHAMPEIL P, 1986, BIOCHEMISTRY-US, V25, P7623, DOI 10.1021/bi00371a053; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; Cho YK, 2001, J BIOL CHEM, V276, P12573, DOI 10.1074/jbc.M011478200; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; Clausen JD, 2011, J BIOL CHEM, V286, P11792, DOI 10.1074/jbc.M110.206094; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Daiho T, 2010, J BIOL CHEM, V285, P24538, DOI 10.1074/jbc.M110.144535; Durrer P, 1996, J BIOL CHEM, V271, P13417, DOI 10.1074/jbc.271.23.13417; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; Echarte MM, 2007, BIOCHEMISTRY-US, V46, P1034, DOI 10.1021/bi061857x; Echarte MM, 2001, ANAL BIOCHEM, V289, P267, DOI 10.1006/abio.2000.4950; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; Ferreira-Gomes MS, 2011, J BIOL CHEM, V286, P32018, DOI 10.1074/jbc.M111.266650; Filomatori CV, 2003, J BIOL CHEM, V278, P22265, DOI 10.1074/jbc.M302657200; Fiske CH, 1925, J BIOL CHEM, V66, P375; Forbush B., 1988, NA PLUS K PLUS PUM A, P229; Giraldo AMV, 2006, FEBS LETT, V580, P607, DOI 10.1016/j.febslet.2005.12.078; Herscher CJ, 1996, BIOCHEMISTRY-US, V35, P14917, DOI 10.1021/bi961879r; Hiratsuka T, 2003, EUR J BIOCHEM, V270, P3479, DOI 10.1046/j.1432-1033.2003.03748.x; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15336, DOI 10.1021/bi981094g; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KREBS J, 1987, BIOCHEMISTRY-US, V26, P3921, DOI 10.1021/bi00387a027; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lin SH, 1996, BIOCHEMISTRY-US, V35, P8419, DOI 10.1021/bi960407+; LUTERBACHER S, 1983, EXPERIENTIA, V39, P311, DOI 10.1007/BF01955322; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Mangialavori I, 2011, J BIOL CHEM, V286, P18397, DOI 10.1074/jbc.M110.210088; Mangialavori I, 2011, FEBS LETT, V585, P1153, DOI 10.1016/j.febslet.2011.03.024; Mangialavori I, 2010, J BIOL CHEM, V285, P123, DOI 10.1074/jbc.M109.076679; Mangialavori I, 2009, J BIOL CHEM, V284, P4823, DOI 10.1074/jbc.M806912200; Mangialavori IC, 2012, BIOCHEM J, V443, P125, DOI 10.1042/BJ20111035; MARKUS S, 1989, BIOCHEMISTRY-US, V28, P793, DOI 10.1021/bi00428a057; MCINTOSH DB, 1983, BIOCHEMISTRY-US, V22, P2867, DOI 10.1021/bi00281a015; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; MOUTIN MJ, 1994, J BIOL CHEM, V269, P11147; NAKAMURA J, 1987, J BIOL CHEM, V262, P14492; NIGGLI V, 1979, J BIOL CHEM, V254, P9955; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Perez-Gordones MC, 2009, ARCH BIOCHEM BIOPHYS, V489, P55, DOI 10.1016/j.abb.2009.07.010; PICK U, 1982, J BIOL CHEM, V257, P6111; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; Rega A., 1986, CA2 PUMP PLASMA MEMB, P115; REYNOLDS JA, 1985, P NATL ACAD SCI USA, V82, P3658, DOI 10.1073/pnas.82.11.3658; ROSSI JPFC, 1981, BIOCHIM BIOPHYS ACTA, V648, P145, DOI 10.1016/0005-2736(81)90029-8; Rossi RC, 1999, ANAL BIOCHEM, V270, P276, DOI 10.1006/abio.1999.4094; SARKADI B, 1986, J BIOL CHEM, V261, P9552; Scarborough GA, 2003, TRENDS BIOCHEM SCI, V28, P581, DOI 10.1016/j.tibs.2003.08.010; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCOFANO HM, 1979, J BIOL CHEM, V254, P227; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Stewart RC, 1998, BIOCHEMISTRY-US, V37, P12269, DOI 10.1021/bi980970n; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Vanagas L, 2013, CELL BIOCHEM BIOPHYS, V66, P187, DOI 10.1007/s12013-012-9467-6; VAS M, 1994, BIOCHEM J, V301, P885, DOI 10.1042/bj3010885; WAKABAYASHI S, 1990, BIOCHEMISTRY-US, V29, P7309, DOI 10.1021/bi00483a022; WAKABAYASHI S, 1986, J BIOL CHEM, V261, P9762	73	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31030	31041		10.1074/jbc.M113.494633	http://dx.doi.org/10.1074/jbc.M113.494633			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24025327	hybrid, Green Published			2022-12-28	WOS:000330778900022
J	Beyer, SR; Mallmann, RT; Jaenecke, I; Habermeier, A; Boissel, JP; Closs, EI				Beyer, Sarah R.; Mallmann, Robert T.; Jaenecke, Isabel; Habermeier, Alice; Boissel, Jean-Paul; Closs, Ellen I.			Identification of Cysteine Residues in Human Cationic Amino Acid Transporter hCAT-2A That Are Targets for Inhibition by N-Ethylmaleimide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; Mutagenesis Site-specific; Plasma Membrane; Sulfhydryl; Xenopus; l-Arginine Transport; N-Ethylmaleimide (NEM); Solute Carrier Family 7; System y(+); System y(+)L	HUMAN ERYTHROCYTES; PROTEIN; FAMILY; MECHANISM; AFFINITY; MEMBER; NITROSYLATION; ANTIPORTER; TOPOLOGY; LOCATION	In most cells, cationic amino acids such as l-arginine, l-lysine, and l-ornithine are transported by cationic (CAT) and y(+)L (y(+)LAT) amino acid transporters. In human erythrocytes, the cysteine-modifying agent N-ethylmaleimide (NEM) has been shown to inhibit system y(+) (most likely CAT-1), but not system y(+)L (Deves, R., Angelo, S., and Chavez, P. (1993) J. Physiol. 468, 753-766). We thus wondered if sensitivity to NEM distinguishes generally all CAT and y(+)LAT isoforms. Transport assays in Xenopus laevis oocytes established that indeed all human CATs (including the low affinity hCAT-2A), but neither y(+)LAT isoform, are inhibited by NEM. hCAT-2A inhibition was not due to reduced transporter expression in the plasma membrane, indicating that NEM reduces the intrinsic transporter activity. Individual mutation of each of the seven cysteine residues conserved in all CAT isoforms did not lead to NEM insensitivity of hCAT-2A. However, a cysteine-less mutant was no longer inhibited by NEM, suggesting that inhibition occurs through modification of more than one cysteine in hCAT-2A. Indeed, also the double mutant C33A/C273A was insensitive to NEM inhibition, whereas reintroduction of a cysteine at either position 33 or 273 in the cysteine-less mutant led to NEM sensitivity. We thus identified Cys-33 and Cys-273 in hCAT-2A as the targets of NEM inhibition. In addition, all proteins with Cys-33 mutations showed a pronounced reduction in transport activity, suggesting that, surprisingly, this residue, located in the cytoplasmic N terminus, is important for transporter function.	[Beyer, Sarah R.; Mallmann, Robert T.; Jaenecke, Isabel; Habermeier, Alice; Boissel, Jean-Paul; Closs, Ellen I.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Pharmacol, D-55131 Mainz, Germany	Johannes Gutenberg University of Mainz	Closs, EI (corresponding author), Univ Med Ctr Mainz, Dept Pharmacol, Obere Zahlbacher Str 67, D-55131 Mainz, Germany.	closs@uni-mainz.de	Closs, Ellen/ABD-5217-2020	Closs, Ellen/0000-0002-9505-2289				ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Blondeau JP, 2002, GENE, V286, P241, DOI 10.1016/S0378-1119(02)00435-3; Chairoungdua A, 2001, J BIOL CHEM, V276, P49390, DOI 10.1074/jbc.M107517200; CHRISTENSEN HN, 1966, J BIOL CHEM, V241, P5542; Closs EI, 2006, J MEMBRANE BIOL, V213, P67, DOI 10.1007/s00232-006-0875-7; CLOSS EI, 1993, J BIOL CHEM, V268, P7538; Closs EI, 1997, BIOCHEMISTRY-US, V36, P6462, DOI 10.1021/bi962829p; DEVES R, 1993, J PHYSIOL-LONDON, V468, P753, DOI 10.1113/jphysiol.1993.sp019799; DEVES R, 1992, J PHYSIOL-LONDON, V454, P491, DOI 10.1113/jphysiol.1992.sp019275; Eswar N., 2007, CURR PROTOC PROTEIN; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Habermeier A, 2003, J BIOL CHEM, V278, P19492, DOI 10.1074/jbc.M210254200; Haratake M, 2009, INORG CHEM, V48, P7805, DOI 10.1021/ic900988j; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hosokawa H, 1997, J BIOL CHEM, V272, P8717, DOI 10.1074/jbc.272.13.8717; Ito K, 1997, J BIOL CHEM, V272, P26780, DOI 10.1074/jbc.272.42.26780; KAVANAUGH MP, 1994, J BIOL CHEM, V269, P15445; KOLBE HVJ, 1985, J BIOL CHEM, V260, P5899; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Marino SM, 2010, J MOL BIOL, V395, P844, DOI 10.1016/j.jmb.2009.10.042; Matsuo H, 2002, J BIOL CHEM, V277, P21017, DOI 10.1074/jbc.M200019200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer R, 1999, EMBO J, V18, P49, DOI 10.1093/emboj/18.1.49; Rotoli BM, 2009, PFLUG ARCH EUR J PHY, V458, P1163, DOI 10.1007/s00424-009-0692-9; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; SMYTH DG, 1964, BIOCHEM J, V91, P589, DOI 10.1042/bj0910589; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vekony N, 2001, BIOCHEMISTRY-US, V40, P12387, DOI 10.1021/bi011345c; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; WHITE MF, 1982, J BIOL CHEM, V257, P4443; WOHLRAB H, 1994, BIOCHEMISTRY-US, V33, P9371, DOI 10.1021/bi00198a001; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou JG, 2010, AM J PHYSIOL-CELL PH, V299, pC230, DOI 10.1152/ajpcell.00077.2010	41	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30411	30419		10.1074/jbc.M113.490698	http://dx.doi.org/10.1074/jbc.M113.490698			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24019517	Green Published, hybrid			2022-12-28	WOS:000329868100037
J	De-la-Rosa, V; Rangel-Yescas, GE; Ladron-de-Guevara, E; Rosenbaum, T; Islas, LD				De-la-Rosa, Victor; Rangel-Yescas, Gisela E.; Ladron-de-Guevara, Ernesto; Rosenbaum, Tamara; Islas, Leon D.			Coarse Architecture of the Transient Receptor Potential Vanilloid 1 (TRPV1) Ion Channel Determined by Fluorescence Resonance Energy Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; CAPSAICIN RECEPTOR; IN-VIVO; SENSITIVITY; ACTIVATION; SUBUNIT; FRET; IDENTIFICATION; STOICHIOMETRY; DISPLACEMENT	The transient receptor potential vanilloid 1 ion channel is responsible for the perception of high temperatures and low extracellular pH, and it is also involved in the response to some pungent compounds. Importantly, it is also associated with the perception of pain and noxious stimuli. Here, we attempt to discern the molecular organization and location of the N and C termini of the transient receptor potential vanilloid 1 ion channel by measuring FRET between genetically attached enhanced yellow and cyan fluorescent protein to the N or C terminus of the channel protein, expressed in transfected HEK 293 cells or Xenopus laevis oocytes. The static measurements of the domain organization were mapped into an available cryo-electron microscopy density of the channel with good agreement. These measurements also provide novel insights into the organization of terminal domains and their proximity to the plasma membrane.	[De-la-Rosa, Victor; Rangel-Yescas, Gisela E.; Ladron-de-Guevara, Ernesto; Islas, Leon D.] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City 04510, DF, Mexico; [Rosenbaum, Tamara] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Islas, LD (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City 04510, DF, Mexico.	islas@liceaga.facmed.unam.mx	Ladrón-de-Guevara, Ernesto/F-4304-2014; Islas, Leon D/AAW-9845-2020; De la Rosa, Victor/AAM-8583-2021	Ladrón-de-Guevara, Ernesto/0000-0001-5122-1848; Islas, Leon D/0000-0002-7461-5214; De la Rosa, Victor/0000-0001-5161-3083; Rosenbaum, Tamara/0000-0002-4791-3195; Rangel-Yescas, Gisela Edith/0000-0003-2766-6040	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [309408]; CONACYT [151297, 129474]; Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica (DGAPA-PAPIIT) [IN209209]; Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF) [PIFUTP09-262]; Marcos Moshinsky Foundation; PAPIIT Grant [IN204111]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica (DGAPA-PAPIIT); Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF); Marcos Moshinsky Foundation; PAPIIT Grant(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT) Scholarship 309408 (to V. D.-R.), CONACYT Grant 151297, Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica (DGAPA-PAPIIT) Grant IN209209, and Instituto de Ciencia y Tecnologia del Distrito Federal (ICyT-DF) PIFUTP09-262 (to L. D. I.) and the Marcos Moshinsky Foundation, CONACYT Grant 129474, and PAPIIT Grant IN204111 (to T. R.).	Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Cui YY, 2012, J GEN PHYSIOL, V139, P273, DOI 10.1085/jgp.201110724; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; FERNANDEZ JM, 1983, J GEN PHYSIOL, V82, P331, DOI 10.1085/jgp.82.3.331; Fernandez-Ballester G, 2008, J MEMBRANE BIOL, V223, P161, DOI 10.1007/s00232-008-9123-7; Fujiwara Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1823; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Gaudet R, 2009, J GEN PHYSIOL, V133, P231, DOI 10.1085/jgp.200810137; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; HAAS E, 1978, BIOCHEMISTRY-US, V17, P5064, DOI 10.1021/bi00616a032; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Islas LD, 2006, J GEN PHYSIOL, V128, P337, DOI 10.1085/jgp.200609556; Jara-Oseguera A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198010; Jara-Oseguera A, 2008, J GEN PHYSIOL, V132, P547, DOI 10.1085/jgp.200810051; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Kuzhikandathil EV, 2001, J NEUROSCI, V21, P8697, DOI 10.1523/JNEUROSCI.21-22-08697.2001; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P443, DOI DOI 10.1007/978-0-387-46312-4_13; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Marshall J, 1920, J IND ENG CHEM-US, V12, P336, DOI 10.1021/ie50124a010; Miranda P, 2008, BBA-MOL CELL RES, V1783, P1681, DOI 10.1016/j.bbamcr.2008.06.009; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Nieto-Posadas A, 2012, NAT CHEM BIOL, V8, P78, DOI 10.1038/nchembio.712; Ottolia M, 2007, AM J PHYSIOL-CELL PH, V292, pC1519, DOI 10.1152/ajpcell.00435.2006; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piper AS, 1999, J PHYSIOL-LONDON, V518, P721, DOI 10.1111/j.1469-7793.1999.0721p.x; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Salazar H, 2009, NAT STRUCT MOL BIOL, V16, P704, DOI 10.1038/nsmb.1633; Salonikidis PS, 2011, J BIOL CHEM, V286, P23419, DOI 10.1074/jbc.M111.236869; Taraska JW, 2007, NAT STRUCT MOL BIOL, V14, P854, DOI 10.1038/nsmb1281; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; van der Meer B W, 2002, J Biotechnol, V82, P181, DOI 10.1016/S1389-0352(01)00037-X; Wang DS, 2010, BIOPHYS J, V99, P2355, DOI 10.1016/j.bpj.2010.07.037; Xia R, 2011, ADV EXP MED BIOL, V704, P637, DOI 10.1007/978-94-007-0265-3_34; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Zhang F, 2011, J BIOL CHEM, V286, P15308, DOI 10.1074/jbc.M111.223941; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	46	30	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29506	29517		10.1074/jbc.M113.479618	http://dx.doi.org/10.1074/jbc.M113.479618			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23965996	Green Published, hybrid			2022-12-28	WOS:000330615300027
J	Viola, M; Bartolini, B; Vigetti, D; Karousou, E; Moretto, P; Deleonibus, S; Sawamura, T; Wight, TN; Hascall, VC; De Luca, G; Passi, A				Viola, Manuela; Bartolini, Barbara; Vigetti, Davide; Karousou, Evgenia; Moretto, Paola; Deleonibus, Sara; Sawamura, Tatsuya; Wight, Thomas N.; Hascall, Vincent C.; De Luca, Giancarlo; Passi, Alberto			Oxidized Low Density Lipoprotein (LDL) Affects Hyaluronan Synthesis in Human Aortic Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SYNTHASE 2; CHONDROITIN SULFATE; CHOLESTEROL; ACCUMULATION; EXPRESSION; RECEPTOR; MONOCYTE; ATHEROSCLEROSIS; PROLIFERATION	Thickening of the vessel in response to high low density lipoprotein( s) (LDL) levels is a hallmark of atherosclerosis, characterized by increased hyaluronan (HA) deposition in the neointima. Human native LDL trapped within the arterial wall undergoes modifications such as oxidation (oxLDL). The aim of our study is to elucidate the link between internalization of oxLDL and HA production in vitro, using human aortic smooth muscle cells. LDL were used at an effective protein concentration of 20-50 mu g/ml, which allowed 80% cell viability. HA content in the medium of untreated cells was 28.9 +/- 3.7 nmol HA-disaccharide/cell and increased after oxLDL treatment to 53.9 +/- 5.6. OxLDL treatments doubled the transcripts of HA synthase HAS2 and HAS3. Accumulated HA stimulated migration of aortic smooth muscle cells and monocyte adhesiveness to extracellular matrix. The effects induced by oxLDL were inhibited by blocking LOX-1 scavenger receptor with a specific antibody (10 mu g/ml). The cholesterol moiety of LDL has an important role in HA accumulation because cholesterol-free oxLDL failed to induce HA synthesis. Nevertheless, cholesterol-free oxLDL and unmodified cholesterol (20 mu g/ml) induce only HAS3 transcription, whereas 22, oxysterol affects both HAS2 and HAS3. Moreover, HA deposition was associated with higher expression of endoplasmic reticulum stress markers (CHOP and GRP78). Our data suggest that HA synthesis can be induced in response to specific oxidized sterol-related species delivered through oxLDL.	[Viola, Manuela; Bartolini, Barbara; Vigetti, Davide; Karousou, Evgenia; Moretto, Paola; Deleonibus, Sara; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Chirurg & Morfol, I-21100 Varese, Italy; [Sawamura, Tatsuya] Natl Cerebral & Cardiovasc Ctr, Dept Vasc Physiol, Suita, Osaka 5658565, Japan; [Wight, Thomas N.] Benaroya Res Inst Virginia Mason, Hope Heart Matrix Biol Program, Seattle, WA 98101 USA; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	University of Insubria; National Cerebral & Cardiovascular Center - Japan; Benaroya Research Institute; Virginia Mason Medical Center; Cleveland Clinic Foundation	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Chirurg & Morfol, Via JH Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	passi, alberto g/A-1752-2018; Viola, Manuela/B-7120-2011; Sawamura, Tatsuya/E-7103-2010	passi, alberto g/0000-0003-3328-3089; Viola, Manuela/0000-0002-0634-6390; vigetti, davide/0000-0002-6339-8453	PRIN	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by a grant from PRIN 2009 (to E. K.).	Albertini R, 1997, FEBS LETT, V403, P154, DOI 10.1016/S0014-5793(97)00043-4; Badimon L, 2012, ANN NY ACAD SCI, V1254, P18, DOI 10.1111/j.1749-6632.2012.06480.x; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chang MY, 2012, J BIOL CHEM, V287, P14122, DOI 10.1074/jbc.M111.324988; Chang MY, 2006, ARTERIOSCL THROM VAS, V26, P494, DOI 10.1161/01.ATV.0000200135.61362.27; Christian AE, 1997, J LIPID RES, V38, P2264; Colgan SM, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001742; Dickhout JG, 2011, FASEB J, V25, P576, DOI 10.1096/fj.10-159319; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goyal T, 2012, CURR ATHERO IN PRESS; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Karousou EG, 2004, ELECTROPHORESIS, V25, P2919, DOI 10.1002/elps.200406034; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Kataoka H, 1999, CIRCULATION, V99, P3110, DOI 10.1161/01.CIR.99.24.3110; Khalil MF, 2004, ARTERIOSCL THROM VAS, V24, P2211, DOI 10.1161/01.ATV.0000147163.54024.70; Kolodgie FD, 2002, ARTERIOSCL THROM VAS, V22, P1642, DOI 10.1161/01.ATV.0000034021.92658.4C; Kultti A, 2010, J BIOL CHEM, V285, P22899, DOI 10.1074/jbc.M109.088435; Lee S, 2012, EXP CELL RES, V318, P2128, DOI 10.1016/j.yexcr.2012.06.012; Leonarduzzi G, 2012, FREE RADICAL BIO MED, V52, P19, DOI 10.1016/j.freeradbiomed.2011.09.031; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; Lu JJ, 2011, ANTIOXID REDOX SIGN, V15, P2301, DOI 10.1089/ars.2010.3792; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Merrilees MJ, 2011, ARTERIOSCL THROM VAS, V31, P1309, DOI 10.1161/ATVBAHA.111.225573; Mitra S, 2011, CARDIOVASC DRUG THER, V25, P419, DOI 10.1007/s10557-011-6341-5; Morello F, 2009, ATHEROSCLEROSIS, V207, P38, DOI 10.1016/j.atherosclerosis.2009.04.001; Moriwaki H, 1998, ARTERIOSCL THROM VAS, V18, P1541, DOI 10.1161/01.ATV.18.10.1541; Nagy N, 2010, CIRCULATION, V122, P2313, DOI 10.1161/CIRCULATIONAHA.110.972653; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; REYNOLDS GD, 1985, AM J PATHOL, V121, P200; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Sakr SW, 2008, J BIOL CHEM, V283, P36195, DOI 10.1074/jbc.M807772200; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; Steck TL, 2010, TRENDS CELL BIOL, V20, P680, DOI 10.1016/j.tcb.2010.08.007; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Vigetti D, 2008, J BIOL CHEM, V283, P4448, DOI 10.1074/jbc.M709051200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; Vigetti D, 2011, J BIOL CHEM, V286, P34497, DOI 10.1074/jbc.M111.266312; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Vijayagopal P, 1996, ATHEROSCLEROSIS, V127, P195, DOI 10.1016/S0021-9150(96)05954-0; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Yoshida H, 2010, CLIN CHIM ACTA, V411, P1875, DOI 10.1016/j.cca.2010.08.038	58	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29595	29603		10.1074/jbc.M113.508341	http://dx.doi.org/10.1074/jbc.M113.508341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979132	Green Published, hybrid			2022-12-28	WOS:000330615300035
J	Kumar, A; Torii, T; Ishino, Y; Muraoka, D; Yoshimura, T; Togayachi, A; Narimatsu, H; Ikenaka, K; Hitoshi, S				Kumar, Akhilesh; Torii, Tomohiro; Ishino, Yugo; Muraoka, Daisuke; Yoshimura, Takeshi; Togayachi, Akira; Narimatsu, Hisashi; Ikenaka, Kazuhiro; Hitoshi, Seiji			The Lewis X-related alpha 1,3-Fucosyltransferase, Fut10, Is Required for the Maintenance of Stem Cell Populations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Embryonic Stem Cell; Glycobiology; Glycosyltransferases; HPLC; Neural Stem Cell; Bisecting N-Glycans; Stemness	CENTRAL-NERVOUS-SYSTEM; EMBRYONIC ANTIGEN; PROGENITOR CELLS; N-GLYCANS; MOUSE; OLIGOSACCHARIDES; BRAIN; MICE; DIFFERENTIATION; DISAPPEARANCE	Lewis X (Le(X), Gal1-4(Fuc1-3)GlcNAc) is a carbohydrate epitope that is present at the nonreducing terminus of sugar chains of glycoproteins and glycolipids, and is abundantly expressed in several stem cell populations. Le(X) antigen can be used in conjunction with fluorescence-activated cell sorting to isolate neurosphere-forming neural stem cells (NSCs) from embryonic mouse brains. However, its function in the maintenance and differentiation of stem cells remains largely unknown. In this study, we examined mice deficient for fucosyltransferase 9 (Fut9), which is thought to synthesize most, if not all, of the Le(X) moieties in the brain. We found that the number of NSCs was increased in the brain of Fut9(-/-) embryos, suggesting that Fut9-synthesized Le(X) is dispensable for the maintenance of NSCs. Another 1,3-fucosyltransferase gene, fucosyltransferase 10 (Fut10), is expressed in the ventricular zone of the embryonic brain. Overexpression of Fut10 enhanced the self-renewal of NSCs. Conversely, suppression of Fut10 expression induced the differentiation of NSCs and embryonic stem cells. In addition, knockdown of Fut10 expression in the cortical ventricular zone of the embryonic brain by in utero electroporation of Fut10-miRNAs impaired the radial migration of neural precursor cells. Our data suggest that Fut10 is involved in a unique 1,3-fucosyltransferase activity with stringent substrate specificity, and that this activity is required to maintain stem cells in an undifferentiated state.	[Kumar, Akhilesh; Torii, Tomohiro; Ishino, Yugo; Muraoka, Daisuke; Yoshimura, Takeshi; Ikenaka, Kazuhiro; Hitoshi, Seiji] Grad Univ Adv Studies, Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 4448787, Japan; [Kumar, Akhilesh; Torii, Tomohiro; Ishino, Yugo; Muraoka, Daisuke; Yoshimura, Takeshi; Ikenaka, Kazuhiro; Hitoshi, Seiji] Grad Univ Adv Studies, Sch Life Sci, Dept Physiol Sci, Okazaki, Aichi 4448787, Japan; [Togayachi, Akira; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Glycogene Funct Team, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan; [Hitoshi, Seiji] Shiga Univ Med Sci, Dept Integrat Physiol, Otsu, Shiga 5202192, Japan	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; National Institute of Advanced Industrial Science & Technology (AIST); Shiga University of Medical Science	Hitoshi, S (corresponding author), Shiga Univ Med Sci, Dept Integrat Physiol, Otsu, Shiga 5202192, Japan.	shitoshi-tky@umin.ac.jp	Togayachi, Akira/M-4144-2018; Narimatsu, Hisashi/M-4757-2018	Togayachi, Akira/0000-0003-3600-9149; Narimatsu, Hisashi/0000-0002-8402-133X; Torii, Tomohiro/0000-0002-0039-923X; Yoshimura, Takeshi/0000-0002-0316-8082	Ministry of Education, Culture, Sports, Science and Technology of Japan [21650092, 20019032]; Sankyo Foundation of Life Science; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [24770138] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sankyo Foundation of Life Science; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Exploratory Research (21650092) (to S. H.) and Scientific Research on Priority Area (20019032) (to K. I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and grants from the Sankyo Foundation of Life Science and the Astellas Foundation for Research on Metabolic Disorders (to S. H.).	ALLENDOERFER KL, 1995, MOL CELL NEUROSCI, V6, P381, DOI 10.1006/mcne.1995.1029; Baboval T, 2002, MAMM GENOME, V13, P538, DOI 10.1007/s00335-001-2152-5; BIRD JM, 1984, DEV BIOL, V104, P449, DOI 10.1016/0012-1606(84)90101-5; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; GOOI HC, 1981, NATURE, V292, P156, DOI 10.1038/292156a0; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hitoshi S, 2011, NEUROGENESIS IN THE ADULT BRAIN II: CLINICAL IMPLICATIONS, P189, DOI 10.1007/978-4-431-53945-2_10; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kudo T, 2004, MOL CELL BIOL, V24, P4221, DOI 10.1128/MCB.24.10.4221-4228.2004; Kudo T, 2002, J BIOL CHEM, V277, P47724, DOI 10.1074/jbc.M205839200; Kudo T, 2007, GLYCOBIOLOGY, V17, P1, DOI 10.1093/glycob/cwl047; Masae N, 2006, DEV BIOL, V297, P262, DOI 10.1016/j.ydbio.2006.05.017; Mollicone R, 2009, J BIOL CHEM, V284, P4723, DOI 10.1074/jbc.M809312200; MURAMATSU T, 1988, BIOCHIMIE, V70, P1587, DOI 10.1016/0300-9084(88)90294-5; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nishihara S, 2003, GLYCOBIOLOGY, V13, P445, DOI 10.1093/glycob/cwg048; Nishihara S, 1999, FEBS LETT, V462, P289, DOI 10.1016/S0014-5793(99)01549-5; Patnaik S. K., 2007, NATURE PRECEDINGS; Rebbaa A, 1996, J NEUROCHEM, V67, P2265; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roos C, 2002, J BIOL CHEM, V277, P3168, DOI 10.1074/jbc.m107927200; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Tanabe K, 2006, ANAL BIOCHEM, V348, P324, DOI 10.1016/j.ab.2005.10.035; Toumadje A, 2003, IN VITRO CELL DEV-AN, V39, P449; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Yagi H, 2012, J BIOL CHEM, V287, P24356, DOI 10.1074/jbc.M112.365643; YAMAMOTO M, 1985, P NATL ACAD SCI USA, V82, P3045, DOI 10.1073/pnas.82.9.3045; Yan LY, 1997, GLYCOCONJUGATE J, V14, P45, DOI 10.1023/A:1018508914551; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Yoshimura T, 2012, ANAL BIOCHEM, V423, P253, DOI 10.1016/j.ab.2012.01.023	31	18	19	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28859	28868		10.1074/jbc.M113.469403	http://dx.doi.org/10.1074/jbc.M113.469403			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23986452	hybrid, Green Published			2022-12-28	WOS:000330298800038
J	Viswakarma, N; Jia, YZ; Bai, L; Gao, Q; Lin, BL; Zhang, XH; Misra, P; Rana, A; Jain, S; Gonzalez, FJ; Zhu, YJ; Thimmapaya, B; Reddy, JK				Viswakarma, Navin; Jia, Yuzhi; Bai, Liang; Gao, Qian; Lin, Bingliang; Zhang, Xiaohong; Misra, Parimal; Rana, Ajay; Jain, Sanjay; Gonzalez, Frank J.; Zhu, Yi-Jun; Thimmapaya, Bayar; Reddy, Janardan K.			The Med1 Subunit of the Mediator Complex Induces Liver Cell Proliferation and Is Phosphorylated by AMP Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; RECEPTOR-BINDING PROTEIN; RNA-POLYMERASE-II; PEROXISOME-PROLIFERATOR; MOUSE-LIVER; TRANSCRIPTIONAL COACTIVATOR; (PPAR)-BINDING PROTEIN; HEPATIC STEATOSIS; TRAP220 COMPONENT; NUCLEAR RECEPTORS	Mediator, a large multisubunit protein complex, plays a pivotal role in gene transcription by linking gene-specific transcription factors with the preinitiation complex and RNA polymerase II. In the liver, the key subunit of the Mediator complex, Med1, interacts with several nuclear receptors and transcription factors to direct gene-specific transcription. Conditional knock-out of Med1 in the liver showed that hepatocytes lacking Med1 did not regenerate following either partial hepatectomy or treatment with certain nuclear receptor activators and failed to give rise to tumors when challenged with carcinogens. We now report that the adenovirally driven overexpression of Med1 in mouse liver stimulates hepatocyte DNA synthesis with enhanced expression of DNA replication, cell cycle control, and liver-specific genes, indicating that Med1 alone is necessary and sufficient for liver cell proliferation. Importantly, we demonstrate that AMP-activated protein kinase (AMPK), an important cellular energy sensor, interacts with, and directly phosphorylates, Med1 in vitro at serine 656, serine 756, and serine 796. AMPK also phosphorylates Med1 in vivo in mouse liver and in cultured primary hepatocytes and HEK293 and HeLa cells. In addition, we demonstrate that PPAR alpha activators increase AMPK-mediated Med1 phosphorylation in vivo. Inhibition of AMPK by compound C decreased hepatocyte proliferation induced by Med1 and also by the PPAR alpha activators fenofibrate and Wy-14,643. Co-treatment with compound C attenuated PPAR alpha activator-inducible fatty acid beta-oxidation in liver. Our results suggest that Med1 phosphorylation by its association with AMPK regulates liver cell proliferation and fatty acid oxidation, most likely as a downstream effector of PPAR alpha and AMPK.	[Viswakarma, Navin; Jia, Yuzhi; Bai, Liang; Gao, Qian; Lin, Bingliang; Zhang, Xiaohong; Zhu, Yi-Jun; Reddy, Janardan K.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Misra, Parimal] Dr Reddys Inst Life Sci, Hyderabad 500046, Andhra Pradesh, India; [Rana, Ajay] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Jain, Sanjay] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Thimmapaya, Bayar] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Loyola University Chicago; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University; Feinberg School of Medicine	Reddy, JK (corresponding author), 303 E Chicago Ave, Chicago, IL 60611 USA.	jkreddy@northwestern.edu	Rana, Ajay/ABE-3739-2020	Rana, Ajay/0000-0003-0951-2566; jain, sanjay/0000-0003-2804-127X	National Institutes of Health Cancer Center [NIH CA06600553]; NATIONAL CANCER INSTITUTE [P30CA060553, ZIABC005708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097249, R01DK083163, R56DK083163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055835] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Samuel G. Mackintosh (Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock) for his generous help with LC-MS/MS studies. We express our appreciation to Dr. Aurore Vluggens for her participation in the early phases of this work. We also thank Rahil Hasan, Sandeep Bharadwaj, and Izer Martinez for their participation in this work as summer students and Dr. Nadereh Zafri for helpful discussions on microarray studies. The genomic core facility used in this study was supported by National Institutes of Health Cancer Center Support Grant NIH CA06600553.	Apte U, 2008, HEPATOLOGY, V47, P288, DOI 10.1002/hep.21973; Bai LA, 2011, HEPATOLOGY, V53, P1164, DOI 10.1002/hep.24155; Belakavadi M, 2008, MOL CELL BIOL, V28, P3932, DOI 10.1128/MCB.02191-07; Boden G, 2001, DIABETES, V50, P810, DOI 10.2337/diabetes.50.4.810; BUCHER NLR, 1963, INT REV CYTOL, V15, P245, DOI 10.1016/S0074-7696(08)61119-5; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Chen W, 2011, SEMIN CELL DEV BIOL, V22, P749, DOI 10.1016/j.semcdb.2011.07.026; Chen W, 2010, P NATL ACAD SCI USA, V107, P10196, DOI 10.1073/pnas.1005626107; Chen WL, 2012, BIOCHEM PHARMACOL, V84, P522, DOI 10.1016/j.bcp.2012.05.022; Chen Z, 2011, EMBO J, V30, P2405, DOI 10.1038/emboj.2011.154; Crawford SE, 2002, J BIOL CHEM, V277, P3585, DOI 10.1074/jbc.M107995200; Cui JJ, 2012, CANCER RES, V72, P5625, DOI 10.1158/0008-5472.CAN-12-1305; Frade R, 2000, CANCER RES, V60, P6585; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hasegawa N, 2012, MOL CELL BIOL, V32, P1483, DOI 10.1128/MCB.05245-11; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Huang JS, 2011, MOL PATHOL LIB, V5, P133, DOI 10.1007/978-1-4419-7107-4_10; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jia YZ, 2009, GENE EXPRESSION, V14, P291, DOI 10.3727/105221609788681213; Jia YZ, 2005, P NATL ACAD SCI USA, V102, P12531, DOI 10.1073/pnas.0506000102; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Jin F, 2013, MOL CANCER RES, V11, P736, DOI 10.1158/1541-7786.MCR-12-0618; Kim HJ, 2012, CANCER LETT, V321, P195, DOI 10.1016/j.canlet.2012.02.009; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kornberg R, 2007, ANGEW CHEM INT EDIT, V46, P6957, DOI 10.1002/anie.200701832; Krebs P, 2011, P NATL ACAD SCI USA, V108, P19678, DOI 10.1073/pnas.1117835108; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Lamy PJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2824; Landles C, 2003, MOL ENDOCRINOL, V17, P2418, DOI 10.1210/me.2003-0097; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Lee SK, 2012, CELL SIGNAL, V24, P2329, DOI 10.1016/j.cellsig.2012.07.022; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lee WH, 2010, PPAR RES, V2010, DOI 10.1155/2010/549101; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liangpunsakul S, 2009, ARCH BIOCHEM BIOPHYS, V485, P10, DOI 10.1016/j.abb.2009.02.006; Locker J, 2003, HEPATOLOGY, V38, P314, DOI 10.1053/jhep.2003.50299; Matsumoto K, 2007, J BIOL CHEM, V282, P17053, DOI 10.1074/jbc.M701956200; Matsumoto K, 2010, CARCINOGENESIS, V31, P318, DOI 10.1093/carcin/bgp306; Meng RS, 2011, ARCH BIOCHEM BIOPHYS, V511, P1, DOI 10.1016/j.abb.2011.04.010; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Misra P, 2002, J BIOL CHEM, V277, P48745, DOI 10.1074/jbc.M208829200; Murakami H, 2006, BIOCHEM BIOPH RES CO, V341, P973, DOI 10.1016/j.bbrc.2006.01.052; Pyper S.R., 2010, NUCL RECEPT SIGNAL, V8; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; REDDY JK, 1979, CANCER RES, V39, P152; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Riehle KJ, 2011, J GASTROEN HEPATOL, V26, P203, DOI 10.1111/j.1440-1746.2010.06539.x; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sanders Jennifer A., 2012, BMC Physiology, V12, P1, DOI 10.1186/1472-6793-12-1; Shaw RJ, 2012, SCIENCE, V336, P813, DOI 10.1126/science.1223140; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Solaz-Fuster MC, 2006, CELL SIGNAL, V18, P1702, DOI 10.1016/j.cellsig.2006.01.021; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Viswakarma N, 2010, PPAR RES, V2010, DOI 10.1155/2010/250126; Walsh C., 2006, POSTTRANSLATIONAL MO; White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200; Wolf J, 2010, FEBS J, V277, P3268, DOI 10.1111/j.1742-4658.2010.07739.x; Yu ST, 2001, J BIOL CHEM, V276, P42485, DOI 10.1074/jbc.M106480200; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhu YJ, 2000, J BIOL CHEM, V275, P14779, DOI 10.1074/jbc.C000121200; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500; Zhu YJ, 1999, P NATL ACAD SCI USA, V96, P10848, DOI 10.1073/pnas.96.19.10848	72	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27898	27911		10.1074/jbc.M113.486696	http://dx.doi.org/10.1074/jbc.M113.486696			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23943624	hybrid, Green Published			2022-12-28	WOS:000330612800018
J	Nihira, T; Suzuki, E; Kitaoka, M; Nishimoto, M; Ohtsubo, K; Nakai, H				Nihira, Takanori; Suzuki, Erika; Kitaoka, Motomitsu; Nishimoto, Mamoru; Ohtsubo, Ken'ichi; Nakai, Hiroyuki			Discovery of beta-1,4-D-Mannosyl-N-acetyl-D-glucosamine Phosphorylase Involved in the Metabolism of N-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTENSIVE DNA INVERSIONS; COMPLETE GENOME SEQUENCE; BACTEROIDES-THETAIOTAOMICRON; LAMINARIBIOSE PHOSPHORYLASE; BIOSE PHOSPHORYLASE; GUT; IDENTIFICATION; PREDICTION; MICROBIOTA; MECHANISM	A gene cluster involved in N-glycan metabolism was identified in the genome of Bacteroides thetaiotaomicron VPI-5482. This gene cluster encodes a major facilitator superfamily transporter, a starch utilization system-like transporter consisting of a TonB-dependent oligosaccharide transporter and an outer membrane lipoprotein, four glycoside hydrolases (alpha-mannosidase, beta-N-acetylhexosaminidase, exo-alpha-sialidase, and endo-beta-N-acetylglucosaminidase), and a phosphorylase (BT1033) with unknown function. It was demonstrated that BT1033 catalyzed the reversible phosphorolysis of beta-1,4-D-mannosyl-N-acetyl-D-glucosamine in a typical sequential Bi Bi mechanism. These results indicate that BT1033 plays a crucial role as a key enzyme in the N-glycan catabolism where beta-1,4-D-mannosyl-N-acetyl-D-glucosamine is liberated from N-glycans by sequential glycoside hydrolase-catalyzed reactions, transported into the cell, and intracellularly converted into alpha-D-mannose 1-phosphate and N-acetyl-D-glucosamine. In addition, intestinal anaerobic bacteria such as Bacteroides fragilis, Bacteroides helcogenes, Bacteroides salanitronis, Bacteroides vulgatus, Prevotella denticola, Prevotella dentalis, Prevotella melaninogenica, Parabacteroides distasonis, and Alistipes finegoldii were also suggested to possess the similar metabolic pathway for N-glycans. A notable feature of the new metabolic pathway for N-glycans is the more efficient use of ATP-stored energy, in comparison with the conventional pathway where beta-mannosidase and ATP-dependent hexokinase participate, because it is possible to directly phosphorylate the D-mannose residue of beta-1,4-D-mannosyl-N-acetyl-D-glucosamine to enter glycolysis. This is the first report of a metabolic pathway for N-glycans that includes a phosphorylase. We propose 4-O-beta-D-mannopyranosyl-N-acetyl-D-glucosamine:phosphate alpha-D-mannosyltransferase as the systematic name and beta-1,4-D-mannosyl-N-acetyl-D-glucosamine phosphorylase as the short name for BT1033.	[Nihira, Takanori; Suzuki, Erika; Ohtsubo, Ken'ichi; Nakai, Hiroyuki] Niigata Univ, Fac Agr, Niigata 9502181, Japan; [Kitaoka, Motomitsu; Nishimoto, Mamoru] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	Niigata University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Nakai, H (corresponding author), Niigata Univ, Fac Agr, Nishi Ku, 8050 Ikarashi 2 No Cho, Niigata 9502181, Japan.	nakai@agr.niigata-u.ac.jp	Ohtsubo, Kenichi/AAW-1700-2020; Kitaoka, Motomitsu/R-1536-2019	Ohtsubo, Kenichi/0000-0001-9354-3087; Kitaoka, Motomitsu/0000-0002-0083-1838	MEXT Promotion of Environmental Improvement for Independence of Young Researchers Program under the Special Coordination Funds for Promoting Science and Technology; Sapporo Bioscience Foundation Research Grant	MEXT Promotion of Environmental Improvement for Independence of Young Researchers Program under the Special Coordination Funds for Promoting Science and Technology; Sapporo Bioscience Foundation Research Grant	This work was supported in part by the MEXT Promotion of Environmental Improvement for Independence of Young Researchers Program under the Special Coordination Funds for Promoting Science and Technology and Sapporo Bioscience Foundation Research Grant.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 2009, ESSENTIALS GLYCOBIOL; Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Gronow S, 2011, STAND GENOMIC SCI, V4, P191, DOI 10.4056/sigs.1704212; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; Ito Y., 2001, GLYCOSCIENCE CHEM CH, V2, P1589; Kawahara R, 2012, J BIOL CHEM, V287, P42389, DOI 10.1074/jbc.M112.390336; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; KITAOKA M, 1993, ARCH BIOCHEM BIOPHYS, V304, P508, DOI 10.1006/abbi.1993.1383; Kitaoka M, 2012, BIOSCI BIOTECH BIOCH, V76, P343, DOI 10.1271/bbb.110772; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kuwahara T, 2004, P NATL ACAD SCI USA, V101, P14919, DOI 10.1073/pnas.0404172101; LOWRY OH, 1946, J BIOL CHEM, V162, P421; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Nakajima M, 2008, APPL MICROBIOL BIOT, V78, P465, DOI 10.1007/s00253-007-1319-8; Nakajima M, 2009, J BIOL CHEM, V284, P19220, DOI 10.1074/jbc.M109.007666; Nakayama-Imaohji H, 2012, J MED INVESTIG, V59, P79, DOI 10.2152/jmi.59.79; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nihira T., 2013, J APPL GLYCOSCI, V60, P137; Nihira T, 2012, CARBOHYD RES, V361, P49, DOI 10.1016/j.carres.2012.08.006; Nihira T, 2012, CARBOHYD RES, V360, P25, DOI 10.1016/j.carres.2012.07.014; Nihira T, 2012, APPL MICROBIOL BIOT, V93, P1513, DOI 10.1007/s00253-011-3515-9; Nihira T, 2012, CARBOHYD RES, V350, P94, DOI 10.1016/j.carres.2011.12.019; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pati A, 2011, STAND GENOMIC SCI, V4, P45, DOI 10.4056/sigs.1513795; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; WHITE RJ, 1968, BIOCHEM J, V106, P847, DOI 10.1042/bj1060847; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Zocco MA, 2007, DIGEST LIVER DIS, V39, P707, DOI 10.1016/j.dld.2007.04.003	40	51	55	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27366	27374		10.1074/jbc.M113.469080	http://dx.doi.org/10.1074/jbc.M113.469080			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23943617	Green Published, hybrid			2022-12-28	WOS:000330597300032
J	Wang, HJ; Dey, D; Carrera, I; Minond, D; Bianchi, E; Xu, SH; Lakshmana, MK				Wang, Hongjie; Dey, Debleena; Carrera, Ivan; Minond, Dmitriy; Bianchi, Elisabetta; Xu, Shaohua; Lakshmana, Madepalli K.			COPS5 (Jab1) Protein Increases beta Site Processing of Amyloid Precursor Protein and Amyloid beta Peptide Generation by Stabilizing RanBP9 Protein Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; INTEGRIN LFA-1; DEGRADATION; INTERACTS; PATHWAY; COMPLEX; APP; LOCALIZATION; COACTIVATOR; SIGNALOSOME	Increased processing of amyloid precursor protein (APP) and accumulation of neurotoxic amyloid beta peptide (A beta) in the brain is central to the pathogenesis of Alzheimer's disease (AD). Therefore, the identification of molecules that regulate A beta generation is crucial for future therapeutic approaches for AD. We demonstrated previously that RanBP9 regulates A beta generation in a number of cell lines and primary neuronal cultures by forming tripartite protein complexes with APP, low-density lipoprotein-related protein, and BACE1, consequently leading to increased amyloid plaque burden in the brain. RanBP9 is a scaffold protein that exists and functions in multiprotein complexes. To identify other proteins that may bind RanBP9 and regulate A beta levels, we used a two-hybrid analysis against a human brain cDNA library and identified COPS5 as a novel RanBP9-interacting protein. This interaction was confirmed by coimmunoprecipitation experiments in both neuronal and non-neuronal cells and mouse brain. Colocalization of COPS5 and RanBP9 in the same subcellular compartments further supported the interaction of both proteins. Furthermore, like RanBP9, COPS5 robustly increased A beta generation, followed by increased soluble APP-beta (sAPP-beta) and decreased soluble-APP-alpha (sAPP-alpha) levels. Most importantly, down-regulation of COPS5 by siRNAs reduced A beta generation, implying that endogenous COPS5 regulates A beta generation. Finally, COPS5 levels were increased significantly in AD brains and AP Delta E9 transgenic mice, and overexpression of COPS5 strongly increased RanBP9 protein levels by increasing its half-life. Taken together, these results suggest that COPS5 increases A beta generation by increasing RanBP9 levels. Thus, COPS5 is a novel RanBP9-binding protein that increases APP processing and A beta generation by stabilizing RanBP9 protein levels.	[Wang, Hongjie; Dey, Debleena; Lakshmana, Madepalli K.] Torrey Pines Inst Mol Studies, Neurobiol Sect, Port St Lucie, FL 34987 USA; [Minond, Dmitriy; Lakshmana, Madepalli K.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA; [Carrera, Ivan] Euroespes Biotechnol, Dept Neurosci, Poligono Bergondo, Coruna, Spain; [Bianchi, Elisabetta] Inst Pasteur, Dept Immunol, Immunoregulat Unit, F-75724 Paris, France; [Xu, Shaohua] Florida Inst Technol, Melbourne, FL 32901 USA	Torrey Pines Institute for Molecular Studies, Florida; Torrey Pines Institute for Molecular Studies, Florida; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Florida Institute of Technology	Lakshmana, MK (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	mlakshmana@tpims.org		Xu, Shaohua/0000-0003-1221-6354; Carrera, Ivan/0000-0003-0055-7530; Minond, Dmitriy/0000-0003-2473-5944	NIA, National Institutes of Health [1R01AG036859-01]; PHS [R24MH068855]; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036859] Funding Source: NIH RePORTER	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by NIA, National Institutes of Health Grant 1R01AG036859-01 (to M. K. L.). This work was also supported by PHS Grant R24MH068855 (to the Harvard Brain Tissue Resource Center).	Arefin AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045535; Bae MK, 2002, J BIOL CHEM, V277, P9, DOI 10.1074/jbc.C100442200; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Bird TD, 2008, GENET MED, V10, P231, DOI 10.1097/GIM.0b013e31816b64dc; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; Chen YZ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-29; Cong SY, 2012, NEUROBIOL DIS, V46, P673, DOI 10.1016/j.nbd.2012.03.008; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayes CD, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-81; Hayes CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045841; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kamboh MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.45; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lakshmana MK, 2012, FASEB J, V26, P2072, DOI 10.1096/fj.11-196709; Lakshmana MK, 2010, FASEB J, V24, P119, DOI 10.1096/fj.09-136457; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Lakshmana MK, 2008, J CELL MOL MED, V12, P2665, DOI 10.1111/j.1582-4934.2008.00320.x; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Oh W, 2006, J BIOL CHEM, V281, P30166, DOI 10.1074/jbc.M602651200; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Poirier MB, 2006, J MOL ENDOCRINOL, V36, P313, DOI 10.1677/jme.1.01891; Schutz AK, 2012, FEBS LETT, V586, P1645, DOI 10.1016/j.febslet.2012.04.037; Shackleford TJ, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-26; Spijkers PPEM, 2005, BLOOD, V105, P170, DOI 10.1182/blood-2004-02-0498; Suresh B, 2012, DRUG DISCOV TODAY, V17, P379, DOI 10.1016/j.drudis.2011.10.030; Tanzi RE, 2013, ADV ALZH DIS, V3, P5, DOI 10.3233/978-1-61499-154-0-5; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; Wan M, 2002, EMBO REP, V3, P171, DOI 10.1093/embo-reports/kvf024; Wimo A, 2010, ALZHEIMERS DEMENT, V6, P98, DOI 10.1016/j.jalz.2010.01.010; Woo JA, 2012, CELL DEATH DIFFER, V19, P1413, DOI 10.1038/cdd.2012.14; Yun HM, 2010, J BIOL CHEM, V285, P10016, DOI 10.1074/jbc.M109.068759; Zhou J, 2012, BIOCHEM BIOPH RES CO, V422, P647, DOI 10.1016/j.bbrc.2012.05.045; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200	42	15	16	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26668	26677		10.1074/jbc.M113.476689	http://dx.doi.org/10.1074/jbc.M113.476689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23926111	Green Published, hybrid			2022-12-28	WOS:000330594500032
J	Dementiev, A; Swanson, R; Roth, R; Isetti, G; Izaguirre, G; Olson, ST; Gettins, PGW				Dementiev, Alexey; Swanson, Richard; Roth, Ryan; Isetti, Giulia; Izaguirre, Gonzalo; Olson, Steven T.; Gettins, Peter G. W.			The Allosteric Mechanism of Activation of Antithrombin as an Inhibitor of Factor IXa and Factor Xa HEPARIN-INDEPENDENT FULL ACTIVATION THROUGH MUTATIONS ADJACENT TO HELIX D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antithrombin; Blood Coagulation Factors; Circular Dichroism (CD); Coagulation Factors; Enzyme Kinetics; Fluorescence; Heparin; Mutagenesis; Protease Inhibitor; Serine Protease	HIGH-AFFINITY HEPARIN; CONFORMATIONAL-CHANGE; H-1-NMR SPECTROSCOPY; CIRCULAR-DICHROISM; RAPID INHIBITION; TERNARY COMPLEX; BETA-SHEET; BINDING; SERPIN; PENTASACCHARIDE	Allosteric conformational changes in antithrombin induced by binding a specific heparin pentasaccharide result in very large increases in the rates of inhibition of factors IXa and Xa but not of thrombin. These are accompanied by CD, fluorescence, and NMR spectroscopic changes. X-ray structures show that heparin binding results in extension of helix D in the region 131-136 with coincident, and possibly coupled, expulsion of the hinge of the reactive center loop. To examine the importance of helix D extension, we have introduced strong helix-promoting mutations in the 131-136 region of antithrombin (YRKAQK to LEEAAE). The resulting variant has endogenous fluorescence indistinguishable from WT antithrombin yet, in the absence of heparin, shows massive enhancements in rates of inhibition of factors IXa and Xa (114- and 110-fold, respectively), but not of thrombin, together with changes in near- and far-UV CD and H-1 NMR spectra. Heparin binding gives only approximate to 3-4-fold further rate enhancement but increases tryptophan fluorescence by approximate to 23% without major additional CD or NMR changes. Variants with subsets of these mutations show intermediate activation in the absence of heparin, again with basal fluorescence similar to WT and large increases upon heparin binding. These findings suggest that in WT antithrombin there are two major complementary sources of conformational activation of antithrombin, probably involving altered contacts of side chains of Tyr-131 and Ala-134 with core hydrophobic residues, whereas the reactive center loop hinge expulsion plays only a minor additional role.	[Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Swanson, Richard; Roth, Ryan; Izaguirre, Gonzalo; Olson, Steven T.] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	pgettins@uic.edu			National Institutes of Health [R37 HL49234, R37 HL 39888]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049234, R37HL039888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 HL49234 (to P. G. W. G.) and R37 HL 39888 (to S. T. O.).	Arocas V, 2000, BIOCHEMISTRY-US, V39, P8512, DOI 10.1021/bi9928243; Backovic M, 2002, J PROTEOME RES, V1, P367, DOI 10.1021/pr025515z; Belzar KJ, 2002, J BIOL CHEM, V277, P8551, DOI 10.1074/jbc.M110807200; Bjork I., 1979, PHYSL INHIBITORS COA, P67; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; Chuang YJ, 2001, BIOCHEMISTRY-US, V40, P6670, DOI 10.1021/bi002933d; dela Cruz RGC, 2006, J BIOL CHEM, V281, P31668, DOI 10.1074/jbc.M604826200; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; ERSDALBADJU E, 1995, BIOCHEM J, V310, P323, DOI 10.1042/bj3100323; Futamura A, 2000, J BIOL CHEM, V275, P4092, DOI 10.1074/jbc.275.6.4092; GETTINS P, 1987, BIOCHEMISTRY-US, V26, P1391, DOI 10.1021/bi00379a027; GETTINS P, 1989, CARBOHYD RES, V185, P69, DOI 10.1016/0008-6215(89)84022-4; Gettins PGW, 2009, FEBS LETT, V583, P3397, DOI 10.1016/j.febslet.2009.10.005; HORNE A, 1992, BIOCHEMISTRY-US, V31, P2286, DOI 10.1021/bi00123a011; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; McCoy AJ, 2003, J MOL BIOL, V326, P823, DOI 10.1016/S0022-2836(02)01382-7; Meagher JL, 1996, J BIOL CHEM, V271, P29353, DOI 10.1074/jbc.271.46.29353; Meagher JL, 2000, J BIOL CHEM, V275, P2698, DOI 10.1074/jbc.275.4.2698; Meagher JL, 1998, J BIOL CHEM, V273, P23283, DOI 10.1074/jbc.273.36.23283; MILETICH JP, 1980, ANAL BIOCHEM, V105, P304, DOI 10.1016/0003-2697(80)90462-5; NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1981, J BIOL CHEM, V256, P1065; Olson ST, 2010, BIOCHIMIE, V92, P1587, DOI 10.1016/j.biochi.2010.05.011; Rogers DM, 2004, BIOCHEMISTRY-US, V43, P11092, DOI 10.1021/bi049031n; Skinner R, 1997, J MOL BIOL, V266, P601, DOI 10.1006/jmbi.1996.0798; STONE AL, 1982, P NATL ACAD SCI-BIOL, V79, P7190, DOI 10.1073/pnas.79.23.7190; TURKO IV, 1993, FEBS LETT, V335, P9, DOI 10.1016/0014-5793(93)80429-X; VANBOECKEL CAA, 1994, NAT STRUCT BIOL, V1, P423, DOI 10.1038/nsb0794-423; Whisstock JC, 2000, J MOL BIOL, V301, P1287, DOI 10.1006/jmbi.2000.3982	36	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33611	33619		10.1074/jbc.M113.510727	http://dx.doi.org/10.1074/jbc.M113.510727			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24068708	Green Published, hybrid			2022-12-28	WOS:000327250200010
J	Hwang, JH; Jiang, T; Kulkarni, S; Faure, N; Schaffhausen, BS				Hwang, Justin H.; Jiang, Tao; Kulkarni, Shreya; Faure, Nathalie; Schaffhausen, Brian S.			Protein Phosphatase 2A Isoforms Utilizing A beta Scaffolds Regulate Differentiation through Control of Akt Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; TUMOR-SUPPRESSOR PP2A; PHOSPHATIDYLINOSITOL 3-KINASE; CELL-TRANSFORMATION; SUBUNIT INTERACTION; SIGNALING PATHWAY; T-ANTIGENS; KINASE; PHOSPHORYLATION; IDENTIFICATION	Protein phosphatase 2A (PP2A) regulates almost all cell signaling pathways. It consists of a scaffolding A subunit to which a catalytic C subunit and one of many regulatory B subunits bind. Of the more than 80 PP2A isoforms, 10% use A beta as a scaffold. This study demonstrates the isoform-specific function of the A scaffold subunits. Polyomaviruses have shown the importance of phosphotyrosine, PI3K, and p53 in transformation. Comparisons of polyoma and SV40 small T antigens implicate A beta in the control of differentiation. Knockdown of A beta enhanced differentiation. Akt signaling regulated differentiation; its activation or inhibition promoted or blocked it, respectively. A beta bound Akt. Enhancement of PP2A A beta/Akt interaction by polyoma small T antigen increased turnover of Akt Ser-473 phosphorylation. Conversely, knockdown of A beta promoted Akt activity and reduced turnover of phosphate at Ser-473 of Akt. These data provide new insight into the regulation of Akt, a protein of extreme importance in cancer. Furthermore, our results suggest that the role for A beta in differentiation and perhaps tumor suppression may lie partly in its ability to negatively regulate Akt.	[Hwang, Justin H.; Jiang, Tao; Faure, Nathalie; Schaffhausen, Brian S.] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Hwang, Justin H.; Kulkarni, Shreya; Schaffhausen, Brian S.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Biochem, Boston, MA 02111 USA; [Kulkarni, Shreya] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University	Schaffhausen, BS (corresponding author), Tufts Univ, Sch Med, Dept Biochem, 136 Harrison Ave, Boston, MA 02111 USA.	brian.schaffhausen@tufts.edu		Hwang, Justin/0000-0003-1686-7103	National Institutes of Health [R01 CA34722, P01 CA50661]; NATIONAL CANCER INSTITUTE [R01CA034722, P01CA050661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA34722 and P01 CA50661.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Andrabi S, 2007, P NATL ACAD SCI USA, V104, P19011, DOI 10.1073/pnas.0706696104; Andrabi S, 2011, J VIROL, V85, P10649, DOI 10.1128/JVI.05034-11; BRAUTIGAN DL, 1995, SEMIN CANCER BIOL, V6, P211, DOI 10.1006/scbi.1995.0028; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; Esplin ED, 2006, GENE CHROMOSOME CANC, V45, P182, DOI 10.1002/gcc.20284; Gherzi R, 2010, CELL DEATH DIFFER, V17, P975, DOI 10.1038/cdd.2009.194; Gonzalez I, 2004, MOL CELL BIOL, V24, P3607, DOI 10.1128/MCB.24.9.3607-3622.2004; Hao YS, 2008, MOL CELL BIOL, V28, P2851, DOI 10.1128/MCB.01917-07; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; Heron-Milhavet L, 2008, J CELL PHYSIOL, V214, P158, DOI 10.1002/jcp.21177; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2012, CURR MOL MED, V12, P268, DOI 10.2174/156652412799218930; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kim SP, 2010, BIOCHEM BIOPH RES CO, V399, P55, DOI 10.1016/j.bbrc.2010.07.038; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Liu QS, 2011, J MED CHEM, V54, P1473, DOI 10.1021/jm101520v; McConnell JL, 2007, ONCOGENE, V26, P6021, DOI 10.1038/sj.onc.1210406; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Moreno CS, 2004, CANCER RES, V64, P6978, DOI 10.1158/0008-5472.CAN-04-1150; Naiki T, 2007, J BIOL CHEM, V282, P24075, DOI 10.1074/jbc.M701409200; Nazarewicz Rafal Robert, 2011, J Biol Chem, V286, P2886, DOI 10.1074/jbc.M110.141499; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Rotwein P, 2009, J CELL PHYSIOL, V219, P503, DOI 10.1002/jcp.21692; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Tian Y, 2004, J VIROL, V78, P12657, DOI 10.1128/JVI.78.22.12657-12664.2004; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; WALTER G, 1990, P NATL ACAD SCI USA, V87, P2521, DOI 10.1073/pnas.87.7.2521; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Wilson EM, 2004, MOL BIOL CELL, V15, P497, DOI 10.1091/mbc.E03-05-0351; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yen A, 2001, J VIROL, V75, P5302, DOI 10.1128/JVI.75.11.5302-5314.2001; Yuan H, 2002, J VIROL, V76, P10685, DOI 10.1128/JVI.76.21.10685-10691.2002; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	48	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					32064	32073		10.1074/jbc.M113.497644	http://dx.doi.org/10.1074/jbc.M113.497644			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052256	Green Published, hybrid			2022-12-28	WOS:000330596200057
J	Ohno, K; Sawada, J; Takiya, S; Kimoto, M; Matsumoto, A; Tsubota, T; Uchino, K; Hui, CC; Sezutsu, H; Handa, H; Suzuki, Y				Ohno, Kaoru; Sawada, Jun-ichi; Takiya, Shigeharu; Kimoto, Mai; Matsumoto, Akiko; Tsubota, Takuya; Uchino, Keiro; Hui, Chi-chung; Sezutsu, Hideki; Handa, Hiroshi; Suzuki, Yoshiaki			Silk Gland Factor-2, Involved in Fibroin Gene Transcription, Consists of LIM Homeodomain, LIM-interacting, and Single-stranded DNA-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOMBYX-MORI SILKGLAND; WING MARGIN ENHANCER; MESSENGER-RNA; IN-VIVO; DOMAIN; DROSOPHILA; PROMOTER; SEQUENCE; LDB1; CONTAINS	SGF-2 binds to promoter elements governing posterior silk gland-specific expression of the fibroin gene in Bombyx mori. Wepurified SGF-2 and showed that SGF-2 contains at least four gene products: the silkworm orthologues of LIM homeodomain protein Awh, LIM domain-binding protein (Ldb), a sequence-specific single-stranded DNA-binding protein (Lcaf), and the silk protein P25/fibrohexamerin (fhx). Using co-expression of these factors in Sf9 cells, Awh, Ldb, and Lcaf proteins were co-purified as a ternary complex that bound to the enhancer sequence in vitro. Lcaf interacts with Ldb as well as Awh through the conserved regions to mediate transcriptional activation in yeast. Misexpression of Awh in transgenic silkworms induces ectopic expression of the fibroin gene in the middle silk glands, where Ldb and Lcaf are expressed. Taken together, this study demonstrates that SGF-2 is a multisubunit activator complex containing Awh. Moreover, our results suggest that the Ldb.Lcaf protein complex serves as a scaffold to facilitate communication between transcriptional control elements.	[Ohno, Kaoru; Takiya, Shigeharu; Hui, Chi-chung; Suzuki, Yoshiaki] Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Sawada, Jun-ichi; Matsumoto, Akiko; Handa, Hiroshi] Tokyo Inst Technol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Takiya, Shigeharu; Kimoto, Mai] Hokkaido Univ, Sapporo, Hokkaido 0600810, Japan; [Tsubota, Takuya; Sezutsu, Hideki] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Tokyo Institute of Technology; Hokkaido University; National Institute of Agrobiological Sciences - Japan	Takiya, S (corresponding author), Hokkaido Univ, Fac Sci, Div Biol Sci, Kita Ku, North 10 West 8, Sapporo, Hokkaido 0600810, Japan.	takiya@sci.hokudai.ac.jp		Sezutsu, Hideki/0000-0001-8886-1611; Uchino, Keiro/0000-0003-3650-7359; Tsubota, Takuya/0000-0002-5839-4570; Ohno, Kaoru/0000-0001-7648-3940	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Corporation (JST); Japan Society for the Promotion of Science for Young Scientists; New Energy and Industrial Technology Development Organization (NEDO)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was partially supported by a grant-in-aid for scientific research on priority areas from The Ministry of Education, Culture, Sports, Science and Technology (MEXT), and by a grant from the Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan, a research grant from Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Corporation (JST), research fellowships from the Japan Society for the Promotion of Science for Young Scientists, and a grant for R&D projects in cooperation with academic institutions from the New Energy and Industrial Technology Development Organization (NEDO).	Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Bayarsaihan D, 2002, BBA-PROTEINS PROTEOM, V1599, P152, DOI 10.1016/S1570-9639(02)00376-X; Bayarsaihan D, 1998, BIOCHEM J, V331, P447, DOI 10.1042/bj3310447; Breen JJ, 1998, J BIOL CHEM, V273, P4712, DOI 10.1074/jbc.273.8.4712; Chen L, 2002, P NATL ACAD SCI USA, V99, P14320, DOI 10.1073/pnas.212532399; CHEVILLARD M, 1986, NUCLEIC ACIDS RES, V14, P6341, DOI 10.1093/nar/14.15.6341; COUBLE P, 1983, DEV BIOL, V97, P398, DOI 10.1016/0012-1606(83)90096-9; COUBLE P, 1987, DEV BIOL, V124, P431, DOI 10.1016/0012-1606(87)90496-9; Curtiss J, 1997, DEV BIOL, V190, P129, DOI 10.1006/dbio.1997.8659; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; HUI CC, 1990, J MOL BIOL, V213, P651, DOI 10.1016/S0022-2836(05)80253-0; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; MACH V, 1995, J BIOL CHEM, V270, P9340, DOI 10.1074/jbc.270.16.9340; Morcillo P, 1996, GENETICS, V144, P1143; Morcillo P, 1997, GENE DEV, V11, P2729, DOI 10.1101/gad.11.20.2729; Nony P, 1995, BIOL CELL, V84, P43, DOI 10.1016/0248-4900(96)81317-7; OKAMOTO H, 1982, J BIOL CHEM, V257, P5192; Rincon-Limas DE, 2000, EMBO J, V19, P2602, DOI 10.1093/emboj/19.11.2602; Sakudoh T, 2007, P NATL ACAD SCI USA, V104, P8941, DOI 10.1073/pnas.0702860104; SAVOYSKY E, 1994, ONCOGENE, V9, P1839; Shimizu K, 2007, INSECT BIOCHEM MOLEC, V37, P713, DOI 10.1016/j.ibmb.2007.03.016; SUZUKI T, 1988, J BIOL CHEM, V263, P5979; SUZUKI Y, 1974, J MOL BIOL, V88, P393, DOI 10.1016/0022-2836(74)90490-2; SUZUKI Y, 1986, P NATL ACAD SCI USA, V83, P9522, DOI 10.1073/pnas.83.24.9522; Suzuki Y., 1990, MOL INSECT SCI, P83; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P339, DOI 10.1016/j.ibmb.2010.02.010; Takiya S, 1997, BIOCHEM J, V321, P645, DOI 10.1042/bj3210645; Takiya S, 2005, NUCLEIC ACIDS RES, V33, P786, DOI 10.1093/nar/gki228; TAKIYA S, 1990, EMBO J, V9, P489, DOI 10.1002/j.1460-2075.1990.tb08135.x; Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0; TSUDA M, 1981, CELL, V27, P175, DOI 10.1016/0092-8674(81)90371-8; TSUDA M, 1983, P NATL ACAD SCI-BIOL, V80, P7442, DOI 10.1073/pnas.80.24.7442; Uchino Keiro, 2006, Journal of Insect Biotechnology and Sericology, V75, P89; van Meyel DJ, 2000, DEVELOPMENT, V127, P1823; van Meyel DJ, 2003, DEVELOPMENT, V130, P1915, DOI 10.1242/dev.00389; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang Y, 2010, ONCOGENE, V29, P3044, DOI 10.1038/onc.2010.78; Xu ZX, 2007, GENE DEV, V21, P942, DOI 10.1101/gad.1528507	44	30	31	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31581	31591		10.1074/jbc.M113.514471	http://dx.doi.org/10.1074/jbc.M113.514471			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24022586	Green Published, hybrid			2022-12-28	WOS:000330596200017
J	Xu, F; Silva, T; Joshi, M; Zahid, S; Nanda, V				Xu, Fei; Silva, Teresita; Joshi, Mihir; Zahid, Sohail; Nanda, Vikas			Circular Permutation Directs Orthogonal Assembly in Complex Collagen Peptide Mixtures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX; ELECTROSTATIC INTERACTIONS; COMPUTATIONAL DESIGN; FIBRILLAR COLLAGEN; BACTERIAL COLLAGEN; PROTEIN; EVOLUTION; STABILITY; SEQUENCE; TRIMERIZATION	Multiple types of natural collagens specifically assemble and co-exist in the extracellular matrix. Although noncollagenous trimerization domains facilitate the folding of triple-helical regions, it is intriguing to ask whether collagen sequences are also capable of controlling heterospecific association. In this study, we designed a model system mimicking simultaneous specific assembly of two collagen heterotrimers using a genetically inspired operation, circular permutation. Previously, surface charge-pair interactions were optimized on three collagen peptides to promote the formation of an abc-type heterotrimer. Circular permutation of these sequences retained networks of stabilizing interactions, preserving both triple-helical structure and heterospecificity of assembly. Combining original peptides A, B, and C and permuted peptides D, E, and F resulted primarily in formation of A: B: C and D: E: F, a heterospecificity of 2 of 56 possible stoichiometries. This degree of specificity in collagen molecular recognition is unprecedented in natural or synthetic collagens. Analysis of natural collagen sequences indicates low similarity between the neighboring exons. Combining the synthetic collagen model and bioinformatic analysis provides insight on how fibrillar collagens might have arisen from the duplication of smaller domains.	[Xu, Fei; Silva, Teresita; Joshi, Mihir; Zahid, Sohail; Nanda, Vikas] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Nanda, V (corresponding author), Rutgers State Univ UMDNJ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.	nanda@cabm.rutgers.edu		Nanda, Vikas/0000-0003-2786-8347; Xu, Fei/0000-0003-1077-0431	National Institutes of Health New Innovator Award [DP2 OD006478-01]; National Science Foundation [DMR-0907273]; Direct For Mathematical & Physical Scien [0907273] Funding Source: National Science Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006478] Funding Source: NIH RePORTER	National Institutes of Health New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health New Innovator Award DP2 OD006478-01. This work was also supported by National Science Foundation Grant DMR-0907273.	BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Boot-Handford RP, 2003, BIOESSAYS, V25, P142, DOI 10.1002/bies.10230; Boudko SP, 2012, INT J BIOCHEM CELL B, V44, P21, DOI 10.1016/j.biocel.2011.09.009; Bourhis JM, 2012, NAT STRUCT MOL BIOL, V19, P1031, DOI 10.1038/nsmb.2389; Bulaj G, 2004, PROTEIN SCI, V13, P1182, DOI 10.1110/ps.03563704; BUTTICE G, 1990, J MOL EVOL, V30, P479, DOI 10.1007/BF02101102; Chan VC, 1997, J BIOL CHEM, V272, P31441, DOI 10.1074/jbc.272.50.31441; Eisenbeis S, 2010, J PEPT SCI, V16, P538, DOI 10.1002/psc.1233; Fallas JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2084; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; Giddu S, 2013, PROTEINS, V81, P386, DOI 10.1002/prot.24194; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Heino J, 2009, INT J BIOCHEM CELL B, V41, P341, DOI 10.1016/j.biocel.2008.08.021; HELLINGA HW, 1994, P NATL ACAD SCI USA, V91, P5803, DOI 10.1073/pnas.91.13.5803; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; Kar K, 2006, J BIOL CHEM, V281, P33283, DOI 10.1074/jbc.M605747200; Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Lindberg M, 2002, NAT STRUCT BIOL, V9, P818, DOI 10.1038/nsb847; Lukatsky DB, 2007, J MOL BIOL, V365, P1596, DOI 10.1016/j.jmb.2006.11.020; McLaughlin SH, 1998, MATRIX BIOL, V16, P369, DOI 10.1016/S0945-053X(98)90010-5; Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532; Pandya MJ, 2000, BIOCHEMISTRY-US, V39, P8728, DOI 10.1021/bi000246g; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r; Reinke AW, 2010, J AM CHEM SOC, V132, P6025, DOI 10.1021/ja907617a; Sanders KE, 2002, BLOOD, V100, P299, DOI 10.1182/blood.V100.1.299; Summa CM, 2002, J MOL BIOL, V321, P923, DOI 10.1016/S0022-2836(02)00589-2; Thompson KE, 2012, ACS SYNTH BIOL, V1, P118, DOI 10.1021/sb200015u; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; VITELLAROZUCCARELLO L, 1992, CELL TISSUE RES, V268, P505, DOI 10.1007/BF00319157; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Wu JJ, 2009, J BIOL CHEM, V284, P5539, DOI 10.1074/jbc.M806369200; Xu CY, 2010, BIOMACROMOLECULES, V11, P348, DOI 10.1021/bm900894b; Xu F, 2011, J AM CHEM SOC, V133, P15260, DOI 10.1021/ja205597g; Yang W, 1997, J BIOL CHEM, V272, P28837, DOI 10.1074/jbc.272.46.28837; Yoshizumi A, 2011, J BIOL CHEM, V286, P17512, DOI 10.1074/jbc.M110.217364; Yu ZX, 2011, J BIOL CHEM, V286, P18960, DOI 10.1074/jbc.M110.217422	46	9	9	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31616	31623		10.1074/jbc.M113.501056	http://dx.doi.org/10.1074/jbc.M113.501056			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043622	Green Published, hybrid			2022-12-28	WOS:000330596200020
J	Park, WJ; Park, JW; Erez-Roman, R; Kogot-Levin, A; Bame, JR; Tirosh, B; Saada, A; Merrill, AH; Pewzner-Jung, Y; Futerman, AH				Park, Woo-Jae; Park, Joo-Won; Erez-Roman, Racheli; Kogot-Levin, Aviram; Bame, Jessica R.; Tirosh, Boaz; Saada, Ann; Merrill, Alfred H., Jr.; Pewzner-Jung, Yael; Futerman, Anthony H.			Protection of a Ceramide Synthase 2 Null Mouse from Drug-induced Liver Injury ROLE OF GAP JUNCTION DYSFUNCTION AND CONNEXIN 32 MISLOCALIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUMONISIN B-1 TOXICITY; MEDIATED GENE-TRANSFER; OXIDATIVE STRESS; LIPID RAFTS; ACETAMINOPHEN HEPATOTOXICITY; INTERCELLULAR COMMUNICATION; SPHINGOLIPID METABOLISM; INSULIN-RESISTANCE; TERMINAL KINASE; MICE	Very long chain (C22-C24) ceramides are synthesized by ceramide synthase 2 (CerS2). A CerS2 null mouse displays hepatopathy because of depletion of C22-C24 ceramides, elevation of C16-ceramide, and/or elevation of sphinganine. Unexpectedly, CerS2 null mice were resistant to acetaminophen-induced hepatotoxicity. Although there were a number of biochemical changes in the liver, such as increased levels of glutathione and multiple drug-resistant protein 4, these effects are unlikely to account for the lack of acetaminophen toxicity. A number of other hepatotoxic agents, such as D-galactosamine, CCl4, and thioacetamide, were also ineffective in inducing liver damage. All of these drugs and chemicals require connexin (Cx) 32, a key gap junction protein, to induce hepatotoxicity. Cx32 was mislocalized to an intracellular location in hepatocytes from CerS2 null mice, which resulted in accelerated rates of its lysosomal degradation. This mislocalization resulted from the altered membrane properties of the CerS2 null mice, which was exemplified by the disruption of detergent-resistant membranes. The lack of acetaminophen toxicity and Cx32 mislocalization were reversed upon infection with recombinant adeno-associated virus expressing CerS2. We establish that Gap junction function is compromised upon altering the sphingolipid acyl chain length composition, which is of relevance for understanding the regulation of drug-induced liver injury.	[Pewzner-Jung, Yael; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Park, Woo-Jae] Gachon Univ, Sch Med, Dept Biochem, Inchon 406799, South Korea; [Park, Joo-Won] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul 158710, South Korea; [Kogot-Levin, Aviram; Saada, Ann] Hadassah & Hebrew Univ Med Ctr, Dept Genet & Metab Dis, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Pharmacol & Expt Therapeut, Sch Pharm, IL-91120 Jerusalem, Israel; [Bame, Jessica R.; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Bame, Jessica R.; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Weizmann Institute of Science; Gachon University; Ewha Womans University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il	Saada, Ann/J-6864-2017; Pewzner, Faivish/I-6225-2017	Saada, Ann/0000-0003-2951-0656; Pewzner, Faivish/0000-0002-7490-8121; Futerman, Anthony/0000-0003-0013-0115; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [GM076217]; Minerva Foundation; Israel Science Foundation [0888/11]; National Research Foundation of Korea [NRF-2010-357-C00069, 2012R1A6A3A03038319]; Korean Government (Ministry of Education, Science and Technology); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minerva Foundation; Israel Science Foundation(Israel Science Foundation); National Research Foundation of Korea(National Research Foundation of Korea); Korean Government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076217. This work was also supported by the Minerva Foundation, by Israel Science Foundation Grant 0888/11, and by National Research Foundation of Korea Grants NRF-2010-357-C00069 and 2012R1A6A3A03038319 funded by the Korean Government (Ministry of Education, Science and Technology) (to J. W. P. and W. J. P.).	Aleksunes LM, 2008, TOXICOL SCI, V104, P261, DOI 10.1093/toxsci/kfn093; Aleksunes LM, 2006, TOXICOL SCI, V89, P370, DOI 10.1093/toxsci/kfi332; Andersen JK, 1996, J NEUROCHEM, V67, P2164; Asamoto M, 2004, HEPATOLOGY, V40, P205, DOI 10.1002/hep.20256; Berthoud VM, 2000, METHODS, V20, P180, DOI 10.1006/meth.1999.0935; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Cuenda A, 2000, INT J BIOCHEM CELL B, V32, P581, DOI 10.1016/S1357-2725(00)00003-0; Dugyala RR, 1998, J PHARMACOL EXP THER, V285, P317; Fukuda T, 2000, J GASTROENTEROL, V35, P361, DOI 10.1007/s005350050361; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Han D., 2010, HDB EXP PHARM, V196, P267, DOI DOI 10.1007/978-3-642-00663-0_10; Hara Y, 2011, J CLIN INVEST, V121, P2888, DOI 10.1172/JCI45023; Henderson NC, 2007, GUT, V56, P982, DOI 10.1136/gut.2006.104372; Holt MP, 2006, AAPS J, V8, pE48, DOI 10.1208/aapsj080106; Jung SC, 2001, P NATL ACAD SCI USA, V98, P2676, DOI 10.1073/pnas.051634498; Jung SC, 2008, J KOREAN MED SCI, V23, P877, DOI 10.3346/jkms.2008.23.5.877; Lang C, 2007, PHARMACOGENET GENOM, V17, P47, DOI 10.1097/01.fpc.0000230418.28091.76; Le ACN, 1998, DEV BIOL, V204, P80, DOI 10.1006/dbio.1998.9030; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Locke D, 2005, BIOCHEMISTRY-US, V44, P13027, DOI 10.1021/bi050495a; Manautou JE, 2005, HEPATOLOGY, V42, P1091, DOI 10.1002/hep.20898; Maurel Marion, 2012, Hepatology, V56, P781, DOI 10.1002/hep.25779; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; Naiki-Ito A, 2010, TOXICOL PATHOL, V38, P280, DOI 10.1177/0192623309357951; Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006; Oh HJ, 2004, PEDIATR RES, V56, P278, DOI 10.1203/01.PDR.0000132837.29067.0E; Okuyama H, 2003, HEPATOLOGY, V37, P1015, DOI 10.1053/jhep.2003.50203; Park JW, 2013, HEPATOLOGY, V57, P525, DOI 10.1002/hep.26015; Patel SJ, 2012, NAT BIOTECHNOL, V30, P179, DOI 10.1038/nbt.2089; Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Saito C, 2010, HEPATOLOGY, V51, P246, DOI 10.1002/hep.23267; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Silva LC, 2012, J LIPID RES, V53, P430, DOI 10.1194/jlr.M022715; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sullards MC, 2011, BBA-MOL CELL BIOL L, V1811, P838, DOI 10.1016/j.bbalip.2011.06.027; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Tsunoda M, 1998, J BIOCHEM MOL TOXIC, V12, P281, DOI 10.1002/(SICI)1099-0461(1998)12:5<281::AID-JBT4>3.0.CO;2-H; Upham B.L., 2011, CURR PROTOC TOXICOL; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Yurlova L, 2011, BIOPHYS J, V101, P2713, DOI 10.1016/j.bpj.2011.10.026; Zamek-Gliszczynski MJ, 2006, J PHARMACOL EXP THER, V319, P1485, DOI 10.1124/jpet.106.110106; Zigdon H, 2013, J BIOL CHEM, V288, P4947, DOI 10.1074/jbc.M112.402719	47	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30904	30916		10.1074/jbc.M112.448852	http://dx.doi.org/10.1074/jbc.M112.448852			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24019516	Green Published, hybrid			2022-12-28	WOS:000330778900011
J	Wang, ZW; Qiu, Y; Liu, YX; Qi, N; Si, J; Xia, XL; Wu, D; Hu, YY; Zhou, X				Wang, Zhaowei; Qiu, Yang; Liu, Yongxiang; Qi, Nan; Si, Jie; Xia, Xiaoling; Wu, Di; Hu, Yuanyang; Zhou, Xi			Characterization of a Nodavirus Replicase Revealed a de Novo Initiation Mechanism of RNA Synthesis and Terminal Nucleotidyltransferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; FLOCK-HOUSE-VIRUS; VIRAL-RNA; POLYMERASE-ACTIVITY; GENOMIC RNA; PROTEIN-A; MEMBRANE ASSOCIATION; DROSOPHILA-CELLS; ANIMAL VIRUS; IN-VITRO	Nodaviruses are a family of positive-stranded RNA viruses with a bipartite genome of RNAs. In nodaviruses, genomic RNA1 encodes protein A, which is recognized as an RNA-dependent RNA polymerase (RdRP) and functions as the sole viral replicase protein responsible for its RNA replication. Although nodaviral RNA replication has been studied in considerable detail, and nodaviruses are well recognized models for investigating viral RNA replication, the mechanism(s) governing the initiation of nodaviral RNA synthesis have not been determined. In this study, we characterized the RdRP activity of Wuhan nodavirus (WhNV) protein A in detail and determined that this nodaviral protein A initiates RNA synthesis via a de novo mechanism, and this RNA synthesis initiation could be independent of other viral or cellular factors. Moreover, we uncovered that WhNV protein A contains a terminal nucleotidyltransferase (TNTase) activity, which is the first time such an activity has been identified in nodaviruses. We subsequently found that the TNTase activity could function in vitro to repair the 3' initiation site, which may be digested by cellular exonucleases, to ensure the efficiency and accuracy of viral RNA synthesis initiation. Furthermore, we determined the cis-acting elements for RdRP or TNTase activity at the 3'-end of positive or negative strand RNA1. Taken together, our data establish the de novo synthesis initiation mechanism and the TNTase activity of WhNV protein A, and this work represents an important advance toward understanding the mechanism(s) of nodaviral RNA replication.	[Wang, Zhaowei; Qiu, Yang; Liu, Yongxiang; Qi, Nan; Si, Jie; Xia, Xiaoling; Wu, Di; Hu, Yuanyang; Zhou, Xi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Zhou, X (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	zhouxi@whu.edu.cn	Qiu, Yang/AAQ-4435-2020; Zhou, Xi/J-1902-2012	Zhou, Xi/0000-0002-3846-5079; Qiu, Yang/0000-0001-5152-1242	National Basic Research Program of China (973 Program) [2014CB542603]; National Natural Science Foundation of China [31270190, 81201292, 31270189]; Fundamental Research Funds for the Central Universities [204274386]; Chinese 111 Project [B06018]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Basic Research Program of China (973 Program, 2014CB542603); National Natural Science Foundation of China Grants 31270190 (to X. Z.), 81201292 (to X. Z.), and 31270189 (to Y. H.); Fundamental Research Funds for the Central Universities Grant 204274386 (to Z. W.); and Chinese 111 Project Grant B06018.	Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; ARGOS P, 1988, NUCLEIC ACIDS RES, V16, P9909, DOI 10.1093/nar/16.21.9909; Arnold JJ, 1999, J BIOL CHEM, V274, P37060, DOI 10.1074/jbc.274.52.37060; BALL LA, 1994, P NATL ACAD SCI USA, V91, P12443, DOI 10.1073/pnas.91.26.12443; BALL LA, 1993, J VIROL, V67, P3544, DOI 10.1128/JVI.67.6.3544-3551.1993; BALL LA, 1995, J VIROL, V69, P2722, DOI 10.1128/JVI.69.4.2722-2722.1995; Ball LA, 1999, ADV VIRUS RES, V53, P229, DOI 10.1016/S0065-3527(08)60350-4; Beerens N, 2007, J VIROL, V81, P8384, DOI 10.1128/JVI.00564-07; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Binne UK, 2002, J VIROL, V76, P10282, DOI 10.1128/JVI.76.20.10282-10289.2002; Cai DW, 2010, VIRUS RES, V151, P153, DOI 10.1016/j.virusres.2010.04.010; Castorena Kathryn M, 2010, BMC Genomics, V11, P183, DOI 10.1186/1471-2164-11-183; DeFrancesco R, 1996, METHOD ENZYMOL, V275, P58; Denison MR, 2008, PLOS BIOL, V6, P2098, DOI 10.1371/journal.pbio.0060270; Dye BT, 2005, J VIROL, V79, P8909, DOI 10.1128/JVI.79.14.8909-8919.2005; Fukushi S, 2004, J VIROL, V78, P3889, DOI 10.1128/JVI.78.8.3889-3896.2004; Fullerton SWB, 2007, J VIROL, V81, P1858, DOI 10.1128/JVI.01462-06; GALLAGHER TM, 1983, J VIROL, V46, P481, DOI 10.1128/JVI.46.2.481-489.1983; Guan HC, 2000, P NATL ACAD SCI USA, V97, P12451, DOI 10.1073/pnas.97.23.12451; Huang Yi, 2012, Virologica Sinica, V27, P273, DOI 10.1007/s12250-012-3252-y; Hung M, 2002, ANTIVIR RES, V56, P99, DOI 10.1016/S0166-3542(02)00101-8; Ishii K, 1999, HEPATOLOGY, V29, P1227, DOI 10.1002/hep.510290448; Johnson KN, 2001, J GEN VIROL, V82, P1855, DOI 10.1099/0022-1317-82-8-1855; KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/nar/12.18.7269; Kampmueller KM, 2005, J VIROL, V79, P6827, DOI 10.1128/JVI.79.11.6827-6837.2005; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Kao CC, 1999, VIROLOGY, V253, P1, DOI 10.1006/viro.1998.9517; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Kopek BG, 2007, PLOS BIOL, V5, P2022, DOI 10.1371/journal.pbio.0050220; Kopek BG, 2010, J VIROL, V84, P12492, DOI 10.1128/JVI.01495-10; Kovalev N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002537; LARDER BA, 1987, EMBO J, V6, P169, DOI 10.1002/j.1460-2075.1987.tb04735.x; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lohmann V, 1999, J BIOL CHEM, V274, P10807, DOI 10.1074/jbc.274.16.10807; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; MAO JCH, 1975, J VIROL, V15, P1281, DOI 10.1128/JVI.15.5.1281-1283.1975; Miller DJ, 2003, J VIROL, V77, P12193, DOI 10.1128/JVI.77.22.12193-12202.2003; Miller DJ, 2002, J VIROL, V76, P9856, DOI 10.1128/JVI.76.19.9856-9867.2002; Miller DJ, 2001, J VIROL, V75, P11664, DOI 10.1128/JVI.75.23.11664-11676.2001; MILLER WA, 1985, NATURE, V313, P68, DOI 10.1038/313068a0; NEUFELD KL, 1994, J VIROL, V68, P5811, DOI 10.1128/JVI.68.9.5811-5818.1994; OBERG B, 1989, PHARMACOL THERAPEUT, V40, P213, DOI 10.1016/0163-7258(89)90097-1; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Poranen MM, 2008, J VIROL, V82, P9254, DOI 10.1128/JVI.01044-08; Qi N, 2012, J VIROL, V86, P5763, DOI 10.1128/JVI.07229-11; Qi N, 2011, J VIROL, V85, P9543, DOI 10.1128/JVI.00785-11; Qiu Y, 2013, VIROLOGY, V439, P140, DOI 10.1016/j.virol.2013.02.010; Qiu Y, 2011, J VIROL, V85, P4440, DOI 10.1128/JVI.02410-10; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; Ranjith-Kumar CT, 2001, J VIROL, V75, P8615, DOI 10.1128/JVI.75.18.8615-8623.2001; Reigadas S, 2001, EUR J BIOCHEM, V268, P5857, DOI 10.1046/j.0014-2956.2001.02532.x; RODRIGUEZ PL, 1992, J VIROL, V66, P1971, DOI 10.1128/JVI.66.4.1971-1976.1992; Rubach JK, 2009, VIROLOGY, V384, P201, DOI 10.1016/j.virol.2008.10.030; Sarin LP, 2012, VIROLOGY, V432, P184, DOI 10.1016/j.virol.2012.05.035; SCHNEEMANN A, 1992, J VIROL, V66, P6728, DOI 10.1128/JVI.66.11.6728-6734.1992; Schneemann A, 1998, ADV VIRUS RES, V50, P381, DOI 10.1016/S0065-3527(08)60812-X; SELLING BH, 1990, P NATL ACAD SCI USA, V87, P434, DOI 10.1073/pnas.87.1.434; Stapleford KA, 2009, J VIROL, V83, P4498, DOI 10.1128/JVI.00040-09; TADDIE JA, 1991, J VIROL, V65, P869, DOI 10.1128/JVI.65.2.869-879.1991; van Dijk AA, 2004, J GEN VIROL, V85, P1077, DOI 10.1099/vir.0.19731-0; Van Wynsberghe PA, 2007, J VIROL, V81, P4633, DOI 10.1128/JVI.02267-06; Van Wynsberghe PM, 2009, J VIROL, V83, P2976, DOI 10.1128/JVI.02040-08; Vazquez AL, 2001, ARCH VIROL, V146, P59, DOI 10.1007/s007050170191; Venter PA, 2008, CELL MOL LIFE SCI, V65, P2675, DOI 10.1007/s00018-008-8037-y; Weeks SA, 2010, J VIROL, V84, P330, DOI 10.1128/JVI.01808-09; Wright S, 2012, J VIROL, V86, P2837, DOI 10.1128/JVI.05168-11; WU SX, 1992, P NATL ACAD SCI USA, V89, P11136, DOI 10.1073/pnas.89.23.11136; WU SX, 1991, VIROLOGY, V183, P392, DOI 10.1016/0042-6822(91)90153-3; Ye S, 2012, VIROLOGY, V428, P136, DOI 10.1016/j.virol.2012.04.002; Yi GH, 2003, EUR J BIOCHEM, V270, P4952, DOI 10.1046/j.1432-1033.2003.03897.x	74	15	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30785	30801		10.1074/jbc.M113.492728	http://dx.doi.org/10.1074/jbc.M113.492728			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24019510	Green Published, hybrid			2022-12-28	WOS:000330778900001
J	Akin, BL; Hurley, TD; Chen, ZH; Jones, LR				Akin, Brandy L.; Hurley, Thomas D.; Chen, Zhenhui; Jones, Larry R.			The Structural Basis for Phospholamban Inhibition of the Calcium Pump in Sarcoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium ATPase; Calcium Transport; Crystal Structure; Protein Cross-linking; Protein Crystallization; Sarcoplasmic Reticulum (SR); SERCA; Phospholamban; Sarcolipin	CARDIAC CA2+ PUMP; BETA-ADRENERGIC STIMULATION; CROSS-LINKING; FUNCTIONAL INTERACTIONS; PROTEIN-STRUCTURE; TRANSMEMBRANE DOMAIN; ATPASE SERCA; CA2+-ATPASE; PHOSPHORYLATION; SARCOLIPIN	Background: Phospholamban (PLB) regulates sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) activity and is thus a key regulator of cardiac contractility. Results: We present the crystal structure of SERCA in complex with PLB at 2.8- resolution. Conclusion: PLB stabilizes a divalent cation-free conformation of SERCA with collapsed Ca2+ binding sites. We call the structure E2-PLB. Significance: The E2-PLB structure explains how PLB decreases Ca2+ affinity and depresses cardiac contractility. P-type ATPases are a large family of enzymes that actively transport ions across biological membranes by interconverting between high (E1) and low (E2) ion-affinity states; these transmembrane transporters carry out critical processes in nearly all forms of life. In striated muscle, the archetype P-type ATPase, SERCA (sarco(endo)plasmic reticulum Ca2+-ATPase), pumps contractile-dependent Ca2+ ions into the lumen of sarcoplasmic reticulum, which initiates myocyte relaxation and refills the sarcoplasmic reticulum in preparation for the next contraction. In cardiac muscle, SERCA is regulated by phospholamban (PLB), a small inhibitory phosphoprotein that decreases the Ca2+ affinity of SERCA and attenuates contractile strength. cAMP-dependent phosphorylation of PLB reverses Ca2+-ATPase inhibition with powerful contractile effects. Here we present the long sought crystal structure of the PLB-SERCA complex at 2.8- resolution. The structure was solved in the absence of Ca2+ in a novel detergent system employing alkyl mannosides. The structure shows PLB bound to a previously undescribed conformation of SERCA in which the Ca2+ binding sites are collapsed and devoid of divalent cations (E2-PLB). This new structure represents one of the key unsolved conformational states of SERCA and provides a structural explanation for how dephosphorylated PLB decreases Ca2+ affinity and depresses cardiac contractility.	Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Akin, Brandy L.; Chen, Zhenhui; Jones, Larry R.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Hurley, Thomas D.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Akin, BL (corresponding author), 1800 N Capitol Ave, Indianapolis, IN 46202 USA.	bbudryns@iu.edu; lrjones@iu.edu		HURLEY, THOMAS/0000-0002-5942-1163	US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027281] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018123] Funding Source: NIH RePORTER	US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. We thank Stephan Ginell and Marianne Cuff for assistance at SBC-CAT 19ID. We also thank Glen Schmeisser.	Akin BL, 2012, J BIOL CHEM, V287, P7582, DOI 10.1074/jbc.M111.334987; Akin BL, 2010, J BIOL CHEM, V285, P28540, DOI 10.1074/jbc.M110.151779; ANDERSEN JP, 1992, J BIOL CHEM, V267, P2767; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Bublitz M, 2013, J BIOL CHEM, V288, P10759, DOI 10.1074/jbc.R112.436550; Chen ZH, 2005, J BIOL CHEM, V280, P10530, DOI 10.1074/jbc.M414007200; Chen ZH, 2003, J BIOL CHEM, V278, P48348, DOI 10.1074/jbc.M309545200; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JONES LR, 1978, J BIOL CHEM, V253, P1643; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; JONES LR, 1985, J BIOL CHEM, V260, P7721; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Li JH, 2004, BIOCHEMISTRY-US, V43, P3870, DOI 10.1021/bi036183u; LINDEMANN JP, 1983, J BIOL CHEM, V258, P464; LYTTON J, 1992, J BIOL CHEM, V267, P14483; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montigny C, 2010, BIOCHEM BIOPH RES CO, V391, P1067, DOI 10.1016/j.bbrc.2009.12.021; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; REDDY LG, 1995, J BIOL CHEM, V270, P9390, DOI 10.1074/jbc.270.16.9390; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Sorensen TLM, 2006, J BIOTECHNOL, V124, P704, DOI 10.1016/j.jbiotec.2006.02.004; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; WEGENER AD, 1984, J BIOL CHEM, V259, P1834; WEGENER AD, 1989, J BIOL CHEM, V264, P11468; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Young HS, 2004, J MEMBRANE BIOL, V198, P55, DOI 10.1007/s00232-004-0666-y	48	87	88	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30181	30191		10.1074/jbc.M113.501585	http://dx.doi.org/10.1074/jbc.M113.501585			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23996003	Green Published, hybrid			2022-12-28	WOS:000329868100018
J	Lee, D; Goldberg, AL				Lee, Donghoon; Goldberg, Alfred L.			SIRT1 Protein, by Blocking the Activities of Transcription Factors FoxO1 and FoxO3, Inhibits Muscle Atrophy and Promotes Muscle Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						FoxO; Muscle Atrophy; Sirt1; Skeletal Muscle; Transcription Factors; FoxO3; Deacetylase; Hypertrophy	FATTY-ACID OXIDATION; SKELETAL-MUSCLE; UBIQUITIN LIGASES; MITOCHONDRIAL-FUNCTION; ACTIVATING SIRT1; CANCER CACHEXIA; HYPERTROPHY; DEGRADATION; PGC-1-ALPHA; PREVENTS	In several cell types, the protein deacetylase SIRT1 regulates the activities of FoxO transcription factors whose activation is critical in muscle atrophy. However, the possible effects of SIRT1 on the activity of FoxOs in skeletal muscle and on the regulation of muscle size have not been investigated. Here, we show that after food deprivation, SIRT1 levels fall dramatically in type II skeletal muscles (tibialis anterior), which show marked atrophy, unlike in the liver (where SIRT1 rises) or heart or the soleus, a type I muscle (where SIRT1 is unchanged). Maintenance of high SIRT1 levels by electroporation in mouse muscle inhibits markedly the muscle wasting induced by fasting as well as by denervation, and these protective effects require its deacetylase activity. SIRT1 overexpression reduces muscle wasting by blocking the activation of FoxO1 and 3. It thus prevents the induction of key atrogenes, including the muscle-specific ubiquitin ligases, atrogin1 and MuRF1, and multiple autophagy (Atg) genes and the increase in overall proteolysis. In normal muscle, SIRT1 overexpression by electroporation causes rapid fiber hypertrophy without, surprisingly, activation of the PI3K-AKT signaling pathway. Thus, SIRT1 activation favors postnatal muscle growth, and its fall appears to be critical for atrophy during fasting. Consequently, SIRT1 activation represents an attractive possible pharmacological approach to prevent muscle wasting and cachexia.	[Lee, Donghoon; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	alfred_goldberg@hms.harvard.edu			National Institutes of Health [1R01 AR055255-04]; Amyotrophic Lateral Sclerosis Association; Muscular Dystrophy Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amyotrophic Lateral Sclerosis Association; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01 AR055255-04. This work was also supported by the Amyotrophic Lateral Sclerosis Association and the Muscular Dystrophy Association.	Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; LI JB, 1976, AM J PHYSIOL, V231, P441, DOI 10.1152/ajplegacy.1976.231.2.441; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Raffaello A, 2010, J CELL BIOL, V191, P101, DOI 10.1083/jcb.201001136; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	50	126	140	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30515	30526		10.1074/jbc.M113.489716	http://dx.doi.org/10.1074/jbc.M113.489716			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003218	Green Published, hybrid			2022-12-28	WOS:000329868100054
J	Majorek, KA; Kuhn, ML; Chruszcz, M; Anderson, WF; Minor, W				Majorek, Karolina A.; Kuhn, Misty L.; Chruszcz, Maksymilian; Anderson, Wayne F.; Minor, Wladek			Structural, Functional, and Inhibition Studies of a Gcn5-related N-Acetyltransferase (GNAT) Superfamily Protein PA4794 A NEW C-TERMINAL LYSINE PROTEIN ACETYLTRANSFERASE FROM PSEUDOMONAS AERUGINOSA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Crystal Structure; Enzyme inhibitors; High Throughput Screening (HTS); Pseudomonas; GNAT; Gcn5-related N-Acetyltransferase; Acetyltransferase; Cephalosporin; Lysine Acetylation	ACETYLATION; DIFFRACTION; MODEL	Background: Gcn5-related N-acetyltransferases (GNATs) are involved in small molecule and protein acetylation in all organisms. Results: Crystallographic and biochemical characterization of PA4794 is shown, including identification of substrates and inhibitors. Conclusion: PA4794 is a new bacterial C-terminal lysine protein acetyltransferase inhibited by cephalosporins. Significance: PA4794 is the first identified acetyltransferase specific for C-terminal lysine; identified interactions with cephalosporins may be of clinical relevance. The Gcn5-related N-acetyltransferase (GNAT) superfamily is a large group of evolutionarily related acetyltransferases, with multiple paralogs in organisms from all kingdoms of life. The functionally characterized GNATs have been shown to catalyze the transfer of an acetyl group from acetyl-coenzyme A (Ac-CoA) to the amine of a wide range of substrates, including small molecules and proteins. GNATs are prevalent and implicated in a myriad of aspects of eukaryotic and prokaryotic physiology, but functions of many GNATs remain unknown. In this work, we used a multi-pronged approach of x-ray crystallography and biochemical characterization to elucidate the sequence-structure-function relationship of the GNAT superfamily member PA4794 from Pseudomonas aeruginosa. We determined that PA4794 acetylates the NE amine of a C-terminal lysine residue of a peptide, suggesting it is a protein acetyltransferase specific for a C-terminal lysine of a substrate protein or proteins. Furthermore, we identified a number of molecules, including cephalosporin antibiotics, which are inhibitors of PA4794 and bind in its substrate-binding site. Often, these molecules mimic the conformation of the acetylated peptide product. We have determined structures of PA4794 in the apo-form, in complexes with Ac-CoA, CoA, several antibiotics and other small molecules, and a ternary complex with the products of the reaction: CoA and acetylated peptide. Also, we analyzed PA4794 mutants to identify residues important for substrate binding and catalysis.	[Majorek, Karolina A.; Chruszcz, Maksymilian; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Majorek, Karolina A.] Adam Mickiewicz Univ, Bioinformat Lab, Inst Mol Biol & Biotechnol, Fac Biol, PL-61614 Poznan, Poland; [Kuhn, Misty L.; Anderson, Wayne F.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA; [Chruszcz, Maksymilian] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Majorek, Karolina A.; Chruszcz, Maksymilian; Anderson, Wayne F.; Minor, Wladek] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA	University of Virginia; Adam Mickiewicz University; Northwestern University; Feinberg School of Medicine; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; United States Department of Energy (DOE); Argonne National Laboratory	Minor, W (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	wladek@iwonka.med.virginia.edu	Chruszcz, Maksymilian/E-6407-2011; Minor, Wladek/F-3096-2014	Chruszcz, Maksymilian/0000-0001-7521-5485; Minor, Wladek/0000-0001-7075-7090	United States DOE Office of Biological and Environmental Research [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor Grant [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585] Funding Source: NIH RePORTER	United States DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Igor Shumilin and Przemyslaw Porebski for valuable discussions and Dr. Matthew D. Zimmerman for critically reading the manuscript. Additionally, we thank Drs. Sergii Pshenychnyi and Izolda Popova at the Recombinant Protein Production Core at Northwestern University for expression and purification services. Some results shown in this report are derived from work performed at the Structural Biology Center Sector 19 and LS-CAT Sector 21 at the Advanced Photon Source. The Advanced Photon Source, an Office of Science User Facility, is operated for the United States Dept. of Energy (DOE) Office of Science by Argonne National Laboratory. Argonne is operated by University of Chicago Argonne, LLC, for the United States DOE Office of Biological and Environmental Research under contract DE-AC02-06CH11357. Use of LS-CAT Sector 21 was also supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor Grant 085P1000817	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brent MM, 2009, J BIOL CHEM, V284, P19412, DOI 10.1074/jbc.M109.014951; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Izadpanah A, 2005, J AM ACAD DERMATOL, V52, P381, DOI 10.1016/j.jaad.2004.08.026; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kim C, 2007, BIOCHEMISTRY-US, V46, P5270, DOI 10.1021/bi700111z; Kuhn ML, 2013, PROTEIN SCI, V22, P222, DOI 10.1002/pro.2199; Lin SK, 2004, MOL PHARMACOL, V66, P612; Malmsten M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016400; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Naghmouchi K, 2012, RES MICROBIOL, V163, P101, DOI 10.1016/j.resmic.2011.11.002; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Sajjan US, 2001, ANTIMICROB AGENTS CH, V45, P3437, DOI 10.1128/AAC.45.12.3437-3444.2001; Shumilin IA, 2012, STRUCTURE, V20, P1715, DOI 10.1016/j.str.2012.07.016; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vetting MW, 2008, PROTEIN SCI, V17, P1781, DOI 10.1110/ps.035899.108; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/jbc.M502401200; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Vetting MW, 2004, CHEM BIOL, V11, P565, DOI 10.1016/j.chembiol.2004.03.017; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zimmerman M, 2005, ACTA CRYSTALLOGR A, V61, pC178, DOI 10.1107/S0108767305092391	35	31	31	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30223	30235		10.1074/jbc.M113.501353	http://dx.doi.org/10.1074/jbc.M113.501353			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003232	Green Published, hybrid			2022-12-28	WOS:000329868100021
J	Alzayady, KJ; Wagner, LE; Chandrasekhar, R; Monteagudo, A; Godiska, R; Tall, GG; Joseph, SK; Yule, DI				Alzayady, Kamil J.; Wagner, Larry E., II; Chandrasekhar, Rahul; Monteagudo, Alina; Godiska, Ronald; Tall, Gregory G.; Joseph, Suresh K.; Yule, David I.			Functional Inositol 1,4,5-Trisphosphate Receptors Assembled from Concatenated Homo- and Heteromeric Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTYPE-SPECIFIC REGULATION; LIGAND-BINDING AFFINITY; CA2+ RELEASE; DIFFERENTIAL EXPRESSION; TRISPHOSPHATE RECEPTOR; ATP-BINDING; TYPE-1; CALCIUM; PHOSPHORYLATION; MODULATION	Vertebrate genomes code for three subtypes of inositol 1,4,5-trisphosphate (IP3) receptors (IP(3)R1, -2, and -3). Individual IP3R monomers are assembled to form homo-and heterotetrameric channels that mediate Ca2+ release from intracellular stores. IP3R subtypes are regulated differentially by IP3, Ca2+, ATP, and various other cellular factors and events. IP3R subtypes are seldom expressed in isolation in individual cell types, and cells often express different complements of IP3R subtypes. When multiple subtypes of IP3R are co-expressed, the subunit composition of channels cannot be specifically defined. Thus, how the subunit composition of heterotetrameric IP3R channels contributes to shaping the spatio-temporal properties of IP3-mediated Ca2+ signals has been difficult to evaluate. To address this question, we created concatenated IP3R linked by short flexible linkers. Dimeric constructs were expressed in DT40-3KO cells, an IP3R null cell line. The dimeric proteins were localized to membranes, ran as intact dimeric proteins on SDS-PAGE, and migrated as an similar to 1100-kDa band on blue native gels exactly as wild type IP3R. Importantly, IP3R channels formed from concatenated dimers were fully functional as indicated by agonist-induced Ca2+ release. Using single channel "on-nucleus" patch clamp, the channels assembled from homodimers were essentially indistinguishable from those formed by the wild type receptor. However, the activity of channels formed from concatenated IP(3)R1 and IP(3)R2 heterodimers was dominated by IP(3)R2 in terms of the characteristics of regulation by ATP. These studies provide the first insight into the regulation of heterotetrameric IP3R of defined composition. Importantly, the results indicate that the properties of these channels are not simply a blend of those of the constituent IP3R monomers.	[Alzayady, Kamil J.; Wagner, Larry E., II; Chandrasekhar, Rahul; Monteagudo, Alina; Tall, Gregory G.; Yule, David I.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Godiska, Ronald] Lucigen Corp, Middleton, WI 53562 USA; [Joseph, Suresh K.] Thomas Jefferson Univ, Dept Pathol & Cell Biol, Philadelphia, PA 19107 USA	University of Rochester; Jefferson University	Yule, DI (corresponding author), Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	david_Yule@urmc.rochester.edu	Godiska, Ronald/V-7489-2017	Godiska, Ronald/0000-0003-0101-6365	National Institutes of Health [DE14756, DE19245]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R43HG006084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756, T90DE021985, R01DE019245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE014756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE14756 and DE19245.	Alzayady KJ, 2013, J BIOL CHEM, V288, P11122, DOI 10.1074/jbc.M113.453241; Barrera NP, 2008, TRENDS NEUROSCI, V31, P569, DOI 10.1016/j.tins.2008.08.001; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Betzenhauser MJ, 2008, J BIOL CHEM, V283, P21579, DOI 10.1074/jbc.M801680200; Betzenhauser MJ, 2010, CURR TOP MEMBR, V66, P273, DOI 10.1016/S1063-5823(10)66012-7; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P16156, DOI 10.1074/jbc.M109.006452; Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Bhanumathy C, 2012, J BIOL CHEM, V287, P43674, DOI 10.1074/jbc.M112.415786; Bimboese P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206482; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Boehning D, 2001, BIOPHYS J, V81, P117, DOI 10.1016/S0006-3495(01)75685-8; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; FUJINO I, 1995, CELL TISSUE RES, V280, P201, DOI 10.1007/s004410050345; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Goonasekera SA, 2012, J MOL CELL CARDIOL, V52, P317, DOI 10.1016/j.yjmcc.2011.05.001; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; Joseph SK, 2000, J BIOL CHEM, V275, P16084, DOI 10.1074/jbc.M000506200; JOSEPH SK, 1995, J BIOL CHEM, V270, P23310, DOI 10.1074/jbc.270.40.23310; JOSEPH SK, 1994, J BIOL CHEM, V269, P5673; Krizanova O, 2003, GEN PHYSIOL BIOPHYS, V22, P295; Mak DOD, 2001, J GEN PHYSIOL, V117, P435, DOI 10.1085/jgp.117.5.435; Masuda W, 2010, J BIOL CHEM, V285, P37927, DOI 10.1074/jbc.M110.168989; Mesonero JE, 2000, BIOL REPROD, V63, P532, DOI 10.1095/biolreprod63.2.532; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; NICOTERA P, 1992, ANN NY ACAD SCI, V648, P17, DOI 10.1111/j.1749-6632.1992.tb24520.x; Nucifora FC, 1996, MOL BIOL CELL, V7, P949, DOI 10.1091/mbc.7.6.949; Onoue H, 2000, BIOCHEM BIOPH RES CO, V267, P928, DOI 10.1006/bbrc.1999.2065; Park HS, 2008, J BIOL CHEM, V283, P26081, DOI 10.1074/jbc.M804184200; Parker AKT, 2004, J BIOL CHEM, V279, P23797, DOI 10.1074/jbc.M402098200; Ramos-Franco J, 2000, BIOPHYS J, V79, P1388, DOI 10.1016/S0006-3495(00)76391-0; Ramos-Franco J, 1998, BIOPHYS J, V75, P834, DOI 10.1016/S0006-3495(98)77572-1; Reisinger Veronika, 2008, V424, P423, DOI 10.1007/978-1-60327-064-9_33; Sack JT, 2008, J GEN PHYSIOL, V131, P415, DOI 10.1085/jgp.200709939; Salazar C, 2008, BIOPHYS J, V94, P1203, DOI 10.1529/biophysj.107.113084; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Sharp AH, 1999, J COMP NEUROL, V406, P207; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Taylor Colin W, 2012, Subcell Biochem, V59, P1, DOI 10.1007/978-94-007-3015-1_1; Taylor CW, 2009, IMMUNOL REV, V231, P23, DOI 10.1111/j.1600-065X.2009.00807.x; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; Tovey SC, 2000, PHARMACOL RES, V42, P581, DOI 10.1006/phrs.2000.0733; Tu HP, 2005, BIOPHYS J, V88, P1056, DOI 10.1529/biophysj.104.049601; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Wagner LE, 2008, J PHYSIOL-LONDON, V586, P3577, DOI 10.1113/jphysiol.2008.152314; Wagner LE, 2006, J BIOL CHEM, V281, P17410, DOI 10.1074/jbc.M601340200; Wagner LE, 2012, J PHYSIOL-LONDON, V590, P3245, DOI 10.1113/jphysiol.2012.228320; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 1998, MOL PHARMACOL, V53, P656, DOI 10.1124/mol.53.4.656; WOJCIKIEWICZ RJH, 1995, BIOCHEM BIOPH RES CO, V213, P334, DOI 10.1006/bbrc.1995.2134; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129; Yule DI, 2001, J GEN PHYSIOL, V117, P431, DOI 10.1085/jgp.117.5.431; Zhang SB, 2011, NEUROCHEM RES, V36, P1175, DOI 10.1007/s11064-011-0457-7	61	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29772	29784		10.1074/jbc.M113.502203	http://dx.doi.org/10.1074/jbc.M113.502203			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23955339	hybrid, Green Published			2022-12-28	WOS:000330615300052
J	Benson, MA; Batchelor, H; Chuaiphichai, S; Bailey, J; Zhu, HN; Stuehr, DJ; Bhattacharya, S; Channon, KM; Crabtree, MJ				Benson, Matthew A.; Batchelor, Helen; Chuaiphichai, Surawee; Bailey, Jade; Zhu, Hanneng; Stuehr, Dennis J.; Bhattacharya, Shoumo; Channon, Keith M.; Crabtree, Mark J.			A Pivotal Role for Tryptophan 447 in Enzymatic Coupling of Human Endothelial Nitric Oxide Synthase (eNOS) EFFECTS ON TETRAHYDROBIOPTERIN-DEPENDENT CATALYSIS AND eNOS DIMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOHYDROLASE-I OVEREXPRESSION; CORONARY-ARTERY-DISEASE; PROTEIN-KINASE-C; SUPEROXIDE-PRODUCTION; INTRACELLULAR SUPEROXIDE; DIABETES-MELLITUS; VASCULAR-DISEASE; NAD(P)H OXIDASE; GENE-TRANSFER; BINDING-SITE	Tetrahydrobiopterin (BH4) is a required cofactor for the synthesis of NO by NOS. Bioavailability of BH4 is a critical factor in regulating the balance between NO and superoxide production by endothelial NOS (eNOS coupling). Crystal structures of the mouse inducible NOS oxygenase domain reveal a homologous BH4-binding site located in the dimer interface and a conserved tryptophan residue that engages in hydrogen bonding or aromatic stacking interactions with the BH4 ring. The role of this residue in eNOS coupling remains unexplored. We overexpressed human eNOS W447A and W447F mutants in novel cell lines with tetracycline-regulated expression of human GTP cyclohydrolase I, the rate-limiting enzyme in BH4 synthesis, to determine the importance of BH4 and Trp-447 in eNOS uncoupling. NO production was abolished in eNOS-W447A cells and diminished in cells expressing W447F, despite high BH4 levels. eNOS-derived superoxide production was significantly elevated in W447A and W447F versus wild-type eNOS, and this was sufficient to oxidize BH4 to 7,8-dihydrobiopterin. In uncoupled, BH4-deficient cells, the deleterious effects of W447A mutation were greatly exacerbated, resulting in further attenuation of NO and greatly increased superoxide production. eNOS dimerization was attenuated in W447A eNOS cells and further reduced in BH4-deficient cells, as demonstrated using a novel split Renilla luciferase biosensor. Reduction of cellular BH4 levels resulted in a switch from an eNOS dimer to an eNOS monomer. These data reveal a key role for Trp-447 in determining NO versus superoxide production by eNOS, by effects on BH4-dependent catalysis, and by modulating eNOS dimer formation.	[Batchelor, Helen; Chuaiphichai, Surawee; Bailey, Jade; Bhattacharya, Shoumo; Channon, Keith M.; Crabtree, Mark J.] Univ Oxford, John Radcliffe Hosp, British Heart Fdn Ctr Res Excellence, Div Cardiovasc Med, Oxford OX3 9DU, England; [Benson, Matthew A.; Zhu, Hanneng] Wellcome Trust Ctr Human Genet, Target Discovery Inst, Nuffield Dept Clin Med, Oxford OX3 7BN, England; [Stuehr, Dennis J.] Cleveland Clin Fdn, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Cleveland Clinic Foundation	Channon, KM (corresponding author), Univ Oxford, John Radcliffe Hosp, British Heart Fdn Ctr Res Excellence, Div Cardiovasc Med, Oxford OX3 9DU, England.	keith.channon@cardiov.ox.ac.uk	Bhattacharya, Shoumo/F-4127-2010	Bhattacharya, Shoumo/0000-0002-5571-0478; Chuaiphichai, Surawee/0000-0002-7512-6252; Crabtree, Mark/0000-0003-3298-2697; Benson, Matthew/0000-0003-4459-0439; channon, keith/0000-0002-1043-4342	National Institute for Health Research (NIHR); British Heart Foundation Centre of Research Excellence Intermediate Fellowship Award [RE/08/004]; Wellcome Trust [090532/Z/09/Z]; Oxford Biomedical Research Centre;  [RG/12/5/29756]; British Heart Foundation [RG/12/5/29576, RG/10/17/28553, RG/07/003/23133] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10247] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); British Heart Foundation Centre of Research Excellence Intermediate Fellowship Award; Wellcome Trust(Wellcome TrustEuropean Commission); Oxford Biomedical Research Centre; ; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported, in whole or in part, by National Institute for Health Research (NIHR). This work was also supported by British Heart Foundation Centre of Research Excellence Intermediate Fellowship Award RE/08/004 (to M. J. C.), by RE/08/004 Programme Grant RG/12/5/29756, by The Wellcome Trust Grant 090532/Z/09/Z, and by the Oxford Biomedical Research Centre.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P413, DOI 10.1161/01.ATV.0000110785.96039.f6; Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Alp NJ, 2003, J CLIN INVEST, V112, P725, DOI 10.1172/JCI200317786; Aoyagi M, 2001, BIOCHEMISTRY-US, V40, P12826, DOI 10.1021/bi011183k; BREDT DS, 1992, J BIOL CHEM, V267, P10976; Cai S, 2005, DIABETOLOGIA, V48, P1933, DOI 10.1007/s00125-005-1857-5; Cai S, 2002, CARDIOVASC RES, V55, P838, DOI 10.1016/S0008-6363(02)00460-1; Channon KM, 2004, TRENDS CARDIOVAS MED, V14, P323, DOI 10.1016/j.tcm.2004.10.003; CHEN PF, 1995, BIOCHEM BIOPH RES CO, V215, P1119, DOI 10.1006/bbrc.1995.2579; Cosentino F, 1997, CIRCULATION, V96, P25; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; Crabtree MJ, 2009, J BIOL CHEM, V284, P1136, DOI 10.1074/jbc.M805403200; Cunnington C, 2012, CIRCULATION, V125, P1356, DOI 10.1161/CIRCULATIONAHA.111.038919; de Bono JP, 2007, NITRIC OXIDE-BIOL CH, V16, P1, DOI 10.1016/j.niox.2006.03.008; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fukuda Y, 2002, HEART, V87, P264, DOI 10.1136/heart.87.3.264; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; HEALES S, 1989, J CHROMATOGR-BIOMED, V494, P77, DOI 10.1016/S0378-4347(00)82658-4; Heitzer T, 2000, CIRC RES, V86, pE36, DOI 10.1161/01.RES.86.2.e36; Heitzer T, 1996, CIRCULATION, V93, P1346, DOI 10.1161/01.CIR.93.7.1346; Heitzer T, 1999, KIDNEY INT, V55, P252, DOI 10.1046/j.1523-1755.1999.00229.x; Heitzer T, 2000, DIABETOLOGIA, V43, P1435, DOI 10.1007/s001250051551; Higashi Y, 2002, AM J HYPERTENS, V15, P326, DOI 10.1016/S0895-7061(01)02317-2; Katusic ZS, 2001, AM J PHYSIOL-HEART C, V281, pH981, DOI 10.1152/ajpheart.2001.281.3.H981; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Kunuthur SP, 2011, EUR J PHARMACOL, V650, P371, DOI 10.1016/j.ejphar.2010.09.070; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Maier W, 2000, J CARDIOVASC PHARM, V35, P173, DOI 10.1097/00005344-200002000-00001; Masters BSS, 1996, ADV EXP MED BIOL, V387, P163; Masters BSS, 1996, FASEB J, V10, P1107; McDonald DM, 2004, PHARMACOGENETICS, V14, P831, DOI 10.1097/00008571-200412000-00006; Ozaki M, 2002, J CLIN INVEST, V110, P331, DOI 10.1172/JCI200215215; Sagami I, 2000, J BIOL CHEM, V275, P26150, DOI 10.1074/jbc.M000534200; Stroes E, 1997, J CLIN INVEST, V99, P41, DOI 10.1172/JCI119131; STROES ESG, 1995, LANCET, V346, P467, DOI 10.1016/S0140-6736(95)91322-X; Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; TZENG E, 1995, P NATL ACAD SCI USA, V92, P11771, DOI 10.1073/pnas.92.25.11771; Vasquez-Vivar J, 2000, FEBS LETT, V481, P305, DOI 10.1016/S0014-5793(00)02001-9; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Wang ZQ, 2001, BIOCHEMISTRY-US, V40, P12819, DOI 10.1021/bi011182s; XIE QW, 1994, J LEUKOCYTE BIOL, V56, P576, DOI 10.1002/jlb.56.5.576; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zheng JS, 2003, CIRCULATION, V108, P1238, DOI 10.1161/01.CIR.0000089082.40285.C3; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	46	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29836	29845		10.1074/jbc.M113.493023	http://dx.doi.org/10.1074/jbc.M113.493023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23965989	Green Published, hybrid			2022-12-28	WOS:000330615300057
J	Ferreira, E; Porter, RM; Wehling, N; O'Sullivan, RP; Liu, FJ; Boskey, A; Estok, DM; Harris, MB; Vrahas, MS; Evans, CH; Wells, JW				Ferreira, Elisabeth; Porter, Ryan M.; Wehling, Nathalie; O'Sullivan, Regina P.; Liu, Fangjun; Boskey, Adele; Estok, Daniel M.; Harris, Mitchell B.; Vrahas, Mark S.; Evans, Christopher H.; Wells, James W.			Inflammatory Cytokines Induce a Unique Mineralizing Phenotype in Mesenchymal Stem Cells Derived from Human Bone Marrow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; NONSPECIFIC ALKALINE-PHOSPHATASE; INORGANIC PYROPHOSPHATE; OSTEOBLASTS; DIFFERENTIATION; CALCIFICATION; CARTILAGE; MODEL; INTERLEUKIN-1-BETA; EXPRESSION	Bone marrow contains mesenchymal stem cells (MSCs) that can differentiate along multiple mesenchymal lineages. In this capacity they are thought to be important in the intrinsic turnover and repair of connective tissues while also serving as a basis for tissue engineering and regenerative medicine. However, little is known of the biological responses of human MSCs to inflammatory conditions. When cultured with IL-1 beta, marrow-derived MSCs from 8 of 10 human subjects deposited copious hydroxyapatite, in which authenticity was confirmed by Fourier transform infrared spectroscopy. Transmission electron microscopy revealed the production of fine needles of hydroxyapatite in conjunction with matrix vesicles. Alkaline phosphatase activity did not increase in response to inflammatory mediators, but PPi production fell, reflecting lower ectonucleotide pyrophosphatase activity in cells and matrix vesicles. Because PPi is the major physiological inhibitor of mineralization, its decline generated permissive conditions for hydroxyapatite formation. This is in contrast to MSCs treated with dexamethasone, where PPi levels did not fall and mineralization was fuelled by a large and rapid increase in alkaline phosphatase activity. Bone sialoprotein was the only osteoblast marker strongly induced by IL-1 beta; thus these cells do not become osteoblasts despite depositing abundant mineral. RT-PCR did not detect transcripts indicative of alternative mesenchymal lineages, including chondrocytes, myoblasts, adipocytes, ligament, tendon, or vascular smooth muscle cells. IL-1 beta phosphorylated multiple MAPKs and activated nuclear factor-kappa B (NF-kappa B). Certain inhibitors of MAPK and PI3K, but not NF-kappa B, prevented mineralization. The findings are of importance to soft tissue mineralization, tissue engineering, and regenerative medicine.	[Ferreira, Elisabeth; Porter, Ryan M.; O'Sullivan, Regina P.; Liu, Fangjun; Evans, Christopher H.; Wells, James W.] Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA; [Ferreira, Elisabeth; Porter, Ryan M.; Vrahas, Mark S.; Evans, Christopher H.; Wells, James W.] AO Fdn, Collaborat Res Ctr, CH-7270 Davos, Switzerland; [Wehling, Nathalie] Asklepios Stadtklin, Dept Surg, D-83646 Bad Tolz, Germany; [Boskey, Adele] Hosp Special Surg, New York, NY 10021 USA; [Estok, Daniel M.; Harris, Mitchell B.] Brigham & Womens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA; [Vrahas, Mark S.] Massachusetts Gen Hosp, Dept Orthopaed Surg, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Evans, CH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, RN-115,330 Brookline Ave, Boston, MA 02215 USA.	cevans@bidmc.harvard.edu	Wells, James W./C-7480-2011; Porter, Ryan M./AAU-9182-2020	Wells, James W./0000-0002-9618-6940; Porter, Ryan M./0000-0002-0246-5747; Boskey, Adele/0000-0002-6181-2219	National Institutes of Health [AR050243]; AO Foundation [S-10-72F]; GENDEF	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AO Foundation; GENDEF	This work was supported, in whole or in part, by National Institutes of Health Grant AR050243 (NIAMS). This work was also supported by AO Foundation Grants S-10-72F and GENDEF.	ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266; Arthur A, 2009, J CELL PHYSIOL, V218, P237, DOI 10.1002/jcp.21592; Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446; BELLOWS CG, 1992, BONE MINER, V17, P15, DOI 10.1016/0169-6009(92)90707-K; Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y; BOSKEY AL, 1992, CLIN ORTHOP RELAT R, P244; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Choileain NN, 2006, ARCH SURG-CHICAGO, V141, P1132, DOI 10.1001/archsurg.141.11.1132; Diefenderfer DL, 2003, J BONE JOINT SURG AM, V85A, P19, DOI 10.2106/00004623-200300003-00005; Ding J, 2009, LIFE SCI, V84, P499, DOI 10.1016/j.lfs.2009.01.013; FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0; Gilbert L, 2000, ENDOCRINOLOGY, V141, P3956, DOI 10.1210/en.141.11.3956; GOWEN M, 1988, ARTHRITIS RHEUM, V31, P1500, DOI 10.1002/art.1780311206; Guardavaccaro D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002921; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Johnson K, 2005, FRONT BIOSCI-LANDMRK, V10, P988, DOI 10.2741/1593; Johnson KA, 2000, AM J PHYSIOL-REG I, V279, pR1365, DOI 10.1152/ajpregu.2000.279.4.R1365; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; KUROKI T, 1994, BRIT J RHEUMATOL, V33, P224; Lacey DC, 2009, OSTEOARTHR CARTILAGE, V17, P735, DOI 10.1016/j.joca.2008.11.011; McNamara CR, 2011, FUTURE MED CHEM, V3, P549, DOI [10.4155/fmc.11.12, 10.4155/FMC.11.12]; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Pape HC, 2010, J ORTHOP TRAUMA, V24, P522, DOI 10.1097/BOT.0b013e3181ed1361; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porter RM, 2009, J ORTHOP RES, V27, P42, DOI 10.1002/jor.20715; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; Scrivo R, 2011, AUTOIMMUN REV, V10, P369, DOI 10.1016/j.autrev.2010.12.006; Sonomoto K, 2012, ARTHRITIS RHEUM-US, V64, P3355, DOI 10.1002/art.34555; Southerland JH, 2006, PERIODONTOL 2000, V40, P130, DOI 10.1111/j.1600-0757.2005.00138.x; Terkeltaub RA, 1998, J BONE MINER RES, V13, P931, DOI 10.1359/jbmr.1998.13.6.931; Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Xiao Z, 2007, J CELL PHYSIOL, V210, P325, DOI 10.1002/jcp.20826; Yao Z, 2004, ANN RHEUM DIS, V63, P252, DOI 10.1136/ard.2003.008045	36	51	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29494	29505		10.1074/jbc.M113.471268	http://dx.doi.org/10.1074/jbc.M113.471268			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23970554	hybrid, Green Published			2022-12-28	WOS:000330615300026
J	Feinberg, H; Jegouzo, SAF; Rowntree, TJW; Guan, Y; Brash, MA; Taylor, ME; Weis, WI; Drickamer, K				Feinberg, Hadar; Jegouzo, Sabine A. F.; Rowntree, Thomas J. W.; Guan, Yue; Brash, Matthew A.; Taylor, Maureen E.; Weis, William I.; Drickamer, Kurt			Mechanism for Recognition of an Unusual Mycobacterial Glycolipid by the Macrophage Receptor Mincle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate-binding Protein; Crystal Structure; Glycobiology; Glycolipids; Mycobacterium tuberculosis; CLEC4E; Cord Factor	C-TYPE LECTIN; CARBOHYDRATE-RECOGNITION; ASIALOGLYCOPROTEIN RECEPTOR; DC-SIGN; PATHOGENIC FUNGUS; STRUCTURAL BASIS; LIGAND-BINDING; TUBERCULOSIS; IDENTIFICATION; MALASSEZIA	Binding of the macrophage lectin mincle to trehalose dimycolate, a key glycolipid virulence factor on the surface of Mycobacterium tuberculosis and Mycobacterium bovis, initiates responses that can lead both to toxicity and to protection of these pathogens from destruction. Crystallographic structural analysis, site-directed mutagenesis, and binding studies with glycolipid mimics have been used to define an extended binding site in the C-type carbohydrate recognition domain (CRD) of bovine mincle that encompasses both the headgroup and a portion of the attached acyl chains. One glucose residue of the trehalose Glc1-1Glc headgroup is liganded to a Ca2+ in a manner common to many C-type CRDs, whereas the second glucose residue is accommodated in a novel secondary binding site. The additional contacts in the secondary site lead to a 36-fold higher affinity for trehalose compared with glucose. An adjacent hydrophobic groove, not seen in other C-type CRDs, provides a docking site for one of the acyl chains attached to the trehalose, which can be targeted with small molecule analogs of trehalose dimycolate that bind with 52-fold higher affinity than trehalose. The data demonstrate how mincle bridges between the surfaces of the macrophage and the mycobacterium and suggest the possibility of disrupting this interaction. In addition, the results may provide a basis for design of adjuvants that mimic the ability of mycobacteria to stimulate a response to immunization that can be employed in vaccine development.	[Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Jegouzo, Sabine A. F.; Rowntree, Thomas J. W.; Guan, Yue; Brash, Matthew A.; Taylor, Maureen E.; Drickamer, Kurt] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	Stanford University; Stanford University; Imperial College London	Drickamer, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England.	k.drickamer@imperial.ac.uk	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Drickamer, Kurt/0000-0001-5026-5996; Jegouzo, Sabine/0000-0001-7768-0102; Taylor, Maureen/0000-0001-8300-4987	Wellcome Trust [093599]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grant 093599 (to M. E. T. and K. D.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOCK K, 1983, EUR J BIOCHEM, V131, P595, DOI 10.1111/j.1432-1033.1983.tb07304.x; Cooper AM, 2012, CURR OPIN IMMUNOL, V24, P431, DOI 10.1016/j.coi.2012.04.008; Cormack B., 1997, SHORT PROTOCOLS MOL; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2000, J BIOL CHEM, V275, P35176, DOI 10.1074/jbc.M005557200; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Gilbert M, 2005, NATURE, V435, P491, DOI 10.1038/nature03548; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Ishikawa T, 2013, CELL HOST MICROBE, V13, P477, DOI 10.1016/j.chom.2013.03.008; Kobayashi T, 2011, BIOTECHNOL LETT, V33, P1911, DOI 10.1007/s10529-011-0663-z; Lang R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00005; Lang R, 2011, IMMUNOBIOLOGY, V216, P1184, DOI 10.1016/j.imbio.2011.06.005; Levitz SM, 2012, CELL, V148, P1284, DOI 10.1016/j.cell.2012.02.012; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Masumoto M, 1999, J IMMUNOL, V163, P5039; Matsunaga I, 2009, J EXP MED, V206, P2865, DOI 10.1084/jem.20092533; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier M, 2000, J MOL BIOL, V300, P857, DOI 10.1006/jmbi.2000.3853; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Segrest J P, 1971, Biochem Biophys Res Commun, V44, P390; Schafer G, 2009, J INNATE IMMUN, V1, P231, DOI 10.1159/000173703; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; SKIPSKI VP, 1967, J LIPID RES, V8, P295; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; Wragg S, 1999, J BIOL CHEM, V274, P35400, DOI 10.1074/jbc.274.50.35400; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Young DC, 2006, GLYCOBIOLOGY, V16, p103R, DOI 10.1093/glycob/cwj111	40	87	88	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28457	28465		10.1074/jbc.M113.497149	http://dx.doi.org/10.1074/jbc.M113.497149			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23960080	Green Published, hybrid			2022-12-28	WOS:000330298800004
J	Kadiyala, V; Patrick, NM; Mathieu, W; Jaime-Frias, R; Pookhao, N; An, LL; Smith, CL				Kadiyala, Vineela; Patrick, Nina M.; Mathieu, Wana; Jaime-Frias, Rosa; Pookhao, Naruekamol; An, Lingling; Smith, Catharine L.			Class I Lysine Deacetylases Facilitate Glucocorticoid-induced Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Transcription; Glucocorticoid Receptor; Histone Deacetylase; Histone Deacetylase Inhibitors; Transcription Coactivators	HISTONE DEACETYLASES; SODIUM-BUTYRATE; N-COR; RECEPTOR; ACETYLATION; INHIBITION; REGULATORS; RECRUITMENT; ACTIVATION; DIVERSITY	Nuclear receptors use lysine acetyltransferases and lysine deacetylases (KDACs) in regulating transcription through histone acetylation. Lysine acetyltransferases interact with steroid receptors upon binding of an agonist and are recruited to target genes. KDACs have been shown to interact with steroid receptors upon binding to an antagonist. We have shown previously that KDAC inhibitors (KDACis) potently repress the mouse mammary tumor virus promoter through transcriptional mechanisms and impair the ability of the glucocorticoid receptor (GR) to activate it, suggesting that KDACs can play a positive role in GR transactivation. In the current study, we extended this analysis to the entire GR transcriptome and found that the KDACi valproic acid impairs the ability of agonist-bound GR to activate about 50% of its target genes. This inhibition is largely due to impaired transcription rather than defective GR processing and was also observed using a structurally distinct KDACi. Depletion of KDAC1 expression mimicked the effects of KDACi in over half of the genes found to be impaired in GR transactivation. Simultaneous depletion of KDACs 1 and 2 caused full or partial impairment of several more GR target genes. Altogether we found that Class I KDAC activity facilitates GR-mediated activation at a sizable fraction of GR-activated target genes and that KDAC1 alone or in coordination with KDAC2 is required for efficient GR transactivation at many of these target genes. Finally, our work demonstrates that KDACi exposure has a significant impact on GR signaling and thus has ramifications for the clinical use of these drugs.	[Kadiyala, Vineela; Patrick, Nina M.; Mathieu, Wana; Jaime-Frias, Rosa; Smith, Catharine L.] Univ Arizona, Dept Pharmacol & Toxicol, Coll Pharm, Tucson, AZ 85721 USA; [Kadiyala, Vineela] Univ Arizona, Dept Chem & Biochem, Coll Agr & Life Sci, Tucson, AZ 85721 USA; [Pookhao, Naruekamol; An, Lingling] Univ Arizona, Dept Agr & Biosyst Engn, Coll Agr & Life Sci, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of Arizona	Smith, CL (corresponding author), Univ Arizona, Dept Pharmacol & Toxicol, Coll Pharm, 1703 E Mabel St, Tucson, AZ 85721 USA.	csmith@pharmacy.arizona.edu			Southwest Environmental Health Science Center; National Institutes of Health [ES006694]; Arizona Cancer Center; Direct For Biological Sciences [1122088] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008718] Funding Source: NIH RePORTER	Southwest Environmental Health Science Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arizona Cancer Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	For assistance with expression profiling, we thank the staff of the Genomics Shared Service, which is jointly supported by the Southwest Environmental Health Science Center (National Institutes of Health Grant ES006694) and the Arizona Cancer Center. We are also grateful to Dr. Dean Billheimer (University of Arizona) for providing guidance with the statistical analyses of the RT-qPCR results. Finally, we thank Drs. Gordon Hager and Sam John (National Cancer Institute) for providing us with the positions of GR binding sites in Hepa-1c1c7 cells as determined by ChIP-sequencing.	Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; BRESNICK EH, 1990, P NATL ACAD SCI USA, V87, P3977, DOI 10.1073/pnas.87.10.3977; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen JD, 1998, CRIT REV EUKAR GENE, V8, P169, DOI 10.1615/CritRevEukarGeneExpr.v8.i2.40; Chng KR, 2012, EMBO J, V31, P2810, DOI 10.1038/emboj.2012.112; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Dinarello CA, 2011, MOL MED, V17, P333, DOI 10.2119/molmed.2011.00116; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Isojarvi JIT, 2005, CNS DRUGS, V19, P207, DOI 10.2165/00023210-200519030-00003; Isojarvi J, 2008, SEIZURE-EUR J EPILEP, V17, P111, DOI 10.1016/j.seizure.2007.11.007; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kidder BL, 2012, NUCLEIC ACIDS RES, V40, P2925, DOI 10.1093/nar/gkr1151; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lee HA, 2013, CIRC RES, V112, P1004, DOI 10.1161/CIRCRESAHA.113.301071; Lee SC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/416905; Luef G, 2009, EPILEPSY RES, V86, P42, DOI 10.1016/j.eplepsyres.2009.04.004; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; Mulholland NM, 2003, ONCOGENE, V22, P4807, DOI 10.1038/sj.onc.1206722; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; PLESKO MM, 1983, J BIOL CHEM, V258, P3738; Pylvanen V, 2006, EPILEPSY BEHAV, V8, P643, DOI 10.1016/j.yebeh.2006.02.008; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Qiu Y, 2011, J BIOL CHEM, V286, P7641, DOI 10.1074/jbc.M110.185488; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Rascle A, 2003, MOL CELL BIOL, V23, P4162, DOI 10.1128/MCB.23.12.4162-4173.2003; Robyr D, 2000, MOL ENDOCRINOL, V14, P329, DOI 10.1210/me.14.3.329; Sheldon LA, 2001, J BIOL CHEM, V276, P32423, DOI 10.1074/jbc.C100315200; Spiegel S, 2012, ONCOGENE, V31, P537, DOI 10.1038/onc.2011.267; Terbach N, 2009, BIOCHEM SOC T, V37, P1126, DOI 10.1042/BST0371126; TICHONICKY L, 1981, EUR J BIOCHEM, V120, P427, DOI 10.1111/j.1432-1033.1981.tb05720.x; Wagner BL, 1998, MOL CELL BIOL, V18, P1369, DOI 10.1128/MCB.18.3.1369; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Welsbie DS, 2009, CANCER RES, V69, P958, DOI 10.1158/0008-5472.CAN-08-2216; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	45	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28900	28912		10.1074/jbc.M113.505115	http://dx.doi.org/10.1074/jbc.M113.505115			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946490	hybrid, Green Published			2022-12-28	WOS:000330298800042
J	Qiu, YX; Fakas, S; Han, GS; Barbosa, AD; Siniossoglou, S; Carman, GM				Qiu, Yixuan; Fakas, Stylianos; Han, Gil-Soo; Barbosa, Antonio Daniel; Siniossoglou, Symeon; Carman, George M.			Transcription Factor Reb1p Regulates DGK1-encoded Diacylglycerol Kinase and Lipid Metabolism in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diacylglycerol; Glycerolipid; Phosphatidate; Phospholipid; Phospholipid Metabolism; Phospholipid Turnover; Diacylglycerol Kinase	FATTY-ACID SYNTHASE; DNA-BINDING PROTEIN; MG2+-DEPENDENT PHOSPHATIDATE PHOSPHATASE; NUCLEAR-MEMBRANE GROWTH; ACETYL-COA CARBOXYLASE; PHOSPHOLIPID-SYNTHESIS; SIGNALING FUNCTIONS; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; ORTHOLOGUE PAH1P	In the yeast Saccharomyces cerevisiae, the DGK1-encoded diacylglycerol kinase catalyzes the CTP-dependent phosphorylation of diacylglycerol to form phosphatidate. This enzyme, in conjunction with PAH1-encoded phosphatidate phosphatase, controls the levels of phosphatidate and diacylglycerol for phospholipid synthesis, membrane growth, and lipid droplet formation. In this work, we showed that a functional level of diacylglycerol kinase is regulated by the Reb1p transcription factor. In the electrophoretic mobility shift assay, purified recombinant Reb1p was shown to specifically bind its consensus recognition sequence (CGGGTAA, -166 to -160) in the DGK1 promoter. Analysis of cells expressing the P-DGK1-lacZ reporter gene showed that mutations (GTTG) in the Reb1p-binding sequence caused an 8.6-fold reduction in -galactosidase activity. The expression of DGK1(reb1), a DGK1 allele containing the Reb1p-binding site mutation, was greatly lower than that of the wild type allele, as indicated by analyses of DGK1 mRNA, Dgk1p, and diacylglycerol kinase activity. In the presence of cerulenin, an inhibitor of de novo fatty acid synthesis, the dgk1 mutant expressing DGK1(reb1) exhibited a significant defect in growth as well as in the synthesis of phospholipids from triacylglycerol mobilization. Unlike DGK1, the DGK1(reb1) expressed in the dgk1 pah1 mutant did not result in the nuclear/endoplasmic reticulum membrane expansion, which occurs in cells lacking phosphatidate phosphatase activity. Taken together, these results indicate that the Reb1p-mediated regulation of diacylglycerol kinase plays a major role in its in vivo functions in lipid metabolism.	[Qiu, Yixuan; Fakas, Stylianos; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Qiu, Yixuan; Fakas, Stylianos; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA; [Barbosa, Antonio Daniel; Siniossoglou, Symeon] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Cambridge	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Fakas, Stylianos/AAQ-7594-2020; Barbosa, Antonio Daniel/N-8248-2019; Fakas, Stylianos/R-9908-2019	Fakas, Stylianos/0000-0001-8692-1326; Barbosa, Antonio Daniel/0000-0002-5555-3230; Fakas, Stylianos/0000-0001-8692-1326	National Institutes of Health [GM-28140]; Medical Research Council [G0701446]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER; MRC [G0701446] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140. This work was also supported by Medical Research Council Grant G0701446 (to S. S.).	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; ALFEEL W, 1992, P NATL ACAD SCI USA, V89, P4534, DOI 10.1073/pnas.89.10.4534; Angermayr M, 1997, MOL GEN GENET, V256, P682, DOI 10.1007/s004380050616; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; CARMEN AA, 1994, J BIOL CHEM, V269, P9790; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; CHASMAN DI, 1990, GENE DEV, V4, P503, DOI 10.1101/gad.4.4.503; CHIRALA SS, 1987, J BIOL CHEM, V262, P4231; CRAVEN GR, 1965, J BIOL CHEM, V240, P2468; Dominguez CL, 2013, CANCER DISCOV, V3, P782, DOI 10.1158/2159-8290.CD-12-0215; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; GAIGG B, 1995, BBA-BIOMEMBRANES, V1234, P214, DOI 10.1016/0005-2736(94)00287-Y; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Goto K, 1999, CHEM PHYS LIPIDS, V98, P109, DOI 10.1016/S0009-3084(99)00023-7; GRAHAM IR, 1994, MOL MICROBIOL, V12, P931, DOI 10.1111/j.1365-2958.1994.tb01081.x; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; INOKOSHI J, 1994, MOL GEN GENET, V244, P90, DOI 10.1007/BF00280191; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JU QD, 1990, MOL CELL BIOL, V10, P5226, DOI 10.1128/MCB.10.10.5226; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; KRATZER S, 1995, GENE, V161, P75, DOI 10.1016/0378-1119(95)00289-I; Krishna S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00178; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; KUZIORA MA, 1983, J BIOL CHEM, V258, P1648; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANG WH, 1993, MOL CELL BIOL, V13, P649, DOI 10.1128/MCB.13.1.649; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIAW PCY, 1994, YEAST, V10, P771, DOI 10.1002/yea.320100608; McLean M, 1995, MOL MICROBIOL, V18, P605, DOI 10.1111/j.1365-2958.1995.mmi_18040605.x; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; MORROW BE, 1990, J BIOL CHEM, V265, P20778; Muller MO, 2000, J BIOL CHEM, V275, P19475, DOI 10.1074/jbc.M002575200; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Omura S, 1981, Methods Enzymol, V72, P520; Oshiro J, 2000, J BIOL CHEM, V275, P40887, DOI 10.1074/jbc.M008144200; Packham EA, 1996, MOL GEN GENET, V250, P348; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Raben DM, 2008, FRONT BIOSCI-LANDMRK, V13, P590, DOI 10.2741/2704; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; REMACLE JE, 1992, MOL CELL BIOL, V12, P5516, DOI 10.1128/MCB.12.12.5516; Rijken PJ, 2009, J BIOL CHEM, V284, P27609, DOI 10.1074/jbc.M109.016311; Rincon E, 2012, PROG LIPID RES, V51, P1, DOI 10.1016/j.plipres.2011.10.001; Rose MD., 1990, METHODS YEAST GENETI; Sakane F, 2008, CURR DRUG TARGETS, V9, P626, DOI 10.2174/138945008785132394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Schjerling P, 1996, NUCLEIC ACIDS RES, V24, P4599, DOI 10.1093/nar/24.23.4599; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHULLER HJ, 1994, EUR J BIOCHEM, V225, P213, DOI 10.1111/j.1432-1033.1994.00213.x; SCHWEIZER M, 1986, MOL GEN GENET, V203, P479, DOI 10.1007/BF00422073; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Soto A, 2008, J BIOL CHEM, V283, P10079, DOI 10.1074/jbc.M800502200; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Tu-Sekine B, 2011, CRIT REV BIOCHEM MOL, V46, P353, DOI 10.3109/10409238.2011.577761; Verschuur AC, 2001, LEUKEMIA RES, V25, P891, DOI 10.1016/S0145-2126(01)00047-9; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; WANG HM, 1990, MOL CELL BIOL, V10, P1743, DOI 10.1128/MCB.10.4.1743; Wang KLC, 1998, MOL CELL BIOL, V18, P4368, DOI 10.1128/MCB.18.7.4368; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; Zanghellini J, 2008, FEBS J, V275, P5552, DOI 10.1111/j.1742-4658.2008.06681.x; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	101	10	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29124	29133		10.1074/jbc.M113.507392	http://dx.doi.org/10.1074/jbc.M113.507392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23970552	Green Published, hybrid			2022-12-28	WOS:000330298800065
J	Wu, SF; Grunwald, T; Kharitonenkov, A; Dam, J; Jockers, R; De Luca, F				Wu, Shufang; Grunwald, Tal; Kharitonenkov, Alexei; Dam, Julie; Jockers, Ralf; De Luca, Francesco			RETRACTED: Increased Expression of Fibroblast Growth Factor 21 (FGF21) during Chronic Undernutrition Causes Growth Hormone Insensitivity in Chondrocytes by Inducing Leptin Receptor Overlapping Transcript (LEPROT) and Leptin Receptor Overlapping Transcript-like 1 (LEPROTL1) Expression (Retracted article. See vol. 295, pg. 13137, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							FACTOR-I; FACTORS IGFS; INSULIN; DEPRIVATION; PROTEIN; FGF-21	During calorie restriction in mice, increased expression of FGF21 causes growth attenuation and growth hormone (GH) insensitivity. Previous evidence also indicates that fasting-associated increased expression of leptin receptor overlapping transcript (LEPROT) and LEPROT-like 1 (LEPROTL1) (two proteins that regulate intracellular protein trafficking) reduces GH receptor cell-surface expression in the liver. Thus, we hypothesized that FGF21 causes GH insensitivity through regulation of LEPROT and/or LEPROTL1 expression. After 4 weeks of food restriction, LEPROT and LEPROTL1 mRNA expression in the liver and in the tibial growth plate of wild-type (WT) mice was increased compared with WT mice fed ad libitum. In Fgf21 knock-out (KO) mice, LEPROT and LEPROTL1 mRNA expression in food-restricted and fed ad libitum was similar, with the exception of a subgroup of food-restricted Fgf21 KO mice treated with recombinant human (rh) FGF21 that experienced increased LEPROT and LEPROTL1 mRNA expression compared with untreated food-restricted Fgf21 KO mice. In cultured growth plate chondrocytes, FGF21 stimulated LEPROT and LEPROTL1 mRNA expression, with such effect being prevented in chondrocytes transfected with FGFR1 siRNA or ERK1 siRNA. In cells transfected with control siRNA, GH increased [H-3]thymidine incorporation, collagen X, and IGF-1 mRNA expression, with all effects being prevented by rhFGF21. In addition, rhFGF21 decreased I-125-GH binding. In LEPROT siRNA- and/or LEPROTL1 siRNA-transfected cells, rhFGF21 did not prevent the GH stimulatory effects on thymidine incorporation, collagen X, and IGF-1 expression; furthermore, rhFGF21 did not prevent I-125-GH binding. Consistent with the effects of rhFGF21, LEPROT overexpression in chondrocytes resulted in the inhibition of GH action. Our findings indicate that the increased expression of FGF21 during chronic undernutrition inhibits GH action on chondrocytes by activating LEPROT and LEPROTL1.	[Wu, Shufang; Grunwald, Tal; De Luca, Francesco] Drexel Univ, Coll Med, St Christophers Hosp Children, Sect Endocrinol & Diabet, Philadelphia, PA 19134 USA; [Wu, Shufang] Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis, Sch Med, Minist Educ,Affiliated Hosp 1, Xian 710061, Peoples R China; [Kharitonenkov, Alexei] Lilly Res Labs, Indianapolis, IN USA; [Dam, Julie; Jockers, Ralf] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Dam, Julie; Jockers, Ralf] CNRS, UMR 8104, F-75014 Paris, France; [Dam, Julie; Jockers, Ralf] Univ Paris 05, Sorbonne Paris Cite, F-75270 Paris, France	Drexel University; Xi'an Jiaotong University; Eli Lilly; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	De Luca, F (corresponding author), St Christophers Hosp Children, 3601 A St, Philadelphia, PA 19134 USA.	francesco.deluca@drexelmed.edu	Dam, Julie/O-1625-2018; Jockers, Ralf/P-2272-2017; Jockers, Ralf/Q-2100-2019	Dam, Julie/0000-0001-6871-2678; Jockers, Ralf/0000-0002-4354-1750; Jockers, Ralf/0000-0002-4354-1750	National Natural Science Foundation of China [81071440/H0601, 81222026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported in part by National Natural Science Foundation of China Grants 81071440/H0601 and 81222026.	Adams AC, 2012, CURR DIABETES REV, V8, P285, DOI 10.2174/157339912800840505; BANG P, 1994, J CLIN ENDOCR METAB, V78, P960, DOI 10.1210/jc.78.4.960; Belgareh-Touze N, 2002, MOL BIOL CELL, V13, P1694, DOI 10.1091/mbc.01-12-0597; BORNFELDT KE, 1989, J ENDOCRINOL, V122, P651, DOI 10.1677/joe.0.1220651; BREIER BH, 1986, J ENDOCRINOL, V111, P209, DOI 10.1677/joe.0.1110209; BUONOMO FC, 1991, J ANIM SCI, V69, P755; COUNTS DR, 1992, J CLIN ENDOCR METAB, V75, P762, DOI 10.1210/jc.75.3.762; Couturier C, 2007, P NATL ACAD SCI USA, V104, P19476, DOI 10.1073/pnas.0706671104; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Heinrichs C, 1997, ENDOCRINOLOGY, V138, P5359, DOI 10.1210/en.138.12.5359; HO KY, 1988, J CLIN INVEST, V81, P968, DOI 10.1172/JCI113450; Huang Y, 2001, BBA-GENE STRUCT EXPR, V1517, P327, DOI 10.1016/S0167-4781(00)00266-9; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kubicky RA, 2012, ENDOCRINOLOGY, V153, P2287, DOI 10.1210/en.2011-1909; Leung KC, 2000, J CLIN ENDOCR METAB, V85, P4712, DOI 10.1210/jc.85.12.4712; MAES M, 1983, J ENDOCRINOL, V97, P243, DOI 10.1677/joe.0.0970243; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Reitman ML, 2007, CELL METAB, V5, P405, DOI 10.1016/j.cmet.2007.05.010; Seron K, 2011, J BIOL CHEM, V286, P17968, DOI 10.1074/jbc.M111.224857; STRAUS DS, 1990, MOL ENDOCRINOL, V4, P91, DOI 10.1210/mend-4-1-91; TANNENBAUM GS, 1979, ENDOCRINOLOGY, V104, P1733, DOI 10.1210/endo-104-6-1733; Touvier T, 2009, J CLIN INVEST, V119, P3830, DOI 10.1172/JCI34997; Wu SF, 2012, J BIOL CHEM, V287, P26060, DOI 10.1074/jbc.M112.343707	25	34	35	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27375	27383		10.1074/jbc.M113.462218	http://dx.doi.org/10.1074/jbc.M113.462218			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23940039	Green Published, hybrid			2022-12-28	WOS:000330597300033
J	Lee, KW; Cho, JG; Kim, CM; Kang, AY; Kim, M; Ahn, BY; Chung, SS; Lim, KH; Baek, KH; Sung, JH; Park, KS; Park, SG				Lee, Kyeong Won; Cho, Jin Gu; Kim, Chul Min; Kang, A. Young; Kim, Min; Ahn, Byung Yong; Chung, Sung Soo; Lim, Key-Hwan; Baek, Kwang-Hyun; Sung, Jong-Hyuk; Park, Kyong Soo; Park, Sang Gyu			Herpesvirus-associated Ubiquitin-specific Protease (HAUSP) Modulates Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Stability through Its Deubiquitinating Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Deubiquitination; Diabetes; Glucose Metabolism; Metabolism; Peroxisome Proliferator-activated receptor (PPAR)	KINASE-MEDIATED PHOSPHORYLATION; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; DEPENDENT DEGRADATION; DIABETES-MELLITUS; P53-MDM2 PATHWAY; BREAST-CANCER; CELLS; P53; MICE	Background: The increase of PPAR stability could contribute to lower blood glucose levels. Results: PPAR stability is increased by the deubiquitinating activity of HAUSP. Conclusion: HAUSP overexpression could decrease blood glucose and triglyceride levels at least in part by deubiquitinating and stabilizing PPAR in the liver. Significance: Identification of a novel enzyme (HAUSP) that deubiquitinates and stabilizes PPAR and its potential role in liver glucose and lipid metabolism are significant. The peroxisome proliferator-activated receptor (PPAR) is a central regulator of adipogenesis and modulates glucose and lipid metabolism. In this study, herpesvirus-associated ubiquitin-specific protease (HAUSP) was isolated as a binding partner of PPAR. Both endogenous and exogenous PPAR associated with HAUSP in co-immunoprecipitation analysis. HAUSP, but not the catalytically inactive HAUSP C223S mutant, increased the stability of both endogenous and exogenous PPAR through its deubiquitinating activity. Site-directed mutagenesis experiments showed that the Lys(462) residue of PPAR is critical for ubiquitination. HBX 41,108, a specific inhibitor of HAUSP, abolished the increase in PPAR stability induced by HAUSP. In addition, knockdown of endogenous HAUSP using siRNA decreased PPAR protein levels. HAUSP enhanced the transcriptional activity of both exogenous and endogenous PPAR in luciferase activity assays. Quantitative RT-PCR analysis showed that HAUSP increased the transcript levels of PPAR target genes in HepG2 cells, resulting in the enhanced uptake of glucose and fatty acids, and vice versa, upon siRNA knockdown of HAUSP. In vivo analysis using adenoviruses confirmed that HAUSP, but not the HAUSP C223S mutant, decreased blood glucose and triglyceride levels, which are associated with the increased expression of endogenous PPAR and lipid accumulation in the liver. Our results demonstrate that the stability and activity of PPAR are modulated by the deubiquitinating activity of HAUSP, which may be a target for the development of anti-diabetic drugs.	[Lee, Kyeong Won; Kim, Min; Ahn, Byung Yong; Chung, Sung Soo; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea; [Cho, Jin Gu; Kim, Chul Min; Kang, A. Young; Lim, Key-Hwan; Baek, Kwang-Hyun; Park, Sang Gyu] CHA Univ, Dept Biomed Sci, Sungnamsi 463840, Gyunggido, South Korea; [Sung, Jong-Hyuk] CHA Univ, Dept Appl Biosci, Sungnamsi 463840, Gyunggido, South Korea; [Park, Kyong Soo] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, World Class Univ Dept Mol Med & Biopharmaceut Sci, Seoul 110744, South Korea	Seoul National University (SNU); Pochon Cha University; Pochon Cha University; Seoul National University (SNU)	Park, KS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 28 Yongon Dong, Seoul 110744, South Korea.	kspark@snu.ac.kr; sgpark@cha.ac.kr	Park, Kyong Soo/C-2265-2008; Cho, JinGu/GQB-2969-2022; Ahn, Byungyong/AHB-6077-2022	Park, Kyong Soo/0000-0003-3597-342X; Baek, Kwang-Hyun/0000-0001-7662-7190; Ahn, Byungyong/0000-0002-9871-5180	Bio and Medical Technology Development Program of the National Research Foundation; Korean Government [2012M3A9C6049719]; Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science, and Technology [2012R1A1A2005546, 2010-0008279]; Basic Research Program through the National Research Foundation of Korea	Bio and Medical Technology Development Program of the National Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government); Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Basic Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Bio and Medical Technology Development Program of the National Research Foundation funded by Korean Government Grant 2012M3A9C6049719 (to S. G. P.), Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grant 2012R1A1A2005546 (to K. S. P.), and the Basic Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grant 2010-0008279 (K.-H. B.).	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Bedoucha M, 2001, J HEPATOL, V35, P17, DOI 10.1016/S0168-8278(01)00066-6; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Camp HS, 1997, J BIOL CHEM, V272, P10811; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; Chung SS, 2011, BIOCHEM J, V433, P155, DOI 10.1042/BJ20100749; Chung SS, 2009, MOL CELL BIOL, V29, P20, DOI 10.1128/MCB.00544-08; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DuBois RN, 1998, CARCINOGENESIS, V19, P49, DOI 10.1093/carcin/19.1.49; Floyd ZE, 2002, J BIOL CHEM, V277, P4062, DOI 10.1074/jbc.M108473200; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Iankova I, 2006, MOL ENDOCRINOL, V20, P1494, DOI 10.1210/me.2005-0222; Jennewein C, 2008, J IMMUNOL, V181, P5646, DOI 10.4049/jimmunol.181.8.5646; Kase ET, 2005, DIABETES, V54, P1108, DOI 10.2337/diabetes.54.4.1108; Keshamouni VG, 2004, ONCOGENE, V23, P100, DOI 10.1038/sj.onc.1206885; Kilroy GE, 2009, OBESITY, V17, P665, DOI 10.1038/oby.2008.616; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Laplante M, 2003, DIABETES, V52, P291, DOI 10.2337/diabetes.52.2.291; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lim S, 2009, ATHEROSCLEROSIS, V206, P411, DOI 10.1016/j.atherosclerosis.2009.02.031; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Mueller E, 2000, P NATL ACAD SCI USA, V97, P10990, DOI 10.1073/pnas.180329197; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Nagashima K, 2005, J CLIN INVEST, V115, P1323, DOI 10.1172/JCI200523219; Nunez NP, 2006, CANCER LETT, V236, P133, DOI 10.1016/j.canlet.2005.05.009; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Palakurthi SS, 2001, CANCER RES, V61, P6213; Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Waite KJ, 2001, J BIOL CHEM, V276, P7062, DOI 10.1074/jbc.M007894200; Yamazaki T, 2011, J NUTR BIOCHEM, V22, P543, DOI 10.1016/j.jnutbio.2010.04.009; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771	48	16	18	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32886	32896		10.1074/jbc.M113.496331	http://dx.doi.org/10.1074/jbc.M113.496331			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24072712	hybrid, Green Published			2022-12-28	WOS:000328841700007
J	Saburi, W; Kobayashi, M; Mori, H; Okuyama, M; Kimura, A				Saburi, Wataru; Kobayashi, Momoko; Mori, Haruhide; Okuyama, Masayuki; Kimura, Atsuo			Replacement of the Catalytic Nucleophile Aspartyl Residue of Dextran Glucosidase by Cysteine Sulfinate Enhances Transglycosylation Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ALPHA-AMYLASE FAMILY; ENZYME INTERMEDIATE; CYCLODEXTRIN GLYCOSYLTRANSFERASE; STREPTOCOCCUS-MUTANS; CRYSTAL-STRUCTURE; SPECIFICITY; SUBSTRATE; CYSTEINESULFINATE; IDENTIFICATION	Dextran glucosidase from Streptococcus mutans (SmDG) catalyzes the hydrolysis of an alpha-1,6-glucosidic linkage at the non-reducing end of isomaltooligosaccharides and dextran. This enzyme has an Asp-194 catalytic nucleophile and two catalytically unrelated Cys residues, Cys-129 and Cys-532. Cys-free SmDG was constructed by replacement with Ser (C129S/C532S (2CS), the activity of which was the same as that of the wild type, SmDG). The nucleophile mutant of 2CS was generated by substitution of Asp-194 with Cys (D194C-2CS). The hydrolytic activity of D194C-2CS was 8.1 x 10(-4) % of 2CS. KI-associated oxidation of D194C-2CS increased the activity up to 0.27% of 2CS, which was 330 times higher than D194C-2CS. Peptide-mapping mass analysis of the oxidized D194C-2CS (Ox-D194C-2CS) revealed that Cys-194 was converted into cysteine sulfinate. Ox-D194C-2CS and 2CS shared the same properties (optimum pH, pI, and substrate specificity), whereas Ox-D194C-2CS had much higher transglucosylation activity than 2CS. This is the first study indicating that a more acidic nucleophile (-SOO-) enhances transglycosylation. The introduction of cysteine sulfinate as a catalytic nucleophile could be a novel approach to enhance transglycosylation.	[Saburi, Wataru; Kobayashi, Momoko; Mori, Haruhide; Okuyama, Masayuki; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan	Hokkaido University	Kimura, A (corresponding author), Hokkaido Univ, Res Fac Agr, Kita Ku, Kita 9 Nishi 9, Sapporo, Hokkaido 0608589, Japan.	kimura@abs.agr.hokudai.ac.jp	Mori, Haruhide/AAV-6374-2021; Okuyama, Masayuki/D-8739-2012; Saburi, Wataru/A-4271-2012	Mori, Haruhide/0000-0001-7346-9131; Okuyama, Masayuki/0000-0001-7013-6032; Saburi, Wataru/0000-0002-2015-7086				Blanchard JE, 2001, CHEM BIOL, V8, P627, DOI 10.1016/S1074-5521(01)00038-2; Braun C, 1996, BIOCHEMISTRY-US, V35, P5458, DOI 10.1021/bi9526488; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; Cockburn DW, 2010, BIOCHEMISTRY-US, V49, P2042, DOI 10.1021/bi1000596; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fierobe HP, 1998, BIOCHEMISTRY-US, V37, P3743, DOI 10.1021/bi972231x; GETHING MJH, 1972, EUR J BIOCHEM, V30, P352; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hondoh H, 2008, J MOL BIOL, V378, P913, DOI 10.1016/j.jmb.2008.03.016; Kobayashi M, 2011, BIOSCI BIOTECH BIOCH, V75, P1557, DOI 10.1271/bbb.110256; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Lawson SL, 1996, BIOCHEMISTRY-US, V35, P10110, DOI 10.1021/bi960586v; Lodge JA, 2003, J BIOL CHEM, V278, P19151, DOI 10.1074/jbc.M211626200; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; McCarter JD, 1996, J BIOL CHEM, V271, P6889, DOI 10.1074/jbc.271.12.6889; MIWA I, 1972, CLIN CHIM ACTA, V37, P538, DOI 10.1016/0009-8981(72)90483-4; Moller MS, 2012, J BACTERIOL, V194, P4249, DOI 10.1128/JB.00622-12; MOORE S, 1948, J BIOL CHEM, V176, P367; Mosi R, 1997, BIOCHEMISTRY-US, V36, P9927, DOI 10.1021/bi970618u; PALMIERI F, 1979, BIOCHIM BIOPHYS ACTA, V555, P531, DOI 10.1016/0005-2736(79)90407-3; ROBERTSON JJ, 1957, J BACTERIOL, V73, P186, DOI 10.1128/JB.73.2.186-198.1957; Rydberg EH, 2002, BIOCHEMISTRY-US, V41, P4492, DOI 10.1021/bi011821z; Rye CS, 2000, CURR OPIN CHEM BIOL, V4, P573, DOI 10.1016/S1367-5931(00)00135-6; Saburi W, 2006, BBA-PROTEINS PROTEOM, V1764, P688, DOI 10.1016/j.bbapap.2006.01.012; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; STREET IP, 1992, BIOCHEMISTRY-US, V31, P9970, DOI 10.1021/bi00156a016; TREVELYAN W. E., 1966, CARBOHYD RES, V2, P418, DOI 10.1016/S0008-6215(00)80337-7; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967	33	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31670	31677		10.1074/jbc.M113.491449	http://dx.doi.org/10.1074/jbc.M113.491449			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052257	Green Published, hybrid			2022-12-28	WOS:000330596200025
J	Kinder, M; Greenplate, AR; Grugan, KD; Soring, KL; Heeringa, KA; McCarthy, SG; Bannish, G; Perpetua, M; Lynch, F; Jordan, RE; Strohl, WR; Brezski, RJ				Kinder, Michelle; Greenplate, Allison R.; Grugan, Katharine D.; Soring, Keri L.; Heeringa, Katharine A.; McCarthy, Stephen G.; Bannish, Gregory; Perpetua, Meredith; Lynch, Frank; Jordan, Robert E.; Strohl, William R.; Brezski, Randall J.			Engineered Protease-resistant Antibodies with Selectable Cell-killing Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-GAMMA-RI; ANTI-CD20 MONOCLONAL-ANTIBODY; IMMUNE EFFECTOR FUNCTION; IGG BINDING-SITE; IN-VITRO; MATRIX METALLOPROTEINASES; THERAPEUTIC ACTIVITY; RECEPTOR; CLEAVAGE; AFFINITY	Molecularly engineered antibodies with fit-for-purpose properties will differentiate next generation antibody therapeutics from traditional IgG1 scaffolds. One requirement for engineering the most appropriate properties for a particular therapeutic area is an understanding of the intricacies of the target microenvironment in which the antibody is expected to function. Our group and others have demonstrated that proteases secreted by invasive tumors and pathological microorganisms are capable of cleaving human IgG1, the most commonly adopted isotype among monoclonal antibody therapeutics. Specific cleavage in the lower hinge of IgG1 results in a loss of Fc-mediated cell-killing functions without a concomitant loss of antigen binding capability or circulating antibody half-life. Proteolytic cleavage in the hinge region by tumor-associated or microbial proteases is postulated as a means of evading host immune responses, and antibodies engineered with potent cell-killing functions that are also resistant to hinge proteolysis are of interest. Mutation of the lower hinge region of an IgG1 resulted in protease resistance but also resulted in a profound loss of Fc-mediated cell-killing functions. In the present study, we demonstrate that specific mutations of the C(H)2 domain in conjunction with lower hinge mutations can restore and sometimes enhance cell-killing functions while still retaining protease resistance. By identifying mutations that can restore either complement-or Fc gamma receptor-mediated functions on a protease-resistant scaffold, we were able to generate a novel protease-resistant platform with selective cell-killing functionality.	[Kinder, Michelle; Greenplate, Allison R.; Grugan, Katharine D.; Soring, Keri L.; Heeringa, Katharine A.; McCarthy, Stephen G.; Jordan, Robert E.; Strohl, William R.; Brezski, Randall J.] Janssen Res & Dev LLC, Biol Res, Spring House, PA 19477 USA; [Bannish, Gregory; Perpetua, Meredith] Huntingdon Life Sci, E Millstone, NJ 08873 USA; [Lynch, Frank] QualTek Mol Labs, Newtown, PA 18940 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Brezski, RJ (corresponding author), Janssen Res & Dev LLC, 1400 McKean Rd, Spring House, PA 19477 USA.	rbrezski@its.jnj.com	Greenplate, Allison/F-7360-2015	Greenplate, Allison/0000-0002-2614-3072; Strohl, William/0000-0002-8271-6875; Brezski, Randall/0000-0003-4028-4741				Adams GP, 2001, CANCER RES, V61, P4750; Anderson DR, 1997, BIOCHEM SOC T, V25, P705, DOI 10.1042/bst0250705; Ang KK, 2002, CANCER RES, V62, P7350; Armour KL, 1999, EUR J IMMUNOL, V29, P2613, DOI 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J; Beers SA, 2008, BLOOD, V112, P4170, DOI 10.1182/blood-2008-04-149161; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Brezski RJ, 2008, J IMMUNOL, V181, P3183, DOI 10.4049/jimmunol.181.5.3183; Brezski RJ, 2011, MABS-AUSTIN, V3, P558, DOI 10.4161/mabs.3.6.18119; Brezski RJ, 2010, MABS-AUSTIN, V2, P212, DOI 10.4161/mabs.2.3.11780; Brezski RJ, 2009, P NATL ACAD SCI USA, V106, P17864, DOI 10.1073/pnas.0904174106; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BURTON DR, 1988, MOL IMMUNOL, V25, P1175, DOI 10.1016/0161-5890(88)90153-8; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Cooper JB, 2009, HEAD NECK-J SCI SPEC, V31, P1086, DOI 10.1002/hed.21109; Cragg MS, 2003, BLOOD, V101, P1045, DOI 10.1182/blood-2002-06-1761; Dall'Acqua WF, 2006, J IMMUNOL, V177, P1129, DOI 10.4049/jimmunol.177.2.1129; Di Gaetano N, 2003, J IMMUNOL, V171, P1581, DOI 10.4049/jimmunol.171.3.1581; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Fan XJ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3240; Gearing AJH, 2002, IMMUNOL LETT, V81, P41, DOI 10.1016/S0165-2478(01)00333-9; Golay J, 2006, HAEMATOL-HEMATOL J, V91, P176; Gong Q, 2005, J IMMUNOL, V174, P817, DOI 10.4049/jimmunol.174.2.817; Grugan KD, 2012, J IMMUNOL, V189, P5457, DOI 10.4049/jimmunol.1201889; Guentsch A, 2013, J PERIODONTAL RES, V48, P458, DOI 10.1111/jre.12027; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; HULETT MD, 1994, J BIOL CHEM, V269, P15287; Idusogie EE, 2001, J IMMUNOL, V166, P2571, DOI 10.4049/jimmunol.166.4.2571; JEFFERIS R, 1968, NATURE, V219, P646, DOI 10.1038/219646b0; JEFFERIS R, 1990, MOL IMMUNOL, V27, P1237, DOI 10.1016/0161-5890(90)90027-W; Jefferis R, 2007, EXPERT OPIN BIOL TH, V7, P1401, DOI 10.1517/14712598.7.9.1401; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Johansson BP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001692; Johansson N, 1997, AM J PATHOL, V151, P499; Jung ST, 2010, P NATL ACAD SCI USA, V107, P604, DOI 10.1073/pnas.0908590107; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; LUND J, 1991, J IMMUNOL, V147, P2657; Moore GL, 2010, MABS-AUSTIN, V2, P181, DOI 10.4161/mabs.2.2.11158; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Nandakumar KS, 2008, TRENDS IMMUNOL, V29, P173, DOI 10.1016/j.it.2008.01.007; Nandakumar KS, 2007, ARTHRITIS RHEUM-US, V56, P3253, DOI 10.1002/art.22930; Natsume A, 2008, CANCER RES, V68, P3863, DOI 10.1158/0008-5472.CAN-07-6297; Natsume A, 2008, DRUG DES DEV THER, V3, P7; Natsume A, 2009, CANCER SCI, V100, P2411, DOI 10.1111/j.1349-7006.2009.01327.x; Nesspor TC, 2012, J MOL RECOGNIT, V25, P147, DOI 10.1002/jmr.2155; Ngo CV, 2007, INT J CANCER, V120, P1261, DOI 10.1002/ijc.22426; Niwa R, 2004, CLIN CANCER RES, V10, P6248, DOI 10.1158/1078-0432.CCR-04-0850; Oflazoglu E, 2009, BRIT J CANCER, V100, P113, DOI 10.1038/sj.bjc.6604812; Oganesyan V, 2008, MOL IMMUNOL, V45, P1872, DOI 10.1016/j.molimm.2007.10.042; PARTRIDGE LJ, 1986, MOL IMMUNOL, V23, P1365, DOI 10.1016/0161-5890(86)90022-2; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; REFF ME, 1994, BLOOD, V83, P435; Reichert JM, 2010, MABS-AUSTIN, V2, P695, DOI 10.4161/mabs.2.6.13603; Richards JO, 2008, MOL CANCER THER, V7, P2517, DOI 10.1158/1535-7163.MCT-08-0201; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Ryan MH, 2008, MOL IMMUNOL, V45, P1837, DOI 10.1016/j.molimm.2007.10.043; SANDERS LAM, 1995, INFECT IMMUN, V63, P73, DOI 10.1128/IAI.63.1.73-81.1995; Sazinsky SL, 2008, P NATL ACAD SCI USA, V105, P20167, DOI 10.1073/pnas.0809257105; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-5472.CAN-07-0696; Strohl WR, 2009, CURR OPIN BIOTECH, V20, P685, DOI 10.1016/j.copbio.2009.10.011; Strohl WR, 2012, WOODH PUB SER BIOMED, P1, DOI 10.1533/9781908818096; Tamm A, 1996, J BIOL CHEM, V271, P3659; TAO MH, 1989, J IMMUNOL, V143, P2595; Teeling JL, 2006, J IMMUNOL, V177, P362, DOI 10.4049/jimmunol.177.1.362; TURNER M W, 1970, Clinical and Experimental Immunology, V7, P603; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Vincents B, 2004, BIOCHEMISTRY-US, V43, P15540, DOI 10.1021/bi048284d; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; von Pawel-Rammingen U, 2012, J INNATE IMMUN, V4, P132, DOI 10.1159/000332940; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wines BD, 2000, J IMMUNOL, V164, P5313, DOI 10.4049/jimmunol.164.10.5313; WOOF JM, 1986, MOL IMMUNOL, V23, P319, DOI 10.1016/0161-5890(86)90059-3; Yan BX, 2012, J BIOL CHEM, V287, P5891, DOI 10.1074/jbc.M111.311811; Yee AMF, 2000, CLIN INFECT DIS, V30, P25, DOI 10.1086/313588	80	25	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30843	30854		10.1074/jbc.M113.486142	http://dx.doi.org/10.1074/jbc.M113.486142			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	23986451	Green Published, hybrid			2022-12-28	WOS:000330778900005
J	Lee, JW; Kim, JH				Lee, Jin-Wook; Kim, Jae-Hong			Activation of the Leukotriene B-4 Receptor 2-Reactive Oxygen Species (BLT2-ROS) Cascade following Detachment Confers Anoikis Resistance in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cancer; Cancer Biology; NADPH Oxidase; Prostate Cancer; Anokis Resistance	FACTOR-KAPPA-B; REDOX REGULATION; CARCINOMA-CELLS; PRO-SURVIVAL; INHIBITION; PATHWAY; GROWTH; OVEREXPRESSION; EXPRESSION; APOPTOSIS	Background: Despite the critical role of anoikis resistance in prostate cancer progression, the molecular mechanism causing anoikis resistance remains unclear. Results: BLT2 protects prostate cancer cells against anoikis via a NOX-ROS-NF-B-linked pathway. Conclusion: Activation of the BLT2-linked pathway following cell detachment confers anoikis resistance. Significance: Our findings suggest BLT2 as a key regulator of anoikis resistance in prostate cancer cells. The majority of prostate cancer-related deaths are associated with advanced and metastatic malignancies. Although anoikis resistance has been recognized as one of the hallmarks of metastatic prostate malignancies, the molecular events that cause anoikis resistance are poorly understood. In this study, we found that the detachment of PC-3 prostate cancer cells caused a time-dependent increase in the expression level of the leukotriene B-4 receptor-2 (BLT2) and that BLT2 played a critical role in establishing anoikis resistance in these cells. Blocking BLT2 with the pharmacological inhibitor LY255283 or with RNAi knockdown clearly abolished anoikis resistance and resulted in severe apoptotic death. Additionally, we demonstrated that the activation of NADPH oxidase (NOX) and subsequent generation of reactive oxygen species (ROS) were downstream of BLT2 signaling and led to the activation of NF-B, thus establishing anoikis resistance during cell detachment. Furthermore, we observed that the ectopic expression of BLT2 in normal prostate PWR-1E cells rendered the cells resistant to anoikis and apparently diminished apoptotic cell death following detachment. Taken together, our results suggest that BLT2-NOX-ROS-NF-B cascade induction during detachment confers a novel mechanism of anoikis resistance in prostate cancer cells and potentially contributes to prostate cancer progression.	[Lee, Jin-Wook; Kim, Jae-Hong] Korea Univ, Coll Life Sci & Biotechnol, Seoul 136701, South Korea	Korea University	Kim, JH (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, 5-1 Anam Dong, Seoul 136701, South Korea.	jhongkim@korea.ac.kr	Kim, Jae-Hong/B-2530-2009	Kim, Jae-Hong/0000-0002-8019-0208	Bio & Medical Technology Development Program Grant [2012M3A9C5048709]; National Research Foundation [2012R1A2A2A01044526]; Ministry of Science, Information and Communication Technologies (ICT) and Future Planning, Republic of Korea; National Research and Development Program for Cancer Control Grant [1220020]; Ministry for Health and Welfare, Republic of Korea; Korea University [G1300090]	Bio & Medical Technology Development Program Grant; National Research Foundation; Ministry of Science, Information and Communication Technologies (ICT) and Future Planning, Republic of Korea; National Research and Development Program for Cancer Control Grant; Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea University	This work was supported by Bio & Medical Technology Development Program Grant 2012M3A9C5048709, Basic Science Research Program Grant 2012R1A2A2A01044526 through the National Research Foundation funded by the Ministry of Science, Information and Communication Technologies (ICT) and Future Planning, Republic of Korea, and the National Research and Development Program for Cancer Control Grant 1220020, Ministry for Health and Welfare, Republic of Korea. This work was also supported by Korea University Grant G1300090.	Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Chamulitrat W, 2003, ONCOGENE, V22, P6045, DOI 10.1038/sj.onc.1206654; Chell SD, 2006, CANCER RES, V66, P3106, DOI 10.1158/0008-5472.CAN-05-3702; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Cho KJ, 2011, MOL CELLS, V32, P1, DOI 10.1007/s10059-011-1021-7; Cho KJ, 2010, J IMMUNOL, V185, P6329, DOI 10.4049/jimmunol.1001213; Choi JA, 2008, FREE RADICAL BIO MED, V44, P624, DOI 10.1016/j.freeradbiomed.2007.10.041; Choi JA, 2010, CARCINOGENESIS, V31, P543, DOI 10.1093/carcin/bgp203; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Ghosh J, 2003, BIOCHEM BIOPH RES CO, V307, P342, DOI 10.1016/S0006-291X(03)01201-4; Giannoni E, 2008, CELL DEATH DIFFER, V15, P867, DOI 10.1038/cdd.2008.3; Giannoni E, 2009, ONCOGENE, V28, P2074, DOI 10.1038/onc.2009.77; Greene ER, 2011, PROSTAG OTH LIPID M, V96, P27, DOI 10.1016/j.prostaglandins.2011.08.004; Hennig R, 2008, BRIT J CANCER, V99, P1064, DOI 10.1038/sj.bjc.6604655; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim EY, 2010, FREE RADICAL BIO MED, V49, P1072, DOI 10.1016/j.freeradbiomed.2010.06.023; Kim GY, 2010, J IMMUNOL, V184, P3946, DOI 10.4049/jimmunol.0901735; Kim GY, 2009, ARTERIOSCL THROM VAS, V29, P915, DOI 10.1161/ATVBAHA.109.185793; Kim HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043223; Kim SH, 2011, CANCER RES, V71, P7010, DOI 10.1158/0008-5472.CAN-11-1262; Krishnamoorthy S, 2011, CANCER METAST REV, V30, P613, DOI 10.1007/s10555-011-9309-9; Kumar S, 2011, MOL CELL BIOL, V31, P4036, DOI 10.1128/MCB.01342-10; Larre S, 2008, PROSTAG OTH LIPID M, V87, P14, DOI 10.1016/j.prostaglandins.2008.05.001; Lee JW, 2012, BIOCHEM BIOPH RES CO, V420, P428, DOI 10.1016/j.bbrc.2012.03.012; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; McCabe NP, 2006, PROSTATE, V66, P779, DOI 10.1002/pros.20360; Michael J Morgan, 2011, Cell Research, V21, P103; Neiva KG, 2009, NEOPLASIA, V11, P583, DOI 10.1593/neo.09266; Nie DT, 2003, CLIN EXP METASTAS, V20, P657, DOI 10.1023/A:1027302408187; Nie DT, 2001, CANCER METAST REV, V20, P195, DOI 10.1023/A:1015579209850; Oyoshi MK, 2012, IMMUNITY, V37, P747, DOI 10.1016/j.immuni.2012.06.018; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Pidgeon GP, 2003, CANCER RES, V63, P4258; Pidgeon GP, 2002, CANCER RES, V62, P2721; Rennebeck G, 2005, CANCER RES, V65, P11230, DOI 10.1158/0008-5472.CAN-05-2763; Rocconi RP, 2008, REPROD SCI, V15, P321, DOI 10.1177/1933719108316390; Rungtabnapa P, 2011, AM J PHYSIOL-CELL PH, V300, pC235, DOI 10.1152/ajpcell.00249.2010; Ryu HC, 2010, J INVEST DERMATOL, V130, P1095, DOI 10.1038/jid.2009.436; Sakamoto S, 2010, MOL ASPECTS MED, V31, P205, DOI 10.1016/j.mam.2010.02.001; Schneider C, 2011, CANCER METAST REV, V30, P277, DOI 10.1007/s10555-011-9310-3; Seo JM, 2012, J BIOL CHEM, V287, P13840, DOI 10.1074/jbc.M111.317131; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Terada LS, 2011, CANCER CELL, V19, P297, DOI 10.1016/j.ccr.2011.02.019; Toruner M, 2006, J BIOL CHEM, V281, P8686, DOI 10.1074/jbc.M512178200; Woo CH, 2006, BIOCHEM BIOPH RES CO, V351, P972, DOI 10.1016/j.bbrc.2006.10.154; Yan SR, 2005, ONCOGENE, V24, P6482, DOI 10.1038/sj.onc.1208810; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yoo MH, 2004, ONCOGENE, V23, P9259, DOI 10.1038/sj.onc.1208151; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018	49	35	35	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30054	30063		10.1074/jbc.M113.481283	http://dx.doi.org/10.1074/jbc.M113.481283			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986446	hybrid, Green Published			2022-12-28	WOS:000329868100006
J	Ma, Y; Krueger, JJ; Redmon, SN; Uppuganti, S; Nyman, JS; Hahn, MK; Elefteriou, F				Ma, Yun; Krueger, Jessica J.; Redmon, Sara N.; Uppuganti, Sasidhar; Nyman, Jeffry S.; Hahn, Maureen K.; Elefteriou, Florent			Extracellular Norepinephrine Clearance by the Norepinephrine Transporter Is Required for Skeletal Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Knockout; Mouse; Nerve; Neurotransmitter Transport; Osteoblasts; ADHD; Bone Remodeling; Norepinephrine Transporter; Sympathetic Nervous System	SYMPATHETIC-NERVOUS-SYSTEM; REGULATES BONE-FORMATION; BLOOD-PRESSURE; BETA-BLOCKERS; MASS; MICE; DIFFERENTIATION; IMMOBILIZATION; HYPERACTIVITY; OSTEOPOROSIS	Background: The contribution of endogenous norepinephrine (NE) to skeletal homeostasis is unclear. Results: Bone forming cells, not only neurons, express the norepinephrine transporter (NET), and blockade of extracellular NE clearance causes alterations in bone homeostasis. Conclusion: NE clearance by NET is a component of the homeostatic machinery by which sympathetic nerves and osteoblasts control bone remodeling. Significance: NET blockers may increase fracture risk. Changes in bone remodeling induced by pharmacological and genetic manipulation of -adrenergic receptor (AR) signaling in osteoblasts support a role of sympathetic nerves in the regulation of bone remodeling. However, the contribution of endogenous sympathetic outflow and nerve-derived norepinephrine (NE) to bone remodeling under pathophysiological conditions remains unclear. We show here that differentiated osteoblasts, like neurons, express the norepinephrine transporter (NET), exhibit specific NE uptake activity via NET and can catabolize, but not generate, NE. Pharmacological blockade of NE transport by reboxetine induced bone loss in WT mice. Similarly, lack of NE reuptake in norepinephrine transporter (Net)-deficient mice led to reduced bone formation and increased bone resorption, resulting in suboptimal peak bone mass and mechanical properties associated with low sympathetic outflow and high plasma NE levels. Last, daily sympathetic activation induced by mild chronic stress was unable to induce bone loss, unless NET activity was blocked. These findings indicate that the control of endogenous NE release and reuptake by presynaptic neurons and osteoblasts is an important component of the complex homeostatic machinery by which the sympathetic nervous system controls bone remodeling. These findings also suggest that drugs antagonizing NET activity, used for the treatment of hyperactivity disorders, may have deleterious effects on bone accrual.	[Ma, Yun; Elefteriou, Florent] Vanderbilt Univ, Dept Med, Div Clin Pharmacol, Nashville, TN 37232 USA; [Ma, Yun; Uppuganti, Sasidhar; Nyman, Jeffry S.; Elefteriou, Florent] Vanderbilt Ctr Bone Biol, Nashville, TN 37232 USA; [Krueger, Jessica J.; Redmon, Sara N.; Hahn, Maureen K.] Vanderbilt Univ, Dept Med, Div Med Genet, Nashville, TN 37232 USA; [Hahn, Maureen K.; Elefteriou, Florent] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Hahn, Maureen K.] Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA; [Uppuganti, Sasidhar; Nyman, Jeffry S.] Dept Orthopaed Surg & Rehabil, Nashville, TN 37232 USA; [Elefteriou, Florent] Dept Canc Biol, Nashville, TN 37232 USA; [Nyman, Jeffry S.] Dept Vet Affairs, Tennessee Valley Healthcare Syst, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Elefteriou, F (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Bone Biol, 2215 Garland Ave,Light Hall,Room 1255H, Nashville, TN 37232 USA.	florent.elefteriou@vanderbilt.edu	Elefteriou, Florent/GMW-8429-2022; Elefteriou, Florent/P-2586-2017	Elefteriou, Florent/0000-0002-2972-5633; Elefteriou, Florent/0000-0002-2972-5633; Nyman, Jeffry/0000-0001-7403-7605	National Institutes of Health; NIDDK [5R01DK082471-03]; Clinical and Translational Science Awards (CTSA) [UL11R000445]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Clinical and Translational Science Awards (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK Grant 5R01DK082471-03 and Grant UL11R000445 from the Clinical and Translational Science Awards (CTSA).	Aitken SJ, 2009, ARCH BIOCHEM BIOPHYS, V482, P96, DOI 10.1016/j.abb.2008.11.012; Bertram D, 2000, AM J PHYSIOL-REG I, V279, pR1257, DOI 10.1152/ajpregu.2000.279.4.R1257; Bonnet N, 2008, J CELL PHYSIOL, V217, P819, DOI 10.1002/jcp.21564; Bonnet N, 2007, J APPL PHYSIOL, V102, P1502, DOI 10.1152/japplphysiol.00815.2006; Bonnet N, 2007, BONE, V40, P1209, DOI 10.1016/j.bone.2007.01.006; Bonnet N, 2006, J PHARMACOL EXP THER, V318, P1118, DOI 10.1124/jpet.106.105437; Bonnet N, 2005, BONE, V37, P622, DOI 10.1016/j.bone.2005.07.012; Campbell JP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001363; Camporeale A, 2013, DRUG SAFETY, V36, P663, DOI 10.1007/s40264-013-0074-2; Carson RP, 2002, J APPL PHYSIOL, V93, P2192, DOI 10.1152/japplphysiol.00033.2002; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Cuscito C, 2011, ANN NY ACAD SCI, V1237, P53, DOI 10.1111/j.1749-6632.2011.06235.x; Dziedzicka-Wasylewska M, 2006, NEUROPSYCHOPHARMACOL, V31, P2424, DOI 10.1038/sj.npp.1301064; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Fonseca TL, 2011, J BONE MINER RES, V26, P591, DOI 10.1002/jbmr.243; Franquinho F, 2010, FEBS J, V277, P3664, DOI 10.1111/j.1742-4658.2010.07774.x; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Gilsbach R, 2006, J NEUROCHEM, V96, P1111, DOI 10.1111/j.1471-4159.2005.03598.x; Gotoh M, 2005, HYPERTENS RES, V28, P565, DOI 10.1291/hypres.28.565; Graham S, 2008, EXPERT OPIN INV DRUG, V17, P1281, DOI [10.1517/13543784.17.9.1281, 10.1517/13543784.17.9.1281 ]; Hahn MK, 2009, NEUROPHARMACOLOGY, V57, P694, DOI 10.1016/j.neuropharm.2009.08.002; Hahn MK, 2005, MOL PHARMACOL, V68, P457, DOI 10.1124/mol.105.011270; Hart EC, 2009, HYPERTENSION, V53, P571, DOI 10.1161/HYPERTENSIONAHA.108.126391; HEAL DJ, 1989, BRIT J PHARMACOL, V97, P111, DOI 10.1111/j.1476-5381.1989.tb11930.x; Hinojosa-Laborde CM, 1999, CLIN EXP PHARMACOL P, V26, P122, DOI 10.1046/j.1440-1681.1999.02995.x; Horvath G, 2003, AM J PHYSIOL-LUNG C, V285, pL829, DOI 10.1152/ajplung.00054.2003; Huang H, 2009, DYNAMICS OF SURFACE WAVES IN COASTAL WATERS: WAVE-CURRENT-BOTTOM INTERACTIONS, P1; JOHNSTON CC, 1990, NEW ENGL J MED, V323, P1271, DOI 10.1056/NEJM199011013231809; Joo Y, 2009, NEUROSCI LETT, V461, P121, DOI 10.1016/j.neulet.2009.06.025; Kajimura D, 2011, J EXP MED, V208, P841, DOI 10.1084/jem.20102608; Keller NR, 2004, CIRCULATION, V110, P1191, DOI 10.1161/01.CIR.0000141804.90845.E6; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Kondo H, 2011, CALCIFIED TISSUE INT, V88, P23, DOI 10.1007/s00223-010-9421-9; Lee NJ, 2009, NEUROPEPTIDES, V43, P457, DOI 10.1016/j.npep.2009.08.006; Li HF, 2010, MOL CELL ENDOCRINOL, V323, P201, DOI 10.1016/j.mce.2010.03.021; Lin SF, 2012, NUCL MED BIOL, V39, P1081, DOI 10.1016/j.nucmedbio.2012.04.005; MATKOVIC V, 1994, J CLIN INVEST, V93, P799, DOI 10.1172/JCI117034; Moldovanova I, 2008, HYPERTENSION, V51, P1203, DOI 10.1161/HYPERTENSIONAHA.107.107433; Pierroz DD, 2012, J BONE MINER RES, V27, P1252, DOI 10.1002/jbmr.1594; Reid I. R., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P105; Ren ZG, 2003, DEV NEUROSCI-BASEL, V25, P1, DOI 10.1159/000071462; Sato T, 2010, J PHARMACOL EXP THER, V334, P99, DOI 10.1124/jpet.110.167643; Schroeder C, 2004, AM J PHYSIOL-REG I, V286, pR851, DOI 10.1152/ajpregu.00689.2003; Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tam J, 2008, FASEB J, V22, P285, DOI 10.1096/fj.06-7957com; Tank J, 2003, CIRCULATION, V107, P2949, DOI 10.1161/01.CIR.0000072786.99163.FE; Tjurmina OA, 2002, ENDOCRINOLOGY, V143, P4520, DOI 10.1210/en.2002-220416; Veldhuis-Vlug AG, 2012, J CLIN ENDOCR METAB, V97, pE2093, DOI 10.1210/jc.2012-2823; WANG TM, 1993, BONE MINER, V20, P251, DOI 10.1016/S0169-6009(08)80006-2; Watkins MP, 2012, BONE, V51, P787, DOI 10.1016/j.bone.2012.06.018; Ziere G, 2008, J CLIN PSYCHOPHARM, V28, P411, DOI 10.1097/JCP.0b013e31817e0ecb	53	34	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30105	30113		10.1074/jbc.M113.481309	http://dx.doi.org/10.1074/jbc.M113.481309			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24005671	Green Published, hybrid			2022-12-28	WOS:000329868100011
J	Ramirez-Peinado, S; Leon-Annicchiarico, CL; Galindo-Moreno, J; Iurlaro, R; Caro-Maldonado, A; Prehn, JHM; Ryan, KM; Munoz-Pinedo, C				Ramirez-Peinado, Silvia; Lucia Leon-Annicchiarico, Clara; Galindo-Moreno, Javier; Iurlaro, Raffaella; Caro-Maldonado, Alfredo; Prehn, Jochen H. M.; Ryan, Kevin M.; Munoz-Pinedo, Cristina			Glucose-starved Cells Do Not Engage in Prosurvival Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Autophagy; Glucose; mTOR; Necrosis (Necrotic Death)	ACTIVATED PROTEIN-KINASE; STARVATION; APOPTOSIS; DEATH; PHOSPHORYLATION; PROMOTES; STRESS; CANCER; AMPK; 2-DEOXYGLUCOSE	In response to nutrient shortage or organelle damage, cells undergo macroautophagy. Starvation of glucose, an essential nutrient, is thought to promote autophagy in mammalian cells. We thus aimed to determine the role of autophagy in cell death induced by glucose deprivation. Glucose withdrawal induces cell death that can occur by apoptosis (in Bax, Bak-deficient mouse embryonic fibroblasts or HeLa cells) or by necrosis (in Rh4 rhabdomyosarcoma cells). Inhibition of autophagy by chemical or genetic means by using 3-methyladenine, chloroquine, a dominant negative form of ATG4B or silencing Beclin-1, Atg7, or p62 indicated that macroautophagy does not protect cells undergoing necrosis or apoptosis upon glucose deprivation. Moreover, glucose deprivation did not induce autophagic flux in any of the four cell lines analyzed, even though mTOR was inhibited. Indeed, glucose deprivation inhibited basal autophagic flux. In contrast, the glycolytic inhibitor 2-deoxyglucose induced prosurvival autophagy. Further analyses indicated that in the absence of glucose, autophagic flux induced by other stimuli is inhibited. These data suggest that the role of autophagy in response to nutrient starvation should be reconsidered.	[Ramirez-Peinado, Silvia; Lucia Leon-Annicchiarico, Clara; Galindo-Moreno, Javier; Iurlaro, Raffaella; Caro-Maldonado, Alfredo; Munoz-Pinedo, Cristina] IDIBELL Bellvitge Biomed Res Inst, Cell Death Regulat Grp, Barcelona 08908, Spain; [Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Ryan, Kevin M.] Canc Res UK Beatson Inst, Tumour Cell Death Lab, Glasgow G61 1BD, Lanark, Scotland	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Royal College of Surgeons - Ireland; Beatson Institute	Munoz-Pinedo, C (corresponding author), Hosp Duran & Reynals 3A Planta, IDIBELL, Gran Via LHospitalet 199, Barcelona 08908, Spain.	cmunoz@idibell.cat	Prehn, Jochen HM/A-3928-2010; Munoz-Pinedo, Cristina/B-6118-2008; Caro-Maldonado, Alfredo/D-3288-2014; Caro-Maldonado, Alfredo/A-7364-2010	Prehn, Jochen HM/0000-0003-3479-7794; Munoz-Pinedo, Cristina/0000-0002-9120-664X; Caro-Maldonado, Alfredo/0000-0002-5431-7949; Iurlaro, Raffaella/0000-0003-1019-6679; Ryan, Kevin M./0000-0002-1059-9681	Fundacio Marato TV3 Grant [111630/31]; Secretaria for Universities and Research (SUR) of the ECO of the Government of Catalonia fellowship; Fondo de Investigaciones Sanitarias of Spain [PI10/00104]; Cancer Research UK [15816] Funding Source: researchfish	Fundacio Marato TV3 Grant; Secretaria for Universities and Research (SUR) of the ECO of the Government of Catalonia fellowship; Fondo de Investigaciones Sanitarias of Spain(Instituto de Salud Carlos III); Cancer Research UK(Cancer Research UK)	This work was supported by Fundacio Marato TV3 Grant 111630/31 (to C. M.-P. and J. H. M. P.), Secretaria for Universities and Research (SUR) of the ECO of the Government of Catalonia fellowship (to R. I.), and Fondo de Investigaciones Sanitarias of Spain Grant PI10/00104 (to C. M.-P.).	Aki T, 2003, ONCOGENE, V22, P8529, DOI 10.1038/sj.onc.1207197; Altman BJ, 2011, ONCOGENE, V30, P1855, DOI 10.1038/onc.2010.561; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Caro-Maldonado A, 2010, CELL DEATH DIFFER, V17, P1335, DOI 10.1038/cdd.2010.21; Caro-Maldonado A., 2011, OPEN CELL SIGNAL J, V3, P42, DOI DOI 10.2174/1876390101103010042; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Decuypere JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061020; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; DiPaola RS, 2008, PROSTATE, V68, P1743, DOI 10.1002/pros.20837; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; El Mjiyad N, 2011, ONCOGENE, V30, P253, DOI 10.1038/onc.2010.466; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; Moruno-Manchon JF, 2013, BIOCHEM J, V449, P497, DOI 10.1042/BJ20121122; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Germain M, 2011, EMBO J, V30, P395, DOI 10.1038/emboj.2010.327; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Liu TJ, 2009, MOL CANCER THER, V8, P2204, DOI 10.1158/1535-7163.MCT-09-0160; Rodriguez-Vargas JM, 2012, CELL RES, V22, P1181, DOI 10.1038/cr.2012.70; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; McAlpine F, 2013, AUTOPHAGY, V9, P361, DOI 10.4161/auto.23066; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; Ramirez-Peinado S, 2011, CANCER RES, V71, P6796, DOI 10.1158/0008-5472.CAN-11-0759; Ravikumar B, 2003, HUM MOL GENET, V12, P985, DOI 10.1093/hmg/ddg109; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Wang YJ, 2008, J BIOL CHEM, V283, P4766, DOI 10.1074/jbc.M706666200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xi HB, 2013, BIOCHEM PHARMACOL, V85, P1463, DOI 10.1016/j.bcp.2013.02.037; Xi HB, 2011, CANCER CHEMOTH PHARM, V67, P899, DOI 10.1007/s00280-010-1391-0	37	48	48	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30387	30398		10.1074/jbc.M113.490581	http://dx.doi.org/10.1074/jbc.M113.490581			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014036	hybrid, Green Published			2022-12-28	WOS:000329868100035
J	Zeng, LY; Wan, YH; Li, D; Wu, J; Shao, ML; Chen, J; Hui, LJ; Ji, HB; Zhu, XL				Zeng, Liyong; Wan, Yihan; Li, Dan; Wu, Jing; Shao, Mengle; Chen, Jiong; Hui, Lijian; Ji, Hongbin; Zhu, Xueliang			The m Subunit of Murine Translation Initiation Factor elF3 Maintains the Integrity of the elF3 Complex and Is Required for Embryonic Development, Homeostasis, and Organ Size Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Embryo; Mouse Genetics; Protein Complexes; Protein Stability; Translation Initiation Factors; Eukaryotic Initiation Factor; Knock-out Mice	NEURONAL MIGRATION DEFECTS; FACTOR EIF3; IN-VIVO; EXPRESSION; REVEALS; BINDING; INHIBITION; GROWTH; CANCER; GENES	Background: eIF3m is a non-core subunit of eIF3. Results: eIF3m deficiency in mice results in animal death and instability of other eIF3 subunits; haploinsufficiency reduces organ size. Conclusion: eIF3m is critical for eIF3 structure and function. Significance: Understanding the mechanism of eIF3 complex formation and its role in embryonic development and homeostasis is crucial for determining the physiological function of this eukaryotic translation factor. Mammalian eIF3 is composed of 13 subunits and is the largest eukaryotic initiation factor. eIF3 plays a key role in protein biosynthesis. However, it is not fully understood how different subunits contribute to the structural integrity and function of the eIF3 complex. Whether eIF3 is essential for embryonic development and homeostasis is also not known. Here, we show that eIF3m null embryos are lethal at the peri-implantation stage. Compound heterozygotes (eIF3m(flox/-)) or FABP4-Cre-mediated conditional knock-out mice are lethal at mid-gestation stages. Although the heterozygotes are viable, they show markedly reduced organ size and diminished body weight. Acute ablation of eIF3m in adult mouse liver leads to rapidly decreased body weight and death within 2 weeks; these effects are correlated with a severe decline of protein biogenesis in the liver. Protein analyses reveal that eIF3m deficiency significantly impairs the integrity of the eIF3 complex due to down-regulation of multiple other subunits. Two of the subunits, eIF3f and eIF3h, are stabilized by eIF3m through subcomplex formation. Therefore, eIF3m is required for the structural integrity and translation initiation function of eIF3. Furthermore, not only is eIF3m an essential gene, but its expression level is also important for mouse embryonic development and the control of organ size.	[Zeng, Liyong; Wan, Yihan; Li, Dan; Hui, Lijian; Ji, Hongbin; Zhu, Xueliang] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Shao, Mengle] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Wu, Jing; Chen, Jiong] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing University	Zhu, XL (corresponding author), Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	xlzhu@sibcb.ac.cn	Shao, Mengle/AAH-8392-2019; Shao, Mengle/D-9951-2014	Shao, Mengle/0000-0002-5488-9904; Shao, Mengle/0000-0002-5488-9904; Li, Dan/0000-0002-8777-4580; Wan, Yihan/0000-0003-4272-0340	Chinese Academy of Sciences [XDA01010107]; Ministry of Science and Technology of China [2012CB945003, 2006BAI23B02]; Shanghai Municipal Science and Technology Commission [12JC1409900]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Chinese Academy of Sciences Grant XDA01010107, Ministry of Science and Technology of China Grants 2012CB945003 and 2006BAI23B02, and Shanghai Municipal Science and Technology Commission Grant 12JC1409900.	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; Billon N, 2008, BIOL CELL, V100, P563, DOI 10.1042/BC20080011; Chaudhuri J, 1999, J BIOL CHEM, V274, P17975, DOI 10.1074/jbc.274.25.17975; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Derivery E, 2010, BIOESSAYS, V32, P119, DOI 10.1002/bies.200900123; Fraser CS, 2004, J BIOL CHEM, V279, P8946, DOI 10.1074/jbc.M312745200; Goh SH, 2011, ONCOGENE, V30, P398, DOI 10.1038/onc.2010.422; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Rogers AN, 2011, CELL METAB, V14, P55, DOI 10.1016/j.cmet.2011.05.010; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Satterfield MC, 2011, FRONT BIOSCI-LANDMRK, V16, P1589, DOI 10.2741/3807; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Urs S, 2006, TRANSGENIC RES, V15, P647, DOI 10.1007/s11248-006-9000-z; Wang FB, 2008, EXP CELL RES, V314, P213, DOI 10.1016/j.yexcr.2007.09.022; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wu S, 2012, CELL RES, V22, P1270, DOI 10.1038/cr.2012.47; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	36	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30087	30093		10.1074/jbc.M113.506147	http://dx.doi.org/10.1074/jbc.M113.506147			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003236	Green Published, hybrid			2022-12-28	WOS:000329868100009
J	Hollingsworth, TJ; Gross, AK				Hollingsworth, T. J.; Gross, Alecia K.			The Severe Autosomal Dominant Retinitis Pigmentosa Rhodopsin Mutant Ter349Glu Mislocalizes and Induces Rapid Rod Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cilia; G Protein-coupled Receptors (GPCRs); Neurodegeneration; Neurodegenerative Diseases; Photoreceptors; Phototransduction; Retinal Degeneration; Rhodopsin; Vision; Ter349Glu	BIEDL-SYNDROME PROTEINS; KNOCKIN MOUSE MODEL; TERMINAL SEQUENCE; MUTATION; GENE; TRAFFICKING; MICE; COMPLEX; IDENTIFICATION; LOCALIZATION	Mutations in the rhodopsin gene cause approximately one-tenth of retinitis pigmentosa cases worldwide, and most result in endoplasmic reticulum retention and apoptosis. Other rhodopsin mutations cause receptor mislocalization, diminished/constitutive activity, or faulty protein-protein interactions. The purpose of this study was to test for mechanisms by which the autosomal dominant rhodopsin mutation Ter349Glu causes an early, rapid retinal degeneration in patients. The mutation adds an additional 51 amino acids to the C terminus of the protein. Folding and ligand interaction of Ter349Glu rhodopsin were tested by ultraviolet-visible (UV-visible) spectrophotometry. The ability of the mutant to initiate phototransduction was tested using a radioactive filter binding assay. Photoreceptor localization was assessed both in vitro and in vivo utilizing fluorescent immunochemistry on transfected cells, transgenic Xenopus laevis, and knock-in mice. Photoreceptor ultrastructure was observed by transmission electron microscopy. Spectrally, Ter349Glu rhodopsin behaves similarly to wild-type rhodopsin, absorbing maximally at 500 nm. The mutant protein also displays in vitro G protein activation similar to that of WT. In cultured cells, mislocalization was observed at high expression levels whereas ciliary localization occurred at low expression levels. Similarly, transgenic X. laevis expressing Ter349Glu rhodopsin exhibited partial mislocalization. Analysis of the Ter349Glu rhodopsin knock-in mouse showed a rapid, early onset degeneration in homozygotes with a loss of proper rod outer segment development and improper disc formation. Together, the data show that both mislocalization and rod outer segment morphogenesis are likely associated with the human phenotype.	Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Optometry, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Gross, AK (corresponding author), Univ Alabama Birmingham, Sch Optometry, Dept Vis Sci, 1825 Univ Blvd,SHEL 970, Birmingham, AL 35294 USA.	agross@uab.edu	Hollingsworth, T.J./AAD-2814-2022; Gross, Alecia K./AAJ-1792-2021	Gross, Alecia K./0000-0003-1857-6633; Hollingsworth, T.J./0000-0002-2119-521X	National Institutes of Health from NEI [R01 EY019311]; Eye-Sight Foundation of Alabama; Karl Kirchgessner Foundation; Matilda E. Ziegler Foundation; NATIONAL EYE INSTITUTE [R01EY019311] Funding Source: NIH RePORTER	National Institutes of Health from NEI; Eye-Sight Foundation of Alabama; Karl Kirchgessner Foundation; Matilda E. Ziegler Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY019311 from NEI. This work was also supported by the Eye-Sight Foundation of Alabama, the Karl Kirchgessner Foundation, and The Matilda E. Ziegler Foundation.	Abd-El-Barr MM, 2007, VISION RES, V47, P3394, DOI 10.1016/j.visres.2007.09.016; ALMAGHTHEH M, 1993, HUM MUTAT, V2, P249, DOI 10.1002/humu.1380020403; Amaya E, 1999, METH MOL B, V97, P393, DOI 10.1385/1-59259-270-8:393; APFELSTEDTSYLLA E, 1993, BRIT J OPHTHALMOL, V77, P495, DOI 10.1136/bjo.77.8.495; BAEHR W, 1982, J BIOL CHEM, V257, P6452; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Bessant D A, 1999, Hum Mutat, V13, P83, DOI 10.1002/(SICI)1098-1004(1999)13:1<83::AID-HUMU12>3.0.CO;2-5; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Chuang JZ, 1998, J CELL BIOL, V142, P1245, DOI 10.1083/jcb.142.5.1245; Concepcion F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010904; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; Gross AK, 2006, VISION RES, V46, P4510, DOI 10.1016/j.visres.2006.07.012; Hagstrom SA, 1999, INVEST OPHTH VIS SCI, V40, P2795; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; Hashimoto T, 2007, GENE THER, V14, P584, DOI 10.1038/sj.gt.3302897; Hollingsworth TJ, 2012, INT REV CEL MOL BIO, V293, P1, DOI 10.1016/B978-0-12-394304-0.00006-3; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lehtokari VL, 2008, EUR J HUM GENET, V16, P1055, DOI 10.1038/ejhg.2008.60; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Leroux A, 2005, EUR J HAEMATOL, V74, P389, DOI 10.1111/j.1600-0609.2004.00388.x; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nakao T., 2012, PLOS ONE, V7; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; PETERS KR, 1983, J CELL BIOL, V96, P265, DOI 10.1083/jcb.96.1.265; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Price BA, 2011, INVEST OPHTH VIS SCI, V52, P9728, DOI 10.1167/iovs.11-8654; Robinson PR, 2000, METHOD ENZYMOL, V315, P207; Sancho-Pelluz J, 2012, MOL MED, V18, P549, DOI 10.2119/molmed.2011.00475; Schluter MA, 2009, MOL BIOL CELL, V20, P4652, DOI 10.1091/mbc.E09-02-0137; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; SUNG CH, 1994, J NEUROSCI, V14, P5818; Swiderski RE, 2007, INVEST OPHTH VIS SCI, V48, P3329, DOI 10.1167/iovs.06-1477; Tam BM, 2009, J NEUROSCI, V29, P15145, DOI 10.1523/JNEUROSCI.4259-09.2009; Zeitz C, 2008, INVEST OPHTH VIS SCI, V49, P4105, DOI 10.1167/iovs.08-1717; Zirn B, 2005, AM J KIDNEY DIS, V45, P1100, DOI 10.1053/j.ajkd.2005.03.013	42	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29047	29055		10.1074/jbc.M113.495184	http://dx.doi.org/10.1074/jbc.M113.495184			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940033	Green Published, hybrid			2022-12-28	WOS:000330298800058
J	Reiter, K; Mukhopadhyay, D; Zhang, H; Boucher, LE; Kumar, N; Bosch, J; Matunis, MJ				Reiter, Katherine; Mukhopadhyay, Debaditya; Zhang, Hong; Boucher, Lauren E.; Kumar, Nirbhay; Bosch, Juergen; Matunis, Michael J.			Identification of Biochemically Distinct Properties of the Small Ubiquitin-related Modifier (SUMO) Conjugation Pathway in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; STRUCTURE VALIDATION; PROTEIN SUMOYLATION; BINDING; INSIGHTS; UBC9; LIFE; MECHANISMS; RESISTANCE; MODEL	Small ubiquitin-related modifiers (SUMOs) are post-translationally conjugated to other proteins and are thereby essential regulators of a wide range of cellular processes. Sumoylation, and enzymes of the sumoylation pathway, are conserved in the malaria causing parasite, Plasmodium falciparum. However, the specific functions of sumoylation in P. falciparum, and the degree of functional conservation between enzymes of the human and P. falciparum sumoylation pathways, have not been characterized. Here, we demonstrate that sumoylation levels peak during midstages of the intra-erythrocyte developmental cycle, concomitant with hemoglobin consumption and elevated oxidative stress. In vitro studies revealed that P. falciparum E1- and E2-conjugating enzymes interact effectively to recognize and modify RanGAP1, a model mammalian SUMO substrate. However, in heterologous reactions, P. falciparum E1 and E2 enzymes failed to interact with cognate human E2 and E1 partners, respectively, to modify RanGAP1. Structural analysis, binding studies, and functional assays revealed divergent amino acid residues within the E1-E2 binding interface that define organism-specific enzyme interactions. Our studies identify sumoylation as a potentially important regulator of oxidative stress response during the P. falciparum intra-erythrocyte developmental cycle, and define E1 and E2 interactions as a promising target for development of parasite-specific inhibitors of sumoylation and parasite replication.	[Reiter, Katherine; Mukhopadhyay, Debaditya; Zhang, Hong; Boucher, Lauren E.; Bosch, Juergen; Matunis, Michael J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Zhang, Hong] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Boucher, Lauren E.; Kumar, Nirbhay; Bosch, Juergen] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Baltimore, MD 21205 USA; [Kumar, Nirbhay] Tulane Univ, Dept Trop Med, New Orleans, LA 70112 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tulane University	Matunis, MJ (corresponding author), 615 N Wolfe St, Baltimore, MD 21205 USA.	mmatunis@jhsph.edu	Bosch, Jürgen/E-9370-2011	Bosch, Jürgen/0000-0002-2624-4105; Boucher, Lauren/0000-0003-3152-6155; Matunis, Michael/0000-0002-9350-6611	National Institutes of Health [GM060980]; Sommer Scholar's Program; Bloomberg Philanthropies and Johns Hopkins Malaria Research Institute; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sommer Scholar's Program; Bloomberg Philanthropies and Johns Hopkins Malaria Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM060980 (to M. J. M.), the Sommer Scholar's Program (to K. R.), and the Bloomberg Philanthropies and Johns Hopkins Malaria Research Institute (to J. B. and M. J. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chung DWD, 2009, MOL BIOCHEM PARASIT, V168, P123, DOI 10.1016/j.molbiopara.2009.08.001; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Gallagher JR, 2011, TRAFFIC, V12, P1124, DOI 10.1111/j.1600-0854.2011.01232.x; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Issar N, 2008, CELL MICROBIOL, V10, P1999, DOI 10.1111/j.1462-5822.2008.01183.x; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Jortzik E, 2012, INT J MED MICROBIOL, V302, P187, DOI 10.1016/j.ijmm.2012.07.007; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Muller IB, 2010, FUTURE MICROBIOL, V5, P1857, DOI 10.2217/FMB.10.136; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; Ponder EL, 2011, CHEM BIOL, V18, P711, DOI 10.1016/j.chembiol.2011.04.010; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Tilley L, 2011, INT J BIOCHEM CELL B, V43, P839, DOI 10.1016/j.biocel.2011.03.012; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Waardenburg RCAM, 2006, MOL CELL BIOL, V26, P4958, DOI 10.1128/MCB.00160-06; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Wan J, 2012, CURR PROTEIN PEPT SC, V13, P467, DOI 10.2174/138920312802430563; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015805; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	53	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27724	27736		10.1074/jbc.M113.498410	http://dx.doi.org/10.1074/jbc.M113.498410			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23943616	Green Published, hybrid			2022-12-28	WOS:000330612800003
J	Ferreira, APS; Cassago, A; Goncalves, KD; Dias, MM; Adamoski, D; Ascencao, CFR; Honorato, RV; de Oliveira, JF; Ferreira, IM; Fornezari, C; Bettini, J; Oliveira, PSL; Leme, AFP; Portugal, RV; Ambrosio, ALB; Dias, SMG				Scota Ferreira, Amanda Petrina; Cassago, Alexandre; Goncalves, Kaliandra de Almeida; Dias, Marilia Meira; Adamoski, Douglas; Rodrigues Ascencao, Carolline Fernanda; Honorato, Rodrigo Vargas; de Oliveira, Juliana Ferreira; Ferreira, Igor Monteze; Fornezari, Camila; Bettini, Jefferson; Lopes Oliveira, Paulo Sergio; Paes Leme, Adriana Franco; Portugal, Rodrigo Villares; Berteli Ambrosio, Andre Luis; Gomes Dias, Sandra Martha			Active Glutaminase C Self-assembles into a Supratetrameric Oligomer That Can Be Disrupted by an Allosteric Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATE-DEPENDENT GLUTAMINASE; TARGETING CANCER METABOLISM; KIDNEY-TYPE GLUTAMINASE; PURIFICATION; EXPRESSION; MECHANISM; ULTRASTRUCTURE; ACTIVATION; GLUCOSE; SYSTEM	The phosphate-dependent transition between enzymatically inert dimers into catalytically capable tetramers has long been the accepted mechanism for the glutaminase activation. Here, we demonstrate that activated glutaminase C(GAC) self-assembles into a helical, fiber-like double-stranded oligomer and propose a molecular model consisting of seven tetramer copies per turn per strand interacting via the N-terminal domains. The loop (LRFNKL326)-L-321 is projected as the major regulating element for self-assembly and enzyme activation. Furthermore, the previously identified in vivo lysine acetylation (Lys(311) in humans, Lys(316) in mouse) is here proposed as an important down-regulator of superoligomer assembly and protein activation. Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl) ethyl sulfide, a known glutaminase inhibitor, completely disrupted the higher order oligomer, explaining its allosteric mechanism of inhibition via tetramer stabilization. A direct correlation between the tendency to self-assemble and the activity levels of the three mammalian glutaminase isozymes was established, with GAC being the most active enzyme while forming the longest structures. Lastly, the ectopic expression of a fiber-prone superactive GAC mutant in MDA-MB 231 cancer cells provided considerable proliferative advantages to transformed cells. These findings yield unique implications for the development of GAC-oriented therapeutics targeting tumor metabolism.	[Scota Ferreira, Amanda Petrina; Goncalves, Kaliandra de Almeida; Dias, Marilia Meira; Adamoski, Douglas; Rodrigues Ascencao, Carolline Fernanda; Honorato, Rodrigo Vargas; de Oliveira, Juliana Ferreira; Ferreira, Igor Monteze; Fornezari, Camila; Lopes Oliveira, Paulo Sergio; Paes Leme, Adriana Franco; Berteli Ambrosio, Andre Luis; Gomes Dias, Sandra Martha] CNPEM, Lab Nacionais Biociencias, BR-13083100 Campinas, SP, Brazil; [Cassago, Alexandre; Bettini, Jefferson; Portugal, Rodrigo Villares] CNPEM, BR-13083100 Campinas, SP, Brazil		Ambrosio, ALB (corresponding author), CNPEM, LNBio, Rua Giuseppe Maximo Scolfaro 10-000, BR-13083100 Campinas, SP, Brazil.	andre.ambrosio@lnbio.cnpem.br; sandra.dias@lnbio.cnpem.br	Cassago, Alexandre/AAL-2760-2020; Ambrosio, Andre/C-9089-2012; Bettini, Jefferson/G-4554-2013; Dias, Sandra/AAB-7042-2019; Honorato, Rodrigo Vargas/AAY-9375-2020; Oliveira, Paulo S/K-5588-2013; Ambrosio, Andre/AAB-1178-2020; Honorato, Rodrigo/H-9773-2013; Dias, Marília M/C-3014-2012; Portugal, Rodrigo V/H-3951-2012; Adamoski, Douglas/J-8570-2014; de Oliveira, Juliana F./Q-8813-2018; Leme, Adriana F Paes/C-9679-2012	Cassago, Alexandre/0000-0003-1032-4749; Ambrosio, Andre/0000-0002-9515-930X; Bettini, Jefferson/0000-0001-7316-0804; Honorato, Rodrigo Vargas/0000-0001-5267-3002; Honorato, Rodrigo/0000-0001-5267-3002; Portugal, Rodrigo V/0000-0002-8136-904X; Adamoski, Douglas/0000-0001-5062-2586; de Oliveira, Juliana F./0000-0001-7636-0270; Leme, Adriana F Paes/0000-0001-7959-147X; Dias, Marilia/0000-0003-1415-9023; Goncalves, Kaliandra/0000-0002-1733-3763	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/10875-9, 2010/05003-0, 2012/14298-9, 2010/05987-0, 2011/06654-7, 2009/54067-3]; Laboratorio Nacional de Biociencias	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Laboratorio Nacional de Biociencias	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) under Grants 2009/10875-9 (to S. M. G. D.) and 2010/05003-0 and 2012/14298-9 (to A. L. B. A.) and Fellowships 2010/05987-0 (to A. P. S. F.), 2010/05987-0 (to A. C.), 2011/06654-7 (to K. A. G.), and 2009/54067-3 (to A. F. P. L.). This work was also supported in part by the Laboratorio Nacional de Biociencias.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aragao AZB, 2012, J BIOL CHEM, V287, P43071, DOI 10.1074/jbc.M112.364513; Campos-Sandoval JA, 2007, INT J BIOCHEM CELL B, V39, P765, DOI 10.1016/j.biocel.2006.12.002; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; CURTHOYS NP, 1976, ARCH BIOCHEM BIOPHYS, V174, P82, DOI 10.1016/0003-9861(76)90326-X; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FAN TWM, 1991, BIOCHIM BIOPHYS ACTA, V1092, P39, DOI 10.1016/0167-4889(91)90176-X; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GODFREY S, 1977, J BIOL CHEM, V252, P1927; Gorman MW, 1997, AM J PHYSIOL-HEART C, V272, pH913, DOI 10.1152/ajpheart.1997.272.2.H913; Jones NP, 2012, DRUG DISCOV TODAY, V17, P232, DOI 10.1016/j.drudis.2011.12.017; JOSEPHS R, 1972, J MOL BIOL, V65, P127, DOI 10.1016/0022-2836(72)90496-2; Katt WP, 2012, MOL CANCER THER, V11, P1269, DOI 10.1158/1535-7163.MCT-11-0942; Kenny J, 2003, PROTEIN EXPRES PURIF, V31, P140, DOI 10.1016/S1046-5928(03)00161-X; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOREHOUSE RF, 1981, BIOCHEM J, V193, P709, DOI 10.1042/bj1930709; OLSEN BR, 1973, J MOL BIOL, V74, P239, DOI 10.1016/0022-2836(73)90109-5; OLSEN BR, 1970, J MOL BIOL, V52, P239, DOI 10.1016/0022-2836(70)90028-8; READ RJ, 1988, J APPL CRYSTALLOGR, V21, P490, DOI 10.1107/S002188988800562X; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015	32	56	56	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28009	28020		10.1074/jbc.M113.501346	http://dx.doi.org/10.1074/jbc.M113.501346			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23935106	hybrid, Green Published			2022-12-28	WOS:000330612800027
J	Zhu, L; Kaback, HR; Dalbey, RE				Zhu, Lu; Kaback, H. Ronald; Dalbey, Ross E.			YidC Protein, a Molecular Chaperone for LacY Protein Folding via the SecYEG Protein Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; INNER MEMBRANE-PROTEINS; F1F0 ATP SYNTHASE; PF3 COAT PROTEIN; BACTERIAL CYTOPLASMIC MEMBRANE; ESCHERICHIA-COLI YIDC; M13 PROCOAT PROTEIN; LACTOSE PERMEASE; SUBUNIT-C; MONOCLONAL-ANTIBODY	To understand how YidC and SecYEG function together in membrane protein topogenesis, insertion and folding of the lactose permease of Escherichia coli (LacY), a 12-transmembrane helix protein LacY that catalyzes symport of a galactoside and an H+, was studied. Although both the SecYEG machinery and signal recognition particle are required for insertion of LacY into the membrane, YidC is not required for translocation of the six periplasmic loops in LacY. Rather, YidC acts as a chaperone, facilitating LacY folding. Upon YidC depletion, the conformation of LacY is perturbed, as judged by monoclonal antibody binding studies and by in vivo cross-linking between introduced Cys pairs. Disulfide cross-linking also demonstrates that YidC interacts with multiple transmembrane segments of LacY during membrane biogenesis. Moreover, YidC is strictly required for insertion of M13 procoat protein fused into the middle cytoplasmic loop of LacY. In contrast, the loops preceding and following the inserted procoat domain are dependent on SecYEG for insertion. These studies demonstrate close cooperation between the two complexes in membrane biogenesis and that YidC functions primarily as a foldase for LacY.	[Zhu, Lu; Dalbey, Ross E.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Kaback, H. Ronald] Univ Calif Los Angeles, Dept Physiol, Immunol & Mol Biol Inst, Los Angeles, CA 90095 USA; [Kaback, H. Ronald] Univ Calif Los Angeles, Dept Microbiol, Immunol & Mol Biol Inst, Los Angeles, CA 90095 USA	University System of Ohio; Ohio State University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Dalbey, RE (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.	dalbey@chemistry.ohio-state.edu			National Institutes of Health [DK51131, DK069463, GM073210]; National Science Foundation [MCB-1052033, MCB-1129551]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051131, R01DK069463, R56DK051131, R56DK069463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK51131, DK069463, and GM073210 (to H.R.K.). This work was also supported by National Science Foundation Grants MCB-1052033 (to R.E.D.) and MCB-1129551 (to H.R.K.).	ANDERSSON H, 1993, EMBO J, V12, P683, DOI 10.1002/j.1460-2075.1993.tb05702.x; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; BIBI E, 1990, P NATL ACAD SCI USA, V87, P4325, DOI 10.1073/pnas.87.11.4325; Bohnert M, 2010, CURR BIOL, V20, P1227, DOI 10.1016/j.cub.2010.05.058; Boy D, 2009, MOL BIOL CELL, V20, P1804, DOI 10.1091/mbc.E08-08-0886; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Chen MY, 2005, BIOCHEMISTRY-US, V44, P10741, DOI 10.1021/bi047418k; Chen MY, 2002, J BIOL CHEM, V277, P7670, DOI 10.1074/jbc.M110644200; CONSLER TG, 1993, P NATL ACAD SCI USA, V90, P6934, DOI 10.1073/pnas.90.15.6934; Dalbey RE, 2004, J CELL BIOL, V166, P769, DOI 10.1083/jcb.200405161; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; DATE T, 1980, P NATL ACAD SCI-BIOL, V77, P4669, DOI 10.1073/pnas.77.8.4669; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; Deitermann S, 2005, J BIOL CHEM, V280, P39077, DOI 10.1074/jbc.M509647200; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Funes S, 2011, BIOL CHEM, V392, P13, DOI 10.1515/BC.2011.013; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Houben ENG, 2002, J BIOL CHEM, V277, P35880, DOI 10.1074/jbc.M205556200; ITO K, 1991, MOL MICROBIOL, V5, P2243, DOI 10.1111/j.1365-2958.1991.tb02154.x; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Klenner C, 2012, J BIOL CHEM, V287, P3769, DOI 10.1074/jbc.M111.307223; Klenner C, 2008, FEBS LETT, V582, P3967, DOI 10.1016/j.febslet.2008.10.044; KUHN A, 1988, EUR J BIOCHEM, V177, P267, DOI 10.1111/j.1432-1033.1988.tb14372.x; KUHN A, 1985, J BIOL CHEM, V260, P5914; Luirink J, 2012, BBA-BIOENERGETICS, V1817, P965, DOI 10.1016/j.bbabio.2011.12.006; Luke I, 2009, ARCH MICROBIOL, V191, P919, DOI 10.1007/s00203-009-0516-5; MACFARLANE J, 1995, EUR J BIOCHEM, V233, P766, DOI 10.1111/j.1432-1033.1995.766_3.x; MATSUYAMA S, 1990, FEBS LETT, V269, P96, DOI 10.1016/0014-5793(90)81128-B; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nagamori S, 2003, J BIOL CHEM, V278, P14820, DOI 10.1074/jbc.M300332200; Neale EJ, 2007, J BIOL CHEM, V282, P37597, DOI 10.1074/jbc.M706437200; Neugebauer SA, 2012, J MOL BIOL, V417, P375, DOI 10.1016/j.jmb.2012.01.046; PHILLIPS GJ, 1992, NATURE, V359, P744, DOI 10.1038/359744a0; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; Saaf A, 1998, J BIOL CHEM, V273, P30415, DOI 10.1074/jbc.273.46.30415; SAHINTOTH M, 1995, BIOCHEMISTRY-US, V34, P1107, DOI 10.1021/bi00004a001; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Seluanov A, 1997, J BIOL CHEM, V272, P2053; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; SHORT SA, 1975, J BIOL CHEM, V250, P4291; Stephenson K, 2005, MOL MEMBR BIOL, V22, P17, DOI 10.1080/09687860500063308; Sun JZ, 1996, BIOCHEMISTRY-US, V35, P990, DOI 10.1021/bi952166w; Sun JZ, 1997, BIOCHEMISTRY-US, V36, P274, DOI 10.1021/bi962292f; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Traxler B, 1996, J BIOL CHEM, V271, P12394, DOI 10.1074/jbc.271.21.12394; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van Bloois E, 2005, J BIOL CHEM, V280, P12996, DOI 10.1074/jbc.M414094200; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; VANIWAARDEN PR, 1991, BIOCHEMISTRY-US, V30, P9595, DOI 10.1021/bi00104a005; Vitrac H, 2013, P NATL ACAD SCI USA, V110, P9338, DOI 10.1073/pnas.1304375110; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Wang P, 2011, BBA-BIOMEMBRANES, V1808, P866, DOI 10.1016/j.bbamem.2010.08.014; Wang P, 2010, J BACTERIOL, V192, P2193, DOI 10.1128/JB.00484-09; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhu L, 2013, J BIOL CHEM, V288, P7704, DOI 10.1074/jbc.M112.429431; Zhu L, 2012, J MOL BIOL, V424, P354, DOI 10.1016/j.jmb.2012.09.026	75	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28180	28194		10.1074/jbc.M113.491613	http://dx.doi.org/10.1074/jbc.M113.491613			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23928306	hybrid, Green Published			2022-12-28	WOS:000330612800041
J	Jiang, MG; Li, TD; Feng, CJ; Fu, R; Yuan, Y; Zhou, Q; Li, X; Wan, HF; Wang, L; Li, W; Xiao, YM; Zhao, XY; Zhou, Q				Jiang, Ming-Gui; Li, Tianda; Feng, Chunjing; Fu, Rui; Yuan, Yan; Zhou, Quan; Li, Xin; Wan, Haifeng; Wang, Liu; Li, Wei; Xiao, Yamei; Zhao, Xiao-Yang; Zhou, Qi			Generation of Transgenic Rats through Induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								The rat is an important animal model for human disease research. Using inhibitors of glycogen synthase kinase 3 and MAPK signaling pathways, rat embryonic stem cells and rat induced pluripotent stem cells (riPSCs) have been derived. However, unlike rat embryonic stem cells, germ line competent riPSCs have only been derived from Wistar rats at low efficiency. Here, we found that an optimized induction medium containing knock-out serum replacement and vitamin C improved the rate and efficiency of riPSCs generation from Dark Agouti rat fibroblasts and Sertoli cells. riPSCs maintained an undifferentiated status for > 30 passages and could differentiate into various cells types including germ cells when injected into rat blastocysts. Moreover, transgenic riPSCs could be generated through the PiggyBac transposon, which could be used to generate transgenic rats through germ line transmission. riPSCs can be used as a novel tool in genetic and genomic studies of the rat.	[Jiang, Ming-Gui; Li, Tianda; Feng, Chunjing; Fu, Rui; Yuan, Yan; Zhou, Quan; Li, Xin; Wan, Haifeng; Wang, Liu; Li, Wei; Zhao, Xiao-Yang; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Jiang, Ming-Gui; Xiao, Yamei] Hunan Normal Univ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China; [Jiang, Ming-Gui; Li, Tianda; Feng, Chunjing; Fu, Rui; Wan, Haifeng; Wang, Liu; Li, Wei; Zhao, Xiao-Yang; Zhou, Qi] Chinese Acad Sci, Inst Zool, Key Lab Translat Stem Cell Res, Beijing 100101, Peoples R China; [Feng, Chunjing] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China; [Yuan, Yan; Zhou, Quan] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing 210000, Jiangsu, Peoples R China; [Li, Xin] Northeast Agr Univ China, Coll Life Sci, Harbin 150030, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Hunan Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing Medical University; Northeast Agricultural University - China	Zhao, XY (corresponding author), Chinese Acad Sci, Inst Zool Biol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	xyzhao@ioz.ac.cn; qzhou@ioz.ac.cn	Wilson, Matthew H/K-3193-2013	ZHAO, Xiao-Yang/0000-0003-2544-8293	China National Basic Research Program [2012CBA01300, 2011CB965301]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01020101, XDA01030101]	China National Basic Research Program(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by China National Basic Research Program Grants 2012CBA01300 (to Qi Zhou) and 2011CB965301 (to X. Z.) and Strategic Priority Research Program of the Chinese Academy of Sciences Grants XDA01020101 (to Qi Zhou) and XDA01030101 (to L. W.).	Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Hamanaka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022008; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Kawamata M, 2010, P NATL ACAD SCI USA, V107, P14223, DOI 10.1073/pnas.1009582107; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wu GM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001099; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhao XY, 2010, CELL RES, V20, P383, DOI 10.1038/cr.2010.26; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhao XY, 2010, J GENET GENOMICS, V37, P467, DOI 10.1016/S1673-8527(09)60066-7	19	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27150	27158		10.1074/jbc.M113.492900	http://dx.doi.org/10.1074/jbc.M113.492900			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23926100	hybrid, Green Published			2022-12-28	WOS:000330597300014
J	Ruane, KM; Lloyd, AJ; Fulop, V; Dowson, CG; Barreteau, H; Boniface, A; Dementin, S; Blanot, D; Mengin-Lecreulx, D; Gobec, S; Dessen, A; Roper, DI				Ruane, Karen M.; Lloyd, Adrian J.; Fueloep, Vilmos; Dowson, Christopher G.; Barreteau, Helene; Boniface, Audrey; Dementin, Sebastien; Blanot, Didier; Mengin-Lecreulx, Dominique; Gobec, Stanislav; Dessen, Andrea; Roper, David I.			Specificity Determinants for Lysine Incorporation in Staphylococcus aureus Peptidoglycan as Revealed by the Structure of a MurE Enzyme Ternary Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Antibiotic Resistance; Bacterial Metabolism; Peptidoglycan; X-ray Crystallography; MurE; Enzyme Kinetics; Structural Biology	ALANYL-D-GLUTAMATE; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; PENTAPEPTIDE TRANSLOCASE; SUBSTRATE-SPECIFICITY; THERMOTOGA-MARITIMA; CYTOPLASMIC STEPS; IN-VITRO; LIGASE; BIOSYNTHESIS	Formation of the peptidoglycan stem pentapeptide requires the insertion of both l and d amino acids by the ATP-dependent ligase enzymes MurC, -D, -E, and -F. The stereochemical control of the third position amino acid in the pentapeptide is crucial to maintain the fidelity of later biosynthetic steps contributing to cell morphology, antibiotic resistance, and pathogenesis. Here we determined the x-ray crystal structure of Staphylococcus aureus MurE UDP-N-acetylmuramoyl-l-alanyl-d-glutamate:meso-2,6-diaminopimelate ligase (MurE) (E.C. 6.3.2.7) at 1.8 resolution in the presence of ADP and the reaction product, UDP-MurNAc-l-Ala--d-Glu-l-Lys. This structure provides for the first time a molecular understanding of how this Gram-positive enzyme discriminates between l-lysine and d,l-diaminopimelic acid, the predominant amino acid that replaces l-lysine in Gram-negative peptidoglycan. Despite the presence of a consensus sequence previously implicated in the selection of the third position residue in the stem pentapeptide in S. aureus MurE, the structure shows that only part of this sequence is involved in the selection of l-lysine. Instead, other parts of the protein contribute substrate-selecting residues, resulting in a lysine-binding pocket based on charge characteristics. Despite the absolute specificity for l-lysine, S. aureus MurE binds this substrate relatively poorly. In vivo analysis and metabolomic data reveal that this is compensated for by high cytoplasmic l-lysine concentrations. Therefore, both metabolic and structural constraints maintain the structural integrity of the staphylococcal peptidoglycan. This study provides a novel focus for S. aureus-directed antimicrobials based on dual targeting of essential amino acid biogenesis and its linkage to cell wall assembly.	[Ruane, Karen M.; Lloyd, Adrian J.; Fueloep, Vilmos; Dowson, Christopher G.; Roper, David I.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Barreteau, Helene; Boniface, Audrey; Dementin, Sebastien; Blanot, Didier; Mengin-Lecreulx, Dominique] Univ Paris 11, Lab Enveloppes Bacteriennes & Antibiot, Inst Biochim & Biophys Mol & Cellulaire, CNRS,UMR 8619, F-91405 Orsay, France; [Gobec, Stanislav] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia; [Dessen, Andrea] Univ Grenoble 1, Commissariat Energie Atom, Bacterial Pathogenesis Grp, Inst Biol Struct,CNRS, F-38027 Grenoble, France	University of Warwick; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Ljubljana; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Roper, DI (corresponding author), Univ Warwick, Sch Life Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	david.roper@warwick.ac.uk	Dowson, Christopher/ABG-5083-2021; Roper, David I/A-2323-2011; Dowson, Chris/N-6195-2014; Fulop, Vilmos/AAZ-7720-2021	Dowson, Christopher/0000-0002-8294-8836; Roper, David I/0000-0003-0009-621X; Dowson, Chris/0000-0002-8294-8836; Dessen, Andrea/0000-0001-6487-4020; MENGIN-LECREULX, Dominique/0000-0003-3205-0275; Lloyd, Adrian/0000-0002-4638-4586; Gobec, Stanislav/0000-0002-9678-3083; Dementin, Sebastien/0000-0001-6168-5371; , Karen/0000-0003-2612-168X	Advantage West Midlands (AWM); Biotechnology and Biological Sciences Research Council [BB/K017268/1] Funding Source: researchfish; Medical Research Council [G0400848, G0600801, G1100127] Funding Source: researchfish; BBSRC [BB/K017268/1] Funding Source: UKRI; MRC [G1100127, G0600801, G0400848] Funding Source: UKRI	Advantage West Midlands (AWM); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Equipment used in this research was obtained through the Birmingham-Warwick Science City Translational Medicine: Experimental Medicine Network of Excellence project, with support from Advantage West Midlands (AWM). Crystallographic data were collected at the beamline IO2 at Diamond Light Source, Didcot, UK, and we acknowledge the support of beamline scientist Thomas Sorensen.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Basavannacharya C, 2010, PROTEIN CELL, V1, P1011, DOI 10.1007/s13238-010-0132-9; Basavannacharya C, 2010, TUBERCULOSIS, V90, P16, DOI 10.1016/j.tube.2009.10.007; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bertrand JA, 1999, J MOL BIOL, V289, P579, DOI 10.1006/jmbi.1999.2800; Bertrand JA, 2000, J MOL BIOL, V301, P1257, DOI 10.1006/jmbi.2000.3994; Boniface A, 2006, J BIOL CHEM, V281, P15680, DOI 10.1074/jbc.M506311200; Boniface A, 2009, J BIOL CHEM, V284, P21856, DOI 10.1074/jbc.M109.034363; Bouhss A, 1999, MOL MICROBIOL, V34, P576, DOI 10.1046/j.1365-2958.1999.01623.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bugg TDH, 2011, TRENDS BIOTECHNOL, V29, P167, DOI 10.1016/j.tibtech.2010.12.006; Bugg Timothy D. H., 2006, Infectious Disorders - Drug Targets, V6, P85, DOI 10.2174/187152606784112128; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clancy KW, 2010, BIOPOLYMERS, V94, P385, DOI 10.1002/bip.21472; Clarke TB, 2011, IMMUNOL REV, V243, P9, DOI 10.1111/j.1600-065X.2011.01039.x; Clarke TB, 2009, BIOCHEMISTRY-US, V48, P2675, DOI 10.1021/bi801993x; Cox RJ, 1996, NAT PROD REP, V13, P29, DOI 10.1039/np9961300029; Cressina E, 2007, BIOORG MED CHEM LETT, V17, P4654, DOI 10.1016/j.bmcl.2007.05.071; Crouvoisier M, 2007, BIOCHIMIE, V89, P1498, DOI 10.1016/j.biochi.2007.06.011; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Favini-Stabile S, 2013, ENV MICROBIOL, DOI 10.1111/1462-2920.12171; Figueiredo TA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002508; Gardete S, 2004, J BACTERIOL, V186, P1705, DOI 10.1128/JB.186.6.1705-1713.2004; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Gordon E, 2001, J BIOL CHEM, V276, P10999, DOI 10.1074/jbc.M009835200; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Huber J, 2009, CHEM BIOL, V16, P837, DOI 10.1016/j.chembiol.2009.05.012; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lee SH, 2011, CHEM BIOL, V18, P1379, DOI 10.1016/j.chembiol.2011.08.015; Liebeke M, 2011, MOL BIOSYST, V7, P1241, DOI 10.1039/c0mb00315h; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Lloyd AJ, 2004, J BACTERIOL, V186, P1747, DOI 10.1128/JB.186.6.1747-1757.2004; Lundqvist T, 2007, NATURE, V447, P817, DOI 10.1038/nature05689; Lysenko ES, 2007, PLOS PATHOG, V3, P1073, DOI 10.1371/journal.ppat.0030118; Mattei PJ, 2010, CURR OPIN STRUC BIOL, V20, P749, DOI 10.1016/j.sbi.2010.09.014; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Mengin-Lecreulx D, 1999, J BACTERIOL, V181, P5909, DOI 10.1128/JB.181.19.5909-5914.1999; MENGINLECREULX D, 1982, J BACTERIOL, V151, P1109, DOI 10.1128/JB.151.3.1109-1117.1982; Mohammadi T, 2007, MOL MICROBIOL, V65, P1106, DOI 10.1111/j.1365-2958.2007.05851.x; Munch D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002509; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; ORNELASSOARES A, 1994, J BIOL CHEM, V269, P27246; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Paradis-Bleau C, 2009, BIOCHEM J, V421, P263, DOI 10.1042/BJ20081395; Paradis-Bleau C, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-33; Patin D, 2010, BIOCHIMIE, V92, P1793, DOI 10.1016/j.biochi.2010.07.009; Perdih A, 2009, BIOORG MED CHEM LETT, V19, P2668, DOI 10.1016/j.bmcl.2009.03.141; Ray SS, 2002, STRUCTURE, V10, P1499, DOI 10.1016/S0969-2126(02)00880-8; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schouten JA, 2006, MOL BIOSYST, V2, P484, DOI 10.1039/b607908c; Smith CA, 2006, J MOL BIOL, V362, P640, DOI 10.1016/j.jmb.2006.07.066; Sosic I, 2011, EUR J MED CHEM, V46, P2880, DOI 10.1016/j.ejmech.2011.04.011; Sova M, 2009, BIOORG MED CHEM LETT, V19, P1376, DOI 10.1016/j.bmcl.2009.01.034; Thedieck K, 2006, MOL MICROBIOL, V62, P1325, DOI 10.1111/j.1365-2958.2006.05452.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Young KD, 2003, MOL MICROBIOL, V49, P571, DOI 10.1046/j.1365-2958.2003.03607.x; Zawadzke LE, 2008, ASSAY DRUG DEV TECHN, V6, P95, DOI 10.1089/adt.2007.114	73	23	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33439	33448		10.1074/jbc.M113.508135	http://dx.doi.org/10.1074/jbc.M113.508135			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24064214	hybrid, Green Published			2022-12-28	WOS:000328841700056
J	Miura, A; Kambe, Y; Inoue, K; Tatsukawa, H; Kurihara, T; Griffin, M; Kojima, S; Miyata, A				Miura, Ayako; Kambe, Yuki; Inoue, Kazuhiko; Tatsukawa, Hideki; Kurihara, Takashi; Griffin, Martin; Kojima, Soichi; Miyata, Atsuro			Pituitary Adenylate Cyclase-activating Polypeptide Type 1 Receptor (PAC1) Gene Is Suppressed by Transglutaminase 2 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ER Stress; G Protein-coupled Receptors (GPCRs); Gene Expression; Ischemia; Neurons; Neuropeptide; Sp1; PAC1; Pituitary Adenylate Cyclase-activating Polypeptide; Transglutaminase 2	TRANSIENT FOCAL ISCHEMIA; NERVE GROWTH-FACTOR; ER-STRESS; TISSUE TRANSGLUTAMINASE; ENDOPLASMIC-RETICULUM; PC12 CELLS; EXPRESSION; SP1; INDUCTION; APOPTOSIS	Background: The expression of PAC1, a specific receptor for PACAP, is decreased in brain ischemia. Results:PAC1 expression was attenuated by inactivation of Sp1 through cross-linking by transglutaminase 2 (TG2) activated by ER stress. Conclusion: TG2 is involved in negative regulation of PAC1 gene expression. Significance: Suppression of PAC1 by TG2 might be involved in neuronal damage from brain ischemia. Pituitary adenylate cyclase-activating polypeptide (PACAP) functions as a neuroprotective factor through the PACAP type 1 receptor, PAC1. In a previous work, we demonstrated that nerve growth factor augmented PAC1 gene expression through the activation of Sp1 via the Ras/MAPK pathway. We also observed that PAC1 expression in Neuro2a cells was transiently suppressed during in vitro ischemic conditions, oxygen-glucose deprivation (OGD). Because endoplasmic reticulum (ER) stress is induced by ischemia, we attempted to clarify how ER stress affects the expression of PAC1. Tunicamycin, which induces ER stress, significantly suppressed PAC1 gene expression, and salubrinal, a selective inhibitor of the protein kinase RNA-like endoplasmic reticulum kinase signaling pathway of ER stress, blocked the suppression. In luciferase reporter assay, we found that two Sp1 sites were involved in suppression of PAC1 gene expression due to tunicamycin or OGD. Immunocytochemical staining demonstrated that OGD-induced transglutaminase 2 (TG2) expression was suppressed by salubrinal or cystamine, a TG activity inhibitor. Further, the OGD-induced accumulation of cross-linked Sp1 in nuclei was suppressed by cystamine or salubrinal. Together with cystamine, R283, TG2-specific inhibitor, and siRNA specific for TG2 also ameliorated OGD-induced attenuation of PAC1 gene expression. These results suggest that Sp1 cross-linking might be crucial in negative regulation of PAC1 gene expression due to TG2 in OGD-induced ER stress.	[Miura, Ayako; Kambe, Yuki; Inoue, Kazuhiko; Kurihara, Takashi; Miyata, Atsuro] Kagoshima Univ, Dept Pharmacol, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan; [Tatsukawa, Hideki; Kojima, Soichi] RIKEN, Mol Ligand Biol Res Team, Chem Genom Res Grp, Dept Biol Chem,Adv Sci Inst, Wako, Saitama 3510198, Japan; [Griffin, Martin] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Kagoshima University; RIKEN; Aston University	Miyata, A (corresponding author), Kagoshima Univ, Dept Pharmacol, Grad Sch Med & Dent Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	amiyata@m3.kufm.kagoshima-u.ac.jp	Tatsukawa, Hideki/AAE-8377-2020; Kojima, Soichi/N-7104-2015	Kojima, Soichi/0000-0002-5252-1612; Griffin, Martin/0000-0003-3824-306X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21591182]; Grants-in-Aid for Scientific Research [25462225] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research 21591182 (to A. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Caccamo D, 2004, AMINO ACIDS, V27, P373, DOI 10.1007/s00726-004-0117-1; Colak G, 2012, NEUROBIOL DIS, V45, P1042, DOI 10.1016/j.nbd.2011.12.023; Curro M, 2009, AMINO ACIDS, V36, P725, DOI 10.1007/s00726-008-0122-x; Griffin M, 2008, BIOORG MED CHEM LETT, V18, P5559, DOI 10.1016/j.bmcl.2008.09.006; Hayashi T, 2004, NEUROBIOL DIS, V15, P229, DOI 10.1016/j.nbd.2003.10.005; Hoffmann A, 1998, ANN NY ACAD SCI, V865, P49, DOI 10.1111/j.1749-6632.1998.tb11162.x; Ientile R, 2004, NEUROSCI LETT, V363, P173, DOI 10.1016/j.neulet.2004.04.003; Kambe Y, 2012, J MOL NEUROSCI, V48, P550, DOI 10.1007/s12031-012-9754-0; Kuo TF, 2012, J CELL PHYSIOL, V227, P1130, DOI 10.1002/jcp.22833; Lee J, 2006, FASEB J, V20, P2375, DOI 10.1096/fj.06-5957fje; Lee MH, 2004, PHARM RES-DORDR, V21, P736, DOI 10.1023/B:PHAM.0000026421.09367.b3; Lee TH, 1998, STROKE, V29, P1687, DOI 10.1161/01.STR.29.8.1687; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Miki N, 2004, J BIOL CHEM, V279, P15025, DOI 10.1074/jbc.M313186200; Miura A, 2012, FEBS LETT, V586, P1731, DOI 10.1016/j.febslet.2012.05.009; Nakka VP, 2010, NEUROTOX RES, V17, P189, DOI 10.1007/s12640-009-9110-5; Reglodi D, 2000, ANN NY ACAD SCI, V921, P119; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Riek-Burchardt M, 2010, NEUROPHARMACOLOGY, V58, P199, DOI 10.1016/j.neuropharm.2009.07.032; Ryu H, 2003, J NEUROSCI, V23, P3597; Shin DM, 2008, BIOCHEM BIOPH RES CO, V365, P509, DOI 10.1016/j.bbrc.2007.11.007; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Tatsukawa H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-4; Tatsukawa H, 2009, GASTROENTEROLOGY, V136, P1783, DOI 10.1053/j.gastro.2009.01.007; Tolentino PJ, 2004, J NEUROCHEM, V89, P1301, DOI 10.1111/j.1471-4159.2004.02436.x; Tominaga A, 2008, J MOL NEUROSCI, V36, P73, DOI 10.1007/s12031-008-9127-x; Uchida D, 1996, BRAIN RES, V736, P280, DOI 10.1016/0006-8993(96)00716-0; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Verhaar R, 2012, NEUROBIOL DIS, V45, P839, DOI 10.1016/j.nbd.2011.10.012; Woo SK, 2012, J CEREBR BLOOD F MET, V32, P525, DOI 10.1038/jcbfm.2011.159; Yeh SH, 2011, NUCLEIC ACIDS RES, V39, P5412, DOI 10.1093/nar/gkr161; Yoo JO, 2012, J BIOL CHEM, V287, P14377, DOI 10.1074/jbc.M111.326074	34	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32720	32730		10.1074/jbc.M113.452706	http://dx.doi.org/10.1074/jbc.M113.452706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24045949	Green Published, hybrid			2022-12-28	WOS:000328681700056
J	Melo, Z; de los Heros, P; Cruz-Rangel, S; Vazquez, N; Bobadilla, NA; Pasantes-Morales, H; Alessi, DR; Mercado, A; Gamba, G				Melo, Zesergio; de los Heros, Paola; Cruz-Rangel, Silvia; Vazquez, Norma; Bobadilla, Norma A.; Pasantes-Morales, Herminia; Alessi, Dario R.; Mercado, Adriana; Gamba, Gerardo			N-terminal Serine Dephosphorylation Is Required for KCC3 Cotransporter Full Activation by Cell Swelling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL COTRANSPORTER; CORPUS-CALLOSUM; PROTEIN-KINASES; SPAK KINASES; PHOSPHORYLATION; WNK3; MECHANISM; NKCC2; OSR1; HYPERTENSION	The K+:Cl- cotransporter (KCC) activity is modulated by phosphorylation/dephosphorylation processes. In isotonic conditions, KCCs are inactive and phosphorylated, whereas hypotonicity promotes their dephosphorylation and activation. Two phosphorylation sites (Thr-991 and Thr-1048) in KCC3 have been found to be critical for its regulation. However, here we show that the double mutant KCC3-T991A/T1048A could be further activated by hypotonicity, suggesting that additional phosphorylation site(s) are involved. We observed that in vitro activated STE20/SPS1-related proline/alanine-rich kinase (SPAK) complexed to its regulatory MO25 subunit phosphorylated KCC3 at Ser-96 and that in Xenopus laevis oocytes Ser-96 of human KCC3 is phosphorylated in isotonic conditions and becomes dephosphorylated during incubation in hypotonicity, leading to a dramatic increase in KCC3 function. Additionally, WNK3, which inhibits the activity of KCC3, promoted phosphorylation of Ser-96 as well as Thr-991 and Thr-1048. These observations were corroborated in HEK293 cells stably transfected with WNK3. Mutation of Ser-96 alone (KCC3-S96A) had no effect on the activity of the cotransporter when compared with wild type KCC3. However, when compared with the double mutant KCC3-T991A/T1048A, the triple mutant KCC3-S96A/T991A/T1048A activity in isotonic conditions was significantly higher, and it was not further increased by hypotonicity or inhibited by WNK3. We conclude that serine residue 96 of human KCC3 is a third site that has to be dephosphorylated for full activation of the cotransporter during hypotonicity.	[Melo, Zesergio; Vazquez, Norma; Bobadilla, Norma A.; Gamba, Gerardo] Univ Nacl Autonoma Mexico, Mol Physiol Unit, Inst Invest Biomed, Mexico City 14000, DF, Mexico; [Melo, Zesergio; Vazquez, Norma; Bobadilla, Norma A.; Gamba, Gerardo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico; [de los Heros, Paola; Alessi, Dario R.] Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [Cruz-Rangel, Silvia; Pasantes-Morales, Herminia] Univ Nacl Autonoma Mexico, Div Neurociencias, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Mercado, Adriana] Inst Nacl Cardiol Ignacio Chavez, Dept Nefrol, Mexico City 14080, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of Dundee; Universidad Nacional Autonoma de Mexico; National Institute of Cardiology - Mexico	Gamba, G (corresponding author), Mol Physiol Unit, Vasco Quiroga 15, Mexico City 14000, DF, Mexico.	gamba@biomedicas.unam.mx	Mercado, Adriana/AAR-6143-2021; Melo, Zesergio/AAB-7153-2022; Gamba, Gerardo/P-4873-2016	Mercado, Adriana/0000-0002-6881-0160; Alessi, Dario/0000-0002-2140-9185; Melo, Zesergio/0000-0002-6702-204X; Gamba, Gerardo/0000-0002-4378-9043	Mexican Council of Science and Technology (CONACYT) [132503, 165815]; Wellcome Trust [091415]; CONACYT-Mexico; Medical Research Council [MC_UU_12016/2, MC_U127070193] Funding Source: researchfish; MRC [MC_UU_12016/2, MC_U127070193] Funding Source: UKRI	Mexican Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Wellcome Trust(Wellcome TrustEuropean Commission); CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Grants 132503 and 165815 from the Mexican Council of Science and Technology (CONACYT) (to A. M. and G. G., respectively), and by the Grant 091415 from the Wellcome Trust (to D. R. A. and G. G.).; Supported by a scholarship from CONACYT-Mexico.	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; BIANCHINI L, 1988, J EXP BIOL, V137, P303; Campbell David G, 2002, J Biomol Tech, V13, P119; Chen YF, 2010, AM J TRANSL RES, V2, P345; Cruz-Rangel S, 2012, PFLUG ARCH EUR J PHY, V464, P317, DOI 10.1007/s00424-012-1137-4; Cruz-Rangel S, 2011, AM J PHYSIOL-CELL PH, V301, pC601, DOI 10.1152/ajpcell.00070.2011; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI 10.1073/pnas.0510947103; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Flatman PW, 2002, BBA-BIOMEMBRANES, V1566, P140, DOI 10.1016/S0005-2736(02)00586-2; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gamba G, 2012, AM J PHYSIOL-RENAL, V303, pF1573, DOI 10.1152/ajprenal.00508.2012; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002; Khan MZH, 2012, BIOCHEM BIOPH RES CO, V425, P456, DOI 10.1016/j.bbrc.2012.07.124; LAUF PK, 1988, AM J PHYSIOL, V255, pC331, DOI 10.1152/ajpcell.1988.255.3.C331; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; Mercado A, 2005, AM J PHYSIOL-RENAL, V289, pF1246, DOI 10.1152/ajprenal.00464.2004; Mercado A, 2001, AM J PHYSIOL-CELL PH, V281, pC670, DOI 10.1152/ajpcell.2001.281.2.C670; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Pacheco-Alvarez D, 2012, CELL PHYSIOL BIOCHEM, V29, P291, DOI 10.1159/000337610; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Richardson C, 2011, J CELL SCI, V124, P789, DOI 10.1242/jcs.077230; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rust MB, 2006, CIRC RES, V98, P549, DOI 10.1161/01.RES.0000204449.83861.22; Salin-Cantegrel A, 2011, J BIOL CHEM, V286, P28456, DOI 10.1074/jbc.M111.226894; Uyanik G, 2006, NEUROLOGY, V66, P1044, DOI 10.1212/01.wnl.0000204181.31175.8b; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180	33	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31468	31476		10.1074/jbc.M113.475574	http://dx.doi.org/10.1074/jbc.M113.475574			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043619	Green Published, hybrid			2022-12-28	WOS:000330596200006
J	Huo, L; Davis, I; Chen, LR; Liu, AM				Huo, Lu; Davis, Ian; Chen, Lirong; Liu, Aimin			The Power of Two ARGININE 51 AND ARGININE 239* FROM A NEIGHBORING SUBUNIT ARE ESSENTIAL FOR CATALYSIS IN alpha-AMINO-beta-CARBOXYMUCONATE-epsilon-SEMIALDEHYDE DECARBOXYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED ARGININE RESIDUES; ACTIVE-SITE ARGININE; CRYSTAL-STRUCTURE; PHTHALATE-ESTERS; KEY ENZYME; BACTERIAL; DIMERIZATION; ACID; PHOSPHORYLATION; QUINOLINATE	Although the crystal structure of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase from Pseudomonas fluorescens was solved as a dimer, this enzyme is a mixture of monomer, dimer, and higher order structures in solution. In this work, we found that the dimeric state, not the monomeric state, is the functionally active form. Two conserved arginine residues are present in the active site: Arg-51 and an intruding Arg-239* from the neighboring subunit. In this study, they were each mutated to alanine and lysine, and all four mutants were catalytically inactive. The mutants were also incapable of accommodating pyridine-2,6-dicarboxylic acid, a competitive inhibitor of the native enzyme, suggesting that the two Arg residues are involved in substrate binding. It was also observed that the decarboxylase activity was partially recovered in a heterodimer hybridization experiment when inactive R51(A/K) and R239(A/K) mutants were mixed together. Of the 20 crystal structures obtained from mixing inactive R51A and R239A homodimers that diffracted to a resolution lower than 3.00 angstrom, two structures are clearly R51A/R239A heterodimers and belong to the C2 space group. They were refined to 1.80 and 2.00 angstrom resolutions, respectively. Four of the remaining crystals are apparently single mutants and belong to the P4(2)2(1)2 space group. In the heterodimer structures, one active site is shown to contain dual mutation of Ala-51 and Ala-239*, whereas the other contains the native Arg-51 and Arg-239* residues, identical to the wildtype structure. Thus, these observations provide the foundation for a molecular mechanism by which the oligomerization state of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase could regulate the enzyme activity.	[Liu, Aimin] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Liu, AM (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.	Feradical@gsu.edu	Huo, Lu/O-7598-2016; Liu, Aimin/C-1572-2017	Liu, Aimin/0000-0002-4182-8176; Davis, Ian/0000-0002-1566-4972	National Science Foundation [MCB-0843537]; Georgia Research Alliance Distinguished Scholar Program; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; Molecular Basis of Disease program of Georgia State University; Direct For Biological Sciences [0843537] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Georgia Research Alliance Distinguished Scholar Program; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Molecular Basis of Disease program of Georgia State University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part or whole by National Science Foundation Grant MCB-0843537 and funds from the Georgia Research Alliance Distinguished Scholar Program (to A. L.) and by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.; Supported by a fellowship from the Molecular Basis of Disease program of Georgia State University.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blachnio Karina, 2005, Postepy Biochem, V51, P339; CHAIDAROGLOU A, 1988, BIOCHEMISTRY-US, V27, P8338, DOI 10.1021/bi00422a008; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Colabroy KL, 2005, J AM CHEM SOC, V127, P840, DOI 10.1021/ja0446395; Datta D, 2013, J BIOL CHEM, V288, P9971, DOI 10.1074/jbc.M112.426460; Doherty MK, 2000, BIOCHEMISTRY-US, V39, P10695, DOI 10.1021/bi000871l; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Ellis KE, 2012, BIOCHEMISTRY-US, V51, P10008, DOI 10.1021/bi301150n; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukuwatari T, 2003, ADV EXP MED BIOL, V527, P659; Fukuwatari T, 2004, TOXICOL SCI, V81, P302, DOI 10.1093/toxsci/kfh204; Garavaglia S, 2009, FEBS J, V276, P6615, DOI 10.1111/j.1742-4658.2009.07372.x; GHOSH M, 1994, BIOCHEM J, V298, P295, DOI 10.1042/bj2980295; Guidetti P, 2003, ADV EXP MED BIOL, V527, P137; Guillemin GJ, 2003, ADV EXP MED BIOL, V527, P167; HESS JF, 1988, NATURE, V336, P139, DOI 10.1038/336139a0; HESS JF, 1987, P NATL ACAD SCI USA, V84, P7609, DOI 10.1073/pnas.84.21.7609; Hor L, 2013, J BIOL CHEM, V288, P9238, DOI 10.1074/jbc.M113.450148; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Huo L, 2012, BIOCHEMISTRY-US, V51, P5811, DOI 10.1021/bi300635b; KOONTZ WA, 1976, J BIOL CHEM, V251, P368; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li TF, 2005, J AM CHEM SOC, V127, P12282, DOI 10.1021/ja0532234; Li TF, 2007, J AM CHEM SOC, V129, P9278, DOI 10.1021/ja073648l; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Martynowski D, 2006, BIOCHEMISTRY-US, V45, P10412, DOI 10.1021/bi060903q; MEHLER AH, 1964, SCIENCE, V145, P817, DOI 10.1126/science.145.3634.817; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Prell JS, 2009, J AM CHEM SOC, V131, P11442, DOI 10.1021/ja901870d; Pucci L, 2007, FEBS J, V274, P827, DOI 10.1111/j.1742-4658.2007.05635.x; Reczkowski RS, 1998, BIOCHEMISTRY-US, V37, P13499, DOI 10.1021/bi9811011; Reinhard JF, 2004, ANN NY ACAD SCI, V1035, P335, DOI 10.1196/annals.1332.020; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Schlippe YVG, 2005, BIOCHEMISTRY-US, V44, P11700, DOI 10.1021/bi048342v; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; SWANSON RV, 1993, MOL MICROBIOL, V8, P435, DOI 10.1111/j.1365-2958.1993.tb01588.x; Unkles SE, 2004, P NATL ACAD SCI USA, V101, P17549, DOI 10.1073/pnas.0405054101; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589	44	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30862	30871		10.1074/jbc.M113.496869	http://dx.doi.org/10.1074/jbc.M113.496869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24019523	Green Published, hybrid			2022-12-28	WOS:000330778900007
J	Lim, SP; Koh, JHK; Seh, CC; Liew, CW; Davidson, AD; Chua, LS; Chandrasekaran, R; Cornvik, TC; Shi, PY; Lescar, J				Lim, Siew Pheng; Koh, Jolene Hong Kiew; Seh, Cheah Chen; Liew, Chong Wai; Davidson, Andrew D.; Chua, Leng Shiew; Chandrasekaran, Ramya; Cornvik, Tobias C.; Shi, Pei-Yong; Lescar, Julien			A Crystal Structure of the Dengue Virus Non-structural Protein 5 (NS5) Polymerase Delineates Interdomain Amino Acid Residues That Enhance Its Thermostability and de Novo Initiation Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; OLIGOMERIZATION; FLEXIBILITY; MUTAGENESIS; DOMAIN; TYPE-2	The dengue virus (DENV) non-structural protein 5 (NS5) comprises an N-terminal methyltransferase and a C-terminal RNA-dependent RNA polymerase (RdRp) domain. Both enzymatic activities form attractive targets for antiviral development. Available crystal structures of NS5 fragments indicate that residues 263-271 (using the DENV serotype 3 numbering) located between the two globular domains of NS5 could be flexible. We observed that the addition of linker residues to the N-terminal end of the DENV RdRp core domain stabilizes DENV1-4 proteins and improves their de novo polymerase initiation activities by enhancing the turnover of the RNA and NTP substrates. Mutation studies of linker residues also indicate their importance for viral replication. We report the structure at 2.6-angstrom resolution of an RdRp fragment from DENV3 spanning residues 265-900 that has enhanced catalytic properties compared with the RdRp fragment (residues 272-900) reported previously. This new orthorhombic crystal form (space group P2(1)2(1)2) comprises two polymerases molecules arranged as a dimer around a non-crystallographic dyad. The enzyme adopts a closed "preinitiation" conformation similar to the one that was captured previously in space group C222(1) with one molecule per asymmetric unit. The structure reveals that residues 269-271 interact with the RdRp domain and suggests that residues 263-268 of the NS5 protein from DENV3 are the major contributors to the flexibility between its methyltransferase and RdRp domains. Together, these results should inform the screening and development of antiviral inhibitors directed against the DENV RdRp.	[Lim, Siew Pheng; Seh, Cheah Chen; Shi, Pei-Yong] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Koh, Jolene Hong Kiew; Davidson, Andrew D.] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Liew, Chong Wai; Chua, Leng Shiew; Chandrasekaran, Ramya; Cornvik, Tobias C.; Lescar, Julien] Nanyang Technol Univ, Div Struct Biol & Biochem, Sch Biol Sci, Singapore 138673, Singapore; [Lescar, Julien] CHU Pitie Salpetriere, Fac Med, INSERM UMRS 945 Immunite & Infect, F-75013 Paris, France; [Lescar, Julien] Univ Paris 06, F-75013 Paris, France	Novartis; University of Bristol; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Lim, SP (corresponding author), Novartis Inst Trop Dis, 10 Biopolis Rd,05-01 Chromos, Singapore 138670, Singapore.	siew_pheng.lim@novartis.com; julien@ntu.edu.sg	Lim, Siew Pheng/P-8528-2016; Pheng, Lim Siew/AAG-4368-2021	Pheng, Lim Siew/0000-0002-7377-5662; Chandrasekaran, Ramya/0000-0002-3468-2092	Biomedical Research Council Grant [0912219/599]; National Research Foundation [CRP2008]; MRC [G0801973] Funding Source: UKRI; Medical Research Council [G0801973] Funding Source: researchfish	Biomedical Research Council Grant(Agency for Science Technology & Research (A*STAR)); National Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biomedical Research Council Grant 0912219/599 and in part by Competitive Research Programme Grant CRP2008 from the National Research Foundation (to the J. L. laboratory).	Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bussetta C, 2012, BIOCHEMISTRY-US, V51, P5921, DOI 10.1021/bi300406n; Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hanley KA, 2002, J VIROL, V76, P525, DOI 10.1128/JVI.76.2.525-531.2002; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184; Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09; Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13; Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007; PATA JD, 1995, RNA, V1, P466; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Tellez AB, 2011, J MOL BIOL, V412, P737, DOI 10.1016/j.jmb.2011.07.053; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Yap LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012836; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Yap TL, 2007, ACTA CRYSTALLOGR F, V63, P78, DOI 10.1107/S1744309106055084; Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189	28	64	67	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31105	31114		10.1074/jbc.M113.508606	http://dx.doi.org/10.1074/jbc.M113.508606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24025331	hybrid, Green Published			2022-12-28	WOS:000330778900029
J	Berezniuk, I; Lyons, PJ; Sironi, JJ; Xiao, H; Setou, M; Angeletti, RH; Ikegami, K; Fricker, LD				Berezniuk, Iryna; Lyons, Peter J.; Sironi, Juan J.; Xiao, Hui; Setou, Mitsutoshi; Angeletti, Ruth H.; Ikegami, Koji; Fricker, Lloyd D.			Cytosolic Carboxypeptidase 5 Removes alpha- and gamma-Linked Glutamates from Tubulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carboxypeptidase; Enzymes; Metalloenzymes; Peptidases; Tubulin; Cytosolic Carboxypeptidase	PURKINJE-CELL DEGENERATION; AXONAL-TRANSPORT; BETA-TUBULIN; TYROSINE LIGASE; POLYGLUTAMYLASE; DISRUPTION; HUNTINGTIN; MUTATIONS; MECHANISM; PROTEINS	Cytosolic carboxypeptidase 5 (CCP5) is a member of a subfamily of enzymes that cleave C-terminal and/or side chain amino acids from tubulin. CCP5 was proposed to selectively cleave the branch point of glutamylated tubulin, based on studies involving overexpression of CCP5 in cell lines and detection of tubulin forms with antisera. In the present study, we examined the activity of purified CCP5 toward synthetic peptides as well as soluble - and -tubulin and paclitaxel-stabilized microtubules using a combination of antisera and mass spectrometry to detect the products. Mouse CCP5 removes multiple glutamate residues and the branch point glutamate from the side chains of porcine brain - and -tubulin. In addition, CCP5 excised C-terminal glutamates from detyrosinated -tubulin. The enzyme also removed multiple glutamate residues from side chains and C termini of paclitaxel-stabilized microtubules. CCP5 both shortens and removes side chain glutamates from synthetic peptides corresponding to the C-terminal region of 3-tubulin, whereas cytosolic carboxypeptidase 1 shortens the side chain without cleaving the peptides' -linked residues. The rate of cleavage of linkages by CCP5 is considerably slower than that of removal of a single -linked glutamate residue. Collectively, our data show that CCP5 functions as a dual-functional deglutamylase cleaving both - and -linked glutamate from tubulin.	[Berezniuk, Iryna; Lyons, Peter J.; Sironi, Juan J.; Fricker, Lloyd D.] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Berezniuk, Iryna; Fricker, Lloyd D.] Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Xiao, Hui; Angeletti, Ruth H.] Albert Einstein Coll Med, Lab Macromol Anal & Prote, Bronx, NY 10461 USA; [Setou, Mitsutoshi; Ikegami, Koji] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Hamamatsu, Shizuoka 4313192, Japan	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Hamamatsu University School of Medicine	Fricker, LD (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lloyd.fricker@einstein.yu.edu		Lyons, Peter/0000-0001-5214-5445	National Institutes of Health [DA-004494, 1P20 DA026149, 1R01 CA124898];  [23117517];  [25113511]; Grants-in-Aid for Scientific Research [23570209] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA124898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494, P20DA026149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA-004494 (to L. D. F.), 1P20 DA026149 (to R. H. A.), and 1R01 CA124898 (to S. B. Horwitz). This work was also supported by Grants-in-aid for Scientific Research on Innovative Areas 23117517 and 25113511 (K I.).	Berezniuk I, 2012, J BIOL CHEM, V287, P6503, DOI 10.1074/jbc.M111.309138; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Eschbach J, 2011, PHARMACOL THERAPEUT, V130, P348, DOI 10.1016/j.pharmthera.2011.03.004; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Her LS, 2008, J NEUROSCI, V28, P13662, DOI 10.1523/JNEUROSCI.4144-08.2008; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Ikegami K, 2009, FEBS LETT, V583, P1957, DOI 10.1016/j.febslet.2009.05.003; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Lyons PJ, 2013, J BIOL CHEM, V288, P30454, DOI 10.1074/jbc.M113.497933; Lyons PJ, 2011, J BIOL CHEM, V286, P39023, DOI 10.1074/jbc.M111.265819; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Otero A, 2012, FASEB J, V26, P3754, DOI 10.1096/fj.12-209601; Peethumnongsin E, 2010, J NEUROSCI, V30, P13409, DOI 10.1523/JNEUROSCI.1964-10.2010; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Regnard C, 1998, BIOCHEMISTRY-US, V37, P8395, DOI 10.1021/bi9804131; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; RUDIGER M, 1994, EUR J BIOCHEM, V220, P309, DOI 10.1111/j.1432-1033.1994.tb18627.x; Saha AR, 2004, J CELL SCI, V117, P1017, DOI 10.1242/jcs.00967; Sahab ZJ, 2011, CANCER RES, V71, P1219, DOI 10.1158/0008-5472.CAN-10-2294; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Sinadinos C, 2009, NEUROBIOL DIS, V34, P389, DOI 10.1016/j.nbd.2009.02.012; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Szyk A, 2011, NAT STRUCT MOL BIOL, V18, P1250, DOI 10.1038/nsmb.2148; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Verdier-Pinard P, 2009, ANAL BIOCHEM, V384, P197, DOI 10.1016/j.ab.2008.09.020; WEHLAND J, 1987, J CELL BIOL, V104, P1059, DOI 10.1083/jcb.104.4.1059; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008; WOLFF A, 1992, EUR J CELL BIOL, V59, P425; Wu HY, 2012, FASEB J, V26, P4468, DOI 10.1096/fj.12-205047	37	28	30	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30445	30453		10.1074/jbc.M113.497917	http://dx.doi.org/10.1074/jbc.M113.497917			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24022482	Green Published, hybrid			2022-12-28	WOS:000329868100040
J	Gajda, AM; Zhou, YX; Agellon, LB; Fried, SK; Kodukula, S; Fortson, W; Patel, K; Storch, J				Gajda, Angela M.; Zhou, Yin Xiu; Agellon, Luis B.; Fried, Susan K.; Kodukula, Sarala; Fortson, Walter; Patel, Khamoshi; Storch, Judith			Direct Comparison of Mice Null for Liver or Intestinal Fatty Acid-binding Proteins Reveals Highly Divergent Phenotypic Responses to High Fat Feeding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fatty Acid; Fatty Acid-binding Protein; Intestine; Lipid Metabolism; Monoacylglycerol	DIET-INDUCED OBESITY; EXACERBATES WEIGHT-GAIN; PROTECTS FEMALE MICE; BODY-WEIGHT; HEPATIC STEATOSIS; ENDOCANNABINOID SYSTEM; ENERGY-EXPENDITURE; INSULIN-RESISTANCE; PPAR-ALPHA; METABOLISM	The enterocyte expresses two fatty acid-binding proteins (FABP), intestinal FABP (IFABP; FABP2) and liver FABP (LFABP; FABP1). LFABP is also expressed in liver. Despite ligand transport and binding differences, it has remained uncertain whether these intestinally coexpressed proteins, which both bind long chain fatty acids (FA), are functionally distinct. Here, we directly compared IFABP(-/-) and LFABP(-/-) mice fed high fat diets containing long chain saturated or unsaturated fatty acids, reasoning that providing an abundance of dietary lipid would reveal unique functional properties. The results showed that mucosal lipid metabolism was indeed differentially modified, with significant decreases in FA incorporation into triacylglycerol (TG) relative to phospholipid (PL) in IFABP(-/-) mice, whereas LFABP(-/-) mice had reduced monoacylglycerol incorporation in TG relative to PL, as well as reduced FA oxidation. Interestingly, striking differences were found in whole body energy homeostasis; LFABP(-/-) mice fed high fat diets became obese relative to WT, whereas IFABP(-/-) mice displayed an opposite, lean phenotype. Fuel utilization followed adiposity, with LFABP(-/-) mice preferentially utilizing lipids, and IFABP(-/-) mice preferentially metabolizing carbohydrate for energy production. Changes in body weight and fat may arise, in part, from altered food intake; mucosal levels of the endocannabinoids 2-arachidonoylglycerol and arachidonoylethanolamine were elevated in LFABP(-/-), perhaps contributing to increased energy intake. This direct comparison provides evidence that LFABP and IFABP have distinct roles in intestinal lipid metabolism; differential intracellular functions in intestine and in liver, for LFABP(-/-) mice, result in divergent downstream effects at the systemic level.	[Gajda, Angela M.; Zhou, Yin Xiu; Kodukula, Sarala; Fortson, Walter; Patel, Khamoshi; Storch, Judith] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Gajda, Angela M.; Storch, Judith] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Agellon, Luis B.] McGill Univ, Sch Dietet & Human Nutr, Montreal, PQ H9X 3V9, Canada; [Fried, Susan K.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; McGill University; Boston University	Storch, J (corresponding author), Rutgers State Univ, Dept Nutr Sci, Thompson Hall,96 Lipman Dr, New Brunswick, NJ 08901 USA.	Storch@aesop.rutgers.edu	Zhou, yixin/HGE-2329-2022	Gajda, Angela/0000-0002-5374-2054; Storch, Judith/0000-0001-5482-1777	National Institutes of Health from NIDDK [DK-38389]; New Jersey Agricultural Experiment Station; Canadian Institute of Health Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038389, R01DK038389] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; New Jersey Agricultural Experiment Station; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-38389 from NIDDK. This work was also supported by funds from the New Jersey Agricultural Experiment Station (to J. S.) and in part by the Canadian Institute of Health Research (to L. B. A.).	Agellon LB, 2007, BBA-MOL CELL BIOL L, V1771, P1283, DOI 10.1016/j.bbalip.2007.08.004; Agellon LB, 2006, MOL CELL BIOCHEM, V284, P159, DOI 10.1007/s11010-005-9042-1; Alpers DH, 2000, BBA-MOL CELL BIOL L, V1483, P352, DOI 10.1016/S1388-1981(99)00200-0; Atshaves BP, 2010, J NUTR BIOCHEM, V21, P1015, DOI 10.1016/j.jnutbio.2010.01.005; Atshaves BP, 2010, LIPIDS, V45, P97, DOI 10.1007/s11745-009-3379-2; Atshaves BP, 2004, J BIOL CHEM, V279, P30954, DOI 10.1074/jbc.M313571200; Bach AC, 1996, J LIPID RES, V37, P708; BASS NM, 1985, J BIOL CHEM, V260, P1432; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Chen HC, 2003, AM J PHYSIOL-ENDOC M, V284, pE213, DOI 10.1152/ajpendo.00248.2002; Chon SH, 2007, J BIOL CHEM, V282, P33346, DOI 10.1074/jbc.M706994200; Chon SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043962; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Corsico B, 1998, P NATL ACAD SCI USA, V95, P12174, DOI 10.1073/pnas.95.21.12174; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; DiPatrizio NV, 2013, FASEB J, V27, P2513, DOI 10.1096/fj.13-227587; DiPatrizio NV, 2011, P NATL ACAD SCI USA, V108, P12904, DOI 10.1073/pnas.1104675108; Douglass JD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00025; Erol E, 2003, FASEB J, V17, P347, DOI 10.1096/fj.03-0330fje; Falomir-Lockhart LJ, 2011, BBA-MOL CELL BIOL L, V1811, P452, DOI 10.1016/j.bbalip.2011.04.005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; GANGL A, 1975, J CLIN INVEST, V55, P803, DOI 10.1172/JCI107991; GORDON JI, 1985, J BIOL CHEM, V260, P1995; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Hsu KT, 1996, J BIOL CHEM, V271, P13317, DOI 10.1074/jbc.271.23.13317; Izzo AA, 2009, BRIT J PHARMACOL, V158, P451, DOI 10.1111/j.1476-5381.2009.00183.x; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kahn C. R., 2013, KEYSTONE S DIABETES, P42; Kennedy ET, 1999, J AM COLL NUTR, V18, P207, DOI 10.1080/07315724.1999.10718853; Krempler F, 1998, ARTERIOSCL THROM VAS, V18, P1686, DOI 10.1161/01.ATV.18.11.1686; Labonte ED, 2003, PROTEIN EXPRES PURIF, V28, P25, DOI 10.1016/S1046-5928(02)00561-2; Lagakos WS, 2013, J BIOL CHEM, V288, P19805, DOI 10.1074/jbc.M113.473579; Lagakos WS, 2011, AM J PHYSIOL-GASTR L, V300, pG803, DOI 10.1152/ajpgi.00229.2010; Lambert DM, 2005, J MED CHEM, V48, P5059, DOI 10.1021/jm058183t; Leamy LJ, 2012, PHYSIOL GENOMICS, V44, P1141, DOI 10.1152/physiolgenomics.00115.2012; Levy E, 2009, HISTOCHEM CELL BIOL, V132, P351, DOI 10.1007/s00418-009-0608-y; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Lusk G, 1928, ELEMENTS SCI NUTR; Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200; Martin GG, 2008, J NUTR, V138, P1859, DOI 10.1093/jn/138.10.1859; Martin GG, 2009, MOL CELL BIOCHEM, V324, P101, DOI 10.1007/s11010-008-9989-9; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McIntosh AL, 2013, LIPIDS, V48, P435, DOI 10.1007/s11745-013-3777-3; McIntosh AL, 2009, ARCH BIOCHEM BIOPHYS, V485, P160, DOI 10.1016/j.abb.2009.03.004; McLean J., 1987, ANIMAL HUMAN CALORIM, P30; MISHKIN S, 1972, BIOCHEM BIOPH RES CO, V47, P997, DOI 10.1016/0006-291X(72)90931-X; Murphy EJ, 1996, BBA-LIPID LIPID MET, V1301, P191, DOI 10.1016/0005-2760(96)00024-0; Neeli I, 2007, J BIOL CHEM, V282, P17974, DOI 10.1074/jbc.M610765200; Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473; Newberry EP, 2008, AM J PHYSIOL-GASTR L, V294, pG307, DOI 10.1152/ajpgi.00377.2007; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Newberry EP, 2012, J LIPID RES, V53, P744, DOI 10.1194/jlr.M020966; Newberry EP, 2009, MOL CELL BIOCHEM, V326, P79, DOI 10.1007/s11010-008-0002-4; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Nishiumi S, 2010, J AGR FOOD CHEM, V58, P12916, DOI 10.1021/jf102840w; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Omar B, 2012, NUTRIENTS, V4, P1367, DOI 10.3390/nu4101367; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Praslickova D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050810; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; RICHIERI GV, 1994, J BIOL CHEM, V269, P23918; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; SACCHETTINI JC, 1990, J BIOL CHEM, V265, P19199; Siddiqi S, 2010, J LIPID RES, V51, P1918, DOI 10.1194/jlr.M005611; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Storch J., 2001, Nutrient-gene interactions in health and disease, P101; STORCH J, 1993, MOL CELL BIOCHEM, V123, P45, DOI 10.1007/BF01076474; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2008, J LIPID RES, V49, P1762, DOI 10.1194/jlr.M800116-JLR200; Storr MA, 2007, CURR OPIN PHARMACOL, V7, P575, DOI 10.1016/j.coph.2007.08.008; Stubbins RE, 2012, DIABETES OBES METAB, V14, P58, DOI 10.1111/j.1463-1326.2011.01488.x; Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4; Sugiyama MG, 2012, J NUTRIGENET NUTRIGE, V5, P45, DOI 10.1159/000337193; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Uchida A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00026; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Vassileva G, 2000, FASEB J, V14, P2040, DOI 10.1096/fj.99-0959com; Wolfrum C, 2000, BIOCHEMISTRY-US, V39, P14363, DOI 10.1021/bi0051187; Xie Y, 2009, J LIPID RES, V50, P977, DOI 10.1194/jlr.M800645-JLR200; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937	84	33	35	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30330	30344		10.1074/jbc.M113.501676	http://dx.doi.org/10.1074/jbc.M113.501676			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23990461	hybrid, Green Published			2022-12-28	WOS:000329868100030
J	Urzica, EI; Vieler, A; Hong-Hermesdorf, A; Page, MD; Casero, D; Gallaher, SD; Kropat, J; Pellegrini, M; Benning, C; Merchant, SS				Urzica, Eugen I.; Vieler, Astrid; Hong-Hermesdorf, Anne; Page, M. Dudley; Casero, David; Gallaher, Sean D.; Kropat, Janette; Pellegrini, Matteo; Benning, Christoph; Merchant, Sabeeha S.			Remodeling of Membrane Lipids in Iron-starved Chlamydomonas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Algae; Iron; Lipid Metabolism; Plant Biochemistry; Triacylglycerol; Fatty Acid Desaturase	TRIACYLGLYCEROL ACCUMULATION; NITROGEN DEPRIVATION; FATTY-ACIDS; PHOTOSYNTHETIC APPARATUS; THYLAKOID MEMBRANES; GENE-EXPRESSION; REINHARDTII; DEFICIENCY; BIOSYNTHESIS; ARABIDOPSIS	Background: Iron starvation triggers lipid droplet and triacylglycerol (TAG) accumulation in Chlamydomonas reinhardtii. Results: The overall lipid profile shows a decrease in the absolute content of monogalactosyldiacylglycerol (MGDG) and an increase in saturated and monounsaturated fatty acids. Conclusion: Iron starvation has an early and distinct effect on membrane lipids, before onset of chlorosis. Significance: Iron deficiency affects distribution of lipid type as well as fatty acid profile. Chlamydomonas reinhardtii cells exposed to abiotic stresses (e.g. nitrogen, zinc, or phosphorus deficiency) accumulate triacylglycerols (TAG), which are stored in lipid droplets. Here, we report that iron starvation leads to formation of lipid droplets and accumulation of TAGs. This occurs between 12 and 24 h after the switch to iron-starvation medium. C. reinhardtii cells deprived of iron have more saturated fatty acid (FA), possibly due to the loss of function of FA desaturases, which are iron-requiring enzymes with diiron centers. The abundance of a plastid acyl-ACP desaturase (FAB2) is decreased to the same degree as ferredoxin. Ferredoxin is a substrate of the desaturases and has been previously shown to be a major target of the iron deficiency response. The increase in saturated FA (C16:0 and C18:0) is concomitant with the decrease in unsaturated FA (C16:4, C18:3, or C18:4). This change was gradual for diacylglyceryl-N,N,N-trimethylhomoserine (DGTS) and digalactosyldiacylglycerol (DGDG), whereas the monogalactosyldiacylglycerol (MGDG) FA profile remained stable during the first 12 h, whereas MGDG levels were decreasing over the same period of time. These changes were detectable after only 2 h of iron starvation. On the other hand, DGTS and DGDG contents gradually decreased until a minimum was reached after 24-48 h. RNA-Seq analysis of iron-starved C. reinhardtii cells revealed notable changes in many transcripts coding for enzymes involved in FA metabolism. The mRNA abundances of genes coding for components involved in TAG accumulation (diacylglycerol acyltransferases or major lipid droplet protein) were increased. A more dramatic increase at the transcript level has been observed for many lipases, suggesting that major remodeling of lipid membranes occurs during iron starvation in C. reinhardtii.	[Urzica, Eugen I.; Hong-Hermesdorf, Anne; Page, M. Dudley; Gallaher, Sean D.; Kropat, Janette; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Casero, David; Pellegrini, Matteo; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Casero, David; Pellegrini, Matteo; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Vieler, Astrid; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Michigan State University	Urzica, EI (corresponding author), Univ Munster, Inst Plant Biol & Biotechnol, D-48143 Munster, Germany.	eugen.urzica@uni-muenster.de; sabeeha@chem.ucla.edu	Vieler, Astrid/J-2749-2019; Vieler, Astrid/P-5825-2014; Benning, Christoph/Y-2528-2019; Urzica, Eugen I/B-7903-2013; Casero, David/E-7365-2010; Vieler, Astrid/A-7334-2013; Urzica, Eugen Ioan/GXV-9546-2022	Vieler, Astrid/0000-0003-0009-7490; Vieler, Astrid/0000-0003-0009-7490; Benning, Christoph/0000-0001-8585-3667; Casero, David/0000-0002-7347-3330; Vieler, Astrid/0000-0003-0009-7490; Urzica, Eugen Ioan/0000-0002-1028-7442; Gallaher, Sean/0000-0002-9773-6051; Pellegrini, Matteo/0000-0001-9355-9564	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FD02-04ER15529]; Air Force Office of Science Research [FA 9550-10-1-0095, FA9550-08-0165]	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Air Force Office of Science Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grant DE-FD02-04ER15529 (to S. M.) and Air Force Office of Science Research Grants FA 9550-10-1-0095 (to M. P.) and FA9550-08-0165 (to C. B.).	ABADIA A, 1988, PHYSIOL PLANTARUM, V72, P713, DOI 10.1111/j.1399-3054.1988.tb06370.x; Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blouin A, 2003, PLANT PHYSIOL BIOCH, V41, P11, DOI 10.1016/S0981-9428(02)00003-7; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Busch A, 2008, PLANT J, V55, P201, DOI 10.1111/j.1365-313X.2008.03490.x; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Chen JCH, 2008, INT J TECHNOL MANAGE, V43, P1; Chen M, 2011, BIORESOURCE TECHNOL, V102, P1649, DOI 10.1016/j.biortech.2010.09.062; Deng XD, 2011, AFR J MICROBIOL RES, V5, P260; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; FISCHER W, 1973, H-S Z PHYSIOL CHEM, V354, P1115, DOI 10.1515/bchm2.1973.354.2.1115; FOLCH J, 1957, J BIOL CHEM, V226, P497; FOX BG, 1993, P NATL ACAD SCI USA, V90, P2486, DOI 10.1073/pnas.90.6.2486; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Hsieh SI, 2013, MOL CELL PROTEOMICS, V12, P65, DOI 10.1074/mcp.M112.021840; HUTNER S. H., 1950, PROC AMER PHIL SOC, V94, P152; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Kobayashi K, 2013, PLANT J, V73, P250, DOI 10.1111/tpj.12028; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; La Russa M, 2012, J BIOTECHNOL, V162, P13, DOI 10.1016/j.jbiotec.2012.04.006; Li XB, 2012, PLANT CELL, V24, P4670, DOI 10.1105/tpc.112.105106; Li XB, 2012, EUKARYOT CELL, V11, P1451, DOI 10.1128/EC.00268-12; Liu BS, 2013, CURR OPIN BIOTECH, V24, P300, DOI 10.1016/j.copbio.2012.08.008; Hernandez ML, 2012, PLANT PHYSIOL, V160, P215, DOI 10.1104/pp.112.201541; Matthew T, 2009, J BIOL CHEM, V284, P23415, DOI 10.1074/jbc.M109.003541; Merchant SS, 2012, CURR OPIN BIOTECH, V23, P352, DOI 10.1016/j.copbio.2011.12.001; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Miquel M, 1998, PLANT PHYSIOL, V117, P923, DOI 10.1104/pp.117.3.923; Moellering ER, 2010, EUKARYOT CELL, V9, P97, DOI 10.1128/EC.00203-09; MONGE E, 1993, PLANT SOIL, V154, P97, DOI 10.1007/BF00011077; Moore TS, 2001, PLANT PHYSIOL, V125, P423, DOI 10.1104/pp.125.1.423; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Msanne J, 2012, PHYTOCHEMISTRY, V75, P50, DOI 10.1016/j.phytochem.2011.12.007; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Nguyen HM, 2011, PROTEOMICS, V11, P4266, DOI 10.1002/pmic.201100114; NISHIO JN, 1985, PLANT PHYSIOL, V77, P705, DOI 10.1104/pp.77.3.705; Page MD, 2012, PLANT CELL, V24, P2649, DOI 10.1105/tpc.112.098962; Pineau B, 2004, EUR J BIOCHEM, V271, P329, DOI 10.1046/j.1432-1033.2003.03931.x; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; Riekhof WR, 2005, EUKARYOT CELL, V4, P242, DOI 10.1128/EC.4.2.242-252.2005; Riekhof WR, 2003, PLANT PHYSIOL, V133, P864, DOI 10.1104/pp.103.029249; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; SCHMIDT H, 1990, P NATL ACAD SCI USA, V87, P9477, DOI 10.1073/pnas.87.23.9477; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; STOCKING CR, 1975, PLANT PHYSIOL, V55, P626, DOI 10.1104/pp.55.4.626; Terauchi AM, 2010, PHOTOSYNTH RES, V105, P39, DOI 10.1007/s11120-010-9562-8; TERRY N, 1980, PLANT PHYSIOL, V65, P114, DOI 10.1104/pp.65.1.114; Urzica EI, 2012, PLANT CELL, V24, P3921, DOI 10.1105/tpc.112.102491; WADA H, 1993, J BACTERIOL, V175, P544, DOI 10.1128/JB.175.2.544-547.1993; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Weers PMM, 1997, LIMNOL OCEANOGR, V42, P1584, DOI 10.4319/lo.1997.42.7.1584; Yang WY, 2004, BIOCHEM J, V382, P51, DOI 10.1042/BJ20040254; Yoon K, 2012, PLANT CELL, V24, P3708, DOI 10.1105/tpc.112.100701; Zauner S, 2012, EUKARYOT CELL, V11, P856, DOI 10.1128/EC.00079-12; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795	59	62	64	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30246	30258		10.1074/jbc.M113.490425	http://dx.doi.org/10.1074/jbc.M113.490425			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23983122	Green Published, hybrid			2022-12-28	WOS:000329868100023
J	Baranova, NS; Foulcer, SJ; Briggs, DC; Tilakaratna, V; Enghild, JJ; Milner, CM; Day, AJ; Richter, RP				Baranova, Natalia S.; Foulcer, Simon J.; Briggs, David C.; Tilakaratna, Viranga; Enghild, Jan J.; Milner, Caroline M.; Day, Anthony J.; Richter, Ralf P.			Inter-alpha-inhibitor Impairs TSG-6-induced Hyaluronan Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-STIMULATED GENE-6; BLOOD FOLLICLE BARRIER; SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; TRYPSIN-INHIBITOR; RHEUMATOID-ARTHRITIS; PROTEIN TSG-6; HEAVY-CHAINS; GRAFTED HYALURONAN; OOCYTE COMPLEXES	Under inflammatory conditions and in the matrix of the cumulus-oocyte complex, the polysaccharide hyaluronan (HA) becomes decorated covalently with heavy chains (HCs) of the serum glycoprotein inter-alpha-inhibitor (I alpha I). This alters the functional properties of the HA as well as its structural role within extracellular matrices. The covalent transfer of HCs from I alpha I to HA is catalyzed by TSG-6 (tumor necrosis factor-stimulated gene-6), but TSG-6 is also known as a HA cross-linker that induces condensation of the HA matrix. Here, we investigate the interplay of these two distinct functions of TSG-6 by studying the ternary interactions of I alpha I and TSG-6 with well defined films of end-grafted HA chains. We demonstrate that TSG-6-mediated cross-linking of HA films is impaired in the presence of I alpha I and that this effect suppresses the TSG-6-mediated enhancement of HA binding to CD44-positive cells. Furthermore, we find that the interaction of TSG-6 and I alpha I in the presence of HA gives rise to two types of complexes that independently promote the covalent transfer of heavy chains to HA. One type of complex interacts very weakly with HA and is likely to correspond to the previously reported covalent HC.TSG-6 complexes. The other type of complex is novel and binds stably but noncovalently to HA. Prolonged incubation with TSG-6 and I alpha I leads toHA films that contain, in addition to covalently HA-bound HCs, several tightly but noncovalently bound molecular species. These findings have important implications for understanding how the biological activities of TSG-6 are regulated, such that the presence or absence of I alpha I will dictate its function.	[Baranova, Natalia S.; Richter, Ralf P.] CIC BiomaGUNE, Biosurfaces Unit, Donostia San Sebastian 20009, Spain; [Foulcer, Simon J.; Briggs, David C.; Tilakaratna, Viranga; Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Milner, Caroline M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Enghild, Jan J.] Univ Aarhus, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Richter, Ralf P.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Richter, Ralf P.] Univ Grenoble 1, Dept Mol Chem, F-38041 Grenoble 9, France	CIC biomaGUNE; University of Manchester; University of Manchester; Aarhus University; Max Planck Society; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Day, AJ (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	anthony.day@manchester.ac.uk; rrichter@cicbiomagune.es	Day, Anthony/O-1658-2015; Milner, Caroline M/P-5526-2015; Richter, Ralf Peter/B-3343-2013; biomaGUNE, CIC/J-9136-2014	Day, Anthony/0000-0002-1415-3134; Milner, Caroline M/0000-0001-7355-9655; Richter, Ralf Peter/0000-0003-3071-2837; Baranova, Natalia/0000-0002-3086-9124; Enghild, Jan Johannes/0000-0001-9292-9172; Briggs, David/0000-0002-9793-7339; biomaGUNE, CIC/0000-0001-7690-0660	German Federal Ministry of Education and Research [0315157]; Spanish Ministry of Economy and Competitiveness [MAT2011-24306, RYC2009-04275]; European Research Council [306435]; Arthritis Research UK [18472, 19489]; Medical Research Council [G0701180, G0800127]; MRC [G0701180] Funding Source: UKRI; Versus Arthritis [19489, 18472] Funding Source: researchfish	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Spanish Ministry of Economy and Competitiveness(Spanish Government); European Research Council(European Research Council (ERC)European Commission); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Versus Arthritis(Versus Arthritis)	This work was supported by German Federal Ministry of Education and Research Grant 0315157, Spanish Ministry of Economy and Competitiveness Grants MAT2011-24306 and RYC2009-04275, and European Research Council Starting Grant 306435 (to R. P. R.). This work was also supported by Arthritis Research UK Grants 18472 and 19489 and Medical Research Council Grant G0701180 (to A. J. D. and C. M. M.).; Recipient of Medical Research Council Doctoral Training Award Grant G0800127.	Attili S, 2012, BIOMACROMOLECULES, V13, P1466, DOI 10.1021/bm3001759; Attili S, 2012, LANGMUIR, V28, P3206, DOI 10.1021/la204602n; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Carrette O, 2001, BIOL REPROD, V65, P301, DOI 10.1095/biolreprod65.1.301; CHEN L, 1992, J BIOL CHEM, V267, P12380; Chen L, 1996, J BIOL CHEM, V271, P19409, DOI 10.1074/jbc.271.32.19409; Colon E, 2009, J BIOL CHEM, V284, P2320, DOI 10.1074/jbc.M807183200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Day AJ, 2001, CURR OPIN STRUC BIOL, V11, P617, DOI 10.1016/S0959-440X(00)00256-6; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; DEGENNES PG, 1987, ADV COLLOID INTERFAC, V27, P189, DOI 10.1016/0001-8686(87)85003-0; Eisele NB, 2010, EMBO REP, V11, P366, DOI 10.1038/embor.2010.34; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Fujimoto T, 2002, AM J PATHOL, V160, P1495, DOI 10.1016/S0002-9440(10)62575-8; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gal I, 2003, J BIOL CHEM, V278, P11150, DOI 10.1074/jbc.M210661200; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; HAMERMAN D, 1963, J CLIN INVEST, V42, P1882, DOI 10.1172/JCI104873; Heng BC, 2008, J BIOL CHEM, V283, P32294, DOI 10.1074/jbc.M804155200; Hess KA, 1998, BIOL REPROD, V58, P705, DOI 10.1095/biolreprod58.3.705; Ievoli E, 2011, MATRIX BIOL, V30, P330, DOI 10.1016/j.matbio.2011.05.002; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Jessen TE, 2004, OSTEOARTHR CARTILAGE, V12, P142, DOI 10.1016/j.joca.2003.10.004; Kida D, 1999, J RHEUMATOL, V26, P1230; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; LESLEY J, 1992, J EXP MED, V175, P257, DOI 10.1084/jem.175.1.257; Luchetti MM, 2000, CLIN EXP IMMUNOL, V119, P196, DOI 10.1046/j.1365-2249.2000.01110.x; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Mahoney DJ, 2001, J BIOL CHEM, V276, P22764, DOI 10.1074/jbc.M100666200; Marson A, 2009, GLYCOBIOLOGY, V19, P1537, DOI 10.1093/glycob/cwp132; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; POWERS RW, 1995, AM J PHYSIOL-ENDOC M, V269, pE290, DOI 10.1152/ajpendo.1995.269.2.E290; Richter RP, 2007, J AM CHEM SOC, V129, P5306, DOI 10.1021/ja068768s; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Russell DL, 2006, SEMIN REPROD MED, V24, P217, DOI 10.1055/s-2006-948551; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Wisniewski HG, 2005, J BIOL CHEM, V280, P14476, DOI 10.1074/jbc.M411734200; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Yoshihara Y, 2008, OSTEOARTHR CARTILAGE, V16, P1343, DOI 10.1016/j.joca.2008.04.004; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	64	49	50	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29642	29653		10.1074/jbc.M113.477422	http://dx.doi.org/10.1074/jbc.M113.477422			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24005673	Green Published, hybrid			2022-12-28	WOS:000330615300040
J	Govorunova, EG; Sineshchekov, OA; Li, H; Janz, R; Spudich, JL				Govorunova, Elena G.; Sineshchekov, Oleg A.; Li, Hai; Janz, Roger; Spudich, John L.			Characterization of a Highly Efficient Blue-shifted Channelrhodopsin from the Marine Alga Platymonas subcordiformis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY RHODOPSIN; PHOTOPHOBIC RESPONSES; OPTOGENETIC TOOLS; VOLVOX-CARTERI; SCHIFF-BASE; LIGHT; BACTERIORHODOPSIN; CHLAMYDOMONAS; PHOTOTAXIS; CHANNEL	Rhodopsin photosensors of phototactic algae act as light-gated cation channels when expressed in animal cells. These proteins (channelrhodopsins) are extensively used for millisecond scale photocontrol of cellular functions (optogenetics). We report characterization of PsChR, one of the phototaxis receptors in the alga Platymonas (Tetraselmis) subcordiformis. PsChR exhibited similar to 3-fold higher unitary conductance and greater relative permeability for Na+ ions, as compared with the most frequently used channelrhodopsin-2 from Chlamydomonas reinhardtii (CrChR2). Photocurrents generated by PsChR in HEK293 cells showed lesser inactivation and faster peak recovery than those by CrChR2. Their maximal spectral sensitivity was at 445 nm, making PsChR the most blue-shifted channel-rhodopsin so far identified. The lambda(max) of detergent-purified PsChR was 437 nm at neutral pH and exhibited red shifts (pK(a) values at 6.6 and 3.8) upon acidification. The purified pigment undergoes a photocycle with a prominent red-shifted intermediate whose formation and decay kinetics match the kinetics of channel opening and closing. The rise and decay of an M-like intermediate prior to formation of this putative conductive state were faster than in CrChR2. PsChR mediated sufficient light-induced membrane depolarization in cultured hippocampal neurons to trigger reliable repetitive spiking at the upper threshold frequency of the neurons. At low frequencies spiking probability decreases less with PsChR than with CrChR2 because of the faster recovery of the former. Its blue-shifted absorption enables optogenetics at wavelengths even below 400 nm. A combination of characteristics makes PsChR important for further research on structure-function relationships in ChRs and potentially useful for optogenetics, especially for combinatorial applications when short wavelength excitation is required.	[Govorunova, Elena G.; Sineshchekov, Oleg A.; Li, Hai; Spudich, John L.] Univ Texas Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA; [Janz, Roger] Univ Texas Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Spudich, JL (corresponding author), Univ Texas Med Sch, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA.	john.l.spudich@uth.tmc.edu	LI, HAI/G-3823-2012; LI, HAI/B-4052-2012; Li, Hai/J-5419-2014	Govorunova, Elena/0000-0003-0522-9683; Janz, Roger/0000-0002-9872-0596	National Institutes of Health [R01GM027750, R21MH098288]; Hermann Eye Fund; Endowed Chair from the Robert A. Welch Foundation [AU-0009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH098288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hermann Eye Fund; Endowed Chair from the Robert A. Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM027750 and R21MH098288. This work was also supported by the Hermann Eye Fund and Endowed Chair AU-0009 from the Robert A. Welch Foundation.	Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Brewer GJ, 2008, J NEUROSCI METH, V170, P181, DOI 10.1016/j.jneumeth.2008.01.009; Cherny VV, 2003, J GEN PHYSIOL, V121, P615, DOI 10.1085/jgp.200308813; Collot M, 2012, J AM CHEM SOC, V134, P14923, DOI 10.1021/ja304018d; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; GERGELY C, 1995, J PHOTOCH PHOTOBIO B, V27, P27, DOI 10.1016/1011-1344(94)07057-U; Govorunova EG, 2004, BIOPHYS J, V86, P2342, DOI 10.1016/S0006-3495(04)74291-5; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Gradmann D, 2011, BIOPHYS J, V101, P1057, DOI 10.1016/j.bpj.2011.07.040; Gray PT, 1994, PLYMOUTH WORKSHOP HD, P189; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; HALLDAL, 1958, PHYSIOL PLANTARUM, V11, P118; Han X, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.012.2009; Hegemann P, 2008, ANNU REV PLANT BIOL, V59, P167, DOI 10.1146/annurev.arplant.59.032607.092847; Hegemann P, 2013, EMBO MOL MED, V5, P173, DOI 10.1002/emmm.201202387; Hegemann P, 2011, NAT METHODS, V8, P39, DOI 10.1038/NMETH.F.327; HONIG B, 1976, BIOCHEMISTRY-US, V15, P4593, DOI 10.1021/bi00666a008; Hou SY, 2012, PHOTOCHEM PHOTOBIOL, V88, P119, DOI 10.1111/j.1751-1097.2011.01027.x; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kianianmomeni A, 2009, PLANT PHYSIOL, V151, P347, DOI 10.1104/pp.109.143297; Kleinlogel S, 2011, NAT METHODS, V8, P1083, DOI [10.1038/NMETH.1766, 10.1038/nmeth.1766]; KREIMER G, 1994, INT REV CYTOL, V148, P229, DOI 10.1016/S0074-7696(08)62409-2; Li YL, 2012, NAT NEUROSCI, V15, P1047, DOI 10.1038/nn.3126; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; LITVIN FF, 1978, NATURE, V271, P476, DOI 10.1038/271476a0; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MARTI T, 1991, J BIOL CHEM, V266, P18674; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; MCLACHLAN J, 1960, CAN J MICROBIOL, V6, P367, DOI 10.1139/m60-041; Mei Y, 2012, BIOL PSYCHIAT, V71, P1033, DOI 10.1016/j.biopsych.2012.02.019; Nack M, 2009, FEBS LETT, V583, P3676, DOI 10.1016/j.febslet.2009.10.052; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; OHNO K, 1977, BIOCHIM BIOPHYS ACTA, V462, P575, DOI 10.1016/0005-2728(77)90102-5; PETTEI MJ, 1977, BIOCHEMISTRY-US, V16, P1955, DOI 10.1021/bi00628a031; Plazzo AP, 2012, J BIOL CHEM, V287, P4818, DOI 10.1074/jbc.M111.326207; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Richards R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050018; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Ruffert K, 2011, BIOCHEM BIOPH RES CO, V410, P737, DOI 10.1016/j.bbrc.2011.06.024; SAUVE R, 1985, J THEOR BIOL, V113, P501, DOI 10.1016/S0022-5193(85)80035-7; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; SINESHCHEKOV OA, 1992, J PHOTOCH PHOTOBIO B, V13, P119, DOI 10.1016/1011-1344(92)85051-U; Sineshchekov OA, 2005, BIOPHYS J, V89, P4310, DOI 10.1529/biophysj.105.070920; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Sineshchekov OA, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P25, DOI 10.1002/352760510X.ch2; Sineshchekov OA, 2013, BIOPHYS J, V104, P807, DOI 10.1016/j.bpj.2013.01.002; Sineshchevkov OA, 2005, J BIOL CHEM, V280, P14663, DOI 10.1074/jbc.m501416200; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; SUBRAMANIAM S, 1990, P NATL ACAD SCI USA, V87, P1013, DOI 10.1073/pnas.87.3.1013; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; TAKAHASHI T, 1990, BIOCHEMISTRY-US, V29, P8467, DOI 10.1021/bi00488a038; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tsuda S, 2013, NEUROSCI RES, V75, P76, DOI 10.1016/j.neures.2012.11.006; Tsunoda SP, 2009, PHOTOCHEM PHOTOBIOL, V85, P564, DOI 10.1111/j.1751-1097.2008.00519.x; Ullrich S, 2013, BIOL CHEM, V394, P271, DOI 10.1515/hsz-2012-0256; Verhoefen MK, 2010, CHEMPHYSCHEM, V11, P3113, DOI 10.1002/cphc.201000181; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Wang JH, 2012, J BIOL CHEM, V287, P21316, DOI 10.1074/jbc.M112.344622; Wang WW, 2003, J BIOL CHEM, V278, P33985, DOI 10.1074/jbc.M305716200; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Yawo H, 2013, DEV GROWTH DIFFER, V55, P474, DOI 10.1111/dgd.12053; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	70	59	66	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29911	29922		10.1074/jbc.M113.505495	http://dx.doi.org/10.1074/jbc.M113.505495			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23995841	Green Published, hybrid			2022-12-28	WOS:000330615300064
J	He, J; Kauffman, WB; Fuselier, T; Naveen, SK; Voss, TG; Hristova, K; Wimley, WC				He, Jing; Kauffman, W. Berkeley; Fuselier, Taylor; Naveen, Somanna K.; Voss, Thomas G.; Hristova, Kalina; Wimley, William C.			Direct Cytosolic Delivery of Polar Cargo to Cells by Spontaneous Membrane-translocating Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENETRATING PEPTIDES; INTERFACIAL ACTIVITY; UPTAKE KINETICS; MECHANISM; TRANSFECTION; ENDOCYTOSIS; EFFICIENCY; BILAYERS; PATHWAYS; SYSTEM	Direct cellular entry of potentially useful polar compounds into cells is prevented by the hydrophobic barrier of the membrane. Toward circumventing this barrier, we used high throughput screening to identify a family of peptides that carry membrane-impermeant cargos across synthetic membranes. Here we characterize the plasma membrane translocation of these peptides with polar cargos under a variety of conditions. The spontaneous membrane-translocating peptides (SMTPs) delivered the zwitterionic, membrane-impermeant dye tetramethylrhodamine (TAMRA) into cells even when the conditions were not permissive for endocytosis. They also delivered the larger, anionic membrane-impermeant dye Alexa Fluor 546 but did not deliver a quantum dot nanoparticle. Under all conditions, the SMTP-cargo filled the cytoplasm with a diffuse, non-punctate fluorescence that was partially excluded from the nucleus. D-Amino acid peptides behaved identically in vitro, ruling out proteolysis as an important factor in the diffuse cellular distribution. Thus, cytosolic delivery of SMTP-cargo conjugates is dominated by direct membrane translocation. This is in sharp contrast to Arg(9)-TAMRA, a representative highly cationic, cell-penetrating peptide, which entered cells only when endocytosis was permitted. Arg(9)-TAMRA triggered large scale endocytosis and did not appreciably escape the endosomal compartments in the 1-h timescales we studied. When injected into mice, SMTP-TAMRA conjugates were found in many tissues even after 2 h. Unconjugated TAMRA was rapidly cleared and did not become systemically distributed. SMTPs are a platform that could improve delivery of many polar compounds to cells, in the laboratory or in the clinic, including those that would otherwise be rejected as drugs because they are membrane-impermeant.	[He, Jing; Kauffman, W. Berkeley; Fuselier, Taylor; Wimley, William C.] Tulane Univ, Sch Med, Dept Biochem, New Orleans, LA 70112 USA; [Naveen, Somanna K.; Voss, Thomas G.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	Tulane University; Tulane University; Johns Hopkins University	Wimley, WC (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	wwimley@tulane.edu	He, Jing/B-2400-2015	Kauffman, William/0000-0003-0571-5403	National Institutes of Health [GM60000]; National Science Foundation Division of Materials Research [1003441, 1003411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Division of Materials Research(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60000 (to W. C. W.). This work was also supported by National Science Foundation Division of Materials Research Grants 1003441 (to W. C. W.) and 1003411 (to K.H.).	Abes S, 2006, J CONTROL RELEASE, V110, P595, DOI 10.1016/j.jconrel.2005.10.026; Aguilera TA, 2009, INTEGR BIOL, V1, P371, DOI 10.1039/b904878b; Bayley H, 2004, MOL MEMBR BIOL, V21, P209, DOI 10.1080/09687680410001716853; Bessodes Michel, 2013, Methods Mol Biol, V948, P67, DOI 10.1007/978-1-62703-140-0_6; Chugh A, 2010, IUBMB LIFE, V62, P183, DOI 10.1002/iub.297; Cruz J, 2013, BIOPHYS J, V104, P2419, DOI 10.1016/j.bpj.2013.04.043; Debart F, 2007, CURR TOP MED CHEM, V7, P727, DOI 10.2174/156802607780487704; Delehanty JB, 2010, INTEGR BIOL-UK, V2, P265, DOI 10.1039/c0ib00002g; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dong M, 2012, CLIN CANCER RES, V18, P1830, DOI 10.1158/1078-0432.CCR-11-2105; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Dupont E, 2011, METHODS MOL BIOL, V683, P21, DOI 10.1007/978-1-60761-919-2_2; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Fazio N, 2010, CANCER TREAT REV, V36, pS87, DOI 10.1016/S0305-7372(10)70026-8; Floren A, 2011, METHODS MOL BIOL, V683, P117, DOI 10.1007/978-1-60761-919-2_9; Fonseca SB, 2009, ADV DRUG DELIVER REV, V61, P953, DOI 10.1016/j.addr.2009.06.001; Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x; Gautam A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-74; Gerlach SL, 2010, BIOPOLYMERS, V94, P617, DOI 10.1002/bip.21435; GIOCONDI MC, 1989, BIOCHEM BIOPH RES CO, V162, P1004, DOI 10.1016/0006-291X(89)90773-0; He J, 2012, ANGEW CHEM INT EDIT, V51, P7150, DOI 10.1002/anie.201202741; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jafari M, 2013, BIOCHEMISTRY-US, V52, P3428, DOI 10.1021/bi4001326; Jarver P, 2010, TRENDS PHARMACOL SCI, V31, P528, DOI 10.1016/j.tips.2010.07.006; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Langel U., 2006, HDB CELL PENETRATING; Lehto T, 2010, J CONTROL RELEASE, V141, P42, DOI 10.1016/j.jconrel.2009.08.028; Longmuir KJ, 2009, INT J PHARMACEUT, V382, P222, DOI 10.1016/j.ijpharm.2009.07.030; Mager I, 2012, BBA-BIOMEMBRANES, V1818, P502, DOI 10.1016/j.bbamem.2011.11.020; Marks JR, 2011, J AM CHEM SOC, V133, P8995, DOI 10.1021/ja2017416; Montrose K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01661; Mukai Y, 2006, BIOL PHARM BULL, V29, P1570, DOI 10.1248/bpb.29.1570; Nakase I, 2012, ACCOUNTS CHEM RES, V45, P1132, DOI 10.1021/ar200256e; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Palm-Apergi C, 2009, FASEB J, V23, P214, DOI 10.1096/fj.08-110254; Raagel H, 2010, BBA-BIOMEMBRANES, V1798, P2240, DOI 10.1016/j.bbamem.2010.02.013; Rathinakumar R, 2010, FASEB J, V24, P3232, DOI 10.1096/fj.10-157040; Rathinakumar R, 2009, J AM CHEM SOC, V131, P7609, DOI 10.1021/ja8093247; Rausch JM, 2007, BIOCHEMISTRY-US, V46, P12124, DOI 10.1021/bi700978h; Sadler K, 2002, BIOCHEMISTRY-US, V41, P14150, DOI 10.1021/bi026661l; Salomone F, 2012, J CONTROL RELEASE, V163, P293, DOI 10.1016/j.jconrel.2012.09.019; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Tan YX, 2012, J GENE MED, V14, P241, DOI 10.1002/jgm.2609; TSONG TY, 1991, BIOPHYS J, V60, P297, DOI 10.1016/S0006-3495(91)82054-9; Van Overstraeten-Schlogel N, 2012, DRUG DELIV, V19, P112, DOI 10.3109/10717544.2011.649219; Wang S, 2012, J MED CHEM, V55, P2427, DOI 10.1021/jm201743s; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yandek LE, 2007, BIOPHYS J, V92, P2434, DOI 10.1529/biophysj.106.100198; Yu HJ, 2011, ACS NANO, V5, P9246, DOI 10.1021/nn203503h	52	46	46	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29974	29986		10.1074/jbc.M113.488312	http://dx.doi.org/10.1074/jbc.M113.488312			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23983125	hybrid, Green Published			2022-12-28	WOS:000330615300070
J	Iwata, J; Suzuki, A; Pelikan, RC; Ho, TV; Chai, Y				Iwata, Jun-ichi; Suzuki, Akiko; Pelikan, Richard C.; Thach-Vu Ho; Chai, Yang			Noncanonical Transforming Growth Factor beta (TGF beta) Signaling in Cranial Neural Crest Cells Causes Tongue Muscle Developmental Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; BONE MORPHOGENETIC PROTEINS; CRANIOFACIAL MUSCLES; MUTANT MICE; DIFFERENTIATION; FATE; TENDONS; BMP7; PROLIFERATION; MACHINERY	Microglossia is a congenital birth defect in humans and adversely impacts quality of life. In vertebrates, tongue muscle derives from the cranial mesoderm, whereas tendons and connective tissues in the craniofacial region originate from cranial neural crest (CNC) cells. Loss of transforming growth factor beta (TGF beta) type II receptor in CNC cells in mice (Tgfbr2(fl/fl); Wnt1-Cre) causes microglossia due to a failure of cell-cell communication between cranial mesoderm and CNC cells during tongue development. However, it is still unclear how TGF beta signaling in CNC cells regulates the fate of mesoderm-derived myoblasts during tongue development. Here we show that activation of the cytoplasmic and nuclear tyrosine kinase 1 (ABL1) cascade in Tgfbr2(fl/fl); Wnt1-Cre mice results in a failure of CNC-derived cell differentiation followed by a disruption of TGF beta-mediated induction of growth factors and reduction of myogenic cell proliferation and differentiation activities. Among the affected growth factors, the addition of fibroblast growth factor 4 (FGF4) and neutralizing antibody for follistatin (FST; an antagonist of bone morphogenetic protein (BMP)) could most efficiently restore cell proliferation, differentiation, and organization of muscle cells in the tongue of Tgfbr2(fl/fl); Wnt1-Cre mice. Thus, our data indicate that CNC-derived fibroblasts regulate the fate of mesoderm-derived myoblasts through TGF beta-mediated regulation of FGF and BMP signaling during tongue development.	[Iwata, Jun-ichi; Suzuki, Akiko; Pelikan, Richard C.; Thach-Vu Ho; Chai, Yang] Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA	University of Southern California	Chai, Y (corresponding author), Univ So Calif, Ostrow Sch Dent, Ctr Craniofacial Mol Biol, 2250 Alcazar St CSA 103, Los Angeles, CA 90033 USA.	ychai@usc.edu			National Institutes of Health through the NIDCR [DE14078, DE020065, DE012711]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014078, R37DE012711, U01DE020065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012711] Funding Source: NIH RePORTER	National Institutes of Health through the NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE14078, DE020065, and DE012711 (to Y.C.) through the NIDCR.	Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dudley AT, 1997, DEV DYNAM, V208, P349; Edom-Vovard F, 2004, DEV DYNAM, V229, P449, DOI 10.1002/dvdy.10481; Eloy-Trinquet S, 2009, DEV DYNAM, V238, P1195, DOI 10.1002/dvdy.21946; Emmanouil-Nikoloussi E N, 1992, Bull Group Int Rech Sci Stomatol Odontol, V35, P5; Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040; Grenier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004381; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; HAHN GV, 1992, GENOMICS, V14, P759, DOI 10.1016/S0888-7543(05)80181-8; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Iwata J, 2006, J BIOL CHEM, V281, P4035, DOI 10.1074/jbc.M512283200; Iwata J, 2011, ORAL DIS, V17, P733, DOI 10.1111/j.1601-0825.2011.01806.x; Iwata J, 2012, J CLIN INVEST, V122, P873, DOI 10.1172/JCI61498; Iwata J, 2012, J BIOL CHEM, V287, P2353, DOI 10.1074/jbc.M111.280974; Iwata J, 2010, J BIOL CHEM, V285, P4975, DOI 10.1074/jbc.M109.035105; Jones PL, 2000, MATRIX BIOL, V19, P581, DOI 10.1016/S0945-053X(00)00106-2; Kim RY, 2001, DEV BIOL, V235, P449, DOI 10.1006/dbio.2001.0284; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; Massague J, 2000, GENE DEV, V14, P627; McLennan IS, 2002, INT J DEV BIOL, V46, P559; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; OLSON EN, 1986, J CELL BIOL, V103, P1799, DOI 10.1083/jcb.103.5.1799; Parada C, 2012, J DENT RES, V91, P528, DOI 10.1177/0022034511434055; Pounds S, 2004, BIOINFORMATICS, V20, P1737, DOI 10.1093/bioinformatics/bth160; Sambasivan R, 2011, DEVELOPMENT, V138, P2401, DOI 10.1242/dev.040972; Schneider MD, 2003, CYTOKINE GROWTH F R, V14, P1, DOI 10.1016/S1359-6101(02)00053-9; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Shimokawa K, 2011, DEV CELL, V21, P257, DOI 10.1016/j.devcel.2011.06.027; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Tirosh-Finkel L, 2010, DEVELOPMENT, V137, P2989, DOI 10.1242/dev.051649; TRAINOR PA, 1994, DEVELOPMENT, V120, P2397; Tsuchida K, 2006, EXPERT OPIN BIOL TH, V6, P147, DOI 10.1517/14712598.6.2.147; van Wijk B, 2007, CARDIOVASC RES, V74, P244, DOI 10.1016/j.cardiores.2006.11.022; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Wang Y., 2009, COLD SPRING HARB PRO; Xia XQ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-306; Xu X, 2008, DEV CELL, V15, P322, DOI 10.1016/j.devcel.2008.06.004; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493	47	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29760	29770		10.1074/jbc.M113.493551	http://dx.doi.org/10.1074/jbc.M113.493551			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23950180	Green Published, hybrid			2022-12-28	WOS:000330615300051
J	Luque-Almagro, VM; Lyall, VJ; Ferguson, SJ; Roldan, MD; Richardson, DJ; Gates, AJ				Luque-Almagro, Victor M.; Lyall, Verity J.; Ferguson, Stuart J.; Dolores Roldan, M.; Richardson, David J.; Gates, Andrew J.			Nitrogen Oxyanion-dependent Dissociation of a Two-component Complex That Regulates Bacterial Nitrate Assimilation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ANTITERMINATION; OPERON EXPRESSION; REDUCTASE OPERON; BINDING PROTEIN; NITRITE; GENE; NASR; INDUCTION; CRYSTAL; SYSTEM	Nitrogen is an essential nutrient for growth and is readily available to microbes in many environments in the form of ammonium and nitrate. Both ions are of environmental significance due to sustained use of inorganic fertilizers on agricultural soils. Diverse species of bacteria that have an assimilatory nitrate/nitrite reductase system (NAS) can use nitrate or nitrite as the sole nitrogen source for growth when ammonium is limited. In Paracoccus denitrificans, the pathway-specific two-component regulator for NAS expression is encoded by the nasT and nasS genes. Here, we show that the putative RNA-binding protein NasT is a positive regulator essential for expression of the nas gene cluster (i.e. nasABGHC). By contrast, a nitrogen oxyanion-binding sensor (NasS) is required for nitrate/nitrite-responsive control of nas gene expression. The NasS and NasT proteins co-purify as a stable heterotetrameric regulatory complex, NasS-NasT. This protein-protein interaction is sensitive to nitrate and nitrite, which cause dissociation of the NasS-NasT complex into monomeric NasS and an oligomeric form of NasT. NasT has been shown to bind the leader RNA for nasA. Thus, upon liberation from the complex, the positive regulator NasT is free to up-regulate nas gene expression.	[Luque-Almagro, Victor M.; Lyall, Verity J.; Richardson, David J.; Gates, Andrew J.] Univ E Anglia, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Luque-Almagro, Victor M.; Lyall, Verity J.; Richardson, David J.; Gates, Andrew J.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Dolores Roldan, M.] Univ Cordoba, Dept Bioquim & Biol Mol, E-14071 Cordoba, Spain; [Ferguson, Stuart J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of East Anglia; University of East Anglia; Universidad de Cordoba; University of Oxford	Gates, AJ (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	a.gates@uea.ac.uk	Gates, Andrew J/F-8218-2011; Luque-Almagro, Victor M./A-3516-2011; Roldán Ruiz, María Dolores/K-4370-2014	Gates, Andrew J/0000-0002-4594-5038; Roldán Ruiz, María Dolores/0000-0001-7173-8641; Luque-Almagro, Victor M./0000-0003-1447-4795	United Kingdom Biotechnology and Biological Science Research Council [BB/E021999/1]; Spanish Ministerio de Ciencia y Tecnologia [BIO2008-04542-C02-01, BIO2011-30026-C02-01]; Junta de Andalucia [CVI-7560]; Ministerio de Ciencia y Tecnologia; Royal Society Wolfson Foundation; Biotechnology and Biological Sciences Research Council [BB/D523019/1, BB/E021999/1] Funding Source: researchfish; BBSRC [BB/D523019/1, BB/E021999/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Royal Society Wolfson Foundation(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by United Kingdom Biotechnology and Biological Science Research Council Grant BB/E021999/1, Spanish Ministerio de Ciencia y Tecnologia Grants BIO2008-04542-C02-01 and BIO2011-30026-C02-01, and Junta de Andalucia Grant CVI-7560.; Recipient of a postdoctoral fellowship from the Ministerio de Ciencia y Tecnologia.; Royal Society Wolfson Foundation Research Merit Award Fellow.	Boudes M, 2012, MOL MICROBIOL, V85, P431, DOI 10.1111/j.1365-2958.2012.08111.x; Caballero A, 2005, J BACTERIOL, V187, P396, DOI 10.1128/JB.187.1.396-399.2005; Chai WH, 1998, J MOL BIOL, V283, P339, DOI 10.1006/jmbi.1998.2105; Demeler B., 2010, CURR PROTOC PROTEIN, DOI DOI 10.1002/0471140864.PS0713S60; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Frigaard NU, 2004, J BACTERIOL, V186, P646, DOI 10.1128/JB.186.3.646-653.2004; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Gates AJ, 2011, BIOCHEM J, V435, P743, DOI 10.1042/BJ20101920; GOLDMAN BS, 1994, J BACTERIOL, V176, P5077, DOI 10.1128/jb.176.16.5077-5085.1994; GUTIERREZ JC, 1995, MOL MICROBIOL, V18, P579, DOI 10.1111/j.1365-2958.1995.mmi_18030579.x; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Koropatkin NM, 2006, P NATL ACAD SCI USA, V103, P9820, DOI 10.1073/pnas.0602517103; LIN JT, 1993, J BACTERIOL, V175, P2370, DOI 10.1128/JB.175.8.2370-2378.1993; Lin JT, 1996, J MOL BIOL, V256, P423, DOI 10.1006/jmbi.1996.0098; Luque-Almagro VM, 2011, BIOCHEM SOC T, V39, P1838, DOI 10.1042/BST20110688; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; Morth JP, 2004, STRUCTURE, V12, P1595, DOI 10.1016/j.str.2004.06.018; O'Hara BP, 1999, EMBO J, V18, P5175, DOI 10.1093/emboj/18.19.5175; OGAWA KI, 1995, J BACTERIOL, V177, P1409, DOI 10.1128/jb.177.5.1409-1413.1995; Pino C, 2006, BIOCHEM SOC T, V34, P127, DOI 10.1042/BST0340127; Ramesh A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002666; Romeo A, 2012, MICROBIOL-SGM, V158, P1543, DOI 10.1099/mic.0.053850-0; Sambrook J., 2001, MOL CLONING LAB MANU; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shu CYJ, 2002, TRENDS BIOCHEM SCI, V27, P3, DOI 10.1016/S0968-0004(01)02036-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stewart V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002773; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wang BM, 2012, APPL ENVIRON MICROB, V78, P6558, DOI 10.1128/AEM.01720-12; Wilson SA, 1996, EMBO J, V15, P5907, DOI 10.1002/j.1460-2075.1996.tb00977.x; Wu SQT, 1999, J BACTERIOL, V181, P7274, DOI 10.1128/JB.181.23.7274-7284.1999	31	20	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29692	29702		10.1074/jbc.M113.459032	http://dx.doi.org/10.1074/jbc.M113.459032			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24005668	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000330615300044
J	Wang, CB; Low, WC; Liu, AM; Wang, BL				Wang, Chengbing; Low, Wee-Chuang; Liu, Aimin; Wang, Baolin			Centrosomal Protein DZIP1 Regulates Hedgehog Signaling by Promoting Cytoplasmic Retention of Transcription Factor GLI3 and Affecting Ciliogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; SONIC HEDGEHOG; PRIMARY CILIUM; MOTHER CENTRIOLES; CELL CYCLE; DEGRADATION; SUPPRESSOR; ENCODES; TRANSDUCTION; COMPONENT	The primary cilium is required for Hedgehog signaling. So far, all known ciliogenic proteins regulate Hedgehog signaling through their role in ciliogenesis. Here we show that the mouse DZIP1 regulates Hedgehog signaling through two mechanisms. First, DZIP1 interacts with GLI3, a transcriptional regulator for Hedgehog signaling, and prevents GLI3 from entering the nucleus. Second, DZIP1 is required for ciliogenesis. We show that DZIP1 colocalizes and interacts with CEP164, a protein localizing at appendages of the mother centrioles, and IFT88, a component of the intraflagellar transport (IFT) machinery. Functionally, both CEP164 and Ninein appendage proteins fail to localize to ciliary appendages in Dzip1 mutant cells; IFT components are not recruited to the basal body of cilia. Importantly, the accumulation of GLI3 in the nucleus is independent of loss of primary cilia in Dzip1 mutant cells. Therefore, DZIP1 is the first known ciliogenic protein that regulates Hedgehog signaling through a dual mechanism and that biochemically links IFT machinery with Hedgehog pathway components.	[Wang, Chengbing; Low, Wee-Chuang; Wang, Baolin] Cornell Univ, Weill Med Coll, Dept Med Genet, New York, NY 10065 USA; [Wang, Baolin] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Liu, Aimin] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Cornell University; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wang, BL (corresponding author), Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, Dept Med Genet, 1300 York Ave,W404, New York, NY 10065 USA.	baw2001@med.cornell.edu		Liu, Aimin/0000-0003-0099-0879	NICHD, National Institutes of Health [NO1-HD-7-3263]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD073263] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA111673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070820] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Jerome Rattner, Gregory Pazour, and Brian Dynlacht for Ninein, IFT57 and IFT140, and CEP97 antibodies, respectively. Isl1, Hb9, Pax6, Pax7, Nkx2.2, Nkx6.1, and Foxa2 monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank maintained by the University of Iowa Department of Biological Sciences under contract NO1-HD-7-3263 from NICHD, National Institutes of Health. Procedures involving mice were performed under an approved protocol.	Bershteyn M, 2010, DEV CELL, V19, P270, DOI 10.1016/j.devcel.2010.07.009; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Glazer AM, 2010, DEV BIOL, V337, P148, DOI 10.1016/j.ydbio.2009.10.025; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kim HR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-65; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; LANGE BMH, 1995, J CELL BIOL, V130, P919, DOI 10.1083/jcb.130.4.919; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Mogensen MM, 2000, J CELL SCI, V113, P3013; Moore FL, 2004, GENOMICS, V83, P834, DOI 10.1016/j.ygeno.2003.11.005; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Ou YC, 2000, CELL MOTIL CYTOSKEL, V47, P13, DOI 10.1002/1097-0169(200009)47:1<13::AID-CM2>3.0.CO;2-C; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Saarikangas J, 2011, J CELL SCI, V124, P1245, DOI 10.1242/jcs.082610; Sekimizu K, 2004, DEVELOPMENT, V131, P2521, DOI 10.1242/dev.01059; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Silverman MA, 2009, TRENDS CELL BIOL, V19, P306, DOI 10.1016/j.tcb.2009.04.002; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Tay SY, 2010, DEV DYNAM, V239, P527, DOI 10.1002/dvdy.22199; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Zeng HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015900	47	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29518	29529		10.1074/jbc.M113.492066	http://dx.doi.org/10.1074/jbc.M113.492066			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23955340	hybrid, Green Published			2022-12-28	WOS:000330615300028
J	Adams, NBP; Reid, JD				Adams, Nathan B. P.; Reid, James D.			The Allosteric Role of the AAA(+) Domain of ChlD Protein from the Magnesium Chelatase of Synechocystis Species PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Biosynthesis; Enzyme Catalysis; Mutagenesis Site-specific; Porphyrin	PROTOPORPHYRIN IX CHELATASE; ATPASE ACTIVITY; RHODOBACTER-SPHAEROIDES; ESCHERICHIA-COLI; BARLEY MUTANTS; MG-CHELATASE; SUBUNIT; PCC6803; HYDROLYSIS; COMPLEX	Magnesium chelatase is an AAA(+) ATPase that catalyzes the first step in chlorophyll biosynthesis, the energetically unfavorable insertion of a magnesium ion into a porphyrin ring. This enzyme contains two AAA(+) domains, one active in the ChlI protein and one inactive in the ChlD protein. Using a series of mutants in the AAA(+) domain of ChlD, we show that this site is essential for magnesium chelation and allosterically regulates Mg2+ and MgATP(2-) binding.	[Adams, Nathan B. P.; Reid, James D.] Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England	University of Sheffield	Reid, JD (corresponding author), Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England.	j.reid@sheffield.ac.uk		Reid, James/0000-0003-4921-1047; Adams, Nathan/0000-0003-3080-3448	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom.	Adams NBP, 2012, BIOCHEMISTRY-US, V51, P2029, DOI 10.1021/bi300149z; Axelsson E, 2006, PLANT CELL, V18, P3606, DOI 10.1105/tpc.106.042374; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Dawson R. M. C., 1991, DATA BIOCH RES, V3rd, P363; Elmlund H, 2008, J MOL BIOL, V375, P934, DOI 10.1016/j.jmb.2007.11.028; Falk JE, 1964, PORPHYRINS METALLOPO, P236; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; GIBSON LCD, 1995, P NATL ACAD SCI USA, V92, P1941, DOI 10.1073/pnas.92.6.1941; Grafe S, 1999, P NATL ACAD SCI USA, V96, P1941, DOI 10.1073/pnas.96.5.1941; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hansson A, 2002, P NATL ACAD SCI USA, V99, P13944, DOI 10.1073/pnas.212504499; Jensen PE, 1999, BIOCHEM J, V339, P127, DOI 10.1042/0264-6021:3390127; Jensen PE, 1998, BIOCHEM J, V334, P335, DOI 10.1042/bj3340335; Jensen PE, 1996, J BIOL CHEM, V271, P16662, DOI 10.1074/jbc.271.28.16662; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Lundqvist J, 2010, STRUCTURE, V18, P354, DOI 10.1016/j.str.2010.01.001; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Reid JD, 2003, BIOCHEMISTRY-US, V42, P6912, DOI 10.1021/bi034082q; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Willows RD, 1996, EUR J BIOCHEM, V235, P438, DOI 10.1111/j.1432-1033.1996.00438.x	23	13	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28727	28732		10.1074/jbc.M113.477943	http://dx.doi.org/10.1074/jbc.M113.477943			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940041	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000330298800026
J	Lima, MA; Oliveira-Neto, M; Kadowaki, MAS; Rosseto, FR; Prates, ET; Squina, FM; Leme, AFP; Skaf, MS; Polikarpov, I				Lima, Marisa A.; Oliveira-Neto, Mario; Kadowaki, Marco Antonio S.; Rosseto, Flavio R.; Prates, Erica T.; Squina, Fabio M.; Leme, Adriana F. P.; Skaf, Munir S.; Polikarpov, Igor			Aspergillus niger beta-Glucosidase Has a Cellulase-like Tadpole Molecular Shape INSIGHTS INTO GLYCOSIDE HYDROLASE FAMILY 3 (GH3) beta-GLUCOSIDASE STRUCTURE AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mechanisms; Enzyme Structure; Enzymes; Fungi; Glycobiology; Aspergillus niger; SAXS; -Glucosidase; Glycoside Hydrolase Family 3; Multidomain Proteins	CATION-PI INTERACTIONS; FAMILY 3; BIOLOGICAL MACROMOLECULES; INITIAL CONFIGURATIONS; SOLUTION SCATTERING; KINETIC-ANALYSIS; DYNAMICS; PROTEINS; DOMAIN; IDENTIFICATION	Background: -Glucosidase completes cellulose enzymatic hydrolysis by releasing glucose from cellobiose. Results: SAXS experiments revealed that Aspergillus niger -glucosidase has a cellulase-like tadpole molecular shape, uncommon to enzymes that act on the soluble substrates. Conclusion: We show that AnBgl1 N- and C-terminal domains are linked by a long extended linker. Significance: Understanding AnBgl1 architecture is useful for comprehension of the enzyme-cell wall interaction and the process of biomass saccharification. Aspergillus niger is known to secrete large amounts of -glucosidases, which have a variety of biotechnological and industrial applications. Here, we purified an A. niger -glucosidase (AnBgl1) and conducted its biochemical and biophysical analyses. Purified enzyme with an apparent molecular mass of 116 kDa forms monomers in solution as judged by native gel electrophoresis and has a pI value of 4.55, as found for most of the fungi of -glucosidases. Surprisingly, the small angle x-ray experiments reveal that AnBgl1 has a tadpole-like structure, with the N-terminal catalytic domain and C-terminal fibronectin III-like domain (FnIII) connected by the long linker peptide (approximate to 100 amino acid residues) in an extended conformation. This molecular organization resembles the one adopted by other cellulases (such as cellobiohydrolases, for example) that frequently contain a catalytic domain linked to the cellulose-binding module that mediates their binding to insoluble and polymeric cellulose. The reasons why AnBgl1, which acts on the small soluble substrates, has a tadpole molecular shape are not entirely clear. However, our enzyme pulldown assays with different polymeric substrates suggest that AnBgl1 has little or no capacity to bind to and to adsorb cellulose, xylan, and starch, but it has high affinity to lignin. Molecular dynamics simulations suggested that clusters of residues located in the C-terminal FnIII domain interact strongly with lignin fragments. The simulations showed that numerous arginine residues scattered throughout the FnIII surface play an important role in the interaction with lignin by means of cation- stacking with the lignin aromatic rings. These results indicate that the C-terminal FnIII domain could be operational for immobilization of the enzyme on the cell wall and for the prevention of unproductive binding of cellulase to the biomass lignin.	[Lima, Marisa A.; Kadowaki, Marco Antonio S.; Rosseto, Flavio R.; Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil; [Oliveira-Neto, Mario; Prates, Erica T.] Univ Estadual Paulista, Dept Fis & Biofis, Inst Biociencias Botucatu, BR-18618000 Botucatu, SP, Brazil; [Squina, Fabio M.] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Ciencia & Tecnol Bioetanol, BR-13083970 Campinas, SP, Brazil; [Leme, Adriana F. P.] Ctr Nacl Pesquisa Energia & Mat, Lab Espectrometria Massas, Lab Nacl Biociencias, BR-13083970 Campinas, SP, Brazil; [Skaf, Munir S.] Univ Estadual Campinas, Inst Quim, BR-13084862 Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual de Campinas	Polikarpov, I (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Av Trabalhador Sao Carlense 400,Caixa Postal 36, BR-13560590 Sao Carlos, SP, Brazil.	ipolikarpov@ifsc.usp.br	Squina, Fabio/J-8130-2012; Teixeira Prates, Erica/GLU-6833-2022; Leme, Adriana F Paes/C-9679-2012; Skaf, Munir S/B-1614-2013; UNICAMP, CCES -/J-7787-2015; Rosseto, Flavio R/A-2966-2016; Polikarpov, Igor/D-2575-2012; Neto, Mario Oliveira/F-2717-2013; Prates, Erica/E-3858-2016; Kadowaki, Marco/AAA-9024-2021	Squina, Fabio/0000-0002-8154-7459; Leme, Adriana F Paes/0000-0001-7959-147X; Skaf, Munir S/0000-0001-7485-1228; Rosseto, Flavio R/0000-0001-6272-8644; Kadowaki, Marco/0000-0003-0188-2079; Polikarpov, Igor/0000-0001-9496-4174	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [08/56255-9, 09/54035-4, 10/16542-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [490022/2009-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Instituto Nacional de Ciencia e Tecnologia do Bioetanol	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia do Bioetanol	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants 08/56255-9, 09/54035-4, and 10/16542-9], Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grant 490022/2009-0, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Instituto Nacional de Ciencia e Tecnologia do Bioetanol.	Aragao AZB, 2012, J BIOL CHEM, V287, P43071, DOI 10.1074/jbc.M112.364513; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Bhatia Y, 2002, CRIT REV BIOTECHNOL, V22, P375, DOI 10.1080/07388550290789568; Bleicher L, 2011, J PHYS CHEM B, V115, P7940, DOI 10.1021/jp200330z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; CAMPBELL ID, 1994, STRUCTURE, V2, P333, DOI 10.1016/S0969-2126(00)00034-4; Chauve M, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-3; CHEN FTA, 1995, ANAL BIOCHEM, V230, P273, DOI 10.1006/abio.1995.1474; Dan S, 2000, J BIOL CHEM, V275, P4973, DOI 10.1074/jbc.275.7.4973; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L, PYMOL MOL GRAPHICS S; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guinier A., 1955, SMALL ANGLE SCATTERI, V18, P1; Hammond A, 1995, ESRF97HA02T, P1; HESTENES MR, 1952, J RES NAT BUR STAND, V49, P409, DOI 10.6028/jres.049.044; HIMMEL ME, 1993, APPL BIOCHEM BIOTECH, V39, P213, DOI 10.1007/BF02918991; Hong J, 2007, APPL MICROBIOL BIOT, V73, P1331, DOI 10.1007/s00253-006-0618-9; Jeng WY, 2011, J STRUCT BIOL, V173, P46, DOI 10.1016/j.jsb.2010.07.008; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kataeva IA, 2002, APPL ENVIRON MICROB, V68, P4292, DOI 10.1128/AEM.68.9.4292-4300.2002; Kim DY, 2009, APPL ENVIRON MICROB, V75, P7275, DOI 10.1128/AEM.01075-09; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Korotkova OG, 2009, BIOCHEMISTRY-MOSCOW+, V74, P569, DOI 10.1134/S0006297909050137; KUBICEK CP, 1993, ENZYME MICROB TECH, V15, P90, DOI 10.1016/0141-0229(93)90030-6; Kunst A., 1984, METHOD ENZYMAT AN, P178; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Traon-Masson MP, 1998, ENZYME MICROB TECH, V22, P374, DOI 10.1016/S0141-0229(97)00206-8; Li JG, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3469790; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; LYMAR ES, 1995, APPL ENVIRON MICROB, V61, P2976, DOI 10.1128/AEM.61.8.2976-2980.1995; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marin-Navarro J, 2011, APPL MICROBIOL BIOT, V89, P121, DOI 10.1007/s00253-010-2845-3; Martinez JM, 2003, J COMPUT CHEM, V24, P819, DOI 10.1002/jcc.10216; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Martis RL, 2008, J THEOR BIOL, V250, P655, DOI 10.1016/j.jtbi.2007.10.024; MARTYNA GJ, 1994, PHYS REV E, V50, P3234, DOI 10.1103/PhysRevE.50.3234; Meirelles GV, 2010, J PROTEOME RES, V9, P6298, DOI 10.1021/pr100562w; Mingardon F, 2011, APPL ENVIRON MICROB, V77, P1436, DOI 10.1128/AEM.01802-10; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nakatani Y, 2012, FEBS J, V279, P464, DOI 10.1111/j.1742-4658.2011.08439.x; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Petridis L, 2009, J COMPUT CHEM, V30, P457, DOI 10.1002/jcc.21075; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PILZ I, 1990, BIOCHEM J, V271, P277, DOI 10.1042/bj2710277; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; Receveur V, 2002, J BIOL CHEM, V277, P40887, DOI 10.1074/jbc.M205404200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sangha AK, 2012, ENVIRON PROG SUSTAIN, V31, P47, DOI 10.1002/ep.10628; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; Sorensen A., 2010, THESIS AALBORG U COP; Suzuki K, 2013, BIOCHEM J, V452, P211, DOI 10.1042/BJ20130054; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tu MB, 2007, BIOTECHNOL PROGR, V23, P398, DOI 10.1021/bp060354f; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; WANG Q, 1995, BIOCHEMISTRY-US, V34, P14554, DOI 10.1021/bi00044a034; WOOD TM, 1988, METHOD ENZYMOL, V160, P87; Yoshida E, 2010, BIOCHEM J, V431, P39, DOI 10.1042/BJ20100351; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n; Zhu ZG, 2009, ANALYST, V134, P2267, DOI 10.1039/b906065k; Zmudka MW, 2013, PROTEIN SCI, V22, P883, DOI 10.1002/pro.2204	77	51	54	1	74	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32991	33005		10.1074/jbc.M113.479279	http://dx.doi.org/10.1074/jbc.M113.479279			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24064212	Green Published, hybrid			2022-12-28	WOS:000328841700016
J	Carland, JE; Cooper, MA; Livesey, MR; Hales, TG; Peters, JA; Lambert, JJ				Carland, Jane E.; Cooper, Michelle A.; Livesey, Matthew R.; Hales, Tim G.; Peters, John A.; Lambert, Jeremy J.			Mutagenic Analysis of the Intracellular Portals of the Human 5-HT(3)A Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SINGLE-CHANNEL CONDUCTANCE; GATED ION CHANNELS; LARGE CYTOPLASMIC LOOP; CHARGED AMINO-ACIDS; 5-HT3 RECEPTOR; 5-HYDROXYTRYPTAMINE TYPE-3; STRUCTURAL DETERMINANTS; PROTEIN-PHOSPHORYLATION; SEROTONIN-RECEPTOR	Structural models of Cys-loop receptors based on homology with the Torpedo marmorata nicotinic acetylcholine receptor infer the existence of cytoplasmic portals within the conduction pathway framed by helical amphipathic regions (termed membrane-associated (MA) helices) of adjacent intracellular M3-M4 loops. Consistent with these models, two arginine residues (Arg(436) and Arg(440)) within the MA helix of 5-hydroxytryptamine type 3A (5-HT(3)A) receptors act singularly as rate-limiting determinants of single-channel conductance (gamma). However, there is little conservation in primary amino acid sequences across the cytoplasmic loops of Cys-loop receptors, limiting confidence in the fidelity of this particular aspect of the 5-HT(3)A receptor model. We probed the majority of residues within the MA helix of the human 5-HT(3)A subunit using alanine-and arginine-scanning mutagenesis and the substituted cysteine accessibility method to determine their relative influences upon gamma. Numerous residues, prominently those at the 435, 436, 439, and 440 positions, were found to markedly influence gamma. This approach yielded a functional map of the 5-HT(3)A receptor portals, which agrees well with the homology model.	[Lambert, Jeremy J.] Univ Dundee, Ninewells Hosp & Med Sch, Div Neurosci, Med Res Inst, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Div Neurosci, Med Educ Inst, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	Lambert, JJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Neurosci, Med Res Inst, Dundee DD1 9SY, Scotland.	j.a.peters@dundee.ac.uk; j.j.lambert@dundee.ac.uk		Carland, Jane/0000-0002-1456-876X; Livesey, Matthew/0000-0002-3441-7977	Wellcome Trust; Tenovus Scotland; Anonymous Trust; Biotechnology and Biological Sciences Research Council; Lilly; National Science Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Tenovus Scotland; Anonymous Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lilly(Eli Lilly); National Science Foundation(National Science Foundation (NSF))	The work was supported by the Wellcome Trust, Tenovus Scotland, the Anonymous Trust (to J. A. P. and J. J. L.), the Biotechnology and Biological Sciences Research Council in conjunction with Lilly (to M. R. L.), and the National Science Foundation (to T. G. H.).	Baptista-Hon DT, 2013, J BIOL CHEM, V288, P21558, DOI 10.1074/jbc.M113.481689; Baptista-Hon DT, 2012, BRIT J PHARMACOL, V165, P693, DOI 10.1111/j.1476-5381.2011.01582.x; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Brown AM, 1998, J PHYSIOL-LONDON, V507, P653, DOI 10.1111/j.1469-7793.1998.653bs.x; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; Changeux JP, 2012, J BIOL CHEM, V287, P40207, DOI 10.1074/jbc.R112.407668; Criado M, 2011, FEBS LETT, V585, P2477, DOI 10.1016/j.febslet.2011.06.028; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; Dutertre S, 2012, J BIOL CHEM, V287, P40216, DOI 10.1074/jbc.R112.408229; GILL CH, 1995, BRIT J PHARMACOL, V114, P1211, DOI 10.1111/j.1476-5381.1995.tb13335.x; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Gunthorpe MJ, 2000, J PHYSIOL-LONDON, V522, P187, DOI 10.1111/j.1469-7793.2000.00187.x; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2009, CURR OPIN STRUC BIOL, V19, P418, DOI 10.1016/j.sbi.2009.07.006; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; Ilegems E, 2005, CHEMBIOCHEM, V6, P2180, DOI 10.1002/cbic.200500191; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Kottwitz D, 2004, PROTEIN EXPRES PURIF, V38, P237, DOI 10.1016/j.pep.2004.07.017; Kracun S, 2008, BRIT J PHARMACOL, V153, P1474, DOI 10.1038/sj.bjp.0707676; Kukhtina V, 2006, J NEUROCHEM, V97, P63, DOI 10.1111/j.1471-4159.2005.03468.x; Le Novere N, 1999, BIOPHYS J, V76, P2329, DOI 10.1016/S0006-3495(99)77390-X; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; McKinnon NK, 2011, J GEN PHYSIOL, V138, P453, DOI 10.1085/jgp.201110686; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mochizuki S, 1999, AMINO ACIDS, V17, P243, DOI 10.1007/BF01366923; Mukherjee J, 2009, J NEUROCHEM, V110, P1885, DOI 10.1111/j.1471-4159.2009.06285.x; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Peters JA, 2005, TRENDS PHARMACOL SCI, V26, P587, DOI 10.1016/j.tips.2005.09.011; Peters JA, 2010, J PHYSIOL-LONDON, V588, P587, DOI 10.1113/jphysiol.2009.183137; Reeves DC, 2001, J BIOL CHEM, V276, P42035, DOI 10.1074/jbc.M106066200; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Thompson AJ, 2003, BRIT J PHARMACOL, V140, P359, DOI 10.1038/sj.bjp.0705424; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Valor LM, 2002, BIOCHEMISTRY-US, V41, P7931, DOI 10.1021/bi025831r; Williams BM, 1998, NAT NEUROSCI, V1, P557, DOI 10.1038/2792; Wolstenholme AJ, 2012, J BIOL CHEM, V287, P40232, DOI 10.1074/jbc.R112.406280; Xu J, 2006, J NEUROSCI, V26, P9780, DOI 10.1523/JNEUROSCI.0840-06.2006; YU XM, 1994, NEURON, V13, P247, DOI 10.1016/0896-6273(94)90473-1	53	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31592	31601		10.1074/jbc.M113.503300	http://dx.doi.org/10.1074/jbc.M113.503300			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24030822	Green Published, hybrid			2022-12-28	WOS:000330596200018
J	Horimoto, S; Ninagawa, S; Okada, T; Koba, H; Sugimoto, T; Kamiya, Y; Kato, K; Takeda, S; Mori, K				Horimoto, Satoshi; Ninagawa, Satoshi; Okada, Tetsuya; Koba, Hibiki; Sugimoto, Takehiro; Kamiya, Yukiko; Kato, Koichi; Takeda, Shunichi; Mori, Kazutoshi			The Unfolded Protein Response Transducer ATF6 Represents a Novel Transmembrane-type Endoplasmic Reticulum-associated Degradation Substrate Requiring Both Mannose Trimming and SEL1L Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; TRANSCRIPTION FACTOR; STRESS; HOMOLOG	Proteins misfolded in the endoplasmic reticulum (ER) are cleared by the ubiquitin-dependent proteasome system in the cytosol, a series of events collectively termed ER-associated degradation (ERAD). It was previously shown that SEL1L, a partner protein of the E3 ubiquitin ligase HRD1, is required for degradation of misfolded luminal proteins (ERAD-Ls substrates) but not misfolded transmembrane proteins (ERAD-Lm substrates) in both mammalian and chicken DT40 cells. Here, we analyzed ATF6, a type II transmembrane glycoprotein that serves as a sensor/transducer of the unfolded protein response, as a potential ERAD-Lm substrate in DT40 cells. Unexpectedly, degradation of endogenous ATF6 and exogenously expressed chicken and human ATF6 by the proteasome required SEL1L. Deletion analysis revealed that the luminal region of ATF6 is a determinant for SEL1L-dependent degradation. Chimeric analysis showed that the luminal region of ATF6 confers SEL1L dependence on type I transmembrane protein as well. In contrast, degradation of other known type I ERAD-Lm substrates (BACE457, T-cell receptor-alpha, CD3-delta, and CD147) did not require SEL1L. Thus, ATF6 represents a novel type of ERAD-Lm substrate requiring SEL1L for degradation despite its transmembrane nature. In addition, endogenous ATF6 was markedly stabilized in wild-type cells treated with kifunensine, an inhibitor of alpha 1,2-mannosidase in the ER, indicating that degradation of ATF6 requires proper mannose trimming. Our further analyses revealed that the five ERAD-Lm substrates examined are classified into three subgroups based on their dependence on mannose trimming and SEL1L. Thus, ERAD-Lm substrates are degraded through much more diversified mechanisms in higher eukaryotes than previously thought.	[Horimoto, Satoshi; Ninagawa, Satoshi; Okada, Tetsuya; Koba, Hibiki; Sugimoto, Takehiro; Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; [Kamiya, Yukiko; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Kamiya, Yukiko; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan; [Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Kyoto 6068501, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Nagoya City University; Kyoto University	Mori, K (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	mori@upr.biophys.kyoto-u.ac.jp	Mori, Kazutoshi/K-6106-2015; Mori, Kazutoshi/AAW-5449-2020	Kato, Koichi/0000-0001-7187-9612; Kamiya, Yukiko/0000-0001-7582-3886; Okada, Tetsuya/0000-0002-2513-1301; Takeda, Shunichi/0000-0002-7924-7991; Ninagawa, Satoshi/0000-0002-8005-4716	Ministry of Education, Culture, Sports, Science and Technology of Japan [19058009, 23221005, 22020039, 24249002]; Global Center of Excellence Program; Grants for Excellent Graduate Schools from the Ministry of Education, Culture, Sports and Technology of Japan; Grants-in-Aid for Scientific Research [25102008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants for Excellent Graduate Schools from the Ministry of Education, Culture, Sports and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants 19058009 (to K. M.), 23221005 (to T. O.), 22020039 (to Y. K.), and 24249002 (to K. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Global Center of Excellence Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem"; and Grants for Excellent Graduate Schools from the Ministry of Education, Culture, Sports and Technology of Japan.	Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Chen X, 2011, J CELL BIOL, V192, P825, DOI 10.1083/jcb.201008090; Fonseca SG, 2010, J CLIN INVEST, V120, P744, DOI 10.1172/JCI39678; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P567, DOI 10.1093/glycob/cwq001; Ishikawa T, 2013, MOL BIOL CELL, V24, P1387, DOI 10.1091/mbc.E12-11-0830; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Ninagawa S, 2011, CELL STRUCT FUNCT, V36, P187, DOI 10.1247/csf.11018; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Sambrook J., 2002, MOL CLONING LAB MANU; Sato Y, 2011, CELL STRUCT FUNCT, V36, P35, DOI 10.1247/csf.10010; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; TOMIYA N, 1991, ANAL BIOCHEM, V193, P90, DOI 10.1016/0003-2697(91)90047-W; Tremblay LO, 1999, GLYCOBIOLOGY, V9, P1073, DOI 10.1093/glycob/9.10.1073; Tyler RE, 2012, MOL BIOL CELL, V23, P4668, DOI 10.1091/mbc.E12-06-0428; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	26	53	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31517	31527		10.1074/jbc.M113.476010	http://dx.doi.org/10.1074/jbc.M113.476010			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043630	Green Published, hybrid			2022-12-28	WOS:000330596200011
J	Kumari, R; Castillo, C; Francesconi, A				Kumari, Ranju; Castillo, Catherine; Francesconi, Anna			Agonist-dependent Signaling by Group I Metabotropic Glutamate Receptors Is Regulated by Association with Lipid Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; FRAGILE-X; TRANSMEMBRANE DOMAIN; MOUSE MODEL; PROTEIN; CHOLESTEROL; RAFTS; PALMITOYLATION; ACTIVATION; TRAFFICKING	Group I metabotropic glutamate receptors (mGluRs), mGluR1 and mGluR5, play critical functions in forms of activity-dependent synaptic plasticity and synapse remodeling in physiological and pathological states. Importantly, in animal models of fragile X syndrome, group I mGluR activity is abnormally enhanced, a dysfunction that may partly underlie cognitive deficits in the condition. Lipid rafts are cholesterol- and sphingolipid-enriched membrane domains that are thought to form transient signaling platforms for ligand-activated receptors. Many G protein-coupled receptors, including group I mGluRs, are present in lipid rafts, but the mechanisms underlying recruitment to these membrane domains remain incompletely understood. Here, we show that mGluR1 recruitment to lipid rafts is enhanced by agonist binding and is supported at least in part by an intact cholesterol recognition/interaction amino acid consensus (CRAC) motif in the receptor. Substitutions of critical residues in the motif reduce mGluR1 association with lipid rafts and agonist-induced, mGluR1-dependent activation of extracellular-signal-activated kinase1/2 MAP kinase (ERK-MAPK). We find that alteration of membrane cholesterol content or perturbation of lipid rafts regulates agonist-dependent activation of ERK-MAPK by group I mGluRs, suggesting a potential function for cholesterol as a positive allosteric modulator of receptor function(s). Together, these findings suggest that drugs that alter membrane cholesterol levels or directed to the receptor-cholesterol interface could be employed to modulate abnormal group I mGluR activity in neuropsychiatric conditions, including fragile X syndrome.	[Kumari, Ranju; Castillo, Catherine; Francesconi, Anna] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Francesconi, A (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	anna.francesconi@einstein.yu.edu			RFK-IDDRC Core services [NICHD P30 HD071593]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082870] Funding Source: NIH RePORTER	RFK-IDDRC Core services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Drs. Anne Etgen and Diane Lebesgue (Albert Einstein College of Medicine) for reagents and assistance with binding assays. We acknowledge support by the RFK-IDDRC Core services (NICHD P30 HD071593).	ALALUF S, 1995, J NEUROCHEM, V64, P1548; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Allen JA, 2009, MOL PHARMACOL, V76, P1082, DOI 10.1124/mol.109.060160; Anwyl R, 2009, NEUROPHARMACOLOGY, V56, P735, DOI 10.1016/j.neuropharm.2009.01.002; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Bhatnagar A, 2004, J BIOL CHEM, V279, P34614, DOI 10.1074/jbc.M404673200; Bjork K, 2011, ANNU REV PHARMACOL, V51, P211, DOI 10.1146/annurev-pharmtox-010510-100520; Bruno A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042023; Burgueno J, 2003, J NEUROCHEM, V86, P785, DOI 10.1046/j.1471-4159.2003.01842.x; Carroll FY, 2001, MOL PHARMACOL, V59, P965, DOI 10.1124/mol.59.5.965; Catania MV, 2007, MOL NEUROBIOL, V35, P298, DOI 10.1007/s12035-007-0022-1; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christian AE, 1997, J LIPID RES, V38, P2264; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; El Moustaine D, 2012, P NATL ACAD SCI USA, V109, P16342, DOI 10.1073/pnas.1205838109; Emery AC, 2012, MOL PHARMACOL, V82, P291, DOI 10.1124/mol.112.078444; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Eroglu C, 2002, EMBO REP, V3, P491, DOI 10.1093/embo-reports/kvf088; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Frisz JF, 2013, P NATL ACAD SCI USA, V110, pE613, DOI 10.1073/pnas.1216585110; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Gerber U, 2007, CURR OPIN PHARMACOL, V7, P56, DOI 10.1016/j.coph.2006.08.008; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hemstapat K, 2006, MOL PHARMACOL, V70, P616, DOI 10.1124/mol.105.021857; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hong YH, 2009, J NEUROCHEM, V111, P61, DOI 10.1111/j.1471-4159.2009.06289.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huang SL, 2011, P NATL ACAD SCI USA, V108, P15480, DOI 10.1073/pnas.1107775108; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; ITO I, 1992, NEUROREPORT, V3, P1013, DOI 10.1097/00001756-199211000-00017; Jafurulla M, 2011, BIOCHEM BIOPH RES CO, V404, P569, DOI 10.1016/j.bbrc.2010.12.031; Kaiser HJ, 2011, P NATL ACAD SCI USA, V108, P16628, DOI 10.1073/pnas.1103742108; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kirsch C, 2003, BIOCHEM PHARMACOL, V65, P843, DOI 10.1016/S0006-2952(02)01654-4; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Kumari R, 2011, METHODS MOL BIOL, V746, P411, DOI 10.1007/978-1-61779-126-0_24; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Litschig S, 1999, MOL PHARMACOL, V55, P453; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Mutel V, 2000, J NEUROCHEM, V75, P2590, DOI 10.1046/j.1471-4159.2000.0752590.x; Nicodemo AA, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-4; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Oddi S, 2011, J NEUROCHEM, V116, P858, DOI 10.1111/j.1471-4159.2010.07041.x; Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034; Parmentier ML, 1996, J NEUROSCI, V16, P6687; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Prezeau L, 1996, MOL PHARMACOL, V49, P422; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Silvius JR, 2005, BBA-MOL CELL RES, V1746, P193, DOI 10.1016/j.bbamcr.2005.09.003; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Takayasu Y, 2010, P NATL ACAD SCI USA, V107, P21778, DOI 10.1073/pnas.1015553107; Wang JQ, 2007, J NEUROCHEM, V100, P1, DOI 10.1111/j.1471-4159.2006.04208.x; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Yanagawa M, 2009, MOL PHARMACOL, V76, P201, DOI 10.1124/mol.109.056549; Zheng H, 2008, P NATL ACAD SCI USA, V105, P9421, DOI 10.1073/pnas.0802253105; Zheng H, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-6	81	27	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					32004	32019		10.1074/jbc.M113.475863	http://dx.doi.org/10.1074/jbc.M113.475863			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045944	Green Published, hybrid			2022-12-28	WOS:000330596200053
J	Xuan, Z; Barthet, G; Shioi, J; Xu, JD; Georgakopoulos, A; Bruban, J; Robakis, NK				Xuan, Zhao; Barthet, Gael; Shioi, Junichi; Xu, Jindong; Georgakopoulos, Anastasios; Bruban, Julien; Robakis, Nikolaos K.			Presenilin-1/gamma-Secretase Controls Glutamate Release, Tyrosine Phosphorylation, and Surface Expression of N-Methyl-D-aspartate Receptor (NMDAR) Subunit GluN2B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calpain; Glutamate; Glutamate Receptor Ionotropic (AMPA; NMDA); Presenilin; Secretases	AMYLOID PRECURSOR PROTEIN; CALPAIN-I ACTIVATION; HIPPOCAMPAL-NEURONS; NA+/CA2+ EXCHANGER; MECHANISMS; CLEAVAGE; BINDING; BETA; NEURODEGENERATION; PRESENILINS	Abnormally high concentrations of extracellular glutamate in the brain may cause neuronal damage via excitotoxicity. Thus, tight regulation of glutamate release is critical to neuronal function and survival. Excitotoxicity is caused mainly by overactivation of the extrasynaptic NMDA receptor (NMDAR) and results in specific cellular changes, including calcium-induced activation of calpain proteases. Here, we report that presenilin-1 (PS1) null mouse cortical neuronal cultures have increased amounts of calpain-dependent spectrin breakdown products (SBDPs) compared with WT cultures. NMDAR antagonists blocked accumulation of SBDPs, suggesting abnormal activation of this receptor in PS1 null cultures. Importantly, an increase in SBDPs was detected in cultures of at least 7 days in vitro but not in younger cultures. Conditioned medium from PS1 null neuronal cultures at 8 days in vitro contained higher levels of glutamate than medium from WT cultures and stimulated production of SBDPs when added to WT cultures. Use of glutamate reuptake inhibitors indicated that accumulation of this neurotransmitter in the media of PS1 null cultures was due to increased rates of release. PS1 null neurons showed decreased cell surface expression and phosphorylation of the GluN2B subunit of NMDAR, indicating decreased amounts of extrasynaptic NMDAR in the absence of PS1. Inhibition of -secretase activity in WT neurons caused changes similar to those observed in PS1 null neurons. Together, these data indicate that the PS1/-secretase system regulates release of glutamate, tyrosine phosphorylation, and surface expression of GluN2B-containing NMDARs.	Icahn Sch Med Mt Sinai, Ctr Mol Biol & Genet Neurodegenerat, Dept Psychiat, Grad Sch Biomed Sci, New York, NY 10029 USA; Icahn Sch Med Mt Sinai, Ctr Mol Biol & Genet Neurodegenerat, Dept Neurosci, Grad Sch Biomed Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Robakis, NK (corresponding author), Icahn Sch Med Mt Sinai, Ctr Mol Biol & Genet Neurodegenerat, Dept Psychiat, New York, NY 10029 USA.	nikos.robakis@mssm.edu	Robakis, Nikolaos/AAA-1838-2021	Xuan, Zhao/0000-0002-8254-2887; Barthet, Gael/0000-0003-4025-1616; Georgakopoulos, Anastasios/0000-0001-8241-6306	National Institutes of Health [AG-17926, NS047229, AG-05138]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005138, R01AG017926, R37AG017926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG-17926, NS047229, and AG-05138.	Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Baki L, 2008, J NEUROSCI, V28, P483, DOI 10.1523/JNEUROSCI.4067-07.2008; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Barthet G, 2013, NEUROBIOL AGING, V34, P499, DOI 10.1016/j.neurobiolaging.2012.02.024; Barthet G, 2012, PROG NEUROBIOL, V98, P166, DOI 10.1016/j.pneurobio.2012.05.006; Barthet G, 2011, FASEB J, V25, P2937, DOI 10.1096/fj.11-183806; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brustovetsky T, 2010, J NEUROSCI RES, V88, P1317, DOI 10.1002/jnr.22295; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; Gunawardena S, 2013, HUM MOL GENET, V22, P3828, DOI 10.1093/hmg/ddt237; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Kouchi Z, 2009, J BIOL CHEM, V284, P1954, DOI 10.1074/jbc.M806250200; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Nixon RA, 2003, AGEING RES REV, V2, P407, DOI 10.1016/S1568-1637(03)00029-1; Petralia RS, 2012, SCI WORLD J, DOI 10.1100/2012/267120; Pimplikar SW, 2010, J NEUROSCI, V30, P14946, DOI 10.1523/JNEUROSCI.4305-10.2010; Pratt KG, 2011, J NEUROSCI, V31, P899, DOI 10.1523/JNEUROSCI.4625-10.2011; Robakis NK, 2011, NEUROBIOL AGING, V32, P372, DOI 10.1016/j.neurobiolaging.2010.05.022; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; SIMAN R, 1989, J NEUROSCI, V9, P1579; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wahl AS, 2009, NEUROSCIENCE, V158, P344, DOI 10.1016/j.neuroscience.2008.06.018; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Yang Y, 2004, NEUROSCIENCE, V124, P501, DOI 10.1016/j.neuroscience.2003.11.029; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	47	2	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30495	30501		10.1074/jbc.M113.499004	http://dx.doi.org/10.1074/jbc.M113.499004			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24025330	Green Published, hybrid			2022-12-28	WOS:000329868100045
J	Sckolnick, M; Krementsova, EB; Warshaw, DM; Trybus, KM				Sckolnick, Maria; Krementsova, Elena B.; Warshaw, David M.; Trybus, Kathleen M.			More Than Just a Cargo Adapter, Melanophilin Prolongs and Slows Processive Runs of Myosin Va	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAND-OVER-HAND; MELANOSOME TRANSPORT; SECRETORY GRANULES; STRUCTURAL BASIS; BINDING DOMAIN; GLOBULAR TAIL; LINKS RAB27A; DYNAMICS; ACTIN; ORGANELLE	Myosin Va (myoVa) is a molecular motor that processively transports cargo along actin tracks. One well studied cargo in vivo is the melanosome, a pigment organelle that is moved first by kinesin on microtubules and then handed off to myoVa for transport in the actin-rich dendritic periphery of melanocytes. Melanophilin (Mlph) is the adapter protein that links Rab27a-melanosomes to myoVa. Using total internal reflection fluorescence microscopy and quantum dot-labeled full-length myoVa, we show at the single-molecule level that Mlph increases the number of processively moving myoVa motors by 17-fold. Surprisingly, myoVa-Mlph moves similar to 4-fold slower than myoVa alone and with twice the run length. These two changes greatly increase the time spent on actin, a property likely to enhance the transfer of melanosomes to the adjacent keratinocyte. In contrast to the variable stepping pattern of full-length myoVa, the myoVa-Mlph complex shows a normal gating pattern between the heads typical of a fully active motor and consistent with a cargo-dependent activation mechanism. The Mlph-dependent changes in myoVa depend on a positively charged cluster of amino acids in the actin binding domain of Mlph, suggesting that Mlph acts as a "tether" that links the motor to the track. Our results provide a molecular explanation for the uncharacteristically slow speed of melanosome movement by myoVa in vivo. More generally, these data show that proteins that link motors to cargo can modify motor properties to enhance their biological role.	[Sckolnick, Maria; Krementsova, Elena B.; Warshaw, David M.; Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	University of Vermont	Trybus, KM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	kathleen.trybus@uvm.edu			National Institutes of Health [GM078097, GM094229, T32HL07647]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078097, R01GM094229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM078097 (to K. M. T.) and GM094229 (to D. M. W.), and Training Grant T32HL07647 (to M. S.).	Armstrong JM, 2012, P NATL ACAD SCI USA, V109, pE218, DOI 10.1073/pnas.1109709109; Arnold DB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.283pe49; Brozzi F, 2012, TRAFFIC, V13, P54, DOI 10.1111/j.1600-0854.2011.01301.x; Brunstein M, 2009, BIOPHYS J, V97, P1548, DOI 10.1016/j.bpj.2009.06.048; Clemen AEM, 2005, BIOPHYS J, V88, P4402, DOI 10.1529/biophysj.104.053504; Fukuda M, 2004, J CELL SCI, V117, P583, DOI 10.1242/jcs.00891; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Geething NC, 2007, J BIOL CHEM, V282, P21518, DOI 10.1074/jbc.M701932200; Huang JD, 1998, GENETICS, V148, P1963; Huet S, 2012, J NEUROSCI, V32, P2564, DOI 10.1523/JNEUROSCI.2724-11.2012; Hume AN, 2006, MOL BIOL CELL, V17, P4720, DOI 10.1091/mbc.E06-05-0457; Hume AN, 2011, BIOCHEM SOC T, V39, P1191, DOI 10.1042/BST0391191; Kad NM, 2008, J BIOL CHEM, V283, P17477, DOI 10.1074/jbc.M800539200; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Kukimoto-Niino M, 2008, STRUCTURE, V16, P1478, DOI 10.1016/j.str.2008.07.014; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Lambert J, 1998, BIOCHEM BIOPH RES CO, V252, P329, DOI 10.1006/bbrc.1998.9644; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Lopes VS, 2007, TRAFFIC, V8, P486, DOI 10.1111/j.1600-0854.2007.00548.x; Lu HL, 2010, J BIOL CHEM, V285, P42068, DOI 10.1074/jbc.M110.180265; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Nagashima K, 2002, FEBS LETT, V517, P233, DOI 10.1016/S0014-5793(02)02634-0; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Pylypenko O, 2012, P NATL ACAD SCI USA, V109, P5555, DOI 10.1073/pnas.1202494109; Rogers SL, 1998, CURR BIOL, V8, P161, DOI 10.1016/S0960-9822(98)70063-6; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Snyder GE, 2004, BIOPHYS J, V87, P1776, DOI 10.1529/biophysj.103.036897; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Wang J, 1999, J BIOL CHEM, V274, P28542, DOI 10.1074/jbc.274.40.28542; Warshaw DM, 2005, BIOPHYS J, V88, pL30, DOI 10.1529/biophysj.105.061903; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Wu XF, 2001, J CELL SCI, V114, P1091; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Wu XS, 2005, J CELL BIOL, V171, P201, DOI 10.1083/jcb.200503028; Wu XF, 2006, FEBS LETT, V580, P5863, DOI 10.1016/j.febslet.2006.09.047	47	29	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29313	29322		10.1074/jbc.M113.476929	http://dx.doi.org/10.1074/jbc.M113.476929			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979131	hybrid, Green Published			2022-12-28	WOS:000330615300011
J	Bergmayr, C; Thurner, P; Keuerleber, S; Kudlacek, O; Nanoff, C; Freissmuth, M; Gruber, CW				Bergmayr, Christian; Thurner, Patrick; Keuerleber, Simon; Kudlacek, Oliver; Nanoff, Christian; Freissmuth, Michael; Gruber, Christian W.			Recruitment of a Cytoplasmic Chaperone Relay by the A(2A) Adenosine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-Helix Receptor; Adenosine Receptor; Adenylate Cyclase (Adenylyl Cyclase); Endoplasmic Reticulum (ER); G Protein-coupled Receptors (GPCR); G Proteins; Heat-Shock Protein	SHOCK-PROTEIN 90; MOLECULAR CHAPERONES; CARBOXYL-TERMINUS; ESCHERICHIA-COLI; DISTINCT ROLES; HSP90; EXPRESSION; BINDING; MUTANT; DEGRADATION	The adenosine A(2A) receptor is a prototypical rhodopsin-like G protein-coupled receptor but has several unique structural features, in particular a long C terminus (of >120 residues) devoid of a palmitoylation site. It is known to interact with several accessory proteins other than those canonically involved in signaling. However, it is evident that many more proteins must interact with the A(2A) receptor, if the trafficking trajectory of the receptor is taken into account from its site of synthesis in the endoplasmic reticulum (ER) to its disposal by the lysosome. Affinity-tagged versions of the A(2A) receptor were expressed in HEK293 cells to identify interacting partners residing in the ER by a proteomics approach based on tandem affinity purification. The receptor-protein complexes were purified in quantities sufficient for analysis by mass spectrometry. We identified molecular chaperones (heat-shock proteins HSP90 and HSP70-1A) that interact with and retain partially folded A(2A) receptor prior to ER exit. Complex formation between the A(2A) receptor and HSP90 (but not HSP90) and HSP70-1A was confirmed by co-affinity precipitation. HSP90 inhibitors also enhanced surface expression of the receptor in PC12 cells, which endogenously express the A(2A) receptor. Finally, proteins of the HSP relay machinery (e.g. HOP/HSC70-HSP90 organizing protein and P23/HSP90 co-chaperone) were recovered in complexes with the A(2A) receptor. These observations are consistent with the proposed chaperone/coat protein complex II exchange model. This posits that cytosolic HSP proteins are sequentially recruited to folding intermediates of the A(2A) receptor. Release of HSP90 is required prior to recruitment of coat protein complex II components. This prevents premature ER export of partially folded receptors.	[Bergmayr, Christian; Thurner, Patrick; Keuerleber, Simon; Kudlacek, Oliver; Nanoff, Christian; Freissmuth, Michael; Gruber, Christian W.] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	Medical University of Vienna	Freissmuth, M (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringerstr 13A, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at		nanoff, christian/0000-0002-8857-2470; Freissmuth, Michael/0000-0001-9398-1765; Kudlacek, Oliver/0000-0002-3086-8551; Gruber, Christian/0000-0001-6060-7048	Austrian Science Fund (FWF) [M1086, W1205-B09]; European Union [23097]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Union(European Commission)	This work was supported by Austrian Science Fund (FWF) Grants M1086 and W1205-B09 and European Union Seventh Framework Programme Grant FP7/2007-2013 under Grant Agreement 23097.	An WG, 2000, CELL GROWTH DIFFER, V11, P355; Arslan G, 2002, N-S ARCH PHARMACOL, V365, P150, DOI 10.1007/s002100100456; Arslan G, 1999, N-S ARCH PHARMACOL, V359, P28, DOI 10.1007/PL00005319; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; BERTIN B, 1992, J BIOL CHEM, V267, P8200; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Burgueno J, 2003, J BIOL CHEM, V278, P37545, DOI 10.1074/jbc.M302809200; Chanoux RA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00137; Charalambous C, 2008, J BIOL CHEM, V283, P9276, DOI 10.1074/jbc.M706275200; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Coppinger JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037682; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; FREISSMUTH M, 1991, P NATL ACAD SCI USA, V88, P8548, DOI 10.1073/pnas.88.19.8548; Fuxe K, 2005, J MOL NEUROSCI, V26, P209, DOI 10.1385/JMN:26:2-3:209; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Gsandtner I, 2005, J BIOL CHEM, V280, P31898, DOI 10.1074/jbc.M506515200; Gsandtner I, 2006, MOL PHARMACOL, V70, P447, DOI 10.1124/mol.106.026757; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hohenegger M, 1996, MOL PHARMACOL, V49, P73; JOCKERS R, 1994, J BIOL CHEM, V269, P32077; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Keuerleber S, 2012, J BIOL CHEM, V287, P42104, DOI 10.1074/jbc.M112.393579; Keuerleber S, 2011, BBA-BIOMEMBRANES, V1808, P1350, DOI 10.1016/j.bbamem.2010.05.009; Klinger M, 2004, CANCER RES, V64, P1087, DOI 10.1158/0008-5472.CAN-03-2435; Klinger M, 2002, CELL SIGNAL, V14, P99, DOI 10.1016/S0898-6568(01)00235-2; Klinger M, 2002, N-S ARCH PHARMACOL, V366, P287, DOI 10.1007/s00210-002-0617-z; Korkhov VM, 2008, J MOL BIOL, V378, P337, DOI 10.1016/j.jmb.2008.02.056; Kudlacek O, 2003, NEUROPSYCHOPHARMACOL, V28, P1317, DOI 10.1038/sj.npp.1300181; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Malaga-Dieguez L, 2010, MOL PHARMACOL, V77, P940, DOI 10.1124/mol.110.063511; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Minami Y, 2000, J BIOL CHEM, V275, P9055, DOI 10.1074/jbc.275.12.9055; Nanoff Christian, 2012, Subcell Biochem, V63, P1, DOI 10.1007/978-94-007-4765-4_1; Needham PG, 2011, J BIOL CHEM, V286, P43611, DOI 10.1074/jbc.M111.288928; Onuoha SC, 2007, J MOL BIOL, V372, P287, DOI 10.1016/j.jmb.2007.06.065; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; PIERSEN CE, 1994, MOL PHARMACOL, V45, P861; Ramanathan RK, 2010, J CLIN ONCOL, V28, P1520, DOI 10.1200/JCO.2009.25.0415; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; Sun CN, 2006, MOL PHARMACOL, V70, P454, DOI 10.1124/mol.105.021261; Vanderheyden PML, 1999, BRIT J PHARMACOL, V126, P1057, DOI 10.1038/sj.bjp.0702398; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200; Yonehara M, 1996, J BIOL CHEM, V271, P2641, DOI 10.1074/jbc.271.5.2641	51	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28831	28844		10.1074/jbc.M113.464776	http://dx.doi.org/10.1074/jbc.M113.464776			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23965991	hybrid, Green Published			2022-12-28	WOS:000330298800036
J	Besprozvannaya, M; Pivorunas, VL; Feldman, Z; Burton, BM				Besprozvannaya, Marina; Pivorunas, Valerie L.; Feldman, Zachary; Burton, Briana M.			SpoIIIE Protein Achieves Directional DNA Translocation through Allosteric Regulation of ATPase Activity by an Accessory Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; ATPases; Chromosomes; DNA-Protein Interaction; Molecular Motors	BACILLUS-SUBTILIS; FTSK-TRANSLOCASE; CHROMOSOME ORIENTATION; CELL-DIVISION; STRANDED-DNA; KOPS; MECHANISM; COLI; SEGREGATION; SPORULATION	Bacterial chromosome segregation utilizes highly conserved directional translocases of the SpoIIIE/FtsK family. These proteins employ an accessory DNA-binding domain () to dictate directionality of DNA transport. It remains unclear how the interaction of with specific recognition sequences coordinates directional DNA translocation. We demonstrate that the domain of SpoIIIE inhibits ATPase activity of the motor domain in the absence of DNA but stimulates ATPase activity through sequence-specific DNA recognition. Furthermore, we observe that communication between subunits is necessary for both regulatory roles. Consistent with these findings, the domain is necessary for robust DNA transport along the length of the chromosome in vivo. Together, our data reveal that directional activation involves allosteric regulation of ATP turnover through coordinated action of domains. Thus, we propose a coordinated stimulation model in which - communication is required to translate DNA sequence information from each to its respective motor domain.	[Besprozvannaya, Marina; Pivorunas, Valerie L.; Feldman, Zachary; Burton, Briana M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Burton, BM (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	bburton@mcb.harvard.edu			Massachusetts Life Science Foundation; National Institutes of Health [GM-07598]; National Science Foundation [DGE-1144152, DGE-0946799]	Massachusetts Life Science Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the Massachusetts Life Science Foundation (to B. M. B.).; Supported by National Institutes of Health Training Grant GM-07598 (Molecules Cells and Organisms) and National Science Foundation Graduate Research Fellowship Program Grant DGE-1144152.; Supported by National Science Foundation Graduate Research Fellowship Program Grants DGE-0946799 and DGE-1144152.	Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Barre FX, 2007, MOL MICROBIOL, V66, P1051, DOI 10.1111/j.1365-2958.2007.05981.x; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; Becker EC, 2007, MOL MICROBIOL, V66, P1066, DOI 10.1111/j.1365-2958.2007.05992.x; BERMAN J, 1987, METHOD ENZYMOL, V155, P528; Bigot S, 2005, EMBO J, V24, P3770, DOI 10.1038/sj.emboj.7600835; Bigot S, 2006, NAT STRUCT MOL BIOL, V13, P1026, DOI 10.1038/nsmb1159; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Burton BM, 2007, CELL, V131, P1301, DOI 10.1016/j.cell.2007.11.009; Cattoni DI, 2013, EMBO REP, V14, P473, DOI 10.1038/embor.2013.39; Graham JE, 2010, P NATL ACAD SCI USA, V107, P20263, DOI 10.1073/pnas.1007518107; Grainge I, 2008, CURR BIOL, V18, pR871, DOI 10.1016/j.cub.2008.07.047; Harwood C. R., 1990, MOL BIOL METHODS BAC, p[393, 432]; Ishikawa T, 2012, J STRUCT BIOL, V179, P229, DOI 10.1016/j.jsb.2012.05.016; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Lee JY, 2012, P NATL ACAD SCI USA, V109, P6531, DOI 10.1073/pnas.1201613109; Levy O, 2005, P NATL ACAD SCI USA, V102, P17618, DOI 10.1073/pnas.0508932102; Lowe J, 2008, MOL CELL, V31, P498, DOI 10.1016/j.molcel.2008.05.027; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Masson P, 2002, BBA-PROTEIN STRUCT M, V1594, P313, DOI 10.1016/S0167-4838(01)00323-5; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; MURAKAMI A, 1991, NUCLEIC ACIDS RES, V19, P4097, DOI 10.1093/nar/19.15.4097; Nolivos S, 2012, NUCLEIC ACIDS RES, V40, P5535, DOI 10.1093/nar/gks171; Pease PJ, 2005, SCIENCE, V307, P586, DOI 10.1126/science.1104885; Ptacin JL, 2008, NAT STRUCT MOL BIOL, V15, P485, DOI 10.1038/nsmb.1412; Ptacin JL, 2006, NAT STRUCT MOL BIOL, V13, P1023, DOI 10.1038/nsmb1157; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Sambrook J, 1989, MOL CLONING LAB MANU, P174; Sharp MD, 2002, SCIENCE, V295, P137, DOI 10.1126/science.1066274; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sivanathan V, 2006, NAT STRUCT MOL BIOL, V13, P965, DOI 10.1038/nsmb1158; WILSON GA, 1968, J BACTERIOL, V95, P1439, DOI 10.1128/JB.95.4.1439-1449.1968; Wu LJ, 1998, MOL MICROBIOL, V27, P777, DOI 10.1046/j.1365-2958.1998.00724.x; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305	34	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28962	28974		10.1074/jbc.M113.484055	http://dx.doi.org/10.1074/jbc.M113.484055			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23974211	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000330298800051
J	Chang, JLYF; Wang, C; Liu, JC; Huang, YQ; Jin, CL; Yang, CF; Hai, B; Liu, F; D'Souza, RN; McKeehan, WL; Wang, F				Chang, Julia Yu Fong; Wang, Cong; Liu, Junchen; Huang, Yanqing; Jin, Chengliu; Yang, Chaofeng; Hai, Bo; Liu, Fei; D'Souza, Rena N.; McKeehan, Wallace L.; Wang, Fen			Fibroblast Growth Factor Signaling Is Essential for Self-renewal of Dental Epithelial Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Fibroblast Growth Factor (FGF); Fibroblast Growth Factor Receptor (FGFR); Stem Cells; Tooth; Wnt Signaling	MOUSE INCISORS; TOOTH MORPHOGENESIS; MULTILINEAGE DIFFERENTIATION; IN-VITRO; WNT; GENERATION; PROGENITORS; EXPRESSION; NICHE; IDENTIFICATION	A constant supply of epithelial cells from dental epithelial stem cell (DESC) niches in the cervical loop (CL) enables mouse incisors to grow continuously throughout life. Elucidation of the cellular and molecular mechanisms underlying this unlimited growth potential is of broad interest for tooth regenerative therapies. Fibroblast growth factor (FGF) signaling is essential for the development of mouse incisors and for maintenance of the CL during prenatal development. However, how FGF signaling in DESCs controls the self-renewal and differentiation of the cells is not well understood. Herein, we report that FGF signaling is essential for self-renewal and the prevention of cell differentiation of DESCs in the CL as well as in DESC spheres. Inhibiting the FGF signaling pathway decreased proliferation and increased apoptosis of the cells in DESC spheres. Suppressing FGFR or its downstream signal transduction pathways diminished Lgr5-expressing cells in the CL and promoted cell differentiation both in DESC spheres and the CL. Furthermore, disruption of the FGF pathway abrogated Wnt signaling to promote Lgr5 expression in DESCs both in vitro and in vivo. This study sheds new light on understanding the mechanism by which the homeostasis, expansion, and differentiation of DESCs are regulated.	[Chang, Julia Yu Fong; Wang, Cong; Liu, Junchen; Huang, Yanqing; Jin, Chengliu; Yang, Chaofeng; McKeehan, Wallace L.; Wang, Fen] Texas A&M Univ, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA; [Chang, Julia Yu Fong; D'Souza, Rena N.] Texas A&M Univ, Dept Biomed Sci, Baylor Coll Dent, Dallas, TX 75246 USA; [Wang, Cong] Wenzhou Med Univ, Coll Pharm, Wenzhou 325000, Zhejiang, Peoples R China; [Hai, Bo; Liu, Fei] Texas A&M Univ, Coll Med, Dept Mol & Cellular Med, Bryan, TX 77807 USA	Texas A&M University System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Wenzhou Medical University; Texas A&M University System; Texas A&M University College Station	Chang, JLYF (corresponding author), Univ Washington, Sch Dent, Oral & Maxillofacial Surg Oral Pathol Div, Seattle, WA 98195 USA.	jyfchang@uw.edu; fwang@ibt.tamhsc.edu		CHANG, JULIA YU-FONG/0000-0002-3880-3787; Liu, Fei/0000-0002-7398-2274; Liu, Junchen/0000-0003-2765-9780; D'Souza, Rena/0000-0002-1505-5173; Huang, Yanqing/0000-0001-7275-3333	National Institutes of Health [K08DE020883, T32DE018380, CA096824, CA140388]; John S. Dunn Research Foundation; Cancer Prevention and Research Institution of Texas [CPRIT 110555]; NATIONAL CANCER INSTITUTE [R01CA096824, P50CA140388, R56CA096824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE023106, K08DE020883, T32DE018380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John S. Dunn Research Foundation; Cancer Prevention and Research Institution of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants K08DE020883 (to J. Y. F. C.), T32DE018380 (R. N. D.), CA096824 (to F. W.), and CA140388 (to W. L. M. and F. W.). This work was also supported by the John S. Dunn Research Foundation (to W. L. M.) and the Cancer Prevention and Research Institution of Texas Grant CPRIT 110555 (to F. W. and W. L. M.).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chang JYF, 2013, STEM CELL RES, V11, P990, DOI 10.1016/j.scr.2013.06.008; Charles C, 2011, DEVELOPMENT, V138, P4063, DOI 10.1242/dev.069195; Chen G, 2012, STEM CELLS, V30, P623, DOI 10.1002/stem.1021; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fujimori S, 2010, DEV BIOL, V348, P97, DOI 10.1016/j.ydbio.2010.09.009; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Handrigan GR, 2010, DEV BIOL, V348, P130, DOI 10.1016/j.ydbio.2010.09.003; Handrigan GR, 2010, DEVELOPMENT, V137, P3545, DOI 10.1242/dev.052415; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Harada H, 2002, DEVELOPMENT, V129, P1533; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Ille F, 2005, CELL MOL LIFE SCI, V62, P1100, DOI 10.1007/s00018-005-4552-2; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kettunen P, 2000, DEV DYNAM, V219, P322, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1062>3.0.CO;2-J; Kettunen P, 1998, DEV GENET, V22, P374, DOI 10.1002/(SICI)1520-6408(1998)22:4<374::AID-DVG7>3.0.CO;2-3; Kettunen P, 1998, DEV DYNAM, V211, P256, DOI 10.1002/(SICI)1097-0177(199803)211:3<256::AID-AJA7>3.0.CO;2-G; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kratochwil K, 2002, GENE DEV, V16, P3173, DOI 10.1101/gad.1035602; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Levenstein ME, 2008, STEM CELLS, V26, P3099, DOI 10.1634/stemcells.2007-1056; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lin YS, 2007, GENESIS, V45, P554, DOI 10.1002/dvg.20327; Lin YS, 2009, DEV DYNAM, V238, P324, DOI 10.1002/dvdy.21778; Liu F, 2010, J DENT RES, V89, P909, DOI 10.1177/0022034510370090; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; MCKEEHAN WL, 2009, HDB CELL SIGNALING, P253; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Parsa S, 2010, DEVELOPMENT, V137, P3743, DOI 10.1242/dev.051672; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Shi FX, 2012, J NEUROSCI, V32, P9639, DOI 10.1523/JNEUROSCI.1064-12.2012; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Suomalainen M, 2010, DEV DYNAM, V239, P364, DOI 10.1002/dvdy.22106; Takamori K, 2008, J DENT RES, V87, P238, DOI 10.1177/154405910808700307; Trokovic R, 2003, EMBO J, V22, P1811, DOI 10.1093/emboj/cdg169; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zhang YY, 2008, DEVELOPMENT, V135, P775, DOI 10.1242/dev.009910	56	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28952	28961		10.1074/jbc.M113.506873	http://dx.doi.org/10.1074/jbc.M113.506873			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23979135	Green Published, hybrid			2022-12-28	WOS:000330298800050
J	Kim, HD; Yu, SJ; Kim, HS; Kim, YJ; Choe, JM; Park, YG; Kim, J; Sohn, J				Kim, Hag Dong; Yu, Su-Jin; Kim, Hee Suk; Kim, Yong-Jin; Choe, Jeong Min; Park, Yun Gyu; Kim, Joon; Sohn, Jeongwon			Interleukin-4 Induces Senescence in Human Renal Carcinoma Cell Lines through STAT6 and p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Interleukin; p38 MAPK; Renal Physiology; Senescence; STAT Transcription Factor; IL-4; Renal Cell Carcinoma; STAT6; p21WAF1; CIP1	ONCOGENE-INDUCED SENESCENCE; BREAST-CANCER CELLS; GROWTH-INHIBITION; IL-4 RECEPTOR; SIGNALING MECHANISMS; GENE-EXPRESSION; IN-VITRO; APOPTOSIS; PATHWAY; ACTIVATION	Interleukin (IL)-4, originally identified as a lymphocyte growth factor, can directly inhibit growth of certain tumor cell types. We reported previously that IL-4 induced cell cycle arrest in G(1) phase through an increase in p21(WAF1/CIP1) expression in human renal cell carcinoma (RCC) cell lines. In the present study, we investigated the underlying mechanism of IL-4-induced growth inhibition. In four of six human RCC cell lines, including Caki-1, A498, SNU482, and SNU228, IL-4 induced cellular senescence as demonstrated by enlarged and flattened morphology, increased granularity, and senescence-associated--galactosidase (SA--gal) staining. Signal tranducer and activator of transcription 6 (STAT6) and p38 MAPK were found to mediate IL-4-induced growth inhibition and cellular senescence. Both of these molecules were activated by 10 min after IL-4 treatment, and inhibition of their activity or expression prevented growth suppression and cellular senescence induced by IL-4. Inhibiting or silencing either STAT6 or p38 MAPK alone partially reduced the effect of IL-4, whereas inhibiting or silencing both molecules exerted an additive effect and almost completely abrogated the effect of IL-4. Thus STAT6 and p38 MAPK appeared to independently mediate IL-4-induced growth inhibition and cellular senescence. The p21(WAF1/CIP1) up-regulation that accompanied growth inhibition and cellular senescence by IL-4 was also attenuated additively when p38 MAPK and STAT6 were silenced. Taken together, these results show that IL-4 induces cellular senescence through independent signaling pathways involving STAT6 and p38 MAPK in some human RCC cell lines.	[Kim, Hag Dong; Yu, Su-Jin; Kim, Hee Suk; Kim, Yong-Jin; Choe, Jeong Min; Park, Yun Gyu; Sohn, Jeongwon] Korea Univ, Coll Med, Dept Biochem, Seoul 136705, South Korea; [Kim, Hag Dong; Yu, Su-Jin; Kim, Hee Suk; Kim, Yong-Jin; Choe, Jeong Min; Park, Yun Gyu; Sohn, Jeongwon] Korean Inst Mol Med & Nutr, Seoul 136705, South Korea; [Kim, Joon] Korea Univ, Sch Life Sci & Biotechnol, Biochem Lab, Seoul 136701, South Korea; [Kim, Joon] Korea Univ, Bioinst, Seoul 136701, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University	Sohn, J (corresponding author), Korea Univ, Coll Med, Dept Biochem, 126-1 Anam Dong 5 Ga, Seoul 136705, South Korea.	biojs@korea.ac.kr		Sohn, Jeongwon/0000-0003-2395-458X	National Research Foundation of Korea from the Korean government [2010-0024981]; Korea University Grant [K1132201]	National Research Foundation of Korea from the Korean government(National Research Foundation of Korea); Korea University Grant	This work was supported by National Research Foundation of Korea Grant 2010-0024981 from the Korean government and Korea University Grant K1132201.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Andrews AL, 2009, BIOCHEM SOC T, V37, P873, DOI 10.1042/BST0370873; Aoudjehane L, 2007, FASEB J, V21, P1433, DOI 10.1096/fj.06-6319com; Arpa L, 2009, EUR J IMMUNOL, V39, P514, DOI 10.1002/eji.200838283; Bailey DP, 2004, EXP HEMATOL, V32, P52, DOI 10.1016/j.exphem.2003.10.011; Bernard J, 2001, LAB INVEST, V81, P1223, DOI 10.1038/labinvest.3780336; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chang TLY, 2000, J BIOL CHEM, V275, P10212, DOI 10.1074/jbc.275.14.10212; Cheon J, 1996, Int J Urol, V3, P196, DOI 10.1111/j.1442-2042.1996.tb00516.x; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Furusu A, 1997, J AM SOC NEPHROL, V8, P730; Gooch JL, 2002, NEOPLASIA, V4, P324, DOI 10.1038/sj.neo.7900248; Guiter C, 2004, BLOOD, V104, P543, DOI 10.1182/blood-2003-10-3545; Haq R, 2002, CANCER RES, V62, P5076; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Hunt AE, 2002, CYTOKINE, V18, P295, DOI 10.1006/cyto.2002.1043; Ito H, 2012, J AM SOC NEPHROL, V23, P1797, DOI 10.1681/ASN.2012020126; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Kawakami K, 2001, CRIT REV IMMUNOL, V21, P299; Kawakami K, 2000, HUM GENE THER, V11, P1829, DOI 10.1089/10430340050129459; KEEGAN A, 1994, ADV EXP MED BIOL, V365, P211; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; Kim HD, 2012, BIOCHEM BIOPH RES CO, V422, P213, DOI 10.1016/j.bbrc.2012.04.086; Kioi M, 2005, CANCER RES, V65, P8388, DOI 10.1158/0008-5472.CAN-05-1043; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kwong J, 2009, J BIOL CHEM, V284, P11237, DOI 10.1074/jbc.M808327200; LAHM H, 1994, INT J CANCER, V59, P440, DOI 10.1002/ijc.2910590325; Lee JY, 2007, MOL CELL BIOL, V27, P3187, DOI 10.1128/MCB.01461-06; Lee YW, 2000, FEBS LETT, V485, P122, DOI 10.1016/S0014-5793(00)02208-0; Li BH, 2008, BIOCHEM BIOPH RES CO, V369, P554, DOI 10.1016/j.bbrc.2008.02.052; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; MANGAN DF, 1992, J IMMUNOL, V148, P1812; Melk A, 2003, NEPHROL DIAL TRANSPL, V18, P2474, DOI 10.1093/ndt/gfg322; Moiseeva O, 2006, MOL BIOL CELL, V17, P1583, DOI 10.1091/mbc.E05-09-0858; MORISAKI T, 1992, CANCER RES, V52, P6059; MORISAKI T, 1994, CANCER RES, V54, P1113; Myers JN, 1996, CLIN CANCER RES, V2, P127; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Ni ZY, 2002, J UROLOGY, V167, P1859, DOI 10.1016/S0022-5347(05)65249-4; OBIRI NI, 1993, J CLIN INVEST, V91, P88, DOI 10.1172/JCI116205; PERNIS A, 1995, P NATL ACAD SCI USA, V92, P7971, DOI 10.1073/pnas.92.17.7971; Pesu M, 2002, J BIOL CHEM, V277, P38254, DOI 10.1074/jbc.M201427200; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Prokopchuk O, 2005, BRIT J CANCER, V92, P921, DOI 10.1038/sj.bjc.6602416; Singh RR, 2003, J IMMUNOL, V170, P4818, DOI 10.4049/jimmunol.170.9.4818; TAYLOR CW, 1990, BLOOD, V75, P1114; Vijayachandra K, 2003, CANCER RES, V63, P3447; Walston J, 2005, EXP GERONTOL, V40, P344, DOI 10.1016/j.exger.2005.01.012; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wery-Zennaro S, 2000, ONCOGENE, V19, P1596, DOI 10.1038/sj.onc.1203458; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Yu SJ, 2004, EXP MOL MED, V36, P372, DOI 10.1038/emm.2004.49; Zhang WJ, 2008, CYTOKINE, V42, P39, DOI 10.1016/j.cyto.2008.01.016	56	24	26	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28743	28754		10.1074/jbc.M113.499053	http://dx.doi.org/10.1074/jbc.M113.499053			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23935100	Green Published, hybrid			2022-12-28	WOS:000330298800028
J	Kim, JA; Kim, Y; Kwon, BM; Han, DC				Kim, Joo Ae; Kim, Youngmi; Kwon, Byoung-Mog; Han, Dong Cho			The Natural Compound Cantharidin Induces Cancer Cell Death through Inhibition of Heat Shock Protein 70 (HSP70) and Bcl-2-associated Athanogene Domain 3 (BAG3) Expression by Blocking Heat Shock Factor 1 (HSF1) Binding to Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bcl-2 Family Proteins; Cancer Therapy; Drug Screening; Heat Shock Protein; PP2A	PROTEIN PHOSPHATASE 2A; NON-ONCOGENE ADDICTION; BH3 MIMETIC ABT-737; NF-KAPPA-B; TUMOR-SUPPRESSOR; SIGNALING PATHWAYS; BCL-2 PROTEINS; OKADAIC ACID; APOPTOSIS; STRESS	Heat shock factor 1 (HSF1) enhances the survival of cancer cells under various stresses. The knock-out of HSF1 impairs cancer formation and progression, suggesting that HSF1 is a promising therapeutic target. To identify inhibitors of HSF1 activity, we performed cell-based screening with a library of marketed and experimental drugs and identified cantharidin as an HSF1 inhibitor. Cantharidin is a potent antitumor agent from traditional Chinese medicine. Cantharidin inhibited heat shock-induced luciferase activity with an IC50 of 4.2 m. In contrast, cantharidin did not inhibit NF-B luciferase reporter activity, demonstrating that cantharidin is not a general transcription inhibitor. When the HCT-116 colorectal cancer cells were exposed to heat shock in the presence of cantharidin, the induction of HSF1 downstream target proteins, such as HSP70 and BAG3 (Bcl-2-associated athanogene domain 3), was suppressed. HSP70 and its co-chaperone BAG3 have been reported to protect cells from apoptosis by stabilizing anti-apoptotic Bcl-2 family proteins. As expected, treating HCT-116 cancer cells with cantharidin significantly decreased the amounts of BCL-2, BCL-x(L), and MCL-1 protein and induced apoptotic cell death. Chromatin immunoprecipitation analysis showed that cantharidin inhibited the binding of HSF1 to the HSP70 promoter and subsequently blocked HSF1-dependent p-TEFb recruitment. Therefore, the p-TEFb-dependent phosphorylation of the C-terminal domain of RNA polymerase II was blocked, arresting transcription at the elongation step. Protein phosphatase 2A inhibition with PP2CA siRNA or okadaic acid did not block HSF1 activity, suggesting that cantharidin inhibits HSF1 in a protein phosphatase 2A-independent manner. We show for the first time that cantharidin inhibits HSF1 transcriptional activity.	[Kim, Joo Ae; Kim, Youngmi; Kwon, Byoung-Mog; Han, Dong Cho] Korea Res Inst Biosci & Biotechnol, Biomed Genom Res Ctr, Taejon 305806, South Korea; [Kim, Joo Ae; Kim, Youngmi; Kwon, Byoung-Mog; Han, Dong Cho] Univ Sci & Technol, Taejon 305806, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kwon, BM (corresponding author), 111 Gwahangno, Taejon 305806, South Korea.	kwonbm@kribb.re.kr; dchan@kribb.re.kr			National Chemical Genomics Research Program NRF [2011-0018688]; KRIBB Research Initiative Program; Bio & Medical Technology Development Program of the National Research Foundation; Korean Government [2012M3A9C404877]	National Chemical Genomics Research Program NRF; KRIBB Research Initiative Program; Bio & Medical Technology Development Program of the National Research Foundation; Korean Government(Korean Government)	This work was supported by the National Chemical Genomics Research Program NRF Grant 2011-0018688, the KRIBB Research Initiative Program, and the Bio & Medical Technology Development Program of the National Research Foundation funded by Korean Government Grant 2012M3A9C404877.	Akgul C, 2000, FEBS LETT, V478, P72, DOI 10.1016/S0014-5793(00)01809-3; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boiani M, 2013, J BIOL CHEM, V288, P6980, DOI 10.1074/jbc.M112.414177; Chang CC, 2008, FOOD CHEM TOXICOL, V46, P3116, DOI 10.1016/j.fct.2008.06.084; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Deng LP, 2013, CURR MED CHEM, V20, P159, DOI 10.2174/092986713804806711; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; EPSTEIN WL, 1958, ARCH DERMATOL, V77, P508, DOI 10.1001/archderm.1958.01560050014003; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Huang WW, 2011, INT J ONCOL, V38, P1067, DOI 10.3892/ijo.2011.922; Jacobs AT, 2009, J BIOL CHEM, V284, P9176, DOI 10.1074/jbc.M808656200; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Keuling AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006651; KINGSTON RE, 1986, MOL CELL BIOL, V6, P3180, DOI 10.1128/MCB.6.9.3180; KINGSTON RE, 1984, NATURE, V312, P280, DOI 10.1038/312280a0; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Lee JH, 2002, J BIOL CHEM, V277, P18411, DOI 10.1074/jbc.M201368200; Li W, 2011, CANCER LETT, V304, P117, DOI 10.1016/j.canlet.2011.02.009; Li W, 2010, CANCER SCI, V101, P1226, DOI 10.1111/j.1349-7006.2010.01523.x; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Lin XH, 1998, P NATL ACAD SCI USA, V95, P14693, DOI 10.1073/pnas.95.25.14693; Lis JT, 2000, GENE DEV, V14, P792; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; Mitra A, 2012, ONCOGENE, V31, P4472, DOI 10.1038/onc.2011.623; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Rocchi P, 2005, CANCER RES, V65, P11083, DOI 10.1158/0008-5472.CAN-05-1840; Sagawa M, 2008, CANCER SCI, V99, P1820, DOI 10.1111/j.1349-7006.2008.00872.x; Sanchez-Serrano I, 2006, NAT REV DRUG DISCOV, V5, P107, DOI 10.1038/nrd1959; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Solit DB, 2008, DRUG DISCOV TODAY, V13, P38, DOI 10.1016/j.drudis.2007.10.007; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Stanhill A, 2006, ONCOGENE, V25, P1485, DOI 10.1038/sj.onc.1209193; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; SZATROWSKI TP, 1991, CANCER RES, V51, P794; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Van Hoof C, 2004, CANCER CELL, V5, P105, DOI 10.1016/S1535-6108(04)00027-3; Walter G, 2012, CELL CYCLE, V11, P451, DOI 10.4161/cc.11.3.19057; Wang CC, 2000, TOXICOLOGY, V147, P77, DOI 10.1016/S0300-483X(00)00185-2; WANG GS, 1989, J ETHNOPHARMACOL, V26, P147, DOI 10.1016/0378-8741(89)90062-7; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yan Y, 1997, J BIOL CHEM, V272, P15220, DOI 10.1074/jbc.272.24.15220; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yoon YJ, 2011, J BIOL CHEM, V286, P1737, DOI 10.1074/jbc.M110.179440	55	70	70	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28713	28726		10.1074/jbc.M113.488346	http://dx.doi.org/10.1074/jbc.M113.488346			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23983126	hybrid, Green Published			2022-12-28	WOS:000330298800025
J	Hu, S; Liang, SY; Guo, HZ; Zhang, DP; Li, H; Wang, XZ; Yang, WL; Qian, WZ; Hou, S; Wang, H; Guo, YJ; Lou, ZY				Hu, Shi; Liang, Shuaiyi; Guo, Huaizu; Zhang, Dapeng; Li, Hui; Wang, Xiaoze; Yang, Weili; Qian, Weizhu; Hou, Sheng; Wang, Hao; Guo, Yajun; Lou, Zhiyong			Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor alpha-Associated Diseases from a Molecular View	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; TNF-ALPHA; CLINICAL-PRACTICE; CRYSTAL-STRUCTURE; EFFICACY; ETANERCEPT; SAFETY; METAANALYSIS; SUPERFAMILY	TNF alpha-targeting therapy with the use of the drugs Etanercept, Infliximab, and Adalimumab is used in the clinical treatment of various inflammatory and immune diseases. Although all of these reagents function to disrupt the interaction between TNF alpha and its receptors, clinical investigations showed the advantages of Adalimumab treatment compared with Etanercept and Infliximab. However, the underlying molecular mechanism of action of Adalimumab remains unclear. In our previous work, we presented structural data on how Infliximab binds with the E-F loop of TNF alpha and functions as a TNF alpha receptor-binding blocker. To further elucidate the variations between TNF alpha inhibitors, we solved the crystal structure of TNF alpha in complex with Adalimumab Fab. The structural observation and the mutagenesis analysis provided direct evidence for identifying the Adalimumab epitope on TNF alpha and revealed the mechanism of Adalimumab inhibition of TNF alpha by occupying the TNF alpha receptor-binding site. The larger antigen-antibody interface in TNF alpha Adalimumab also provided information at a molecular level for further understanding the clinical advantages of Adalimumab therapy compared with Infliximab.	[Hu, Shi; Liang, Shuaiyi; Lou, Zhiyong] Tsinghua Univ, Sch Med, Struct Biol Lab, Beijing 100084, Peoples R China; [Hu, Shi; Liang, Shuaiyi; Lou, Zhiyong] Tsinghua Univ, Sch Med, Minist Educ Lab Prot Sci, Beijing 100084, Peoples R China; [Hu, Shi; Guo, Huaizu; Zhang, Dapeng; Qian, Weizhu; Hou, Sheng; Wang, Hao; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China; [Guo, Huaizu; Zhang, Dapeng; Qian, Weizhu; Hou, Sheng; Wang, Hao; Guo, Yajun] Natl Engn Res Ctr Antibody Med, Shanghai 201203, Peoples R China; [Guo, Huaizu; Zhang, Dapeng; Qian, Weizhu; Hou, Sheng; Wang, Hao; Guo, Yajun] Shanghai Key Lab Cell Engn & Antibody, Shanghai 201203, Peoples R China; [Guo, Huaizu; Zhang, Dapeng; Li, Hui; Qian, Weizhu; Hou, Sheng; Wang, Hao; Guo, Yajun] Peoples Liberat Army PLA Gen Hosp Canc Ctr, PLA Postgrad Sch Med, Beijing 100853, Peoples R China; [Wang, Xiaoze; Yang, Weili; Guo, Yajun] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China	Tsinghua University; Tsinghua University; Naval Medical University; Nankai University	Guo, YJ (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China.	yjguo@smmu.edu.cn; louzy@xtal.tsinghua.edu.cn	Hu, Shi/ABF-4231-2020; Hu, Shi/A-2140-2015	Hu, Shi/0000-0002-7905-4284	973 Project [2010CB833600, 2013CB911103, 2012CB724500, 2010CB735605]; National Natural Science Foundation of China [31170678, 31000332]; Tianjin Science and Technology Pillar Program [10ZCKFSY08800]; Science and Technology Innovation Fund [11C26211203971]	973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Pillar Program; Science and Technology Innovation Fund	This work was supported by 973 Project Grants 2010CB833600, 2013CB911103, 2012CB724500, and 2010CB735605; National Natural Science Foundation of China Grants 31170678 and 31000332; Key Projects in the Tianjin Science and Technology Pillar Program Grant 10ZCKFSY08800; and 2011 Science and Technology Innovation Fund Grant 11C26211203971.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Alonso-Ruiz A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-52; Bachmann F, 2010, SEMIN CUTAN MED SURG, V29, P35, DOI 10.1016/j.sder.2010.02.002; Baidoo L, 2005, AM J GASTROENTEROL, V100, P80, DOI 10.1111/j.1572-0241.2005.41716.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bernett MJ, 2010, J MOL BIOL, V396, P1474, DOI 10.1016/j.jmb.2009.12.046; Davis T., 2002, ANN RHEUM DIS S1, V61, P184; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Granneman RG, 2003, ARTHRITIS RHEUM, V48, pS140; Hetland ML, 2010, ARTHRITIS RHEUM-US, V62, P22, DOI 10.1002/art.27227; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; Kievit W, 2008, ANN RHEUM DIS, V67, P1229, DOI 10.1136/ard.2007.083675; Kirson Noam Y, 2013, J Med Econ, V16, P479, DOI 10.3111/13696998.2013.768530; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang SY, 2013, J BIOL CHEM, V288, P13799, DOI 10.1074/jbc.M112.433961; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Matthews N., 1987, LYMPHOKINES INTERFER, P296; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Mukai Y, 2009, J MOL BIOL, V385, P1221, DOI 10.1016/j.jmb.2008.11.053; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Santora LC, 2001, ANAL BIOCHEM, V299, P119, DOI 10.1006/abio.2001.5380; Scallon B, 2002, J PHARMACOL EXP THER, V301, P418, DOI 10.1124/jpet.301.2.418; Schnitzler F, 2009, GUT, V58, P492, DOI 10.1136/gut.2008.155812; Seminerio JL, 2013, DIGEST DIS SCI, V58, P797, DOI 10.1007/s10620-012-2405-z; Shealy D. J., 2008, V181, P101; Tansey MG, 2009, DRUG DISCOV TODAY, V14, P1082, DOI 10.1016/j.drudis.2009.10.002; Tursi A, 2013, ALIMENT PHARM THER, V37, P763, DOI 10.1111/apt.12238; VANOSTADE X, 1994, PROTEIN ENG, V7, P5, DOI 10.1093/protein/7.1.5; Wiens A, 2010, PHARMACOTHERAPY, V30, P339, DOI 10.1592/phco.30.4.339; Yang ZR, 2009, NAT STRUCT MOL BIOL, V16, P1189, DOI 10.1038/nsmb.1683; Zorzi F, 2012, ALIMENT PHARM THER, V35, P1397, DOI 10.1111/j.1365-2036.2012.05100.x	38	91	105	4	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27059	27067		10.1074/jbc.M113.491530	http://dx.doi.org/10.1074/jbc.M113.491530			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23943614	hybrid, Green Published			2022-12-28	WOS:000330597300007
J	Li, ZM; Peng, H; Qin, L; Qi, J; Zuo, XB; Liu, JY; Zhang, JT				Li, Zhaomin; Peng, Hui; Qin, Li; Qi, Jing; Zuo, Xiaobing; Liu, Jing-Yuan; Zhang, Jian-Ting			Determinants of 14-3-3 sigma Protein Dimerization and Function in Drug and Radiation Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; BREAST-CANCER CELLS; X-RAY-SCATTERING; PROTEOMIC ANALYSIS; MITOTIC CATASTROPHE; PHOSPHORYLATION; OLIGOMERIZATION; APOPTOSIS; SURVIVAL; ABCG2	Many proteins exist and function as homodimers. Understanding the detailed mechanism driving the homodimerization is important and will impact future studies targeting the "undruggable" oncogenic protein dimers. In this study, we used 14-3-3 sigma as a model homodimeric protein and performed a systematic investigation of the potential roles of amino acid residues in the interface for homodimerization. Unlike other members of the conserved 14-3-3 protein family, 14-3-3 sigma prefers to form a homodimer with two subareas in the dimeric interface that has 180 degrees symmetry. We found that both subareas of the dimeric interface are required to maintain full dimerization activity. Although the interfacial hydrophobic core residues Leu(12) and Tyr(84) play important roles in 14-3-3 sigma dimerization, the non-core residue Phe(25) appears to be more important in controlling 14-3-3 sigma dimerization activity. Interestingly, a similar non-core residue (Val(81)) is less important than Phe(25) in contributing to 14-3-3 sigma dimerization. Furthermore, dissociating dimeric 14-3-3 sigma into monomers by mutating the Leu(12), Phe(25), or Tyr(84) dimerization residue individually diminished the function of 14-3-3 sigma in resisting drug-induced apoptosis and in arresting cells at G(2)/M phase in response to DNA-damaging treatment. Thus, dimerization appears to be required for the function of 14-3-3 sigma.	[Li, Zhaomin; Peng, Hui; Qin, Li; Qi, Jing; Liu, Jing-Yuan; Zhang, Jian-Ting] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Zhang, Jian-Ting] Indiana Univ Sch Med, IU Simon Canc Ctr, Indianapolis, IN 46202 USA; [Zuo, Xiaobing] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Liu, Jing-Yuan] Indiana Univ Purdue Univ, Dept Comp & Informat Sci, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; United States Department of Energy (DOE); Argonne National Laboratory; Indiana University System; Indiana University-Purdue University Indianapolis	Liu, JY (corresponding author), IUPUI, 723 W Michigan St,SL280C, Indianapolis, IN 46202 USA.	jliu2@iupui.edu; jianzhan@iupui.edu	Zhang, Jian-Ting/L-8334-2015	Zhang, Jian-Ting/0000-0002-2803-9914	United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA140582] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, which is supported by the United States Department of Energy under Contract DE-AC02-06CH11357.	Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chu K, 2004, RADIAT RES, V162, P270, DOI 10.1667/RR3221; Dong ZZ, 2009, EXP CELL RES, V315, P1889, DOI 10.1016/j.yexcr.2009.03.009; Dong ZZ, 2005, NUCLEIC ACIDS RES, V33, P2715, DOI 10.1093/nar/gki569; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Glatter O., 1982, SMALL ANGLE XRAY SCA; Han BG, 2006, MOL CANCER THER, V5, P903, DOI 10.1158/1535-7163.MCT-05-0393; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Hirai M, 2004, BIOCHEMISTRY-US, V43, P9036, DOI 10.1021/bi0499664; Laronga C, 2000, J BIOL CHEM, V275, P23106, DOI 10.1074/jbc.M905616199; Li Zhaomin, 2010, BMC Cancer, V10, P598, DOI 10.1186/1471-2407-10-598; Li ZM, 2009, AM J TRANSL RES, V1, P326; Liu JY, 2011, J CHEM INF MODEL, V51, P2612, DOI 10.1021/ci200212y; Liu Y, 2006, CANCER RES, V66, P3248, DOI 10.1158/0008-5472.CAN-05-3801; Mo W, 2012, BIOCHEMISTRY-US, V51, P3634, DOI 10.1021/bi300301a; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Neupane D, 2008, CLIN CANCER RES, V14, P7614, DOI 10.1158/1078-0432.CCR-08-1366; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Samuel T, 2001, J BIOL CHEM, V276, P45201, DOI 10.1074/jbc.M106427200; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vercoutter-Edouart AS, 2001, CANCER RES, V61, P76; Verdoodt B, 2006, CELL CYCLE, V5, P2920, DOI 10.4161/cc.5.24.3571; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Xu JK, 2007, CANCER RES, V67, P4373, DOI 10.1158/0008-5472.CAN-06-3169; Yang YY, 2010, BIOCHEMISTRY-US, V49, P10854, DOI 10.1021/bi101350x; Yang YY, 2002, J BIOL CHEM, V277, P44268, DOI 10.1074/jbc.M207003200; Zhang JT, 2007, CANCER TREAT REV, V33, P741, DOI 10.1016/j.ctrv.2007.07.018; Zhang JT, 2000, J CELL SCI, V113, P2545; Zhou Y, 2003, J BIOL CHEM, V278, P10073, DOI 10.1074/jbc.M211907200	35	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31447	31457		10.1074/jbc.M113.467753	http://dx.doi.org/10.1074/jbc.M113.467753			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043626	Green Published, hybrid			2022-12-28	WOS:000330596200004
J	Pietras, Z; Hardwick, SW; Swiezewski, S; Luisi, BF				Pietras, Zbigniew; Hardwick, Steven W.; Swiezewski, Szymon; Luisi, Ben F.			Potential Regulatory Interactions of Escherichia coli RraA Protein with DEAD-box Helicases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA HELICASE; CRYSTAL-STRUCTURE; NUCLEOPORIN NUP214; DEGRADOSOME; RECOGNITION; INHIBITOR; MUTATION; REVEALS; BINDING; ATPASE	Members of the DEAD-box family of RNA helicases contribute to virtually every aspect of RNA metabolism, in organisms from all domains of life. Many of these helicases are constituents of multicomponent assemblies, and their interactions with partner proteins within the complexes underpin their activities and biological function. In Escherichia coli the DEAD-box helicase RhlB is a component of the multienzyme RNA degradosome assembly, and its interaction with the core ribonuclease RNase E boosts the ATP-dependent activity of the helicase. Earlier studies have identified the regulator of ribonuclease activity A (RraA) as a potential interaction partner of both RNase E and RhlB. We present structural and biochemical evidence showing how RraA can bind to, and modulate the activity of RhlB and another E. coli DEAD-box enzyme, SrmB. Crystallographic structures are presented of RraA in complex with a portion of the natively unstructured C-terminal tail of RhlB at 2.8-angstrom resolution, and in complex with the C-terminal RecA-like domain of SrmB at 2.9 angstrom. The models suggest two distinct mechanisms by which RraA might modulate the activity of these and potentially other helicases.	[Pietras, Zbigniew; Hardwick, Steven W.; Luisi, Ben F.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Pietras, Zbigniew; Swiezewski, Szymon] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	University of Cambridge; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Luisi, BF (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.	bfl20@cam.ac.uk		Pietras, Zbigniew/0000-0002-0365-7257; Swiezewski, Szymon/0000-0002-2007-2779; Hardwick, Steven/0000-0001-9246-1864	Wellcome Trust; Biotechnology and Biological Sciences Research Council; Peterhouse studentships	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Peterhouse studentships	This work was supported in part by the Wellcome Trust.; Supported by Biotechnology and Biological Sciences Research Council and Peterhouse studentships.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bizebard T, 2004, BIOCHEMISTRY-US, V43, P7857, DOI 10.1021/bi049852s; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Callaghan AJ, 2004, J MOL BIOL, V340, P965, DOI 10.1016/j.jmb.2004.05.046; Calleja M., 2004, P 2004 UK E SCI ALL; Carabetta VJ, 2010, J BACTERIOL, V192, P3713, DOI 10.1128/JB.00300-10; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Cartier G, 2010, BIOCHEMISTRY-US, V49, P2636, DOI 10.1021/bi902082d; Chandran V, 2006, J MOL BIOL, V358, P8, DOI 10.1016/j.jmb.2006.02.012; Chandran V, 2007, J MOL BIOL, V367, P113, DOI 10.1016/j.jmb.2006.12.014; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Elles LM, 2008, NUCLEIC ACIDS RES, V36, P41, DOI 10.1093/nar/gkm926; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gorna MW, 2010, RNA, V16, P553, DOI 10.1261/rna.1858010; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Iost I, 2013, BBA-GENE REGUL MECH, V1829, P866, DOI 10.1016/j.bbagrm.2013.01.012; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee KS, 2003, CELL, V114, P623, DOI 10.1016/j.cell.2003.08.003; Mallam AL, 2011, P NATL ACAD SCI USA, V108, P12254, DOI 10.1073/pnas.1109566108; Manasherob R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038426; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOLIN S, 1977, J BACTERIOL, V131, P7, DOI 10.1128/JB.131.1.7-17.1977; Monzingo AF, 2003, J MOL BIOL, V332, P1015, DOI 10.1016/S0022-2836(03)00970-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Napetschnig J, 2009, P NATL ACAD SCI USA, V106, P3089, DOI 10.1073/pnas.0813267106; NICOL SM, 1995, P NATL ACAD SCI USA, V92, P11681, DOI 10.1073/pnas.92.25.11681; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Proux F, 2011, MOL MICROBIOL, V82, P300, DOI 10.1111/j.1365-2958.2011.07779.x; Prud'homme-Genereux A, 2004, MOL MICROBIOL, V54, P1409, DOI 10.1111/j.1365-2958.2004.04360.x; Pulk A, 2010, MOL MICROBIOL, V75, P801, DOI 10.1111/j.1365-2958.2009.07002.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Taghbalout A, 2010, J BACTERIOL, V192, P3222, DOI 10.1128/JB.00105-10; Tamura M, 2012, J BACTERIOL, V194, P1919, DOI 10.1128/JB.06652-11; Tang JA, 2010, PROTEIN J, V29, P583, DOI 10.1007/s10930-010-9293-x; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Trubetskoy D, 2009, NUCLEIC ACIDS RES, V37, P6540, DOI 10.1093/nar/gkp685; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Worrall JAR, 2008, J BIOL CHEM, V283, P5567, DOI 10.1074/jbc.M708620200	51	9	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31919	31929		10.1074/jbc.M113.502146	http://dx.doi.org/10.1074/jbc.M113.502146			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045937	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000330596200044
J	Kaiser, WJ; Sridharan, H; Huang, CZ; Mandal, P; Upton, JW; Gough, PJ; Sehon, CA; Marquis, RW; Bertin, J; Mocarski, ES				Kaiser, William J.; Sridharan, Haripriya; Huang, Chunzi; Mandal, Pratyusha; Upton, Jason W.; Gough, Peter J.; Sehon, Clark A.; Marquis, Robert W.; Bertin, John; Mocarski, Edward S.			Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; HOMOTYPIC INTERACTION MOTIF; MIXED LINEAGE KINASE; TNF-INDUCED NECROSIS; CELL-DEATH PATHWAY; PROGRAMMED NECROSIS; INTERACTING PROTEIN; INDUCED APOPTOSIS; ADAPTER TRIF; DOMAIN-LIKE	Toll-like receptor (TLR) signaling is triggered by pathogen-associated molecular patterns that mediate well established cytokine-driven pathways, activating NF-kappa B together with IRF3/IRF7. In addition, TLR3 drives caspase 8-regulated programmed cell death pathways reminiscent of TNF family death receptor signaling. We find that inhibition or elimination of caspase 8 during stimulation of TLR2, TLR3, TLR4, TLR5, or TLR9 results in receptor interacting protein (RIP) 3 kinase-dependent programmed necrosis that occurs through either TIR domain-containing adapter-inducing interferon-gamma (TRIF) or MyD88 signal transduction. TLR3 or TLR4 directly activates programmed necrosis through a RIP homotypic interaction motif-dependent association of TRIF with RIP3 kinase (also called RIPK3). In fibroblasts, this pathway proceeds independent of RIP1 or its kinase activity, but it remains dependent on mixed lineage kinase domain-like protein (MLKL) downstream of RIP3 kinase. Here, we describe two small molecule RIP3 kinase inhibitors and employ them to demonstrate the common requirement for RIP3 kinase in programmed necrosis induced by RIP1-RIP3, DAI-RIP3, and TRIF-RIP3 complexes. Cell fate decisions following TLR signaling parallel death receptor signaling and rely on caspase 8 to suppress RIP3-dependent programmed necrosis whether initiated directly by a TRIF-RIP3-MLKL pathway or indirectly via TNF activation and the RIP1-RIP3-MLKL necroptosis pathway.	[Kaiser, William J.; Huang, Chunzi; Mandal, Pratyusha; Mocarski, Edward S.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Sridharan, Haripriya; Upton, Jason W.] Univ Texas Austin, Sect Mol Genet & Microbiol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Gough, Peter J.; Sehon, Clark A.; Marquis, Robert W.; Bertin, John] GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance U, Immunoinflammat Therapeut Area, Collegeville, PA 19426 USA	Emory University; University of Texas System; University of Texas Austin; GlaxoSmithKline	Mocarski, ES (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, 1462 Clifton Rd,Rm 429, Atlanta, GA 30322 USA.	mocarski@emory.edu	Mocarski, Edward/ABC-2893-2020	Upton, Jason/0000-0002-4218-4026	National Institutes of Health [RO1 AI030363, AI020211]; ACTSI [UL1 RR025008]; University of Texas at Austin; Cancer Prevention Research Institute of Texas; GlaxoSmithKline;  [OD012198]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020211, R01AI030363] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACTSI; University of Texas at Austin; Cancer Prevention Research Institute of Texas; GlaxoSmithKline(GlaxoSmithKline); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI030363 and AI020211, Pilot Grant UL1 RR025008 from ACTSI (to E. S. M.), and OD012198 (to W. J. K.). This work was also supported by funds from the University of Texas at Austin, the Cancer Prevention Research Institute of Texas (to J. W. U.), and by GlaxoSmithKline (to P. J. G., C. A. S., R. W. M., and J. B.).	Brune W, 2001, SCIENCE, V291, P303, DOI 10.1126/science.291.5502.303; Brune W, 2011, VIRUS RES, V157, P144, DOI 10.1016/j.virusres.2010.10.012; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Estornes Y, 2012, CELL DEATH DIFFER, V19, P1482, DOI 10.1038/cdd.2012.22; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Fliss PM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002517; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Kaiser WJ, 2013, CURR OPIN VIROL, V3, P296, DOI 10.1016/j.coviro.2013.05.019; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kalai M, 2002, CELL DEATH DIFFER, V9, P981, DOI 10.1038/sj.cdd.4401051; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kuprash DV, 2002, MOL CELL BIOL, V22, P8626, DOI 10.1128/MCB.22.24.8626-8634.2002; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lu JV, 2011, P NATL ACAD SCI USA, V108, P15312, DOI 10.1073/pnas.1102779108; Mack C, 2008, P NATL ACAD SCI USA, V105, P3094, DOI 10.1073/pnas.0800168105; Medzhitov R, 2010, NAT IMMUNOL, V11, P551, DOI 10.1038/ni0710-551; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Rebsamen M, 2008, CELL DEATH DIFFER, V15, P1804, DOI 10.1038/cdd.2008.119; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Skaletskaya A, 2001, P NATL ACAD SCI USA, V98, P7829, DOI 10.1073/pnas.141108798; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Upton JW, 2008, J BIOL CHEM, V283, P16966, DOI 10.1074/jbc.C800051200; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Vivarelli MS, 2004, J EXP MED, V200, P399, DOI 10.1084/jem.20040446; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	60	546	574	9	78	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31268	31279		10.1074/jbc.M113.462341	http://dx.doi.org/10.1074/jbc.M113.462341			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24019532	Green Published, hybrid			2022-12-28	WOS:000330778900043
J	Deng, MZ; He, WX; Tan, Y; Han, HL; Hu, XY; Xia, K; Zhang, ZH; Yan, RQ				Deng, Minzi; He, Wanxia; Tan, Ya; Han, Hailong; Hu, Xiangyou; Xia, Kun; Zhang, Zhuohua; Yan, Riqiang			Increased Expression of Reticulon 3 in Neurons Leads to Reduced Axonal Transport of beta Site Amyloid Precursor Protein-cleaving Enzyme 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid Precursor Protein; Confocal Microscopy; Secretases; Synapses; BACE1; RTN3; Axonal Transport; Kymograph; Synaptic Localization	ALZHEIMERS-DISEASE; A-BETA; ASPARTYL PROTEASE; GAMMA-SECRETASE; BACE1; APP; TRAFFICKING; DEFICITS; FAMILY; RTN3	Background: Axonal transport of BACE1 and the regulation of BACE1 synaptic localization remain to be fully characterized. Results: Colocalization of BACE1 with synaptophysin was reduced by overexpression of RTN3. This reduction was due to reduced BACE1 axonal transport. Conclusion: Increased interaction of RTN3 with BACE1 in the soma impacts axonal transport of BACE1. Significance: Changes of BACE1 synaptic localization potentially alter synaptic A generation and amyloid deposition. BACE1 is the sole enzyme responsible for cleaving amyloid precursor protein at the -secretase site, and this cleavage initiates the generation of -amyloid peptide (A). Because amyloid precursor protein is predominantly expressed by neurons and deposition of A aggregates in the human brain is highly correlated with the A released at axonal terminals, we focused our investigation of BACE1 localization on the neuritic region. We show that BACE1 was not only enriched in the late Golgi, trans-Golgi network, and early endosomes but also in both axons and dendrites. BACE1 was colocalized with the presynaptic vesicle marker synaptophysin, indicating the presence of BACE1 in synapses. Because the excessive release of A from synapses is attributable to an increase in amyloid deposition, we further explored whether the presence of BACE1 in synapses was regulated by reticulon 3 (RTN3), a protein identified previously as a negative regulator of BACE1. We found that RTN3 is not only localized in the endoplasmic reticulum but also in neuritic regions where no endoplasmic reticulum-shaping proteins are detected, implicating additional functions of RTN3 in neurons. Coexpression of RTN3 with BACE1 in cultured neurons was sufficient to reduce colocalization of BACE1 with synaptophysin. This reduction correlated with decreased anterograde transport of BACE1 in axons in response to overexpressed RTN3. Our results in this study suggest that altered RTN3 levels can impact the axonal transport of BACE1 and demonstrate that reducing axonal transport of BACE1 in axons is a viable strategy for decreasing BACE1 in axonal terminals and, perhaps, reducing amyloid deposition.	[Deng, Minzi; Tan, Ya; Han, Hailong; Xia, Kun; Zhang, Zhuohua] Cent S Univ, State Key Lab Med Genet, Xiangya Med Sch, Changsha 410078, Hunan, Peoples R China; [He, Wanxia; Hu, Xiangyou; Yan, Riqiang] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Central South University; Cleveland Clinic Foundation	Zhang, ZH (corresponding author), Cent S Univ, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China.	zhangzhuohua@sklmg.edu.cn; yanr@ccf.org	XIA, KUN/AAO-3525-2020	Yan, Riqiang/0000-0001-7195-7617	National Institutes of Health [AG025493, NS074256]; Chinese Overseas, Hong Kong and Macao Scholars Collaborated Researching Fund Grant [81028008]; Chinese 973 Program Project Grant [2011CB510002]; Alzheimer's Association [NPSPAD-10-174543]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Overseas, Hong Kong and Macao Scholars Collaborated Researching Fund Grant; Chinese 973 Program Project Grant(National Basic Research Program of China); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG025493 and NS074256 (to R. Y.). This work was also supported by Chinese Overseas, Hong Kong and Macao Scholars Collaborated Researching Fund Grant 81028008 (to R. Y. and Z. Z.), by Chinese 973 Program Project Grant 2011CB510002 (to Z. Z.), and by Alzheimer's Association Grant NPSPAD-10-174543 (to R. Y.).	Araki W, 2013, CURR ALZHEIMER RES, V10, P135, DOI 10.2174/1567205011310020003; Cumming JN, 2004, CURR OPIN DRUG DISC, V7, P536; Dislich B, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00008; Finan GM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.170217; Ghosh AK, 2012, J NEUROCHEM, V120, P71, DOI 10.1111/j.1471-4159.2011.07476.x; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hampel H, 2009, SCAND J CLIN LAB INV, V69, P8, DOI 10.1080/00365510701864610; He WX, 2007, J BIOL CHEM, V282, P29144, DOI 10.1074/jbc.M704181200; He WX, 2006, J MOL BIOL, V363, P625, DOI 10.1016/j.jmb.2006.07.094; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hu XY, 2007, EMBO J, V26, P2755, DOI 10.1038/sj.emboj.7601707; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Iwahashi J, 2007, BIOCHEM BIOPH RES CO, V355, P508, DOI 10.1016/j.bbrc.2007.02.001; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kandalepas PC, 2013, ACTA NEUROPATHOL, V126, P329, DOI 10.1007/s00401-013-1152-3; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kasa P, 2001, BRAIN RES, V909, P159, DOI 10.1016/S0006-8993(01)02679-8; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kume H, 2009, J NEUROSCI RES, V87, P2963, DOI 10.1002/jnr.22112; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lazarov O, 2007, J NEUROSCI, V27, P7011, DOI 10.1523/JNEUROSCI.4272-06.2007; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo XY, 2010, INT J CLIN EXP PATHO, V3, P618; Murayama KS, 2006, EUR J NEUROSCI, V24, P1237, DOI 10.1111/j.1460-9568.2006.05005.x; Muresan V, 2009, J NEUROSCI, V29, P3565, DOI 10.1523/JNEUROSCI.2558-08.2009; Oertle T, 2003, FASEB J, V17, P1238, DOI 10.1096/fj.02-1166hyp; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Prior M, 2010, NEUROSCI BIOBEHAV R, V34, P1201, DOI 10.1016/j.neubiorev.2010.01.017; Rodrigues EM, 2012, HUM MOL GENET, V21, P4587, DOI 10.1093/hmg/dds297; Santosa C, 2011, NEUROBIOL DIS, V43, P176, DOI 10.1016/j.nbd.2011.03.009; Schroeder BE, 2005, NEURON, V48, P873, DOI 10.1016/j.neuron.2005.12.005; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Shi Q, 2013, J NEUROSCI, V33, P3059, DOI 10.1523/JNEUROSCI.2445-12.2013; Shi Q, 2009, J NEUROSCI, V29, P9163, DOI 10.1523/JNEUROSCI.5741-08.2009; Shi Q, 2009, J NEUROSCI, V29, P5108, DOI 10.1523/JNEUROSCI.5887-08.2009; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Siegenthaler BM, 2012, NEURODEGENER DIS, V10, P116, DOI 10.1159/000335910; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Steuble M, 2012, BIOL OPEN, V1, P761, DOI 10.1242/bio.20121578; Szodorai A, 2009, J NEUROSCI, V29, P14534, DOI 10.1523/JNEUROSCI.1546-09.2009; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tamayev R, 2011, EMBO J, V30, P2501, DOI 10.1038/emboj.2011.161; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tan JG, 2012, J NEUROCHEM, V120, P869, DOI 10.1111/j.1471-4159.2011.07623.x; Teng FYH, 2005, J NEUROSCI RES, V79, P273, DOI 10.1002/jnr.20361; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Vagnoni A, 2012, HUM MOL GENET, V21, P2845, DOI 10.1093/hmg/dds109; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Wang CL, 2012, BIOL OPEN, V1, P1248, DOI 10.1242/bio.20122451; Wang ZL, 2012, CURR ALZHEIMER RES, V9, P217, DOI 10.2174/156720512799361691; Wen L, 2011, J CELL BIOL, V195, P765, DOI 10.1083/jcb.201105109; Wojcik S, 2007, ACTA NEUROPATHOL, V114, P517, DOI 10.1007/s00401-007-0281-y; Yan R, 2006, CELL MOL LIFE SCI, V63, P877, DOI 10.1007/s00018-005-5338-2; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yang YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-234; Zhao B, 2013, J BIOL CHEM, V288, P15590, DOI 10.1074/jbc.M112.440784	64	38	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30236	30245		10.1074/jbc.M113.480079	http://dx.doi.org/10.1074/jbc.M113.480079			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24005676	Green Published, hybrid			2022-12-28	WOS:000329868100022
J	Dutta, T; Malhotra, A; Deutscher, MP				Dutta, Tanmay; Malhotra, Arun; Deutscher, Murray P.			How a CCA Sequence Protects Mature tRNAs and tRNA Precursors from Action of the Processing Enzyme RNase BN/RNase Z	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Structure; Nucleic Acid Chemistry; Nucleic Acid Enzymology; Phosphodiesterases; Protein-Nucleic Acid Interaction; RNA Catalysis; RNA Processing; RNA-Protein Interaction; Structural Biology; Transfer RNA (tRNA)	STRUCTURAL BASIS; STABLE RNA; EXORIBONUCLEASES; DEGRADATION; MATURATION; END; BN; RECOGNITION; CYTOSINE; BINDING	In many organisms, 3 maturation of tRNAs is catalyzed by the endoribonuclease, RNase BN/RNase Z, which cleaves after the discriminator nucleotide to generate a substrate for addition of the universal CCA sequence. However, tRNAs or tRNA precursors that already contain a CCA sequence are not cleaved, thereby avoiding a futile cycle of removal and readdition of these essential residues. We show here that the adjacent C residues of the CCA sequence and an Arg residue within a highly conserved sequence motif in the channel leading to the RNase catalytic site are both required for the protective effect of the CCA sequence. When both of these determinants are present, CCA-containing RNAs in the channel are unable to move into the catalytic site; however, substitution of either of the C residues by A or U or mutation of Arg(274) to Ala allows RNA movement and catalysis to proceed. These data define a novel mechanism for how tRNAs are protected against the promiscuous action of a processing enzyme.	[Dutta, Tanmay; Malhotra, Arun; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Dutta, Tanmay/ABH-2431-2021; Malhotra, Arun/Z-5140-2019; Malhotra, Arun/A-3916-2008	Malhotra, Arun/0000-0001-6656-7841; Malhotra, Arun/0000-0001-6656-7841	National Institutes of Health [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM016317, R01GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317 (to M. P. D.).	Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; ASHA PK, 1983, P NATL ACAD SCI-BIOL, V80, P3301, DOI 10.1073/pnas.80.11.3301; de la Sierra-Gallay IL, 2006, NAT STRUCT MOL BIOL, V13, P376, DOI 10.1038/nsmb1066; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; DEUTSCHER MP, 1985, P NATL ACAD SCI USA, V82, P6427, DOI 10.1073/pnas.82.19.6427; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; DEUTSCHER MP, 1988, TRENDS BIOCHEM SCI, V13, P136, DOI 10.1016/0968-0004(88)90070-9; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dong SY, 2011, J BIOL CHEM, V286, P26732, DOI 10.1074/jbc.M111.244889; Dutta T, 2012, J BIOL CHEM, V287, P35747, DOI 10.1074/jbc.M112.407403; Dutta T, 2010, J BIOL CHEM, V285, P22872, DOI 10.1074/jbc.M110.141101; Dutta T, 2009, J BIOL CHEM, V284, P15425, DOI 10.1074/jbc.M109.005462; Ezraty B, 2005, J BIOL CHEM, V280, P16542, DOI 10.1074/jbc.C500098200; Filipovska A, 2011, NAT CHEM BIOL, V7, P425, DOI [10.1038/NCHEMBIO.577, 10.1038/nchembio.577]; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hsiao YY, 2011, NAT CHEM BIOL, V7, P236, DOI 10.1038/NCHEMBIO.524; Kostelecky B, 2006, J BACTERIOL, V188, P1607, DOI 10.1128/JB.188.4.1607-1614.2006; LI ZW, 1994, J BIOL CHEM, V269, P6064; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Mohan A, 1999, RNA, V5, P245, DOI 10.1017/S1355838299981256; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pan BC, 2010, SCIENCE, V330, P937, DOI 10.1126/science.1194985; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Pellegrini O, 2012, STRUCTURE, V20, P1769, DOI 10.1016/j.str.2012.08.002; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; REUVEN NB, 1993, FASEB J, V7, P143, DOI 10.1096/fasebj.7.1.8422961; Xiong Y, 2006, CURR OPIN STRUC BIOL, V16, P12, DOI 10.1016/j.sbi.2005.12.001; Zuo YH, 2002, J BIOL CHEM, V277, P29654, DOI 10.1074/jbc.M204252200	33	12	12	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30636	30644		10.1074/jbc.M113.514570	http://dx.doi.org/10.1074/jbc.M113.514570			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24022488	Green Published, hybrid			2022-12-28	WOS:000329868100064
J	Liu, F; Gamez, G; Myers, DR; Clemmons, W; Lam, WA; Jobe, SM				Liu, Fang; Gamez, Graciela; Myers, David R.; Clemmons, Wayne; Lam, Wilbur A.; Jobe, Shawn M.			Mitochondrially Mediated Integrin alpha(IIb)beta(3) Protein Inactivation Limits Thrombus Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calpain; Integrin; Mitochondria; Platelets; Thrombosis	PERMEABILITY TRANSITION PORE; COATED-PLATELET FORMATION; VON-WILLEBRAND-FACTOR; PHOSPHATIDYLSERINE EXPOSURE; PROCOAGULANT ACTIVITY; CYTOPLASMIC DOMAIN; CALPAIN CLEAVAGE; ADHERENT PLATELETS; BLEEDING DISORDER; NA+/H+ EXCHANGER	When platelets are strongly stimulated, a procoagulant platelet subpopulation is formed that is characterized by phosphatidylserine (PS) exposure and epitope modulation of integrin (IIb3) or a loss of binding of activation-dependent antibodies. Mitochondrial permeability transition pore (mPTP) formation, which is essential for the formation of procoagulant platelets, is impaired in the absence of cyclophilin D (CypD). Here we investigate the mechanisms responsible for these procoagulant platelet-associated changes in integrin (IIb3) and the physiologic role of procoagulant platelet formation in the regulation of platelet aggregation. Among strongly stimulated adherent platelets, integrin (IIb3) epitope changes, mPTP formation, PS exposure, and platelet rounding were closely associated. Furthermore, platelet mPTP formation resulted in a decreased ability to recruit additional platelets. In the absence of CypD, integrin (IIb3) function was accentuated in both static and flow conditions, and, in vivo, a prothrombotic phenotype occurred in mice with a platelet-specific deficiency of CypD. CypD-dependent proteolytic events, including cleavage of the integrin (3) cytoplasmic domain, coincided closely with integrin (IIb3) inactivation. Calpain inhibition blocked integrin (3) cleavage and inactivation but not mPTP formation or PS exposure, indicating that integrin inactivation and PS exposure are mediated by distinct pathways subsequent to mPTP formation. mPTP-dependent alkalinization occurred in procoagulant platelets, suggesting a possible alternative mechanism for enhancement of calpain activity in procoagulant platelets. Together, these results indicate that, in strongly stimulated platelets, mPTP formation initiates the calpain-dependent cleavage of integrin (3) and associated regulatory proteins, resulting in integrin (IIb3) inactivation, and demonstrate a novel CypD-dependent negative feedback mechanism that limits platelet aggregation and thrombotic occlusion.	[Liu, Fang; Gamez, Graciela; Myers, David R.; Clemmons, Wayne; Lam, Wilbur A.; Jobe, Shawn M.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Myers, David R.; Lam, Wilbur A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Lam, Wilbur A.; Jobe, Shawn M.] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA	Emory University; University System of Georgia; Georgia Institute of Technology; Children's Healthcare of Atlanta (CHOA)	Jobe, SM (corresponding author), BloodCtr Wisconsin, POB 2178, Milwaukee, WI 53201 USA.	shawn.jobe@bcw.edu	Myers, David Richard/G-7542-2017	Myers, David Richard/0000-0001-9659-3274	National Institutes of Health [HL095858]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health grant HL095858. This work was also supported by American Heart Association Fellow-to-Faculty Transition Award 2006-2011.	Alberio L, 2000, BLOOD, V95, P1694, DOI 10.1182/blood.V95.5.1694.005k24_1694_1702; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Briede JJ, 2003, J THROMB HAEMOST, V1, P559, DOI 10.1046/j.1538-7836.2003.00077.x; Brooks MB, 2007, J THROMB HAEMOST, V5, P1972, DOI 10.1111/j.1538-7836.2007.02683.x; Brooks MB, 2002, BLOOD, V99, P2434, DOI 10.1182/blood.V99.7.2434; Bucki R, 2006, BBA-MOL CELL BIOL L, V1761, P195, DOI 10.1016/j.bbalip.2005.12.008; Choo HJ, 2012, ARTERIOSCL THROM VAS, V32, P2946, DOI 10.1161/ATVBAHA.112.300433; Cosemans JMEM, 2011, BLOOD, V117, P651, DOI 10.1182/blood-2010-01-262683; Dale GL, 2005, J THROMB HAEMOST, V3, P2185, DOI 10.1111/j.1538-7836.2005.01274.x; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146; GAFFET P, 1995, EUR J CELL BIOL, V67, P336; Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; Hess MW, 2001, HISTOCHEM CELL BIOL, V115, P439; HORNE WC, 1981, EUR J BIOCHEM, V120, P295, DOI 10.1111/j.1432-1033.1981.tb05703.x; Jobe SM, 2008, BLOOD, V111, P1257, DOI 10.1182/blood-2007-05-092684; Jobe SM, 2005, BLOOD, V106, P4146, DOI 10.1182/blood-2005-03-1223; Kamocka MM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3322676; Kulkarni S, 2004, J BIOL CHEM, V279, P30697, DOI 10.1074/jbc.M403559200; Leo L, 2002, BLOOD, V100, P2839, DOI 10.1182/blood-2002-04-1234; Leytin V, 2004, BIOCHEM BIOPH RES CO, V320, P303, DOI 10.1016/j.bbrc.2004.05.166; Lishko VK, 2010, J THROMB HAEMOST, V8, P799, DOI 10.1111/j.1538-7836.2010.03778.x; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Lopez E, 2011, CURR MED CHEM, V18, P5414, DOI 10.2174/092986711798194405; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; Munnix ICA, 2009, THROMB HAEMOSTASIS, V102, P1149, DOI 10.1160/TH09-05-0289; MURER EH, 1969, BIOCHIM BIOPHYS ACTA, V172, P266, DOI 10.1016/0005-2728(69)90069-3; Neeves KB, 2008, J THROMB HAEMOST, V6, P2193, DOI 10.1111/j.1538-7836.2008.03188.x; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Remenyi G, 2005, ARTERIOSCL THROM VAS, V25, P467, DOI 10.1161/01.ATV.0000152726.49229.bf; Samson J, 2001, PLATELETS, V12, P436, DOI 10.1080/09537100120078395; Schoenwaelder SM, 2009, BLOOD, V114, P663, DOI 10.1182/blood-2009-01-200345; Schoenwaelder SM, 1997, J BIOL CHEM, V272, P1694, DOI 10.1074/jbc.272.3.1694; van Kruchten R, 2013, BLOOD, V121, P1850, DOI 10.1182/blood-2012-09-454314; Wolf BB, 1999, BLOOD, V94, P1683, DOI 10.1182/blood.V94.5.1683.417k37_1683_1692; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120; Yakimenko AO, 2012, BIOPHYS J, V102, P2261, DOI 10.1016/j.bpj.2012.04.004; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhao X, 1998, NEUROSCI LETT, V247, P53, DOI 10.1016/S0304-3940(98)00219-5; Zhao YZ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.380469; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	47	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30672	30681		10.1074/jbc.M113.472688	http://dx.doi.org/10.1074/jbc.M113.472688			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014035	hybrid, Green Published			2022-12-28	WOS:000329868100067
J	Stewart, DS; Hotta, M; Li, GD; Desai, R; Chiara, DC; Olsen, RW; Forman, SA				Stewart, Deirdre S.; Hotta, Mayo; Li, Guo-dong; Desai, Rooma; Chiara, David C.; Olsen, Richard W.; Forman, Stuart A.			Cysteine Substitutions Define Etomidate Binding and Gating Linkages in the alpha-M1 Domain of gamma-Aminobutyric Acid Type A (GABA(A)) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Anesthetics; GABA Receptors; Ion Channels; Nicotinic Acetylcholine Receptors; Sulfhydryl	GENERAL ANESTHETIC ETOMIDATE; GATED ION-CHANNEL; TRANSMEMBRANE DOMAIN; SUBUNIT INTERFACE; PROPOFOL BINDING; SITES; MUTATIONS; STATE; MODULATION; ACTIVATION	Etomidate is a potent general anesthetic that acts as an allosteric co-agonist at GABA(A) receptors. Photoreactive etomidate derivatives labeled Met-236 in transmembrane domain M1, which structural models locate in the +/- subunit interface. Other nearby residues may also contribute to etomidate binding and/or transduction through rearrangement of the site. In human 122L GABA(A) receptors, we applied the substituted cysteine accessibility method to 1-M1 domain residues extending from 1Gln-229 to 1Gln-242. We used electrophysiology to characterize each mutant's sensitivity to GABA and etomidate. We also measured rates of sulfhydryl modification by p-chloromercuribenzenesulfonate (pCMBS) with and without GABA and tested if etomidate blocks modification of pCMBS-accessible cysteines. Cys substitutions in the outer 1-M1 domain impaired GABA activation and variably affected etomidate sensitivity. In seven of eight residues where pCMBS modification was evident, rates of modification were accelerated by GABA co-application, indicating that channel activation increases water and/or pCMBS access. Etomidate reduced the rate of modification for cysteine substitutions at 1Met-236, 1Leu-232 and 1Thr-237. We infer that these residues, predicted to face 2-M3 or M2 domains, contribute to etomidate binding. Thus, etomidate interacts with a short segment of the outer 1-M1 helix within a subdomain that undergoes significant structural rearrangement during channel gating. Our results are consistent with in silico docking calculations in a homology model that orient the long axis of etomidate approximately orthogonal to the transmembrane axis.	[Stewart, Deirdre S.; Hotta, Mayo; Desai, Rooma; Forman, Stuart A.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Stewart, Deirdre S.; Chiara, David C.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Li, Guo-dong; Olsen, Richard W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Li, Guo-dong] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Forman, SA (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Jackson 444, Boston, MA 02114 USA.	saforman@partners.org	Forman, Stuart/Q-6590-2019	Forman, Stuart/0000-0001-6340-2478	National Institutes of Health [R01GM089745, P01GM58448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448, R01GM089745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM089745 and P01GM58448.	Akk G, 2008, MOL PHARMACOL, V74, P614, DOI 10.1124/mol.108.048520; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bali M, 2012, J BIOL CHEM, V287, P27762, DOI 10.1074/jbc.M112.363341; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Burkat PM, 2001, J NEUROSCI, V21, P7026, DOI 10.1523/JNEUROSCI.21-18-07026.2001; Carlson BX, 2000, MOL PHARMACOL, V57, P474, DOI 10.1124/mol.57.3.474; Chiara DC, 2013, J BIOL CHEM, V288, P19343, DOI 10.1074/jbc.M113.479725; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Desai R, 2009, ANESTHESIOLOGY, V111, P774, DOI 10.1097/ALN.0b013e3181b55fae; Forman SA, 2011, CAN J ANESTH, V58, P191, DOI 10.1007/s12630-010-9419-9; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Ghosh B, 2013, J BIOL CHEM, V288, P17420, DOI 10.1074/jbc.M113.464040; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Greenfield LJ, 2002, NEUROPHARMACOLOGY, V42, P502, DOI 10.1016/S0028-3908(01)00196-4; Guitchounts G, 2012, ANESTHESIOLOGY, V116, P1235, DOI 10.1097/ALN.0b013e3182567df3; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; HillVenning C, 1997, BRIT J PHARMACOL, V120, P749, DOI 10.1038/sj.bjp.0700927; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Husain SS, 2006, J MED CHEM, V49, P4818, DOI 10.1021/jm051207b; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Keramidas A, 2006, J PHYSIOL-LONDON, V575, P11, DOI 10.1113/jphysiol.2005.102756; Krasowski MD, 1998, J PHARMACOL EXP THER, V284, P934; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Li GD, 2009, J BIOL CHEM, V284, P11771, DOI 10.1074/jbc.C900016200; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Reynolds DS, 2003, J NEUROSCI, V23, P8608; Rusch D, 2005, ANESTHESIOLOGY, V102, P783; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Sauguet L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2682; Scheller M, 2002, J NEUROSCI, V22, P8411; Siegwart Roberta, 2003, BMC Pharmacol, V3, P13, DOI 10.1186/1471-2210-3-13; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Stewart DS, 2013, MOL PHARMACOL, V83, P1200, DOI 10.1124/mol.112.084558; Tomlin SL, 1998, ANESTHESIOLOGY, V88, P708, DOI 10.1097/00000542-199803000-00022; Yang J, 1996, NEUROSCIENCE, V73, P69, DOI 10.1016/0306-4522(96)00018-8	50	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30373	30386		10.1074/jbc.M113.494583	http://dx.doi.org/10.1074/jbc.M113.494583			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24009076	Green Published, hybrid			2022-12-28	WOS:000329868100034
J	Bondarev, SA; Shchepachev, VV; Kajava, AV; Zhouravleva, GA				Bondarev, Stanislav A.; Shchepachev, Vadim V.; Kajava, Andrey V.; Zhouravleva, Galina A.			Effect of Charged Residues in the N-domain of Sup35 Protein on Prion [PSI+] Stability and Propagation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Prions; Protein Misfolding; Protein Structure; Translation Release Factors; Saccharomyces cerevisiae; [PSI plus ]; Superpleated -Structure; Translation Termination	SACCHAROMYCES-CEREVISIAE; BETA-SHEET; GUANIDINE-HYDROCHLORIDE; DETERMINANT PSI(+); STRUCTURAL BASIS; YEAST; GENE; MUTATION; REPEATS; IDENTIFICATION	Recent studies have shown that Sup35p prion fibrils probably have a parallel in-register -structure. However, the part(s) of the N-domain critical for fibril formation and maintenance of the [PSI+] phenotype remains unclear. Here we designed a set of five SUP35 mutant alleles (sup35(KK)) with lysine substitutions in each of five N-domain repeats, and investigated their effect on infectivity and ability of corresponding proteins to aggregate and coaggregate with wild type Sup35p in the [PSI+] strain. Alleles sup35-M1 (Y46K/Q47K) and sup35-M2 (Q61K/Q62K) led to prion loss, whereas sup35-M3 (Q70K/Q71K), sup35-M4 (Q80K/Q81K), and sup35-M5 (Q89K/Q90K) were able to maintain the [PSI+] prion. This suggests that the critical part of the parallel in-register -structure for the studied [PSI+] prion variant lies in the first 63-69 residues. Our study also reveals an unexpected interplay between the wild type Sup35p and proteins expressed from the sup35(KK) alleles during prionization. Both Sup35-M1p and Sup35-M2p coaggregated with Sup35p, but only sup35-M2 led to prion loss in a dominant manner. We suggest that in the fibrils, Sup35p can bind to Sup35-M1p in the same conformation, whereas Sup35-M2p only allowed the Sup35p conformation that leads to the non-heritable fold. Mutations sup35-M4 and sup35-M5 influence the structure of the prion forming region to a lesser extent, and can lead to the formation of new prion variants.	[Bondarev, Stanislav A.; Shchepachev, Vadim V.; Zhouravleva, Galina A.] St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg 199034, Russia; [Kajava, Andrey V.] Univ Montpellier 1 & 2, CNRS, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France; [Kajava, Andrey V.] Inst Biol Computat, F-34095 Montpellier, France	Saint Petersburg State University; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier	Zhouravleva, GA (corresponding author), St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg 199034, Russia.	zhouravleva@bio.pu.ru	Kajava, Andrey V/E-1107-2014; Zhouravleva, Galina/G-8651-2013; Bondarev, Stanislav/F-7518-2014	Kajava, Andrey V/0000-0002-2342-6886; Zhouravleva, Galina/0000-0002-3013-4662; Bondarev, Stanislav/0000-0003-3137-944X	Dynasty Foundation	Dynasty Foundation	We are very grateful to A. Borchsenius and M. D. Ter-Avanesyan for plasmids and yeast strains, A. Masharsky for sequencing, E. Besedina and N. Trubicina for help in some experiments, A. Galkin and P. Drozdova for critical reading of the manuscript, Y. Chernoff and members of the Physiological Genetics laboratory of Saint Petersburg State University for fruitful discussions and a "Dynasty Foundation" for travel grant (to A. V. K.).	Afanasieva EG, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.183889; Baxa U, 2006, ADV PROTEIN CHEM, V73, P125, DOI 10.1016/S0065-3233(06)73005-4; Baxa U, 2011, MOL MICROBIOL, V79, P523, DOI 10.1111/j.1365-2958.2010.07466.x; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Chabelskaya S, 2004, MOL GENET GENOMICS, V272, P297, DOI 10.1007/s00438-004-1053-1; Chang HY, 2008, P NATL ACAD SCI USA, V105, P13345, DOI 10.1073/pnas.0802215105; Chen BX, 2007, P NATL ACAD SCI USA, V104, P2791, DOI 10.1073/pnas.0611158104; Chen BX, 2010, MOL MICROBIOL, V76, P1483, DOI 10.1111/j.1365-2958.2010.07177.x; Chen W, 2010, BIOCHEMISTRY-US, V49, P9874, DOI 10.1021/bi101449f; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; Crow ET, 2011, SEMIN CELL DEV BIOL, V22, P452, DOI 10.1016/j.semcdb.2011.03.003; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1999, CURR GENET, V35, P59, DOI 10.1007/s002940050433; Derkatch IL, 1996, GENETICS, V144, P1375; DiSalvo S, 2011, NAT STRUCT MOL BIOL, V18, P486, DOI 10.1038/nsmb.2031; DOEL SM, 1994, GENETICS, V137, P659; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Helsen CW, 2012, PRION, V6, P234, DOI 10.4161/pri.19913; Hennetin J, 2006, J MOL BIOL, V358, P1094, DOI 10.1016/j.jmb.2006.02.039; Inge-Vechtomov S, 2003, BIOL CELL, V95, P195, DOI 10.1016/S0248-4900(03)00035-2; Inge-Vechtomov S G, 1974, Sov Genet, V7, P1190; Jorda J, 2009, BIOINFORMATICS, V25, P2632, DOI 10.1093/bioinformatics/btp482; Kaiser C., 1994, METHODS YEAST GENETI, P234; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kajava AV, 2010, FASEB J, V24, P1311, DOI 10.1096/fj.09-145979; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; Kochneva-Pervukhova NV, 1998, EMBO J, V17, P5805, DOI 10.1093/emboj/17.19.5805; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kushnirov V V, 1995, Mol Biol (Mosk), V29, P750; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; Lin JY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002297; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Nelson ACG, 2011, SEMIN CELL DEV BIOL, V22, P437, DOI 10.1016/j.semcdb.2011.02.022; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Sambrook J., 1989, MOL CLONING LAB MANU, P2344; Schutt CR, 2008, PRION, V2, P61, DOI 10.4161/pri.2.2.6806; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Shewmaker F, 2009, BIOCHEMISTRY-US, V48, P5074, DOI 10.1021/bi900345q; Shkundina IS, 2006, GENETICS, V172, P827, DOI 10.1534/genetics.105.048660; Sigurdson CJ, 2011, PRION, V5, P52, DOI 10.4161/pri.5.2.16173; STANSFIELD I, 1995, CURR GENET, V27, P417, DOI 10.1007/BF00311210; Tanaka M, 2006, METHOD ENZYMOL, V412, P185, DOI 10.1016/S0076-6879(06)12012-1; Ter-Avanesyan MD, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1382; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; Pastor MT, 2007, PRION, V1, P9, DOI 10.4161/pri.1.1.4100; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tuite MF, 1996, TRENDS GENET, V12, P467, DOI 10.1016/0168-9525(96)10045-7; TUITE MF, 1981, GENETICS, V98, P691; Volkov KV, 2002, GENETICS, V160, P25; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2010, WIRES RNA, V1, P81, DOI 10.1002/wrna.8	59	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28503	28513		10.1074/jbc.M113.471805	http://dx.doi.org/10.1074/jbc.M113.471805			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23965990	Green Published, hybrid			2022-12-28	WOS:000330298800008
J	Kanatsuna, N; Taneera, J; Vaziri-Sani, F; Wierup, N; Larsson, HE; Delli, A; Skarstrand, H; Balhuizen, A; Bennet, H; Steiner, DF; Torn, C; Fex, M; Lernmark, A				Kanatsuna, Norio; Taneera, Jalal; Vaziri-Sani, Fariba; Wierup, Nils; Larsson, Helena Elding; Delli, Ahmed; Skarstrand, Hanna; Balhuizen, Alexander; Bennet, Hedvig; Steiner, Donald F.; Torn, Carina; Fex, Malin; Lernmark, Ake			Autoimmunity against INS-IGF2 Protein Expressed in Human Pancreatic Islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Antigen; Beta Cell; Diabetes; Insulin; Insulin-like Growth Factor (IGF); Pancreatic Islets; Radioimmune Assays	ANTIBODY STANDARDIZATION PROGRAM; DEPENDENT DIABETES-MELLITUS; GLUTAMIC-ACID DECARBOXYLASE; INSULIN AUTOANTIBODIES; RADIOBINDING ASSAY; T-CELLS; INTERNATIONAL WORKSHOP; SWEDISH PATIENTS; BETA-CELLS; TYPE-1	Insulin is a major autoantigen in islet autoimmunity and progression to type 1 diabetes. It has been suggested that the insulin B-chain may be critical to insulin autoimmunity in type 1 diabetes. INS-IGF2 consists of the preproinsulin signal peptide, the insulin B-chain, and eight amino acids of the C-peptide in addition to 138 amino acids from the IGF2 gene. We aimed to determine the expression of INS-IGF2 in human pancreatic islets and autoantibodies in newly diagnosed children with type 1 diabetes and controls. INS-IGF2, expressed primarily in beta cells, showed higher levels of expression in islets from normal compared with donors with either type 2 diabetes (p = 0.006) or high HbA1c levels (p < 0.001). INS-IGF2 autoantibody levels were increased in newly diagnosed patients with type 1 diabetes (n = 304) compared with healthy controls (n = 355; p < 0.001). Displacement with cold insulin and INS-IGF2 revealed that more patients than controls had doubly reactive insulin-INS-IGF2 autoantibodies. These data suggest that INS-IGF2, which contains the preproinsulin signal peptide, the B-chain, and eight amino acids of the C-peptide may be an autoantigen in type 1 diabetes. INS-IGF2 and insulin may share autoantibody-binding sites, thus complicating the notion that insulin is the primary autoantigen in type 1 diabetes.	[Kanatsuna, Norio; Taneera, Jalal; Vaziri-Sani, Fariba; Wierup, Nils; Larsson, Helena Elding; Delli, Ahmed; Skarstrand, Hanna; Balhuizen, Alexander; Bennet, Hedvig; Torn, Carina; Fex, Malin; Lernmark, Ake] Lund Univ, Ctr Diabet, Skane Univ Hosp SUS, Dept Clin Sci, SE-20502 Malmo, Sweden; [Steiner, Donald F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Lund University; Skane University Hospital; University of Chicago	Kanatsuna, N (corresponding author), Lund Univ, Ctr Diabet, Skane Univ Hosp SUS, Dept Clin Sci, Jan Waldenstroms Gata 35, SE-20502 Malmo, Sweden.	norio.kanatsuna@med.lu.se	Lernmark, Åke/F-8140-2015; Vaziri-Sani, Fariba/J-6390-2014	Lernmark, Åke/0000-0003-1735-0499; Vaziri-Sani, Fariba/0000-0002-9953-2829; Elding Larsson, Helena/0000-0003-3306-1742; Balhuizen, Alexander/0000-0001-7581-121X; Taneera, Jalal/0000-0002-3341-1063; Fex, Malin/0000-0003-0675-7576	Swedish Research Council [K2001-54X-15312-07-6, 521-2008-2974, 2009-1039, 349-2008-6589]; Skane University Hospital Funds and Donations; Diabetes Fund; Skane County Council for Research and Development; Swedish Childhood Diabetes Fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Skane University Hospital Funds and Donations; Diabetes Fund; Skane County Council for Research and Development; Swedish Childhood Diabetes Fund	This work was supported by Swedish Research Council Grant K2001-54X-15312-07-6, Skane University Hospital Funds and Donations, the Diabetes Fund, the Skane County Council for Research and Development, the Swedish Childhood Diabetes Fund (to Better Diabetes Diagnosis Study Group), and Collaborative Project Grant Dnr. 521-2008-2974, Strategic Research Area Grant Excellence in Diabetes Research in Sweden Dnr. 2009-1039, and Linnaeus Grant Dnr. 349-2008-6589 from the Swedish Research Council (to Lund University Diabetes Center/Excellence in Diabetes Research in Sweden the Nordic Network for Clinical Islet Transplantation).	Agardh D, 2006, CLIN EXP IMMUNOL, V144, P67, DOI 10.1111/j.1365-2249.2006.03036.x; Agardh D, 2001, Pediatr Diabetes, V2, P58, DOI 10.1034/j.1399-5448.2001.002002058.x; Alleva DG, 2001, J CLIN INVEST, V107, P173, DOI 10.1172/JCI8525; Andersson C, 2011, AUTOIMMUNITY, V44, P394, DOI 10.3109/08916934.2010.540604; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bingley PJ, 2003, DIABETES, V52, P1128, DOI 10.2337/diabetes.52.5.1128; Bingley PJ, 2010, CLIN TRIALS, V7, pS56, DOI 10.1177/1740774510373496; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Carlsson AK, 1999, PEDIATRICS, V103, P1248, DOI 10.1542/peds.103.6.1248; Colman PG, 2000, DIABETOLOGIA, V43, P203, DOI 10.1007/s001250050030; Delli AJ, 2012, DIABETES, V61, P2556, DOI 10.2337/db11-1659; Delli AJ, 2010, PEDIATR DIABETES, V11, P513, DOI 10.1111/j.1399-5448.2010.00637.x; Devendra D, 2004, BMJ-BRIT MED J, V328, P750, DOI 10.1136/bmj.328.7442.750; DIAZ JL, 1988, CLIN CHEM, V34, P356; Durinovic-Bello I, 2002, J AUTOIMMUN, V18, P55, DOI 10.1006/jaut.2001.0566; Eisenbarth GS, 2008, ARQ BRAS ENDOCRINOL, V52, P146, DOI 10.1590/S0004-27302008000200002; Elfving AM, 2003, AUTOIMMUNITY, V36, P227, DOI 10.1080/0891693031000141040; FALORNI A, 1995, J CLIN ENDOCR METAB, V80, P2752, DOI 10.1210/jc.80.9.2752; FALORNI A, 1995, J IMMUNOL METHODS, V186, P89, DOI 10.1016/0022-1759(95)00139-2; Graham J, 2002, DIABETES, V51, P1346, DOI 10.2337/diabetes.51.5.1346; GREENBAUM CJ, 1992, J CLIN ENDOCR METAB, V74, P1040, DOI 10.1210/jc.74.5.1040; Kanatsuna N., 2012, ANAT RES INT, V2012; Knight RR, 2013, DIABETES, V62, P205, DOI 10.2337/db12-0315; Kulmala P, 1998, J CLIN INVEST, V101, P327, DOI 10.1172/JCI119879; Kupila A, 2002, DIABETES, V51, P646, DOI 10.2337/diabetes.51.3.646; La Torre D, 2010, ADV EXP MED BIOL, V654, P537, DOI 10.1007/978-90-481-3271-3_24; Lampasona V, 2011, CLIN CHEM, V57, P1693, DOI 10.1373/clinchem.2011.170662; LEVYMARCHAL C, 1991, DIABETES CARE, V14, P61, DOI 10.2337/diacare.14.1.61; Lindberg B, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e12; Lo B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-203; Mallone R, 2007, DIABETES, V56, P613, DOI 10.2337/db06-1419; Mire-Sluis AR, 2000, DIABETOLOGIA, V43, P1282, DOI 10.1007/s001250051524; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Noso S, 2010, DIABETES, V59, P2579, DOI 10.2337/db10-0476; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; Pihoker C, 2005, DIABETES, V54, pS52, DOI 10.2337/diabetes.54.suppl_2.S52; Schlosser M, 2010, DIABETOLOGIA, V53, P2611, DOI 10.1007/s00125-010-1915-5; Schlosser M, 2011, DIABETES CARE, V34, P2410, DOI 10.2337/dc11-1161; Siljander HTA, 2009, DIABETES, V58, P2835, DOI 10.2337/db08-1305; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; STENTZ FB, 1982, DIABETES, V31, P1128, DOI 10.2337/diabetes.31.12.1128; Toma A, 2005, P NATL ACAD SCI USA, V102, P10581, DOI 10.1073/pnas.0504230102; Torn C, 2008, DIABETOLOGIA, V51, P846, DOI 10.1007/s00125-008-0967-2; Unger WW, 2011, J AUTOIMMUN, V37, P151, DOI 10.1016/j.jaut.2011.05.012; VARDI P, 1988, DIABETES CARE, V11, P736, DOI 10.2337/diacare.11.9.736; Vaziri-Sani F, 2011, J IMMUNOL METHODS, V371, P25, DOI 10.1016/j.jim.2011.06.011; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Verge CF, 1998, DIABETES, V47, P1857, DOI 10.2337/diabetes.47.12.1857; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; Wenzlau JM, 2011, DIABETES-METAB RES, V27, P887, DOI 10.1002/dmrr.1267; Wenzlau JM, 2008, DIABETES, V57, P2693, DOI 10.2337/db08-0522; WILKIN T, 1988, DIABETOLOGIA, V31, P449, DOI 10.1007/BF00271590; Wilkin T, 1987, DIABETOLOGIA, V30, P676; Williams AJK, 1997, J AUTOIMMUN, V10, P473, DOI 10.1006/jaut.1997.0154; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Yu LP, 2012, DIABETES, V61, P179, DOI 10.2337/db11-0670	57	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29013	29023		10.1074/jbc.M113.478222	http://dx.doi.org/10.1074/jbc.M113.478222			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23935095	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000330298800055
J	Lafferty, MJ; Bradford, KC; Erie, DA; Neher, SB				Lafferty, Michael J.; Bradford, Kira C.; Erie, Dorothy A.; Neher, Saskia B.			Angiopoietin-like Protein 4 Inhibition of Lipoprotein Lipase EVIDENCE FOR REVERSIBLE COMPLEX FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atomic Force Microscopy; Enzyme Inhibitors; Enzyme Mechanisms; Lipase; Lipid Metabolism; Angiopoietin-like Protein 4; Lipoprotein Lipase	CARDIOVASCULAR-DISEASE; TERMINAL DOMAIN; ANGPTL4; GPIHBP1; BINDING; GENE; OLIGOMERIZATION; TRIGLYCERIDES; INACTIVATION; ASSOCIATION	Elevated triglycerides are associated with an increased risk of cardiovascular disease, and lipoprotein lipase (LPL) is the rate-limiting enzyme for the hydrolysis of triglycerides from circulating lipoproteins. The N-terminal domain of angiopoietin-like protein 4 (ANGPTL4) inhibits LPL activity. ANGPTL4 was previously described as an unfolding molecular chaperone of LPL that catalytically converts active LPL dimers into inactive monomers. Our studies show that ANGPTL4 is more accurately described as a reversible, noncompetitive inhibitor of LPL. We find that inhibited LPL is in a complex with ANGPTL4, and upon dissociation, LPL regains lipase activity. Furthermore, we have generated a variant of ANGPTL4 that is dependent on divalent cations for its ability to inhibit LPL. We show that LPL inactivation by this regulatable variant of ANGPTL4 is fully reversible after treatment with a chelator.	[Lafferty, Michael J.; Neher, Saskia B.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Bradford, Kira C.; Erie, Dorothy A.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Neher, SB (corresponding author), Univ N Carolina, Dept Biochem & Biophys, 120 Mason Farm Rd,CB 7260, Chapel Hill, NC 27599 USA.	neher@email.unc.edu	Bradford, Barry/B-7870-2010	Bradford, Barry/0000-0002-6775-4961; Neher, Saskia/0000-0003-4165-6674; Bradford, Kira/0000-0003-2403-817X	Pew Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079480] Funding Source: NIH RePORTER	Pew Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Pew Foundation (to S. B. N.).	Arias HR, 2006, INT J BIOCHEM CELL B, V38, P1254, DOI 10.1016/j.biocel.2006.01.006; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; BENGTSSON G, 1979, BIOCHIM BIOPHYS ACTA, V575, P471, DOI 10.1016/0005-2760(79)90118-8; BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345; BOURNE Y, 1994, J MOL BIOL, V238, P709, DOI 10.1006/jmbi.1994.1331; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; D'Agostino RB, 2004, DIABETES CARE, V27, P2234, DOI 10.2337/diacare.27.9.2234; Davies BSJ, 2012, J LIPID RES, V53, P2690, DOI 10.1194/jlr.M031559; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; Der BS, 2012, J AM CHEM SOC, V134, P375, DOI 10.1021/ja208015j; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Gaudet D, 2013, GENE THER, V20, P361, DOI 10.1038/gt.2012.43; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Gin P, 2012, HUM MOL GENET, V21, P2961, DOI 10.1093/hmg/dds127; Johansen CT, 2011, CURR OPIN LIPIDOL, V22, P247, DOI 10.1097/MOL.0b013e3283471972; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kersten S, 2005, BIOCHEM SOC T, V33, P1059, DOI 10.1042/BST0331059; Kobayashi Y, 2002, EUR J BIOCHEM, V269, P4701, DOI 10.1046/j.1432-1033.2002.03179.x; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; Lookene A, 2004, J BIOL CHEM, V279, P49964, DOI 10.1074/jbc.M407419200; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Nichols GA, 2011, AM J CARDIOL, V107, P225, DOI 10.1016/j.amjcard.2010.09.010; Nilsson SK, 2012, BBA-MOL CELL BIOL L, V1821, P1370, DOI 10.1016/j.bbalip.2012.06.003; OSBORNE JC, 1985, BIOCHEMISTRY-US, V24, P5606, DOI 10.1021/bi00341a048; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; PETERSON J, 1992, J LIPID RES, V33, P1165; Ratcliff GC, 2001, J AM CHEM SOC, V123, P5632, DOI 10.1021/ja005750n; Robal T, 2012, J BIOL CHEM, V287, P29739, DOI 10.1074/jbc.M111.303529; Robciuc MR, 2010, J LIPID RES, V51, P824, DOI 10.1194/jlr.M002618; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Ruge T, 2005, EUR J CLIN INVEST, V35, P194, DOI 10.1111/j.1365-2362.2005.01470.x; SEGEL IH, 1975, ENZYME KINETICS, P125; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Smart-Halajko MC, 2010, ARTERIOSCL THROM VAS, V30, P2277, DOI 10.1161/ATVBAHA.110.212209; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wong H, 2002, J LIPID RES, V43, P993, DOI 10.1194/jlr.R200007-JLR200; Wong H, 1997, P NATL ACAD SCI USA, V94, P5594, DOI 10.1073/pnas.94.11.5594; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	49	64	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28524	28534		10.1074/jbc.M113.497602	http://dx.doi.org/10.1074/jbc.M113.497602			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23960078	Green Published, hybrid			2022-12-28	WOS:000330298800010
J	Offenbacher, AR; Polander, BC; Barry, BA				Offenbacher, Adam R.; Polander, Brandon C.; Barry, Bridgette A.			An Intrinsically Disordered Photosystem II Subunit, PsbO, Provides a Structural Template and a Sensor of the Hydrogen-bonding Network in Photosynthetic Water Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Intrinsically Disordered Proteins; Metalloproteins; Photosynthesis; Protein Dynamics; Protein-Protein Interactions; Conformational Landscape	MANGANESE-STABILIZING PROTEIN; OXYGEN-EVOLVING COMPLEX; RAY-ABSORPTION SPECTROSCOPY; ELECTRON-PARAMAGNETIC-RES; 33-KDA EXTRINSIC PROTEIN; SITE-DIRECTED MUTANTS; AMINO-ACID-SEQUENCES; ARABIDOPSIS-THALIANA; CONFORMATIONAL-CHANGES; INFRARED-SPECTROSCOPY	Photosystem II (PSII) is a membrane-bound enzyme that utilizes solar energy to catalyze the photooxidation of water. Molecular oxygen is evolved after four sequential light-driven oxidation reactions at the Mn4CaO5 oxygen-evolving complex, producing five sequentially oxidized states, S-n. PSII is composed of 17 membrane-spanning subunits and three extrinsic subunits, PsbP, PsbQ, and PsbO. PsbO is intrinsically disordered and plays a role in facilitation of the water oxidizing cycle. Native PsbO can be removed and substituted with recombinant PsbO, thereby restoring steady-state activity. In this report, we used reaction-induced Fourier transform infrared spectroscopy to obtain information concerning the role of PsbP, PsbQ, and PsbO during the S state cycle. Light-minus-dark difference spectra were acquired, monitoring structural changes associated with each accessible flash-induced S state transition in a highly purified plant PSII preparation (Triton X-100, octylthioglucoside). A comparison of S-2 minus S-1 spectra revealed that removal of PsbP and PsbQ had no significant effect on the data, whereas amide frequency and intensity changes were associated with PsbO removal. These data suggest that PsbO acts as an organizational template for the PSII reaction center. To identify any coupled conformational changes arising directly from PsbO, global C-13-PsbO isotope editing was employed. The reaction-induced Fourier transform infrared spectra of accessible S states provide evidence that PsbO spectral contributions are temperature (263 and 277 K) and S state dependent. These experiments show that PsbO undergoes catalytically relevant structural dynamics, which are coupled over long distance to hydrogen-bonding changes at the Mn4CaO5 cluster.	Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Barry, BA (corresponding author), 901 Atlantic Dr NW, Atlanta, GA 30332 USA.	bridgette.barry@chemistry.gatech.edu		Offenbacher, Adam/0000-0001-6990-7178	National Science Foundation [MCB 08-42246]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 08-42246 (to B. A. B.)	Al-Khaldi SF, 2000, PLANT MOL BIOL, V43, P33, DOI 10.1023/A:1006419928712; Allahverdiyeva Y, 2009, BBA-BIOENERGETICS, V1787, P1230, DOI 10.1016/j.bbabio.2009.05.013; Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; BARRY BA, 1995, METHOD ENZYMOL, V258, P303; Barry BA, 2006, P NATL ACAD SCI USA, V103, P7288, DOI 10.1073/pnas.0600216103; Barry BA, 2011, J PHOTOCH PHOTOBIO B, V104, P60, DOI 10.1016/j.jphotobiol.2011.01.026; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Betts SD, 1998, BIOCHEMISTRY-US, V37, P14230, DOI 10.1021/bi981305h; Betts SD, 1997, BIOCHEMISTRY-US, V36, P4047, DOI 10.1021/bi962413b; BETTS SD, 1994, PLANT MOL BIOL, V26, P117, DOI 10.1007/BF00039525; Betts SD, 1996, BIOCHEMISTRY-US, V35, P6302, DOI 10.1021/bi953066t; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Bondar AN, 2012, BBA-BIOENERGETICS, V1817, P1177, DOI 10.1016/j.bbabio.2012.03.031; Bricker T. M., 2013, PHOTOSYNTH RES, DOI 10.1007/s11120-013-9820-7; Bricker TM, 2008, J BIOL CHEM, V283, P29022, DOI 10.1074/jbc.M805122200; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Bricker TM, 2011, J PHOTOCH PHOTOBIO B, V104, P165, DOI 10.1016/j.jphotobiol.2011.01.025; BRICKER TM, 1992, BIOCHEMISTRY-US, V31, P4623, DOI 10.1021/bi00134a012; Bricker TM, 1998, PHOTOSYNTH RES, V56, P157, DOI 10.1023/A:1006068615220; BURNAP RL, 1994, BIOCHEMISTRY-US, V33, P13712, DOI 10.1021/bi00250a023; BURNAP RL, 1992, BIOCHEMISTRY-US, V31, P7404, DOI 10.1021/bi00147a027; Campbell KA, 1998, BIOCHEMISTRY-US, V37, P5039, DOI 10.1021/bi9800552; Commet A, 2012, BIOCHEMISTRY-US, V51, P3808, DOI 10.1021/bi201678m; Dau H, 2012, CURR OPIN CHEM BIOL, V16, P3, DOI 10.1016/j.cbpa.2012.02.011; De Riso A, 2006, BIOPHYS J, V91, P1999, DOI 10.1529/biophysj.106.087171; Dwyer SA, 2012, J EXP BOT, V63, P4781, DOI 10.1093/jxb/ers156; EATONRYE JJ, 1989, BIOCHIM BIOPHYS ACTA, V977, P219, DOI 10.1016/S0005-2728(89)80075-1; Enami I, 1998, J BIOL CHEM, V273, P4629, DOI 10.1074/jbc.273.8.4629; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; FRANKEL LK, 1995, BIOCHEMISTRY-US, V34, P7492, DOI 10.1021/bi00022a024; Freier E, 2011, P NATL ACAD SCI USA, V108, P11435, DOI 10.1073/pnas.1104735108; GHANOTAKIS DF, 1985, FEBS LETT, V192, P1, DOI 10.1016/0014-5793(85)80030-2; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Haumann M, 2002, FEBS LETT, V512, P116, DOI 10.1016/S0014-5793(02)02237-8; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hillier W, 2001, BIOCHEMISTRY-US, V40, P1503, DOI 10.1021/bi002436x; Hutchison RS, 1998, BIOCHEMISTRY-US, V37, P5643, DOI 10.1021/bi9724467; Hutchison RS, 1999, J BIOL CHEM, V274, P31987, DOI 10.1074/jbc.274.45.31987; Joliot P., 1975, BIOENERG PHOTOSYNTH, P388; Kapoor S, 2012, P NATL ACAD SCI USA, V109, P460, DOI 10.1073/pnas.1110553109; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kotting C, 2005, CHEMPHYSCHEM, V6, P881, DOI 10.1002/cphc.200400504; Leuschner C, 1996, BIOCHEMISTRY-US, V35, P4551, DOI 10.1021/bi9522615; Liang WC, 2000, J AM CHEM SOC, V122, P3399, DOI 10.1021/ja992501u; Liu HJ, 2007, BIOCHEMISTRY-US, V46, P7607, DOI 10.1021/bi700107w; Lundin B, 2008, PHOTOSYNTH RES, V98, P405, DOI 10.1007/s11120-008-9325-y; Lundin B, 2007, BBA-BIOENERGETICS, V1767, P500, DOI 10.1016/j.bbabio.2006.10.009; Lundin B, 2007, PLANT J, V49, P528, DOI 10.1111/j.1365-313X.2006.02976.x; Lydakis-Simantiris N, 1999, BIOCHEMISTRY-US, V38, P404, DOI 10.1021/bi981847z; Lydakis-Simantiris N, 1999, BIOCHEMISTRY-US, V38, P15528, DOI 10.1021/bi991599m; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; MAYFIELD SP, 1987, P NATL ACAD SCI USA, V84, P749, DOI 10.1073/pnas.84.3.749; MILLER AF, 1987, PHOTOSYNTH RES, V12, P205, DOI 10.1007/BF00055121; MISHRA RK, 1994, PHOTOSYNTH RES, V42, P37, DOI 10.1007/BF00019056; Miura T, 1997, J BIOL CHEM, V272, P3788, DOI 10.1074/jbc.272.6.3788; MIYAO M, 1984, FEBS LETT, V168, P118, DOI 10.1016/0014-5793(84)80218-5; MIYAO M, 1984, FEBS LETT, V170, P350, DOI 10.1016/0014-5793(84)81342-3; MIYAO M, 1987, BIOCHIM BIOPHYS ACTA, V890, P151, DOI 10.1016/0005-2728(87)90016-8; Motoki A, 2002, J BIOL CHEM, V277, P14747, DOI 10.1074/jbc.M100766200; Murakami R, 2005, FEBS J, V272, P2165, DOI 10.1111/j.1742-4658.2005.04636.x; Murakami R, 2002, FEBS LETT, V523, P138, DOI 10.1016/S0014-5793(02)02963-0; Murray JW, 2007, J STRUCT BIOL, V159, P228, DOI 10.1016/j.jsb.2007.01.016; Nagel ZD, 2013, J BIOL CHEM, V288, P14087, DOI 10.1074/jbc.M113.453951; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Noguchi T, 2001, BIOCHEMISTRY-US, V40, P1497, DOI 10.1021/bi0023807; NOREN GH, 1991, BIOCHEMISTRY-US, V30, P3943, DOI 10.1021/bi00230a020; ONO T, 1984, FEBS LETT, V168, P281, DOI 10.1016/0014-5793(84)80263-X; Ouelette AJA, 2002, PHOTOSYNTH RES, V72, P159, DOI 10.1023/A:1016132700844; PICCIONI R, 1982, METHODS CHLOROPLAST, P985; Polander BC, 2013, P NATL ACAD SCI USA, V110, P10634, DOI 10.1073/pnas.1306532110; Polander BC, 2013, J PHYS CHEM LETT, V4, P786, DOI 10.1021/jz400071k; Polander BC, 2012, P NATL ACAD SCI USA, V109, P6112, DOI 10.1073/pnas.1200093109; Popelka H, 2012, PHOTOSYNTH RES, V112, P117, DOI 10.1007/s11120-012-9745-6; Popelkova H, 2006, BIOCHEMISTRY-US, V45, P3107, DOI 10.1021/bi0523759; Popelkova H, 2003, PHOTOSYNTH RES, V77, P21, DOI 10.1023/A:1024970926655; Popelkova H, 2003, BIOCHEMISTRY-US, V42, P6193, DOI 10.1021/bi0207115; Popelkova H, 2002, BIOCHEMISTRY-US, V41, P2702, DOI 10.1021/bi0118761; Popelkova H, 2002, BIOCHEMISTRY-US, V41, P10038, DOI 10.1021/bi020228u; Popelkova H, 2008, BIOCHEMISTRY-US, V47, P12593, DOI 10.1021/bi801512s; Popelkova H, 2007, PHOTOSYNTH RES, V93, P111, DOI 10.1007/s11120-006-9121-5; Popelkova H, 2011, PHOTOSYNTH RES, V110, P111, DOI 10.1007/s11120-011-9703-8; Popelkova H, 2010, FEBS LETT, V584, P4009, DOI 10.1016/j.febslet.2010.08.011; Popelkova H, 2009, BIOCHEMISTRY-US, V48, P11920, DOI 10.1021/bi9016999; Popelkova L, 2011, J PHOTOCH PHOTOBIO B, V104, P179, DOI 10.1016/j.jphotobiol.2011.01.015; Qian M, 1997, BIOCHEMISTRY-US, V36, P15244, DOI 10.1021/bi9713198; Roose JL, 2011, BIOCHEMISTRY-US, V50, P5988, DOI 10.1021/bi2008068; Roose JL, 2010, BIOCHEMISTRY-US, V49, P6042, DOI 10.1021/bi100303f; Roose JL, 2010, BIOCHEMISTRY-US, V49, P36, DOI 10.1021/bi9017818; Sachs RK, 2003, J BIOL CHEM, V278, P44222, DOI 10.1074/jbc.M307148200; Seidler A, 1996, BBA-BIOENERGETICS, V1277, P35, DOI 10.1016/S0005-2728(96)00102-8; SEIDLER A, 1994, PROTEIN ENG, V7, P1277, DOI 10.1093/protein/7.10.1277; Shutova T, 2007, BBA-BIOENERGETICS, V1767, P434, DOI 10.1016/j.bbabio.2007.01.020; Speranskiy K, 2004, J CHEM PHYS, V121, P1516, DOI 10.1063/1.1752887; STYRING S, 1987, BIOCHIM BIOPHYS ACTA, V890, P32, DOI 10.1016/0005-2728(87)90065-X; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Svensson B, 2004, BIOPHYS J, V86, P1807, DOI 10.1016/S0006-3495(04)74247-2; Thornton LE, 2004, PLANT CELL, V16, P2164, DOI 10.1105/tpc.104.023515; Tomita M, 2009, BIOCHEMISTRY-US, V48, P6318, DOI 10.1021/bi9006308; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wyman AJ, 2008, BIOCHEMISTRY-US, V47, P6490, DOI 10.1021/bi800225m; Wyman AJ, 2005, PHOTOSYNTH RES, V85, P359, DOI 10.1007/s11120-005-7385-9; XU Q, 1992, J BIOL CHEM, V267, P25816; YAMAMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V255, P156, DOI 10.1016/0003-9861(87)90305-5; Yi XP, 2006, J BIOL CHEM, V281, P26260, DOI 10.1074/jbc.M603582200; Yi XP, 2008, PHOTOSYNTH RES, V98, P439, DOI 10.1007/s11120-008-9352-8; Yi XP, 2005, J BIOL CHEM, V280, P16170, DOI 10.1074/jbc.M501550200; Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010; Zhang F, 2005, BIOCHEMISTRY-US, V44, P719, DOI 10.1021/bi0483559	111	22	23	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29056	29068		10.1074/jbc.M113.487561	http://dx.doi.org/10.1074/jbc.M113.487561			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940038	hybrid, Green Published			2022-12-28	WOS:000330298800059
J	Mailu, BM; Ramasamay, G; Mudeppa, DG; Li, L; Lindner, SE; Peterson, MJ; DeRocher, AE; Kappe, SHI; Rathod, PK; Gardner, MJ				Mailu, Boniface M.; Ramasamay, Gowthaman; Mudeppa, Devaraja G.; Li, Ling; Lindner, Scott E.; Peterson, Megan J.; DeRocher, Amy E.; Kappe, Stefan H. I.; Rathod, Pradipsinh K.; Gardner, Malcolm J.			A Nondiscriminating Glutamyl-tRNA Synthetase in the Plasmodium Apicoplast THE FIRST ENZYME IN AN INDIRECT AMINOACYLATION PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminoacyl tRNA Synthetase; Malaria; Nucleic Acid Enzymology; Plasmodium; Transfer RNA (tRNA); Apicoplast	MULTIPLE SEQUENCE ALIGNMENTS; ZINC-BINDING SITE; ESCHERICHIA-COLI; AMINO-ACID; GENOME SEQUENCE; ANTICODON RECOGNITION; HELICOBACTER-PYLORI; MALARIA PARASITES; STRUCTURAL BASIS; CIRCULAR DNA	The malaria parasite Plasmodium falciparum and related organisms possess a relict plastid known as the apicoplast. Apicoplast protein synthesis is a validated drug target in malaria because antibiotics that inhibit translation in prokaryotes also inhibit apicoplast protein synthesis and are sometimes used for malaria prophylaxis or treatment. We identified components of an indirect aminoacylation pathway for Gln-tRNA(Gln) biosynthesis in Plasmodium that we hypothesized would be essential for apicoplast protein synthesis. Here, we report our characterization of the first enzyme in this pathway, the apicoplast glutamyl-tRNA synthetase (GluRS). We expressed the recombinant P. falciparum enzyme in Escherichia coli, showed that it is nondiscriminating because it glutamylates both apicoplast tRNA(Glu) and tRNA(Gln), determined its kinetic parameters, and demonstrated its inhibition by a known bacterial GluRS inhibitor. We also localized the Plasmodium berghei ortholog to the apicoplast in blood stage parasites but could not delete the PbGluRS gene. These data show that Gln-tRNA(Gln) biosynthesis in the Plasmodium apicoplast proceeds via an essential indirect aminoacylation pathway that is reminiscent of bacteria and plastids.	[Peterson, Megan J.; DeRocher, Amy E.; Kappe, Stefan H. I.; Gardner, Malcolm J.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Mudeppa, Devaraja G.; Rathod, Pradipsinh K.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Kappe, Stefan H. I.; Rathod, Pradipsinh K.; Gardner, Malcolm J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gardner, MJ (corresponding author), Seattle Biomed Res Inst, 307 Westlake Ave N,Ste 500, Seattle, WA 98109 USA.	malcolm.gardner@seattlebiomed.org			National Institutes of Health Grant from the NIAID [R21AI81097]; Murdock Trust; Seattle Biomedical Research Institute; Puget Sound Partners for Global Health;  [AI 093380];  [AI 099280]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093380, R21AI081097, R01AI099280] Funding Source: NIH RePORTER	National Institutes of Health Grant from the NIAID; Murdock Trust; Seattle Biomedical Research Institute; Puget Sound Partners for Global Health; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R21AI81097 from the NIAID (to M. J. G.) and Grants AI 093380 and AI 099280 (to P. K. R.). This work was also supported by the Murdock Trust, Seattle Biomedical Research Institute, and Puget Sound Partners for Global Health (to M. J. G.).	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Baick JW, 2004, J MICROBIOL, V42, P111; Bailly M, 2007, MOL CELL, V28, P228, DOI 10.1016/j.molcel.2007.08.017; Baker SJ, 2006, J MED CHEM, V49, P4447, DOI 10.1021/jm0603724; Banerjee R, 2004, EUR J BIOCHEM, V271, P724, DOI 10.1111/j.1432-1033.2003.03976.x; Bernier S, 2005, J ENZYM INHIB MED CH, V20, P61, DOI 10.1080/14756360400002007; Bhatt TK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-644; Bour T, 2009, J BIOL CHEM, V284, P18893, DOI 10.1074/jbc.M109.015297; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brown P, 1999, BIOORGAN MED CHEM, V7, P2473, DOI 10.1016/S0968-0896(99)00192-3; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Dahl EL, 2008, TRENDS PARASITOL, V24, P279, DOI 10.1016/j.pt.2008.03.007; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dubois DY, 2009, BIOCHEMISTRY-US, V48, P6012, DOI 10.1021/bi801690f; Duchene AM, 2005, P NATL ACAD SCI USA, V102, P16484, DOI 10.1073/pnas.0504682102; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Feng L, 2005, J BIOL CHEM, V280, P8150, DOI 10.1074/jbc.M411098200; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Frechin M, 2009, GENE DEV, V23, P1119, DOI 10.1101/gad.518109; FREIST W, 1989, EUR J BIOCHEM, V186, P535, DOI 10.1111/j.1432-1033.1989.tb15239.x; FREIST W, 1989, BIOCHEMISTRY-US, V28, P6787, DOI 10.1021/bi00443a001; GARDNER MJ, 1991, MOL BIOCHEM PARASIT, V44, P115, DOI 10.1016/0166-6851(91)90227-W; GARDNER MJ, 1991, MOL BIOCHEM PARASIT, V48, P77, DOI 10.1016/0166-6851(91)90166-4; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GEARY TG, 1983, AM J TROP MED HYG, V32, P221, DOI 10.4269/ajtmh.1983.32.221; George GM, 2010, PLANT PHYSIOL, V154, P55, DOI 10.1104/pp.110.157776; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GINSBURG H, 1986, J PROTOZOOL, V33, P121, DOI 10.1111/j.1550-7408.1986.tb05570.x; Goodman CD, 2013, EXPERT OPIN THER TAR, V17, P167, DOI 10.1517/14728222.2013.739158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gunther S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005510; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Hoen R, 2013, CHEMBIOCHEM, V14, P499, DOI 10.1002/cbic.201200620; Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015; Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1; Huot JL, 2011, NUCLEIC ACIDS RES, V39, P9306, DOI 10.1093/nar/gkr619; ILAN J, 1969, SCIENCE, V164, P560, DOI 10.1126/science.164.3879.560; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Ito T, 2010, NATURE, V467, P612, DOI 10.1038/nature09411; Jackson KE, 2012, INT J PARASITOL, V42, P177, DOI 10.1016/j.ijpara.2011.11.008; Jackson KE, 2011, TRENDS PARASITOL, V27, P467, DOI 10.1016/j.pt.2011.05.005; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Jortzik E, 2011, BIOCHEM J, V436, P641, DOI 10.1042/BJ20110170; Katz A, 2010, BIOCHEM BIOPH RES CO, V398, P51, DOI 10.1016/j.bbrc.2010.06.031; Khan S., 2013, PLOS ONE, V8; Khan S, 2013, ACTA CRYSTALLOGR D, V69, P785, DOI 10.1107/S0907444913001923; Koh CY, 2013, MOL BIOCHEM PARASIT, V189, P26, DOI 10.1016/j.molbiopara.2013.04.007; Labaied M, 2007, INFECT IMMUN, V75, P3758, DOI 10.1128/IAI.00225-07; Labaied M, 2007, MOL BIOCHEM PARASIT, V153, P158, DOI 10.1016/j.molbiopara.2007.03.001; LAPOINTE J, 1986, J BACTERIOL, V165, P88, DOI 10.1128/jb.165.1.88-93.1986; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Lee J, 2004, J MOL BIOL, V344, P1167, DOI 10.1016/j.jmb.2004.10.013; LIU JH, 1995, J BIOL CHEM, V270, P15162, DOI 10.1074/jbc.270.25.15162; Lv PC, 2012, CURR MED CHEM, V19, P3550, DOI 10.2174/092986712801323199; MASSON JM, 1986, GENE, V47, P179, DOI 10.1016/0378-1119(86)90061-2; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; Mikolajczak SA, 2008, MOL BIOCHEM PARASIT, V158, P213, DOI 10.1016/j.molbiopara.2007.12.006; Mudeppa DG, 2007, MOL BIOCHEM PARASIT, V151, P216, DOI 10.1016/j.molbiopara.2006.10.016; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nagaraja VA, 2009, INT J PARASITOL, V39, P559, DOI 10.1016/j.ijpara.2008.10.011; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Oshikane H, 2006, SCIENCE, V312, P1950, DOI 10.1126/science.1128470; Pedroni MJ, 2012, EXP PARASITOL, V131, P261, DOI 10.1016/j.exppara.2012.04.013; Pino P, 2010, MOL MICROBIOL, V76, P706, DOI 10.1111/j.1365-2958.2010.07128.x; Puri SK, 2000, EXP PARASITOL, V94, P8, DOI 10.1006/expr.1999.4465; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Saad NY, 2012, J BIOL CHEM, V287, P20382, DOI 10.1074/jbc.M111.332304; Schulze JO, 2006, J MOL BIOL, V361, P888, DOI 10.1016/j.jmb.2006.06.054; Seeber F, 2002, INT J PARASITOL, V32, P1207, DOI 10.1016/S0020-7519(02)00022-X; Sekine S, 2003, EMBO J, V22, P676, DOI 10.1093/emboj/cdg053; Sekine S, 2001, NAT STRUCT BIOL, V8, P203, DOI 10.1038/84927; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; Sheppard K, 2008, METHODS, V44, P139, DOI 10.1016/j.ymeth.2007.06.010; Sheppard K, 2007, J BIOL CHEM, V282, P11866, DOI 10.1074/jbc.M700398200; Shu NJ, 2008, BIOINFORMATICS, V24, P775, DOI 10.1093/bioinformatics/btm618; Sullivan M, 2000, MOL BIOCHEM PARASIT, V109, P17, DOI 10.1016/S0166-6851(00)00226-7; Tan KR, 2011, AM J TROP MED HYG, V84, P517, DOI 10.4269/ajtmh.2011.10-0285; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Vignali M, 2011, J CLIN INVEST, V121, P1119, DOI 10.1172/JCI43457; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; World Health Organization, 2010, GUID TREATM TUB, P53; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	108	14	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32539	32552		10.1074/jbc.M113.507467	http://dx.doi.org/10.1074/jbc.M113.507467			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072705	Green Published, hybrid			2022-12-28	WOS:000328681700037
J	Mishra, J; Verma, RK; Alpini, G; Meng, FY; Kumar, N				Mishra, Jayshree; Verma, Raj K.; Alpini, Gianfranco; Meng, Fanyin; Kumar, Narendra			Role of Janus Kinase 3 in Mucosal Differentiation and Predisposition to Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DSS-INDUCED COLITIS; TYROSINE PHOSPHORYLATION; CELL-DIFFERENTIATION; JAK3; ACTIVATION; EXPRESSION; JUNCTIONS; DISEASE; FAMILY; MICE	Janus kinase 3 (Jak3) is a nonreceptor tyrosine kinase expressed in both hematopoietic and nonhematopoietic cells. Previously, we characterized the functions of Jak3 in cytoskeletal remodeling, epithelial wound healing, and mucosal homeostasis. However, the role of Jak3 in mucosal differentiation and inflammatory bowel disease was not known. In this report, we characterize the role of Jak3 in mucosal differentiation, basal colonic inflammation, and predisposition toward colitis. Using the Jak3 knock-out (KO) mouse model, we show that Jak3 is expressed in colonic mucosa of mice, and the loss of mucosal expression of Jak3 resulted in reduced expression of differentiation markers for the cells of both enterocytic and secretory lineages. Jak3 KO mice showed reduced expression of colonic villin, carbonic anhydrase, secretory mucin muc2, and increased basal colonic inflammation reflected by increased levels of pro-inflammatory cytokines IL-6 and IL-17A in colon along with increased colonic myeloperoxidase activity. The inflammations in KO mice were associated with shortening of colon length, reduced cecum length, decreased crypt heights, and increased severity toward dextran sulfate sodium-induced colitis. In differentiated human colonic epithelial cells, Jak3 redistributed to basolateral surfaces and interacted with adherens junction (AJ) protein beta-catenin. Jak3 expression in these cells was essential for AJ localization of beta-catenin and maintenance of epithelial barrier functions. Collectively, these results demonstrate the essential role of Jak3 in the colon where it facilitated mucosal differentiation by promoting the expression of differentiation markers and enhanced colonic barrier functions through AJ localization of beta-catenin.	[Mishra, Jayshree; Verma, Raj K.; Kumar, Narendra] Texas A&M Univ Syst Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Kingsville, TX 78363 USA; [Alpini, Gianfranco; Meng, Fanyin] Cent Texas Vet Hlth Care Syst, Scott & White Digest Dis Res Ctr, Temple, TX 76504 USA; [Alpini, Gianfranco; Meng, Fanyin] Texas A&M Hlth Sci Ctr Coll Med, Temple, TX 76504 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Kumar, N (corresponding author), Texas A&M Univ HSC, Coll Pharm, 1010 West Ave,B MSC 131, Kingsville, TX 78363 USA.	nkumar@tamhsc.edu	MISHRA, JAYSHREE/O-3468-2018	MISHRA, JAYSHREE/0000-0003-0619-0629; Kumar, Narendra/0000-0002-1193-0954	National Institutes of Health [DK081661]; Crohn's and Colitis Foundation of America [CCFA 2188]; Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology Endowment from the Scott and White Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK081661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology Endowment from the Scott and White Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK081661 (to N. K.). This work was also supported by Crohn's and Colitis Foundation of America Grant CCFA 2188 and the Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology Endowment from the Scott and White Hospital (to G. A.).	Ahmed M, 2010, CYTOKINE GROWTH F R, V21, P449, DOI 10.1016/j.cytogfr.2010.10.005; Assi K, 2008, GUT, V57, P931, DOI 10.1136/gut.2007.142778; Banner KH, 2004, BRIT J PHARMACOL, V143, P590, DOI 10.1038/sj.bjp.0705982; Beck PL, 2010, AM J PHYSIOL-GASTR L, V299, pG43, DOI 10.1152/ajpgi.00228.2009; Bekku S, 1998, RES EXP MED, V198, P175, DOI 10.1007/s004330050101; Brimnes J, 2000, CLIN IMMUNOL, V96, P222, DOI 10.1006/clim.2000.4891; CHANTRET I, 1988, CANCER RES, V48, P1936; Christodoulou K, 2013, GUT, V62, P977, DOI 10.1136/gutjnl-2011-301833; COOPER HS, 1993, LAB INVEST, V69, P238; Cormet-Boyaka E, 2002, P NATL ACAD SCI USA, V99, P12477, DOI 10.1073/pnas.192203899; Cornejo MG, 2009, INT J BIOCHEM CELL B, V41, P2376, DOI 10.1016/j.biocel.2009.09.004; Dai SX, 2013, DIGEST DIS SCI, V58, P88, DOI 10.1007/s10620-012-2327-9; Dignass AU, 2001, INFLAMM BOWEL DIS, V7, P68, DOI 10.1097/00054725-200102000-00014; Dorofeyev AE, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/431231; Elrod JW, 2005, INFLAMM BOWEL DIS, V11, P883, DOI 10.1097/01.MIB.0000182871.76434.57; Ganta VC, 2010, INFLAMM BOWEL DIS, V16, P1029, DOI 10.1002/ibd.21150; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Hass DJ, 2006, CLIN GASTROENTEROL H, V4, P482, DOI 10.1016/j.cgh.2005.12.015; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Jang YN, 2012, CELL SIGNAL, V24, P742, DOI 10.1016/j.cellsig.2011.11.009; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Joo M, 2009, HUM PATHOL, V40, P872, DOI 10.1016/j.humpath.2008.12.003; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kosa P, 2012, ONCOGENE, V31, P3679, DOI 10.1038/onc.2011.545; Kumar N, 2007, J BIOL CHEM, V282, P30341, DOI 10.1074/jbc.C600319200; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Lo SF, 2013, ARCH PATHOL LAB MED, V137, P912, DOI 10.5858/arpa.2012-0152-CP; Mackay F, 1998, GASTROENTEROLOGY, V115, P1464, DOI 10.1016/S0016-5085(98)70025-3; Mariadason JM, 2001, CANCER RES, V61, P3465; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Mishra J, 2013, CRIT REV ONCOL HEMAT, V86, P232, DOI 10.1016/j.critrevonc.2012.09.014; Mishra J, 2012, J BIOL CHEM, V287, P41386, DOI 10.1074/jbc.C112.363507; Mishra J, 2012, AM J PHYSIOL-CELL PH, V302, pC735, DOI 10.1152/ajpcell.00316.2011; Murata Y, 2002, INT IMMUNOL, V14, P627, DOI 10.1093/intimm/dxf031; Murphy KM, 2008, IMMUNITY, V28, P725, DOI 10.1016/j.immuni.2008.05.004; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Papageorgiou AC, 2004, TRENDS PHARMACOL SCI, V25, P558, DOI 10.1016/j.tips.2004.09.008; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; PULLAN RD, 1994, GUT, V35, P353, DOI 10.1136/gut.35.3.353; Safford MG, 1997, EXP HEMATOL, V25, P374; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Sann H, 2013, LIFE SCI, V92, P708, DOI 10.1016/j.lfs.2013.01.028; Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Shin JK, 2013, MOD RHEUMATOL, V23, P406, DOI 10.1007/s10165-012-0675-0; TAKAHASHI T, 1994, FEBS LETT, V342, P124, DOI 10.1016/0014-5793(94)80485-0; Tominaga J, 2008, GENES CELLS, V13, P67, DOI 10.1111/j.1365-2443.2007.01149.x; Vuitton L., 2013, CURR DRUG T IN PRESS; Xu YH, 2008, CELL RES, V18, P1220, DOI 10.1038/cr.2008.310; You H, 2013, J CELL SCI, V126, P2718, DOI 10.1242/jcs.122903; Zhang HJ, 2012, J GASTROEN HEPATOL, V27, P603, DOI 10.1111/j.1440-1746.2011.06879.x; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	53	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31795	31806		10.1074/jbc.M113.504126	http://dx.doi.org/10.1074/jbc.M113.504126			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045942	hybrid, Green Published			2022-12-28	WOS:000330596200030
J	Zhou, XM; Sebastian, TT; Graham, TR				Zhou, Xiaoming; Sebastian, Tessy T.; Graham, Todd R.			Auto-inhibition of Drs2p, a Yeast Phospholipid Flippase, by Its Carboxyl-terminal Tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; P-TYPE ATPASE; AMINOPHOSPHOLIPID TRANSLOCASE; GOLGI; IDENTIFICATION; TRANSPORT; PHOSPHORYLATION; ACTIVATION; BINDING; MECHANISM	Drs2p, a yeast type IV P-type ATPase (P4-ATPase), or flippase, couples ATP hydrolysis to phosphatidylserine translocation and the establishment of membrane asymmetry. A previous study has shown that affinity-purified Drs2p, possessing an N-terminal tandem affinity purification tag (TAPN-Drs2), retains ATPase and translocase activity, but Drs2p purified using a C-terminal tag (Drs2-TAPC) was inactive. In this study, we show that the ATPase activity of N-terminally purified Drs2p associates primarily with a proteolyzed form of Drs2p lacking the C-terminal cytosolic tail. Truncation of most of the Drs2p C-terminal tail sequence activates its ATPase activity by similar to 4-fold. These observations are consistent with the hypothesis that the C-terminal tail of Drs2p is auto-inhibitory to Drs2p activity. Phosphatidylinositol 4-phosphate (PI(4)P) has been shown to positively regulate Drs2p activity in isolated Golgi membranes through interaction with the C-terminal tail. In proteoliposomes reconstituted with purified, N-terminally TAP-tagged Drs2p, both ATPase and flippase activity were significantly higher in the presence of PI(4) P. In contrast, PI(4) P had no significant effect on the activity of a truncated form of Drs2p, which lacked the C-terminal tail. This work provides the first direct evidence, in a purified system, that a phospholipid flippase is subject to auto-inhibition by its C-terminal tail, which can be relieved by a phosphoinositide to stimulate flippase activity.	[Zhou, Xiaoming; Sebastian, Tessy T.; Graham, Todd R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Graham, TR (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B, Box 35-1634, Nashville, TN 37235 USA.	tr.graham@vanderbilt.edu		Zhou, Xiaoming/0000-0001-8866-7245	National Institutes of Health [R01GM062367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107978, R01GM062367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM062367 (to T. R. G.).	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; AU KS, 1987, BIOCHIM BIOPHYS ACTA, V905, P273, DOI 10.1016/0005-2736(87)90455-X; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baldridge RD, 2013, J BIOL CHEM, V288, P19516, DOI 10.1074/jbc.M113.476911; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; CALDOGNO FR, 1993, PLANT PHYSIOL, V103, P385; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; CARONI P, 1981, J BIOL CHEM, V256, P9371; CARTER SG, 1982, J BIOCHEM BIOPH METH, V7, P7, DOI 10.1016/0165-022X(82)90031-8; Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Cornelius F, 2005, BIOCHEMISTRY-US, V44, P13051, DOI 10.1021/bi0504456; Ding JT, 2000, J BIOL CHEM, V275, P23378, DOI 10.1074/jbc.M910319199; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Hwang I, 2000, PLANT PHYSIOL, V122, P157, DOI 10.1104/pp.122.1.157; Jacquot A, 2012, J BIOL CHEM, V287, P13249, DOI 10.1074/jbc.M111.313916; JAMES P, 1988, J BIOL CHEM, V263, P2905; JAMES PH, 1989, BIOCHEMISTRY-US, V28, P4253, DOI 10.1021/bi00436a020; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Maudoux O, 2000, J BIOL CHEM, V275, P17762, DOI 10.1074/jbc.M909690199; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; Olsson A, 1998, PLANT PHYSIOL, V118, P551, DOI 10.1104/pp.118.2.551; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; PALMGREN MG, 1990, J BIOL CHEM, V265, P13423; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Peyroche A, 2001, J CELL SCI, V114, P2241; Piotrowski M, 1998, J BIOL CHEM, V273, P30018, DOI 10.1074/jbc.273.45.30018; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; RASICALDOGNO F, 1995, PLANT PHYSIOL, V108, P105, DOI 10.1104/pp.108.1.105; RASICALDOGNO F, 1992, PLANT PHYSIOL, V98, P1202, DOI 10.1104/pp.98.3.1202; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sze H, 2000, ANNU REV PLANT PHYS, V51, P433, DOI 10.1146/annurev.arplant.51.1.433; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Tsai PC, 2013, P NATL ACAD SCI USA, V110, pE668, DOI 10.1073/pnas.1221484110; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; ZIMMERMAN ML, 1993, BIOCHEMISTRY-US, V32, P12257, DOI 10.1021/bi00096a040	52	36	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31807	31815		10.1074/jbc.M113.481986	http://dx.doi.org/10.1074/jbc.M113.481986			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045945	hybrid, Green Published			2022-12-28	WOS:000330596200031
J	Beazley, KE; Reckard, S; Nurminsky, D; Lima, F; Nurminskaya, M				Beazley, Kelly E.; Reckard, Steven; Nurminsky, Dmitry; Lima, Florence; Nurminskaya, Maria			Two Sides of MGP Null Arterial Disease CHONDROGENIC LESIONS DEPENDENT ON TRANSGLUTAMINASE 2 AND ELASTIN FRAGMENTATION ASSOCIATED WITH INDUCTION OF ADIPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX GLA PROTEIN; VASCULAR SMOOTH-MUSCLE; COMPLEMENT FACTOR-D; ADIPOSE-TISSUE; TRANSFORMING GROWTH-FACTOR-BETA-1; ELASTIN DEGRADATION; DEFICIENT MICE; MOUSE MODEL; CALCIFICATION; CELLS	Mutations in matrix Gla protein (MGP) have been correlated with vascular calcification. In the mouse model, MGP null vascular disease presents as calcifying cartilaginous lesions and mineral deposition along elastin lamellae (elastocalcinosis). Here we examined the mechanisms underlying both of these manifestations. Genetic ablation of enzyme transglutaminase 2 (TG2) in Mgp(-/-) mice dramatically reduced the size of cartilaginous lesions in the aortic media, attenuated calcium accrual more than 2-fold, and doubled longevity as compared with control Mgp(-/-) animals. Nonetheless, the Mgp(-/-); Tgm2(-/-) mice still died prematurely as compared with wild-type and retained the elastocalcinosis phenotype. This pathology in Mgp(-/-) animals was developmentally preceded by extensive fragmentation of elastic lamellae and associated with elevated serine elastase activity in aortic tissue and vascular smooth muscle cells. Systematic gene expression analysis followed by an immunoprecipitation study identified adipsin as the major elastase that is induced in the Mgp(-/-) vascular smooth muscle even in the TG2 null background. These results reveal a central role for TG2 in chondrogenic transformation of vascular smooth muscle and implicate adipsin in elastin fragmentation and ensuing elastocalcinosis. The importance of elastin calcification in MGP null vascular disease is highlighted by significant residual vascular calcification and mortality in Mgp(-/-);Tgm2(-/-) mice with reduced cartilaginous lesions. Our studies identify two potential therapeutic targets in vascular calcification associated with MGP dysfunction and emphasize the need for a comprehensive approach to this multifaceted disorder.	[Beazley, Kelly E.; Reckard, Steven; Nurminsky, Dmitry; Lima, Florence; Nurminskaya, Maria] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Nurminskaya, M (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St,Rm 329, Baltimore, MD 21201 USA.	mnurminskaya@som.umaryland.edu	Nurminskaya, Maria/GQH-4607-2022		National Institutes of Health [R01HL099305, T32AR007592]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL099305 (to M.N.) and T32AR007592 (to K.B.).	Aikawa E, 2009, CIRCULATION, V119, P1785, DOI 10.1161/CIRCULATIONAHA.108.827972; Al-Jallad HF, 2006, MATRIX BIOL, V25, P135, DOI 10.1016/j.matbio.2005.11.001; Ashcroft GS, 1999, AM J PATHOL, V155, P1137, DOI 10.1016/S0002-9440(10)65217-0; Beazley KE, 2013, J BIOL CHEM, V288, P2632, DOI 10.1074/jbc.M112.368639; Beazley KE, 2013, ARTERIOSCL THROM VAS, V33, P43, DOI 10.1161/ATVBAHA.112.300260; Beazley KE, 2012, ARTERIOSCL THROM VAS, V32, P123, DOI 10.1161/ATVBAHA.111.237834; Bostrom KI, 2011, CIRC RES, V108, P446, DOI 10.1161/CIRCRESAHA.110.236596; Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200; Bouvet C, 2008, ARTERIOSCL THROM VAS, V28, P856, DOI 10.1161/ATVBAHA.107.153056; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; Chatrou MLL, 2011, HAMOSTASEOLOGIE, V31, P251, DOI 10.5482/ha-1157; CHOY LN, 1992, J BIOL CHEM, V267, P12736; COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705; Crosier MD, 2009, J NUTR SCI VITAMINOL, V55, P59, DOI 10.3177/jnsv.55.59; Dao HH, 2002, J HYPERTENS, V20, P1597, DOI 10.1097/00004872-200208000-00023; El-Maadawy S, 2003, CONNECT TISSUE RES, V44, P272, DOI 10.1080/03008200390181762; Faverman L, 2008, FEBS LETT, V582, P1552, DOI 10.1016/j.febslet.2008.03.053; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Herrmann SM, 2000, ARTERIOSCL THROM VAS, V20, P2386, DOI 10.1161/01.ATV.20.11.2386; Hosaka N, 2009, CALCIFIED TISSUE INT, V85, P523, DOI 10.1007/s00223-009-9297-8; Ishizeki K, 1999, J ANAT, V194, P265, DOI 10.1046/j.1469-7580.1999.19420265.x; Johnson KA, 2005, J BIOL CHEM, V280, P15004, DOI 10.1074/jbc.M500962200; Johnson KA, 2003, J BIOL CHEM, V278, P18824, DOI 10.1074/jbc.M301055200; Johnson KA, 2008, CIRC RES, V102, P529, DOI 10.1161/CIRCRESAHA.107.154260; Kaartinen MT, 2007, J HISTOCHEM CYTOCHEM, V55, P375, DOI 10.1369/jhc.6A7087.2006; Khavandgar Z, 2014, J BONE MINER RES, V29, P327, DOI 10.1002/jbmr.2039; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Lomashvili KA, 2011, J BIOL CHEM, V286, P28715, DOI 10.1074/jbc.M111.251462; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mikhaylova L, 2007, CALCIFIED TISSUE INT, V81, P372, DOI 10.1007/s00223-007-9073-6; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Nurminskaya M, 2003, DEV BIOL, V263, P139, DOI 10.1016/S0012-1606(03)00445-7; Nurminsky D, 2011, MECH DEVELOP, V128, P234, DOI 10.1016/j.mod.2010.11.007; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Pai A, 2011, AM J PATHOL, V178, P764, DOI 10.1016/j.ajpath.2010.10.006; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P840, DOI 10.1073/pnas.0607196104; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Qin X, 2006, ARTERIOSCL THROM VAS, V26, P1510, DOI 10.1161/01.ATV.0000225807.76419.a7; ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; Ruan CC, 2010, ARTERIOSCL THROM VAS, V30, P2568, DOI 10.1161/ATVBAHA.110.215525; RUCKER RB, 1974, CALC TISS RES, V14, P317, DOI 10.1007/BF02060306; Schurgers LJ, 2007, J THROMB HAEMOST, V5, P2503, DOI 10.1111/j.1538-7836.2007.02758.x; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; Sharma B, 2013, MICROVASC RES, V85, P24, DOI 10.1016/j.mvr.2012.10.005; Shields KJ, 2011, CTS-CLIN TRANSL SCI, V4, P146, DOI 10.1111/j.1752-8062.2011.00304.x; Simionescu A, 2007, AM J PATHOL, V171, P116, DOI 10.2353/ajpath.2007.060930; Speer MY, 2010, J CELL BIOCHEM, V110, P935, DOI 10.1002/jcb.22607; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Wagenseil JE, 2012, J CARDIOVASC TRANSL, V5, P264, DOI 10.1007/s12265-012-9349-8; WHITE RT, 1992, J BIOL CHEM, V267, P9210; Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398; Yao YC, 2008, CIRC RES, V102, P1065, DOI 10.1161/CIRCRESAHA.107.166124; Yao YC, 2013, CIRC RES, V113, P495, DOI 10.1161/CIRCRESAHA.113.301792; Yao YC, 2011, J CLIN INVEST, V121, P2993, DOI 10.1172/JCI57567; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; ZHU L, 1994, J CLIN INVEST, V94, P1163, DOI 10.1172/JCI117432	58	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31400	31408		10.1074/jbc.M113.495556	http://dx.doi.org/10.1074/jbc.M113.495556			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24036114	hybrid, Green Published			2022-12-28	WOS:000330778900056
J	Liu, S; Yang, H; Zhao, J; Zhang, YH; Song, AX; Hu, HY				Liu, Shuai; Yang, Hui; Zhao, Jian; Zhang, Yu-Hang; Song, Ai-Xin; Hu, Hong-Yu			NEDD8 Ultimate Buster-1 Long (NUB1L) Protein Promotes Transfer of NEDD8 to Proteasome for Degradation through the P97(UFD1/NPL4) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P97 AAA ATPASE; SYNPHILIN-1-BINDING PROTEIN; CONFORMATIONAL-CHANGES; UBIQUITIN; BINDING; FAT10; DOMAINS; SYSTEM; CDC48; IDENTIFICATION	The NEDD8 protein and neddylation levels in cells are modulated by NUB1L or NUB1 through proteasomal degradation, but the underlying molecular mechanism is not well understood. Here, we report that NUB1L down-regulated the protein levels of NEDD8 and neddylation through specifically recognizing NEDD8 and P97/VCP. NUB1L directly interacted with NEDD8, but not with ubiquitin, on the key residue Asn-51 of NEDD8 and with P97/VCP on its positively charged VCP binding motif. In coordination with the P97-UFD1-NPL4 complex (P97(UFD1/NPL4)), NUB1L promotes transfer of NEDD8 to proteasome for degradation. This mechanism is also exemplified by the canonical neddylation of cullin 1 for SCF (SKP1-cullin1-F-box) ubiquitin E3 ligases that is exquisitely regulated by the turnover of NEDD8.	[Liu, Shuai; Yang, Hui; Zhao, Jian; Zhang, Yu-Hang; Song, Ai-Xin; Hu, Hong-Yu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Hu, HY (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	hyhu@sibcb.ac.cn	Hu, Hong-Yu/AAQ-2633-2020	Liu, Shuai/0000-0002-6069-4900	National Basic Research Program of China [2012CB911003]; National Natural Science Foundation of China [31270773]; Sino-Swiss Joint Research Projects [GJHZ0909]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-Swiss Joint Research Projects	This work was supported by grants from the National Basic Research Program of China (2012CB911003), the National Natural Science Foundation of China (31270773), and the Sino-Swiss Joint Research Projects (GJHZ0909).	Akey DT, 2002, HUM MOL GENET, V11, P2723, DOI 10.1093/hmg/11.22.2723; Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Bebeacua C, 2012, P NATL ACAD SCI USA, V109, P1098, DOI 10.1073/pnas.1114341109; Beuron F, 2003, J MOL BIOL, V327, P619, DOI 10.1016/S0022-2836(03)00178-5; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Gong LM, 2000, J BIOL CHEM, V275, P14212, DOI 10.1074/jbc.275.19.14212; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hipp MS, 2004, J BIOL CHEM, V279, P16503, DOI 10.1074/jbc.M310114200; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Hosono T, 2010, BRIT J CANCER, V102, P873, DOI 10.1038/sj.bjc.6605574; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kanaya K, 2004, BIOCHEM BIOPH RES CO, V317, P768, DOI 10.1016/j.bbrc.2004.03.108; Kito K, 2001, J BIOL CHEM, V276, P20603, DOI 10.1074/jbc.M100920200; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Laser H, 2006, MOL BIOL CELL, V17, P1075, DOI 10.1091/mbc.E05-04-0375; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Liu G, 2010, ONCOGENE, V29, P2252, DOI 10.1038/onc.2009.494; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lu BX, 2013, NAT NEUROSCI, V16, P562, DOI 10.1038/nn.3367; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer Hemmo H, 2005, Biochim Biophys Acta, V1744, P481; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Mori F, 2012, PATHOL INT, V62, P407, DOI 10.1111/j.1440-1827.2012.02812.x; Morreale G, 2009, FEBS J, V276, P1208, DOI 10.1111/j.1742-4658.2008.06858.x; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rani N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1752; Reverter D, 2005, J MOL BIOL, V345, P141, DOI 10.1016/j.jmb.2004.10.022; Richet E, 2012, HUM MOL GENET, V21, P5254, DOI 10.1093/hmg/dds376; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Schmidtke G, 2006, J BIOL CHEM, V281, P20045, DOI 10.1074/jbc.M603063200; Schmidtke G, 2009, FEBS LETT, V583, P591, DOI 10.1016/j.febslet.2009.01.006; Shin YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027742; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tanaka T, 2003, J BIOL CHEM, V278, P32905, DOI 10.1074/jbc.M212057200; Tanaka T, 2012, MOL ONCOL, V6, P267, DOI 10.1016/j.molonc.2012.01.003; Tanji K, 2005, BIOCHEM BIOPH RES CO, V337, P116, DOI 10.1016/j.bbrc.2005.09.014; Tanji K, 2007, ACTA NEUROPATHOL, V114, P365, DOI 10.1007/s00401-007-0238-1; Tanji K, 2006, AM J PATHOL, V169, P553, DOI 10.2353/ajpath.2006.051067; Tanji K, 2011, J NEUROPATH EXP NEUR, V70, P879, DOI 10.1097/NEN.0b013e3182303745; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; van der Spuy J, 2004, J BIOL CHEM, V279, P48038, DOI 10.1074/jbc.M407871200; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	74	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31339	31349		10.1074/jbc.M113.484816	http://dx.doi.org/10.1074/jbc.M113.484816			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24019527	Green Published, hybrid			2022-12-28	WOS:000330778900050
J	Sung, YH; Jin, Y; Kang, Y; Devkota, S; Lee, J; Roh, JI; Lee, HW				Sung, Young Hoon; Jin, Young; Kang, Yunhwa; Devkota, Sushil; Lee, Jaehoon; Roh, Jae-Il; Lee, Han-Woong			Ei24, a Novel E2F Target Gene, Affects p53-independent Cell Death upon Ultraviolet C Irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; S-PHASE; TRANSCRIPTION FACTORS; AUTOPHAGY GENES; BREAST-CANCER; P53 RESPONSE; APOPTOSIS; CYCLE; MICE; CARCINOGENESIS	The deficiency of retinoblastoma (Rb) gene deregulates E2F transcription factors and thus induces E2F target genes directly or p53 target genes indirectly via mouse p19(Arf) (or p14(ARF) in humans), an E2F target gene. Here, we identified that etoposide-induced 2.4 mRNA (Ei24)/p53-induced gene 8 (Pig8), a p53 target gene involved in apoptosis and autophagy, was up-regulated in Rb-/- mouse embryonic fibroblasts (MEFs). The Ei24 promoter was activated by E2F1 via multiple E2F-responsive elements, independently of the previously reported p53-responsive element. Chromatin immunoprecipitation assays revealed that E2F1 directly acts on the mouse Ei24 promoter. We observed that Ei24 expression was suppressed in p53(-/-) MEFs upon UVC irradiation, which was exacerbated in p53(-/-) E2f1(-/-) MEFs, supporting the positive role of E2F1 on Ei24 transcription. Furthermore, Ei24 knockdown sensitized p53(-/-) MEFs against UVC irradiation. Together, our data indicate that Ei24 is a novel E2F target gene contributing to the survival of p53-deficient cells upon UVC irradiation and thus may have a potential significance as a therapeutic target of certain chemotherapy for treating p53-deficient tumors.	[Sung, Young Hoon; Jin, Young; Kang, Yunhwa; Devkota, Sushil; Lee, Jaehoon; Roh, Jae-Il; Lee, Han-Woong] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Sung, Young Hoon; Jin, Young; Kang, Yunhwa; Devkota, Sushil; Lee, Jaehoon; Roh, Jae-Il; Lee, Han-Woong] Yonsei Univ, Lab Anim Res Ctr, Seoul 120749, South Korea; [Lee, Jaehoon] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea	Yonsei University; Yonsei University; Sungkyunkwan University (SKKU)	Sung, YH (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	sungyh@yonsei.ac.kr; hwl@yonsei.ac.kr			National Research Foundation of Korea [2009-0081177, 2010-0020878]; Ministry of Education, Science, and Technology (MEST) of the Korean government; Ministry for Health and Welfare Affairs [A085136]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology (MEST) of the Korean government(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health and Welfare Affairs	This work was supported by National Research Foundation of Korea Grants 2009-0081177 and 2010-0020878 funded by the Ministry of Education, Science, and Technology (MEST) of the Korean government and Korea Healthcare Technology R&D Project A085136 from the Ministry for Health and Welfare Affairs.	Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Black AR, 1999, GENE, V237, P281, DOI 10.1016/S0378-1119(99)00305-4; Devkota S, 2012, INT J BIOCHEM CELL B, V44, P1887, DOI 10.1016/j.biocel.2012.06.034; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Gentile M, 2001, ONCOGENE, V20, P7753, DOI 10.1038/sj.onc.1204993; GOODRICH DW, 1993, BIOCHIM BIOPHYS ACTA, V1155, P43, DOI 10.1016/0304-419X(93)90021-4; Gu ZM, 2000, MOL CELL BIOL, V20, P233, DOI 10.1128/MCB.20.1.233-241.2000; HARRIS CC, 1993, SCIENCE, V262, P1980, DOI 10.1126/science.8266092; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Lehar SM, 1996, ONCOGENE, V12, P1181; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Lin WC, 2001, GENE DEV, V15, P1833; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mork CN, 2007, FEBS LETT, V581, P5440, DOI 10.1016/j.febslet.2007.10.046; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Polager S, 2003, J BIOL CHEM, V278, P1443, DOI 10.1074/jbc.M210327200; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; QIN XQ, 1995, MOL CELL BIOL, V15, P742; QUELLE DE, 1995, CELL, V83, P993; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sung YH, 2007, MOL CELLS, V24, P409; Sung YH, 2010, CANCER RES, V70, P10454, DOI 10.1158/0008-5472.CAN-10-0031; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; Zhao XS, 2005, CANCER RES, V65, P2125, DOI 10.1158/0008-5472.CAN-04-3377; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	39	14	14	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31261	31267		10.1074/jbc.M113.477570	http://dx.doi.org/10.1074/jbc.M113.477570			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24014029	hybrid, Green Published			2022-12-28	WOS:000330778900042
J	Do, HT; Bruelle, C; Tselykh, T; Jalonen, P; Korhonen, L; Lindholm, D				Hai Thi Do; Bruelle, Celine; Tselykh, Timofey; Jalonen, Pilvi; Korhonen, Laura; Lindholm, Dan			Reciprocal Regulation of Very Low Density Lipoprotein Receptors (VLDLRs) in Neurons by Brain-derived Neurotrophic Factor (BDNF) and Reelin INVOLVEMENT OF THE E3 LIGASE Mylip/Idol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAJAL-RETZIUS CELLS; RAT HIPPOCAMPUS; GLUTAMATERGIC SYNAPSES; DEPENDENT REGULATION; SYNAPTIC PLASTICITY; NEURITE OUTGROWTH; SIGNALING PATHWAY; APOPTOSIS PROTEIN; LINKED INHIBITOR; MESSENGER-RNA	BDNF positively influences various aspects of neuronal migration, maturation, and survival in the developing brain. Reelin in turn mediates inhibitory signals to migrating neuroblasts, which is crucial for brain development. The interplay between BDNF and Reelin signaling in neurodevelopment is not fully understood. We show here that BDNF increased the levels of the Reelin receptor (VLDL receptor (VLDLR)) in hippocampal neurons by increasing gene expression. In contrast, Reelin decreased VLDLRs, which was accompanied by an increase in the levels of the E3 ligase Mylip/Idol in neurons. Down-regulation of Mylip/Idol using shRNAs abrogated the decrease in VLDLRs induced by Reelin. These results show that VLDLRs are tightly regulated in hippocampal neurons by both transcriptional and post-transcriptional mechanisms. The regulation of VLDLR by BDNF and Reelin may affect the migration of neurons and contribute to neurodevelopmental disorders in the nervous system.	[Hai Thi Do; Bruelle, Celine; Tselykh, Timofey; Korhonen, Laura; Lindholm, Dan] Univ Helsinki, Inst Biomed Biochem & Dev Biol, FIN-00290 Helsinki, Finland; [Hai Thi Do; Bruelle, Celine; Tselykh, Timofey; Jalonen, Pilvi; Korhonen, Laura; Lindholm, Dan] Biomedicum 2, Minerva Fdn Inst Med Res, FIN-00290 Helsinki, Finland	University of Helsinki	Lindholm, D (corresponding author), Univ Helsinki, Inst Biomed Biochem & Dev Biol, Haartmaninkatu 8, FIN-00290 Helsinki, Finland.	dan.lindholm@helsinki.fi	Lindholm, Dan/B-3777-2014; Korhonen, Laura/AAW-3256-2020	Korhonen, Laura/0000-0002-1837-5930	Finska Lakaresallskapet; Sigrid Juselius Foundation; Liv och Halsa; Magnus Ehrnrooth; Minerva Foundation; Academy of Finland	Finska Lakaresallskapet; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Liv och Halsa; Magnus Ehrnrooth; Minerva Foundation; Academy of Finland(Academy of Finland)	This work was supported by Finska Lakaresallskapet, the Sigrid Juselius Foundation, Liv och Halsa, Magnus Ehrnrooth, the Minerva Foundation, and the Academy of Finland.	Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; BERZAGHI MD, 1993, J NEUROSCI, V13, P3818; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Bornhauser BC, 2003, J BIOL CHEM, V278, P35412, DOI 10.1074/jbc.M306271200; Bornhauser BC, 2003, FEBS LETT, V553, P195, DOI 10.1016/S0014-5793(03)01010-X; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Durakoglugil MS, 2009, P NATL ACAD SCI USA, V106, P15938, DOI 10.1073/pnas.0908176106; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; Gao ZH, 2013, CELL MOL LIFE SCI, V70, P2319, DOI 10.1007/s00018-012-1171-6; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Do HT, 2012, J BIOL CHEM, V287, P12602, DOI 10.1074/jbc.M112.341248; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Hyrskyluoto A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.170; Impagnatiello F, 1998, P NATL ACAD SCI USA, V95, P15718, DOI 10.1073/pnas.95.26.15718; Kairisalo M, 2009, EUR J NEUROSCI, V30, P958, DOI 10.1111/j.1460-9568.2009.06898.x; Korhonen L, 2001, MOL CELL NEUROSCI, V17, P364, DOI 10.1006/mcne.2000.0935; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kreuter R, 1999, J LIPID RES, V40, P376; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Lindholm D, 1996, EUR J NEUROSCI, V8, P1452, DOI 10.1111/j.1460-9568.1996.tb01607.x; Marty S, 1996, J NEUROSCI, V16, P675; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Putkonen N, 2011, EUR J NEUROSCI, V34, P1212, DOI 10.1111/j.1460-9568.2011.07858.x; Qiu SF, 2007, J NEUROPHYSIOL, V97, P2312, DOI 10.1152/jn.00869.2006; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Ringstedt T, 1998, NEURON, V21, P305, DOI 10.1016/S0896-6273(00)80540-1; Rogers JT, 2011, LEARN MEMORY, V18, P558, DOI 10.1101/lm.2153511; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Scotti E, 2013, MOL CELL BIOL, V33, P1503, DOI 10.1128/MCB.01716-12; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	47	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29613	29620		10.1074/jbc.M113.500967	http://dx.doi.org/10.1074/jbc.M113.500967			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23990472	Green Published, hybrid			2022-12-28	WOS:000330615300037
J	Karasawa, A; Swier, LJYM; Stuart, MCA; Brouwers, J; Helms, B; Poolman, B				Karasawa, Akira; Swier, Lotteke J. Y. M.; Stuart, Marc C. A.; Brouwers, Jos; Helms, Bernd; Poolman, Bert			Physicochemical Factors Controlling the Activity and Energy Coupling of an Ionic Strength-gated ATP-binding Cassette (ABC) Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; OSMOTIC ACTIVATION; BILAYER NANODISCS; PROTEIN; PROP; BETAINE; BETP; RECONSTITUTION; MECHANISM	Cells control their volume through the accumulation of compatible solutes. The bacterial ATP-binding cassette transporter OpuA couples compatible solute uptake to ATP hydrolysis. Here, we study the gating mechanism and energy coupling of OpuA reconstituted in lipid nanodiscs. We show that anionic lipids are essential both for the gating and the energy coupling. The tight coupling between substrate binding on extracellular domains and ATP hydrolysis by cytoplasmic nucleotide-binding domains allows the study of transmembrane signaling in nanodiscs. From the tight coupling between processes at opposite sides of the membrane, we infer that the ATPase activity of OpuA in nanodiscs reflects solute translocation. Intriguingly, the substrate-dependent, ionic strength-gated ATPase activity of OpuA in nanodiscs is at least an order of magnitude higher than in lipid vesicles (i.e. with identical membrane lipid composition, ionic strength, and nucleotide and substrate concentrations). Even with the chemical components the same, the lateral pressure (profile) of the nanodiscs will differ from that of the vesicles. We thus propose that membrane tension limits translocation in vesicular systems. Increased macromolecular crowding does not activate OpuA but acts synergistically with ionic strength, presumably by favoring gating interactions of like-charged surfaces via excluded volume effects.	[Karasawa, Akira; Swier, Lotteke J. Y. M.; Stuart, Marc C. A.; Poolman, Bert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; [Karasawa, Akira; Swier, Lotteke J. Y. M.; Stuart, Marc C. A.; Poolman, Bert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biophys Chem, Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; [Karasawa, Akira; Swier, Lotteke J. Y. M.; Stuart, Marc C. A.; Poolman, Bert] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Brouwers, Jos; Helms, Bernd] Univ Utrecht, Dept Pharmaceut Sci, NL-3508 TD Utrecht, Netherlands	University of Groningen; University of Groningen; University of Groningen; Utrecht University	Poolman, B (corresponding author), Univ Groningen, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@rug.nl	Institute, Zernike/W-7033-2019; Karasawa, Akira/ABF-4128-2021; Karasawa, Akira/ABC-9782-2021; Brouwers, Jos F/AAH-1444-2019; Stuart, Marc/B-6274-2008	Brouwers, Jos F/0000-0003-2924-3279; Stuart, Marc/0000-0003-0667-6338	Netherlands Organization for Scientific Research (NWO) [700.56.302, 728.011.104]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherlands Organization for Scientific Research (NWO) Top-Subsidy Grant 700.56.302 and ChemThem "Chemical Biology" Grant 728.011.104.	Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; Alvarez FJD, 2010, J AM CHEM SOC, V132, P9513, DOI 10.1021/ja104047c; Bao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034836; Bayburt TH, 2006, ARCH BIOCHEM BIOPHYS, V450, P215, DOI 10.1016/j.abb.2006.03.013; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; Boldog T, 2006, P NATL ACAD SCI USA, V103, P11509, DOI 10.1073/pnas.0604988103; Bolen D W, 2001, Methods Mol Biol, V168, P17; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Brown MF, 2012, BIOCHEMISTRY-US, V51, P9782, DOI 10.1021/bi301332v; Culham DE, 2003, BIOCHEMISTRY-US, V42, P410, DOI 10.1021/bi0264364; Culham DE, 2008, BIOCHEMISTRY-US, V47, P8176, DOI 10.1021/bi800794z; Culham DE, 2012, J BIOL CHEM, V287, P27813, DOI 10.1074/jbc.M112.387936; Dalal K, 2012, P NATL ACAD SCI USA, V109, P4104, DOI 10.1073/pnas.1117783109; Dalal K, 2009, J BIOL CHEM, V284, P7897, DOI 10.1074/jbc.M808305200; Damodaran S, 2012, LANGMUIR, V28, P9475, DOI 10.1021/la300953n; DRIESSEN AJM, 1988, BIOCHEMISTRY-US, V27, P865, DOI 10.1021/bi00403a005; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Inagaki S, 2012, J MOL BIOL, V417, P95, DOI 10.1016/j.jmb.2012.01.023; Ishmukhametov R, 2010, EMBO J, V29, P3911, DOI 10.1038/emboj.2010.259; Karasawa A, 2011, J BIOL CHEM, V286, P37280, DOI 10.1074/jbc.M111.284059; Kawai T, 2011, FEBS LETT, V585, P3533, DOI 10.1016/j.febslet.2011.10.015; Keates RAB, 2010, BIOCHEMISTRY-US, V49, P8847, DOI 10.1021/bi101281f; Li MS, 2011, P NATL ACAD SCI USA, V108, P9390, DOI 10.1073/pnas.1104824108; Mahmood NABN, 2006, J BIOL CHEM, V281, P29830, DOI 10.1074/jbc.M604907200; Marsh D, 2007, BIOPHYS J, V93, P3884, DOI 10.1529/biophysj.107.107938; Mors K, 2013, BBA-BIOMEMBRANES, V1828, P1222, DOI 10.1016/j.bbamem.2012.12.011; Nicklisch SCT, 2012, BBA-BIOMEMBRANES, V1818, P359, DOI 10.1016/j.bbamem.2011.10.021; Parsegian VA, 2000, P NATL ACAD SCI USA, V97, P3987, DOI 10.1073/pnas.97.8.3987; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Perez C, 2011, EMBO J, V30, P1221, DOI 10.1038/emboj.2011.46; Racher KI, 2001, BIOCHEMISTRY-US, V40, P7324, DOI 10.1021/bi002331u; Ranaghan MJ, 2011, J AM CHEM SOC, V133, P18318, DOI 10.1021/ja2070957; Reid C, 1997, BIOPHYS J, V72, P1022, DOI 10.1016/S0006-3495(97)78754-X; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Ritchie TK, 2011, J BIOL CHEM, V286, P39489, DOI 10.1074/jbc.M111.284554; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; SHAPIRO AB, 1995, J BIOL CHEM, V270, P16167, DOI 10.1074/jbc.270.27.16167; Shaw AW, 2007, J BIOL CHEM, V282, P6556, DOI 10.1074/jbc.M607973200; Spitzer JJ, 2005, TRENDS BIOCHEM SCI, V30, P536, DOI 10.1016/j.tibs.2005.08.002; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; Tsatskis Y, 2005, J BIOL CHEM, V280, P41387, DOI 10.1074/jbc.M508362200; van der Heide T, 2001, EMBO J, V20, P7022, DOI 10.1093/emboj/20.24.7022; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wolters JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010361; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Ziegler C, 2010, MOL MICROBIOL, V78, P13, DOI 10.1111/j.1365-2958.2010.07332.x	50	22	22	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29862	29871		10.1074/jbc.M113.499327	http://dx.doi.org/10.1074/jbc.M113.499327			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979139	hybrid, Green Published			2022-12-28	WOS:000330615300059
J	Nolan, M; Bouldin, SD; Bock, PE				Nolan, Miranda; Bouldin, Samantha D.; Bock, Paul E.			Full Time Course Kinetics of the Streptokinase-Plasminogen Activation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; ACTIVE-SITE; M-PROTEIN; CONFORMATIONAL ACTIVATION; AFFINITY-CHROMATOGRAPHY; CATALYZED ACTIVATION; ZYMOGEN ACTIVATION; COMPLEX-FORMATION; HUMAN-FIBRINOGEN; HUMAN-PLASMA	Our previously hypothesized mechanism for the pathway of plasminogen (Pg) activation by streptokinase (SK) was tested by the use of full time course kinetics. Three discontinuous chromogenic substrate initial rate assays were developed with different quenching conditions that enabled quantitation of the time courses of Pg depletion, plasmin (Pm) formation, transient formation of the conformationally activated SK.Pg* catalytic complex intermediate, formation of the SK.Pm catalytic complex, and the free concentrations of Pg, Pm, and SK. Analysis of full time courses of Pg activation by five concentrations of SK along with activity-based titrations of SK.Pg* and SK.Pm formation yielded rate and dissociation constants within 2-fold of those determined previously by continuous measurement of parabolic chromogenic substrate hydrolysis and fluorescence-based equilibrium binding. The results obtained with orthogonal assays provide independent support for a mechanism in which the conformationally activated SK.Pg* complex catalyzes an initial cycle of Pg proteolytic conversion to Pm that acts as a trigger. Higher affinity binding of the formed Pm to SK outcompetes Pg binding, terminating the trigger cycle and initiating the bullet catalytic cycle by the SK.Pm complex that converts the residual Pg into Pm. The new assays can be adapted to quantitate SK-Pg activation in the context of SK-or Pg-directed inhibitors, effectors, and SK allelic variants. To support this, we show for the first time with an assay specific for SK.Pg* that fibrinogen forms a ternary SK.Pg*.fibrinogen complex, which assembles with 200-fold enhanced SK.Pg* affinity, signaled by a perturbation of the SK.Pg* active site.	[Nolan, Miranda; Bouldin, Samantha D.; Bock, Paul E.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University	Bock, PE (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, C3321A Med Ctr North, Nashville, TN 37232 USA.	paul.bock@vanderbilt.edu			National Institutes of Health, NLHBI [RO1 HL056181]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056181] Funding Source: NIH RePORTER	National Institutes of Health, NLHBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NLHBI, Grant RO1 HL056181 (to P.E.B.).	ALKJAERSIG N, 1959, J BIOL CHEM, V234, P832; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bock PE, 1996, J BIOL CHEM, V271, P1072, DOI 10.1074/jbc.271.2.1072; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; CEDERHOLMWILLIAMS SA, 1979, EUR J BIOCHEM, V100, P125, DOI 10.1111/j.1432-1033.1979.tb02040.x; Chaudhary A, 1999, PROTEIN SCI, V8, P2791; CHIBBER BAK, 1985, BIOCHEMISTRY-US, V24, P3429, DOI 10.1021/bi00335a006; Cook SM, 2012, MOL MICROBIOL, V86, P1052, DOI 10.1111/mmi.12037; DAMASCHUN G, 1992, EUR BIOPHYS J BIOPHY, V20, P355; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Dhar J, 2002, J BIOL CHEM, V277, P13257, DOI 10.1074/jbc.M108422200; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Hess JL, 2006, PROTEOMICS, V6, P375, DOI 10.1002/pmic.200500189; HOGG PJ, 1990, J BIOL CHEM, V265, P241; JACKSON KW, 1982, BIOCHEMISTRY-US, V21, P6620, DOI 10.1021/bi00269a001; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Joshi KK, 2012, BBA-PROTEINS PROTEOM, V1824, P326, DOI 10.1016/j.bbapap.2011.10.010; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; LIJNEN HR, 1991, J BIOL CHEM, V266, P11826; Lin LF, 2000, BIOCHEMISTRY-US, V39, P4740, DOI 10.1021/bi992028x; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P539, DOI 10.1016/0167-4838(83)90272-8; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; McNamara C, 2008, SCIENCE, V319, P1405, DOI 10.1126/science.1154470; MOROI M, 1976, J BIOL CHEM, V251, P5956; NASKI MC, 1991, J BIOL CHEM, V266, P13003; NIEUWENHUIZEN W, 1989, THROMB HAEMOSTASIS, V61, P208; Panizzi P, 2006, J BIOL CHEM, V281, P26774, DOI 10.1074/jbc.C600171200; PHILLIPS GN, 1981, P NATL ACAD SCI-BIOL, V78, P4689, DOI 10.1073/pnas.78.8.4689; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2006, J BIOL CHEM, V281, P25965, DOI 10.1074/jbc.M603846200; SJOHOLM I, 1973, EUR J BIOCHEM, V39, P471, DOI 10.1111/j.1432-1033.1973.tb03146.x; STRICKLAND DK, 1982, BIOCHEMISTRY-US, V21, P721, DOI 10.1021/bi00533a021; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; TAKADA A, 1985, THROMB RES, V37, P465, DOI 10.1016/0049-3848(85)90075-1; TAKADA Y, 1989, THROMB RES, V53, P409, DOI 10.1016/0049-3848(89)90320-4; Tharp AC, 2009, J BIOL CHEM, V284, P19511, DOI 10.1074/jbc.M109.005512; Timoney JF, 2004, VET RES, V35, P397, DOI 10.1051/vetres:2004025; Verhamme IM, 2008, J BIOL CHEM, V283, P26137, DOI 10.1074/jbc.M804038200; VIOLAND BN, 1976, J BIOL CHEM, V251, P3906; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; WANG H, 1995, MICROB PATHOGENESIS, V18, P153, DOI 10.1016/S0882-4010(95)90013-6; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; WIMAN B, 1977, EUR J BIOCHEM, V78, P19, DOI 10.1111/j.1432-1033.1977.tb11709.x; WOHL RC, 1980, J BIOL CHEM, V255, P2005; WOHL RC, 1978, J BIOL CHEM, V253, P1402; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	62	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29482	29493		10.1074/jbc.M113.477935	http://dx.doi.org/10.1074/jbc.M113.477935			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23970549	Green Published, hybrid			2022-12-28	WOS:000330615300025
J	Shang, BZ; Chang, R; Chu, JW				Shang, Barry Z.; Chang, Rakwoo; Chu, Jhih-Wei			Systems-level Modeling with Molecular Resolution Elucidates the Rate-limiting Mechanisms of Cellulose Decomposition by Cellobiohydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellulase; Computational Biology; Enzyme Inactivation; Enzyme Kinetics; Macromolecular Crowding; Molecular Modeling; Systems Biology; Interfacial Biocatalysis; Spatiotemporal Modeling	TRICHODERMA-REESEI CELLOBIOHYDROLASE; ENZYMATIC-HYDROLYSIS; BINDING DOMAIN; TRAFFIC JAMS; KINETICS; ADSORPTION; SURFACE; ENDOGLUCANASE; SIMULATIONS; DEGRADATION	Interprotein and enzyme-substrate couplings in interfacial biocatalysis induce spatial correlations beyond the capabilities of classical mass-action principles in modeling reaction kinetics. To understand the impact of spatial constraints on enzyme kinetics, we developed a computational scheme to simulate the reaction network of enzymes with the structures of individual proteins and substrate molecules explicitly resolved in the three-dimensional space. This methodology was applied to elucidate the rate-limiting mechanisms of crystalline cellulose decomposition by cellobiohydrolases. We illustrate that the primary bottlenecks are slow complexation of glucan chains into the enzyme active site and excessive enzyme jamming along the crowded substrate. Jamming could be alleviated by increasing the decomplexation rate constant but at the expense of reduced processivity. We demonstrate that enhancing the apparent reaction rate required a subtle balance between accelerating the complexation driving force and simultaneously avoiding enzyme jamming. Via a spatiotemporal systems analysis, we developed a unified mechanistic framework that delineates the experimental conditions under which different sets of rate-limiting behaviors emerge. We found that optimization of the complexation-exchange kinetics is critical for overcoming the barriers imposed by interfacial confinement and accelerating the apparent rate of enzymatic cellulose decomposition.	[Shang, Barry Z.; Chu, Jhih-Wei] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Chang, Rakwoo] Kwangwoon Univ, Dept Chem, Seoul 139701, South Korea; [Chu, Jhih-Wei] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan; [Chu, Jhih-Wei] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu 300, Taiwan	University of California System; University of California Berkeley; Kwangwoon University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chu, JW (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan.	jwchu@nctu.edu.tw	Chang, Rakwoo/F-9909-2019; Chu, Jhih-Wei/M-2870-2013	Chu, Jhih-Wei/0000-0003-3842-2893	Office of Science of the United States Department of Energy [DE-AC02-05CH11231]	Office of Science of the United States Department of Energy(United States Department of Energy (DOE))	We acknowledge the computational resources provided by the National Energy Research Scientific Computing Center (NERSC), which is supported by the Office of Science of the United States Department of Energy under Contract DE-AC02-05CH11231.	Asztalos A, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-55; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Berry H, 2002, BIOPHYS J, V83, P1891, DOI 10.1016/S0006-3495(02)73953-2; Cao Y, 2005, J CHEM PHYS, V122, DOI [10.1063/1.1824902, 10.1063/1.1924598]; Chang R, 2012, J PHYS CHEM B, V116, P8074, DOI 10.1021/jp302974x; Chatterjee A, 2007, J COMPUT-AIDED MATER, V14, P253, DOI 10.1007/s10820-006-9042-9; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Gusakov AV, 2007, BIOTECHNOL BIOENG, V97, P1028, DOI 10.1002/bit.21329; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hong J, 2007, LANGMUIR, V23, P12535, DOI 10.1021/la7025686; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Imai T, 1998, FEBS LETT, V432, P113, DOI 10.1016/S0014-5793(98)00845-X; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Leduc C, 2012, P NATL ACAD SCI USA, V109, P6100, DOI 10.1073/pnas.1107281109; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Levine SE, 2011, BIOTECHNOL BIOENG, V108, P2561, DOI 10.1002/bit.23249; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; Linder M, 1996, P NATL ACAD SCI USA, V93, P12251, DOI 10.1073/pnas.93.22.12251; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Maurer SA, 2012, IND ENG CHEM RES, V51, P11389, DOI 10.1021/ie3008538; Maurer SA, 2012, LANGMUIR, V28, P14598, DOI 10.1021/la3024524; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Quirk A, 2010, LANGMUIR, V26, P5007, DOI 10.1021/la9037028; Smit B, 2008, CHEM REV, V108, P4125, DOI 10.1021/cr8002642; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; Valjamae P, 1998, EUR J BIOCHEM, V253, P469, DOI 10.1046/j.1432-1327.1998.2530469.x; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Wang QQ, 2012, BIOTECHNOL BIOENG, V109, P1965, DOI 10.1002/bit.24483; Warden AC, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-39; Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	46	31	31	0	46	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29081	29089		10.1074/jbc.M113.497412	http://dx.doi.org/10.1074/jbc.M113.497412			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23950182	Green Published, hybrid			2022-12-28	WOS:000330298800061
J	Yang, ZH; Tsuchiya, H; Zhang, YX; Hartnett, ME; Wang, L				Yang, Zhihong; Tsuchiya, Hiroyuki; Zhang, Yuxia; Hartnett, M. Elizabeth; Wang, Li			MicroRNA-433 Inhibits Liver Cancer Cell Migration by Repressing the Protein Expression and Function of cAMP Response Element-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Liver Cancer; MicroRNA; Post-translational Modification; Translation Regulation; HCC	SMALL HETERODIMER PARTNER; HEPATOCELLULAR-CARCINOMA; SHP INHIBITION; ERR-GAMMA; CREB; MIR-433; MIR-127; GROWTH; PROLIFERATION; ACTIVATION	We show for the first time that potent microRNA-433 (miR-433) inhibition of expression of the cAMP response element-binding protein CREB1 represses hepatocellular carcinoma (HCC) cell migration. We identified a miR-433 seed match region in human and mouse CREB1 3-UTRs. Overexpression of miR-433 markedly decreased human CREB1 3-UTR reporter activity, and the inhibitory effect of miR-433 was alleviated upon mutation of its binding site. Ectopic expression of miR-433 reduced CREB1 protein levels in a variety of human and mouse cancer cells, including HeLa, Hepa1, Huh7, and HepG2. Human CREB1 protein levels in highly invasive MHCC97H cells were diminished by expression of miR-433 but were induced by miR-433 antagomir (anti-miR-433). The expression of mouse CREB1 protein negatively correlated with miR-433 levels in nuclear receptor Shp(-/-) liver tissues and liver tumors compared with wild-type mice. miR-433 exhibited a significant repression of MHCC97H cell migration, which was reversed by anti-miR-433. Overexpressing miR-433 inhibited focus formation dramatically, demonstrating that miR-433 may exert a tumor suppressor function. Knockdown of CREB1 by siRNAs impeded MHCC97H cell migration and invasion and antagonized the effect of anti-miR-433. Interestingly, CREB1 siRNA decreased MHCC97H cell proliferation, which was not influenced by anti-miR-433. Overexpressing CREB1 decreased the inhibitory activity of miR-433. The CpG islands surrounding miR-433 were hypermethylated, and the DNA methylation agent 5-aza-2-deoxycytidine, but not the histone deacetylase inhibitor trichostatin A, drastically stimulated the expression of miR-433 and miR-127 in HCC cells. The latter is clustered with miR-433. The results reveal a critical role of miR-433 in mediating HCC cell migration via CREB1.	[Yang, Zhihong; Tsuchiya, Hiroyuki; Zhang, Yuxia; Wang, Li] Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84132 USA; [Yang, Zhihong; Tsuchiya, Hiroyuki; Zhang, Yuxia; Wang, Li] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84132 USA; [Yang, Zhihong; Hartnett, M. Elizabeth] Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Wang, L (corresponding author), Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84132 USA.	l.wang@hsc.utah.edu			National Institutes of Health [P30 CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY014800, R01EY017011, R01EY015130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge the use of core facilities (Cell Imaging Core) supported by National Institutes of Health Grant P30 CA042014 to the Huntsman Cancer Institute.	Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; De Cesare D, 1999, TRENDS BIOCHEM SCI, V24, P281, DOI 10.1016/S0968-0004(99)01414-0; Estep M, 2010, ALIMENT PHARM THER, V32, P487, DOI 10.1111/j.1365-2036.2010.04366.x; Fimia GM, 1999, NATURE, V398, P165, DOI 10.1038/18237; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kovach SJ, 2006, J CELL PHYSIOL, V206, P411, DOI 10.1002/jcp.20474; Lin X, 2013, LEUKEMIA, V27, P344, DOI 10.1038/leu.2012.224; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Pigazzi M, 2009, CANCER RES, V69, P2471, DOI 10.1158/0008-5472.CAN-08-3404; Simon D, 2010, HUM MOL GENET, V19, P2015, DOI 10.1093/hmg/ddq083; Siu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006880; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Song GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003574; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang W, 2012, WORLD J GASTROENTERO, V18, P5442, DOI 10.3748/wjg.v18.i38.5442; Yang ZH, 2012, BIOCHEM BIOPH RES CO, V417, P744, DOI 10.1016/j.bbrc.2011.12.027; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhang YX, 2011, BIOCHEM BIOPH RES CO, V416, P135, DOI 10.1016/j.bbrc.2011.11.011; Zhang YX, 2011, J BIOL CHEM, V286, P29635, DOI 10.1074/jbc.M111.253039; Zhang YX, 2011, FEBS LETT, V585, P1269, DOI 10.1016/j.febslet.2011.03.059; Zhou TF, 2010, J BIOL CHEM, V285, P24871, DOI 10.1074/jbc.M110.133280	28	82	89	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28893	28899		10.1074/jbc.M113.502682	http://dx.doi.org/10.1074/jbc.M113.502682			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23979134	hybrid, Green Published			2022-12-28	WOS:000330298800041
J	Zhan, XZ; Kaoud, TS; Kook, S; Dalby, KN; Gurevich, VV				Zhan, Xuanzhi; Kaoud, Tamer S.; Kook, Seunghyi; Dalby, Kevin N.; Gurevich, Vsevolod V.			JNK3 Enzyme Binding to Arrestin-3 Differentially Affects the Recruitment of Upstream Mitogen-activated Protein (MAP) Kinase Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Cell Signaling; Jun N-terminal Kinase (JNK); MAP Kinases (MAPKs); Protein Kinases; Protein Phosphorylation	CRYSTAL-STRUCTURE; SCAFFOLD PROTEINS; SIGNAL-TRANSDUCTION; BETA-ARRESTIN; RECEPTOR-BINDING; CLATHRIN ADAPTER; CONE ARRESTIN; MKK7; EXPRESSION; IDENTIFICATION	Arrestin-3 was previously shown to bind JNK32, MKK4, and ASK1. However, full JNK32 activation requires phosphorylation by both MKK4 and MKK7. Using purified proteins we show that arrestin-3 directly interacts with MKK7 and promotes JNK32 phosphorylation by both MKK4 and MKK7 in vitro as well as in intact cells. The binding of JNK32 promotes an arrestin-3 interaction with MKK4 while reducing its binding to MKK7. Interestingly, the arrestin-3 concentration optimal for scaffolding the MKK7-JNK32 module is approximate to 10-fold higher than for the MKK4-JNK32 module. The data provide a mechanistic basis for arrestin-3-dependent activation of JNK32. The opposite effects of JNK32 on arrestin-3 interactions with MKK4 and MKK7 is the first demonstration that the kinase components in mammalian MAPK cascades regulate each other's interactions with a scaffold protein. The results show how signaling outcomes can be affected by the relative expression of scaffolding proteins and components of signaling cascades that they assemble.	[Zhan, Xuanzhi; Kook, Seunghyi; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Kaoud, Tamer S.; Dalby, Kevin N.] Univ Texas Austin, Div Med Chem, Austin, TX 78712 USA	Vanderbilt University; University of Texas System; University of Texas Austin	Gurevich, VV (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Kaoud, Tamer S/C-3618-2019; Dalby, Kevin N/A-1905-2013; Gurevich, Vsevolod/A-3236-2008	Kaoud, Tamer S/0000-0003-1298-8725; Dalby, Kevin N/0000-0001-9272-5129; Gurevich, Vsevolod/0000-0002-3950-5351	National Institutes of Health [EY011500, GM077561, GM081756, GM059802, CA167505]; Welch Foundation [F-1390]; NATIONAL CANCER INSTITUTE [R21CA167505] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059802, R01GM077561, R01GM081756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY011500, GM077561, and GM081756 (to V. V. G.) and GM059802 and CA167505 (to K. N. D.). This work was also supported by the Welch Foundation (F-1390; to K. N. D.).	Ahmed MR, 2011, BIOCHEMISTRY-US, V50, P3749, DOI 10.1021/bi200175q; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Bray D, 1997, P NATL ACAD SCI USA, V94, P13493, DOI 10.1073/pnas.94.25.13493; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; Coffa S, 2011, BIOCHEMISTRY-US, V50, P6951, DOI 10.1021/bi200745k; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Ferrell J E Jr, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.52.pe1; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 2003, STRUCTURE, V11, P1037, DOI 10.1016/S0969-2126(03)00184-9; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Johnson GL, 2011, ACS CHEM BIOL, V6, P18, DOI 10.1021/cb100384z; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Levchenko A., 2004, Systems Biology, V1, P139, DOI 10.1049/sb:20045014; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lisnock J, 2000, BIOCHEMISTRY-US, V39, P3141, DOI 10.1021/bi992410+; Locasale JW, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000099; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schattauer SS, 2012, J BIOL CHEM, V287, P41595, DOI 10.1074/jbc.M112.381368; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Schubert C, 1999, J BIOL CHEM, V274, P21186, DOI 10.1074/jbc.274.30.21186; Seo J, 2011, J BIOL CHEM, V286, P27894, DOI 10.1074/jbc.M111.260448; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2007, J NEUROCHEM, V103, P1053, DOI 10.1111/j.1471-4159.2007.04842.x; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Waetzig V, 2005, TRENDS PHARMACOL SCI, V26, P455, DOI 10.1016/j.tips.2005.07.006; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yamasaki T., 2012, J SIGNAL TRANSDUCT, V2012; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110; Zou HY, 2007, FEBS LETT, V581, P196, DOI 10.1016/j.febslet.2006.12.012	74	27	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28535	28547		10.1074/jbc.M113.508085	http://dx.doi.org/10.1074/jbc.M113.508085			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23960075	Green Published, hybrid			2022-12-28	WOS:000330298800011
J	Zou, HF; Lai, YM; Zhao, XW; Yan, GH; Ma, DZ; Cardenes, N; Shiva, S; Liu, YJ; Bai, XC; Jiang, Y; Jiang, Y				Zou, Huafei; Lai, Yumei; Zhao, Xuwen; Yan, Gonghong; Ma, Dongzhu; Cardenes, Nayra; Shiva, Sruti; Liu, Yongjian; Bai, Xiaochun; Jiang, Yong; Jiang, Yu			Regulation of Mammalian Target of Rapamycin Complex 1 by Bcl-2 and Bcl-X-L Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bcl-2; Mitochondria; mTOR Complex (mTORC); S6 Kinase; Signaling; Bcl-XL; FKBP38; mTORC1	APOPTOSIS; MTOR; EXPRESSION; INHIBITOR; SURVIVAL; FAMILY; POTENT; FKBP38; BAX	Mammalian target of rapamycin complex 1 (mTORC1) is a key regulator of cell growth and metabolism. Its activity is controlled by various types of signals, including growth factors, nutrients, and stresses. In this study, we show that changes in expression levels of two antiapoptotic proteins, Bcl-2 and Bcl-X-L, also affect mTORC1 signaling activity. In cells overexpressing Bcl-X-L, mTORC1 activity is increased and becomes less sensitive to growth factor or nutrient conditions. In contrast, reduction in expression levels of the two antiapoptotic proteins inhibits mTORC1 signaling activity. Our results suggest that the effect of Bcl-2 and Bcl-X-L on mTORC1 is mediated by FKBP38, an inhibitor of mTORC1. The two proteins compete with mTORC1 for FKBP38 binding and hence alter mTORC1 activity. This study reveals a novel cross-talk between Bcl-2/X-L and mTORC1 signaling, which is likely to contribute to cancer development.	[Zou, Huafei; Lai, Yumei; Yan, Gonghong; Ma, Dongzhu; Cardenes, Nayra; Shiva, Sruti; Liu, Yongjian; Jiang, Yu] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Cardenes, Nayra; Shiva, Sruti] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA 15261 USA; [Zhao, Xuwen; Jiang, Yong] Southern Med Univ, Dept Pathol, Sch Basic Med Sci, Guangzhou 510515, Guangdong, Peoples R China; [Bai, Xiaochun] Southern Med Univ, Dept Cell Biol, Sch Basic Med Sci, Guangzhou 510515, Guangdong, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Southern Medical University - China; Southern Medical University - China	Jiang, Y (corresponding author), Southern Med Univ, Dept Pathol, Sch Basic Med Sci, Guangzhou 510515, Guangdong, Peoples R China.	jiang48321@163.com; yuj5@pitt.edu	Liu, Yongjian/J-7852-2018	Bai, Xiaochun/0000-0001-9631-4781	National Institutes of Health [CA129821, CA169186]; National Key Basic Research (973) Program of China [2010CB529704]; NSFC [81030055, 81272269]; PCSIRT [IRT0731]; NATIONAL CANCER INSTITUTE [R21CA169186, R01CA129821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Key Basic Research (973) Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants (CA129821 and CA169186 (to Yu Jiang)). This work was also supported by National Key Basic Research (973) Program of China 2010CB529704, NSFC Grant 81030055 and PCSIRT Grant IRT0731 (to Yong Jiang) and NSFC Grant 81272269 (to Yu Jiang).	Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Bai XC, 2010, CELL MOL LIFE SCI, V67, P239, DOI 10.1007/s00018-009-0163-7; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; Fiebig AA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-213; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jiang M, 2003, GENE DEV, V17, P832, DOI 10.1101/gad.252603; Kang CB, 2005, FEBS LETT, V579, P1469, DOI 10.1016/j.febslet.2005.01.053; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ma DZ, 2010, J BIOL CHEM, V285, P8621, DOI 10.1074/jbc.M109.092353; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Sakai Y, 2009, PROSTATE, V69, P459, DOI 10.1002/pros.20888; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Uhlmann EJ, 1998, J BIOL CHEM, V273, P17926, DOI 10.1074/jbc.273.28.17926; Wang NS, 2001, J BIOL CHEM, V276, P44117, DOI 10.1074/jbc.M101958200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	20	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28824	28830		10.1074/jbc.M113.505370	http://dx.doi.org/10.1074/jbc.M113.505370			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23960074	Green Published, hybrid			2022-12-28	WOS:000330298800035
J	Dong, ZZ; Qi, J; Peng, H; Liu, JG; Zhang, JT				Dong, Zizheng; Qi, Jing; Peng, Hui; Liu, Jianguo; Zhang, Jian-Ting			Spectrin Domain of Eukaryotic Initiation Factor 3a Is the Docking Site for Formation of the a:b:i:g Subcomplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR EIF3; TRANSLATIONAL CONTROL; CELL-GROWTH; PROTEIN; EXPRESSION; CARCINOMA; CANCER; P170; OVEREXPRESSION; IDENTIFICATION	eIF3a (eukaryotic translation initiation factor 3a), one of the core subunits of the eIF3 complex, has been implicated in regulating translation of different mRNAs and in tumorigenesis. A subcomplex consisting of eIF3a, eIF3b, eIF3g, and eIF3i (eIF3(a:b:i:g)) has also been identified. However, how eIF3a participates in translational regulation and in formation of the eIF3(a: b: i: g) subcomplex remain to be solved. In this study, we used the tandem affinity purification approach in combination with tandem MS/MS and identified the spectrin domain of eIF3a as the docking site for the formation of eIF3(a: b: i: g) subcomplex. Although eIF3b and eIF3i bind concurrently to the spectrin domain of eIF3a within similar to 10-15 amino acids apart, eIF3g binds to eIF3a indirectly via binding to the carboxyl-terminal domain of eIF3b. The binding of eIF3b to the spectrin domain of eIF3a occurs in its RNA recognition motif domain where eIF3j also binds in a mutually exclusive manner. Together, we conclude that the spectrin domain of eIF3a is responsible for the formation of eIF3(a: b: i: g) subcomplex and, because of mutually exclusive nature of bindings of eIF3a and eIF3j to eIF3b, different subcomplexes of eIF3 likely exist and may perform noncanonical functions in translational regulation.	Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhang, JT (corresponding author), IUSCC, R3-C570,980 W Walnut St, Indianapolis, IN 46202 USA.	jianzhan@iupui.edu	Zhang, Jian-Ting/L-8334-2015	Zhang, Jian-Ting/0000-0002-2803-9914	National Institutes of Heath [R01 CA94961]; Indiana Clinical and Translational Sciences Institute; NATIONAL CANCER INSTITUTE [R01CA094961] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529] Funding Source: NIH RePORTER	National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Clinical and Translational Sciences Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the National Institutes of Heath Grant R01 CA94961 (to J.-T. Z.) and by the Indiana Clinical and Translational Sciences Institute.	Bachmann F, 1997, CANCER RES, V57, P988; Chen GP, 2004, INT J CANCER, V112, P393, DOI 10.1002/ijc.20443; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Dong ZZ, 2005, MOL CELL PROTEOMICS, V4, P993, DOI 10.1074/mcp.M500044-MCP200; Dong ZZ, 2004, ONCOGENE, V23, P3790, DOI 10.1038/sj.onc.1207465; Dong ZZ, 2003, MOL BIOL CELL, V14, P3942, DOI 10.1091/mbc.E02-12-0784; ElAntak L, 2007, J BIOL CHEM, V282, P8165, DOI 10.1074/jbc.M610860200; Han BG, 2002, MOL CELL BIOL, V22, P7372, DOI 10.1128/MCB.22.21.7372-7384.2002; HEYWOOD SM, 1974, P NATL ACAD SCI USA, V71, P2428, DOI 10.1073/pnas.71.6.2428; Liu RY, 2011, ONCOGENE, V30, P4814, DOI 10.1038/onc.2011.189; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Methot N, 1997, J BIOL CHEM, V272, P1110, DOI 10.1074/jbc.272.2.1110; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Pincheira R, 2001, BRIT J CANCER, V84, P1520, DOI 10.1054/bjoc.2001.1828; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Xu JK, 2007, CANCER RES, V67, P4373, DOI 10.1158/0008-5472.CAN-06-3169; Yang YY, 2012, J PROTEOME RES, V11, P1364, DOI 10.1021/pr201003g; Yin JY, 2013, CARCINOGENESIS, V34, P1224, DOI 10.1093/carcin/bgt052; Yin JY, 2011, CLIN CANCER RES, V17, P4600, DOI 10.1158/1078-0432.CCR-10-2591; Yin JY, 2011, BIOSCIENCE REP, V31, P1, DOI 10.1042/BSR20100077; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	27	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27951	27959		10.1074/jbc.M113.483164	http://dx.doi.org/10.1074/jbc.M113.483164			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23921387	Green Published, hybrid			2022-12-28	WOS:000330612800022
J	Garcia-Alonso, V; Lopez-Vicario, C; Titos, E; Moran-Salvador, E; Gonzalez-Periz, A; Rius, B; Parrizas, M; Werz, O; Arroyo, V; Claria, J				Garcia-Alonso, Veronica; Lopez-Vicario, Cristina; Titos, Esther; Moran-Salvador, Eva; Gonzalez-Periz, Ana; Rius, Bibiana; Parrizas, Marcelina; Werz, Oliver; Arroyo, Vicente; Claria, Joan			Coordinate Functional Regulation between Microsomal Prostaglandin E Synthase-1 (mPGES-1) and Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) in the Conversion of White-to-brown Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE INFLAMMATION; HIGH-FAT DIET; INSULIN-RESISTANCE; STEM-CELLS; DIFFERENTIATION; CYCLOOXYGENASE-2; OBESITY; 5-LIPOXYGENASE; PROTEIN; MICE	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-activated nuclear receptor and a master regulator of adipogenesis. Microsomal prostaglandin E (PGE) synthase-1 (mPGES-1) is an inducible enzyme that couples with cyclooxygenase-2 for the biosynthesis of PGE(2). In this study we demonstrate the existence of a coordinate functional interaction between PPAR gamma and mPGES-1 in controlling the process of preadipocyte differentiation in white adipose tissue (WAT). Adipocyte-specific PPAR gamma knock-out mice carrying an aP2 promoter-driven Cre recombinase transgene showed a blunted response to the adipogenic effects of a high fat diet. Pre-adipocytes from these knock-out mice showed loss of PPAR gamma and were resistant to rosiglitazone-induced WAT differentiation. In parallel, WAT from these mice showed increased expression of uncoupling protein 1, a mitochondrial enzyme that dissipates chemical energy as heat. Adipose tissue from mice lacking PPAR gamma also showed mPGES-1 up-regulation and increased PGE(2) levels. In turn, PGE(2) suppressed PPAR gamma expression and blocked rosiglitazone-induced pre-adipocyte differentiation toward white adipocytes while directly elevating uncoupling protein 1 expression and pre-adipocyte differentiation into mature beige/brite adipocytes. Consistently, pharmacological mPGES-1 inhibition directed pre-adipocyte differentiation toward white adipocytes while suppressing differentiation into beige/brite adipocytes. This browning effect was reproduced in knockdown experiments using a siRNA directed against mPGES-1. The effects of PGE(2) on pre-adipocyte differentiation were not seen in mice lacking PPAR gamma in adipose tissue and were not mirrored by other eicosanoids (i.e. leukotriene B-4). Taken together, these findings identify PGE(2) as a key regulator of white-to-brown adipogenesis and suggest the existence of a coordinate regulation of adipogenesis between PPAR gamma and mPGES-1.	[Garcia-Alonso, Veronica; Lopez-Vicario, Cristina; Titos, Esther; Moran-Salvador, Eva; Gonzalez-Periz, Ana; Rius, Bibiana; Claria, Joan] Hosp Clin Barcelona, Dept Biochem & Mol Genet, IDIBAPS, Esther Koplowitz Ctr, E-08036 Barcelona, Spain; [Titos, Esther; Gonzalez-Periz, Ana; Arroyo, Vicente; Claria, Joan] CIBERehd, Barcelona 08036, Spain; [Parrizas, Marcelina] CIBERdem, IDIBAPS, Diabet & Obes Lab, Barcelona 08036, Spain; [Werz, Oliver] Univ Jena, D-07743 Jena, Germany; [Arroyo, Vicente] Hosp Clin Barcelona, Liver Unit, IDIBAPS, Esther Koplowitz Ctr, E-08036 Barcelona, Spain; [Claria, Joan] Univ Barcelona, Dept Physiol Sci 1, E-08036 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Friedrich Schiller University of Jena; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Claria, J (corresponding author), Hosp Clin Barcelona, Dept Biochem & Mol Genet, Villarroel 170, E-08036 Barcelona, Spain.	jclaria@clinic.ub.es	Parrizas, Marcelina/AAS-3629-2021; Titos, Esther/AAA-5394-2019; Claria, Joan/M-7772-2019; Arroyo, Vicente/F-9189-2015	Titos, Esther/0000-0002-2543-2243; Arroyo, Vicente/0000-0002-2728-1848; Lopez-Vicario, Cristina/0000-0002-6609-8501; Claria, Joan/0000-0003-4333-7749; Parrizas, Marcelina/0000-0003-1296-8302	Instituto de Salud Carlos III; Generalitat de Catalunya [2009SGR1484]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya)	CIBERehd is funded by the Instituto de Salud Carlos III. Our laboratory is a Consolidated Research Group recognized by the Generalitat de Catalunya (Grant 2009SGR1484).	Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; CHATZIPANTELI K, 1992, DIABETES, V41, P927, DOI 10.2337/diabetes.41.8.927; Chu XQ, 2009, BBA-MOL CELL BIOL L, V1791, P273, DOI 10.1016/j.bbalip.2009.01.022; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Ghoshal S, 2011, J BIOL CHEM, V286, P889, DOI 10.1074/jbc.M110.139139; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Horrillo R, 2010, J IMMUNOL, V184, P3978, DOI 10.4049/jimmunol.0901355; Huang ZF, 2000, BIOCHEM PHARMACOL, V59, P187, DOI 10.1016/S0006-2952(99)00312-3; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kapoor M, 2007, J BIOL CHEM, V282, P5356, DOI 10.1074/jbc.M610153200; Karg EM, 2009, J MED CHEM, V52, P3474, DOI 10.1021/jm900212y; Koeberle A, 2009, BIOORGAN MED CHEM, V17, P7924, DOI 10.1016/j.bmc.2009.10.025; Koppen A, 2010, FEBS LETT, V584, P3250, DOI 10.1016/j.febslet.2010.06.035; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; OBrien SN, 1996, ANAL QUANT CYTOL, V18, P137; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Romano M, 2003, FASEB J, V17, P1986, DOI 10.1096/fj.03-0053rev; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Santos SHS, 2012, REGUL PEPTIDES, V178, P64, DOI 10.1016/j.regpep.2012.06.009; Scott MA, 2011, STEM CELLS DEV, V20, P1793, DOI 10.1089/scd.2011.0040; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shan TZ, 2013, FASEB J, V27, P277, DOI 10.1096/fj.12-211516; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Tsuboi H, 2004, BIOCHEM BIOPH RES CO, V322, P1066, DOI 10.1016/j.bbrc.2004.08.018; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Waclawik A, 2009, ENDOCRINOLOGY, V150, P3823, DOI 10.1210/en.2008-1499; WILLOUGHBY DA, 1993, J LIPID MEDIATOR, V6, P287; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	42	57	58	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28230	28242		10.1074/jbc.M113.468603	http://dx.doi.org/10.1074/jbc.M113.468603			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23943621	Green Published, hybrid			2022-12-28	WOS:000330612800045
J	Dick, G; Tan, CL; Alves, JN; Ehlert, EME; Miller, GM; Hsieh-Wilson, LC; Sugahara, K; Oosterhof, A; van Kuppevelt, TH; Verhaagen, J; Fawcett, JW; Kwok, JCF				Dick, Gunnar; Tan, Chin Lik; Alves, Joao Nuno; Ehlert, Erich M. E.; Miller, Gregory M.; Hsieh-Wilson, Linda C.; Sugahara, Kazuyuki; Oosterhof, Arie; van Kuppevelt, Toin H.; Verhaagen, Joost; Fawcett, James W.; Kwok, Jessica C. F.			Semaphorin 3A Binds to the Perineuronal Nets via Chondroitin Sulfate Type E Motifs in Rodent Brains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT NERVOUS-SYSTEM; EXTRACELLULAR-MATRIX; AXON GUIDANCE; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; HEPARAN-SULFATE; SPINAL-CORD; RAT-BRAIN; PROTEOGLYCANS; RECEPTOR	Chondroitin sulfate (CS) and the CS-rich extracellular matrix structures called perineuronal nets (PNNs) restrict plasticity and regeneration in the CNS. Plasticity is enhanced by chondroitinase ABC treatment that removes CS from its core protein in the chondroitin sulfate proteoglycans or by preventing the formation of PNNs, suggesting that chondroitin sulfate proteoglycans in the PNNs control plasticity. Recently, we have shown that semaphorin3A (Sema3A), a repulsive axon guidance molecule, localizes to the PNNs and is removed by chondroitinase ABC treatment (Vo, T., Carulli, D., Ehlert, E. M., Kwok, J. C., Dick, G., Mecollari, V., Moloney, E. B., Neufeld, G., de Winter, F., Fawcett, J. W., and Verhaagen, J. (2013) Mol. Cell. Neurosci. 56C, 186-200). Sema3A is therefore a candidate for a PNN effector in controlling plasticity. Here, we characterize the interaction of Sema3A with CS of the PNNs. Recombinant Sema3A interacts with CS type E (CS-E), and this interaction is involved in the binding of Sema3A to rat brain-derived PNN glycosaminoglycans, as demonstrated by the use of CS-E blocking antibody GD3G7. In addition, we investigate the release of endogenous Sema3A from rat brain by biochemical and enzymatic extractions. Our results confirm the interaction of Sema3A with CS-E containing glycosaminoglycans in the dense extracellular matrix of rat brain. We also demonstrate that the combination of Sema3A and PNN GAGs is a potent inhibitor of axon growth, and this inhibition is reduced by the CS-E blocking antibody. In conclusion, Sema3A binding to CS-E in the PNNs may be a mechanism whereby PNNs restrict growth and plasticity and may represent a possible point of intervention to facilitate neuronal plasticity.	[Dick, Gunnar; Tan, Chin Lik; Alves, Joao Nuno; Fawcett, James W.; Kwok, Jessica C. F.] Univ Cambridge, John van Geest Ctr Brain Repair, Cambridge CB2 0PY, England; [Dick, Gunnar] Univ Oslo, Fac Math & Nat Sci, Dept Biosci, N-0316 Oslo, Norway; [Ehlert, Erich M. E.; Verhaagen, Joost] Inst Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [Miller, Gregory M.; Hsieh-Wilson, Linda C.] CALTECH, Pasadena, CA 91125 USA; [Miller, Gregory M.; Hsieh-Wilson, Linda C.] CALTECH, Howard Hughes Med Inst, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Sugahara, Kazuyuki] Hokkaido Univ, Lab Proteoglycan Signaling & Therapeut, Grad Sch Life Sci, Fac Adv Life Sci, Sapporo, Hokkaido 0010021, Japan; [Oosterhof, Arie; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Verhaagen, Joost] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, NL-1081 HV Amsterdam, Netherlands	University of Cambridge; University of Oslo; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Hokkaido University; Radboud University Nijmegen; Vrije Universiteit Amsterdam	Kwok, JCF (corresponding author), Univ Cambridge, John van Geest Ctr Brain Repair, Forvie Site,Robinson Way, Cambridge CB2 0PY, England.	jcfk2@cam.ac.uk	Kwok, Jessica/A-6740-2013; van Kuppevelt, A.H.M.S.M./L-4463-2015; Verhaagen, Joost/G-4773-2012	Kwok, Jessica/0000-0002-9798-9083; Dick, Gunnar/0000-0003-4529-5239; Fawcett, James/0000-0002-7990-4568; Tan, Chin Lik/0000-0002-3877-7347	National Institutes of Health [R01 GM093627]; Christopher and Dana Reeve Foundation; Wings for Life; European Union; Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [24110501]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Christopher and Dana Reeve Foundation; Wings for Life; European Union(European Commission); Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM093627 (to L. H. W.). This work was also supported by The Christopher and Dana Reeve Foundation (to J. W. F. and L. H. W.), Wings for Life (to J. C. F. K.), European Union FP7 Programme AxRegen, and Grants-in-aid for Scientific Research on Innovative Areas 24110501 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (to K. S.).	Achur RN, 2004, BBA-PROTEINS PROTEOM, V1701, P109, DOI 10.1016/j.bbapap.2004.06.007; Bao XF, 2004, J BIOL CHEM, V279, P9765, DOI 10.1074/jbc.M310877200; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Ben-Zvi A, 2006, J NEUROCHEM, V96, P585, DOI 10.1111/j.1471-4159.2005.03580.x; Blackhall FH, 2003, BIOCHEM J, V375, P131, DOI 10.1042/BJ20030730; Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x; Bruckner G, 1996, J NEUROCYTOL, V25, P333, DOI 10.1007/BF02284806; Carulli D, 2007, J COMP NEUROL, V501, P83, DOI 10.1002/cne.21231; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; CELIO MR, 1994, BRAIN RES REV, V19, P128, DOI 10.1016/0165-0173(94)90006-X; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; De Wit J, 2005, MOL CELL NEUROSCI, V29, P40, DOI 10.1016/j.mcn.2004.12.009; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; de Wit J, 2009, J NEUROSCI, V29, P23, DOI 10.1523/JNEUROSCI.3931-08.2009; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Galtrey CM, 2007, BRAIN, V130, P926, DOI 10.1093/brain/awl372; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Giger RJ, 1998, J NEUROSCI RES, V52, P27, DOI 10.1002/(SICI)1097-4547(19980401)52:1<27::AID-JNR4>3.0.CO;2-M; Harris NG, 2013, J NEUROTRAUM, V30, P1257, DOI 10.1089/neu.2012.2737; HARTIG W, 1994, BRAIN RES, V635, P307, DOI 10.1016/0006-8993(94)91452-4; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kwok J. C. F., 2013, NEUROMETHODS EXTRACE; Li C., 2009, FRONT NEURAL CIRCUIT, DOI [10.3389/neuro.04.011.2009, DOI 10.3389/D0WNL0ADED]; Manns RPC, 2012, J NEUROSCI, V32, P8554, DOI 10.1523/JNEUROSCI.5964-11.2012; Maroto M, 2013, J NEUROCHEM, V125, P205, DOI 10.1111/jnc.12159; Matthews RT, 2002, J NEUROSCI, V22, P7536; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Rogers CJ, 2011, P NATL ACAD SCI USA, V108, P9747, DOI 10.1073/pnas.1102962108; Romberg C, 2013, J NEUROSCI, V33, P7057, DOI 10.1523/JNEUROSCI.6267-11.2013; Sahay A, 2005, J NEUROSCI, V25, P3613, DOI 10.1523/JNEUROSCI.5255-04.2005; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Shipp EL, 2007, CHEM BIOL, V14, P195, DOI 10.1016/j.chembiol.2006.12.009; SUGAHARA K, 1991, EUR J BIOCHEM, V202, P805, DOI 10.1111/j.1432-1033.1991.tb16436.x; SUGAHARA K, 1994, CARBOHYD RES, V255, P145, DOI 10.1016/S0008-6215(00)90976-5; Sugahara K, 1996, EUR J BIOCHEM, V239, P865, DOI 10.1111/j.1432-1033.1996.0865u.x; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Vitellaro-Zuccarello L, 2001, CELL TISSUE RES, V306, P15; Vo T, 2013, MOL CELL NEUROSCI, V56, P186, DOI 10.1016/j.mcn.2013.04.009; Wang DF, 2011, J NEUROSCI, V31, P9332, DOI 10.1523/JNEUROSCI.0983-11.2011; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Zimmer G, 2010, CEREB CORTEX, V20, P2411, DOI 10.1093/cercor/bhp309	57	99	101	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27384	27395		10.1074/jbc.M111.310029	http://dx.doi.org/10.1074/jbc.M111.310029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23940048	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000330597300034
J	Morrison, MJ; Imperiali, B				Morrison, Michael J.; Imperiali, Barbara			Biochemical Analysis and Structure Determination of Bacterial Acetyltransferases Responsible for the Biosynthesis of UDP-N,N '-Diacetylbacillosamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl-coenzyme A; Bacterial Pathogenesis; Enzyme Kinetics; Glycoprotein Biosynthesis; Protein Crystallization; UDP-diNAcBac; Acetyltransferase; Bacillosamine	N-LINKED GLYCAN; PROTEIN-GLYCOSYLATION; CAMPYLOBACTER-JEJUNI; CATALYTIC MECHANISM; PATHWAY; ALIGNMENT	UDP-N,N-diacetylbacillosamine (UDP-diNAcBac) is a unique carbohydrate produced by a number of bacterial species and has been implicated in pathogenesis. The terminal step in the formation of this important bacterial sugar is catalyzed by an acetyl-CoA (AcCoA)-dependent acetyltransferase in both N- and O-linked protein glycosylation pathways. This bacterial acetyltransferase is a member of the left-handed -helix family and forms a homotrimer as the functional unit. Whereas previous endeavors have focused on the Campylobacter jejuni acetyltransferase (PglD) from the N-linked glycosylation pathway, structural characterization of the homologous enzymes in the O-linked glycosylation pathways is lacking. Herein, we present the apo-crystal structures of the acetyltransferase domain (ATD) from the bifunctional enzyme PglB (Neisseria gonorrhoeae) and the full-length acetyltransferase WeeI (Acinetobacter baumannii). Additionally, a PglB-ATD structure was solved in complex with AcCoA. Surprisingly, this structure reveals a contrasting binding mechanism for this substrate when compared with the AcCoA-bound PglD structure. A comparison between these findings and the previously solved PglD crystal structures illustrates a dichotomy among N- and O-linked glycosylation pathway enzymes. Based upon these structures, key residues in the UDP-4-amino and AcCoA binding pockets were mutated to determine their effect on binding and catalysis in PglD, PglB-ATD, and WeeI. Last, a phylogenetic analysis of the aforementioned acetyltransferases was employed to illuminate the diversity among N- and O-linked glycosylation pathway enzymes.	[Imperiali, Barbara] MIT, Dept Chem, Cambridge, MA 02139 USA; [Imperiali, Barbara] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Imperiali, B (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	imper@mit.edu		Imperiali, Barbara/0000-0002-5749-7869	National Institutes of Health [GM097241, T32-GM08334]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097241, T32GM008334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM097241 (to B. I.) and T32-GM08334 (Biotechnology Training Program) (to M. J. M.).	Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel C, 1996, CURR OPIN STRUC BIOL, V6, P790, DOI 10.1016/S0959-440X(96)80009-1; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Hartley MD, 2011, BIOCHEMISTRY-US, V50, P4936, DOI 10.1021/bi2003372; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Kelly J, 2006, J BACTERIOL, V188, P2427, DOI 10.1128/JB.188.7.2427-2434.2006; Lees-Miller RG, 2013, MOL MICROBIOL, V89, P816, DOI 10.1111/mmi.12300; Leslie A. G. W., 2007, EVOLVING METHODS MAC, P245; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Morrison MJ, 2013, ARCH BIOCHEM BIOPHYS, V536, P72, DOI 10.1016/j.abb.2013.05.011; Nothaft H, 2013, J BIOL CHEM, V288, P6912, DOI 10.1074/jbc.R112.417857; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Olivier NB, 2008, J BIOL CHEM, V283, P27937, DOI 10.1074/jbc.M801207200; Olivier NB, 2006, BIOCHEMISTRY-US, V45, P13659, DOI 10.1021/bi061456h; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Rangarajan ES, 2008, BIOCHEMISTRY-US, V47, P1827, DOI 10.1021/bi702032r; REMINGTON S, 1982, J MOL BIOL, V158, P111, DOI 10.1016/0022-2836(82)90452-1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thoden JB, 2012, BIOCHEMISTRY-US, V51, P3433, DOI 10.1021/bi300197h; Thoden JB, 2010, BIOCHEMISTRY-US, V49, P4644, DOI 10.1021/bi1005738; Thoden JB, 2009, BIOCHEMISTRY-US, V48, P2699, DOI 10.1021/bi802313n; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200; ZUCKERKANDL EMILE, 1965, P97	40	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32248	32260		10.1074/jbc.M113.510560	http://dx.doi.org/10.1074/jbc.M113.510560			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24064219	Green Published, hybrid			2022-12-28	WOS:000328681700013
J	Kishimoto, K; Nishizuka, M; Katoh, D; Kato, A; Osada, S; Imagawa, M				Kishimoto, Keishi; Nishizuka, Makoto; Katoh, Daiki; Kato, Ayumi; Osada, Shigehiro; Imagawa, Masayoshi			FAD104, a Regulatory Factor of Adipogenesis, Acts as a Novel Regulator of Calvarial Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; EARLY-STAGE; POSITIVE REGULATOR; 3T3-L1 CELLS; GENE FAD104; CRANIOSYNOSTOSIS; IDENTIFICATION; PHOSPHATASES; MECHANISMS	Osteogenesis is a complex process that is orchestrated by several growth factors, extracellular cues, signaling molecules, and transcriptional factors. Understanding the mechanisms of bone formation is pivotal for clarifying the pathogenesis of bone diseases. Previously, we reported that fad104 (factor for adipocyte differentiation 104), a novel positive regulator of adipocyte differentiation, negatively regulated the differentiation of mouse embryonic fibroblasts into osteocytes. However, the physiological role of fad104 in bone formation has not been elucidated. Here, we clarified the role of fad104 in bone formation in vivo and in vitro. fad104 disruption caused craniosynostosis-like premature ossification of the calvarial bone. Furthermore, analyses using primary calvarial cells revealed that fad104 negatively regulated differentiation and BMP/Smad signaling pathway. FAD104 interacted with Smad1/5/8. The N-terminal region of FAD104, which contains a proline-rich motif, was capable of binding to Smad1/5/8. We demonstrated that down-regulation of Smad1/5/8 phosphorylation by FAD104 is dependent on the N-terminal region of FAD104 and that fad104 functions as a novel negative regulator of BMP/Smad signaling and is required for proper development for calvarial bone. These findings will aid a comprehensive description of the mechanism that controls normal and premature calvarial ossification.	[Kishimoto, Keishi; Nishizuka, Makoto; Katoh, Daiki; Kato, Ayumi; Osada, Shigehiro; Imagawa, Masayoshi] Nagoya City Univ, Dept Mol Biol, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan	Nagoya City University	Imagawa, M (corresponding author), Nagoya City Univ, Dept Mol Biol, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	imagawa@phar.nagoya-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science (JSPS); Mitsui Sumitomo Insurance Welfare Foundation; Nakatomi Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation); Nakatomi Foundation	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, the Japan Society for the Promotion of Science (JSPS), JSPS Research Fellow, the Mitsui Sumitomo Insurance Welfare Foundation, and the Nakatomi Foundation.	Bruce DL, 2012, FEBS LETT, V586, P1897, DOI 10.1016/j.febslet.2012.02.001; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Canalis E, 2009, J CELL BIOCHEM, V108, P769, DOI 10.1002/jcb.22322; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Hishida T, 2008, FEBS J, V275, P5576, DOI 10.1111/j.1742-4658.2008.06682.x; Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296; Imagawa M, 1999, BIOCHEM BIOPH RES CO, V254, P299, DOI 10.1006/bbrc.1998.9937; Kanamoto T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-70; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kishimoto K, 2011, EXP CELL RES, V317, P2110, DOI 10.1016/j.yexcr.2011.06.003; Kishimoto K, 2010, BIOCHEM BIOPH RES CO, V397, P187, DOI 10.1016/j.bbrc.2010.05.077; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Marie PJ, 2002, HISTOL HISTOPATHOL, V17, P877, DOI 10.14670/HH-17.877; Maxson Robert, 2008, V12, P197, DOI 10.1159/000115042; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; MUSACCHIO A, 1992, FEBS LETT, V307, P55, DOI 10.1016/0014-5793(92)80901-R; Nishizuka M, 2002, BIOCHEM J, V361, P629, DOI 10.1042/0264-6021:3610629; Nishizuka M, 2009, EXP CELL RES, V315, P809, DOI 10.1016/j.yexcr.2008.12.013; Obholz KL, 2006, DEV BIOL, V298, P498, DOI 10.1016/j.ydbio.2006.06.054; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Passos-Bueno Maria Rita, 2008, V12, P107, DOI 10.1159/000115035; Rice DPC, 2003, EUR J ORTHODONT, V25, P139, DOI 10.1093/ejo/25.2.139; Suenaga M, 2013, CYTOKINE, V64, P138, DOI 10.1016/j.cyto.2013.07.011; Tagariello A, 2006, J MED GENET, V43, P534, DOI 10.1136/jmg.2005.037820; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tominaga K, 2004, J CELL SCI, V117, P6217, DOI 10.1242/jcs.01546; Tominaga K, 2004, FEBS LETT, V577, P49, DOI 10.1016/j.febslet.2004.09.062; Tominaga K, 2004, J BIOL CHEM, V279, P34840, DOI 10.1074/jbc.M312927200	32	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31772	31783		10.1074/jbc.M113.452961	http://dx.doi.org/10.1074/jbc.M113.452961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052261	Green Published, hybrid			2022-12-28	WOS:000330596200028
J	Yan, DY; Kc, R; Chen, D; Xiao, GZ; Im, HJ				Yan, Dongyao; Kc, Ranjan; Chen, Di; Xiao, Guozhi; Im, Hee-Jeong			Bovine Lactoferricin-induced Anti-inflammation Is, in Part, via Up-regulation of Interleukin-11 by Secondary Activation of STAT3 in Human Articular Cartilage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; C-FOS; KAPPA-B; MATRIX METALLOPROTEINASE-13; RHEUMATOID-ARTHRITIS; INTERVERTEBRAL DISC; TISSUE INHIBITOR; CHONDROCYTES; EXPRESSION; PATHWAYS	Bovine lactoferricin (LfcinB), a multifunctional peptide, was recently demonstrated to be anti-catabolic and anti-inflammatory in human articular cartilage. LfcinB blocks IL-1-mediated proteoglycan depletion, matrix-degrading enzyme expression, and pro-inflammatory mediator induction. LfcinB selectively activates ERK1/2, p38 (but not JNK), and Akt signaling. However, the relationship between these pathways and LfcinB target genes has never been explored. In this study, we uncovered the remarkable ability of LfcinB in the induction of an anti-inflammatory cytokine, IL-11. LfcinB binds to cell surface heparan sulfate to initiate ERK1/2 signaling and activate AP-1 complexes composed of c-Fos and JunD, which transactivate the IL-11 gene. The induced IL-11 functions as an anti-inflammatory and chondroprotective cytokine in articular chondrocytes. Our data show that IL-11 directly attenuates IL-1-mediated catabolic and inflammatory processes ex vivo and in vitro. Moreover, IL-11 activates STAT3 signaling pathway to critically up-regulate TIMP-1 expression, as a consecutive secondary cellular response after IL-11 induction by LfcinB-ERK-AP-1 axis in human adult articular chondrocytes. The pathological relevance of IL-11 signaling to osteoarthritis is evidenced by significant down-regulation of its cognate receptor expression in osteoarthritic chondrocytes. Together, our results suggest a two-step mechanism, whereby LfcinB induces TIMP-1 through an IL-11 dependent pathway involving transcription factor AP-1 and STAT3.	[Yan, Dongyao; Kc, Ranjan; Chen, Di; Xiao, Guozhi; Im, Hee-Jeong] Rush Univ, Med Ctr, Dept Biochem, Rheumatol Sect, Chicago, IL 60612 USA; [Im, Hee-Jeong] Rush Univ, Med Ctr, Dept Orthoped Surg, Rheumatol Sect, Chicago, IL 60612 USA; [Im, Hee-Jeong] Rush Univ, Med Ctr, Dept Internal Med, Rheumatol Sect, Chicago, IL 60612 USA; [Im, Hee-Jeong] Univ Illinois, Dept Bioengn, Chicago, IL 60612 USA	Rush University; Rush University; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Im, HJ (corresponding author), Rush Univ, Med Ctr, Cohn Res BD 516,1735 W Harrison, Chicago, IL 60612 USA.	Hee-Jeong_Sampen@rush.edu	Chen, Di/AAJ-3665-2021		National Institutes of Health [AR053220, AR062136, AR055915]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055915, R01AR062136, R01AR053220] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants AR053220 (to H.-J. I.), AR062136 (to H.-J. I.), and AR055915 (to D. C.).	Andersen JH, 2004, J MED VIROL, V74, P262, DOI 10.1002/jmv.20171; Anguita J, 1999, J INFECT DIS, V179, P734, DOI 10.1086/314613; Bugno M, 1995, NUCLEIC ACIDS RES, V23, P5041, DOI 10.1093/nar/23.24.5041; Calich ALG, 2010, CLIN RHEUMATOL, V29, P451, DOI 10.1007/s10067-009-1352-3; Chen XM, 2003, KIDNEY INT, V64, P459, DOI 10.1046/j.1523-1755.2003.00133.x; Chiu YC, 2007, MOL PHARMACOL, V72, P695, DOI 10.1124/mol.107.036541; Cleaver CS, 2001, ANN RHEUM DIS, V60, P150, DOI 10.1136/ard.60.2.150; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Echtermeyer F, 2009, NAT MED, V15, P1072, DOI 10.1038/nm.1998; Ellman MB, 2013, GENE, V524, P282, DOI 10.1016/j.gene.2013.04.003; Goldring M B, 2000, Curr Rheumatol Rep, V2, P459, DOI 10.1007/s11926-000-0021-y; Healy ZR, 2008, AM J PHYSIOL-CELL PH, V294, pC1146, DOI 10.1152/ajpcell.00542.2007; Hermann JA, 1998, ARTHRITIS RHEUM, V41, P1388, DOI 10.1002/1529-0131(199808)41:8<1388::AID-ART7>3.0.CO;2-F; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hwang SG, 2005, J BIOL CHEM, V280, P29780, DOI 10.1074/jbc.M411793200; Im HJ, 2007, J BIOL CHEM, V282, P11110, DOI 10.1074/jbc.M609040200; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim JS, 2013, J CELL PHYSIOL, V228, P1884, DOI 10.1002/jcp.24350; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Liu-Bryan R, 2010, ARTHRITIS RHEUM-US, V62, P2004, DOI 10.1002/art.27475; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; MAIER R, 1993, J BIOL CHEM, V268, P21527; MALFAIT AM, 1994, J RHEUMATOL, V21, P314; McBride K, 1998, MOL CELL BIOL, V18, P5073, DOI 10.1128/MCB.18.9.5073; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Moos V, 1999, J RHEUMATOL, V26, P870; Moreland L, 2001, ARTHRITIS RES, V3, P247, DOI 10.1186/ar309; Muddasani P, 2007, J BIOL CHEM, V282, P31409, DOI 10.1074/jbc.M706508200; Muehleman C, 1997, OSTEOARTHR CARTILAGE, V5, P23, DOI 10.1016/S1063-4584(97)80029-5; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Su SL, 2005, OSTEOARTHR CARTILAGE, V13, P879, DOI 10.1016/j.joca.2005.04.017; Tang WL, 1998, J BIOL CHEM, V273, P5506, DOI 10.1074/jbc.273.10.5506; Trepicchio WL, 1996, J IMMUNOL, V157, P3627; Trepicchio WL, 1997, J IMMUNOL, V159, P5661; Walmsley M, 1998, IMMUNOLOGY, V95, P31; Wong PKK, 2005, CYTOKINE, V29, P72, DOI 10.1016/j.cyto.2004.09.011; Yan DY, 2013, GENE, V517, P12, DOI 10.1016/j.gene.2013.01.001; Yan DY, 2013, J CELL PHYSIOL, V228, P447, DOI 10.1002/jcp.24151	39	15	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31655	31669		10.1074/jbc.M112.440420	http://dx.doi.org/10.1074/jbc.M112.440420			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24036113	Green Published, hybrid			2022-12-28	WOS:000330596200024
J	Bhattacharjee, P; Bhattacharyya, D				Bhattacharjee, Payel; Bhattacharyya, Debasish			Factor V Activator from Daboia russelli russelli Venom Destabilizes beta-Amyloid Aggregate, the Hallmark of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aggregation; Amyloid; Neurodegenerative Diseases; Peptides; Toxins; Russell's Viper Venom Factor V Activator	BLOOD-BRAIN-BARRIER; DRUG DISCOVERY; PEPTIDE; OLIGOMERS; FIBRILLOGENESIS; NEUROTOXICITY; CLEARANCE; TOXICITY; THERAPY; MODEL	Formation of plaque by fibrils of -amyloid (A) peptide in the brain is the characteristic feature of Alzheimer disease (AD). Inhibition of the process of aggregate formation from A-monomer and destabilization of the aggregate could be useful for prevention and propagation of the disease respectively. Russell's viper venom (RVV) contains protein(s) that destabilize A aggregates as revealed from the thioflavin T assay. The active component was identified as factor V activator (RVV-V). Among the possible mechanisms of destabilization, RVV-V-mediated proteolysis was ruled out from mass spectrometric data and the thioflavin T assay. The alternate hypothesis that small peptides derived from RVV-V destabilize the aggregate is better supported by experimental results. Six small peptides were synthesized using RVV-V as the template, and three unrelated peptides were synthesized to serve as controls. Destabilization of A aggregate by these peptides was studied using spectrofluorometric assays, atomic force microscopy, transmission electron microscopy, and confocal microscopy. Among the peptides, CTNIF and the mixture of the six peptides were most potent in converting the aggregates to the monomeric state and thus, preventing cytotoxicity in SH-SY5Y human neuroblastoma cells. The control peptides failed to show similar effects. Moreover, some of these peptides are stable in blood for 24 h. Therefore, these venom-derived peptides offer an encouraging opportunity to prevent amyloidosis and may provide information to combat AD.	[Bhattacharjee, Payel; Bhattacharyya, Debasish] Indian Inst Chem Biol, Council Sci & Ind Res, Div Struct Biol & Bioinformat, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bhattacharyya, D (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Div Struct Biol & Bioinformat, 4 Raja SC Mullick Rd, Kolkata 700032, India.	payel.iicb@gmail.com; debasish@iicb.res.in			Department of Science and Technology, Cognition Science Initiative [SR/CSI/07/2009(G)]; Council of Scientific and Industrial Research Network [miND BSC0115]; University Grants Commission-National Eligibility Test fellowship	Department of Science and Technology, Cognition Science Initiative(Department of Science & Technology (India)); Council of Scientific and Industrial Research Network; University Grants Commission-National Eligibility Test fellowship	This work was supported by the Department of Science and Technology, Cognition Science Initiative, Project SR/CSI/07/2009(G) and Council of Scientific and Industrial Research Network Project miND BSC0115.; Supported by a University Grants Commission-National Eligibility Test fellowship.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Adessi C, 2003, J BIOL CHEM, V278, P13905, DOI 10.1074/jbc.M211976200; Bellesia G, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216103; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bett CK, 2010, ACS CHEM NEUROSCI, V1, P608, DOI 10.1021/cn100045q; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; DeVries HE, 1997, PHARMACOL REV, V49, P143; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Feng Y, 2009, NEUROTOXICOLOGY, V30, P986, DOI 10.1016/j.neuro.2009.08.013; Finder VH, 2007, NEURODEGENER DIS, V4, P13, DOI 10.1159/000100355; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Gestwicki JE, 2004, SCIENCE, V306, P865, DOI 10.1126/science.1101262; Gordon DJ, 2002, J PEPT RES, V60, P37, DOI 10.1034/j.1399-3011.2002.11002.x; Hawaes C. A., 2009, DRUG DEVELOP RES, V70, P111; Huang THJ, 2000, J MOL BIOL, V297, P73, DOI 10.1006/jmbi.2000.3559; KISIEL W, 1981, METHOD ENZYMOL, V80, P275; Koren J, 2009, J CELL MOL MED, V13, P619, DOI 10.1111/j.1582-4934.2008.00557.x; Kuznetsova I. M., 2012, PLOS ONE, V7; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Marsh NA, 1998, BLOOD COAGUL FIBRIN, V9, P395, DOI 10.1097/00001721-199807000-00001; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Pearson HA, 2006, J PHYSIOL-LONDON, V575, P5, DOI 10.1113/jphysiol.2006.111203; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Shaw C., 2009, BIOCH SOC, V31, P34; SHEARMAN MS, 1995, J NEUROCHEM, V65, P218, DOI 10.1046/j.1471-4159.1995.65010218.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Strober W., 1997, CURRENT PROTOCOLS IM; TOKUNAGA F, 1988, J BIOL CHEM, V263, P17471; Tsai IH, 1996, TOXICON, V34, P99, DOI 10.1016/0041-0101(95)00114-X; Van Dam D, 2006, NAT REV DRUG DISCOV, V5, P956, DOI 10.1038/nrd2075; Westermann Jan-Christoph, 2008, V494, P87, DOI 10.1007/978-1-59745-419-3_6; Witt KA, 2006, AAPS J, V8, pE76, DOI 10.1208/aapsj080109	39	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30559	30570		10.1074/jbc.M113.511410	http://dx.doi.org/10.1074/jbc.M113.511410			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986449	Green Published, hybrid			2022-12-28	WOS:000329868100057
J	Palmer, LD; Downs, DM				Palmer, Lauren D.; Downs, Diana M.			The Thiamine Biosynthetic Enzyme ThiC Catalyzes Multiple Turnovers and Is Inhibited by S-Adenosylmethionine (AdoMet) Metabolites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitors; Iron-Sulfur Protein; Radicals; S-adenosylmethionine (AdoMet); Thiamine; Thiamine Biosynthesis	ANAEROBIC RIBONUCLEOTIDE REDUCTASE; ESCHERICHIA-COLI; RADICAL SAM; 5-AMINOIMIDAZOLE RIBOTIDE; LYSINE 2,3-AMINOMUTASE; BIOTIN SYNTHASE; LIPOYL SYNTHASE; PYRIMIDINE; PROTEIN; CLUSTER	ThiC (4-amino-5-hydroxymethyl-2-methylpyrimidine phosphate synthase; EC 4.1.99.17) is a radical S-adenosylmethionine (AdoMet) enzyme that uses a [4Fe-4S](+) cluster to reductively cleave AdoMet to methionine and a 5-deoxyadenosyl radical that initiates catalysis. In plants and bacteria, ThiC converts the purine intermediate 5-aminoimidazole ribotide to 4-amino-5-hydroxymethyl-2-methylpyrimidine phosphate, an intermediate of thiamine pyrophosphate (coenzyme B1) biosynthesis. In this study, assay conditions were implemented that consistently generated 5-fold molar excess of HMP, demonstrating that ThiC undergoes multiple turnovers. ThiC activity was improved by in situ removal of product 5-deoxyadenosine. The activity was inhibited by AdoMet metabolites S-adenosylhomocysteine, adenosine, 5-deoxyadenosine, S-methyl-5-thioadenosine, methionine, and homocysteine. Neither adenosine nor S-methyl-5-thioadenosine had been shown to inhibit radical AdoMet enzymes, suggesting that ThiC is distinct from other family members. The parameters for improved ThiC activity and turnover described here will facilitate kinetic and mechanistic analyses of ThiC.	[Palmer, Lauren D.; Downs, Diana M.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Downs, DM (corresponding author), Univ Georgia, Dept Microbiol, 527 Biol Sci Bldg,120 Cedar St, Athens, GA 30602 USA.	dmdowns@uga.edu			National Institutes of Health [GM47296]; National Science Foundation [DGE-0718123]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM47296 (to D. M. D.). This work was also supported by National Science Foundation Graduate Research Fellowship grant DGE-0718123 (to L. D. P.).	Allen S, 2002, J BACTERIOL, V184, P6130, DOI 10.1128/JB.184.22.6130-6137.2002; Begley TP, 2008, CURR OPIN CHEM BIOL, V12, P118, DOI 10.1016/j.cbpa.2008.02.006; Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BOCK RM, 1956, ARCH BIOCHEM BIOPHYS, V62, P253, DOI 10.1016/0003-9861(56)90123-0; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Challand MR, 2010, J BIOL CHEM, V285, P5240, DOI 10.1074/jbc.M109.056606; Challand MR, 2009, FEBS LETT, V583, P1358, DOI 10.1016/j.febslet.2009.03.044; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Chatterjee A, 2010, ANGEW CHEM INT EDIT, V49, P8653, DOI 10.1002/anie.201003419; Cheek J, 2002, J AM CHEM SOC, V124, P2860, DOI 10.1021/ja017784g; CHIRPICH TP, 1970, J BIOL CHEM, V245, P1778; Choi-Rhee EJ, 2005, CHEM BIOL, V12, P589, DOI 10.1016/j.chembiol.2005.04.012; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P11770, DOI 10.1021/bi0488505; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Dougherty MJ, 2006, MICROBIOL-SGM, V152, P2345, DOI 10.1099/mic.0.28926-0; ESTRAMAREIX B, 1969, BIOCHIM BIOPHYS ACTA, V192, P375, DOI 10.1016/0304-4165(69)90384-5; ESTRAMAREIX B, 1984, J AM CHEM SOC, V106, P3857, DOI 10.1021/ja00325a025; ESTRAMAREIX B, 1990, BIOCHIM BIOPHYS ACTA, V1035, P154, DOI 10.1016/0304-4165(90)90110-I; Farrar CE, 2010, BIOCHEMISTRY-US, V49, P9985, DOI 10.1021/bi101023c; Frey PA, 1999, ADV FR RAD, V2, P1; Frodyma M, 2000, J BACTERIOL, V182, P236, DOI 10.1128/JB.182.1.236-240.2000; Grove TL, 2008, BIOCHEMISTRY-US, V47, P7523, DOI 10.1021/bi8004297; Halliday NM, 2010, ANAL BIOCHEM, V403, P20, DOI 10.1016/j.ab.2010.04.021; HARDER J, 1992, J BIOL CHEM, V267, P25548; Hiscox MJ, 2012, BBA-PROTEINS PROTEOM, V1824, P1165, DOI 10.1016/j.bbapap.2012.03.013; KENNEDY MC, 1984, J BIOL CHEM, V259, P4463; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; KURAMITSU HK, 1964, J BIOL CHEM, V239, P3425; Martinez-Gomez NC, 2008, BIOCHEMISTRY-US, V47, P9054, DOI 10.1021/bi8010253; Martinez-Gomez NC, 2009, BIOCHEMISTRY-US, V48, P217, DOI 10.1021/bi802154j; Mehl RA, 2002, J LABELLED COMPD RAD, V45, P1097, DOI 10.1002/jlcr.627; MEYER E, 1992, BIOCHEMISTRY-US, V31, P5022, DOI 10.1021/bi00136a016; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; MOSS ML, 1990, J BIOL CHEM, V265, P18112; MOYED HS, 1964, J BACTERIOL, V88, P1024, DOI 10.1128/JB.88.4.1024-1029.1964; Ollagnier-de-Choudens S, 2002, FEBS LETT, V532, P465, DOI 10.1016/S0014-5793(02)03733-X; Palmer LD, 2012, J BACTERIOL, V194, P6088, DOI 10.1128/JB.01361-12; Roach PL, 2011, CURR OPIN CHEM BIOL, V15, P267, DOI 10.1016/j.cbpa.2010.11.015; Segel I.H., 1975, ENZYME KINETICS; Shisler KA, 2012, CURR OPIN STRUC BIOL, V22, P701, DOI 10.1016/j.sbi.2012.10.005; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Tamarit J, 1999, J BIOL CHEM, V274, P31291, DOI 10.1074/jbc.274.44.31291; Tranchimand S, 2011, BIOCHEMISTRY-US, V50, P4623, DOI 10.1021/bi102033a; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; WALKER RD, 1975, CAN J BIOCHEM CELL B, V53, P312, DOI 10.1139/o75-044; Yokoyama K, 2007, J AM CHEM SOC, V129, P15147, DOI 10.1021/ja072481t	47	31	32	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30693	30699		10.1074/jbc.M113.500280	http://dx.doi.org/10.1074/jbc.M113.500280			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014032	hybrid, Green Published			2022-12-28	WOS:000329868100069
J	Yan, XS; Weng, HR				Yan, Xisheng; Weng, Han-Rong			Endogenous Interleukin-1 beta in Neuropathic Rats Enhances Glutamate Release from the Primary Afferents in the Spinal Dorsal Horn through Coupling with Presynaptic N-Methyl-D-aspartic Acid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Glia; Glutamate Receptors Ionotropic (AMPA; NMDA); Pain; Patch Clamp	LONG-TERM POTENTIATION; SUBSTANTIA-GELATINOSA NEURONS; SCIATIC-NERVE LIGATION; SYNAPTIC-TRANSMISSION; NMDA RECEPTORS; TRANSMITTER RELEASE; INFLAMMATORY PAIN; SENSORY NEURONS; ROOT GANGLION; GROWTH-FACTOR	Excessive activation of glutamate receptors and overproduction of proinflammatory cytokines, including interleukin-1 (IL-1) in the spinal dorsal horn, are key mechanisms underlying the development and maintenance of neuropathic pain. In this study, we investigated the mechanisms by which endogenous IL-1 alters glutamatergic synaptic transmission in the spinal dorsal horn in rats with neuropathic pain induced by ligation of the L5 spinal nerve. We demonstrated that endogenous IL-1 in neuropathic rats enhances glutamate release from the primary afferent terminals and non-NMDA glutamate receptor activities in postsynaptic neurons in the spinal dorsal horn. Myeloid differentiation primary response protein 88 (MyD88) is a mediator used by IL-1 to enhance non-NMDA glutamate receptor activities in postsynaptic neurons in the spinal dorsal horn. Presynaptic NMDA receptors are effector receptors used by the endogenous IL-1 to enhance glutamate release from the primary afferents in neuropathic rats. This is further supported by the fact that NMDA currents recorded from small neurons in the dorsal root ganglion of normal rats are potentiated by exogenous IL-1. Furthermore, we provided evidence that functional coupling between IL-1 receptors and presynaptic NMDA receptors at the primary afferent terminals is mediated by the neutral sphingomyelinase/ceramide signaling pathway. Hence, functional coupling between IL-1 receptors and presynaptic NMDA receptors at the primary afferent terminals is a crucial mechanism leading to enhanced glutamate release and activation of non-NMDA receptors in the spinal dorsal horn neurons in neuropathic pain conditions. Interruption of such functional coupling could be an effective approach for the treatment of neuropathic pain.	[Yan, Xisheng; Weng, Han-Rong] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Weng, HR (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, 240 West Green St, Athens, GA 30602 USA.	hrweng@uga.edu			National Institutes of Health from NINDS [RO1 NS-064289]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064289] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 NS-064289 from NINDS (to H. R. W.).	Ataka T, 2000, PAIN, V86, P273, DOI 10.1016/S0304-3959(00)00255-4; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Balosso S, 2008, BRAIN, V131, P3256, DOI 10.1093/brain/awn271; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; BINDONI M, 1988, BRAIN RES, V462, P10, DOI 10.1016/0006-8993(88)90578-1; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; Chen BC, 2009, J BIOL CHEM, V284, P20562, DOI 10.1074/jbc.M109.028084; Chen TJ, 2012, EUR J PHARMACOL, V685, P24, DOI 10.1016/j.ejphar.2012.04.002; Choi JI, 2010, PAIN, V149, P243, DOI 10.1016/j.pain.2010.02.008; Christie JM, 2008, NEURON, V60, P298, DOI 10.1016/j.neuron.2008.08.028; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DEBIASI S, 1988, P NATL ACAD SCI USA, V85, P7820; DeLeo JA, 1997, BRAIN RES, V759, P50, DOI 10.1016/S0006-8993(97)00209-6; Doyle T, 2011, FASEB J, V25, P2782, DOI 10.1096/fj.10-178095; Drdla R, 2009, SCIENCE, V325, P207, DOI 10.1126/science.1171759; Falchi M, 2001, DRUG EXP CLIN RES, V27, P97; Foster T C, 1991, Hippocampus, V1, P79, DOI 10.1002/hipo.450010108; Gerber G, 2000, NEUROSCIENCE, V100, P393, DOI 10.1016/S0306-4522(00)00269-4; Glitsch M, 1999, J NEUROSCI, V19, P511; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Heinke B, 2011, J NEUROSCI, V31, P1313, DOI 10.1523/JNEUROSCI.4060-10.2011; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; Joseph EK, 2004, EUR J NEUROSCI, V20, P2896, DOI 10.1111/j.1460-9568.2004.03750.x; Kawasaki Y, 2003, ANESTHESIOLOGY, V98, P682, DOI 10.1097/00000542-200303000-00016; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kleibeuker W, 2008, BRAIN BEHAV IMMUN, V22, P200, DOI 10.1016/j.bbi.2007.07.009; Kobayashi Y, 2012, BIOCHEM BIOPH RES CO, V421, P318, DOI 10.1016/j.bbrc.2012.03.153; Kohno T, 2003, J PHYSIOL-LONDON, V548, P131, DOI 10.1113/jphysiol.2002.036186; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Kwon MS, 2005, ARCH PHARM RES, V28, P582, DOI 10.1007/BF02977762; Lee HL, 2004, NEUROREPORT, V15, P2807; Lever IJ, 2002, BRIT J PHARMACOL, V135, P21, DOI 10.1038/sj.bjp.0704506; Lissin DV, 1999, J NEUROSCI, V19, P1263; Ma C, 2005, PAIN, V113, P106, DOI 10.1016/j.pain.2004.10.001; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Mao JR, 2002, J NEUROSCI, V22, P8312; McGuinness L, 2010, NEURON, V68, P1109, DOI 10.1016/j.neuron.2010.11.023; Mika J, 2008, PAIN, V138, P587, DOI 10.1016/j.pain.2008.02.015; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Muscoli C, 2010, J NEUROSCI, V30, P15400, DOI 10.1523/JNEUROSCI.2391-10.2010; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nakabo Y, 1997, IMMUNOLOGY, V90, P477, DOI 10.1046/j.1365-2567.1997.d01-2189.x; Ndengele MM, 2009, J PHARMACOL EXP THER, V329, P64, DOI 10.1124/jpet.108.146290; Neale JH, 2005, TRENDS PHARMACOL SCI, V26, P477, DOI 10.1016/j.tips.2005.07.004; Nie H, 2010, J NEUROPHYSIOL, V103, P2570, DOI 10.1152/jn.00013.2010; Nie H, 2009, J NEUROPHYSIOL, V101, P2041, DOI 10.1152/jn.91138.2008; Park CK, 2011, J NEUROSCI, V31, P15072, DOI 10.1523/JNEUROSCI.2443-11.2011; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Reeve AJ, 2000, EUR J PAIN-LONDON, V4, P247, DOI 10.1053/eujp.2000.0177; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Rossi S, 2012, ANN NEUROL, V71, P76, DOI 10.1002/ana.22512; Shamash S, 2002, J NEUROSCI, V22, P3052, DOI 10.1523/JNEUROSCI.22-08-03052.2002; Song JH, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-50; SUGIURA Y, 1986, SCIENCE, V234, P358, DOI 10.1126/science.3764416; Sung BK, 2003, J NEUROSCI, V23, P2899; Tsakiri N, 2008, MOL CELL NEUROSCI, V38, P259, DOI 10.1016/j.mcn.2008.02.015; Wang W, 2012, PAIN PHYSICIAN, V15, pE995; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Weng HR, 2007, NEUROSCIENCE, V149, P898, DOI 10.1016/j.neuroscience.2007.07.063; Weng HR, 2006, NEUROSCIENCE, V138, P1351, DOI 10.1016/j.neuroscience.2005.11.061; Weng HR, 2005, NEUROSCI LETT, V386, P18, DOI 10.1016/j.neulet.2005.05.049; Willis WD, 2002, BRAIN RES REV, V40, P202, DOI 10.1016/S0165-0173(02)00202-3; Willis WD, 2006, PROG NEUROBIOL, V78, P189, DOI 10.1016/j.pneurobio.2006.02.007; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; Wu LJ, 2005, J NEUROSCI, V25, P11107, DOI 10.1523/JNEUROSCI.1678-05.2005; Xin WJ, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-15; Xu H, 2008, J NEUROSCI, V28, P7445, DOI 10.1523/JNEUROSCI.1812-08.2008; Yan XS, 2013, J PHYSIOL-LONDON, V591, P2001, DOI 10.1113/jphysiol.2012.250522; YOSHIMURA M, 1993, NEUROSCIENCE, V53, P519, DOI 10.1016/0306-4522(93)90216-3; YOSHIMURA M, 1989, J NEUROPHYSIOL, V62, P96, DOI 10.1152/jn.1989.62.1.96; Zeng JS, 2006, J NEUROSCI, V26, P12033, DOI 10.1523/JNEUROSCI.2530-06.2006; Zhang RX, 2008, PAIN, V135, P232, DOI 10.1016/j.pain.2007.05.023; Zhang YH, 2002, J PHYSIOL-LONDON, V544, P385, DOI 10.1113/jphysiol.2002.024265; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	81	68	69	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30544	30557		10.1074/jbc.M113.495465	http://dx.doi.org/10.1074/jbc.M113.495465			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003233	Green Published, hybrid			2022-12-28	WOS:000329868100056
J	Cai, K; Frederick, RO; Kim, JH; Reinen, NM; Tonelli, M; Markley, JL				Cai, Kai; Frederick, Ronnie O.; Kim, Jin Hae; Reinen, Nichole M.; Tonelli, Marco; Markley, John L.			Human Mitochondrial Chaperone (mtHSP70) and Cysteine Desulfurase (NFS1) Bind Preferentially to the Disordered Conformation, Whereas Co-chaperone (HSC20) Binds to the Structured Conformation of the Iron-Sulfur Cluster Scaffold Protein (ISCU)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Chaperone Chaperonin; Enzyme Catalysis; Mitochondria; NMR; Protein Conformation; Protein-Protein Interactions; Scaffold Proteins; Spectroscopy	CRYSTAL-STRUCTURE; ASSEMBLY PROTEIN; BIOGENESIS; FRATAXIN; BIOSYNTHESIS; SUBSTRATE; MORTALIN; 2FE-2S; ISD11; FORM	Human ISCU is the scaffold protein for mitochondrial iron-sulfur (Fe-S) cluster biogenesis and transfer. NMR spectra have revealed that ISCU populates two conformational states; that is, a more structured state (S) and a partially disordered state (D). We identified two single amino acid substitutions (D39V and N90A) that stabilize the S-state and two (D39A and H105A) that stabilize the D-state. We isolated the two constituent proteins of the human cysteine desulfurase complex (NFS1 and ISD11) separately and used NMR spectroscopy to investigate their interaction with ISCU. We found that ISD11 does not interact directly with ISCU. By contrast, NFS1 binds preferentially to the D-state of ISCU as does the NFS1-ISD11 complex. An in vitro Fe-S cluster assembly assay showed that [2Fe-2S] and [4Fe-4S] clusters are assembled on ISCU when catalyzed by NFS1 alone and at a higher rate when catalyzed by the NFS1-ISD11 complex. The DnaK-type chaperone (mtHSP70) and DnaJ-type co-chaperone (HSC20) are involved in the transfer of clusters bound to ISCU to acceptor proteins in an ATP-dependent reaction. We found that the ATPase activity of mtHSP70 is accelerated by HSC20 and further accelerated by HSC20 plus ISCU. NMR studies have shown that mtHSP70 binds preferentially to the D-state of ISCU and that HSC20 binds preferentially to the S-state of ISCU.	[Cai, Kai; Frederick, Ronnie O.; Kim, Jin Hae; Reinen, Nichole M.; Markley, John L.] Univ Wisconsin, Ctr Eukaryot Struct Genom, Madison, WI 53706 USA; [Tonelli, Marco; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Markley, JL (corresponding author), Univ Wisconsin, Ctr Eukaryot Struct Genom, Madison, WI 53706 USA.	jmarkley@wisc.edu	Cai, Kai/J-7137-2019	Cai, Kai/0000-0002-4771-7450; Kim, Jin Hae/0000-0002-6776-2451	NIGMS, National Institutes of Health [U01 GM94622, 8P41 GM103399, 3R01GM058667-11S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058667, P41GM103399, U01GM094622] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS, National Institutes of Health Grants U01 GM94622 (Protein Structure Initiative: Biology, Mitochondrial Protein Partnership), 8P41 GM103399 (to the National Magnetic Resonance Facility at Madison, WI), and 3R01GM058667-11S1.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Bitto E, 2008, J BIOL CHEM, V283, P30184, DOI 10.1074/jbc.M804746200; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Blommel PG, 2006, PROTEIN EXPRES PURIF, V47, P562, DOI 10.1016/j.pep.2005.11.007; Bridwell-Rabb J, 2012, BIOCHEMISTRY-US, V51, P2506, DOI 10.1021/bi201628j; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Chylla RA, 2011, ANAL CHEM, V83, P4871, DOI 10.1021/ac200536b; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cupp-Vickery JR, 2004, J MOL BIOL, V342, P1265, DOI 10.1016/j.jmb.2004.07.025; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Cupp-Vickery JR, 2000, J MOL BIOL, V304, P835, DOI 10.1006/jmbi.2000.4252; Dai ZQ, 2012, BIOCHEMISTRY-US, V51, P9595, DOI 10.1021/bi301413y; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deocaris CC, 2009, PROTEIN PEPTIDE LETT, V16, P517, DOI 10.2174/092986609788167770; Fontecave M, 2006, NAT CHEM BIOL, V2, P171, DOI 10.1038/nchembio0406-171; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Foster MW, 2000, J AM CHEM SOC, V122, P6805, DOI 10.1021/ja000800+; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; Goddard T. D., 2008, SPARKY VERSION 3 3; Goswami AV, 2010, J BIOL CHEM, V285, P19472, DOI 10.1074/jbc.M110.105957; Hoff KG, 2003, J BIOL CHEM, V278, P37582, DOI 10.1074/jbc.M305292200; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; Kim JH, 2012, J BIOL CHEM, V287, P31406, DOI 10.1074/jbc.M112.352617; Kim JH, 2012, BIOCHEMISTRY-US, V51, P5557, DOI 10.1021/bi300579p; Kim JH, 2012, P NATL ACAD SCI USA, V109, P454, DOI 10.1073/pnas.1114372109; Kim JH, 2009, BIOCHEMISTRY-US, V48, P6062, DOI 10.1021/bi9002277; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; KNELLER DG, 1993, J CELL BIOCHEM, P254; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Liu JY, 2005, PROTEINS, V59, P875, DOI 10.1002/prot.20421; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Markley JL, 2013, FEBS LETT, V587, P1172, DOI 10.1016/j.febslet.2013.01.003; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Shan YX, 2012, HUM MOL GENET, V21, P1457, DOI 10.1093/hmg/ddr582; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Tapley TL, 2004, J BIOL CHEM, V279, P28435, DOI 10.1074/jbc.M400803200; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Voisine C, 2001, P NATL ACAD SCI USA, V98, P1483, DOI 10.1073/pnas.98.4.1483; Wadhwa R, 2002, CELL STRESS CHAPERON, V7, P309, DOI 10.1379/1466-1268(2002)007<0309:AHFCMM>2.0.CO;2; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Xu XM, 2011, ANTIOXID REDOX SIGN, V15, P271, DOI 10.1089/ars.2010.3259; Zhao Qin, 2004, Journal of Structural and Functional Genomics, V5, P87, DOI 10.1023/B:JSFG.0000029205.65813.42	64	42	44	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28755	28770		10.1074/jbc.M113.482042	http://dx.doi.org/10.1074/jbc.M113.482042			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940031	Green Published, hybrid			2022-12-28	WOS:000330298800029
J	Derler, I; Plenk, P; Fahrner, M; Muik, M; Jardin, I; Schindl, R; Gruber, HJ; Groschner, K; Romanin, C				Derler, Isabella; Plenk, Peter; Fahrner, Marc; Muik, Martin; Jardin, Isaac; Schindl, Rainer; Gruber, Hermann J.; Groschner, Klaus; Romanin, Christoph			Region Combines Binding Interface and Gate for Orai1 Activation by STIM1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channels; Calcium Intracellular Release; Calcium Signaling; Electrophysiology; Ion Channels	PROTEIN-PROTEIN INTERACTIONS; CRAC CHANNEL ACTIVATION; OPERATED CA2+ ENTRY; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; MOLECULAR DETERMINANTS; STORE; DOMAIN; PORE; ORGANIZATION	STIM1 and Orai1 represent the two molecular key components of the Ca2+ release-activated Ca2+ channels. Their activation involves STIM1 C terminus coupling to both the N terminus and the C terminus of Orai. Here we focused on the extended transmembrane Orai1 N-terminal (ETON, aa73-90) region, conserved among the Orai family forming an elongated helix of TM1 as recently shown by x-ray crystallography. To identify hot spot residues in the ETON binding interface for STIM1 interaction, numerous Orai1 constructs with N-terminal truncations or point mutations within the ETON region were generated. N-terminal truncations of the first four residues of the ETON region or beyond completely abolished STIM1-dependent Orai1 function. Loss of Orai1 function resulted from neither an impairment of plasma membrane targeting nor pore damage, but from a disruption of STIM1 interaction. In a complementary approach, we monitored STIM1-Orai interaction via Orai1 V102A by determining restored Ca2+ selectivity as a consequence of STIM1 coupling. Orai1 N-terminal truncations that led to a loss of function consistently failed to restore Ca2+ selectivity of Orai1 V102A in the presence of STIM1, demonstrating impairment of STIM1 binding. Hence, the major portion of the ETON region (aa76-90) is essential for STIM1 binding and Orai1 activation. Mutagenesis within the ETON region revealed several hydrophobic and basic hot spot residues that appear to control STIM1 coupling to Orai1 in a concerted manner. Moreover, we identified two basic residues, which protrude into the elongated pore to redound to Orai1 gating. We suggest that several hot spot residues in the ETON region contribute in aggregate to the binding of STIM1, which in turn is coupled to a conformational reorientation of the gate.	[Derler, Isabella; Plenk, Peter; Fahrner, Marc; Muik, Martin; Jardin, Isaac; Schindl, Rainer; Gruber, Hermann J.; Romanin, Christoph] Johannes Kepler Univ Linz, Inst Biophys, A-4020 Linz, Austria; [Groschner, Klaus] Med Univ Graz, Inst Biophys, A-8010 Graz, Austria	Johannes Kepler University Linz; Medical University of Graz	Derler, I (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria.	isabella.derler@jku.at; christoph.romanin@jku.at	Derler, Isabella/B-7871-2019; Schindl, Rainer/V-4205-2019; Groschner, Klaus/A-2550-2010; Jardin, Isaac/E-8310-2016; Romanin, Christoph/D-5399-2009; Gruber, Hermann J./C-4234-2013; Fahrner, Marc/AAI-7927-2021; Schindl, Rainer/E-3959-2013	Derler, Isabella/0000-0002-4768-146X; Groschner, Klaus/0000-0002-8659-377X; Jardin, Isaac/0000-0003-4575-8264; Romanin, Christoph/0000-0003-3756-4136; Fahrner, Marc/0000-0002-2689-0158; Schindl, Rainer/0000-0003-0896-8887	Austrian Science Fund (FWF) [P25210, P22747, P21925, P25172]; Austrian Research Promotion Agency (FFG, Austrian Nanoscience Initiative) [VO104-08-BI, 819703]; Austrian Science Fund (FWF) [M 1506, P 22747, P 25172, P 21925] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (FFG, Austrian Nanoscience Initiative); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF Project P25210 to I. D., FWF Project P22747 to R. S., FWF Project P21925 to K. G., and FWF Project P25172 to C. R.) and the Austrian Research Promotion Agency (FFG, Austrian Nanoscience Initiative VO104-08-BI Project 819703 NSI-NABIOS to H. J. G).	Bergsmann J, 2011, J BIOL CHEM, V286, P31565, DOI 10.1074/jbc.M111.227546; Derler I, 2009, J BIOL CHEM, V284, P15903, DOI 10.1074/jbc.M808312200; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2008, CHANNELS, V2, P261, DOI 10.4161/chan.2.4.6705; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Keskin O, 2005, PHYS BIOL, V2, pS24, DOI 10.1088/1478-3975/2/2/S03; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Liu YS, 2012, J BIOL CHEM, V287, P43030, DOI 10.1074/jbc.M112.380964; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Moreira IS, 2013, BBA-PROTEINS PROTEOM, V1834, P404, DOI 10.1016/j.bbapap.2012.07.005; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Raj M, 2013, BIOORGAN MED CHEM, V21, P4051, DOI 10.1016/j.bmc.2012.11.023; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rothberg BS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003971; Schindl R, 2012, J BIOL CHEM, V287, P35612, DOI 10.1074/jbc.M112.400952; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254	38	84	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29025	29034		10.1074/jbc.M113.501510	http://dx.doi.org/10.1074/jbc.M113.501510			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23943619	Green Published, hybrid			2022-12-28	WOS:000330298800056
J	Dong, L; Sharma, NP; Jurban, BJ; Smith, WL				Dong, Liang; Sharma, Narayan P.; Jurban, Brice J.; Smith, William L.			Pre-existent Asymmetry in the Human Cyclooxygenase-2 Sequence Homodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arachidonic Acid; Cyclooxygenase (COX) Pathway; Drug Action; Eicosanoid; Protein Conformation	PROSTAGLANDIN-H SYNTHASE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TIME-DEPENDENT INHIBITION; ENDOPLASMIC-RETICULUM; STRUCTURAL BASIS; ENDOCANNABINOID OXYGENATION; ARACHIDONIC-ACID; MOLECULAR-BASIS; ARGININE 120; CROSS-TALK	Prostaglandin endoperoxide H synthase-2 (PGHS-2), also known as cyclooxygenase-2 (COX-2), is a sequence homodimer. However, the enzyme exhibits half-site heme and inhibitor binding and functions as a conformational heterodimer having a catalytic subunit (E-cat) with heme bound and an allosteric subunit (E-allo) lacking heme. Some recombinant heterodimers composed of a COX-deficient mutant subunit and a native subunit (i.e. Mutant/Native PGHS-2) have COX activities similar to native PGHS-2. This suggests that the presence of heme plus substrate leads to the subunits becoming lodged in a semi-stable E-allo-mutant/E-cat-Native approximate to heme form during catalysis. We examined this concept using human PGHS-2 dimers composed of combinations of Y385F, R120Q, R120A, and S530A mutant or native subunits. With some heterodimers (e.g. Y385F/Native PGHS-2), heme binds with significantly higher affinity to the native subunit. This correlates with near native COX activity for the heterodimer. With other heterodimers (e.g. S530A/Native PGHS-2), heme binds with similar affinities to both subunits, and the COX activity approximates that expected for an enzyme in which each monomer contributes equally to the net COX activity. With or without heme, aspirin acetylates one-half of the subunits of the native PGHS-2 dimer, the E-cat subunits. Subunits having an S530A mutation are refractory to acetylation. Curiously, aspirin acetylates only one-quarter of the monomers of S530A/Native PGHS-2 with or without heme. This implies that there are comparable amounts of two noninterchangeable species of apoenzymes, E-allo-S530A/E-cat-Native and E-allo-Native/E-cat-S530A. These results suggest that native PGHS-2 assumes a reasonably stable, asymmetric E-allo/E-cat form during its folding and processing.	[Dong, Liang; Sharma, Narayan P.; Jurban, Brice J.; Smith, William L.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	smithww@med.umich.edu			National Institutes of Health [GM68848, CA130810, HL117798]; NATIONAL CANCER INSTITUTE [P50CA130810] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM68848, CA130810, and HL117798. W. L. S. serves as a consultant for Cayman Chemical Co., products from which were used in this study.	Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Brown JH, 2006, PROTEIN SCI, V15, P1, DOI 10.1110/ps.051658406; CHEN YNP, 1989, FASEB J, V3, P2294, DOI 10.1096/fasebj.3.11.2506093; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Fischer SM, 2011, CANCER PREV RES, V4, P1728, DOI 10.1158/1940-6207.CAPR-11-0166; Gierse JK, 2005, J PHARMACOL EXP THER, V312, P1206, DOI 10.1124/jpet.104.076877; Godoy-Ruiz R, 2011, J AM CHEM SOC, V133, P19578, DOI 10.1021/ja206967d; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; Guo QP, 1997, ARCH BIOCHEM BIOPHYS, V344, P150, DOI 10.1006/abbi.1997.0192; Hochgesang GP, 2000, J AM CHEM SOC, V122, P6514, DOI 10.1021/ja0003932; HOLTZMAN MJ, 1994, ANN NY ACAD SCI, V744, P58, DOI 10.1111/j.1749-6632.1994.tb52724.x; Koljak R, 2001, J BIOL CHEM, V276, P7033, DOI 10.1074/jbc.M009803200; Kozak KR, 2001, J BIOL CHEM, V276, P30072, DOI 10.1074/jbc.M104467200; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; KULMACZ RJ, 1989, J BIOL CHEM, V264, P14136; KULMACZ RJ, 1985, J BIOL CHEM, V260, P2572; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; Liu JY, 2007, J BIOL CHEM, V282, P18233, DOI 10.1074/jbc.M701235200; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; MANCINI JA, 1995, J BIOL CHEM, V270, P29372, DOI 10.1074/jbc.270.49.29372; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Nakanishi M, 2008, CANCER RES, V68, P3251, DOI 10.1158/0008-5472.CAN-07-6100; OTTO JC, 1993, J BIOL CHEM, V268, P18234; OTTO JC, 1994, J BIOL CHEM, V269, P19868; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Prusakiewicz JJ, 2004, BIOCHEMISTRY-US, V43, P15439, DOI 10.1021/bi048534q; Renda G, 2006, CLIN PHARMACOL THER, V80, P264, DOI 10.1016/j.clpt.2006.05.004; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; ROME LH, 1975, P NATL ACAD SCI USA, V72, P4863, DOI 10.1073/pnas.72.12.4863; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Schneider C, 2002, J BIOL CHEM, V277, P478, DOI 10.1074/jbc.M107471200; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Seibold SA, 2000, BIOCHEMISTRY-US, V39, P6616, DOI 10.1021/bi0002333; SEYDOUX F, 1974, Critical Reviews in Biochemistry, V2, P227, DOI 10.3109/10409237409105448; Sharma NP, 2010, MOL PHARMACOL, V77, P979, DOI 10.1124/mol.109.063115; SHIMOKAWA T, 1992, J BIOL CHEM, V267, P12387; Sidhu RS, 2010, BIOCHEMISTRY-US, V49, P7069, DOI 10.1021/bi1003298; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Song I, 2001, BIOCHEM BIOPH RES CO, V289, P869, DOI 10.1006/bbrc.2001.6071; Swapna LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036688; Taketo MM, 2012, J BIOCHEM, V151, P477, DOI 10.1093/jb/mvs035; Thuresson ED, 2001, J BIOL CHEM, V276, P10358, DOI 10.1074/jbc.M009378200; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; Uddin MJ, 2011, CANCER PREV RES, V4, P1536, DOI 10.1158/1940-6207.CAPR-11-0120; Uddin MJ, 2010, CANCER RES, V70, P3618, DOI 10.1158/0008-5472.CAN-09-2664; Vecchio AJ, 2012, J BIOL CHEM, V287, P24619, DOI 10.1074/jbc.M112.372243; Vecchio AJ, 2011, J STRUCT BIOL, V176, P254, DOI 10.1016/j.jsb.2011.07.019; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wada M, 2009, J BIOL CHEM, V284, P30742, DOI 10.1074/jbc.M109.052415; Xiao GS, 1998, J BIOL CHEM, V273, P6801, DOI 10.1074/jbc.273.12.6801; Xiao GS, 1997, BIOCHEMISTRY-US, V36, P1836, DOI 10.1021/bi962476u; Yu Y., 2012, SCI TRANSL MED, V4; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200; Zhen Yuejun, 1999, P157; Zou HC, 2012, J LIPID RES, V53, P1336, DOI 10.1194/jlr.M026856	70	25	26	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28641	28655		10.1074/jbc.M113.505503	http://dx.doi.org/10.1074/jbc.M113.505503			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23955344	hybrid, Green Published			2022-12-28	WOS:000330298800020
J	Hill, DR; Rho, HK; Kessler, SP; Amin, R; Homer, CR; McDonald, C; Cowman, MK; de la Motte, CA				Hill, David R.; Rho, Hyunjin K.; Kessler, Sean P.; Amin, Ripal; Homer, Craig R.; McDonald, Christine; Cowman, Mary K.; de la Motte, Carol A.			Human Milk Hyaluronan Enhances Innate Defense of the Intestinal Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cd44; Defensins; Epithelium; Host Defense; Hyaluronate; Toll-like Receptors (TLR); Salmonella Infection; Human Milk	MOLECULAR-WEIGHT HYALURONAN; IMMUNE-SYSTEM; BREAST; OLIGOSACCHARIDES; EXPRESSION; BETA-DEFENSIN-2; FRAGMENTS; ACID; CD44; PROTECTION	Breast-feeding is associated with enhanced protection from gastrointestinal disease in infants, mediated in part by an array of bioactive glycan components in milk that act through molecular mechanisms to inhibit enteric pathogen infection. Human milk contains hyaluronan (HA), a glycosaminoglycan polymer found in virtually all mammalian tissues. We have shown that synthetic HA of a specific size range promotes expression of antimicrobial peptides in intestinal epithelium. We hypothesize that hyaluronan from human milk also enhances innate antimicrobial defense. Here we define the concentration of HA in human milk during the first 6 months postpartum. Importantly, HA isolated from milk has a biological function. Treatment of HT-29 colonic epithelial cells with human milk HA at physiologic concentrations results in time- and dose-dependent induction of the antimicrobial peptide human -defensin 2 and is abrogated by digestion of milk HA with a specific hyaluronidase. Milk HA induction of human -defensin 2 expression is also reduced in the presence of a CD44-blocking antibody and is associated with a specific increase in ERK1/2 phosphorylation, suggesting a role for the HA receptor CD44. Furthermore, oral administration of human milk-derived HA to adult, wild-type mice results in induction of the murine H D2 ortholog in intestinal mucosa and is dependent upon both TLR4 and CD44 in vivo. Finally, treatment of cultured colonic epithelial cells with human milk HA enhances resistance to infection by the enteric pathogen Salmonella typhimurium. Together, our observations suggest that maternally provided HA stimulates protective antimicrobial defense in the newborn.	[Hill, David R.; McDonald, Christine; de la Motte, Carol A.] Cleveland Clin, Dept Mol Med, Cleveland, OH 44195 USA; [Hill, David R.; Rho, Hyunjin K.; Kessler, Sean P.; Amin, Ripal; Homer, Craig R.; McDonald, Christine; de la Motte, Carol A.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Cowman, Mary K.] NYU, Polytech Inst, Dept Chem & Biol Sci, Brooklyn, NY 11201 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; New York University; New York University Tandon School of Engineering	de la Motte, CA (corresponding author), Cleveland Clin, Dept Pathobiol, Lerner Res Inst, NC2, Cleveland, OH 44195 USA.	delamoc@ccf.org	Hill, David/H-9285-2019	Hill, David/0000-0002-1626-6079; McDonald, Christine/0000-0002-6745-9487	National Institutes of Health [HD061918, HL17147, R01DK82437]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061918] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HD061918 and HL17147 (to C. A. de la M.) and R01DK82437 (to C. M.).	Aksamitiene E, 2007, ELECTROPHORESIS, V28, P3163, DOI 10.1002/elps.200700002; Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Angeloni S, 2005, GLYCOBIOLOGY, V15, P31, DOI 10.1093/glycob/cwh143; Arnett E, 2011, CELL MICROBIOL, V13, P635, DOI 10.1111/j.1462-5822.2010.01563.x; Asakuma S, 2011, J BIOL CHEM, V286, P34583, DOI 10.1074/jbc.M111.248138; Asari A, 2010, J BIOL CHEM, V285, P24751, DOI 10.1074/jbc.M110.104950; Balogh L, 2008, J AGR FOOD CHEM, V56, P10582, DOI 10.1021/jf8017029; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Beck-Schimmer B, 1998, J AM SOC NEPHROL, V9, P2283; Bhilocha S, 2011, ANAL BIOCHEM, V417, P41, DOI 10.1016/j.ab.2011.05.026; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Bokor S, 2007, ANN NUTR METAB, V51, P550, DOI 10.1159/000114209; Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4; Brandtzaeg P, 2010, J PEDIATR-US, V156, pS8, DOI 10.1016/j.jpeds.2009.11.014; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Campo GM, 2010, BIOCHEM PHARMACOL, V80, P480, DOI 10.1016/j.bcp.2010.04.024; Cederlund A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053876; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Coppa GV, 2012, NEONATOLOGY, V101, P74, DOI 10.1159/000330848; Coppa GV, 2011, GLYCOBIOLOGY, V21, P295, DOI 10.1093/glycob/cwq164; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dusio GF, 2011, IMMUNOL CELL BIOL, V89, P630, DOI 10.1038/icb.2010.140; Froy O, 2005, CELL MICROBIOL, V7, P1387, DOI 10.1111/j.1462-5822.2005.00590.x; Gariboldi S, 2008, J IMMUNOL, V181, P2103, DOI 10.4049/jimmunol.181.3.2103; Garreis F, 2010, HISTOCHEM CELL BIOL, V134, P59, DOI 10.1007/s00418-010-0713-y; Gdalevich M, 2001, J AM ACAD DERMATOL, V45, P520, DOI 10.1067/mjd.2001.114741; Grulee CG, 1934, J AMER MED ASSOC, V103, P0735, DOI 10.1001/jama.1934.02750360011006; Hill DR, 2012, J BIOL CHEM, V287, P30610, DOI 10.1074/jbc.M112.356238; Hisada N, 2008, BIOSCI BIOTECH BIOCH, V72, P1111, DOI 10.1271/bbb.70748; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; HOWIE PW, 1990, BRIT MED J, V300, P11, DOI 10.1136/bmj.300.6716.11; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jones TF, 2006, PEDIATRICS, V118, P2380, DOI 10.1542/peds.2006-1218; Klement E, 2004, AM J CLIN NUTR, V80, P1342, DOI 10.1093/ajcn/80.5.1342; Kuntz S, 2008, BRIT J NUTR, V99, P462, DOI 10.1017/S0007114507824068; Kuntz S, 2009, BRIT J NUTR, V101, P1306, DOI 10.1017/S0007114508079622; LAURENT TC, 1995, ANN RHEUM DIS, V54, P429, DOI 10.1136/ard.54.5.429; Le Huerou-Luron I, 2010, NUTR RES REV, V23, P23, DOI 10.1017/S0954422410000065; Liu B, 2012, ANDROLOGIA, V44, P142, DOI 10.1111/j.1439-0272.2010.01122.x; M'Rabet L, 2008, J NUTR, V138, p1782S, DOI 10.1093/jn/138.9.1782S; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Martin LJ, 2006, AM J CLIN NUTR, V83, P1106, DOI 10.1093/ajcn/83.5.1106; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; Moon SK, 2002, BBA-MOL CELL RES, V1590, P41, DOI 10.1016/S0167-4889(02)00196-9; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Newburg DS, 2009, J ANIM SCI, V87, P26, DOI 10.2527/jas.2008-1347; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; NEWBURG DS, 1995, J NUTR, V125, P419; Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373; O'Neil DA, 2003, MOL IMMUNOL, V40, P445, DOI 10.1016/S0161-5890(03)00161-5; O'Neill LAJ, 2002, CURR TOP MICROBIOL, V270, P47; Oddy Wendy H, 2012, Breastfeed Rev, V20, P7; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; OHYA T, 1970, BIOCHIM BIOPHYS ACTA, V198, P607, DOI 10.1016/0005-2744(70)90139-7; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Palma GD, 2012, PLOS ONE, V7; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024; Riehl TE, 2012, AM J PHYSIOL-GASTR L, V302, pG309, DOI 10.1152/ajpgi.00248.2011; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Sela DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193359; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SHIMADA E, 1980, J BIOCHEM-TOKYO, V88, P1015, DOI 10.1093/oxfordjournals.jbchem.a133052; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wada A, 1999, BIOCHEM BIOPH RES CO, V263, P770, DOI 10.1006/bbrc.1999.1452; Ward PP, 2002, BIOCHEM CELL BIOL, V80, P95, DOI 10.1139/o01-214; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209; Yu ZT, 2013, GLYCOBIOLOGY, V23, P169, DOI 10.1093/glycob/cws138; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zheng L, 2009, GASTROENTEROLOGY, V137, P2041, DOI 10.1053/j.gastro.2009.08.055	81	60	63	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29090	29104		10.1074/jbc.M113.468629	http://dx.doi.org/10.1074/jbc.M113.468629			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23950179	Green Published, hybrid			2022-12-28	WOS:000330298800062
J	Thomer, L; Schneewind, O; Missiakas, D				Thomer, Lena; Schneewind, Olaf; Missiakas, Dominique			Multiple Ligands of von Willebrand Factor-binding Protein (vWbp) Promote Staphylococcus aureus Clot Formation in Human Plasma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-XIII; CROSS-LINKING; HUMAN-FIBRINOGEN; GAMMA-CHAINS; ACTIVATION; FIBRONECTIN; PROTHROMBIN; STAPHYLOCOAGULASE; INFECTIONS; THROMBIN	Staphylococcus aureus secretes coagulase (Coa) and von Willebrand factor-binding protein (vWbp) to activate host prothrombin and form fibrin cables, thereby promoting the establishment of infectious lesions. The D1-D2 domains of Coa and vWbp associate with, and non-proteolytically activate prothrombin. Moreover, Coa encompasses C-terminal tandem repeats for binding to fibrinogen, whereas vWbp has been reported to associate with von Willebrand factor and fibrinogen. Here we used affinity chromatography with non-catalytic Coa and vWbp to identify the ligands for these virulence factors in human plasma. vWbp bound to prothrombin, fibrinogen, fibronectin, and factor XIII, whereas Coa co-purified with prothrombin and fibrinogen. vWbp association with fibrinogen and factor XIII, but not fibronectin, required prothrombin and triggered the non-proteolytic activation of FXIII in vitro. Staphylococcus aureus coagulation of human plasma was associated with the recruitment of prothrombin, FXIII, and fibronectin as well as the formation of cross-linked fibrin. FXIII activity in staphylococcal clots could be attributed to thrombin-dependent proteolytic activation as well as vWbp-mediated non-proteolytic activation of FXIII zymogen.	[Thomer, Lena; Schneewind, Olaf; Missiakas, Dominique] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Missiakas, D (corresponding author), Univ Chicago, Dept Microbiol, 920 East 58th St,CLSC609b, Chicago, IL 60637 USA.	dmissiak@bsd.uchicago.edu			National Institutes of Health [AI092711, AI052747, AI075258, 1-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075258, RC4AI092711, U54AI057153, R41AI052747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI092711, AI052747 (to O.S.), and AI075258 (to D. M.) (NIAID, Infectious Diseases Branch) and 1-U54-AI-057153 (Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium).	Adams RLC, 2009, NEPHROLOGY, V14, P462, DOI 10.1111/j.1440-1797.2009.01128.x; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bamberger DM, 2005, AM FAM PHYSICIAN, V72, P2474; Bjerketorp J, 2002, MICROBIOL-SGM, V148, P2037, DOI 10.1099/00221287-148-7-2037; BLOMBACK B, 1985, THROMB RES, V37, P613, DOI 10.1016/0049-3848(85)90094-5; Cheng AG, 2011, TRENDS MICROBIOL, V19, P225, DOI 10.1016/j.tim.2011.01.007; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; CHOW TW, 1983, THROMB RES, V29, P243, DOI 10.1016/0049-3848(83)90146-9; CREDO RB, 1978, P NATL ACAD SCI USA, V75, P4234, DOI 10.1073/pnas.75.9.4234; CURTIS CG, 1974, BIOCHEMISTRY-US, V13, P3774, DOI 10.1021/bi00715a024; FORNACE AJ, 1984, J BIOL CHEM, V259, P2826; Frick IM, 2007, THROMB HAEMOSTASIS, V98, P497, DOI 10.1160/TH07-01-0051; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; GREENBERG CS, 1985, J CLIN INVEST, V75, P1463, DOI 10.1172/JCI111849; Greinacher A, 2008, THROMB HAEMOSTASIS, V99, P819, DOI 10.1160/TH07-11-0693; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Guggenberger C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002434; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HENDRIX H, 1983, J BIOL CHEM, V258, P3637; Herwald H, 2003, J THROMB HAEMOST, V1, P284, DOI 10.1046/j.1538-7836.2003.00105.x; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kroh HK, 2012, J BIOL CHEM, V287, P39149, DOI 10.1074/jbc.M112.415562; Kroh HK, 2009, P NATL ACAD SCI USA, V106, P7786, DOI 10.1073/pnas.0811750106; Levi M, 1997, EUR J CLIN INVEST, V27, P3, DOI 10.1046/j.1365-2362.1997.570614.x; Levi M, 2003, CARDIOVASC RES, V60, P26, DOI 10.1016/S0008-6363(02)00857-X; Loeb L, 1904, J MED RES, V10, P407; Loof TG, 2011, BLOOD, V118, P2589, DOI 10.1182/blood-2011-02-337568; Loof TG, 2011, J INNATE IMMUN, V3, P34, DOI 10.1159/000321641; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Matsuka YV, 2003, BIOCHEMISTRY-US, V42, P14643, DOI 10.1021/bi035239h; McAdow M, 2012, INFECT IMMUN, V80, P3389, DOI 10.1128/IAI.00562-12; McAdow M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002307; MOSHER DF, 1981, J INVEST DERMATOL, V77, P175, DOI 10.1111/1523-1747.ep12479791; Muszbek L, 1999, THROMB RES, V94, P271, DOI 10.1016/S0049-3848(99)00023-7; Nagy J A, 1988, Adv Exp Med Biol, V231, P29; OKADA M, 1985, J BIOL CHEM, V260, P1811; Palma M, 2001, J BIOL CHEM, V276, P31691, DOI 10.1074/jbc.M104554200; Panizzi P, 2004, CELL MOL LIFE SCI, V61, P2793, DOI 10.1007/s00018-004-4285-7; Panizzi P, 2011, NAT MED, V17, P1142, DOI 10.1038/nm.2423; Parry MAA, 1998, NAT STRUCT BIOL, V5, P917, DOI 10.1038/2359; SCHWARTZ ML, 1973, J BIOL CHEM, V248, P1395; SIEBENLIST KR, 1994, J BIOL CHEM, V269, P28414; Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206; Siebenlist KR, 2001, THROMB HAEMOSTASIS, V86, P1221; SKRZYNIA C, 1982, BLOOD, V60, P1089; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Weems JJ, 2001, POSTGRAD MED, V110, P24, DOI 10.3810/pgm.2001.10.1042; WOLFENSTEINTODEL C, 1981, BIOCHEMISTRY-US, V20, P6146, DOI 10.1021/bi00524a036	51	51	54	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28283	28292		10.1074/jbc.M113.493122	http://dx.doi.org/10.1074/jbc.M113.493122			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23960083	Green Published, hybrid			2022-12-28	WOS:000330612800049
J	Cabre, EJ; Sanchez-Gorostiaga, A; Carrara, P; Ropero, N; Casanova, M; Palacios, P; Stano, P; Jimenez, M; Rivas, G; Vicente, M				Cabre, Elisa J.; Sanchez-Gorostiaga, Alicia; Carrara, Paolo; Ropero, Noelia; Casanova, Mercedes; Palacios, Pilar; Stano, Pasquale; Jimenez, Mercedes; Rivas, German; Vicente, Miguel			Bacterial Division Proteins FtsZ and ZipA Induce Vesicle Shrinkage and Cell Membrane Invagination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; GIANT VESICLES; SEPTAL RING; ACTIN; RECONSTITUTION; LIPOSOMES; PROTOFILAMENTS; MORPHOGENESIS; RECRUITMENT; SEQUENCE	Permeable vesicles containing the proto-ring anchoring ZipA protein shrink when FtsZ, the main cell division protein, polymerizes in the presence of GTP. Shrinkage, resembling the constriction of the cytoplasmic membrane, occurs at ZipA densities higher than those found in the cell and is modulated by the dynamics of the FtsZ polymer. In vivo, an excess of ZipA generates multilayered membrane inclusions within the cytoplasm and causes the loss of the membrane function as a permeability barrier. Overproduction of ZipA at levels that block septation is accompanied by the displacement of FtsZ and two additional division proteins, FtsA and FtsN, from potential septation sites to clusters that colocalize with ZipA near the membrane. The results show that elementary constriction events mediated by defined elements involved in cell division can be evidenced both in bacteria and in vesicles.	[Cabre, Elisa J.; Ropero, Noelia; Jimenez, Mercedes; Rivas, German] CSIC, CIB, E-28040 Madrid, Spain; [Sanchez-Gorostiaga, Alicia; Casanova, Mercedes; Palacios, Pilar; Vicente, Miguel] CSIC, Ctr Nacl Biotecnol, Madrid 28049, Spain; [Carrara, Paolo; Stano, Pasquale] Univ Roma Tre, Dipartimento Biol, I-00146 Rome, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Roma Tre University	Vicente, M (corresponding author), CSIC, Ctr Nacl Biotecnol, C Darwin 3, Madrid 28049, Spain.	mvicente@cnb.csic.es	Sánchez-Gorostiaga, Alicia/K-6049-2014; Stano, Pasquale/ABH-1195-2020; Rivas, German/AFL-7528-2022; Sánchez-Gorostiaga, Alicia/AFV-4900-2022; Stano, Pasquale/AGG-8333-2022; Rivas, German/AAG-7458-2022; Jimenez Sarmiento, Mercedes/K-2691-2014	Sánchez-Gorostiaga, Alicia/0000-0002-2719-5659; Rivas, German/0000-0003-3450-7478; Sánchez-Gorostiaga, Alicia/0000-0002-2719-5659; Stano, Pasquale/0000-0002-2228-2825; Rivas, German/0000-0003-3450-7478; Jimenez Sarmiento, Mercedes/0000-0003-2006-1903; Jimenez-Cabre, Elisa/0000-0002-0493-6477	Human Frontier Science Program [RGP0050/2010]; European Commission [HEALTH-F3-2009-223431]; Spanish Government [BIO2011-28941-C03]	Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported by Human Frontier Science Program Grant RGP0050/2010, European Commission Contract HEALTH-F3-2009-223431, and Spanish Government Grant BIO2011-28941-C03 (all to M. V. and G.R.).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Addinall SG, 1996, MOL MICROBIOL, V22, P231, DOI 10.1046/j.1365-2958.1996.00100.x; Bendezu FO, 2008, J BACTERIOL, V190, P1792, DOI 10.1128/JB.01322-07; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Carrara P, 2012, CHEMBIOCHEM, V13, P1497, DOI 10.1002/cbic.201200133; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Corbin BD, 2002, EMBO J, V21, P1998, DOI 10.1093/emboj/21.8.1998; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; GARRIDO T, 1993, EMBO J, V12, P3957, DOI 10.1002/j.1460-2075.1993.tb06073.x; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hale CA, 1999, J BACTERIOL, V181, P167, DOI 10.1128/JB.181.1.167-176.1999; Hale CA, 2002, J BACTERIOL, V184, P2552, DOI 10.1128/JB.184.9.2552-2556.2002; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Hernandez-Rocamora VM, 2012, J BIOL CHEM, V287, P30097, DOI 10.1074/jbc.M112.388959; Hotani H, 1999, CURR OPIN COLLOID IN, V4, P358, DOI 10.1016/S1359-0294(99)90021-3; Rico AI, 2010, MOL MICROBIOL, V76, P760, DOI 10.1111/j.1365-2958.2010.07134.x; Jimenez M, 2011, J BIOL CHEM, V286, P11236, DOI 10.1074/jbc.M110.194365; Kenny CH, 2003, ANAL BIOCHEM, V323, P224, DOI 10.1016/j.ab.2003.08.033; Limozin L, 2003, EUR PHYS J E, V10, P319, DOI 10.1140/epje/i2002-10118-9; Liu AP, 2008, NAT PHYS, V4, P789, DOI 10.1038/nphys1071; Lopez-Montero I, 2013, BBA-BIOMEMBRANES, V1828, P687, DOI 10.1016/j.bbamem.2012.11.003; Lopez-Montero I, 2013, FASEB J, V27, P3363, DOI 10.1096/fj.12-224337; Martos A, 2012, TRENDS CELL BIOL, V22, P634, DOI 10.1016/j.tcb.2012.09.003; Martos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039829; Martos A, 2010, BIOCHEMISTRY-US, V49, P10780, DOI 10.1021/bi101495x; Mercier R, 2013, CELL, V152, P997, DOI 10.1016/j.cell.2013.01.043; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Ohashi T, 2002, J BACTERIOL, V184, P4313, DOI 10.1128/JB.184.15.4313-4315.2002; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2011, MOL MICROBIOL, V81, P571, DOI 10.1111/j.1365-2958.2011.07716.x; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Pautot S, 2003, LANGMUIR, V19, P2870, DOI 10.1021/la026100v; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Sambrook J., 2002, MOL CLONING LAB MANU; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; Sun SX, 2011, MICROBIOL MOL BIOL R, V75, P543, DOI 10.1128/MMBR.00006-11; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Takiguchi K, 2011, LANGMUIR, V27, P11528, DOI 10.1021/la2016287; Takiguchi K, 2009, METHOD ENZYMOL, V464, P31, DOI 10.1016/S0076-6879(09)64003-9; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Vischer N. O. E., 1994, BINARY, V6; Walde P, 2010, CHEMBIOCHEM, V11, P848, DOI 10.1002/cbic.201000010; Yanagisawa M, 2011, J AM CHEM SOC, V133, P11774, DOI 10.1021/ja2040859	52	52	53	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26625	26634		10.1074/jbc.M113.491688	http://dx.doi.org/10.1074/jbc.M113.491688			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23921390	Green Published, hybrid			2022-12-28	WOS:000330594500028
J	Harada, Y; Buser, R; Ngwa, EM; Hirayama, H; Aebi, M; Suzuki, T				Harada, Yoichiro; Buser, Reto; Ngwa, Elsy M.; Hirayama, Hiroto; Aebi, Markus; Suzuki, Tadashi			Eukaryotic Oligosaccharyltransferase Generates Free Oligosaccharides during N-Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Metabolism; Carbohydrate Processing; Endoplasmic Reticulum (ER); Glycobiology; Glycosylation; Glycosyltransferases; Oligosaccharide; N-glycosylation; Free Oligosaccharides; Oligosaccharyltransferase	SACCHAROMYCES-CEREVISIAE; YEAST OLIGOSACCHARYLTRANSFERASE; POLYMANNOSE OLIGOSACCHARIDES; LINKED GLYCANS; PROTEIN; COMPLEX; GENE; MEMBRANE; STT3; MANNOSYLTRANSFERASE	Background: The enzyme generating free oligosaccharides (fOSs) in the lumen of the endoplasmic reticulum (ER) has been unidentified. Results: Oligosaccharyltransferase (OST), the N-glycosylating enzyme, hydrolyzes dolichol-linked oligosaccharides to release the fOSs. Conclusion: OST is responsible for the generation of fOSs in the ER lumen. Significance: This study provides a mechanistic insight into the formation of luminal fOSs in yeast. Asparagine (N)-linked glycosylation regulates numerous cellular activities, such as glycoprotein quality control, intracellular trafficking, and cell-cell communications. In eukaryotes, the glycosylation reaction is catalyzed by oligosaccharyltransferase (OST), a multimembrane protein complex that is localized in the endoplasmic reticulum (ER). During N-glycosylation in the ER, the protein-unbound form of oligosaccharides (free oligosaccharides; fOSs), which is structurally related to N-glycan, is released into the ER lumen. However, the enzyme responsible for this process remains unidentified. Here, we demonstrate that eukaryotic OST generates fOSs. Biochemical and genetic analyses using mutant strains of Saccharomyces cerevisiae revealed that the generation of fOSs is tightly correlated with the N-glycosylation activity of OST. Furthermore, we present evidence that the purified OST complex can generate fOSs by hydrolyzing dolichol-linked oligosaccharide, the glycan donor substrate for N-glycosylation. The heterologous expression of a single subunit of OST from the protozoan Leishmania major in S. cerevisiae demonstrated that this enzyme functions both in N-glycosylation and generation of fOSs. This study provides insight into the mechanism of PNGase-independent formation of fOSs.	[Harada, Yoichiro; Hirayama, Hiroto; Suzuki, Tadashi] RIKEN, RIKEN Max Planck Joint Res Ctr, Global Res Cluster, Glycometabolome Team,Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Buser, Reto; Ngwa, Elsy M.; Aebi, Markus] ETH, Dept Biol, Inst Microbiol, CH-8093 Zurich, Switzerland	RIKEN; Swiss Federal Institutes of Technology Domain; ETH Zurich	Suzuki, T (corresponding author), RIKEN, RIKEN Max Planck Joint Res Ctr, Global Res Cluster, Glycometabolome Team,Syst Glycobiol Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp	hirayama, hiroto/HCH-9202-2022; Suzuki, Tadashi/AAX-5707-2021; Suzuki, Tadashi/I-4536-2014	Suzuki, Tadashi/0000-0003-1030-7631; Hirayama, Hiroto/0000-0003-1909-9488	Ministry of Education, Culture, Sports, Science and Technology of Japan [24770134, 25291030]; Global Center of Excellence Program; Swiss National Science Foundation [31003A_127098]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was partly supported by Grants-in-aid for Scientific Research 24770134 (to Y. H.) and 25291030 (to T. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Global Center of Excellence Program (to T. S.); and Swiss National Science Foundation Grant 31003A_127098 (to M. A.).	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; CACAN R, 1980, EUR J BIOCHEM, V106, P473, DOI 10.1111/j.1432-1033.1980.tb04594.x; Chantret I, 2003, BIOCHEM J, V373, P901, DOI 10.1042/BJ20030384; Chantret I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011734; Chavan M, 2006, P NATL ACAD SCI USA, V103, P8947, DOI 10.1073/pnas.0603262103; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Haga Y, 2009, GLYCOBIOLOGY, V19, P987, DOI 10.1093/glycob/cwp075; HANOVER JA, 1981, ARCH BIOCHEM BIOPHYS, V211, P1, DOI 10.1016/0003-9861(81)90423-9; Harada Y, 2009, P NATL ACAD SCI USA, V106, P6945, DOI 10.1073/pnas.0812489106; Harris SL, 1996, J CELL BIOL, V132, P985, DOI 10.1083/jcb.132.6.985; HASE S, 1979, J BIOCHEM-TOKYO, V85, P989, DOI 10.1093/oxfordjournals.jbchem.a132431; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Karaoglu D, 1997, J BIOL CHEM, V272, P32513, DOI 10.1074/jbc.272.51.32513; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; KELLEHER DJ, 1994, J BIOL CHEM, V269, P12908; Kelleher DJ, 2001, GLYCOBIOLOGY, V11, P321, DOI 10.1093/glycob/11.4.321; Kitajima T, 2006, FEBS J, V273, P5074, DOI 10.1111/j.1742-4658.2006.05505.x; Knauer R, 1999, J BIOL CHEM, V274, P17249, DOI 10.1074/jbc.274.24.17249; LEHLE L, 1984, BIOCHIM BIOPHYS ACTA, V799, P246, DOI 10.1016/0304-4165(84)90267-8; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McConville MJ, 2002, MICROBIOL MOL BIOL R, V66, P122, DOI 10.1128/MMBR.66.1.122-154.2002; MOORE SEH, 1995, EMBO J, V14, P6034, DOI 10.1002/j.1460-2075.1995.tb00292.x; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Nothaft H, 2009, P NATL ACAD SCI USA, V106, P15019, DOI 10.1073/pnas.0903078106; Reiss G, 1996, GLYCOBIOLOGY, V6, P493, DOI 10.1093/glycob/6.5.493; Reiss G, 1997, EMBO J, V16, P1164, DOI 10.1093/emboj/16.6.1164; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Spirig U, 2005, GLYCOBIOLOGY, V15, P1396, DOI 10.1093/glycob/cwj025; SPIRO MJ, 1991, J BIOL CHEM, V266, P5311; SUZUKI T, 1994, J BIOL CHEM, V269, P17611; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Suzuki T, 2008, ANAL BIOCHEM, V381, P224, DOI 10.1016/j.ab.2008.07.002; WELPLY JK, 1983, J BIOL CHEM, V258, P1856	44	37	38	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32673	32684		10.1074/jbc.M113.486985	http://dx.doi.org/10.1074/jbc.M113.486985			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24062310	Green Published, hybrid			2022-12-28	WOS:000328681700052
J	Pilla, E; Kilisch, M; Lenz, C; Urlaub, H; Geiss-Friedlander, R				Pilla, Esther; Kilisch, Markus; Lenz, Christof; Urlaub, Henning; Geiss-Friedlander, Ruth			The SUMO1-E67 Interacting Loop Peptide Is an Allosteric Inhibitor of the Dipeptidyl Peptidases 8 and 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Enzyme Inhibitors; Enzyme Kinetics; Peptidases; Peptide Interactions; Protease Inhibitor; DPP9; Dipeptidyl Peptidase; Prolylpeptidase; Prolylpeptidase; DPP8	CELL-PENETRATING PEPTIDES; IV INHIBITOR; DPP-IV; POTENT; EXPRESSION; LOCALIZATION; ACTIVATION; PROTEINS; DELIVERY; HOMOLOG	Background: SUMO1 binds to an arm motif in the prolyl-peptidase DPP9, leading to allosteric activation of the peptidase. Results: A SUMO1 peptide covering the DPP9 interaction surface inhibits DPP9 activity. Inhibition is dependent on residues in the DPP9 arm motif. Conclusion: The SUMO1 peptide and its variants are allosteric DPP9 inhibitors. Significance: This work highlights the potential use of peptides mimicking interaction surfaces for modulating enzyme activity. The intracellular peptidases dipeptidyl peptidase (DPP) 8 and DPP9 are involved in multiple cellular pathways including antigen maturation, cellular homeostasis, energy metabolism, and cell viability. Previously we showed that the small ubiquitin-like protein modifier SUMO1 interacts with an armlike structure in DPP9, leading to allosteric activation of the peptidase. Here we demonstrate that the E67-interacting loop (EIL) peptide, which corresponds to the interaction surface of SUMO1 with DPP9, acts as a noncompetitive inhibitor of DPP9. Moreover, by analyzing the sensitivity of DPP9 arm mutants to the EIL peptide, we mapped specific residues in the arm that are important for inhibition by the EIL, suggesting that the peptide acts as an allosteric inhibitor of DPP9. By modifying the EIL peptide, we constructed peptide variants with more than a 1,000-fold selectivity toward DPP8 (147 nm) and DPP9 (170 nm) over DPPIV (200 m). Furthermore, application of these peptides to cells leads to a clear inhibition of cellular prolyl peptidase activity. Importantly, in line with previous publications, inhibition of DPP9 with these novel allosteric peptide inhibitors leads to an increase in EGF-mediated phosphorylation of Akt. This work highlights the potential use of peptides that mimic interaction surfaces for modulating enzyme activity.	[Pilla, Esther; Kilisch, Markus; Geiss-Friedlander, Ruth] Univ Gottingen, Dept Mol Biol, Fac Med, D-37073 Gottingen, Germany; [Lenz, Christof; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Lenz, Christof; Urlaub, Henning] Univ Gottingen, Fac Med, Inst Clin Chem, D-37075 Gottingen, Germany	University of Gottingen; Max Planck Society; University of Gottingen	Geiss-Friedlander, R (corresponding author), Univ Gottingen, Dept Mol Biol, Humboldtallee 23, D-37073 Gottingen, Germany.	rgeiss@gwdg.de	Geiss-Friedlander, Ruth/G-3569-2013; Geiss-Friedlander, Ruth/AAT-8768-2020	Geiss-Friedlander, Ruth/0000-0002-1720-3440; Geiss-Friedlander, Ruth/0000-0002-1720-3440	Deutsche Forschungsgemeinschaft [2234/1-1, 1086/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Deutsche Forschungsgemeinschaft Grant 2234/1-1. SPR measurements were performed on a machine funded by Deutsche Forschungsgemeinschaft Grant 1086/2 (to M. K.).	Abbott CA, 2000, EUR J BIOCHEM, V267, P6140, DOI 10.1046/j.1432-1327.2000.01617.x; Ajami K, 2004, BBA-GENE STRUCT EXPR, V1679, P18, DOI 10.1016/j.bbaexp.2004.03.010; Augeri DJ, 2005, J MED CHEM, V48, P5025, DOI 10.1021/jm050261p; Burkey BF, 2008, DIABETES OBES METAB, V10, P1057, DOI 10.1111/j.1463-1326.2008.00860.x; Deshayes S, 2005, CELL MOL LIFE SCI, V62, P1839, DOI 10.1007/s00018-005-5109-0; Geiss-Friedlander R, 2009, J BIOL CHEM, V284, P27211, DOI 10.1074/jbc.M109.041871; Hauske P, 2008, CHEMBIOCHEM, V9, P2920, DOI 10.1002/cbic.200800528; Jiaang WT, 2005, BIOORG MED CHEM LETT, V15, P687, DOI 10.1016/j.bmcl.2004.11.023; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Lu CY, 2011, J BIOL CHEM, V286, P27494, DOI 10.1074/jbc.M111.224089; Matheeussen V, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0350-4; McIntosh CHS, 2005, REGUL PEPTIDES, V128, P159, DOI 10.1016/j.regpep.2004.06.001; Merdanovic M, 2013, ACS CHEM BIOL, V8, P19, DOI 10.1021/cb3005935; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Olsen C, 2002, GENE, V299, P185, DOI 10.1016/S0378-1119(02)01059-4; Park J., 2008, OPEN ENZYM INHIB J, V1, P52, DOI [10.2174/1874940200801010052, DOI 10.2174/1874940200801010052]; Pilla E, 2012, J BIOL CHEM, V287, P44320, DOI 10.1074/jbc.M112.397224; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Rummey C, 2007, PROTEINS, V66, P160, DOI 10.1002/prot.21138; Schade J, 2008, J HISTOCHEM CYTOCHEM, V56, P147, DOI 10.1369/jhc.7A7319.2007; Spagnuolo PA, 2013, LEUKEMIA, V27, P1236, DOI 10.1038/leu.2013.9; Sulda ML, 2010, CANCER BIOL THER, V10, P180, DOI 10.4161/cbt.10.2.12168; Tang HK, 2011, FEBS LETT, V585, P3409, DOI 10.1016/j.febslet.2011.10.009; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Van der Veken P, 2007, J MED CHEM, V50, P5568, DOI 10.1021/jm701005a; van Endert P, 2011, CELL MOL LIFE SCI, V68, P1553, DOI 10.1007/s00018-011-0662-1; Van Goethem S, 2011, J MED CHEM, V54, P5737, DOI 10.1021/jm200383j; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Vigneron N, 2011, CELL MOL LIFE SCI, V68, P1503, DOI 10.1007/s00018-011-0658-x; Villhauer EB, 2003, J MED CHEM, V46, P2774, DOI 10.1021/jm030091l; Wilson CH, 2013, J BIOL CHEM, V288, P13936, DOI 10.1074/jbc.M112.445841; Wolf BB, 2008, MINI-REV MED CHEM, V8, P719, DOI 10.2174/138955708784567449; Wu JJ, 2009, BIOCHEM PHARMACOL, V78, P203, DOI 10.1016/j.bcp.2009.03.032; Yao TW, 2011, MOL CANCER RES, V9, P948, DOI 10.1158/1541-7786.MCR-10-0272; Yu DMT, 2006, FEBS J, V273, P2447, DOI 10.1111/j.1742-4658.2006.05253.x; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Zhang H., 2013, MOL CANC RES, DOI 10.1158/1541-7786.MCR-13-0272	40	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32787	32796		10.1074/jbc.M113.489179	http://dx.doi.org/10.1074/jbc.M113.489179			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072711	Green Published, hybrid			2022-12-28	WOS:000328681700062
J	Ugolev, Y; Segal, T; Yaffe, D; Gros, Y; Schuldiner, S				Ugolev, Yelena; Segal, Tali; Yaffe, Dana; Gros, Yael; Schuldiner, Shimon			Identification of Conformationally Sensitive Residues Essential for Inhibition of Vesicular Monoamine Transport by the Noncompetitive Inhibitor Tetrabenazine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Directed Evolution; Membrane Proteins; Multidrug Transporters; Neurotransmitter Transport; Neurotransmitters; Ion-coupled Transporters; MFS Superfamily; PXXP Motifs	NEUROTRANSMITTER TRANSPORTERS; LIGAND RECOGNITION; MEMBRANE; MECHANISM; BINDING; ACETYLCHOLINE; CONTRIBUTE	Vesicular monoamine transporter 2 (VMAT2) transports monoamines into storage vesicles in a process that involves exchange of the charged monoamine with two protons. VMAT2 is a member of the DHA12 family of multidrug transporters that belongs to the major facilitator superfamily of secondary transporters. Tetrabenazine (TBZ) is a non-competitive inhibitor of VMAT2 that is used in the treatment of hyperkinetic disorders associated with Huntington disease and Tourette syndrome. Previous biochemical studies suggested that the recognition site for TBZ and monoamines is different. However, the precise mechanism of TBZ interaction with VMAT2 remains unknown. Here we used a random mutagenesis approach and selected TBZ-resistant mutants. The mutations clustered around the lumenal opening of the transporter and mapped to either conserved proline or glycine, or to residues immediately adjacent to conserved proline and glycine. Directed mutagenesis provides further support for the essential role of the latter residues. Our data strongly suggest that the conserved -helix breaking residues identified in this work play an important role in conformational rearrangements required for TBZ binding and substrate transport. Our results provide a novel insight into the mechanism of transport and TBZ binding by VMAT2.	[Ugolev, Yelena; Segal, Tali; Yaffe, Dana; Gros, Yael; Schuldiner, Shimon] Hebrew Univ Jerusalem, Alexander A Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Jerusalem, Israel.	Shimon.Schuldiner@huji.ac.il	Schuldiner, Shimon/F-7628-2012	Schuldiner, Shimon/0000-0002-4874-6237	National Institutes of Health [NS16708]; Lady Davis Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016708, R56NS016708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lady Davis Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS16708.; Recipient of a Lady Davis Fellowship.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adam Y, 2008, AM J PHYSIOL-CELL PH, V294, pC1004, DOI 10.1152/ajpcell.00348.2007; Blakely RD, 2012, COLD SPRING HARBOR P, V4; Chandrasekaran A, 2006, J NEUROCHEM, V98, P1551, DOI 10.1111/J.1471-4159.2006.03975.X; Chaudhry FA, 2008, ANNU REV PHARMACOL, V48, P277, DOI 10.1146/annurev.pharmtox.46.120604.141146; CONSLER TG, 1991, BIOCHEMISTRY-US, V30, P1291, DOI 10.1021/bi00219a019; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DARCHEN F, 1988, BIOCHEM PHARMACOL, V37, P4381, DOI 10.1016/0006-2952(88)90621-1; Eiden LE, 2000, FASEB J, V14, P2396, DOI 10.1096/fj.00-0817rev; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Erickson JD, 2000, FASEB J, V14, P2450, DOI 10.1096/fj.00-0206rev; Finn JP, 1998, J BIOL CHEM, V273, P3943, DOI 10.1074/jbc.273.7.3943; Finn JP, 1997, J BIOL CHEM, V272, P16301, DOI 10.1074/jbc.272.26.16301; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Friedmann Y, 2006, MOL PHARMACOL, V70, P1395, DOI 10.1124/mol.106.022962; Gros Y, 2010, J BIOL CHEM, V285, P5076, DOI 10.1074/jbc.M109.081216; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kenney Christopher, 2006, Expert Rev Neurother, V6, P7, DOI 10.1586/14737175.6.1.7; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Sagne C, 1997, BIOCHEMISTRY-US, V36, P3345, DOI 10.1021/bi9623439; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; SCHERMAN D, 1984, MOL PHARMACOL, V25, P113; SCHERMAN D, 1983, P NATL ACAD SCI-BIOL, V80, P584, DOI 10.1073/pnas.80.2.584; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHULDINER S, 1993, MOL PHARMACOL, V44, P1227; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sievert MK, 1997, J BIOL CHEM, V272, P26049, DOI 10.1074/jbc.272.41.26049; Sugihara J, 2012, P NATL ACAD SCI USA, V109, P14847, DOI 10.1073/pnas.1213445109; Vardy E, 2005, J BACTERIOL, V187, P7518, DOI 10.1128/JB.187.21.7518-7525.2005; Yaffe D, 2013, P NATL ACAD SCI USA, V110, pE1332, DOI 10.1073/pnas.1220497110; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Yelin R, 1995, FEBS LETT, V377, P201, DOI 10.1016/0014-5793(95)01346-6; Yelin R, 1998, J NEUROCHEM, V71, P2518; Zhou YG, 2009, J MOL BIOL, V394, P219, DOI 10.1016/j.jmb.2009.09.043	40	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32160	32171		10.1074/jbc.M113.502971	http://dx.doi.org/10.1074/jbc.M113.502971			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24062308	Green Published, hybrid			2022-12-28	WOS:000328681700006
J	Yu, YM; Schurpf, T; Springer, TA				Yu, Yamei; Schuerpf, Thomas; Springer, Timothy A.			How Natalizumab Binds and Antagonizes alpha(4) Integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Cell Surface; Crystal Structure; Immunology; Integrins; Structure	CELL-ADHESION MOLECULE-1; AMINO-ACID-RESIDUES; LIGAND-BINDING; COST-EFFECTIVENESS; CRYSTAL-STRUCTURE; AFFINITY; VCAM-1; ANTIBODIES; RECEPTOR; SITES	Natalizumab antibody to (4)-integrins is used in therapy of multiple sclerosis and Crohn's disease. A crystal structure of the Fab bound to an (4) integrin -propeller and thigh domain fragment shows that natalizumab recognizes human-mouse differences on the circumference of the -propeller domain. The epitope is adjacent to but outside of a ligand-binding groove formed at the interface with the -subunit I domain and shows no difference in structure when bound to Fab. Competition between Fab and the ligand vascular cell adhesion molecule (VCAM) for binding to cell surface (41) shows noncompetitive antagonism. In agreement, VCAM docking models suggest that binding of domain 1 of VCAM to (4)-integrins is unimpeded by the Fab, and that bound Fab requires a change in orientation between domains 1 and 2 of VCAM for binding to (41). Mapping of species-specific differences onto (41) and (47) shows that their ligand-binding sites are highly conserved. Skewing away from these conserved regions of the epitopes recognized by current therapeutic function-blocking antibodies has resulted in previously unanticipated mechanisms of action.	[Springer, Timothy A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02115 USA.	timothy.springer@childrens.harvard.edu	Schürpf, Thomas/E-7380-2012	Schurpf, Thomas/0000-0003-3023-1136	National Institutes of Health [HL-103526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health inhibitors than was originally envisioned. Grant HL-103526.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bakhshai Justin, 2010, J Med Econ, V13, P63, DOI 10.3111/13696990903543424; Bauer M, 2009, P NATL ACAD SCI USA, V106, P1920, DOI 10.1073/pnas.0808909106; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chigaev A, 2003, J BIOL CHEM, V278, P38174, DOI 10.1074/jbc.M210472200; CHIU HH, 1995, J IMMUNOL, V155, P5257; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; CHULUYAN HE, 1995, J IMMUNOL, V155, P3135; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DAVIS LS, 1990, J IMMUNOL, V145, P785; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; JONES EY, 1995, NATURE, V373, P539, DOI 10.1038/373539a0; KABSCH W, 2001, CRYSTALLOGRAPHY BIOL, P730; KAMATA T, 1995, BIOCHEM J, V305, P945, DOI 10.1042/bj3050945; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KENT SJ, 1995, J NEUROIMMUNOL, V58, P1, DOI 10.1016/0165-5728(94)00165-K; LAZARENO S, 1993, BRIT J PHARMACOL, V109, P1110, DOI 10.1111/j.1476-5381.1993.tb13737.x; Leger Olivier J. P., 1997, Human Antibodies, V8, P3; Li S, 2009, P NATL ACAD SCI USA, V106, P4349, DOI 10.1073/pnas.0810844106; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mi LZ, 2008, BIOCHEMISTRY-US, V47, P10314, DOI 10.1021/bi801006s; MURZIN AG, 1992, PROTEINS, V14, P191, DOI 10.1002/prot.340140206; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Newham P, 1998, J IMMUNOL, V160, P4508; Newham P, 1997, J BIOL CHEM, V272, P19429, DOI 10.1074/jbc.272.31.19429; O'Day Ken, 2011, J Med Econ, V14, P617, DOI 10.3111/13696998.2011.602444; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; PULIDO R, 1991, J BIOL CHEM, V266, P10241; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; SCHIFFER SG, 1995, J BIOL CHEM, V270, P14270, DOI 10.1074/jbc.270.24.14270; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Shapiro RI, 2011, J PHARMACEUT BIOMED, V55, P168, DOI 10.1016/j.jpba.2011.01.006; Sidhu SS, 2012, FEBS LETT, V586, P2778, DOI 10.1016/j.febslet.2012.05.044; Soler D, 2009, J PHARMACOL EXP THER, V330, P864, DOI 10.1124/jpet.109.153973; Springer TA, 2000, CELL, V102, P275, DOI 10.1016/S0092-8674(00)00033-7; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Targan SR, 2007, GASTROENTEROLOGY, V132, P1672, DOI 10.1053/j.gastro.2007.03.024; Thomas Saskia, 2012, Inflammopharmacology, V20, P1, DOI 10.1007/s10787-011-0104-6; von Andrian UH, 2003, NEW ENGL J MED, V348, P68, DOI 10.1056/NEJMe020157; VONDERHEIDE RH, 1994, J CELL BIOL, V125, P215, DOI 10.1083/jcb.125.1.215; VONDERHEIDE RH, 1992, J EXP MED, V175, P1433, DOI 10.1084/jem.175.6.1433; Wang JH, 1996, ACTA CRYSTALLOGR D, V52, P369, DOI 10.1107/S0907444995012352; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yu YM, 2012, J CELL BIOL, V196, P131, DOI 10.1083/jcb.201110023	51	49	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32314	32325		10.1074/jbc.M113.501668	http://dx.doi.org/10.1074/jbc.M113.501668			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24047894	Green Published, hybrid			2022-12-28	WOS:000328681700018
J	Shymanets, A; Prajwal; Bucher, K; Beer-Hammer, S; Harteneck, C; Nurnberg, B				Shymanets, Aliaksei; Prajwal; Bucher, Kirsten; Beer-Hammer, Sandra; Harteneck, Christian; Nuernberg, Bernd			p87 and p101 Subunits Are Distinct Regulators Determining Class I-B Phosphoinositide 3-Kinase (PI3K) Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-BETA-GAMMA; PROTEIN-COUPLED RECEPTORS; CATALYTIC SUBUNIT; ACTIVATION; PI3K-GAMMA; P110-BETA; ISOFORM; KINASE; ROLES; INHIBITION	Class IB phosphoinositide 3-kinase gamma (PI3K gamma) comprises a single catalytic p110 gamma subunit, which binds to two non-catalytic subunits, p87 or p101, and controls a plethora of fundamental cellular responses. The non-catalytic subunits are assumed to be redundant adaptors for G beta gamma enabling G-protein-coupled receptor-mediated regulation of PI3K gamma. Growing experimental data provide contradictory evidence. To elucidate the roles of the non-catalytic subunits in determining the specificity of PI3K gamma, we tested the impact of p87 and p101 in heterodimeric p87-p110 gamma and p101-p110 gamma complexes on the modulation of PI3K gamma activity in vitro and in living cells. RT-PCR, biochemical, and imaging data provide four lines of evidence: (i) specific expression patterns of p87 and p101, (ii) up-regulation of p101, providing the basis to consider p87 as a protein forming a constitutively and p101 as a protein forming an inducibly expressed PI3K gamma, (iii) differences in basal and stimulated enzymatic activities, and (iv) differences in complex stability, all indicating apparent diversity within class IB PI3K gamma. In conclusion, expression and activities of PI3K gamma are modified differently by p87 and p101 in vitro and in living cells, arguing for specific regulatory roles of the non-catalytic subunits in the differentiation of PI3K gamma signaling pathways.	[Nuernberg, Bernd] Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, D-72074 Tubingen, Germany; Univ Tubingen, Interfac Ctr Pharmacogen & Pharmaceut Res, D-72074 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Nurnberg, B (corresponding author), Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, Wilhelmstr 56, D-72074 Tubingen, Germany.	bernd.nuernberg@uni-tuebingen.de	Beer-Hammer, Sandra/C-7442-2014; Beer-Hammer, Sandra/AAK-4516-2020	Beer-Hammer, Sandra/0000-0001-6049-0257; Nurnberg, Bernd/0000-0002-5995-6555; , Prajwal/0000-0002-2621-3886; Bucher, Kirsten/0000-0003-4746-6337	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Deutsche Forschungsgemeinschaft.	Bohnacker T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000259; Brazzatti JA, 2012, ONCOGENE, V31, P2350, DOI 10.1038/onc.2011.414; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Ciraolo E, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1161577; Czupalla C, 2003, J BIOL CHEM, V278, P11536, DOI 10.1074/jbc.M210351200; Damilano F, 2010, ANN NY ACAD SCI, V1188, P39, DOI 10.1111/j.1749-6632.2009.05081.x; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Dbouk HA, 2010, P NATL ACAD SCI USA, V107, P19897, DOI 10.1073/pnas.1008739107; Fruman DA, 2009, IMMUNOL REV, V228, P253, DOI 10.1111/j.1600-065X.2008.00750.x; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kirsch C, 2001, BIOCHEM BIOPH RES CO, V282, P691, DOI 10.1006/bbrc.2001.4623; Kurig B, 2009, P NATL ACAD SCI USA, V106, P20312, DOI 10.1073/pnas.0905506106; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leopoldt D, 1997, N-S ARCH PHARMACOL, V356, P216, DOI 10.1007/PL00005044; Leopoldt D, 1998, J BIOL CHEM, V273, P7024, DOI 10.1074/jbc.273.12.7024; Luk SK, 2012, EUR J CANCER, V48, P149, DOI 10.1016/j.ejca.2011.09.006; Maier U, 2000, J BIOL CHEM, V275, P13746, DOI 10.1074/jbc.275.18.13746; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Perino A, 2011, MOL CELL, V42, P84, DOI 10.1016/j.molcel.2011.01.030; Preuss I, 2009, CELL SIGNAL, V21, P551, DOI 10.1016/j.cellsig.2008.12.007; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Shymanets A, 2012, BIOCHEM J, V441, P851, DOI 10.1042/BJ20111664; Shymanets A, 2009, PROTEIN PEPTIDE LETT, V16, P1053, DOI 10.2174/092986609789055340; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; Voigt P, 2005, J BIOL CHEM, V280, P5121, DOI 10.1074/jbc.M413104200; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walser R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001587; Williams R, 2009, BIOCHEM SOC T, V37, P615, DOI 10.1042/BST0370615; Wu H, 2007, BIOCHEM SOC T, V35, P242, DOI 10.1042/BST0350242; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Zhang XX, 2011, MOL CELL, V41, P567, DOI 10.1016/j.molcel.2011.01.026; Zhao L, 2010, CELL CYCLE, V9, P596, DOI 10.4161/cc.9.3.10599	50	32	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31059	31068		10.1074/jbc.M113.508234	http://dx.doi.org/10.1074/jbc.M113.508234			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24014027	Green Published, hybrid			2022-12-28	WOS:000330778900025
J	Wright, J; Birk, J; Haataja, L; Liu, M; Ramming, T; Weiss, MA; Appenzeller-Herzog, C; Arvan, P				Wright, Jordan; Birk, Julia; Haataja, Leena; Liu, Ming; Ramming, Thomas; Weiss, Michael A.; Appenzeller-Herzog, Christian; Arvan, Peter			Endoplasmic Reticulum Oxidoreductin-1 alpha (Ero1 alpha) Improves Folding and Secretion of Mutant Proinsulin and Limits Mutant Proinsulin-induced Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; SMALL-MOLECULE INHIBITOR; PANCREATIC BETA-CELLS; IN-VITRO; DIABETES-MELLITUS; OXIDATIVE STRESS; PATHWAY; PEPTIDE; PEROXIREDOXIN; GLUTATHIONE	Upon chronic up-regulation of proinsulin synthesis, misfolded proinsulin can accumulate in the endoplasmic reticulum (ER) of pancreatic beta-cells, promoting ER stress and type 2 diabetes mellitus. In Mutant Ins-gene-induced Diabetes of Youth (MIDY), misfolded mutant proinsulin impairs ER exit of co-expressed wild-type proinsulin, limiting insulin production and leading to eventual beta-cell death. In this study we have investigated the hypothesis that increased expression of ER oxidoreductin-1 alpha (Ero1 alpha), despite its established role in the generation of H2O2, might nevertheless be beneficial in limiting proinsulin misfolding and its adverse downstream consequences. Increased Ero1 alpha expression is effective in promoting wild-type proinsulin export from cells co-expressing misfolded mutant proinsulin. In addition, we find that upon increased Ero1 alpha expression, some of the MIDY mutants themselves are directly rescued from ER retention. Secretory rescue of proinsulin-G(B23)V is correlated with improved oxidative folding of mutant proinsulin. Indeed, using three different variants of Ero1 alpha, we find that expression of either wild-type or an Ero1 alpha variant lacking regulatory disulfides can rescue mutant proinsulin-G(B23)V, in parallel with its ability to provide an oxidizing environment in the ER lumen, whereas beneficial effects were less apparent for a redox-inactive form of Ero1. Increased expression of protein disulfide isomerase antagonizes the rescue provided by oxidatively active Ero1. Importantly, ER stress induced by misfolded proinsulin was limited by increased expression of Ero1 alpha, suggesting that enhancing the oxidative folding of proinsulin may be a viable therapeutic strategy in the treatment of type 2 diabetes.	[Wright, Jordan; Haataja, Leena; Liu, Ming; Arvan, Peter] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Birk, Julia; Ramming, Thomas; Appenzeller-Herzog, Christian] Univ Basel, Dept Pharmaceut Sci, Div Mol & Syst Toxicol, CH-4056 Basel, Switzerland; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; University of Basel; Case Western Reserve University	Arvan, P (corresponding author), Univ Michigan, Div Metab Endocrinol & Diabet, 5112 Brehm Ctr,1000 Wall St, Ann Arbor, MI 48105 USA.	parvan@umich.edu	Appenzeller-Herzog, Christian/A-2894-2014; Wright, Jordan/AAO-4376-2021	Appenzeller-Herzog, Christian/0000-0001-7430-294X; Wright, Jordan/0000-0002-2043-0150	Administrative Core of the National Institutes of Institutes of Health [NIH P60-DK20572]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572, R01DK069764, F30DK095504, R01DK048280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322, T32GM007863] Funding Source: NIH RePORTER	Administrative Core of the National Institutes of Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the Administrative Core of the National Institutes of Institutes of Health-funded Diabetes Research Center (NIH P60-DK20572) and thank S. B. Kent (University of Chicago) for discussions regarding chemical proinsulin synthesis. We acknowledge Bill and Dee Brehm for helping to create the Brehm Center for Diabetes Research at the University of Michigan and their support of the Brehm Coalition. We thank Ann Soliman, Ali Reda, and Kathryn Hutchison for technical assistance.	Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Appenzeller-Herzog C, 2011, J CELL SCI, V124, P847, DOI 10.1242/jcs.080895; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Birk Julia, 2013, Frontiers in Genetics, V4, P108, DOI 10.3389/fgene.2013.00108; Birk J, 2013, J CELL SCI, V126, P1604, DOI 10.1242/jcs.117218; Blais JD, 2010, J BIOL CHEM, V285, P20993, DOI 10.1074/jbc.M110.126599; Bulleid NJ, 2011, TRENDS BIOCHEM SCI, V36, P485, DOI 10.1016/j.tibs.2011.05.004; Enyedi B, 2010, ANTIOXID REDOX SIGN, V13, P721, DOI 10.1089/ars.2009.2880; Ferris SP, 2013, MOL BIOL CELL, V24, P2597, DOI 10.1091/mbc.E13-02-0101; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Haataja L, 2013, J BIOL CHEM, V288, P1896, DOI 10.1074/jbc.M112.420018; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hansen HG, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405050; Harding HP, 2012, J BIOL CHEM, V287, P44338, DOI 10.1074/jbc.M112.428987; Hodish I, 2010, J BIOL CHEM, V285, P685, DOI 10.1074/jbc.M109.038042; Karunakaran U, 2013, DIABETES METAB J, V37, P106, DOI 10.4093/dmj.2013.37.2.106; Khoo C, 2011, ENDOCRINOLOGY, V152, P2599, DOI 10.1210/en.2010-1420; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2003, J BIOL CHEM, V278, P14798, DOI 10.1074/jbc.M212070200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2012, DIABETES, V61, P828, DOI 10.2337/db11-0878; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Park SY, 2010, BIOCHEM BIOPH RES CO, V391, P1449, DOI 10.1016/j.bbrc.2009.12.090; Qiao ZS, 2003, J BIOL CHEM, V278, P17800, DOI 10.1074/jbc.M300906200; Rajan S, 2010, AM J PHYSIOL-ENDOC M, V298, pE403, DOI 10.1152/ajpendo.00592.2009; Rajpal G, 2012, J BIOL CHEM, V287, P43, DOI 10.1074/jbc.C111.279927; Ramming T, 2012, ANTIOXID REDOX SIGN, V16, P1109, DOI 10.1089/ars.2011.4475; Ron D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013177; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Thomas SE, 2011, WORLD J DIABETES, V2, P114, DOI 10.4239/wjd.v2.i7.114; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Volchuk A, 2010, DIABETES OBES METAB, V12, P48, DOI 10.1111/j.1463-1326.2010.01271.x; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Weiss MA, 2013, FEBS LETT, V587, P1942, DOI 10.1016/j.febslet.2013.04.044; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Wright J, 2013, J CLIN INVEST, V123, P3124, DOI 10.1172/JCI67260; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	45	29	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31010	31018		10.1074/jbc.M113.510065	http://dx.doi.org/10.1074/jbc.M113.510065			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24022479	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000330778900020
J	Taft, MH; Behrmann, E; Munske-Weidemann, LC; Thiel, C; Raunser, S; Manstein, DJ				Taft, Manuel H.; Behrmann, Elmar; Munske-Weidemann, Lena-Christin; Thiel, Claudia; Raunser, Stefan; Manstein, Dietmar J.			Functional Characterization of Human Myosin-18A and Its Interaction with F-actin and GOLPH3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cytoskeleton; Myosin; Protein Domains; Protein-Protein Interactions	PDZ-CONTAINING MYOSIN; KINETIC MECHANISM; MYSPDZ MYO18A; BINDING SITE; SALT-BRIDGE; MOTOR; DOMAIN; MUSCLE; IDENTIFICATION; COMPLEX	Background: Class-18A myosins share a unique N-terminal extension comprising a PDZ module and a KE-rich region. Results: Human myosin-18A binds F-actin via its motor domain in a nucleotide-dependent manner and via the KE-rich region, modulated by direct interaction between the PDZ module and GOLPH3. Conclusion: Myosin-18A binds F-actin and recruits interaction partners to the cytoskeleton. Significance: This work establishes a molecular basis for myosin-18A mediated membrane-cytoskeleton interplay. Molecular motors of the myosin superfamily share a generic motor domain region. They commonly bind actin in an ATP-sensitive manner, exhibit actin-activated ATPase activity, and generate force and movement in this interaction. Class-18 myosins form heavy chain dimers and contain protein interaction domains located at their unique N-terminal extension. Here, we characterized human myosin-18A molecular function in the interaction with nucleotides, F-actin, and its putative binding partner, the Golgi-associated phosphoprotein GOLPH3. We show that myosin-18A comprises two actin binding sites. One is located in the KE-rich region at the start of the N-terminal extension and appears to mediate ATP-independent binding to F-actin. The second actin-binding site resides in the generic motor domain and is regulated by nucleotide binding in the absence of intrinsic ATP hydrolysis competence. This core motor domain displays its highest actin affinity in the ADP state. Electron micrographs of myosin-18A motor domain-decorated F-actin filaments show a periodic binding pattern independent of the nucleotide state. We show that the PDZ module mediates direct binding of myosin-18A to GOLPH3, and this interaction in turn modulates the actin binding properties of the N-terminal extension. Thus, myosin-18A can act as an actin cross-linker with multiple regulatory modulators that targets interacting proteins or complexes to the actin-based cytoskeleton.	[Taft, Manuel H.; Munske-Weidemann, Lena-Christin; Thiel, Claudia; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Behrmann, Elmar; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany	Hannover Medical School; Max Planck Society	Taft, MH (corresponding author), Hannover Med Sch, Inst Biophys Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Taft.Manuel@MH-Hannover.de	Manstein, Dietmar J./AAG-2640-2019; Behrmann, Elmar/I-5808-2015; Raunser, Stefan/AHE-1573-2022; Taft, Manuel/O-1396-2019; Taft, Manuel H/T-2508-2017; Manstein, Dietmar J. J/M-1034-2013	Manstein, Dietmar J./0000-0003-0763-0147; Behrmann, Elmar/0000-0001-6794-3669; Taft, Manuel/0000-0001-5853-8629; Taft, Manuel H/0000-0001-5853-8629; Manstein, Dietmar J. J/0000-0003-0763-0147; Raunser, Stefan/0000-0001-9373-3016	Deutsche Forschungsgemeinschaft [MA 1081/19-1, RA 1781/1-1]; Fonds der Chemischen Industrie [684052]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by Deutsche Forschungsgemeinschaft Grants MA 1081/19-1 (to D. J. M.) and RA 1781/1-1 (to S. R.), Fonds der Chemischen Industrie Grant 684052 (to E. B.), and the Max Planck Society (to S. R. and E. B.).	BAGSHAW CR, 1975, FEBS LETT, V58, P197, DOI 10.1016/0014-5793(75)80258-4; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Diensthuber RP, 2011, FEBS LETT, V585, P767, DOI 10.1016/j.febslet.2011.01.042; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Dose AC, 2007, J BIOL CHEM, V282, P216, DOI 10.1074/jbc.M605964200; Dose AC, 2008, BIOCHEMISTRY-US, V47, P2485, DOI 10.1021/bi7021574; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; Furusawa T, 2000, BIOCHEM BIOPH RES CO, V270, P67, DOI 10.1006/bbrc.2000.2377; Guzik-Lendrum S, 2013, J BIOL CHEM, V288, P9532, DOI 10.1074/jbc.M112.441238; Guzik-Lendrum S, 2011, J BIOL CHEM, V286, P21755, DOI 10.1074/jbc.M111.218669; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; Hsu RM, 2010, MOL BIOL CELL, V21, P287, DOI 10.1091/mbc.E09-03-0232; Isogawa Y, 2005, BIOCHEMISTRY-US, V44, P6190, DOI 10.1021/bi0475931; Khromov A, 1998, BIOPHYS J, V75, P1926, DOI 10.1016/S0006-3495(98)77633-7; Kliche W, 2001, EMBO J, V20, P40, DOI 10.1093/emboj/20.1.40; KRISANDA JM, 1983, AM J PHYSIOL, V244, pC385, DOI 10.1152/ajpcell.1983.244.5.C385; Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061; Langer W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-676; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Lowey S, 2007, J MOL BIOL, V371, P902, DOI 10.1016/j.jmb.2007.05.080; Matsui K, 2011, J PROTEOME RES, V10, P3983, DOI 10.1021/pr200577d; Mori K, 2005, BIOCHEM BIOPH RES CO, V326, P491, DOI 10.1016/j.bbrc.2004.11.058; Mori K, 2003, J BIOCHEM, V133, P405, DOI 10.1093/jb/mvg053; Nalavadi V, 2005, J BIOL CHEM, V280, P38957, DOI 10.1074/jbc.M507161200; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Onishi H, 1998, P NATL ACAD SCI USA, V95, P6653, DOI 10.1073/pnas.95.12.6653; Ponomarev MA, 2000, BIOCHEMISTRY-US, V39, P4527, DOI 10.1021/bi992420a; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; ROTH K, 1991, MAGNET RESON MED, V22, P505, DOI 10.1002/mrm.1910220258; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; Struchholz S, 2009, J BIOL CHEM, V284, P3663, DOI 10.1074/jbc.M808338200; Taft MH, 2008, J BIOL CHEM, V283, P26902, DOI 10.1074/jbc.M802957200; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Ussowicz M, 2012, CANCER GENET-NY, V205, P261, DOI 10.1016/j.cancergen.2012.02.006; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; Walz C, 2005, LEUKEMIA, V19, P1005, DOI 10.1038/sj.leu.2403712; Waz C, 2009, GENE CHROMOSOME CANC, V48, P179, DOI 10.1002/gcc.20629; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Yang CH, 2005, J BIOL CHEM, V280, P34447, DOI 10.1074/jbc.M505229200; Zolkiewski M, 1996, BIOPHYS CHEM, V59, P365, DOI 10.1016/0301-4622(95)00129-8	46	44	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30029	30041		10.1074/jbc.M113.497180	http://dx.doi.org/10.1074/jbc.M113.497180			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23990465	hybrid, Green Published			2022-12-28	WOS:000329868100004
J	Arya, S; Sethi, D; Singh, S; Hade, MD; Singh, V; Raju, P; Chodisetti, SB; Verma, D; Varshney, GC; Agrewala, JN; Dikshit, KL				Arya, Swati; Sethi, Deepti; Singh, Sandeep; Hade, Mangesh Dattu; Singh, Vijender; Raju, Preeti; Chodisetti, Sathi Babu; Verma, Deepshikha; Varshney, Grish C.; Agrewala, Javed N.; Dikshit, Kanak L.			Truncated Hemoglobin, HbN, Is Post-translationally Modified in Mycobacterium tuberculosis and Modulates Host-Pathogen Interactions during Intracellular Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; GENE-EXPRESSION; OXYGEN-BINDING; IN-VITRO; MACROPHAGES; CELL; PROTEINS; RESPONSES; SURVIVAL; MANNOSE	Mycobacterium tuberculosis (Mtb) is a phenomenally successful human pathogen having evolved mechanisms that allow it to survive within the hazardous environment of macrophages and establish long term, persistent infection in the host against the control of cell-mediated immunity. One such mechanism is mediated by the truncated hemoglobin, HbN, of Mtb that displays a potent O-2-dependent nitric oxide dioxygenase activity and protects its host from the toxicity of macrophage-generated nitric oxide (NO). Here we demonstrate for the first time that HbN is post-translationally modified by glycosylation in Mtb and remains localized on the cell membrane and the cell wall. The glycan linkage in the HbN was identified as mannose. The elevated expression of HbN in Mtb and M. smegmatis facilitated their entry within the macrophages as compared with isogenic control cells, and mutation in the glycan linkage of HbN disrupted this effect. Additionally, HbN-expressing cells exhibited higher survival within the THP-1 and mouse peritoneal macrophages, simultaneously increasing the intracellular level of proinflammatory cytokines IL-6 and TNF-alpha and suppressing the expression of co-stimulatory surface markers CD80 and CD86. These results, thus, suggest the involvement of HbN in modulating the host-pathogen interactions and immune system of the host apart from protecting the bacilli from nitrosative stress inside the activated macrophages, consequently driving cells toward increased infectivity and intracellular survival.	[Arya, Swati; Sethi, Deepti; Singh, Sandeep; Hade, Mangesh Dattu; Singh, Vijender; Raju, Preeti; Chodisetti, Sathi Babu; Verma, Deepshikha; Varshney, Grish C.; Agrewala, Javed N.; Dikshit, Kanak L.] CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Dikshit, KL (corresponding author), CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India.		Hade, Mangesh/AAF-7217-2019; Agrewala, Javed Naim/AAS-8449-2021; Hade, Mangesh/ABD-8535-2021; Chodisetti, Sathi Babu/H-3239-2018	Hade, Mangesh/0000-0002-5937-9049; Chodisetti, Sathi Babu/0000-0001-7473-9420; Singh, Sandeep/0000-0001-9322-2929	European Commission; CSIR [SIP10, BSC0210]; Department of Biotechnology	European Commission(European CommissionEuropean Commission Joint Research Centre); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology	This work was supported by the European Commission under the FP7 program on health and CSIR Supra-institutional Project Grants SIP10 and BSC0210. This work was also supported by CSIR and the Department of Biotechnology (to S. A., D. S., and S.S.).	Agrewala JN, 1998, J IMMUNOL, V160, P1067; Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; Balkhi MY, 2004, J LEUKOCYTE BIOL, V75, P874, DOI 10.1189/jlb.1003476; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Cowley SC, 2001, GENE, V264, P225, DOI 10.1016/S0378-1119(01)00336-5; Craney A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019421; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Dahl JL, 2001, INFECT IMMUN, V69, P4295, DOI 10.1128/IAI.69.7.4295-4302.2001; Dutta NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028958; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Fimereli Danai K., 2012, Artificial Intelligence: Theories and Applications. Proceedings 7th Hellenic Conference on AI, SETN 2012, P285, DOI 10.1007/978-3-642-30448-4_36; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gao Q, 2005, MICROBIOL-SGM, V151, P5, DOI 10.1099/mic.0.27539-0; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; Giffin MM, 2012, J BACTERIOL, V194, P1045, DOI 10.1128/JB.05914-11; Gonzalez-Zamnorano M, 2009, J PROTEOME RES, V8, P721, DOI 10.1021/pr800756a; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; Herrmann JL, 2000, FEBS LETT, V473, P358, DOI 10.1016/S0014-5793(00)01553-2; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Khan N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002676; Koo MS, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-2; Lama A, 2006, FEBS LETT, V580, P4031, DOI 10.1016/j.febslet.2006.06.037; Lama A, 2009, J BIOL CHEM, V284, P14457, DOI 10.1074/jbc.M807436200; Manca C, 1999, J IMMUNOL, V162, P6740; Mendelson M, 2005, TUBERCULOSIS, V85, P407, DOI 10.1016/j.tube.2005.08.004; Michell SL, 2003, J BIOL CHEM, V278, P16423, DOI 10.1074/jbc.M207959200; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Pawaria S, 2008, APPL ENVIRON MICROB, V74, P3512, DOI 10.1128/AEM.02663-07; Pawaria S, 2007, MICROB PATHOGENESIS, V42, P119, DOI 10.1016/j.micpath.2006.12.001; Ragas A, 2007, J BIOL CHEM, V282, P5133, DOI 10.1074/jbc.M610183200; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Suvas S, 2002, J BIOL CHEM, V277, P7766, DOI 10.1074/jbc.M105902200; Wei J, 2000, J BACTERIOL, V182, P377, DOI 10.1128/JB.182.2.377-384.2000; WHO, 2008, TUB FACTS	49	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29987	29999		10.1074/jbc.M113.507301	http://dx.doi.org/10.1074/jbc.M113.507301			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23983123	Green Published, hybrid			2022-12-28	WOS:000330615300071
J	Charvet, CD; Saadane, A; Wang, MY; Salomon, RG; Brunengraber, H; Turko, IV; Pikuleva, IA				Charvet, Casey D.; Saadane, Aicha; Wang, Meiyao; Salomon, Robert G.; Brunengraber, Henri; Turko, Illarion V.; Pikuleva, Irina A.			Pretreatment with Pyridoxamine Mitigates Isolevuglandin-associated Retinal Effects in Mice Exposed to Bright Light	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED PHOTORECEPTOR DEGENERATION; 4-HYDROXYNONENAL PROTEIN ADDUCTS; LIPID-PEROXIDATION; GAMMA-KETOALDEHYDES; ISOPROSTANE PATHWAY; LIPOXIDATION REACTIONS; MOLECULAR-MECHANISMS; PIGMENT EPITHELIUM; ADVANCED GLYCATION; OXIDATIVE DAMAGE	The benefits of antioxidant therapy for treating age-related macular degeneration, a devastating retinal disease, are limited. Perhaps species other than reactive oxygen intermediates should be considered as therapeutic targets. These could be lipid peroxidation products, including isolevuglandins (isoLGs), prototypical and extraordinarily reactive gamma-ketoaldehydes that avidly bind to proteins, phospholipids, and DNA and modulate the properties of these biomolecules. We found isoLG adducts in aged human retina but not in the retina of mice kept under dim lighting. Hence, to test whether scavenging of isoLGs could complement or supplant antioxidant therapy, we exposed mice to bright light and found that this insult leads to retinal isoLG-adduct formation. We then pretreated mice with pyridoxamine, a B-6 vitamer and efficient scavenger of gamma-ketoaldehydes, and found that the levels of retinal isoLG adducts are decreased, and morphological changes in photoreceptor mitochondria are not as pronounced as in untreated animals. Our study demonstrates that preventing the damage to biomolecules by lipid peroxidation products, a novel concept in vision research, is a viable strategy to combat oxidative stress in the retina.	[Charvet, Casey D.; Saadane, Aicha; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Brunengraber, Henri] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Wang, Meiyao; Turko, Illarion V.] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Wang, Meiyao; Turko, Illarion V.] NIST, Div Analyt Chem, Gaithersburg, MD 20899 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; National Institute of Standards & Technology (NIST) - USA	Pikuleva, IA (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd,Rm 303, Cleveland, OH 44106 USA.	iap8@case.edu		Salomon, Robert/0000-0001-9456-3557; Pikuleva, Irina/0000-0001-9742-6232; Saadane, Aicha/0000-0001-9985-2147	National Institutes of Health [EY018383, GM21249, R33DK070291, T32-EY007157]; Visual Sciences Research Center [P30 EY11373]; Jules and Doris Stein Research Professorship from Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY018383, R01EY016813, P30EY011373, T32EY007157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Visual Sciences Research Center; Jules and Doris Stein Research Professorship from Research to Prevent Blindness; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY018383 (to I.A.P.), GM21249 (to R.G.S.), and R33DK070291 (to H.B.), and Visual Sciences Research Center Core Grant P30 EY11373. This work was also supported by the Jules and Doris Stein Research Professorship from Research to Prevent Blindness (to I.A.P.).; Recipient of a fellowship from the National Institutes of Health (Training Grant T32-EY007157).	Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bacot S, 2003, J LIPID RES, V44, P917, DOI 10.1194/jlr.M200450-JLR200; BASU AK, 1984, MUTAT RES, V129, P39, DOI 10.1016/0027-5107(84)90121-0; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Brame CJ, 1999, J BIOL CHEM, V274, P13139, DOI 10.1074/jbc.274.19.13139; Caldes C, 2011, CHEM BIODIVERS, V8, P1318, DOI 10.1002/cbdv.201000296; Charvet C, 2011, J BIOL CHEM, V286, P20413, DOI 10.1074/jbc.M111.232546; Charvet CD, 2013, J LIPID RES, V54, P1421, DOI 10.1194/jlr.M035790; Chen L, 2004, EXP EYE RES, V79, P239, DOI 10.1016/j.exer.2004.05.002; Chew EY, 2009, ARCH OPHTHALMOL-CHIC, V127, P1678, DOI 10.1001/archophthalmol.2009.312; Clayton PT, 2006, J INHERIT METAB DIS, V29, P317, DOI 10.1007/s10545-005-0243-2; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Davies SS, 2006, BIOCHEMISTRY-US, V45, P15756, DOI 10.1021/bi061860g; Davies SS, 2011, J ALZHEIMERS DIS, V27, P49, DOI 10.3233/JAD-2011-102118; Davies SS, 2004, CHEM PHYS LIPIDS, V128, P85, DOI 10.1016/j.chemphyslip.2003.10.007; Degenhardt TP, 2002, KIDNEY INT, V61, P939, DOI 10.1046/j.1523-1755.2002.00207.x; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; DIFRANCO E, 1995, CHEM RES TOXICOL, V8, P61, DOI 10.1021/tx00043a008; Donovan M, 2001, J BIOL CHEM, V276, P23000, DOI 10.1074/jbc.M005359200; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; EDER E, 1990, ENVIRON HEALTH PERSP, V88, P99, DOI 10.2307/3431058; ELDRED GE, 1993, NATURE, V364, P396; ESTERBAUER H, 1993, AM J CLIN NUTR, V57, P779, DOI 10.1093/ajcn/57.5.779S; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Fukuda K, 2005, CIRC RES, V97, P1262, DOI 10.1161/01.RES.0000195844.31466.e9; Galluzzi L, 2013, ONCOGENE, V32, P4995, DOI 10.1038/onc.2012.623; Govindarajan B, 2008, BIOCHEMISTRY-US, V47, P817, DOI 10.1021/bi701517m; Govindarajan B, 2009, MOL VIS, V15, P1079; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; GULCAN HG, 1993, INVEST OPHTH VIS SCI, V34, P3187; HABERLAND ME, 1988, SCIENCE, V241, P215, DOI 10.1126/science.2455346; Hahn P, 2004, MOL VIS, V10, P598; HENNIG B, 1988, FREE RADICAL BIO MED, V4, P99, DOI 10.1016/0891-5849(88)90070-6; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; HOUGLUM K, 1990, J CLIN INVEST, V86, P1991, DOI 10.1172/JCI114934; HUNT RC, 1992, J CELL PHYSIOL, V152, P102, DOI 10.1002/jcp.1041520114; Imanishi Y, 2008, J BIOL CHEM, V283, P25091, DOI 10.1074/jbc.M802981200; Jump DB, 2012, J LIPID RES, V53, P2525, DOI 10.1194/jlr.R027904; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kaur K, 1997, CHEM RES TOXICOL, V10, P1387, DOI 10.1021/tx970112c; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Krishnadev N, 2010, CURR OPIN OPHTHALMOL, V21, P184, DOI 10.1097/ICU.0b013e32833866ee; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; LAVAIL MM, 1987, CURR EYE RES, V6, P825, DOI 10.3109/02713688709034850; Levin L. A., 2011, ADLERS PHYSL EYE CLI, P243; Lewis EJ, 2012, J AM SOC NEPHROL, V23, P131, DOI 10.1681/ASN.2011030272; Li W, 2009, FREE RADICAL BIO MED, V47, P1539, DOI 10.1016/j.freeradbiomed.2009.09.003; Liao WL, 2008, ANAL BIOCHEM, V377, P55, DOI 10.1016/j.ab.2008.03.016; Liton PB, 2008, INVEST OPHTH VIS SCI, V49, P3961, DOI 10.1167/iovs.08-1915; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Malek G, 2003, AM J PATHOL, V162, P413, DOI 10.1016/S0002-9440(10)63836-9; Marchette LD, 2010, FREE RADICAL BIO MED, V48, P16, DOI 10.1016/j.freeradbiomed.2009.08.005; Markesbery WR, 1998, NEUROBIOL AGING, V19, P33, DOI 10.1016/S0197-4580(98)00009-8; Metz TO, 2003, ARCH BIOCHEM BIOPHYS, V419, P41, DOI 10.1016/j.abb.2003.08.021; Morris MC, 2002, JAMA-J AM MED ASSOC, V287, P3230, DOI 10.1001/jama.287.24.3230; Noell W K, 1966, Invest Ophthalmol, V5, P450; Ohishi K, 2005, FREE RADICAL RES, V39, P875, DOI 10.1080/10715760500177807; Ohishi K, 2006, FREE RADICAL RES, V40, P799, DOI 10.1080/10715760600555027; Omarova S, 2012, J CLIN INVEST, V122, P3012, DOI 10.1172/JCI63816; Onorato JM, 2000, J BIOL CHEM, V275, P21177, DOI 10.1074/jbc.M003263200; Ortega-Castro J, 2012, J PHYS CHEM A, V116, P2961, DOI 10.1021/jp210188w; Pascolini D, 2004, OPHTHAL EPIDEMIOL, V11, P67, DOI 10.1076/opep.11.2.67.28158; Poliakov E, 2003, FASEB J, V17, P2209, DOI 10.1096/fj.03-0086com; RIMINGTON C, 1965, LANCET, V1, P624; Roca A, 2004, NEUROSCIENCE, V129, P779, DOI 10.1016/j.neuroscience.2004.08.021; Rodriguez IR, 2009, PHOTOCHEM PHOTOBIOL, V85, P1116, DOI 10.1111/j.1751-1097.2009.00568.x; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Salomon R G, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P323; Salomon RG, 1999, J BIOL CHEM, V274, P20271, DOI 10.1074/jbc.274.29.20271; Salomon RG, 2000, TRENDS CARDIOVAS MED, V10, P53, DOI 10.1016/S1050-1738(00)00040-2; Salomon RG, 1997, CHEM RES TOXICOL, V10, P750, DOI 10.1021/tx970016b; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Sha W, 2000, J ORG CHEM, V65, P5315, DOI 10.1021/jo000537v; Siems WG, 1996, FREE RADICAL BIO MED, V20, P215, DOI 10.1016/0891-5849(95)02041-1; Smith RS, 2002, RES METH MUT M SER, P25; Song DL, 2012, FREE RADICAL BIO MED, V53, P64, DOI 10.1016/j.freeradbiomed.2012.04.020; Stavrovskaya IG, 2010, FREE RADICAL BIO MED, V49, P567, DOI 10.1016/j.freeradbiomed.2010.04.037; Stitt A, 2002, DIABETES, V51, P2826, DOI 10.2337/diabetes.51.9.2826; Stone J, 2008, BRAIN RES, V1189, P58, DOI 10.1016/j.brainres.2007.10.083; Subbanagounder G, 1997, J ORG CHEM, V62, P7658, DOI 10.1021/jo970858f; Sullivan CB, 2010, J LIPID RES, V51, P999, DOI 10.1194/jlr.M001040; TANDLER B, 1972, ANAT REC, V173, P309, DOI 10.1002/ar.1091730306; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P3859, DOI 10.1167/iovs.05-0672; van der Ham M, 2012, ANAL CHIM ACTA, V712, P108, DOI 10.1016/j.aca.2011.11.018; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Williams ME, 2007, AM J NEPHROL, V27, P605, DOI 10.1159/000108104; Xu LB, 2009, J AM CHEM SOC, V131, P13037, DOI 10.1021/ja9029076; Yefimova MG, 2000, INVEST OPHTH VIS SCI, V41, P2343; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6; Zagol-Ikapitte I, 2005, J NEUROCHEM, V94, P1140, DOI 10.1111/j.1471-4159.2005.03264.x	100	21	21	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29267	29280		10.1074/jbc.M113.498832	http://dx.doi.org/10.1074/jbc.M113.498832			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23970548	hybrid, Green Published			2022-12-28	WOS:000330615300007
J	Keyamura, K; Sakaguchi, C; Kubota, Y; Niki, H; Hishida, T				Keyamura, Kenji; Sakaguchi, Chikako; Kubota, Yoshino; Niki, Hironori; Hishida, Takashi			RecA Protein Recruits Structural Maintenance of Chromosomes (SMC)-like RecN Protein to DNA Double-strand Breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; BACILLUS-SUBTILIS RECN; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; HOLLIDAY JUNCTION; CRYSTAL-STRUCTURE; RECBCD ENZYME; GENE-PRODUCT; SMC PROTEINS; REPAIR	Escherichia coli RecN is an SMC (structural maintenance of chromosomes) family protein that is required for DNA double-strand break (DSB) repair. Previous studies show that GFP-RecN forms nucleoid-associated foci in response to DNA damage, but the mechanism by which RecN is recruited to the nucleoid is unknown. Here, we show that the assembly of GFP-RecN foci on the nucleoid in response to DNA damage involves a functional interaction between RecN and RecA. A novel RecA allele identified in this work, recA(Q300R), is proficient in SOS induction and repair of UV-induced DNA damage, but is deficient in repair of mitomycin C (MMC)-induced DNA damage. Cells carrying recA(Q300R) fail to recruit RecN to DSBs and accumulate fragmented chromosomes after exposure to MMC. The ATPase-deficient RecN(K35A) binds and forms foci at MMC-induced DSBs, but is not released from the MMC-induced DNA lesions, resulting in a defect in homologous recombination-dependent DSB repair. These data suggest that RecN plays a crucial role in homologous recombination-dependent DSB repair and that it is required upstream of RecA-mediated strand exchange.	[Keyamura, Kenji; Hishida, Takashi] Gakushuin Univ, Grad Sch Sci, Dept Life Sci, Tokyo 1718588, Japan; [Sakaguchi, Chikako; Kubota, Yoshino; Hishida, Takashi] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Niki, Hironori] Natl Inst Genet, Genet Strains Res Ctr, Microbial Genet Lab, Mishima, Shizuoka 4118540, Japan	Gakushuin University; Osaka University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Hishida, T (corresponding author), Gakushuin Univ, Grad Sch Sci, Dept Life Sci, Tokyo 1718588, Japan.	takashi.hishida@gakushuin.ac.jp		Hishida, Takashi/0000-0002-9752-6599; Niki, Hironori/0000-0002-5391-6595	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [24114516, 24570010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T.H.).	Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Au N, 2005, J BACTERIOL, V187, P7655, DOI 10.1128/JB.187.22.7655-7666.2005; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bentchikou E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000774; Cao Z, 2010, DNA REPAIR, V9, P66, DOI 10.1016/j.dnarep.2009.10.009; Courcelle J, 2001, GENETICS, V158, P41; Cox MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000815; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2001, P NATL ACAD SCI USA, V98, P8173, DOI 10.1073/pnas.131004998; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FINCH PW, 1985, J BACTERIOL, V164, P653, DOI 10.1128/JB.164.2.653-658.1985; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Graumann PL, 2001, BIOCHIMIE, V83, P53, DOI 10.1016/S0300-9084(00)01218-9; Grove JI, 2009, DNA REPAIR, V8, P1434, DOI 10.1016/j.dnarep.2009.09.015; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Humayun MZ, 1998, MOL MICROBIOL, V30, P905, DOI 10.1046/j.1365-2958.1998.01120.x; Ishioka K, 1998, GENES CELLS, V3, P209, DOI 10.1046/j.1365-2443.1998.00185.x; Kosa JL, 2004, MUTAT RES-FUND MOL M, V554, P149, DOI 10.1016/j.mrfmmm.2004.04.011; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; LITTLE JW, 1979, P NATL ACAD SCI USA, V76, P6147, DOI 10.1073/pnas.76.12.6147; LLOYD RG, 1993, EMBO J, V12, P17, DOI 10.1002/j.1460-2075.1993.tb05627.x; LLOYD RG, 1983, MOL GEN GENET, V190, P162, DOI 10.1007/BF00330340; LLOYD RG, 1987, J GEN MICROBIOL, V133, P2531; LLOYD RG, 1996, ESCHERICHIA COLI SAL, P2236; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; Meddows TR, 2004, MOL MICROBIOL, V52, P119, DOI 10.1111/j.1365-2958.2003.03970.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Nagashima K, 2006, J BIOL CHEM, V281, P30941, DOI 10.1074/jbc.M606566200; Nozaki S, 2009, J BACTERIOL, V191, P4807, DOI 10.1128/JB.00435-09; Pellegrino S, 2012, STRUCTURE, V20, P2076, DOI 10.1016/j.str.2012.09.010; PICKSLEY SM, 1984, MOL GEN GENET, V195, P267, DOI 10.1007/BF00332758; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Reyes ED, 2010, J BIOL CHEM, V285, P16521, DOI 10.1074/jbc.M110.119164; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; ROSTAS K, 1987, NUCLEIC ACIDS RES, V15, P5041, DOI 10.1093/nar/15.13.5041; Sambrook J., 2002, MOL CLONING LAB MANU; Sanchez H, 2005, NUCLEIC ACIDS RES, V33, P2343, DOI 10.1093/nar/gki533; Sanchez H, 2006, J BACTERIOL, V188, P353, DOI 10.1128/JB.188.2.353-360.2006; SARGENTINI NJ, 1983, RADIAT RES, V93, P461, DOI 10.2307/3576026; Sharples GJ, 1999, J BACTERIOL, V181, P5543, DOI 10.1128/JB.181.18.5543-5550.1999; Shibata T, 2005, GENES CELLS, V10, P181, DOI 10.1111/j.1365-2443.2005.00831.x; Shinagawa H, 1996, TRENDS BIOCHEM SCI, V21, P107, DOI 10.1016/0968-0004(96)10014-1; Simmons LA, 2009, J BACTERIOL, V191, P1152, DOI 10.1128/JB.01292-08; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; WANG TCV, 1988, J BACTERIOL, V170, P2555, DOI 10.1128/jb.170.6.2555-2559.1988	55	28	28	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29229	29237		10.1074/jbc.M113.485474	http://dx.doi.org/10.1074/jbc.M113.485474			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23974212	Green Published, hybrid			2022-12-28	WOS:000330615300002
J	Pathak, RR; Grover, A; Malaney, P; Quarni, W; Pandit, A; Allen-Gipson, D; Dave, V				Pathak, Ravi Ramesh; Grover, Aditya; Malaney, Prerna; Quarni, Waise; Pandit, Ashish; Allen-Gipson, Diane; Dave, Vrushank			Loss of Phosphatase and Tensin Homolog (PTEN) Induces Leptin-mediated Leptin Gene Expression FEED-FORWARD LOOP OPERATING IN THE LUNG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; FALSE DISCOVERY RATE; MOUSE OBESE GENE; BREAST-CANCER; CELL-PROLIFERATION; PULMONARY HOMEOSTASIS; ANTITUMOR-ACTIVITY; OB GENE; INJURY	Elevated levels of systemic and pulmonary leptin are associated with diseases related to lung injury and lung cancer. However, the role of leptin in lung biology and pathology, including the mechanism of leptin gene expression in the pathogenesis of lung diseases, including lung cancer, remains elusive. Here, using conditional deletion of tumor suppressor gene Pten in the lung epithelium in vivo in transgenic mice and human PTEN-null lung epithelial cells, we identify the leptin-driven feed-forward signaling loop in the lung epithelial cells. Leptin-mediated leptin/leptin-receptor gene expression likely amplifies leptin signaling that may contribute to the pathogenesis and severity of lung diseases, resulting in poor clinical outcomes. Loss of Pten in the lung epithelial cells in vivo activated adipokine signaling and induced leptin synthesis as ascertained by genome-wide mRNA profiling and pathway analysis. Leptin gene transcription was mediated by binding of transcription factors NRF-1 and CCAAT/enhancer-binding protein delta (C/EBP) to the proximal promoter regions and STAT3 to the distal promoter regions as revealed by leptin promoter-mutation, chromatin immunoprecipitation, and gain-and loss-of-function studies in lung epithelial cells. Leptin treatment induced expression of the leptin/leptin receptor in the lung epithelial cells via activation of MEK/ERK, PI3K/AKT/mammalian target of rapamycin (mTOR), and JAK2/STAT3 signaling pathways. Expression of constitutively active MEK-1, AKT, and STAT3 proteins increased expression, and treatment with MEK, PI3K, AKT, and mTOR inhibitors decreased LEP expression, indicating that leptin via MAPK/ERK1/2, PI3K/AKT/mTOR, and JAK2/STAT3 pathways, in turn, further induces its own gene expression. Thus, targeted inhibition of the leptin-mediated feed-forward loop provides a novel rationale for pharmacotherapy of disease associated with lung injury and remodeling, including lung cancer.	[Dave, Vrushank] Morsani Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Dave, Vrushank] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Grover, Aditya] Univ S Florida, Coll Arts & Sci Undergrad Honors Program, Tampa, FL 33620 USA; [Pandit, Ashish; Allen-Gipson, Diane] Univ S Florida, Coll Pharm, Tampa, FL 33620 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Dave, V (corresponding author), Morsani Coll Med, Dept Pathol & Cell Biol, MDC 64,12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	vdave@health.usf.edu	Quarni, Waise/J-1095-2019; Dave, Vrushank/K-5262-2012	Dave, Vrushank/0000-0003-4044-2658; Allen-Gipson, Diane/0000-0001-6976-3960	National Institutes of Health-Lung SPORE Career Development Grant; American Heart Association Scientist Development Grant [SDG-0830101N]	National Institutes of Health-Lung SPORE Career Development Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health-Lung SPORE Career Development Grant (to V. D.). This work was supported by American Heart Association Scientist Development Grant SDG-0830101N (to V.D.).	Aleffi S, 2005, HEPATOLOGY, V42, P1339, DOI 10.1002/hep.20965; Aleman MR, 2002, CYTOKINE, V19, P21, DOI 10.1006/cyto.2002.1051; Ando S, 2012, NAT REV ENDOCRINOL, V8, P263, DOI 10.1038/nrendo.2011.184; Barazzone-Argiroffo C, 2001, AM J PHYSIOL-LUNG C, V281, pL1150, DOI 10.1152/ajplung.2001.281.5.L1150; Bellmeyer A, 2007, AM J RESP CRIT CARE, V175, P587, DOI 10.1164/rccm.200603-312OC; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bergen HT, 2002, AM J RESP CELL MOL, V27, P71, DOI 10.1165/ajrcmb.27.1.4540; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Broekhuizen R, 2005, RESP MED, V99, P70, DOI 10.1016/j.rmed.2004.03.029; Bruno A, 2005, EUR RESPIR J, V26, P398, DOI 10.1183/09031936.05.00092404; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Calfee CS, 2011, AM J RESP CRIT CARE, V183, P1660, DOI 10.1164/rccm.201011-1802OC; Carpagnano GE, 2007, ONCOL RES, V16, P375; Cassel TN, 2003, AM J PHYSIOL-LUNG C, V285, pL773, DOI 10.1152/ajplung.00023.2003; da Silva PL, 2012, OBESITY FACTS, V5, P806, DOI 10.1159/000345840; Dave V, 2008, AM J RESP CELL MOL, V38, P337, DOI 10.1165/rcmb.2007-0182OC; delaBrousse FC, 1996, P NATL ACAD SCI USA, V93, P4096, DOI 10.1073/pnas.93.9.4096; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; DOBBS LG, 1989, ANNU REV MED, V40, P431; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Ekins S., 2006, HIGH CONTENT SCREENI, P319, DOI [10.1385/1-59745-217-3:319, DOI 10.1385/1-59745-217-3:319]; Ekins S, 2007, METH MOL B, V356, P319; Fuke T, 2010, INT J OBESITY, V34, P670, DOI 10.1038/ijo.2009.295; Gao HW, 2004, J IMMUNOL, V172, P7703, DOI 10.4049/jimmunol.172.12.7703; Gong DW, 1996, J BIOL CHEM, V271, P3971; Gonzalez RR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2321; Gonzalez-Perez RR, 2010, CELL SIGNAL, V22, P1350, DOI 10.1016/j.cellsig.2010.05.003; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; HE YF, 1995, J BIOL CHEM, V270, P28887, DOI 10.1074/jbc.270.48.28887; Henson MC, 2004, REPRODUCTION, V127, P87, DOI 10.1530/rep.1.00037; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hokuto I, 2004, J CLIN INVEST, V113, P28, DOI 10.1172/JCI200419491; Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jain M, 2011, AM J RESP CRIT CARE, V183, P1490, DOI 10.1164/rccm.201009-1409OC; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karakas S, 2005, INT J CLIN PRACT, V59, P1167, DOI 10.1111/j.1368-5031.2005.00567.x; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; MacCallum NS, 2005, CURR OPIN CRIT CARE, V11, P43, DOI 10.1097/00075198-200502000-00007; Maina JN, 2005, PHYSIOL REV, V85, P811, DOI 10.1152/physrev.00022.2004; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Malli F, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-152; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Mihai C, 2012, AM J PHYSIOL-LUNG C, V302, pL287, DOI 10.1152/ajplung.00037.2011; Miller SG, 1996, P NATL ACAD SCI USA, V93, P5507, DOI 10.1073/pnas.93.11.5507; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Minokoshi Y, 2003, BIOCHEM SOC T, V31, P196, DOI 10.1042/bst0310196; Miyoshi K, 2013, AM J RESP CRIT CARE, V187, P262, DOI 10.1164/rccm.201205-0851OC; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Okumura M, 2002, BBA-MOL CELL RES, V1592, P107, DOI 10.1016/S0167-4889(02)00276-8; Onuma M, 2003, J BIOL CHEM, V278, P42660, DOI 10.1074/jbc.M304984200; Porter RK, 1998, P NUTR SOC, V57, P455, DOI 10.1079/PNS19980065; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ribeiro R, 2007, J THORAC ONCOL, V2, P105, DOI 10.1016/S1556-0864(15)30035-6; Roos AB, 2012, J ENDOCRINOL, V212, P291, DOI 10.1530/JOE-11-0369; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Schiller KR, 2010, AM J PHYSIOL-CELL PH, V299, pC912, DOI 10.1152/ajpcell.00215.2010; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Semba S, 2002, CLIN CANCER RES, V8, P1957; Shen YH, 2009, MOL MED REP, V2, P295, DOI 10.3892/mmr_00000099; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Sood A, 2010, J APPL PHYSIOL, V108, P744, DOI 10.1152/japplphysiol.00838.2009; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Tiozzo C, 2009, AM J RESP CRIT CARE, V180, P701, DOI 10.1164/rccm.200901-0100OC; Torday JS, 2002, AM J PHYSIOL-LUNG C, V282, pL405, DOI 10.1152/ajplung.2002.282.3.L405; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; VanSaun MN, 2013, CLIN CANCER RES, V19, P1926, DOI 10.1158/1078-0432.CCR-12-0930; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Vernooy JHJ, 2009, THORAX, V64, P26, DOI 10.1136/thx.2007.085423; Vernooy JHJ, 2013, PULM PHARMACOL THER, V26, P464, DOI 10.1016/j.pupt.2013.03.016; Vernooy JHJ, 2010, J IMMUNOL, V184, P7169, DOI 10.4049/jimmunol.0900963; Wolf G, 2006, CONTRIB NEPHROL, V151, P175, DOI 10.1159/000095328; Wu NL, 2010, EXP DERMATOL, V19, pE173, DOI 10.1111/j.1600-0625.2009.01036.x; Xu YJ, 2011, J CANCER RES CLIN, V137, P1841, DOI 10.1007/s00432-011-1054-5; Yan CG, 2013, AM J PATHOL, V182, P420, DOI 10.1016/j.ajpath.2012.10.013; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Zhou W, 2011, BRIT J CANCER, V104, P128, DOI 10.1038/sj.bjc.6606013	90	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29821	29835		10.1074/jbc.M113.481523	http://dx.doi.org/10.1074/jbc.M113.481523			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23963458	hybrid, Green Published			2022-12-28	WOS:000330615300056
J	Caster, AH; Kahn, RA				Caster, Amanda H.; Kahn, Richard A.			Recruitment of the Mint3 Adaptor Is Necessary for Export of the Amyloid Precursor Protein (APP) from the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Proteins; Amyloid Precursor Protein; Golgi; Lysosomes; Membrane Trafficking; ADP-ribosylation Factor; Mint3; Recycling Endosomes	BREFELDIN-A; COAT PROTEINS; TRAFFICKING PATHWAYS; DEPENDENT ADAPTER; CELL BIOLOGY; BETA; TRANSPORT; ARF; SIGNALS; CARGO	The amyloid precursor protein (APP) is a ubiquitously expressed single-pass transmembrane protein that undergoes proteolytic processing by secretases to generate the pathogenic amyloid- peptide, the major component in Alzheimer plaques. The traffic of APP through the cell determines its exposure to secretases and consequently the cleavages that generate the pathogenic or nonpathogenic peptide fragments. Despite the likely importance of APP traffic to Alzheimer disease, we still lack clear models for the routing and regulation of APP in cells. Like the traffic of most transmembrane proteins, the binding of adaptors to its cytoplasmic tail, which is 47 residues long and contains at least four distinct sorting motifs, regulates that of APP. We tested each of these for effects on the traffic of APP from the Golgi by mutating key residues within them and examining adaptor recruitment at the Golgi and traffic to post-Golgi site(s). We demonstrate strict specificity for recruitment of the Mint3 adaptor by APP at the Golgi, a critical role for Tyr-682 (within the YENPTY motif) in Mint3 recruitment and export of APP from the Golgi, and we identify LAMP1(+) structures as the proximal destination of APP after leaving the Golgi. Together, these data provide a detailed view of the first sorting step in its route to the cell surface and processing by secretases and further highlight the critical role played by Mint3.	[Caster, Amanda H.; Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	rkahn@emory.edu	Kahn, Richard/ABD-2666-2020	Kahn, Richard/0000-0002-0259-0601	National Institutes of Health from NIGMS [R01 GM067226]; Imaging Core of the Emory Neuroscience NINDS Core Facilities [P30 NS055077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Imaging Core of the Emory Neuroscience NINDS Core Facilities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM067226 from NIGMS and Grant P30 NS055077 (Imaging Core of the Emory Neuroscience NINDS Core Facilities).	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Aridor M, 2002, TRAFFIC, V3, P537, DOI 10.1034/j.1600-0854.2002.30804.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Caster Amanda H, 2012, Cell Logist, V2, P176; Caster AH, 2013, J BIOL CHEM, V288, P14788, DOI 10.1074/jbc.M113.453621; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; DUCLOS F, 1993, P NATL ACAD SCI USA, V90, P109, DOI 10.1073/pnas.90.1.109; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; Han JB, 2008, J CELL SCI, V121, P2217, DOI 10.1242/jcs.019745; Hill K, 2003, J BIOL CHEM, V278, P36032, DOI 10.1074/jbc.M301632200; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Hirst J, 2007, TRAFFIC, V8, P594, DOI 10.1111/j.1600-0854.2007.00556.x; Icking A, 2007, TRAFFIC, V8, P285, DOI 10.1111/j.1600-0854.2006.00526.x; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; Lah JJ, 2000, MOL CELL NEUROSCI, V16, P111, DOI 10.1006/mcne.2000.0861; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Marks MS, 1996, J CELL BIOL, V135, P341, DOI 10.1083/jcb.135.2.341; Nordeng TW, 1999, J BIOL CHEM, V274, P21139, DOI 10.1074/jbc.274.30.21139; Okamoto M, 2001, NEUROSCIENCE, V104, P653, DOI 10.1016/S0306-4522(01)00124-5; Okamoto M, 1998, EUR J CELL BIOL, V77, P161, DOI 10.1016/S0171-9335(98)80103-9; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pols MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2360; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Ramelot TA, 2000, BIOCHEMISTRY-US, V39, P2714, DOI 10.1021/bi992580m; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; Saito Y., 2011, PLOS ONE, V6; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Shrivastava-Ranjan P, 2008, MOL BIOL CELL, V19, P51, DOI 10.1091/mbc.E07-05-0465; Siman R, 2003, J NEUROCHEM, V84, P1143, DOI 10.1046/j.1471-4159.2003.01616.x; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; STROUS GJ, 1991, BIOL CELL, V71, P25, DOI 10.1016/0248-4900(91)90048-R; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; VALNES K, 1985, J HISTOCHEM CYTOCHEM, V33, P755, DOI 10.1177/33.8.3926864; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748	55	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28567	28580		10.1074/jbc.M113.481101	http://dx.doi.org/10.1074/jbc.M113.481101			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23965993	hybrid, Green Published			2022-12-28	WOS:000330298800014
J	Yumimoto, K; Matsumoto, M; Onoyama, I; Imaizumi, K; Nakayama, KI				Yumimoto, Kanae; Matsumoto, Masaki; Onoyama, Ichiro; Imaizumi, Kazunori; Nakayama, Keiichi I.			F-box and WD Repeat Domain-containing-7 (Fbxw7) Protein Targets Endoplasmic Reticulum-anchored Osteogenic and Chondrogenic Transcriptional Factors for Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mesenchymal Stem Cells; Protein Degradation; Proteomics; Transcription Factors; Ubiquitin Ligase; F-box Protein	PHOSPHORYLATION-DEPENDENT DEGRADATION; STEM-CELL DIFFERENTIATION; FBW7 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; CYCLIN-E; C-MYC; CAENORHABDITIS-ELEGANS; STRESS TRANSDUCER; HUMAN CANCER; FACTOR OASIS	Although identification of substrates for an enzyme is a key step in elucidation of its biological functions, detection of the interaction between enzymes and substrates remains challenging. We recently developed a new approach, termed differential proteomics-based identification of ubiquitylation substrates (DiPIUS), for the discovery of substrates of ubiquitin ligases. We have now applied this approach to Fbxw7, the F-box protein component of an Skp1-Cul1-F-box protein-type ubiquitin ligase and, thereby, identified two similar transcription factors, old astrocyte specifically induced substance (OASIS) and BBF2 human homolog on chromosome 7 (BBF2H7), as candidate substrates. Coimmunoprecipitation analysis confirmed that the and isoforms of Fbxw7 interact with OASIS and BBF2H7 in vivo. Sustained overexpression of Fbxw7 resulted in marked down-regulation of OASIS and BBF2H7, whereas RNAi-mediated Fbxw7 depletion stabilized both proteins. Mutation of a putative Cdc4 phosphodegron in OASIS and BBF2H7 attenuated their association with Fbxw7 and resulted in their stabilization. Depletion of Fbxw7 promoted the differentiation of mouse C2C12 mesenchymal cells into osteoblasts in association with the accumulation of OASIS. Conversely, overexpression of Fbxw7 in C2C12 cells resulted in down-regulation of Col1A1 mRNA, a target of OASIS. Conditional ablation of Fbxw7 in primary mouse mesenchymal cells promoted chondrogenesis in association with up-regulation of BBF2H7, whereas overexpression of Fbxw7 inhibited chondrogenesis in ATDC5 cells. Collectively, our results suggest that OASIS and BBF2H7 are bona fide substrates of Fbxw7 and that Fbxw7 controls osteogenesis and chondrogenesis by targeting OASIS and BBF2H7, respectively, for degradation.	[Yumimoto, Kanae; Matsumoto, Masaki; Onoyama, Ichiro; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Yumimoto, Kanae; Matsumoto, Masaki; Onoyama, Ichiro; Nakayama, Keiichi I.] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Imaizumi, Kazunori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Biochem, Minami Ku, Hiroshima 7348553, Japan	Kyushu University; Japan Science & Technology Agency (JST); Hiroshima University	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp		Matsumoto, Masaki/0000-0002-6987-0288	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [25650069] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Babaei-Jadidi R, 2011, J EXP MED, V208, P295, DOI 10.1084/jem.20100830; Bengoechea-Alonso MT, 2010, P NATL ACAD SCI USA, V107, P11817, DOI 10.1073/pnas.0913367107; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cassavaugh JM, 2011, J CELL BIOCHEM, V112, P3882, DOI 10.1002/jcb.23321; Flugel D, 2012, BLOOD, V119, P1292, DOI 10.1182/blood-2011-08-375014; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hoeck JD, 2010, NAT NEUROSCI, V13, P1365, DOI 10.1038/nn.2644; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kumadaki S, 2011, J BIOL CHEM, V286, P40835, DOI 10.1074/jbc.M111.235283; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Matsumoto A, 2011, J BIOL CHEM, V286, P13754, DOI 10.1074/jbc.M110.194936; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nikaido T, 2001, HISTOCHEM CELL BIOL, V116, P141; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Onoyama I, 2011, J CLIN INVEST, V121, P342, DOI 10.1172/JCI40725; Reavie L, 2013, CANCER CELL, V23, P362, DOI 10.1016/j.ccr.2013.01.025; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Sancho R, 2010, GASTROENTEROLOGY, V139, P929, DOI 10.1053/j.gastro.2010.05.078; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; SUNDARAM M, 1993, GENETICS, V135, P765; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Takeishi S, 2013, CANCER CELL, V23, P347, DOI 10.1016/j.ccr.2013.01.026; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yumimoto K, 2012, J PROTEOME RES, V11, P3175, DOI 10.1021/pr201216u; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040	52	28	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28488	28502		10.1074/jbc.M113.465179	http://dx.doi.org/10.1074/jbc.M113.465179			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23955342	Green Published, hybrid			2022-12-28	WOS:000330298800007
J	Le Nours, J; Paton, AW; Byres, E; Troy, S; Herdman, BP; Johnson, MD; Paton, JC; Rossjohn, J; Beddoe, T				Le Nours, Jerome; Paton, Adrienne W.; Byres, Emma; Troy, Sally; Herdman, Brock P.; Johnson, Matthew D.; Paton, James C.; Rossjohn, Jamie; Beddoe, Travis			Structural Basis of Subtilase Cytotoxin SubAB Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-LABILE ENTEROTOXIN; ESCHERICHIA-COLI; HYBRID TOXINS; CHOLERA-TOXIN; CHAPERONE; SUBUNIT; TRAFFICKING; GENERATION	Pathogenic strains of Escherichia coli produce a number of toxins that belong to the AB(5) toxin family, which comprise a catalytic A-subunit that induces cellular dysfunction and a B-pentamer that recognizes host glycans. Although the molecular actions of many of the individual subunits of AB(5) toxins are well understood, how they self-associate and the effect of this association on cytotoxicity are poorly understood. Here we have solved the structure of the holo-SubAB toxin that, in contrast to other AB(5) toxins whose molecular targets are located in the cytosol, cleaves the endoplasmic reticulum chaperone BiP. SubA interacts with SubB in a similar manner to other AB(5) toxins via the A2 helix and a conserved disulfide bond that joins the A1 domain with the A2 helix. The structure revealed that the active site of SubA is not occluded by the B-pentamer, and the B-pentamer does not enhance or inhibit the activity of SubA. Structure-based sequence comparisons with other AB(5) toxin family members, combined with extensive mutagenesis studies on SubB, show how the hydrophobic patch on top of the B-pentamer plays a dominant role in binding the A-subunit. The structure of SubAB and the accompanying functional characterization of various mutants of SubAB provide a framework for understanding the important role of the B-pentamer in the assembly and the intracellular trafficking of this AB(5) toxin.	[Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Australian Res Council ARC Ctr Excellence Struct, Clayton, Vic 3800, Australia; [Le Nours, Jerome; Byres, Emma; Troy, Sally; Johnson, Matthew D.; Rossjohn, Jamie; Beddoe, Travis] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic, Australia; [Paton, Adrienne W.; Herdman, Brock P.; Paton, James C.] Univ Adelaide, Res Ctr Infect Dis, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; University of Adelaide; Cardiff University	Rossjohn, J (corresponding author), Monash Univ, Australian Res Council ARC Ctr Excellence Struct, Clayton, Vic 3800, Australia.	Jamie.Rossjohn@monash.edu; Travis.Beddoe@monash.edu	Rossjohn, Jamie/F-9032-2013; johnson, matthew/L-7626-2017; Beddoe, Travis/F-3415-2014	Rossjohn, Jamie/0000-0002-2020-7522; johnson, matthew/0000-0002-0808-3336; Beddoe, Travis/0000-0003-4550-2277; Le Nours, Jerome/0000-0002-2221-7636	National Health and Medical Research Council of Australia (NHMRC) [565526, 1002792]; Australian Research Council [DP1095420, DP120103178]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by Program Grant 565526 and Project Grant 1002792 from the National Health and Medical Research Council of Australia (NHMRC) and Discovery Grants DP1095420 and DP120103178 from the Australian Research Council.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Bricogne G, 2011, AUTO BUSTER VERSION; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chong DC, 2008, CELL MICROBIOL, V10, P795, DOI 10.1111/j.1462-5822.2007.01085.x; CONNELL TD, 1992, INFECT IMMUN, V60, P1653, DOI 10.1128/IAI.60.4.1653-1661.1992; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W., 2006, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan EK, 2000, CURR OPIN STRUC BIOL, V10, P680, DOI 10.1016/S0959-440X(00)00152-4; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Holst M, 2000, J COMPUT CHEM, V21, P1319, DOI 10.1002/1096-987X(20001130)21:15<1319::AID-JCC1>3.0.CO;2-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; Madsen D., 2005, INDONESIA INTEGRATED; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okamoto K, 1998, J BACTERIOL, V180, P1368, DOI 10.1128/JB.180.6.1368-1374.1998; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rodighiero C, 1999, J BIOL CHEM, V274, P3962, DOI 10.1074/jbc.274.7.3962; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TAKEDA Y, 1981, INFECT IMMUN, V34, P341, DOI 10.1128/IAI.34.2.341-346.1981; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Tinker JK, 2003, INFECT IMMUN, V71, P4093, DOI 10.1128/IAI.71.7.4093-4101.2003; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; vandenAkker F, 1996, STRUCTURE, V4, P665, DOI 10.1016/S0969-2126(96)00073-1; WEINSTEIN DL, 1989, INFECT IMMUN, V57, P3743, DOI 10.1128/IAI.57.12.3743-3750.1989; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	33	18	21	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27505	27516		10.1074/jbc.M113.462622	http://dx.doi.org/10.1074/jbc.M113.462622			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23921389	hybrid, Green Published			2022-12-28	WOS:000330597300045
J	Wei, JD; Kim, JY; Kim, AK; Jang, SK; Kim, JH				Wei, Jun-Dong; Kim, Joo-Young; Kim, Ae-Kyoung; Jang, Sung Key; Kim, Jae-Hong			RanBPM Protein Acts as a Negative Regulator of BLT2 Receptor to Attenuate BLT2-mediated Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOTRIENE B-4 RECEPTOR; INTERACTING PROTEINS; SCAFFOLDING PROTEIN; PANCREATIC-CANCER; SIGNALING PATHWAY; BINDING-PROTEIN; BREAST-CANCER; ACTIVATION; CHEMOTAXIS; EXPRESSION	BLT2, a low affinity receptor for leukotriene B-4 (LTB4), is a member of the G protein-coupled receptor family and is involved in many signal transduction pathways associated with various cellular phenotypes, including chemotactic motility. However, the regulatory mechanism for BLT2 has not yet been demonstrated. To understand the regulatory mechanism of BLT2, we screened and identified the proteins that bind to BLT2. Using a yeast two-hybrid assay with the BLT2 C-terminal domain as bait, we found that RanBPM, a previously proposed scaffold protein, interacts with BLT2. We demonstrated the specific interaction between BLT2 and RanBPM by GST pull-down assay and co-immunoprecipitation assay. To elucidate the biological function of the RanBPM-BLT2 interaction, we evaluated the effects of RanBPM overexpression or knockdown. We found that BLT2-mediated motility was severely attenuated by RanBPM overexpression and that knockdown of endogenous RanBPM by shRNA strongly promoted BLT2-mediated motility, suggesting a negative regulatory function of RanBPM toward BLT2. Furthermore, we observed that the addition of BLT2 ligands caused the dissociation of BLT2 and RanBPM, thus releasing the negative regulatory effect of RanBPM. Finally, we propose that Akt-induced BLT2 phosphorylation at residue Thr(355), which occurs after the addition of BLT2 ligands, is a potential mechanism by which BLT2 dissociates from RanBPM, resulting in stimulation of BLT2 signaling. Taken together, our results suggest that RanBPM acts as a negative regulator of BLT2 signaling to attenuate BLT2-mediated cell motility.	[Wei, Jun-Dong; Kim, Joo-Young; Kim, Jae-Hong] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Kim, Ae-Kyoung] Panbionet Corp, POSTECH Biotech Ctr, Pohang 790784, Kyungbuk, South Korea; [Jang, Sung Key] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea	Korea University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, JH (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, 5-1 Anam Dong, Seoul 136701, South Korea.	jhongkim@korea.ac.kr	Kim, Jae-Hong/B-2530-2009; Jang, Sung K/P-1230-2017	Kim, Jae-Hong/0000-0002-8019-0208; 	Bio and Medical Technology Development Program [2012M3A9C5048709]; Basic Science Research Program through the National Research Foundation (NRF) [2012R1A2A2A01044526]; Ministry of Science, ICT and Future Planning, Republic of Korea; National Research and Development Program for Cancer Control [1220020]; Ministry for Health and Welfare, Republic of Korea; Korea University [G1300090]	Bio and Medical Technology Development Program; Basic Science Research Program through the National Research Foundation (NRF); Ministry of Science, ICT and Future Planning, Republic of Korea; National Research and Development Program for Cancer Control; Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea University	This work was supported by grants from the Bio and Medical Technology Development Program (Grant 2012M3A9C5048709), the Basic Science Research Program (Grant 2012R1A2A2A01044526) through the National Research Foundation (NRF) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea, and the National Research and Development Program for Cancer Control (Grant 1220020), Ministry for Health and Welfare, Republic of Korea. This work was also supported by a Korea University grant (Grant G1300090).	Bai D, 2003, BIOCHEM BIOPH RES CO, V309, P552, DOI 10.1016/j.bbrc.2003.08.033; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Bridges TM, 2008, ACS CHEM BIOL, V3, P530, DOI 10.1021/cb800116f; Chen ZG, 2004, MOL PHARMACOL, V66, P377; Cheng L, 2005, J NEUROCHEM, V94, P1102, DOI 10.1111/j.1471-4159.2005.03254.x; Choi JA, 2008, FREE RADICAL BIO MED, V44, P624, DOI 10.1016/j.freeradbiomed.2007.10.041; Choi JA, 2010, CARCINOGENESIS, V31, P543, DOI 10.1093/carcin/bgp203; Cork DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010829; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Donepudi M, 2008, CELL SIGNAL, V20, P1359, DOI 10.1016/j.cellsig.2008.03.007; Emberley ED, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-28; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gaudreau R, 2002, J BIOL CHEM, V277, P31567, DOI 10.1074/jbc.M202723200; Haribabu B, 1999, J BIOL CHEM, V274, P37087, DOI 10.1074/jbc.274.52.37087; Hennig R, 2008, BRIT J CANCER, V99, P1064, DOI 10.1038/sj.bjc.6604655; Ihara A, 2007, J PHARMACOL SCI, V103, P24, DOI 10.1254/jphs.FP0060651; Iizuka Y, 2005, J BIOL CHEM, V280, P24816, DOI 10.1074/jbc.M413257200; Kamohara M, 2000, J BIOL CHEM, V275, P27000; Kim C, 2008, BMB REP, V41, P555, DOI 10.5483/BMBRep.2008.41.8.555; Kim EY, 2010, FREE RADICAL BIO MED, V49, P1072, DOI 10.1016/j.freeradbiomed.2010.06.023; Kim JY, 2010, BIOCHEM PHARMACOL, V79, P1506, DOI 10.1016/j.bcp.2010.01.018; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Leff AR, 2000, AM J RESP CRIT CARE, V161, pS125, DOI 10.1164/ajrccm.161.supplement_1.ltta-25; Murrin LC, 2007, J NEUROIMMUNE PHARM, V2, P290, DOI 10.1007/s11481-007-9079-x; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Peres CM, 2007, J IMMUNOL, V179, P5454, DOI 10.4049/jimmunol.179.8.5454; Rao MA, 2002, J BIOL CHEM, V277, P48020, DOI 10.1074/jbc.M209741200; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Rocconi RP, 2008, REPROD SCI, V15, P321, DOI 10.1177/1933719108316390; Seebahn A, 2008, FEBS LETT, V582, P2453, DOI 10.1016/j.febslet.2008.06.010; Sugimoto N, 2006, EXP CELL RES, V312, P1899, DOI 10.1016/j.yexcr.2006.02.020; Suresh B, 2010, J BIOL CHEM, V285, P35340, DOI 10.1074/jbc.M110.156836; Sveinbjornsson B, 2008, FASEB J, V22, P3525, DOI 10.1096/fj.07-103457; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Talbot JN, 2009, NEUROSCI LETT, V466, P154, DOI 10.1016/j.neulet.2009.09.048; Togashi H, 2006, J NEUROSCI, V26, P4961, DOI 10.1523/JNEUROSCI.0704-06.2006; Tong WG, 2005, BIOCHEM BIOPH RES CO, V335, P949, DOI 10.1016/j.bbrc.2005.07.166; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wei JD, 2011, FEBS LETT, V585, P3501, DOI 10.1016/j.febslet.2011.10.037; Woo CH, 2002, J BIOL CHEM, V277, P8572, DOI 10.1074/jbc.M104766200; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yoo MH, 2004, ONCOGENE, V23, P9259, DOI 10.1038/sj.onc.1208151; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200	47	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2013	288	37					26753	26763		10.1074/jbc.M113.470260	http://dx.doi.org/10.1074/jbc.M113.470260			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HM	23928309	Green Published, hybrid			2022-12-28	WOS:000330594500040
J	Zhang, XS; Zhang, BL; Gao, JD; Wang, X; Liu, ZH				Zhang, Xusen; Zhang, Bailin; Gao, Jidong; Wang, Xiang; Liu, Zhihua			Regulation of the MicroRNA 200b (miRNA-200b) by Transcriptional Regulators PEA3 and ELK-1 Protein Affects Expression of Pin1 Protein to Control Anoikis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AKT; Apoptosis; ERK; ETS Family Transcription Factor; MicroRNA	EPITHELIAL-MESENCHYMAL TRANSITION; CIRCULATING TUMOR-CELLS; MIR-200 FAMILY; DOWN-REGULATION; E-CADHERIN; REPRESSORS ZEB1; ISOMERASE PIN1; GROWTH; ACTIVATION; ERK	Background: The role of miRNA-200b in the regulation of anoikis is not well understood. Results: miRNA-200b controls anoikis by targeting Pin1, and its expression is regulated by PEA3 and ELK-1. Conclusion: Pin1 acts as a functional target gene of miRNA-200b. Significance: These findings characterize the self-regulation of miRNA-200b and its role in the regulation of anoikis. MicroRNA (miRNA) 200s regulate E-cadherin by directly targeting ZEB1/ZEB2, which are transcriptional repressors of E-cadherin. Decreased expression of E-cadherin results in cancer cells losing interaction with the extracellular matrix and detaching from the primary tumor. Normally, cells will undergo anoikis after losing interaction with the extracellular matrix. Cancer cells must, therefore, possess the ability to resist anoikis during the process of metastasis. Here we show that miRNA-200b regulates anoikis by directly targeting the 3 UTR of Pin1 mRNA and regulating Pin1 expression at the translational level. We found that down-regulation of miRNA-200b promotes cancer cells survival during metastasis, and the homeless state of these cells resulted in decreased expression of miRNA-200b in the MCF-7 cell line. We also found that expression of miRNA-200b is down-regulated in human breast cancer during lymph node metastasis, which has a significant negative correlation with Pin1 expression. Two members of the ETS (E-26) family (PEA3 and ELK-1) regulate the expression of miRNA-200b. PEA3 promotes the expression of miRNA-200b, and ELK-1 is a transcriptional repressor of miRNA-200b. In addition, miRNA-200b regulates the activity of PEA3 and ELK-1 via the Pin1-pERK pathway and forms self-regulated feedback loops. This study characterizes the role of miRNA-200b in the regulation of anoikis and demonstrates the regulation of its own expression in the process of metastasis.	[Zhang, Xusen; Liu, Zhihua] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China; [Zhang, Bailin; Gao, Jidong; Wang, Xiang] Chinese Acad Med Sci, Dept Abdominal Surg, Canc Inst & Hosp, Beijing 100021, Peoples R China; [Liu, Zhihua] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, ZH (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn		Zhang, Bailin/0000-0003-2759-7727	National Natural Science Foundation of China [91019009, 81130043]; National Basic Research Program of China [2011CB504205]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 91019009 and 81130043 and by National Basic Research Program of China Grant 2011CB504205.	A-Ayoubi A, 2008, J CELL BIOCHEM, V105, P875, DOI 10.1002/jcb.21889; Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Aydogdu E, 2012, CARCINOGENESIS, V33, P1502, DOI 10.1093/carcin/bgs161; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Castaneda CA, 2011, EXPERT REV ANTICANC, V11, P1265, DOI [10.1586/era.11.40, 10.1586/ERA.11.40]; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Choi YC, 2011, MOL CELLS, V32, P77, DOI 10.1007/s10059-011-1042-2; Cohen-Armon M, 2007, TRENDS PHARMACOL SCI, V28, P556, DOI 10.1016/j.tips.2007.08.005; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fukuchi M, 2006, INT J ONCOL, V29, P329; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo BQ, 2009, MOL CELL BIOL, V29, P3204, DOI 10.1128/MCB.01128-08; Gutierrez-Hartmann A, 2007, TRENDS ENDOCRIN MET, V18, P150, DOI 10.1016/j.tem.2007.03.002; Guttilla IK, 2012, TRENDS ENDOCRIN MET, V23, P73, DOI 10.1016/j.tem.2011.12.001; Han CY, 2011, BIOCHEM BIOPH RES CO, V410, P68, DOI 10.1016/j.bbrc.2011.05.106; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Kamarajugadda S, 2012, MOL CELL BIOL, V32, P1893, DOI 10.1128/MCB.06248-11; Kim JB, 2010, PHYTOMEDICINE, V17, P436, DOI 10.1016/j.phymed.2009.08.012; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Liao Y, 2009, ONCOGENE, V28, P2436, DOI 10.1038/onc.2009.98; Liao Y, 2010, AM J TRANSL RES, V2, P19; Lu KP, 2006, MOL CARCINOGEN, V45, P397, DOI 10.1002/mc.20216; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Ma B, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.100; Mathiesen RR, 2012, INT J CANCER, V131, pE405, DOI 10.1002/ijc.26444; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Meadows SM, 2011, SEMIN CELL DEV BIOL, V22, P976, DOI 10.1016/j.semcdb.2011.09.009; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Oh YT, 2010, J BIOL CHEM, V285, P41310, DOI 10.1074/jbc.M110.153775; Pang RW, 2006, J PATHOL, V210, P19, DOI 10.1002/path.2024; Pang R, 2007, GASTROENTEROLOGY, V132, P1088, DOI 10.1053/j.gastro.2006.12.030; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Sieuwerts AM, 2011, CLIN CANCER RES, V17, P3600, DOI 10.1158/1078-0432.CCR-11-0255; Smit MA, 2011, ONCOGENE, V30, P3735, DOI 10.1038/onc.2011.96; Tan XG, 2010, CANCER BIOL THER, V9, P111, DOI 10.4161/cbt.9.2.10341; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Turner DP, 2008, EXPERT REV ANTICANC, V8, P33, DOI 10.1586/14737140.8.1.33; Uchida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031823; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Wang ZS, 2012, ENVIRON HEALTH PERSP, V120, P92, DOI 10.1289/ehp.1104061; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Xia W, 2010, MOL CELL BIOCHEM, V344, P261, DOI 10.1007/s11010-010-0550-2; Xu K, 2011, J VIROL, V85, P1086, DOI 10.1128/JVI.00877-10; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	61	40	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32742	32752		10.1074/jbc.M113.478016	http://dx.doi.org/10.1074/jbc.M113.478016			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072701	Green Published, hybrid			2022-12-28	WOS:000328681700058
J	Liu, T; O'Rourke, B				Liu, Ting; O'Rourke, Brian			Regulation of the Na+/Ca2+ Exchanger by Pyridine Nucleotide Redox Potential in Ventricular Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGER; CARDIAC SARCOLEMMAL VESICLES; INDUCED HEART-FAILURE; NA+-CA2+ EXCHANGER; ISCHEMIA/REPERFUSION INJURY; DEPENDENT REGULATION; SELECTIVE INHIBITOR; RAT-HEART; CELLS; EXPRESSION	The cardiac Na+/Ca2+ exchanger (NCX) is the major Ca2+ efflux pathway on the sarcolemma, counterbalancing Ca2+ influx via L-type Ca2+ current during excitation-contraction coupling. Altered NCX activity modulates the sarcoplastic reticulum Ca2+ load and can contribute to abnormal Ca2+ handling and arrhythmias. NADH/NAD(+) is the main redox couple controlling mitochondrial energy production, glycolysis, and other redox reactions. Here, we tested whether cytosolic NADH/NAD(+) redox potential regulates NCX activity in adult cardiomyocytes. NCX current (I-NCX), measured with whole cell patch clamp, was inhibited in response to cytosolic NADH loaded directly via pipette or increased by extracellular lactate perfusion, whereas an increase of mitochondrial NADH had no effect. Reactive oxygen species (ROS) accumulation was enhanced by increasing cytosolic NADH, and NADH-induced I-NCX inhibition was abolished by the H2O2 scavenger catalase. NADH-induced ROS accumulation was independent of mitochondrial respiration (rotenone-insensitive) but was inhibited by the flavoenzyme blocker diphenylene iodonium. NADPH oxidase was ruled out as the effector because I-NCX was insensitive to cytosolic NADPH, and NADH-induced ROS and I-NCX inhibition were not abrogated by the specific NADPH oxidase inhibitor gp91ds-tat. This study reveals a novel mechanism of NCX regulation by cytosolic NADH/NAD(+) redox potential through a ROS-generating NADH-driven flavoprotein oxidase. The mechanism is likely to play a key role in Ca2+ homeostasis and the response to alterations in the cytosolic pyridine nucleotide redox state during ischemia-reperfusion or other cardiovascular diseases.	[Liu, Ting; O'Rourke, Brian] Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD 21205 USA	Johns Hopkins University	O'Rourke, B (corresponding author), Johns Hopkins Univ, Dept Med, Div Cardiol, 720 Rutland Ave,1060 Ross Bldg, Baltimore, MD 21205 USA.	bor@jhmi.edu		O'Rourke, Brian/0000-0002-5548-4853; Liu, Ting/0000-0002-8304-5751	NHLBI National Institutes of Health [R01HL105216, R01HL101235]; Leducq Foundation Transatlantic Networks of Excellence Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105216, R01HL101235] Funding Source: NIH RePORTER	NHLBI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Leducq Foundation Transatlantic Networks of Excellence Program(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI National Institutes of Health Grants R01HL105216 and R01HL101235 (to B. O.). This work was also supported by the Leducq Foundation Transatlantic Networks of Excellence Program.	Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Boyman L, 2011, J BIOL CHEM, V286, P28811, DOI 10.1074/jbc.M110.214106; BULLIARD C, 1990, J BIOENERG BIOMEMBR, V22, P645, DOI 10.1007/BF00809069; COLLINS A, 1992, J PHYSIOL-LONDON, V454, P27, DOI 10.1113/jphysiol.1992.sp019253; CONDRESCU M, 1995, J BIOL CHEM, V270, P9137, DOI 10.1074/jbc.270.16.9137; Crawford SO, 2010, INT J EPIDEMIOL, V39, P1647, DOI 10.1093/ije/dyq126; DIXON IMC, 1990, MOL CELL BIOCHEM, V99, P125; Feng NC, 2006, J CARDIOVASC PHARM, V47, P263, DOI 10.1097/01.fjc.0000202561.69291.ac; Flesch M, 1996, CIRCULATION, V94, P992, DOI 10.1161/01.CIR.94.5.992; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Hagihara H, 2005, AM J PHYSIOL-HEART C, V288, pH1699, DOI 10.1152/ajpheart.01033.2004; HAWORTH RA, 1987, CIRC RES, V60, P586, DOI 10.1161/01.RES.60.4.586; HAWORTH RA, 1992, CIRC RES, V71, P210, DOI 10.1161/01.RES.71.1.210; Hobai IA, 2000, CIRC RES, V87, P690, DOI 10.1161/01.RES.87.8.690; Hobai IA, 2004, CIRC RES, V95, P292, DOI 10.1161/01.RES.0000136817.28691.2d; Huschenbett J, 1998, BBA-BIOMEMBRANES, V1374, P34, DOI 10.1016/S0005-2736(98)00121-7; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; Iwamoto T, 1996, J BIOL CHEM, V271, P13609, DOI 10.1074/jbc.271.23.13609; Liu M, 2010, CIRC RES, V107, P967, DOI 10.1161/CIRCRESAHA.110.220673; Liu M, 2009, CIRC RES, V105, P737, DOI 10.1161/CIRCRESAHA.109.197277; LOVEJOY J, 1992, METABOLISM, V41, P22, DOI 10.1016/0026-0495(92)90185-D; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; Maddaford TG, 2010, AM J PHYSIOL-HEART C, V298, pH360, DOI 10.1152/ajpheart.00932.2009; Missan S, 2004, BRIT J PHARMACOL, V143, P943, DOI 10.1038/sj.bjp.0706011; MohazzabH KM, 1997, CIRCULATION, V96, P614; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; O'Rourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562; Ohtsuka M, 2004, BIOCHEM BIOPH RES CO, V314, P849, DOI 10.1016/j.bbrc.2003.12.165; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; PHILIPSON KD, 1982, CIRC RES, V50, P287, DOI 10.1161/01.RES.50.2.287; Piacentino V, 2002, ANN NY ACAD SCI, V976, P476; Pogwizd SM, 1999, CIRC RES, V85, P1009; REEVES JP, 1986, J BIOL CHEM, V261, P4948; Riedel MJ, 2006, EMBO J, V25, P4605, DOI 10.1038/sj.emboj.7601321; Santacruz-Toloza L, 2000, J BIOL CHEM, V275, P182, DOI 10.1074/jbc.275.1.182; SCHOLZ TD, 1995, PEDIATR RES, V38, P221, DOI 10.1203/00006450-199508000-00015; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Shigekawa M, 2001, CIRC RES, V88, P864, DOI 10.1161/hh0901.090298; Sipido KR, 2002, CARDIOVASC RES, V53, P782, DOI 10.1016/S0008-6363(01)00470-9; Takahashi K, 2003, EUR J PHARMACOL, V458, P155, DOI 10.1016/S0014-2999(02)02732-2; Takimoto E, 2002, FASEB J, V16, DOI 10.1096/fj.01-0735com; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Vernon C, 2010, CRIT CARE CLIN, V26, P255, DOI 10.1016/j.ccc.2009.12.007; Wagner S, 2013, ANTIOXID REDOX SIGN, V18, P1063, DOI 10.1089/ars.2012.4818; Yang YC, 2013, ADV EXP MED BIOL, V961, P163, DOI 10.1007/978-1-4614-4756-6_14; Zhang QH, 2002, SCIENCE, V295, P1895; Zima AV, 2006, CARDIOVASC RES, V71, P310, DOI 10.1016/j.cardiores.2006.02.019; Zima AV, 2004, J PHYSIOL-LONDON, V555, P727, DOI 10.1113/jphysiol.2003.055848	50	23	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31984	31992		10.1074/jbc.M113.496588	http://dx.doi.org/10.1074/jbc.M113.496588			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045952	Green Published, hybrid			2022-12-28	WOS:000330596200051
J	Iwasa, H; Kudo, T; Maimaiti, S; Ikeda, M; Maruyama, J; Nakagawa, K; Hata, Y				Iwasa, Hiroaki; Kudo, Takumi; Maimaiti, Sainawaer; Ikeda, Mitsunobu; Maruyama, Junichi; Nakagawa, Kentaro; Hata, Yutaka			The RASSF6 Tumor Suppressor Protein Regulates Apoptosis and the Cell Cycle via MDM2 Protein and p53 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Checkpoint Control; DNA Damage; p53; Tumor Suppressor Gene; Hippo Pathway; RASSF	HIPPO PATHWAY; MST2 PATHWAY; FAMILY; ACTIVATION; COMPLEX; KINASE; CANCER	Ras association domain family (RASSF) 6 is a member of the C-terminal RASSF proteins such as RASSF1A and RASSF3. RASSF6 is involved in apoptosis in various cells under miscellaneous conditions, but it remains to be clarified how RASSF6 exerts tumor-suppressive roles. We reported previously that RASSF3 facilitates the degradation of MDM2, a major E3 ligase of p53, and stabilizes p53 to function as a tumor suppressor. In this study, we demonstrate that RASSF6 overexpression induces G(1)/S arrest in p53-positive cells. Its depletion prevents UV- and VP-16-induced apoptosis and G(1)/S arrest in HCT116 and U2OS cells. RASSF6-induced apoptosis partially depends on p53. RASSF6 binds MDM2 and facilitates its ubiquitination. RASSF6 depletion blocks the increase of p53 in response to UV exposure and up-regulation of p53 target genes. RASSF6 depletion delays DNA repair in UV- and VP-16-treated cells and increases polyploid cells after VP-16 treatment. These findings indicate that RASSF6 stabilizes p53, regulates apoptosis and the cell cycle, and functions as a tumor suppressor. Together with the previous reports regarding RASSF1A and RASSF3, the stabilization of p53 may be the common function of the C-terminal RASSF proteins.	[Iwasa, Hiroaki; Kudo, Takumi; Maimaiti, Sainawaer; Ikeda, Mitsunobu; Maruyama, Junichi; Nakagawa, Kentaro; Hata, Yutaka] Tokyo Med & Dent Univ, Grad Sch Med, Dept Med Biochem, Tokyo 1138519, Japan; [Kudo, Takumi] Tokyo Med & Dent Univ, Grad Sch Med, Dept Neurosurg, Tokyo 1138519, Japan; [Maimaiti, Sainawaer] Fourth Peoples Hosp Urumqi, Dept Psychotherapy, Urumqi 830000, Peoples R China	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Hata, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Med Biochem, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	yuhammch@tmd.ac.jp	Iwasa, Hiroaki/ABG-9082-2021	MARUYAMA, Junichi/0000-0002-3665-2700	Ministry of Education, Sports, Science, and Technology [17081008]; Japan Society for the Promotion of Science (JSPS) [22790275, 22590267]	Ministry of Education, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Ministry of Education, Sports, Science, and Technology Grant 17081008 and by Japan Society for the Promotion of Science (JSPS) Grants 22790275 and 22590267.	Allen NPC, 2007, ONCOGENE, V26, P6203, DOI 10.1038/sj.onc.1210440; Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; Bao YJ, 2011, J BIOCHEM, V149, P361, DOI 10.1093/jb/mvr021; Calvisi DF, 2009, CANCER RES, V69, P4629, DOI 10.1158/0008-5472.CAN-08-3672; Chan Jia Jia, 2013, Advances in Biological Regulation, V53, P258, DOI [10.1016/j.jbior.2013.07.008, 10.1016/j.jbior.2012.12.001]; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Hamilton G, 2009, CURR BIOL, V19, P2020, DOI 10.1016/j.cub.2009.10.040; Hesson LB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-42; Ikeda M, 2007, EXP CELL RES, V313, P1484, DOI 10.1016/j.yexcr.2007.02.013; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kudo T, 2012, CANCER RES, V72, P2901, DOI 10.1158/0008-5472.CAN-12-0572; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Sherwood V, 2010, BIOCHEM J, V425, P303, DOI 10.1042/BJ20091318; Song H, 2010, BIOCHEM BIOPH RES CO, V391, P969, DOI 10.1016/j.bbrc.2009.11.175; Song MS, 2008, EMBO J, V27, P1863, DOI 10.1038/emboj.2008.115; Tommasi S, 2011, ONCOGENE, V30, P690, DOI 10.1038/onc.2010.440; Underhill-Day N, 2011, EPIGENETICS-US, V6, P284, DOI 10.4161/epi.6.3.14108; Wen YG, 2011, ANN SURG ONCOL, V18, P3858, DOI 10.1245/s10434-011-1668-5; Withanage K, 2012, J BIOCHEM, V152, P111, DOI 10.1093/jb/mvs056; Yee KS, 2012, CANCER RES, V72, P2206, DOI 10.1158/0008-5472.CAN-11-2906; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303	28	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30320	30329		10.1074/jbc.M113.507384	http://dx.doi.org/10.1074/jbc.M113.507384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003224	Green Published, hybrid			2022-12-28	WOS:000329868100029
J	Moon, HJ; Finney, J; Xu, L; Moore, D; Welch, DR; Mure, M				Moon, Hee-Jung; Finney, Joel; Xu, Li; Moore, David; Welch, Danny R.; Mure, Minae			MCF-7 Cells Expressing Nuclear Associated Lysyl Oxidase-like 2 (LOXL2) Exhibit an Epithelial-to-Mesenchymal Transition (EMT) Phenotype and Are Highly Invasive in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Invasion; Epithelial-to-mesenchymal Transition; Lysyl Oxidase; Post-translational Modification; Site-directed Mutagenesis; Lysyl Oxidase-Like 2	TRANSCRIPTION FACTOR SNAIL; POSTTRANSLATIONAL MODIFICATIONS; LINKED GLYCOSYLATION; MOLECULAR ROLE; AMINE OXIDASE; MIGRATION; COFACTOR; ENZYME; PROGRESSION; MMP	Background: LOXL2 induces metastasis/invasion of breast cancer cells. Results: MCF-7 cells expressing nuclear associated LOXL2 have an invasive EMT phenotype. Conclusion: Nuclear associated catalytically competent LOXL2 contributes to stabilization of Snail1 transcription factor. Significance: This is the first study to directly compare the potencies of nuclear associated and secreted LOXL2s in breast cancer metastasis/invasion in vitro. LOXL2 is a copper- and lysine tyrosylquinone-dependent amine oxidase that has been proposed to function both extracellularly and intracellularly to activate oncogenic signaling pathways leading to EMT and invasion of breast cancer cells. In this study, we selected MCF-7 cells that stably express forms of recombinant LOXL2 differing in their subcellular localizations and catalytic competencies. This enabled us to dissect the molecular functions of intracellular and extracellular LOXL2s and examine their contributions to breast cancer metastasis/invasion. We discovered that secreted LOXL2 (approximate to 100-kDa) is N-glycosylated at Asn-455 and Asn-644, whereas intracellular LOXL2 (approximate to 75-kDa) is nonglycosylated and N-terminally processed, and is primarily associated with the nucleus. Both forms of LOXL2 can oxidize lysine in solution. However, we found that expression of intracellular LOXL2 is more strongly associated with EMT and invasiveness than secreted LOXL2 in vitro. The results indicate that nuclear associated LOXL2 contributes to the stabilization of Snail1 transcription factor at the protein level to induce EMT and promote invasion in vitro, through repression of E-cadherin, occludin, and estrogen receptor-, and up-regulation of vimentin, fibronectin, and MT1-MMP.	[Moon, Hee-Jung; Finney, Joel; Xu, Li; Mure, Minae] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; [Moore, David] Univ Kansas, KU Microscopy & Analyt Imaging Lab, Lawrence, KS 66045 USA; [Welch, Danny R.] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66160 USA; [Welch, Danny R.] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66160 USA	University of Kansas; University of Kansas; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Mure, M (corresponding author), Univ Kansas, Dept Chem, 1251 Wescoe Hall Dr,2054 Malott Hall, Lawrence, KS 66045 USA.	mmure@ku.edu	Welch, Danny R/B-7310-2009; Finney, Joel/AAD-3773-2021	Welch, Danny R/0000-0002-1951-4947; Finney, Joel/0000-0002-3755-8425	National Institutes of Health [P20 RR015563, GM079446-02, P30-CA168524]; American Heart Association [AHA0765445Z]; National Science Foundation [CAREER MCB-0747377]; National Foundation for Cancer Research; Div Of Molecular and Cellular Bioscience [0747377] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [P30CA168524] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); National Foundation for Cancer Research; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR015563 (to M. M., Center of Biomedical Research Excellence for Cancer Experimental Therapeutics), GM079446-02 (to M. M.), and P30-CA168524 (to D. R. W.). This work was also supported by American Heart Association Grant AHA0765445Z (to M. M.) and National Science Foundation Grant CAREER MCB-0747377 (to M. M.).; A Kansas Bioscience Authority Eminent Scholar. Supported, in part, by funding from the National Foundation for Cancer Research.	Akiri G, 2003, CANCER RES, V63, P1657; Baker AM, 2013, ONCOGENE, V32, P1863, DOI 10.1038/onc.2012.202; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bence M, 2011, FEBS J, V278, P4338, DOI 10.1111/j.1742-4658.2011.08351.x; Bollinger JA, 2005, BIOCHEMISTRY-US, V44, P11708, DOI 10.1021/bi0504310; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cano A, 2012, FUTURE ONCOL, V8, P1095, DOI [10.2217/FON.12.105, 10.2217/fon.12.105]; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Herranz N, 2012, MOL CELL, V46, P369, DOI 10.1016/j.molcel.2012.03.002; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kim ES, 2011, J CELL SCI, V124, P2220, DOI 10.1242/jcs.076794; Kirschmann DA, 2002, CANCER RES, V62, P4478; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lin CY, 2011, CANCER SCI, V102, P815, DOI 10.1111/j.1349-7006.2011.01861.x; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Miyazawa Y, 2013, MOL CANCER RES, V11, P628, DOI 10.1158/1541-7786.MCR-12-0544; Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685; Moore RH, 2007, J AM CHEM SOC, V129, P11524, DOI 10.1021/ja0731165; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Mure M, 2003, J AM CHEM SOC, V125, P6113, DOI 10.1021/ja0214274; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Peinado H, 2005, CELL CYCLE, V4, P1749, DOI 10.4161/cc.4.12.2224; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Rebecchi KR, 2011, ANAL CHEM, V83, P8484, DOI 10.1021/ac2017037; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; Saad S, 2002, CANCER RES, V62, P283; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Shields MA, 2011, J BIOL CHEM, V286, P10495, DOI 10.1074/jbc.M110.195628; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Sodek KL, 2007, BRIT J CANCER, V97, P358, DOI 10.1038/sj.bjc.6603863; Stanisavljevic J, 2011, J CELL SCI, V124, P4159, DOI 10.1242/jcs.078824; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Tang CL, 2001, J BIOL CHEM, V276, P30575, DOI 10.1074/jbc.C100138200; TANG SS, 1983, J BIOL CHEM, V258, P4331; Terry SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050188; Toth M, 2003, BIOCHEM BIOPH RES CO, V308, P386, DOI 10.1016/S0006-291X(03)01405-0; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Wang SX, 1996, SCIENCE, V273, P1078, DOI 10.1126/science.273.5278.1078; Welm B, 2002, CURR BIOL, V12, pR209, DOI 10.1016/S0960-9822(02)00752-2; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Xu L, 2013, J BIOL CHEM, V288, P5357, DOI 10.1074/jbc.C112.421768	55	62	64	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30000	30008		10.1074/jbc.C113.502310	http://dx.doi.org/10.1074/jbc.C113.502310			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014025	hybrid, Green Published			2022-12-28	WOS:000329868100001
J	Zhou, J; Ye, SQ; Fujiwara, T; Manolagas, SC; Zhao, HB				Zhou, Jian; Ye, Shiqiao; Fujiwara, Toshifumi; Manolagas, Stavros C.; Zhao, Haibo			Steap4 Plays a Critical Role in Osteoclastogenesis in Vitro by Regulating Cellular Iron/Reactive Oxygen Species (ROS) Levels and cAMP Response Element-binding Protein (CREB) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Iron Metabolism; Mitochondria; Osteoclast; Oxidative Stress	FORKHEAD-BOX-O; OXIDATIVE STRESS; BONE LOSS; PROSTATE-CANCER; DOWN-REGULATION; ADIPOSE-TISSUE; IRON OVERLOAD; BETA-CATENIN; CRUCIAL ROLE; DIFFERENTIATION	Background: Iron uptake through the transferrin-dependent pathway is essential for osteoclast differentiation. Results: Knocking down the expression of Steap4, an endosomal ferrireductase, inhibits osteoclast formation and decreases cellular iron and ROS production. Conclusion: Steap4 regulates cellular iron metabolism during osteoclast differentiation. Significance: This work provides new insights into the molecular mechanisms regulating cellular iron metabolism in osteoclast lineage cells. Iron is essential for osteoclast differentiation, and iron overload in a variety of hematologic diseases is associated with excessive bone resorption. Iron uptake by osteoclast precursors via the transferrin cycle increases mitochondrial biogenesis, reactive oxygen species production, and activation of cAMP response element-binding protein, a critical transcription factor downstream of receptor activator of NF-B-ligand-induced calcium signaling. These changes are required for the differentiation of osteoclast precursors to mature bone-resorbing osteoclasts. However, the molecular mechanisms regulating cellular iron metabolism in osteoclasts remain largely unknown. In this report, we provide evidence that Steap4, a member of the six-transmembrane epithelial antigen of prostate (Steap) family proteins, is an endosomal ferrireductase with a critical role in cellular iron utilization in osteoclasts. Specifically, we show that Steap4 is the only Steap family protein that is up-regulated during osteoclast differentiation. Knocking down Steap4 expression in vitro by lentivirus-mediated short hairpin RNAs inhibits osteoclast formation and decreases cellular ferrous iron, reactive oxygen species, and the activation of cAMP response element-binding protein. These results demonstrate that Steap4 is a critical enzyme for cellular iron uptake and utilization in osteoclasts and, thus, indispensable for osteoclast development and function.	[Zhao, Haibo] Univ Arkansas Med Sci, Ctr Osteoporosis & Bone Metab Dis, Div Endocrinol & Metab, Dept Internal Med, Little Rock, AR 72205 USA; Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Zhao, HB (corresponding author), Univ Arkansas Med Sci, Ctr Osteoporosis & Bone Metab Dis, Div Endocrinol & Metab, Dept Internal Med, 4301 W Markham St,Slot 587, Little Rock, AR 72205 USA.	hzhao@uams.edu	Zhao, Haibo/ABG-9729-2021; Ye, Shiqiao/N-2873-2015	Ye, Shiqiao/0000-0003-1529-7102; ZHAO, HAIBO/0000-0003-0836-7555	NIAMS; NIA, National Institutes of Health [AR055694, AR062012, P01 AG13918]; University of Arkansas for Medical Sciences Tobacco Settlement Funds by the Arkansas Biosciences Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062012, R03AR055694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Arkansas for Medical Sciences Tobacco Settlement Funds by the Arkansas Biosciences Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by NIAMS and NIA, National Institutes of Health Grants AR055694, AR062012, and P01 AG13918. This work was also partially supported by University of Arkansas for Medical Sciences Tobacco Settlement Funds provided by the Arkansas Biosciences Institute.	Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Arner P, 2008, J CLIN ENDOCR METAB, V93, P2249, DOI 10.1210/jc.2008-0206; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Haidar R, 2011, BONE, V48, P425, DOI 10.1016/j.bone.2010.10.173; Helfrich MH, 2003, MICROSC RES TECHNIQ, V61, P514, DOI 10.1002/jemt.10375; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Kim H, 2013, CELL METAB, V17, P249, DOI 10.1016/j.cmet.2013.01.002; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; Korkmaz CG, 2005, ONCOGENE, V24, P4934, DOI 10.1038/sj.onc.1208677; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Li GF, 2012, OSTEOPOROSIS INT, V23, P2403, DOI 10.1007/s00198-012-1982-1; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; RYAN TP, 1992, CRIT REV TOXICOL, V22, P119, DOI 10.3109/10408449209146308; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tsay J, 2010, BLOOD, V116, P2582, DOI 10.1182/blood-2009-12-260083; Wang L, 2010, CANCER RES, V70, P5818, DOI 10.1158/0008-5472.CAN-09-4697; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Ye S., 2011, PLOS ONE, V6; Zhang CM, 2008, ACTA PHARMACOL SIN, V29, P587, DOI 10.1111/j.1745-7254.2008.00793.x; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200	47	59	61	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30064	30074		10.1074/jbc.M113.478750	http://dx.doi.org/10.1074/jbc.M113.478750			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23990467	Green Published, hybrid			2022-12-28	WOS:000329868100007
J	Ludwig, CF; Ullrich, F; Leisle, L; Stauber, T; Jentsch, TJ				Ludwig, Carmen F.; Ullrich, Florian; Leisle, Lilia; Stauber, Tobias; Jentsch, Thomas J.			Common Gating of Both CLC Transporter Subunits Underlies Voltage-dependent Activation of the 2Cl(-)/1H(+) Exchanger ClC-7/Ostm1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anion Transport; Chloride Transport; Gating; Ion Channels; Lysosomal Storage Disease; Albers-Schonberg Disease; Antiport; Split-channel	CHLORIDE CHANNEL FUNCTION; COMPLEMENTARY FRAGMENTS; CYTOPLASMIC DOMAIN; TORPEDO-MARMORATA; REQUIRES OSTM1; POINT MUTATION; BETA-SUBUNIT; CBS DOMAINS; C-TERMINUS; OSTEOPETROSIS	CLC anion transporters form dimers that function either as Cl- channels or as electrogenic Cl-/H+ exchangers. CLC channels display two different types of gates, protopore gates that open and close the two pores of a CLC dimer independently of each other and common gates that act on both pores simultaneously. ClC-7/Ostm1 is a lysosomal 2Cl(-)/1H(+) exchanger that is slowly activated by depolarization. This gating process is drastically accelerated by many CLCN7 mutations underlying human osteopetrosis. Making use of some of these mutants, we now investigate whether slow voltage activation of plasma membrane-targeted ClC-7/Ostm1 involves protopore or common gates. Voltage activation of wild-type ClC-7 subunits was accelerated by co-expressing an excess of ClC-7 subunits carrying an accelerating mutation together with a point mutation rendering these subunits transport-deficient. Conversely, voltage activation of a fast ClC-7 mutant could be slowed by co-expressing an excess of a transport-deficient mutant. These effects did not depend on whether the accelerating mutation localized to the transmembrane part or to cytoplasmic cystathionine--synthase (CBS) domains of ClC-7. Combining accelerating mutations in the same subunit did not speed up gating further. No currents were observed when ClC-7 was truncated after the last intramembrane helix. Currents and slow gating were restored when the C terminus was co-expressed by itself or fused to the C terminus of the -subunit Ostm1. We conclude that common gating underlies the slow voltage activation of ClC-7. It depends on the CBS domain-containing C terminus that does not require covalent binding to the membrane domain of ClC-7.	[Ludwig, Carmen F.; Ullrich, Florian; Leisle, Lilia; Stauber, Tobias; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Ludwig, Carmen F.; Ullrich, Florian; Leisle, Lilia; Stauber, Tobias; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Jentsch, Thomas J.] Charite, NeuroCure Cluster Excellence, D-10117 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jentsch, TJ (corresponding author), FMP MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Ullrich, Florian/AAA-6043-2019; Stauber, Tobias/E-4005-2010	Ullrich, Florian/0000-0002-1153-2040; Stauber, Tobias/0000-0003-0727-6109; Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft [JE164/7, JE164/9, SFB740 TP C5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in part, by grants from the Deutsche Forschungsgemeinschaft (JE164/7, JE164/9, and SFB740 TP C5).	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; BAUER CK, 1991, P NATL ACAD SCI USA, V88, P11052, DOI 10.1073/pnas.88.24.11052; Bennetts B, 2012, J BIOL CHEM, V287, P25808, DOI 10.1074/jbc.M111.327551; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Cederholm JM, 2010, INT J BIOCHEM CELL B, V42, P1182, DOI 10.1016/j.biocel.2010.04.004; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Chen MF, 2001, J GEN PHYSIOL, V118, P23, DOI 10.1085/jgp.118.1.23; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; de Santiago JA, 2005, J GEN PHYSIOL, V126, P591, DOI 10.1085/jgp.200509310; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Elvington SM, 2009, EMBO J, V28, P3090, DOI 10.1038/emboj.2009.259; Estevez R, 2004, J PHYSIOL-LONDON, V557, P363, DOI 10.1113/jphysiol.2003.058453; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Fong PY, 1998, AM J PHYSIOL-CELL PH, V274, pC966, DOI 10.1152/ajpcell.1998.274.4.C966; Frattini A, 2003, J BONE MINER RES, V18, P1740, DOI 10.1359/jbmr.2003.18.10.1740; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Jeworutzki E, 2012, NEURON, V73, P951, DOI 10.1016/j.neuron.2011.12.039; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; Lin YW, 1999, J GEN PHYSIOL, V114, P1, DOI 10.1085/jgp.114.1.1; Lisal J, 2008, NAT STRUCT MOL BIOL, V15, P805, DOI 10.1038/nsmb.1466; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Ludewig U, 1997, BIOPHYS J, V73, P789, DOI 10.1016/S0006-3495(97)78111-6; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Ma L, 2008, BIOCHEM J, V413, P61, DOI 10.1042/BJ20071489; Ma LL, 2011, BIOCHEM J, V436, P415, DOI 10.1042/BJ20102153; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; Mo L, 2004, AM J PHYSIOL-CELL PH, V286, pC79, DOI 10.1152/ajpcell.00009.2003; Neagoe I, 2010, J BIOL CHEM, V285, P21689, DOI 10.1074/jbc.M110.125971; Pusch M, 1995, NEURON, V15, P1455, DOI 10.1016/0896-6273(95)90023-3; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; SchmidtRose T, 1997, J BIOL CHEM, V272, P20515, DOI 10.1074/jbc.272.33.20515; Stauber T, 2012, COMPR PHYSIOL, V2, P1701, DOI 10.1002/cphy.c110038; Stauber T, 2013, ANNU REV PHYSIOL, V75, P453, DOI 10.1146/annurev-physiol-030212-183702; Stauber T, 2010, J BIOL CHEM, V285, P34537, DOI 10.1074/jbc.M110.162545; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Traverso S, 2006, J GEN PHYSIOL, V127, P51, DOI 10.1085/jgp.200509340; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Wu WP, 2006, BIOCHEM J, V395, P89, DOI 10.1042/BJ20050966; Yusef YR, 2006, J PHYSIOL-LONDON, V572, P173, DOI 10.1113/jphysiol.2005.102392; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	59	28	30	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28611	28619		10.1074/jbc.M113.509364	http://dx.doi.org/10.1074/jbc.M113.509364			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23983121	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000330298800017
J	Chatterjee, P; Seal, S; Mukherjee, S; Kundu, R; Mukherjee, S; Ray, S; Mukhopadhyay, S; Majumdar, SS; Bhattacharya, S				Chatterjee, Priyajit; Seal, Soma; Mukherjee, Sandip; Kundu, Rakesh; Mukherjee, Sutapa; Ray, Sukanta; Mukhopadhyay, Satinath; Majumdar, Subeer S.; Bhattacharya, Samir			Adipocyte Fetuin-A Contributes to Macrophage Migration into Adipose Tissue and Polarization of Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISMS LINKING OBESITY; INDUCED INSULIN-RESISTANCE; CRUCIAL ROLE; KAPPA-B; INFLAMMATION; ACCUMULATION; DISEASE; PLAYS; TLR4; MICE	Macrophage infiltration into adipose tissue during obesity and their phenotypic conversion from anti-inflammatory M2 to proinflammatory M1 subtype significantly contributes to develop a link between inflammation and insulin resistance; signaling molecule(s) for these events, however, remains poorly understood. We demonstrate here that excess lipid in the adipose tissue environment may trigger one such signal. Adipose tissue from obese diabetic db/db mice, high fat diet-fed mice, and obese diabetic patients showed significantly elevated fetuin-A (FetA) levels in respect to their controls; partially hepatectomized high fat diet mice did not show noticeable alteration, indicating adipose tissue to be the source of this alteration. In adipocytes, fatty acid induces FetA gene and protein expressions, resulting in its copious release. We found that FetA could act as a chemoattractant for macrophages. To simulate lipid-induced inflammatory conditions when proinflammatory adipose tissue and macrophages create a niche of an altered microenvironment, we set up a transculture system of macro-phages and adipocytes; the addition of fatty acid to adipocytes released FetA into the medium, which polarized M2 macrophages to M1. This was further confirmed by direct FetA addition to macrophages. Taken together, lipid-induced FetA from adipocytes is an efficient chemokine for macrophage migration and polarization. These findings open a new dimension for understanding obesity-induced inflammation.	[Chatterjee, Priyajit; Seal, Soma; Mukherjee, Sandip; Kundu, Rakesh; Mukherjee, Sutapa; Bhattacharya, Samir] Visva Bharati Univ, Sch Life Sci, Dept Zool, Santini Ketan 731235, W Bengal, India; [Ray, Sukanta; Mukhopadhyay, Satinath] Postgrad Inst Med Educ & Res, Dept Endocrinol & Metab, Kolkata 700020, India; [Ray, Sukanta; Mukhopadhyay, Satinath] IPGMER SSKM Hosp, Seth Sukhlal Karnani Mem Hosp, Kolkata 700020, India; [Majumdar, Subeer S.] Natl Inst Immunol, Div Cellular Endocrinol, New Delhi 110067, India	Visva Bharati University; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Bhattacharya, S (corresponding author), Visva Bharati Univ, Ctr Adv Studies Zool, Santini Ketan 731235, W Bengal, India.	bhattacharyasa@gmail.com	Kundu, Rakesh/AAG-2582-2021; Mukherjee, Sutapa/AAV-1322-2020; Kundu, Rakesh Kundu/AAC-3543-2019; Kundu, Rakesh/ABE-3083-2021	Kundu, Rakesh Kundu/0000-0001-8871-0565; Majumdar, Subeer/0000-0003-1724-7483; CHATTERJEE, PRIYAJIT/0000-0001-6728-0981; Mukhopadhyay, Satinath/0000-0001-8033-5748	National Academy of Sciences, India (NASI); Department of Science and Technology, Ministry of Science and Technology [VI-D&P/413/2012-13/TDT]; Council of Scientific and Industrial Research [CSC 207]	National Academy of Sciences, India (NASI)(Department of Science & Technology (India)); Department of Science and Technology, Ministry of Science and Technology(Department of Science & Technology (DOST), Philippines); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science and Technology, Ministry of Science and Technology (Grant VI-D&P/413/2012-13/TDT) and Council of Scientific and Industrial Research (Grant CSC 207).; Supported by a fellowship from National Academy of Sciences, India (NASI). To whom correspondence should be addressed: Centre for Advanced Studies in Zoology, Visva-Bharati University, Santiniketan-731 235, West Bengal, India. Tel.: 91-3463-261268; Fax: 91-3463-261176; E-mail: bhattacharyasa@gmail.com.	Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dey D, 2006, MOL CELL ENDOCRINOL, V246, P60, DOI 10.1016/j.mce.2005.12.014; Feve B, 2009, NAT REV ENDOCRINOL, V5, P305, DOI 10.1038/nrendo.2009.62; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Ix JH, 2010, J AM SOC NEPHROL, V21, P406, DOI 10.1681/ASN.2009080820; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yu RN, 2006, OBESITY, V14, P1353, DOI 10.1038/oby.2006.153	24	88	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28324	28330		10.1074/jbc.C113.495473	http://dx.doi.org/10.1074/jbc.C113.495473			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23943623	hybrid, Green Published			2022-12-28	WOS:000330612800061
J	Vergnolle, O; Xu, H; Blanchard, JS				Vergnolle, Olivia; Xu, Hua; Blanchard, John S.			Mechanism and Regulation of Mycobactin Fatty Acyl-AMP Ligase FadD33	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON ACQUISITION; COA SYNTHETASE; BIOSYNTHETIC-ENZYMES; GENE-CLUSTER; STEADY-STATE; TUBERCULOSIS; PROTEIN; MACROPHAGES; SIDEROPHORE; CAMP	Mycobacterial siderophores are critical components for bacterial virulence in the host. Pathogenic mycobacteria synthesize iron chelating siderophores named mycobactin and carboxymy-cobactin to extract intracellular macrophage iron. The two siderophores differ in structure only by a lipophilic aliphatic chain attached on the epsilon-amino group of the lysine mycobactin core, which is transferred by MbtK. Prior to acyl chain transfer, the lipophilic chain requires activation by a specific fatty acyl-AMP ligase FadD33 (also known as MbtM) and is then loaded onto phosphopantetheinylated acyl carrier protein (holo-MbtL) to form covalently acylated MbtL. We demonstrate that FadD33 prefers long chain saturated lipids and initial velocity studies showed that FadD33 proceeds via a Bi Uni Uni Bi ping-pong mechanism. Inhibition experiments suggest that, during the first half-reaction (adenylation), fatty acid binds first to the free enzyme, followed by ATP and the release of pyrophosphate to form the adenylate intermediate. During the second half-reaction (ligation), holo-MbtL binds to the enzyme followed by the release of products AMP and acylated MbtL. In addition, we characterized a post-translational regulation mechanism of FadD33 by the mycobacterial protein lysine acetyltransferase in a cAMP-dependent manner. FadD33 acetylation leads to enzyme inhibition, which can be reversed by the NAD(+) -dependent deacetylase, MSMEG_5175 (DAc1). To the best of our knowledge, this is the first time that bacterial siderophore synthesis has been shown to be regulated via post-translational protein acetylation.	[Vergnolle, Olivia; Xu, Hua; Blanchard, John S.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Blanchard, JS (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	john.blanchard@einstein.yu.edu			National Institutes of Health [AI60899]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI60899 (to J.S.B.).	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Andersson CS, 2012, STRUCTURE, V20, P1062, DOI 10.1016/j.str.2012.03.012; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Botella H, 2012, TRENDS MICROBIOL, V20, P106, DOI 10.1016/j.tim.2012.01.005; Brandel J, 2012, DALTON T, V41, P2820, DOI 10.1039/c1dt11804h; BYRD TF, 1993, J CLIN INVEST, V91, P969, DOI 10.1172/JCI116318; Cellier MF, 2007, MICROBES INFECT, V9, P1662, DOI 10.1016/j.micinf.2007.09.006; Chaturvedi KS, 2012, NAT CHEM BIOL, V8, P731, DOI [10.1038/NCHEMBIO.1020, 10.1038/nchembio.1020]; Chavadi SS, 2011, J BACTERIOL, V193, P5905, DOI 10.1128/JB.05811-11; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Duckworth BP, 2012, CURR TOP MED CHEM, V12, P766; Frankel BA, 2008, ARCH BIOCHEM BIOPHYS, V477, P259, DOI 10.1016/j.abb.2008.05.013; Gazdik MA, 2009, MOL MICROBIOL, V71, P434, DOI 10.1111/j.1365-2958.2008.06541.x; GOBIN J, 1995, P NATL ACAD SCI USA, V92, P5189, DOI 10.1073/pnas.92.11.5189; Goyal A, 2012, J MOL BIOL, V416, P221, DOI 10.1016/j.jmb.2011.12.031; Kalamidas SA, 2006, J CELL SCI, V119, P3686, DOI 10.1242/jcs.03091; KIM YS, 1994, BIOCHEM J, V297, P327, DOI 10.1042/bj2970327; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Krithika R, 2006, P NATL ACAD SCI USA, V103, P2069, DOI 10.1073/pnas.0507924103; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Lane SJ, 1998, BIOMETALS, V11, P13, DOI 10.1023/A:1009249122146; Lee HJ, 2012, NAT STRUCT MOL BIOL, V19, P811, DOI 10.1038/nsmb.2318; LOWRIE DB, 1979, J GEN MICROBIOL, V110, P431, DOI 10.1099/00221287-110-2-431; Luo MK, 2005, NAT CHEM BIOL, V1, P149, DOI 10.1038/nchembio717; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; PFLEIDERER G, 1960, BIOCHEM Z, V333, P308; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Rowland JL, 2012, TUBERCULOSIS, V92, P202, DOI 10.1016/j.tube.2011.12.006; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Somu RV, 2006, J MED CHEM, V49, P31, DOI 10.1021/jm051060o; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Zheng RJ, 2001, BIOCHEMISTRY-US, V40, P12904, DOI 10.1021/bi011522+	39	30	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28116	28125		10.1074/jbc.M113.495549	http://dx.doi.org/10.1074/jbc.M113.495549			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23935107	Green Published, hybrid			2022-12-28	WOS:000330612800036
J	Chen, CH; Kiyan, V; Zhylkibayev, AA; Kazyken, D; Bulgakova, O; Page, KE; Bersimbaev, RI; Spooner, E; Sarbassov, DD				Chen, Chien-Hung; Kiyan, Vladimir; Zhylkibayev, Assylbek A.; Kazyken, Dubek; Bulgakova, Olga; Page, Kent E.; Bersimbaev, Rakhmet I.; Spooner, Eric; Sarbassov, Dos D.			Autoregulation of the Mechanistic Target of Rapamycin (mTOR) Complex 2 Integrity Is Controlled by an ATP-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; PHOSPHORYLATION; AKT; RICTOR; PATHWAY; GROWTH; RAPTOR; SITE; TOR; STABILITY	Nutrients are essential for living organisms because they fuel biological processes in cells. Cells monitor nutrient abundance and coordinate a ratio of anabolic and catabolic reactions. Mechanistic target of rapamycin (mTOR) signaling is the essential nutrient-sensing pathway that controls anabolic processes in cells. The central component of this pathway is mTOR, a highly conserved and essential protein kinase that exists in two distinct functional complexes. The nutrient-sensitive mTOR complex 1 (mTORC1) controls cell growth and cell size by phosphorylation of the regulators of protein synthesis S6K1 and 4EBP1, whereas its second complex, mTORC2, regulates cell proliferation by functioning as the regulatory kinase of Akt and other members of the AGC kinase family. The regulation of mTORC2 remains poorly characterized. Our study shows that the cellular ATP balance controls a basal kinase activity of mTORC2 that maintains the integrity of mTORC2 and phosphorylation of Akt on the turn motif Thr-450 site. We found that mTOR stabilizes SIN1 by phosphorylation of its hydrophobic and conserved Ser-260 site to maintain the integrity of mTORC2. The optimal kinase activity of mTORC2 requires a concentration of ATP above 1.2 mM and makes this kinase complex highly sensitive to ATP depletion. We found that not amino acid but glucose deprivation of cells or acute ATP depletion prevented the mTOR-dependent phosphorylation of SIN1 on Ser-260 and Akt on Thr-450. In a low glucose medium, the cells carrying a substitution of SIN1 with its phosphomimetic mutant show an increased rate of cell proliferation related to a higher abundance of mTORC2 and phosphorylation of Akt. Thus, the homeostatic ATP sensor mTOR controls the integrity of mTORC2 and phosphorylation of Akt on the turn motif site.	[Chen, Chien-Hung; Kiyan, Vladimir; Zhylkibayev, Assylbek A.; Kazyken, Dubek; Bulgakova, Olga; Page, Kent E.; Sarbassov, Dos D.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chen, Chien-Hung; Sarbassov, Dos D.] Univ Texas Grad Sch Biomed Sci, Houston, TX 77030 USA; [Kiyan, Vladimir; Zhylkibayev, Assylbek A.; Kazyken, Dubek; Bulgakova, Olga; Bersimbaev, Rakhmet I.] LN Gumilyov Eurasian Natl Univ, Dept Nat Sci, Astana 010008, Kazakhstan; [Page, Kent E.] Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA; [Spooner, Eric] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of Texas System; UTMD Anderson Cancer Center; L.N. Gumilyov Eurasian National University; University of Houston System; University of Houston; Massachusetts Institute of Technology (MIT); Whitehead Institute	Sarbassov, DD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dsarbass@mdanderson.org	Bulgakova, Olga/P-7825-2014; Zhylkibayev, Assylbek A/N-4113-2017; Sarbassov, Dos/AAS-4950-2020; Kiyan, Vladimir/O-7403-2017	Bulgakova, Olga/0000-0003-3272-0638; Zhylkibayev, Assylbek A/0000-0001-9244-1505; Kiyan, Vladimir/0000-0001-9787-9151; Sarbassov, Dos/0000-0002-6848-1133	National Institutes of Health [CA 133522]; M. D. Anderson Trust; L. N. Gumilyov Eurasian National University; NATIONAL CANCER INSTITUTE [R01CA133522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. D. Anderson Trust; L. N. Gumilyov Eurasian National University(L.N. Gumilyov Eurasian National University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 133522 (to D. D. S.) This work was also supported by the M. D. Anderson Trust Fellow Fund.; Supported in part by a Ph.D. training grant from L. N. Gumilyov Eurasian National University.	Aimbetov R, 2012, ONCOGENE, V31, P2115, DOI 10.1038/onc.2011.404; Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Boulbes DR, 2011, BIOCHEM BIOPH RES CO, V413, P46, DOI 10.1016/j.bbrc.2011.08.034; Chen CH, 2011, J BIOL CHEM, V286, P40386, DOI 10.1074/jbc.M111.282590; Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Meriin AB, 1999, MOL CELL BIOL, V19, P2547; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2012, METHODS MOL BIOL, V821, P59, DOI 10.1007/978-1-61779-430-8_5; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	27	27	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27019	27030		10.1074/jbc.M113.498055	http://dx.doi.org/10.1074/jbc.M113.498055			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23928304	Green Published, hybrid			2022-12-28	WOS:000330597300004
J	Zhang, Y; Wolfle, T; Rospert, S				Zhang, Ying; Woelfle, Tina; Rospert, Sabine			Interaction of Nascent Chains with the Ribosomal Tunnel Proteins Rpl4, Rpl17, and Rpl39 of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein Folding; Protein Synthesis; Ribosomes; Translation; Yeast; Newly Synthesized Polypeptides; Site-specific Cross-linking	EXIT TUNNEL; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; MEMBRANE-PROTEIN; TRANSMEMBRANE SEGMENTS; ENDOPLASMIC-RETICULUM; SIDE-CHAINS; YEAST; POLYPEPTIDE; PEPTIDE	As translation proceeds, nascent polypeptides pass through an exit tunnel that traverses the large ribosomal subunit. Three ribosomal proteins, termed Rpl4, Rpl17, and Rpl39 expose domains to the interior of the exit tunnel of eukaryotic ribosomes. Here we generated ribosome-bound nascent chains in a homologous yeast translation system to analyze contacts between the tunnel proteins and nascent chains. As model proteins we employed Dap2, which contains a hydrophobic signal anchor (SA) segment, and the chimera Dap2, in which the SA was replaced with a hydrophilic segment, with the propensity to form an -helix. Employing a newly developed FLAG exposure assay, we find that the nascent SA segment but not the hydrophilic segment adopted a stable, -helical structure within the tunnel when the most C-terminal SA residue was separated by 14 residues from the peptidyl transferase center. Using UV cross-linking, antibodies specifically recognizing Rpl17 or Rpl39, and a His(6)-tagged version of Rpl4, we established that all three tunnel proteins of yeast contact the SA, whereas only Rpl4 and Rpl39 also contact the hydrophilic segment. Consistent with the localization of the tunnel exposed domains of Rpl17 and Rpl39, the SA was in contact with Rpl17 in the middle region and with Rpl39 in the exit region of the tunnel. In contrast, Rpl4 was in contact with nascent chain residues throughout the ribosomal tunnel.	[Zhang, Ying; Woelfle, Tina; Rospert, Sabine] Univ Freiburg, Inst Biochem & Mol Biol, Ctr Biochem & Mol Cell Res, ZBMZ, D-79104 Freiburg, Germany; [Zhang, Ying; Rospert, Sabine] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Rospert, S (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Ctr Biochem & Mol Cell Res, ZBMZ, Stefan Meier Str 17, D-79104 Freiburg, Germany.	sabine.rospert@biochemie.uni-freiburg.de	Abou Hachem, Maher/M-4772-2019	Abou Hachem, Maher/0000-0001-8250-1842; Lee, Sang-Kyu/0000-0002-3367-5229; Rospert, Sabine/0000-0002-3089-9614	SFB [746]; Forschergruppe [967]; Excellence Initiative of the German federal and state governments [EXC 294]	SFB(Austrian Science Fund (FWF)); Forschergruppe; Excellence Initiative of the German federal and state governments	This work was supported by SFB 746, Forschergruppe 967, and by the Excellence Initiative of the German federal and state governments (EXC 294) ( to S. R).	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Cheng ZL, 2006, NAT STRUCT MOL BIOL, V13, P930, DOI 10.1038/nsmb1146; Dresios J, 2000, BIOCHEMISTRY-US, V39, P7236, DOI 10.1021/bi9925266; Fulle S, 2009, J MOL BIOL, V387, P502, DOI 10.1016/j.jmb.2009.01.037; Funfschilling U, 1999, MOL BIOL CELL, V10, P3289, DOI 10.1091/mbc.10.10.3289; GARCIA PD, 1991, METHOD ENZYMOL, V194, P675; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948; Jenner L, 2012, CURR OPIN STRUC BIOL, V22, P759, DOI 10.1016/j.sbi.2012.07.013; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kosolapov A, 2004, NEURON, V44, P295, DOI 10.1016/j.neuron.2004.09.011; Lin PJ, 2011, J CELL BIOL, V195, P41, DOI 10.1083/jcb.201103117; Lin PJ, 2011, J CELL BIOL, V195, P55, DOI 10.1083/jcb.201103118; Lu JL, 2011, J MOL BIOL, V411, P499, DOI 10.1016/j.jmb.2011.05.038; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Mankin AS, 2006, TRENDS BIOCHEM SCI, V31, P11, DOI 10.1016/j.tibs.2005.11.007; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Peisker K, 2008, MOL BIOL CELL, V19, P5279, DOI 10.1091/mbc.E08-06-0661; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; ROBERTS CJ, 1989, J CELL BIOL, V108, P1363, DOI 10.1083/jcb.108.4.1363; Roosild TP, 2006, ACTA CRYSTALLOGR F, V62, P835, DOI 10.1107/S1744309106029125; Rospert S, 2004, CURR BIOL, V14, pR386, DOI 10.1016/j.cub.2004.05.013; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; Tu LW, 2010, J MOL BIOL, V396, P1346, DOI 10.1016/j.jmb.2009.12.059; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; WATSON HC, 1982, EMBO J, V1, P1635, DOI 10.1002/j.1460-2075.1982.tb01366.x; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang Y, 2012, MOL BIOL CELL, V23, P3027, DOI 10.1091/mbc.E12-02-0112	40	25	25	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33697	33707		10.1074/jbc.M113.508283	http://dx.doi.org/10.1074/jbc.M113.508283			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24072706	Green Published, hybrid			2022-12-28	WOS:000327250200017
J	Kvist, T; Steffensen, TB; Greenwood, JR; Tabrizi, F; Hansen, KB; Gajhede, M; Pickering, DS; Traynelis, SF; Kastrup, JS; Brauner-Osborne, H				Kvist, Trine; Steffensen, Thomas Bielefeldt; Greenwood, Jeremy R.; Mehrzad Tabrizi, Fatemeh; Hansen, Kasper B.; Gajhede, Michael; Pickering, Darryl S.; Traynelis, Stephen F.; Kastrup, Jette Sandholm; Braeuner-Osborne, Hans			Crystal Structure and Pharmacological Characterization of a Novel N-Methyl-D-aspartate (NMDA) Receptor Antagonist at the GluN1 Glycine Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Ion Channels; Ligand-binding Protein; Molecular Pharmacology; Neurotransmitter Receptors; NMDA Receptor; Schild Analysis; Bioisoster; Competitive Antagonist; Glycine Site	GLUTAMATE; ACTIVATION; DOMAIN; CRYSTALLOGRAPHY; INHIBITION; COMPLEX; ROLES; MODEL; TOOL	Background: The glycine-binding GluN1 and GluN3 subunits of NMDA receptors have distinctive selectivity profiles. Results: TK40 binds to the GluN1 orthosteric binding site and competitively reduces the potency of glycine. Conclusion: TK40 is a novel glycine site antagonist with selectivity for the GluN1 subunit compared with GluN3. Significance: The imino acetamido moiety acts as an -amino acid bioisostere, as predicted by virtual screening. NMDA receptors are ligand-gated ion channels that mediate excitatory neurotransmission in the brain. They are tetrameric complexes composed of glycine-binding GluN1 and GluN3 subunits together with glutamate-binding GluN2 subunits. Subunit-selective antagonists that discriminate between the glycine sites of GluN1 and GluN3 subunits would be valuable pharmacological tools for studies on the function and physiological roles of NMDA receptor subtypes. In a virtual screening for antagonists that exploit differences in the orthosteric binding site of GluN1 and GluN3 subunits, we identified a novel glycine site antagonist, 1-thioxo-1,2-dihydro-[1,2,4]triazolo[4,3-a]quinoxalin-4(5H)-one (TK40). Here, we show by Schild analysis that TK40 is a potent competitive antagonist with K-b values of 21-63 nm at the GluN1 glycine-binding site of the four recombinant GluN1/N2A-D receptors. In addition, TK40 displayed >100-fold selectivity for GluN1/N2 NMDA receptors over GluN3A- and GluN3B-containing NMDA receptors and no appreciable effects at AMPA receptors. Binding experiments on rat brain membranes and the purified GluN1 ligand-binding domain using glycine site GluN1 radioligands further confirmed the competitive interaction and high potency. To delineate the binding mechanism, we have solved the crystal structure of the GluN1 ligand-binding domain in complex with TK40 and show that TK40 binds to the orthosteric binding site of the GluN1 subunit with a binding mode that was also predicted by virtual screening. Furthermore, the structure reveals that the imino acetamido group of TK40 acts as an -amino acid bioisostere, which could be of importance in bioisosteric replacement strategies for future ligand design.	[Kvist, Trine; Steffensen, Thomas Bielefeldt; Mehrzad Tabrizi, Fatemeh; Gajhede, Michael; Pickering, Darryl S.; Kastrup, Jette Sandholm; Braeuner-Osborne, Hans] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark; [Greenwood, Jeremy R.] Schrodinger Inc, New York, NY 10036 USA; [Hansen, Kasper B.; Traynelis, Stephen F.] Emory Univ, Dept Pharmacol, Rollins Res Ctr, Sch Med, Atlanta, GA 30322 USA	University of Copenhagen; Emory University	Brauner-Osborne, H (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Fruebjergvej 3, DK-2100 Copenhagen, Denmark.	hbo@sund.ku.dk	Bräuner-Osborne, Hans/D-7260-2011; Hansen, Kasper B/C-4062-2008	Bräuner-Osborne, Hans/0000-0001-9495-7388; Hansen, Kasper B/0000-0002-3303-4819; Gajhede, Michael/0000-0001-9864-2287; Kastrup, Jette Sandholm/0000-0003-2654-1510	Lundbeck Foundation; GluTarget Programme of Excellence at the University of Copenhagen; Danish Ministry of Science, Innovation, and Higher Education EliteForsk Programme; Augustinus Foundation DanScatt; Danish Council for Independent Research-Medical Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065371] Funding Source: NIH RePORTER; Lundbeck Foundation [R34-2009-3779] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); GluTarget Programme of Excellence at the University of Copenhagen; Danish Ministry of Science, Innovation, and Higher Education EliteForsk Programme; Augustinus Foundation DanScatt; Danish Council for Independent Research-Medical Sciences(Det Frie Forskningsrad (DFF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation; the GluTarget Programme of Excellence at the University of Copenhagen; the Danish Ministry of Science, Innovation, and Higher Education EliteForsk Programme; the Augustinus Foundation DanScatt; and the Danish Council for Independent Research-Medical Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Awobuluyi M, 2007, MOL PHARMACOL, V71, P112, DOI 10.1124/mol.106.03070; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brauner-Osborne H, 2000, J MED CHEM, V43, P2609, DOI 10.1021/jm000007r; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Danysz W, 1998, PHARMACOL REV, V50, P597; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gellert L, 2011, EUR J PHARMACOL, V667, P182, DOI 10.1016/j.ejphar.2011.05.069; GRIMWOOD S, 1992, MOL PHARMACOL, V41, P923; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hess SD, 1998, J NEUROCHEM, V70, P1269; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huang YH, 2011, J NEUROSCI, V31, P18453, DOI 10.1523/JNEUROSCI.3824-11.2011; Jansen M, 2003, EUR J MED CHEM, V38, P661, DOI 10.1016/S0223-5234(03)00113-2; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kasper C, 2006, J MOL BIOL, V357, P1184, DOI 10.1016/j.jmb.2006.01.024; Kenny AV, 2009, J BIOL CHEM, V284, P324, DOI 10.1074/jbc.M804023200; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Kvist T, 2013, NEUROPHARMACOLOGY, V75, P324, DOI 10.1016/j.neuropharm.2013.08.003; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laube B, 1998, J NEUROSCI, V18, P2954; LEESON PD, 1992, J MED CHEM, V35, P1954, DOI 10.1021/jm00089a004; LEESON PD, 1991, J MED CHEM, V34, P1243, DOI 10.1021/jm00108a002; LEESON PD, 1994, J MED CHEM, V37, P4053, DOI 10.1021/jm00050a001; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; Madry C, 2007, BIOCHEM BIOPH RES CO, V354, P102, DOI 10.1016/j.bbrc.2006.12.153; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Nacher J, 2006, HIPPOCAMPUS, V16, P267, DOI 10.1002/hipo.20160; Nielsen BS, 1998, EUR J PHARMACOL, V360, P227, DOI 10.1016/S0014-2999(98)00668-2; Nilsson A, 2007, NEUROPHARMACOLOGY, V52, P1151, DOI 10.1016/j.neuropharm.2006.12.002; Paas Y, 1998, TRENDS NEUROSCI, V21, P117, DOI 10.1016/S0166-2236(97)01184-3; Pina-Crespo JC, 2010, J NEUROSCI, V30, P11501, DOI 10.1523/JNEUROSCI.1593-10.2010; RANSOM RW, 1988, J NEUROCHEM, V51, P830, DOI 10.1111/j.1471-4159.1988.tb01818.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Yao YN, 2006, J NEUROSCI, V26, P4559, DOI 10.1523/JNEUROSCI.0560-06.2006; Yao Y, 2008, EMBO J, V27, P2158, DOI 10.1038/emboj.2008.140	45	19	21	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33124	33135		10.1074/jbc.M113.480210	http://dx.doi.org/10.1074/jbc.M113.480210			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24072709	hybrid, Green Published			2022-12-28	WOS:000328841700028
J	Maddur, AA; Swanson, R; Izaguirre, G; Gettins, PGW; Olson, ST				Maddur, Ashoka A.; Swanson, Richard; Izaguirre, Gonzalo; Gettins, Peter G. W.; Olson, Steven T.			Kinetic Intermediates en Route to the Final Serpin-Protease Complex STUDIES OF COMPLEXES OF alpha(1)-PROTEASE INHIBITOR WITH TRYPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; PROTEINASE COMPLEX; CONFORMATIONAL-CHANGE; MICHAELIS COMPLEX; COVALENT COMPLEX; MECHANISM; PITTSBURGH; ANTITHROMBIN; DEFORMATION; DISTORTION	Serpin protein protease inhibitors inactivate their target proteases through a unique mechanism in which a major serpin conformational change, resulting in a 70-angstrom translocation of the protease from its initial reactive center loop docking site to the opposite pole of the serpin, kinetically traps the acyl-intermediate complex. Although the initial Michaelis and final trapped acyl-intermediate complexes have been well characterized structurally, the intermediate stages involved in this remarkable transformation are not well understood. To better characterize such intermediate steps, weundertook rapid kinetic studies of the FRET and fluorescence perturbation changes of site-specific fluorophore-labeled derivatives of the serpin, alpha(1)-protease inhibitor (alpha 1PI), which report the serpin and protease conformational changes involved in transforming the Michaelis complex to the trapped acyl-intermediate complex in reactions with trypsin. Two kinetically resolvable conformational changes were observed in the reactions, ascribable to (i) serpin reactive center loop insertion into sheet A with full protease translocation but incomplete protease distortion followed by, (ii) full conformational distortion and movement of the protease and coupled serpin conformational changes involving the F helix-sheet A interface. Kinetic studies of calcium effects on the labeled alpha 1PI-trypsin reactions demonstrated both inactive and low activity states of the distorted protease in the final complex that were distinct from the intermediate distorted state. These studies provide new insights into the nature of the serpin and protease conformational changes involved in trapping the acyl-intermediate complex in serpin-protease reactions and support a previously proposed role for helix F in the trapping mechanism.	Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; Univ Illinois, Dept Periodont, Chicago, IL 60612 USA; [Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Olson, ST (corresponding author), 801 South Paulina St,MC 860, Chicago, IL 60612 USA.	stolson@uic.edu			National Institutes of Health [R01 HL-78827, R37 HL39888]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888, R01HL078827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL-78827 and R37 HL39888 (to S. T. O.).	Calugaru SV, 2001, J BIOL CHEM, V276, P32446, DOI 10.1074/jbc.M104731200; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Futamura A, 1998, BIOCHEMISTRY-US, V37, P13110, DOI 10.1021/bi981234m; Gettins PGW, 2002, FEBS LETT, V523, P2, DOI 10.1016/S0014-5793(02)02924-1; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Izaguirre G, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702462200; Izaguirre G, 2009, J BIOL CHEM, V284, P1550, DOI 10.1074/jbc.M807340200; LINDAHL P, 1991, BIOCHEM J, V276, P387, DOI 10.1042/bj2760387; OLSON ST, 1995, J BIOL CHEM, V270, P30007; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; Olson ST, 2011, PROG MOL BIOL TRANSL, V99, P185, DOI 10.1016/S1877-1173(11)99005-X; PANNELL R, 1974, BIOCHEMISTRY-US, V13, P5439, DOI 10.1021/bi00723a031; Perron MJ, 2003, J BIOL CHEM, V278, P48197, DOI 10.1074/jbc.M306184200; Peterson FC, 2000, BIOCHEMISTRY-US, V39, P11884, DOI 10.1021/bi001152+; Peterson FC, 2001, BIOCHEMISTRY-US, V40, P6284, DOI 10.1021/bi010100x; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Stratikos E, 1997, P NATL ACAD SCI USA, V94, P453, DOI 10.1073/pnas.94.2.453; Stratikos E, 1998, J BIOL CHEM, V273, P15582, DOI 10.1074/jbc.273.25.15582; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; Swanson R, 2007, J BIOL CHEM, V282, P2305, DOI 10.1074/jbc.M609546200; Tew DJ, 2001, FEBS LETT, V494, P30, DOI 10.1016/S0014-5793(01)02305-5; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979	25	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					32020	32035		10.1074/jbc.M113.510990	http://dx.doi.org/10.1074/jbc.M113.510990			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047901	Green Published, hybrid			2022-12-28	WOS:000330596200054
J	Zheng, YH; Yang, WW; Aldape, K; He, J; Lu, ZM				Zheng, Yanhua; Yang, Weiwei; Aldape, Kenneth; He, Jie; Lu, Zhimin			Epidermal Growth Factor (EGF)-enhanced Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression Promotes Macrophage and Glioblastoma Cell Interaction and Tumor Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; MAMMARY-TUMORS; BREAST-CANCER; ANTICANCER THERAPIES; PTP-PEST; PROGRESSION; METASTASIS; MIGRATION	Activated EGF receptor (EGFR) signaling plays an instrumental role in glioblastoma (GBM) progression. However, how EGFR activation regulates the tumor microenvironment to promote GBM cell invasion remains to be clarified. Here, we demonstrate that the levels of EGFR activation in tumor cells correlated with the levels of macrophage infiltration in human GBM specimens. This was supported by our observation that EGFR activation enhanced the interaction between macrophages and GBM cells. In addition, EGF treatment induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) expression in a PKC epsilon- and NF-kappa B-dependent manner. Depletion of VCAM-1 interrupted the binding of macrophages to GBM cells and inhibited EGF-induced and macrophage-promoted GBM cell invasion. These results demonstrate an instrumental role for EGF-induced up-regulation of VCAM-1 expression in EGFR activation-promoted macrophage-tumor cell interaction and tumor cell invasion and indicate that VCAM-1 is a potential molecular target for improving cancer therapy.	[Zheng, Yanhua; Yang, Weiwei; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Zheng, Yanhua; Yang, Weiwei; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Aldape, Kenneth] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [He, Jie] Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst & Hosp, Lab Thorac Surg, Beijing 100730, Peoples R China; [Lu, Zhimin] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; University of Texas System; University of Texas Health Science Center Houston	Lu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA.	zhiminlu@mdanderson.org	yang, zheng/HGC-7753-2022		National Institutes of Health from NCI [2R01CA109035, 1R0CA169603]; MD Anderson Cancer Center Support Grant [CA016672]; Cancer Prevention and Research Institute of Texas Research [RP110252, RP130389]; American Cancer Society Research Scholar Grant [RSG-09-277-01-CSM]; James S. McDonnell Foundation 21st Century Science Initiative in Brain Cancer Research Award [220020318]; Sister Institution Network Fund grants from the MDAnderson Cancer Center; Cancer Institute and Hospital of Chinese Academy of Medical Sciences; NATIONAL CANCER INSTITUTE [R01CA109035, P30CA016672, R01CA169603] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MD Anderson Cancer Center Support Grant; Cancer Prevention and Research Institute of Texas Research; American Cancer Society Research Scholar Grant(American Cancer Society); James S. McDonnell Foundation 21st Century Science Initiative in Brain Cancer Research Award; Sister Institution Network Fund grants from the MDAnderson Cancer Center; Cancer Institute and Hospital of Chinese Academy of Medical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01CA109035 and 1R0CA169603 (to Z. L.) from NCI. This work was also supported by MD Anderson Cancer Center Support Grant CA016672, Cancer Prevention and Research Institute of Texas Research Grants RP110252 and RP130389 (to Z. L.), American Cancer Society Research Scholar Grant RSG-09-277-01-CSM (to Z. L.), James S. McDonnell Foundation 21st Century Science Initiative in Brain Cancer Research Award 220020318 (to Z. L.), and Sister Institution Network Fund grants from the MDAnderson Cancer Center (to Z. L.) and the Cancer Institute and Hospital of Chinese Academy of Medical Sciences (to J. H.).	Andjelkovic AV, 1998, BRAIN RES, V814, P13, DOI 10.1016/S0006-8993(98)00830-0; Ayuso-Sacido A, 2010, J NEURO-ONCOL, V97, P323, DOI 10.1007/s11060-009-0035-x; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Chen Q, 2012, CLIN CANCER RES, V18, P5520, DOI 10.1158/1078-0432.CCR-11-2904; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Cook-Mills JM, 2002, MOL IMMUNOL, V39, P499, DOI 10.1016/S0161-5890(02)00206-7; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Green CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006713; Heidemann J, 2006, INT J ONCOL, V28, P77; Heimberger AB, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-38; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; Kim JY, 2012, VASC PHARMACOL, V56, P131, DOI 10.1016/j.vph.2011.11.007; Komohara Y, 2011, CANCER SCI, V102, P1424, DOI 10.1111/j.1349-7006.2011.01945.x; Larysz D, 2011, FOLIA NEUROPATHOL, V49, P28; Lewis C, 2005, AM J PATHOL, V167, P627, DOI 10.1016/S0002-9440(10)62038-X; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; LIBERMANN TA, 1984, CANCER RES, V44, P753; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Maenpaa A, 1997, ACTA NEUROPATHOL, V94, P216, DOI 10.1007/s004010050696; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Ruco LP, 1996, J PATHOL, V179, P266; SCHLEGEL J, 1994, INT J CANCER, V56, P72; Shin J, 2006, CELL PHYSIOL BIOCHEM, V17, P211, DOI 10.1159/000094126; Sun DI, 2008, INT IMMUNOPHARMACOL, V8, P1272, DOI 10.1016/j.intimp.2008.05.006; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yang CR, 2005, J IMMUNOL, V174, P1647, DOI 10.4049/jimmunol.174.3.1647; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Zerfaoui M, 2008, CELL SIGNAL, V20, P186, DOI 10.1016/j.cellsig.2007.10.007; Zheng YH, 2011, MOL CELL BIOL, V31, P4258, DOI 10.1128/MCB.05547-11; Zheng YH, 2009, MOL CELL, V35, P11, DOI 10.1016/j.molcel.2009.06.013; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866	45	41	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31488	31495		10.1074/jbc.M113.499020	http://dx.doi.org/10.1074/jbc.M113.499020			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045955	Green Published, hybrid			2022-12-28	WOS:000330596200008
J	Kogawa, M; Hisatake, K; Atkins, GJ; Findlay, DM; Enoki, Y; Sato, T; Gray, PC; Kanesaki-Yatsuka, Y; Anderson, PH; Wada, S; Kato, N; Fukuda, A; Katayama, S; Tsujimoto, M; Yoda, T; Suda, T; Okazaki, Y; Matsumoto, M				Kogawa, Masakazu; Hisatake, Koji; Atkins, Gerald J.; Findlay, David M.; Enoki, Yuichiro; Sato, Tsuyoshi; Gray, Peter C.; Kanesaki-Yatsuka, Yukiko; Anderson, Paul H.; Wada, Seiki; Kato, Naoki; Fukuda, Aya; Katayama, Shigehiro; Tsujimoto, Masafumi; Yoda, Tetsuya; Suda, Tatsuo; Okazaki, Yasushi; Matsumoto, Masahito			The Paired-box Homeodomain Transcription Factor Pax6 Binds to the Upstream Region of the TRAP Gene Promoter and Suppresses Receptor Activator of NF-kappa B Ligand (RANKL)-induced Osteoclast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-PHOSPHATASE GENE; TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE; C-FOS; TERMINAL DIFFERENTIATION; BONE-RESORPTION; MICE; RANKL; EXPRESSION; CELLS	Osteoclast formation is regulated by balancing between the receptor activator of nuclear factor-kappa B ligand (RANKL) expressed in osteoblasts and extracellular negative regulatory cytokines such as interferon-gamma (IFN-gamma) and interferon-beta (IFN-beta), which can suppress excessive bone destruction. However, relatively little is known about intrinsic negative regulatory factors in RANKL-mediated osteoclast differentiation. Here, we show the paired-box homeodomain transcription factor Pax6 acts as a negative regulator of RANKL-mediated osteoclast differentiation. Electrophoretic mobility shift and reporter assays found that Pax6 binds endogenously to the proximal region of the tartrate acid phosphatase (TRAP) gene promoter and suppresses nuclear factor of activated T cells c1 (NFATc1)-induced TRAP gene expression. Introduction of Pax6 retrovirally into bone marrow macrophages attenuates RANKL-induced osteoclast formation. Moreover, we found that the Groucho family member co-repressor Grg6 contributes to Pax6-mediated suppression of the TRAP gene expression induced by NFATc1. These results suggest that Pax6 interferes with RANKL-mediated osteoclast differentiation together with Grg6. Our results demonstrate that the Pax6 pathway constitutes a new aspect of the negative regulatory circuit of RANKL-RANK signaling in osteoclastogenesis and that the augmentation of Pax6 might therefore represent a novel target to block pathological bone resorption.	[Kogawa, Masakazu; Hisatake, Koji; Fukuda, Aya; Matsumoto, Masahito] Saitama Med Univ, Res Ctr Genom Med, Dept Biol Mol, Hidaka City, Saitama 3501241, Japan; [Kogawa, Masakazu; Wada, Seiki; Katayama, Shigehiro] Saitama Med Univ, Res Ctr Genom Med, Dept Endocrinol & Diabet, Hidaka City, Saitama 3501241, Japan; [Enoki, Yuichiro; Sato, Tsuyoshi; Yoda, Tetsuya] Saitama Med Univ, Res Ctr Genom Med, Dept Oral & Maxillofacial Surg, Hidaka City, Saitama 3501241, Japan; [Kato, Naoki] Saitama Med Univ, Res Ctr Genom Med, Dept Orthopaed Surg, Hidaka City, Saitama 3501241, Japan; [Kanesaki-Yatsuka, Yukiko; Suda, Tatsuo; Okazaki, Yasushi; Matsumoto, Masahito] Saitama Med Univ, Div Funct Genom & Syst Med, Res Ctr Genom Med, Hidaka City, Saitama 3501241, Japan; [Kogawa, Masakazu; Atkins, Gerald J.; Findlay, David M.] Univ Adelaide, Discipline Orthopaed & Trauma, Adelaide, SA 5000, Australia; [Hisatake, Koji; Fukuda, Aya] Univ Tsukuba, Fac Med, Lab Gene Regulat, Tsukuba, Ibaraki 3050006, Japan; [Gray, Peter C.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Anderson, Paul H.] Univ Adelaide, Sch Pharm & Med Sci, Div Hlth Sci, Adelaide, SA 5000, Australia; [Tsujimoto, Masafumi] Teikyo Heisei Univ, Fac Pharmaceut Sci, Tokyo 1648530, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; University of Adelaide; University of Tsukuba; Salk Institute; University of Adelaide	Matsumoto, M (corresponding author), Saitama Med Univ, Div Funct Genom & Syst Med, Res Ctr Genom Med, 1397-1 Yamane, Hidaka City, Saitama 3501241, Japan.	masam@saitama-med.ac.jp	Matsumoto, Masahito/AGS-0755-2022; Anderson, Paul H/F-4198-2013	Anderson, Paul H/0000-0002-8685-3252; Atkins, Gerald/0000-0002-3123-9861; Okazaki, Yasushi/0000-0003-3241-5502; Hisatake, Koji/0000-0002-5795-3115	MEXT; JSPS KAKENHI Grant [25462380]; Kanzawa Medical Research; Kowa Life Science Foundation; Life Science; Japan Diabetes Foundations; Clayton Medical Research Foundation, Inc.; Cancer Center Core Grant [P30 CA014195-38]; Ochiai Memorial Awards; Maruki Memorial Awards; Saitama Medical University Internal Research Grant [11B-08]; Kawano Masanori Memorial Foundation for the promotion of Pediatrics; Grants-in-Aid for Scientific Research [25460354] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kanzawa Medical Research; Kowa Life Science Foundation; Life Science; Japan Diabetes Foundations; Clayton Medical Research Foundation, Inc.; Cancer Center Core Grant; Ochiai Memorial Awards; Maruki Memorial Awards; Saitama Medical University Internal Research Grant(Saitama Medical University); Kawano Masanori Memorial Foundation for the promotion of Pediatrics(Kawano Masanori Memorial Foundation for Promotion of Pediatrics); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by MEXT and JSPS KAKENHI Grant 25462380, grants from the Kanzawa Medical Research, the Kowa Life Science Foundation, the Life Science, the Japan Diabetes Foundations (to M. M.), the Clayton Medical Research Foundation, Inc. (to P. C. G.), Cancer Center Core Grant P30 CA014195-38 (to P. C. G.), Ochiai Memorial Awards (2001 and 2007), Maruki Memorial Awards (to M. M.), Saitama Medical University Internal Research Grant 11B-08 (to M. M.), "Support Project of Strategic Research Center in Private Universities" from MEXT and a grant from Kawano Masanori Memorial Foundation for the promotion of Pediatrics (to M. M.).	Abu-Amer Y, 2001, J CLIN INVEST, V107, P1375, DOI 10.1172/JCI10530; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Cai Y, 2003, EMBO J, V22, P5522, DOI 10.1093/emboj/cdg536; Castori M, 2009, AM J MED GENET A, V149A, P1768, DOI 10.1002/ajmg.a.32960; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Conway SJ, 2000, CARDIOVASC RES, V47, P314, DOI 10.1016/S0008-6363(00)00098-5; Dang JJ, 2001, MOL CELL BIOL, V21, P5935, DOI 10.1128/MCB.21.17.5935-5945.2001; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Elvenes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024659; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Hasson P, 2006, BRIT J CANCER, V94, P771, DOI 10.1038/sj.bjc.6603019; Hayman AR, 1996, DEVELOPMENT, V122, P3151; Hikata T, 2009, BLOOD, V113, P2202, DOI 10.1182/blood-2008-06-162594; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Horowitz MC, 2004, J IMMUNOL, V173, P6583, DOI 10.4049/jimmunol.173.11.6583; HOTH CF, 1993, AM J HUM GENET, V52, P455; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kralova J, 2002, GENE, V286, P271, DOI 10.1016/S0378-1119(02)00425-0; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Linderson Y, 2004, EMBO REP, V5, P291, DOI 10.1038/sj.embor.7400089; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Mansouri A, 1996, DEVELOPMENT, V122, P831; Marcal N, 2005, MOL CELL BIOL, V25, P10916, DOI 10.1128/MCB.25.24.10916-10929.2005; Matsumoto M, 2000, FEBS LETT, V486, P23, DOI 10.1016/S0014-5793(00)02231-6; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsumoto M, 2001, J BIOL CHEM, V276, P33086, DOI 10.1074/jbc.M104299200; Matsumoto M, 1999, BIOL CHEM, V380, P699, DOI 10.1515/BC.1999.087; Moreno JL, 2003, BLOOD, V102, P1078, DOI 10.1182/blood-2002-11-3437; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Pfeffer PL, 1998, DEVELOPMENT, V125, P3063; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Torres MA, 1996, DEVELOPMENT, V122, P3381; Wang WF, 2004, DEV BIOL, V270, P364, DOI 10.1016/j.ydbio.2004.03.003; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wolf G, 2010, MOL ENDOCRINOL, V24, P2331, DOI 10.1210/me.2009-0220; Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329	63	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31299	31312		10.1074/jbc.M113.461848	http://dx.doi.org/10.1074/jbc.M113.461848			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	23990468	Green Published, hybrid			2022-12-28	WOS:000330778900047
J	Mangione, PP; Esposito, G; Relini, A; Raimondi, S; Porcari, R; Giorgetti, S; Corazza, A; Fogolari, F; Penco, A; Goto, Y; Lee, YH; Yagi, H; Cecconi, C; Naqvi, MM; Gillmore, JD; Hawkins, PN; Chiti, F; Rolandi, R; Taylor, GW; Pepys, MB; Stoppini, M; Bellotti, V				Mangione, P. Patrizia; Esposito, Gennaro; Relini, Annalisa; Raimondi, Sara; Porcari, Riccardo; Giorgetti, Sofia; Corazza, Alessandra; Fogolari, Federico; Penco, Amanda; Goto, Yuji; Lee, Young-Ho; Yagi, Hisashi; Cecconi, Ciro; Naqvi, Mohsin M.; Gillmore, Julian D.; Hawkins, Philip N.; Chiti, Fabrizio; Rolandi, Ranieri; Taylor, Graham W.; Pepys, Mark B.; Stoppini, Monica; Bellotti, Vittorio			Structure, Folding Dynamics, and Amyloidogenesis of D76N beta(2)-Microglobulin ROLES OF SHEAR FLOW, HYDROPHOBIC SURFACES, AND alpha-CRYSTALLIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMYLOID PEPTIDE; GLOBULAR-PROTEINS; ELECTROSTATIC PROPERTIES; PHYSIOLOGICAL CONDITIONS; ENERGY LANDSCAPE; ADSORPTION; FORCE; AGGREGATION; INTERFACE; CONFORMATION	Systemic amyloidosis is a fatal disease caused by misfolding of native globular proteins, which then aggregate extracellularly as insoluble fibrils, damaging the structure and function of affected organs. The formation of amyloid fibrils in vivo is poorly understood. We recently identified the first naturally occurring structural variant, D76N, of human beta(2)-microglobulin (beta(2)m), the ubiquitous light chain of class I major histocompatibility antigens, as the amyloid fibril protein in a family with a new phenotype of late onset fatal hereditary systemic amyloidosis. Here we show that, uniquely, D76N beta(2)m readily forms amyloid fibrils in vitro under physiological extracellular conditions. The globular native fold transition to the fibrillar state is primed by exposure to a hydrophobic-hydrophilic interface under physiological intensity shear flow. Wild type beta(2)m is recruited by the variant into amyloid fibrils in vitro but is absent from amyloid deposited in vivo. This may be because, as we show here, such recruitment is inhibited by chaperone activity. Our results suggest general mechanistic principles of in vivo amyloid fibrillogenesis by globular proteins, a previously obscure process. Elucidation of this crucial causative event in clinical amyloidosis should also help to explain the hitherto mysterious timing and location of amyloid deposition.	[Gillmore, Julian D.; Hawkins, Philip N.; Taylor, Graham W.; Pepys, Mark B.; Bellotti, Vittorio] UCL, Wolfson Drug Discovery Unit, Ctr Amyloidosis & Acute Phase Prot, Div Med, London NW3 2PF, England; [Mangione, P. Patrizia; Raimondi, Sara; Giorgetti, Sofia; Stoppini, Monica; Bellotti, Vittorio] Univ Pavia, Dept Mol Med, Inst Biochem, I-27100 Pavia, Italy; [Esposito, Gennaro; Corazza, Alessandra; Fogolari, Federico] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [Relini, Annalisa; Penco, Amanda; Rolandi, Ranieri] Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Goto, Yuji; Lee, Young-Ho; Yagi, Hisashi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Cecconi, Ciro] CNR, Nanosci Inst, I-41125 Modena, Italy; [Naqvi, Mohsin M.] Univ Modena & Reggio Emilia, Dept Phys, I-41125 Modena, Italy; [Chiti, Fabrizio] Univ Florence, Dept Biochem Sci, I-50134 Florence, Italy	University of London; University College London; University of Pavia; University of Udine; University of Genoa; Osaka University; Consiglio Nazionale delle Ricerche (CNR); Universita di Modena e Reggio Emilia; University of Florence	Bellotti, V (corresponding author), UCL, Wolfson Drug Discovery Unit, Ctr Amyloidosis & Acute Phase Prot, Div Med, Rowland Hill St, London NW3 2PF, England.	v.bellotti@ucl.ac.uk	Rolandi, Ranieri/C-4765-2012; Giorgetti, Sofia/AAD-4341-2019; Corazza, Alessandra/AGB-1457-2022; Relini, Annalisa/AHC-3105-2022; Cecconi, Ciro/K-5028-2016; Bellotti, Vittorio/A-6201-2014	Rolandi, Ranieri/0000-0002-0580-1611; Giorgetti, Sofia/0000-0001-9438-6511; Corazza, Alessandra/0000-0003-2272-1928; Cecconi, Ciro/0000-0002-6101-2609; Fogolari, Federico/0000-0001-9862-250X; RELINI, ANNALISA/0000-0002-4040-9279; Taylor, Graham/0000-0002-9672-8463; Bellotti, Vittorio/0000-0001-8678-662X; Mangione, Palma/0000-0003-0260-1400	United Kingdom Medical Research Council [MR/K000187/1]; University College London (UCL) Amyloidosis Research Fund; UCL Wolfson Drug Discovery Unit Funds; Cariplo Foundation [2009-2543, 2011-2096]; Italian Ministry of University; Research Project FIRB RBFR109EOS; Regione Lombardia; International Collaborative Research Program of the Institute for Protein Research, Osaka University; MRC [MR/K000187/1, G7900510] Funding Source: UKRI; Grants-in-Aid for Scientific Research [25870407] Funding Source: KAKEN; Medical Research Council [MR/K000187/1, G7900510] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College London (UCL) Amyloidosis Research Fund; UCL Wolfson Drug Discovery Unit Funds; Cariplo Foundation(Fondazione Cariplo); Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Research Project FIRB RBFR109EOS; Regione Lombardia(Regione Lombardia); International Collaborative Research Program of the Institute for Protein Research, Osaka University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by United Kingdom Medical Research Council Grant MR/K000187/1 (to V. B.), the University College London (UCL) Amyloidosis Research Fund and UCL Wolfson Drug Discovery Unit Funds, Cariplo Foundation Projects 2009-2543 and 2011-2096 (to V. B.), Italian Ministry of University and Research Project FIRB RBFR109EOS (to S. G.), Regione Lombardia (to V. B.), and the International Collaborative Research Program of the Institute for Protein Research, Osaka University (to R. P.). Core support for the Wolfson Drug Discovery Unit is provided by the United Kingdom National Institute for Health Research Biomedical Research Centre and Unit Funding Scheme.	Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bekard IB, 2011, BIOPOLYMERS, V95, P733, DOI 10.1002/bip.21646; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; BOTHNERBY AA, 1984, J AM CHEM SOC, V106, P811, DOI 10.1021/ja00315a069; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chiti F, 2001, J BIOL CHEM, V276, P46714, DOI 10.1074/jbc.M107040200; Chiti F, 2001, J MOL BIOL, V307, P379, DOI 10.1006/jmbi.2000.4478; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Donaldson SH, 2011, P NATL ACAD SCI USA, V108, P15699, DOI 10.1073/pnas.1112411108; Dyson HJ, 2006, P NATL ACAD SCI USA, V103, P13057, DOI 10.1073/pnas.0605504103; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; FARMER BT, 1992, J BIOMOL NMR, V2, P195, DOI 10.1007/BF01875530; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fogolari F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S18; Garvey M, 2011, BIOPOLYMERS, V95, P376, DOI 10.1002/bip.21584; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Hammer MU, 2010, FARADAY DISCUSS, V146, P299, DOI 10.1039/b926184b; Hoernke M, 2011, LANGMUIR, V27, P14218, DOI 10.1021/la203016z; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P291, DOI 10.1016/B978-0-12-375182-9.10014-4; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Jean L, 2010, FASEB J, V24, P309, DOI 10.1096/fj.09-137653; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Kameda A, 2005, J MOL BIOL, V348, P383, DOI 10.1016/j.jmb.2005.02.050; Kardos J, 2004, J BIOL CHEM, V279, P55308, DOI 10.1074/jbc.M409677200; Kay Lewis E, 2011, J Magn Reson, V213, P423, DOI 10.1016/j.jmr.2011.09.004; KEELER J, 1994, METHOD ENZYMOL, V239, P145; Keutsch FN, 2001, P NATL ACAD SCI USA, V98, P10533, DOI 10.1073/pnas.191266498; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Krasowska M, 2009, ADV COLLOID INTERFAC, V147-48, P155, DOI 10.1016/j.cis.2008.10.003; Lad MD, 2006, PHYS CHEM CHEM PHYS, V8, P2179, DOI 10.1039/b515934b; Lapidus S, 2008, P NATL ACAD SCI USA, V105, P6039, DOI 10.1073/pnas.0708708105; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Marshall KE, 2011, BIOCHEMISTRY-US, V50, P2061, DOI 10.1021/bi101936c; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Munson B.R., 2009, FUNDAMENTALS FLUID M, V6th; NARSIMHAN G, 1992, BIOTECHNOL PROGR, V8, P187, DOI 10.1021/bp00015a003; Ozawa D, 2011, J BIOL CHEM, V286, P9668, DOI 10.1074/jbc.M110.167965; Piazza R, 2006, EUR BIOPHYS J BIOPHY, V35, P439, DOI 10.1007/s00249-006-0051-0; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pronchik J, 2010, J AM CHEM SOC, V132, P9797, DOI 10.1021/ja102896h; Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007; Rennella E, 2012, BBA-PROTEINS PROTEOM, V1824, P842, DOI 10.1016/j.bbapap.2012.04.002; Rennella E, 2012, J AM CHEM SOC, V134, P4457, DOI 10.1021/ja209004q; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Sethuraman A, 2004, PROTEINS, V56, P669, DOI 10.1002/prot.20183; Shankaran H, 2004, BIOPHYS J, V86, P576, DOI 10.1016/S0006-3495(04)74136-3; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Szymczak P, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/3/033102; Teoh CL, 2011, BIOCHEMISTRY-US, V50, P4046, DOI 10.1021/bi2002482; TRIPP BC, 1995, J COLLOID INTERF SCI, V173, P16, DOI 10.1006/jcis.1995.1291; Urry DW, 2002, J MUSCLE RES CELL M, V23, P543, DOI 10.1023/A:1023422925910; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Walsh I, 2012, BIOINFORMATICS, V28, P2189, DOI 10.1093/bioinformatics/bts343; Wang QM, 2011, PHYS CHEM CHEM PHYS, V13, P15200, DOI 10.1039/c1cp21156k; Webster GT, 2011, J PHYS CHEM B, V115, P2617, DOI 10.1021/jp110367t; Wierenga PA, 2003, LANGMUIR, V19, P8964, DOI 10.1021/la034868p; Wierenga PA, 2006, J COLLOID INTERF SCI, V299, P850, DOI 10.1016/j.jcis.2006.03.016; Yanagi K, 2011, J BIOL CHEM, V286, P23959, DOI 10.1074/jbc.M111.226688; Yu X, 2012, LANGMUIR, V28, P6595, DOI 10.1021/la3002306	74	67	68	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30917	30930		10.1074/jbc.M113.498857	http://dx.doi.org/10.1074/jbc.M113.498857			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24014031	Green Published, hybrid			2022-12-28	WOS:000330778900012
J	She, P; Bunpo, P; Cundiff, JK; Wek, RC; Harris, RA; Anthony, TG				She, Pengxiang; Bunpo, Piyawan; Cundiff, Judy K.; Wek, Ronald C.; Harris, Robert A.; Anthony, Tracy G.			General Control Nonderepressible 2 (GCN2) Kinase Protects Oligodendrocytes and White Matter during Branched-chain Amino Acid Deficiency in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATED STRESS-RESPONSE; MYELIN; BRAIN; RAT; DEHYDROGENASE; DEPRIVATION; MUTANT; ABNORMALITIES; TRANSLATION; GLUTATHIONE	Branched-chain amino acid (BCAA) catabolism is regulated by branched-chain alpha-keto acid dehydrogenase, an enzyme complex that is inhibited when phosphorylated by its kinase (BDK). Loss of BDK function in mice and humans causes BCAA deficiency and epilepsy with autistic features. In response to amino acid deficiency, phosphorylation of eukaryotic initiation factor 2 alpha (eIF2 similar to P) by general control nonderepressible 2 (GCN2) activates the amino acid stress response. We hypothesized that GCN2 functions to protect the brain during chronic BCAA deficiency. To test this idea, we generated mice lacking both Gcn2 and Bdk (GBDK) and examined the development of progeny. GBDK mice appeared normal at birth, but they soon stopped growing, developed severe ataxia, tremor, and anorexia, and died by postnatal day 15. BCAA levels in brain were diminished in both Bdk(-/-) and GBDK pups. Brains from Bdk(-/-) pups exhibited robust eIF2 similar to P and amino acid stress response induction, whereas these responses were absent in GBDK mouse brains. Instead, myelin deficiency and diminished expression of myelin basic protein were noted in GBDK brains. Genetic markers of oligodendrocytes and astrocytes were also reduced in GBDK brains in association with apoptotic cell death in white matter regions of the brain. GBDK brains further demonstrated reduced Sod2 and Cat mRNA and increased Tnf alpha mRNA expression. The data are consistent with the idea that loss of GCN2 during BCAA deficiency compromises glial cell defenses to oxidative and inflammatory stress. We conclude that GCN2 protects the brain from developing a lethal leukodystrophy in response to amino acid deficiencies.	[She, Pengxiang; Anthony, Tracy G.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Bunpo, Piyawan; Cundiff, Judy K.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Evansville, IN 47712 USA; [Wek, Ronald C.; Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Harris, Robert A.] Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA	Rutgers State University New Brunswick; Indiana University System; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Anthony, TG (corresponding author), Rutgers State Univ, 59 Dudley Rd, New Brunswick, NJ 08901 USA.	tracy.anthony@rutgers.edu	Anthony, Tracy/K-7951-2017	Anthony, Tracy/0000-0002-8586-5884	National Institutes of Health [HD070487, GM049164]; Veterans Affairs merit award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049164, R01GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD070487 (to T. G. A.) and GM049164 (to R. C. W.). This work was also supported by a Veterans Affairs merit award (to R. A. H.).	Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Baud O, 2004, J NEUROSCI, V24, P1531, DOI 10.1523/JNEUROSCI.3989-03.2004; Baud O, 2004, EUR J NEUROSCI, V20, P29, DOI 10.1111/j.0953-816X.2004.03451.x; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Bunpo P, 2010, J NUTR, V140, P2020, DOI 10.3945/jn.110.129197; Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chaveroux C, 2011, BIOCHEM BIOPH RES CO, V415, P120, DOI 10.1016/j.bbrc.2011.10.027; di Penta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054722; DUNCAN ID, 1992, J NEUROCYTOL, V21, P870, DOI 10.1007/BF01191684; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HARRIS RA, 1990, ADV ENZYME REGUL, V30, P245; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Jacobs EC, 2005, J NEUROL SCI, V228, P195, DOI 10.1016/j.jns.2004.10.008; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kim S, 2011, J NEUROCHEM, V116, P53, DOI 10.1111/j.1471-4159.2010.07084.x; KUNTZ MJ, 1986, BIOCHEM SOC T, V14, P1077, DOI 10.1042/bst0141077; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Marion V, 2011, J BIOL CHEM, V286, P8866, DOI 10.1074/jbc.M110.216119; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; MILLER RH, 1988, J BIOL CHEM, V263, P3454; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; OKA A, 1993, J NEUROSCI, V13, P1441; Pang Y, 2010, NEUROSCIENCE, V166, P464, DOI 10.1016/j.neuroscience.2009.12.040; Peng W., 2012, SCI TRANSL MED, V4; Perlman SJ, 2012, ADV EXP MED BIOL, V724, P154, DOI 10.1007/978-1-4614-0653-2_13; Reinert RB, 2006, J BIOL CHEM, V281, P31222, DOI 10.1074/jbc.M604511200; Schmitz T, 2008, THESCIENTIFICWORLDJO, V8, P1119, DOI 10.1100/tsw.2008.140; SCHMUED LC, 1990, J HISTOCHEM CYTOCHEM, V38, P717, DOI 10.1177/38.5.1692056; She PX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059443; Sikalidis AK, 2011, AMINO ACIDS, V41, P159, DOI 10.1007/s00726-010-0571-x; Su ZD, 2011, J NEUROTRAUM, V28, P1089, DOI 10.1089/neu.2010.1597; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; van der Voorn JP, 2005, J NEUROPATH EXP NEUR, V64, P770, DOI 10.1097/01.jnen.0000178446.41595.3a; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vela JM, 1998, BRAIN RES REV, V26, P29, DOI 10.1016/S0165-0173(97)00055-6; Wahlsten D, 2003, J NEUROSCI METH, V123, P207, DOI 10.1016/S0165-0270(02)00359-X; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Yudkoff M, 2005, J NUTR, V135, p1531S, DOI 10.1093/jn/135.6.1531S; Yue T, 2006, J NEUROSCI, V26, P1275, DOI 10.1523/JNEUROSCI.4717-05.2006	52	8	9	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31250	31260		10.1074/jbc.M113.498469	http://dx.doi.org/10.1074/jbc.M113.498469			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24019515	Green Published, hybrid			2022-12-28	WOS:000330778900041
J	Kasbek, C; Wang, F; Price, CM				Kasbek, Christopher; Wang, Feng; Price, Carolyn M.			Human TEN1 Maintains Telomere Integrity and Functions in Genome-wide Replication Restart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromosomes; DNA-binding Protein; DNA Replication; Genomic Instability; Telomerase; Telomeres; CST; CTC1; OBFC1; STN1	PROTECTS CHROMOSOME ENDS; LAGGING-STRAND SYNTHESIS; MAINTENANCE COMPONENT 1; DNA-POLYMERASE-ALPHA; HUMAN CST; LENGTH HOMEOSTASIS; DUPLEX REPLICATION; FILL-IN; COMPLEX; CDC13	Background: Although CTC1-STN1-TEN1 (CST) is considered a specialized replication factor, TEN1 is largely uncharacterized. Results: Like CTC1 and STN1, TEN1 is needed for telomere replication and genome-wide replication rescue; however, TEN1 depletion causes more severe phenotypes. Conclusion: TEN1 likely functions with CTC1 and STN1 in most contexts, but TEN1 may have additional roles. Significance: TEN1/CST help solve a diverse array of replication problems. TEN1 is a component of the mammalian CTC1-STN1-TEN1 complex. CTC1 and/or STN1 functions in telomere duplex replication, C-strand fill-in, and genome-wide restart of replication following fork stalling. Here we examine the role of human TEN1 and ask whether it also functions as a specialized replication factor. TEN1 depletion causes an increase in multitelomere fluorescent in situ hybridization (FISH) signals similar to that observed after CTC1 or STN1 depletion. However, TEN1 depletion also results in increased telomere loss. This loss is not accompanied by increased telomere deprotection, recombination, or T-circle release. Thus, it appears that both the multiple telomere signals and telomere loss stem from problems in telomere duplex replication. TEN1 depletion can also affect telomere length, but whether telomeres lengthen or shorten is cell line-dependent. Like CTC1 and STN1, TEN1 is needed for G-overhang processing. Depletion of TEN1 does not effect overhang elongation in mid-S phase, but it delays overhang shortening in late S/G(2). These results indicate a role for TEN1 in C-strand fill-in but do not support a direct role in telomerase regulation. Finally, TEN1 depletion causes a decrease in genome-wide replication restart following fork stalling similar to that observed after STN1 depletion. However, anaphase bridge formation is more severe than with CTC1 or STN1 depletion. Our findings indicate that TEN1 likely functions in conjunction with CTC1 and STN1 at the telomere and elsewhere in the genome. They also raise the possibility that TEN1 has additional roles and indicate that TEN1/CTC1-STN1-TEN1 helps solve a wide range of challenges to the replication machinery.	[Kasbek, Christopher; Wang, Feng; Price, Carolyn M.] Univ Cincinnati, Dept Canc Biol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Price, CM (corresponding author), Univ Cincinnati, Dept Canc Biol, 3125 Eden Ave, Cincinnati, OH 45267 USA.	carolyn.price@uc.edu		Wang, Feng/0000-0001-7235-1676; PRICE, Carolyn/0000-0002-7865-2303	National Institutes of Health [GM041803, T32CA117846, F32CA177120]; NATIONAL CANCER INSTITUTE [T32CA117846, F32CA177120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM041803, R01GM041803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM041803 (to C. M. P.) and T32CA117846 and F32CA177120 (to C. K).	Anderson BH, 2012, NAT GENET, V44, P338, DOI 10.1038/ng.1084; Bailey SM, 2010, METHODS MOL BIOL, V659, P173, DOI 10.1007/978-1-60761-789-1_12; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Bryan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066756; Casteel DE, 2009, J BIOL CHEM, V284, P5807, DOI 10.1074/jbc.M807593200; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Chandra A, 2001, GENE DEV, V15, P404, DOI 10.1101/gad.861001; Chen LY, 2012, NATURE, V488, P540, DOI 10.1038/nature11269; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; DeZwaan DC, 2009, NAT STRUCT MOL BIOL, V16, P711, DOI 10.1038/nsmb.1616; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Gelinas AD, 2009, P NATL ACAD SCI USA, V106, P19298, DOI 10.1073/pnas.0909203106; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; GOULIAN M, 1990, J BIOL CHEM, V265, P13221; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Gu P., 2013, AGING CELL, DOI 10.1111/acel.12139; Gu PL, 2012, EMBO J, V31, P2309, DOI 10.1038/emboj.2012.96; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Huang CH, 2012, CELL RES, V22, P1681, DOI 10.1038/cr.2012.132; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; Keller RB, 2012, PEDIATR BLOOD CANCER, V59, P311, DOI 10.1002/pbc.24193; Leehy KA, 2013, PLANT CELL, V25, P1343, DOI 10.1105/tpc.112.107425; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Li BM, 2008, MOL CELL BIOL, V28, P1892, DOI 10.1128/MCB.01364-07; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; Mitton-Fry RM, 2004, J MOL BIOL, V338, P241, DOI 10.1016/j.jmb.2004.01.063; Miyake Y, 2009, MOL CELL, V36, P193, DOI 10.1016/j.molcel.2009.08.009; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Oganesian L, 2013, DNA REPAIR, V12, P238, DOI 10.1016/j.dnarep.2012.12.008; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Petreaca RC, 2006, NAT CELL BIOL, V8, P748, DOI 10.1038/ncb1430; Pickett HA, 2009, EMBO J, V28, P799, DOI 10.1038/emboj.2009.42; Polvi A, 2012, AM J HUM GENET, V90, P540, DOI 10.1016/j.ajhg.2012.02.002; Price CM, 2010, CELL CYCLE, V9, P3157, DOI 10.4161/cc.9.16.12547; Puglisi A, 2008, EMBO J, V27, P2328, DOI 10.1038/emboj.2008.158; Qi HY, 2000, GENE DEV, V14, P1777; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Song XY, 2008, P NATL ACAD SCI USA, V105, P19815, DOI 10.1073/pnas.0807867105; Stewart JA, 2012, EMBO J, V31, P3537, DOI 10.1038/emboj.2012.215; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Sun J, 2009, GENE DEV, V23, P2900, DOI 10.1101/gad.1851909; Surovtseva YV, 2009, MOL CELL, V36, P207, DOI 10.1016/j.molcel.2009.09.017; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tseng SF, 2009, NUCLEIC ACIDS RES, V37, P3602, DOI 10.1093/nar/gkp235; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Wang F, 2012, CELL REP, V2, P1096, DOI 10.1016/j.celrep.2012.10.007; Wu P, 2012, CELL, V150, P39, DOI 10.1016/j.cell.2012.05.026; Zellinger B, 2007, MOL CELL, V27, P163, DOI 10.1016/j.molcel.2007.05.025; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026	55	55	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30139	30150		10.1074/jbc.M113.493478	http://dx.doi.org/10.1074/jbc.M113.493478			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24025336	hybrid, Green Published			2022-12-28	WOS:000329868100014
J	De La Mota-Peynado, A; Lee, SYC; Pierce, BM; Wani, P; Singh, CR; Roelofs, J				De La Mota-Peynado, Alina; Lee, Stella Yu-Chien; Pierce, Brianne Marie; Wani, Prashant; Singh, Chingakham Ranjit; Roelofs, Jeroen			The Proteasome-associated Protein Ecm29 Inhibits Proteasomal ATPase Activity and in Vivo Protein Degradation by the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26 S-PROTEASOME; REGULATORY PARTICLE; CORE PARTICLE; ORNITHINE DECARBOXYLASE; MOLECULAR ARCHITECTURE; STRESS-RESPONSE; CANCER-THERAPY; SUBUNITS; TERMINI; BINDING	Several proteasome-associated proteins regulate degradation by the 26 S proteasome using the ubiquitin chains that mark most substrates for degradation. The proteasome-associated protein Ecm29, however, has no ubiquitin-binding or modifying activity, and its direct effect on substrate degradation is unclear. Here, we show that Ecm29 acts as a proteasome inhibitor. Besides inhibiting the proteolytic cleavage of peptide substrates in vitro, it inhibits the degradation of ubiquitin-dependent and -independent substrates in vivo. Binding of Ecm29 to the proteasome induces a closed conformation of the substrate entry channel of the core particle. Furthermore, Ecm29 inhibits proteasomal ATPase activity, suggesting that the mechanism of inhibition and gate regulation by Ecm29 is through regulation of the proteasomal ATPases. Consistent with this, we identified through chemical cross-linking that Ecm29 binds to, or in close proximity to, the proteasomal ATPase subunit Rpt5. Additionally, we show that Ecm29 preferentially associates with both mutant and nucleotide depleted proteasomes. We propose that the inhibitory ability of Ecm29 is important for its function as a proteasome quality control factor by ensuring that aberrant proteasomes recognized by Ecm29 are inactive.	[De La Mota-Peynado, Alina; Lee, Stella Yu-Chien; Pierce, Brianne Marie; Singh, Chingakham Ranjit; Roelofs, Jeroen] Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA; [Wani, Prashant; Roelofs, Jeroen] Kansas State Univ, Grad Biochem Grp, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Roelofs, J (corresponding author), Kansas State Univ, Div Biol, 338 Ackert Hall, Manhattan, KS 66506 USA.	jroelofs@ksu.edu	Roelofs, Jeroen/AAC-5119-2021	Roelofs, Jeroen/0000-0003-0944-2465; Dentel, Brianne/0000-0003-4384-3529	National Institutes of Health from the National Center for Research Resources [5P20 RR017708, P20 RR016475]; National Institutes of Health from NIGMS [8 P20 GM103420, P20 GM103418]; Johnson Cancer Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708, P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418, P20GM103420] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Johnson Cancer Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P20 RR017708 and P20 RR016475 (from the National Center for Research Resources) and 8 P20 GM103420 and P20 GM103418 (from NIGMS). This work was also supported by the Johnson Cancer Research Center.	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Barrault MB, 2012, P NATL ACAD SCI USA, V109, pE1001, DOI 10.1073/pnas.1116538109; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Cho-Park PF, 2013, CELL, V153, P614, DOI 10.1016/j.cell.2013.03.040; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Erales J, 2012, J BIOL CHEM, V287, P18535, DOI 10.1074/jbc.M112.357327; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Gandre S, 2002, BIOCHEM BIOPH RES CO, V293, P139, DOI 10.1016/S0006-291X(02)00194-8; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Gorbea C, 2004, J BIOL CHEM, V279, P54849, DOI 10.1074/jbc.M410444200; Gorbea C, 2010, J BIOL CHEM, V285, P31616, DOI 10.1074/jbc.M110.154120; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Guerrero C, 2006, MOL CELL PROTEOMICS, V5, P366, DOI 10.1074/mcp.M500303-MCP200; Guo X, 2011, P NATL ACAD SCI USA, V108, P18649, DOI 10.1073/pnas.1113170108; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kim YC, 2013, J BIOL CHEM, V288, P3334, DOI 10.1074/jbc.M112.424788; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Lander GC, 2013, CURR OPIN STRUC BIOL, V23, P243, DOI 10.1016/j.sbi.2013.02.004; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee SH, 2012, J BIOL CHEM, V287, P9269, DOI 10.1074/jbc.M111.316208; Lee SYC, 2011, J BIOL CHEM, V286, P36641, DOI 10.1074/jbc.M111.280875; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehmann A, 2010, MOL CELL, V38, P879, DOI 10.1016/j.molcel.2010.06.016; Liu CW, 2013, TRENDS BIOCHEM SCI, V38, P103, DOI 10.1016/j.tibs.2012.11.009; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Panasenko OO, 2011, MOL CELL BIOL, V31, P1610, DOI 10.1128/MCB.01210-10; Park S, 2013, NATURE, V497, P512, DOI 10.1038/nature12123; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shim SM, 2012, CELL REP, V2, P603, DOI 10.1016/j.celrep.2012.07.013; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Smulski PA, 2009, STRUCTURE, V17, P1137, DOI 10.1016/j.str.2009.06.011; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Tian G, 2011, NAT STRUCT MOL BIOL, V18, P1259, DOI 10.1038/nsmb.2147; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Um JW, 2010, J BIOL CHEM, V285, P36434, DOI 10.1074/jbc.M110.133777; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232	61	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29467	29481		10.1074/jbc.M113.491662	http://dx.doi.org/10.1074/jbc.M113.491662			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23995839	hybrid, Green Published			2022-12-28	WOS:000330615300024
J	Krumm, SA; Takeda, M; Plemper, RK				Krumm, Stefanie A.; Takeda, Makoto; Plemper, Richard K.			The Measles Virus Nucleocapsid Protein Tail Domain Is Dispensable for Viral Polymerase Recruitment and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; RESPIRATORY SYNCYTIAL VIRUS; RNA-SYNTHESIS; P PROTEIN; CRYSTAL-STRUCTURE; PHOSPHOPROTEIN; NUCLEOPROTEIN; BINDING; COMPLEX; GENOME	Paramyxovirus genomes are ribonucleoprotein (RNP) complexes consisting of nucleoprotein (N)-encapsidated viral RNA. Measles virus (MeV) N features an amino-terminal RNA-binding core and a 125-residue tail domain, of which only the last 75 residues are considered fully mobile on the nucleocapsid surface. A molecular recognition element (MoRE) domain mediates binding of the viral phosphoprotein (P). This P N-tail interaction is considered instrumental for recruiting the polymerase complex to the template. We have engineered MeV N variants with tail truncations progressively eliminating the MoRE domain and upstream tail sections. Confirming previous reports, RNPs with N truncations lacking the carboxyl-terminal 43-residues harboring the MoRE domain cannot serve as polymerase template. Remarkably, further removal of all tail residues predicted to be surface-exposed significantly restores RNP bioactivity. Insertion of structurally dominant tags into the central N-tail section reduces bioactivity, but the negative regulatory effect of exposed N-tail stems is sequence-independent. Bioactive nucleocapsids lacking exposed N-tail sections are unable to sustain virus replication, because of weakened interaction of the advancing polymerase complex with the template. Deletion of the N-MoRE-binding domain in P abrogates polymerase recruitment to standard nucleocapsids, but polymerase activity is partially restored when N-tail truncated RNPs serve as template. Revising central elements of the current replication model, these data reveal that MeV polymerase is capable of productively docking directly to the nucleocapsid core. Dispensable for polymerase recruitment, N-MoRE binding to P-tail stabilizes the advancing polymerase-RNP complex and may rearrange unstructured central tail sections to facilitate polymerase access to the template.	[Krumm, Stefanie A.; Plemper, Richard K.] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Takeda, Makoto] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Musashimurayama 2080011, Japan	University System of Georgia; Georgia State University; National Institute of Infectious Diseases (NIID)	Plemper, RK (corresponding author), Georgia State Univ, Ctr Inflammat Immun & Infect, Petit Sci Ctr Ste 712,100 Piedmont Ave, Atlanta, GA 30303 USA.	rplemper@gsu.edu	Takeda, Makoto/J-2550-2018	Takeda, Makoto/0000-0002-8194-7727	National Institutes of Health [AI071002, AI085328, AI083402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071002, R56AI083402, R01AI083402, R21AI085328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI071002, AI085328, and AI083402 (to R.K.P.).	Bankamp B, 1996, VIROLOGY, V216, P272, DOI 10.1006/viro.1996.0060; Bhella D, 2004, J MOL BIOL, V340, P319, DOI 10.1016/j.jmb.2004.05.015; Bourhis JM, 2006, VIROLOGY, V344, P94, DOI 10.1016/j.virol.2005.09.025; BUCHHOLZ CJ, 1993, J VIROL, V67, P5803, DOI 10.1128/JVI.67.10.5803-5812.1993; BUCHHOLZ CJ, 1994, VIROLOGY, V204, P770, DOI 10.1006/viro.1994.1592; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Cathomen T, 1998, EMBO J, V17, P3899, DOI 10.1093/emboj/17.14.3899; Cevik B, 2004, VIROLOGY, V325, P216, DOI 10.1016/j.virol.2004.05.012; COLLINS PL, 1983, P NATL ACAD SCI-BIOL, V80, P3208, DOI 10.1073/pnas.80.11.3208; Communie G, 2013, J VIROL, V87, P7166, DOI 10.1128/JVI.00487-13; Couturier M, 2010, J MOL RECOGNIT, V23, P301, DOI 10.1002/jmr.982; Cox R, 2013, J VIROL, V87, P7558, DOI 10.1128/JVI.00653-13; CURRAN J, 1993, J VIROL, V67, P4358, DOI 10.1128/JVI.67.7.4358-4364.1993; Curran J, 1999, ADV VIRUS RES, V54, P403, DOI 10.1016/S0065-3527(08)60373-5; Curran J, 1998, J VIROL, V72, P4274, DOI 10.1128/JVI.72.5.4274-4280.1998; CURRAN J, 1994, VIROLOGY, V202, P875, DOI 10.1006/viro.1994.1409; Desfosses A, 2011, J VIROL, V85, P1391, DOI 10.1128/JVI.01459-10; DIALLO A, 1994, J GEN VIROL, V75, P233, DOI 10.1099/0022-1317-75-1-233; Dochow M, 2012, J BIOL CHEM, V287, P6878, DOI 10.1074/jbc.M111.325258; Doyle J, 2006, J VIROL, V80, P1524, DOI 10.1128/JVI.80.3.1524-1536.2006; Duprex WP, 1999, J VIROL, V73, P9568, DOI 10.1128/JVI.73.11.9568-9575.1999; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Houben K, 2007, BIOPHYS J, V93, P2830, DOI 10.1529/biophysj.107.108829; Houben K, 2007, J VIROL, V81, P6807, DOI 10.1128/JVI.00338-07; Iwasaki M, 2009, J VIROL, V83, P10374, DOI 10.1128/JVI.01056-09; Jensen MR, 2011, P NATL ACAD SCI USA, V108, P9839, DOI 10.1073/pnas.1103270108; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; Kingston RL, 2004, J VIROL, V78, P8630, DOI 10.1128/JVI.78.16.8630-8640.2004; Kingston RL, 2004, P NATL ACAD SCI USA, V101, P8301, DOI 10.1073/pnas.0402690101; Kolakofsky D, 2004, VIROLOGY, V318, P463, DOI 10.1016/j.virol.2003.10.031; Laine D, 2003, J VIROL, V77, P11332, DOI 10.1128/JVI.77.21.11332-11346.2003; Laine D, 2005, J GEN VIROL, V86, P1771, DOI 10.1099/vir.0.80791-0; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Longhi S, 2009, CURR TOP MICROBIOL, V329, P103; Longhi S., 2011, NEGATIVE STRAND RNA, P95; Longhi S, 2012, ADV EXP MED BIOL, V725, P126, DOI 10.1007/978-1-4614-0659-4_8; Madani F, 2009, J AM CHEM SOC, V131, P4613, DOI 10.1021/ja809315x; Paal T, 2009, J VIROL, V83, P10480, DOI 10.1128/JVI.01195-09; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Rennick LJ, 2007, J GEN VIROL, V88, P2710, DOI 10.1099/vir.0.83106-0; Ruigrok RWH, 2011, CURR OPIN MICROBIOL, V14, P504, DOI 10.1016/j.mib.2011.07.011; Schoehn G, 2004, J MOL BIOL, V339, P301, DOI 10.1016/j.jmb.2004.03.073; Seki F, 2011, J VIROL, V85, P11871, DOI 10.1128/JVI.05067-11; Shu YL, 2012, J BIOL CHEM, V287, P11951, DOI 10.1074/jbc.M111.333088; Takeda M, 2000, J VIROL, V74, P6643, DOI 10.1128/JVI.74.14.6643-6647.2000; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Zhang XS, 2005, VIROLOGY, V337, P162, DOI 10.1016/j.virol.2005.03.035; Zhang XS, 2002, J VIROL, V76, P8737, DOI 10.1128/JVI.76.17.8737-8746.2002	49	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29943	29953		10.1074/jbc.M113.503862	http://dx.doi.org/10.1074/jbc.M113.503862			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003217	Green Published, hybrid			2022-12-28	WOS:000330615300067
J	Kurita, S; Yamada, T; Rikitsu, E; Ikeda, W; Takai, Y				Kurita, Souichi; Yamada, Tomohiro; Rikitsu, Etsuko; Ikeda, Wataru; Takai, Yoshimi			Binding between the Junctional Proteins Afadin and PLEKHA7 and Implication in the Formation of Adherens Junction in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION MOLECULE NECTIN; E-CADHERIN; TIGHT JUNCTIONS; CYTOPLASMIC DOMAIN; ALPHA-CATENIN; MDCK CELLS; POLARITY; COMPLEX; ROLES; ACTIN	Adherens junction (AJ) is a specialized cell-cell junction structure that plays a role in mechanically connecting adjacent cells to resist strong contractile forces and to maintain tissue structure, particularly in the epithelium. AJ is mainly comprised of cell adhesion molecules cadherin and nectin and their associating cytoplasmic proteins including beta-catenin, alpha-catenin, p120(ctn), and afadin. Our series of studies have revealed that nectin first forms cell-cell adhesion and then recruits cadherin to form AJ. The recruitment of cadherin by nectin is mediated by the binding of alpha-catenin and p120(ctn) to afadin. Recent studies showed that PLEKHA7 binds to p120(ctn), which is associated with E-cadherin, and maintains the integrity of AJ in epithelial cells. In this study, we showed that PLEKHA7 bound to afadin in addition to p120(ctn) and was recruited to the nectin-3 alpha-based cell-cell adhesion site in a manner dependent on afadin, but not on p120(ctn). The binding of PLEKHA7 to afadin was required for the proper formation of AJ, but not for the formation of tight junction, in EpH4 mousemammarygland epithelial cells. These results indicate that PLEKHA7 plays a cooperative role with nectin and afadin in the proper formation of AJ in epithelial cells.	[Kurita, Souichi; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 6500017, Japan; [Kurita, Souichi; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Pathogenet Signaling, Dept Biochem & Mol Biol, Kobe, Hyogo 6500047, Japan; [Yamada, Tomohiro; Rikitsu, Etsuko; Ikeda, Wataru] KAN Res Inst Inc, Kobe, Hyogo 6500047, Japan; [Takai, Yoshimi] Japan Sci & Technol Agcy JST, CREST, Kobe, Hyogo 6500047, Japan	Kobe University; Kobe University; KAN Research Institute; Japan Science & Technology Agency (JST)	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Pathogenet Signaling, Dept Biochem & Mol Biol,Chuo Ku, 1-5-6 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	ytakai@med.kobe-u.ac.jp	Ikeda, Wataru/V-8531-2019	Ikeda, Wataru/0000-0002-6907-9058	Global Centers of Excellence Program; Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency; Naito Foundation; Sagawa Foundation; Yasuda Medical Foundation	Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Naito Foundation(Naito Memorial Foundation); Sagawa Foundation; Yasuda Medical Foundation	This work was supported by the Global Centers of Excellence Program "Global Center for Education and Research in Integrative Membrane Biology" and the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology, Japan, by grants-in-aid from the Japan Society for the Promotion of Science, by the Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency, and by grants from the Naito Foundation, the Sagawa Foundation, and the Yasuda Medical Foundation.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Ikenouchi J, 2012, J BIOL CHEM, V287, P9525, DOI 10.1074/jbc.M111.327064; KINCH MS, 1995, J CELL BIOL, V130, P461, DOI 10.1083/jcb.130.2.461; Kuramitsu K, 2008, GENES CELLS, V13, P797, DOI 10.1111/j.1365-2443.2008.01206.x; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Miyahara M, 2000, J BIOL CHEM, V275, P613, DOI 10.1074/jbc.275.1.613; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200; Okamoto R, 2005, GENES CELLS, V10, P435, DOI 10.1111/j.1365-2443.2005.00846.x; Ooshio' T, 2007, J CELL SCI, V120, P2352, DOI 10.1242/jcs.03470; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Pulimeno P, 2011, J BIOL CHEM, V286, P16743, DOI 10.1074/jbc.M111.230862; Pulimeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012207; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Sakisaka T, 1999, ONCOGENE, V18, P1609, DOI 10.1038/sj.onc.1202451; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Yamada A, 2006, ONCOGENE, V25, P5085, DOI 10.1038/sj.onc.1209525; Zhang L, 2011, J BIOL CHEM, V286, P16879, DOI 10.1074/jbc.M110.186932	42	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29356	29368		10.1074/jbc.M113.453464	http://dx.doi.org/10.1074/jbc.M113.453464			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23990464	hybrid, Green Published			2022-12-28	WOS:000330615300015
J	Mak, CH; Pham, P; Afif, SA; Goodman, MF				Mak, Chi H.; Phuong Pham; Afif, Samir A.; Goodman, Myron F.			A Mathematical Model for Scanning and Catalysis on Single-stranded DNA, Illustrated with Activation-induced Deoxycytidine Deaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSINE DEAMINASE; CLUSTERED MUTATIONS; CYTIDINE DEAMINASE; PROTEIN; AID; DIFFUSION; SEARCH; REPAIR; TRANSLOCATION; TRANSCRIPTION	We formulated a master equation-based mathematical model to analyze random scanning and catalysis for enzymes that act on single-stranded DNA (ssDNA) substrates. Catalytic efficiencies and intrinsic scanning distances are deduced from the distribution of positions and gap lengths between a series of catalytic events occurring over time, which are detected as point mutations in a lacZ alpha-based reporter sequence containing enzyme target motifs. Mathematical analysis of the model shows how scanning motions become separable from the catalysis when the proper statistical properties of the mutation pattern are used to interpret the readouts. Two-point correlations between all catalytic events determine intrinsic scanning distances, whereas gap statistics between mutations determine their catalytic efficiencies. Applying this model to activation-induced deoxycytidine deaminase (AID), which catalyzes C -> U deaminations processively on ssDNA, we have established that deaminations of AGC hot motifs occur at a low rate, similar to 0.03 s(-1), and low efficiency, similar to 3%. AID performs random bidirectional movements for an average distance of 6.2 motifs, at a rate of about 15 nucleotides per second, and "dwells" at a motif site for 2.7s while bound >4 min to the same DNA molecule. These results provide new and important insights on how AID may be optimized for generating mutational diversity in Ig genes, and we discuss how the properties of AID acting freely on a "naked" ssDNA relate to the constrained action of AID during transcription-dependent somatic hypermutation and class-switch recombination.	[Mak, Chi H.; Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Mak, Chi H.] Univ So Calif, Ctr Appl Math Sci, Los Angeles, CA 90089 USA; [Phuong Pham; Afif, Samir A.; Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Mak, CH (corresponding author), Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA.	cmak@usc.edu; mgoodman@usc.edu			National Institutes of Health [ES13192, GM21422]; National Science Foundation [CHE-0713981]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES013192, R01ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021422, R37GM021422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES13192 and GM21422 (to M. F. G.). This work was also supported by National Science Foundation Grant CHE-0713981 (to C.H.M.).	Benichou O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198101; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Canugovi C, 2009, FASEB J, V23, P34, DOI 10.1096/fj.08-115352; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Coppey M, 2004, BIOPHYS J, V87, P1640, DOI 10.1529/biophysj.104.045773; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Doi M., 1988, THEORY POLYM DYNAMIC; FISHER ME, 1984, J STAT PHYS, V34, P667, DOI 10.1007/BF01009436; Flory PJ., 1953, PRINCIPLES POLYM CHE, V672; Gardiner C. W., 1994, HDB STOCHASTIC METHO, P236; Gorman J, 2008, NAT STRUCT MOL BIOL, V15, P768, DOI 10.1038/nsmb.1441; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Halford SE, 2001, BIOCHEM SOC T, V29, P363, DOI 10.1042/BST0290363; Hu T, 2006, BIOPHYS J, V90, P2731, DOI 10.1529/biophysj.105.078162; Jaszczur M, 2013, CELL MOL LIFE SCI, V70, P3089, DOI 10.1007/s00018-012-1212-1; Lada AG, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-47; Lomholt MA, 2009, P NATL ACAD SCI USA, V106, P8204, DOI 10.1073/pnas.0903293106; LORING RF, 1982, CHEM PHYS, V70, P139, DOI 10.1016/0301-0104(82)85114-8; Marcovitz A, 2011, P NATL ACAD SCI USA, V108, P17957, DOI 10.1073/pnas.1109594108; Meester R., 2008, NATURAL INTRO PROBAB, P137; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2011, J BIOL CHEM, V286, P24931, DOI 10.1074/jbc.M111.241208; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; Press W.H, 2007, NUMERICAL RECIPES C, P82; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Schonhoft JD, 2012, NAT CHEM BIOL, V8, P205, DOI 10.1038/nchembio.764; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Shen HM, 2005, MOL CELL BIOL, V25, P10815, DOI 10.1128/MCB.25.24.10815-10821.2005; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Storb U, 2009, CELL CYCLE, V8, P3097, DOI 10.4161/cc.8.19.9658; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	47	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29786	29795		10.1074/jbc.M113.506550	http://dx.doi.org/10.1074/jbc.M113.506550			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979486	Green Published, hybrid			2022-12-28	WOS:000330615300053
J	Patel, PC; Lee, HSW; Ming, AYK; Rath, A; Deber, CM; Yip, CM; Rocheleau, JV; Gray-Owen, SD				Patel, Prerna C.; Lee, Hannah S. W.; Ming, Aaron Y. K.; Rath, Arianna; Deber, Charles M.; Yip, Christopher M.; Rocheleau, Jonathan V.; Gray-Owen, Scott D.			Inside-out Signaling Promotes Dynamic Changes in the Carcinoembryonic Antigen-related Cellular Adhesion Molecule 1 (CEACAM1) Oligomeric State to Control Its Cell Adhesion Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIARY GLYCOPROTEIN; C-CAM; NEISSERIA-GONORRHOEAE; CYTOPLASMIC DOMAIN; TRANSMEMBRANE DOMAIN; HOMOPHILIC ADHESION; CALMODULIN-BINDING; EPITHELIAL-CELLS; FAMILY; PROTEIN	Cell-cell contacts are fundamental to multicellular organisms and are subject to exquisite levels of control. The carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) can engage in both cis-homophilic (parallel) oligomerization and trans-homophilic(anti-parallel) binding. In this study, we establish that the CEACAM1 transmembrane domain has a propensity to form cis-dimers via the transmembrane-embedded (432)GXXXG(436) motif and that this basal state is overcome when activated calmodulin binds to the CEACAM1 cytoplasmic domain. Although mutation of the (432)GXXXG(436) motif reduced CEACAM1 oligomerization, it did not affect surface localization of the receptor or influence CEACAM1-dependent cellular invasion by the pathogenic Neisseria. The mutation did, however, have a striking effect on CEACAM1-dependent cellular aggregation, increasing both the kinetics of cell-cell association and the size of cellular aggregates formed. CEACAM1 association with tyrosine kinase c-Src and tyrosine phosphatases SHP-1 and SHP-2 was not affected by the (432)GXXXG(436) mutation, consistent with their association with the monomeric form of wild type CEACAM1. Collectively, our results establish that a dynamic oligomer-to-monomer shift in surface-expressed CEACAM1 facilitates trans-homophilic binding and downstream effector signaling.	[Patel, Prerna C.; Lee, Hannah S. W.; Gray-Owen, Scott D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Deber, Charles M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Ming, Aaron Y. K.; Yip, Christopher M.; Rocheleau, Jonathan V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada; [Rath, Arianna; Deber, Charles M.] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Gray-Owen, SD (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	scott.gray.owen@utoronto.ca	Gray-Owen, Scott/AFL-7380-2022; Gray-Owen, Scott/AAG-7337-2022	Gray-Owen, Scott D./0000-0002-1477-3616; Yip, Christopher/0000-0003-4507-556X; Rocheleau, Jonathan/0000-0002-1760-2564	Canadian Institutes of Health Research Training Program in Protein Folding and Interaction Dynamics; Canadian Institutes of Health Research [FRN-5810]; Canada Research Chairs Program; Natural Sciences and Engineering Research Council of Canada/Canadian Institutes of Health Research Collaborative Health Research Program [365861-09]; Canadian Foundation for Innovation [JVR-NMD106997]; Banting and Best Diabetes Centre, University of Toronto	Canadian Institutes of Health Research Training Program in Protein Folding and Interaction Dynamics(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada/Canadian Institutes of Health Research Collaborative Health Research Program(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Banting and Best Diabetes Centre, University of Toronto(University of Toronto)	This work was supported in part by the Canadian Institutes of Health Research Training Program in Protein Folding and Interaction Dynamics (to P. C. P.), Canadian Institutes of Health Research Grant FRN-5810 (to C. M. D.), the Canada Research Chairs Program (to C. M. Y.), Natural Sciences and Engineering Research Council of Canada/Canadian Institutes of Health Research Collaborative Health Research Program Grant 365861-09 (to C. M. Y. and S. D. G.), and Canadian Foundation for Innovation Grant JVR-NMD106997.; Recipient of stipend support from the Banting and Best Diabetes Centre, University of Toronto.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B; ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; AXELROD D, 1989, METHOD CELL BIOL, V30, P333; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; BARNETT TR, 1993, MOL CELL BIOL, V13, P1273, DOI 10.1128/MCB.13.2.1273; BARNETT TR, 1989, J CELL BIOL, V108, P267, DOI 10.1083/jcb.108.2.267; Beauchemin N, 1999, EXP CELL RES, V252, P243; Beauchemin N, 1997, ONCOGENE, V14, P783, DOI 10.1038/sj.onc.1200888; Billker O, 2000, TRENDS MICROBIOL, V8, P258, DOI 10.1016/S0966-842X(00)01771-6; BLIKSTAD I, 1992, FEBS LETT, V302, P26, DOI 10.1016/0014-5793(92)80276-M; Booth JW, 2003, J BIOL CHEM, V278, P14037, DOI 10.1074/jbc.M211879200; Bos MP, 1997, INFECT IMMUN, V65, P2353, DOI 10.1128/IAI.65.6.2353-2361.1997; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; BRUMMER J, 1995, ONCOGENE, V11, P1649; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Chen DH, 2004, J IMMUNOL, V172, P3535, DOI 10.4049/jimmunol.172.6.3535; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; EDLUND M, 1993, FEBS LETT, V327, P90, DOI 10.1016/0014-5793(93)81046-3; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; GrayOwen SD, 1997, EMBO J, V16, P3435, DOI 10.1093/emboj/16.12.3435; HINODA Y, 1988, P NATL ACAD SCI USA, V85, P6959, DOI 10.1073/pnas.85.18.6959; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Hunter I, 1996, BIOCHEM J, V320, P847, DOI 10.1042/bj3200847; Izzi L, 1999, ONCOGENE, V18, P5563, DOI 10.1038/sj.onc.1202935; Kammerer R, 2001, J IMMUNOL, V166, P6537, DOI 10.4049/jimmunol.166.11.6537; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; KUROKI M, 1991, J BIOL CHEM, V266, P11810; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; Lawson EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029606; Lee HSW, 2008, J IMMUNOL, V180, P6827, DOI 10.4049/jimmunol.180.10.6827; LIN SH, 1995, BIOCHEM J, V311, P239, DOI 10.1042/bj3110239; Luo WP, 1997, ONCOGENE, V14, P1697, DOI 10.1038/sj.onc.1200999; Markel G, 2004, J IMMUNOL, V173, P3732, DOI 10.4049/jimmunol.173.6.3732; Markel G, 2002, J IMMUNOL, V168, P2803, DOI 10.4049/jimmunol.168.6.2803; Markel G, 2002, J CLIN INVEST, V110, P943, DOI 10.1172/JCI200215643; McCaw SE, 2004, INFECT IMMUN, V72, P2742, DOI 10.1128/IAI.72.5.2742-2752.2004; Morales VM, 1999, J IMMUNOL, V163, P1363; Muller MM, 2009, J CELL BIOL, V187, P569, DOI 10.1083/jcb.200904150; N'Guessan PD, 2007, J INFECT DIS, V195, P1651, DOI 10.1086/514820; Nagaishi T, 2006, IMMUNITY, V25, P769, DOI 10.1016/j.immuni.2006.08.026; Ng DP, 2012, BBA-BIOMEMBRANES, V1818, P1115, DOI 10.1016/j.bbamem.2011.07.046; Nittka S, 2004, ONCOGENE, V23, P9306, DOI 10.1038/sj.onc.1208259; Obrink B, 2002, ANN NY ACAD SCI, V971, P597; OIKAWA S, 1992, BIOCHEM BIOPH RES CO, V186, P881, DOI 10.1016/0006-291X(92)90828-9; Okegawa T, 2004, ACTA BIOCHIM POL, V51, P445; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Popp A, 1999, CELL MICROBIOL, V1, P169, DOI 10.1046/j.1462-5822.1999.00017.x; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Rocheleau JV, 2003, BIOPHYS J, V84, P4078, DOI 10.1016/S0006-3495(03)75133-9; ROJAS M, 1990, CELL GROWTH DIFFER, V1, P527; Rowe HA, 2007, CELL MICROBIOL, V9, P154, DOI 10.1111/j.1462-5822.2006.00775.x; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schumann D, 2004, BIOCHEM BIOPH RES CO, V318, P227, DOI 10.1016/j.bbrc.2004.04.024; Singer BB, 2000, CANCER RES, V60, P1236; SKUBITZ KM, 1995, J IMMUNOL, V155, P5382; Skubitz KM, 1996, J LEUKOCYTE BIOL, V60, P106, DOI 10.1002/jlb.60.1.106; Stern N, 2005, J IMMUNOL, V174, P6692, DOI 10.4049/jimmunol.174.11.6692; Sundberg U, 2004, J CELL SCI, V117, P1091, DOI 10.1242/jcs.00944; Tamamizu S, 1999, J MEMBRANE BIOL, V170, P157, DOI 10.1007/s002329900545; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; TINGSTROM A, 1990, J CELL SCI, V96, P17; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Volkmer A, 2000, BIOPHYS J, V78, P1589, DOI 10.1016/S0006-3495(00)76711-7; Wagener C, 2000, EXP CELL RES, V261, P19, DOI 10.1006/excr.2000.5038; WATT SM, 1991, BLOOD, V78, P63; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; Wikstrom K, 1996, EXP CELL RES, V227, P360, DOI 10.1006/excr.1996.0285	74	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29654	29669		10.1074/jbc.M113.504639	http://dx.doi.org/10.1074/jbc.M113.504639			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24005674	Green Published, hybrid			2022-12-28	WOS:000330615300041
J	Reschke, S; Sigfridsson, KGV; Kaufmann, P; Leidel, N; Horn, S; Gast, K; Schulzke, C; Haumann, M; Leimkuhler, S				Reschke, Stefan; Sigfridsson, Kajsa G. V.; Kaufmann, Paul; Leidel, Nils; Horn, Sebastian; Gast, Klaus; Schulzke, Carola; Haumann, Michael; Leimkuehler, Silke			Identification of a Bis-molybdopterin Intermediate in Molybdenum Cofactor Biosynthesis in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GUANINE DINUCLEOTIDE; SULFITE OXIDASE; GENE-PRODUCTS; MOLYBDOENZYME; REDUCTASE; BINDING; STEP; DEFICIENCY; MATURATION	The molybdenum cofactor is an important cofactor, and its biosynthesis is essential for many organisms, including humans. Its basic form comprises a single molybdopterin (MPT) unit, which binds a molybdenum ion bearing three oxygen ligands via a dithiolene function, thus forming Mo-MPT. In bacteria, this form is modified to form the bis-MPT guanine dinucleotide cofactor with two MPT units coordinated at one molybdenum atom, which additionally contains GMPs bound to the terminal phosphate group of the MPTs (bis-MGD). The MobA protein catalyzes the nucleotide addition to MPT, but the mechanism of the biosynthesis of the bis-MGD cofactor has remained enigmatic. We have established an in vitro system for studying bis-MGD assembly using purified compounds. Quantification of the MPT/molybdenum and molybdenum/phosphorus ratios, time-dependent assays for MPT and MGD detection, and determination of the numbers and lengths of Mo-S and Mo-O bonds by X-ray absorption spectroscopy enabled identification of a novel bis-Mo-MPT intermediate on MobA prior to nucleotide attachment. The addition of Mg-GTP to MobA loaded with bis-Mo-MPT resulted in formation and release of the final bis-MGD product. This cofactor was fully functional and reconstituted the catalytic activity of apo-TMAO reductase (TorA). We propose a reaction sequence for bis-MGD formation, which involves 1) the formation of bis-Mo-MPT, 2) the addition of two GMP units to form bis-MGD on MobA, and 3) the release and transfer of the mature cofactor to the target protein TorA, in a reaction that is supported by the specific chaperone TorD, resulting in an active molybdoenzyme.	[Reschke, Stefan; Kaufmann, Paul; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Dept Mol Enzymol, D-14476 Potsdam, Germany; [Gast, Klaus] Univ Potsdam, Dept Phys Biochem, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Sigfridsson, Kajsa G. V.; Leidel, Nils; Horn, Sebastian; Haumann, Michael] Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany; [Schulzke, Carola] Ernst Moritz Arndt Univ Greifswald, Inst Biochem, D-17487 Greifswald, Germany	University of Potsdam; University of Potsdam; Free University of Berlin; Ernst Moritz Arndt Universitat Greifswald	Leimkuhler, S (corresponding author), Univ Potsdam, Inst Biochemie & Biol, Karl Lieknecht Str 24-25, D-14476 Potsdam, Germany.	sleim@uni-potsdam.de	Schulzke, Carola/AAT-8055-2021; MIchael, Haumann/A-7087-2013	Schulzke, Carola/0000-0002-7530-539X; Sigfridsson Clauss, Kajsa/0000-0002-7604-251X; Horn, Sebastian/0000-0001-7812-5813; Leimkuhler, Silke/0000-0003-3238-2122	Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Unifying Concepts in Catalysis"; DFG [LE1171/6-1, Ha3265/3-1, Ha3265/6-1]; Heisenberg Fellowship; European Cooperation in Science and Technology (COST) Action [CM1003]; Stiftelsen Bengt Lundqvist minne; Wenner-Gren Foundation; European Research Council (ERC)	Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Unifying Concepts in Catalysis"(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Heisenberg Fellowship(German Research Foundation (DFG)); European Cooperation in Science and Technology (COST) Action(European Cooperation in Science and Technology (COST)); Stiftelsen Bengt Lundqvist minne; Wenner-Gren Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Unifying Concepts in Catalysis" (to S. L.), by DFG Grant LE1171/6-1 (to S. L.), and by a Heisenberg Fellowship and Grants Ha3265/3-1 and Ha3265/6-1 from the DFG (to M. H.). This work was also supported by European Cooperation in Science and Technology (COST) Action CM1003 (to S. L. and C. S.).; Recipient of fellowships from "Stiftelsen Bengt Lundqvist minne" and the Wenner-Gren Foundation. Present address: MAX IV Laboratory, Lund University, 22100 Lund, Sweden.; Supported by the European Research Council (ERC).	Chen MD, 2002, CHINESE SCI BULL, V47, P978; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Genes O, 2005, J BIOL CHEM, V280, P15644, DOI 10.1074/jbc.M501119200; Genest O, 2008, J BIOL CHEM, V283, P21433, DOI 10.1074/jbc.M802954200; Genest O, 2006, FEMS MICROBIOL LETT, V265, P51, DOI 10.1111/j.1574-6968.2006.00468.x; Genest O, 2009, FEMS MICROBIOL LETT, V297, P1, DOI 10.1111/j.1574-6968.2009.01660.x; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Havelius KGV, 2011, INORG CHEM, V50, P741, DOI 10.1021/ic101291j; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hilton JC, 1996, ARCH BIOCHEM BIOPHYS, V325, P139, DOI 10.1006/abbi.1996.0017; Hover BM, 2013, J AM CHEM SOC, V135, P7019, DOI 10.1021/ja401781t; Iobbi-Nivol C, 2013, BBA-BIOENERGETICS, V1827, P1086, DOI 10.1016/j.bbabio.2012.11.007; JOHNSON JL, 1990, P NATL ACAD SCI USA, V87, P3190, DOI 10.1073/pnas.87.8.3190; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; Joshi MS, 1996, J BACTERIOL, V178, P4310, DOI 10.1128/jb.178.14.4310-4312.1996; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Klockenkamper R., 1996, TOTAL REFLECTION XRA; Kuper J, 2003, ARCH BIOCHEM BIOPHYS, V411, P36, DOI 10.1016/S0003-9861(02)00714-2; Lake MW, 2000, J BIOL CHEM, V275, P40211, DOI 10.1074/jbc.M007406200; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Liu MTW, 2000, J BIOL CHEM, V275, P1814, DOI 10.1074/jbc.275.3.1814; LIU WT, 1993, INORG CHEM, V32, P4102, DOI 10.1021/ic00071a023; Llamas A, 2004, J BIOL CHEM, V279, P55241, DOI 10.1074/jbc.M409862200; Magalon A, 2002, J BIOL CHEM, V277, P48199, DOI 10.1074/jbc.M205806200; McLuskey K, 2003, J BIOL CHEM, V278, P23706, DOI 10.1074/jbc.M301485200; Neumann M, 2008, FEBS J, V275, P5678, DOI 10.1111/j.1742-4658.2008.06694.x; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Neumann M, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/850924; Neumann M, 2011, J BIOL CHEM, V286, P1400, DOI 10.1074/jbc.M110.155671; Neumann M, 2009, J BIOL CHEM, V284, P21891, DOI 10.1074/jbc.M109.008565; Neumann M, 2009, FEBS J, V276, P2762, DOI 10.1111/j.1742-4658.2009.07000.x; Nichols J, 2002, J BIOL CHEM, V277, P24995, DOI 10.1074/jbc.M203238200; Nichols JD, 2005, J BIOL CHEM, V280, P7817, DOI 10.1074/jbc.M413783200; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; PALMER T, 1994, EUR J BIOCHEM, V222, P687, DOI 10.1111/j.1432-1033.1994.tb18913.x; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; Qiu JA, 2010, BIOCHEMISTRY-US, V49, P3989, DOI 10.1021/bi1001954; Rajagopalan K. V., 1996, ESCHERICHIA COLI SAL, VI, P674; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Rudolph MJ, 2003, J BIOL CHEM, V278, P14514, DOI 10.1074/jbc.M300449200; Samuel PP, 2011, EUR J INORG CHEM, P4387, DOI 10.1002/ejic.201100331; Stevenson CEM, 2000, STRUCTURE, V8, P1115, DOI 10.1016/S0969-2126(00)00518-9; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Temple CA, 2000, J BIOL CHEM, V275, P40202, DOI 10.1074/jbc.M007407200; Wuebbens MM, 2003, J BIOL CHEM, V278, P14523, DOI 10.1074/jbc.M300453200; Xiang S, 2001, STRUCTURE, V9, P299, DOI 10.1016/S0969-2126(01)00588-3; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995	49	39	41	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29736	29745		10.1074/jbc.M113.497453	http://dx.doi.org/10.1074/jbc.M113.497453			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003231	Green Published, hybrid			2022-12-28	WOS:000330615300049
J	Hammed, A; Matagrin, B; Spohn, G; Prouillac, C; Benoit, E; Lattard, V				Hammed, Abdessalem; Matagrin, Benjamin; Spohn, Gabriele; Prouillac, Caroline; Benoit, Etienne; Lattard, Virginie			VKORC1L1, an Enzyme Rescuing the Vitamin K 2,3-Epoxide Reductase Activity in Some Extrahepatic Tissues during Anticoagulation Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Resistance; Enzyme Inhibitors; Enzyme Kinetics; Hemostasis; Vitamin K; VKORC1; VKORC1L1; Vitamin K Antagonist; Vitamin K Epoxide Reductase	GAMMA-CARBOXYGLUTAMIC ACID; MATRIX GLA PROTEIN; WARFARIN RESISTANCE; DEPENDENT PROTEINS; GENE-EXPRESSION; BONE; DEFICIENCY; KIDNEY; CALCIFICATION; PROTHROMBIN	Vitamin K is involved in the -carboxylation of the vitamin K-dependent proteins, and vitamin K epoxide is a by-product of this reaction. Due to the limited intake of vitamin K, its regeneration is necessary and involves vitamin K 2,3-epoxide reductase (VKOR) activity. This activity is known to be supported by VKORC1 protein, but recently a second gene, VKORC1L1, appears to be able to support this activity when the encoded protein is expressed in HEK293T cells. Nevertheless, this protein was described as being responsible for driving the vitamin K-mediated antioxidation pathways. In this paper we precisely analyzed the catalytic properties of VKORC1L1 when expressed in Pichia pastoris and more particularly its susceptibility to vitamin K antagonists. Vitamin K antagonists are also inhibitors of VKORC1L1, but this enzyme appears to be 50-fold more resistant to vitamin K antagonists than VKORC1. The expression of Vkorc1l1 mRNA was observed in all tissues assayed, i.e. in C57BL/6 wild type and VKORC1-deficient mouse liver, lung, and testis and rat liver, lung, brain, kidney, testis, and osteoblastic cells. The characterization of VKOR activity in extrahepatic tissues demonstrated that a part of the VKOR activity, more or less important according to the tissue, may be supported by VKORC1L1 enzyme especially in testis, lung, and osteoblasts. Therefore, the involvement of VKORC1L1 in VKOR activity partly explains the low susceptibility of some extrahepatic tissues to vitamin K antagonists and the lack of effects of vitamin K antagonists on the functionality of the vitamin K-dependent protein produced by extrahepatic tissues such as matrix Gla protein or osteocalcin.	[Hammed, Abdessalem; Matagrin, Benjamin; Prouillac, Caroline; Benoit, Etienne; Lattard, Virginie] Inst Natl Rech Agron INRA Vetagro Sup, Vet Sch Lyon, Unite Contrat USC 1233, F-69280 Marcy Letoile, France; [Spohn, Gabriele] Goethe Univ Frankfurt, German Red Cross Blood Serv, D-60528 Frankfurt, Germany; [Spohn, Gabriele] Goethe Univ Frankfurt, Inst Transfus Med & Immunohematol, D-60528 Frankfurt, Germany	INRAE; VetAgro Sup; Goethe University Frankfurt; Goethe University Frankfurt	Lattard, V (corresponding author), Inst Natl Rech Agron INRA Vetagro Sup, Vet Sch Lyon, Unite Contrat USC 1233, F-69280 Marcy Letoile, France.	virginie.lattard@vetagro-sup.fr	Prouillac, Caroline/H-1667-2011; HAMMED, Abdessalem/ABF-8875-2021	Prouillac, Caroline/0000-0002-7244-6162; HAMMED, Abdessalem/0000-0001-8714-2789	Agence Nationale pour la Recherche [RODENT 2009-CESA-008-03]; Direction Generale de l'Enseignement et de la Recherche (DGER)	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Direction Generale de l'Enseignement et de la Recherche (DGER)	This work was supported by Agence Nationale pour la Recherche Grant RODENT 2009-CESA-008-03 and by Direction Generale de l'Enseignement et de la Recherche (DGER).	Binkley N, 2007, J BONE MINER RES, V22, P695, DOI 10.1359/JBMR.070208; Cadavid JC, 2011, CHEST, V139, P1503, DOI 10.1378/chest.10-1322; Chatrou MLL, 2011, HAMOSTASEOLOGIE, V31, P251, DOI 10.5482/ha-1157; Chu PH, 2006, P NATL ACAD SCI USA, V103, P19308, DOI 10.1073/pnas.0609401103; Coutu DL, 2008, J BIOL CHEM, V283, P17991, DOI 10.1074/jbc.M708029200; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Gilbert KA, 2004, AM J PHYSIOL-LUNG C, V286, pL1179, DOI 10.1152/ajplung.00188.2003; Grover PK, 2000, EUR J BIOCHEM, V267, P61, DOI 10.1046/j.1432-1327.2000.00954.x; Hara K, 2005, J BONE MINER METAB, V23, P366, DOI 10.1007/s00774-005-0614-7; Hodroge A, 2012, J THROMB HAEMOST, V10, P2535, DOI 10.1111/jth.12019; Hodroge A, 2011, ARCH BIOCHEM BIOPHYS, V515, P14, DOI 10.1016/j.abb.2011.08.010; Knapen MHJ, 2012, BRIT J NUTR, V108, P1017, DOI 10.1017/S000711451100626X; Lasseur R, 2005, J BIOCHEM MOL TOXIC, V19, P379, DOI 10.1002/jbt.20104; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Nakano T, 1997, BIOCHEM J, V323, P387, DOI 10.1042/bj3230387; Oldenburg J, 2008, VITAM HORM, V78, P35, DOI 10.1016/S0083-6729(07)00003-9; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; PRICE PA, 1982, P NATL ACAD SCI-BIOL, V79, P7734, DOI 10.1073/pnas.79.24.7734; PRICE PA, 1987, THROMB RES, V46, P121, DOI 10.1016/0049-3848(87)90212-X; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P3374, DOI 10.1073/pnas.73.10.3374; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; PRICE PA, 1981, J BIOL CHEM, V256, P2754; PRICE PA, 1983, BIOCHEM BIOPH RES CO, V117, P765, DOI 10.1016/0006-291X(83)91663-7; PRICE PA, 1981, J BIOL CHEM, V256, P2760; RANNELS SR, 1993, AM J PHYSIOL, V265, pL270, DOI 10.1152/ajplung.1993.265.3.L270; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Schurgers LJ, 2007, BLOOD, V109, P2823, DOI 10.1182/blood-2006-07-035345; Schurgers LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043229; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; Spohn G, 2009, THROMB HAEMOSTASIS, V101, P1044, DOI 10.1160/TH09-03-0204; Stapleton AMF, 1998, BRIT J UROL, V81, P666; Stenova E, 2011, BRATISL MED J, V112, P71; Viegas CSB, 2008, J BIOL CHEM, V283, P36655, DOI 10.1074/jbc.M802761200; Villines TC, 2009, CALCIFIED TISSUE INT, V85, P494, DOI 10.1007/s00223-009-9300-4; Westhofen P, 2011, J BIOL CHEM, V286, P15085, DOI 10.1074/jbc.M110.210971; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Zhu AH, 2007, BLOOD, V109, P5270, DOI 10.1182/blood-2006-12-064188	38	45	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28733	28742		10.1074/jbc.M113.457119	http://dx.doi.org/10.1074/jbc.M113.457119			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23928358	Green Published, hybrid			2022-12-28	WOS:000330298800027
J	Majewska, J; Ciesielski, SJ; Schilke, B; Kominek, J; Blenska, A; Delewski, W; Song, JY; Marszalek, J; Craig, EA; Dutkiewicz, R				Majewska, Julia; Ciesielski, Szymon J.; Schilke, Brenda; Kominek, Jacek; Blenska, Anna; Delewski, Wojciech; Song, Ji-Yoon; Marszalek, Jaroslaw; Craig, Elizabeth A.; Dutkiewicz, Rafal			Binding of the Chaperone Jac1 Protein and Cysteine Desulfurase Nfs1 to the Iron-Sulfur Cluster Scaffold Isu Protein Is Mutually Exclusive	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Iron-Sulfur Protein; Mitochondria; Molecular Chaperone; Scaffold Proteins; Yeast; ISC System; J-protein	MULTIPLE SEQUENCE ALIGNMENT; INTERACTING PROTEIN; FRIEDREICHS-ATAXIA; IN-VIVO; BIOGENESIS; FRATAXIN; ISCU; HSCB; MITOCHONDRIA; REFINEMENT	Biogenesis of mitochondrial iron-sulfur (Fe/S) cluster proteins requires the interaction of multiple proteins with the highly conserved 14-kDa scaffold protein Isu, on which clusters are built prior to their transfer to recipient proteins. For example, the assembly process requires the cysteine desulfurase Nfs1, which serves as the sulfur donor for cluster assembly. The transfer process requires Jac1, a J-protein Hsp70 cochaperone. We recently identified three residues on the surface of Jac1 that form a hydrophobic patch critical for interaction with Isu. The results of molecular modeling of the Isu1-Jac1 interaction, which was guided by these experimental data and structural/biophysical information available for bacterial homologs, predicted the importance of three hydrophobic residues forming a patch on the surface of Isu1 for interaction with Jac1. Using Isu variants having alterations in residues that form the hydrophobic patch on the surface of Isu, this prediction was experimentally validated by in vitro binding assays. In addition, Nfs1 was found to require the same hydrophobic residues of Isu for binding, as does Jac1, suggesting that Jac1 and Nfs1 binding is mutually exclusive. In support of this conclusion, Jac1 and Nfs1 compete for binding to Isu. Evolutionary analysis revealed that residues involved in these interactions are conserved and that they are critical residues for the biogenesis of Fe/S cluster protein in vivo. We propose that competition between Jac1 and Nfs1 for Isu binding plays an important role in transitioning the Fe/S cluster biogenesis machinery from the cluster assembly step to the Hsp70-mediated transfer of the Fe/S cluster to recipient proteins.	[Majewska, Julia; Kominek, Jacek; Blenska, Anna; Delewski, Wojciech; Marszalek, Jaroslaw; Dutkiewicz, Rafal] Univ Gdansk, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland; [Ciesielski, Szymon J.; Schilke, Brenda; Song, Ji-Yoon; Marszalek, Jaroslaw; Craig, Elizabeth A.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Ciesielski, Szymon J.; Schilke, Brenda; Song, Ji-Yoon; Marszalek, Jaroslaw; Craig, Elizabeth A.] Univ Wisconsin, Madison, WI 53706 USA	Fahrenheit Universities; University of Gdansk; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Craig, EA (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ecraig@wisc.edu; dutkiew@biotech.ug.gda.pl	Dutkiewicz, Rafal/F-5956-2011; Dutkiewicz, Rafal/ABE-6979-2020; Marszalek, Jaroslaw/F-5824-2011	Dutkiewicz, Rafal/0000-0003-4150-0450; Ciesielski, Szymon/0000-0002-9041-7162; Marszalek, Jaroslaw/0000-0002-6978-1189; Kominek, Jacek/0000-0002-1916-0122	National Institutes of Health [GM27870]; Polish Ministry of Science and Higher Education [N N301314137]; Foundation for Polish Science International PhD Projects [MPD/2010/5]; European Union; Operational Program Innovative Economy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science International PhD Projects; European Union(European Commission); Operational Program Innovative Economy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM27870 (to E. A. C.). This work was also supported by Polish Ministry of Science and Higher Education Grant N N301314137 (to R. D.) and by Foundation for Polish Science International PhD Projects Grant MPD/2010/5) cofinanced by the European Union European Regional Development Fund, Operational Program Innovative Economy 2007-2013 (to J. M.).	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amela I, 2013, PROTEIN J, V32, P183, DOI 10.1007/s10930-013-9475-4; Andrew AJ, 2006, J BIOL CHEM, V281, P14580, DOI 10.1074/jbc.M600842200; Bonomi F, 2011, BIOCHEMISTRY-US, V50, P9641, DOI 10.1021/bi201123z; Bonomi F, 2008, BIOCHEMISTRY-US, V47, P12795, DOI 10.1021/bi801565j; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Ciesielski SJ, 2012, J MOL BIOL, V417, P1, DOI 10.1016/j.jmb.2012.01.022; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Dutkiewicz R, 2006, J BIOL CHEM, V281, P7801, DOI 10.1074/jbc.M513301200; Dutkiewicz R, 2004, J BIOL CHEM, V279, P29167, DOI 10.1074/jbc.M402947200; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fuzery AK, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-3; Fuzery AK, 2008, BIOCHEMISTRY-US, V47, P9394, DOI 10.1021/bi800502r; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; Jaschkowitz K, 2000, BIOCHEMISTRY-US, V39, P3416, DOI 10.1021/bi992147c; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim JH, 2009, BIOCHEMISTRY-US, V48, P6062, DOI 10.1021/bi9002277; Kota P, 2011, BIOINFORMATICS, V27, P2209, DOI 10.1093/bioinformatics/btr374; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Pandey A, 2012, BIOCHEM J, V448, P171, DOI 10.1042/BJ20120951; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Song JY, 2012, P NATL ACAD SCI USA, V109, P10370, DOI 10.1073/pnas.1206945109; Stehling Oliver, 2007, Methods Mol Biol, V372, P325, DOI 10.1007/978-1-59745-365-3_24; THORPE GHG, 1985, CLIN CHEM, V31, P1335; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819	49	40	42	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29134	29142		10.1074/jbc.M113.503524	http://dx.doi.org/10.1074/jbc.M113.503524			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946486	Green Published, hybrid			2022-12-28	WOS:000330298800066
J	Ricard, MJ; Gudas, LJ				Ricard, Megan J.; Gudas, Lorraine J.			Cytochrome P450 Cyp26a1 Alters Spinal Motor Neuron Subtype Identity in Differentiating Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Differentiation; Neurological Diseases; Retinoid; Stem Cells	AMYOTROPHIC-LATERAL-SCLEROSIS; RETINOIC ACID SYNTHESIS; COLUMNAR ORGANIZATION; TRANSCRIPTION FACTORS; POSITIONAL IDENTITY; REPRESSOR ACTIVITY; GENE-EXPRESSION; HOMEOBOX GENES; REQUIREMENT; GROWTH	The ability to differentiate embryonic stem cells (ESCs) into specific cell types is critical for improved regenerative medicine strategies, cancer chemotherapeutic approaches, and regimens to combat chronic diseases associated with aging. Subclasses of motor neurons (MNs) are generated at different positions along the rostrocaudal axis of the spinal cord, and the signals that specify MN subtype fates remain poorly defined. We show here that the cytochrome P450 enzyme Cyp26a1, which metabolizes all-trans-retinoic acid (RA) and thereby reduces RA levels, plays a crucial role in specifying MN columnar subtypes. Lack of Cyp26a1 in ESCs during differentiation to spinal MNs increases Aldh1a2 (RALDH2) and Hoxc6, markers of the Hox-dependent, lateral motor column (LMC) subtype identity. In contrast, Lhx3, a marker for median motor column identity, showed lower expression in Cyp26a1(-/-)-derived MNs compared with WT. Without Cyp26a1, an increase in intracellular RA concentration plus sonic hedgehog agonist treatment confer an LMC fate on differentiating MNs. Our data suggest a strategy for increasing LMC-type MNs from ESCs by blocking Cyp26a1 in cell replacement/ESC differentiation therapy to treat neurodegenerative diseases, such as amyotrophic lateral sclerosis.	[Ricard, Megan J.; Gudas, Lorraine J.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Gudas, Lorraine J.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Gudas, Lorraine J.] Weill Cornell Canc Ctr, New York, NY 10065 USA	Cornell University; Cornell University	Gudas, LJ (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, 1300 York Ave, New York, NY 10065 USA.	ljgudas@med.cornell.edu			National Institutes of Health [R01CA43796, T32CA062948]; Weill Cornell funds; Department of Defense [W81XWH-09-1-0158]; NATIONAL CANCER INSTITUTE [R01CA043796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell funds; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA43796 (to L. J. G.). This work was also supported by Weill Cornell funds.; Supported for a portion of this research by Department of Defense Grant W81XWH-09-1-0158 and by National Institutes of Health Grant T32CA062948.	Abu-Abed S, 2002, MECH DEVELOP, V110, P173, DOI 10.1016/S0925-4773(01)00572-X; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bain G, 1996, BIOCHEM BIOPH RES CO, V223, P691, DOI 10.1006/bbrc.1996.0957; Bjorklund LM, 2002, PROG BRAIN RES, V138, P411, DOI 10.1016/S0079-6123(02)38090-7; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chen AC, 1997, CANCER RES, V57, P4642; Chen AC, 1996, J BIOL CHEM, V271, P14971, DOI 10.1074/jbc.271.25.14971; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; Deshpande DM, 2006, ANN NEUROL, V60, P32, DOI 10.1002/ana.20901; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Golden MG, 2012, GENE DEV, V26, P2236, DOI 10.1101/gad.199133.112; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Guo XJ, 1998, CANCER RES, V58, P166; GUTMAN CR, 1993, BRAIN RES, V609, P129, DOI 10.1016/0006-8993(93)90865-K; Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101; HOLLYDAY M, 1980, J COMP NEUROL, V194, P143, DOI 10.1002/cne.901940108; Hollyday M., 1980, Current Topics in Developmental Biology, V15, P181; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jung H, 2010, NEURON, V67, P781, DOI 10.1016/j.neuron.2010.08.008; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Langton S, 2008, DEV BIOL, V315, P331, DOI 10.1016/j.ydbio.2007.12.021; Laursen KB, 2012, NUCLEIC ACIDS RES, V40, P102, DOI 10.1093/nar/gkr637; Liang XQ, 2011, MOL CELL NEUROSCI, V47, P215, DOI 10.1016/j.mcn.2011.04.007; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Lopez-Gonzalez R, 2009, CELL TRANSPLANT, V18, P1171, DOI 10.3727/096368909X12483162197123; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Ludolph AC, 2012, CURR OPIN NEUROL, V25, P530, DOI 10.1097/WCO.0b013e328356d328; Mic FA, 2002, DEVELOPMENT, V129, P2271; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Peljto M, 2011, CURR OPIN NEUROBIOL, V21, P43, DOI 10.1016/j.conb.2010.09.012; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Soundararajan P, 2010, J NEUROSCI, V30, P6595, DOI 10.1523/JNEUROSCI.4932-09.2010; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Touma SE, 2009, BIOCHEM PHARMACOL, V78, P1127, DOI 10.1016/j.bcp.2009.06.022; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wichterle H, 2008, CURR PROTOC STEM CEL; William CM, 2003, DEVELOPMENT, V130, P1523, DOI 10.1242/dev.00358; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	69	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28801	28813		10.1074/jbc.M113.474254	http://dx.doi.org/10.1074/jbc.M113.474254			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946489	Green Published, hybrid			2022-12-28	WOS:000330298800033
J	Tsukamoto, H; Farrens, DL				Tsukamoto, Hisao; Farrens, David L.			A Constitutively Activating Mutation Alters the Dynamics and Energetics of a Key Conformational Change in a Ligand-free G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE HELICES; CRYSTAL-STRUCTURE; BINDING-SITE; RHODOPSIN; OPSIN; LIGHT; FLUORESCENCE; SPECTROSCOPY; STABILITY; NANODISCS	G protein-coupled receptors (GPCRs) undergo dynamic transitions between active and inactive conformations. Usually, these conversions are triggered when the receptor detects an external signal, but some so-called constitutively activating mutations, or CAMs, induce a GPCR to bind and activate G proteins in the absence of external stimulation, in ways still not fully understood. Here, we investigated how a CAM alters the structure of a GPCR and the dynamics involved as the receptor transitions between different conformations. Our approach used site-directed fluorescence labeling (SDFL) spectroscopy to compare opsin, the ligand-free form of the GPCR rhodopsin, with opsin containing the CAM M257Y, focusing specifically on key movements that occur in the sixth transmembrane helix (TM6) during GPCR activation. The site-directed fluorescence labeling data indicate opsin is constrained to an inactive conformation both in detergent micelles and lipid membranes, but when it contains the M257Y CAM, opsin is more dynamic and can interact with a G protein mimetic. Further study of these receptors using tryptophan-induced quenching (TrIQ) methods indicates that in detergent, the CAM significantly increases the population of receptors in the active state, but not in lipids. Subsequent Arrhenius analysis of the TrIQ data suggests that, both in detergent and lipids, the CAM lowers the energy barrier for TM6 movement, a key transition required for conversion between the inactive and active conformations. Together, these data suggest that the lowered energy barrier is a primary effect of the CAM on the receptor dynamics and energetics.	[Tsukamoto, Hisao; Farrens, David L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Farrens, DL (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	farrensd@ohsu.edu			National Institutes of Health [EY015436]; Grants-in-Aid for Scientific Research [25840122] Funding Source: KAKEN; NATIONAL EYE INSTITUTE [R01EY015436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY015436 (to D.L.F.).	Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Farrens DL, 2010, PHOTOCH PHOTOBIO SCI, V9, P1466, DOI 10.1039/c0pp00283f; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kusnetzow AK, 2006, BIOCHEMISTRY-US, V45, P5538, DOI 10.1021/bi060101v; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Mansoor SE, 2004, BIOCHEMISTRY-US, V43, P9426, DOI 10.1021/bi036259m; Mansoor SE, 2002, BIOCHEMISTRY-US, V41, P2475, DOI 10.1021/bi011198i; Mansoor SE, 2010, BIOCHEMISTRY-US, V49, P9722, DOI 10.1021/bi100907m; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Shi XG, 2008, J PHYS CHEM B, V112, P12801, DOI 10.1021/jp8033598; Spencer R. D., 1970, THESIS U ILLINOIS UR; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Thompson Miles D., 2008, V448, P109, DOI 10.1007/978-1-59745-205-2_7; Tsukamoto H, 2011, BIOCHEMISTRY-US, V50, P5086, DOI 10.1021/bi200391a; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948	40	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28207	28216		10.1074/jbc.M113.472464	http://dx.doi.org/10.1074/jbc.M113.472464			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940032	Green Published, hybrid			2022-12-28	WOS:000330612800043
J	Agrahari, G; Liang, Z; Mayfield, JA; Balsara, RD; Ploplis, VA; Castellino, FJ				Agrahari, Garima; Liang, Zhong; Mayfield, Jeffrey A.; Balsara, Rashna D.; Ploplis, Victoria A.; Castellino, Francis J.			Complement-mediated Opsonization of Invasive Group A Streptococcus pyogenes Strain AP53 Is Regulated by the Bacterial Two-component Cluster of Virulence Responder/Sensor (CovRS) System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; C4B-BINDING PROTEIN; FUNCTIONAL DIFFERENCES; PLASMINOGEN-BINDING; POSITIVE REGULATOR; FACTOR-H; ACTIVATION; INHIBITOR; EXPRESSION; INFECTION	Group A Streptococcus pyogenes (GAS) strain AP53 is a primary isolate from a patient with necrotizing fasciitis. These AP53 cells contain an inactivating mutation in the sensor component of the cluster of virulence (cov) responder (R)/sensor (S) two-component gene regulatory system (covRS), which enhances the virulence of the primary strain, AP53/covR(+)S(-). However, specific mechanisms by which the covRS system regulates the survival of GAS in humans are incomplete. Here, we show a key role for covRS in the regulation of opsonophagocytosis of AP53 by human neutrophils. AP53/covR(+)S(-) cells displayed potent binding of host complement inhibitors of C3 convertase, viz. Factor H (FH) and C4-binding protein (C4BP), which concomitantly led to minimal C3b deposition on AP53 cells, further showing that these plasma protein inhibitors are active on GAS cells. This resulted in weak killing of the bacteria by human neutrophils and a corresponding high death rate of mice after injection of these cells. After targeted allelic alteration of covS(-) to wild-type covS (covS(+)), a dramatic loss of FH and C4BP binding to the AP53/covR(+)S(-) cells was observed. This resulted in elevated C3b deposition on AP53/covR(+)S(-) cells, a high level of opsonophagocytosis by human neutrophils, and a very low death rate of mice infected with AP53/covR(+)S(-). We show that covRS is a critical transcriptional regulator of genes directing AP53 killing by neutrophils and regulates the levels of the receptors for FH and C4BP, which we identify as the products of the fba and enn genes, respectively.	[Agrahari, Garima; Liang, Zhong; Mayfield, Jeffrey A.; Balsara, Rashna D.; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Agrahari, Garima; Balsara, Rashna D.; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu			National Institutes of Health [HL013423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013423, R37HL013423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL013423.	Agarwal V, 2012, J IMMUNOL, V189, P3575, DOI 10.4049/jimmunol.1102934; Ato M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003455; Barthel D, 2012, J BIOL CHEM, V287, P18831, DOI 10.1074/jbc.M111.323287; BERGE A, 1993, J BIOL CHEM, V268, P25417; Blackmore TK, 1998, INFECT IMMUN, V66, P1427, DOI 10.1128/IAI.66.4.1427-1431.1998; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; FUJITA T, 1978, J EXP MED, V148, P1044, DOI 10.1084/jem.148.4.1044; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; Gustafsson MCU, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003323; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Hytonen J, 2001, MOL MICROBIOL, V39, P512, DOI 10.1046/j.1365-2958.2001.02269.x; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Jenkins HT, 2006, J BIOL CHEM, V281, P3690, DOI 10.1074/jbc.M511563200; Kondo H, 1997, NAT STRUCT BIOL, V4, P28, DOI 10.1038/nsb0197-28; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Li K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-64; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Lindahl G, 2000, CURR OPIN IMMUNOL, V12, P44, DOI 10.1016/S0952-7915(99)00049-7; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; MCLANDSBOROUGH LA, 1995, FEMS MICROBIOL LETT, V128, P45, DOI 10.1111/j.1574-6968.1995.tb07498.x; Nordstrom T, 2004, J IMMUNOL, V173, P4598, DOI 10.4049/jimmunol.173.7.4598; Pandiripally V, 2002, INFECT IMMUN, V70, P6206, DOI 10.1128/IAI.70.11.6206-6214.2002; PANGBURN MK, 1980, J EXP MED, V152, P1102, DOI 10.1084/jem.152.4.1102; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pietikainen J, 2010, MOL IMMUNOL, V47, P1299, DOI 10.1016/j.molimm.2009.11.028; PODBIELSKI A, 1993, MOL GEN GENET, V237, P287, DOI 10.1007/BF00282810; Rawal N, 2009, MOL IMMUNOL, V46, P2902, DOI 10.1016/j.molimm.2009.07.006; Rezcallah MS, 2004, MICROBIOL-SGM, V150, P365, DOI 10.1099/mic.0.26826-0; Roberts SA, 2007, MOL MICROBIOL, V66, P1506, DOI 10.1111/j.1365-2958.2007.06015.x; ROSS GD, 1985, ADV IMMUNOL, V37, P217, DOI 10.1016/S0065-2776(08)60341-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Souza NM, 2012, MICROB PATHOGENESIS, V53, P125, DOI 10.1016/j.micpath.2012.06.001; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Vieira ML, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/758513; WEIS JJ, 1985, J IMMUNOL, V134, P500; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; WYATT RJ, 1982, J CLIN IMMUNOL, V2, P110, DOI 10.1007/BF00916894; ZHANG Y, 2012, J IMMUNOL, V173, P6899; Zhang YL, 2013, FEBS LETT, V587, P1304, DOI 10.1016/j.febslet.2013.02.033	49	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27494	27504		10.1074/jbc.M113.494864	http://dx.doi.org/10.1074/jbc.M113.494864			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23928307	Green Published, hybrid			2022-12-28	WOS:000330597300044
J	Mihara, K; Ramachandran, R; Renaux, B; Saifeddine, M; Hollenberg, MD				Mihara, Koichiro; Ramachandran, Rithwik; Renaux, Bernard; Saifeddine, Mahmoud; Hollenberg, Morley D.			Neutrophil Elastase and Proteinase-3 Trigger G Protein-biased Signaling through Proteinase-activated Receptor-1 (PAR1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Endothelial Cell; G Protein-coupled Receptors (GPCR); Intracellular Trafficking; MAP Kinases (MAPKs); Neutrophil; Thrombin; Biased Signaling; Proteinase-activated Receptor	BREAST-CANCER CELLS; THROMBIN-RECEPTOR; MOLECULAR-CLONING; ENDOTHELIAL-CELLS; FUNCTIONAL SELECTIVITY; TETHERED-LIGAND; C RECEPTOR; EXPRESSION; INFLAMMATION; PLATELET	Background: Proteinase-activated receptor-1 (PAR1) is a proteolytically activated G protein-coupled receptor. Neutrophil-derived enzymes might regulate PAR1 signaling. Results: Neutrophil elastase and proteinase-3 cleave and activate PAR1 signaling that is distinct from thrombin-triggered responses. Neutrophil elastase and proteinase-3 signaling through PAR1 modulates endothelial cell signaling. Conclusion: Neutrophil enzymes are G(i)-biased agonists for PAR1. Significance: Biased PAR1-activating compounds may prove of value as therapeutic agents to treat cardiovascular and inflammatory diseases. Neutrophil proteinases released at sites of inflammation can affect tissue function by either activating or disarming signal transduction mediated by proteinase-activated receptors (PARs). Because PAR1 is expressed at sites where abundant neutrophil infiltration occurs, we hypothesized that neutrophil-derived enzymes might also regulate PAR1 signaling. We report here that both neutrophil elastase and proteinase-3 cleave the human PAR1 N terminus at sites distinct from the thrombin cleavage site. This cleavage results in a disarming of thrombin-activated calcium signaling through PAR1. However, the distinct non-canonical tethered ligands unmasked by neutrophil elastase and proteinase-3, as well as synthetic peptides with sequences derived from these novel exposed tethered ligands, selectively stimulated PAR1-mediated mitogen-activated protein kinase activation. This signaling was blocked by pertussis toxin, implicating a G(i)-triggered signal pathway. We conclude that neutrophil proteinases trigger biased PAR1 signaling and we describe a novel set of tethered ligands that are distinct from the classical tethered ligand revealed by thrombin. We further demonstrate the function of this biased signaling in regulating endothelial cell barrier integrity.	[Mihara, Koichiro; Ramachandran, Rithwik; Renaux, Bernard; Saifeddine, Mahmoud; Hollenberg, Morley D.] Univ Calgary, Inflammat Res Network, Snyder Inst Chron Dis, Calgary, AB T2N 4N1, Canada; [Mihara, Koichiro; Ramachandran, Rithwik; Renaux, Bernard; Saifeddine, Mahmoud; Hollenberg, Morley D.] Univ Calgary, Dept Physiol & Pharmacol, Fac Med, Calgary, AB T2N 4N1, Canada; [Hollenberg, Morley D.] Univ Calgary, Dept Med, Fac Med, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary; University of Calgary	Mihara, K (corresponding author), Univ Calgary, Inflammat Res Network, Snyder Inst Chron Dis, Calgary, AB T2N 4N1, Canada.	mihara@ucalgary.ca; rramacha@ucalgary.ca	Hollenberg, Morley/AFV-6966-2022; Ramachandran, Rithwik/N-7815-2015	Ramachandran, Rithwik/0000-0001-9557-9905	Canadian Foundation Innovation; Alberta Science and Research Authority	Canadian Foundation Innovation(Canada Foundation for Innovation); Alberta Science and Research Authority	The microscopy work was supported by the Snyder Institute Live Cell Imaging Facility funded by an equipment and infrastructure grant from the Canadian Foundation Innovation and the Alberta Science and Research Authority.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Al-Ani B, 2002, J PHARMACOL EXP THER, V302, P1046, DOI 10.1124/jpet.302.3.1046; Andrade-Gordon P, 1999, P NATL ACAD SCI USA, V96, P12257, DOI 10.1073/pnas.96.22.12257; Ayoub MA, 2010, FASEB J, V24, P3522, DOI 10.1096/fj.10-154997; Bae JS, 2008, J THROMB HAEMOST, V6, P954, DOI 10.1111/j.1538-7836.2008.02924.x; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; Blackburn JS, 2008, AM J PATHOL, V173, P1736, DOI 10.2353/ajpath.2008.080512; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Burgun C, 2000, FEBS LETT, V484, P189, DOI 10.1016/S0014-5793(00)02153-0; Chackalamannil S, 2005, J MED CHEM, V48, P5884, DOI 10.1021/jm0502236; Chackalamannil S, 2008, J MED CHEM, V51, P3061, DOI 10.1021/jm800180e; Jaffre F, 2012, CIRCULATION, V125, P2993, DOI 10.1161/CIRCULATIONAHA.111.066787; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; LEROYVIARD K, 1989, EXP CELL RES, V181, P1, DOI 10.1016/0014-4827(89)90177-8; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; McLaughlin JN, 2005, J BIOL CHEM, V280, P25048, DOI 10.1074/jbc.M414090200; MOLINO M, 1995, J BIOL CHEM, V270, P11168, DOI 10.1074/jbc.270.19.11168; Mosnier LO, 2012, BLOOD, V120, P5237, DOI 10.1182/blood-2012-08-452169; NYSTEDT S, 1995, J BIOL CHEM, V270, P5950, DOI 10.1074/jbc.270.11.5950; NYSTEDT S, 1995, EUR J BIOCHEM, V232, P84, DOI 10.1111/j.1432-1033.1995.tb20784.x; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Schuepbach RA, 2012, J THROMB HAEMOST, V10, P1675, DOI 10.1111/j.1538-7836.2012.04825.x; Schuepbach RA, 2008, BLOOD, V111, P2667, DOI 10.1182/blood-2007-09-113076; Schuepbach RA, 2009, THROMB HAEMOSTASIS, V101, P724, DOI 10.1160/TH08-10-0632; Soh UJK, 2011, P NATL ACAD SCI USA, V108, pE1372, DOI 10.1073/pnas.1112482108; Tressel SL, 2011, EMBO MOL MED, V3, P370, DOI 10.1002/emmm.201100145; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Verrall S, 1997, J BIOL CHEM, V272, P6898, DOI 10.1074/jbc.272.11.6898; Villegas-Mendez A, 2007, J THROMB HAEMOST, V5, P980, DOI 10.1111/j.1538-7836.2007.02480.x; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Zania P, 2009, J PHARMACOL EXP THER, V328, P378, DOI 10.1124/jpet.108.145664	49	82	84	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32979	32990		10.1074/jbc.M113.483123	http://dx.doi.org/10.1074/jbc.M113.483123			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24052258	Green Published, hybrid			2022-12-28	WOS:000328841700015
J	Shirey, C; Badieyan, S; Sobrado, P				Shirey, Carolyn; Badieyan, Somayesadat; Sobrado, Pablo			Role of Ser-257 in the Sliding Mechanism of NADP(H) in the Reaction Catalyzed by the Aspergillus fumigatus Flavin-dependent Ornithine N-5-Monooxygenase SidA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aspergillus; Flavin; Molecular Dynamics; Mutagenesis; Siderophores; C4a-hydroperoxyflavin; N-Hydroxylating; SidA; Flavin-dependent Monooxygenase; NADP(H) Role	CONTAINING MONO-OXYGENASE; PSEUDOMONAS-AERUGINOSA; CYCLOHEXANONE MONOOXYGENASE; FLAVOPROTEIN MONOOXYGENASES; KINETIC MECHANISM; HYDROXYLASE; ACTIVATION; PURIFICATION; BIOCATALYSTS; COFACTOR	SidA (siderophore A) is a flavin-dependent N-hydroxylating monooxygenase that is essential for virulence in Aspergillus fumigatus. SidA catalyzes the NADPH- and oxygen-dependent formation of N-5-hydroxyornithine. In this reaction, NADPH reduces the flavin, and the resulting NADP(+) is the last product to be released. The presence of NADP(+) is essential for activity, as it is required for stabilization of the C4a-hydroperoxyflavin, which is the hydroxylating species. As part of our efforts to determine the molecular details of the role of NADP(H) in catalysis, we targeted Ser-257 for site-directed mutagenesis and performed extensive characterization of the S257A enzyme. Using a combination of steady-state and stopped-flow kinetic experiments, substrate analogs, and primary kinetic isotope effects, we show that the interaction between Ser-257 and NADP(H) is essential for stabilization of the C4a-hydroperoxyflavin. Molecular dynamics simulation results suggest that Ser-257 functions as a pivot point, allowing the nicotinamide of NADP(+) to slide into position for stabilization of the C4a-hydroperoxyflavin.	[Shirey, Carolyn; Badieyan, Somayesadat; Sobrado, Pablo] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Sobrado, Pablo] Virginia Tech, Virginia Tech Ctr Drug Discovery, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Sobrado, P (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	psobrado@vt.edu			National Science Foundation [MCB 1021384]; Virginia Tech Biodesign and Bioprocessing Center; Direct For Biological Sciences [1021384] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Virginia Tech Biodesign and Bioprocessing Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grant MCB 1021384 and by the Virginia Tech Biodesign and Bioprocessing Center.	Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Badieyan S, 2012, PROTEIN ENG DES SEL, V25, P223, DOI 10.1093/protein/gzs010; BEATY NB, 1980, J BIOL CHEM, V255, P3817; BEATY NB, 1981, J BIOL CHEM, V256, P4619; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x; Eppink MHM, 1997, J BACTERIOL, V179, P6680, DOI 10.1128/jb.179.21.6680-6687.1997; Franceschini S, 2012, BIOCHEMISTRY-US, V51, P7043, DOI 10.1021/bi301072w; Han A, 2013, ARCH BIOCHEM BIOPHYS, V532, P46, DOI 10.1016/j.abb.2013.01.004; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; JEONG SS, 1994, ANAL BIOCHEM, V221, P273, DOI 10.1006/abio.1994.1411; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578; Meneely KM, 2007, BIOCHEMISTRY-US, V46, P11930, DOI 10.1021/bi700932q; Meneely KM, 2009, BIOCHEMISTRY-US, V48, P4371, DOI 10.1021/bi900442z; Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578; Olucha J, 2011, BIOORG CHEM, V39, P171, DOI 10.1016/j.bioorg.2011.07.006; Olucha J, 2011, J BIOL CHEM, V286, P31789, DOI 10.1074/jbc.M111.265876; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Orru R, 2011, J BIOL CHEM, V286, P29284, DOI 10.1074/jbc.M111.255075; Orru R, 2010, J BIOL CHEM, V285, P35021, DOI 10.1074/jbc.M110.161372; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; Pazmino DET, 2008, BIOCHEMISTRY-US, V47, P4082, DOI 10.1021/bi702296k; Robinson R, 2011, BIOCHEMISTRY-US, V50, P8489, DOI 10.1021/bi200933h; Romero E., 2013, FLAVINS FLAVOPROTEIN, P289; Romero E., 2012, J VIS EXP, V61, pe3803, DOI 10.3791/3803; Romero E, 2012, BBA-PROTEINS PROTEOM, V1824, P850, DOI 10.1016/j.bbapap.2012.03.004; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Sucharitakul J, 2011, J BIOL CHEM, V286, P16900, DOI 10.1074/jbc.M111.222976; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650	37	20	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32440	32448		10.1074/jbc.M113.487181	http://dx.doi.org/10.1074/jbc.M113.487181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072704	hybrid, Green Published			2022-12-28	WOS:000328681700029
J	Lee, KW; Okot-Kotber, C; LaComb, JF; Bogenhagen, DF				Lee, Ken-Wing; Okot-Kotber, Cynthia; LaComb, Joseph F.; Bogenhagen, Daniel F.			Mitochondrial Ribosomal RNA (rRNA) Methyltransferase Family Members Are Positioned to Modify Nascent rRNA in Foci near the Mitochondrial DNA Nucleoid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPERRESOLUTION FLUORESCENCE MICROSCOPY; REGULATES TRANSLATION; PROTEIN COMPLEX; LARGE SUBUNIT; BIOGENESIS; TRANSCRIPTION; REVEALS; METHYLATION; MEMBRANE; SITE	We have identified RNMTL1, MRM1, and MRM2 (FtsJ2) as members of the RNA methyltransferase family that may be responsible for the three known 2 '-O-ribose modifications of the 16 S rRNA core of the large mitochondrial ribosome subunit. These proteins are confined to foci located in the vicinity of mtDNA nucleoids. They show distinct patterns of association with mtDNA nucleoids and/or mitochondrial ribosomes in cell fractionation studies. We focused on the role of the least studied protein in this set, RNMTL1, to show that this protein interacts with the large ribosomal subunit as well as with a series of non-ribosomal proteins that may be involved in coupling of the rate of rRNA transcription and ribosome assembly in mitochondria. siRNA-directed silencing of RNMTL1 resulted in a significant inhibition of translation on mitochondrial ribosomes. Our results are consistent with a role for RNMTL1 in methylation of G(1370) of human 16 S rRNA.	[Lee, Ken-Wing; Okot-Kotber, Cynthia; LaComb, Joseph F.; Bogenhagen, Daniel F.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bogenhagen, DF (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	daniel.bogenhagen@stonybrook.edu		LaComb, Joseph/0000-0002-2981-1072	Ellison Medical Foundation	Ellison Medical Foundation(Lawrence Ellison Foundation)	This work was supported in part by a Senior Scholar Award from the Ellison Medical Foundation (to D.F.B.).	Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Antonicka H, 2010, AM J HUM GENET, V87, P115, DOI 10.1016/j.ajhg.2010.06.004; BAER RJ, 1981, NUCLEIC ACIDS RES, V9, P323, DOI 10.1093/nar/9.2.323; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11; Brown TA, 2010, METHODS, V51, P458, DOI 10.1016/j.ymeth.2010.01.001; Caldas T, 2000, J BIOL CHEM, V275, P16414, DOI 10.1074/jbc.M001854200; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Ching YP, 2002, GENOMICS, V79, P2, DOI 10.1006/geno.2001.6670; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Connolly K, 2008, MOL MICROBIOL, V70, P1062, DOI 10.1111/j.1365-2958.2008.06485.x; Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Dennerlein S, 2010, BIOCHEM J, V430, P551, DOI 10.1042/BJ20100757; DUBIN DT, 1978, J MOL BIOL, V121, P523, DOI 10.1016/0022-2836(78)90398-4; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fischer RS, 2011, TRENDS CELL BIOL, V21, P682, DOI 10.1016/j.tcb.2011.09.008; Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; KELLEMS RE, 1975, J CELL BIOL, V65, P1, DOI 10.1083/jcb.65.1.1; Koc EC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00183; Koc EC, 2010, ISR J CHEM, V50, P45, DOI 10.1002/ijch.201000002; Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Lafontaine DLJ, 1998, MOL CELL BIOL, V18, P2360, DOI 10.1128/MCB.18.4.2360; Leach KL, 2007, MOL CELL, V26, P393, DOI 10.1016/j.molcel.2007.04.005; Luongo CL, 1998, J BIOL CHEM, V273, P23773, DOI 10.1074/jbc.273.37.23773; MADEN BEH, 1995, BIOCHIMIE, V77, P22, DOI 10.1016/0300-9084(96)88100-4; Mangat CS, 2008, MOL MICROBIOL, V70, P1051, DOI 10.1111/j.1365-2958.2008.06484.x; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Mears JA, 2006, J MOL BIOL, V358, P193, DOI 10.1016/j.jmb.2006.01.094; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Pintard L, 2002, EMBO J, V21, P1139, DOI 10.1093/emboj/21.5.1139; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1; SIRUMCONNOLLY K, 1993, SCIENCE, V262, P1886, DOI 10.1126/science.8266080; Spahr H, 2012, P NATL ACAD SCI USA, V109, P15253, DOI 10.1073/pnas.1210688109; Surovtseva YV, 2013, NUCLEIC ACIDS RES, V41, P2479, DOI 10.1093/nar/gks1447; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Uchiumi T, 2010, NUCLEIC ACIDS RES, V38, P5554, DOI 10.1093/nar/gkq305; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wredenberg A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003178; Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774; Yakubovskaya E, 2012, STRUCTURE, V20, P1940, DOI 10.1016/j.str.2012.08.027	62	56	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31386	31399		10.1074/jbc.M113.515692	http://dx.doi.org/10.1074/jbc.M113.515692			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24036117	Green Published, hybrid			2022-12-28	WOS:000330778900055
J	Martinez-Sanchez, A; Murphy, CL				Martinez-Sanchez, Aida; Murphy, Chris L.			miR-1247 Functions by Targeting Cartilage Transcription Factor SOX9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTICULAR CHONDROCYTE PHENOTYPE; II COLLAGEN; MICRORNA EXPRESSION; HYPOXIA PROMOTES; DIFFERENTIATION; GENE; MOUSE; RNA; CELLS; SITES	microRNAs are a large and essential class of gene regulators that play key roles in development, homeostasis, and disease. They are necessary for normal skeletal development, and their expression is altered in arthritis. However, the specific role of individual microRNAs is only beginning to be unraveled. Using microRNA expression profiling in healthy human articular cartilage cells (chondrocytes), we identified miR-1247 expression as highly correlated with that of the differentiated cell phenotype. Transcribed from the DLK1-DIO3 locus, the function of miR-1247 is completely unknown. In mice its expression level was relatively high in cartilage tissue, and correlated with cartilage-associated microRNA miR-675 across a range of 15 different mouse tissues. To further probe miR-1247 function, overexpression and inhibition studies were performed in isolated human chondrocytes. Modulation of miR-1247 was found to exert profound phenotypic effects altering expression levels of cartilage master regulator transcription factor SOX9. SOX9 is essential for cartilage development and subsequent function throughout life, and mutations in this gene result in severe dwarfism. Putative miR-1247 binding sites were further investigated using luciferase reporter assays, which indicated binding of miR-1247 to a highly conserved region in the coding sequence of SOX9 but not in its 3'-UTR. Interestingly, depletion of SOX9 in human chondrocytes resulted in increased levels of the mature, processed microRNA, suggesting a negative feedback loop between miR-1247 and its target SOX9.	[Martinez-Sanchez, Aida; Murphy, Chris L.] Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England	University of Oxford	Murphy, CL (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Roosevelt Dr, Oxford OX3 7FY, England.	chris.murphy@kennedy.ox.ac.uk	Sanchez, Aida Martinez/ABH-5957-2020	Sanchez, Aida Martinez/0000-0001-5142-2527	Biotechnology and Biological Sciences Research Council UK [BB/G006555/1]; Arthritis Research UK; Biotechnology and Biological Sciences Research Council [BB/G006555/2, BB/G006555/1] Funding Source: researchfish; BBSRC [BB/G006555/1, BB/G006555/2] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council UK Grant BB/G006555/1 and by Arthritis Research UK.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bohm B, 2010, ARTHRITIS RHEUM-US, V62, P1372, DOI 10.1002/art.27387; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cuesta R, 2009, MOL CELL BIOL, V29, P2841, DOI 10.1128/MCB.01971-08; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Diaz-Prado S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-144; Dudek KA, 2010, J BIOL CHEM, V285, P24381, DOI 10.1074/jbc.M110.111328; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Henry SP, 2012, J BONE MINER RES, V27, P2511, DOI 10.1002/jbmr.1696; Ikegami D, 2011, DEVELOPMENT, V138, P1507, DOI 10.1242/dev.057802; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jones SW, 2009, OSTEOARTHR CARTILAGE, V17, P464, DOI 10.1016/j.joca.2008.09.012; Kim D, 2010, J BIOL CHEM, V285, P26900, DOI 10.1074/jbc.M110.115105; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; Lee JS, 2011, CONNECT TISSUE RES, V52, P496, DOI 10.3109/03008207.2011.585409; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; Martinez-Sanchez A, 2012, J BIOL CHEM, V287, P916, DOI 10.1074/jbc.M111.302430; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Suomi S, 2008, GENE REGUL SYST BIO, V2, P177; Swingler TE, 2012, ARTHRITIS RHEUM-US, V64, P1909, DOI 10.1002/art.34314; Thoms BL, 2013, ARTHRITIS RHEUM-US, V65, P1302, DOI 10.1002/art.37867; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yan HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020628; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	53	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30802	30814		10.1074/jbc.M113.496729	http://dx.doi.org/10.1074/jbc.M113.496729			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24014021	Green Published, hybrid			2022-12-28	WOS:000330778900002
J	Ruiz, A; Xu, XJ; Carlson, M				Ruiz, Amparo; Xu, Xinjing; Carlson, Marian			Ptc1 Protein Phosphatase 2C Contributes to Glucose Regulation of SNF1/AMP-activated Protein Kinase (AMPK) in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION-LOOP PHOSPHORYLATION; SNF1 KINASE; YEAST; SUBUNIT; SIT4; DEPHOSPHORYLATION; REG1-GLC7; PATHWAYS; REQUIRES; FAMILY	The SNF1/AMP-activated protein kinases (AMPKs) function in energy regulation in eukaryotic cells. SNF1/AMPKs are alpha beta gamma heterotrimers that are activated by phosphorylation of the activation loop Thr on the catalytic subunit. Protein kinases that activate SNF1/AMPK have been identified, but the protein phosphatases responsible for dephosphorylation of the activation loop are less well defined. For Saccharomyces cerevisiae SNF1/AMPK, Reg1-Glc7 protein phosphatase 1 and Sit4 type 2A-related phosphatase function together to dephosphorylate Thr-210 on the Snf1 catalytic subunit during growth on high concentrations of glucose; reg1 Delta and sit4 Delta single mutations do not impair dephosphorylation when inappropriate glycogen synthesis, also caused by these mutations, is blocked. We here present evidence that Ptc1 protein phosphatase 2C also has a role in dephosphorylation of Snf1 Thr-210 in vivo. The sit4 Delta ptc1 Delta mutant exhibited partial defects in regulation of the phosphorylation state of Snf1. The reg1 Delta ptc1 Delta mutant was viable only when expressing mutant Snf1 proteins with reduced kinase activity, and Thr-210 phosphorylation of the mutant SNF1 heterotrimers was substantially elevated during growth on high glucose. This evidence, together with findings on the reg1 Delta sit4 Delta mutant, indicates that although Reg1-Glc7 plays the major role, all three phosphatases contribute to maintenance of the Snf1 activation loop in the dephosphorylated state during growth on high glucose. Ptc1 has overlapping functions with Reg1-Glc7 and Sit4 in glucose regulation of SNF1/AMPK and cell viability.	[Ruiz, Amparo; Xu, Xinjing; Carlson, Marian] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University	Carlson, M (corresponding author), 701 W 168th St,HSC1412, New York, NY 10032 USA.	mbc1@columbia.edu	Ruiz, Amparo/AAZ-2317-2021	Ruiz, Amparo/0000-0002-3947-4540	National Institutes of Health [GM34095]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034095, R01GM034095] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34095 (to M. C.).	Arino J, 2011, EUKARYOT CELL, V10, P21, DOI 10.1128/EC.00249-10; CELENZA JL, 1989, MOL CELL BIOL, V9, P5034, DOI 10.1128/MCB.9.11.5034; Chandrashekarappa DG, 2011, J BIOL CHEM, V286, P44532, DOI 10.1074/jbc.M111.315895; Cherkasova V, 2010, MOL CELL BIOL, V30, P2862, DOI 10.1128/MCB.00183-10; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Garcia-Haro L, 2010, FASEB J, V24, P5080, DOI 10.1096/fj.10-166306; Gonzalez A, 2006, J BIOL CHEM, V281, P35057, DOI 10.1074/jbc.M607919200; Gonzalez A, 2009, MOL CELL BIOL, V29, P2876, DOI 10.1128/MCB.01740-08; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Hruby A, 2011, J CELL SCI, V124, P35, DOI 10.1242/jcs.077065; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Liu Y, 2011, EUKARYOT CELL, V10, P313, DOI 10.1128/EC.00291-10; Liu Y, 2010, GENETICS, V184, P91, DOI 10.1534/genetics.109.110957; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; Luke MM, 1996, MOL CELL BIOL, V16, P2744; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Momcilovic M., 2010, THESIS COLUMBIA U; Momcilovic M, 2011, J BIOL CHEM, V286, P23544, DOI 10.1074/jbc.M111.244111; Munoz I, 2003, YEAST, V20, P157, DOI 10.1002/yea.938; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Ruiz A, 2006, MOL MICROBIOL, V62, P263, DOI 10.1111/j.1365-2958.2006.05370.x; Ruiz A, 2012, P NATL ACAD SCI USA, V109, P8652, DOI 10.1073/pnas.1206280109; Ruiz A, 2011, P NATL ACAD SCI USA, V108, P6349, DOI 10.1073/pnas.1102758108; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIKORSKI RS, 1989, GENETICS, V122, P19; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; SUTTON A, 1991, MOL CELL BIOL, V11, P2133, DOI 10.1128/MCB.11.4.2133; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; van Wageningen S, 2010, CELL, V143, P991, DOI 10.1016/j.cell.2010.11.021; Voss M, 2011, CELL SIGNAL, V23, P114, DOI 10.1016/j.cellsig.2010.08.010; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Wilson M, 2011, J PETROL, V52, P1, DOI 10.1093/petrology/egq092; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WOODS A, 1994, J BIOL CHEM, V269, P19509	40	27	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31052	31058		10.1074/jbc.M113.503763	http://dx.doi.org/10.1074/jbc.M113.503763			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24019512	Green Published, hybrid			2022-12-28	WOS:000330778900024
J	Furman, C; Mehla, J; Ananthaswamy, N; Arya, N; Kulesh, B; Kovach, I; Ambudkar, SV; Golin, J				Furman, Christopher; Mehla, Jitender; Ananthaswamy, Neeti; Arya, Nidhi; Kulesh, Bridget; Kovach, Ildiko; Ambudkar, Suresh V.; Golin, John			The Deviant ATP-binding Site of the Multidrug Efflux Pump Pdr5 Plays an Active Role in the Transport Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; ATPases; Drug Transport; Membrane Proteins; Multidrug Transporters	DOUBLE-MUTANT CYCLES; CANDIDA-ALBICANS; ABC TRANSPORTER; DRUG TRANSPORTER; RESISTANCE; HYDROLYSIS; YEAST; DOMAIN; MECHANISMS; INTERFACE	Pdr5 is the founding member of a large subfamily of evolutionarily distinct, clinically important fungal ABC transporters containing a characteristic, deviant ATP-binding site with altered Walker A, Walker B, Signature (C-loop), and Q-loop residues. In contrast to these motifs, the D-loops of the two ATP-binding sites have similar sequences, including a completely conserved aspartate residue. Alanine substitution mutants in the deviant Walker A and Signature motifs retain significant, albeit reduced, ATPase activity and drug resistance. The D-loop residue mutants D340A and D1042A showed a striking reduction in plasma membrane transporter levels. The D1042N mutation localized properly had nearly WT ATPase activity but was defective in transport and was profoundly hypersensitive to Pdr5 substrates. Therefore, there was a strong uncoupling of ATPase activity and drug efflux. Taken together, the properties of the mutants suggest an additional, critical intradomain signaling role for deviant ATP-binding sites.	[Furman, Christopher; Mehla, Jitender; Ananthaswamy, Neeti; Arya, Nidhi; Kulesh, Bridget; Kovach, Ildiko; Golin, John] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA; Catholic Univ Amer, Dept Chem, Washington, DC 20064 USA; [Ambudkar, Suresh V.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Catholic University of America; Catholic University of America; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Golin, J (corresponding author), Catholic Univ Amer, Dept Biol, 620 Michigan Ave NE, Washington, DC 20064 USA.	golin@cua.edu	Ambudkar, Suresh V/L-1317-2016; Mehla, Jitender/M-6165-2016	Mehla, Jitender/0000-0002-7829-557X	National Institutes of Health [GM07721]; National Science Foundation [MCB1048838]; Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM007721, R15GM077211] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM07721 (to J.G.). This work was also supported by National Science Foundation Grant MCB1048838 and funds from the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research (to S. V. A.).	Ananthaswamy N, 2010, BIOCHEMISTRY-US, V49, P4440, DOI 10.1021/bi100394j; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; De la Rosa MB, 2011, J BIOL CHEM, V286, P26258, DOI 10.1074/jbc.M111.256305; de Thozee CP, 2007, MOL MICROBIOL, V63, P811, DOI 10.1111/j.1365-2958.2006.05562.x; DECOTTIGNIES A, 1994, J BIOL CHEM, V269, P12797; Downes MT, 2013, ANTIMICROB AGENTS CH, V57, P1025, DOI 10.1128/AAC.02133-12; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Golin J, 2007, BIOCHEMISTRY-US, V46, P13109, DOI 10.1021/bi701414f; Gupta RP, 2011, BIOL CHEM, V392, P53, DOI 10.1515/BC.2011.011; Hanson L, 2005, BIOCHEMISTRY-US, V44, P9703, DOI 10.1021/bi0502994; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Hou YX, 2003, J BIOL CHEM, V278, P3599, DOI 10.1074/jbc.M210480200; Jha S, 2003, BIOCHEMISTRY-US, V42, P10822, DOI 10.1021/bi0345900; Jones PM, 2012, J PHYS CHEM A, V116, P3004, DOI 10.1021/jp211139s; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; Kolaczkowski M, 2013, BBA-BIOMEMBRANES, V1828, P479, DOI 10.1016/j.bbamem.2012.10.024; Kumar A, 2010, BBA-BIOMEMBRANES, V1798, P1757, DOI 10.1016/j.bbamem.2010.05.017; Leroux P, 2002, PEST MANAG SCI, V58, P876, DOI 10.1002/ps.566; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Loeffler J, 2003, CLIN INFECT DIS, V36, pS31, DOI 10.1086/344658; Martinez M, 2002, J ANTIMICROB CHEMOTH, V49, P515, DOI 10.1093/jac/49.3.515; Prasad R., 2011, J AMINO ACIDS; Quiram PA, 2000, J BIOL CHEM, V275, P4889, DOI 10.1074/jbc.275.7.4889; Rutledge RM, 2011, J STRUCT BIOL, V173, P333, DOI 10.1016/j.jsb.2010.10.012; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; Sauna ZE, 2008, J BIOL CHEM, V283, P35010, DOI 10.1074/jbc.M806446200; Schultz KM, 2011, BIOCHEMISTRY-US, V50, P2594, DOI 10.1021/bi1018418; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P11921, DOI 10.1021/bi001220s; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wandschneider E, 2003, BIOCHEMISTRY-US, V42, P10659, DOI 10.1021/bi034958t; Yang RY, 2011, BBA-BIOMEMBRANES, V1808, P1790, DOI 10.1016/j.bbamem.2011.02.004	33	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30420	30431		10.1074/jbc.M113.494682	http://dx.doi.org/10.1074/jbc.M113.494682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24019526	Green Published, hybrid			2022-12-28	WOS:000329868100038
J	Fu, P; Yang, ZY; Bach, LA				Fu, Ping; Yang, Zhiyong; Bach, Leon A.			Prohibitin-2 Binding Modulates Insulin-like Growth Factor-binding Protein-6 (IGFBP-6)-induced Rhabdomyosarcoma Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGF-BINDING; MUSCLE DIFFERENTIATION; CRISTAE MORPHOGENESIS; TERMINAL DOMAINS; PROSTATE-CANCER; FAMILY-MEMBERS; T-CELLS; EXPRESSION; RECEPTOR; PHOSPHORYLATION	Insulin-like growth factor (IGF)-binding protein (IGFBP)-6 decreases cancer cell proliferation and survival by inhibiting the effects of IGF-II. More recently, IGFBP-6 was found to promote the migration of rhabdomyosarcoma (RMS) cells in an IGF-independent manner, and MAPK pathways were involved in this process. However, the precise molecular mechanisms of these IGF-independent migratory actions of IGFBP-6 are largely unknown. Here, we report that prohibitin-2 (PHB2), a single-span membrane protein, is a key regulator of IGFBP-6-induced RMS cell migration. PHB2 and IGFBP-6 co-localize on the RMS cell surface, and they specifically interact, as demonstrated by affinity chromatography, co-immunoprecipitation, biosensor analysis, and confocal microscopy. Binding affinities for PHB2 are 9.0 +/- 1.0 nM for IGFBP-6 and 10.2 +/- 0.5 nM for mIGFBP-6, a non-IGF-binding mutant of IGFBP-6. The C-domain but not the N-domain of IGFBP-6 is involved in PHB2 binding. In addition, IGFBP-6 indirectly increases PHB2 tyrosine phosphorylation on RMS membranes. Importantly, PHB2 knockdown completely abolished IGFBP-6-mediated RMS cell migration. In contrast, IGFBP-6-induced MAPK pathway activation was not affected, suggesting that PHB2 may act as a downstream effector of these pathways. These results indicate that PHB2 plays a key role in this IGF-independent action of IGFBP-6 and suggest a possible therapeutic target for RMS.	[Fu, Ping; Yang, Zhiyong; Bach, Leon A.] Monash Univ, Dept Med, Cent Clin Sch, Alfred Med Res & Educ Precinct, Prahran, Vic 3181, Australia; [Bach, Leon A.] Alfred Hosp, Dept Endocrinol & Diabet, Melbourne, Vic 3004, Australia	Monash University; Florey Institute of Neuroscience & Mental Health	Bach, LA (corresponding author), Alfred Hosp, Dept Endocrinol & Diabet, Commercial Rd, Melbourne, Vic 3004, Australia.	leon.bach@monash.edu		Bach, Leon/0000-0002-9062-1518	National Health and Medical Research Council of Australia; Cancer Council Victoria; Alfred Research Trust	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Alfred Research Trust	This work was supported by grants from the National Health and Medical Research Council of Australia, Cancer Council Victoria, and the Alfred Research Trust.	Ande SR, 2012, INT J OBESITY, V36, P1236, DOI 10.1038/ijo.2011.227; Ande SR, 2009, BIOCHEM BIOPH RES CO, V390, P1023, DOI 10.1016/j.bbrc.2009.10.101; Ande SR, 2009, BBA-MOL CELL RES, V1793, P1372, DOI 10.1016/j.bbamcr.2009.05.008; Ande SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004586; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Bach LA, 1999, HORM METAB RES, V31, P226, DOI 10.1055/s-2007-978723; Bach LA, 2005, GROWTH HORM IGF RES, V15, P185, DOI 10.1016/j.ghir.2005.04.001; Bacher S, 2002, BIOCHIMIE, V84, P1207; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Berger KH, 1998, MOL CELL BIOL, V18, P4043, DOI 10.1128/MCB.18.7.4043; Chiu CF, 2013, ONCOGENE, V32, P777, DOI 10.1038/onc.2012.86; Chiu CF, 2012, CANCER LETT, V320, P205, DOI 10.1016/j.canlet.2012.02.027; Emerson V, 2010, J VIROL, V84, P1355, DOI 10.1128/JVI.01641-09; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fu P, 2007, J BIOL CHEM, V282, P22298, DOI 10.1074/jbc.M703066200; Fu P, 2010, J CELL PHYSIOL, V224, P636, DOI 10.1002/jcp.22156; Fukasawa H, 2011, AM J PATHOL, V179, P2254, DOI 10.1016/j.ajpath.2011.07.046; Gallicchio MA, 2001, INT J CANCER, V94, P645, DOI 10.1002/ijc.1519; Headey SJ, 2004, J MOL ENDOCRINOL, V33, P377, DOI 10.1677/jme.1.01547; Heron-Milhavet L, 2008, J CELL PHYSIOL, V214, P158, DOI 10.1002/jcp.21177; Ingermann AR, 2010, J BIOL CHEM, V285, P30233, DOI 10.1074/jbc.M110.122226; Iosef C, 2008, ENDOCRINOLOGY, V149, P1214, DOI 10.1210/en.2007-0959; Iosef C, 2010, CELL SIGNAL, V22, P1033, DOI 10.1016/j.cellsig.2010.02.006; JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kim JW, 2009, CANCER SCI, V100, P1468, DOI 10.1111/j.1349-7006.2009.01209.x; Kokkinakis DM, 2004, J NEUROPATH EXP NEUR, V63, P1182, DOI 10.1093/jnen/63.11.1182; Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015; Martins Ana Sofia, 2011, Sarcoma, V2011, P209736, DOI 10.1155/2011/209736; McRobert EA, 2003, J BIOL CHEM, V278, P25783, DOI 10.1074/jbc.M210433200; Mengwasser J, 2004, ONCOGENE, V23, P7430, DOI 10.1038/sj.onc.1207987; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Mishra S, 2005, TRENDS MOL MED, V11, P192, DOI 10.1016/j.molmed.2005.02.004; Mishra S, 2010, FEBS J, V277, P3937, DOI 10.1111/j.1742-4658.2010.07809.x; Nordqvist ACS, 2002, J NEURO-ONCOL, V57, P19; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Ponce J, 2010, PROTEOMICS, V10, P1954, DOI 10.1002/pmic.200900055; Rajalingam K, 2005, CELL CYCLE, V4, P1503, DOI 10.4161/cc.4.11.2142; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Scholl FA, 2000, BRIT J CANCER, V82, P1239; Schutt BS, 2004, J MOL ENDOCRINOL, V32, P859, DOI 10.1677/jme.0.0320859; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Sievers C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012735; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Sun LG, 2004, J CELL SCI, V117, P3021, DOI 10.1242/jcs.01142; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Velazquez-Fernandez D, 2005, SURGERY, V138, P1087, DOI 10.1016/j.surg.2005.09.031; Visser M, 1997, ONCOGENE, V15, P1309, DOI 10.1038/sj.onc.1201302; Wang Sheng, 2008, Transl Oncogenomics, V3, P23; Xu Xuan-Fu, 2009, J Carcinog, V8, P13, DOI 10.4103/1477-3163.55429; Yurugi H, 2012, BIOCHEM BIOPH RES CO, V420, P275, DOI 10.1016/j.bbrc.2012.02.149; Zhang CY, 2012, INT J CANCER, V130, P2003, DOI 10.1002/ijc.26201; Zhu BB, 2006, CANCER RES, V66, P8640, DOI 10.1158/0008-5472.CAN-06-1443; Zhu B, 2010, PROSTATE, V70, P17, DOI 10.1002/pros.21033; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	59	34	37	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29890	29900		10.1074/jbc.M113.510826	http://dx.doi.org/10.1074/jbc.M113.510826			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003225	Green Published, hybrid			2022-12-28	WOS:000330615300062
J	Herr, DR; Lee, CW; Wang, W; Ware, A; Rivera, R; Chun, J				Herr, Deron R.; Lee, Chang-Wook; Wang, Wei; Ware, Adam; Rivera, Richard; Chun, Jerold			Sphingosine 1-Phosphate Receptors Are Essential Mediators of Eyelid Closure during Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CELL-MIGRATION; LYSOPHOSPHATIDIC ACID; EGF RECEPTOR; LYSOPHOSPHOLIPID RECEPTORS; FINGOLIMOD FTY720; ENDOTHELIAL-CELLS; MICE LACKING; WAVY HAIR; KAPPA-B	The fetal development of the mammalian eyelid involves the expansion of the epithelium over the developing cornea, fusion into a continuous sheet covering the eye, and a splitting event several weeks later that results in the formation of the upper and lower eyelids. Recent studies have revealed a significant number of molecular signaling components that are essential mediators of eyelid development. Receptor-mediated sphingosine 1-phosphate (S1P) signaling is known to influence diverse biological processes, but its involvement in eyelid development has not been reported. Here, we show that two S1P receptors, S1P(2) and S1P(3), are collectively essential mediators of eyelid closure during murine development. Homozygous deletion of the gene encoding either receptor has no apparent effect on eyelid development, but double-null embryos are born with an "eyes open at birth" defect due to a delay in epithelial sheet extension. Both receptors are expressed in the advancing epithelial sheet during the critical period of extension. Fibroblasts derived from double-null embryos have a deficient response to epidermal growth factor, suggesting that S1P(2) and S1P(3) modulate this essential signaling pathway during eyelid closure.	[Herr, Deron R.; Lee, Chang-Wook; Ware, Adam; Rivera, Richard; Chun, Jerold] Scripps Res Inst, Dept Mol & Cellular Neurosci, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Herr, Deron R.; Wang, Wei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore	Scripps Research Institute; National University of Singapore	Chun, J (corresponding author), Scripps Res Inst, Dept Mol & Cellular Neurosci, Dorris Neurosci Ctr, 10550 North Torrey Pines Rd,DNC 118, La Jolla, CA 92037 USA.	jchun@scripps.edu	Herr, Deron/AAB-7380-2020; Chun, Jerold/Y-4670-2019	Herr, Deron/0000-0001-5755-0896; Lee, Chang-Wook/0000-0002-0907-8475	National Institutes of Health [MH051699, NS048478, DC009505, DA019674]; Capita Foundation; National University of Singapore; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH051699, R01MH051699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC009505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Capita Foundation; National University of Singapore(National University of Singapore); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants MH051699, NS048478, DC009505, and DA019674 (to J. C.). This work was also supported by the Capita Foundation and the National University of Singapore (to D.R.H.).	Abrahan CE, 2010, INVEST OPHTH VIS SCI, V51, P1171, DOI 10.1167/iovs.09-3909; Addison WHF, 1921, AM J ANAT, V29, P1, DOI 10.1002/aja.1000290103; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Baudhuin LM, 2002, MOL PHARMACOL, V62, P660, DOI 10.1124/mol.62.3.660; Byun TH, 2011, ANAT REC, V294, P789, DOI 10.1002/ar.21366; Caballero S, 2009, EXP EYE RES, V88, P367, DOI 10.1016/j.exer.2008.07.012; Choi JW, 2008, BBA-MOL CELL BIOL L, V1781, P531, DOI 10.1016/j.bbalip.2008.03.004; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Copland DA, 2012, AM J PATHOL, V180, P672, DOI 10.1016/j.ajpath.2011.10.008; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Du X, 2004, GENETICS, V166, P331, DOI 10.1534/genetics.166.1.331; Esche M, 2010, NEUROSCI LETT, V480, P101, DOI 10.1016/j.neulet.2010.06.014; FINDLATER GS, 1993, J ANAT, V183, P121; French KJ, 2003, CANCER RES, V63, P5962; Groves A, 2013, J NEUROL SCI, V328, P9, DOI 10.1016/j.jns.2013.02.011; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Herr DR, 2007, J NEUROSCI, V27, P1474, DOI 10.1523/JNEUROSCI.4245-06.2007; Herr KJ, 2011, P NATL ACAD SCI USA, V108, P15444, DOI 10.1073/pnas.1106129108; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hsieh HL, 2008, J CELL BIOCHEM, V103, P1732, DOI 10.1002/jcb.21563; Huang J, 2009, DEVELOPMENT, V136, P1741, DOI 10.1242/dev.034082; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Jin C, 2008, INVEST OPHTH VIS SCI, V49, P4245, DOI 10.1167/iovs.08-1860; Johnstone ED, 2005, PLACENTA, V26, P548, DOI 10.1016/j.placenta.2004.08.012; Kamada K, 2009, PATHOL INT, V59, P382, DOI 10.1111/j.1440-1827.2009.02381.x; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Kurose S, 2000, EXP EYE RES, V70, P7, DOI 10.1006/exer.1999.0777; Lepley D, 2005, CANCER RES, V65, P3788, DOI 10.1158/0008-5472.CAN-04-2311; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; MacLennan AJ, 2001, EUR J NEUROSCI, V14, P203, DOI 10.1046/j.0953-816x.2001.01634.x; Maines LW, 2006, INVEST OPHTH VIS SCI, V47, P5022, DOI 10.1167/iovs.05-1236; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McGuire PG, 2011, ARTERIOSCL THROM VAS, V31, pE107, DOI 10.1161/ATVBAHA.111.235408; Mine N, 2005, DEVELOPMENT, V132, P4317, DOI 10.1242/dev.02030; Mutoh T, 2012, BRIT J PHARMACOL, V165, P829, DOI 10.1111/j.1476-5381.2011.01622.x; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Raveney BJE, 2008, ARCH OPHTHALMOL-CHIC, V126, P1390, DOI 10.1001/archopht.126.10.1390; Rotstein NP, 2010, J LIPID RES, V51, P1247, DOI 10.1194/jlr.R003442; Salomone S, 2003, EUR J PHARMACOL, V469, P125, DOI 10.1016/S0014-2999(03)01731-X; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Sukocheva O, 2009, ENDOCRINOLOGY, V150, P4484, DOI 10.1210/en.2009-0391; Sumida GM, 2011, AM J PHYSIOL-CELL PH, V300, pC1164, DOI 10.1152/ajpcell.00437.2010; Takatori A, 2008, DEVELOPMENT, V135, P23, DOI 10.1242/dev.007120; Tao H, 2005, DEVELOPMENT, V132, P3217, DOI 10.1242/dev.01892; Tateossian Hilda, 2009, Pathogenetics, V2, P5, DOI 10.1186/1755-8417-2-5; Usui S, 2004, J BIOL CHEM, V279, P12300, DOI 10.1074/jbc.M305025200; Wang ZL, 2010, FEBS LETT, V584, P4057, DOI 10.1016/j.febslet.2010.08.028; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Xia Y, 2004, BIOCHEM PHARMACOL, V68, P997, DOI 10.1016/j.bcp.2004.05.028; Xie B, 2009, J CELL PHYSIOL, V218, P192, DOI 10.1002/jcp.21588; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhang L, 2003, MOL VIS, V9, P584; Zhang L, 2005, MOL CELL BIOL, V25, P60, DOI 10.1128/MCB.25.1.60-65.2005; Zhu DH, 2010, VISION RES, V50, P643, DOI 10.1016/j.visres.2009.09.002	64	20	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29882	29889		10.1074/jbc.M113.510099	http://dx.doi.org/10.1074/jbc.M113.510099			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003216	hybrid, Green Published			2022-12-28	WOS:000330615300061
J	Rhee, Y; Lee, EY; Lezcano, V; Ronda, AC; Condon, KW; Allen, MR; Plotkin, LI; Bellido, T				Rhee, Yumie; Lee, Eun-Young; Lezcano, Virginia; Ronda, Ana C.; Condon, Keith W.; Allen, Matthew R.; Plotkin, Lilian I.; Bellido, Teresita			Resorption Controls Bone Anabolism Driven by Parathyroid Hormone (PTH) Receptor Signaling in Osteocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTH/PTHRP RECEPTOR; INTERMITTENT PTH; MICE; SCLEROSTIN; OSTEOBLASTS; EXPRESSION; CELLS; GENE; DIFFERENTIATION; BISPHOSPHONATE	The contribution of remodeling-based bone formation coupled to osteoclast activity versus modeling-based bone formation that occurs independently of resorption, to the anabolic effect of PTH remains unclear. We addressed this question using transgenic mice with activated PTH receptor signaling in osteocytes that exhibit increased bone mass and remodeling, recognized skeletal effects of PTH elevation. Direct inhibition of bone formation was accomplished genetically by overexpressing the Wnt antagonist Sost/sclerostin; and resorption-dependent bone formation was inhibited pharmacologically with the bisphosphonate alendronate. We found that bone formation induced by osteocytic PTH receptor signaling on the periosteal surface depends on Wnt signaling but not on resorption. In contrast, bone formation on the endocortical surface results from a combination of Wnt-driven increased osteoblast number and resorption-dependent osteoblast activity. Moreover, elevated osteoclasts and intracortical/calvarial porosity is exacerbated by overexpressing Sost and reversed by blocking resorption. Furthermore, increased cancellous bone is abolished by Wnt inhibition but further increased by blocking resorption. Thus, resorption induced by PTH receptor signaling in osteocytes is critical for full anabolism in cortical bone, but tempers bone gain in cancellous bone. Dissecting underlying mechanisms of PTH receptor signaling would allow targeting actions in different bone compartments, enhancing the therapeutic potential of the pathway.	[Rhee, Yumie; Lee, Eun-Young; Lezcano, Virginia; Ronda, Ana C.; Condon, Keith W.; Allen, Matthew R.; Plotkin, Lilian I.; Bellido, Teresita] Indiana Univ Sch Med, Dept Anat & Cell Biol, Div Endocrinol, Indianapolis, IN 46202 USA; [Bellido, Teresita] Indiana Univ Sch Med, Dept Med, Div Endocrinol, Indianapolis, IN 46202 USA; [Bellido, Teresita] Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Bellido, T (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,MS5035, Indianapolis, IN 46202 USA.	tbellido@iupui.edu	Rhee, Yumie/L-8020-2019; Plotkin, Lilian/H-7188-2019	Rhee, Yumie/0000-0003-4227-5638; Plotkin, Lilian/0000-0002-9537-4544; Ronda, Ana Carolina/0000-0001-9411-8306	National Institutes of Health [R01AR059357, R01DK076007]; Dept. of Veterans Affairs (VA Merit Award); Yonsei University College of Medicine [620110126]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Veterans Affairs (VA Merit Award)(US Department of Veterans Affairs); Yonsei University College of Medicine(General Electric); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by Grants R01AR059357 and R01DK076007 (to T. B.) from the National Institutes of Health and the Dept. of Veterans Affairs (VA Merit Award).; Recipient of a faculty research grant from Yonsei University College of Medicine (No. 620110126). Current address: Dept. of Internal Medicine, College of Medicine, Yonsei University, Seoul, Korea.	Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bellido T, 2013, BONE, V54, P250, DOI 10.1016/j.bone.2012.09.016; Bivi N, 2013, J ORTHOP RES, V31, P1075, DOI 10.1002/jor.22341; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Calvi LM, 2004, MECH DEVELOP, V121, P397, DOI 10.1016/j.mod.2004.02.004; Cheung MS, 2009, J BONE MINER RES, V24, P669, DOI [10.1359/jbmr.081225, 10.1359/JBMR.081225]; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Jilka RL, 2009, BONE, V44, P275, DOI 10.1016/j.bone.2008.10.037; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Li CJ, 2013, J BONE MINER RES, V28, P2094, DOI 10.1002/jbmr.1962; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Martin RB, 1998, SKELETAL TISSUE MECH; Nakanishi R, 2006, J BONE MINER RES, V21, P1713, DOI 10.1359/JBMR.060719; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Parfitt AM, 2002, J BONE MINER RES, V17, P1741, DOI 10.1359/jbmr.2002.17.10.1741; Plotkin LI, 2011, BONE, V49, P122, DOI 10.1016/j.bone.2010.08.011; Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308; Rhee Y, 2011, BONE, V49, P636, DOI 10.1016/j.bone.2011.06.025; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Signorelli S, 2010, CELL PHYSIOL BIOCHEM, V25, P135, DOI 10.1159/000272066; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Weinstein RS, 2009, NEW ENGL J MED, V360, P53, DOI 10.1056/NEJMoa0802633; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yang MB, 2010, BONE, V47, P573, DOI 10.1016/j.bone.2010.06.002; Zanchetta JR, 2003, J BONE MINER RES, V18, P539, DOI 10.1359/jbmr.2003.18.3.539	34	34	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29809	29820		10.1074/jbc.M113.485938	http://dx.doi.org/10.1074/jbc.M113.485938			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23963454	Green Published, hybrid			2022-12-28	WOS:000330615300055
J	Ruzanski, C; Smirnova, J; Rejzek, M; Cockburn, D; Pedersen, HL; Pike, M; Willats, WGT; Svensson, B; Steup, M; Ebenhoh, O; Smith, AM; Field, RA				Ruzanski, Christian; Smirnova, Julia; Rejzek, Martin; Cockburn, Darrell; Pedersen, Henriette L.; Pike, Marilyn; Willats, William G. T.; Svensson, Birte; Steup, Martin; Ebenhoeh, Oliver; Smith, Alison M.; Field, Robert A.			A Bacterial Glucanotransferase Can Replace the Complex Maltose Metabolism Required for Starch to Sucrose Conversion in Leaves at Night	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Metabolism; Computer Modeling; Metabolic Regulation; Oligosaccharide; Plant Biochemistry; Glucanotransferase; Leaf Cell; Maltose Metabolism; Starch Degradation	CYTOSOLIC HETEROGLYCANS; DISPROPORTIONATING ENZYME; ESCHERICHIA-COLI; ARABIDOPSIS; PHOSPHORYLASE; AMYLOMALTASE; DEGRADATION; IDENTIFICATION; RELOCATION; EVOLUTION	Controlled conversion of leaf starch to sucrose at night is essential for the normal growth of Arabidopsis. The conversion involves the cytosolic metabolism of maltose to hexose phosphates via an unusual, multidomain protein with 4-glucanotransferase activity, DPE2, believed to transfer glucosyl moieties to a complex heteroglycan prior to their conversion to hexose phosphate via a cytosolic phosphorylase. The significance of this complex pathway is unclear; conversion of maltose to hexose phosphate in bacteria proceeds via a more typical 4-glucanotransferase that does not require a heteroglycan acceptor. It has recently been suggested that DPE2 generates a heterogeneous series of terminal glucan chains on the heteroglycan that acts as a glucosyl buffer to ensure a constant rate of sucrose synthesis in the leaf at night. Alternatively, DPE2 and/or the heteroglycan may have specific properties important for their function in the plant. To distinguish between these ideas, we compared the properties of DPE2 with those of the Escherichia coli glucanotransferase MalQ. We found that MalQ cannot use the plant heteroglycan as an acceptor for glucosyl transfer. However, experimental and modeling approaches suggested that it can potentially generate a glucosyl buffer between maltose and hexose phosphate because, unlike DPE2, it can generate polydisperse malto-oligosaccharides from maltose. Consistent with this suggestion, MalQ is capable of restoring an essentially wild-type phenotype when expressed in mutant Arabidopsis plants lacking DPE2. In light of these findings, we discuss the possible evolutionary origins of the complex DPE2-heteroglycan pathway.	[Ruzanski, Christian; Rejzek, Martin; Pike, Marilyn; Smith, Alison M.; Field, Robert A.] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Smirnova, Julia; Steup, Martin] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Cockburn, Darrell; Svensson, Birte] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Pedersen, Henriette L.; Willats, William G. T.] Univ Copenhagen, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg C, Denmark; [Ebenhoeh, Oliver] Univ Aberdeen, Inst Complex Syst & Math Biol, Aberdeen AB24 3UE, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Potsdam; Technical University of Denmark; University of Copenhagen; University of Aberdeen	Smith, AM (corresponding author), John Innes Ctr Plant Sci Res, Dept Metab Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	alison.smith@jic.ac.uk	Cockburn, Darrell/F-6172-2011; Ebenhoeh, Oliver/C-8974-2011	Cockburn, Darrell/0000-0001-6791-6599; Ebenhoeh, Oliver/0000-0002-7229-7398; Willats, William/0000-0003-2064-4025; Svensson, Birte/0000-0002-2993-8196; Field, Rob/0000-0001-8574-0275	Biotechnology and Biological Sciences Research Council (UK) [BB/J004561/1]; John Innes Foundation; Deutsche Forschungsgemeinschaft [SFB 429]; instrument grant (Biacore T100); Danish Council for Independent Research, Natural Sciences; Danish Technical University; Danish Council for Independent Research, Technology and Production Sciences; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0618, BBS/E/J/00000020, BB/C507361/1] Funding Source: researchfish; BBSRC [BBS/E/J/000C0618] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); instrument grant (Biacore T100); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Danish Technical University; Danish Council for Independent Research, Technology and Production Sciences(Det Frie Forskningsrad (DFF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work at the John Innes Centre was supported by Biotechnology and Biological Sciences Research Council (UK) Grant BB/J004561/1 and by the John Innes Foundation.; Supported by the Deutsche Forschungsgemeinschaft (SFB 429 Molecular Physiology, Energetics and Regulation of Primary Plant Metabolism, TPB2).; Supported by an instrument grant (Biacore T100) and a research grant from the Danish Council for Independent Research, Natural Sciences.; Recipient of an H. C. Orsted postdoctoral fellowship from Danish Technical University.; Supported by a research grant from the Danish Council for Independent Research, Technology and Production Sciences.	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Arias Maria Cecilia, 2012, Mob Genet Elements, V2, P81; Ball S, 2011, J EXP BOT, V62, P1775, DOI 10.1093/jxb/erq411; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cheng HY, 1999, MOL CELL BIOL, V19, P8335; Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Ciucanu I, 2006, ANAL CHIM ACTA, V576, P147, DOI 10.1016/j.aca.2006.06.009; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Deschamps P, 2008, TRENDS PLANT SCI, V13, P574, DOI 10.1016/j.tplants.2008.08.009; Deschamps P, 2008, MOL BIOL EVOL, V25, P536, DOI 10.1093/molbev/msm280; Deschamps P, 2008, GENETICS, V178, P2373, DOI 10.1534/genetics.108.087205; Dippel R, 2005, J BACTERIOL, V187, P8322, DOI 10.1128/JB.187.24.8322-8331.2005; Fettke J, 2006, PLANT J, V46, P668, DOI 10.1111/j.1365-313X.2006.02732.x; Fettke J, 2005, PLANT CELL PHYSIOL, V46, P1987, DOI 10.1093/pcp/pci214; Fettke J, 2005, PLANT J, V43, P568, DOI 10.1111/j.1365-313X.2005.02475.x; Fettke J, 2004, PLANT J, V39, P933, DOI 10.1111/j.1365-313X.2004.02181.x; Fettke J, 2008, PLANT PHYSIOL, V148, P1614, DOI 10.1104/pp.108.127969; Fettke J, 2009, J EXP BOT, V60, P2907, DOI 10.1093/jxb/erp054; Fettke J, 2009, PHYTOCHEMISTRY, V70, P696, DOI 10.1016/j.phytochem.2009.03.016; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Kartal O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.76; Lengsfeld C, 2009, J BACTERIOL, V191, P701, DOI 10.1128/JB.00767-08; Lloyd JR, 2004, PLANT PHYSIOL, V134, P1347, DOI 10.1104/pp.103.038026; Lu Y, 2004, PLANTA, V218, P466, DOI 10.1007/s00425-003-1127-z; Lu Y, 2006, PLANT PHYSIOL, V142, P878, DOI 10.1104/pp.106.086850; Malinova I, 2011, PLANT SIGNAL BEHAV, V6, P1060, DOI 10.4161/psb.6.7.15629; Malinova I, 2011, J PLANT PHYSIOL, V168, P1406, DOI 10.1016/j.jplph.2010.12.008; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Moller I, 2007, PLANT J, V50, P1118, DOI 10.1111/j.1365-313X.2007.03114.x; Oxley D., 2006, COLD SPRING HARB PRO, DOI 10.1101/pdb.prot4249; PALMER TN, 1976, EUR J BIOCHEM, V69, P105, DOI 10.1111/j.1432-1033.1976.tb10863.x; Park JT, 2011, J BACTERIOL, V193, P2517, DOI 10.1128/JB.01238-10; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Schupp N, 2004, PLANT CELL PHYSIOL, V45, P1471, DOI 10.1093/pcp/pch170; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Smith AM, 2012, STARCH-STARKE, V64, P421, DOI 10.1002/star.201100163; Sorensen I, 2011, METHODS MOL BIOL, V715, P115, DOI 10.1007/978-1-61779-008-9_8; Sorensen I, 2009, CARBOHYD RES, V344, P1872, DOI 10.1016/j.carres.2008.12.008; Steichen JM, 2008, J BIOL CHEM, V283, P20797, DOI 10.1074/jbc.M803051200; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	42	26	26	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28581	28598		10.1074/jbc.M113.497867	http://dx.doi.org/10.1074/jbc.M113.497867			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23950181	Green Published, hybrid			2022-12-28	WOS:000330298800015
J	Hajrasouliha, AR; Jiang, GM; Lu, QX; Lu, HY; Kaplan, HJ; Zhang, HG; Shao, H				Hajrasouliha, Amir Reza; Jiang, Guomin; Lu, Qingxian; Lu, Huayi; Kaplan, Henry J.; Zhang, Huang-Ge; Shao, Hui			Exosomes from Retinal Astrocytes Contain Antiangiogenic Components That Inhibit Laser-induced Choroidal Neovascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACULAR DEGENERATION; COMPLEMENT ACTIVATION; T-CELLS; ANGIOGENESIS; PROTEINS; IMMUNOTHERAPY; PEPTIDE; GROWTH; MODEL; MICE	Exosomes released from different types of host cells have different biological effects. We report that exosomes released from retinal astroglial cells (RACs) suppress retinal vessel leakage and inhibit choroidal neovascularization (CNV) in a laser-induced CNV model, whereas exosomes released from retinal pigmental epithelium do not. RAC exosomes inhibit the migration of macrophages and the tubule forming of mouse retinal microvascular endothelial cells. Further, we analyzed antiangiogenic components in RAC exosomes using an angiogenesis array kit and detected several endogenous inhibitors of angiogenesis exclusively present in RAC exosomes, such as endostatin. Moreover, blockade of matrix metalloproteinases in the cleavage of collagen XVIII to form endostatin using FN-439 reverses RAC exosome-mediated retinal vessel leakage. This study demonstrates that exosomes released from retinal tissue cells have different angiogenic effects, with exosomes from RACs containing antiangiogenic components that might protect the eye from angiogenesis and maintain its functional integrity. In addition, by identifying additional components and their functions of RAC exosomes, we might improve the antiangiogenic therapy for CNV in age-related macular degeneration and diabetic retinopathy.	[Hajrasouliha, Amir Reza; Jiang, Guomin; Lu, Qingxian; Lu, Huayi; Kaplan, Henry J.; Shao, Hui] Univ Louisville, Dept Ophthalmol & Visual Sci, Kentucky Lions Eye Ctr, Louisville, KY 40202 USA; [Zhang, Huang-Ge] Univ Louisville, Dept Res & Dev, Robley Rex Med Ctr, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Shao, H (corresponding author), Univ Louisville, Dept Ophthalmol & Vis Sci, Kentucky Lions Eye Ctr, 301 E Muhammad Ali Blvd, Louisville, KY 40202 USA.	h0shao01@louisville.edu			Research to Prevent Blindness Lew R. Wasserman merit award; Research to Prevent Blindness, New York; Commonwealth of Kentucky Research Challenge Trust Fund	Research to Prevent Blindness Lew R. Wasserman merit award(Research to Prevent Blindness (RPB)); Research to Prevent Blindness, New York(Research to Prevent Blindness (RPB)); Commonwealth of Kentucky Research Challenge Trust Fund	This work was supported in part by a Research to Prevent Blindness Lew R. Wasserman merit award (to H. S.), an unrestricted grant from Research to Prevent Blindness (to H.J.K.), New York, and the Commonwealth of Kentucky Research Challenge Trust Fund (to H.J.K.).	Bora PS, 2003, P NATL ACAD SCI USA, V100, P2679, DOI 10.1073/pnas.0438014100; Bussolati B, 2011, FASEB J, V25, P2874, DOI 10.1096/fj.10-180323; Cao XG, 2011, PATHOL INT, V61, P528, DOI 10.1111/j.1440-1827.2011.02695.x; Martinez MC, 2006, BLOOD, V108, P3012, DOI 10.1182/blood-2006-04-019109; Chan CC, 2008, OPHTHALMIC RES, V40, P124, DOI 10.1159/000119862; Cho YE, 2009, INVEST OPHTH VIS SCI, V50, P5614, DOI 10.1167/iovs.09-3688; Couch SM, 2011, SEMIN OPHTHALMOL, V26, P114, DOI 10.3109/08820538.2011.577130; Courrier HM, 2002, CRIT REV THER DRUG, V19, P425, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.40; Delcayre A, 2006, CURR OPIN MOL THER, V8, P31; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ethen CM, 2007, INVEST OPHTH VIS SCI, V48, P3469, DOI 10.1167/iovs.06-1058; Fujimoto T, 2010, INVEST OPHTH VIS SCI, V51, P4694, DOI 10.1167/iovs.09-4464; Hao SG, 2007, CANCER BIOTHER RADIO, V22, P692, DOI 10.1089/cbr.2007.368-R; Huber M, 2012, OPHTHALMOLOGICA, V228, P188, DOI 10.1159/000339952; Jiang GM, 2008, INVEST OPHTH VIS SCI, V49, P282, DOI 10.1167/iovs.07-0371; Jiang GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040510; Jiang GM, 2009, INVEST OPHTH VIS SCI, V50, P4769, DOI 10.1167/iovs.08-3303; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; JOHNSON MD, 1994, J CELL PHYSIOL, V160, P194, DOI 10.1002/jcp.1041600122; Lavalette S, 2011, AM J PATHOL, V178, P2416, DOI 10.1016/j.ajpath.2011.01.013; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; Liao TJ, 2006, INVEST OPHTH VIS SCI, V47, P1543, DOI 10.1167/iovs.05-1238; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015; Lorentzen E, 2006, CELL, V125, P651, DOI 10.1016/j.cell.2006.05.002; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Marneros AG, 2007, FASEB J, V21, P3809, DOI 10.1096/fj.07-8422com; Martinez MC, 2011, CIRC RES, V109, P110, DOI 10.1161/CIRCRESAHA.110.233049; Mirochnik Y, 2009, CLIN CANCER RES, V15, P1655, DOI 10.1158/1078-0432.CCR-08-2113; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Totan Y, 2009, CURR EYE RES, V34, P1089, DOI 10.3109/02713680903353772; Wang Y, 2011, EYE, V25, P127, DOI 10.1038/eye.2010.196; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Zhang HG, 2011, CLIN CANCER RES, V17, P959, DOI 10.1158/1078-0432.CCR-10-1489; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164	44	86	92	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28058	28067		10.1074/jbc.M113.470765	http://dx.doi.org/10.1074/jbc.M113.470765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23926109	hybrid, Green Published			2022-12-28	WOS:000330612800031
J	Johnson, BJ; Yukl, ET; Klema, VJ; Klinman, JP; Wilmot, CM				Johnson, Bryan J.; Yukl, Erik T.; Klema, Valerie J.; Klinman, Judith P.; Wilmot, Carrie M.			Structural Snapshots from the Oxidative Half-reaction of a Copper Amine Oxidase IMPLICATIONS FOR O-2 ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ELECTRON-TRANSFER; ACTIVE-SITE COPPER; TOPA QUINONE; HANSENULA-POLYMORPHA; MOLECULAR-OXYGEN; SUBSTRATE-SPECIFICITY; CATALYTIC MECHANISM; GALACTOSE-OXIDASE; CRYSTAL-STRUCTURE; DIOXYGEN	The mechanism of molecular oxygen activation is the subject of controversy in the copper amine oxidase family. At their active sites, copper amine oxidases contain both a mononuclear copper ion and a protein-derived quinone cofactor. Proposals have been made for the activation of molecular oxygen via both a Cu(II)-aminoquinol catalytic intermediate and a Cu(I)-semiquinone intermediate. Using protein crystallographic freeze-trapping methods under low oxygen conditions combined with single-crystal microspectrophotometry, we have determined structures corresponding to the iminoquinone and semiquinone forms of the enzyme. Methylamine reduction at acidic or neutral pH has revealed protonated and deprotonated forms of the iminoquinone that are accompanied by a bound oxygen species that is likely hydrogen peroxide. However, methylamine reduction at pH 8.5 has revealed a copper-ligated cofactor proposed to be the semiquinone form. A copper-ligated orientation, be it the sole identity of the semiquinone or not, blocks the oxygen-binding site, suggesting that accessibility of Cu(I) may be the basis of partitioning O-2 activation between the aminoquinol and Cu(I).	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wilmot, CM (corresponding author), Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	wilmo004@umn.edu		Yukl, Erik/0000-0001-6519-6938; Wilmot, Carrie/0000-0002-8706-0000	National Institutes of Health [GM008700, GM66569, GM25765]; Minnesota Medical Foundation [3714-9221-06]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025765, T32GM008700, R01GM066569, R37GM025765, R01GM039296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Medical Foundation; United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Training Grant GM008700 (to B. J. J.) and Grants GM66569 (to C. M. W.) and GM25765 (to J. P. K.). This work was also supported by Minnesota Medical Foundation Grant 3714-9221-06 (to C. M. W.). Final X-ray diffraction data were collected at the Structural Biology Center of the Advanced Photon Source at Argonne National Laboratory. Argonne National Laboratory is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357. Computer resources were provided by the Basic Sciences Computing Laboratory of the Minnesota Supercomputing Institute.	Airenne TT, 2005, PROTEIN SCI, V14, P1964, DOI 10.1110/ps.051438105; Bellelli A, 2000, EUR J BIOCHEM, V267, P3264, DOI 10.1046/j.1432-1327.2000.01351.x; CAI DY, 1994, BIOCHEMISTRY-US, V33, P7647, DOI 10.1021/bi00190a019; Chang CM, 2010, BIOCHEMISTRY-US, V49, P2540, DOI 10.1021/bi901933d; Dooley DM, 1996, J BIOL INORG CHEM, V1, P205, DOI 10.1007/s007750050044; Dooley DM, 1998, J AM CHEM SOC, V120, P2599, DOI 10.1021/ja970312a; DOOLEY DM, 1991, NATURE, V349, P262, DOI 10.1038/349262a0; Dooley DM, 1999, J BIOL INORG CHEM, V4, P1, DOI 10.1007/s007750050283; Dove JE, 2001, ADV PROTEIN CHEM, V58, P141; DRUMMOND JT, 1994, BIOCHEMISTRY-US, V33, P3732, DOI 10.1021/bi00178a033; DuBois JL, 2004, METHOD ENZYMOL, V378, P17; Duff AP, 2003, BIOCHEMISTRY-US, V42, P15148, DOI 10.1021/bi035338v; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goto Y, 2002, BIOCHEMISTRY-US, V41, P13637, DOI 10.1021/bi0204591; HADFIELD A, 1993, J APPL CRYSTALLOGR, V26, P839, DOI 10.1107/S0021889893005552; Hirota S, 2001, BIOCHEMISTRY-US, V40, P15789, DOI 10.1021/bi011631o; Humphreys KJ, 2009, J AM CHEM SOC, V131, P4657, DOI 10.1021/ja807963e; Jazdzewski BA, 2003, J BIOL INORG CHEM, V8, P381, DOI 10.1007/s00775-002-0420-9; Johnson BJ, 2007, J BIOL CHEM, V282, P17767, DOI 10.1074/jbc.M701308200; Kishishita S, 2003, J AM CHEM SOC, V125, P1041, DOI 10.1021/ja017899k; Klema VJ, 2013, BIOCHEMISTRY-US, V52, P2291, DOI 10.1021/bi3016845; Klinman JP, 1996, CHEM REV, V96, P2541, DOI 10.1021/cr950047g; Lewis EA, 2004, CHEM REV, V104, P1047, DOI 10.1021/cr020633r; Liu Y, 2013, J PHYS CHEM B, V117, P218, DOI 10.1021/jp3121484; Medda R, 1999, FEBS LETT, V453, P1, DOI 10.1016/S0014-5793(99)00675-4; Mills SA, 2000, J AM CHEM SOC, V122, P9897, DOI 10.1021/ja000325f; Mills SA, 2002, BIOCHEMISTRY-US, V41, P10577, DOI 10.1021/bi0200864; Mills SA, 2012, J BIOL INORG CHEM, V17, P507, DOI 10.1007/s00775-011-0872-x; Mukherjee A, 2008, J AM CHEM SOC, V130, P9459, DOI 10.1021/ja801378f; Mure M, 2002, BIOCHEMISTRY-US, V41, P9269, DOI 10.1021/bi020246b; MURE M, 1995, METHOD ENZYMOL, V258, P39; MURE M, 1993, J AM CHEM SOC, V115, P7117, DOI 10.1021/ja00069a008; MURE M, 1995, J AM CHEM SOC, V117, P8707, DOI 10.1021/ja00139a003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padiglia A, 2001, EUR J BIOCHEM, V268, P4686, DOI 10.1046/j.1432-1327.2001.02390.x; Padiglia A, 2001, EUR J INORG CHEM, P35; Pearson AR, 2003, BBA-PROTEINS PROTEOM, V1647, P381, DOI 10.1016/S1570-9639(03)00099-2; Pietrangeli P, 2003, BBA-PROTEINS PROTEOM, V1647, P152, DOI 10.1016/S1570-9639(03)00083-9; Plastino J, 1999, BIOCHEMISTRY-US, V38, P8204, DOI 10.1021/bi9826660; Schwartz B, 2001, BIOCHEMISTRY-US, V40, P2954, DOI 10.1021/bi0021378; Shepard EM, 2006, J BIOL INORG CHEM, V11, P1039, DOI 10.1007/s00775-006-0153-2; Shepard EM, 2008, BIOCHEMISTRY-US, V47, P13907, DOI 10.1021/bi8011516; Smith MA, 2010, BIOCHEMISTRY-US, V49, P1268, DOI 10.1021/bi901738k; Su QJ, 1998, BIOCHEMISTRY-US, V37, P12513, DOI 10.1021/bi981103l; Takahashi K, 2006, BIOCHEMISTRY-US, V45, P4683, DOI 10.1021/bi0521893; TUROWSKI PN, 1993, J BIOL CHEM, V268, P17680; Welford RWD, 2007, BIOCHEMISTRY-US, V46, P10817, DOI 10.1021/bi700943r; Whittaker JW, 2005, ARCH BIOCHEM BIOPHYS, V433, P227, DOI 10.1016/j.abb.2004.08.034; Wilmot CM, 1999, SCIENCE, V286, P1724, DOI 10.1126/science.286.5445.1724; Wilmot CM, 2002, METHOD ENZYMOL, V353, P301; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	52	15	15	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28409	28417		10.1074/jbc.M113.501791	http://dx.doi.org/10.1074/jbc.M113.501791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940035	hybrid, Green Published			2022-12-28	WOS:000330612800068
J	Zhou, J; Liu, MM; Fleming, AM; Burrows, CJ; Wallace, SS				Zhou, Jia; Liu, Minmin; Fleming, Aaron M.; Burrows, Cynthia J.; Wallace, Susan S.			Neil3 and NEIL1 DNA Glycosylases Remove Oxidative Damages from Quadruplex DNA and Exhibit Preferences for Lesions in the Telomeric Sequence Context	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; ELECTRON-TRANSFER; CHARGE-TRANSPORT; MOUSE ORTHOLOG; OXIDIZED BASES; GGG SEQUENCE; IN-VITRO; 8-OXOGUANINE; EXPRESSION; GUANINE	The telomeric DNA of vertebrates consists of d(TTAGGG)(n) tandem repeats, which can form quadruplex DNA structures in vitro and likely in vivo. Despite the fact that the G-rich telomeric DNA is susceptible to oxidation, few biochemical studies of base excision repair in telomeric DNA and quadruplex structures have been done. Here, we show that telomeric DNA containing thymine glycol (Tg), 8-oxo-7,8-dihydroguanine (8-oxoG), guanidinohydantoin (Gh), or spiroiminodihydantoin (Sp) can form quadruplex DNA structures in vitro. We have tested the base excision activities of five mammalian DNA glycosylases (NEIL1, NEIL2, mNeil3, NTH1, and OGG1) on these lesion-containing quadruplex substrates and found that only mNeil3 had excision activity on Tg in quadruplex DNA and that the glycosylase exhibited a strong preference for Tg in the telomeric sequence context. Although Sp and Gh in quadruplex DNA were good substrates for mNeil3 and NEIL1, none of the glycosylases had activity on quadruplex DNA containing 8-oxoG. In addition, NEIL1 but not mNeil3 showed enhanced glycosylase activity on Gh in the telomeric sequence context. These data suggest that one role for Neil3 and NEIL1 is to repair DNA base damages in telomeres in vivo and that Neil3 and Neil1 may function in quadruplex-mediated cellular events, such as gene regulation via removal of damaged bases from quadruplex DNA.	[Zhou, Jia; Liu, Minmin; Wallace, Susan S.] Univ Vermont, Markey Ctr Mol Genet, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Fleming, Aaron M.; Burrows, Cynthia J.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	University of Vermont; Utah System of Higher Education; University of Utah	Wallace, SS (corresponding author), Univ Vermont, Markey Ctr Mol Genet, Dept Microbiol & Mol Genet, Stafford Hall,95 Carrigan Dr, Burlington, VT 05405 USA.	susan.wallace@uvm.edu	Liu, Minmin/B-9056-2018; Zhou, Jia/C-5940-2017	Liu, Minmin/0000-0002-7405-8972; Zhou, Jia/0000-0002-2156-0483; Wallace, Susan S./0000-0002-3906-0321	National Institutes of Health from the NCI [P01 CA 098993, CA 090689]; NATIONAL CANCER INSTITUTE [R01CA090689, P01CA098993] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants P01 CA 098993 (to S. S. W.) and CA 090689 (to C. J. B.) from the NCI.	Aller P, 2007, P NATL ACAD SCI USA, V104, P814, DOI 10.1073/pnas.0606648104; Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bandaru V, 2006, METHOD ENZYMOL, V408, P15, DOI 10.1016/S0076-6879(06)08002-5; Berg J.M., 2007, BIOCHEMISTRY-US, V6th ed.; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Blaisdell JO, 2007, NUCLEIC ACIDS RES, V35, P1601, DOI 10.1093/nar/gkm021; CHENG KC, 1992, J BIOL CHEM, V267, P166; Clark DW, 2012, FREE RADICAL BIO MED, V53, P51, DOI 10.1016/j.freeradbiomed.2012.04.024; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Duarte V, 1999, NUCLEIC ACIDS RES, V27, P496, DOI 10.1093/nar/27.2.496; Duclos S, 2012, ISSUES TOXICOL, V13, P115, DOI 10.1039/9781849732925-00115; Fleming AM, 2013, CHEM RES TOXICOL, V26, P593, DOI 10.1021/tx400028y; Genereux JC, 2010, J AM CHEM SOC, V132, P891, DOI 10.1021/ja907669c; Gillespie MN, 2010, RESP PHYSIOL NEUROBI, V174, P244, DOI 10.1016/j.resp.2010.08.025; Guo Y, 2010, DNA REPAIR, V9, P177, DOI 10.1016/j.dnarep.2009.11.008; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hailer MK, 2005, DNA REPAIR, V4, P41, DOI 10.1016/j.dnarep.2004.07.006; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2001, NUCLEIC ACIDS RES, V29, P1967, DOI 10.1093/nar/29.9.1967; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Henderson PT, 2003, BIOCHEMISTRY-US, V42, P9257, DOI 10.1021/bi0347252; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; IDE H, 1985, NUCLEIC ACIDS RES, V13, P8035, DOI 10.1093/nar/13.22.8035; Katafuchi A, 2004, J BIOL CHEM, V279, P14464, DOI 10.1074/jbc.M400393200; Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578; Krishnamurthy N, 2008, BIOCHEMISTRY-US, V47, P7137, DOI 10.1021/bi800160s; Li W, 2002, FEBS LETT, V526, P77, DOI 10.1016/S0014-5793(02)03118-6; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Liu MM, 2013, MUTAT RES-FUND MOL M, V743, P4, DOI 10.1016/j.mrfmmm.2012.12.003; Liu MM, 2013, STRUCTURE, V21, P247, DOI 10.1016/j.str.2012.12.008; Liu MM, 2012, PROTEIN EXPRES PURIF, V84, P130, DOI 10.1016/j.pep.2012.04.022; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Merino EJ, 2008, CURR OPIN CHEM BIOL, V12, P229, DOI 10.1016/j.cbpa.2008.01.046; Miller H, 2004, NUCLEIC ACIDS RES, V32, P338, DOI 10.1093/nar/gkh190; Neidle S, 2002, NAT REV DRUG DISCOV, V1, P383, DOI 10.1038/nrd793; Neurauter CG, 2012, DNA REPAIR, V11, P401, DOI 10.1016/j.dnarep.2012.01.007; O'Callaghan N, 2011, BIOTECHNIQUES, V51, P403, DOI 10.2144/000113788; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Oikawa S, 2001, BIOCHEMISTRY-US, V40, P4763, DOI 10.1021/bi002721g; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Prakash A, 2012, PROG MOL BIOL TRANSL, V110, P71, DOI 10.1016/B978-0-12-387665-2.00004-3; Rhee DB, 2011, DNA REPAIR, V10, P34, DOI 10.1016/j.dnarep.2010.09.008; Robey-Bond SM, 2008, BIOCHEMISTRY-US, V47, P7626, DOI 10.1021/bi800162e; SAITO I, 1995, J AM CHEM SOC, V117, P6406, DOI 10.1021/ja00128a050; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Sugiyama H, 1996, J AM CHEM SOC, V118, P7063, DOI 10.1021/ja9609821; Szalai VA, 2002, J AM CHEM SOC, V124, P1625, DOI 10.1021/ja0119651; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Vorlickova M, 2012, FEBS J, V279, P29, DOI 10.1111/j.1742-4658.2011.08396.x; Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4; Wallace SS, 2003, DNA REPAIR, V2, P441, DOI 10.1016/S1568-7864(02)00182-9; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Yang QF, 2009, CHEM COMMUN, P1103, DOI 10.1039/b820101c	64	86	86	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27263	27272		10.1074/jbc.M113.479055	http://dx.doi.org/10.1074/jbc.M113.479055			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23926102	hybrid, Green Published			2022-12-28	WOS:000330597300023
J	Gilliland, CT; Salanga, CL; Kawamura, T; Trejo, J; Handel, TM				Gilliland, C. Taylor; Salanga, Catherina L.; Kawamura, Tetsuya; Trejo, JoAnn; Handel, Tracy M.			The Chemokine Receptor CCR1 Is Constitutively Active, Which Leads to G Protein-independent, beta-Arrestin-mediated Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Bioluminescence Resonance Energy Transfer (BRET); Cell Migration; Chemokines; G Protein-coupled Receptors (GPCR); CCR1; Constitutive Activity; Internalization	COUPLED RECEPTORS; DEPENDENT INTERNALIZATION; CONFORMATIONAL-CHANGES; ADENYLYL-CYCLASE; POINT MUTATION; ACTIVATION; AGONIST; ANTAGONIST; CXCR4; PHOSPHORYLATION	Activation of G protein-coupled receptors by their associated ligands has been extensively studied, and increasing structural information about the molecular mechanisms underlying ligand-dependent receptor activation is beginning to emerge with the recent expansion in GPCR crystal structures. However, some GPCRs are also able to adopt active conformations in the absence of agonist binding that result in the initiation of signal transduction and receptor down-modulation. In this report, we show that the CC-type chemokine receptor 1 (CCR1) exhibits significant constitutive activity leading to a variety of cellular responses. CCR1 expression is sufficient to induce inhibition of cAMP formation, increased F-actin content, and basal migration of human and murine leukocytes. The constitutive activity leads to basal phosphorylation of the receptor, recruitment of beta-arrestin-2, and subsequent receptor internalization. CCR1 concurrently engages G alpha(i) and beta-arrestin-2 in a multiprotein complex, which may be accommodated by homo-oligomerization or receptor clustering. The data suggest the presence of two functional states for CCR1; whereas receptor coupled to G alpha(i) functions as a canonical GPCR, albeit with high constitutive activity, the CCR1.beta-arrestin-2 complex is required for G protein-independent constitutive receptor internalization. The pertussis toxin-insensitive uptake of chemokine by the receptor suggests that the CCR1.beta-arrestin-2 complex may be related to a potential scavenging function of the receptor, which may be important for maintenance of chemokine gradients and receptor responsiveness in complex fields of chemokines during inflammation.	[Gilliland, C. Taylor; Salanga, Catherina L.; Kawamura, Tetsuya; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Trejo, JoAnn] Univ Calif San Diego, Dept Pharmacol, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Handel, TM (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr,MC0684, La Jolla, CA 92093 USA.	thandel@ucsd.edu		TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [U01 GM094612, R01 GM081763, R01 GM090689]; University of California, San Diego; NIGMS, National Institutes of Health [T32 GM007752]; NIGMS, National Institutes of Health, MARC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081763, R01GM090689, U01GM094612, T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego(University of California System); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS, National Institutes of Health, MARC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U01 GM094612 and R01 GM081763 (to T. M. H.) and R01 GM090689 (to J. T.).; Supported in part by the University of California, San Diego, Graduate Training Program in Cellular and Molecular Pharmacology through an institutional training grant from NIGMS, National Institutes of Health, Grant T32 GM007752.; Supported by an NIGMS, National Institutes of Health, MARC Predoctoral F31 fellowship.	Allen SJ, 2011, CYTOKINE, V55, P168, DOI 10.1016/j.cyto.2011.05.002; Allen SJ, 2009, PROTEIN EXPRES PURIF, V66, P73, DOI 10.1016/j.pep.2009.03.001; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Arai H, 1997, P NATL ACAD SCI USA, V94, P14495, DOI 10.1073/pnas.94.26.14495; Arias DA, 2003, J BIOL CHEM, V278, P36513, DOI 10.1074/jbc.M303739200; Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Benned-Jensen T, 2010, BRIT J PHARMACOL, V159, P1092, DOI 10.1111/j.1476-5381.2009.00633.x; Benned-Jensen T, 2008, MOL PHARMACOL, V74, P1008, DOI 10.1124/mol.108.049676; Bennett LD, 2011, IMMUNOLOGY, V134, P246, DOI 10.1111/j.1365-2567.2011.03485.x; Borroni EM, 2013, METHOD ENZYMOL, V521, P151, DOI 10.1016/B978-0-12-391862-8.00008-9; Borroni EM, 2013, SCI SIGNAL, V6, pS1; Bouschet T, 2007, J CELL SCI, V120, P2489, DOI 10.1242/jcs.03469; Burger M, 1999, J IMMUNOL, V163, P2017; Cancellieri C, 2013, MOL IMMUNOL, V55, P87, DOI 10.1016/j.molimm.2012.08.003; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Chou CC, 2002, BRIT J PHARMACOL, V137, P663, DOI 10.1038/sj.bjp.0704907; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; de Ligt RAF, 2000, BRIT J PHARMACOL, V130, P1, DOI 10.1038/sj.bjp.0703311; DECAILLOT FM, 2011, J BIOL CHEM; El Far O, 2002, BIOCHEM J, V365, P329, DOI 10.1042/BJ20020481; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Flower DR, 1999, BBA-REV BIOMEMBRANES, V1422, P207, DOI 10.1016/S0304-4157(99)00006-4; Franci C, 1996, J IMMUNOL, V157, P5606; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Gao W, 2000, J CLIN INVEST, V105, P35, DOI 10.1172/JCI8126; Gladue RP, 2010, CURR TOP MED CHEM, V10, P1268; Godessart N, 2001, CURR OPIN IMMUNOL, V13, P670, DOI 10.1016/S0952-7915(01)00277-1; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hall DA, 1999, BRIT J PHARMACOL, V126, P810, DOI 10.1038/sj.bjp.0702329; Halls ML, 2012, BRIT J PHARMACOL, V165, P1644, DOI 10.1111/j.1476-5381.2011.01470.x; Halls ML, 2010, EMBO J, V29, P2772, DOI 10.1038/emboj.2010.168; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Hamdan Fadi F, 2006, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0523s34; Horuk R, 2005, MINI-REV MED CHEM, V5, P791, DOI 10.2174/1389557054867057; Horuk R, 2001, IMMUNOL LETT, V76, P193, DOI 10.1016/S0165-2478(01)00172-9; Horuk R, 2001, J BIOL CHEM, V276, P4199, DOI 10.1074/jbc.M007457200; Hoshino A, 2010, J BIOL CHEM, V285, P28826, DOI 10.1074/jbc.M109.099424; Hvas J, 1997, SCAND J IMMUNOL, V46, P195, DOI 10.1046/j.1365-3083.1997.d01-100.x; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jensen PC, 2007, MOL PHARMACOL, V72, P327, DOI 10.1124/mol.106.035543; KARPUS WJ, 1995, J IMMUNOL, V155, P5003; Kenakin T, 2005, TRENDS PHARMACOL SCI, V26, P603, DOI 10.1016/j.tips.2005.10.007; Kim IS, 2004, BIOCHEM PHARMACOL, V68, P611, DOI 10.1016/j.bcp.2004.03.041; Kleemann P, 2008, N-S ARCH PHARMACOL, V378, P261, DOI 10.1007/s00210-008-0313-8; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Lebre MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021772; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Loetscher P, 2002, ARTHRITIS RES, V4, P233, DOI 10.1186/ar412; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Munoz LM, 2012, IMMUNOL LETT, V145, P23, DOI 10.1016/j.imlet.2012.04.012; Miller AL, 2006, J IMMUNOL, V176, P2562, DOI 10.4049/jimmunol.176.4.2562; Miller WE, 2003, J BIOL CHEM, V278, P21663, DOI 10.1074/jbc.M303219200; Min L, 2000, MOL ENDOCRINOL, V14, P1797, DOI 10.1210/me.14.11.1797; Ninichuk V, 2005, AM J NEPHROL, V25, P365, DOI 10.1159/000087185; Olbrich H, 1999, J LEUKOCYTE BIOL, V65, P281, DOI 10.1002/jlb.65.3.281; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; PEI G, 1994, P NATL ACAD SCI USA, V91, P2699, DOI 10.1073/pnas.91.7.2699; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Proudfoot A E, 2001, Curr Protoc Pharmacol, VChapter 12, DOI 10.1002/0471141755.ph1204s14; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rodriguez-Frade JM, 1999, P NATL ACAD SCI USA, V96, P3628, DOI 10.1073/pnas.96.7.3628; Rodriguez-Sosa M, 2003, IMMUNOL CELL BIOL, V81, P114, DOI 10.1046/j.0818-9641.2002.01132.x; Rondou P, 2010, CELL SIGNAL, V22, P900, DOI 10.1016/j.cellsig.2010.01.014; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Schneider EH, 2009, BIOCHEMISTRY-US, V48, P1424, DOI 10.1021/bi802050d; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Slack RJ, 2012, BRIT J PHARMACOL, V166, P1774, DOI 10.1111/j.1476-5381.2012.01901.x; Spooren A, 2010, CELL SIGNAL, V22, P600, DOI 10.1016/j.cellsig.2009.11.013; Springael JY, 2007, CELL SIGNAL, V19, P1446, DOI 10.1016/j.cellsig.2007.01.022; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Stephens B, 2013, PROG MOL BIOL TRANSL, V115, P375, DOI 10.1016/B978-0-12-394587-7.00009-9; SterneMarr R, 1995, VITAM HORM, V51, P193, DOI 10.1016/S0083-6729(08)61039-0; Tao YX, 2008, PHARMACOL THERAPEUT, V120, P129, DOI 10.1016/j.pharmthera.2008.07.005; Tenenbaum J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008383; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Tsou CL, 1998, J EXP MED, V188, P603, DOI 10.1084/jem.188.3.603; Vergunst CE, 2009, ARTHRITIS RHEUM-US, V60, P3572, DOI 10.1002/art.24978; Vielhauer V, 2004, KIDNEY INT, V66, P2264, DOI 10.1111/j.1523-1755.2004.66038.x; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Volpe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037208; Wan YT, 2002, EUR J PHARMACOL, V456, P1, DOI 10.1016/S0014-2999(02)02621-3; Wells TNC, 2006, TRENDS PHARMACOL SCI, V27, P41, DOI 10.1016/j.tips.2005.11.001; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	95	50	50	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32194	32210		10.1074/jbc.M113.503797	http://dx.doi.org/10.1074/jbc.M113.503797			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24056371	hybrid, Green Published			2022-12-28	WOS:000328681700009
J	Hess, V; Schuchmann, K; Muller, V				Hess, Verena; Schuchmann, Kai; Mueller, Volker			The Ferredoxin: NAD(+) Oxidoreductase (Rnf) from the Acetogen Acetobacterium woodii Requires Na+ and Is Reversibly Coupled to the Membrane Potential	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP SYNTHASE; TRANSLOCATING ATPASE; SODIUM-IONS; IDENTIFICATION; METHYLTRANSFERASE; DECARBOXYLASE; DEHYDROGENASE; PURIFICATION; F1F0-ATPASE; COMPLEX	The anaerobic acetogenic bacterium Acetobacterium woodii has a novel Na+-translocating electron transport chain that couples electron transfer from reduced ferredoxin to NAD(+) with the generation of a primary electrochemical Na+ potential across its cytoplasmic membrane. In previous assays in which Ti3+ was used to reduce ferredoxin, Na+ transport was observed, but not a Na+ dependence of the electron transfer reaction. Here, we describe a new biological reduction system for ferredoxin in which ferredoxin is reduced with CO, catalyzed by the purified acetyl-CoA synthase/CO dehydrogenase from A. woodii. Using CO-reduced ferredoxin, NAD(+) reduction was highly specific and strictly dependent on ferredoxin and occurred at a rate of 50 milliunits/mg of protein. Most important, this assay revealed for the first time a strict Na+ dependence of this electron transfer reaction. The K-m was 0.2 mM. Na+ could be partly substituted by Li+. Na+ dependence was observed at neutral and acidic pH values, indicating the exclusive use of Na+ as a coupling ion. Electron transport from reduced ferredoxin to NAD(+) was coupled to electrogenic Na+ transport, indicating the generation of Delta(mu) over tilde (Na+). Vice versa, endergonic ferredoxin reduction with NADH as reductant was possible, but only in the presence of Delta(mu) over tilde (Na+), and was accompanied by Na+ efflux out of the vesicles. This is consistent with the hypothesis that Rnf also catalyzes ferredoxin reduction at the expense of an electrochemical Na+ gradient. The physiological significance of this finding is discussed.	[Hess, Verena; Schuchmann, Kai; Mueller, Volker] Goethe Univ Frankfurt, Dept Mol Microbiol & Bioenerget, Inst Mol Biosci, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Muller, V (corresponding author), Goethe Univ Frankfurt, Dept Mol Microbiol & Bioenerget, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	vmueller@bio.uni-frankfurt.de	Mueller, Volker/ABE-4305-2021	Mueller, Volker/0000-0001-7955-5508	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft.	BECHER B, 1992, J BACTERIOL, V174, P7656, DOI 10.1128/JB.174.23.7656-7660.1992; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Biegel E, 2009, ENVIRON MICROBIOL, V11, P1438, DOI 10.1111/j.1462-2920.2009.01871.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCKEL W, 1982, FEBS LETT, V148, P35, DOI 10.1016/0014-5793(82)81237-4; Buckel W, 2013, BBA-BIOENERGETICS, V1827, P94, DOI 10.1016/j.bbabio.2012.07.002; DIMROTH P, 1982, EUR J BIOCHEM, V121, P443, DOI 10.1111/j.1432-1033.1982.tb05807.x; Fritz M, 2007, FEBS J, V274, P3421, DOI 10.1111/j.1742-4658.2007.05874.x; GARTNER P, 1994, EUR J BIOCHEM, V226, P465, DOI 10.1111/j.1432-1033.1994.tb20071.x; HEISE R, 1989, J BACTERIOL, V171, P5473, DOI 10.1128/jb.171.10.5473-5478.1989; HEISE R, 1992, EUR J BIOCHEM, V206, P553, DOI 10.1111/j.1432-1033.1992.tb16959.x; IMAE Y, 1989, J BIOENERG BIOMEMBR, V21, P705, DOI 10.1007/BF00762688; Imkamp F, 2007, J BACTERIOL, V189, P8145, DOI 10.1128/JB.01017-07; Jayamani E., 2008, THESIS PHILIPPS U MA; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUBINGER W, 1988, BIOCHEMISTRY-US, V27, P7531, DOI 10.1021/bi00419a053; Muller V, 1995, ARCH MICROBIOL, V164, P363, DOI 10.1007/s002030050276; Muller V, 2003, APPL ENVIRON MICROB, V69, P6345, DOI 10.1128/AEM.69.11.6345-6353.2003; Muller V, 2001, BBA-BIOENERGETICS, V1505, P108, DOI 10.1016/S0005-2728(00)00281-4; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; RAGSDALE SW, 1983, J BACTERIOL, V155, P1224, DOI 10.1128/JB.155.3.1224-1237.1983; REIDLINGER J, 1994, EUR J BIOCHEM, V223, P275, DOI 10.1111/j.1432-1033.1994.tb18992.x; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; SCHMEHL M, 1993, MOL GEN GENET, V241, P602, DOI 10.1007/BF00279903; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; SCHONHEIT P, 1978, FEBS LETT, V89, P219, DOI 10.1016/0014-5793(78)80221-X; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; TAKASE K, 1994, J BIOL CHEM, V269, P11037; Terahara N, 2008, P NATL ACAD SCI USA, V105, P14359, DOI 10.1073/pnas.0802106105; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008	33	104	110	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31496	31502		10.1074/jbc.M113.510255	http://dx.doi.org/10.1074/jbc.M113.510255			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045950	hybrid, Green Published			2022-12-28	WOS:000330596200009
J	Narayanan, S; Kranz, DM				Narayanan, Samanthi; Kranz, David M.			The Same Major Histocompatibility Complex Polymorphism Involved in Control of HIV Influences Peptide Binding in the Mouse H-2L(d) System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; HLA CLASS-I; T-CELL REPERTOIRE; ANTIGEN PRESENTATION; AMINOPEPTIDASE ERAAP; SURFACE EXPRESSION; THYMIC SELECTION; MOLECULES; TCR; AFFINITY	Single-site polymorphisms in human class I major histocompatibility complex (MHC) products (HLA-B) have recently been shown to correlate with HIV disease progression or control. An identical single-site polymorphism (at residue 97) in the mouse class I product H-2L(d) influences stability of the complex. To gain insight into the human polymorphisms, here we examined peptide binding, stability, and structures of the corresponding L-d polymorphisms, Trp(97) and Arg(97). Expression of L(d)W97 and L(d)R97 genes in a cell line that is antigen-processing competent showed that L(d)R97 was expressed at higher levels than L(d)W97, consistent with enhanced stability of self-peptide.L(d)R97 complexes. To further examine peptide-binding capacities of these two allelic variants, we used a high affinity pep-L-d specific probe to quantitatively examine a collection of self- and foreign peptides that bind to Ld. L(d)R97 bound more effectively than L(d)W97 to most peptides, although L(d)W97 bound more effectively to two peptides. The results support the view that many self-peptides in the L-d system (or the HLA-B system) would exhibit enhanced binding to Arg(97) alleles compared with Trp(97) alleles. Accordingly, the self-peptide.MHC-Arg(97) complexes would influence T-cell selection behavior, impacting the T-cell repertoire of these individuals, and could also impact peripheral T cell activity through effects of self-peptide.L-d interacting with TCR and/or CD8. The structures of several peptide.L(d)R97 and peptide.L(d)W97 complexes provided a framework of how this single polymorphism could impact peptide binding.	[Narayanan, Samanthi; Kranz, David M.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kranz, DM (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	d-kranz@illinois.edu			National Institutes of Health [GM55767]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55767 (to D. M. K.).	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; ALEXANDERMILLER M, 1994, INT IMMUNOL, V6, P1699, DOI 10.1093/intimm/6.11.1699; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; Balendiran GK, 1997, P NATL ACAD SCI USA, V94, P6880, DOI 10.1073/pnas.94.13.6880; BECK JC, 1986, J IMMUNOL, V137, P916; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Bowerman NA, 2009, J BIOL CHEM, V284, P32551, DOI 10.1074/jbc.M109.040501; Bowerman NA, 2009, MOL IMMUNOL, V46, P3000, DOI 10.1016/j.molimm.2009.06.012; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Chen HY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002514; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Cresswell P, 1998, SCIENCE, V280, P394, DOI 10.1126/science.280.5362.394; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Engels B, 2012, MOL THER, V20, P652, DOI 10.1038/mt.2011.286; GABATHULER R, 1994, J EXP MED, V180, P1415, DOI 10.1084/jem.180.4.1415; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Hornell TMC, 2003, J IMMUNOL, V170, P4506, DOI 10.4049/jimmunol.170.9.4506; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Jones LL, 2008, BIOCHEMISTRY-US, V47, P12398, DOI 10.1021/bi801349g; Jones LL, 2006, J BIOL CHEM, V281, P25734, DOI 10.1074/jbc.M604343200; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kloverpris HN, 2012, J VIROL, V86, P919, DOI 10.1128/JVI.06150-11; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; LATRON F, 1991, P NATL ACAD SCI USA, V88, P11325, DOI 10.1073/pnas.88.24.11325; LIE WR, 1990, NATURE, V344, P439, DOI 10.1038/344439a0; LIE WR, 1991, J EXP MED, V173, P449, DOI 10.1084/jem.173.2.449; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; Matthews PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047799; McMichael AJ, 2010, SCIENCE, V330, P1488, DOI 10.1126/science.1200035; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Panter MS, 2012, J BIOL CHEM, V287, P31172, DOI 10.1074/jbc.M112.387704; PARHAM P, 1988, P NATL ACAD SCI USA, V85, P4005, DOI 10.1073/pnas.85.11.4005; PARHAM P, 1990, NATURE, V346, P793, DOI 10.1038/346793a0; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; POTTER TA, 1981, J IMMUNOL, V127, P580; Quezada SA, 2011, IMMUNOL REV, V241, P104, DOI 10.1111/j.1600-065X.2011.01007.x; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; REDDEHASE MJ, 1989, NATURE, V337, P651, DOI 10.1038/337651a0; Redpath S, 2001, ANNU REV MICROBIOL, V55, P531, DOI 10.1146/annurev.micro.55.1.531; Robinson RA, 1996, J IMMUNOL, V156, P4266; Schlueter CJ, 1996, J IMMUNOL, V157, P4478; Shields MJ, 1998, MOL IMMUNOL, V35, P919, DOI 10.1016/S0161-5890(98)00083-2; SMITH JD, 1993, J EXP MED, V178, P2035, DOI 10.1084/jem.178.6.2035; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Sprent J, 1995, Int Rev Immunol, V13, P95, DOI 10.3109/08830189509061740; Stone JD, 2011, J IMMUNOL, V186, P5193, DOI 10.4049/jimmunol.1003755; SYKULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487, DOI 10.1073/pnas.91.24.11487; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tan P, 2002, J IMMUNOL, V168, P1950, DOI 10.4049/jimmunol.168.4.1950; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; Yewdell JW, 2011, TRENDS IMMUNOL, V32, P548, DOI 10.1016/j.it.2011.08.001; Zernich D, 2004, J EXP MED, V200, P13, DOI 10.1084/jem.20031680; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	64	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31784	31794		10.1074/jbc.M113.478412	http://dx.doi.org/10.1074/jbc.M113.478412			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24064213	Green Published, hybrid			2022-12-28	WOS:000330596200029
J	Feldman, JL; Baeza, J; Denu, JM				Feldman, Jessica L.; Baeza, Josue; Denu, John M.			Activation of the Protein Deacetylase SIRT6 by Long-chain Fatty Acids and Widespread Deacylation by Mammalian Sirtuins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; METABOLISM; ACYLATION; GLUCOSE; ASSAYS	Mammalian sirtuins (SIRT1 through SIRT7) are members of a highly conserved family of NAD(+)-dependent protein deacetylases that function in metabolism, genome maintenance, and stress responses. Emerging evidence suggests that some sirtuins display substrate specificity toward other acyl groups attached to the lysine epsilon-amine. SIRT6 was recently reported to preferentially hydrolyze long-chain fatty acyl groups over acetyl groups. Here we investigated the catalytic ability of all sirtuins to hydrolyze 13 different acyl groups from histone H3 peptides, ranging in carbon length, saturation, and chemical diversity. We find that long-chain deacylation is a general feature of mammalian sirtuins, that SIRT1 and SIRT2 act as efficient decrotonylases, and that SIRT1, SIRT2, SIRT3, and SIRT4 can remove lipoic acid. These results provide new insight into sirtuin function and a means for cellular removal of an expanding list of endogenous lysine modifications. Given that SIRT6 is a poor deacetylase in vitro, but binds and prefers to hydrolyze long-chain acylated peptides, we hypothesize that binding of certain free fatty acids (FFAs) could stimulate deacetylation activity. Indeed, we demonstrate that several biologically relevant FFAs (including myristic, oleic, and linoleic acids) at physiological concentrations induce up to a 35-fold increase in catalytic efficiency of SIRT6 but not SIRT1. The activation mechanism is consistent with fatty acid inducing a conformation that binds acetylated H3 with greater affinity. Binding of long-chain FFA and myristoylated H3 peptide is mutually exclusive. We discuss the implications of discovering endogenous, small-molecule activators of SIRT6.	[Feldman, Jessica L.; Baeza, Josue; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53715 USA; [Feldman, Jessica L.; Baeza, Josue; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), Univ Wisconsin, 330 N Orchard St,WID 2178, Madison, WI 53715 USA.	jmdenu@wisc.edu		Baeza, Josue/0000-0003-4960-3905	National Institutes of Health [GM065386]; American Heart Association [11PRE7300059]; National Science Foundation [1256259]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386, T32GM007215, R37GM059785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065386 (to J.M.D.), a predoctoral fellowship (to J.L.F.) from the American Heart Association (11PRE7300059) and a predoctoral fellowship (to J.B.) from the National Science Foundation (1256259).	Adkins Y, 2010, J NUTR BIOCHEM, V21, P781, DOI 10.1016/j.jnutbio.2009.12.004; Berndsen CE, 2005, METHODS, V36, P321, DOI 10.1016/j.ymeth.2005.03.002; Borra MT, 2004, METHOD ENZYMOL, V376, P171; Calder PC, 2010, NUTRIENTS, V2, P355, DOI 10.3390/nu2030355; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; de Albuquerque CFG, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/601032; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; JUMP DB, 1994, J LIPID RES, V35, P1076; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Lin HN, 2012, ACS CHEM BIOL, V7, P947, DOI 10.1021/cb3001793; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; NORTHROP DB, 1983, ANAL BIOCHEM, V132, P457, DOI 10.1016/0003-2697(83)90034-9; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Preyat N, 2013, J LEUKOCYTE BIOL, V93, P669, DOI 10.1189/jlb.1112557; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Spalding MD, 2010, MICROBIOL MOL BIOL R, V74, P200, DOI 10.1128/MMBR.00008-10; STEVENSON FT, 1992, J EXP MED, V176, P1053, DOI 10.1084/jem.176.4.1053; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tholstrup T, 2001, AM J CLIN NUTR, V73, P198; Xu JH, 2006, J BIOL CHEM, V281, P18351, DOI 10.1074/jbc.M601277200; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhu AY, 2012, ACS CHEM BIOL, V7, P155, DOI 10.1021/cb200230x	36	432	438	5	64	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31350	31356		10.1074/jbc.C113.511261	http://dx.doi.org/10.1074/jbc.C113.511261			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24052263	Green Published, hybrid			2022-12-28	WOS:000330778900051
J	Berk, JM; Maitra, S; Dawdy, AW; Shabanowitz, J; Hunt, DF; Wilson, KL				Berk, Jason M.; Maitra, Sushmit; Dawdy, Andrew W.; Shabanowitz, Jeffrey; Hunt, Donald F.; Wilson, Katherine L.			O-Linked beta-N-Acetylglucosamine (O-GlcNAc) Regulates Emerin Binding to Barrier to Autointegration Factor (BAF) in a Chromatin- and Lamin B-enriched "Niche"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiomyopathy; Chromosomes; Non-histone Chromosomal Proteins; Lamin; Muscular Dystrophy; Nuclear Matrix; Nuclear Membrane; O-GlcNAc; Emerin; Laminopathy; Nucleoskeleton	INNER NUCLEAR-MEMBRANE; DREIFUSS MUSCULAR-DYSTROPHY; DISTINCT FUNCTIONAL DOMAINS; TRANSCRIPTIONAL REPRESSOR; MODIFIED PROTEINS; ENVELOPE PROTEIN; PHOSPHORYLATION; TRANSFERASE; ROLES; DNA	Background: Nuclear membrane protein emerin binding to nuclear intermediate filaments (lamins) and BAF contributes to forming a nuclear lamina structure. Results: Emerin is O-GlcNAc-modified at eight sites: two (Ser-53 and Ser-54) influence further O-GlcNAcylation, and one (Ser-173) regulates association with BAF in the chromatin/lamin B niche. Conclusion:O-GlcNAc transferase, a nutrient-responsive enzyme, regulates emerin. Significance: Emerin hyper-O-GlcNAcylation may contribute to cardiomyopathy and other conditions. Emerin, a membrane component of nuclear lamina networks with lamins and barrier to autointegration factor (BAF), is highly O-GlcNAc-modified (O-GlcNAcylated) in mammalian cells. Mass spectrometry analysis revealed eight sites of O-GlcNAcylation, including Ser-53, Ser-54, Ser-87, Ser-171, and Ser-173. Emerin O-GlcNAcylation was reduced approximate to 50% by S53A or S54A mutation in vitro and in vivo. O-GlcNAcylation was reduced approximate to 66% by the triple S52A/S53A/S54A mutant, and S173A reduced O-GlcNAcylation of the S52A/S53A/S54A mutant by approximate to 30%, in vivo. We separated two populations of emerin, A-type lamins and BAF; one population solubilized easily, and the other required sonication and included histones and B-type lamins. Emerin and BAF associated only in histone- and lamin-B-containing fractions. The S173D mutation specifically and selectively reduced GFP-emerin association with BAF by 58% and also increased GFP-emerin hyper-phosphorylation. We conclude that -N-acetylglucosaminyltransferase, an essential enzyme, controls two regions in emerin. The first region, defined by residues Ser-53 and Ser-54, flanks the LEM domain. O-GlcNAc modification at Ser-173, in the second region, is proposed to promote emerin association with BAF in the chromatin/lamin B niche. These results reveal direct control of a conserved LEM domain nuclear lamina component by -N-acetylglucosaminyltransferase, a nutrient sensor that regulates cell stress responses, mitosis, and epigenetics.	[Berk, Jason M.; Wilson, Katherine L.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Maitra, Sushmit; Dawdy, Andrew W.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA	Johns Hopkins University; University of Virginia	Wilson, KL (corresponding author), Johns Hopkins Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.	klwilson@jhmi.edu	Wilson, Katherine/HII-8144-2022	Dawdy, Andrew/0000-0003-1932-012X	National Institutes of Health [RO1 GM37537, RO1 GM048646]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445, R01GM048646, R01GM037537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM37537 (to D. F. H.) and RO1 GM048646 (to K. L. W.).	Akimoto Y, 2003, BRAIN RES, V966, P194, DOI 10.1016/S0006-8993(02)04158-6; Barkan R, 2012, MOL BIOL CELL, V23, P543, DOI 10.1091/mbc.E11-06-0505; Bengtsson L, 2004, CURR OPIN CELL BIOL, V16, P73, DOI 10.1016/j.ceb.2003.11.012; Berk JM, 2013, NUCLEUS-PHILA, V4, P298, DOI 10.4161/nucl.25751; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Bonne G, 2010, EMERY DREIFUSS MUSCU; Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; Bradley CM, 2005, NAT STRUCT MOL BIOL, V12, P935, DOI 10.1038/nsmb989; BRIDGER JM, 1993, J CELL SCI, V104, P297; Broers JLV, 1999, J CELL SCI, V112, P3463; Cabanillas R, 2011, AM J MED GENET A, V155A, P2617, DOI 10.1002/ajmg.a.34249; Cantin GT, 2008, J PROTEOME RES, V7, P1346, DOI 10.1021/pr0705441; Chen YX, 2006, CHEM BIOL, V13, P937, DOI 10.1016/j.chembiol.2006.06.017; Cheng XG, 2000, J STEROID BIOCHEM, V75, P147, DOI 10.1016/S0960-0760(00)00167-9; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Clements L, 2000, BIOCHEM BIOPH RES CO, V267, P709, DOI 10.1006/bbrc.1999.2023; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; de Oca RM, 2011, NUCLEUS-PHILA, V2, P580, DOI 10.4161/nucl.2.6.17960; Dechat T, 2004, J CELL SCI, V117, P6117, DOI 10.1242/jcs.01529; Dedeic Z, 2011, J CELL SCI, V124, P1691, DOI 10.1242/jcs.080259; Demmerle J, 2012, J BIOL CHEM, V287, P22080, DOI 10.1074/jbc.M111.325308; Dittrich CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024555; Dorner D, 2007, FEBS J, V274, P1362, DOI 10.1111/j.1742-4658.2007.05695.x; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fairley EAL, 2002, J CELL SCI, V115, P341; Gloster TM, 2010, CURR SIGNAL TRANSD T, V5, P74, DOI 10.2174/157436210790226537; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Gueneau L, 2009, AM J HUM GENET, V85, P338, DOI 10.1016/j.ajhg.2009.07.015; Hahne H, 2012, MOL CELL PROTEOMICS, V11, P843, DOI 10.1074/mcp.M112.019463; HANOVER JA, 1987, J BIOL CHEM, V262, P9887; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Haraguchi T, 2001, J CELL SCI, V114, P4575; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Haraguchi T, 2007, J CELL SCI, V120, P1967, DOI 10.1242/jcs.03461; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hirano Y, 2005, J BIOL CHEM, V280, P39925, DOI 10.1074/jbc.M503214200; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bi602636m; Holaska JM, 2006, HUM MOL GENET, V15, P3459, DOI 10.1093/hmg/ddl423; Holaska JM, 2004, PLOS BIOL, V2, P1354, DOI 10.1371/journal.pbio.0020231; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Ibrahim N, 2011, J VIROL, V85, P11588, DOI 10.1128/JVI.00641-11; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Jiang XY, 2008, DEV CELL, V14, P494, DOI 10.1016/j.devcel.2008.02.018; Kazemi Z, 2010, J BIOL CHEM, V285, P39096, DOI 10.1074/jbc.M110.131102; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Leach N, 2007, J VIROL, V81, P10792, DOI 10.1128/JVI.00196-07; Leach NR, 2010, VIROLOGY, V406, P127, DOI 10.1016/j.virol.2010.07.002; Lee KK, 2001, J CELL SCI, V114, P4567; Liang WC, 2011, ANN NEUROL, V69, P1005, DOI 10.1002/ana.22338; Liu J, 2003, P NATL ACAD SCI USA, V100, P4598, DOI 10.1073/pnas.0730821100; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Manilal S, 1996, HUM MOL GENET, V5, P801, DOI 10.1093/hmg/5.6.801; Maraldi NM, 2011, J CELL BIOCHEM, V112, P979, DOI 10.1002/jcb.22992; Margalit A, 2005, P NATL ACAD SCI USA, V102, P3290, DOI 10.1073/pnas.0408364102; Margalit A, 2007, J CELL BIOL, V178, P661, DOI 10.1083/jcb.200704049; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Meister P, 2011, CURR OPIN GENET DEV, V21, P167, DOI 10.1016/j.gde.2011.01.023; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Morris JB, 2007, J VIROL, V81, P4429, DOI 10.1128/JVI.02354-06; Muchir A, 2007, HUM MOL GENET, V16, P1884, DOI 10.1093/hmg/ddm137; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Puente XS, 2011, AM J HUM GENET, V88, P650, DOI 10.1016/j.ajhg.2011.04.010; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Sarras H, 2010, THESCIENTIFICWORLDJO, V10, P1450, DOI 10.1100/tsw.2010.132; Scott ES, 2001, J VIROL, V75, P8818, DOI 10.1128/JVI.75.18.8818-8830.2001; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shimi T, 2004, J STRUCT BIOL, V147, P31, DOI 10.1016/j.jsb.2003.11.013; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Simon DN, 2013, CHROMOSOMA, V122, P13, DOI 10.1007/s00412-013-0399-8; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Skoko D, 2009, P NATL ACAD SCI USA, V106, P16610, DOI 10.1073/pnas.0909077106; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Sui C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-539; Tifft KE, 2009, J CELL SCI, V122, P3780, DOI 10.1242/jcs.048397; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Tsuchiya Y, 1999, EUR J BIOCHEM, V259, P859, DOI 10.1046/j.1432-1327.1999.00112.x; Tunnah D, 2005, J MOL HISTOL, V36, P337, DOI 10.1007/s10735-005-9004-7; Udeshi ND, 2008, NAT PROTOC, V3, P1709, DOI 10.1038/nprot.2008.159; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wang ZH, 2010, MOL CELL PROTEOMICS, V9, P153, DOI 10.1074/mcp.M900268-MCP200; Wheeler MA, 2007, EXP CELL RES, V313, P2845, DOI 10.1016/j.yexcr.2007.03.025; Wheeler MA, 2010, CELL MOL LIFE SCI, V67, P781, DOI 10.1007/s00018-009-0219-8; Wilson K. L., 2010, COLD SPRING HARB PER, V2; Wilson KL, 2010, J CELL SCI, V123, P1973, DOI 10.1242/jcs.019042; Wozniak MA, 2013, PEERJ, V1, DOI 10.7717/peerj.134; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yip SC, 2012, J CELL SCI, V125, P310, DOI 10.1242/jcs.086256; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2012, AM J PHYSIOL-HEART C, V302, pH1905, DOI 10.1152/ajpheart.00445.2011; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035; Zwerger M, 2011, ANNU REV BIOMED ENG, V13, P397, DOI 10.1146/annurev-bioeng-071910-124736	111	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30192	30209		10.1074/jbc.M113.503060	http://dx.doi.org/10.1074/jbc.M113.503060			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014020	hybrid, Green Published			2022-12-28	WOS:000329868100019
J	Camenares, D; Dulebohn, DP; Svetlanov, A; Karzai, AW				Camenares, Devin; Dulebohn, Daniel P.; Svetlanov, Anton; Karzai, A. Wali			Active and Accurate trans-Translation Requires Distinct Determinants in the C-terminal Tail of SmpB Protein and the mRNA-like Domain of Transfer Messenger RNA (tmRNA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding Protein; tmRNA; Transfer RNA (tRNA); Translation; Translation Control; SmpB; Ribosome	RIBOSOME-RESCUE; MEDIATED SURVEILLANCE; STALLED RIBOSOMES; BINDING; SYSTEM; DECAY; BACTERIA; DEGRADATION; INITIATION; MECHANISM	Unproductive ribosome stalling in eubacteria is resolved by the actions of SmpB protein and transfer messenger (tm) RNA. We examined the functional significance of conserved regions of SmpB and tmRNA to the trans-translation process. Our investigations reveal that the N-terminal 20 residues of SmpB, which are located near the ribosomal decoding center, are dispensable for all known SmpB activities. In contrast, a set of conserved residues that reside at the junction between the tmRNA-binding core and the C-terminal tail of SmpB play an important role in tmRNA accommodation. Our data suggest that the highly conserved glycine 132 acts as a flexible hinge that enables movement of the C-terminal tail, thus permitting proper positioning and establishment of the tmRNA open reading frame (ORF) as the surrogate template. To gain further insights into the function of the SmpB C-terminal tail, we examined the tagging activity of hybrid variants of tmRNA and the SmpB protein, in which the tmRNA ORF or the SmpB C-terminal tail was substituted with the equivalent but highly divergent sequences from Francisella tularensis. We observed that the hybrid tmRNA was active but resulted in less accurate selection of the resume codon. Cognate hybrid SmpB was necessary to restore activity. Furthermore, accurate tagging was observed when the identity of the resume codon was reverted from GGC to GCA. Taken together, these data suggest that the engagement of the tmRNA ORF and the selection of the correct translation resumption point are distinct activities that are influenced by independent tmRNA and SmpB determinants.	[Camenares, Devin; Dulebohn, Daniel P.; Svetlanov, Anton; Karzai, A. Wali] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Camenares, Devin; Svetlanov, Anton; Karzai, A. Wali] SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Karzai, AW (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Ctr Infect Dis, Stony Brook, NY 11794 USA.	wali.karzai@stonybrook.edu		Camenares, Devin/0000-0001-7047-1682	National Institutes of Health [R01 GM065319]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065319.	Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; Barends S, 2011, WIRES RNA, V2, P233, DOI 10.1002/wrna.48; Bessho Y, 2007, P NATL ACAD SCI USA, V104, P8293, DOI 10.1073/pnas.0700402104; Cheng K, 2010, J STRUCT BIOL, V169, P342, DOI 10.1016/j.jsb.2009.10.015; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Dulebohn D, 2007, BIOCHEMISTRY-US, V46, P4681, DOI 10.1021/bi6026055; Dulebohn DP, 2006, J BIOL CHEM, V281, P28536, DOI 10.1074/jbc.M605137200; Ge ZY, 2010, MOL MICROBIOL, V78, P1159, DOI 10.1111/j.1365-2958.2010.07396.x; Ge ZY, 2009, MOL MICROBIOL, V74, P1083, DOI 10.1111/j.1365-2958.2009.06923.x; Hayes CS, 2010, FEBS LETT, V584, P413, DOI 10.1016/j.febslet.2009.11.023; Janssen BD, 2012, ADV PROTEIN CHEM STR, V86, P151, DOI 10.1016/B978-0-12-386497-0.00005-0; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; Konno T, 2007, RNA, V13, P1723, DOI 10.1261/rna.604907; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Mehta P, 2006, RNA, V12, P2187, DOI 10.1261/rna.247706; Metzinger L, 2008, RNA, V14, P1761, DOI 10.1261/rna.1185808; Miller MR, 2011, RNA, V17, P1727, DOI 10.1261/rna.2821711; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Neubauer C, 2012, SCIENCE, V335, P1366, DOI 10.1126/science.1217039; Nonin-Lecomte S, 2009, EMBO REP, V10, P160, DOI 10.1038/embor.2008.243; Okan Nihal A., 2006, PLoS Pathogens, V2, P50; Okan NA, 2010, INFECT IMMUN, V78, P1284, DOI 10.1128/IAI.00976-09; Ramrath DJF, 2012, NATURE, V485, P526, DOI 10.1038/nature11006; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Sundermeier T, 2008, METHOD ENZYMOL, V447, P329, DOI 10.1016/S0076-6879(08)02217-9; Sundermeier TR, 2007, J BIOL CHEM, V282, P34779, DOI 10.1074/jbc.M707256200; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; Svetlanov A, 2012, MOL MICROBIOL, V85, P122, DOI 10.1111/j.1365-2958.2012.08093.x; Watts T, 2009, J MOL BIOL, V391, P275, DOI 10.1016/j.jmb.2009.06.037; Williams KP, 1999, EMBO J, V18, P5423, DOI 10.1093/emboj/18.19.5423; Wills NM, 2008, EMBO J, V27, P2533, DOI 10.1038/emboj.2008.170; Withey J, 1999, J BACTERIOL, V181, P2148, DOI 10.1128/JB.181.7.2148-2157.1999; Withey JH, 2003, ANNU REV MICROBIOL, V57, P101, DOI 10.1146/annurev.micro.57.030502.090945; Withey JH, 2002, CURR OPIN MICROBIOL, V5, P154, DOI 10.1016/S1369-5274(02)00299-0; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361	41	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30527	30542		10.1074/jbc.M113.503896	http://dx.doi.org/10.1074/jbc.M113.503896			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986442	Green Published, hybrid			2022-12-28	WOS:000329868100055
J	Yan, F; Liu, LP; Dempsey, PJ; Tsai, YH; Raines, EW; Wilson, CL; Cao, HL; Cao, Z; Liu, LS; Polk, DB				Yan, Fang; Liu, Liping; Dempsey, Peter J.; Tsai, Yu-Hwai; Raines, Elaine W.; Wilson, Carole L.; Cao, Hailong; Cao, Zheng; Liu, LinShu; Polk, D. Brent			A Lactobacillus rhamnosus GG-derived Soluble Protein, p40, Stimulates Ligand Release from Intestinal Epithelial Cells to Transactivate Epidermal Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Epidermal Growth Factor (EGF); Intestinal Epithelium; Probiotics; Tight Junctions	ALPHA-CONVERTING-ENZYME; EGF RECEPTOR; COLONIC-MUCOSA; POTENTIAL ROLE; DRUG-DELIVERY; MICE; INFLAMMATION; ACTIVATION; PROBIOTICS; COLITIS	p40, a Lactobacillus rhamnosus GG (LGG)-derived soluble protein, ameliorates intestinal injury and colitis, reduces apoptosis, and preserves barrier function by transactivation of the EGF receptor (EGFR) in intestinal epithelial cells. The aim of this study is to determine the mechanisms by which p40 transactivates the EGFR in intestinal epithelial cells. Here we show that p40-conditioned medium activates EGFR in young adult mouse colon epithelial cells and human colonic epithelial cell line, T84 cells. p40 up-regulates a disintegrin and metalloproteinase domain-containing protein 17 (ADAM17) catalytic activity, and broad spectrum metalloproteinase inhibitors block EGFR transactivation by p40 in these two cell lines. In ADAM17-deficient mouse colonic epithelial (ADAM17(-/-) MCE) cells, p40 transactivation of EGFR is blocked, but can be rescued by re-expression with WT ADAM17. Furthermore, p40 stimulates release of heparin binding (HB)-EGF, but not transforming growth factor (TGF) or amphiregulin, in young adult mouse colon cells and ADAM17(-/-) MCE cells overexpressing WT ADAM17. Knockdown of HB-EGF expression by siRNA suppresses p40 effects on transactivating EGFR and Akt, preventing apoptosis, and preserving tight junction function. The effects of p40 on HB-EGF release and ADAM17 activation in vivo are examined after administration of p40-containing pectin/zein hydrogel beads to mice. p40 stimulates ADAM17 activity and EGFR activation in colonic epithelial cells and increases HB-EGF levels in blood from WT mice, but not from mice with intestinal epithelial cell-specific ADAM17 deletion. Thus, these data define a mechanism of a probiotic-derived soluble protein in modulating intestinal epithelial cell homeostasis through ADAM17-mediated HB-EGF release, leading to transactivation of EGFR.	[Yan, Fang; Liu, Liping; Cao, Hailong] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Cao, Zheng] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA; [Dempsey, Peter J.; Tsai, Yu-Hwai] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Dempsey, Peter J.; Tsai, Yu-Hwai] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Raines, Elaine W.; Wilson, Carole L.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Cao, Hailong] Tianjin Med Univ, Gen Hosp, Dept Gastroenterol, Tianjin 300052, Peoples R China; [Liu, LinShu] ARS, Eastern Reg Res Ctr, USDA, Wyndmoor, PA 19038 USA; [Polk, D. Brent] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Polk, D. Brent] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Polk, D. Brent] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90089 USA	Vanderbilt University; Vanderbilt University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; Tianjin Medical University; United States Department of Agriculture (USDA); University of Southern California; University of Southern California; Children's Hospital Los Angeles	Polk, DB (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr, 2215 Garland Ave,MRB 4,Rm 1035, Nashville, TN 37232 USA.	fang.yan@vanderbilt.edu	liu, li/HGC-0900-2022	Liu, LinShu/0000-0003-3962-290X	National Institutes of Health [R01DK081134, R01DK93697, R01HL067267, P01HL018645, R01DK56008, R01DK54993, R01DK066176, P30DK058404]; Tianjin Research Program of Application Foundation and Advanced Technology for Young Scientists of China [13JCQNJC10600]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645, R01HL067267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056008, R01DK093697, R01DK066176, R01DK081134, R01DK054993, P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tianjin Research Program of Application Foundation and Advanced Technology for Young Scientists of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK081134 (to F. Y.), R01DK93697 (to P. J. D), R01HL067267 and P01HL018645 (to E W. R.), and R01DK56008, R01DK54993, and R01DK066176 (to D. B. P.). This work was also supported by Tianjin Research Program of Application Foundation and Advanced Technology for Young Scientists of China Grant 13JCQNJC10600 (to H. C.) and core services performed through Vanderbilt University Medical Center Digestive Disease Research Center supported by National Institutes of Health Grant P30DK058404.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Arribas J, 2003, CURR TOP DEV BIOL, V54, P125, DOI 10.1016/S0070-2153(03)54007-8; Bauerl C, 2010, J MOL MICROB BIOTECH, V19, P231, DOI 10.1159/000322233; Basu S, 2009, J CLIN GASTROENTEROL, V43, P208, DOI 10.1097/MCG.0b013e31815a5780; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Blaydon DC, 2011, NEW ENGL J MED, V365, P1502, DOI 10.1056/NEJMoa1100721; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Brandl K, 2010, P NATL ACAD SCI USA, V107, P19967, DOI 10.1073/pnas.1014669107; Brynskov J, 2002, GUT, V51, P37, DOI 10.1136/gut.51.1.37; Caruso R, 2020, NAT REV IMMUNOL, V20, P411, DOI [10.4161/gmic.20228, 10.1038/s41577-019-0268-7]; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Claes IJJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031588; Colon AL, 2001, CYTOKINE, V16, P220, DOI 10.1006/cyto.2001.0969; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Doron S, 2005, GASTROENTEROL CLIN N, V34, P483, DOI 10.1016/j.gtc.2005.05.011; Dube PE, 2012, J CLIN INVEST, V122, P2780, DOI 10.1172/JCI62888; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; FAN SJ, 1994, CANCER RES, V54, P5824; Garton KJ, 2003, J BIOL CHEM, V278, P37459, DOI 10.1074/jbc.M305877200; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gorbach SL, 1996, NUTR TODAY, V31, P25, DOI DOI 10.1097/00017285-199611001-00002; Land MH, 2005, PEDIATRICS, V115, P178, DOI 10.1542/peds.2004-2137; Liu LS, 2006, DRUG DELIV, V13, P417, DOI 10.1080/10717540500394935; Liu LS, 2003, BIOMATERIALS, V24, P3333, DOI 10.1016/S0142-9612(03)00213-8; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Regulski K., 2012, PLOS ONE, V7; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Seth A, 2008, AM J PHYSIOL-GASTR L, V294, pG1060, DOI 10.1152/ajpgi.00202.2007; Sinha A, 2003, NEW ENGL J MED, V349, P350, DOI 10.1056/NEJMoa013136; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Szajewska H, 2011, ALIMENT PHARM THER, V34, P1079, DOI 10.1111/j.1365-2036.2011.04837.x; Vahabnezhad E, 2013, J CLIN GASTROENTEROL, V47, P437, DOI 10.1097/MCG.0b013e318279abf0; Vanderpool C, 2008, INFLAMM BOWEL DIS, V14, P1585, DOI 10.1002/ibd.20525; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Wilson CL, 2013, MECH DEVELOP, V130, P272, DOI 10.1016/j.mod.2013.01.001; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105; Yan F, 2002, J BIOL CHEM, V277, P50959, DOI 10.1074/jbc.M207050200; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yan F, 2011, CURR OPIN GASTROEN, V27, P496, DOI 10.1097/MOG.0b013e32834baa4d; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031; Yan F, 2010, CURR OPIN GASTROEN, V26, P95, DOI 10.1097/MOG.0b013e328335239a; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zocco MA, 2006, ALIMENT PHARM THER, V23, P1567, DOI 10.1111/j.1365-2036.2006.02927.x	49	91	94	6	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30742	30751		10.1074/jbc.M113.492397	http://dx.doi.org/10.1074/jbc.M113.492397			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24043629	Green Published, hybrid			2022-12-28	WOS:000329868100074
J	Eyler, DE; Wehner, KA; Green, R				Eyler, Daniel E.; Wehner, Karen A.; Green, Rachel			Eukaryotic Release Factor 3 Is Required for Multiple Turnovers of Peptide Release Catalysis by Eukaryotic Release Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; STOP CODON RECOGNITION; NO-GO; TRANSLATION TERMINATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; QUALITY-CONTROL; FACTOR ERF3; RIBOSOME; DISSOCIATION	Eukaryotic peptide release factor 3 (eRF3) is a conserved, essential gene in eukaryotes implicated in translation termination. We have systematically measured the contribution of eRF3 to the rates of peptide release with both saturating and limiting levels of eukaryotic release factor 1 (eRF1). Although eRF3 modestly stimulates the absolute rate of peptide release (similar to 5-fold), it strongly increases the rate of peptide release when eRF1 is limiting (>20-fold). This effect was generalizable across all stop codons and in a variety of contexts. Further investigation revealed that eRF1 remains associated with ribosomal complexes after peptide release and subunit dissociation and that eRF3 promotes the dissociation of eRF1 from these post-termination complexes. These data are consistent with models where eRF3 principally affects binding interactions between eRF1 and the ribosome, either prior to or subsequent to peptide release. A role for eRF3 as an escort for eRF1 into its fully accommodated state is easily reconciled with its close sequence similarity to the translational GTPase EFTu.	[Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 702 PCTB,725 N Wolfe St, Baltimore, MD 21205 USA.	ragreen@jhmi.edu			Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (to R. G.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Atkinson GC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-290; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Becker T, 2011, NAT STRUCT MOL BIOL, V18, P715, DOI 10.1038/nsmb.2057; BOEHLKE KW, 1975, J BACTERIOL, V121, P429, DOI 10.1128/JB.121.2.429-433.1975; Brunelle JL, 2006, RNA, V12, P33, DOI 10.1261/rna.2256706; Cheng Z, 2009, GENE DEV, V23, P1106, DOI 10.1101/gad.1770109; Eyler DE, 2011, RNA, V17, P925, DOI 10.1261/rna.2623711; Fan-Minogue H, 2008, MOL CELL, V30, P599, DOI 10.1016/j.molcel.2008.03.020; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Frolova L, 1996, RNA, V2, P334; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Hoshino S, 1998, J BIOL CHEM, V273, P22254, DOI 10.1074/jbc.273.35.22254; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kong CG, 2004, MOL CELL, V14, P233, DOI 10.1016/S1097-2765(04)00206-0; Lee HH, 2007, MOL CELL, V27, P938, DOI 10.1016/j.molcel.2007.07.019; Pisarev AV, 2010, MOL CELL, V37, P196, DOI 10.1016/j.molcel.2009.12.034; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Salas-Marco J, 2004, MOL CELL BIOL, V24, P7769, DOI 10.1128/MCB.24.17.7769-7778.2004; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; STANSFIELD I, 1992, MOL MICROBIOL, V6, P3469, DOI 10.1111/j.1365-2958.1992.tb01782.x; Taylor D, 2012, P NATL ACAD SCI USA, V109, P18413, DOI 10.1073/pnas.1216730109; Zaher HS, 2011, CELL, V147, P396, DOI 10.1016/j.cell.2011.08.045; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	29	29	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29530	29538		10.1074/jbc.M113.487090	http://dx.doi.org/10.1074/jbc.M113.487090			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23963452	hybrid, Green Published			2022-12-28	WOS:000330615300029
J	Coulter, JB; O'Driscoll, CM; Bressler, JP				Coulter, Jonathan B.; O'Driscoll, Cliona M.; Bressler, Joseph P.			Hydroquinone Increases 5-Hydroxymethylcytosine Formation through Ten Eleven Translocation 1 (TET1) 5-Methylcytosine Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dioxygenase; DNA Methylation; Epigenetics; Quinones; Reactive Oxygen Species (ROS); Benzene; DNA Demethylation; Hydroquinone; Ten Eleven Translocation 1; TET1	DNA METHYLATION; PROMOTER METHYLATION; 14-3-3 SIGMA; BENZENE; DEMETHYLATION; INACTIVATION; CONVERSION; INHIBITOR; REPRESSOR; DAMAGE	DNA methylation regulates gene expression throughout development and in a wide range of pathologies such as cancer and neurological disorders. Pathways controlling the dynamic levels and targets of methylation are known to be disrupted by chemicals and are therefore of great interest in both prevention and clinical contexts. Benzene and its metabolite hydroquinone have been shown to lead to decreased levels of DNA methylation, although the mechanism is not known. This study employs a cell culture model to investigate the mechanism of hydroquinone-mediated changes in DNA methylation. Exposures that do not affect HEK293 cell viability led to genomic and methylated reporter DNA demethylation. Hydroquinone caused reactivation of a methylated reporter plasmid that was prevented by the addition of N-acetylcysteine. Hydroquinone also caused an increase in Ten Eleven Translocation 1 activity and global levels of 5-hydroxymethylcytosine. 5-Hydroxymethylcytosine was found enriched at LINE-1 prior to a decrease in both 5-hydroxymethylcytosine and 5-methylcytosine. Ten Eleven Translocation-1 knockdown decreased 5-hydroxymethylcytosine formation following hydroquinone exposure as well as the induction of glutamate-cysteine ligase catalytic subunit and 14-3-3 sigma. Finally, Ten Eleven Translocation 1 knockdown decreased the percentage of cells accumulating in G(2)+M following hydroquinone exposure, indicating that it may have a role in cell cycle changes in response to toxicants. This work demonstrates that hydroquinone exposure leads to active and functional DNA demethylation in HEK293 cells in a mechanism involving reactive oxygen species and Ten Eleven Translocation 1 5-methylcytosine dioxygenase.	[Coulter, Jonathan B.] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Hugo Moser Res Inst Kennedy Krieger, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Coulter, JB (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	jcoulter@jhsph.edu; bressler@kennedykrieger.org		Coulter, Jonathan/0000-0003-0380-9254	National Institutes of Health [1U18TR000547]; Hopkins University Center in Urban and Environmental Health [30 ES003819]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U18TR000547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141, P30ES003819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hopkins University Center in Urban and Environmental Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1U18TR000547. This work was also supported by Johns Hopkins University Center in Urban and Environmental Health Grant 30 ES003819.	[Anonymous], 1987, IARC Monogr Eval Carcinog Risks Hum Suppl, V7, P1; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Castro GD, 1996, CHEM-BIOL INTERACT, V99, P289, DOI 10.1016/0009-2797(95)03680-6; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Du W, 2012, BLOOD, V119, P4142, DOI 10.1182/blood-2011-09-381970; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Ponferrada-Marin MI, 2010, J BIOL CHEM, V285, P23030, DOI 10.1074/jbc.M110.124578; Ishida K, 2012, J PERIODONTOL, V83, P917, DOI 10.1902/jop.2011.110356; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ji Z, 2010, LEUKEMIA, V24, P986, DOI 10.1038/leu.2010.43; KOLACHANA P, 1993, CANCER RES, V53, P1023; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; Lee WJ, 2006, CARCINOGENESIS, V27, P269, DOI 10.1093/carcin/bgi206; Lertratanangkoon K, 1997, CANCER LETT, V120, P149, DOI 10.1016/S0304-3835(97)00300-5; Liu C, 2013, PLOS ONE, V8; Lodygin D, 2005, CELL RES, V15, P237, DOI 10.1038/sj.cr.7290292; Millan MJ, 2013, NEUROPHARMACOLOGY, V68, P2, DOI 10.1016/j.neuropharm.2012.11.015; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; O'Driscoll CM, 2013, BBA-MOL CELL RES, V1833, P460, DOI 10.1016/j.bbamcr.2012.11.012; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; ONG CN, 1994, INT J CANCER, V59, P177, DOI 10.1002/ijc.2910590206; Orr BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041036; PARKE DV, 1953, BIOCHEM J, V54, P231, DOI 10.1042/bj0540231; PARMENTIER R, 1948, NATURE, V161, P527, DOI 10.1038/161527a0; Shen DX, 2003, CHEM-BIOL INTERACT, V145, P225, DOI 10.1016/S0009-2797(03)00003-6; Snyder R, 1996, ENVIRON HEALTH PERSP, V104, P1165, DOI 10.1289/ehp.961041165; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Wagner JR, 2010, ACCOUNTS CHEM RES, V43, P564, DOI 10.1021/ar9002637; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Yi B, 2009, J CELL BIOCHEM, V106, P858, DOI 10.1002/jcb.22051	37	74	76	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28792	28800		10.1074/jbc.M113.491365	http://dx.doi.org/10.1074/jbc.M113.491365			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940045	Green Published, hybrid			2022-12-28	WOS:000330298800032
J	Shen, S; Horowitz, ED; Troupes, AN; Brown, SM; Pulicherla, N; Samulski, RJ; Agbandje-McKenna, M; Asokan, A				Shen, Shen; Horowitz, Eric D.; Troupes, Andrew N.; Brown, Sarah M.; Pulicherla, Nagesh; Samulski, Richard J.; Agbandje-McKenna, Mavis; Asokan, Aravind			Engraftment of a Galactose Receptor Footprint onto Adeno-associated Viral Capsids Improves Transduction Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate; Cell Surface Receptor; Gene Therapy; Protein Engineering; Virus Entry; Adeno-associated Virus	HEPARAN-SULFATE PROTEOGLYCAN; HUMAN GENE-THERAPY; VIRUS SEROTYPE 6; MUSCULAR-DYSTROPHY; AAV VECTOR; BINDING; IDENTIFICATION; TYPE-2; MICE; TRANSMISSION	New viral strains can be evolved to recognize different host glycans through mutagenesis and experimental adaptation. However, such mutants generally harbor amino acid changes that affect viral binding to a single class of carbohydrate receptors. We describe the rational design and synthesis of novel, chimeric adeno-associated virus (AAV) strains that exploit an orthogonal glycan receptor for transduction. A dual glycan-binding AAV strain was first engineered as proof of concept by grafting a galactose (Gal)-binding footprint from AAV serotype 9 onto the heparan sulfate-binding AAV serotype 2. The resulting chimera, AAV2G9, continues to bind heparin affinity columns but interchangeably exploits Gal and heparan sulfate receptors for infection, as evidenced by competitive inhibition assays with lectins, glycans, and parental AAV strains. Although remaining hepatotropic like AAV2, the AAV2G9 chimera mediates rapid onset and higher transgene expression in mice. Similarly, engraftment of the Gal footprint onto the laboratory-derived strain AAV2i8 yielded an enhanced AAV2i8G9 chimera. This new strain remains liver-detargeted like AAV2i8 while selectively transducing muscle tissues at high efficiency, comparable with AAV9. The AAV2i8G9 chimera is a promising vector candidate for targeted gene therapy of cardiac and musculoskeletal diseases. In addition to demonstrating the modularity of glycan receptor footprints on viral capsids, our approach provides design strategies to expand the AAV vector toolkit.	[Shen, Shen; Horowitz, Eric D.; Troupes, Andrew N.; Brown, Sarah M.; Pulicherla, Nagesh; Samulski, Richard J.; Asokan, Aravind] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Shen, Shen; Asokan, Aravind] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Asokan, Aravind] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Agbandje-McKenna, Mavis] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida	Asokan, A (corresponding author), Univ N Carolina, Gene Therapy Ctr, CB 7352,5123 Thurston Bldg, Chapel Hill, NC 27599 USA.	aravind@med.unc.edu			National Institutes of Health [R01HL089221, P01HL112761, R01AI072176, R01GM082946]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL112761, R01HL089221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL089221 and P01HL112761 (to A. A. and R. J. S.), R01AI072176 (to R. J. S.), and R01GM082946 (to M. A. M.).	Adachi K., 2012, 15 ANN M AM SOC GEN, pS4; Agbandje-McKenna M, 2011, METHODS MOL BIOL, V807, P47, DOI 10.1007/978-1-61779-370-7_3; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Asokan A, 2010, NAT BIOTECHNOL, V28, P79, DOI 10.1038/nbt.1599; Bell CL, 2012, J VIROL, V86, P7326, DOI 10.1128/JVI.00448-12; Bell CL, 2011, J CLIN INVEST, V121, P2427, DOI 10.1172/JCI57367; Bowles DE, 2012, MOL THER, V20, P443, DOI 10.1038/mt.2011.237; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DiMattia MA, 2012, J VIROL, V86, P6947, DOI 10.1128/JVI.07232-11; Fan Z, 2012, MOL THER, V20, P456, DOI 10.1038/mt.2011.137; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; High KA, 2012, BLOOD, V120, P4482, DOI 10.1182/blood-2012-05-423210; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Kern A, 2003, J VIROL, V77, P11072, DOI 10.1128/JVI.77.20.11072-11081.2003; Kornegay JN, 2010, MOL THER, V18, P1501, DOI 10.1038/mt.2010.94; Lerch TF, 2012, VIROLOGY, V423, P6, DOI 10.1016/j.virol.2011.10.007; Levy HC, 2009, J STRUCT BIOL, V165, P146, DOI 10.1016/j.jsb.2008.12.002; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Neu U, 2011, CURR OPIN STRUC BIOL, V21, P610, DOI 10.1016/j.sbi.2011.08.009; Ng R, 2010, J VIROL, V84, P12945, DOI 10.1128/JVI.01235-10; O'Donnell J, 2009, VIROLOGY, V385, P434, DOI 10.1016/j.virol.2008.11.037; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Opie SR, 2003, J VIROL, V77, P6995, DOI 10.1128/JVI.77.12.6995-7006.2003; Shen S, 2012, J VIROL, V86, P10408, DOI 10.1128/JVI.01155-12; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Wu Z, 2006, J VIROL, V80, P11393, DOI 10.1128/JVI.01288-06; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Xie Q, 2011, VIROLOGY, V420, P10, DOI 10.1016/j.virol.2011.08.011; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	39	58	67	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28814	28823		10.1074/jbc.M113.482380	http://dx.doi.org/10.1074/jbc.M113.482380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940044	Green Published, hybrid			2022-12-28	WOS:000330298800034
J	Asano, A; Nelson-Harrington, JL; Travis, AJ				Asano, Atsushi; Nelson-Harrington, Jacquelyn L.; Travis, Alexander J.			Phospholipase B Is Activated in Response to Sterol Removal and Stimulates Acrosome Exocytosis in Murine Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZONA-PELLUCIDA; LIPID RAFTS; CRYPTOCOCCUS-NEOFORMANS; DIFFERENTIAL RELEASE; CHOLESTEROL EFFLUX; MOUSE SPERMATOZOA; MEMBRANE RAFTS; IDENTIFICATION; EXPRESSION; PROTEIN	Despite a strict requirement for sterol removal for sperm to undergo acrosome exocytosis (AE), the mechanisms by which changes in membrane sterols are transduced into changes in sperm fertilization competence are poorly understood. We have previously shown in live murine sperm that the plasma membrane overlying the acrosome (APM) contains several types of microdomains known as membrane rafts. When characterizing the membrane raft-associated proteomes, we identified phospholipase B (PLB), a calcium-independent enzyme exhibiting multiple activities. Here, we show that sperm surface PLB is activated in response to sterol removal. Both biochemical activity assays and immunoblots of subcellular fractions of sperm incubated with the sterol acceptor 2-hydroxypropyl-beta-cyclodextrin (2-OHCD) confirmed the release of an active PLB fragment. Specific protease inhibitors prevented PLB activation, revealing a mechanistic requirement for proteolytic cleavage. Competitive inhibitors of PLB reduced the ability of sperm both to undergo AE and to fertilize oocytes in vitro, suggesting an important role in fertilization. This was reinforced by our finding that incubation either with protein concentrate released from 2-OHCD-treated sperm or with recombinant PLB peptide corresponding to the catalytic domain was able to induce AE in the absence of other stimuli. Together, these results lead us to propose a novel mechanism by which sterol removal promotes membrane fusogenicity and AE, helping confer fertilization competence. Importantly, this mechanism provides a basis for the newly emerging model of AE in which membrane fusions occur during capacitation/transit through the cumulus, prior to any physical contact between the sperm and the oocyte's zona pellucida.	[Asano, Atsushi; Nelson-Harrington, Jacquelyn L.; Travis, Alexander J.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA	Cornell University	Asano, A (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan.	asano.atsushi.ft@u.tsukuba.ac.jp			National Institutes of Health [R01-HD-045664, DP-OD-006431]; Baker Institute for Animal Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045664] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baker Institute for Animal Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HD-045664 and DP-OD-006431 (to A.J.T.). This work was also supported by the Baker Institute for Animal Health.	Asano A, 2010, PROTEOMICS, V10, P3494, DOI 10.1002/pmic.201000002; Asano A, 2009, J CELL PHYSIOL, V218, P537, DOI 10.1002/jcp.21623; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Basak A, 2005, FEBS LETT, V579, P4813, DOI 10.1016/j.febslet.2005.07.062; Basak A, 2008, PROTEIN EXPRES PURIF, V60, P117, DOI 10.1016/j.pep.2008.03.013; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Bergeron F, 2000, J MOL ENDOCRINOL, V24, P1, DOI 10.1677/jme.0.0240001; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Buffone MG, 2008, J BIOL CHEM, V283, P12438, DOI 10.1074/jbc.M706421200; Buffone MG, 2009, J CELL SCI, V122, P3153, DOI 10.1242/jcs.052977; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chen SCA, 2000, BIOCHEM J, V347, P431, DOI 10.1042/0264-6021:3470431; CROSS NL, 1986, CELL BIOL INT REP, V10, P545, DOI 10.1016/0309-1651(86)90029-9; Darrow AL, 2011, J LIPID RES, V52, P374, DOI 10.1194/jlr.D007971; Delagebeaudeuf C, 1998, J BIOL CHEM, V273, P13407, DOI 10.1074/jbc.273.22.13407; DENAULT JB, 1995, J CARDIOVASC PHARM, V26, pS47; Djordjevic JT, 2005, BIOCHEM J, V389, P803, DOI 10.1042/BJ20050063; ERBACH GT, 1994, BIOL REPROD, V50, P1027, DOI 10.1095/biolreprod50.5.1027; Escoffier J, 2011, J CELL PHYSIOL, V226, P2601, DOI 10.1002/jcp.22606; Escoffier J, 2010, J CLIN INVEST, V120, P1415, DOI 10.1172/JCI40494; GASSAMADIAGNE A, 1989, J BIOL CHEM, V264, P9470; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Gyamera-Acheampong C, 2006, BIOL REPROD, V74, P666, DOI 10.1095/biolreprod.105.046821; Gyamera-Acheampong C, 2010, FERTIL STERIL, V93, P1112, DOI 10.1016/j.fertnstert.2008.12.013; Gyamera-Acheampong C, 2009, HUM REPROD UPDATE, V15, P237, DOI 10.1093/humupd/dmn060; Harper CV, 2008, J CELL SCI, V121, P2130, DOI 10.1242/jcs.030379; Hendrickson HS, 1999, METH MOL B, V109, P1; Honda A, 2002, J BIOL CHEM, V277, P16976, DOI 10.1074/jbc.M112470200; Hruskova-Heidingsfeldova O, 2008, FRONT BIOSCI, V13, P7227, DOI 10.2741/3224; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Kim KS, 2003, DEV BIOL, V264, P141, DOI 10.1016/j.ydbio.2003.08.006; Kim KS, 2001, BIOL REPROD, V64, P148, DOI 10.1095/biolreprod64.1.148; Kohler GA, 2006, BBA-MOL CELL BIOL L, V1761, P1391, DOI 10.1016/j.bbalip.2006.09.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson JL, 1999, MOL REPROD DEV, V52, P445, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;445::AID-MRD14&gt;3.0.CO;2-6; Lu T, 2001, BIOCHEMISTRY-US, V40, P7133, DOI 10.1021/bi010237n; Maury E, 2002, BIOCHEM BIOPH RES CO, V295, P362, DOI 10.1016/S0006-291X(02)00657-5; Mbikay M, 1997, P NATL ACAD SCI USA, V94, P6842, DOI 10.1073/pnas.94.13.6842; NAKAYAMA K, 1992, J BIOL CHEM, V267, P5897; Nauze M, 2002, J BIOL CHEM, V277, P44093, DOI 10.1074/jbc.M205761200; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Roldan E. R. S., 1998, Frontiers in Bioscience, V3, pD1109; Roldan ERS, 2007, FRONT BIOSCI-LANDMRK, V12, P89, DOI 10.2741/2050; SAITO K, 1991, METHOD ENZYMOL, V197, P446; Santangelo RT, 1999, J MED MICROBIOL, V48, P731, DOI 10.1099/00222615-48-8-731; Selvaraj V, 2006, J CELL PHYSIOL, V206, P636, DOI 10.1002/jcp.20504; Selvaraj V, 2010, DEV BIOL, V348, P177, DOI 10.1016/j.ydbio.2010.09.019; Selvaraj V, 2009, J CELL PHYSIOL, V218, P522, DOI 10.1002/jcp.21624; Shannon M, 1999, FEBS LETT, V462, P329, DOI 10.1016/S0014-5793(99)01546-X; Siafakas AR, 2006, EUKARYOT CELL, V5, P488, DOI 10.1128/EC.5.3.488-498.2006; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SUGATANI J, 1980, BIOCHIM BIOPHYS ACTA, V620, P372; Takemori H, 1998, J BIOL CHEM, V273, P2222, DOI 10.1074/jbc.273.4.2222; Tchoua U, 2000, BBA-MOL CELL BIOL L, V1487, P255, DOI 10.1016/S1388-1981(00)00101-3; Tojo H, 1998, J BIOL CHEM, V273, P2214, DOI 10.1074/jbc.273.4.2214; Travis AJ, 1998, MOL BIOL CELL, V9, P263, DOI 10.1091/mbc.9.2.263; Travis AJ, 2002, J CLIN INVEST, V110, P731, DOI [10.1172/JCI200216392, 10.1172/JCI0216392]; Travis AJ, 2001, DEV BIOL, V240, P599, DOI 10.1006/dbio.2001.0475; Travis AJ, 2001, J BIOL CHEM, V276, P7630, DOI 10.1074/jbc.M006217200; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Visconti PE, 1999, DEV BIOL, V214, P429, DOI 10.1006/dbio.1999.9428; Wang X, 2001, J BIOL CHEM, V276, P35953, DOI 10.1074/jbc.M103680200; Wright LC, 2007, EUKARYOT CELL, V6, P37, DOI 10.1128/EC.00262-06; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	64	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28104	28115		10.1074/jbc.M113.450981	http://dx.doi.org/10.1074/jbc.M113.450981			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23943622	Green Published, hybrid			2022-12-28	WOS:000330612800035
J	Bharti, SK; Sommers, JA; George, F; Kuper, J; Hamon, F; Shin-ya, K; Teulade-Fichou, MP; Kisker, C; Brosh, RM				Bharti, Sanjay Kumar; Sommers, Joshua A.; George, Fourbears; Kuper, Jochen; Hamon, Florian; Shin-ya, Kazuo; Teulade-Fichou, Marie-Paule; Kisker, Caroline; Brosh, Robert M., Jr.			Specialization among Iron-Sulfur Cluster Helicases to Resolve G-quadruplex DNA Structures That Threaten Genomic Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANEMIA GROUP J; BIOCHEMICAL-CHARACTERIZATION; SMALL-MOLECULE; FANCJ; REPLICATION; GENE; BACH1; TELOMESTATIN; MAINTENANCE; INSTABILITY	G-quadruplex (G4) DNA, an alternate structure formed by Hoogsteen hydrogen bonds between guanines in G-rich sequences, threatens genomic stability by perturbing normal DNA transactions including replication, repair, and transcription. A variety of G4 topologies (intra- and intermolecular) can form in vitro, but the molecular architecture and cellular factors influencing G4 land-scape in vivo are not clear. Helicases that unwind structured DNA molecules are emerging as an important class of G4-resolving enzymes. The BRCA1-associated FANCJ helicase is among those helicases able to unwind G4 DNA in vitro, and FANCJ mutations are associated with breast cancer and linked to Fanconi anemia. FANCJ belongs to a conserved iron-sulfur (Fe S) cluster family of helicases important for genomic stability including XPD (nucleotide excision repair), DDX11 (sister chromatid cohesion), and RTEL (telomere metabolism), genetically linked to xeroderma pigmentosum/Cockayne syndrome, Warsaw breakage syndrome, and dyskeratosis congenita, respectively. To elucidate the role of FANCJ in genomic stability, its molecular functions in G4 metabolism were examined. FANCJ efficiently unwound in a kinetic and ATPase-dependent manner entropically favored unimolecular G4 DNA, whereas other Fe-S helicases tested did not. The G4-specific ligands Phen-DC3 or Phen-DC6 inhibited FANCJ helicase on unimolecular G4 similar to 1000-fold better than bi- or tetramolecular G4 DNA. The G4 ligand telomestatin induced DNA damage inhuman cells deficient in FANCJ but not DDX11 or XPD. These findings suggest FANCJ is a specialized Fe-S cluster helicase that preserves chromosomal stability by unwinding unimolecular G4 DNA likely to form in transiently unwound single-stranded genomic regions.	[Bharti, Sanjay Kumar; Sommers, Joshua A.; George, Fourbears; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA; [Kuper, Jochen; Kisker, Caroline] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Hamon, Florian; Teulade-Fichou, Marie-Paule] Univ Paris 11, CNRS, UMR 176, Inst Curie, F-91405 Orsay, France; [Shin-ya, Kazuo] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Wurzburg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; National Institute of Advanced Industrial Science & Technology (AIST)	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.	broshr@mail.nih.gov	Shin-ya, Kazuo/L-9613-2018; Brosh, Robert/AAR-6124-2020; Kisker, Caroline/T-1724-2019	Shin-ya, Kazuo/0000-0002-4702-0661; Kisker, Caroline/0000-0002-0216-6026	National Institutes of Health, NIA; Fanconi Anemia Research Fund; Deutsche Forschungsgemeinschaft [Forschungszentrum FZ82]; NATIONAL INSTITUTE ON AGING [ZIAAG000741, ZIAAG000752, ZIAAG000753] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fanconi Anemia Research Fund; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research program of the National Institutes of Health, NIA. This work was also supported by the Fanconi Anemia Research Fund (to R. M. B.) and through the Deutsche Forschungsgemeinschaft (Forschungszentrum FZ82; to C.K.).	Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Capo-Chichi JM, 2013, HUM MUTAT, V34, P103, DOI 10.1002/humu.22226; Chavez A, 2009, BBA-MOL BASIS DIS, V1792, P329, DOI 10.1016/j.bbadis.2009.02.008; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; De Cian A, 2007, J AM CHEM SOC, V129, P1856, DOI 10.1021/ja067352b; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; GOZUKARA EM, 1994, CANCER RES, V54, P3837; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Johnson JE, 2010, NUCLEIC ACIDS RES, V38, P1114, DOI 10.1093/nar/gkp1103; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Largy E, 2011, ANAL BIOANAL CHEM, V400, P3419, DOI 10.1007/s00216-011-5018-z; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Muller S, 2010, NAT CHEM, V2, P1095, DOI 10.1038/NCHEM.842; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Paeschke K, 2010, FEBS LETT, V584, P3760, DOI 10.1016/j.febslet.2010.07.007; Tran PLT, 2013, TOP CURR CHEM, V330, P243, DOI 10.1007/128_2012_334; Piazza A, 2010, NUCLEIC ACIDS RES, V38, P4337, DOI 10.1093/nar/gkq136; Pokharel S, 2012, NUCLEIC ACIDS RES, V40, P7821, DOI 10.1093/nar/gks534; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Rodriguez R, 2008, J AM CHEM SOC, V130, P15758, DOI 10.1021/ja805615w; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009; Shin-ya K, 2001, J AM CHEM SOC, V123, P1262, DOI 10.1021/ja005780q; Shin-ya Kazuo, 2004, Nihon Rinsho, V62, P1277; Singh DK, 2012, MUTAT RES-FUND MOL M, V736, P15, DOI 10.1016/j.mrfmmm.2011.06.002; Smith JS, 2010, METHODS MOL BIOL, V608, P207, DOI 10.1007/978-1-59745-363-9_13; Stegle O, 2009, BIOINFORMATICS, V25, pI374, DOI 10.1093/bioinformatics/btp210; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2012, J BIOL CHEM, V287, P21699, DOI 10.1074/jbc.M112.351338; Wu YL, 2012, J BIOL CHEM, V287, P1007, DOI 10.1074/jbc.M111.276022; Wu YL, 2010, FEBS J, V277, P3470, DOI 10.1111/j.1742-4658.2010.07760.x	43	88	89	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28217	28229		10.1074/jbc.M113.496463	http://dx.doi.org/10.1074/jbc.M113.496463			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23935105	hybrid, Green Published			2022-12-28	WOS:000330612800044
J	Dillon, MBC; Rust, HL; Thompson, PR; Mowen, KA				Dillon, Myles B. C.; Rust, Heather L.; Thompson, Paul R.; Mowen, Kerri A.			Automethylation of Protein Arginine Methyltransferase 8 (PRMT8) Regulates Activity by Impeding S-Adenosylmethionine Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; N-METHYLTRANSFERASE; KINETIC MECHANISM; IN-VITRO; METHYLATION; RNA; SEQUENCES; REVEALS; FAMILY; DOMAIN	Protein arginine methyltransferase (PRMT) 8 is unique among the PRMTs, as it has a highly restricted tissue expression pattern and an N terminus that contains two automethylation sites and a myristoylation site. PRMTs catalyze the transfer of a methyl group from S-adenosylmethionine (AdoMet) to a peptidylarginine on a protein substrate. Currently, the physiological roles, regulation, and cellular substrates of PRMT8 are poorly understood. However, a thorough understanding of PRMT8 kinetics should provide insights into each of these areas, thereby enhancing our understanding of this unique enzyme. In this study, we determined how automethylation regulates the enzymatic activity of PRMT8. We found that preventing automethylation with lysine mutations (preserving the positive charge of the residue) increased the turnover rate and decreased the Km of AdoMet but did not affect the Km of the protein substrate. In contrast, mimicking automethylation with phenylalanine (i.e. mimicking the increased hydrophobicity) decreased the turnover rate. The inhibitory effect of the PRMT8 N terminus could be transferred to PRMT1 by creating a chimeric protein containing the N terminus of PRMT8 fused to PRMT1. Thus, automethylation of the N terminus likely regulates PRMT8 activity by decreasing the affinity of the enzyme for AdoMet.	[Dillon, Myles B. C.; Mowen, Kerri A.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Rust, Heather L.; Thompson, Paul R.] Scripps Res Inst Florida, Dept Chem, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	Mowen, KA (corresponding author), Scripps Res Inst, Dept Physiol Chem, IMM 11,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	kmowen@scripps.edu			National Institutes of Health from NIAID [5R01 AI067460-05]; National Institutes of Health from NIGMS [5R01 GM85117-04, T32 AI007606]; Scripps Research Institute/Scripps Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067460, T32AI007606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085117] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Scripps Research Institute/Scripps Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01 AI067460-05 from NIAID and Grants 5R01 GM85117-04 and T32 AI007606 from NIGMS (to M. B. C. D. and K. A. M.). This work was also supported by The Scripps Research Institute/Scripps Florida (to H. L. R. and P. R. T.).	Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bicker KL, 2011, MOL BIOSYST, V7, P48, DOI 10.1039/c0mb00015a; Blanchet F, 2005, J EXP MED, V202, P371, DOI 10.1084/jem.20050176; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cheng DH, 2004, J BIOL CHEM, V279, P23892, DOI 10.1074/jbc.M401853200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; DEICHAITE I, 1988, MOL CELL BIOL, V8, P4295, DOI 10.1128/MCB.8.10.4295; Frankel A, 2000, J BIOL CHEM, V275, P32974, DOI 10.1074/jbc.M006445200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gui SY, 2011, J BIOL CHEM, V286, P29118, DOI 10.1074/jbc.M111.224097; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kuhn P, 2011, NUCLEIC ACIDS RES, V39, P2717, DOI 10.1093/nar/gkq1246; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Lee DY, 2007, MOL ENDOCRINOL, V21, P1381, DOI 10.1210/me.2006-0389; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lim Y, 2005, BBA-GEN SUBJECTS, V1723, P240, DOI 10.1016/j.bbagen.2005.02.015; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Lin YL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055221, 10.1371/journal.pone.0061031, 10.1371/journal.pone.0079417, 10.1371/journal.pone.0082678, 10.1371/journal.pone.0072930, 10.1371/journal.pone.0080097, 10.1371/journal.pone.0075318]; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Obianyo O, 2012, J BIOL CHEM, V287, P6062, DOI 10.1074/jbc.M111.333609; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pak ML, 2011, BIOCHEMISTRY-US, V50, P8226, DOI 10.1021/bi200644c; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Robin-Lespinasse Y, 2007, J CELL SCI, V120, P638, DOI 10.1242/jcs.03357; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Rust HL, 2011, BIOCHEMISTRY-US, V50, P3332, DOI 10.1021/bi102022e; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Siddique A, 2011, FEBS J, V278, P2055, DOI 10.1111/j.1742-4658.2011.08121.x; Singh V, 2004, ONCOGENE, V23, P7761, DOI 10.1038/sj.onc.1208057; Singhroy DN, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-73; Taneda T, 2007, BRAIN RES, V1155, P1, DOI 10.1016/j.brainres.2007.03.086; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Wei Y, 2003, BIOCHEMISTRY-US, V42, P7044, DOI 10.1021/bi0343976; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; WILCOX C, 1987, SCIENCE, V238, P1275, DOI 10.1126/science.3685978; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Xu W, 2004, GENE DEV, V18, P144, DOI 10.1101/gad.1141704; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	53	44	44	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27872	27880		10.1074/jbc.M113.491092	http://dx.doi.org/10.1074/jbc.M113.491092			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23946480	hybrid, Green Published			2022-12-28	WOS:000330612800015
J	Feinstein, TN; Yui, N; Webber, MJ; Wehbi, VL; Stevenson, HP; King, JD; Hallows, KR; Brown, D; Bouley, R; Vilardaga, JP				Feinstein, Timothy N.; Yui, Naofumi; Webber, Matthew J.; Wehbi, Vanessa L.; Stevenson, Hilary P.; King, J. Darwin, Jr.; Hallows, Kenneth R.; Brown, Dennis; Bouley, Richard; Vilardaga, Jean-Pierre			Noncanonical Control of Vasopressin Receptor Type 2 Signaling by Retromer and Arrestin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARATHYROID-HORMONE RECEPTOR; COLLECTING DUCT; BETA-ARRESTIN; PROTEIN-KINASE; CELL-LINE; KIDNEY; WATER; AQUAPORIN-2; DEGRADATION; ENDOCYTOSIS	The vasopressin type 2 receptor (V2R) is a critical G protein-coupled receptor (GPCR) for vertebrate physiology, including the balance of water and sodium ions. It is unclear how its two native hormones, vasopressin (VP) and oxytocin (OT), both stimulate the same cAMP/PKA pathway yet produce divergent antinatriuretic and antidiuretic effects that are either strong (VP) or weak (OT). Here, we present a new mechanism that differentiates the action of VP and OT on V2R signaling. We found that vasopressin, as opposed to OT, continued to generate cAMP and promote PKA activation for prolonged periods after ligand washout and receptor internalization in endosomes. Contrary to the classical model of arrestin-mediated GPCR desensitization, arrestins bind the VP-V2R complex yet extend rather than shorten the generation of cAMP. Signaling is instead turned off by the endosomal retromer complex. We propose that this mechanism explains how VP sustains water and Na+ transport in renal collecting duct cells. Together with recent work on the parathyroid hormone receptor, these data support the existence of a novel "noncanonical" regulatory pathway for GPCR activation and response termination, via the sequential action of beta-arrestin and the retromer complex.	[Feinstein, Timothy N.; Wehbi, Vanessa L.; Stevenson, Hilary P.; Vilardaga, Jean-Pierre] Univ Pittsburgh, Sch Med, Lab GPCR Biol, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Yui, Naofumi; Webber, Matthew J.; Brown, Dennis; Bouley, Richard] Massachusetts Gen Hosp, Ctr Syst Biol, Program Membrane Biol, Boston, MA 02114 USA; [Yui, Naofumi; Webber, Matthew J.; Brown, Dennis; Bouley, Richard] Massachusetts Gen Hosp, Div Nephrol, Dept Med, Boston, MA 02114 USA; [Yui, Naofumi; Webber, Matthew J.; Brown, Dennis; Bouley, Richard] Harvard Univ, Sch Med, Boston, MA 02114 USA; [King, J. Darwin, Jr.; Hallows, Kenneth R.] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bouley, R (corresponding author), Massachusetts Gen Hosp, Simches Res Ctr, Program Membrane Biol, 185 Cambridge St,CPZN 8218, Boston, MA 02114 USA.	Bouley.Richard@mgh.harvard.edu; jpv@pitt.edu		Hallows, Kenneth/0000-0002-2964-2440; Webber, Matthew/0000-0003-1092-4410; Vilardaga, Jean-Pierre/0000-0002-1217-1435	National Institutes of Health [R01 DK087688, R01 DK38452, R01 DK96586, R01 DK075048, P30 DK079307]; Boston Area Diabetes and Endocrinology Research Center [DK57521]; Center for the Study of Inflammatory Bowel Disease [DK43341]; Cystic Fibrosis Foundation [KING10F0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075048, P30DK043351, P01DK038452, R01DK096586, R01DK087688, R29DK043341, P30DK057521, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Area Diabetes and Endocrinology Research Center; Center for the Study of Inflammatory Bowel Disease; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK087688 (to J.-P. V.), R01 DK38452, and R01 DK96586 (to D. B.), R01 DK075048 (to K. R. H.), and P30 DK079307 (to the Pittsburgh Kidney Research Center). This work was also supported by Boston Area Diabetes and Endocrinology Research Center Grant DK57521, Center for the Study of Inflammatory Bowel Disease Grant DK43341, and Cystic Fibrosis Foundation Grant KING10F0 (to D. K.).	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; BALMENT RJ, 1986, J PHYSIOL-LONDON, V381, P453, DOI 10.1113/jphysiol.1986.sp016338; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bouley R, 2005, AM J PHYSIOL-CELL PH, V288, pC1390, DOI 10.1152/ajpcell.00353.2004; Brown D, 2012, AM J PHYSIOL-CELL PH, V302, pC1421, DOI 10.1152/ajpcell.00085.2012; Brown D, 2009, TRAFFIC, V10, P275, DOI 10.1111/j.1600-0854.2008.00867.x; Burtey A, 2007, TRAFFIC, V8, P914, DOI 10.1111/j.1600-0854.2007.00578.x; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Carattino MD, 2005, J BIOL CHEM, V280, P17608, DOI 10.1074/jbc.M501770200; Chen S, 2011, ENDOCRINOLOGY, V152, P3893, DOI 10.1210/en.2011-1049; CHOU CL, 1995, AM J PHYSIOL-RENAL, V269, pF78, DOI 10.1152/ajprenal.1995.269.1.F78; CHOU CL, 1995, AM J PHYSIOL-RENAL, V269, pF70, DOI 10.1152/ajprenal.1995.269.1.F70; Collins BM, 2008, TRAFFIC, V9, P1811, DOI 10.1111/j.1600-0854.2008.00777.x; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DiPilato LM, 2009, MOL BIOSYST, V5, P832, DOI 10.1039/b823243a; Edinger RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046593; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Gumz ML, 2010, BBA-GENE REGUL MECH, V1799, P622, DOI 10.1016/j.bbagrm.2010.09.003; Hallows KR, 2009, J BIOL CHEM, V284, P5774, DOI 10.1074/jbc.M805501200; Hoare S, 1999, J BIOL CHEM, V274, P28682, DOI 10.1074/jbc.274.40.28682; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Katsura T., 1997, AM J PHYSIOL, V272, pF817; Keyel PA, 2008, MOL BIOL CELL, V19, P5309, DOI 10.1091/mbc.E08-07-0712; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; LENCER WI, 1990, AM J PHYSIOL, V259, pC920, DOI 10.1152/ajpcell.1990.259.6.C920; Li C, 2008, J AM SOC NEPHROL, V19, P225, DOI 10.1681/ASN.2007010029; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Lu HAJ, 2007, J BIOL CHEM, V282, P28721, DOI 10.1074/jbc.M611101200; Luttrell LM, 2002, J CELL SCI, V115, P455; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; MORGAN T, 1968, AM J PHYSIOL, V215, P108, DOI 10.1152/ajplegacy.1968.215.1.108; MORGAN T, 1968, AM J PHYSIOL, V214, P574, DOI 10.1152/ajplegacy.1968.214.3.574; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Nelson CD, 2007, SCIENCE, V315, P663, DOI 10.1126/science.1134562; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Pioszak AA, 2010, J BIOL CHEM, V285, P12435, DOI 10.1074/jbc.M109.093138; Robben JH, 2009, P NATL ACAD SCI USA, V106, P12195, DOI 10.1073/pnas.0900130106; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Shi M, 2003, BIOCHEMISTRY-US, V42, P7283, DOI 10.1021/bi0341657; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; van Balkom BWM, 2004, AM J PHYSIOL-CELL PH, V286, pC372, DOI 10.1152/ajpcell.00271.2003; Vilardaga JP, 2012, TRENDS PHARMACOL SCI, V33, P423, DOI 10.1016/j.tips.2012.05.004; Wehbi VL, 2013, P NATL ACAD SCI USA, V110, P1530, DOI 10.1073/pnas.1205756110; Yui N, 2013, AM J PHYSIOL-CELL PH, V304, pC38, DOI 10.1152/ajpcell.00109.2012; Yui N, 2009, AM J PHYSIOL-CELL PH, V297, pC1389, DOI 10.1152/ajpcell.00098.2009; Zalyapin EA, 2008, KIDNEY INT, V74, P1557, DOI 10.1038/ki.2008.412	55	126	129	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27849	27860		10.1074/jbc.M112.445098	http://dx.doi.org/10.1074/jbc.M112.445098			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23935101	Green Published, hybrid			2022-12-28	WOS:000330612800013
J	Ahijado-Guzman, R; Alfonso, C; Reija, B; Salvarelli, E; Mingorance, J; Zorrilla, S; Monterroso, B; Rivas, G				Ahijado-Guzman, Ruben; Alfonso, Carlos; Reija, Belen; Salvarelli, Estefania; Mingorance, Jesus; Zorrilla, Silvia; Monterroso, Begona; Rivas, German			Control by Potassium of the Size Distribution of Escherichia coli FtsZ Polymers Is Independent of GTPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVISION PROTEIN FTSZ; BACTERIAL-CELL DIVISION; LIGHT-SCATTERING; POLYMERIZATION; DYNAMICS; TUBULIN; ULTRACENTRIFUGATION; PROTOFILAMENTS; HYDROLYSIS; TURNOVER	The influence of potassium content (at neutral pH and millimolar Mg2+) on the size distribution of FtsZ polymers formed in the presence of constantly replenished GTP under steady-state conditions was studied by a combination of biophysical methods. The size of the GTP-FtsZ polymers decreased with lower potassium concentration, in contrast with the increase in the mass of the GDP-FtsZ oligomers, whereas no effect was observed on FtsZ GTPase activity and critical concentration of polymerization. Remarkably, the concerted formation of a narrow size distribution of GTP-FtsZ polymers previously observed at high salt concentration was maintained in all KCl concentrations tested. Polymers induced with guanosine 5 '-(alpha,beta-methylene)triphosphate, a slowly hydrolyzable analog of GTP, became larger and polydisperse as the potassium concentration was decreased. Our results suggest that the potassium dependence of the GTP-FtsZ polymer size may be related to changes in the subunit turnover rate that are independent of the GTP hydrolysis rate. The formation of a narrow size distribution of FtsZ polymers under very different solution conditions indicates that it is an inherent feature of FtsZ, not observed in other filament forming proteins, with potential implications in the structural organization of the functional Z-ring.	[Ahijado-Guzman, Ruben; Alfonso, Carlos; Monterroso, Begona; Rivas, German] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Reija, Belen; Zorrilla, Silvia] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [Salvarelli, Estefania; Mingorance, Jesus] Hosp Univ La Paz, IdiPAZ, Microbiol Serv, Madrid 28046, Spain; [Salvarelli, Estefania] Biomol Informat SL, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Hospital Universitario La Paz	Monterroso, B (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	monterroso@cib.csic.es; grivas@cib.csic.es	Monterroso, Begoña/J-9748-2014; Rivas, German/AFL-7528-2022; Rivas, German/AAG-7458-2022; Ahijado-Guzmán, Rubén/F-7934-2016; Mingorance, Jesus/B-7562-2009; Alfonso, Carlos/K-1316-2014; Zorrilla, Silvia/J-9771-2014	Monterroso, Begoña/0000-0003-2538-084X; Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Ahijado-Guzmán, Rubén/0000-0002-9863-0443; Mingorance, Jesus/0000-0001-6173-5711; Alfonso, Carlos/0000-0001-7165-4800; Zorrilla, Silvia/0000-0002-6309-9058	Human Frontier Science Program [RGP0050/2010]; European Commission [HEALTH-F3-2009-223431]; Spanish Government [BIO2008-04478-C03, CSIC PIE-201020I001, BFU2010-14910, BIO2011-28941-C03]	Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported in part by Human Frontier Science Program Grant RGP0050/2010; European Commission Contract HEALTH-F3-2009-223431 (to G. R.); and Spanish Government Grants BIO2008-04478-C03 (to G. R.), CSIC PIE-201020I001 (to C. A.), BFU2010-14910 (to S. Z.), and BIO2011-28941-C03 (to G. R. and S. Z.).	Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Fernandez C, 2008, ANAL BIOCHEM, V381, P254, DOI 10.1016/j.ab.2008.06.032; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Hernandez-Rocamora VM, 2013, J BIOL CHEM, V288, P24625, DOI 10.1074/jbc.M113.483222; Hernandez-Rocamora VM, 2012, J BIOL CHEM, V287, P30097, DOI 10.1074/jbc.M112.388959; HOENIG M, 1989, J BIOCHEM BIOPH METH, V19, P249, DOI 10.1016/0165-022X(89)90031-6; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Laue TN, 1992, ANAL ULTRACENTRIFUGA, V224, P90; Mateos-Gil P, 2012, P NATL ACAD SCI USA, V109, P8133, DOI 10.1073/pnas.1204844109; Mendieta J, 2009, J MOL BIOL, V390, P17, DOI 10.1016/j.jmb.2009.05.018; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Monterroso B, 2013, METHODS, V59, P349, DOI 10.1016/j.ymeth.2012.12.014; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P6108, DOI 10.1021/bi300891q; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P4541, DOI 10.1021/bi300401b; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Pacheco-Gomez R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019369; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P190, DOI 10.1016/S0968-0004(98)01207-9; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Romberg L, 2004, BIOCHEMISTRY-US, V43, P282, DOI 10.1021/bi035465r; Salvarelli E, 2011, FEBS LETT, V585, P3880, DOI 10.1016/j.febslet.2011.10.046; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Strauss MP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001389; Svedberg T, 1940, THE ULTRACENTRIFUGE; Tadros M, 2006, FEBS LETT, V580, P4941, DOI 10.1016/j.febslet.2006.07.083; Turner DJ, 2012, BIOPHYS J, V102, P731, DOI 10.1016/j.bpj.2012.01.015	32	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27358	27365		10.1074/jbc.M113.482943	http://dx.doi.org/10.1074/jbc.M113.482943			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23940054	hybrid, Green Published			2022-12-28	WOS:000330597300031
J	Chun, Y; Lee, M; Park, B; Lee, S				Chun, Younghwa; Lee, Miae; Park, Byoungwoo; Lee, Soojin			CSN5/JAB1 Interacts with the Centromeric Components CENP-T and CENP-W and Regulates Their Proteasome-mediated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 2 CUG2; COP9 SIGNALOSOME; PROTEIN ICP0; CELL-CYCLE; CANCER; COMPLEX; JAB1/CSN5; APOPTOSIS; KINETOCHORE; SUBUNITS	The CENP-T.CENP-W complex is a recently identified inner centromere component that plays crucial roles in the formation of a functional kinetochore involved in cell division during mitosis. Using yeast two-hybrid screening, we identified an interaction between CENP-T and CSN5, the fifth component of the COP9 signalosome and a key modulator of the cell cycle and cancer. Co-immunoprecipitation revealed that CSN5 directly interacts with both CENP-T and CENP-W. Ectopically expressed CSN5 promoted the ubiquitin-and proteasome-dependent degradation of CENP-T.CENP-W. The formation of a CENP-T.CENP-W complex greatly enhanced the stabilities of the respective proteins, possibly by blocking CSN5-mediated degradation. Furthermore, dysregulation of CSN5 induced severe defects in the recruitment of CENP-T.CENP-W to the kinetochore during the prophase stage of mitosis. Thus, our results indicate that CSN5 regulates the stability of the inner kinetochore components CENP-T and CENP-W, providing the first direct link between CSN5 and the mitotic apparatus, highlighting the role of CSN5 as a multifunctional cell cycle regulator.	[Chun, Younghwa; Lee, Miae; Park, Byoungwoo; Lee, Soojin] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Taejon 305764, South Korea	Chungnam National University	Lee, S (corresponding author), Chungnam Natl Univ, Dept Microbiol & Mol Biol, Taejon 305764, South Korea.	leesoojin@cnu.ac.kr		Lee, Soojin/0000-0002-0383-5025	Basic Science Research Program through the National Research Foundation of Korea (NRF) by Ministry of Education, Science and Technology [20100026575, 2013R1A1A3A04005274]	Basic Science Research Program through the National Research Foundation of Korea (NRF) by Ministry of Education, Science and Technology	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) by Ministry of Education, Science and Technology Grants 20100026575 and 2013R1A1A3A04005274.	Adler AS, 2008, CANCER RES, V68, P506, DOI 10.1158/0008-5472.CAN-07-3060; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; Chun Y, 2011, J BIOL CHEM, V286, P42758, DOI 10.1074/jbc.M111.228411; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Fukumoto A, 2006, FEBS LETT, V580, P5836, DOI 10.1016/j.febslet.2006.09.042; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Kim H, 2009, MOL CELLS, V27, P697, DOI 10.1007/s10059-009-0083-2; Kim HT, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-49; Labazi M, 2003, ESSAYS BIOCHEM, V39, P89, DOI 10.1042/bse0390089; Lee S, 2007, BIOCHEM BIOPH RES CO, V360, P633, DOI 10.1016/j.bbrc.2007.06.102; Lee S, 2010, CELL BIOCHEM FUNCT, V28, P461, DOI 10.1002/cbf.1678; Lomonte P, 2001, J BIOL CHEM, V276, P5829, DOI 10.1074/jbc.M008547200; Lomonte P, 2007, FEBS LETT, V581, P658, DOI 10.1016/j.febslet.2007.01.027; Mellone B, 2006, NAT CELL BIOL, V8, P427, DOI 10.1038/ncb0506-427; Mukhopadhyay D, 2010, CELL CYCLE, V9, P3194, DOI 10.4161/cc.9.16.12619; Nishino T, 2012, CELL, V148, P487, DOI 10.1016/j.cell.2011.11.061; Pearce C, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-31; Richardson KS, 2005, MOL CANCER RES, V3, P645, DOI 10.1158/1541-7786.MCR-05-0233; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; Shackleford TJ, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-26; Tian L, 2010, ONCOGENE, V29, P6125, DOI 10.1038/onc.2010.345; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Yoshida A, 2010, FEBS LETT, V584, P4545, DOI 10.1016/j.febslet.2010.10.039	26	13	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27208	27219		10.1074/jbc.M113.469221	http://dx.doi.org/10.1074/jbc.M113.469221			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23926101	Green Published, hybrid			2022-12-28	WOS:000330597300019
J	Verma, N; Hung, KH; Kang, JJ; Barakat, NH; Stumph, WE				Verma, Neha; Hung, Ko-Hsuan; Kang, Jin Joo; Barakat, Nermeen H.; Stumph, William E.			Differential Utilization of TATA Box-binding Protein (TBP) and TBP-related Factor 1 (TRF1) at Different Classes of RNA Polymerase III Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE NUCLEAR FRACTION; TRANSCRIPTION FACTOR; DROSOPHILA U1; GENE PROMOTERS; FACTOR-TFIIIB; C-ELEGANS; IN-VITRO; ELEMENT; EXPRESSION; SUBUNITS	In the fruit fly Drosophila melanogaster, RNA polymerase III transcription was found to be dependent not upon the canonical TATA box-binding protein (TBP) but instead upon the TBP-related factor 1 (TRF1) (Takada, S., Lis, J. T., Zhou, S., and Tjian, R. (2000) Cell 101, 459-469). Here we confirm that transcription of fly tRNA genes requires TRF1. However, we unexpectedly find that U6 snRNA gene promoters are occupied primarily by TBP in cells and that knockdown of TBP, but not TRF1, inhibits U6 transcription in cells. Moreover, U6 transcription in vitro effectively utilizes TBP, whereas TBP cannot substitute for TRF1 to promote tRNA transcription in vitro. Thus, in fruit flies, different classes of RNA polymerase III promoters differentially utilize TBP and TRF1 for the initiation of transcription.	[Verma, Neha; Hung, Ko-Hsuan; Kang, Jin Joo; Barakat, Nermeen H.; Stumph, William E.] San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA; [Verma, Neha] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Hung, Ko-Hsuan; Kang, Jin Joo; Barakat, Nermeen H.; Stumph, William E.] San Diego State Univ, Dept Chem & Biochem, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University	Stumph, WE (corresponding author), San Diego State Univ, Dept Chem & Biochem, 5500 Campanile Dr, San Diego, CA 92182 USA.	wstumph@mail.sdsu.edu			National Science Foundation [MCB-1157549]; California Metabolic Research Foundation; Direct For Biological Sciences [1157549] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); California Metabolic Research Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB-1157549 (to W. E. S.) and in part by the California Metabolic Research Foundation.	Barakat NH, 2008, FEBS LETT, V582, P2413, DOI 10.1016/j.febslet.2008.06.003; Berk AJ, 2000, CELL, V103, P5, DOI 10.1016/S0092-8674(00)00098-2; CROWLEY TE, 1993, NATURE, V361, P557, DOI 10.1038/361557a0; Dantonel JC, 2000, MOL CELL, V6, P715, DOI 10.1016/S1097-2765(00)00069-1; Dantonel JC, 1999, TRENDS BIOCHEM SCI, V24, P335, DOI 10.1016/S0968-0004(99)01436-X; DAS G, 1987, J BIOL CHEM, V262, P1187; Davidson I, 2003, TRENDS BIOCHEM SCI, V28, P391, DOI 10.1016/S0968-0004(03)00117-8; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Egloff S, 2008, BIOCHEM SOC T, V36, P590, DOI 10.1042/BST0360590; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Holmes MC, 2000, SCIENCE, V288, P867, DOI 10.1126/science.288.5467.867; Hung KH, 2012, FEBS LETT, V586, P841, DOI 10.1016/j.febslet.2012.02.009; Hung KH, 2011, CRIT REV BIOCHEM MOL, V46, P11, DOI 10.3109/10409238.2010.518136; Isogai Y, 2007, GENE DEV, V21, P2936, DOI 10.1101/gad.1608807; Isogai Y, 2007, EMBO J, V26, P76, DOI 10.1038/sj.emboj.7601448; Jawdekar GW, 2008, BBA-GENE REGUL MECH, V1779, P295, DOI 10.1016/j.bbagrm.2008.04.001; Kaltenbach L, 2000, MOL CELL, V6, P705, DOI 10.1016/S1097-2765(00)00068-X; KAMAKAKA RT, 1991, P NATL ACAD SCI USA, V88, P1024, DOI 10.1073/pnas.88.3.1024; KAMAKAKA RT, 1994, METHOD CELL BIOL, V44, P225, DOI 10.1016/S0091-679X(08)60916-4; KASSAVETIS GA, 1991, P NATL ACAD SCI USA, V88, P7308, DOI 10.1073/pnas.88.16.7308; Li C, 2004, MOL CELL BIOL, V24, P1897, DOI 10.1128/MCB.24.5.1897-1906.2004; McNamara-Schroeder KJ, 2001, J BIOL CHEM, V276, P31786, DOI 10.1074/jbc.M101273200; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Reina JH, 2007, GENE DEV, V21, P2855, DOI 10.1101/gad.1623207; SADOWSKI CL, 1993, GENE DEV, V7, P1535, DOI 10.1101/gad.7.8.1535; Saida F, 2008, BIOCHEMISTRY-US, V47, P13197, DOI 10.1021/bi801406z; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Su Y, 1997, EUR J BIOCHEM, V248, P231, DOI 10.1111/j.1432-1033.1997.t01-1-00231.x; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; Trivedi A, 1996, MOL CELL BIOL, V16, P6909; Veenstra GJC, 2000, SCIENCE, V290, P2312, DOI 10.1126/science.290.5500.2312; Vilalta A, 1997, J BIOL CHEM, V272, P18087, DOI 10.1074/jbc.272.29.18087; Willis IM, 2002, GENE DEV, V16, P1337, DOI 10.1101/gad.998102; WILLIS IM, 1993, EUR J BIOCHEM, V212, P1, DOI 10.1111/j.1432-1033.1993.tb17626.x; Yoon JB, 1996, MOL CELL BIOL, V16, P1; ZAMROD Z, 1993, MOL CELL BIOL, V13, P5918, DOI 10.1128/MCB.13.9.5918	40	10	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27564	27570		10.1074/jbc.C113.503094	http://dx.doi.org/10.1074/jbc.C113.503094			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23955442	Green Published, hybrid			2022-12-28	WOS:000330597300051
J	Capecci, J; Forgac, M				Capecci, Joseph; Forgac, Michael			The Function of Vacuolar ATPase (V-ATPase) a Subunit Isoforms in Invasiveness of MCF10a and MCF10CA1a Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Breast Cancer; Invasion; Proton Pumps; Proton Transport; Vacuolar ATPase; a Subunit Isoforms	H+-ATPASE; A3 ISOFORM; PROTON PUMPS; METASTASIS; EXPRESSION; MEMBRANE; PH; HOMEOSTASIS; INHIBITION; INVASION	Background: The V-ATPase has been suggested to function in tumor cell invasion. Results: Invasion by MCF10CA1a cells is inhibited by knockdown of the a3 isoform, whereas a3 overexpression increases invasion and plasma membrane localization of V-ATPases in MCF10a cells. Conclusion: Invasion and plasma membrane V-ATPase localization can be controlled by expression of a3. Significance: a3 is a possible therapeutic target to limit metastasis. The vacuolar H+ ATPases (V-ATPases) are ATP-driven proton pumps that transport protons across both intracellular and plasma membranes. Previous studies have implicated V-ATPases in the invasiveness of various cancer cell lines. In this study, we evaluated the role of V-ATPases in the invasiveness of two closely matched human breast cancer lines. MCF10a cells are a non-invasive, immortalized breast epithelial cell line, and MCF10CA1a cells are a highly invasive, H-Ras-transformed derivative of MCF10a cells selected for their metastatic potential. Using an in vitro Matrigel assay, MCF10CA1a cells showed a much higher invasion than the parental MCF10a cells. Moreover, this increased invasion was completely sensitive to the specific V-ATPase inhibitor concanamycin. MCF10CA1a cells expressed much higher levels of both a1 and a3 subunit isoforms relative to the parental line. Isoforms of subunit a are responsible for subcellular localization of V-ATPases, with a3 and a4 targeting V-ATPases to the plasma membrane of specialized cells. Knockdown of either a3 alone or a3 and a4 together using isoform-specific siRNAs inhibited invasion by MCF10CA1a cells. Importantly, overexpression of a3 but not the other a subunit isoforms greatly increased the invasiveness of the parental MCF10a cells. Similarly, overexpression of a3 significantly increased expression of V-ATPases at the plasma membrane. These studies suggest that breast tumor cells employ particular a subunit isoforms to target V-ATPases to the plasma membrane, where they function in tumor cell invasion.	[Forgac, Michael] Tufts Univ, Dept Dev Mol & Chem Biol, Sch Med, Boston, MA 02111 USA; Tufts Univ, Program Cellular & Mol Physiol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA	Tufts University; Tufts University	Forgac, M (corresponding author), Tufts Univ, Dept Dev Mol & Chem Biol, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			National Institutes of Health [GM34478]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34478 (to M. F.).	Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Cao XQ, 2012, AM J PHYSIOL-RENAL, V302, pF1121, DOI 10.1152/ajprenal.00278.2011; Chung CH, 2011, LAB INVEST, V91, P732, DOI 10.1038/labinvest.2011.8; Dawson PJ, 1996, AM J PATHOL, V148, P313; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Gillet L, 2009, J BIOL CHEM, V284, P8671, DOI 10.1074/jbc.M806891200; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gondi CS, 2013, EXPERT OPIN THER TAR, V17, P281, DOI 10.1517/14728222.2013.740461; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hendrix A, 2013, INT J CANCER, V133, P843, DOI 10.1002/ijc.28079; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hu YW, 2005, FEBS LETT, V579, P4937, DOI 10.1016/j.febslet.2005.07.078; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; Michel V, 2013, INT J CANCER, V132, pE1, DOI 10.1002/ijc.27811; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Partridge J, 2009, JOVE-J VIS EXP, P1475; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Rojas JD, 2006, AM J PHYSIOL-HEART C, V291, pH1147, DOI 10.1152/ajpheart.00166.2006; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Smith AB, 2000, ORG LETT, V2, P1; Smith AN, 2001, J BIOL CHEM, V276, P42382, DOI 10.1074/jbc.M107267200; SOULE HD, 1990, CANCER RES, V50, P6075; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Wang Y, 2008, J BIOL CHEM, V283, P20696, DOI 10.1074/jbc.M803258200; Wiedmann RM, 2012, CANCER RES, V72, P5976, DOI 10.1158/0008-5472.CAN-12-1772	42	63	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32731	32741		10.1074/jbc.M113.503771	http://dx.doi.org/10.1074/jbc.M113.503771			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072707	Green Published, hybrid			2022-12-28	WOS:000328681700057
J	Schwend, T; Jin, ZG; Jiang, K; Mitchell, BJ; Jia, JH; Yang, J				Schwend, Tyler; Jin, Zhigang; Jiang, Kai; Mitchell, Brian J.; Jia, Jianhang; Yang, Jing			Stabilization of Speckle-type POZ Protein (Spop) by Daz Interacting Protein 1 (Dzip1) Is Essential for Gli Turnover and the Proper Output of Hedgehog Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cilia; Development; Hedgehog; Protein Degradation; Xenopus; Dzip1; Gli; Spop	ZINC-FINGER PROTEIN; SONIC HEDGEHOG; CUBITUS-INTERRUPTUS; UBIQUITIN LIGASE; PRIMARY CILIUM; CELL IDENTITY; FLOOR PLATE; GENE; SUPPRESSOR; ZEBRAFISH	Background: Although Dzip1 positively influences Hedgehog signaling by regulating ciliogenesis, it inhibits the Hedgehog pathway through an unclear mechanism. Results: Dzip1 knockdown destabilizes Spop E3 ubiquitin ligase, leading to increased Gli transcription factor levels and phenotypes resembling Hedgehog signaling activation. Conclusion: Dzip1 inhibits Hedgehog signaling through stabilizing Spop. Significance: We uncover a novel Gli regulatory mechanism. The Hedgehog (Hh) pathway is essential for embryonic development and adult tissue homeostasis. The Gli/Cubitus interruptus (Ci) family of transcription factors acts at the downstream end of the pathway to mediate Hh signaling. Both Hh-dependent and -independent Gli regulatory mechanisms are important for the output of Hh signaling. Daz interacting protein 1 (Dzip1) has bipartite positive and negative functions in the Hh pathway. The positive Hh regulatory function appears to be attributed to a requirement for Dzip1 during ciliogenesis. The mechanism by which Dzip1 inhibits Hh signaling, however, remains largely unclear. We recently found that Dzip1 is required for Gli turnover, which may account for its inhibitory function in Hh signaling. Here, we report that Dzip1 regulates Gli/Ci turnover by preventing degradation of speckle-type POZ protein (Spop), a protein that promotes proteasome-dependent turnover of Gli proteins. We provide evidence that Dzip1 regulates the stability of Spop independent of its function in ciliogenesis. Partial knockdown of Dzip1 to levels insufficient for perturbing ciliogenesis, sensitized Xenopus embryos to Hh signaling, leading to phenotypes that resemble activation of Hh signaling. Importantly, overexpression of Spop was able to restore proper Gli protein turnover and rescue phenotypes in Dzip1-depleted embryos. Consistently, depletion of Dzip1 in Drosophila S2 cells destabilized Hh-induced BTB protein (HIB), the Drosophila homolog of Spop, and increased the level of Ci. Thus, Dzip1-dependent stabilization of Spop/HIB is evolutionarily conserved and essential for proper regulation of Gli/Ci proteins in the Hh pathway.	[Schwend, Tyler; Jin, Zhigang; Yang, Jing] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Urbana, IL 61802 USA; [Jiang, Kai; Jia, Jianhang] Univ Kentucky, Dept Mol & Cellular Biochem, Markey Canc Ctr, Lexington, KY 40536 USA; [Mitchell, Brian J.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Kentucky; Northwestern University; Feinberg School of Medicine	Yang, J (corresponding author), Univ Illinois, Coll Vet Med, Dept Comparat Biosci, 2001 South Lincoln Ave,3411 VMBSB, Urbana, IL 61802 USA.	yangj@illinois.edu	Jin, Zhigang/T-7125-2019	Jin, Zhigang/0000-0001-7557-2968; Jiang, Kai/0000-0002-8507-1945; Mitchell, Brian/0000-0001-6281-1536; Jia, Jianhang/0000-0002-9313-3843	NICHD, National Institutes of Health; NATIONAL EYE INSTITUTE [F32EY021708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093217, R01GM079684] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. A. Liu and R. Harland for plasmids. BA-F8 and 12/101 antibodies were obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the NICHD, National Institutes of Health and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242.	AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dammermann A, 2009, GENE DEV, V23, P2046, DOI 10.1101/gad.1810409; Dellovade T, 2006, ANNU REV NEUROSCI, V29, P539, DOI 10.1146/annurev.neuro.29.051605.112858; Ding Q, 1998, DEVELOPMENT, V125, P2533; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; EKKER SC, 1995, DEVELOPMENT, V121, P2337; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Glazer AM, 2010, DEV BIOL, V337, P148, DOI 10.1016/j.ydbio.2009.10.025; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Grimaldi A, 2004, DEVELOPMENT, V131, P3249, DOI 10.1242/dev.01194; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jin ZG, 2011, J BIOL CHEM, V286, P36171, DOI 10.1074/jbc.M111.274761; Jin ZG, 2010, J BIOL CHEM, V285, P34493, DOI 10.1074/jbc.M110.169581; Jin Z, 2009, J BIOL CHEM, V284, P7190, DOI 10.1074/jbc.M807907200; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Kim HR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-65; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Lupo G, 2005, DEVELOPMENT, V132, P1737, DOI 10.1242/dev.01726; MACDONALD R, 1995, DEVELOPMENT, V121, P3267; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Matise MP, 1998, DEVELOPMENT, V125, P2759; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Nagai Y, 1997, FEBS LETT, V418, P23, DOI 10.1016/S0014-5793(97)01340-9; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Oro AE, 2007, CURR OPIN CELL BIOL, V19, P691, DOI 10.1016/j.ceb.2007.10.008; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; Perron M, 2003, DEVELOPMENT, V130, P1565, DOI 10.1242/dev.00391; Peyrot SM, 2011, DEV BIOL, V352, P254, DOI 10.1016/j.ydbio.2011.01.021; PREAT T, 1992, GENETICS, V132, P725; Rorick AM, 2007, DEV BIOL, V302, P477, DOI 10.1016/j.ydbio.2006.10.011; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Sekimizu K, 2004, DEVELOPMENT, V131, P2521, DOI 10.1242/dev.01059; Sive H., 2000, LAB MANUAL, P91; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tay SY, 2010, DEV DYNAM, V239, P527, DOI 10.1002/dvdy.22199; Vokes SA, 2004, CURR BIOL, V14, pR668, DOI 10.1016/j.cub.2004.08.015; Wang CB, 2013, J BIOL CHEM, V288, P29518, DOI 10.1074/jbc.M113.492066; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wang GL, 2000, GENE DEV, V14, P2893, DOI 10.1101/gad.843900; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106; Zhang XM, 2001, DEV BIOL, V233, P271, DOI 10.1006/dbio.2000.0195; Zhang XM, 2001, DEVELOPMENT, V128, P943	64	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32809	32820		10.1074/jbc.M113.512962	http://dx.doi.org/10.1074/jbc.M113.512962			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072710	Green Published, hybrid			2022-12-28	WOS:000328681700064
J	Kim, M; Song, LK; Moon, J; Sun, ZYJ; Bershteyn, A; Hanson, M; Cain, D; Goka, S; Kelsoe, G; Wagner, G; Irvine, D; Reinherz, EL				Kim, Mikyung; Song, Likai; Moon, James; Sun, Zhen-Yu J.; Bershteyn, Anna; Hanson, Melissa; Cain, Derek; Goka, Selasie; Kelsoe, Garnett; Wagner, Gerhard; Irvine, Darrell; Reinherz, Ellis L.			Immunogenicity of Membrane-bound HIV-1 gp41 Membrane-proximal External Region (MPER) Segments Is Dominated by Residue Accessibility and Modulated by Stereochemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL RESPONSES; IMMUNE-RESPONSE; NEUTRALIZING ANTIBODIES; PEPTIDE EPITOPE; VIRUS; PROTEIN; AFFINITY; ANTIGEN; MATURATION; BROAD	Structural characterization of epitope-paratope pairs has contributed to the understanding of antigenicity. By contrast, few structural studies relate to immunogenicity, the process of antigen-induced immune responses in vivo. Using a lipid-arrayed membrane-proximal external region (MPER) of HIV-1 glycoprotein 41 as a model antigen, we investigated the influence of physicochemical properties on immunogenicity in relation to structural modifications of MPER/liposome vaccines. Anchoring the MPER to the membrane via an alkyl tail or transmembrane domain retained the MPER on liposomes in vivo, while preserving MPER secondary structure. However, structural modifications that affected MPER membrane orientation and antigenic residue accessibility strongly impacted induced antibody responses. The solvent-exposed MPER tryptophan residue (Trp-680) was immunodominant, focusing immune responses, despite sequence variability elsewhere. Nonetheless, immunogenicity could be readily manipulated using site-directed mutagenesis or structural constraints to modulate amino acid surface display. These studies provide fundamental insights for immunogen design aimed at targeting B cell antibody responses.	[Kim, Mikyung; Goka, Selasie; Reinherz, Ellis L.] Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA; [Kim, Mikyung; Goka, Selasie; Reinherz, Ellis L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kim, Mikyung] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Song, Likai] Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Moon, James; Bershteyn, Anna; Hanson, Melissa; Irvine, Darrell] MIT, Dept Mat Sci & Engn & Biol Engn, Cambridge, MA 02139 USA; [Sun, Zhen-Yu J.; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Cain, Derek; Kelsoe, Garnett] Duke Univ, Dept Immunol, Sch Med, Durham, NC 27710 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; State University System of Florida; Florida State University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Duke University	Kim, M (corresponding author), Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA.	mikyung_kim@dfci.harvard.edu; ellis_reinherz@dfci.harvard.edu	Moon, James/AAA-9905-2020; Moon, James J/ABE-4429-2021	Moon, James/0000-0001-8071-1491; Moon, James J/0000-0003-2238-2372; Hanson, Melissa/0000-0003-3270-8460	National Institutes of Health [AI 84785, AI 91693, AI 81579]; NIAID [HHSN272201000053C]; Bill and Melinda Gates Foundation; National High Magnetic Field Laboratory User Collaboration Grants Program [5080]; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084785, R01AI081579, U19AI091693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National High Magnetic Field Laboratory User Collaboration Grants Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI 84785 (to E. L. R. and G. W.), AI 91693 (to E. L. R., G. W., G. H. K., and D. I.), AI 81579 and HHSN272201000053C from NIAID and a Collaboration for AIDS Vaccine Discovery grant from the Bill and Melinda Gates Foundation (to E. L. R., G. W. and D. I.) and a Global Health grant from the Bill and Melinda Gates Foundation (to G. H. K.).; Supported by National High Magnetic Field Laboratory User Collaboration Grants Program Grant 5080.	Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Bershteyn A, 2008, SOFT MATTER, V4, P1787, DOI 10.1039/b804933e; BERZOFSKY JA, 1985, SCIENCE, V229, P932, DOI 10.1126/science.2410982; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chies MD, 2001, IMMUNOLOGY, V103, P172, DOI 10.1046/j.1365-2567.2001.01242.x; CHUA MM, 1987, J IMMUNOL, V138, P1281; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CLARKE SH, 1990, J IMMUNOL, V144, P2795; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; GEYSEN HM, 1987, SCIENCE, V235, P1184, DOI 10.1126/science.3823878; GRASMASSE HS, 1986, MOL IMMUNOL, V23, P1391, DOI 10.1016/0161-5890(86)90025-8; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jackson RM, 1999, PROTEIN SCI, V8, P603; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; McLellan JS, 2011, J MOL BIOL, V409, P853, DOI 10.1016/j.jmb.2011.04.044; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; Nakra P, 2000, J IMMUNOL, V164, P5615, DOI 10.4049/jimmunol.164.11.5615; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stanfield RL, 2011, J MOL BIOL, V414, P460, DOI 10.1016/j.jmb.2011.10.014; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; TAINER JA, 1984, NATURE, V312, P127, DOI 10.1038/312127a0; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; TORCHILIN VP, 1994, BBA-BIOMEMBRANES, V1195, P11, DOI 10.1016/0005-2736(94)90003-5; Vijayakrishnan L, 1997, J IMMUNOL, V159, P1809; Watson DS, 2009, VACCINE, V27, P4672, DOI 10.1016/j.vaccine.2009.05.059; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977; Yu XC, 2008, J IMMUNOL METHODS, V336, P142, DOI 10.1016/j.jim.2008.04.008; Zlatkovic J, 2011, J VIROL, V85, P1994, DOI 10.1128/JVI.01886-10	55	35	38	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31888	31901		10.1074/jbc.M113.494609	http://dx.doi.org/10.1074/jbc.M113.494609			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047898	hybrid, Green Published			2022-12-28	WOS:000330596200038
J	Morgan-Fisher, M; Couchman, JR; Yoneda, A				Morgan-Fisher, Marie; Couchman, John R.; Yoneda, Atsuko			Phosphorylation and mRNA Splicing of Collapsin Response Mediator Protein-2 Determine Inhibition of Rho-associated Protein Kinase (ROCK) II Function in Carcinoma Cell Migration and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; SIGNALING PATHWAYS; MYOSIN; ACTIVATION; SURVIVAL; CANCER; GSK-3; TARGET; CRMP-2	The Rho-associated protein kinases (ROCK I and II) are central regulators of important cellular processes such as migration and invasion downstream of the GTP-Rho. Recently, we reported collapsin response mediator protein (CRMP)-2 as an endogenous ROCK II inhibitor. To reveal how the CRMP-2-ROCK II interaction is controlled, we further mapped the ROCK II interaction site of CRMP-2 and examined whether phosphorylation states of CRMP-2 affected the interaction. Here, we show that an N-terminal fragment of the long CRMP-2 splice variant (CRMP-2L) alone binds ROCK II and inhibits colon carcinoma cell migration and invasion. Furthermore, the interaction of CRMP-2 and ROCK II is partially regulated by glycogen synthase kinase (GSK)-3 phosphorylation of CRMP-2, downstream of PI3K. Inhibition of PI3K reduced interaction of CRMP-2 with ROCK II, an effect rescued by simultaneous inhibition of GSK3. Inhibition of PI3K also reduced colocalization of ROCK II and CRMP-2 at the cell periphery in human breast carcinoma cells. Mimicking GSK3 phosphorylation of CRMP-2 significantly reduced CRMP-2 binding of recombinant full-length and catalytic domain of ROCK II. These data implicate GSK3 in the regulation of ROCK II-CRMP-2 interactions. Using phosphorylation-mimetic and -resistant CRMP-2L constructs, it was revealed that phosphorylation of CRMP-2L negatively regulates its inhibitory function in ROCK-dependent haptotactic cell migration, as well as invasion of human colon carcinoma cells. Collectively, the presented data show that CRMP-2-dependent regulation of ROCK II activity is mediated through interaction of the CRMP-2L N terminus with the ROCK II catalytic domain as well as by GSK3-dependent phosphorylation of CRMP-2.	[Morgan-Fisher, Marie; Couchman, John R.; Yoneda, Atsuko] Univ Copenhagen, Dept Biomed Sci, Fac Hlth & Med Sci, DK-2200 Copenhagen N, Denmark; [Morgan-Fisher, Marie; Couchman, John R.; Yoneda, Atsuko] Univ Copenhagen, BRIC, DK-2200 Copenhagen N, Denmark; [Yoneda, Atsuko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignals, Hachioji, Tokyo 1920392, Japan	University of Copenhagen; University of Copenhagen; Tokyo University of Pharmacy & Life Sciences	Yoneda, A (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignals, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	ayoneda@toyaku.ac.jp			Danish Medical Research Council; Novo Nordisk Foundation; Danish Cancer Research Foundation; Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [25440091]; Danish National Research Foundation; Lundbeck Foundation; Faculty of Health and Medical Sciences at the University of Copenhagen	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Research Foundation; Japan Society for the Promotion of Science (JSPS) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Faculty of Health and Medical Sciences at the University of Copenhagen	This work was supported by the Danish Medical Research Council (to A. Y. and J. R. C.), the Novo Nordisk Foundation (to A. Y. and J. R. C.), the Danish Cancer Research Foundation and Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 25440091 (to A. Y.), the Danish National Research Foundation (to J. R. C.), the Lundbeck Foundation (to J. R. C.), and the Faculty of Health and Medical Sciences at the University of Copenhagen (to J. R. C. and M. M.-F.).	Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Mesquita DD, 2001, FEBS LETT, V502, P84, DOI 10.1016/S0014-5793(01)02669-2; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Fang XJ, 2002, MOL CELL BIOL, V22, P2099, DOI 10.1128/MCB.22.7.2099-2110.2002; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gosens R, 2007, AM J PHYSIOL-LUNG C, V293, pL1348, DOI 10.1152/ajplung.00346.2007; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Hall C, 2001, J BIOL CHEM, V276, P43482, DOI 10.1074/jbc.C100455200; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; Hosono Y, 2012, EMBO J, V31, P481, DOI 10.1038/emboj.2011.416; Kher SS, 2011, EXP CELL RES, V317, P2845, DOI 10.1016/j.yexcr.2011.09.009; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Komers R, 2011, CURR OPIN NEPHROL HY, V20, P77, DOI 10.1097/MNH.0b013e32834131f8; Kubo Takekazu, 2008, Ther Clin Risk Manag, V4, P605; Lydolph MC, 2009, EXP CELL RES, V315, P3312, DOI 10.1016/j.yexcr.2009.09.022; Ma Z, 2006, MOL CELL BIOL, V26, P9016, DOI 10.1128/MCB.01383-06; Majava V, 2008, FEBS J, V275, P4583, DOI 10.1111/j.1742-4658.2008.06601.x; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Miller MC, 2009, ARTHRITIS RHEUM-US, V60, P686, DOI 10.1002/art.24331; Morgan-Fisher M, 2013, J HISTOCHEM CYTOCHEM, V61, P185, DOI 10.1369/0022155412470834; Niault T, 2009, J CELL BIOL, V187, P335, DOI 10.1083/jcb.200906178; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048773; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Pan SH, 2011, J CLIN INVEST, V121, P3189, DOI 10.1172/JCI42975; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Rahajeng J, 2010, J BIOL CHEM, V285, P31918, DOI 10.1074/jbc.C110.166066; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI 10.1152/ajpheart.00327.2011; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Shimada K, 2014, BREAST CANCER-TOKYO, V21, P715, DOI 10.1007/s12282-013-0447-5; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Vincent P, 2005, J IMMUNOL, V175, P7650, DOI 10.4049/jimmunol.175.11.7650; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yoneda A, 2012, MOL CELL BIOL, V32, P1788, DOI 10.1128/MCB.06235-11; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yuasa-Kawada J, 2003, EUR J NEUROSCI, V17, P2329, DOI 10.1046/j.1460-9568.2003.02664.x; Zeller KS, 2010, CELL SIGNAL, V22, P1838, DOI 10.1016/j.cellsig.2010.07.011; Zhou QA, 2011, TRENDS PHARMACOL SCI, V32, P167, DOI 10.1016/j.tips.2010.12.006	54	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31229	31240		10.1074/jbc.M113.505602	http://dx.doi.org/10.1074/jbc.M113.505602			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24036111	Green Published, hybrid			2022-12-28	WOS:000330778900039
J	Perni, S; Close, M; Franzini-Armstrong, C				Perni, Stefano; Close, Matthew; Franzini-Armstrong, Clara			Novel Details of Calsequestrin Gel Conformation in Situ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE UNITS; CAPACITY CA2+ BINDING; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; SMOOTH-MUSCLE; PROTEIN; PURIFICATION; OVEREXPRESSION; JUNCTIN; FIBERS	Calsequestrin (CASQ) is the major component of the sarcoplasmic reticulum (SR) lumen in skeletal and cardiac muscles. This calcium-binding protein localizes to the junctional SR (jSR) cisternae, where it is responsible for the storage of large amounts of Ca2+, whereas it is usually absent, at least in its polymerized form, in the free SR. The retention of CASQ inside the jSR is due partly to its association with other jSR proteins, such as junctin and triadin, and partly to its ability to polymerize, in a high Ca2+ environment, into an intricate gel that holds the protein in place. In this work, we shed some light on the still poorly described in situ structure of polymerized CASQ using detailed EM images from thin sections, with and without tilting, and from deep-etched rotary-shadowed replicas. The latter directly illustrate the fundamental network nature of polymerized CASQ, revealing repeated nodal points connecting short segments of the linear polymer.	[Perni, Stefano; Franzini-Armstrong, Clara] Univ Penn, Dept Cell Dev Biol, Philadelphia, PA 19104 USA; [Close, Matthew] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	University of Pennsylvania; Lehigh University	Close, M (corresponding author), Univ Colorado, Dept Physiol & Biophys, Anschutz Med Campus, Aurora, CO 80045 USA.	stefano.perni@ucdenver.edu	Perni, Stefano/M-1925-2016	Perni, Stefano/0000-0002-0591-4376	National Institutes of Health [AR055104]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055104, P01AR052354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR055104 (to K. G. Beam).	Boncompagni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039962; Boncompagni S, 2012, AGE, V34, P27, DOI 10.1007/s11357-011-9211-y; Boncompagni S, 2010, AGING CELL, V9, P958, DOI 10.1111/j.1474-9726.2010.00623.x; Cala S E, 1990, Semin Cell Biol, V1, P265; CALA SE, 1983, J BIOL CHEM, V258, P1932; Franzini-Armstrong C, 2010, CURR TOP MEMBR, V66, P3, DOI 10.1016/S1063-5823(10)66001-2; FRANZINIARMSTRONG C, 1987, J CELL BIOL, V105, P49, DOI 10.1083/jcb.105.1.49; FRANZINIARMSTRONG C, 1984, TISSUE CELL, V16, P647, DOI 10.1016/0040-8166(84)90038-7; Gatti G, 2001, J CELL BIOL, V154, P525, DOI 10.1083/jcb.200103002; INUI M, 1988, J BIOL CHEM, V263, P10843; JORGENSEN AO, 1985, J CELL BIOL, V101, P257, DOI 10.1083/jcb.101.1.257; Lee KW, 2012, J BIOL CHEM, V287, P1679, DOI 10.1074/jbc.M111.254045; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; MAURER A, 1985, P NATL ACAD SCI USA, V82, P4036, DOI 10.1073/pnas.82.12.4036; MEISSNER G, 1975, BIOCHIM BIOPHYS ACTA, V389, P51, DOI 10.1016/0005-2736(75)90385-5; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; PEACHEY LD, 1965, J CELL BIOL, V25, P209, DOI 10.1083/jcb.25.3.209; Renken C, 2009, J STRUCT BIOL, V165, P53, DOI 10.1016/j.jsb.2008.09.011; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Sanchez EJ, 2012, J BIOL CHEM, V287, P11592, DOI 10.1074/jbc.M111.335075; Tijskens P, 2003, J MOL CELL CARDIOL, V35, P961, DOI 10.1016/S0022-2828(03)00181-0; Tomasi M, 2012, AM J PHYSIOL-CELL PH, V302, pC575, DOI 10.1152/ajpcell.00119.2011; VILLA A, 1991, J CELL BIOL, V113, P779, DOI 10.1083/jcb.113.4.779; VILLA A, 1993, J CELL BIOL, V121, P1041, DOI 10.1083/jcb.121.5.1041; VOLPE P, 1991, BIOCHEM BIOPH RES CO, V181, P28, DOI 10.1016/S0006-291X(05)81377-4; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; WUYTACK F, 1987, BIOCHIM BIOPHYS ACTA, V899, P151, DOI 10.1016/0005-2736(87)90395-6; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zhang L, 2001, J MOL CELL CARDIOL, V33, P233, DOI 10.1006/jmcc.2000.1295	31	20	20	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31358	31362		10.1074/jbc.M113.507749	http://dx.doi.org/10.1074/jbc.M113.507749			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24025332	hybrid, Green Published			2022-12-28	WOS:000330778900052
J	Rengachari, S; Aschauer, P; Schittmayer, M; Mayer, N; Gruber, K; Breinbauer, R; Birner-Gruenberger, R; Dreveny, I; Oberer, M				Rengachari, Srinivasan; Aschauer, Philipp; Schittmayer, Matthias; Mayer, Nicole; Gruber, Karl; Breinbauer, Rolf; Birner-Gruenberger, Ruth; Dreveny, Ingrid; Oberer, Monika			Conformational Plasticity and Ligand Binding of Bacterial Monoacylglycerol Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOGLYCERIDE LIPASE; MACROMOLECULAR STRUCTURES; DIACYLGLYCEROL LIPASE; MALASSEZIA-GLOBOSA; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; PURIFICATION; MODEL; 2-ARACHIDONOYLGLYCEROL; PHOSPHONATE	Monoacylglycerol lipases (MGLs) play an important role in lipid catabolism across all kingdoms of life by catalyzing the release of free fatty acids from monoacylglycerols. The three-dimensional structures of human and a bacterial MGL were determined only recently as the first members of this lipase family. In addition to the alpha/beta-hydrolase core, they showed unexpected structural similarities even in the cap region. Nevertheless, the structural basis for substrate binding and conformational changes of MGLs is poorly understood. Here, we present a comprehensive study of five crystal structures of MGL from Bacillus sp. H257 in its free form and in complex with different substrate analogs and the natural substrate 1-lauroylglycerol. The occurrence of different conformations reveals a high degree of conformational plasticity of the cap region. We identify a specific residue, Ile-145, that might act as a gatekeeper restricting access to the binding site. Site-directed mutagenesis of Ile-145 leads to significantly reduced hydrolase activity. Bacterial MGLs in complex with 1-lauroylglycerol, myristoyl, palmitoyl, and stearoyl substrate analogs enable identification of the binding sites for the alkyl chain and the glycerol moiety of the natural ligand. They also provide snapshots of the hydrolytic reaction of a bacterial MGL at different stages. The alkyl chains are buried in a hydrophobic tunnel in an extended conformation. Binding of the glycerol moiety is mediated via Glu-156 and water molecules. Analysis of the structural features responsible for cap plasticity and the binding modes of the ligands suggests conservation of these features also in human MGL.	[Rengachari, Srinivasan; Aschauer, Philipp; Gruber, Karl; Oberer, Monika] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Schittmayer, Matthias; Birner-Gruenberger, Ruth] Med Univ Graz, Inst Pathol, A-8010 Graz, Austria; [Schittmayer, Matthias; Birner-Gruenberger, Ruth] Med Univ Graz, Med Res Ctr, A-8010 Graz, Austria; [Mayer, Nicole; Breinbauer, Rolf] Graz Univ Technol, Inst Organ Chem, A-8010 Graz, Austria; [Dreveny, Ingrid] Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England	University of Graz; Medical University of Graz; Medical University of Graz; Graz University of Technology; University of Nottingham	Dreveny, I (corresponding author), Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England.	ingrid.dreveny@nottingham.ac.uk; m.oberer@uni-graz.at	Birner-Gruenberger, Ruth/E-8623-2010; Schittmayer, Matthias/AAW-1020-2021; Gruber, Karl/GPP-6706-2022; Dreveny, Ingrid/E-8939-2017; Breinbauer, Rolf/AAK-1750-2020; Birner-Gruenberger, Ruth/X-9433-2019	Birner-Gruenberger, Ruth/0000-0003-3950-0312; Schittmayer, Matthias/0000-0003-3249-655X; Gruber, Karl/0000-0002-3485-9740; Dreveny, Ingrid/0000-0003-2256-642X; Breinbauer, Rolf/0000-0001-6009-7359; Birner-Gruenberger, Ruth/0000-0003-3950-0312; Rengachari, Srinivasan/0000-0003-4237-8258; Oberer, Monika/0000-0003-2525-9513	Doctoral School "DK Molecular Enzymology" Grant [W901-B12]; Austrian Science Fund;  [FWF P24857]; Austrian Science Fund (FWF) [W 901, P 24857] Funding Source: researchfish	Doctoral School "DK Molecular Enzymology" Grant; Austrian Science Fund(Austrian Science Fund (FWF)); ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Doctoral School "DK Molecular Enzymology" Grant W901-B12 and by Project FWF P24857 funded by the Austrian Science Fund.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colton IJ, 2011, ADV SYNTH CATAL, V353, P2529, DOI 10.1002/adsc.201100459; CONLEY AJ, 1973, ANTIMICROB AGENTS CH, V4, P501, DOI 10.1128/AAC.4.5.501; Cotes K, 2007, BIOCHEM J, V408, P417, DOI 10.1042/BJ20070745; DeLano WL, 2010, PYMOL MOL GRAPH SYST; DEREWENDA U, 1992, BIOCHEMISTRY-US, V31, P1532, DOI 10.1021/bi00120a034; Dhouib R, 2010, J BACTERIOL, V192, P4776, DOI 10.1128/JB.00261-10; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; EGLOFF MP, 1995, BIOCHEMISTRY-US, V34, P2751, DOI 10.1021/bi00009a003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; Heier C, 2010, BBA-MOL CELL BIOL L, V1801, P1063, DOI 10.1016/j.bbalip.2010.06.001; Imamura S, 2000, J BIOCHEM-TOKYO, V127, P419, DOI 10.1093/oxfordjournals.jbchem.a022623; Kabara J.J., 1978, PHARM EFFECT LIPIDS, P25; KABARA JJ, 1977, LIPIDS, V12, P753, DOI 10.1007/BF02570908; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlsson M, 2000, PROTEIN EXPRES PURIF, V18, P286, DOI 10.1006/prep.1999.1194; Kitaura S, 2001, J BIOCHEM-TOKYO, V129, P397, DOI 10.1093/oxfordjournals.jbchem.a002870; Labar G, 2010, CURR MED CHEM, V17, P2588, DOI 10.2174/092986710791859414; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Liu L, 2012, BIOCHEM BIOPH RES CO, V424, P285, DOI 10.1016/j.bbrc.2012.06.108; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; MANNESSE MLM, 1995, BBA-LIPID LIPID MET, V1259, P56, DOI 10.1016/0005-2760(95)00145-3; MARGUET F, 1994, BBA-LIPID LIPID MET, V1210, P157, DOI 10.1016/0005-2760(94)90116-3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; POPE JL, 1962, FED PROC, V21, P259; Rengachari S, 2012, BBA-MOL CELL BIOL L, V1821, P1012, DOI 10.1016/j.bbalip.2012.04.006; Sakiyama T, 2001, J BIOSCI BIOENG, V91, P88, DOI 10.1263/jbb.91.88; Schalk-Hihi C, 2011, PROTEIN SCI, V20, P670, DOI 10.1002/pro.596; Schrag JD, 1997, METHOD ENZYMOL, V284, P85; Steinkellner G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-32; Susani-Etzerodt H, 2006, CHEM PHYS LIPIDS, V144, P60, DOI 10.1016/j.chemphyslip.2006.06.018; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Thornton JM, 2000, NAT STRUCT BIOL, V7, P991, DOI 10.1038/80784; WHITTLE PJ, 1994, ANNU REV BIOPH BIOM, V23, P349, DOI 10.1146/annurev.bb.23.060194.002025; Xu TT, 2012, J STRUCT BIOL, V178, P363, DOI 10.1016/j.jsb.2012.03.006	46	34	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31093	31104		10.1074/jbc.M113.491415	http://dx.doi.org/10.1074/jbc.M113.491415			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24014019	Green Published, hybrid			2022-12-28	WOS:000330778900028
J	Zhang, QF; Raje, V; Yakovlev, VA; Yacoub, A; Szczepanek, K; Meier, J; Derecka, M; Chen, Q; Hu, Y; Sisler, J; Hamed, H; Lesnefsky, EJ; Valerie, K; Dent, P; Larner, AC				Zhang, Qifang; Raje, Vidisha; Yakovlev, Vasily A.; Yacoub, Adly; Szczepanek, Karol; Meier, Jeremy; Derecka, Marta; Chen, Qun; Hu, Ying; Sisler, Jennifer; Hamed, Hossein; Lesnefsky, Edward J.; Valerie, Kristoffer; Dent, Paul; Larner, Andrew C.			Mitochondrial Localized Stat3 Promotes Breast Cancer Growth via Phosphorylation of Serine 727	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIGNAL TRANSDUCER; COMPLEX-I; CELL-DEATH; ACTIVATES TRANSCRIPTION; OXIDATIVE STRESS; NUCLEAR IMPORT; EXPRESSION; GRIM-19; BINDING	Signal transducer and activator of transcription 3 (Stat3) is a key mediator in the development of many cancers. For 20 years, it has been assumed that Stat3 mediates its biological activities as a nuclear localized transcription factor activated by many cytokines. However, recent studies from this laboratory and others indicate that Stat3 has an independent function in the mitochondria (mitoStat3) where it controls the activity of the electron transport chain (ETC) and mediates Ras-induced transformation of mouse embryo fibroblasts. The actions of mitoStat3 in controlling respiration and Ras transformation are mediated by the phosphorylation state of serine 727. To address the role of mitoStat3 in the pathogenesis of cells that are transformed, we used 4T1 breast cancer cells, which form tumors that metastasize in immunocompetent mice. Substitution of Ser-727 for an alanine or aspartate in Stat3 that has a mitochondrial localization sequence, MLS-Stat3, has profound effects on tumor growth, complex I activity of the ETC, and accumulation of reactive oxygen species (ROS). Cells expressing MLS-Stat3(S727A) display slower tumor growth, decreased complex I activity of the ETC, and increased ROS accumulation under hypoxia compared with cells expressing MLS-Stat3. In contrast, cells expressing MLS-Stat3(S727D) show enhanced tumor growth and complex I activity and decreased production of ROS. These results highlight the importance of serine 727 of mitoStat3 in breast cancer and suggest a novel role for mitoStat3 in regulation of ROS concentrations through its action on the ETC.	[Zhang, Qifang; Raje, Vidisha; Szczepanek, Karol; Meier, Jeremy; Derecka, Marta; Sisler, Jennifer; Larner, Andrew C.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Zhang, Qifang; Raje, Vidisha; Yakovlev, Vasily A.; Yacoub, Adly; Szczepanek, Karol; Meier, Jeremy; Derecka, Marta; Sisler, Jennifer; Hamed, Hossein; Valerie, Kristoffer; Dent, Paul; Larner, Andrew C.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Yakovlev, Vasily A.; Valerie, Kristoffer] Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA USA; [Yacoub, Adly; Hamed, Hossein; Dent, Paul] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA; [Szczepanek, Karol; Chen, Qun; Hu, Ying; Lesnefsky, Edward J.] Virginia Commonwealth Univ, Dept Internal Med, Div Cardiol, Pauley Heart Ctr, Richmond, VA 23298 USA; [Lesnefsky, Edward J.] McGuire Dept Vet Affairs Med Ctr, Med Serv, Richmond, VA 23249 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Larner, AC (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, MMRB, Rm 2050,1220 East Broad St, Richmond, VA 23298 USA.	alarner@vcu.edu	Yakovlev, Vasily/X-3634-2019; Valerie, Kristoffer/AAL-8299-2021; Yakovlev, Vasily/A-2980-2008; Zhang, Grace/AAH-7495-2020; Chen, Qun/HGD-0868-2022	Yakovlev, Vasily/0000-0002-1298-0232; Derecka, Marta/0000-0001-6265-9781; Raje, Vidisha/0000-0003-1808-6511	National Institutes of Health [R01 1GM101677, R21 AI088487, R01 CA90881]; NATIONAL CANCER INSTITUTE [R01CA090881, R01CA150214, R01CA141703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101677] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01 1GM101677 and R21 AI088487 (to A. C. L.).; Supported by National Institutes of Health Grant R01 CA90881.	Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Frank DA, 1997, J CLIN INVEST, V100, P3140, DOI 10.1172/JCI119869; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; FU XY, 1993, CELL, V74, P1135, DOI 10.1016/0092-8674(93)90734-8; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Haghikia A, 2011, HEART FAIL REV, V16, P35, DOI 10.1007/s10741-010-9170-x; Heusch G, 2011, CIRC RES, V109, P1302, DOI 10.1161/CIRCRESAHA.111.255604; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Huang G, 2007, CELL DEATH DIFFER, V14, P327, DOI 10.1038/sj.cdd.4402004; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; Mackenzie GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061532; Maximo V, 2005, BRIT J CANCER, V92, P1892, DOI 10.1038/sj.bjc.6602547; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Pizzimenti Stefania, 2010, Cancers (Basel), V2, P338, DOI 10.3390/cancers2020338; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578; Sharma LK, 2011, HUM MOL GENET, V20, P4605, DOI 10.1093/hmg/ddr395; Shaw PE, 2010, CELL CYCLE, V9, P4294, DOI 10.4161/cc.9.21.13677; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Szczepanek K, 2012, TRENDS CELL BIOL, V22, P429, DOI 10.1016/j.tcb.2012.05.001; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Yakovlev VA, 2007, BIOCHEMISTRY-US, V46, P11671, DOI 10.1021/bi701107z; Yakovlev VA, 2010, BIOCHEMISTRY-US, V49, P5331, DOI 10.1021/bi100564w; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yeh YT, 2006, INT J CANCER, V118, P2943, DOI 10.1002/ijc.21771; Zhang F, 2003, ONCOGENE, V22, P894, DOI 10.1038/sj.onc.1206158; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhou LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021680	40	120	124	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31280	31288		10.1074/jbc.M113.505057	http://dx.doi.org/10.1074/jbc.M113.505057			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24019511	Green Published, hybrid			2022-12-28	WOS:000330778900044
J	Kaymak, E; Ryder, SP				Kaymak, Ebru; Ryder, Sean P.			RNA Recognition by the Caenorhabditis elegans Oocyte Maturation Determinant OMA-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; elegans; RNA; RNA-binding Protein; RNA-binding Proteins; RNA-Protein Interaction; Caenorhabditis elegans; OMA-1; RNA-binding Protein; glp-1; Post-transcriptional Regulation	ZINC-FINGER PROTEINS; CELL FATE DETERMINANT; MESSENGER-RNA; TRANSLATIONAL REPRESSION; TARGET SPECIFICITY; MEIOTIC MATURATION; MATERNAL PROTEINS; BINDING PROTEINS; GENE-EXPRESSION; GERM-LINE	Maternally supplied mRNAs encode proteins that pattern early embryos in many species. In the nematode Caenorhabditis elegans, a suite of RNA-binding proteins regulates expression of maternal mRNAs during oogenesis, the oocyte to embryo transition, and early embryogenesis. To understand how these RNA-binding proteins contribute to development, it is necessary to determine how they select specific mRNA targets for regulation. OMA-1 and OMA-2 are redundant proteins required for oocyte maturationan essential part of meiosis that prepares oocytes for fertilization. Both proteins have CCCH type tandem zinc finger RNA-binding domains. Here, we define the RNA binding specificity of OMA-1 and demonstrate that OMA-1/2 are required to repress the expression of a glp-1 3-UTR reporter in developing oocytes. OMA-1 binds with high affinity to a conserved region of the glp-1 3-UTR previously shown to interact with POS-1 and GLD-1, RNA-binding proteins required for glp-1 reporter repression in the posterior of fertilized embryos. Our results reveal that OMA-1 is a sequence-specific RNA-binding protein required to repress expression of maternal transcripts during oogenesis and suggest that interplay between OMA-1 and other factors for overlapping binding sites helps to coordinate the transition from oocyte to embryo.	[Kaymak, Ebru; Ryder, Sean P.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Ryder, SP (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	Sean.Ryder@umassmed.edu			National Institutes of Health [GM081422, GM098643]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081422, R01GM098643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081422 and GM098643 (to S. P. R.).	Berry LW, 1997, DEVELOPMENT, V124, P925; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2005, MOL B INT U, P80; BRENNER S, 1974, GENETICS, V77, P71; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; CLARKMAGUIRE S, 1994, GENETICS, V136, P533; CLARKMAGUIRE S, 1994, J CELL BIOL, V126, P199, DOI 10.1083/jcb.126.1.199; Colegrove-Otero LJ, 2005, CRIT REV BIOCHEM MOL, V40, P21, DOI 10.1080/10409230590918612; CRITTENDEN SL, 1994, DEVELOPMENT, V120, P2901; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; Detwiler MR, 2001, DEV CELL, V1, P187, DOI 10.1016/S1534-5807(01)00026-0; EVANS TC, 1994, CELL, V77, P183, DOI 10.1016/0092-8674(94)90311-5; Farley BM, 2008, CRIT REV BIOCHEM MOL, V43, P135, DOI [10.1080/10409230801921338, 10.1080/10409230801921338 ]; Farley BM, 2012, MOL BIOL CELL, V23, P4473, DOI 10.1091/mbc.E12-03-0216; Farley BM, 2008, RNA, V14, P2685, DOI 10.1261/rna.1256708; Greenstein David, 2005, WormBook, P1, DOI 10.1895/wormbook.1.53.1; Guedes S, 1997, DEVELOPMENT, V124, P731; Guven-Ozkan T, 2010, DEVELOPMENT, V137, P3373, DOI 10.1242/dev.055327; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Jadhav S, 2008, DEVELOPMENT, V135, P1803, DOI 10.1242/dev.013656; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaymak E, 2010, CURR OPIN STRUC BIOL, V20, P305, DOI 10.1016/j.sbi.2010.03.010; Kimble J, 2007, ANNU REV CELL DEV BI, V23, P405, DOI 10.1146/annurev.cellbio.23.090506.123326; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lee Min-Ho, 2006, WormBook, P1; Lin RL, 2003, DEV BIOL, V258, P226, DOI 10.1016/S0012-1606(03)00119-2; Lublin AL, 2007, DEV BIOL, V303, P635, DOI 10.1016/j.ydbio.2006.12.004; Marin VA, 2003, DEVELOPMENT, V130, P2623, DOI 10.1242/dev.00486; Masui Y, 1979, Int Rev Cytol, V57, P185, DOI 10.1016/S0074-7696(08)61464-3; Masui Y, 2001, DIFFERENTIATION, V69, P1, DOI 10.1046/j.1432-0436.2001.690101.x; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; MELLO CC, 1992, CELL, V70, P163, DOI 10.1016/0092-8674(92)90542-K; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Pagano JM, 2011, RNA, V17, P14, DOI 10.1261/rna.2428111; Pagano JM, 2009, P NATL ACAD SCI USA, V106, P20252, DOI 10.1073/pnas.0907916106; Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; Shimada M, 2002, GENES CELLS, V7, P933, DOI 10.1046/j.1365-2443.2002.00570.x; Spirin A. S., 1966, Current Topics in Developmental Biology, V1, P1; Standart Nancy, 1992, Seminars in Developmental Biology, V3, P367; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; Tabara H, 1999, DEVELOPMENT, V126, P1; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wright JE, 2011, EMBO J, V30, P533, DOI 10.1038/emboj.2010.334; Yamamoto I, 2006, DEV DYNAM, V235, P571, DOI 10.1002/dvdy.20662	52	17	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30463	30472		10.1074/jbc.M113.496547	http://dx.doi.org/10.1074/jbc.M113.496547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014033	hybrid, Green Published			2022-12-28	WOS:000329868100042
J	Kumar, R; Moure, CM; Khan, SH; Callaway, C; Grimm, SL; Goswami, D; Griffin, PR; Edwards, DP				Kumar, Raj; Moure, Carmen M.; Khan, Shagufta H.; Callaway, Celetta; Grimm, Sandra L.; Goswami, Devrishi; Griffin, Patrick R.; Edwards, Dean P.			Regulation of the Structurally Dynamic N-terminal Domain of Progesterone Receptor by Protein-induced Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Intrinsically Disordered Proteins; Mass Spectrometry (MS); Progesterone; Protein Folding; Steroid Hormone Receptor; TATA-binding Protein; N-terminal Transcription Activation domain AF1; Hydrogen Deuterium Exchange Mass; Progesterone Receptor	NUCLEAR HORMONE-RECEPTORS; GLUCOCORTICOID-RECEPTOR; INTRINSIC DISORDER; COREPRESSOR BINDING; ANDROGEN RECEPTOR; LIGAND-BINDING; IN-VITRO; COACTIVATOR; TRANSCRIPTION; ACTIVATION	The N-terminal domain (NTD) of steroid receptors harbors a transcriptional activation function (AF1) that is composed of an intrinsically disordered polypeptide. We examined the interaction of the TATA-binding protein (TBP) with the NTD of the progesterone receptor (PR) and its ability to regulate AF1 activity through coupled folding and binding. As assessed by solution phase biophysical methods, the isolated NTD of PR contains a large content of random coil, and it is capable of adopting secondary -helical structure and more stable tertiary folding either in the presence of the natural osmolyte trimethylamine-N-oxide or through a direct interaction with TBP. Hydrogen-deuterium exchange coupled with mass spectrometry confirmed the highly dynamic intrinsically disordered property of the NTD within the context of full-length PR. Deletion mapping and point mutagenesis defined a region of the NTD (amino acids 350-428) required for structural folding in response to TBP interaction. Overexpression of TBP in cells enhanced transcriptional activity mediated by the PR NTD, and deletion mutations showed that a region (amino acids 327-428), similar to that required for TBP-induced folding, was required for functional response. TBP also increased steroid receptor co-activator 1 (SRC-1) interaction with the PR NTD and cooperated with SRC-1 to stimulate NTD-dependent transcriptional activity. These data suggest that TBP can mediate structural reorganization of the NTD to facilitate the binding of co-activators required for maximal transcriptional activation.	[Moure, Carmen M.; Callaway, Celetta; Grimm, Sandra L.; Edwards, Dean P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Edwards, Dean P.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Kumar, Raj; Khan, Shagufta H.] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA 18509 USA	Baylor College of Medicine; Baylor College of Medicine; Scripps Research Institute; Geisinger Commonwealth School of Medicine	Edwards, DP (corresponding author), Baylor Coll Med, 1 Baylor Plaza, Houston, TX 77030 USA.	deane@bcm.edu	Goswami, Devrishi/A-8891-2014		National Institutes of Health from USPHS [RO1CA046938];  [GM084041];  [P30 NCI-CA125123]; NATIONAL CANCER INSTITUTE [R01CA046938, P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA046938 from USPHS (to D. P. E.), GM084041 to NIGMS (to P. R. G.), and Grant P30 NCI-CA125123 (to Monoclonal Antibody/Baculovirus Shared Resource of the Dan L. Duncan Cancer Center, and Kurt Christensen, Director of the Shared Resource).	Abdel-Hafiz H, 2009, J BIOL CHEM, V284, P9099, DOI 10.1074/jbc.M805226200; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Bain DL, 2000, J BIOL CHEM, V275, P7313, DOI 10.1074/jbc.275.10.7313; Bain DL, 2001, J BIOL CHEM, V276, P23825, DOI 10.1074/jbc.M102611200; Billas I, 2013, J MOL BIOL, V425, P2317, DOI 10.1016/j.jmb.2013.03.017; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Busby SA, 2007, INT J MASS SPECTROM, V259, P130, DOI 10.1016/j.ijms.2006.08.006; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Clemm DL, 2000, MOL ENDOCRINOL, V14, P52, DOI 10.1210/me.14.1.52; Copik AJ, 2006, MOL ENDOCRINOL, V20, P1218, DOI 10.1210/me.2005-0257; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fischer K, 2010, MOL ENDOCRINOL, V24, P1935, DOI 10.1210/me.2010-0005; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; Garza AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025875; Giangrande PH, 1997, J BIOL CHEM, V272, P32889, DOI 10.1074/jbc.272.52.32889; Goswami D., 2013, J AM SOC MASS SPECTR, V110, P11475; Hill KK, 2012, MOL CELL ENDOCRINOL, V348, P418, DOI 10.1016/j.mce.2011.07.017; Hill KK, 2009, J BIOL CHEM, V284, P24415, DOI 10.1074/jbc.M109.003244; Hilser VJ, 2011, J BIOL CHEM, V286, P39675, DOI 10.1074/jbc.R111.278929; Hovland AR, 1998, J BIOL CHEM, V273, P5455, DOI 10.1074/jbc.273.10.5455; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Khan S. H., 2011, PLOS ONE, V6; Khan SH, 2012, J BIOL CHEM, V287, P44546, DOI 10.1074/jbc.M112.411330; Krasowski MD, 2008, J PROTEOME RES, V7, P4359, DOI 10.1021/pr8003024; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; Kumar R, 2003, MOL ENDOCRINOL, V17, P1, DOI 10.1210/me.2002-0258; Kumar R, 2004, P NATL ACAD SCI USA, V101, P16425, DOI 10.1073/pnas.0407160101; Kumar R, 2004, BIOCHEMISTRY-US, V43, P3008, DOI 10.1021/bi035934p; Kumar R, 2012, MOL CELL ENDOCRINOL, V348, P450, DOI 10.1016/j.mce.2011.03.024; Kumar R, 2012, ENDOCR REV, V33, P271, DOI 10.1210/er.2011-1033; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; McEwan Iain J, 2007, Nucl Recept Signal, V5, pe001; McEwan IJ, 2012, MOL CELL ENDOCRINOL, V348, P345, DOI 10.1016/j.mce.2011.08.035; Metivier R, 2001, MOL ENDOCRINOL, V15, P1953, DOI 10.1210/me.15.11.1953; MEYER ME, 1992, J BIOL CHEM, V267, P10882; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Press M, 2002, STEROIDS, V67, P799, DOI 10.1016/S0039-128X(02)00039-9; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Roemer SC, 2006, MOL ENDOCRINOL, V20, P3042, DOI 10.1210/me.2005-0511; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Takimoto GS, 2003, J STEROID BIOCHEM, V85, P209, DOI 10.1016/S0960-0760(03)00197-3; Tantos A, 2012, MOL CELL ENDOCRINOL, V348, P457, DOI 10.1016/j.mce.2011.07.015; Tung L, 2006, MOL ENDOCRINOL, V20, P2656, DOI 10.1210/me.2006-0105; Wang DQ, 2007, BIOCHEMISTRY-US, V46, P8036, DOI 10.1021/bi7004575; Wang DQ, 2005, MOL ENDOCRINOL, V19, P1483, DOI 10.1210/me.2005-0012; Wardell SE, 2005, MOL CELL BIOL, V25, P8792, DOI 10.1128/MCB.25.20.8792-8808.2005; Wardell SE, 2005, SEMIN REPROD MED, V23, P9, DOI 10.1055/s-2005-864030; Wardell SE, 2010, MOL ENDOCRINOL, V24, P335, DOI 10.1210/me.2008-0081; Warnmark A, 2003, MOL ENDOCRINOL, V17, P1901, DOI 10.1210/me.2002-0384; Warnmark A, 2001, J BIOL CHEM, V276, P45939, DOI 10.1074/jbc.M107875200; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; WEIGEL NL, 1992, MOL ENDOCRINOL, V6, P1585, DOI 10.1210/me.6.10.1585; West GM, 2013, STRUCTURE, V21, P229, DOI 10.1016/j.str.2012.12.001; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zhang J, 2011, NAT STRUCT MOL BIOL, V18, P556, DOI 10.1038/nsmb.2046	66	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30285	30299		10.1074/jbc.M113.491787	http://dx.doi.org/10.1074/jbc.M113.491787			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23995840	Green Published, hybrid			2022-12-28	WOS:000329868100026
J	Shen, CX; Jo, SY; Liao, CZ; Hess, JL; Nikolovska-Coleska, Z				Shen, Chenxi; Jo, Stephanie Y.; Liao, Chenzhong; Hess, Jay L.; Nikolovska-Coleska, Zaneta			Targeting Recruitment of Disruptor of Telomeric Silencing 1-like (DOT1L) CHARACTERIZING THE INTERACTIONS BETWEEN DOT1L AND MIXED LINEAGE LEUKEMIA (MLL) FUSION PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fusion Protein; Histone Methylation; Peptides; Protein-Protein Interactions; Surface Plasmon Resonance (SPR); AF9; DOT1L; ENL; Mixed Lineage Leukemia	TRANSCRIPTIONAL ELONGATION; H3K79 METHYLATION; LEUKEMIA; GENE; ENL; METHYLTRANSFERASE; REPRESSION; PARTNERS; REQUIRES; COMPLEX	The MLL fusion proteins, AF9 and ENL, activate target genes in part via recruitment of the histone methyltransferase DOT1L (disruptor of telomeric silencing 1-like). Here we report biochemical, biophysical, and functional characterization of the interaction between DOT1L and MLL fusion proteins, AF9/ENL. The AF9/ENL-binding site in human DOT1L was mapped, and the interaction site was identified to a 10-amino acid region (DOT1L(865-874)). This region is highly conserved in DOT1L from a variety of species. Alanine scanning mutagenesis analysis shows that four conserved hydrophobic residues from the identified binding motif are essential for the interactions with AF9/ENL. Binding studies demonstrate that the entire intact C-terminal domain of AF9/ENL is required for optimal interaction with DOT1L. Functional studies show that the mapped AF9/ENL interacting site is essential for immortalization by MLL-AF9, indicating that DOT1L interaction with MLL-AF9 and its recruitment are required for transformation by MLL-AF9. These results strongly suggest that disruption of interaction between DOT1L and AF9/ENL is a promising therapeutic strategy with potentially fewer adverse effects than enzymatic inhibition of DOT1L for MLL fusion protein-associated leukemia.	[Shen, Chenxi; Jo, Stephanie Y.; Hess, Jay L.; Nikolovska-Coleska, Zaneta] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Shen, Chenxi; Hess, Jay L.; Nikolovska-Coleska, Zaneta] Univ Michigan, Sch Med, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA; [Liao, Chenzhong] Hefei Univ Technol, Sch Med Engn, Hefei 230009, Anhui, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Hefei University of Technology	Nikolovska-Coleska, Z (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1150 West Med Ctr Dr, Ann Arbor, MI 48109 USA.	zanetan@med.umich.edu		Liao, Chenzhong/0000-0001-7080-1768; Shen, Chenxi/0000-0002-0045-8850	National Institutes of Health; Ruth Kirschstein Award; Cancer Research Committee Fund of the University of Michigan Comprehensive Cancer Center; Lymphoma and Leukemia Society; NATIONAL CANCER INSTITUTE [R01CA151425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth Kirschstein Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Committee Fund of the University of Michigan Comprehensive Cancer Center; Lymphoma and Leukemia Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a National Institutes of Health grant (to J. L. H.) and the Ruth Kirschstein Award (to S. Y. J.). This work was also supported by funds from the Cancer Research Committee Fund of the University of Michigan Comprehensive Cancer Center (to Z. N. C.) and the Lymphoma and Leukemia Society (to J. L. H.).	Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Nguyen AT, 2011, BLOOD, V117, P6912, DOI 10.1182/blood-2011-02-334359; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Bernt KM, 2011, EPIGENOMICS-UK, V3, P667, DOI [10.2217/EPI.11.98, 10.2217/epi.11.98]; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Biswas D, 2011, P NATL ACAD SCI USA, V108, P15751, DOI 10.1073/pnas.1111498108; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; Chang MJ, 2010, CANCER RES, V70, P10234, DOI 10.1158/0008-5472.CAN-10-3294; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; DelProposto J, 2009, PROTEIN EXPRES PURIF, V63, P40, DOI 10.1016/j.pep.2008.08.011; Dobson CL, 1999, EMBO J, V18, P3564, DOI 10.1093/emboj/18.13.3564; Eguchi M, 2003, INT J HEMATOL, V78, P390, DOI 10.1007/BF02983811; Feng Y, 2010, BLOOD, V116, P4483, DOI 10.1182/blood-2010-03-276501; Huret JL, 2001, LEUKEMIA, V15, P987, DOI 10.1038/sj.leu.2402135; Jo SY, 2011, BLOOD, V117, P4759, DOI 10.1182/blood-2010-12-327668; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Leach BI, 2013, STRUCTURE, V21, P176, DOI 10.1016/j.str.2012.11.011; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Schulze JM, 2009, BIOCHEM CELL BIOL, V87, P65, DOI 10.1139/O08-111; Slany RK, 2005, HEMATOL ONCOL, V23, P1, DOI 10.1002/hon.739; Slany RK, 1998, MOL CELL BIOL, V18, P122, DOI 10.1128/MCB.18.1.122; Srinivasan RS, 2004, LEUKEMIA, V18, P1364, DOI 10.1038/sj.leu.2403415; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zeisig DT, 2005, ONCOGENE, V24, P5525, DOI 10.1038/sj.onc.1208699; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200	34	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30585	30596		10.1074/jbc.M113.457135	http://dx.doi.org/10.1074/jbc.M113.457135			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23996074	Green Published, hybrid			2022-12-28	WOS:000329868100059
J	Terai, K; Shibata, E; Abbas, T; Dutta, A				Terai, Kenta; Shibata, Etsuko; Abbas, Tarek; Dutta, Anindya			Degradation of p12 Subunit by CRL4(Cdt2) E3 Ligase Inhibits Fork Progression after DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Checkpoint Control; DNA Damage Response; DNA Polymerase; DNA Replication; Ubiquitination	S-PHASE; POLYMERASE-DELTA; SINGLE-CELL; REPLICATION; PCNA; CHECKPOINT; DESTRUCTION; CDT1; P21; ELONGATION	After acute DNA damage, the cell arrests S-phase progression by inhibiting origin initiation and fork progression to repair damaged DNA. The intra-S-phase checkpoint kinase Chk1 phosphorylates Cdc25A to target the latter for degradation by CRL1(-TrCP) and so inhibit origin firing. The mechanism for inhibiting fork progression, however, has not been identified. Here, we show that degradation of p12, the fourth subunit of DNA polymerase , is critical for inhibiting fork progression. CRL4(Cdt2) is an E3 ligase that ubiquitinates and degrades p12 after UV treatment. Cells expressing a stable form of p12 exhibit UV-resistant DNA synthesis. DNA fiber assay and alkaline-sucrose gradient assay demonstrate that the impairment of fork progression after DNA damage requires p12 degradation. These results suggest that ubiquitination of p12 through CRL4(Cdt2) and subsequent degradation form one mechanism by which a cell responds to DNA damage to inhibit fork progression.	[Terai, Kenta; Shibata, Etsuko; Abbas, Tarek; Dutta, Anindya] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Dutta, A (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Dutta, Anindya/P-3203-2016; 寺井, 健太/AFQ-7663-2022	寺井, 健太/0000-0001-7638-3720; Dutta, Anindya/0000-0002-4319-0073	National Institutes of Health [CA60499, GM84465, CA140774]; Department of Defense Breast Cancer Research Program; Uehara Memorial Foundation; NATIONAL CANCER INSTITUTE [K99CA140774, R00CA140774, P30CA044579, R01CA060499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA60499 and GM84465 (to A. D.) and CA140774 (to T. A.). This work was also supported by Department of Defense Breast Cancer Research Program and Uehara Memorial Foundation (to K. T.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chastain PD, 2006, CELL CYCLE, V5, P2160, DOI 10.4161/cc.5.18.3236; Conti C, 2007, CELL CYCLE, V6, P2760, DOI 10.4161/cc.6.22.4932; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Huang QM, 2010, BIOCHEM BIOPH RES CO, V391, P542, DOI 10.1016/j.bbrc.2009.11.094; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kaufmann WK, 2010, CARCINOGENESIS, V31, P751, DOI 10.1093/carcin/bgp230; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Miao H, 2003, J BIOL CHEM, V278, P4295, DOI 10.1074/jbc.M204264200; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Selak N, 2008, NUCLEIC ACIDS RES, V36, P5166, DOI 10.1093/nar/gkn498; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zhang SF, 2013, J BIOL CHEM, V288, P2941, DOI 10.1074/jbc.M112.423392	31	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30509	30514		10.1074/jbc.C113.505586	http://dx.doi.org/10.1074/jbc.C113.505586			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24022480	Green Published, hybrid			2022-12-28	WOS:000329868100053
J	Abaeva, AA; Canault, M; Kotova, YN; Obydennyy, SI; Yakimenko, AO; Podoplelova, NA; Kolyadko, VN; Chambost, H; Mazurov, AV; Ataullakhanov, FI; Nurden, AT; Alessi, MC; Panteleev, MA				Abaeva, Anastasia A.; Canault, Matthias; Kotova, Yana N.; Obydennyy, Sergey I.; Yakimenko, Alena O.; Podoplelova, Nadezhda A.; Kolyadko, Vladimir N.; Chambost, Herve; Mazurov, Aleksei V.; Ataullakhanov, Fazoil I.; Nurden, Alan T.; Alessi, Marie-Christine; Panteleev, Mikhail A.			Procoagulant Platelets Form an alpha-Granule Protein-covered "Cap" on Their Surface That Promotes Their Attachment to Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; INTEGRIN ALPHA(IIB)BETA(3); THROMBUS FORMATION; GLANZMANN THROMBASTHENIA; STIMULATED PLATELETS; ADHERENT PLATELETS; COATED-PLATELETS; FACTOR-XIIIA; FIBRINOGEN; SUBPOPULATIONS	Strongly activated "coated" platelets are characterized by increased phosphatidylserine (PS) surface expression, alpha-granule protein retention, and lack of active integrin alpha(IIb)beta(3). To study how they are incorporated into thrombi despite a lack of free activated integrin, we investigated the structure, function, and formation of the alpha-granule protein "coat." Confocal microscopy revealed that fibrin(ogen) and thrombospondin colocalized as "cap," a single patch on the PS-positive platelet surface. In aggregates, the cap was located at the point of attachment of the PS-positive platelets. Without fibrin(ogen) retention, their ability to be incorporated in aggregates was drastically reduced. The surface fibrin(ogen) was strongly decreased in the presence of a fibrin polymerization inhibitor GPRP and also in platelets from a patient with dysfibrinogenemia and a fibrinogen polymerization defect. In contrast, a fibrinogen-clotting protease ancistron increased the amount of fibrin(ogen) and thrombospondin on the surface of the PS-positive platelets stimulated with collagen-related peptide. Transglutaminases are also involved in fibrin( ogen) retention. However, platelets from patients with factor XIII deficiency had normal retention, and a pan-transglutaminase inhibitor T101 had only a modest inhibitory effect. Fibrin( ogen) retention was normal in Bernard-Soulier syndrome and kindlin-3 deficiency, but not in Glanzmann thrombasthenia lacking the platelet pool of fibrinogen and alpha(IIb)beta(3). These data show that the fibrin(ogen)-covered cap, predominantly formed as a result of fibrin polymerization, is a critical mechanism that allows coated (or rather "capped") platelets to become incorporated into thrombi despite their lack of active integrins.	[Abaeva, Anastasia A.; Kotova, Yana N.; Obydennyy, Sergey I.; Yakimenko, Alena O.; Podoplelova, Nadezhda A.; Kolyadko, Vladimir N.; Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Ctr Theoret Problems Physicochem Pharmacol, Moscow 119991, Russia; [Canault, Matthias; Chambost, Herve; Alessi, Marie-Christine] Univ Aix Marseille 2, F-13284 Marseille 07, France; [Canault, Matthias; Alessi, Marie-Christine] Hop Enfants La Timone, INSERM, UMR 1062, INRA 1260, F-13385 Marseille 05, France; [Kotova, Yana N.; Obydennyy, Sergey I.; Yakimenko, Alena O.; Podoplelova, Nadezhda A.; Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Fed Res & Clin Ctr Pediat Hematol Oncol & Immunol, Moscow 117198, Russia; [Yakimenko, Alena O.; Podoplelova, Nadezhda A.; Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] HemaCore LLC, Moscow 125319, Russia; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Natl Res Ctr Hematol, Moscow 125167, Russia; [Mazurov, Aleksei V.] Russian Cardiol Res & Prod Complex, Moscow 121552, Russia; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Moscow MV Lomonosov State Univ, Fac Phys, Moscow 119899, Russia; [Nurden, Alan T.] Hop Xavier Arnozan, F-33604 Pessac, France	Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; National Medical Research Center of Cardiology; Lomonosov Moscow State University; CHU Bordeaux	Alessi, MC (corresponding author), Hop Enfants La Timone, INSERM, UMR 1062, 27 Bd Jean Moulin, F-13385 Marseille 05, France.	marie-christine.alessi@univ-amu.fr; mapanteleev@yandex.ru	Podoplelova, Nadezhda/AAT-3654-2020; Podoplelova, Nadezhda/A-7482-2014; Ataullakhanov, Fazoil/J-8076-2012; Alexey, Mazurov/AAB-4104-2020; Ataullakhanov, Fazoil/O-3458-2019; Panteleev, Mikhail A/H-5491-2012; Obydennyy, Sergey I/B-1051-2014; Kotova, Yana/A-7935-2014; Canault, Matthias/H-5128-2013; ALESSI, Marie-christine/AAK-3582-2020	Podoplelova, Nadezhda/0000-0001-8013-1112; Podoplelova, Nadezhda/0000-0001-8013-1112; Panteleev, Mikhail A/0000-0002-8128-7757; Obydennyy, Sergey I/0000-0002-2930-8768; Kotova, Yana/0000-0003-4769-8162; Canault, Matthias/0000-0002-7880-5250; ALESSI, Marie-christine/0000-0003-3927-5792; CHAMBOST, HERVE/0000-0002-5319-1969; Kolyadko, Vladimir/0000-0003-4008-2461	Russian Foundation for Basic Research [11-04-00303, 12-04-00438, 12-04-31401, 12-04-31788, 12-04-32246, 12-04-31873, 12-04-33055, 13-04-00401]; Russian Academy of Sciences Presidium Basic Research Program "Molecular and Cellular Biology"; Russian Academy of Sciences Presidium Basic Research Program "Basic Science for Medicine"; Russian Academy of Sciences Presidium Basic Research Program "Molecular Mechanisms of Physiologic Functions"; Russian Federation [SP-2274.2012.4]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences Presidium Basic Research Program "Molecular and Cellular Biology"; Russian Academy of Sciences Presidium Basic Research Program "Basic Science for Medicine"; Russian Academy of Sciences Presidium Basic Research Program "Molecular Mechanisms of Physiologic Functions"; Russian Federation(Russian Federation)	This work was supported by Russian Foundation for Basic Research Grants 11-04-00303, 12-04-00438, 12-04-31401, 12-04-31788, 12-04-32246, 12-04-31873, 12-04-33055, and 13-04-00401; by the Russian Academy of Sciences Presidium Basic Research Programs "Molecular and Cellular Biology," "Basic Science for Medicine," and "Molecular Mechanisms of Physiologic Functions"; and by Russian Federation President Fellowship for Young Scientists SP-2274.2012.4.	Alberio L, 2000, BLOOD, V95, P1694, DOI 10.1182/blood.V95.5.1694.005k24_1694_1702; BALE MD, 1985, J BIOL CHEM, V260, P7502; BALE MD, 1986, J BIOL CHEM, V261, P862; Berny MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010415; Briede JJ, 1999, BBA-MOL CELL RES, V1451, P163, DOI 10.1016/S0167-4889(99)00085-3; Dale GL, 2005, J THROMB HAEMOST, V3, P2185, DOI 10.1111/j.1538-7836.2005.01274.x; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; DISDIER M, 1989, THROMB RES, V53, P521, DOI 10.1016/0049-3848(89)90142-4; Fager AM, 2010, ARTERIOSCL THROM VAS, V30, P2400, DOI 10.1161/ATVBAHA.110.216531; HANDAGAMA P, 1993, BLOOD, V82, P135, DOI 10.1182/blood.V82.1.135.bloodjournal821135; HANTGAN RR, 1990, BLOOD, V76, P345; Hayashi T, 2008, PFLUG ARCH EUR J PHY, V456, P1239, DOI 10.1007/s00424-008-0466-9; Heemskerk JWM, 2013, J THROMB HAEMOST, V11, P2, DOI 10.1111/jth.12045; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; HOURDILLE P, 1985, BLOOD, V65, P912; Jackson SP, 2010, BLOOD, V116, P2011, DOI 10.1182/blood-2010-01-261669; Jobe SM, 2008, BLOOD, V111, P1257, DOI 10.1182/blood-2007-05-092684; Jobe SM, 2005, BLOOD, V106, P4146, DOI 10.1182/blood-2005-03-1223; Kempton CL, 2005, ARTERIOSCL THROM VAS, V25, P861, DOI 10.1161/01.ATV.0000155987.26583.9b; Kotova YN, 2008, J THROMB HAEMOST, V6, P1603, DOI 10.1111/j.1538-7836.2008.03052.x; Kulkarni S, 2004, J BIOL CHEM, V279, P30697, DOI 10.1074/jbc.M403559200; Mattheij NJA, 2013, J BIOL CHEM, V288, P13325, DOI 10.1074/jbc.M112.428359; Mazurov AV, 2002, PLATELETS, V13, P465, DOI 10.1080/0953710021000057839; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; Munnix ICA, 2009, THROMB HAEMOSTASIS, V102, P1149, DOI 10.1160/TH09-05-0289; Nurden AT, 2011, BLOOD, V118, P5996, DOI 10.1182/blood-2011-07-365635; Panteleev MA, 2005, J THROMB HAEMOST, V3, P2545, DOI 10.1111/j.1538-7836.2005.01616.x; PEERSCHKE EIB, 1995, AM J PATHOL, V147, P678; Robert P, 2011, J IMMUNOL, V186, P5273, DOI 10.4049/jimmunol.1003141; Sugimura Y, 2006, J BIOL CHEM, V281, P17699, DOI 10.1074/jbc.M513538200; Topalov NN, 2012, BRIT J HAEMATOL, V157, P105, DOI 10.1111/j.1365-2141.2011.09021.x; Topalov NN, 2012, ARTERIOSCL THROM VAS, V32, P2475, DOI 10.1161/ATVBAHA.112.253765; Yakimenko AO, 2012, BIOPHYS J, V102, P2261, DOI 10.1016/j.bpj.2012.04.004; Yamauchi Y, 2002, MATRIX BIOL, V21, P441, DOI 10.1016/S0945-053X(02)00036-7	34	59	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29621	29632		10.1074/jbc.M113.474163	http://dx.doi.org/10.1074/jbc.M113.474163			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23995838	Green Published, hybrid			2022-12-28	WOS:000330615300038
J	Walter-Nuno, AB; Oliveira, MP; Oliveira, MF; Goncalves, RL; Ramos, IB; Koerich, LB; Oliveira, PL; Paiva-Silva, GO				Walter-Nuno, Ana Beatriz; Oliveira, Matheus P.; Oliveira, Marcus F.; Goncalves, Renata L.; Ramos, Isabela B.; Koerich, Leonardo B.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.			Silencing of Maternal Heme-binding Protein Causes Embryonic Mitochondrial Dysfunction and Impairs Embryogenesis in the Blood Sucking Insect Rhodnius prolixus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-REGULATED FUSION; BOOPHILUS-MICROPLUS; BLOODSUCKING INSECT; LIPID-PEROXIDATION; YOLK GRANULES; CATTLE TICK; DEGRADATION; BIOSYNTHESIS; EGG; TRAFFICKING	The heme molecule is the prosthetic group of many hemeproteins involved in essential physiological processes, such as electron transfer, transport of gases, signal transduction, and gene expression modulation. However, heme is a pro-oxidant molecule capable of propagating reactions leading to the generation of reactive oxygen species. The blood-feeding insect Rhodnius prolixus releases enormous amounts of heme during host blood digestion in the midgut lumen when it is exposed to a physiological oxidative challenge. Additionally, this organism produces a hemolymphatic heme-binding protein (RHBP) that transports heme to pericardial cells for detoxification and to growing oocytes for yolk granules and as a source of heme for embryo development. Here, we show that silencing of RHBP expression in female fat bodies reduced total RHBP circulating in the hemolymph, promoting oxidative damage to hemolymphatic proteins. Moreover, RHBP knockdown did not cause reduction in oviposition but led to the production of heme-depleted eggs (white eggs). A lack of RHBP did not alter oocyte fecundation. However, produced white eggs were nonviable. Embryo development cellularization and vitellin yolk protein degradation, processes that normally occur in early stages of embryogenesis, were compromised in white eggs. Total cytochrome c content, cytochrome c oxidase activity, citrate synthase activity, and oxygen consumption, parameters that indicate mitochondrial function, were significantly reduced in white eggs compared with normal dark red eggs. Our results showed that reduction of heme transport from females to growing oocytes by RHBP leads to embryonic mitochondrial dysfunction and impaired embryogenesis.	[Walter-Nuno, Ana Beatriz; Oliveira, Matheus P.; Oliveira, Marcus F.; Goncalves, Renata L.; Ramos, Isabela B.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; [Koerich, Leonardo B.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, BR-21941590 Rio De Janeiro, Brazil; [Oliveira, Matheus P.; Oliveira, Marcus F.; Goncalves, Renata L.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Lab Inflamacao & Metab, BR-21941590 Rio De Janeiro, Brazil; [Walter-Nuno, Ana Beatriz; Koerich, Leonardo B.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] Inst Nacl Ciencia & Tecnol Entomol Mol, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Paiva-Silva, GO (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med, CCS,Ilha Fundao, Sala 5,Bloco D Subsolo, BR-21941590 Rio De Janeiro, Brazil.	gosilva@bioqmed.ufrj.br	Oliveira, Marcus/G-3158-2011; Ramos, Isabela B/N-7091-2017; Koerich, Leonardo/J-7004-2014; L. Oliveira, Pedro/A-9438-2010	Oliveira, Marcus/0000-0002-9890-8425; Ramos, Isabela B/0000-0003-0874-7902; Koerich, Leonardo/0000-0002-5668-3934; Pinto De Oliveira, Matheus/0000-0002-2124-8799; L. Oliveira, Pedro/0000-0003-0307-354X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior; Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro; Howard Hughes Medical Institute	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior; Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior, Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro, and the Howard Hughes Medical Institute.	AFT RL, 1983, J BIOL CHEM, V258, P2069; AFT RL, 1984, J BIOL CHEM, V259, P301; Braz GRC, 2002, INSECT BIOCHEM MOLEC, V32, P361, DOI 10.1016/S0965-1748(01)00163-1; Braz GRC, 2001, INSECT BIOCHEM MOLEC, V31, P359, DOI 10.1016/S0965-1748(00)00129-6; Braz GRC, 1999, CURR BIOL, V9, P703, DOI 10.1016/S0960-9822(99)80312-1; CANTATORE P, 1974, CELL DIFFER DEV, V3, P45, DOI 10.1016/0045-6039(74)90039-6; Chen CY, 2012, J BIOL CHEM, V287, P9601, DOI 10.1074/jbc.M111.307694; Chen CY, 2011, CELL, V145, P720, DOI 10.1016/j.cell.2011.04.025; DANSAPETRETSKI M, 1995, J BIOL CHEM, V270, P10893, DOI 10.1074/jbc.270.18.10893; Duchen MR, 2008, CELL CALCIUM, V44, P1, DOI 10.1016/j.ceca.2008.02.001; Dumollard R, 2004, DEVELOPMENT, V131, P3057, DOI 10.1242/dev.01181; Dumollard R, 2006, SEMIN CELL DEV BIOL, V17, P314, DOI 10.1016/j.semcdb.2006.02.009; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; FRIEND WG, 1965, CAN J ZOOLOG, V43, P891, DOI 10.1139/z65-092; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; GUTTERIDGE JMC, 1988, BIOCHEM J, V256, P861, DOI 10.1042/bj2560861; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; HANSEN CA, 1983, AM J PHYSIOL, V244, pR356, DOI 10.1152/ajpregu.1983.244.3.R356; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; KELLY GM, 1989, J MORPHOL, V199, P175, DOI 10.1002/jmor.1051990205; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Machado EA, 1998, ARCH INSECT BIOCHEM, V39, P133, DOI 10.1002/(SICI)1520-6327(1998)39:4&lt;133::AID-ARCH1&gt;3.0.CO;2-D; Maya-Monteiro CM, 2000, J BIOL CHEM, V275, P36584, DOI 10.1074/jbc.M007344200; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Miao YL, 2012, MOL REPROD DEV, V79, P742, DOI 10.1002/mrd.22078; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; OLIVEIRA PL, 1995, J BIOL CHEM, V270, P10897, DOI 10.1074/jbc.270.18.10897; OLIVEIRA PL, 1989, INSECT BIOCHEM, V19, P489; ORJIH AU, 1981, SCIENCE, V214, P667, DOI 10.1126/science.7027441; Paiva-Silva GO, 2006, P NATL ACAD SCI USA, V103, P8030, DOI 10.1073/pnas.0602224103; Paiva-Silva GO, 2002, INSECT BIOCHEM MOLEC, V32, P1533, DOI 10.1016/S0965-1748(02)00074-7; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Rafie-Kolpin M, 2000, J BIOL CHEM, V275, P5171, DOI 10.1074/jbc.275.7.5171; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Ramos IB, 2007, J EXP BIOL, V210, P138, DOI 10.1242/jeb.02652; Ramos IB, 2006, MOL REPROD DEV, V73, P1247, DOI 10.1002/mrd.20560; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Severance S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001044; TAPPEL AL, 1955, J BIOL CHEM, V217, P721; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P8742, DOI 10.1073/pnas.90.18.8742; VINCENT SH, 1989, SEMIN HEMATOL, V26, P105; WHITE DC, 1963, J BACTERIOL, V85, P842, DOI 10.1128/JB.85.4.842-850.1963; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	53	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29323	29332		10.1074/jbc.M113.504985	http://dx.doi.org/10.1074/jbc.M113.504985			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23986441	Green Published, hybrid			2022-12-28	WOS:000330615300012
J	Giancaspero, TA; Busco, G; Panebianco, C; Carmone, C; Miccolis, A; Liuzzi, GM; Colella, M; Barile, M				Giancaspero, Teresa Anna; Busco, Giovanni; Panebianco, Concetta; Carmone, Claudia; Miccolis, Angelica; Liuzzi, Grazia Maria; Colella, Matilde; Barile, Maria			FAD Synthesis and Degradation in the Nucleus Create a Local Flavin Cofactor Pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Confocal Microscopy; FAD; FMN; Nucleus; Rat; Riboflavin; FAD Synthase; FAD Hydrolysis; NUDIX Hydrolase	SACCHAROMYCES-CEREVISIAE MITOCHONDRIA; ADENINE-DINUCLEOTIDE SYNTHESIS; RAT-LIVER MITOCHONDRIA; FUNCTIONAL-CHARACTERIZATION; RIBOFLAVIN TRANSPORTER; ESCHERICHIA-COLI; OVER-EXPRESSION; SYNTHETASE; IDENTIFICATION; PURIFICATION	FAD is a redox cofactor ensuring the activity of many flavoenzymes mainly located in mitochondria but also relevant for nuclear redox activities. The last enzyme in the metabolic pathway producing FAD is FAD synthase (EC 2.7.7.2), a protein known to be localized both in cytosol and in mitochondria. FAD degradation to riboflavin occurs via still poorly characterized enzymes, possibly belonging to the NUDIX hydrolase family. By confocal microscopy and immunoblotting experiments, we demonstrate here the existence of FAD synthase in the nucleus of different experimental rat models. HPLC experiments demonstrated that isolated rat liver nuclei contain approximate to 300 pmol of FADmg(-1) protein, which was mainly protein-bound FAD. A mean FAD synthesis rate of 18.1 pmolmin(-1)mg(-1) protein was estimated by both HPLC and continuous coupled enzymatic spectrophotometric assays. Rat liver nuclei were also shown to be endowed with a FAD pyrophosphatase that hydrolyzes FAD with an optimum at alkaline pH and is significantly inhibited by adenylate-containing nucleotides. The coordinate activity of these FAD forming and degrading enzymes provides a potential mechanism by which a dynamic pool of flavin cofactor is created in the nucleus. These data, which significantly add to the biochemical comprehension of flavin metabolism and its subcellular compartmentation, may also provide the basis for a more detailed comprehension of the role of flavin homeostasis in biologically and clinically relevant epigenetic events.	[Giancaspero, Teresa Anna; Barile, Maria] CNR, Ist Biomembrane & Bioenerget, I-70126 Bari, Italy; [Busco, Giovanni; Panebianco, Concetta; Carmone, Claudia; Miccolis, Angelica; Liuzzi, Grazia Maria; Colella, Matilde; Barile, Maria] Univ Bari Aldo Moro, Dipartimento Biosci Biotecnol & Biofarmaceut, I-70126 Bari, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR); Universita degli Studi di Bari Aldo Moro	Colella, M (corresponding author), Univ Bari Aldo Moro, Dipartimento Biosci Biotecnol & Biofarmaceut, Via Orabona 4, I-70126 Bari, Italy.	matilde.colella@uniba.it; maria.barile@uniba.it	Liuzzi, Grazia Maria/GVR-7164-2022; Busco, Giovanni/F-2711-2018; Panebianco, Concetta/K-6380-2016; Colella, Matilde/G-9246-2011; Barile, Maria/R-6171-2016	Busco, Giovanni/0000-0001-6859-9468; Panebianco, Concetta/0000-0003-2819-3505; Colella, Matilde/0000-0002-9584-7030; Latronico, Tiziana/0000-0001-6971-5416; Giancaspero, Teresa Anna/0000-0002-3293-7426; Liuzzi, Grazia Maria/0000-0001-5692-9335; Barile, Maria/0000-0001-5025-551X	PON-Ricerca e Competitivita [01_00937]; Fondazione Cassa di Risparmio di Puglia	PON-Ricerca e Competitivita(Ministry of Education, Universities and Research (MIUR)); Fondazione Cassa di Risparmio di Puglia	This work was supported by PON-Ricerca e Competitivita 2007-2013 Project 01_00937 Modelli sperimentali Biotecnologici integrati per lo Sviluppo e la selezione di molecole di interesse per la salute dell'uomo (to M. B.).; Supported by a post-doctoral fellowship from Fondazione Cassa di Risparmio di Puglia on the project "Caratterizzazione dei meccanismi biochimici implicati nell'induzione dell'ipertrofia cardiaca da parte dei recettori accoppiati a proteine G".	Abdelraheim SR, 2003, BIOCHEM J, V374, P329, DOI 10.1042/BJ20030441; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; Barile M, 1997, EUR J BIOCHEM, V249, P777, DOI 10.1111/j.1432-1033.1997.00777.x; BARILE M, 1993, ARCH BIOCHEM BIOPHYS, V305, P442, DOI 10.1006/abbi.1993.1444; Barile M, 1996, BIOCHEM MOL BIOL INT, V38, P297; Barile M, 2000, EUR J BIOCHEM, V267, P4888, DOI 10.1046/j.1432-1327.2000.01552.x; Barile M, 2013, CURR PHARM DESIGN, V19, P2649, DOI 10.2174/1381612811319140014; Bergmeyer H.U., 1963, METHOD ENZYMAT AN, P736; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brizio C, 2000, EUR J BIOCHEM, V267, P4346, DOI 10.1046/j.1432-1327.2000.01464.x; Brizio C, 2008, INT J BIOL MACROMOL, V42, P455, DOI 10.1016/j.ijbiomac.2008.03.001; Brizio C, 2006, BIOCHEM BIOPH RES CO, V344, P1008, DOI 10.1016/j.bbrc.2006.04.003; Cardone A, 2012, BBA-BIOMEMBRANES, V1818, P2808, DOI 10.1016/j.bbamem.2012.06.011; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; CHAUVEAU J, 1957, B SOC CHIM BIOL, V39, P1521; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Colella M, 2008, ANN NY ACAD SCI, V1123, P64, DOI 10.1196/annals.1420.008; De Colibus L, 2006, CURR OPIN STRUC BIOL, V16, P722, DOI 10.1016/j.sbi.2006.10.003; DELUCA C, 1958, BIOCHIM BIOPHYS ACTA, V30, P6, DOI 10.1016/0006-3002(58)90233-6; DOSTAL DE, 1992, AM J PHYSIOL, V263, pC851, DOI 10.1152/ajpcell.1992.263.4.C851; GALLUCCIO M, 2013, FLAVINS FLAVOPROTEIN, P509; Galluccio M, 2007, PROTEIN EXPRES PURIF, V52, P175, DOI 10.1016/j.pep.2006.09.002; Gerbino A, 2012, CELL CALCIUM, V51, P393, DOI 10.1016/j.ceca.2012.01.002; Ghosal A, 2012, AM J PHYSIOL-GASTR L, V303, pG1052, DOI 10.1152/ajpgi.00314.2012; Giancaspero TA, 2010, EUR J CLIN INVEST, V40, P65; Giancaspero TA, 2009, FEBS J, V276, P219, DOI 10.1111/j.1742-4658.2008.06775.x; Heikal AA, 2010, BIOMARK MED, V4, P241, DOI 10.2217/BMM.10.1; Hino S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1755; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Kasprzak KS, 2001, EXP TOXICOL PATHOL, V53, P325, DOI 10.1078/0940-2993-00201; KING TE, 1962, J BIOL CHEM, V237, P2941; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; KUNZ WS, 1988, BIOCHIM BIOPHYS ACTA, V932, P8, DOI 10.1016/0005-2728(88)90134-X; Latronico T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049656; Lau BW, 2005, GASTROENTEROLOGY, V128, P695, DOI 10.1053/j.gastro.2004.12.046; Lin J, 2009, J NEUROL, V256, P774, DOI 10.1007/s00415-009-5015-8; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Mansoorabadi SO, 2007, J ORG CHEM, V72, P6329, DOI 10.1021/jo0703092; MASSEY V, 1995, FASEB J, V9, P473, DOI 10.1096/fasebj.9.7.7737454; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; MCCORMICK DB, 1989, PHYSIOL REV, V69, P1170, DOI 10.1152/physrev.1989.69.4.1170; McCormick DB, 1997, METHOD ENZYMOL, V280, P407; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; OKA M, 1987, J BIOL CHEM, V262, P7418; Oka S, 2012, CIRC RES, V111, P611, DOI 10.1161/CIRCRESAHA.111.247932; Pallotta ML, 1998, FEBS LETT, V428, P245, DOI 10.1016/S0014-5793(98)00544-4; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHIBKO S, 1963, BIOCHIM BIOPHYS ACTA, V73, P76; Sun L, 2012, MOL BIOL REP, V39, P4119, DOI 10.1007/s11033-011-1194-3; Torchetti EM, 2011, FEBS J, V278, P4435, DOI 10.1111/j.1742-4658.2011.08368.x; Torchetti EM, 2010, MITOCHONDRION, V10, P263, DOI 10.1016/j.mito.2009.12.149; WU M, 1995, MOL CELL BIOL, V15, P264, DOI 10.1128/MCB.15.1.264; YAMADA Y, 1990, ARCH BIOCHEM BIOPHYS, V278, P125, DOI 10.1016/0003-9861(90)90240-Y; Yamamoto S, 2009, J BIOCHEM, V145, P437, DOI 10.1093/jb/mvn181; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yao Y, 2010, J NUTR, V140, P1220, DOI 10.3945/jn.110.122911; Yonezawa A, 2008, AM J PHYSIOL-CELL PH, V295, pC632, DOI 10.1152/ajpcell.00019.2008; Yonezawa A, 2013, MOL ASPECTS MED, V34, P693, DOI 10.1016/j.mam.2012.07.014	62	51	54	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29069	29080		10.1074/jbc.M113.500066	http://dx.doi.org/10.1074/jbc.M113.500066			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946482	hybrid, Green Published			2022-12-28	WOS:000330298800060
J	Orebaugh, CD; Fye, JM; Harvey, S; Hollis, T; Wilkinson, JC; Perrino, FW				Orebaugh, Clinton D.; Fye, Jason M.; Harvey, Scott; Hollis, Thomas; Wilkinson, John C.; Perrino, Fred W.			The TREX1 C-terminal Region Controls Cellular Localization through Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmune Diseases; DNA; DNA Enzymes; Nucleic Acid; Ubiquitination	AICARDI-GOUTIERES-SYNDROME; FAMILIAL CHILBLAIN LUPUS; DNA EXONUCLEASE TREX1; DOMINANT MUTATIONS; GENE; PROTEIN; DEGRADATION; IDENTIFICATION; ERYTHEMATOSUS; ENCEPHALITIS	TREX1 is an autonomous 3-exonuclease that degrades DNA to prevent inappropriate immune activation. The TREX1 protein is composed of 314 amino acids; the N-terminal 242 amino acids contain the catalytic domain, and the C-terminal region (CTR) localizes TREX1 to the cytosolic compartment. In this study, we show that TREX1 modification by ubiquitination is controlled by a highly conserved sequence in the CTR to affect cellular localization. Transfection of TREX1 deletion constructs into human cells demonstrated that this sequence is required for ubiquitination at multiple lysine residues through a non-canonical ubiquitin linkage. A proteomic approach identified ubiquilin 1 as a TREX1 CTR-interacting protein, and this interaction was verified in vitro and in vivo. Cotransfection studies indicated that ubiquilin 1 localizes TREX1 to cytosolic punctate structures dependent upon the TREX1 CTR and lysines within the TREX1 catalytic core. Several TREX1 mutants linked to the autoimmune diseases Aicardi-Goutieres syndrome and systemic lupus erythematosus that exhibit full catalytic function were tested for altered ubiquitin modification and cellular localization. Our data show that these catalytically competent disease-causing TREX1 mutants exhibit differential levels of ubiquitination relative to WT TREX1, suggesting a novel mechanism of dysfunction. Furthermore, these differentially ubiquitinated disease-causing mutants also exhibit altered ubiquilin 1 co-localization. Thus, TREX1 post-translational modification indicates an additional mechanism by which mutations disrupt TREX1 biology, leading to human autoimmune disease.	[Orebaugh, Clinton D.; Fye, Jason M.; Harvey, Scott; Hollis, Thomas; Wilkinson, John C.; Perrino, Fred W.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University	Perrino, FW (corresponding author), Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wakehealth.edu			National Institutes of Health [GM069962]; Alliance for Lupus Research [179222]; American Heart Association [10GRNT3650033]; American Cancer Society Research Scholar Award [RSG-09-166-01-CCG]; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; American Heart Association(American Heart Association); American Cancer Society Research Scholar Award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069962 (to F. W. P.). This work was also supported by Alliance for Lupus Research Grant 179222 (to F. W. P.), American Heart Association Grant 10GRNT3650033 (to T. H.), and American Cancer Society Research Scholar Award RSG-09-166-01-CCG (to J. C. W.).	Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Beverly LJ, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1119167109; Biswas N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021153; BLACK DN, 1988, ANN NEUROL, V24, P483, DOI 10.1002/ana.410240402; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Crow YJ, 2003, J MED GENET, V40, P183, DOI 10.1136/jmg.40.3.183; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; de Vries B, 2010, ANN RHEUM DIS, V69, P1886, DOI 10.1136/ard.2009.114157; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Funakoshi M, 1999, EMBO J, V18, P5009, DOI 10.1093/emboj/18.18.5009; Fye JM, 2011, J BIOL CHEM, V286, P32373, DOI 10.1074/jbc.M111.276287; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao L, 2003, J VIROL, V77, P4149, DOI 10.1128/JVI.77.7.4149-4159.2003; Gruver AM, 2011, J NEURO-OPHTHALMOL, V31, P20, DOI 10.1097/WNO.0b013e3181f45dba; Gunther C, 2009, DERMATOLOGY, V219, P162, DOI 10.1159/000222430; Hasan M, 2013, NAT IMMUNOL, V14, P61, DOI 10.1038/ni.2475; Hedrich CM, 2008, CLIN RHEUMATOL, V27, P949, DOI 10.1007/s10067-008-0942-9; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lee-Kirsch MA, 2006, AM J HUM GENET, V79, P731, DOI 10.1086/507848; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lewis EM, 2011, BIOCHEMISTRY-US, V50, P11084, DOI 10.1021/bi201483g; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Migliorini A, 2012, NAT REV NEPHROL, V8, P183, DOI 10.1038/nrneph.2011.197; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakayasu ES, 2013, J AM SOC MASS SPECTR, V24, P1214, DOI 10.1007/s13361-013-0619-8; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Orebaugh CD, 2011, J BIOL CHEM, V286, P40246, DOI 10.1074/jbc.M111.297903; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Poole BD, 2009, AUTOIMMUN REV, V8, P337, DOI 10.1016/j.autrev.2008.12.008; Prendiville JS, 2009, J AM ACAD DERMATOL, V61, P727, DOI 10.1016/j.jaad.2009.05.002; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Rekvig OP, 2006, ADV EXP MED BIOL, V577, P117; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Stam AH, 2009, CEPHALALGIA, V29, P1006, DOI 10.1111/j.1468-2982.2009.01940.x; Stephenson JBP, 2008, EUR J PAEDIATR NEURO, V12, P355, DOI 10.1016/j.ejpn.2007.11.010; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wilkinson JC, 2008, MOL CELL BIOL, V28, P237, DOI 10.1128/MCB.01065-07; Wu AL, 1999, MOL CELL, V4, P619, DOI 10.1016/S1097-2765(00)80212-9; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yan N, 2011, CURR OPIN IMMUNOL, V23, P21, DOI 10.1016/j.coi.2010.11.004; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029	68	22	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28881	28892		10.1074/jbc.M113.503391	http://dx.doi.org/10.1074/jbc.M113.503391			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23979357	Green Published, hybrid			2022-12-28	WOS:000330298800040
J	Carlsson, MC; Bengtson, P; Cucak, H; Leffler, H				Carlsson, Michael C.; Bengtson, Per; Cucak, Helena; Leffler, Hakon			Galectin-3 Guides Intracellular Trafficking of Some Human Serotransferrin Glycoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SERUM GLYCOPROTEINS; HUMAN TRANSFERRIN; CANCER PROGRESSION; CELL-PROLIFERATION; NEOPLASTIC-CELLS; EPITHELIAL-CELLS; GLYCOSYLATION; ENDOCYTOSIS; RECEPTORS; MEMBRANE	Transferrin internalization via clathrin-mediated endocytosis and subsequent recycling after iron delivery has been extensively studied. Here we demonstrate a previously unrecognized parameter regulating this recycling, the binding of galectin-3 to particular glycoforms of transferrin. Two fractions of transferrin, separated by affinity chromatography based on their binding or not to galectin-3, are targeted to kinetically different endocytic pathways in HFL-1 cells expressing galectin-3 but not in SKBR3 cells lacking galectin-3; the SKBR3 cells, however, can acquire the ability to target these transferrin glycoforms differently after preloading with exogenously added galectin-3. In all, this study provides the first evidence of a functional role for transferrin glycans, in intracellular trafficking after uptake. Moreover, the galectin-3-bound glycoform increased in cancer, suggesting a pathophysiological regulation. These are novel aspects of transferrin cell biology, which has previously considered only a degree of iron loading, but not other forms of heterogeneity.	[Carlsson, Michael C.; Cucak, Helena; Leffler, Hakon] Lund Univ, Dept Lab Med, Sect MIG Microbiol Immunol Glycobiol, S-22100 Lund, Sweden; [Bengtson, Per] Lund Univ, Div Clin Chem & Pharmacol, S-22100 Lund, Sweden	Lund University; Lund University	Carlsson, MC (corresponding author), Sect MIG Microbiol Immunol Glycobiol, Dept Lab Med, Solvegatan 23, S-22362 Lund, Sweden.	michael.carlsson@med.lu.se; hakon.leffler@med.lu.se	Leffler, Hakon/A-2416-2019	Leffler, Hakon/0000-0003-4482-8945	Swedish Research Council (Vetenskapsradet); Region Skane	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Region Skane	The work was supported by grants from the Swedish Research Council (Vetenskapsradet) and Region Skane.	Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; Carlsson A, 2008, EUR J CANCER, V44, P472, DOI 10.1016/j.ejca.2007.11.025; Carlsson MC, 2012, BBA-GEN SUBJECTS, V1820, P1366, DOI 10.1016/j.bbagen.2012.01.007; Carlsson MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026560; Carlsson S, 2007, GLYCOBIOLOGY, V17, P906, DOI 10.1093/glycob/cwm059; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Crack JC, 2006, J BIOL CHEM, V281, P18909, DOI 10.1074/jbc.C600042200; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Cumpstey I, 2007, CHEMBIOCHEM, V8, P1389, DOI 10.1002/cbic.200700040; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Flahaut C, 2003, GLYCOBIOLOGY, V13, P191, DOI 10.1093/glycob/cwg016; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Gao XG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052430; Granovsky M, 2000, NAT MED, V6, P306; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; HATTON MWC, 1979, BIOCHEM J, V181, P633, DOI 10.1042/bj1810633; HERRMANN J, 1993, J BIOL CHEM, V268, P26704; Jiang XP, 2010, ANTICANCER RES, V30, P759; Kwok JC, 2002, CRIT REV ONCOL HEMAT, V42, P65, DOI 10.1016/S1040-8428(01)00213-X; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lepur A, 2012, BBA-GEN SUBJECTS, V1820, P804, DOI 10.1016/j.bbagen.2012.02.018; MASON AB, 1993, BIOCHEMISTRY-US, V32, P5472, DOI 10.1021/bi00071a025; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; O'Brien J. F., 2001, CURRENT PROTOCOLS HU, V54; Ohtsubo K, 2005, GLYCOBIOLOGY, V15, P1196; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pipalia NH, 2007, TRAFFIC, V8, P130, DOI 10.1111/j.1600-0854.2006.00513.x; Richardson DR, 2009, BBA-GEN SUBJECTS, V1790, P702, DOI 10.1016/j.bbagen.2008.04.003; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Shakor ABA, 2011, J BIOL CHEM, V286, P36053, DOI 10.1074/jbc.M111.228593; Sheff D, 2002, J CELL BIOL, V156, P797, DOI 10.1083/jcb.20111048; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Sorme P, 2004, ANAL BIOCHEM, V334, P36, DOI 10.1016/j.ab.2004.06.042; Stechly L, 2009, TRAFFIC, V10, P438, DOI 10.1111/j.1600-0854.2009.00882.x; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Straube T, 2013, TRAFFIC, V14, P1014, DOI 10.1111/tra.12086; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; WARD JH, 1982, BIOCHEM J, V208, P19, DOI 10.1042/bj2080019; YAMASHITA K, 1989, J BIOL CHEM, V264, P2415; Zhang H.-L., 2010, J BIOMED OPT, V15	50	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28398	28408		10.1074/jbc.M113.487793	http://dx.doi.org/10.1074/jbc.M113.487793			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23926108	hybrid, Green Published			2022-12-28	WOS:000330612800067
J	Takahashi, M; Dillon, TJ; Liu, C; Kariya, Y; Wang, ZP; Stork, PJS				Takahashi, Maho; Dillon, Tara J.; Liu, Chang; Kariya, Yumi; Wang, Zhiping; Stork, Philip J. S.			Protein Kinase A-dependent Phosphorylation of Rap1 Regulates Its Membrane Localization and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; PLASMA-MEMBRANE; CARCINOMA-CELLS; ELECTROSTATIC SWITCH; EPAC PROTEINS; LEADING-EDGE; SMALL GTPASE; ADHESION; ACTIVATION; INTEGRIN	The small G protein Rap1 can mediate "inside-out signaling" by recruiting effectors to the plasma membrane that signal to pathways involved in cell adhesion and cell migration. This action relies on the membrane association of Rap1, which is dictated by post-translational prenylation as well as by a stretch of basic residues within its carboxyl terminus. One feature of this stretch of acidic residues is that it lies adjacent to a functional phosphorylation site for the cAMP-dependent protein kinase PKA. This phosphorylation has two effects on Rap1 action. One, it decreases the level of Rap1 activity as measured by GTP loading and the coupling of Rap1 to RapL, a Rap1 effector that couples Rap1 GTP loading to integrin activation. Two, it destabilizes the membrane localization of Rap1, promoting its translocation into the cytoplasm. These two actions, decreased GTP loading and decreased membrane localization, are related, as the translocation of Rap1-GTP into the cytoplasm is associated with its increased GTP hydrolysis and inactivation. The consequences of this phosphorylation in Rap1-dependent cell adhesion and cell migration were also examined. Active Rap1 mutants that lack this phosphorylation site had a minimal effect on cell adhesion but strongly reduced cell migration, when compared with an active Rap1 mutant that retained the phosphorylation site. This suggests that optimal cell migration is associated with cycles of Rap1 activation, membrane egress, and inactivation, and requires the regulated phosphorylation of Rap1 by PKA.	[Takahashi, Maho; Dillon, Tara J.; Liu, Chang; Kariya, Yumi; Wang, Zhiping; Stork, Philip J. S.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Wang, Zhiping] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97239 USA; [Kariya, Yumi] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	Oregon Health & Science University; Oregon Health & Science University; University of Tokyo	Stork, PJS (corresponding author), L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	stork@ohsu.edu			National Institutes of Health [DK090309]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK090309.	Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Baillie GS, 2005, FEBS LETT, V579, P3264, DOI 10.1016/j.febslet.2005.03.089; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Carey KD, 2000, MOL CELL BIOL, V20, P8409, DOI 10.1128/MCB.20.22.8409-8419.2000; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Edreira MM, 2009, J BIOL CHEM, V284, P27480, DOI 10.1074/jbc.M109.011312; Emery AC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003993; Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200; FISCHER TH, 1991, FEBS LETT, V283, P173, DOI 10.1016/0014-5793(91)80581-M; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Freeman SA, 2010, CANCER RES, V70, P4590, DOI 10.1158/0008-5472.CAN-09-3414; Fujita H, 2005, J BIOL CHEM, V280, P5022, DOI 10.1074/jbc.M409701200; GHOMASHCHI F, 1995, BIOCHEMISTRY-US, V34, P11910, DOI 10.1021/bi00037a032; Grandoch M, 2009, BRIT J CANCER, V101, P2038, DOI 10.1038/sj.bjc.6605439; He Y, 2011, J CELL SCI, V124, P2153, DOI 10.1242/jcs.078535; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hernandez-Varas P, 2011, J BIOL CHEM, V286, P18492, DOI 10.1074/jbc.M110.189811; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Hu CD, 1999, J BIOL CHEM, V274, P48, DOI 10.1074/jbc.274.1.48; Kinashi T, 2004, IMMUNOL LETT, V93, P1, DOI 10.1016/j.imlet.2004.02.008; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; McKenzie AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026552; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Menon J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049893; Meyer CJ, 2000, NAT CELL BIOL, V2, P666, DOI 10.1038/35023621; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; POLAKIS PG, 1991, P NATL ACAD SCI USA, V88, P239, DOI 10.1073/pnas.88.1.239; Price LS, 2004, NAT IMMUNOL, V5, P1007, DOI 10.1038/ni1004-1007; Raab M, 2011, J BIOL CHEM, V286, P29663, DOI 10.1074/jbc.M111.222661; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Raymond DR, 2007, CELL SIGNAL, V19, P2507, DOI 10.1016/j.cellsig.2007.08.005; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Ross SH, 2011, J CELL SCI, V124, P1808, DOI 10.1242/jcs.079830; Roy MO, 2000, BIOCHEMISTRY-US, V39, P8298, DOI 10.1021/bi000512q; Rundell CJ, 2004, BIOCHEM BIOPH RES CO, V315, P1077, DOI 10.1016/j.bbrc.2004.01.161; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Serrels Bryan, 2011, Small GTPases, V2, P54; Silvius JR, 2006, MOL BIOL CELL, V17, P192, DOI 10.1091/mbc.e05-05-0408; Smolen GA, 2007, GENE DEV, V21, P2131, DOI 10.1101/gad.1561507; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Whittard JD, 2001, J CELL SCI, V114, P3265; Zhang ZC, 2005, J BIOL CHEM, V280, P33200, DOI 10.1074/jbc.M505057200	63	40	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27712	27723		10.1074/jbc.M113.466904	http://dx.doi.org/10.1074/jbc.M113.466904			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23946483	Green Published, hybrid			2022-12-28	WOS:000330612800002
J	Ray, A; Alalem, M; Ray, BK				Ray, Alpana; Alalem, Mohamed; Ray, Bimal K.			Loss of Epigenetic Kruppel-like Factor 4 Histone Deacetylase (KLF-4-HDAC)-mediated Transcriptional Suppression Is Crucial in Increasing Vascular Endothelial Growth Factor (VEGF) Expression in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; TUMOR-SUPPRESSOR; GENE-EXPRESSION; PROTEIN EXPRESSION; DOWN-REGULATION; DNA-BINDING; FACTOR SAF; KLF4; CELLS; SP1	Vascular endothelial growth factor (VEGF) is recognized as an important angiogenic factor that promotes angiogenesis in a series of pathological conditions, including cancer, inflammation, and ischemic disorders. We have recently shown that the inflammatory transcription factor SAF-1 is, at least in part, responsible for the marked increase of VEGF levels in breast cancer. Here, we show that SAF-1-mediated induction of VEGF is repressed by KLF-4 transcription factor. KLF-4 is abundantly present in normal breast epithelial cells, but its level is considerably reduced in breast cancer cells and clinical cancer tissues. In the human VEGF promoter, SAF-1- and KLF-4-binding elements are overlapping, whereas SAF-1 induces and KLF-4 suppresses VEGF expression. Ectopic overexpression of KLF-4 and RNAi-mediated inhibition of endogenous KLF-4 supported the role of KLF-4 as a transcriptional repressor of VEGF and an inhibitor of angiogenesis in breast cancer cells. We show that KLF-4 recruits histone deacetylases (HDACs) -2 and -3 at the VEGF promoter. Chronological ChIP assays demonstrated the occupancy of KLF-4, HDAC2, and HDAC3 in the VEGF promoter in normal MCF-10A cells but not in MDA-MB-231 cancer cells. Co-transfection of KLF-4 and HDAC expression plasmids in breast cancer cells results in synergistic repression of VEGF expression and inhibition of angiogenic potential of these carcinoma cells. Together these results identify a new mechanism of VEGF up-regulation in cancer that involves concomitant loss of KLF-4-HDAC-mediated transcriptional repression and active recruitment of SAF-1-mediated transcriptional activation.	[Ray, Alpana; Alalem, Mohamed; Ray, Bimal K.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Ray, A (corresponding author), Univ Missouri, Dept Vet Pathobiol, 126A Connaway Hall, Columbia, MO 65211 USA.	rayal@missouri.edu; rayb@missouri.edu	Alalem, Mohamed/K-9011-2016	Alalem, Mohamed/0000-0003-2626-295X	United States Army Medical Research and Material Command; College of Veterinary Medicine, University of Missouri	United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); College of Veterinary Medicine, University of Missouri	This work was supported in part by grants from the United States Army Medical Research and Material Command and the College of Veterinary Medicine, University of Missouri.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Ai WD, 2004, J BIOL CHEM, V279, P27830; Ai WD, 2004, J BIOL CHEM, V279, P8684, DOI 10.1074/jbc.M308278200; Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151; ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bianchi F, 2004, CLIN CANCER RES, V10, P6023, DOI 10.1158/1078-0432.CCR-04-0619; Bouras T, 2001, CANCER RES, V61, P903; BROWN LF, 1995, HUM PATHOL, V26, P86, DOI 10.1016/0046-8177(95)90119-1; Burke LJ, 2000, FASEB J, V14, P1876, DOI 10.1096/fj.99-0943rev; Deacon K, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397042; Engels K, 1997, J PATHOL, V181, P207; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; FERRARA N, 1995, BREAST CANCER RES TR, V36, P127, DOI 10.1007/BF00666035; Finkenzeller G, 1997, ONCOGENE, V15, P669, DOI 10.1038/sj.onc.1201219; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Foster KW, 2000, CANCER RES, V60, P6488; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Jacobs EJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1400; Kanai M, 2006, CLIN CANCER RES, V12, P6395, DOI 10.1158/1078-0432.CCR-06-1034; Kee HJ, 2009, J MOL CELL CARDIOL, V47, P770, DOI 10.1016/j.yjmcc.2009.08.022; Kumar D, 2009, J BIOL CHEM, V284, P1853, DOI 10.1074/jbc.M806289200; Li J, 2012, CARCINOGENESIS, V33, P1239, DOI 10.1093/carcin/bgs143; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Miller KA, 2001, J BIOL CHEM, V276, P42863, DOI 10.1074/jbc.M108130200; Nagata T., 2012, BREAST CANC IN PRESS; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Ray A, 1999, J BIOL CHEM, V274, P4300, DOI 10.1074/jbc.274.7.4300; Ray A, 1998, MOL CELL BIOL, V18, P7327, DOI 10.1128/MCB.18.12.7327; Ray A, 2003, J BIOL CHEM, V278, P22586, DOI 10.1074/jbc.M300705200; Ray A, 2002, MOL CELL BIOL, V22, P1027, DOI 10.1128/MCB.22.4.1027-1035.2002; Ray A, 2002, DNA CELL BIOL, V21, P31, DOI 10.1089/10445490252810294; Ray A, 1996, MOL CELL BIOL, V16, P1584; Ray A, 2000, J BIOL CHEM, V275, P39727, DOI 10.1074/jbc.M007907200; Ray A, 2011, MOL CANCER RES, V9, P1030, DOI 10.1158/1541-7786.MCR-10-0598; Ray BK, 2007, J IMMUNOL, V178, P1774, DOI 10.4049/jimmunol.178.3.1774; Ray BK, 1999, DNA CELL BIOL, V18, P65, DOI 10.1089/104454999315637; Ray BK, 1997, BIOCHEMISTRY-US, V36, P4662, DOI 10.1021/bi9624595; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Song J, 2003, INT J MOL MED, V11, P547; Song YD, 2009, CLIN CANCER RES, V15, P492, DOI 10.1158/1078-0432.CCR-08-1945; Stoner M, 2000, J BIOL CHEM, V275, P22769, DOI 10.1074/jbc.M002188200; Stoner M, 2004, ONCOGENE, V23, P1052, DOI 10.1038/sj.onc.1207201; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Tsutsui H, 1999, BIOCHEM BIOPH RES CO, V262, P198, DOI 10.1006/bbrc.1999.1130; Van der Auwera I, 2004, CLIN CANCER RES, V10, P7965, DOI 10.1158/1078-0432.CCR-04-0063; Wade PA, 2001, HUM MOL GENET, V10, P693, DOI 10.1093/hmg/10.7.693; Wang J, 2010, CANCER RES, V70, P10182, DOI 10.1158/0008-5472.CAN-10-2414; Wang L, 2003, CLIN CANCER RES, V9, P3660; Wang N, 2002, WORLD J GASTROENTERO, V8, P966, DOI 10.3748/wjg.v8.i6.966; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wei XL, 2007, CANCER RES, V67, P1853, DOI 10.1158/0008-5472.CAN-06-3063; Wolffe AP, 1996, SCIENCE, V272, P371, DOI 10.1126/science.272.5260.371; Yancy Haile F, 2007, J Carcinog, V6, P8; Yasunaga J, 2004, CANCER RES, V64, P6002, DOI 10.1158/0008-5472.CAN-04-1422; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yori JL, 2011, NEOPLASIA, V13, P601, DOI 10.1593/neo.11260; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yoshiji H, 1996, CANCER RES, V56, P2013; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Yu TX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032492; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200	72	27	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27232	27242		10.1074/jbc.M113.481184	http://dx.doi.org/10.1074/jbc.M113.481184			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23926105	Green Published, hybrid			2022-12-28	WOS:000330597300021
J	Wanaguru, M; Crosnier, C; Johnson, S; Rayner, JC; Wright, GJ				Wanaguru, Madushi; Crosnier, Cecile; Johnson, Steven; Rayner, Julian C.; Wright, Gavin J.			Biochemical Analysis of the Plasmodium falciparum Erythrocyte-binding Antigen-175 (EBA175)-Glycophorin-A Interaction IMPLICATIONS FOR VACCINE DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate-binding Protein; Cell Invasion; Cell Surface Receptor; Infectious Diseases; Malaria; Protein-Protein Interactions; Surface Plasmon Resonance (SPR)	RECEPTOR-BINDING; MALARIA VACCINE; INVASION; EBA-175; PROTEINS; RECOGNIZES; ANTIBODIES	PfEBA175 has an important role in the invasion of human erythrocytes by Plasmodium falciparum and is therefore considered a high priority blood-stage malaria vaccine candidate. PfEBA175 mediates adhesion to erythrocytes through binding of the Duffy-binding-like (DBL) domains in its extracellular domain to Neu5Ac2-3Gal displayed on the O-linked glycans of glycophorin-A (GYPA). Because of the difficulties in expressing active full-length (FL) P. falciparum proteins in a recombinant form, previous analyses of the PfEBA175-GYPA interaction have largely focused on the DBL domains alone, and therefore they have not been performed in the context of the native protein sequence. Here, we express the entire ectodomain of PfEBA175 (PfEBA175 FL) in soluble form, allowing us to compare the biochemical and immunological properties with a fragment containing only the tandem DBL domains (region II, PfEBA175 RII). Recombinant PfEBA175 FL bound human erythrocytes in a trypsin and neuraminidase-sensitive manner and recognized Neu5Ac2-3Gal-containing glycans, confirming its biochemical activity. A quantitative binding analysis showed that PfEBA175 FL interacted with native GYPA with a K-D approximate to 0.26 m and is capable of self-association. By comparison, the RII fragment alone bound GYPA with a lower affinity demonstrating that regions outside of the DBL domains are important for interactions with GYPA; antibodies directed to these other regions also contributed to the inhibition of parasite invasion. These data demonstrate the importance of PfEBA175 regions other than the DBL domains in the interaction with GYPA and merit their inclusion in an EBA175-based vaccine.	[Wanaguru, Madushi; Crosnier, Cecile; Wright, Gavin J.] Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge CB10 1HH, England; [Wanaguru, Madushi; Crosnier, Cecile; Rayner, Julian C.; Wright, Gavin J.] Wellcome Trust Sanger Inst, Malaria Programme, Cambridge CB10 1SA, England; [Johnson, Steven] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; University of Oxford	Wright, GJ (corresponding author), Wellcome Trust Sanger Inst, Cell Surface Signalling Lab, Cambridge CB10 2DP, England.	gw2@sanger.ac.uk	Johnson, Steven J/F-9182-2016	Johnson, Steven J/0000-0002-7877-3543; Wright, Gavin/0000-0003-0537-0863; Rayner, Julian/0000-0002-9835-1014	Wellcome Trust [098051]; MRC [G0900888]; MRC [MR/J002283/1] Funding Source: UKRI; Medical Research Council [MR/J002283/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust Grant 098051 and MRC Grant G0900888.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Bartholdson SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003031; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Birkholtz LM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-197; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Bustamante LY, 2013, VACCINE, V31, P373, DOI 10.1016/j.vaccine.2012.10.106; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Crosnier C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-76; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; El Sahly HM, 2010, CLIN VACCINE IMMUNOL, V17, P1552, DOI 10.1128/CVI.00082-10; Geels MJ, 2011, EXPERT REV VACCINES, V10, P1697, DOI [10.1586/erv.11.158, 10.1586/ERV.11.158]; Greenwood BM, 2011, CLIN MICROBIOL INFEC, V17, P1600, DOI 10.1111/j.1469-0691.2011.03612.x; Jakobsen PH, 1998, INFECT IMMUN, V66, P4203; Jiang LB, 2011, P NATL ACAD SCI USA, V108, P7553, DOI 10.1073/pnas.1104050108; KAIN KC, 1993, J EXP MED, V178, P1497, DOI 10.1084/jem.178.5.1497; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Muchmore EA, 1998, AM J PHYS ANTHROPOL, V107, P187, DOI 10.1002/(SICI)1096-8644(199810)107:2<187::AID-AJPA5>3.3.CO;2-M; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; ORLANDI PA, 1990, MOL BIOCHEM PARASIT, V40, P285, DOI 10.1016/0166-6851(90)90050-V; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Peek LJ, 2006, VACCINE, V24, P5839, DOI 10.1016/j.vaccine.2006.04.067; Rayner JC, 2011, TRENDS PARASITOL, V27, P222, DOI 10.1016/j.pt.2011.01.006; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Rodriguez LE, 2000, PARASITOLOGY, V120, P225, DOI 10.1017/S003118209900551X; Sim BKL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018393; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Theron M, 2010, CYTOM PART A, V77A, P1067, DOI 10.1002/cyto.a.20972; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; TOMITA M, 1975, P NATL ACAD SCI USA, V72, P2964, DOI 10.1073/pnas.72.8.2964; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wright GJ, 2009, MOL BIOSYST, V5, P1405, DOI [10.1039/B903580J, 10.1039/b903580j]; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Zhang DM, 2005, INFECT IMMUN, V73, P6530, DOI 10.1128/IAI.73.10.6530-6536.2005	42	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32106	32117		10.1074/jbc.M113.484840	http://dx.doi.org/10.1074/jbc.M113.484840			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24043627	Green Published, hybrid			2022-12-28	WOS:000328681700001
J	Fu, XM; Shi, XD; Yan, LX; Zhang, HL; Chang, ZY				Fu, Xinmiao; Shi, Xiaodong; Yan, Linxuan; Zhang, Hanlin; Chang, Zengyi			In Vivo Substrate Diversity and Preference of Small Heat Shock Protein IbpB as Revealed by Using a Genetically Incorporated Photo-cross-linker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE ALPHA-CRYSTALLIN; MOLTEN GLOBULE STATES; ESCHERICHIA-COLI; MOLECULAR CHAPERONE; MULTICHAPERONE NETWORK; DENATURED PROTEINS; OXIDATIVE STRESS; COMPETENT STATE; DISAGGREGATION; RESISTANCE	Small heat shock proteins (sHSPs), as ubiquitous molecular chaperones found in all forms of life, are known to be able to protect cells against stresses and suppress the aggregation of a variety of model substrate proteins under in vitro conditions. Nevertheless, it is poorly understood what natural substrate proteins are protected by sHSPs in living cells. Here, by using a genetically incorporated photo-cross-linker (p-benzoyl-L-phenylalanine), we identified a total of 95 and 54 natural substrate proteins of IbpB (an sHSP from Escherichia coli) in living cells with and without heat shock, respectively. Functional profiling of these proteins (110 in total) suggests that IbpB, although binding to a wide range of cellular proteins, has a remarkable substrate preference for translation-related proteins (e. g. ribosomal proteins and amino-acyl tRNA synthetases) and moderate preference for metabolic enzymes. Furthermore, these two classes of proteins were found to be more prone to aggregation and/or inactivation in cells lacking IbpB under stress conditions (e. g. heat shock). Together, our in vivo data offer novel insights into the chaperone function of IbpB, or sHSPs in general, and suggest that the preferential protection on the protein synthesis machine and metabolic enzymes may dominantly contribute to the well known protective effect of sHSPs on cell survival against stresses.	[Fu, Xinmiao; Shi, Xiaodong; Yan, Linxuan; Zhang, Hanlin; Chang, Zengyi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Shi, Xiaodong] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221002, Peoples R China	Peking University; Xuzhou Medical University	Fu, XM (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	fuxinmiao@pku.edu.cn; changzy@pku.edu.cn	Fu, Xinmiao/ABE-9050-2020	Fu, Xinmiao/0000-0003-3361-6904; Zhang, Hanlin/0000-0001-9353-6071	National Natural Science Foundation of China [31170738, 31100559, 31270804]; National Basic Research Program of China 973 Program [2012CB917300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Research Grants 31170738 (to Z. C.) and 31100559 and 31270804 (to X. F.) and National Basic Research Program of China 973 Program Grant 2012CB917300 (to X. F. and Z. C.).	ARATA S, 1995, J CELL PHYSIOL, V163, P458, DOI 10.1002/jcp.1041630305; Balogi Z, 2008, J BIOL CHEM, V283, P22983, DOI 10.1074/jbc.M710400200; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Bepperling A, 2012, P NATL ACAD SCI USA, V109, P20407, DOI 10.1073/pnas.1209565109; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CARVER JA, 1995, BBA-PROTEIN STRUCT M, V1252, P251, DOI 10.1016/0167-4838(95)00146-L; Carver JA, 2002, J MOL BIOL, V318, P815, DOI 10.1016/S0022-2836(02)00144-4; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; Chang ZY, 1996, J BIOL CHEM, V271, P7218, DOI 10.1074/jbc.271.12.7218; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Das KP, 1996, J BIOL CHEM, V271, P10449, DOI 10.1074/jbc.271.18.10449; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; Farrelli IS, 2005, NAT METHODS, V2, P377, DOI 10.1038/nmeth0505-377; Fu XM, 2013, J BIOL CHEM, V288, P11897, DOI 10.1074/jbc.M113.450437; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Gu LX, 2002, J MOL BIOL, V319, P517, DOI 10.1016/S0022-2836(02)00311-X; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hu YL, 2012, SCI CHINA LIFE SCI, V55, P927, DOI 10.1007/s11427-012-4388-6; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Jiao WW, 2008, BIOCHEM J, V410, P63, DOI 10.1042/BJ20071120; Jiao WW, 2005, J MOL BIOL, V347, P871, DOI 10.1016/j.jmb.2005.01.029; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kitagawa M, 2000, FEMS MICROBIOL LETT, V184, P165, DOI 10.1111/j.1574-6968.2000.tb09009.x; Kuczynska-Wisnik D, 2002, MICROBIOL-SGM, V148, P1757, DOI 10.1099/00221287-148-6-1757; Laskowska E, 2010, CURR PHARM BIOTECHNO, V11, P146, DOI 10.2174/138920110790909669; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Leng FW, 2012, SCI CHINA LIFE SCI, V55, P837, DOI 10.1007/s11427-012-4372-1; Lindner RA, 1997, J BIOL CHEM, V272, P27722, DOI 10.1074/jbc.272.44.27722; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Matuszewska E, 2008, MICROBIOL-SGM, V154, P1739, DOI 10.1099/mic.0.2007/014696-0; Matuszewska E, 2009, ACTA BIOCHIM POL, V56, P55; Matuszewska M, 2005, J BIOL CHEM, V280, P12292, DOI 10.1074/jbc.M412706200; MERCK KB, 1993, J BIOL CHEM, V268, P1046; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; Moller IM, 2011, J PROTEOMICS, V74, P2228, DOI 10.1016/j.jprot.2011.05.004; Morrow G, 2004, J BIOL CHEM, V279, P43382, DOI 10.1074/jbc.C400357200; Morrow G, 2012, INT J BIOCHEM CELL B, V44, P1613, DOI 10.1016/j.biocel.2012.03.009; Muchowski PJ, 1998, P NATL ACAD SCI USA, V95, P1004, DOI 10.1073/pnas.95.3.1004; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ratajczak E, 2009, J MOL BIOL, V386, P178, DOI 10.1016/j.jmb.2008.12.009; Richards EH, 1996, CANCER RES, V56, P2446; Rinas U, 2007, J BIOTECHNOL, V127, P244, DOI 10.1016/j.jbiotec.2006.07.004; Salinthone S, 2007, AM J PHYSIOL-LUNG C, V293, pL1194, DOI 10.1152/ajplung.00453.2006; Soto A, 1999, PLANT PHYSIOL, V120, P521, DOI 10.1104/pp.120.2.521; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; Treweek TM, 2000, BBA-PROTEIN STRUCT M, V1481, P175, DOI 10.1016/S0167-4838(00)00109-6; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Waters ER, 2008, GENOME, V51, P177, DOI 10.1139/G07-114; Waters ER, 1999, P NATL ACAD SCI USA, V96, P14394, DOI 10.1073/pnas.96.25.14394; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Yeh CH, 1997, P NATL ACAD SCI USA, V94, P10967, DOI 10.1073/pnas.94.20.10967; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]	65	36	39	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31646	31654		10.1074/jbc.M113.501817	http://dx.doi.org/10.1074/jbc.M113.501817			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045939	Green Published, hybrid			2022-12-28	WOS:000330596200023
J	Lee, C; Marians, KJ				Lee, Chong; Marians, Kenneth J.			Characterization of the Nucleoid-associated Protein YejK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; DNA GYRASE; H-NS; GENES; ACID; FIS	Nucleoid-associated proteins play an important role in condensing chromosomal DNA and regulating gene expression. We report here the characterization of the nucleoid-associated protein YejK, which was detected in a yeast two-hybrid screen using the ParE subunit of topoisomerase IV as bait. The purified protein likely exists in a monomer-dimer equilibrium in solution and can form tetramers. Cross-linking of the protein bound to DNA suggests that the active form could be either a dimer or tetramer. YejK, which is present at about 24,000 copies of monomer per mid-log phase cell, binds double-stranded DNA with a site size of 12-14 base pairs/monomer, does not display a significant preference for either bent compared with straight DNA or supercoiled compared with relaxed DNA, and untwists DNA somewhat as it binds. YejK binds RNA, but not single-stranded DNA, with 65% of the avidity with which it binds DNA. However, cells deleted for yejK do not show defects in either RNA or protein synthesis. YejK interacts with all the subunits of both DNA gyrase and topoisomerase IV and has measurable effects on their activities. In the presence of YejK, relaxation of negatively supercoiled DNA by topoisomerase IV becomes distributive, whereas relaxation of positively supercoiled DNA is stimulated. Relaxation of negatively supercoiled DNA by DNA gyrase is inhibited, whereas the extent of supercoiling of relaxed DNA is limited. A YejK-GFP chimera is an effective marker for the nucleoid in live cell imaging.	[Lee, Chong; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), 1275 York Ave, New York, NY 10065 USA.	kmarians@sloankettering.edu			National Institutes of Health [GM34558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34558 (to K. J. M.).	Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Corcoran CP, 2010, J BACTERIOL, V192, P4790, DOI 10.1128/JB.00531-10; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Espeli O, 2003, MOL MICROBIOL, V50, P495, DOI 10.1046/j.1365-2958.2003.03736.x; Ferullo DJ, 2009, METHODS, V48, P8, DOI 10.1016/j.ymeth.2009.02.010; Grainger DC, 2008, MOL MICROBIOL, V68, P1366, DOI 10.1111/j.1365-2958.2008.06253.x; Guo FS, 2007, P NATL ACAD SCI USA, V104, P4309, DOI 10.1073/pnas.0611686104; Keane OM, 2003, MOL GENET GENOMICS, V270, P56, DOI 10.1007/s00438-003-0896-1; KLEVAN L, 1980, BIOCHEMISTRY-US, V19, P5229, DOI 10.1021/bi00564a012; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; MARIANS KJ, 1987, J BIOL CHEM, V262, P10362; Marie D, 1996, APPL ENVIRON MICROB, V62, P1649, DOI 10.1128/AEM.62.5.1649-1655.1996; McClendon AK, 2005, J BIOL CHEM, V280, P39337, DOI 10.1074/jbc.M503320200; McLeod SM, 2002, J MOL BIOL, V316, P517, DOI 10.1006/jmbi.2001.5391; MENZEL R, 1983, CELL, V34, P105, DOI 10.1016/0092-8674(83)90140-X; Murphy LD, 1999, J BACTERIOL, V181, P3842, DOI 10.1128/JB.181.12.3842-3844.1999; Schneider R, 1999, MOL MICROBIOL, V34, P953, DOI 10.1046/j.1365-2958.1999.01656.x; Takeda Toshiharu, 2011, Int J Evol Biol, V2011, P685015, DOI 10.4061/2011/685015; Vlahovicek K, 2003, NUCLEIC ACIDS RES, V31, P3686, DOI 10.1093/nar/gkg559; WANG Q, 1993, EMBO J, V12, P2495, DOI 10.1002/j.1460-2075.1993.tb05904.x; Weinstein-Fischer D, 2007, MOL MICROBIOL, V63, P1131, DOI 10.1111/j.1365-2958.2006.05569.x; Williams NL, 2001, J MOL BIOL, V306, P969, DOI 10.1006/jmbi.2001.4468	26	9	9	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31503	31516		10.1074/jbc.M113.494237	http://dx.doi.org/10.1074/jbc.M113.494237			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043617	Green Published, hybrid			2022-12-28	WOS:000330596200010
J	Xiao, J; Zhou, YC; Lai, H; Lei, S; Chi, LH; Mo, XW				Xiao, Jun; Zhou, Yongchun; Lai, Hao; Lei, Shi; Chi, Lisa H.; Mo, Xianwei			Transcription Factor NF-Y Is a Functional Regulator of the Transcription of Core Clock Gene Bmal1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCADIAN TRANSCRIPTION; SP1; PROMOTER	The circadian clock enables organisms to adjust to daily environmental changes and synchronize multiple molecular, biochemical, physiological, and behavioral processes accordingly. In mammalian clock work, Bmal1 is the most important core clock gene, which works with another core clock gene Clock to drive the expression of other clock genes and clock-controlled genes. However, the regulation of Bmal1 has not been fully understood. This work was aimed at identifying the positive regulator(s) of Bmal1 transcription. A series of 5' deletion reporter constructs was generated, and binding site mutations of mouse Bmal1 promoter fragments were cloned into pGL3-basic and pGL3(R2.1)-basic plasmids and transfected into NIH 3T3 cells. Luciferase activity was either measured 48 h after transfection or recorded for 4 days after serum shock. DNA affinity precipitation assay was used to detect the transcription factors binding to Bmal1 promoter. Small interfering RNA against nuclear factor Y, subunit A (NF-YA) and dominant negative NF-YA were employed to study the role of NF-Y in Bmal1 transcription regulation. Deletion and mutation analyses identified two clusters of CCAAT/GC-boxes at the proximal region of Bmal1 promoter as the activating cis-elements. Bmal1 promoter activity was up-regulated by NF-Y and/or Sp1 and repressed by dominant negative NF-YA or siRNA against NF-YA. The activation of Bmal1 promoter activity by NF-Y and Sp1 was inhibited by Rev-Erb alpha. DNA affinity precipitation assay showed that NF-Y and Sp1 bound to the two CCAAT/GC clusters of Bmal1 promoter. These results indicate that NF-Y is a functional activator of Bmal1 transcription and it cooperates with Sp1 and Rev-Erb alpha to generate the daily cycle of Bmal1 expression.	[Xiao, Jun; Lai, Hao; Mo, Xianwei] Guangxi Med Univ, Dept Gastrointestinal Surg, Tumour Hosp, Nanning 530021, Guangxi, Peoples R China; [Zhou, Yongchun] Guigang City Peoples Hosp, Dept Gastrointestinal Surg, Guigang 537100, Guangxi Autonom, Peoples R China; [Lei, Shi] Chi Sci, Jiangyin 214434, Jiangsu, Peoples R China; [Chi, Lisa H.] CHI Sci Inc, Maynard, MA 01754 USA	Guangxi Medical University	Lei, S (corresponding author), Chi Sci, 85 Shashan Rd, Jiangyin 214434, Jiangsu, Peoples R China.	shi.lei@chiscientific.cn; lyzlyynanning@aliyun.com						Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Armengol S, 2013, BIOCHIMIE, V95, P735, DOI 10.1016/j.biochi.2012.10.029; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Dalvai M, 2011, ONCOGENE, V30, P2282, DOI 10.1038/onc.2010.588; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Lee Y, 2010, J CELL SCI, V123, P3547, DOI 10.1242/jcs.070300; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Lutzner N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032590; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Onishi Y, 2008, MOL CELL BIOL, V28, P3477, DOI 10.1128/MCB.02227-07; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Smith JEH, 2011, NEW SYNTH HIST LIB, V67, P1, DOI 10.1007/978-94-007-0041-3_1; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wu YF, 2010, ACTA MED OKAYAMA, V64, P95	19	12	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31930	31936		10.1074/jbc.M113.507038	http://dx.doi.org/10.1074/jbc.M113.507038			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24030830	Green Published, hybrid			2022-12-28	WOS:000330596200045
J	Kurokawa, K; Jung, DJ; An, JH; Fuchs, K; Jeon, YJ; Kim, NH; Li, XH; Tateishi, K; Park, JA; Xia, GQ; Matsushita, M; Takahashi, K; Park, HJ; Peschel, A; Lee, BL				Kurokawa, Kenji; Jung, Dong-Jun; An, Jang-Hyun; Fuchs, Katharina; Jeon, Yu-Jin; Kim, Na-Hyang; Li, Xuehua; Tateishi, Koichiro; Park, Ji Ae; Xia, Guoqing; Matsushita, Misao; Takahashi, Kazue; Park, Hee-Ju; Peschel, Andreas; Lee, Bok Luel			Glycoepitopes of Staphylococcal Wall Teichoic Acid Govern Complement-mediated Opsonophagocytosis via Human Serum Antibody and Mannose-binding Lectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOTEICHOIC ACID; AUREUS; PEPTIDOGLYCAN; VIRULENCE; GENE; IMMUNOCHEMISTRY; ASSOCIATION; ACTIVATION; RESISTANCE; REGULATORS	Serum antibodies and mannose-binding lectin (MBL) are important host defense factors for host adaptive and innate immunity, respectively. Antibodies and MBL also initiate the classical and lectin complement pathways, respectively, leading to opsonophagocytosis. We have shown previously that Staphylococcus aureus wall teichoic acid (WTA), a cell wall glycopolymer consisting of ribitol phosphate substituted with alpha- or beta-O-N-acetyl-D-glucosamine (GlcNAc) and D-alanine, is recognized by MBL and serum anti-WTA IgG. However, the exact antigenic determinants to which anti-WTA antibodies or MBL bind have not been determined. To answer this question, several S. aureus mutants, such as alpha-GlcNAc glycosyltransferase-deficient S. aureus Delta tarM, beta-GlcNAc glycosyltransferase-deficient Delta tarS, and Delta tarMS double mutant cells, were prepared from a laboratory and a community-associated methicillin-resistant S. aureus strain. Here, we describe the unexpected finding that beta-GlcNAc WTA-deficient Delta tarS mutant cells (which have intact alpha-GlcNAc) escape from anti-WTA antibody-mediated opsonophagocytosis, whereas alpha-GlcNAc WTA-deficient Delta tarM mutant cells (which have intact beta-GlcNAc) are efficiently engulfed by human leukocytes via anti-WTA IgG. Likewise, MBL binding in S. aureus cells was lost in the Delta tarMS double mutant but not in either single mutant. When we determined the serum concentrations of the anti-alpha- or anti-beta-GlcNAc-specific WTA IgGs, anti-beta-GlcNAc WTA-IgG was dominant in pooled human IgG fractions and in the intact sera of healthy adults and infants. These data demonstrate the importance of the WTA sugar conformation for human innate and adaptive immunity against S. aureus infection.	[Kurokawa, Kenji; Jung, Dong-Jun; An, Jang-Hyun; Jeon, Yu-Jin; Kim, Na-Hyang; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea; [Fuchs, Katharina; Li, Xuehua; Xia, Guoqing; Peschel, Andreas] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Cellular & Mol Microbiol Sect, D-72076 Tubingen, Germany; [Tateishi, Koichiro; Matsushita, Misao] Tokai Univ, Dept Appl Biochem, Hiratsuka, Kanagawa 2591292, Japan; [Park, Ji Ae; Park, Hee-Ju] Pusan Natl Univ, Dept Pediat, Coll Med, Yangsan 626870, Gyeongsangnam D, South Korea; [Takahashi, Kazue] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pediat, Boston, MA 02114 USA	Pusan National University; Eberhard Karls University of Tubingen; Tokai University; Pusan National University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea.	brlee@pusan.ac.kr	Xia, Guoqing/C-2365-2015	Xia, Guoqing/0000-0003-4492-9156	Korean National Research Foundation [2012-0139-0002, 2011-002-7773]; German Research Council [TRR34, SFB766]	Korean National Research Foundation(National Research Foundation of Korea); German Research Council(German Research Foundation (DFG))	This work was supported by Korean National Research Foundation Programs 2012-0139-0002 and 2011-002-7773 (to B. L. L.) and by German Research Council Grants TRR34 (to A. P.) and SFB766 (to G. X.).	Alonzo F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003143; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Colque-Navarro P, 2010, CLIN VACCINE IMMUNOL, V17, P1117, DOI 10.1128/CVI.00506-09; Daha NA, 2011, MOL IMMUNOL, V48, P1656, DOI 10.1016/j.molimm.2011.04.024; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x; ENGHOFER E, 1979, CARBOHYD RES, V76, P233, DOI 10.1016/0008-6215(79)80022-1; Frankel MB, 2012, J BIOL CHEM, V287, P10460, DOI 10.1074/jbc.M111.336404; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; JOINER KA, 1984, ANNU REV IMMUNOL, V2, P461, DOI 10.1146/annurev.immunol.2.1.461; JUERGENS WG, 1963, J EXP MED, V117, P925, DOI 10.1084/jem.117.6.925; Jung DJ, 2012, J IMMUNOL, V189, P4951, DOI 10.4049/jimmunol.1201294; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; Kurokawa K, 2011, DEV COMP IMMUNOL, V35, P835, DOI 10.1016/j.dci.2011.03.001; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Li Y, 2004, MOL GENET GENOMICS, V271, P447, DOI 10.1007/s00438-004-0996-6; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; MORSE SI, 1962, J EXP MED, V116, P229, DOI 10.1084/jem.116.2.229; NATHENSON SG, 1962, J BIOL CHEM, V237, P3839; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Oku Y, 2009, J BACTERIOL, V191, P141, DOI 10.1128/JB.01221-08; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Park KH, 2010, J BIOL CHEM, V285, P27167, DOI 10.1074/jbc.M110.141309; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Pozzi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046648; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Shiratsuchi A, 2010, IMMUNOLOGY, V129, P268, DOI 10.1111/j.1365-2567.2009.03168.x; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229; SUPER M, 1989, LANCET, V2, P1236; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Tabuchi Y, 2010, J IMMUNOL, V185, P2424, DOI 10.4049/jimmunol.1000625; Takahashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069739; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; TORII M, 1964, J EXP MED, V120, P13, DOI 10.1084/jem.120.1.13; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Vandenesch F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00012; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Weidenmaier C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013227; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001	54	39	39	4	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30956	30968		10.1074/jbc.M113.509893	http://dx.doi.org/10.1074/jbc.M113.509893			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24045948	Green Published, hybrid			2022-12-28	WOS:000330778900015
J	Lin, Z; Puchalla, J; Shoup, D; Rye, HS				Lin, Zong; Puchalla, Jason; Shoup, Daniel; Rye, Hays S.			Repetitive Protein Unfolding by the trans Ring of the GroEL-GroES Chaperonin Complex Stimulates Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; RESONANCE ENERGY-TRANSFER; SURFACE DENATURATION; ESCHERICHIA-COLI; SINGLE-MOLECULE; REACTION CYCLE; SUBSTRATE PROTEIN; CENTRAL CAVITY; ATPASE CYCLE; BINDING	A key constraint on the growth of most organisms is the slow and inefficient folding of many essential proteins. To deal with this problem, several diverse families of protein folding machines, known collectively as molecular chaperones, developed early in evolutionary history. The functional role and operational steps of these remarkably complex nanomachines remain subjects of active debate. Here we present evidence that, for the GroEL-GroES chaperonin system, the non-native substrate protein enters the folding cycle on the trans ring of the double-ring GroEL-ATP-GroES complex rather than the ADP-bound complex. The properties of this ATP complex are designed to ensure that non-native substrate protein binds first, followed by ATP and finally GroES. This binding order ensures efficient occupancy of the open GroEL ring and allows for disruption of misfolded structures through two phases of multiaxis unfolding. In this model, repeated cycles of partial unfolding, followed by confinement within the GroEL-GroES chamber, provide the most effective overall mechanism for facilitating the folding of the most stringently dependent GroEL substrate proteins.	[Lin, Zong] Tsinghua Univ, Yangtze Delta Reg Inst, Dept Biotechnol & Biomed, Jiaxing 314006, Zhejiang, Peoples R China; [Puchalla, Jason] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Shoup, Daniel; Rye, Hays S.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Tsinghua University; Princeton University; Texas A&M University System; Texas A&M University College Station	Rye, HS (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	haysrye@tamu.edu		Rye, Hays/0000-0002-9420-3137	National Institutes of Health [GM065421]; National Natural Science Foundation of China [31370743]; Zhejiang Natural Science Foundation [LR12C05001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065421 (to H. S. R.). This work was also supported by National Natural Science Foundation of China Grant 31370743 (to Z. L.) and Zhejiang Natural Science Foundation Grant LR12C05001 (to Z. L.).	BADCOE IG, 1991, BIOCHEMISTRY-US, V30, P9195, DOI 10.1021/bi00102a010; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Bull HB, 1937, J BIOL CHEM, V118, P163; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; Csermely P, 1999, BIOESSAYS, V21, P959, DOI 10.1002/(SICI)1521-1878(199911)21:11<959::AID-BIES8>3.0.CO;2-1; EDWARDS RA, 1992, BIOCHEM CELL BIOL, V70, P63, DOI 10.1139/o92-009; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GRAHAM DE, 1979, J COLLOID INTERF SCI, V70, P403, DOI 10.1016/0021-9797(79)90048-1; Grason JP, 2008, P NATL ACAD SCI USA, V105, P17334, DOI 10.1073/pnas.0807429105; Hammarstrom P, 2001, J BIOL CHEM, V276, P21765, DOI 10.1074/jbc.M010858200; Hammarstrom P, 2000, J BIOL CHEM, V275, P22832, DOI 10.1074/jbc.M000649200; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hofmann H, 2010, P NATL ACAD SCI USA, V107, P11793, DOI 10.1073/pnas.1002356107; Horst R, 2007, P NATL ACAD SCI USA, V104, P20788, DOI 10.1073/pnas.0710042105; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; Jewett AI, 2010, CELL MOL LIFE SCI, V67, P255, DOI 10.1007/s00018-009-0164-6; Kad NM, 1998, J MOL BIOL, V278, P267, DOI 10.1006/jmbi.1998.1704; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim SY, 2010, J MOL BIOL, V401, P553, DOI 10.1016/j.jmb.2010.06.050; Koike-Takeshita A, 2008, J BIOL CHEM, V283, P23774, DOI 10.1074/jbc.M802542200; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Lorimer G, 1997, NATURE, V388, P720, DOI 10.1038/41892; Madan D, 2008, J BIOL CHEM, V283, P32003, DOI 10.1074/jbc.M802898200; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Puchalla J, 2008, P NATL ACAD SCI USA, V105, P14400, DOI 10.1073/pnas.0805969105; RANSON NA, 1995, J MOL BIOL, V250, P581, DOI 10.1006/jmbi.1995.0399; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Rye HS, 2001, METHODS, V24, P278, DOI 10.1006/meth.2001.1188; SAIBIL HR, 1993, CURR BIOL, V3, P265, DOI 10.1016/0960-9822(93)90176-O; Sameshima T, 2008, J BIOL CHEM, V283, P23765, DOI 10.1074/jbc.M802541200; Sameshima T, 2010, J BIOL CHEM, V285, P23157, DOI 10.1074/jbc.M110.122101; Sameshima T, 2010, BIOCHEM J, V427, P247, DOI 10.1042/BJ20091845; SCHMIDT M, 1994, J BIOL CHEM, V269, P10304; Sen P, 2008, J PHYS CHEM B, V112, P13473, DOI 10.1021/jp8061288; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Sparrer H, 1997, J BIOL CHEM, V272, P14080, DOI 10.1074/jbc.272.22.14080; STANIFORTH RA, 1994, BIOCHEM J, V300, P651, DOI 10.1042/bj3000651; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; Tyagi NK, 2009, P NATL ACAD SCI USA, V106, P20264, DOI 10.1073/pnas.0911556106; VANDERVIES SM, 1992, BIOCHEMISTRY-US, V31, P3635, DOI 10.1021/bi00129a012; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; YIFRACH O, 1994, J MOL BIOL, V243, P397, DOI 10.1006/jmbi.1994.1667; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Zahn R, 1996, SCIENCE, V271, P642, DOI 10.1126/science.271.5249.642	58	20	20	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30944	30955		10.1074/jbc.M113.480178	http://dx.doi.org/10.1074/jbc.M113.480178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24022487	hybrid, Green Published			2022-12-28	WOS:000330778900014
J	Melhorn, MI; Brodsky, AS; Estanislau, J; Khoory, JA; Illigens, B; Hamachi, I; Kurishita, Y; Fraser, AD; Nicholson-Weller, A; Dolmatova, E; Duffy, HS; Ghiran, IC				Melhorn, Mark I.; Brodsky, Abigail S.; Estanislau, Jessica; Khoory, Joseph A.; Illigens, Ben; Hamachi, Itaru; Kurishita, Yasutaka; Fraser, Andrew D.; Nicholson-Weller, Anne; Dolmatova, Elena; Duffy, Heather S.; Ghiran, Ionita C.			CR1-mediated ATP Release by Human Red Blood Cells Promotes CR1 Clustering and Modulates the Immune Transfer Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; NUCLEOSIDE POLYPHOSPHATES; HUMAN ERYTHROCYTES; HUMAN-NEUTROPHILS; C3B RECEPTOR; PANNEXIN 1; PHAGOCYTOSIS; ASSOCIATION; CHANNELS; PROTEIN	Humans and other higher primates are unique among mammals in using complement receptor 1 (CR1, CD35) on red blood cells (RBC) to ligate complement-tagged inflammatory particles (immune complexes, apoptotic/necrotic debris, and microbes) in the circulation for quiet transport to the sinusoids of spleen and liver where resident macrophages remove the particles, but allow the RBC to return unharmed to the circulation. This process is called immune-adherence clearance. In this study we found using luminometric- and fluorescence-based methods that ligation of CR1 on human RBC promotes ATP release. Our data show that CR1-mediated ATP release does not depend on Ca2+ or enzymes previously shown to mediate an increase in membrane deformability promoted by CR1 ligation. Furthermore, ATP release following CR1 ligation increases the mobility of the lipid fraction of RBC membranes, which in turn facilitates CR1 clustering, and thereby enhances the binding avidity of complement-opsonized particles to the RBC CR1. Finally, we have found that RBC-derived ATP has a stimulatory effect on phagocytosis of immune-adherent immune complexes.	[Melhorn, Mark I.; Brodsky, Abigail S.; Estanislau, Jessica; Khoory, Joseph A.; Fraser, Andrew D.; Nicholson-Weller, Anne; Ghiran, Ionita C.] Beth Israel Deaconess Med Ctr, Div Allergy & Inflammat, Boston, MA 02115 USA; [Nicholson-Weller, Anne] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02115 USA; [Dolmatova, Elena; Duffy, Heather S.] Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02115 USA; [Illigens, Ben] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hamachi, Itaru; Kurishita, Yasutaka] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Kyoto 6158510, Japan	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Kyoto University	Ghiran, IC (corresponding author), Ctr Life Sci CLS 934, 3 Blackfan Circle, Boston, MA 02115 USA.	ighiran@bidmc.harvard.edu			National Institutes of Health [HL096795]; Bill and Melinda Gates Foundation [OPP1032683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL096795 (to I. C. G.) and Bill and Melinda Gates Foundation Grant OPP1032683 (to I. C. G.).	Abraham EH, 2001, BLOOD CELL MOL DIS, V27, P165, DOI 10.1006/bcmd.2000.0357; An XL, 2004, BIOCHEMISTRY-US, V43, P310, DOI 10.1021/bi035653h; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bonner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034730; BROWN EJ, 1995, BIOESSAYS, V17, P109, DOI 10.1002/bies.950170206; CHANGELIAN PS, 1985, J IMMUNOL, V134, P1851; CHASIS JA, 1992, BLOOD, V80, P1869; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chen Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000549; Clarke A, 2013, ANAL BIOCHEM, V436, P66, DOI 10.1016/j.ab.2013.01.024; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Crehan H, 2012, IMMUNOBIOLOGY, V217, P244, DOI 10.1016/j.imbio.2011.07.017; Darby M, 2003, J NEUROPHYSIOL, V89, P1870, DOI 10.1152/jn.00510.2002; Enjeti AK, 2008, SEMIN THROMB HEMOST, V34, P683, DOI 10.1055/s-0028-1104547; Fan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038059; FEARON DT, 1980, J EXP MED, V152, P20, DOI 10.1084/jem.152.1.20; Fung CYE, 2012, BLOOD, V119, P3613, DOI 10.1182/blood-2011-10-386052; Gandy S, 2013, BIOL PSYCHIAT, V73, P393, DOI 10.1016/j.biopsych.2013.01.013; Ghiran I, 2000, J EXP MED, V192, P1797, DOI 10.1084/jem.192.12.1797; Ghiran I, 2008, BLOOD, V112, P3465, DOI 10.1182/blood-2008-04-151845; Ghiran IC, 2011, ARTHRITIS RHEUM-US, V63, P503, DOI 10.1002/art.30143; Glodek AM, 2010, BLOOD, V116, P6063, DOI 10.1182/blood-2010-04-273904; Souza VDG, 2012, PURINERG SIGNAL, V8, P753, DOI 10.1007/s11302-012-9322-7; Klickstein LB, 1997, IMMUNITY, V7, P345, DOI 10.1016/S1074-7613(00)80356-8; Kurishita Y, 2012, J AM CHEM SOC, V134, P18779, DOI 10.1021/ja308754g; Kurishita Y, 2010, J AM CHEM SOC, V132, P13290, DOI 10.1021/ja103615z; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; MACFARLANE GD, 1994, ORAL MICROBIOL IMMUN, V9, P180, DOI 10.1111/j.1399-302X.1994.tb00056.x; MISETA A, 1993, BIOCHIM BIOPHYS ACTA, V1175, P133, DOI 10.1016/0167-4889(93)90015-H; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; Nickells M, 1998, CLIN EXP IMMUNOL, V112, P27; Odhiambo CO, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-23; Ohi H, 2008, NEPHRON CLIN PRACT, V108, pC23, DOI 10.1159/000112478; Ojida A, 2008, J AM CHEM SOC, V130, P12095, DOI 10.1021/ja803262w; Oldenborg PA, 2004, LEUKEMIA LYMPHOMA, V45, P1319, DOI 10.1080/1042819042000201989; Pilsczek FH, 2005, J INFECT DIS, V192, P200, DOI 10.1086/430947; Regateiro FS, 2013, CLIN EXP IMMUNOL, V171, P1, DOI 10.1111/j.1365-2249.2012.04623.x; Roman RM, 1999, AM J PHYSIOL-GASTR L, V277, pG1222, DOI 10.1152/ajpgi.1999.277.6.G1222; SCHARFSTEIN J, 1979, J CLIN INVEST, V63, P437, DOI 10.1172/JCI109320; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Sridharan M, 2012, AM J PHYSIOL-HEART C, V302, pH553, DOI 10.1152/ajpheart.00998.2011; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P89, DOI 10.1016/S0962-8924(00)88956-4; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043	49	23	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31139	31153		10.1074/jbc.M113.486035	http://dx.doi.org/10.1074/jbc.M113.486035			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24022490	hybrid, Green Published			2022-12-28	WOS:000330778900032
J	Belkaya, S; Murray, SE; Eitson, JL; de la Morena, MT; Forman, JA; van Oers, NSC				Belkaya, Serkan; Murray, Sean E.; Eitson, Jennifer L.; de la Morena, M. Teresa; Forman, James A.; van Oers, Nicolai S. C.			Transgenic Expression of MicroRNA-185 Causes a Developmental Arrest of T Cells by Targeting Multiple Genes Including Mzb1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Intracellular Release; Genetic Diseases; Immunodeficiency; MicroRNA; T Cell Biology; Transcription Target Genes; Transgenic Mice; 22q11; 2 Deletion Syndrome	22Q11.2; ACTIVATION; DIFFERENTIATION; TRANSCRIPTION; MICRODUPLICATION; HOMEOSTASIS; GENERATION; SECRETION; SURVIVAL; LINKING	miR-185 is a microRNA (miR) that targets Bruton's tyrosine kinase in B cells, with reductions in miR-185 linked to B cell autoantibody production. In hippocampal neurons, miR-185 targets both sarcoplasmic/endoplasmic reticulum calcium ATPase 2 and a novel Golgi inhibitor. This miR is haploinsufficient in 90-95% of individuals with chromosome 22q11.2 deletion syndrome, patients who can present with immune, cardiac, and parathyroid problems, learning disorders, and a high incidence of schizophrenia in adults. The reduced levels of miR-185 in neurons cause presynaptic neurotransmitter release. Many of the 22q11.2 deletion syndrome patients have a thymic hypoplasia, which results in a peripheral T cell lymphopenia and unusual T helper cell skewing. The molecular targets of miR-185 in thymocytes are unknown. Using an miR-185 T cell transgenic approach, increasing levels of miR-185 attenuated T cell development at the T cell receptor (TCR) selection checkpoint and during positive selection. This caused a peripheral T cell lymphopenia. Mzb1, Nfatc3, and Camk4 were identified as novel miR-185 targets. Elevations in miR-185 enhanced TCR-dependent intracellular calcium levels, whereas a knockdown of miR-185 diminished these calcium responses. These effects concur with reductions in Mzb1, an endoplasmic reticulum calcium regulator. Consistent with their haploinsufficiency of miR-185, Mzb1 levels were elevated in thymocyte extracts from several 22q11.2 deletion syndrome patients. Our findings indicate that miR-185 regulates T cell development through its targeting of several mRNAs including Mzb1.	[Belkaya, Serkan; Murray, Sean E.; Eitson, Jennifer L.; Forman, James A.; van Oers, Nicolai S. C.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [de la Morena, M. Teresa; van Oers, Nicolai S. C.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [van Oers, Nicolai S. C.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [de la Morena, M. Teresa] Childrens Med Ctr, Dallas, TX 75235 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	van Oers, NSC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, NA2-200,6000 Harry Hines Blvd, Dallas, TX 75390 USA.	nicolai.vanoers@utsouthwestern.edu	Van+Oers, Nicolai/ABA-2437-2021; Belkaya, Serkan/ABD-4504-2020	Belkaya, Serkan/0000-0003-4214-382X; van Oers, Nicolai/0000-0002-6545-8405	National Institutes of Health [R21 AI083827-01]; Children's Medical Center Foundation; Jeffrey Modell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Medical Center Foundation; Jeffrey Modell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants R21 AI083827-01 (to N. S. C. v. O.). This work was also supported by Children's Medical Center Foundation (to N. S. C. v. O. and M. T. d. I. M.) and the Jeffrey Modell Foundation (to M. T. d. I. M.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker AM, 2010, J IMMUNOL, V184, P6822, DOI 10.4049/jimmunol.0902058; Belkaya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027580; Belver L, 2010, IMMUNITY, V33, P713, DOI 10.1016/j.immuni.2010.11.010; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; de la Morena MT, 2013, CLIN IMMUNOL, V147, P11, DOI 10.1016/j.clim.2013.01.011; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Earls LR, 2012, J NEUROSCI, V32, P14132, DOI 10.1523/JNEUROSCI.1312-12.2012; Ensenauer RE, 2003, AM J HUM GENET, V73, P1027, DOI 10.1086/378818; Flach H, 2010, IMMUNITY, V33, P723, DOI 10.1016/j.immuni.2010.11.013; Hoffman BG, 2006, GENES IMMUN, V7, P101, DOI 10.1038/sj.gene.6364270; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Kanaya Y, 2006, CLIN EXP IMMUNOL, V144, P85, DOI 10.1111/j.1365-2249.2006.03038.x; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Kirigin FF, 2012, J IMMUNOL, V188, P3257, DOI 10.4049/jimmunol.1103175; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Liu M, 2011, CANCER LETT, V301, P151, DOI 10.1016/j.canlet.2010.11.009; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Papadopoulou AS, 2012, NAT IMMUNOL, V13, P181, DOI 10.1038/ni.2193; Piliero LM, 2004, BLOOD, V103, P1020, DOI 10.1182/blood-2003-08-2824; Raman V, 2001, J IMMUNOL, V167, P6270, DOI 10.4049/jimmunol.167.11.6270; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shimizu Y, 2009, P NATL ACAD SCI USA, V106, P17013, DOI 10.1073/pnas.0811591106; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Trotta R, 2013, BLOOD, V121, P3126, DOI 10.1182/blood-2012-12-467597; van Anken E, 2009, P NATL ACAD SCI USA, V106, P17019, DOI 10.1073/pnas.0903036106; Xu B, 2013, CELL, V152, P262, DOI 10.1016/j.cell.2012.11.052; Yobb TM, 2005, AM J HUM GENET, V76, P865, DOI 10.1086/429841; Zemble R, 2010, CLIN IMMUNOL, V136, P409, DOI 10.1016/j.clim.2010.04.011; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	35	28	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30752	30762		10.1074/jbc.M113.503532	http://dx.doi.org/10.1074/jbc.M113.503532			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014023	hybrid, Green Published			2022-12-28	WOS:000329868100075
J	Risner, LE; Kuntimaddi, A; Lokken, AA; Achille, NJ; Birch, NW; Schoenfelt, K; Bushweller, JH; Zeleznik-Le, NJ				Risner, Laurie E.; Kuntimaddi, Aravinda; Lokken, Alyson A.; Achille, Nicholas J.; Birch, Noah W.; Schoenfelt, Kelly; Bushweller, John H.; Zeleznik-Le, Nancy J.			Functional Specificity of CpG DNA-binding CXXC Domains in Mixed Lineage Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN MBD1; TRANSCRIPTIONAL REPRESSION; METHYLATION; GENE; COMPLEX; TRANSFORMATION; EXPRESSION; TRITHORAX; METHYLTRANSFERASE; TRANSLOCATIONS	The MLL CXXC domain binds nonmethylated CpG-containing DNA and is essential for the oncogenic properties of MLL fusion proteins. To determine potential functional promiscuity of similar DNA binding domains, we replaced the MLL CXXC domain in the context of the leukemogenic MLL-AF9 fusion with CXXC domains from DNMT1, CGBP (CFP1), and MBD1, or with a methyl-CpG-binding domain (MBD) from MBD1. MLL(DNMT1CXXC)-AF9 shows robust in vitro colony forming activity and in vivo leukemogenesis, similar to MLL-AF9. However, colony forming ability and leukemogenicity are abrogated in MLL-AF9 containing either the CGBP or MBD1 CXXC domains or the MBD1 MBD domain. Direct comparison of in vitro DNA binding affinity of the isolated CXXC or MBD domains demonstrated that MLL, DNMT1, and CGBP CXXC domains could each bind to unmethylated DNA but with differing affinity. In contrast, the isolated MBD1 CXXC and MBD1 MBD domains were unable to bind to the same DNA. However, all substituted domains still allowed targeting of the MLL fusions to the functionally important Hoxa9 locus in primary bone marrow progenitor cells. In addition to DNA binding activity, it was critical that specific CpG residues in the Hoxa9 locus were protected from methylation for leukemia development. This ultimately prevented histone 3 lysine 9 trimethylation (H3K9me3) of the locus and enabled Hoxa9 expression. These were properties shared by MLL and DNMT1 CXXC domains but not by CGBP CXXC or the other swapped fusions tested. We demonstrate that similar CXXC domains can be mechanistically distinguished by specificity of CpG nucleotides preferentially protected from DNA methylation.	[Risner, Laurie E.; Lokken, Alyson A.] Loyola Univ, Med Ctr, Program Mol Biol, Maywood, IL 60153 USA; [Kuntimaddi, Aravinda; Bushweller, John H.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Achille, Nicholas J.; Zeleznik-Le, Nancy J.] Loyola Univ, Med Ctr, Inst Oncol, Maywood, IL 60153 USA; [Birch, Noah W.] Loyola Univ, Med Ctr, Mol & Cellular Biochem Program, Maywood, IL 60153 USA; [Schoenfelt, Kelly] Loyola Univ, Med Ctr, Dept Physiol, Maywood, IL 60153 USA; [Zeleznik-Le, Nancy J.] Loyola Univ, Med Ctr, Dept Med, Maywood, IL 60153 USA	Loyola University Chicago; University of Virginia; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Zeleznik-Le, NJ (corresponding author), Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, 2160 S 1st Ave,Bldg 112,Rm 337, Maywood, IL 60153 USA.	nzelezn@lumc.edu		Bushweller, John/0000-0002-5386-1758	National Institutes of Health [CA105049, HL087188]; Dr. Ralph and Marian Falk Medical Research Trust; Arthur J. Schmitt Foundation; Leukemia and Lymphoma Society SCOR Grant [7006-05]; National Institutes of Health, NHLBI [1F30HL103208-01]; Stritch School of Medicine M.D./Ph.D. program; National Institutes of Health Experimental Immunology Training Grant [T32 AI007508-11A1]; NATIONAL CANCER INSTITUTE [R01CA155328, P01CA105049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087188, F30HL103208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Ralph and Marian Falk Medical Research Trust; Arthur J. Schmitt Foundation; Leukemia and Lymphoma Society SCOR Grant(Leukemia and Lymphoma Society); National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Stritch School of Medicine M.D./Ph.D. program; National Institutes of Health Experimental Immunology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA105049 and HL087188 (to N. J. Z.-L.); the Dr. Ralph and Marian Falk Medical Research Trust (to N. J. Z.-L.); the Arthur J. Schmitt Foundation (to L. E. R.); National Institutes of Health Experimental Immunology Training Grant T32 AI007508-11A1 (to L. E. R.); Leukemia and Lymphoma Society SCOR Grant 7006-05 (to J. H. B.); National Institutes of Health, NHLBI 1F30HL103208-01 (to N. W. B.); and the Stritch School of Medicine M.D./Ph.D. program (to N.W.B.).	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2004, MOL CELL BIOL, V24, P10470, DOI 10.1128/MCB.24.23.10470-10478.2004; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; BERNARD OA, 1995, GENE CHROMOSOME CANC, V13, P75, DOI 10.1002/gcc.2870130202; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; CHEN CS, 1993, BLOOD, V82, P1080; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Erfurth FE, 2008, P NATL ACAD SCI USA, V105, P7517, DOI 10.1073/pnas.0800090105; Fujita N, 2003, J BIOL CHEM, V278, P24132, DOI 10.1074/jbc.M302283200; Fujita N, 1999, MOL CELL BIOL, V19, P6415; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Iida T, 2002, GENES CELLS, V7, P997, DOI 10.1046/j.1365-2443.2002.00584.x; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; MA Q, 1993, P NATL ACAD SCI USA, V90, P6350, DOI 10.1073/pnas.90.13.6350; Mann G, 2010, BLOOD, V116, P2644, DOI 10.1182/blood-2010-03-273532; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Muntean AG, 2010, CANCER CELL, V17, P609, DOI 10.1016/j.ccr.2010.04.012; Ng HH, 2000, MOL CELL BIOL, V20, P1394, DOI 10.1128/MCB.20.4.1394-1406.2000; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Reese BE, 2003, MOL CELL BIOL, V23, P3226, DOI 10.1128/MCB.23.9.3226-3236.2003; ROWLEY JD, 1993, SEMIN CANCER BIOL, V4, P377; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Wade PA, 2001, BIOESSAYS, V23, P1131, DOI 10.1002/bies.10008; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; ZELEZNIKLE NJ, 1994, P NATL ACAD SCI USA, V91, P10610, DOI 10.1073/pnas.91.22.10610	35	21	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29901	29910		10.1074/jbc.M113.474858	http://dx.doi.org/10.1074/jbc.M113.474858			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23990460	Green Published, hybrid			2022-12-28	WOS:000330615300063
J	Schulte, B; John, I; Simon, B; Brockmann, C; Oelmeier, SA; Jahraus, B; Kirchgessner, H; Riplinger, S; Carlomagno, T; Wabnitz, GH; Samstag, Y				Schulte, Bianca; John, Isabel; Simon, Bernd; Brockmann, Christoph; Oelmeier, Stefan A.; Jahraus, Beate; Kirchgessner, Henning; Riplinger, Selina; Carlomagno, Teresa; Wabnitz, Guido H.; Samstag, Yvonne			A Reducing Milieu Renders Cofilin Insensitive to Phosphatidylinositol 4,5-Bisphosphate (PIP2) Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; ACTIN-DEPOLYMERIZING FACTOR; DENDRITIC CELLS; IMMUNOLOGICAL SYNAPSE; LYMPHOCYTE ACTIVATION; OXIDATIVE STRESS; CARCINOMA-CELLS; FORCE-FIELD; DEPHOSPHORYLATION; CYTOSKELETON	Oxidative stress can lead to T cell hyporesponsiveness. A reducing micromilieu (e. g. provided by dendritic cells) can rescue T cells from such oxidant-induced dysfunction. However, the reducing effects on proteins leading to restored T cell activation remained unknown. One key molecule of T cell activation is the actin-remodeling protein cofilin, which is dephosphorylated on serine 3 upon T cell costimulation and has an essential role in formation of mature immune synapses between T cells and antigen-presenting cells. Cofilin is spatiotemporally regulated; at the plasma membrane, it can be inhibited by phosphatidylinositol 4,5-bisphosphate (PIP2). Here, we show by NMR spectroscopy that a reducing milieu led to structural changes in the cofilin molecule predominantly located on the protein surface. They overlapped with the PIP2-but not actin-binding sites. Accordingly, reduction of cofilin had no effect on F-actin binding and depolymerization and did not influence the cofilin phosphorylation state. However, it did prevent inhibition of cofilin activity through PIP2. Therefore, a reducing milieu may generate an additional pool of active cofilin at the plasma membrane. Consistently, in-flow microscopy revealed increased actin dynamics in the immune synapse of untransformed human T cells under reducing conditions. Altogether, we introduce a novel mechanism of redox regulation: reduction of the actin-remodeling protein cofilin renders it insensitive to PIP2 inhibition, resulting in enhanced actin dynamics.	[Schulte, Bianca; John, Isabel; Jahraus, Beate; Kirchgessner, Henning; Riplinger, Selina; Wabnitz, Guido H.; Samstag, Yvonne] Heidelberg Univ, Inst Immunol, D-69120 Heidelberg, Germany; [Simon, Bernd; Brockmann, Christoph; Carlomagno, Teresa] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Oelmeier, Stefan A.] Karlsruhe Inst Technol, Inst Proc Engn Life Sci, Sect Biomol Separat Engn 4, D-76131 Karlsruhe, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Karlsruhe Institute of Technology	Samstag, Y (corresponding author), Heidelberg Univ, Inst Immunol, Neuenheimer Feld 305, D-69120 Heidelberg, Germany.	yvonne.samstag@urz.uni-heidelberg.de		Carlomagno, Teresa/0000-0002-2437-2760; Oelmeier, Stefan/0000-0001-6863-8375; Wabnitz, Guido/0000-0001-5101-9885; Schulte, Bianca/0000-0003-1096-3751; Simon, Bernd/0000-0003-0164-5516	German Research Foundation [SFB 938, DFG Sa393/3-4]	German Research Foundation(German Research Foundation (DFG))	This work was supported in part by German Research Foundation Grants SFB 938 and DFG Sa393/3-4.	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Allen PG, 1997, FEBS LETT, V401, P89, DOI 10.1016/S0014-5793(96)01439-1; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Bernstein BW, 2012, J NEUROSCI, V32, P6670, DOI 10.1523/JNEUROSCI.6020-11.2012; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Eibert SM, 2004, P NATL ACAD SCI USA, V101, P1957, DOI 10.1073/pnas.0308282100; Goddard T., 2007, SPARKY 3 VERSION 3 1; Gorbatyuk VY, 2006, MOL CELL, V24, P511, DOI 10.1016/j.molcel.2006.10.007; Goyal P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071769; Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; Klemke M, 2008, IMMUNITY, V29, P404, DOI 10.1016/j.immuni.2008.06.016; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lee KH, 2000, EUR J IMMUNOL, V30, P892, DOI 10.1002/1521-4141(200003)30:3<892::AID-IMMU892>3.0.CO;2-U; Martner A, 2011, J IMMUNOL, V187, P6243, DOI 10.4049/jimmunol.1102138; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; Pfannstiel J, 2001, J BIOL CHEM, V276, P49476, DOI 10.1074/jbc.M104760200; Pope BJ, 2004, J BIOL CHEM, V279, P4840, DOI 10.1074/jbc.M310148200; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; SAMSTAG Y, 1992, INT IMMUNOL, V4, P1255, DOI 10.1093/intimm/4.11.1255; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; SAMSTAG Y, 1994, P NATL ACAD SCI USA, V91, P4494, DOI 10.1073/pnas.91.10.4494; Song XY, 2006, J CELL SCI, V119, P2871, DOI 10.1242/jcs.03017; Sun Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027227; Thoren FB, 2007, J IMMUNOL, V179, P21, DOI 10.4049/jimmunol.179.1.21; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Wabnitz GH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.36; Wabnitz GH, 2006, J IMMUNOL, V176, P1668, DOI 10.4049/jimmunol.176.3.1668; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382; Zhao HX, 2010, BIOPHYS J, V98, P2327, DOI 10.1016/j.bpj.2010.01.046	36	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29430	29439		10.1074/jbc.M113.479766	http://dx.doi.org/10.1074/jbc.M113.479766			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003227	hybrid, Green Published			2022-12-28	WOS:000330615300021
J	Wagner, GR; Payne, RM				Wagner, Gregory R.; Payne, R. Mark			Widespread and Enzyme-independent N-is an element of-Acetylation and N-is an element of-Succinylation of Proteins in the Chemical Conditions of the Mitochondrial Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Metabolic Diseases; Metabolic Regulation; Mitochondrial Metabolism; pH Regulation; Sirtuins; Acetylation; Nonenzymatic; Succinyl Coenzyme A; Succinylation	HISTONE ACETYLTRANSFERASE GCN5; STEADY-STATE CONCENTRATIONS; KETONE-BODY PRODUCTION; FATTY-ACID OXIDATION; LYSINE ACETYLATION; CALORIE RESTRICTION; PK(A) VALUES; SIRT3; DEACETYLATION; METABOLISM	Alterations in mitochondrial protein acetylation are implicated in the pathophysiology of diabetes, the metabolic syndrome, mitochondrial disorders, and cancer. However, a viable mechanism responsible for the widespread acetylation in mitochondria remains unknown. Here, we demonstrate that the physiologic pH and acyl-CoA concentrations of the mitochondrial matrix are sufficient to cause dose- and time-dependent, but enzyme-independent acetylation and succinylation of mitochondrial and nonmitochondrial proteins in vitro. These data suggest that protein acylation in mitochondria may be a chemical event facilitated by the alkaline pH and high concentrations of reactive acyl-CoAs present in the mitochondrial matrix. Although these results do not exclude the possibility of enzyme-mediated protein acylation in mitochondria, they demonstrate that such a mechanism may not be required in its unique chemical environment. These findings may have implications for the evolutionary roles that the mitochondria-localized SIRT3 deacetylase and SIRT5 desuccinylase have in the maintenance of metabolic health.	[Wagner, Gregory R.; Payne, R. Mark] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Payne, R. Mark] Indiana Univ Sch Med, Dept Pediat, Riley Heart Res Ctr, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Payne, RM (corresponding author), Wells Ctr Pediat Res, Riley Heart Res Ctr, 1044 West Walnut,R4302B, Indianapolis, IN 46202 USA.	rpayne@iupui.edu			National Institutes of Health [1P01HL085098]; American Heart Association [0855646G, 11PRE7290079]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P01HL085098 (to R. M. P.). This work was also supported by American Heart Association Grant in Aid 0855646G (to R. M. P.) and American Heart Association Fellowship 11PRE7290079 (to G. R. W.).	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; BADDILEY J, 1952, NATURE, V170, P968, DOI 10.1038/170968a0; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Fritz KS, 2011, CHEM RES TOXICOL, V24, P651, DOI 10.1021/tx100355a; GARLAND PB, 1965, BIOCHEM J, V97, P587, DOI 10.1042/bj0970587; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; HANSFORD RG, 1975, J BIOL CHEM, V250, P8361; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; JENKINS DW, 1971, J AMER MED ASSOC, V217, P177, DOI 10.1001/jama.217.2.177; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; KIRSCHENBAUM DM, 1982, MED HYPOTHESES, V8, P491, DOI 10.1016/0306-9877(82)90010-X; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; MacKenzie JA, 2004, J BIOL CHEM, V279, P9803, DOI 10.1074/jbc.M307167200; Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; Martin J, 2013, HEPATOLOGY, V57, P2037, DOI 10.1002/hep.26060; McBrian MA, 2013, MOL CELL, V49, P310, DOI 10.1016/j.molcel.2012.10.025; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; McMurry J., 2005, ORGANIC CHEM BIOL PA, P26; Moellering RE, 2013, SCIENCE, V341, P549, DOI 10.1126/science.1238327; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Smith BC, 2011, ACS CHEM BIOL, V6, P146, DOI 10.1021/cb100218d; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Stanton CL, 2008, J CHEM THEORY COMPUT, V4, P951, DOI 10.1021/ct8000014; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; STARK GR, 1965, BIOCHEMISTRY-US, V4, P1030, DOI 10.1021/bi00882a008; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Wagner GR, 2012, HUM MOL GENET, V21, P2688, DOI 10.1093/hmg/dds095; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Yu W, 2009, J BIOL CHEM, V284, P13669, DOI 10.1074/jbc.M901921200; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495	51	339	342	6	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29036	29045		10.1074/jbc.M113.486753	http://dx.doi.org/10.1074/jbc.M113.486753			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946487	hybrid, Green Published			2022-12-28	WOS:000330298800057
J	Martin-Montalvo, A; Gonzalez-Mariscal, I; Pomares-Viciana, T; Padilla-Lopez, S; Ballesteros, M; Vazquez-Fonseca, L; Gandolfo, P; Brautigan, DL; Navas, P; Santos-Ocana, C				Martin-Montalvo, Alejandro; Gonzalez-Mariscal, Isabel; Pomares-Viciana, Teresa; Padilla-Lopez, Sergio; Ballesteros, Manuel; Vazquez-Fonseca, Luis; Gandolfo, Pablo; Brautigan, David L.; Navas, Placido; Santos-Ocana, Carlos			The Phosphatase Ptc7 Induces Coenzyme Q Biosynthesis by Activating the Hydroxylase Coq7 in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN PHOSPHATASE; GENE; KINASE; 2C; PHOSPHORYLATION; IDENTIFICATION; RESPIRATION; METABOLISM; EXPRESSION	The study of the components of mitochondrial metabolism has potential benefits for health span and lifespan because the maintenance of efficient mitochondrial function and antioxidant capacity is associated with improved health and survival. In yeast, mitochondrial function requires the tight control of several metabolic processes such as coenzyme Q biosynthesis, assuring an appropriate energy supply and antioxidant functions. Many mitochondrial processes are regulated by phosphorylation cycles mediated by protein kinases and phosphatases. In this study, we determined that the mitochondrial phosphatase Ptc7p, a Ser/Thr phosphatase, was required to regulate coenzyme Q(6) biosynthesis, which in turn activated aerobic metabolism and enhanced oxidative stress resistance. We showed that Ptc7p phosphatase specifically activated coenzyme Q(6) biosynthesis through the dephosphorylation of the demethoxy-Q(6) hydroxylase Coq7p. The current findings revealed that Ptc7p is a regulator of mitochondrial metabolism that is essential to maintain proper function of the mitochondria by regulating energy metabolism and oxidative stress resistance.	[Martin-Montalvo, Alejandro; Gonzalez-Mariscal, Isabel; Pomares-Viciana, Teresa; Ballesteros, Manuel; Vazquez-Fonseca, Luis; Gandolfo, Pablo; Navas, Placido; Santos-Ocana, Carlos] Univ Pablo de Olavide, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Inst Salud Carlos III, Ctr Andaluz Biol Desarrollo,CSIC, Seville 41013, Spain; [Padilla-Lopez, Sergio] Sanford Res Univ South Dakota, Sanford Children Hlth Res Ctr, Sioux Falls, SD 57104 USA; [Brautigan, David L.] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Instituto de Salud Carlos III; Sanford Health; University of South Dakota; University of Virginia	Martin-Montalvo, A (corresponding author), Univ Pablo de Olavide, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Inst Salud Carlos III, Ctr Andaluz Biol Desarrollo,CSIC, Seville 41013, Spain.	amarsan@upo.es; csanoca@upo.es	Vazquez-Fonseca, Luis/Z-6251-2019; NAVAS, PLACIDO/R-5943-2019; Martin-Montalvo, Alejandro/C-2031-2017; Ocaña, Carlos Santos/E-8115-2011	Vazquez-Fonseca, Luis/0000-0002-0870-6935; NAVAS, PLACIDO/0000-0002-4115-7966; Martin-Montalvo, Alejandro/0000-0002-3886-5355; Ocaña, Carlos Santos/0000-0002-2379-796X; Gonzalez Mariscal, Isabel/0000-0003-1186-1212	Spanish Ministerio de Ciencia y Tecnologia [PI11/00078]; Junta de Andalucia Grant [P08-CTS-03988]; International Q10 Association	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia Grant(Junta de Andalucia); International Q10 Association	The work was supported in part by the Spanish Ministerio de Ciencia y Tecnologia Grant PI11/00078, Junta de Andalucia Grant P08-CTS-03988, and the International Q<INF>10</INF> Association "Phosphorylation based regulation of coenzyme Q biosynthesis in yeast."	Abdulrehman D, 2011, NUCLEIC ACIDS RES, V39, pD136, DOI 10.1093/nar/gkq964; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Brautigan DL, 2005, BIOCHEMISTRY-US, V44, P11067, DOI 10.1021/bi0508845; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colquhoun A, 2001, BBA-MOL CELL BIOL L, V1533, P207, DOI 10.1016/S1388-1981(01)00136-6; Costa Vitor, 2001, Molecular Aspects of Medicine, V22, P217, DOI 10.1016/S0098-2997(01)00012-7; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Gee KR, 1999, BIOORG MED CHEM LETT, V9, P1395, DOI 10.1016/S0960-894X(99)00199-7; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Hans SK, 2010, BIOORGAN MED CHEM, V18, P1103, DOI 10.1016/j.bmc.2009.12.056; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Jiang LH, 2002, FEBS LETT, V527, P323, DOI 10.1016/S0014-5793(02)03247-7; Jimenez-Hidalgo M, 2009, AGING CELL, V8, P140, DOI 10.1111/j.1474-9726.2009.00461.x; Joseph-Horne T, 2001, BBA-BIOENERGETICS, V1504, P179, DOI 10.1016/S0005-2728(00)00251-6; Juneau K, 2009, GENETICS, V183, P185, DOI 10.1534/genetics.109.105155; Krause-Buchholz U, 2006, FEBS LETT, V580, P2553, DOI 10.1016/j.febslet.2006.04.002; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lee J, 2007, MOL CELL PROTEOMICS, V6, P669, DOI 10.1074/mcp.M600218-MCP200; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; MAEDA T, 1993, MOL CELL BIOL, V13, P5408, DOI 10.1128/MCB.13.9.5408; Mao M, 2004, GENOMICS, V83, P989, DOI 10.1016/j.ygeno.2003.12.019; Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006; Martin-Montalvo A, 2011, BIOCHEM J, V440, P107, DOI 10.1042/BJ20101422; Padilla S, 2004, J BIOL CHEM, V279, P25995, DOI 10.1074/jbc.M400001200; Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7; Rahman A, 2011, NEUROCHEM RES, V36, P195, DOI 10.1007/s11064-010-0300-6; Ramos CW, 2000, IUBMB LIFE, V50, P371, DOI 10.1080/152165400300089411; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Ruan HH, 2007, FEMS YEAST RES, V7, P209, DOI 10.1111/j.1567-1364.2006.00160.x; Runner VM, 2003, YEAST, V20, P913, DOI 10.1002/yea.1019; Sakumoto NM, 1999, YEAST, V15, P1669, DOI 10.1002/(SICI)1097-0061(199911)15:15<1669::AID-YEA480>3.0.CO;2-6; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; SIPPEL CJ, 1983, J BIOL CHEM, V258, P1057; Stetak A, 2001, BIOCHEM BIOPH RES CO, V288, P564, DOI 10.1006/bbrc.2001.5811; Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Tauche A, 2008, FEMS YEAST RES, V8, P1263, DOI 10.1111/j.1567-1364.2008.00436.x; Xie LTX, 2012, J BIOL CHEM, V287, P23571, DOI 10.1074/jbc.M112.360354; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009	42	35	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28126	28137		10.1074/jbc.M113.474494	http://dx.doi.org/10.1074/jbc.M113.474494			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940037	Green Published, hybrid			2022-12-28	WOS:000330612800037
J	Peddada, N; Sagar, A; Rathore, YS; Choudhary, V; Pattnaik, UBK; Khatri, N; Garg, R; Ashish				Peddada, Nagesh; Sagar, Amin; Rathore, Yogendra S.; Choudhary, Vikas; Pattnaik, U. Bharat K.; Khatri, Neeraj; Garg, Renu; Ashish			Global Shapes of F-actin Depolymerization-competent Minimal Gelsolins INSIGHT INTO THE ROLE OF g2-g3 LINKER IN pH/Ca2+ INSENSITIVITY OF THE FIRST HALF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-TERMINAL HALF; PLASMA GELSOLIN; BINDING DOMAINS; SCAVENGER SYSTEM; LOW PH; ACTIVATION; CALCIUM; IDENTIFICATION; EXPRESSION; FILAMENTS	Because of its ability to rapidly depolymerize F-actin, plasma gelsolin has emerged as a therapeutic molecule in different disease conditions. High amounts of exogenous gelsolin are, however, required to treat animal models of different diseases. Knowing that the F-actin depolymerizing property of gelsolin resides in its N terminus, we made several truncated versions of plasma gelsolin. The smaller versions, particularly the one composed of the first 28-161 residues, depolymerized the F-actin much faster than the native gelsolin and other truncates at the same molar ratios. Although G1-G3 loses its dependence on Ca2+ or low pH for the actin depolymerization function, interestingly, G1-G2 and its smaller versions were found to regain this requirement. Small angle x-ray scattering-based shape reconstructions revealed that G1-G3 adopts an open shape in both the presence and the absence of Ca2+ as well as low pH, whereas G1-G2 and residues 28-161 prefer collapsed states in Ca2+ -free conditions at pH 8. The mutations in the g2-g3 linker resulted in the calcium sensitivity of the mutant G1-G3 for F-actin depolymerization activity, although the F-actin-binding sites remained exposed in the mutant G1-G3 as well as in the smaller truncates even in the Ca2+ -free conditions at pH 8. Furthermore, unlike wild type G1-G3, calcium-sensitive mutants of G1-G3 acquired closed shapes in the absence of free calcium, implying a role of g2-g3 linker in determining the open F-actin depolymerizing-competent shape of G1-G3 in this condition. We demonstrate that the mobility of the G1 domain, essential for F-actin depolymerization, is indirectly regulated by the gelsolin-like sequence of g2-g3 linker.	[Peddada, Nagesh; Sagar, Amin; Rathore, Yogendra S.; Choudhary, Vikas; Pattnaik, U. Bharat K.; Khatri, Neeraj; Garg, Renu; Ashish] CSIR, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Ashish (corresponding author), CSIR, Inst Microbial Technol, Chandigarh 160036, India.	ashgang@imtech.res.in	Sagar, Amin/AAF-4044-2021; Peddada, Nagesh/L-6760-2019	Sagar, Amin/0000-0002-6207-9557; Peddada, Nagesh/0000-0003-4033-7305	Projects UNSEEN NWP [OLP-0056, Sip-10]; Department of Biotechnology and Council of Scientific and Industrial Research; Department of Science and Technology-Women Scientist Scheme A Grant [SR/WOS-A/LS-106/2009]	Projects UNSEEN NWP; Department of Biotechnology and Council of Scientific and Industrial Research; Department of Science and Technology-Women Scientist Scheme A Grant	This work was supported in part by Projects UNSEEN NWP, OLP-0056, and Sip-10. This is IMTech Communication Number 65/2012.; Recipients of research fellowships from Department of Biotechnology and Council of Scientific and Industrial Research.; Recipient of Department of Science and Technology-Women Scientist Scheme A Grant SR/WOS-A/LS-106/2009.	Ashish, 2007, J BIOL CHEM, V282, P25884, DOI 10.1074/jbc.M702446200; Bucki R, 2005, BIOCHEMISTRY-US, V44, P9590, DOI 10.1021/bi0503504; Burtnick LD, 2004, EMBO J, V23, P2713, DOI 10.1038/sj.emboj.7600280; Burtnick LD, 1997, CELL, V90, P661, DOI 10.1016/S0092-8674(00)80527-9; CHAPONNIER C, 1986, J CELL BIOL, V103, P1473, DOI 10.1083/jcb.103.4.1473; Cohen TS, 2011, CYTOKINE, V54, P235, DOI 10.1016/j.cyto.2011.02.006; EICHINGER L, 1992, BIOCHEMISTRY-US, V31, P4779, DOI 10.1021/bi00135a006; Garg R, 2011, J BIOL CHEM, V286, P20387, DOI 10.1074/jbc.M111.236943; HADDAD JG, 1990, P NATL ACAD SCI USA, V87, P1381, DOI 10.1073/pnas.87.4.1381; Irobi E, 2003, FEBS LETT, V552, P86, DOI 10.1016/S0014-5793(03)00934-7; Kiselar JG, 2003, P NATL ACAD SCI USA, V100, P3942, DOI 10.1073/pnas.0736004100; Klaavuniemi T, 2008, J BIOL CHEM, V283, P26071, DOI 10.1074/jbc.M803618200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KWIATKOWSKI DJ, 1985, J BIOL CHEM, V260, P5232; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; LAMB JA, 1993, J BIOL CHEM, V268, P8999; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; Lee PS, 2006, ANN SURG, V243, P399, DOI 10.1097/01.sla.0000201798.77133.55; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; LEE WM, 1992, NEW ENGL J MED, V326, P1335; Lin KM, 2000, J BIOL CHEM, V275, P27746; Liu ZM, 2010, BIOCHEMISTRY-US, V49, P4349, DOI 10.1021/bi100215b; Mazumdar B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044461; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Meier U, 2006, CLIN CHEM, V52, P1247, DOI 10.1373/clinchem.2005.065680; Nag S, 2009, P NATL ACAD SCI USA, V106, P13713, DOI 10.1073/pnas.0812374106; PANDITA R, 1992, FEBS LETT, V312, P87, DOI 10.1016/0014-5793(92)81416-J; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Peddada N, 2012, MED HYPOTHESES, V78, P203, DOI 10.1016/j.mehy.2011.10.024; POLLARD TD, 1983, ANAL BIOCHEM, V134, P406, DOI 10.1016/0003-2697(83)90316-0; Pope BJ, 1997, BIOCHEMISTRY-US, V36, P15848, DOI 10.1021/bi972192p; Rothenbach PA, 2004, J APPL PHYSIOL, V96, P25, DOI 10.1152/japplphysiol.01074.2002; Roustan C, 2007, FEBS LETT, V581, P681, DOI 10.1016/j.febslet.2007.01.031; Sagar A, 2013, BIOCHEM BIOPH RES CO, V435, P740, DOI 10.1016/j.bbrc.2013.05.055; Selden LA, 1998, BIOPHYS J, V75, P3092, DOI 10.1016/S0006-3495(98)77750-1; SELVE N, 1986, EUR J BIOCHEM, V155, P397, DOI 10.1111/j.1432-1033.1986.tb09504.x; SOUTHWICK FS, 1995, J BIOL CHEM, V270, P45, DOI 10.1074/jbc.270.1.45; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; SUN HQ, 1994, J BIOL CHEM, V269, P9473; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Terada N, 2007, BIOPHYS J, V92, P2162, DOI 10.1529/biophysj.106.098871; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; WAY M, 1989, J CELL BIOL, V109, P593, DOI 10.1083/jcb.109.2.593; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x; WEBER A, 1991, BIOCHEMISTRY-US, V30, P9327, DOI 10.1021/bi00102a027; WEEDS AG, 1991, BIOCHEM SOC T, V19, P1016, DOI 10.1042/bst0191016; Zhang Y, 2006, EMBO J, V25, P4458, DOI 10.1038/sj.emboj.7601323	50	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28266	28282		10.1074/jbc.M113.463224	http://dx.doi.org/10.1074/jbc.M113.463224			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940055	Green Published, hybrid			2022-12-28	WOS:000330612800048
J	Taylor, MS; Ruch, TR; Hsiao, PY; Hwang, Y; Zhang, PF; Dai, LX; Huang, CRL; Berndsen, CE; Kim, MS; Pandey, A; Wolberger, C; Marmorstein, R; Machamer, C; Boeke, JD; Cole, PA				Taylor, Martin S.; Ruch, Travis R.; Hsiao, Po-Yuan; Hwang, Yousang; Zhang, Pingfeng; Dai, Lixin; Huang, Cheng Ran Lisa; Berndsen, Christopher E.; Kim, Min-Sik; Pandey, Akhilesh; Wolberger, Cynthia; Marmorstein, Ronen; Machamer, Carolyn; Boeke, Jef D.; Cole, Philip A.			Architectural Organization of the Metabolic Regulatory Enzyme Ghrelin O-Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Lipids; Membrane Proteins; Metabolism; Peptide Hormones; Enzyme	TRANSMEMBRANE PROTEIN TOPOLOGY; ACYL-COENZYME; ACTIVE-SITE; CHOLESTEROL ACYLTRANSFERASE-1; CONSENSUS PREDICTION; MEMBRANE-PROTEINS; FATTY-ACIDS; PEPTIDE; PALMITOYLATION; IDENTIFICATION	Ghrelin O-acyltransferase (GOAT) is a polytopic integral membrane protein required for activation of ghrelin, a secreted metabolism-regulating peptide hormone. Although GOAT is a potential therapeutic target for the treatment of obesity and diabetes and plays a key role in other physiologic processes, little is known about its structure or mechanism. GOAT is a member of the membrane-bound O-acyltransferase (MBOAT) family, a group of polytopic integral membrane proteins involved in lipid-biosynthetic and lipid-signaling reactions from prokaryotes to humans. Here we use phylogeny and a variety of bioinformatic tools to predict the topology of GOAT. Using selective permeabilization indirect immunofluorescence microscopy in combination with glycosylation shift immunoblotting, we demonstrate that GOAT contains 11 transmembrane helices and one reentrant loop. Development of the V5Glyc tag, a novel, small, and sensitive dual topology reporter, facilitated these experiments. The MBOAT family invariant residue His-338 is in the ER lumen, consistent with other family members, but conserved Asn-307 is cytosolic, making it unlikely that both are involved in catalysis. Photocross-linking of synthetic ghrelin analogs and inhibitors demonstrates binding to the C-terminal region of GOAT, consistent with a role of His-338 in the active site. This knowledge of GOAT architecture is important for a deeper understanding of the mechanism of GOAT and other MBOATs and could ultimately advance the discovery of selective inhibitors for these enzymes.	[Taylor, Martin S.; Hsiao, Po-Yuan; Hwang, Yousang; Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Taylor, Martin S.; Dai, Lixin; Huang, Cheng Ran Lisa; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Taylor, Martin S.; Dai, Lixin; Huang, Cheng Ran Lisa; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Ruch, Travis R.; Machamer, Carolyn] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Huang, Cheng Ran Lisa; Kim, Min-Sik; Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Berndsen, Christopher E.; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Berndsen, Christopher E.; Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Zhang, Pingfeng; Marmorstein, Ronen] Wistar Inst Anat & Biol, Program Gene Express & Regulat, Philadelphia, PA 19104 USA; [Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; The Wistar Institute; University of Pennsylvania	Machamer, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,105 WBSB, Baltimore, MD 21205 USA.	machamer@jhmi.edu; jboeke@jhmi.edu; pcole@jhmi.edu	Kim, Min-Sik/N-5010-2018; Pandey, Akhilesh/B-4127-2009; Kim, Min-Sik/M-3488-2016	Kim, Min-Sik/0000-0001-7317-5360; Pandey, Akhilesh/0000-0001-9943-6127; Kim, Min-Sik/0000-0001-7317-5360; Taylor, Martin/0000-0003-1560-9276; Taylor, Martin/0000-0001-5824-142X; Berndsen, Christopher/0000-0002-4285-4341; Boeke, Jef/0000-0001-5322-4946; Wolberger, Cynthia/0000-0001-8578-2969	National Institutes of Health [8U54GM103520, GM62437]; Pfeiffer Foundation; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293, U54GM103520, R01GM062437, R37GM062437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfeiffer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 8U54GM103520 and GM62437. This work was also supported by funds from the Pfeiffer Foundation.	Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Baldanzi G, 2002, J CELL BIOL, V159, P1029, DOI 10.1083/jcb.200207165; Barnett BP, 2010, SCIENCE, V330, P1689, DOI 10.1126/science.1196154; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Carlini VP, 2002, BIOCHEM BIOPH RES CO, V299, P739, DOI 10.1016/S0006-291X(02)02740-7; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; CHURCH RFR, 1970, J ORG CHEM, V35, P2465, DOI 10.1021/jo00833a001; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Ejskjaer N, 2013, NEUROGASTROENT MOTIL, V25, pE140, DOI 10.1111/nmo.12064; Goldstein JL, 2011, COLD SH Q B, V76, P121, DOI 10.1101/sqb.2011.76.010447; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hardy RY, 2012, J BIOL CHEM, V287, P42881, DOI 10.1074/jbc.M112.426833; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Inlow D., 1989, J TISSUE CULTURE MET, V12, P13; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kim H, 2003, J BIOL CHEM, V278, P10208, DOI 10.1074/jbc.M300163200; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Li RL, 2012, J BIOL CHEM, V287, P17942, DOI 10.1074/jbc.M112.358051; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Mitchell LA, 2013, ACS SYNTH BIOL, V2, P473, DOI 10.1021/sb300131w; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Nishi Y, 2005, ENDOCRINOLOGY, V146, P2255, DOI 10.1210/en.2004-0695; Nugent T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-169; Okumura H, 2002, J CARDIOVASC PHARM, V39, P779, DOI 10.1097/00005344-200206000-00001; Ozawa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005426; Pagac M, 2012, MOL MICROBIOL, V86, P1156, DOI 10.1111/mmi.12047; Pagac M, 2011, J BIOL CHEM, V286, P36438, DOI 10.1074/jbc.M111.256511; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/NCHEMBIO.1184, 10.1038/nchembio.1184]; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwenke DO, 2008, ENDOCRINOLOGY, V149, P5172, DOI 10.1210/en.2008-0472; Sengstag C, 2000, METHOD ENZYMOL, V327, P175, DOI 10.1016/S0076-6879(00)27275-3; Shen HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002399; Shindou H, 2009, BIOCHEM BIOPH RES CO, V383, P320, DOI 10.1016/j.bbrc.2009.04.013; SWIFT AM, 1991, J CELL BIOL, V115, P19, DOI 10.1083/jcb.115.1.19; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Taylor MS, 2012, METHOD ENZYMOL, V514, P205, DOI 10.1016/B978-0-12-381272-8.00013-1; Trudel L, 2002, AM J PHYSIOL-GASTR L, V282, pG948, DOI 10.1152/ajpgi.00339.2001; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Yang J, 2008, P NATL ACAD SCI USA, V105, P10750, DOI 10.1073/pnas.0805353105; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yi CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032100; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Yu CJ, 1999, J BIOL CHEM, V274, P36139, DOI 10.1074/jbc.274.51.36139	69	52	52	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32211	32228		10.1074/jbc.M113.510313	http://dx.doi.org/10.1074/jbc.M113.510313			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24045953	Green Published, hybrid			2022-12-28	WOS:000328681700010
J	van Ooij, C; Withers-Martinez, C; Ringel, A; Cockcroft, S; Haldar, K; Blackman, MJ				van Ooij, Christiaan; Withers-Martinez, Chrislaine; Ringel, Alessa; Cockcroft, Shamshad; Haldar, Kasturi; Blackman, Michael J.			Identification of a Plasmodium falciparum Phospholipid Transfer Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL TRANSFER PROTEIN; START DOMAIN PROTEIN; RED-BLOOD-CELL; INFECTED ERYTHROCYTES; MALARIA PARASITE; MEMBRANE NETWORK; HOST ERYTHROCYTE; FOLD RECOGNITION; TRAFFICKING; SURFACE	Infection of erythrocytes by the human malaria parasite Plasmodium falciparum results in dramatic modifications to the host cell, including changes to its antigenic and transport properties and the de novo formation of membranous compartments within the erythrocyte cytosol. These parasite-induced structures are implicated in the transport of nutrients, metabolic products, and parasite proteins, as well as in parasite virulence. However, very few of the parasite effector proteins that underlie remodeling of the host erythrocyte are functionally characterized. Using bioinformatic examination and modeling, we have found that the exported P. falciparum protein PFA0210c belongs to the START domain family, members of which mediate transfer of phospholipids, ceramide, or fatty acids between membranes. In vitro phospholipid transfer assays using recombinant PFA0210 confirmed that it can transfer phosphatidylcholine, phosphatidylinositol, phosphatidylethanolamine, and sphingomyelin between phospholipid vesicles. Furthermore, assays using HL60 cells containing radiolabeled phospholipids indicated that orthologs of PFA0210c can also transfer phosphatidylcholine, phosphatidylinositol, and phosphatidylethanolamine. Biochemical and immunochemical analysis showed that PFA0210c associates with membranes in infected erythrocytes at mature stages of intracellular parasite growth. Localization studies in live parasites revealed that the protein is present in the parasitophorous vacuole during growth and is later recruited to organelles in the parasite. Together these data suggest that PFA0210c plays a role in the formation of the membranous structures and nutrient phospholipid transfer in the malaria-parasitized erythrocyte.	[van Ooij, Christiaan; Withers-Martinez, Chrislaine; Ringel, Alessa; Blackman, Michael J.] MRC Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Cockcroft, Shamshad] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6JJ, England; [Haldar, Kasturi] Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Haldar, Kasturi] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	MRC National Institute for Medical Research; University of London; University College London; University of Notre Dame; University of Notre Dame	van Ooij, C (corresponding author), MRC Natl Inst Med Res, Div Parasitol, Mill Hill, London NW7 1AA, England.	cvanooi@nimr.mrc.ac.uk	Haldar, Kasturi/C-6685-2014; Cockcroft, Shamshad/F-9480-2011	Cockcroft, Shamshad/0000-0002-5731-476X; Ringel, Alessa/0000-0002-6392-6076	National Institutes of Health [R01HL069630, P01 HL 078826]; Wellcome Trust [095836/Z/1/Z]; United Kingdom Medical Research Council [U117532063]; MRC [MC_U117532063] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078826, R01HL069630] Funding Source: NIH RePORTER; Medical Research Council [MC_U117532063] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL069630 and P01 HL 078826 (to K. H.), Wellcome Trust Career Re-entry Fellowship 095836/Z/1/Z (to C. v. O.), and United Kingdom Medical Research Council Grant U117532063 (to M. J. B.).	AIKAWA M, 1971, EXP PARASITOL, V30, P284, DOI 10.1016/0014-4894(71)90094-4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angeletti S, 2004, BIOCHEM BIOPH RES CO, V314, P181, DOI 10.1016/j.bbrc.2003.12.076; Angeletti S, 2012, BBA-BIOMEMBRANES, V1818, P425, DOI 10.1016/j.bbamem.2011.10.024; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; BEHARI R, 1994, EXP PARASITOL, V79, P250, DOI 10.1006/expr.1994.1088; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Clark BJ, 2012, J ENDOCRINOL, V212, P257, DOI 10.1530/JOE-11-0313; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; DELPLACE P, 1985, MOL BIOCHEM PARASIT, V17, P239, DOI 10.1016/0166-6851(85)90021-0; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Flores-Martin J, 2013, INT J MOL SCI, V14, P6170, DOI 10.3390/ijms14036170; GEORGE PY, 1985, BIOCHIM BIOPHYS ACTA, V836, P176, DOI 10.1016/0005-2760(85)90064-5; Gruring C, 2012, CELL HOST MICROBE, V12, P717, DOI 10.1016/j.chom.2012.09.010; HIBBS AR, 1994, EXP PARASITOL, V79, P260, DOI 10.1006/expr.1994.1089; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Kanno K, 2007, BBA-MOL CELL BIOL L, V1771, P654, DOI 10.1016/j.bbalip.2007.04.003; KASPER AM, 1981, BIOCHEMISTRY-US, V20, P146, DOI 10.1021/bi00504a024; Knuepfer E, 2005, MOL BIOCHEM PARASIT, V142, P258, DOI 10.1016/j.molbiopara.2005.04.005; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; Lauer SA, 1997, SCIENCE, V276, P1122, DOI 10.1126/science.276.5315.1122; Li H, 2002, BBA-MOL CELL BIOL L, V1580, P67, DOI 10.1016/S1388-1981(01)00191-3; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Moon RW, 2013, P NATL ACAD SCI USA, V110, P531, DOI 10.1073/pnas.1216457110; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; NASH GB, 1989, BLOOD, V74, P855, DOI 10.1182/blood.V74.2.855.bloodjournal742855; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Roobsoong W, 2011, J PROTEOMICS, V74, P1701, DOI 10.1016/j.jprot.2011.03.035; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Segui B, 2002, BIOCHEM J, V366, P23, DOI 10.1042/BJ20020317; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Spycher C, 2006, MOL CELL BIOL, V26, P4074, DOI 10.1128/MCB.00095-06; Tarr SJ, 2013, MOL MICROBIOL, V87, P835, DOI 10.1111/mmi.12133; Thorsell AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019521; Tilley SJ, 2004, STRUCTURE, V12, P317, DOI 10.1016/j.str.2004.01.013; Chu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018396; Tremblay JM, 1996, J BIOL CHEM, V271, P21075, DOI 10.1074/jbc.271.35.21075; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wickert H, 2004, EUR J CELL BIOL, V83, P567, DOI 10.1078/0171-9335-00432; Wickert H, 2003, EUR J CELL BIOL, V82, P271, DOI 10.1078/0171-9335-00319	58	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31971	31983		10.1074/jbc.M113.474189	http://dx.doi.org/10.1074/jbc.M113.474189			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043620	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000330596200050
J	Cao, HL; Zhu, K; Qiu, LG; Li, S; Niu, HJ; Hao, M; Yang, SY; Zhao, ZF; Lai, YM; Anderson, JL; Fan, J; Im, HJ; Chen, D; Roodman, GD; Xiao, GZ				Cao, Huiling; Zhu, Ke; Qiu, Lugui; Li, Shuai; Niu, Hanjie; Hao, Mu; Yang, Shengyong; Zhao, Zhongfang; Lai, Yumei; Anderson, Judith L.; Fan, Jie; Im, Hee-Jeong; Chen, Di; Roodman, G. David; Xiao, Guozhi			Critical Role of AKT Protein in Myeloma-induced Osteoclast Formation and Osteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Bone; Metastasis; Osteoclast; Transcription Factors	ACTIVATING TRANSCRIPTION FACTOR-4; BREAST-CANCER CELLS; PARATHYROID-HORMONE; OSTEOCALCIN GENE; SEQUENTIAL EXPRESSION; BONE METASTASES; KAPPA-B; DIFFERENTIATION; OSTEOPROTEGERIN; LESIONS	Abnormal osteoclast formation and osteolysis are the hallmarks of multiple myeloma (MM) bone disease, yet the underlying molecular mechanisms are incompletely understood. Here, we show that the AKT pathway was up-regulated in primary bone marrow monocytes (BMM) from patients with MM, which resulted in sustained high expression of the receptor activator of NF-B (RANK) in osteoclast precursors. The up-regulation of RANK expression and osteoclast formation in the MM BMM cultures was blocked by AKT inhibition. Conditioned media from MM cell cultures activated AKT and increased RANK expression and osteoclast formation in BMM cultures. Inhibiting AKT in cultured MM cells decreased their growth and ability to promote osteoclast formation. Of clinical significance, systemic administration of the AKT inhibitor LY294002 blocked the formation of tumor tissues in the bone marrow cavity and essentially abolished the MM-induced osteoclast formation and osteolysis in SCID mice. The level of activating transcription factor 4 (ATF4) protein was up-regulated in the BMM cultures from multiple myeloma patients. Adenoviral overexpression of ATF4 activated RANK expression in osteoclast precursors. These results demonstrate a new role of AKT in the MM promotion of osteoclast formation and bone osteolysis through, at least in part, the ATF4-dependent up-regulation of RANK expression in osteoclast precursors.	[Cao, Huiling; Zhu, Ke; Li, Shuai; Niu, Hanjie; Zhao, Zhongfang; Xiao, Guozhi] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Zhu, Ke; Lai, Yumei; Im, Hee-Jeong; Chen, Di; Xiao, Guozhi] Rush Univ, Dept Biochem, Chicago, IL 60612 USA; [Qiu, Lugui; Hao, Mu] Chinese Acad Med Sci, Inst Hematol & Blood Dis, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China; [Yang, Shengyong; Fan, Jie] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15240 USA; [Anderson, Judith L.; Roodman, G. David] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Nankai University; Rush University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University Bloomington	Xiao, GZ (corresponding author), Rm 518,Cohn Res Bldg,1735 West Harrison St, Chicago, IL 60612 USA.	Guozhi_Xiao@rush.edu	Chen, Di/AAJ-3665-2021		National Institutes of Health [AR059647]; Chinese Ministry of Science and Technology [2009CB918902]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059647, R01AR059679, R01AR062136] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant AR059647. This work was also supported by Chinese Ministry of Science and Technology Grant 2009CB918902.	Abe M, 2002, BLOOD, V100, P2195, DOI 10.1182/blood.V100.6.2195.h81802002195_2195_2202; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0; Boyce BF, 1999, ENDOCR-RELAT CANCER, V6, P333, DOI 10.1677/erc.0.0060333; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cai Z, 2009, NEOPLASIA, V11, P228, DOI 10.1593/neo.81282; Cao HL, 2010, J CLIN INVEST, V120, P2755, DOI 10.1172/JCI42106; Casimiro S, 2009, MOL CELL ENDOCRINOL, V310, P71, DOI 10.1016/j.mce.2009.07.004; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; De Souza CT, 2010, J PHYSIOL-LONDON, V588, P2239, DOI 10.1113/jphysiol.2009.183996; Esteve FR, 2007, BEST PRACT RES CL HA, V20, P613, DOI 10.1016/j.beha.2007.08.003; Fujiwara M, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-76; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Hernandez L, 2007, CELL BIOCHEM BIOPHYS, V47, P199, DOI 10.1007/s12013-007-0006-9; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Javed A, 2005, P NATL ACAD SCI USA, V102, P1454, DOI 10.1073/pnas.0409121102; Jiang D, 2004, J BIOL CHEM, V279, P5329, DOI 10.1074/jbc.M311547200; Jourdan M, 1999, EUR CYTOKINE NETW, V10, P65; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; KURIHARA N, 1990, ENDOCRINOLOGY, V127, P3215, DOI 10.1210/endo-127-6-3215; Kurihara N, 2000, J CLIN INVEST, V105, P607, DOI 10.1172/JCI8489; Kurihara N, 2007, J CLIN INVEST, V117, P133, DOI 10.1172/JCI28267; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Liu B, 2003, J ORAL PATHOL MED, V32, P367, DOI 10.1034/j.1600-0714.2003.00126.x; Lu Y, 2007, CANCER RES, V67, P3646, DOI 10.1158/0008-5472.CAN-06-1210; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Menaa C, 2000, BIOCHEM BIOPH RES CO, V267, P943, DOI 10.1006/bbrc.1999.2042; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Oba Y, 2005, EXP HEMATOL, V33, P272, DOI 10.1016/j.exphem.2004.11.015; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Roodman GD, 2007, BONE MARROW TRANSPL, V40, P1139, DOI 10.1038/sj.bmt.1705802; Roodman GD, 2008, EXPERT OPIN THER TAR, V12, P1377, DOI [10.1517/14728222.12.11.1377, 10.1517/14728222.12.11.1377 ]; Roodman GD, 2008, CANCER TREAT REV, V34, P92, DOI 10.1016/j.ctrv.2007.09.002; Roodman G David, 2008, Hematology Am Soc Hematol Educ Program, P313, DOI 10.1182/asheducation-2008.1.313; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Wittrant Y, 2004, BBA-REV CANCER, V1704, P49, DOI 10.1016/j.bbcan.2004.05.002; Xiao GZ, 2012, J BIOL CHEM, V287, P21450, DOI 10.1074/jbc.M111.331249; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yang SY, 2011, J BIOL CHEM, V286, P19149, DOI 10.1074/jbc.M110.197905; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yu SB, 2008, ENDOCRINOLOGY, V149, P1960, DOI 10.1210/en.2007-1573; Yu SB, 2008, J BIOL CHEM, V283, P5542, DOI 10.1074/jbc.M705653200; Yu SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007583; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685	49	43	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30399	30410		10.1074/jbc.M113.469973	http://dx.doi.org/10.1074/jbc.M113.469973			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24005670	hybrid, Green Published			2022-12-28	WOS:000329868100036
J	Gao, Q; Mechin, I; Kothari, N; Guo, ZY; Deng, GJ; Haas, K; McManus, J; Hoffmann, D; Wang, AL; Wiederschain, D; Rocnik, J; Czechtizky, W; Chen, X; McLean, L; Arlt, H; Harper, D; Liu, F; Majid, T; Patel, V; Lengauer, C; Garcia-Echeverria, C; Zhang, BL; Cheng, H; Dorsch, M; Huang, SMA				Gao, Qiang; Mechin, Ingrid; Kothari, Nayantara; Guo, Zhuyan; Deng, Gejing; Haas, Kimberly; McManus, Jessica; Hoffmann, Dietmar; Wang, Anlai; Wiederschain, Dmitri; Rocnik, Jennifer; Czechtizky, Werngard; Chen, Xin; McLean, Larry; Arlt, Heike; Harper, David; Liu, Feng; Majid, Tahir; Patel, Vinod; Lengauer, Christoph; Garcia-Echeverria, Carlos; Zhang, Bailin; Cheng, Hong; Dorsch, Marion; Huang, Shih-Min A.			Evaluation of Cancer Dependence and Druggability of PRP4 Kinase Using Cellular, Biochemical, and Structural Approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Therapy; Crystallography; Drug Discovery; Proteomics; Structural Biology	PROTEIN; PHOSPHORYLATION; DISCOVERY; LOCALIZATION; INTERACTS; REVEALS; SCREEN; GENES; SNRNP; SUITE	Background: Little is known about the cancer dependence and druggability of PRP4. Results: Significance of PRP4 catalytic activity is demonstrated, novel substrates are identified, and features of kinase domain structure are revealed. Conclusion: PRP4 is required for cancer cell survival, displays substrate specificity, and is amenable to pharmacological inhibition. Significance: Our results indicate that PRP4 is a potential drug target to pursue in cancer. PRP4 kinase is known for its roles in regulating pre-mRNA splicing and beyond. Therefore, a wider spectrum of PRP4 kinase substrates could be expected. The role of PRP4 kinase in cancer is also yet to be fully elucidated. Attaining specific and potent PRP4 inhibitors would greatly facilitate the study of PRP4 biological function and its validation as a credible cancer target. In this report, we verified the requirement of enzymatic activity of PRP4 in regulating cancer cell growth and identified an array of potential novel substrates through orthogonal proteomics approaches. The ensuing effort in structural biology unveiled for the first time unique features of PRP4 kinase domain and its potential mode of interaction with a low molecular weight inhibitor. These results provide new and important information for further exploration of PRP4 kinase function in cancer.	[Gao, Qiang; Kothari, Nayantara; Guo, Zhuyan; Deng, Gejing; McManus, Jessica; Hoffmann, Dietmar; Wang, Anlai; Wiederschain, Dmitri; Rocnik, Jennifer; Arlt, Heike; Harper, David; Liu, Feng; Lengauer, Christoph; Garcia-Echeverria, Carlos; Zhang, Bailin; Cheng, Hong; Dorsch, Marion; Huang, Shih-Min A.] Sanofi Oncol, Discovery & Early Dev, Cambridge, MA 02139 USA; [Gao, Qiang; Kothari, Nayantara; Guo, Zhuyan; Deng, Gejing; McManus, Jessica; Hoffmann, Dietmar; Wang, Anlai; Wiederschain, Dmitri; Rocnik, Jennifer; Arlt, Heike; Harper, David; Liu, Feng; Lengauer, Christoph; Garcia-Echeverria, Carlos; Zhang, Bailin; Cheng, Hong; Dorsch, Marion; Huang, Shih-Min A.] Sanofi Oncol, Discovery & Early Dev, F-94400 Vitry Sur Seine, France; [Majid, Tahir; Patel, Vinod] Sanofi, Lead Generat & Candidate Realizat, Waltham, MA 02451 USA; [Czechtizky, Werngard] Sanofi, Lead Generat & Candidate Realizat, D-65926 Frankfurt, Germany; [Haas, Kimberly; Chen, Xin; McLean, Larry] Sanofi, Lead Generat & Candidate Realizat, Bridgewater, NJ 08807 USA; [Mechin, Ingrid] Sanofi, Tucson Res Ctr, Tucson, AZ 85755 USA	Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis	Huang, SMA (corresponding author), Sanofi Oncol, 640 Mem Dr, Cambridge, MA 02139 USA.	alex.huang@sanofi.com						Ackermann BL, 2007, EXPERT REV PROTEOMIC, V4, P175, DOI 10.1586/14789450.4.2.175; ALAHARI SK, 1993, NUCLEIC ACIDS RES, V21, P4079, DOI 10.1093/nar/21.17.4079; Baldassa S, 2010, J CELL PHYSIOL, V224, P722, DOI 10.1002/jcp.22172; Bauer JA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2595; Bennett EM, 2004, J VIROL, V78, P11303, DOI 10.1128/JVI.78.20.11303-11312.2004; BRICOGNE G, 2011, BUSTER VERSION 2 9 1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dellaire G, 2002, MOL CELL BIOL, V22, P5141, DOI 10.1128/MCB.22.14.5141-5156.2002; Duan ZF, 2008, MOL CANCER THER, V7, P2377, DOI 10.1158/1535-7163.MCT-08-0316; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Giroux V, 2006, FASEB J, V20, P1982, DOI 10.1096/fj.06-6239com; *GROUP CC, 2011, MOL OP ENV; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Huang BL, 2007, J IMMUNOL, V178, P7081, DOI 10.4049/jimmunol.178.11.7081; Huang Y, 2000, BIOCHEM BIOPH RES CO, V271, P456, DOI 10.1006/bbrc.2000.2651; Jaffe JD, 2008, MOL CELL PROTEOMICS, V7, P1952, DOI 10.1074/mcp.M800218-MCP200; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kojima T, 2001, J BIOL CHEM, V276, P32247, DOI 10.1074/jbc.M103790200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montembault E, 2007, J CELL BIOL, V179, P601, DOI 10.1083/jcb.200703133; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Ngo JCK, 2005, MOL CELL, V20, P77, DOI 10.1016/j.molcel.2005.08.025; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; ROSENBERG GH, 1991, MOL GEN GENET, V226, P305, DOI 10.1007/BF00273617; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Schneider M, 2010, NAT STRUCT MOL BIOL, V17, P216, DOI 10.1038/nsmb.1718; Schwelnus W, 2001, EMBO REP, V2, P35, DOI 10.1093/embo-reports/kve009; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu RH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009654	40	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30125	30138		10.1074/jbc.M113.473348	http://dx.doi.org/10.1074/jbc.M113.473348			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24003220	Green Published, hybrid			2022-12-28	WOS:000329868100013
J	Ginnan, R; Zou, XJ; Pfleiderer, PJ; Mercure, MZ; Barroso, M; Singer, HA				Ginnan, Roman; Zou, Xiaojing; Pfleiderer, Paul J.; Mercure, Melissa Z.; Barroso, Margarida; Singer, Harold A.			Vascular Smooth Muscle Cell Motility Is Mediated by a Physical and Functional Interaction of Ca2+/Calmodulin-dependent Protein Kinase II delta(2) and Fyn	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASE; FIBROBLAST-GROWTH-FACTOR; DEPENDENT ACTIVATION; RPTP-ALPHA; MIGRATION; INTEGRIN; DELTA; PHOSPHORYLATION; TRAFFICKING; CAMKII	In vascular smooth muscle (VSM) cells, Ca2+/calmodulin-dependent protein kinase II delta(2) (CaMKII delta(2)) activates non-receptor tyrosine kinases and EGF receptor, with a Src family kinase as a required intermediate. siRNA-mediated suppression of Fyn, a Src family kinase, inhibited VSM cell motility. Simultaneous suppression of both Fyn and CaMKII delta(2) was non-additive, suggesting coordinated regulation of cell motility. Confocal immunofluorescence microscopy indicated that CaMKII delta(2) and Fyn selectively (compared with Src) co-localized with the Golgi in quiescent cultured VSM cells. Stimulation with PDGF resulted in a rapid (<5 min) partial redistribution and co-localization of both kinases in peripheral membrane regions. Furthermore, CaMKII delta(2) and Fyn selectively (compared with Src) co-immunoprecipitated, suggesting a physical interaction in a signaling complex. Stimulation of VSM cells with ionomycin, a calcium ionophore, resulted in activation of CaMKII delta(2) and Fyn and disruption of the complex. Pretreatment with KN-93, a pharmacological inhibitor of CaMKII, prevented activation-dependent disruption of CaMKII delta(2) and Fyn, implicating CaMKII delta(2) as an upstream mediator of Fyn. Overexpression of constitutively active CaMKII resulted in the dephosphorylation of Fyn at Tyr-527, which is required for Fyn activation. Taken together, these data demonstrate a dynamic interaction between CaMKII delta(2) and Fyn in VSM cells and indicate a mechanism by which CaMKII delta(2) and Fyn may coordinately regulate VSM cell motility.	[Ginnan, Roman; Zou, Xiaojing; Barroso, Margarida; Singer, Harold A.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Zou, Xiaojing] Huazhong Univ Sci & Technol, Union Hosp, Dept Anesthesiol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China; [Pfleiderer, Paul J.] CAHG, New York, NY 10017 USA; [Mercure, Melissa Z.] Virginia Tech Carilion Sch Med, Dept Basic Sci, Roanoke, VA 24016 USA	Albany Medical College; Huazhong University of Science & Technology	Singer, HA (corresponding author), Albany Med Coll MC8, Ctr Cardiovasc Sci, 47 New Scotland Ave, Albany, NY 12208 USA.	singerh@mail.amc.edu		Barroso, Margarida/0000-0002-0407-3181	National Institutes of Health from NHLBI [T32 HL07194, R01 HL49426, R01 HL092510]; American Heart Association Northeast Affiliate Predoctoral Training Grant [0215300T]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092510, R01HL049426, T32HL007194] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Northeast Affiliate Predoctoral Training Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Predoctoral Training Grant T32 HL07194 and Grants R01 HL49426 and R01 HL092510 (to H. A. S.) from NHLBI. This work was also supported by American Heart Association Northeast Affiliate Predoctoral Training Grant 0215300T (to P. J. P.).	Abraham ST, 1996, J BIOL CHEM, V271, P2506, DOI 10.1074/jbc.271.5.2506; Andoniou CE, 2000, MOL CELL BIOL, V20, P851, DOI 10.1128/MCB.20.3.851-867.2000; Baillat G, 2008, BBA-MOL CELL RES, V1783, P2323, DOI 10.1016/j.bbamcr.2008.08.008; Bard F, 2003, J BIOL CHEM, V278, P46601, DOI 10.1074/jbc.M302221200; Bhandari V, 1998, J BIOL CHEM, V273, P8691, DOI 10.1074/jbc.273.15.8691; Bilato C, 1997, J CLIN INVEST, V100, P693, DOI 10.1172/JCI119582; BILATO C, 1995, J CLIN INVEST, V96, P1905, DOI 10.1172/JCI118236; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Easley CA, 2008, CELL MOTIL CYTOSKEL, V65, P662, DOI 10.1002/cm.20294; Eguchi S, 1999, HYPERTENSION, V33, P201, DOI 10.1161/01.HYP.33.1.201; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Ginnan R, 2004, AM J PHYSIOL-CELL PH, V286, pC1281, DOI 10.1152/ajpcell.00202.2003; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Govindarajan G, 2000, CIRC RES, V87, P710, DOI 10.1161/01.RES.87.8.710; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Kaabeche K, 2004, J BIOL CHEM, V279, P36259, DOI 10.1074/jbc.M402469200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lavoie JN, 2010, CELL SIGNAL, V22, P1604, DOI 10.1016/j.cellsig.2010.04.007; Li WW, 2011, J BIOL CHEM, V286, P7990, DOI 10.1074/jbc.M110.163006; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Lu KK, 2005, AM J PHYSIOL-CELL PH, V289, pC1343, DOI 10.1152/ajpcell.00064.2005; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Mayer BJ, 2001, J CELL SCI, V114, P1253; McGinnis LK, 2011, MOL REPROD DEV, V78, P831, DOI 10.1002/mrd.21326; McMullen M, 2004, ONCOGENE, V23, P1275, DOI 10.1038/sj.onc.1207243; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Musacchio A, 2003, ADV PROTEIN CHEM, V61, P211; Rosenfeldt HM, 2001, BIOCHEM SOC T, V29, P836, DOI 10.1042/0300-5127:0290836; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Taniyama Y, 2003, MOL CELL BIOL, V23, P8019, DOI 10.1128/MCB.23.22.8019-8029.2003; Traver D, 2002, CELL, V108, P731, DOI 10.1016/S0092-8674(02)00686-4; Vacaresse N, 2008, J BIOL CHEM, V283, P35815, DOI 10.1074/jbc.M807964200; Wang Z, 2010, J BIOL CHEM, V285, P21303, DOI 10.1074/jbc.M110.120790; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154	47	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29703	29712		10.1074/jbc.M113.477257	http://dx.doi.org/10.1074/jbc.M113.477257			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003228	hybrid, Green Published			2022-12-28	WOS:000330615300045
J	Gleichmann, T; Diensthuber, RP; Moglich, A				Gleichmann, Tobias; Diensthuber, Ralph P.; Moeglich, Andreas			Charting the Signal Trajectory in a Light-Oxygen-Voltage Photoreceptor by Random Mutagenesis and Covariance Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOV DOMAIN; STRUCTURAL BASIS; PAS DOMAIN; AEROTAXIS RECEPTOR; MEGAPRIMER PCR; REDOX SENSOR; TRANSDUCTION; MECHANISM; PHOTOTROPIN; LIBRARIES	Modular signal receptors empower organisms to process environmental stimuli into adequate physiological responses. At the molecular level, a sensor module receives signals and processes the inherent information into changes of biological activity of an effector module. To better understand the molecular bases underpinning these processes, we analyzed signal reception and processing in the dimeric light-oxygen-voltage (LOV) blue light receptor YF1 that serves as a paradigm for the widespread Per-ARNT-Sim (PAS) signal receptors. Random mutagenesis identifies numerous YF1 variants in which biological activity is retained but where light regulation is abolished or inverted. One group of variants carries mutations within the LOV photosensor that disrupt proper coupling of the flavin-nucleotide chromophore to the protein scaffold. Another larger group bears mutations that cluster at the dyad interface and disrupt signal transmission to two coaxial coiled-coils that connect to the effector. Sequence covariation implies wide conservation of structural and mechanistic motifs, as also borne out by comparison to several PAS domains in which mutations leading to disruption of signal transduction consistently map to confined regions broadly equivalent to those identified in YF1. Not only do these data provide insight into general mechanisms of signal transduction, but also they establish concrete means for customized reprogramming of signal receptors.	[Gleichmann, Tobias; Diensthuber, Ralph P.; Moeglich, Andreas] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany	Humboldt University of Berlin	Diensthuber, RP (corresponding author), Humboldt Univ, Inst Biol, Invalidenstr 42, D-10115 Berlin, Germany.	ralph.diensthuber@hu-berlin.de; andreas.moeglich@hu-berlin.de		Moglich, Andreas/0000-0002-7382-2772	Alexander-von-Humboldt Foundation; Deutsche Forschungsgemeinschaft within research group FOR 1279 [MO 2192/3-1]	Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft within research group FOR 1279	This work was supported by a Sofja-Kovalevskaya Award from the Alexander-von-Humboldt Foundation (to A. M.) and Deutsche Forschungsgemeinschaft Grant MO 2192/3-1 within research group FOR 1279.	Aravind L, 2010, SENSORY MECHANISMS IN BACTERIA: MOLECULAR ASPECTS OF SIGNAL RECOGNITION, P1; Ayers RA, 2008, BIOCHEMISTRY-US, V47, P12078, DOI 10.1021/bi801254c; Campbell AJ, 2010, MOL MICROBIOL, V77, P575, DOI 10.1111/j.1365-2958.2010.07231.x; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Cirino Patrick C, 2003, Methods Mol Biol, V231, P3; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Dago AE, 2012, P NATL ACAD SCI USA, V109, pE1733, DOI 10.1073/pnas.1201301109; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Etzkorn M, 2008, NAT STRUCT MOL BIOL, V15, P1031, DOI 10.1038/nsmb.1493; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Herrou J, 2011, NAT REV MICROBIOL, V9, P713, DOI 10.1038/nrmicro2622; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Lee J, 2008, BIOCHEMISTRY-US, V47, P4051, DOI 10.1021/bi7021156; Little R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046651; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Miyazaki K, 2002, BIOTECHNIQUES, V33, P1033, DOI 10.2144/02335st03; Miyazaki K, 2011, METHOD ENZYMOL, V498, P399, DOI 10.1016/B978-0-12-385120-8.00017-6; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Moglich A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1286, DOI 10.1039/c0pp00167h; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Ohlendorf R, 2012, J MOL BIOL, V416, P534, DOI 10.1016/j.jmb.2012.01.001; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Raffelberg S, 2011, J AM CHEM SOC, V133, P5346, DOI 10.1021/ja1097379; Repik A, 2000, MOL MICROBIOL, V36, P806, DOI 10.1046/j.1365-2958.2000.01910.x; Russo F D, 1993, Trends Microbiol, V1, P306, DOI 10.1016/0966-842X(93)90007-E; Salomon M, 2001, P NATL ACAD SCI USA, V98, P12357, DOI 10.1073/pnas.221455298; Slavny P, 2010, MOL MICROBIOL, V75, P61, DOI 10.1111/j.1365-2958.2009.06956.x; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Szurmant H, 2013, MOL MICROBIOL, V87, P707, DOI 10.1111/mmi.12128; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Watts KJ, 2006, J BACTERIOL, V188, P2154, DOI 10.1128/JB.188.6.2154-2162.2006; Winkler K, 2012, J BIOL CHEM, V287, P15479, DOI 10.1074/jbc.M112.348409; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P8771, DOI 10.1021/bi200976a; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	52	26	26	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29345	29355		10.1074/jbc.M113.506139	http://dx.doi.org/10.1074/jbc.M113.506139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003219	Green Published, hybrid			2022-12-28	WOS:000330615300014
J	Kim, Y; Ha, CM; Chang, S				Kim, Yoonju; Ha, Chang Man; Chang, Sunghoe			SNX26, a GTPase-activating Protein for Cdc42, Interacts with PSD-95 Protein and Is Involved in Activity-dependent Dendritic Spine Formation in Mature Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FYN TYROSINE KINASE; LONG-TERM POTENTIATION; RHO GTPASES; PLASTICITY; RECEPTOR; MATURATION; MORPHOLOGY; RICS; FAMILY; CORTEX	SNX26, a brain-enriched RhoGAP, plays a key role in dendritic arborization during early neuronal development in the neocortex. In mature neurons, it is localized to dendritic spines, but little is known about its role in later stages of development. Our results show that SNX26 interacts with PSD-95 in dendritic spines of cultured hippocampal neurons, and as a GTPase-activating protein for Cdc42, it decreased the F-actin content in COS-7 cells and in dendritic spines of neurons. Overexpression of SNX26 resulted in a GTPase-activating protein activity-dependent decrease in total protrusions and spine density together with dramatic inhibition of filopodia-to-spine transformations. Such effects of SNX26 were largely rescued by a constitutively active mutant of Cdc42. Consistently, an shRNA-mediated knockdown of SNX26 significantly increased total protrusions and spine density, resulting in an increase in thin or stubby type spines at the expense of the mushroom spine type. Moreover, endogenous expression of SNX26 was shown to be bi-directionally modulated by neuronal activity. Therefore, we propose that in addition to its key role in neuronal development, SNX26 also has a role in the activity-dependent structural change of dendritic spines in mature neurons.	[Kim, Yoonju; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Dept Physiol & Biomed Sci, Seoul 110799, South Korea; [Kim, Yoonju; Ha, Chang Man; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Med Res Ctr, Neurosci Res Inst, Seoul 110799, South Korea; [Kim, Yoonju; Ha, Chang Man; Chang, Sunghoe] Seoul Natl Univ, Coll Med, Biomembrane Plast Res Ctr, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chang, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Physiol, 309 Biomed Sci Bldg,28 Yeongeon Dong, Seoul 110799, South Korea.	sunghoe@snu.ac.kr		chang, sunghoe/0000-0002-3446-7288; Kim, Yoonju/0000-0003-2657-2923	Basic Research Promotion Fund [313-2008-2-C00690]; Brain Research Center of the 21st Century Frontier Research Program [M103KV010009-06K2201-00910]; Basic Science Research Program [NRF-2011-355-C00121]; Ministry of Education and Science and Technology, Republic of Korea; National Research Foundation of Korea	Basic Research Promotion Fund(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Basic Science Research Program; Ministry of Education and Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by grants from Basic Research Promotion Fund Grant 313-2008-2-C00690 (to S. C.) funded by the National Research Foundation of Korea, Brain Research Center of the 21st Century Frontier Research Program Grant M103KV010009-06K2201-00910 (to S. C.), and Basic Science Research Program Grant NRF-2011-355-C00121 (to Y.K.) funded by the Ministry of Education and Science and Technology, Republic of Korea.	Arellano JI, 2007, NEUROSCIENCE, V145, P464, DOI 10.1016/j.neuroscience.2006.12.015; Babus LW, 2011, BRAIN RES, V1415, P96, DOI 10.1016/j.brainres.2011.07.059; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Chiang SH, 2003, EMBO J, V22, P2679, DOI 10.1093/emboj/cdg262; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Fiala JC, 1998, J NEUROSCI, V18, P8900; GRANT SGN, 1994, TRENDS NEUROSCI, V17, P71, DOI 10.1016/0166-2236(94)90077-9; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huerta PT, 1996, NEUROREPORT, V7, P1685, DOI 10.1097/00001756-199607080-00032; Isosaka T, 2008, EUR J NEUROSCI, V28, P973, DOI 10.1111/j.1460-9568.2008.06405.x; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kitazawa H, 1998, J NEUROPHYSIOL, V79, P137, DOI 10.1152/jn.1998.79.1.137; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lim SH, 2009, EMBO J, V28, P3564, DOI 10.1038/emboj.2009.289; Liu H, 2006, J BIOL CHEM, V281, P23611, DOI 10.1074/jbc.M511205200; Long H, 2013, CEREB CORTEX, V23, P71, DOI 10.1093/cercor/bhr378; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MANESS PF, 1992, DEV NEUROSCI-BASEL, V14, P257, DOI 10.1159/000111670; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Nakamura T, 2002, MOL CELL BIOL, V22, P8721, DOI 10.1128/MCB.22.24.8721-8734.2002; Nakazawa T, 2008, J NEUROCHEM, V105, P1384, DOI 10.1111/j.1471-4159.2008.05335.x; Nasu-Nishimura Y, 2006, GENES CELLS, V11, P607, DOI 10.1111/j.1365-2443.2006.00966.x; Okabe T, 2003, J BIOL CHEM, V278, P9920, DOI 10.1074/jbc.M208872200; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosario M, 2007, J CELL BIOL, V178, P503, DOI 10.1083/jcb.200609146; Rosario M, 2012, GENE DEV, V26, P1743, DOI 10.1101/gad.191593.112; Shen PC, 2011, NEUROSCIENCE, V199, P589, DOI 10.1016/j.neuroscience.2011.08.053; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Taniguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P151, DOI 10.1016/S0006-291X(03)00923-9; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Yuste R, 2001, NEUROSCIENTIST, V7, P387, DOI 10.1177/107385840100700508; Zhao CM, 2003, J BIOL CHEM, V278, P34641, DOI 10.1074/jbc.M304594200; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	47	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29453	29466		10.1074/jbc.M113.468801	http://dx.doi.org/10.1074/jbc.M113.468801			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003235	Green Published, hybrid			2022-12-28	WOS:000330615300023
J	Peng, WT; Lin, ZJ; Li, WR; Lu, J; Shen, YQ; Wang, CG				Peng, Wentao; Lin, Zhijie; Li, Weirong; Lu, Jing; Shen, Yuequan; Wang, Chunguang			Structural Insights into the Unusually Strong ATPase Activity of the AAA Domain of the Caenorhabditis elegans Fidgetin-like 1 (FIGL-1) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPASTIC PARAPLEGIA; CRYSTAL-STRUCTURE; HOMOLOG FIGL-1; ULTRACENTRIFUGATION; IDENTIFICATION; MECHANISM; MACHINE; MOTIONS; REVEAL	The FIGL-1 (fidgetin like-1) protein is a homolog of fidgetin, a protein whose mutation leads to multiple developmental defects. The FIGL-1 protein contains an AAA (ATPase associated with various activities) domain and belongs to the AAA superfamily. However, the biological functions and developmental implications of this protein remain unknown. Here, we show that the AAA domain of the Caenorhabditis elegans FIGL-1 protein (CeFIGL-1-AAA), in clear contrast to homologous AAA domains, has an unusually high ATPase activity and forms a hexamer in solution. By determining the crystal structure of CeFIGL-1-AAA, we found that the loop linking helices alpha 9 and alpha 10 folds into the short helix alpha 9a, which has an acidic surface and interacts with a positively charged surface of the neighboring subunit. Disruption of this charge interaction by mutagenesis diminishes both the ATPase activity and oligomerization capacity of the protein. Interestingly, the acidic residues in helix alpha 9a of CeFIGL-1-AAA are not conserved in other homologous AAA domains that have relatively low ATPase activities. These results demonstrate that the sequence of CeFIGL-1-AAA has adapted to establish an intersubunit charge interaction, which contributes to its strong oligomerization and ATPase activity. These unique properties of CeFIGL-1-AAA distinguish it from other homologous proteins, suggesting that CeFIGL-1 may have a distinct biological function.	[Peng, Wentao; Li, Weirong; Wang, Chunguang] Tongji Univ, Inst Prot Res, Shanghai 200092, Peoples R China; [Lin, Zhijie; Lu, Jing; Shen, Yuequan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Lin, Zhijie; Lu, Jing; Shen, Yuequan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Tongji University; Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	yshen@nankai.edu.cn; chunguangwang@tongji.edu.cn	Lin, Zhijie/Y-4836-2019		Natural Science Foundation of China [31070690, 31170684]; Chinese Ministry of Science and Technology [2012CB917200, 2013CB910400]; Fundamental Research Funds for the Central Universities [2000219064]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Grants 31070690 and 31170684 from the Natural Science Foundation of China, Grants 2012CB917200 and 2013CB910400 from the Chinese Ministry of Science and Technology, and Grant 2000219064 from the Fundamental Research Funds for the Central Universities (to Tongji University).	Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Cox GA, 2000, NAT GENET, V26, P198, DOI 10.1038/79923; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Glynn SE, 2012, NAT STRUCT MOL BIOL, V19, P616, DOI 10.1038/nsmb.2288; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Grueneberg H., 1943, J GENET, V45, P22; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; KONYUKHOV BV, 1976, DEV BIOL, V54, P13, DOI 10.1016/0012-1606(76)90282-7; L'Hote D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027582; Luke-Glaser S, 2007, J CELL SCI, V120, P3179, DOI 10.1242/jcs.015883; Mackay RG, 2008, BIOCHEMISTRY-US, V47, P1918, DOI 10.1021/bi701714s; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; Mukherjee S, 2012, CELL CYCLE, V11, P2359, DOI 10.4161/cc.20849; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; Onitake A, 2012, J STRUCT BIOL, V179, P143, DOI 10.1016/j.jsb.2012.04.022; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng W., 2011, J SHANGHAI NORM U NA, V40, P533; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sharp DJ, 2012, J CELL SCI, V125, P2561, DOI 10.1242/jcs.101139; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; TAYLOR J, 2012, ANTIOCH REV, V70, P179; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Truslove G. M., 1956, Journal of Genetics, V54, P64, DOI 10.1007/BF02981704; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Vajjhala PR, 2008, FEBS J, V275, P1427, DOI 10.1111/j.1742-4658.2008.06300.x; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang WY, 2012, J BIOL CHEM, V287, P15143, DOI 10.1074/jbc.M111.317859; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Yakushiji Y, 2004, FEBS LETT, V578, P191, DOI 10.1016/j.febslet.2004.11.009; Yakushiji Y, 2006, J STRUCT BIOL, V156, P93, DOI 10.1016/j.jsb.2006.03.001; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	38	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29305	29312		10.1074/jbc.M113.502559	http://dx.doi.org/10.1074/jbc.M113.502559			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979136	Green Published, hybrid			2022-12-28	WOS:000330615300010
J	Mori, T; Shimokawa, Y; Matsui, T; Kinjo, K; Kato, R; Noguchi, H; Sugio, S; Morita, H; Abe, I				Mori, Takahiro; Shimokawa, Yoshihiko; Matsui, Takashi; Kinjo, Keishi; Kato, Ryohei; Noguchi, Hiroshi; Sugio, Shigetoshi; Morita, Hiroyuki; Abe, Ikuro			Cloning and Structure-Function Analyses of Quinolone- and Acridone-producing Novel Type III Polyketide Synthases from Citrus microcarpa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosynthesis; Cloning; Enzymes; Polyketides; Structural Biology	CHAIN-LENGTH CONTROL; CHALCONE SYNTHASE; ENZYMATIC FORMATION; BENZALACETONE SYNTHASE; RUTA-GRAVEOLENS; CELL-CULTURES; BIOSYNTHESIS; SPECIFICITY; ALKALOIDS	Two novel type III polyketide synthases, quinolone synthase (QNS) and acridone synthase (ACS), were cloned from Citrus microcarpa (Rutaceae). The deduced amino acid sequence of C. microcarpa QNS is unique, and it shared only 56-60% identities with C. microcarpa ACS, Medicago sativa chalcone synthase (CHS), and the previously reported Aegle marmelos QNS. In contrast to the quinolone- and acridone-producing A. marmelos QNS, C. microcarpa QNS produces 4-hydroxy-N-methylquinolone as the single product by the one-step condensation of N-methylanthraniloyl-CoA and malonyl-CoA. However, C. microcarpa ACS shows broad substrate specificities and produces not only acridone and quinolone but also chalcone, benzophenone, and phloroglucinol from 4-coumaroyl-CoA, benzoyl-CoA, and hexanoyl-CoA, respectively. Furthermore, the x-ray crystal structures of C. microcarpa QNS and ACS, solved at 2.47- and 2.35- resolutions, respectively, revealed wide active site entrances in both enzymes. The wide active site entrances thus provide sufficient space to facilitate the binding of the bulky N-methylanthraniloyl-CoA within the catalytic centers. However, the active site cavity volume of C. microcarpa ACS (760 (3)) is almost as large as that of M. sativa CHS (750 (3)), and ACS produces acridone by employing an active site cavity and catalytic machinery similar to those of CHS. In contrast, the cavity of C. microcarpa QNS (290 (3)) is significantly smaller, which makes this enzyme produce the diketide quinolone. These results as well as mutagenesis analyses provided the first structural bases for the anthranilate-derived production of the quinolone and acridone alkaloid by type III polyketide synthases.	[Mori, Takahiro; Shimokawa, Yoshihiko; Kinjo, Keishi; Abe, Ikuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Matsui, Takashi; Morita, Hiroyuki] Toyama Univ, Inst Nat Med, Toyama 9300194, Japan; [Kato, Ryohei; Sugio, Shigetoshi] Sci & Technology Res Ctr Inc, Mitsubishi Chem Grp, Aoba Ku, Yokohama, Kanagawa 2278502, Japan; [Noguchi, Hiroshi] Univ Shizuoka, Sch Pharmaceut Sci, Suruga Ku, Yada, Shizuoka 4228526, Japan; [Abe, Ikuro] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	University of Tokyo; University of Toyama; Mitsubishi Chemical Holdings Corporation; Mitsubishi Chemical; University of Shizuoka; Japan Science & Technology Agency (JST)	Morita, H (corresponding author), Toyama Univ, Inst Nat Med, 2630 Sugitani, Toyama 9300194, Japan.	sugio.shigetoshi@mw.m-kagaku.co.jp; hmortia@inm.u-toyama.ac.jp; abei@mol.f.u-tokyo.ac.jp	Abe, Ikuro/E-4449-2010	Abe, Ikuro/0000-0002-3640-888X; Matsui, Takashi/0000-0002-4496-2389	Ministry of Education, Culture, Sports, Science and Technology, Japan, CREST, Japan Science and Technology Agency; Suntory for Bioorganic Research; Grants-in-Aid for Scientific Research [24710246] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan, CREST, Japan Science and Technology Agency; Suntory for Bioorganic Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, CREST, Japan Science and Technology Agency, and a grant from Suntory for Bioorganic Research.	Abe I, 2005, J AM CHEM SOC, V127, P12709, DOI 10.1021/ja053945v; Abe I, 2005, J AM CHEM SOC, V127, P1362, DOI 10.1021/ja0431206; Abe I, 2001, EUR J BIOCHEM, V268, P3354, DOI 10.1046/j.1432-1327.2001.02255.x; Abe I, 2004, PHYTOCHEMISTRY, V65, P2447, DOI 10.1016/j.phytochem.2004.08.005; Abe I, 2000, J AM CHEM SOC, V122, P11242, DOI 10.1021/ja0027113; Abe I, 2006, ORG LETT, V8, P6063, DOI 10.1021/ol0625233; Abe I, 2010, NAT PROD REP, V27, P809, DOI 10.1039/b909988n; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; CASEY AC, 1975, TETRAHEDRON LETT, P401; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dittmer DC, 2005, J ORG CHEM, V70, P4682, DOI 10.1021/jo050070u; Eckermann S, 1998, NATURE, V396, P387, DOI 10.1038/24652; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; FISH F, 1978, PLANTA MED, V33, P228, DOI 10.1055/s-0028-1097380; HAYASHI H, 1993, J MED CHEM, V36, P617, DOI 10.1021/jm00057a011; HELARIUTTA Y, 1995, PLANT MOL BIOL, V28, P47, DOI 10.1007/BF00042037; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jez JM, 2002, P NATL ACAD SCI USA, V99, P5319, DOI 10.1073/pnas.082590499; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Kelly JX, 2009, NATURE, V459, P270, DOI 10.1038/nature07937; Liu B, 2007, PLANTA, V225, P1495, DOI 10.1007/s00425-006-0435-5; Liu BY, 2003, PLANT J, V34, P847, DOI 10.1046/j.1365-313X.2003.01771.x; Lukacin R, 2005, PHYTOCHEMISTRY, V66, P277, DOI 10.1016/j.phytochem.2004.11.023; Lukacin R, 1999, FEBS LETT, V448, P135, DOI 10.1016/S0014-5793(99)00355-5; Lukacin R, 2001, FEBS LETT, V508, P413, DOI 10.1016/S0014-5793(01)03061-7; Morita H, 2007, CHEM BIOL, V14, P359, DOI 10.1016/j.chembiol.2007.02.003; Morita H, 2011, P NATL ACAD SCI USA, V108, P13504, DOI 10.1073/pnas.1107782108; Morita H, 2010, P NATL ACAD SCI USA, V107, P19778, DOI 10.1073/pnas.1011499107; Morita H, 2010, P NATL ACAD SCI USA, V107, P669, DOI 10.1073/pnas.0909982107; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Resmi MS, 2013, J BIOL CHEM, V288, P7271, DOI 10.1074/jbc.M112.429886; Springob K, 2000, EUR J BIOCHEM, V267, P6552, DOI 10.1046/j.1432-1327.2000.01746.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wakimoto T, 2011, J AM CHEM SOC, V133, P4746, DOI 10.1021/ja2006737; Wanibuchi K, 2007, FEBS J, V274, P1073, DOI 10.1111/j.1742-4658.2007.05656.x; WATERMAN PG, 1975, PHYTOCHEMISTRY, V14, P2092, DOI 10.1016/0031-9422(75)83141-4; WATERMAN PG, 1978, BIOCHEM SYST ECOL, V6, P239, DOI 10.1016/0305-1978(78)90012-1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; ZSCHUNKE A, 1982, J CHEM SOC CHEM COMM, P1263, DOI 10.1039/c39820001263	42	24	24	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28845	28858		10.1074/jbc.M113.493155	http://dx.doi.org/10.1074/jbc.M113.493155			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23963450	Green Published, hybrid			2022-12-28	WOS:000330298800037
J	Bradford, HN; Orcutt, SJ; Krishnaswamy, S				Bradford, Harlan N.; Orcutt, Steven J.; Krishnaswamy, Sriram			Membrane Binding by Prothrombin Mediates Its Constrained Presentation to Prothrombinase for Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; FACTOR-XA; MACROMOLECULAR SUBSTRATE; FACTOR-VA; CATALYZED ACTIVATION; REACTION-MECHANISM; ENDOTHELIAL-CELLS; ENZYME COMPLEXES; MEIZOTHROMBIN; BLOOD	Long-standing dogma proposes a profound contribution of membrane binding by prothrombin in determining the rate at which it is converted to thrombin by prothrombinase. We have examined the action of prothrombinase on full-length prothrombin variants lacking gamma-carboxyglutamate modifications (desGla) with impaired membrane binding. We show an unexpectedly modest decrease in the rate of thrombin formation for desGla prothrombin but with a major effect on the pathway for substrate cleavage. Using desGla prothrombin variants in which the individual cleavage sites have been singly rendered uncleavable, we find that loss of membrane binding and other Gla-dependent functions in the substrate leads to a decrease in the rate of cleavage at Arg(320) and a surprising increase in the rate of cleavage at Arg(271). These compensating effects arise from a loss in the membrane component of exosite-dependent tethering of substrate to prothrombinase and a relaxation in the constrained presentation of the individual cleavage sites for active site docking and catalysis. Loss of constraint is evident as a switch in the pathway for prothrombin cleavage and the intermediate produced but without the expected profound decrease in rate. Extension of these findings to the action of prothrombinase assembled on platelets and endothelial cells on fully carboxylated prothrombin reveals new mechanistic insights into function on physiological membranes. Cell-dependent enzyme function is probably governed by a differential ability to support prothrombin binding and the variable accumulation of intermediates from the two possible pathways of prothrombin activation.	[Bradford, Harlan N.; Orcutt, Steven J.; Krishnaswamy, Sriram] Univ Penn, Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019	Bradford, Harlan/0000-0001-5582-278X	National Institutes of Health [HL-074124, HL-108933]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108933, P01HL074124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-074124 and HL-108933 (to S. K.).	Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Bevington P. R, 1992, DATA REDUCTION ERROR; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Blostein MD, 2000, J BIOL CHEM, V275, P38120, DOI 10.1074/jbc.M007174200; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BOCK PE, 1993, METHOD ENZYMOL, V222, P478; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; BOSKOVIC DS, 1990, J BIOL CHEM, V265, P10497; BOVILL EG, 1995, ARTERIOSCL THROM VAS, V15, P754, DOI 10.1161/01.ATV.15.6.754; Bradford HN, 2012, J BIOL CHEM, V287, P30414, DOI 10.1074/jbc.M112.394809; Bradford HN, 2010, J BIOL CHEM, V285, P328, DOI 10.1074/jbc.M109.070334; Brufatto N, 2003, J BIOL CHEM, V278, P6755, DOI 10.1074/jbc.M206413200; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; DOYLE MF, 1993, METHOD ENZYMOL, V222, P299; FRIEDMAN PA, 1977, BIOCHIM BIOPHYS ACTA, V494, P271, DOI 10.1016/0005-2795(77)90155-6; GITEL SN, 1973, P NATL ACAD SCI USA, V70, P1344, DOI 10.1073/pnas.70.5.1344; Gomori G, 1942, J LAB CLIN MED, V27, P955; Hacisalihoglu A, 2007, J BIOL CHEM, V282, P32974, DOI 10.1074/jbc.M706529200; Hackeng TM, 1996, BIOCHEM J, V319, P399, DOI 10.1042/bj3190399; Haynes LM, 2012, J BIOL CHEM, V287, P38647, DOI 10.1074/jbc.M112.407791; Kim PY, 2007, J BIOL CHEM, V282, P32568, DOI 10.1074/jbc.M701781200; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KRISHNASWAMY S, 1994, BIOCHEMISTRY-US, V33, P7897, DOI 10.1021/bi00191a017; Krishnaswamy S, 2013, J THROMB HAEMOST, V11, P265, DOI 10.1111/jth.12217; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lee CJ, 2010, BIOPHYS CHEM, V149, P28, DOI 10.1016/j.bpc.2010.03.011; Lu WP, 2003, ANAL BIOCHEM, V316, P58, DOI 10.1016/S0003-2697(03)00034-4; Lundblad R L, 1976, Methods Enzymol, V45, P156; MALHOTRA OP, 1985, J BIOL CHEM, V260, P279; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1990, BLOOD, V76, P1; Mannucci P. M., 2013, HEMOSTASIS THROMBOSI, P685; Nelsestuen GL, 2000, VITAM HORM, V58, P355, DOI 10.1016/S0083-6729(00)58031-5; NESHEIM ME, 1984, J BIOL CHEM, V259, P1447; NESHEIM ME, 1992, METHOD ENZYMOL, V215, P316; NISHIDA S, 1995, BIOCHEMISTRY-US, V34, P1771, DOI 10.1021/bi00005a034; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; Pozzi N, 2013, J BIOL CHEM, V288, P22734, DOI 10.1074/jbc.M113.466946; PRICE PA, 1983, METHOD ENZYMOL, V91, P13; ROSING J, 1988, THROMB HAEMOSTASIS, V60, P355; Shan N., 2013, HEMOSTASIS THROMBOSI, P1267; TANS G, 1991, J BIOL CHEM, V266, P21864; TIJBURG PNM, 1991, J BIOL CHEM, V266, P4017; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; WALKER RK, 1994, J BIOL CHEM, V269, P27441; Wood JP, 2011, BLOOD, V117, P1710, DOI 10.1182/blood-2010-09-311035; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	53	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27789	27800		10.1074/jbc.M113.502005	http://dx.doi.org/10.1074/jbc.M113.502005			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940050	Green Published, hybrid			2022-12-28	WOS:000330612800008
J	Gordon-Alonso, M; Rocha-Perugini, V; Alvarez, S; Ursa, A; Izquierdo-Useros, N; Martinez-Picado, J; Munoz-Fernandez, MA; Sanchez-Madrid, F				Gordon-Alonso, Monica; Rocha-Perugini, Vera; Alvarez, Susana; Ursa, Angeles; Izquierdo-Useros, Nuria; Martinez-Picado, Javier; Munoz-Fernandez, Maria A.; Sanchez-Madrid, Francisco			Actin-binding Protein Drebrin Regulates HIV-1-triggered Actin Polymerization and Viral Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELLS; VIROLOGICAL SYNAPSE; IMMUNOLOGICAL SYNAPSE; CHEMOKINE RECEPTORS; HIV-1 REPLICATION; DENDRITIC SPINES; LIPID RAFTS; CD4; FUSION	HIV-1 contact with target cells triggers F-actin rearrangements that are essential for several steps of the viral cycle. Successful HIV entry into CD4(+) T cells requires actin reorganization induced by the interaction of the cellular receptor/co-receptor complex CD4/CXCR4 with the viral envelope complex gp120/gp41 (Env). In this report, we analyze the role of the actin modulator drebrin in HIV-1 viral infection and cell to cell fusion. We show that drebrin associates with CXCR4 before and during HIV infection. Drebrin is actively recruited toward cell-virus and Env-driven cell to cell contacts. After viral internalization, drebrin clustering is retained in a fraction of the internalized particles. Through a combination of RNAi-based inhibition of endogenous drebrin and GFP-tagged expression of wild-type and mutant forms, we establish drebrin as a negative regulator of HIV entry and HIV-mediated cell fusion. Down-regulation of drebrin expression promotes HIV-1 entry, decreases F-actin polymerization, and enhances profilin local accumulation in response to HIV-1. These data underscore the negative role of drebrin in HIV infection by modulating viral entry, mainly through the control of actin cytoskeleton polymerization in response to HIV-1.	[Gordon-Alonso, Monica; Rocha-Perugini, Vera; Ursa, Angeles; Sanchez-Madrid, Francisco] Hosp Univ Princesa, Serv Inmunol, Inst Invest Sanitaria Princesa, Madrid 28006, Spain; [Rocha-Perugini, Vera; Sanchez-Madrid, Francisco] CNIC, Vasc Biol & Inflammat Dept, Madrid 28029, Spain; [Alvarez, Susana; Munoz-Fernandez, Maria A.] Hosp Univ Gregorio Maranon, Serv Inmunobiol Mol, Madrid 28007, Spain; [Izquierdo-Useros, Nuria; Martinez-Picado, Javier] Univ Autonoma Barcelona, Inst Invest Ciencies Salut Germans Trias & Pujol, AIDS Res Inst IrsiCaixa, Badalona 08916, Spain; [Izquierdo-Useros, Nuria; Martinez-Picado, Javier] ICREA, Barcelona 08010, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); General University Gregorio Maranon Hospital; Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Institut de Recerca de la Sida - IrsiCaixa; ICREA	Sanchez-Madrid, F (corresponding author), Hosp Univ Princesa, Serv Inmunol, Diego de Leon 62, Madrid 28006, Spain.	fsanchez.hlpr@salud.madrid.org	Rocha-Perugini, Vera/D-6977-2014; Sanchez-Madrid, Francisco/M-7889-2016; Izquierdo-Useros, Nuria/G-2534-2016; Martinez-Picado, Javier/G-5507-2012	Rocha-Perugini, Vera/0000-0002-1761-9884; Sanchez-Madrid, Francisco/0000-0001-5303-0762; Izquierdo-Useros, Nuria/0000-0002-1039-1821; Martinez-Picado, Javier/0000-0002-4916-2129; Munoz-Fernandez/0000-0002-0813-4500; , Susana/0000-0001-8573-9370; Gordon, Monica/0000-0003-1999-8539	Instituto de Salud Carlos III; Instituto de Investigacion Sanitaria Gregorio Maranon, Hospital General Universitario Gregorio Maranon [CA11/00290]; ICREA Funding Source: Custom	Instituto de Salud Carlos III; Instituto de Investigacion Sanitaria Gregorio Maranon, Hospital General Universitario Gregorio Maranon; ICREA(ICREA)	We thank Jose Roman Cabrero for helpful biochemical advice, Manuel Perez-Martinez for confocal assistance, Soraya Lopez-Martin for technical support, Laura Diaz (Research Support Contract (CA11/00290) from the Instituto de Salud Carlos III; Instituto de Investigacion Sanitaria Gregorio Maranon, Hospital General Universitario Gregorio Maranon) for technical assistance at the Flow Cytometry Unit, and Miguel Vicente-Manzanares for critical reading of the manuscript. Simon Bartlett (CNIC) provided English editing.	Aggarwal A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002762; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; Brown C, 2011, J MOL BIOL, V410, P761, DOI 10.1016/j.jmb.2011.03.076; Bubb MR, 2003, J BIOL CHEM, V278, P24629, DOI 10.1074/jbc.M302796200; Calabia-Linares C, 2011, J CELL SCI, V124, P820, DOI 10.1242/jcs.078832; Cao J, 1996, J VIROL, V70, P1340, DOI 10.1128/JVI.70.3.1340-1354.1996; Carter GC, 2011, VIROLOGY, V409, P234, DOI 10.1016/j.virol.2010.10.018; DIANZANI U, 1995, EUR J IMMUNOL, V25, P1306, DOI 10.1002/eji.1830250526; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Duncan CJA, 2011, VIRUSES-BASEL, V3, P2255, DOI 10.3390/v3112255; Finnegan CM, 2007, J VIROL, V81, P5294, DOI 10.1128/JVI.02553-06; Fournier M, 2010, MOL IMMUNOL, V47, P2594, DOI 10.1016/j.molimm.2010.06.010; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gladnikoff M, 2009, BIOPHYS J, V97, P2419, DOI 10.1016/j.bpj.2009.08.016; Goodenow MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/jlb.0306148; Gordon-Alonso M, 2006, J IMMUNOL, V177, P5129, DOI 10.4049/jimmunol.177.8.5129; Gordon-Alonso M, 2012, MOL BIOL CELL, V23, P2253, DOI 10.1091/mbc.E11-12-1003; Gordon-Alonso M, 2012, J IMMUNOL, V189, P689, DOI 10.4049/jimmunol.1103708; Gordon-Alonso M, 2010, CELL HEALTH CYTOSKEL, V2, P33; Grigorov B, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-28; Gummuluru S, 2002, J VIROL, V76, P10692, DOI 10.1128/JVI.76.21.10692-10701.2002; Haller C, 2011, EUR J CELL BIOL, V90, P913, DOI 10.1016/j.ejcb.2010.09.010; Harmon B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000956; Hayashi K, 1996, J NEUROSCI, V16, P7161; Hayashi K, 1999, EXP CELL RES, V253, P673, DOI 10.1006/excr.1999.4663; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Iyengar S, 2004, AIDS REV, V6, P155; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; Izquierdo-Useros N, 2009, BLOOD, V113, P2732, DOI 10.1182/blood-2008-05-158642; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Kadin I, 2007, J IMMUNOL, V178, P6404, DOI 10.4049/jimmunol.178.10.6404; Kamiyama H, 2009, VIROLOGY, V386, P23, DOI 10.1016/j.virol.2008.12.033; Kao H, 2008, J IMMUNOL, V181, P8248, DOI 10.4049/jimmunol.181.12.8248; Komano J, 2004, MOL BIOL CELL, V15, P5197, DOI 10.1091/mbc.E04-04-0279; Krementsov DN, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-64; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Liu Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.266pe23; Majoul I, 2007, HISTOCHEM CELL BIOL, V127, P355, DOI 10.1007/s00418-007-0273-y; Mammoto A, 1998, BIOCHEM BIOPH RES CO, V243, P86, DOI 10.1006/bbrc.1997.8068; Mikati MA, 2013, J BIOL CHEM, V288, P19926, DOI 10.1074/jbc.M113.472647; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Nguyen DH, 2005, EXP CELL RES, V304, P559, DOI 10.1016/j.yexcr.2004.11.022; Peitsch WK, 2005, J INVEST DERMATOL, V125, P761, DOI 10.1111/j.0022-202X.2005.23793.x; Perez-Martinez M, 2010, J CELL SCI, V123, P1160, DOI 10.1242/jcs.064238; Piguet V, 2004, J CLIN INVEST, V114, P605, DOI 10.1172/JCI200422812; Pontow SE, 2004, J VIROL, V78, P7138, DOI 10.1128/JVI.78.13.7138-7147.2004; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Prasad A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048854; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Sasaki Y, 1996, J NEUROCHEM, V66, P980; Sato K, 2008, J VIROL, V82, P1021, DOI 10.1128/JVI.01044-07; Sharma S, 2011, NANO LETT, V11, P825, DOI 10.1021/nl104159v; Valenzuela-Fernandez A, 2005, MOL BIOL CELL, V16, P5445, DOI 10.1091/mbc.e05-04-0354; Vasiliver-Shamis G, 2009, J VIROL, V83, P11341, DOI 10.1128/JVI.01440-09; Warrilow D, 2007, CURR HIV RES, V5, P293, DOI 10.2174/157016207780636579; Weng J, 2009, J VIROL, V83, P7467, DOI 10.1128/JVI.00163-09; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yarmola EG, 2006, TRENDS BIOCHEM SCI, V31, P197, DOI 10.1016/j.tibs.2006.02.006; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036	65	26	27	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28382	28397		10.1074/jbc.M113.494906	http://dx.doi.org/10.1074/jbc.M113.494906			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23926103	hybrid, Green Published			2022-12-28	WOS:000330612800066
J	Guo, JB; Chen, S				Guo, Jiubiao; Chen, Sheng			Unique Substrate Recognition Mechanism of the Botulinum Neurotoxin D Light Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTYPE-A; ZINC PROTEASES; TOXIN; TETANUS; SPECIFICITY; VAMP-2; WEAPON; SNARE	Botulinum neurotoxins are the most potent protein toxins in nature. Despite the potential to block neurotransmitter release at the neuromuscular junction and cause human botulism, they are widely used in protein therapies. Among the seven botulinum neurotoxin serotypes, mechanisms of substrate recognition and specificity are known to a certain extent in the A, B, E, and F light chains, but not in the D light chain (LC/D). In this study, we addressed the unique substrate recognition mechanism of LC/D and showed that this serotype underwent hydrophobic interactions with VAMP-2 at its V1 motif. The LC/D B3, B4, and B5 binding sites specifically recognize the hydrophobic residues in the V1 motif of VAMP-2. Interestingly, we identified a novel dual recognition mechanism employed by LC/D in recognition of VAMP-2sites at both the active site and distal binding sites, in which one site of VAMP-2 was recognized by two independent, but functionally similar LC/D sites that were complementary to each other. The dual recognition strategy increases the tolerance of LC/D to mutations and renders it a good candidate for engineering to improve its therapeutic properties. In conclusion, in this study, we identified a unique multistep substrate recognition mechanism by LC/D and provide insights for LC/D engineering and antitoxin development.	[Guo, Jiubiao; Chen, Sheng] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Chen, S (corresponding author), Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China.	sheng.chen@polyu.edu.hk		Chen, Sheng/0000-0003-3526-7808; Guo, Jiubiao/0000-0003-2716-1712	Hong Kong Research Grant Council [B-Q25N]	Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This work was supported by Grant B-Q25N from the Hong Kong Research Grant Council (to S. C.).	Arndt JW, 2006, BIOCHEMISTRY-US, V45, P3255, DOI 10.1021/bi052518r; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Bossi P, 2003, PRESSE MED, V32, P463; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Chen S, 2008, J BIOL CHEM, V283, P21153, DOI 10.1074/jbc.M800611200; Chen S, 2007, J BIOL CHEM, V282, P25540, DOI 10.1074/jbc.M701922200; Chen S, 2007, J BIOL CHEM, V282, P9621, DOI 10.1074/jbc.M611211200; Chen S, 2012, BIOCHEMISTRY-US, V51, P3941, DOI 10.1021/bi3000098; Chen S, 2011, BIOCHEM J, V433, P277, DOI 10.1042/BJ20101310; Cheng CA, 2006, AM J HEALTH-SYST PH, V63, P225, DOI 10.2146/sp/06001; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; Glogau RG, 2002, CLIN J PAIN, V18, pS191, DOI 10.1097/00002508-200211001-00012; JANKOVIC J, 1991, NEW ENGL J MED, V324, P1186, DOI 10.1056/nejm199104253241707; Klein AW, 2004, DERMATOL SURG, V30, P452, DOI 10.1111/j.1524-4725.2004.30118.x; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; Pearce LB, 1997, TOXICON, V35, P1373, DOI 10.1016/S0041-0101(96)00180-8; ROSSETTO O, 1994, NATURE, V372, P415, DOI 10.1038/372415a0; SCHIAVO G, 1994, ANN NY ACAD SCI, V710, P65, DOI 10.1111/j.1749-6632.1994.tb26614.x; Sikorra S, 2008, J BIOL CHEM, V283, P21145, DOI 10.1074/jbc.M800610200	22	8	8	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27881	27887		10.1074/jbc.M113.491134	http://dx.doi.org/10.1074/jbc.M113.491134			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23963459	Green Published, hybrid			2022-12-28	WOS:000330612800016
J	Tate, JJ; Cooper, TG				Tate, Jennifer J.; Cooper, Terrance G.			Five Conditions Commonly Used to Down-regulate Tor Complex 1 Generate Different Physiological Situations Exhibiting Distinct Requirements and Outcomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; NITROGEN CATABOLITE REPRESSION; TRANSFER-RNA SYNTHETASE; METHIONINE SULFOXIMINE TREATMENT; GATA FACTOR RESPONSES; CELL-CYCLE ARREST; GLN3 PHOSPHORYLATION; NUCLEAR-LOCALIZATION; RAPAMYCIN INHIBITION; TRYPTOPHAN PERMEASE	Five different physiological conditions have been used interchangeably to establish the sequence of molecular events needed to achieve nitrogen-responsive down-regulation of TorC1 and its subsequent regulation of downstream reporters: nitrogen starvation, methionine sulfoximine (Msx) addition, nitrogen limitation, rapamycin addition, and leucine starvation. Therefore, we tested a specific underlying assumption upon which the interpretation of data generated by these five experimental perturbations is premised. It is that they generate physiologically equivalent outcomes with respect to TorC1, i.e. its down-regulation as reflected by TorC1 reporter responses. We tested this assumption by performing head-to-head comparisons of the requirements for each condition to achieve a common outcome for a downstream proxy of TorC1 inactivation, nuclear Gln3 localization. We demonstrate that the five conditions for down-regulating TorC1 do not elicit physiologically equivalent outcomes. Four of the methods exhibit hierarchical Sit4 and PP2A phosphatase requirements to elicit nuclear Gln3-Myc(13) localization. Rapamycin treatment required Sit4 and PP2A. Nitrogen limitation and short-term nitrogen starvation required only Sit4. G(1) arrest-correlated, long-term nitrogen starvation and Msx treatment required neither PP2A nor Sit4. Starving cells of leucine or treating them with leucyl-tRNA synthetase inhibitors did not elicit nuclear Gln3-Myc(13) localization. These data indicate that the five commonly used nitrogen-related conditions of down-regulating TorC1 are not physiologically equivalent and minimally involve partially differing regulatory mechanisms. Further, identical requirements for Msx treatment and long-term nitrogen starvation raise the possibility that their effects are achieved through a common regulatory pathway with glutamine, a glutamate or glutamine metabolite level as the sensed metabolic signal.	[Tate, Jennifer J.; Cooper, Terrance G.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Cooper, TG (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	tcooper@uthsc.edu		Cooper, Terrance G./0000-0002-7651-9963	National Institutes of Health [GM-35642-23]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35642-23.	Ataide SF, 2006, ACS CHEM BIOL, V1, P285, DOI 10.1021/cb600200k; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Chen X, 2011, NUCLEIC ACIDS RES, V39, P235, DOI 10.1093/nar/gkq763; CIEJEK E, 1979, CELL, V18, P623, DOI 10.1016/0092-8674(79)90117-X; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, TOP CURR GENET, V7, P225; COOPER TG, 1976, J BIOL CHEM, V251, P7278; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740; Feller A, 2013, J BIOL CHEM, V288, P1841, DOI 10.1074/jbc.M112.385054; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Georis I, 2011, J BIOL CHEM, V286, P44897, DOI 10.1074/jbc.M111.290577; Georis I, 2011, MOL CELL BIOL, V31, P92, DOI 10.1128/MCB.00482-10; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; HARTWELL LH, 1970, J BACTERIOL, V104, P1280, DOI 10.1128/JB.104.3.1280-1285.1970; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hernandez H, 2011, BIOCHEM BIOPH RES CO, V404, P859, DOI 10.1016/j.bbrc.2010.12.075; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; JOHNSTON GC, 1977, J BACTERIOL, V132, P723, DOI 10.1128/JB.132.2.723-730.1977; KITAMOTO K, 1988, J BACTERIOL, V170, P2683, DOI 10.1128/jb.170.6.2683-2686.1988; Kulkarni A, 2006, FEMS YEAST RES, V6, P218, DOI 10.1111/j.1567-1364.2006.00031.x; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; MAREK ET, 1987, J BACTERIOL, V169, P2440, DOI 10.1128/jb.169.6.2440-2448.1987; MARKWARDT DD, 1995, J BACTERIOL, V177, P6761, DOI 10.1128/jb.177.23.6761-6765.1995; Rai R, 2013, J BIOL CHEM, V288, P2789, DOI 10.1074/jbc.M112.421826; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; SPRAGUE GF, 1981, J MOL BIOL, V153, P305, DOI 10.1016/0022-2836(81)90280-1; SUMRADA R, 1978, J BACTERIOL, V136, P234, DOI 10.1128/JB.136.1.234-246.1978; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2010, J BIOL CHEM, V285, P17880, DOI 10.1074/jbc.M109.085712; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Tate JJ, 2003, J BIOL CHEM, V278, P36924, DOI 10.1074/jbc.M301829200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; UNGER MW, 1976, P NATL ACAD SCI USA, V73, P1664, DOI 10.1073/pnas.73.5.1664; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; WILKINSON LE, 1974, EXP CELL RES, V89, P175, DOI 10.1016/0014-4827(74)90200-6; WILLIAMSON DH, 1962, NATURE, V193, P256, DOI 10.1038/193256a0; Zaman S., 2009, ANNU REV GENET, V42, P21	61	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27243	27262		10.1074/jbc.M113.484386	http://dx.doi.org/10.1074/jbc.M113.484386			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23935103	Green Published, hybrid			2022-12-28	WOS:000330597300022
J	Bonsor, DA; Weiss, E; Iosub-Amir, A; Reingewertz, TH; Chen, TW; Haas, R; Friedler, A; Fischer, W; Sundberg, EJ				Bonsor, Daniel A.; Weiss, Evelyn; Iosub-Amir, Anat; Reingewertz, Tali H.; Chen, Tiffany W.; Haas, Rainer; Friedler, Assaf; Fischer, Wolfgang; Sundberg, Eric J.			Characterization of the Translocation-competent Complex between the Helicobacter pylori Oncogenic Protein CagA and the Accessory Protein CagF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Helicobacter pylori; Protein Secretion; Protein Translocation; Protein-Protein Interactions; CagA; CagF; Type IV Secretion System	IV SECRETION; PATHOGENICITY ISLAND; SECONDARY STRUCTURE; AGROBACTERIUM-TUMEFACIENS; HOST; SIGNAL; CELLS; ONCOPROTEIN; INDUCTION; DIVERSITY	Background: Translocation of the H. pylori oncogenic protein CagA into host cells is dependent on CagF. Results: CagF interacts with all five domains of CagA. Conclusion: CagF protects CagA from degradation such that it can be recognized by the type IV secretion system. Significance: The CagA-CagF interaction is distributed across their molecular surfaces to provide protection to the highly labile effector protein. CagA is a virulence factor that Helicobacter pylori inject into gastric epithelial cells through a type IV secretion system where it can cause gastric adenocarcinoma. Translocation is dependent on the presence of secretion signals found in both the N- and C-terminal domains of CagA and an interaction with the accessory protein CagF. However, the molecular basis of this essential protein-protein interaction is not fully understood. Herein we report, using isothermal titration calorimetry, that CagA forms a 1:1 complex with a monomer of CagF with nm affinity. Peptide arrays and isothermal titration calorimetry both show that CagF binds to all five domains of CagA, each with m affinity. More specifically, a coiled coil domain and a C-terminal helix within CagF contacts domains II-III and domain IV of CagA, respectively. In vivo complementation assays of H. pylori with a double mutant, L36A/I39A, in the coiled coil region of CagF showed a severe weakening of the CagA-CagF interaction to such an extent that it was nearly undetectable. However, it had no apparent effect on CagA translocation. Deletion of the C-terminal helix of CagF also weakened the interaction with CagA but likewise had no effect on translocation. These results indicate that the CagA-CagF interface is distributed broadly across the molecular surfaces of these two proteins to provide maximal protection of the highly labile effector protein CagA.	[Bonsor, Daniel A.; Reingewertz, Tali H.; Sundberg, Eric J.] Univ Maryland, Inst Human Virol, Sch Med, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Dept Med, Sch Med, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA; [Weiss, Evelyn; Haas, Rainer; Fischer, Wolfgang] Univ Munich, Max von Pettenkofer Inst, D-80336 Munich, Germany; [Iosub-Amir, Anat; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Chen, Tiffany W.] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Haas, Rainer] Univ Munich, German Ctr Infect Res, D-80539 Munich, Germany	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Munich; Hebrew University of Jerusalem; Boston Biomedical Research Institute; German Center for Infection Research; University of Munich	Sundberg, EJ (corresponding author), Univ Maryland, Inst Human Virol, Sch Med, 725 West Lombard St, Baltimore, MD 21201 USA.	ESundberg@ihv.umaryland.edu		Sundberg, Eric/0000-0003-0478-3033; Chen, Tiffany/0000-0001-6926-0482	Alexander von Humboldt Foundation; Fulbright scholarship; International Sephardic Education Foundation fellowship; European Research Council under the European Community's Seventh Framework Programme [203413]; Israel Cancer Association	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Fulbright scholarship; International Sephardic Education Foundation fellowship; European Research Council under the European Community's Seventh Framework Programme(European Commission); Israel Cancer Association	This work was supported in part by an Alexander von Humboldt Foundation experienced researcher fellowship (to E. J. S.) as well as a Fulbright scholarship and International Sephardic Education Foundation fellowship (to T. H. R.).; Supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/European Research Council Grant Agreement 203413 and by the Israel Cancer Association.	Abu-Arish A, 2004, J BIOL CHEM, V279, P25359, DOI 10.1074/jbc.M401804200; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Angelini A, 2009, FEBS J, V276, P816, DOI 10.1111/j.1742-4658.2008.06826.x; Backert S, 2001, PROTEOMICS, V1, P608, DOI 10.1002/1615-9861(200104)1:4<608::AID-PROT608>3.3.CO;2-7; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; BLASER MJ, 1995, CANCER RES, V55, P2111; Buti L, 2011, P NATL ACAD SCI USA, V108, P9238, DOI 10.1073/pnas.1106200108; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Couturier MR, 2006, INFECT IMMUN, V74, P273, DOI 10.1128/IAI.74.1.273-281.2006; Fattori J, 2011, PROTEIN PEPTIDE LETT, V18, P158, DOI 10.2174/092986611794475048; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Frenkiel-Krispin D, 2007, J BIOL CHEM, V282, P3458, DOI 10.1074/jbc.M605270200; Hayashi T, 2012, CELL HOST MICROBE, V12, P20, DOI 10.1016/j.chom.2012.05.010; Hohlfeld S, 2006, MOL MICROBIOL, V59, P1624, DOI 10.1111/j.1365-2958.2006.05050.x; Ishikawa S, 2009, FEBS LETT, V583, P2414, DOI 10.1016/j.febslet.2009.06.043; Israel DA, 2001, J CLIN INVEST, V107, P611, DOI 10.1172/JCI11450; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kaplan-Turkoz B, 2012, P NATL ACAD SCI USA, V109, P14640, DOI 10.1073/pnas.1206098109; Kramer RM, 2012, BIOPHYS J, V102, P1907, DOI 10.1016/j.bpj.2012.01.060; Lu HS, 2008, CANCER SCI, V99, P2004, DOI 10.1111/j.1349-7006.2008.00950.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Moese S, 2001, PROTEOMICS, V1, P618, DOI 10.1002/1615-9861(200104)1:4<618::AID-PROT618>3.0.CO;2-C; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Nesic D, 2010, NAT STRUCT MOL BIOL, V17, P130, DOI 10.1038/nsmb.1705; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Pattis I, 2007, MICROBIOL-SGM, V153, P2896, DOI 10.1099/mic.0.2007/007385-0; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Sundberg C, 1996, J BACTERIOL, V178, P1207, DOI 10.1128/jb.178.4.1207-1212.1996; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vergunst AC, 2005, P NATL ACAD SCI USA, V102, P832, DOI 10.1073/pnas.0406241102; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	40	19	20	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32897	32909		10.1074/jbc.M113.507657	http://dx.doi.org/10.1074/jbc.M113.507657			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24072713	Green Published, hybrid			2022-12-28	WOS:000328841700008
J	Hargrove, TY; Wawrzak, Z; Alexander, PW; Chaplin, JH; Keenan, M; Charman, SA; Perez, CJ; Waterman, MR; Chatelain, E; Lepesheva, GI				Hargrove, Tatiana Y.; Wawrzak, Zdzislaw; Alexander, Paul W.; Chaplin, Jason H.; Keenan, Martine; Charman, Susan A.; Perez, Catherine J.; Waterman, Michael R.; Chatelain, Eric; Lepesheva, Galina I.			Complexes of Trypanosoma cruzi Sterol 14 alpha-Demethylase (CYP51) with Two Pyridine-based Drug Candidates for Chagas Disease STRUCTURAL BASIS FOR PATHOGEN SELECTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIFUNGAL AGENTS; ERGOSTEROL BIOSYNTHESIS; SUBSTRATE PREFERENCES; SCHIZOTRYPANUM CRUZI; CYTOCHROMES P450; INHIBITION; KETOCONAZOLE; EPIMASTIGOTES; BINDING; TARGET	Chagas disease, caused by the eukaryotic (protozoan) parasite Trypanosoma cruzi, is an alarming emerging global health problem with no clinical drugs available to treat the chronic stage. Azole inhibitors of sterol 14 alpha-demethylase (CYP51) were proven effective against Chagas, and antifungal drugs posaconazole and ravuconazole have entered clinical trials in Spain, Bolivia, and Argentina. Here we present the x-ray structures of T. cruzi CYP51 in complexes with two alternative drug candidates, pyridine derivatives (S)-(4-chlorophenyl)-1-(4-(4-(trifluoromethyl)phenyl)-piperazin-1-yl)-2-(pyridin-3-yl)ethanone (UDO; Protein Data Bank code 3ZG2) and N-[4-(trifluoromethyl)phenyl]-N-[1-[5-(trifluoromethyl)-2-pyridyl]-4-piperidyl]pyridin-3-amine (UDD; Protein Data Bank code 3ZG3). These compounds have been developed by the Drugs for Neglected Diseases initiative (DNDi) and are highly promising antichagasic agents in both cellular and in vivo experiments. The binding parameters and inhibitory effects on sterol 14 alpha-demethylase activity in reconstituted enzyme reactions confirmed UDO and UDD as potent and selective T. cruzi CYP51 inhibitors. Comparative analysis of the pyridine-and azole-bound CYP51 structures uncovered the features that make UDO and UDD T. cruzi CYP51-specific. The structures suggest that although a precise fit between the shape of the inhibitor molecules and T. cruzi CYP51 active site topology underlies their high inhibitory potency, a longer coordination bond between the catalytic heme iron and the pyridine nitrogen implies a weaker influence of pyridines on the iron reduction potential, which may be the basis for the observed selectivity of these compounds toward the target enzyme versus other cytochrome P450s, including human drug-metabolizing P450s. These findings may pave the way for the development of novel CYP51-targeted drugs with optimized metabolic properties that are very much needed for the treatment of human infections caused by eukaryotic microbial pathogens.	[Hargrove, Tatiana Y.; Waterman, Michael R.; Lepesheva, Galina I.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Synchrotron Res Ctr, Life Sci Collaborat Access Team, Argonne, IL 60439 USA; [Alexander, Paul W.; Chaplin, Jason H.; Keenan, Martine] Murdoch Univ, Epichem Pty Ltd, Murdoch, WA 6150, Australia; [Charman, Susan A.] Monash Univ, Monash Inst Pharmaceut Sci, Ctr Drug Candidate Optimisat, Parkville, Vic 3052, Australia; [Perez, Catherine J.] Murdoch Univ, Dept Parasitol & Vet Sci, Murdoch, WA 6150, Australia; [Chatelain, Eric] Drugs Neglected Dis Initiat, CH-1202 Geneva, Switzerland; [Lepesheva, Galina I.] Vanderbilt Ctr Struct Biol, Nashville, TN 37232 USA; [Lepesheva, Galina I.] Inst Global Hlth, Nashville, TN 37232 USA	Vanderbilt University; Northwestern University; Murdoch University; Monash University; Murdoch University	Lepesheva, GI (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 622 RRB,23rd & Pierce, Nashville, TN 37232 USA.	galina.lepesheva@vanderbilt.edu	Charman, Susan A/E-2221-2011	Charman, Susan A/0000-0003-1753-8213	National Institutes of Health [GM 067871]; Department for International Development (DFID), United Kingdom; Reconstruction Credit Institution-Federal Ministry of Education and Research (KfW-BMBF), Germany; Ministry of Foreign and European Affairs (MAEE), France; Spanish Agency for International Development Cooperation (AECID), Spain; Directorate-General for International Cooperation (DGIS), Netherlands; Medecins Sans Frontieres (Doctors without Borders (international)); Swiss foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department for International Development (DFID), United Kingdom; Reconstruction Credit Institution-Federal Ministry of Education and Research (KfW-BMBF), Germany; Ministry of Foreign and European Affairs (MAEE), France; Spanish Agency for International Development Cooperation (AECID), Spain; Directorate-General for International Cooperation (DGIS), Netherlands(Netherlands Government); Medecins Sans Frontieres (Doctors without Borders (international)); Swiss foundation(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 067871 (to G. I. L.). For synthesis of UDO (EPL-BS1246) and UDD (EPL-BS0967) and their testing in microsomal, cellular experiments and in vivo, DNDi received financial support from the following donors: the Department for International Development (DFID), United Kingdom; the Reconstruction Credit Institution-Federal Ministry of Education and Research (KfW-BMBF), Germany; the Ministry of Foreign and European Affairs (MAEE), France; the Spanish Agency for International Development Cooperation (AECID), Spain; the Directorate-General for International Cooperation (DGIS), Netherlands; Medecins Sans Frontieres (Doctors without Borders (international)); and a Swiss foundation.	Andriani G, 2013, J MED CHEM, V56, P2556, DOI 10.1021/jm400012e; Apt W, 1998, AM J TROP MED HYG, V59, P133, DOI 10.4269/ajtmh.1998.59.133; Araujo MSS, 2000, J ANTIMICROB CHEMOTH, V45, P819, DOI 10.1093/jac/45.6.819; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEACH DH, 1986, BIOCHEM BIOPH RES CO, V136, P851, DOI 10.1016/0006-291X(86)90410-9; BENNETT JE, 1974, NEW ENGL J MED, V290, P320, DOI 10.1056/NEJM197402072900607; Buckner F, 2003, P NATL ACAD SCI USA, V100, P15149, DOI 10.1073/pnas.2535442100; Buckner FS, 2012, ANTIMICROB AGENTS CH, V56, P4914, DOI 10.1128/AAC.06244-11; Buckner FS, 1996, ANTIMICROB AGENTS CH, V40, P2592, DOI 10.1128/AAC.40.11.2592; Bui SH, 2012, J BIOL CHEM, V287, P19699, DOI 10.1074/jbc.M111.319202; Clayton J, 2010, NATURE, V465, pS12, DOI 10.1038/nature09224; Correia MA., 2005, CYTOCHROME P450 STRU, P246; Soeiro MDC, 2013, ANTIMICROB AGENTS CH, V57, P4151, DOI 10.1128/AAC.00070-13; Dobish MC, 2012, ORG LETT, V14, P6322, DOI 10.1021/ol303092v; DOCAMPO R, 1981, MOL BIOCHEM PARASIT, V3, P169, DOI 10.1016/0166-6851(81)90047-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espinel-Ingroff A, 2008, REV IBEROAM MICOL, V25, P101, DOI 10.1016/S1130-1406(08)70027-5; FISCHER RT, 1989, J LIPID RES, V30, P1621; Gubbins PO, 2011, EXPERT OPIN DRUG MET, V7, P1411, DOI 10.1517/17425255.2011.627854; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Hargrove TY, 2012, INT J PARASITOL-DRUG, V2, P178, DOI 10.1016/j.ijpddr.2012.06.001; Hargrove TY, 2012, J LIPID RES, V53, P311, DOI 10.1194/jlr.M021865; Hargrove TY, 2011, J BIOL CHEM, V286, P26838, DOI 10.1074/jbc.M111.237099; Hucke O, 2005, J MED CHEM, V48, P5415, DOI 10.1021/jm050441z; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Keenan M, 2013, BIOORGAN MED CHEM, V21, P1756, DOI 10.1016/j.bmc.2013.01.050; Keenan M, 2012, J MED CHEM, V55, P4189, DOI 10.1021/jm2015809; Konkle ME, 2009, J MED CHEM, V52, P2846, DOI 10.1021/jm801643b; LAZARDI K, 1990, ANTIMICROB AGENTS CH, V34, P2097, DOI 10.1128/AAC.34.11.2097; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva GI, 2011, CURR TOP MED CHEM, V11, P2060; Lepesheva GI, 2011, ADV PARASIT, V75, P65, DOI 10.1016/B978-0-12-385863-4.00004-6; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Lepesheva GI, 2010, J BIOL CHEM, V285, P1773, DOI 10.1074/jbc.M109.067470; Lepesheva G, 2008, LIPIDS, V43, P1117, DOI 10.1007/s11745-008-3225-y; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Lepesheva GI, 2003, BIOCHEMISTRY-US, V42, P9091, DOI 10.1021/bi034663f; Lepesheva GI, 2004, MOL CELL ENDOCRINOL, V215, P165, DOI 10.1016/j.mce.2003.11.016; Lepesheva GI, 2004, BIOCHEMISTRY-US, V43, P10789, DOI 10.1021/bi048967t; Lepesheva GI, 2001, J BIOL CHEM, V276, P28413, DOI 10.1074/jbc.M102767200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Leslie M, 2011, SCIENCE, V333, P933, DOI 10.1126/science.333.6045.933; Maertens JA, 2004, CLIN MICROBIOL INFEC, V10, P1, DOI 10.1111/j.1470-9465.2004.00841.x; Mast N, 2013, MOL PHARMACOL, V84, P86, DOI 10.1124/mol.113.085902; Molina J, 2000, ANTIMICROB AGENTS CH, V44, P150, DOI 10.1128/AAC.44.1.150-155.2000; NES WR, 1977, BIOCH STEROIDS OTHER, P325; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; OMURA T, 1964, J BIOL CHEM, V239, P2370; Roberts CW, 2003, MOL BIOCHEM PARASIT, V126, P129, DOI 10.1016/S0166-6851(02)00280-3; Saari TI, 2010, CURR OPIN ANESTHESIO, V23, P441, DOI 10.1097/ACO.0b013e32833a254d; Schuster I, 2007, DRUG METAB REV, V39, P481, DOI 10.1080/03602530701498455; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; TRZASKOS JM, 1984, J BIOL CHEM, V259, P3402; URBINA JA, 1988, ANTIMICROB AGENTS CH, V32, P1237, DOI 10.1128/AAC.32.8.1237; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van den Bossche H, 1988, MODE ACTION PYRIDINE, P79; Villalta F, 2013, J INFECT DIS, V208, P504, DOI 10.1093/infdis/jit042; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314	61	70	70	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31602	31615		10.1074/jbc.M113.497990	http://dx.doi.org/10.1074/jbc.M113.497990			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047900	hybrid, Green Published			2022-12-28	WOS:000330596200019
J	Alam, M; Ahmad, R; Rajabi, H; Kharbanda, A; Kufe, D				Alam, Maroof; Ahmad, Rehan; Rajabi, Hasan; Kharbanda, Akriti; Kufe, Donald			MUC1-C Oncoprotein Activates ERK -> C/EBP beta Signaling and Induction of Aldehyde Dehydrogenase 1A1 in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-BETA; C/EBP-BETA; TRANSCRIPTION FACTOR; MAMMARY-GLAND; KAPPA-B; ANDROGEN RECEPTOR; REGULATORY LOOP; SIDE POPULATION; DNA-BINDING; STEM-CELLS	Aldehyde dehydrogenase 1A1 (ALDH1A1) activity is used as a marker of breast cancer stem cells; however, little is known about the regulation of ALDH1A1 expression. Mucin 1 (MUC1) is a heterodimeric protein that is aberrantly overexpressed in most human breast cancers. In studies of breast cancer cells stably silenced for MUC1 or overexpressing the oncogenic MUC1-Csubunit, we demonstrate that MUC1-Cis sufficient for induction of MEK -> ERK signaling and that treatment with a MUC1-Cinhibitor suppresses ERK activation. In turn, MUC1-C induces ERK-mediated phosphorylation and activation of the CCAAT/enhancer-binding protein beta (C/EBP beta) transcription factor. The results further show that MUC1-C and C/EBP beta form a complex on the ALDH1A1 gene promoter and activate ALDH1A1 gene transcription. MUC1-C-induced up-regulation of ALDH1A1 expression is associated with increases in ALDH activity and is detectable in stem-like cells when expanded as mammospheres. These findings demonstrate that MUC1-C (i) activates a previously unrecognized ERK -> C/EBP beta -> ALDH1A1 pathway, and (ii) promotes the induction of ALDH activity in breast cancer cells.	[Alam, Maroof; Ahmad, Rehan; Rajabi, Hasan; Kharbanda, Akriti; Kufe, Donald] Harvard Univ, Dana Farber Canc Inst, Sch Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kufe, D (corresponding author), 450 Brookline Ave,Dana 830, Boston, MA 02215 USA.	donald_kufe@dfci.harvard.edu	Rather, R A/J-3509-2019		NCI of the National Institutes of Health [CA97098, CA166480]; NATIONAL CANCER INSTITUTE [R01CA166480, R01CA097098] Funding Source: NIH RePORTER	NCI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the NCI of the National Institutes of Health under award numbers CA97098 and CA166480. D. K. holds equity in Genus Oncology and is a consultant to the company. The other authors disclosed no potential conflicts of interest.	Ahmad R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001426; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Atwood AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025205; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Christgen M, 2007, MOL CELL BIOCHEM, V306, P201, DOI 10.1007/s11010-007-9570-y; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Douville J, 2009, STEM CELLS DEV, V18, P17, DOI 10.1089/scd.2008.0055; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Elizondo G, 2000, J BIOL CHEM, V275, P39747, DOI 10.1074/jbc.M004987200; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Ginestier C, 2009, CELL CYCLE, V8, P3297, DOI 10.4161/cc.8.20.9761; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Grimm SL, 2003, J MAMMARY GLAND BIOL, V8, P191, DOI 10.1023/A:1025900908026; Hattrup CL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1515; Jin CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039432; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; LaMarca HL, 2010, STEM CELLS, V28, P535, DOI 10.1002/stem.297; Lee S, 2010, MOL CELL BIOL, V30, P2621, DOI 10.1128/MCB.00782-09; Leng YM, 2007, J BIOL CHEM, V282, P19321, DOI 10.1074/jbc.M703222200; Li YQ, 2003, MOL CANCER RES, V1, P765; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Niehof M, 2001, J MOL BIOL, V309, P855, DOI 10.1006/jmbi.2001.4708; Panchamoorthy G, 2011, HYBRIDOMA, V30, P531, DOI 10.1089/hyb.2011.0070; PANDEY P, 1995, CANCER RES, V55, P4000; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Piwien-Pilipuk G, 2002, J BIOL CHEM, V277, P44557, DOI 10.1074/jbc.M206886200; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Raina D., 2013, ONCOGENE IN PRESS; Raina D, 2012, INT J ONCOL, V40, P1644, DOI 10.3892/ijo.2011.1308; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Rajabi H., 2013, ONCOGENE IN PRESS; Rajabi H, 2012, PROSTATE, V72, P1659, DOI 10.1002/pros.22519; Rajabi H, 2012, J BIOL CHEM, V287, P10703, DOI 10.1074/jbc.M111.323311; Rajabi H, 2011, PROSTATE, V71, P1299, DOI 10.1002/pros.21344; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Relic B, 2004, J BIOL CHEM, V279, P22399, DOI 10.1074/jbc.M314118200; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Rosen JM, 1999, ANNU REV NUTR, V19, P407, DOI 10.1146/annurev.nutr.19.1.407; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Siroy A, 2013, HUM PATHOL, V44, P2159, DOI 10.1016/j.humpath.2013.04.010; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; Su WC, 2003, J BIOL CHEM, V278, P51150, DOI 10.1074/jbc.M305501200; Trasino SE, 2007, EXP BIOL MED, V232, P762; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; YANAGAWA Y, 1995, J BIOL CHEM, V270, P17521, DOI 10.1074/jbc.270.29.17521; Yao MY, 2011, LUNG, V189, P453, DOI 10.1007/s00408-011-9327-y; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887	60	66	69	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30892	30903		10.1074/jbc.M113.477158	http://dx.doi.org/10.1074/jbc.M113.477158			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24043631	hybrid, Green Published			2022-12-28	WOS:000330778900010
J	Estey, MP; Di Ciano-Oliveira, C; Froese, CD; Fung, KYY; Steels, JD; Litchfield, DW; Trimble, WS				Estey, Mathew P.; Di Ciano-Oliveira, Caterina; Froese, Carol D.; Fung, Karen Y. Y.; Steels, Jonathan D.; Litchfield, David W.; Trimble, William S.			Mitotic Regulation of SEPT9 Protein by Cyclin-dependent Kinase 1 (Cdk1) and Pin1 Protein Is Important for the Completion of Cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDK (Cyclin-dependent Kinase); Cytokinesis; Cytoskeleton; GTPase; Phosphorylation; Pin1; Proline Isomerase; Septin	PROLYL ISOMERASE PIN1; SACCHAROMYCES-CEREVISIAE; MAMMALIAN SEPTINS; BREAST-CANCER; CELL-CYCLE; PHOSPHORYLATION; GENE; EXPRESSION; TUMORIGENESIS; LOCALIZATION	Background: Evidence is lacking to explain how septin function is controlled during the cell cycle. Results: Phosphorylation of SEPT9 by Cdk1 creates a binding site for Pin1 that is required for cytokinesis. Conclusion: Septin interaction with Pin1 is controlled by Cdk1 and is necessary for timely cytokinesis. Significance: Improper cell division results in cancer, in which both SEPT9 and Pin1 have been implicated. Precise cell division is essential for multicellular development, and defects in this process have been linked to cancer. Septins are a family of proteins that are required for mammalian cell division, but their function and mode of regulation during this process are poorly understood. Here, we demonstrate that cyclin-dependent kinase 1 (Cdk1) phosphorylates septin 9 (SEPT9) upon mitotic entry, and this phosphorylation controls association with the proline isomerase, Pin1. Both SEPT9 and Pin1 are critical for mediating the final separation of daughter cells. Expression of mutant SEPT9 that is defective in Pin1 binding was unable to rescue cytokinesis defects caused by SEPT9 depletion but rather induced dominant-negative defects in cytokinesis. However, unlike SEPT9 depletion, Pin1 was not required for the accumulation of the exocyst complex at the midbody. These results suggest that SEPT9 plays multiple roles in abscission, one of which is regulated by the action of Cdk1 and Pin1.	[Estey, Mathew P.; Fung, Karen Y. Y.; Steels, Jonathan D.; Trimble, William S.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Estey, Mathew P.; Di Ciano-Oliveira, Caterina; Froese, Carol D.; Fung, Karen Y. Y.; Steels, Jonathan D.; Trimble, William S.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Litchfield, David W.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Western University (University of Western Ontario)	Trimble, WS (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	wtrimble@sickkids.ca	Litchfield, David/E-4636-2015	Litchfield, David/0000-0002-2425-6620	Canadian Cancer Society; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Research and Innovation	Canadian Cancer Society(Canadian Cancer Society (CCS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported in part by the Canadian Cancer Society.; Recipient of an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada.; Supported by a postdoctoral fellowship from the Ontario Ministry of Research and Innovation.	Amin ND, 2008, J NEUROSCI, V28, P3631, DOI 10.1523/JNEUROSCI.0453-08.2008; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; HANES SD, 1989, YEAST, V5, P55, DOI 10.1002/yea.320050108; Kim MS, 2011, J CELL BIOL, V195, P815, DOI 10.1083/jcb.201106131; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Lu KP, 1996, NATURE, V380, P544; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; McIlhatton MA, 2001, ONCOGENE, V20, P5930, DOI 10.1038/sj.onc.1204752; McMurray MA, 2009, CELL CYCLE, V8, P195, DOI 10.4161/cc.8.2.7381; Messenger MM, 2002, J BIOL CHEM, V277, P23054, DOI 10.1074/jbc.M200111200; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Scott M, 2006, INT J CANCER, V118, P1325, DOI 10.1002/ijc.21486; Sellin ME, 2011, MOL BIOL CELL, V22, P3152, DOI 10.1091/mbc.E11-03-0253; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Tang CSL, 2002, CELL CYCLE, V1, P42, DOI 10.4161/cc.1.1.99; Taniguchi M, 2007, J BIOL CHEM, V282, P7869, DOI 10.1074/jbc.M609457200; van der Horst A, 2009, CANCER RES, V69, P6651, DOI 10.1158/0008-5472.CAN-09-0825; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Xu YX, 2007, MOL CELL, V26, P287, DOI 10.1016/j.molcel.2007.03.020; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zhu JX, 2007, BIOCHEM BIOPH RES CO, V359, P529, DOI 10.1016/j.bbrc.2007.05.124	43	39	39	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30075	30086		10.1074/jbc.M113.474932	http://dx.doi.org/10.1074/jbc.M113.474932			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23990466	Green Published, hybrid			2022-12-28	WOS:000329868100008
J	Lin, CS; Guo, XG; Lange, S; Liu, J; Ouyang, KF; Yin, X; Jiang, LJ; Cai, YB; Mu, YX; Sheikh, F; Ye, S; Chen, J; Ke, YH; Cheng, HQ				Lin, Changsong; Guo, Xiaogang; Lange, Stephan; Liu, Jie; Ouyang, Kunfu; Yin, Xiang; Jiang, Liujun; Cai, Yibo; Mu, Yongxin; Sheikh, Farah; Ye, Sheng; Chen, Ju; Ke, Yuehai; Cheng, Hongqiang			Cypher/ZASP Is a Novel A-kinase Anchoring Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DILATED CARDIOMYOPATHY; MUSCULAR-DYSTROPHY; CALCIUM-CHANNELS; CA2+ CHANNEL; SEVERE FORM; CALCINEURIN; PHOSPHORYLATION; DOMAIN; PDZ; HEART	PKA signaling is important for the post-translational modification of proteins, especially those in cardiomyocytes involved in cardiac excitation-contraction coupling. PKA activity is spatially and temporally regulated through compartmentalization by protein kinase A anchoring proteins. Cypher/ZASP, a member of PDZ-LIM domain protein family, is a cytoskeletal protein that forms multiprotein complexes at sarcomeric Z-lines. It has been demonstrated that Cypher/ZASP plays a pivotal structural role in the structural integrity of sarcomeres, and several of its mutations are associated with myopathies including dilated cardiomyopathy. Here we show that Cypher/ZASP, interacting specifically with the type II regulatory subunit RII alpha of PKA, acted as a typical protein kinase A anchoring protein in cardiomyocytes. In addition, we show that Cypher/ZASP itself was phosphorylated at Ser(265) and Ser(296) by PKA. Furthermore, the PDZ domain of Cypher/ZASP interacted with the L-type calcium channel through its C-terminal PDZ binding motif. Expression of Cypher/ZASP facilitated PKA-mediated phosphorylation of the L-type calcium channel in vitro. Additionally, the phosphorylation of the L-type calcium channel at Ser(1928) induced by isoproterenol was impaired in neonatal Cypher/ZASP-null cardiomyocytes. Moreover, Cypher/ZASP interacted with the Ser/Thr phosphatase calcineurin, which is a phosphatase for the L-type calcium channel. Taken together, our data strongly suggest that Cypher/ZASP not only plays a structural role for the sarcomeric integrity, but is also an important sarcomeric signaling scaffold in regulating the phosphorylation of channels or contractile proteins.	[Ke, Yuehai; Cheng, Hongqiang] Zhejiang Univ, Sch Med, Program Mol Cell Biol, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China; [Guo, Xiaogang; Yin, Xiang] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiovasc Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lange, Stephan; Ouyang, Kunfu; Mu, Yongxin; Sheikh, Farah; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Liu, Jie; Ye, Sheng] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; University of California System; University of California San Diego; Zhejiang University	Ke, YH (corresponding author), Zhejiang Univ, Sch Med, Program Mol Cell Biol, Dept Pathol & Pathophysiol, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	yke@zju.edu.cn; hqcheng11@zju.edu.cn	ouyang, kunfu/B-3073-2011; Chen, Ju/E-5579-2011; mu, yongxin/G-1882-2014; Lange, Stephan/A-1422-2010	ouyang, kunfu/0000-0003-0292-375X; mu, yongxin/0000-0002-5569-5255; Lange, Stephan/0000-0001-9361-6602; lin, changsong/0000-0001-6328-2381; Cheng, Hongqiang/0000-0001-9662-1570	National Natural Science Foundation of China [81170117]; Zhejiang Provincial Natural Science Foundation of China [LY12H02006]; Major Research Program from the state Ministry of Science and Technology of China [2010CB912004]; National Institutes of Health [HL107744]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112388, R00HL107744, K99HL107744, R01HL066100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Major Research Program from the state Ministry of Science and Technology of China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Natural Science Foundation of China Grant 81170117 (to H. C.), Zhejiang Provincial Natural Science Foundation of China Grant LY12H02006 (to X. G.), Major Research Program from the state Ministry of Science and Technology of China Grant 2010CB912004 (to Y.K.), and by National Institutes of Health K99/R00 Grant HL107744 (to S.L.).	Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blant A, 2012, CAN J PHYSIOL PHARM, V90, P1161, DOI [10.1139/y2012-032, 10.1139/Y2012-032]; Cheng HQ, 2011, HUM MOL GENET, V20, P1751, DOI 10.1093/hmg/ddr050; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dong XT, 2012, J BIOL CHEM, V287, P848, DOI 10.1074/jbc.M111.293258; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Harvey RD, 2013, J MOL CELL CARDIOL, V58, P143, DOI 10.1016/j.yjmcc.2012.12.006; Heineke J, 2012, J MOL CELL CARDIOL, V52, P62, DOI 10.1016/j.yjmcc.2011.10.018; Hojayev B, 2012, MOL CELL BIOL, V32, P4025, DOI 10.1128/MCB.05948-11; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kielbasa OM, 2011, FASEB J, V25, P2276, DOI 10.1096/fj.10-169219; Klaavuniemi T, 2004, J BIOL CHEM, V279, P26402, DOI 10.1074/jbc.M401871200; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; Lange S, 2009, J CELL SCI, V122, P2640, DOI 10.1242/jcs.046193; Lemke T, 2008, J BIOL CHEM, V283, P34738, DOI 10.1074/jbc.M804981200; Lim HW, 2000, CIRCULATION, V101, P2431, DOI 10.1161/01.CIR.101.20.2431; Maturana AD, 2008, CARDIOVASC RES, V78, P458, DOI 10.1093/cvr/cvn052; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Pang X, 2009, ACTA PHARMACOL SIN, V30, P537, DOI 10.1038/aps.2009.28; Reynolds JG, 2007, BBA-MOL CELL RES, V1773, P891, DOI 10.1016/j.bbamcr.2007.04.004; Russell MA, 2006, ARCH BIOCHEM BIOPHYS, V456, P204, DOI 10.1016/j.abb.2006.06.010; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376; Sheikh F, 2012, J CLIN INVEST, V122, P1209, DOI 10.1172/JCI61134; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; Sumandea CA, 2011, J BIOL CHEM, V286, P530, DOI 10.1074/jbc.M110.148684; Tandan S, 2009, CIRC RES, V105, P51, DOI 10.1161/CIRCRESAHA.109.199828; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Uys GM, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-18; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Velthuis AJWT, 2007, THESCIENTIFICWORLDJO, V7, P1470, DOI 10.1100/tsw.2007.232; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; Woo AYH, 2012, ACTA PHARMACOL SIN, V33, P335, DOI 10.1038/aps.2011.201; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yang QL, 2001, CARDIOVASC RES, V51, P80, DOI 10.1016/S0008-6363(01)00273-5; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019; Zhang RL, 2009, HUM MOL GENET, V18, P4130, DOI 10.1093/hmg/ddp362; Zheng M, 2010, J MOL CELL BIOL, V2, P96, DOI 10.1093/jmcb/mjp038; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400; Zhou Q, 1999, J BIOL CHEM, V274, P19807, DOI 10.1074/jbc.274.28.19807; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092	51	32	33	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29403	29413		10.1074/jbc.M113.470708	http://dx.doi.org/10.1074/jbc.M113.470708			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23996002	Green Published, hybrid			2022-12-28	WOS:000330615300019
J	Liu, J; Gao, LW; Zhang, H; Wang, DW; Wang, M; Zhu, JQ; Pang, C; Wang, CL				Liu, Jun; Gao, Liuwei; Zhang, Hua; Wang, Daowei; Wang, Meng; Zhu, Jianquan; Pang, Cong; Wang, Changli			Succinate Dehydrogenase 5 (SDH5) Regulates Glycogen Synthase Kinase 3 beta-beta-Catenin-mediated Lung Cancer Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL TRANSITION; CLINICAL-TRIALS; PARAGANGLIOMA; GENE; PHOSPHORYLATION; MUTATIONS; THERAPIES; CARCINOMA; PATHWAY; HEART	We demonstrate that loss of succinate dehydrogenase 5 (SDH5) expression initiates epithelial-mesenchymal transition (EMT), which is visualized by the repression of E-cadherin and up-regulation of vimentin in lung cancer cell lines and clinical lung cancer specimens. In SDH5 knock-out mice, lung epithelial cells exhibited elevated mesenchymal markers, which is characteristic of EMT. Using a human lung xenograft-mouse model, we observed that knocking down endogenous SDH5 in human carcinoma cells leads to the development of multiple lymph node metastases. Moreover, our data indicate that SDH5 functions as a critical protein in regulating EMT by modulating the glycogen synthase kinase (GSK)-3 beta-beta-catenin signaling pathway. These results reveal a critical role for SDH5 in EMT and suggest that SDH5 may be a prognostic biomarker and potential therapeutic target for lung cancer metastasis.	[Liu, Jun; Gao, Liuwei; Zhang, Hua; Wang, Daowei; Wang, Meng; Zhu, Jianquan; Pang, Cong; Wang, Changli] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr, Dept Lung Canc, Tianjin 300060, Peoples R China	Tianjin Medical University	Wang, CL (corresponding author), Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.	changliwangtj@163.com			National Natural Science Foundation of China [81101776]; China Postdoctoral Science Foundation [2013T60256]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China Grant 81101776 and China Postdoctoral Science Foundation Grant 2013T60256.	Bokobza SM, 2011, MOL CELL BIOCHEM, V349, P33, DOI 10.1007/s11010-010-0657-5; Brabant G, 2005, FASEB J, V19, P1048, DOI 10.1096/fj.04-2846fje; Cao YJ, 2011, CANCER RES, V71, P1235, DOI 10.1158/0008-5472.CAN-10-2217; Chen HZ, 2012, GUT, V61, P714, DOI 10.1136/gutjnl-2011-300783; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Couzin-Frankel J, 2012, SCIENCE, V335, P282, DOI 10.1126/science.335.6066.282; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Jakobsen JN, 2013, LUNG CANCER, V79, P1, DOI 10.1016/j.lungcan.2012.10.008; Janku F, 2012, CLIN CANCER RES, V18, P6356, DOI 10.1158/1078-0432.CCR-12-0178; Kaag D, 2013, LUNG CANCER, V79, P54, DOI 10.1016/j.lungcan.2012.10.009; Kaelin WG, 2009, CANCER CELL, V16, P180, DOI 10.1016/j.ccr.2009.08.013; Kitazawa M, 2011, J IMMUNOL, V187, P6539, DOI 10.4049/jimmunol.1100620; Kunst HPM, 2011, CLIN CANCER RES, V17, P247, DOI 10.1158/1078-0432.CCR-10-0420; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027053; Liu J., 2013, J CLIN ONCOL CANC RE, V40, P1789; Matsuda T, 2008, P NATL ACAD SCI USA, V105, P20900, DOI 10.1073/pnas.0808315106; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Ramachandran R, 2011, P NATL ACAD SCI USA, V108, P15858, DOI 10.1073/pnas.1107220108; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Shinagare AB, 2012, LUNG CANCER, V78, P161, DOI 10.1016/j.lungcan.2012.08.007; Starker LF, 2010, ENDOCRINE, V38, P397, DOI 10.1007/s12020-010-9399-0; Toth MJ, 2011, J APPL PHYSIOL, V110, P892, DOI 10.1152/japplphysiol.00545.2010; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Yang WJ, 2009, HEPATOLOGY, V49, P1515, DOI 10.1002/hep.22833; Zhang Y., 2011, J BIOL CHEM, V286, P16218; Zhang YH, 2012, J BIOL CHEM, V287, P17746, DOI 10.1074/jbc.M112.358143; Zhang Y, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-58	28	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29965	29973		10.1074/jbc.M113.450106	http://dx.doi.org/10.1074/jbc.M113.450106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23983127	hybrid, Green Published			2022-12-28	WOS:000330615300069
J	Lopez-Rodriguez, E; Cruz, A; Richter, RP; Taeusch, HW; Perez-Gil, J				Lopez-Rodriguez, Elena; Cruz, Antonio; Richter, Ralf P.; Taeusch, H. William; Perez-Gil, Jesus			Transient Exposure of Pulmonary Surfactant to Hyaluronan Promotes Structural and Compositional Transformations into a Highly Active State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS SP-B; COMPETITIVE ADSORPTION; HYDROPHILIC POLYMERS; GRAFTED HYALURONAN; MOLECULAR-WEIGHT; CHOLESTEROL; SERUM; FILMS; INACTIVATION; MEMBRANES	Pulmonary surfactant is a lipid-protein complex that lowers surface tension at the respiratory air-liquid interface, stabilizing the lungs against physical forces tending to collapse alveoli. Dysfunction of surfactant is associated with respiratory pathologies such as acute respiratory distress syndrome or meconium aspiration syndrome where naturally occurring surfactant-inhibitory agents such as serum, meconium, or cholesterol reach the lung. We analyzed the effect of hyaluronan(HA) on the structure and surface behavior of pulmonary surfactant to understand the mechanism for HA-promoted surfactant protection in the presence of inhibitory agents. In particular, we found that HA affects structural properties such as the aggregation state of surfactant membranes and the size, distribution, and order/packing of phase-segregated lipid domains. These effects do not require a direct interaction between surfactant complexes and HA and are accompanied by a compositional reorganization of large surfactant complexes that become enriched with saturated phospholipid species. HA-exposed surfactant reaches very high efficiency in terms of rapid and spontaneous adsorption of surfactant phospholipids at the air-liquid interface and shows significantly improved resistance to inactivation by serum or cholesterol. We propose that physical effects pertaining to the formation of a meshwork of interpenetrating HA polymer chains are responsible for the changes in surfactant structure and composition that enhance surfactant function and, thus, resistance to inactivation. The higher resistance of HA-exposed surfactant to inactivation persists even after removal of the polymer, suggesting that transient exposure of surfactant to polymers like HA could be a promising strategy for the production of more efficient therapeutic surfactant preparations.	[Lopez-Rodriguez, Elena; Cruz, Antonio; Perez-Gil, Jesus] Univ Complutense, Fac Biol, Dept Biochem & Mol Biol, E-28040 Madrid, Spain; [Richter, Ralf P.] CIC BiomaGUNE, Biosurfaces Unit, San Sebastian 20009, Spain; [Richter, Ralf P.] Univ Grenoble 1, Dept Mol Chem, Lab I2BM, F-38041 Grenoble 9, France; [Richter, Ralf P.] Univ Basque Country, Dept Biochem & Mol Biol, Leioa 48940, Spain; [Richter, Ralf P.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Taeusch, H. William] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94110 USA	Complutense University of Madrid; CIC biomaGUNE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Basque Country; Max Planck Society; University of California System; University of California San Francisco	Perez-Gil, J (corresponding author), Univ Complutense, Fac Biol, Dept Biochem & Mol Biol, C JoseAntonio Novais 2, E-28040 Madrid, Spain.	jperezgil@bio.ucm.es	Richter, Ralf Peter/B-3343-2013; Lopez-Rodriguez, Elena/ABC-4033-2020; Perez-Gil, Jesus/H-3102-2019; Cruz, Antonio/H-2881-2015; biomaGUNE, CIC/J-9136-2014	Richter, Ralf Peter/0000-0003-3071-2837; Lopez-Rodriguez, Elena/0000-0002-1549-8150; Perez-Gil, Jesus/0000-0003-3587-7147; Cruz, Antonio/0000-0002-0465-4111; biomaGUNE, CIC/0000-0001-7690-0660	National Institutes of Health [HLBI RO1 HL 66410]; Spanish Ministry of Economy and Competitivity [BIO2012-30733, MAT2011-24306, CSD2007-00010]; Regional Government of Madrid [S2009MAT-1507]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Economy and Competitivity(Spanish Government); Regional Government of Madrid; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HLBI RO1 HL 66410. This work was also supported by Spanish Ministry of Economy and Competitivity Grants BIO2012-30733, MAT2011-24306, and CSD2007-00010 and by Regional Government of Madrid Grant S2009MAT-1507.	Almond A, 2000, J PHYS CHEM B, V104, P5634, DOI 10.1021/jp000402t; Attili S, 2012, BIOMACROMOLECULES, V13, P1466, DOI 10.1021/bm3001759; Attili S, 2012, LANGMUIR, V28, P3206, DOI 10.1021/la204602n; de la Serna JB, 2009, BIOPHYS J, V97, P1381, DOI 10.1016/j.bpj.2009.06.040; Blanco O, 2007, EUR J PHARMACOL, V568, P1, DOI 10.1016/j.ejphar.2007.04.035; Bray BA, 2001, J THEOR BIOL, V210, P121, DOI 10.1006/jtbi.2001.2305; Campbell H, 2002, AM J RESP CRIT CARE, V165, P475, DOI 10.1164/ajrccm.165.4.2106109; CASTRESANA J, 1992, BIOCHEM J, V282, P467, DOI 10.1042/bj2820467; Chavarha M, 2010, BIOPHYS J, V98, P1549, DOI 10.1016/j.bpj.2009.12.4302; COMPER WD, 1978, PHYSIOL REV, V58, P255, DOI 10.1152/physrev.1978.58.1.255; Cowman MK, 2005, CARBOHYD RES, V340, P791, DOI 10.1016/j.carres.2005.01.022; de la Serna JB, 2004, J BIOL CHEM, V279, P40715, DOI 10.1074/jbc.M404648200; DE SMEDT SC, 1993, BIORHEOLOGY, V30, P31; Dehority W, 2005, PEDIATR RES, V58, P913, DOI 10.1203/01.PDR.0000182581.39561.01; El Shahed A. I., 2007, COCHRANE DB SYST REV, V3; Fam H, 2007, BIORHEOLOGY, V44, P59; Fam H, 2009, BIORHEOLOGY, V46, P31, DOI 10.3233/BIR-2009-0521; Gaver D. P., 2005, LUNG SURFACTANT DYSF, P192; Gomez-Gil L, 2009, BIOPHYS J, V97, P2736, DOI 10.1016/j.bpj.2009.08.045; HEATLEY F, 1988, BIOCHEM J, V254, P489, DOI 10.1042/bj2540489; Hunger J, 2012, BIOPHYS J, V103, pL10, DOI 10.1016/j.bpj.2012.05.028; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; JOANNY JF, 1979, J POLYM SCI POL PHYS, V17, P1073, DOI 10.1002/pol.1979.180170615; Keating E, 2012, BBA-BIOMEMBRANES, V1818, P1225, DOI 10.1016/j.bbamem.2011.12.007; Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32; Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687; Lopez-Rodriguez E, 2012, BIOPHYS J, V103, P1451, DOI 10.1016/j.bpj.2012.08.024; Lopez-Rodriguez E, 2011, BIOPHYS J, V100, P646, DOI 10.1016/j.bpj.2010.12.3715; Lu KW, 2009, BBA-BIOMEMBRANES, V1788, P632, DOI 10.1016/j.bbamem.2009.01.005; Lu KW, 2005, PEDIATR RES, V57, P237, DOI 10.1203/01.PDR.0000150726.75308.22; Matar OK, 2002, J FLUID MECH, V466, P85, DOI 10.1017/S0022112002001106; NETTELBLADT O, 1989, AM J PHYSIOL, V257, pL379, DOI 10.1152/ajplung.1989.257.6.L379; Parra E, 2013, BIOPHYS J, V104, P146, DOI 10.1016/j.bpj.2012.11.014; Parra E, 2011, BIOCHEM J, V438, P555, DOI 10.1042/BJ20110681; Perez-Gil J, 1998, BBA-MOL BASIS DIS, V1408, P203, DOI 10.1016/S0925-4439(98)00068-4; Perkins WR, 1996, SCIENCE, V273, P330, DOI 10.1126/science.273.5273.330; Possmayer F, 2010, RESP PHYSIOL NEUROBI, V173, pS55, DOI 10.1016/j.resp.2010.02.014; Pott T, 2008, CHEM PHYS LIPIDS, V154, P115, DOI 10.1016/j.chemphyslip.2008.03.008; Reviakine I, 2011, ANAL CHEM, V83, P8838, DOI 10.1021/ac201778h; Richter RP, 2007, J AM CHEM SOC, V129, P5306, DOI 10.1021/ja068768s; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Rubinstein M, 2008, POLYM PHYS; SAHU SC, 1980, INFLAMMATION, V4, P107, DOI 10.1007/BF00914107; SCHOEL WM, 1994, BBA-GEN SUBJECTS, V1200, P281, DOI 10.1016/0304-4165(94)90169-4; Schurch S, 1998, BBA-MOL BASIS DIS, V1408, P180, DOI 10.1016/S0925-4439(98)00067-2; Shieh IC, 2012, BIOPHYS J, V102, P777, DOI 10.1016/j.bpj.2012.01.014; Spragg RG, 2011, AM J RESP CRIT CARE, V183, P1055, DOI 10.1164/rccm.201009-1424OC; Stenger PC, 2009, BBA-BIOMEMBRANES, V1788, P1033, DOI 10.1016/j.bbamem.2009.01.006; Strobl G., 2007, PHYS POLYM CONCEPTS; Taeusch HW, 2008, COLLOID SURFACE B, V62, P243, DOI 10.1016/j.colsurfb.2007.10.009; Taeusch HW, 2005, BIOPHYS J, V89, P1769, DOI 10.1529/biophysj.105.062620; Turino GM, 2003, AM J RESP CRIT CARE, V167, P1169, DOI 10.1164/rccm.200205-449PP; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Wolny PM, 2010, LANGMUIR, V26, P1029, DOI 10.1021/la902226b; Zasadzinski JA, 2005, BIOPHYS J, V89, P1621, DOI 10.1529/biophysj.105.062646; Zasadzinski JA, 2010, BBA-BIOMEMBRANES, V1798, P801, DOI 10.1016/j.bbamem.2009.12.010	57	16	17	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29872	29881		10.1074/jbc.M113.493957	http://dx.doi.org/10.1074/jbc.M113.493957			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23983120	hybrid, Green Published			2022-12-28	WOS:000330615300060
J	Hayes, RP; Lewis, KM; Xun, LY; Kang, C				Hayes, Robert P.; Lewis, Kevin M.; Xun, Luying; Kang, ChulHee			Catalytic Mechanism of 5-Chlorohydroxyhydroquinone Dehydrochlorinase from the YCII Superfamily of Largely Unknown Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biodegradation; Enzyme Catalysis; Enzyme Mechanisms; Isothermal Titration Calorimetry; X-ray Crystallography; YCII Superfamily; Chlorophenol; Dehydrochlorinase	CHLOROPHENOL 4-MONOOXYGENASE TFTD; CRYSTAL-STRUCTURE; OXIDOREDUCTASE TFTC; NDDO APPROXIMATIONS; ATOMIC CHARGES; OPTIMIZATION; PARAMETERS; FOLD	TftG, 5-chloro-2-hydroxyhydroquinone (5-CHQ) dehydrochlorinase, is involved in the biodegradation of 2,4,5-trichlorophenoxyacetate by Burkholderia phenoliruptrix AC1100. It belongs to the YCII superfamily, a group of proteins with largely unknown function. In this work, we utilized structural and functional studies, including the apo-form and 2,5-dihydroxybenzoquinone binary complex crystal structures, computational analysis, and site-directed mutagenesis, to determine the dehydrochlorination mechanism. The His-Asp dyad, which initiates catalysis, is strongly conserved in YCII-like proteins. In addition, other catalytically important residues such as Pro-76, which orients the His-Asp catalytic dyad; Arg-17 and Ser-56, which form an oxyanion hole; and Asp-9, which stabilizes the oxyanion hole, are among the most highly conserved residues across the YCII superfamily members. The comprehensive characterization of TftG helps not only for identifying effective mechanisms for chloroaromatic dechlorination but also for understanding the functions of YCII superfamily members, which we propose to be lyases.	[Hayes, Robert P.; Lewis, Kevin M.; Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99164 USA; [Xun, Luying] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University; Washington State University	Xun, LY (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	luying_xun@vetmed.wsu.edu; chkang@wsu.edu		Lewis, Kevin/0000-0003-3403-9520; Hayes, Robert/0000-0003-4947-4410	National Science Foundation [MCB 1021148, DBI 0959778]; M. J. Murdock Charitable Trust	National Science Foundation(National Science Foundation (NSF)); M. J. Murdock Charitable Trust	This work was supported by the National Science Foundation (MCB 1021148 and DBI 0959778) and the M. J. Murdock Charitable Trust.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BESLER BH, 1990, J COMPUT CHEM, V11, P431, DOI 10.1002/jcc.540110404; Burger SK, 2012, J CHEM THEORY COMPUT, V8, P554, DOI 10.1021/ct2007742; Case DA, 2012, AMBER 12; Czaplicka M, 2004, SCI TOTAL ENVIRON, V322, P21, DOI 10.1016/j.scitotenv.2003.09.015; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; Daubaras DL, 1996, GENE, V179, P1, DOI 10.1016/S0378-1119(96)00326-5; Frisch M, 2004, GAUSSVIEW VERSION 3; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gisi MR, 2003, J BACTERIOL, V185, P2786, DOI 10.1128/JB.185.9.2786-2792.2003; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KATTI SK, 1989, J MOL BIOL, V205, P557, DOI 10.1016/0022-2836(89)90226-X; KINTZ P, 1992, ARCH TOXICOL, V66, P298, DOI 10.1007/BF02307178; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Leonard PM, 2001, EMBO J, V20, P990, DOI 10.1093/emboj/20.5.990; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Nagata Y, 2001, PROTEINS, V45, P471, DOI 10.1002/prot.10007; Okai M, 2010, J MOL BIOL, V403, P260, DOI 10.1016/j.jmb.2010.08.043; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peterson KA, 2002, J CHEM PHYS, V117, P10548, DOI 10.1063/1.1520138; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Roth C, 2013, MOL MICROBIOL, V88, P254, DOI 10.1111/mmi.12182; SANGODKAR UMX, 1988, GENE, V71, P267, DOI 10.1016/0378-1119(88)90043-1; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Stewart J. J. P., 2012, MOPAC2012 STEWART CO; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Stewart JJP, 2013, J MOL MODEL, V19, P1, DOI 10.1007/s00894-012-1667-x; Stewart JJP, 2009, J MOL MODEL, V15, P765, DOI 10.1007/s00894-008-0420-y; Tao P, 2010, J COMPUT CHEM, V31, P2363, DOI 10.1002/jcc.21524; U.S. Environmental Protection Agency, 1999, INT RISK INF SYST IR; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135; Willis MA, 2005, PROTEINS, V59, P648, DOI 10.1002/prot.20411; XUN LY, 1995, APPL ENVIRON MICROB, V61, P3499, DOI 10.1128/AEM.61.9.3499-3502.1995; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011; Youn BY, 2005, J BIOL CHEM, V280, P12917, DOI 10.1074/jbc.M413266200; Zaborina O, 1998, J BACTERIOL, V180, P4667, DOI 10.1128/JB.180.17.4667-4675.1998	39	3	3	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28447	28456		10.1074/jbc.M113.499368	http://dx.doi.org/10.1074/jbc.M113.499368			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23955343	hybrid, Green Published			2022-12-28	WOS:000330298800003
J	Park, BH; Kook, S; Lee, S; Jeong, JH; Brufsky, A; Lee, BC				Park, Bae-Hang; Kook, Sungho; Lee, SeanBong; Jeong, Jong-Hyeon; Brufsky, Adam; Lee, Byeong-Chel			An Isoform of C/EBP beta, LIP, Regulates Expression of the Chemokine Receptor CXCR4 and Modulates Breast Cancer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; C; EBP Transcription Factor; Chemotaxis; Cxcr4; Metastasis	TRANSCRIPTION FACTOR; MAMMARY-GLAND; UP-REGULATION; METASTASIS; PROLIFERATION; INVASION; GROWTH; BONE; DIFFERENTIATION; INVOLVEMENT	Metastasis is the primary cause of death in cancer patients. CXCR4/CXCL12 chemokine axis provides directional cues for breast cancer cells to metastasize to specific organs. Despite their potential clinical importance, how CXCR4 expression in breast cancer cells is regulated at the molecular level is not well understood. We identified an isoform of C/EBP, liver-enriched inhibitory protein (LIP), as a previously unrecognized transcriptional regulator of CXCR4 in breast cancer cells. LIP up-regulated the transcription of CXCR4 through direct interaction with the CXCR4 promoter. The increase in CXCR4 mRNA was paralleled by an increased cell surface expression of the CXCR4, which in turn promoted CXCR4-mediated breast cancer cell migration. A significant positive correlation between LIP and CXCR4 expression was observed in stage III and IV human breast carcinoma specimens. Neuregulin 1 (or NRG1, hereafter referred to as heregulin) increased CXCR4 expression in breast cancer cells, and this coincided with increased LIP binding on the CXCR4 promoter. These findings may have important implications for understanding the molecular basis of CXCR4-mediated breast cancer cell metastasis and could potentially allow us to develop novel strategies to reduce morbidity and mortality in patients with metastatic breast cancer.	[Park, Bae-Hang; Kook, Sungho; Brufsky, Adam; Lee, Byeong-Chel] Univ Pittsburgh, Div Hematol & Oncol, Dept Med, Canc Inst,Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Kook, Sungho] Chonbuk Natl Univ, Inst Oral Biosci, Jeonju 561756, South Korea; [Kook, Sungho] Chonbuk Natl Univ, Sch Dent, Jeonju 561756, South Korea; [Lee, SeanBong] Tulane Univ, Sch Med, Dept Pathol & Lab Med, New Orleans, LA 70112 USA; [Jeong, Jong-Hyeon] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jeonbuk National University; Jeonbuk National University; Tulane University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, BC (corresponding author), Hillman Canc Ctr, 2-32d,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	leeb4@upmc.edu	Brufsky, Adam/AAE-7470-2020	Jeong, Jong/0000-0003-0596-2201; Brufsky, Adam/0000-0001-8080-7960; Lee, Sean/0000-0001-6211-3498	National Institutes of Health [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project used the UPCI flow cytometry and animal facility, which was supported in part by the P30CA047904 award from the National Institutes of Health.	Arnal-Estape A, 2010, CANCER RES, V70, P9927, DOI 10.1158/0008-5472.CAN-10-0869; Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004; Carlisle AJ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-126; Chen YC, 2003, CANCER RES, V63, P4801; Cheng LS, 2009, CANCER LETT, V280, P50, DOI 10.1016/j.canlet.2009.02.007; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Dimitrov DS, 1997, CELL, V91, P721, DOI 10.1016/S0092-8674(00)80460-2; Fitzpatrick VD, 1998, FEBS LETT, V431, P102, DOI 10.1016/S0014-5793(98)00737-6; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Hutcheson IR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1754; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kato M, 2003, BREAST CANCER RES, V5, pR144, DOI 10.1186/bcr627; Kominsky SL, 2006, J CLIN ONCOL, V24, P2227, DOI 10.1200/JCO.2005.05.5319; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Lee BC, 2004, MOL CANCER RES, V2, P327; Lee BC, 2005, CANCER RES, V65, P2840, DOI 10.1158/0008-5472.CAN-04-3309; Li HL, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-100; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Mazumdar A, 2001, CANCER RES, V61, P400; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moriuchi M, 1999, J IMMUNOL, V162, P5986; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Tang XY, 2011, J BIOL CHEM, V286, P13244, DOI 10.1074/jbc.M110.206615; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Vaday GG, 2004, CLIN CANCER RES, V10, P5630, DOI 10.1158/1078-0432.CCR-03-0633; Wethmar K, 2010, BIOESSAYS, V32, P885, DOI 10.1002/bies.201000037; Zahnow CA, 2002, BREAST CANCER RES, V4, P109, DOI 10.1186/bcr428; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zahnow CA, 2001, CANCER RES, V61, P261	38	19	20	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28656	28667		10.1074/jbc.M113.509505	http://dx.doi.org/10.1074/jbc.M113.509505			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23966000	Green Published, hybrid			2022-12-28	WOS:000330298800021
J	Abe, A; Takahashi-Niki, K; Takekoshi, Y; Shimizu, T; Kitaura, H; Maita, H; Iguchi-Ariga, SMM; Ariga, H				Abe, Akira; Takahashi-Niki, Kazuko; Takekoshi, Yuka; Shimizu, Takashi; Kitaura, Hirotake; Maita, Hiroshi; Iguchi-Ariga, Sanae M. M.; Ariga, Hiroyoshi			Prefoldin Plays a Role as a Clearance Factor in Preventing Proteasome Inhibitor-induced Protein Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE PREFOLDIN; MYC-BINDING PROTEIN; C-MYC; UNFOLDED PROTEINS; TUMOR-SUPPRESSOR; COMPLEX; GENE; MM-1; SYSTEM; CELLS	Prefoldin is a molecular chaperone composed of six subunits, PFD1-6, and prevents misfolding of newly synthesized nascent polypeptides. Although it is predicted that prefoldin, like other chaperones, modulates protein aggregation, the precise function of prefoldin against protein aggregation under physiological conditions has never been elucidated. In this study, we first established an anti-prefoldin monoclonal antibody that recognizes the prefoldin complex but not its subunits. Using this antibody, it was found that prefoldin was localized in the cytoplasm with dots in co-localization with polyubiquitinated proteins and that the number and strength of dots were increased in cells that had been treated with lactacystin, a proteasome inhibitor, and thapsigargin, an inducer of endoplasmic reticulum stress. Knockdown of prefoldin increased the level of SDS-insoluble ubiquitinated protein and reduced cell viability in lactacystin and thapsigargin-treated cells. Opposite results were obtained in prefoldin-overexpressed cells. It has been reported that mice harboring a missense mutation L110R of MM-1 alpha/PFD5 exhibit neurodegeneration in the cerebellum. Although the prefoldin complex containing L110R MM-1 alpha was properly formed in vitro and in cells derived from L110R MM-1 alpha mice, the levels of ubiquitinated proteins and cytotoxicity were higher in L110R MM-1 alpha cells than in wild-type cells under normal conditions and were increased by lactacystin and thapsigargin treatment, and growth of L110R MM-1 alpha cells was attenuated. Furthermore, the polyubiquitinated protein aggregation level was increased in the brains of L110R MM-1 alpha mice. These results suggest that prefoldin plays a role in quality control against protein aggregation and that dysfunction of prefoldin is one of the causes of neurodegenerative diseases.	[Abe, Akira; Takahashi-Niki, Kazuko; Takekoshi, Yuka; Shimizu, Takashi; Kitaura, Hirotake; Maita, Hiroshi; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University	Ariga, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	hiro@pharm.hokudai.ac.jp	Maita, Hiroshi/D-5495-2012		Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology.	ARIGA H, 1983, J VIROL, V48, P481, DOI 10.1128/JVI.48.2.481-491.1983; Cao S, 2008, J IMMUNOL, V181, P476, DOI 10.4049/jimmunol.181.1.476; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Fujioka Y, 2001, J BIOL CHEM, V276, P45137, DOI 10.1074/jbc.M106127200; Geissler S, 1998, EMBO J, V17, P952, DOI 10.1093/emboj/17.4.952; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee Y, 2011, J BIOL CHEM, V286, P726, DOI 10.1074/jbc.M110.177352; Martin-Benito J, 2007, STRUCTURE, V15, P101, DOI 10.1016/j.str.2006.11.006; Miyazawa M, 2011, J BIOL CHEM, V286, P19191, DOI 10.1074/jbc.M110.216259; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Mousnier A, 2007, P NATL ACAD SCI USA, V104, P13615, DOI 10.1073/pnas.0705162104; Sakono M, 2008, FEBS J, V275, P5982, DOI 10.1111/j.1742-4658.2008.06727.x; Satou A, 2004, FEBS LETT, V572, P211, DOI 10.1016/j.febslet.2004.07.034; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Simons CT, 2004, J BIOL CHEM, V279, P4196, DOI 10.1074/jbc.M306053200; Soergjerd KM, 2013, BIOCHEMISTRY-US, V52, P3532, DOI 10.1021/bi301705c; Tashiro E, 2013, J BIOL CHEM, V288, P19958, DOI 10.1074/jbc.M113.477984; Terada K, 2005, EMBO J, V24, P611, DOI 10.1038/sj.emboj.7600549; Tsuchiya H, 1996, CANCER RES, V56, P2881; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002	26	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27764	27776		10.1074/jbc.M113.476358	http://dx.doi.org/10.1074/jbc.M113.476358			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23946485	hybrid, Green Published			2022-12-28	WOS:000330612800006
J	Khan, S; Fung, KW; Rodriguez, E; Patel, R; Gor, J; Mulloy, B; Perkins, SJ				Khan, Sanaullah; Fung, Ka Wai; Rodriguez, Elizabeth; Patel, Rima; Gor, Jayesh; Mulloy, Barbara; Perkins, Stephen J.			The Solution Structure of Heparan Sulfate Differs from That of Heparin IMPLICATIONS FOR FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; NEUTRON-SCATTERING; SEDIMENTATION-VELOCITY; SOLUTION CONFORMATION; PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; AQUEOUS-SOLUTION; PROTEOGLYCANS; BINDING; DOMAINS	The highly sulfated polysaccharides heparin and heparan sulfate (HS) play key roles in the regulation of physiological and pathophysiological processes. Despite its importance, no molecular structures of free HS have been reported up to now. By combining analytical ultracentrifugation, small angle x-ray scattering, and constrained scattering modeling recently used for heparin, we have analyzed the solution structures for eight purified HS fragments dp6-dp24 corresponding to the predominantly unsulfated GlcA-GlcNAc domains of heparan sulfate. Unlike heparin, the sedimentation coefficient s(20,w) of HS dp6-dp24 showed a small rotor speed dependence, where similar s(20,w) values of 0.82-1.26 S (absorbance optics) and 1.05-1.34 S (interference optics) were determined. The corresponding x-ray scattering measurements of HS dp6-dp24 gave radii of gyration R-G values from 1.03 to 2.82 nm, cross-sectional radii of gyration R-XS values from 0.31 to 0.65 nm, and maximum lengths L from 3.0 to 10.0 nm. These data showed that HS has a longer and more bent structure than heparin. Constrained scattering modeling starting from 5,000 to 12,000 conformationally randomized HS structures gave best fit dp6-dp24 molecular structures that were longer and more bent than their equivalents in heparin. Alternative fits were obtained for HS dp18 and dp24, indicating their higher bending and flexibility. We conclude that HS displays bent conformations that are significantly distinct from that for heparin. The difference is attributed to the different predominant monosaccharide sequence and reduced sulfation of HS, indicating that HS may interact differently with proteins compared with heparin.	[Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, Div Biosci, London WC1E 6BT, England; [Mulloy, Barbara] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosciences Lab, London W12 0NN, England	University of London; University College London; Imperial College London	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@ucl.ac.uk	KHAN, SANAULLAH/A-8386-2015	KHAN, SANAULLAH/0000-0003-2480-6239	Higher Education Commission of Pakistan; Biotechnology and Biological Sciences Research Council; Henry Smith Charity; Mercer Fund of the Fight for Sight Charity; BBSRC [BB/E013104/1] Funding Source: UKRI; EPSRC [EP/K039121/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013104/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K039121/1] Funding Source: researchfish; Medical Research Council [1076433] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA006973, T32CA009071] Funding Source: NIH RePORTER	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Henry Smith Charity; Mercer Fund of the Fight for Sight Charity; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Higher Education Commission of Pakistan, the Biotechnology and Biological Sciences Research Council, the Henry Smith Charity, and the Mercer Fund of the Fight for Sight Charity.	Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bonner A, 2009, MUCOSAL IMMUNOL, V2, P74, DOI 10.1038/mi.2008.68; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CASU B, 1983, ARZNEIMITTELFORSCH, V33-1, P135; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Conrad H. E., 1998, HEPARIN BINDING PROT; Coombe DR, 2005, CELL MOL LIFE SCI, V62, P410, DOI 10.1007/s00018-004-4293-7; Dam J, 2004, METHOD ENZYMOL, V384, P185; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; FUJIWARA S, 1984, EUR J BIOCHEM, V143, P145, DOI 10.1111/j.1432-1033.1984.tb08353.x; Furtado PB, 2008, J MOL BIOL, V375, P102, DOI 10.1016/j.jmb.2007.09.085; Gallagher J T, 2012, Handb Exp Pharmacol, P347, DOI 10.1007/978-3-642-23056-1_15; GALLAGHER JT, 1992, ADV EXP MED BIOL, V313, P49; Gilbert HE, 2006, J MOL BIOL, V362, P1132, DOI 10.1016/j.jmb.2006.08.012; Glatter O., 1982, SMALL ANGLE XRAY SCA; Hricovini M, 1997, CARBOHYD RES, V300, P69, DOI 10.1016/S0008-6215(97)00036-0; Khan S, 2012, BIOCHEM J, V444, P417, DOI 10.1042/BJ20120183; Khan S, 2011, J BIOL CHEM, V286, P24842, DOI 10.1074/jbc.M111.226027; Khan S, 2010, J MOL BIOL, V395, P504, DOI 10.1016/j.jmb.2009.10.064; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE DL, 1989, HEPARIN CHEM BIOL PR; Liu DF, 2002, P NATL ACAD SCI USA, V99, P568, DOI 10.1073/pnas.012578299; Lutteke T, 2009, ACTA CRYSTALLOGR D, V65, P156, DOI 10.1107/S0907444909001905; Lutteke T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-69; Lyon M, 1998, MATRIX BIOL, V17, P485, DOI 10.1016/S0945-053X(98)90096-8; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Mobli M, 2008, GLYCOCONJUGATE J, V25, P401, DOI 10.1007/s10719-007-9081-9; MULLOY B, 1994, CARBOHYD RES, V255, P1, DOI 10.1016/S0008-6215(00)90968-6; Mulloy B, 1997, THROMB HAEMOSTASIS, V77, P668; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; Pavlov G, 2003, EUR BIOPHYS J BIOPHY, V32, P437, DOI 10.1007/s00249-003-0316-9; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Perkins SJ, 1998, INT J BIOL MACROMOL, V22, P1, DOI 10.1016/S0141-8130(97)00088-3; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; PERKINS SJ, 1983, J MOL BIOL, V168, P847, DOI 10.1016/S0022-2836(83)80078-3; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Petitou M, 1999, NATURE, V398, P417, DOI 10.1038/18877; Powell AK, 2010, NAT PROTOC, V5, P821, DOI 10.1038/nprot.2010.17; RICE KG, 1985, ANAL BIOCHEM, V150, P325, DOI 10.1016/0003-2697(85)90518-4; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Sasisekharan R, 1997, Angiogenesis, V1, P45, DOI 10.1023/A:1018318914258; Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shaya D, 2010, J BIOL CHEM, V285, P20051, DOI 10.1074/jbc.M110.101071; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; STEVENS ES, 1989, J AM CHEM SOC, V111, P4149, DOI 10.1021/ja00194a001; Stringer SE, 1997, J BIOL CHEM, V272, P20508, DOI 10.1074/jbc.272.33.20508; Stringer SE, 2002, BLOOD, V100, P1543, DOI 10.1182/blood.V100.5.1543.h81702001543_1543_1550; Vives RR, 2001, BIOCHEM J, V354, P141, DOI 10.1042/0264-6021:3540141	59	29	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27737	27751		10.1074/jbc.M113.492223	http://dx.doi.org/10.1074/jbc.M113.492223			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23921391	hybrid, Green Published			2022-12-28	WOS:000330612800004
J	Kumar, GS; Zettl, H; Page, R; Peti, W				Kumar, Ganesan Senthil; Zettl, Heiko; Page, Rebecca; Peti, Wolfgang			Structural Basis for the Regulation of the Mitogen-activated Protein (MAP) Kinase p38 alpha by the Dual Specificity Phosphatase 16 MAP Kinase Binding Domain in Solution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC TYROSINE PHOSPHATASE; SMALL-ANGLE SCATTERING; DOCKING INTERACTIONS; CRYSTAL-STRUCTURE; THERAPEUTIC TARGETS; ERK2; P38; COMPLEX; SUBSTRATE; ARTHRITIS	Mitogen-activated protein kinases (MAPKs) fulfill essential biological functions and are key pharmaceutical targets. Regulation of MAPKs is achieved via a plethora of regulatory proteins including activating MAPKKs and an abundance of deactivating phosphatases. Although all regulatory proteins use an identical interaction site on MAPKs, the common docking and hydrophobic pocket, they use distinct kinase interaction motif (KIM or D-motif) sequences that are present in linear, peptide-like, or well folded protein domains. It has been recently shown that a KIM-containing MAPK-specific dual specificity phosphatase DUSP10 uses a unique binding mode to interact with p38 alpha. Here we describe the interaction of the MAPK binding domain of DUSP16 with p38 alpha and show that despite belonging to the same dual specificity phosphatase (DUSP) family, its interaction mode differs from that of DUSP10. Indeed, the DUSP16 MAPK binding domain uses an additional helix, alpha-helix 4, to further engage p38 alpha. This leads to an additional interaction surface on p38 alpha. Together, these structural and energetic differences in p38 alpha engagement highlight the fine-tuning necessary to achieve MAPK specificity and regulation among multiple regulatory proteins.	[Kumar, Ganesan Senthil; Zettl, Heiko; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Peti, Wolfgang] Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Peti, W (corresponding author), Brown Univ, Box GE-3, Providence, RI 02903 USA.	wolfgang_peti@brown.edu	Peti, Wolfgang/L-3492-2014		United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100910, R01GM098482] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. D. Francis for help at different points in the project and Drs. L. Yang and M. Allaire (NSLS) for support at NSLS beamline X9. Use of NSLS at Brookhaven National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract Number DE-AC02-98CH10886. 800-MHz NMR data were recorded at Brandeis University (National Institutes of Health S10-RR017269). This research is based in part on data obtained at the Brown University Structural Biology Core Facility, which is supported by the Division of Biology and Medicine, Brown University.	Akella R, 2010, STRUCTURE, V18, P1571, DOI 10.1016/j.str.2010.09.015; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cohen S, 2010, CURR OPIN RHEUMATOL, V22, P330, DOI 10.1097/BOR.0b013e3283378e6f; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Farooq A, 2001, MOL CELL, V7, P387, DOI 10.1016/S1097-2765(01)00186-1; Francis DM, 2011, NAT CHEM BIOL, V7, P916, DOI [10.1038/NCHEMBIO.707, 10.1038/nchembio.707]; Francis DM, 2011, J AM CHEM SOC, V133, P17138, DOI 10.1021/ja2075136; Francis DM, 2013, STRUCTURE, V21, P1612, DOI 10.1016/j.str.2013.07.003; Garai A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003004; Goddard T. D., 2006, SPARKY 3; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Goldsmith Elizabeth J, 2004, Methods Mol Biol, V250, P127; Honndorf VS, 2008, ANGEW CHEM INT EDIT, V47, P3548, DOI 10.1002/anie.200705614; Honndorf VS, 2012, ANGEW CHEM INT EDIT, V51, P2359, DOI 10.1002/anie.201105241; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lawan A, 2013, CELL MOL LIFE SCI, V70, P223, DOI 10.1007/s00018-012-1041-2; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; Mace PD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2687; Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Piserchio A, 2012, BIOCHEMISTRY-US, V51, P8047, DOI 10.1021/bi3012725; Piserchio A, 2011, BIOCHEMISTRY-US, V50, P3660, DOI 10.1021/bi2000559; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tao X, 2007, PROTEIN SCI, V16, P880, DOI 10.1110/ps.062712807; Tarrega C, 2002, J BIOL CHEM, V277, P2629, DOI 10.1074/jbc.M108874200; ter Haar E, 2007, J BIOL CHEM, V282, P9733, DOI 10.1074/jbc.M611165200; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; Vogtherr M, 2005, J BIOMOL NMR, V32, P175, DOI 10.1007/s10858-005-2449-x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang G, 2012, PROG NEUROBIOL, V98, P207, DOI 10.1016/j.pneurobio.2012.06.003; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; White A, 2007, P NATL ACAD SCI USA, V104, P6353, DOI 10.1073/pnas.0701679104; Zhang YY, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002241; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	46	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28347	28356		10.1074/jbc.M113.499178	http://dx.doi.org/10.1074/jbc.M113.499178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23926106	hybrid, Green Published			2022-12-28	WOS:000330612800063
J	Maitra, M; Dey, M; Yuan, WC; Nathanielsz, PW; Garcia, CK				Maitra, Meenakshi; Dey, Moushumi; Yuan, Wen-Cheng; Nathanielsz, Peter W.; Garcia, Christine Kim			Lung Fibrosis-associated Surfactant Protein A1 and C Variants Induce Latent Transforming Growth Factor beta 1 Secretion in Lung Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; IDIOPATHIC PULMONARY-FIBROSIS; BRICHOS MUTANTS; DISEASE; GENE; MUTATION; EXPRESSION; APOPTOSIS; SUSCEPTIBILITY; MECHANISMS	Missense mutations of surfactant proteins are recognized as important causes of inherited lung fibrosis. Here, we study rare and common surfactant protein (SP)-A1 and SP-C variants, either discovered in our familial pulmonary fibrosis cohort or described by others. We show that expression of two SP-A1 (R219W and R242*) and three SP-C (I73T, M71V, and L188Q) variant proteins lead to the secretion of the profibrotic latent transforming growth factor (TGF)-beta 1 in lung epithelial cell lines. The secreted TGF-beta 1 is capable of autocrine and paracrine signaling and is dependent upon expression of the latent TGF-beta 1 binding proteins. The dependence upon unfolded protein response (UPR) mediators for TGF-beta 1 induction differs for each variant. TGF-beta 1 secretion induced by the expression of the common SP-A1 R219W variant is nearly completely blocked by silencing the UPR transducers IRE-1 beta and ATF6. In contrast, the secretion of TGF-beta 1 induced by two rare SP-C mutant proteins (I73T and M71V), is largely unaffected by UPR silencing or by the addition of the small molecular chaperone 4-phenylbutyric acid, implicating a UPR-independent mechanism for these variants. Blocking TGF-beta 1 secretion reverses cell death of RLE-6TN cells expressing these SP-A1 and SP-C variants suggesting that anti-TGF-beta therapeutics may be beneficial to this molecularly defined subgroup of pulmonary fibrosis patients.	[Maitra, Meenakshi; Dey, Moushumi; Yuan, Wen-Cheng; Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Nathanielsz, Peter W.] Univ Texas Hlth Sci Ctr San Antonio, Ctr Pregnancy & Newborn Res, San Antonio, TX 78229 USA; [Garcia, Christine Kim] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Pulm & Crit Care Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garcia, CK (corresponding author), Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	christine.garcia@utsouthwestern.edu		Nathanielsz, Peter/0000-0001-8410-6280	National Institutes of Health [R01 HL093096, P01 HD21350]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD021350] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093096] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01 HL093096 (to C. K. G.) and P01 HD21350 (to P. W. N.).	Azad AK, 2013, GENES IMMUN, V14, P99, DOI 10.1038/gene.2012.61; Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Beers MF, 2011, TRAFFIC, V12, P1196, DOI 10.1111/j.1600-0854.2011.01223.x; Bridges JP, 2006, J CELL BIOL, V172, P395, DOI 10.1083/jcb.200508016; Bridges JP, 2003, J BIOL CHEM, V278, P52739, DOI 10.1074/jbc.M309599200; Cameron HS, 2005, J PEDIATR-US, V146, P370, DOI 10.1016/j.jpeds.2004.10.028; Deutsch GH, 2007, AM J RESP CRIT CARE, V176, P1120, DOI 10.1164/rccm.200703-393OC; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Guillot L, 2009, J MED GENET, V46, P490, DOI 10.1136/jmg.2009.066829; HAAGSMAN HP, 1989, AM J PHYSIOL, V257, pL421, DOI 10.1152/ajplung.1989.257.6.L421; KIM SJ, 1989, J BIOL CHEM, V264, P7041; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Maguire JA, 2012, INT J BIOCHEM CELL B, V44, P101, DOI 10.1016/j.biocel.2011.10.003; Maguire JA, 2011, AM J RESP CELL MOL, V44, P404, DOI 10.1165/rcmb.2009-0382OC; Maitra M, 2012, P NATL ACAD SCI USA, V109, P21064, DOI 10.1073/pnas.1217069110; Maitra M, 2010, J BIOL CHEM, V285, P22103, DOI 10.1074/jbc.M110.121467; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Mulugeta S, 2007, AM J PHYSIOL-LUNG C, V293, pL720, DOI 10.1152/ajplung.00025.2007; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Oida T, 2010, J IMMUNOL, V185, P3529, DOI 10.4049/jimmunol.0904121; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Roberson EC, 2012, AM J RESP CELL MOL, V46, P573, DOI 10.1165/rcmb.2010-0460OC; Schlabritz-Loutsevitch NE, 2004, J MED PRIMATOL, V33, P152, DOI 10.1111/j.1600-0684.2004.00066.x; Schlabritz-Loutsevitch NE, 2004, J MED PRIMATOL, V33, P117, DOI 10.1111/j.1600-0684.2004.00067.x; Selman M, 2003, HUM GENET, V113, P542, DOI 10.1007/s00439-003-1015-4; Silveyra P, 2012, FRONT BIOSCI-LANDMRK, V17, P407, DOI 10.2741/3935; Song Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046559; Tanjore H, 2011, J BIOL CHEM, V286, P30972, DOI 10.1074/jbc.M110.181164; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; van Moorsel CHM, 2010, AM J RESP CRIT CARE, V182, P1419, DOI 10.1164/rccm.200906-0953OC; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wang WJ, 2003, J CELL SCI, V116, P683, DOI 10.1242/jcs.00267; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Willander H, 2012, J BIOL CHEM, V287, P31608, DOI 10.1074/jbc.M112.393157; Willander H, 2012, P NATL ACAD SCI USA, V109, P2325, DOI 10.1073/pnas.1114740109; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Xing G, 2012, ANN HUM GENET, V76, P168, DOI 10.1111/j.1469-1809.2011.00700.x	41	8	8	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27159	27171		10.1074/jbc.M113.475335	http://dx.doi.org/10.1074/jbc.M113.475335			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23926107	Green Published, hybrid			2022-12-28	WOS:000330597300015
J	Tang, M; Shen, HX; Jin, Y; Lin, T; Cai, QS; Pinard, MA; Biswas, S; Tran, Q; Li, GY; Shenoy, AK; Tongdee, E; Lin, SB; Gu, YM; Law, BK; Zhou, L; Mckenna, R; Wu, LZ; Lu, JR				Tang, Ming; Shen, Huangxuan; Jin, Yue; Lin, Tong; Cai, Qingsong; Pinard, Melissa A.; Biswas, Shyamasri; Quyen Tran; Li, Guangyao; Shenoy, Anitha K.; Tongdee, Emily; Lin, Shuibin; Gu, Yumei; Law, Brian K.; Zhou, Lei; Mckenna, Robert; Wu, Lizi; Lu, Jianrong			The Malignant Brain Tumor (MBT) Domain Protein SFMBT1 Is an Integral Histone Reader Subunit of the LSD1 Demethylase Complex for Chromatin Association and Epithelial-to-mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; BREAST-CANCER; STEM-CELLS; DIFFERENTIATION; REPRESSION; SNAIL; TRANSCRIPTION; COREST; DISCOVERY; BINDING	Chromatin readers decipher the functional readouts of histone modifications by recruiting specific effector complexes for subsequent epigenetic reprogramming. The LSD1 (also known as KDM1A) histone demethylase complex modifies chromatin and represses transcription in part by catalyzing demethylation of dimethylated histone H3 lysine 4 (H3K4me2), a mark for active transcription. However, none of its currently known subunits recognizes methylated histones. The Snai1 family transcription factors are central drivers of epithelial-to-mesenchymal transition (EMT) by which epithelial cells acquire enhanced invasiveness. Snai1-mediated transcriptional repression of epithelial genes depends on its recruitment of the LSD1 complex and ensuing demethylation of H3K4me2 at its target genes. Through biochemical purification, we identified the MBT domain-containing protein SFMBT1 as a novel component of the LSD1 complex associated with Snai1. Unlike other mammalian MBT domain proteins characterized to date that selectively recognize mono- and dimethylated lysines, SFMBT1 binds di- and trimethyl H3K4, both of which are enriched at active promoters. We show that SFMBT1 is essential for Snai1-dependent recruitment of LSD1 to chromatin, demethylation of H3K4me2, transcriptional repression of epithelial markers, and induction of EMT by TGF beta. Carcinogenic metal nickel is a widespread environmental and occupational pollutant. Nickel alters gene expression and induces EMT. We demonstrate the nickel-initiated effects are dependent on LSD1-SFMBT1-mediated chromatin modification. Furthermore, in human cancer, expression of SFMBT1 is associated with mesenchymal markers and unfavorable prognosis. These results highlight a critical role of SFMBT1 in epigenetic regulation, EMT, and cancer.	[Tang, Ming; Jin, Yue; Lin, Tong; Cai, Qingsong; Pinard, Melissa A.; Biswas, Shyamasri; Shenoy, Anitha K.; Tongdee, Emily; Mckenna, Robert; Lu, Jianrong] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Hlth Canc Ctr, Gainesville, FL 32610 USA; [Shen, Huangxuan; Li, Guangyao; Lin, Shuibin; Gu, Yumei; Zhou, Lei; Wu, Lizi] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Hlth Canc Ctr, Gainesville, FL 32610 USA; [Law, Brian K.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Hlth Canc Ctr, Gainesville, FL 32610 USA; [Tang, Ming; Lin, Tong; Li, Guangyao; Zhou, Lei; Wu, Lizi; Lu, Jianrong] Univ Florida, Genet & Genom Grad Program, Genet Inst, Gainesville, FL 32610 USA; [Shen, Huangxuan] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Quyen Tran] Agnes Scott Coll, Decatur, GA 30030 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Sun Yat Sen University	Wu, LZ (corresponding author), Univ Florida, Genet & Genom Grad Program, Genet Inst, Gainesville, FL 32610 USA.	lzwu@ufl.edu; jrlu@ufl.edu	Li, Guangyao/I-8241-2015; Law, Brian/L-6043-2019; Lu, Jianrong/F-5240-2013	Li, Guangyao/0000-0003-0029-3854; Lu, Jianrong/0000-0002-4969-6040	National Institutes of Health [R01CA137021]; Florida Bankhead-Coley Cancer Research Program [09BN-12-23092, 2BT01]; NATIONAL CANCER INSTITUTE [R01CA137021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Bankhead-Coley Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA137021 (NCI; to J. L.). This work was also supported by the Florida Bankhead-Coley Cancer Research Program (09BN-12-23092 and 2BT01).	Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Batlle R, 2013, ONCOGENE, V32, P3381, DOI 10.1038/onc.2012.342; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chervona Y, 2012, FREE RADICAL BIO MED, V53, P1041, DOI 10.1016/j.freeradbiomed.2012.07.020; Cui SAY, 2011, MOL CELL BIOL, V31, P3298, DOI 10.1128/MCB.05310-11; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; de Frutos CA, 2009, EMBO J, V28, P686, DOI 10.1038/emboj.2009.23; Ding J, 2013, DIGEST DIS SCI, V58, P1581, DOI 10.1007/s10620-012-2552-2; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang Y, 2007, P NATL ACAD SCI USA, V104, P8023, DOI 10.1073/pnas.0700720104; James LI, 2013, NAT CHEM BIOL, V9, P184, DOI [10.1038/NCHEMBIO.1157, 10.1038/nchembio.1157]; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Koester-Eiserfunke N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002017; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lin SB, 2013, J BIOL CHEM, V288, P6238, DOI 10.1074/jbc.M112.429605; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; Mulligan P, 2011, MOL CELL, V42, P689, DOI 10.1016/j.molcel.2011.04.020; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Serce N, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-13; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Su ST, 2009, MOL CELL BIOL, V29, P1421, DOI 10.1128/MCB.01158-08; Sun GQ, 2010, MOL CELL BIOL, V30, P1997, DOI 10.1128/MCB.01116-09; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai WW, 2008, MOL CELL BIOL, V28, P5139, DOI 10.1128/MCB.00287-08; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wu CH, 2012, J BIOL CHEM, V287, P25292, DOI 10.1074/jbc.M111.291195; Wu SM, 2007, FEBS LETT, V581, P3289, DOI 10.1016/j.febslet.2007.06.025; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P16654, DOI 10.1073/pnas.1205822109; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zhang J, 2013, GENE DEV, V27, P749, DOI 10.1101/gad.210963.112; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	56	35	36	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27680	27691		10.1074/jbc.M113.482349	http://dx.doi.org/10.1074/jbc.M113.482349			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23928305	Green Published, hybrid			2022-12-28	WOS:000330597300061
J	Zhang, XJ; Zhao, QQ; Huang, Y				Zhang, Xiaojie; Zhao, Qiaoqiao; Huang, Ying			Partitioning of the Nuclear and Mitochondrial tRNA 3 '-End Processing Activities between Two different Proteins in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER SUSCEPTIBILITY GENE; SACCHAROMYCES-CEREVISIAE; LA PROTEIN; TRNASE-Z; MATURATION; TRANSCRIPTION; ELAC2; POLYMERASE; EXPRESSION; MUTATIONS	tRNase Z is an essential endonuclease responsible for tRNA 3 '-end maturation. tRNase Z exists in a short form (tRNase Z(S)) and a long form (tRNase Z(L)). Prokaryotes have only tRNase Z(S), whereas eukaryotes can have both forms of tRNase Z. Most eukaryotes characterized thus far, including Saccharomyces cerevisiae, Caenorhabditis elegans, Drosophila melanogaster, and humans, contain only one tRNase Z(L) gene encoding both nuclear and mitochondrial forms of tRNase Z(L). In contrast, Schizosaccharomyces pombe contains two essential tRNase Z(L) genes (trz1 and trz2) encoding two tRNase Z(L) proteins, which are targeted to the nucleus and mitochondria, respectively. Trz1 protein levels are notably higher than Trz2 protein levels. Here, using temperature-sensitive mutants of trz1 and trz2, we provide in vivo evidence that trz1 and trz2 are involved in nuclear and mitochondrial tRNA 3 '-end processing, respectively. In addition, trz2 is also involved in generation of the 5 '-ends of other mitochondrial RNAs, whose 5 '-ends coincide with the 3 '-end of tRNA. Thus, our results provide a rare example showing partitioning of the nuclear and mitochondrial tRNase Z(L) activities between two different proteins in S. pombe. The evolution of two tRNase Z(L) genes and their differential expression in fission yeast may avoid toxic off-target effects.	[Zhang, Xiaojie; Zhao, Qiaoqiao; Huang, Ying] Nanjing Normal Univ, Sch Life Sci, Jiangsu Key Lab Microbes & Genom, Nanjing 210023, Jiangsu, Peoples R China; [Zhang, Xiaojie] Bengbu Med Coll, Dept Lab Med, Bengbu 233030, Anhui, Peoples R China	Nanjing Normal University; Bengbu Medical College	Huang, Y (corresponding author), Nanjing Normal Univ, Sch Life Sci, Jiangsu Key Lab Microbes & Genom, 1 Wenyuan Rd, Nanjing 210023, Jiangsu, Peoples R China.	yhuang@njnu.edu.cn			National Science Foundation of China [2011104GZ30018, 2012104GZ30044]; Priority Academic Program Development of the Jiangsu Higher Education Institutions; Innovation Project for College Graduates of Jiangsu Province [CXZZ11_0886]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of the Jiangsu Higher Education Institutions; Innovation Project for College Graduates of Jiangsu Province	This work was supported by National Science Foundation of China Grants 2011104GZ30018 and 2012104GZ30044 and the Priority Academic Program Development of the Jiangsu Higher Education Institutions (to Y. H.) and by Innovation Project for College Graduates of Jiangsu Province Grant CXZZ11_0886 (to Y. H. and X. Z.). This work was performed in partial fulfillment of the Ph.D. requirements of Nanjing Normal University (for X. Z.).	Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Biswas TK, 1998, GENE, V212, P305, DOI 10.1016/S0378-1119(98)00133-4; Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393; Canino G, 2009, PLANT PHYSIOL, V150, P1494, DOI 10.1104/pp.109.137950; Ceballos M, 2007, PROTEIN PEPTIDE LETT, V14, P137, DOI 10.2174/092986607779816050; Copela LA, 2008, RNA, V14, P1214, DOI 10.1261/rna.1050408; COSTANZO MC, 1990, ANNU REV GENET, V24, P91; DIECKMANN CL, 1994, INT REV CYTOL, V152, P145, DOI 10.1016/S0074-7696(08)62556-5; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Fan LJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-219; Fekete Z, 2008, J BIOL CHEM, V283, P3767, DOI 10.1074/jbc.M709617200; Gan XH, 2011, BIOCHEM J, V435, P103, DOI 10.1042/BJ20101619; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Huang Y, 2005, MOL CELL BIOL, V25, P621, DOI 10.1128/MCB.25.2.621-636.2005; Huang Y, 2006, NAT STRUCT MOL BIOL, V13, P611, DOI 10.1038/nsmb1110; Intine RV, 2002, MOL CELL, V9, P1113, DOI 10.1016/S1097-2765(02)00533-6; Intine RVA, 2000, MOL CELL, V6, P339, DOI 10.1016/S1097-2765(00)00034-4; Irvine DV, 2009, GENOME RES, V19, P1077, DOI 10.1101/gr.089318.108; Jiang HY, 2011, NUCLEIC ACIDS RES, V39, P5119, DOI 10.1093/nar/gkr103; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Maraia RJ, 2011, WIRES RNA, V2, P362, DOI 10.1002/wrna.64; MORENO S, 1991, METHOD ENZYMOL, V194, P795; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Ozanick SG, 2009, NUCLEIC ACIDS RES, V37, P298, DOI 10.1093/nar/gkn925; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; Rossmanith W, 2012, BBA-GENE REGUL MECH, V1819, P1017, DOI 10.1016/j.bbagrm.2011.11.003; Rossmanith W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019152; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schafer B, 2005, GENE, V354, P80, DOI 10.1016/j.gene.2005.03.032; Schafer B, 2005, RNA, V11, P785, DOI 10.1261/rna.7252205; Smith MM, 2004, DEV BIOL, V266, P151, DOI 10.1016/j.ydbio.2003.10.016; Takahashi M, 2008, FEBS LETT, V582, P2532, DOI 10.1016/j.febslet.2008.06.020; Takaku H, 2004, NUCLEIC ACIDS RES, V32, P4429, DOI 10.1093/nar/gkh774; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; TZAGOLOFF A, 1986, ANNU REV BIOCHEM, V55, P249, DOI 10.1146/annurev.bi.55.070186.001341; Van Horn DJ, 1997, RNA, V3, P1434; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wang ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044264; Xie X, 2011, INSECT BIOCHEM MOLEC, V41, P167, DOI 10.1016/j.ibmb.2010.12.001; Yoo CJ, 1997, CELL, V89, P393, DOI 10.1016/S0092-8674(00)80220-2; Zhao W, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-272; Zhao Z, 2009, BIOCHEM J, V422, P483, DOI 10.1042/BJ20090743	47	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27415	27422		10.1074/jbc.M113.501569	http://dx.doi.org/10.1074/jbc.M113.501569			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23928301	hybrid, Green Published			2022-12-28	WOS:000330597300037
J	Bailey, CC; Kondur, HR; Huang, IC; Farzan, M				Bailey, Charles C.; Kondur, Hema R.; Huang, I-Chueh; Farzan, Michael			Interferon-induced Transmembrane Protein 3 Is a Type II Transmembrane Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Flow Cytometry; Interferon; Membrane Proteins; Microscopic Imaging; Virus Entry; Ifitm3	WEST NILE VIRUS; ANTIVIRAL ACTIVITY; S-PALMITOYLATION; IFITM3 RESTRICTS; INFLUENZA; ANTIBODY; SURFACE; AGGREGATION; RESISTANCE; INFECTION	The interferon-induced transmembrane (IFITM) proteins are a family of small membrane proteins that inhibit the cellular entry of several genera of viruses. These proteins had been predicted to adopt a two-pass, type III transmembrane topology with an intracellular loop, two transmembrane helices (TM1 and TM2), and extracellular N and C termini. Recent work, however, supports an intramembrane topology for the helices with cytosolic orientation of both termini. Here we determined the topology of murine Ifitm3. We found that the N terminus of Ifitm3 could be stained by antibodies at the cell surface but that this conformation was cell type-dependent and represented a minority of the total plasma membrane pool. In contrast, the C terminus was readily accessible to antibodies at the cell surface and extracellular C termini comprised most or all of those present at the plasma membrane. The addition of a C-terminal KDEL endoplasmic reticulum retention motif to Ifitm3 resulted in sequestration of Ifitm3 in the ER, demonstrating an ER-luminal orientation of the C terminus. C-terminal, but not N-terminal, epitope tags were also degraded within lysosomes, consistent with their luminal orientation. Furthermore, epitope-tagged Ifitm3 TM2 functioned as a signal anchor sequence when expressed in isolation. Collectively, our results demonstrate a type II transmembrane topology for Ifitm3 and will provide insight into its interaction with potential targets and cofactors.	[Bailey, Charles C.; Kondur, Hema R.; Farzan, Michael] Scripps Res Inst, Dept Infect Dis, Jupiter, FL 33458 USA; [Huang, I-Chueh] Univ Calif Riverside, Dept Cell Biol & Neurosci, Coll Nat & Agr Sci, Riverside, CA 92521 USA	Scripps Research Institute; University of California System; University of California Riverside	Bailey, CC (corresponding author), Scripps Res Inst, Dept Infect Dis, 130 Scripps Way, Jupiter, FL 33458 USA.	cbailey@scripps.edu		Farzan, Michael/0000-0002-2990-5319; Bailey, Charles/0000-0003-0200-3523	National Institutes of Health [U54 AI057159, 13, L40AI091009]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI093679, R01AI100953, U54AI057159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants U54 AI057159 (Project 13) (to M. F.) and L40AI091009 (National Institutes of Health Loan Repayment Program) (to C. C. B.).	Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Anafu AA, 2013, J BIOL CHEM, V288, P17261, DOI 10.1074/jbc.M112.438515; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; CHEN YX, 1984, J IMMUNOL, V133, P2496; Cho TJ, 2012, AM J HUM GENET, V91, P343, DOI 10.1016/j.ajhg.2012.06.005; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; EVANS SS, 1990, BLOOD, V76, P2583; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Hach JC, 2013, J VIROL, V87, P9923, DOI 10.1128/JVI.00621-13; Hanagata N, 2011, J BONE MINER METAB, V29, P279, DOI 10.1007/s00774-010-0221-0; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Mudhasani R, 2013, J VIROL, V87, P8451, DOI 10.1128/JVI.03382-12; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; SINGER SJ, 1990, ANNU REV CELL BIOL, V6, P247, DOI 10.1146/annurev.cb.06.110190.001335; TAKAHASHI S, 1990, J IMMUNOL, V145, P2207; TANG BL, 1992, J BIOL CHEM, V267, P7072; Wakim LM, 2013, NAT IMMUNOL, V14, P238, DOI 10.1038/ni.2525; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433; Zhang Z., 2012, PLOS ONE, V7	32	65	73	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32184	32193		10.1074/jbc.M113.514356	http://dx.doi.org/10.1074/jbc.M113.514356			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24067232	hybrid, Green Published			2022-12-28	WOS:000328681700008
J	Ban, T; Ke, JY; Chen, RZ; Gu, X; Tan, MHE; Zhou, XE; Kang, YY; Melcher, K; Zhu, JK; Xu, HE				Ban, Ting; Ke, Jiyuan; Chen, Runze; Gu, Xin; Tan, M. H. Eileen; Zhou, X. Edward; Kang, Yanyong; Melcher, Karsten; Zhu, Jian-Kang; Xu, H. Eric			Structure of a PLS-class Pentatricopeptide Repeat Protein Provides Insights into Mechanism of RNA Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; IDENTIFICATION; STABILIZATION; CHLAMYDOMONAS; BINDING; TERMINI	Pentatricopeptide repeat (PPR) proteins are sequence-specific RNA-binding proteins that form a pervasive family of proteins conserved in yeast, plants, and humans. The plant PPR proteins are grouped mainly into the P and PLS classes. Here, we report the crystal structure of a PLS-class PPR protein from Arabidopsis thaliana called THA8L (THA8-like) at 2.0 angstrom. THA8L resembles THA8 (thylakoid assembly 8), a protein that is required for the splicing of specific group II introns of genes involved in biogenesis of chloroplast thylakoid membranes. The THA8L structure contains three P-type PPR motifs flanked by one L-type motif and one S-type motif. We identified several putative THA8L-binding sites, enriched with purine sequences, in the group II introns. Importantly, THA8L has strong binding preference for single-stranded RNA over single-stranded DNA or double-stranded RNA. Structural analysis revealed that THA8L contains two extensive patches of positively charged residues next to the residues that are proposed to comprise the RNA-binding codes. Mutations in these two positively charged patches greatly reduced THA8L RNA-binding activity. On the basis of these data, we constructed a model of THA8L-RNA binding that is dependent on two forces: one is the interaction between nucleotide bases and specific amino acids in the PPR motifs (codes), and the other is the interaction between the negatively charged RNA backbone and positively charged residues of PPR motifs. Together, these results further our understanding of the mechanism of PPR protein-RNA interactions.	[Ban, Ting; Zhu, Jian-Kang] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Shanghai 200032, Peoples R China; [Ban, Ting; Zhu, Jian-Kang] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; [Ban, Ting; Chen, Runze; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Van Andel Res Inst Shanghai Inst Mat Med ARI SIMM, Ctr Struct & Funct Drug Targets,Key Lab Receptor, Shanghai 201203, Peoples R China; [Ke, Jiyuan; Gu, Xin; Tan, M. H. Eileen; Zhou, X. Edward; Kang, Yanyong; Melcher, Karsten; Xu, H. Eric] Ctr Struct Biol & Drug Discovery, Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Tan, M. H. Eileen] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hosp, Dept Obstet & Gynecol, Singapore 119228, Singapore; [Zhu, Jian-Kang] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47906 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute; National University of Singapore; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhu, JK (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47906 USA.	zhu132@purdue.edu; eric.xu@vai.org	Melcher, Karsten/AAZ-3861-2020; Zhu, Jian-Kang/F-7658-2011; Xu, H. Eric/ABD-7487-2021; Tan, Min/GQQ-2702-2022	Melcher, Karsten/0000-0002-9125-4027; Zhu, Jian-Kang/0000-0001-5134-731X; Xu, H. Eric/0000-0002-6829-8144	NIDDK NIH HHS [R01 DK071662] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Delannoy E, 2007, BIOCHEM SOC T, V35, P1643, DOI 10.1042/BST0351643; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipovska A, 2012, MOL BIOSYST, V8, P699, DOI 10.1039/c2mb05392f; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Johnson X, 2010, PLANT CELL, V22, P234, DOI 10.1105/tpc.109.066266; Jonietz C, 2011, PLANT PHYSIOL, V157, P1430, DOI 10.1104/pp.111.181552; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P2712, DOI 10.1093/nar/gkr1084; Loiselay C, 2008, MOL CELL BIOL, V28, P5529, DOI 10.1128/MCB.02056-07; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Zhelyazkova P, 2012, NUCLEIC ACIDS RES, V40, P3092, DOI 10.1093/nar/gkr1137	26	49	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31540	31548		10.1074/jbc.M113.496828	http://dx.doi.org/10.1074/jbc.M113.496828			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047899	Green Published, hybrid			2022-12-28	WOS:000330596200013
J	Zeng, LF; Wang, G; Ummarino, D; Margariti, A; Xu, QH; Xiao, QZ; Wang, W; Zhang, ZY; Yin, XK; Mayr, M; Cockerill, G; Li, JYS; Chien, S; Hu, YH; Xu, QB				Zeng, Lingfang; Wang, Gang; Ummarino, Dario; Margariti, Andriana; Xu, Qihe; Xiao, Qingzhong; Wang, Wen; Zhang, Zhongyi; Yin, Xiaoke; Mayr, Manuel; Cockerill, Gillian; Li, Julie Yi-Shuan; Chien, Shu; Hu, Yanhua; Xu, Qingbo			Histone Deacetylase 3 Unconventional Splicing Mediates Endothelial-to-mesenchymal Transition through Transforming Growth Factor beta 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; CELLS; PROTEIN; HDAC3; CANCER; HEART; EXPRESSION; GENE; DIFFERENTIATION; PROGRESSION	Histone deacetylase 3 (HDAC3) plays a critical role in the maintenance of endothelial integrity and other physiological processes. In this study, we demonstrated that HDAC3 undergoes unconventional splicing during stem cell differentiation. Four different splicing variants have been identified, designated as HD3 alpha, -beta, -gamma, and -delta, respectively. HD3 alpha was confirmed in stem cell differentiation by specific antibody against the sequences from intron 12. Immunofluorescence staining indicated that the HD3 alpha isoform co-localized with CD31-positive or alpha-smooth muscle actin-positive cells at different developmental stages of mouse embryos. Overexpression of HD3 alpha reprogrammed human aortic endothelial cells into mesenchymal cells featuring an endothelial-to-mesenchymal transition (EndMT) phenotype. HD3 alpha directly interacts with HDAC3 and Akt1 and selectively activates transforming growth factor beta 2 (TGF beta 2) secretion and cleavage. TGF beta 2 functioned as an autocrine and/or paracrine EndMT factor. The HD3 alpha-induced EndMT was both PI3K/Akt- and TGF beta 2-dependent. This study provides the first evidence of the role of HDAC3 splicing in the maintenance of endothelial integrity.	[Zeng, Lingfang; Ummarino, Dario; Margariti, Andriana; Zhang, Zhongyi; Yin, Xiaoke; Mayr, Manuel; Hu, Yanhua; Xu, Qingbo] Kings Coll London, BHF Ctr, Div Cardiovasc, London SE5 9NU, England; [Wang, Gang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Emergency Med, Xian 710004, Shaanxi, Peoples R China; [Xu, Qihe] Kings Coll London, Dept Renal Med, London SE5 9NU, England; [Xiao, Qingzhong] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Wang, Wen] Queen Mary Univ London, Sch Engn & Mat Sci, Med Engn Div, London E1 4NS, England; [Cockerill, Gillian] St Georges Univ London, Dept Cardiovasc Sci, London SW17 0RE, England; [Li, Julie Yi-Shuan; Chien, Shu] Univ Calif San Diego, Dept Bioengn & Med, La Jolla, CA 92093 USA	University of London; King's College London; Xi'an Jiaotong University; University of London; King's College London; University of London; Queen Mary University London; University of London; Queen Mary University London; St Georges University London; University of California System; University of California San Diego	Zeng, LF (corresponding author), Kings Coll London, BHF Ctr, Div Cardiovasc, 125 Cold Harbour Lane, London SE5 9NU, England.	lingfang.zeng@kcl.ac.uk	Margariti, Andriana/AAH-5318-2019; Yin, Xiaoke/AAZ-2658-2020	Yin, Xiaoke/0000-0002-5172-0935; Mayr, Manuel/0000-0002-0597-829X; Zeng, Lingfang/0000-0002-0390-4561	British Heart Foundation; Oak Foundation; National Natural Science Foundation of China [81300116]; British Heart Foundation [FS/09/044/28007, PG/11/40/28891, FS/13/2/29892] Funding Source: researchfish; Kidney Research UK [IN1/2010] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Oak Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); British Heart Foundation(British Heart Foundation); Kidney Research UK(Kidney Research UK (KRUK))	This work was supported by grants from the British Heart Foundation and the Oak Foundation and National Natural Science Foundation of China Grant 81300116.	Aisagbonhi O, 2011, DIS MODEL MECH, V4, P469, DOI 10.1242/dmm.006510; Alam S, 2011, J BIOL CHEM, V286, P44211, DOI 10.1074/jbc.M111.242289; Arciniegas E, 2007, AM J PHYSIOL-LUNG C, V293, pL1, DOI 10.1152/ajplung.00378.2006; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Azhar M, 2009, DEV DYNAM, V238, P431, DOI 10.1002/dvdy.21854; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Chang ACY, 2011, DEV CELL, V21, P288, DOI 10.1016/j.devcel.2011.06.022; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hatipoglu OF, 2009, J BIOL CHEM, V284, P16325, DOI 10.1074/jbc.M109.001313; Kekatpure VD, 2009, J BIOL CHEM, V284, P7436, DOI 10.1074/jbc.M808999200; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; MARKWALD RR, 1977, AM J ANAT, V148, P85, DOI 10.1002/aja.1001480108; MARKWALD RR, 1975, DEV BIOL, V42, P160, DOI 10.1016/0012-1606(75)90321-8; Meadows Kafi N, 2009, J Angiogenes Res, V1, P2, DOI 10.1186/2040-2384-1-2; Medici D, 2011, BIOCHEM J, V437, P515, DOI 10.1042/BJ20101500; Mihira H, 2012, J BIOCHEM, V151, P145, DOI 10.1093/jb/mvr121; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; POTTS JD, 1989, DEV BIOL, V134, P392, DOI 10.1016/0012-1606(89)90111-5; Schniewind B, 2007, ONCOGENE, V26, P4850, DOI 10.1038/sj.onc.1210272; Strobl JS, 2007, J PARASITOL, V93, P694, DOI 10.1645/GE-1043R.1; Tabata T, 2009, GENES CELLS, V14, P17, DOI 10.1111/j.1365-2443.2008.01246.x; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Togi S, 2009, BIOCHEM BIOPH RES CO, V379, P616, DOI 10.1016/j.bbrc.2008.12.132; Wang JH, 2010, MOL CANCER RES, V8, P266, DOI 10.1158/1541-7786.MCR-09-0221; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50; Zampetaki A, 2010, CIRCULATION, V121, P132, DOI 10.1161/CIRCULATIONAHA.109.890491; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	49	28	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31853	31866		10.1074/jbc.M113.463745	http://dx.doi.org/10.1074/jbc.M113.463745			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045946	Green Published, hybrid			2022-12-28	WOS:000330596200035
J	Lonjedo, M; Poch, E; Mocholi, E; Hernandez-Sanchez, M; Ivorra, C; Franke, TF; Guasch, RM; Perez-Roger, I				Lonjedo, Marta; Poch, Enric; Mocholi, Enric; Hernandez-Sanchez, Marta; Ivorra, Carmen; Franke, Thomas F.; Guasch, Rosa M.; Perez-Roger, Ignacio			The Rho Family Member RhoE Interacts with Skp2 and Is Degraded at the Proteasome during Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RND PROTEINS; ROCK-I; PROSTATE-CANCER; GTPASES; DEGRADATION; UBIQUITIN; PHOSPHORYLATION; UBIQUITYLATION; PROLIFERATION; CYTOSKELETON	RhoE/Rnd3 is an atypical member of the Rho family of small GTPases. In addition to regulating actin cytoskeleton dynamics, RhoE is involved in the regulation of cell proliferation, survival, and metastasis. We examined RhoE expression levels during cell cycle and investigated mechanisms controlling them. We show that RhoE accumulates during G(1), in contact-inhibited cells, and when the Akt pathway is inhibited. Conversely, RhoE levels rapidly decrease at the G(1)/S transition and remain low for most of the cell cycle. We also show that the half-life of RhoE is shorter than that of other Rho proteins and that its expression levels are regulated by proteasomal degradation. The expression patterns of RhoEoverlap with that of the cell cycle inhibitor p27. Consistently with an involvement of RhoE in cell cycle regulation, RhoE and p27 levels decrease after overexpression of the F-box protein Skp2. We have identified a region between amino acids 231 and 240 of RhoEas the Skp2-interacting domain and Lys(235) as the substrate for ubiquitylation. Based on our results, we propose a mechanism according to which proteasomal degradation of RhoE by Skp2 regulates its protein levels to control cellular proliferation.	[Lonjedo, Marta; Poch, Enric; Mocholi, Enric; Hernandez-Sanchez, Marta; Ivorra, Carmen; Perez-Roger, Ignacio] Univ CEU Cardenal Herrera, Fac Ciencias Salud, Inst Ciencias Biomed, Moncada 46113, Valencia, Spain; [Franke, Thomas F.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; [Franke, Thomas F.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Guasch, Rosa M.] Ctr Invest Principe Felipe, Valencia 46012, Spain	Universidad CEU Cardenal Herrera; New York University; New York University; Prince Felipe Research Center	Poch, E (corresponding author), Univ CEU Cardenal Herrera, Fac Ciencias Salud, Inst Ciencias Biomed, Edif Seminario, Moncada 46113, Valencia, Spain.	epoch@uch.ceu.es; iperez@uch.ceu.es	Guasch, Rosa/B-7520-2014; HERNANDEZ-SANCHEZ, MARTA/M-2307-2014; Poch, Enric/C-5258-2013; GUASCH, ROSA MARIA/ABG-9879-2020; HERNANDEZ-SANCHEZ, MARTA/AAE-9432-2019; Mocholi, Enric/ABH-5275-2020; HERNANDEZ-SANCHEZ, MARTA/AAE-9429-2019; Pérez Roger, Ignacio/K-1346-2014	HERNANDEZ-SANCHEZ, MARTA/0000-0001-8689-0582; GUASCH, ROSA MARIA/0000-0001-8284-786X; HERNANDEZ-SANCHEZ, MARTA/0000-0001-8689-0582; Pérez Roger, Ignacio/0000-0002-5564-6912; Ivorra, Carmen/0000-0002-4699-6689	Instituto de Salud Carlos III; Generalitat Valenciana; Universidad CEU Cardenal Herrera Santander-Copernicus; Universidad CEU Cardenal Herrera	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Universidad CEU Cardenal Herrera Santander-Copernicus; Universidad CEU Cardenal Herrera	This work was supported by grants from the Instituto de Salud Carlos III (to I. P.-R. and R. M. G.), the Generalitat Valenciana (to E. P.), and the Universidad CEU Cardenal Herrera Santander-Copernicus (to I. P.-R.). The work was also supported by fellowships from the Universidad CEU Cardenal Herrera (to M. L. and E. M.) and from the Generalitat Valenciana (to M. H.-S.).	Albero MP, 2010, ONCOGENE, V29, P3276, DOI 10.1038/onc.2010.81; Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Bektic J, 2005, PROSTATE, V64, P332, DOI 10.1002/pros.20243; Belgiovine C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014154; Boswell SA, 2007, J BIOL CHEM, V282, P4850, DOI 10.1074/jbc.M610532200; Boulter E, 2012, FASEB J, V26, P469, DOI 10.1096/fj.11-192252; Boyer L, 2006, MOL BIOL CELL, V17, P2489, DOI 10.1091/mbc.E05-09-0876; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Foster R, 1996, MOL CELL BIOL, V16, P2689; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Goh LL, 2012, J BIOL CHEM, V287, P31311, DOI 10.1074/jbc.M111.327056; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lu LF, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-22; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; Mocholi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019236; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Nethe M, 2010, J CELL SCI, V123, P4011, DOI 10.1242/jcs.078360; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; Peris B, 2012, J NEUROCHEM, V121, P903, DOI 10.1111/j.1471-4159.2012.07733.x; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Poch E, 2007, EXP CELL RES, V313, P719, DOI 10.1016/j.yexcr.2006.11.006; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Riou P, 2010, BIOESSAYS, V32, P986, DOI 10.1002/bies.201000060; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Visvikis O, 2008, FEBS J, V275, P386, DOI 10.1111/j.1742-4658.2007.06209.x; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Zhao H, 2012, TUMOR BIOL, V33, P1363, DOI 10.1007/s13277-012-0384-5; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	55	15	16	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30872	30882		10.1074/jbc.M113.511105	http://dx.doi.org/10.1074/jbc.M113.511105			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24045951	Green Published, hybrid			2022-12-28	WOS:000330778900008
J	Bloem, E; van den Biggelaar, M; Wroblewska, A; Voorberg, J; Faber, JH; Kjalke, M; Stennicke, HR; Mertens, K; Meijer, AB				Bloem, Esther; van den Biggelaar, Maartje; Wroblewska, Aleksandra; Voorberg, Jan; Faber, Johan H.; Kjalke, Marianne; Stennicke, Henning R.; Mertens, Koen; Meijer, Alexander B.			Factor VIII C1 Domain Spikes 2092-2093 and 2158-2159 Comprise Regions That Modulate Cofactor Function and Cellular Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-VIII; RECEPTOR-RELATED PROTEIN; VON-WILLEBRAND-FACTOR; HUMAN-FACTOR-V; EXCHANGE MASS-SPECTROMETRY; FACTOR-IX; CRYSTAL-STRUCTURE; HEMOPHILIA-A; C2 DOMAIN; FACTOR-X	The C1 domain of factor VIII (FVIII) has been implicated in binding to multiple constituents, including phospholipids, von Willebrand factor, and low-density lipoprotein receptor-related protein (LRP). We have previously described a human monoclonal antibody called KM33 that blocks these interactions as well as cellular uptake by LRP-expressing cells. To unambiguously identify the apparent "hot spot" on FVIII to which this antibody binds, we have employed hydrogen-deuterium exchange mass spectrometry. The results showed that KM33 protects FVIII regions 2091-2104 and 2157-2162 from hydrogen-deuterium exchange. These comprise the two C1 domain spikes 2092-2093 and 2158-2159. Spike 2092-2093 has been demonstrated recently to contribute to assembly with lipid membranes with low phosphatidylserine (PS) content. Therefore, spike 21582159 might serve a similar role. This was assessed by replacement of Arg-2159 for Asn, which introduces a motif for N-linked glycosylation. Binding studies revealed that the purified, glycosylated R2159N variant had lost its interaction with antibody KM33 but retained substantial binding to von Willebrand factor and LRP. Cellular uptake of the R2159N variant was reduced both by LRP-expressing U87-MG cells and by human monocyte derived dendritic cells. FVIII activity was virtually normal on membranes containing 15% PS but reduced at low PS content. These findings suggest that the C1 domain spikes 2092-2093 and 2158-2159 together modulate FVIII membrane assembly by a subtle, PS-dependent mechanism. These findings contribute evidence in favor of an increasingly important role of the C1 domain in FVIII biology.	[Bloem, Esther; van den Biggelaar, Maartje; Wroblewska, Aleksandra; Voorberg, Jan; Mertens, Koen; Meijer, Alexander B.] Sanquin Res, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands; [Faber, Johan H.; Kjalke, Marianne; Stennicke, Henning R.] Novo Nordisk AS, Biopharmaceut Res Unit, DK-2760 Malov, Denmark; [Mertens, Koen; Meijer, Alexander B.] Univ Utrecht, Dept Pharmaceut, Utrecht Inst Pharmaceut Sci, NL-3584 CG Utrecht, Netherlands	Novo Nordisk; Utrecht University	Meijer, AB (corresponding author), Sanquin Res, Dept Plasma Prot, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	s.meijer@sanquin.nl		Wroblewska, Aleksandra/0000-0003-2059-6158; Voorberg, Jan/0000-0003-4585-2621				Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Andersen MD, 2011, INT J MASS SPECTROM, V302, P139, DOI 10.1016/j.ijms.2010.09.010; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bloem E, 2012, J BIOL CHEM, V287, P5775, DOI 10.1074/jbc.M111.308627; Bovenschen N, 2005, BLOOD, V106, P906, DOI 10.1182/blood-2004-11-4230; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Fribourg C, 2006, BIOCHEMISTRY-US, V45, P10777, DOI 10.1021/bi060451h; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; Herczenik E, 2012, J ALLERGY CLIN IMMUN, V129, P501, DOI 10.1016/j.jaci.2011.08.029; HOYER LW, 1994, NEW ENGL J MED, V330, P38, DOI 10.1056/NEJM199401063300108; KANE WH, 1986, P NATL ACAD SCI USA, V83, P6800, DOI 10.1073/pnas.83.18.6800; Kim SW, 1999, BIOCHEMISTRY-US, V38, P11448, DOI 10.1021/bi991275y; LENTING PJ, 1995, J BIOL CHEM, V270, P14884, DOI 10.1074/jbc.270.25.14884; Lenting PJ, 1999, J BIOL CHEM, V274, P23734, DOI 10.1074/jbc.274.34.23734; Liu ML, 2000, BLOOD, V96, P979, DOI 10.1182/blood.V96.3.979.015k42a_979_987; Lu JH, 2011, BLOOD, V117, P3181, DOI 10.1182/blood-2010-08-301663; Macedo-Ribeiro S, 1999, NATURE, V402, P434, DOI 10.1038/46594; Meems H., 2011, THESIS UTRECHT U; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; Meijer AB, 2007, BBA-PROTEINS PROTEOM, V1774, P714, DOI 10.1016/j.bbapap.2007.04.003; MERTENS K, 1980, BIOCHEM J, V185, P647, DOI 10.1042/bj1850647; MERTENS K, 1985, THROMB HAEMOSTASIS, V54, P654; Mertens K, 1999, THROMB HAEMOSTASIS, V82, P209; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Nicolaes GAF, 1999, BIOCHEMISTRY-US, V38, P13584, DOI 10.1021/bi991165r; Nicolaes GAF, 2002, ARTERIOSCL THROM VAS, V22, P530, DOI 10.1161/01.ATV.0000012665.51263.B7; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Scharrer I, 1999, HAEMOPHILIA, V5, P145; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Stel H. V., 1984, THESIS U AMSTERDAM; Stoilova-McPhie S, 2002, BLOOD, V99, P1215, DOI 10.1182/blood.V99.4.1215; Thim L, 2010, HAEMOPHILIA, V16, P349, DOI 10.1111/j.1365-2516.2009.02135.x; Van den Biggelaar M, 2007, J THROMB HAEMOST, V5, P2235, DOI 10.1111/j.1538-7836.2007.02737.x; van den Biggelaar M, 2011, J THROMB HAEMOST, V9, P821; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; van den Biggelaar M, 2009, BLOOD, V113, P3102, DOI 10.1182/blood-2008-05-159699; van den Brink EN, 2001, BLOOD, V97, P966, DOI 10.1182/blood.V97.4.966; Wakabayashi H, 2010, J BIOL CHEM, V285, P25176, DOI 10.1074/jbc.M110.106906; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wroblewska A, 2012, BLOOD, V119, P5294, DOI 10.1182/blood-2011-11-391680	41	38	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29670	29679		10.1074/jbc.M113.473116	http://dx.doi.org/10.1074/jbc.M113.473116			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24009077	hybrid, Green Published			2022-12-28	WOS:000330615300042
J	Kakihana, T; Araki, K; Vavassori, S; Iemura, S; Cortini, M; Fagioli, C; Natsume, T; Sitia, R; Nagata, K				Kakihana, Taichi; Araki, Kazutaka; Vavassori, Stefano; Iemura, Shun-ichiro; Cortini, Margherita; Fagioli, Claudio; Natsume, Tohru; Sitia, Roberto; Nagata, Kazuhiro			Dynamic Regulation of Ero1 alpha and Peroxiredoxin 4 Localization in the Secretory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; ENDOPLASMIC-RETICULUM; PDI; IV; RETENTION; ERP44	In the early secretory compartment (ESC), a network of chaperones and enzymes assists oxidative folding of nascent proteins. Ero1 flavoproteins oxidize protein disulfide isomerase (PDI), generating H2O2 as a byproduct. Peroxiredoxin 4 (Prx4) can utilize luminal H2O2 to oxidize PDI, thus favoring oxidative folding while limiting oxidative stress. Interestingly, neither ER oxidase contains known ER retention signal(s), raising the question of how cells prevent their secretion. Here we show that the two proteins share similar intracellular localization mechanisms. Their secretion is prevented by sequential interactions with PDI and ERp44, two resident proteins of the ESC-bearing KDEL-like motifs. PDI binds preferentially Ero1 alpha, whereas ERp44 equally retains Ero1 alpha and Prx4. The different binding properties of Ero1 alpha and Prx4 increase the robustness of ER redox homeostasis.	[Kakihana, Taichi] Kyoto Univ, Dept Mol & Cellular Biol, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068397, Japan; [Kakihana, Taichi; Nagata, Kazuhiro] Kyoto Sangyo Univ, Lab Mol & Cellular Biol, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Cortini, Margherita; Fagioli, Claudio; Sitia, Roberto] Univ Vita Salute, San Raffaele Sci Inst, Div Genet & Cell Biol, I-20132 Milan, Italy; [Araki, Kazutaka; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo 1350064, Japan; [Iemura, Shun-ichiro] Fukushima Med Univ, Med Ind Translat Res Ctr, Fukushima 9601295, Japan	Kyoto University; Kyoto Sangyo University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; National Institute of Advanced Industrial Science & Technology (AIST); Fukushima Medical University	Sitia, R (corresponding author), Univ Vita Salute, San Raffaele Sci Inst, Div Genet & Cell Biol, Via Olgettina 58, I-20132 Milan, Italy.	sitia.roberto@hsr.it; nagata@cc.kyoto-su.ac.jp	Araki, Kazutaka/L-6296-2018; Sitia, Roberto/AAB-5005-2019; Cortini, Margherita/J-7325-2018; Fagioli, Claudio/AAN-4147-2020; Natsume, Tohru/M-7627-2018	Araki, Kazutaka/0000-0003-2901-2454; Sitia, Roberto/0000-0001-7086-4152; Fagioli, Claudio/0000-0001-9889-4695; Natsume, Tohru/0000-0002-1510-2582; Kakihana, Taichi/0000-0001-5037-9184; Cortini, Margherita/0000-0002-8151-8105	Human Frontier Science Program (HFSP); Telethon [GGP11077]; Associazione Italiana Ricerca Cancro (AIRC); Japan Society for the Promotion of Science (JSPS) [08J03849, 12J02049, 12J04142]	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Telethon(Fondazione Telethon); Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research (S) 24227009 and a grant from the Human Frontier Science Program (HFSP) (to K. N.), by grants from Telethon (GGP11077) and the Associazione Italiana Ricerca Cancro (AIRC; IG and 5 x 1000 program) (to R. S.), and by Japan Society for the Promotion of Science (JSPS) Fellowships 08J03849 and 12J02049) (to K. A.) and 12J04142 (to T. K.).	Anelli T, 2003, EMBO J, V22, P5015, DOI 10.1093/emboj/cdg491; Anelli T, 2007, EMBO J, V26, P4177, DOI 10.1038/sj.emboj.7601844; Anelli T, 2012, ANTIOXID REDOX SIGN, V16, P1077, DOI 10.1089/ars.2011.4004; Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Birk J, 2013, J CELL SCI, V126, P1604, DOI 10.1242/jcs.117218; Cortini M, 2010, DIABETES OBES METAB, V12, P39, DOI 10.1111/j.1463-1326.2010.01272.x; Fagioli C, 2001, J BIOL CHEM, V276, P40962, DOI 10.1074/jbc.M107456200; Fraldi A, 2008, HUM MOL GENET, V17, P2610, DOI 10.1093/hmg/ddn161; Gilady SY, 2010, CELL STRESS CHAPERON, V15, P619, DOI 10.1007/s12192-010-0174-1; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; Kakihana T, 2012, ANTIOXID REDOX SIGN, V16, P763, DOI 10.1089/ars.2011.4238; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Okado-Matsumoto A, 2000, J BIOCHEM, V127, P493, DOI 10.1093/oxfordjournals.jbchem.a022632; Otsu M, 2006, ANTIOXID REDOX SIGN, V8, P274, DOI 10.1089/ars.2006.8.274; Ronzoni R, 2010, TRAFFIC, V11, P947, DOI 10.1111/j.1600-0854.2010.01071.x; Swiatkowska M, 2010, J BIOL CHEM, V285, P29874, DOI 10.1074/jbc.M109.092486; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tavender TJ, 2010, J CELL SCI, V123, P2672, DOI 10.1242/jcs.067843; Vavassori S, 2013, MOL CELL, V50, P783, DOI 10.1016/j.molcel.2013.04.016; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Zito E, 2013, ANTIOXID REDOX SIGN, V18, P1666, DOI 10.1089/ars.2012.4966; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	35	47	47	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29586	29594		10.1074/jbc.M113.467845	http://dx.doi.org/10.1074/jbc.M113.467845			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979138	hybrid, Green Published			2022-12-28	WOS:000330615300034
J	Koskinen, C; Persson, E; Baldock, P; Stenberg, A; Bostrom, I; Matozaki, T; Oldenborg, PA; Lundberg, P				Koskinen, Cecilia; Persson, Emelie; Baldock, Paul; Stenberg, Asa; Bostrom, Ingrid; Matozaki, Takashi; Oldenborg, Per-Arne; Lundberg, Pernilla			Lack of CD47 Impairs Bone Cell Differentiation and Results in an Osteopenic Phenotype in Vivo due to Impaired Signal Regulatory Protein alpha (SIRP alpha) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCLAST FORMATION; RECEPTOR; EXPRESSION; SHPS-1; GENE	Here, we investigated whether the cell surface glycoprotein CD47 was required for normal formation of osteoblasts and osteoclasts and to maintain normal bone formation activity in vitro and in vivo. In parathyroid hormone or 1 alpha,25(OH)(2)-vitamin D3 (D3)-stimulated bone marrow cultures (BMC) from CD47(-/-) mice, we found a strongly reduced formation of multinuclear tartrate-resistant acid phosphatase (TRAP)(+) osteoclasts, associated with reduced expression of osteoclastogenic genes (nfatc1, Oscar, Trap/Acp, ctr, catK, and dc-stamp). The production of M-CSF andRANKL(receptor activator of nuclear factor kappa beta ligand) was reduced in CD47(-/-) BMC, as compared with CD47(+/+) BMC. The stromal cell phenotype in CD47(-/-) BMC involved a blunted expression of the osteoblast-associated genes osterix, Alp/Akp1, and alpha-1-collagen, and reduced mineral deposition, as compared with that in CD47(+/+) BMC. CD47 is a ligand for SIRP alpha (signal regulatory protein alpha), which showed strongly reduced tyrosine phosphorylation in CD47(-/-) bone marrow stromal cells. In addition, stromal cells lacking the signaling SIRP alpha cytoplasmic domain also had a defect in osteogenic differentiation, and both CD47(-/-) and non-signaling SIRP alpha mutant stromal cells showed a markedly reduced ability to support osteoclastogenesis in wild-type bone marrow macrophages, demonstrating that CD47-induced SIRP alpha signaling is critical for stromal cell support of osteoclast formation. In vivo, femoral bones of 18-or 28-week-old CD47(-/-) mice showed significantly reduced osteoclast and osteoblast numbers and exhibited an osteopenic bone phenotype. In conclusion, lack of CD47 strongly impairs SIRP alpha-dependent osteoblast differentiation, deteriorate bone formation, and cause reduced formation of osteoclasts.	[Koskinen, Cecilia; Persson, Emelie; Bostrom, Ingrid; Lundberg, Pernilla] Umea Univ, Dept Odontol, Sect Mol Periodontol, SE-90187 Umea, Sweden; [Baldock, Paul] St Vincents Hosp, Garvan Inst Med Res, Neurol Dis Div, Darlinghurst, NSW 2010, Australia; [Stenberg, Asa; Oldenborg, Per-Arne] Umea Univ, Sect Histol & Cell Biol, SE-90187 Umea, Sweden; [Matozaki, Takashi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Signaling, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan	Umea University; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Umea University; Kobe University	Lundberg, P (corresponding author), Umea Univ, Dept Odontol, Sect Mol Periodontol, SE-90187 Umea, Sweden.	pernilla.lundberg@odont.umu.se	Baldock, Paul/B-3840-2012		Swedish Research Council; Faculty of Medicine of Umea University; Umea University; Swedish Dental Society; County Council of Vasterbotten	Swedish Research Council(Swedish Research CouncilEuropean Commission); Faculty of Medicine of Umea University; Umea University; Swedish Dental Society; County Council of Vasterbotten	This work was supported by Swedish Research Council 2010-4286 Grant (to P.-A.O.), the Faculty of Medicine of Umea University, a Young Researcher Award from Umea University (to P.-A.O.), the Swedish Dental Society, and the County Council of Vasterbotten.	Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Conaway HH, 2009, FASEB J, V23, P3526, DOI 10.1096/fj.09-132548; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Johansen ML, 2007, J BIOL CHEM, V282, P24219, DOI 10.1074/jbc.M701565200; Kukreja A, 2009, BLOOD, V114, P3413, DOI 10.1182/blood-2009-03-211920; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Lundberg P, 2007, BIOCHEM BIOPH RES CO, V352, P444, DOI 10.1016/j.bbrc.2006.11.057; Maile LA, 2011, J BONE MINER RES, V26, P2068, DOI 10.1002/jbmr.441; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nemeth K, 2011, J IMMUNOL, V186, P13, DOI 10.4049/jimmunol.1002483; Nishimura R, 2008, J BONE MINER METAB, V26, P203, DOI 10.1007/s00774-007-0824-2; Okazawa H, 2005, J IMMUNOL, V174, P2004, DOI 10.4049/jimmunol.174.4.2004; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Uluckan O, 2009, CANCER RES, V69, P3196, DOI 10.1158/0008-5472.CAN-08-3358; van Beek EM, 2009, FASEB J, V23, P4081, DOI 10.1096/fj.09-131557; Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	24	20	21	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29333	29344		10.1074/jbc.M113.494591	http://dx.doi.org/10.1074/jbc.M113.494591			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23990469	Green Published, hybrid			2022-12-28	WOS:000330615300013
J	Ma, WB; Hu, SG; Yao, GX; Xie, SS; Ni, MJ; Liu, Q; Gao, XX; Zhang, J; Huang, XX; Zhang, YL				Ma, Wubin; Hu, Shuanggang; Yao, Guangxin; Xie, Shengsong; Ni, Minjie; Liu, Qiang; Gao, Xinxing; Zhang, Jun; Huang, Xingxu; Zhang, Yonglian			An Androgen Receptor-MicroRNA-29a Regulatory Circuitry in Mouse Epididymis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR AR COREGULATORS; CELL-LINES; EXPRESSION; MICRORNA; GROWTH; SUPPRESSION; ACTIVATION; PROMOTER; MICE; MYC	MicroRNAs are involved in a number of cellular processes; thus, their deregulation is usually apt to the occurrence of diverse diseases. Previous studies indicate that abnormally up-regulated miR-29a is associated with several diseases, such as human acute myeloid leukemia and diabetes; therefore, the proper level of miR-29a is critical for homeostasis. Herein, we observed that miR-29a was repressed by androgen/androgen receptor signaling in mouse epididymis by targeting a conserved androgen response element located 8 kb upstream of miR-29b1a loci. It is well known that multiple regulatory programs often form a complicated network. Here, we found that miR-29a reversibly suppressed androgen receptor and its target genes by targeting IGF1 and p53 pathways. miR-29b1a-overexpressing transgenic mice displayed epididymis hypoplasia partially similar to the phenotype of those mice with an impaired androgen-androgen receptor signal system. Taken together, the results demonstrated that there is a regulatory circuitry between the androgen signaling pathway and miR-29a in mouse epididymis that may be vital for epididymal development and functions.	[Ma, Wubin; Hu, Shuanggang; Yao, Guangxin; Xie, Shengsong; Ni, Minjie; Liu, Qiang; Zhang, Yonglian] Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Hu, Shuanggang; Yao, Guangxin; Xie, Shengsong] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Gao, Xinxing; Zhang, Jun; Huang, Xingxu] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [Zhang, Yonglian] Shanghai Inst Planned Parenthood Res, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Nanjing University	Huang, XX (corresponding author), Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China.	xingxuhuang@mail.nju.edu.cn; ylzhang@sibcb.ac.cn	Liu, Qiang/HHZ-3181-2022; Ma, Wubin/P-3045-2017	huang, xingxu/0000-0001-8934-1247	National Natural Science Foundation of China [31201113, 30930053]; Chinese Academy of Sciences Knowledge Innovation Program [KSCX2-EW-R-07]; National Basic Research Program of China [2014CB943103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Knowledge Innovation Program(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 31201113 and 30930053, Chinese Academy of Sciences Knowledge Innovation Program Grant KSCX2-EW-R-07, and National Basic Research Program of China (2014CB943103).	Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Alimirah F, 2007, NEOPLASIA, V9, P1152, DOI 10.1593/neo.07769; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Araki Y, 2002, J ANDROL, V23, P854; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; Chen PJ, 2012, HEPATOLOGY, V56, P632, DOI 10.1002/hep.25695; CULIG Z, 1995, EUR UROL, V27, P45; Delic D, 2010, STEROIDS, V75, P998, DOI 10.1016/j.steroids.2010.06.010; Epis MR, 2009, J BIOL CHEM, V284, P24696, DOI 10.1074/jbc.M109.030098; Fan XP, 1998, ENDOCRINOLOGY, V139, P2128, DOI 10.1210/en.139.4.2128; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Gupta A, 2011, METHODS MOL BIOL, V676, P73, DOI 10.1007/978-1-60761-863-8_6; Hagen JW, 2008, CELL CYCLE, V7, P2327, DOI 10.4161/cc.6447; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Hand NJ, 2012, J PEDIATR GASTR NUTR, V54, P186, DOI 10.1097/MPG.0b013e318244148b; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Hobisch A, 1998, CANCER RES, V58, P4640; Hu SG, 2010, MOL ENDOCRINOL, V24, P2392, DOI 10.1210/me.2010-0226; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Krutskikh A, 2011, ENDOCRINOLOGY, V152, P689, DOI 10.1210/en.2010-0768; Lareyre JJ, 1997, MOL CELL ENDOCRINOL, V129, P33, DOI 10.1016/S0303-7207(97)04038-0; Li Y, 2009, DEV DYNAM, V238, P2388, DOI 10.1002/dvdy.22056; Ma WB, 2012, J BIOL CHEM, V287, P10189, DOI 10.1074/jbc.M111.303636; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Murata T, 2010, PROSTATE CANCER P D, V13, P356, DOI 10.1038/pcan.2010.32; Nadiminty N, 2012, J BIOL CHEM, V287, P1527, DOI 10.1074/jbc.M111.278705; O'Hara L, 2011, ENDOCRINOLOGY, V152, P718, DOI 10.1210/en.2010-0928; Ott CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016250; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Sikand K, 2011, INT J CANCER, V129, P810, DOI 10.1002/ijc.25753; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Svensson J, 2008, J ENDOCRINOL, V199, P489, DOI 10.1677/JOE-08-0406; Thum T, 2012, CARDIOVASC RES, V93, P543, DOI 10.1093/cvr/cvs085; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Yang X, 2006, ONCOGENE, V25, P3436, DOI 10.1038/sj.onc.1209366; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Zhang LY, 2009, AM J PATHOL, V175, P489, DOI 10.2353/ajpath.2009.080727; Zhu CF, 2007, BIOL REPROD, V76, P63, DOI 10.1095/biolreprod.106.054635	51	22	23	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29369	29381		10.1074/jbc.M113.454066	http://dx.doi.org/10.1074/jbc.M113.454066			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23960076	hybrid, Green Published			2022-12-28	WOS:000330615300016
J	Tse, AKW; Chow, KY; Cao, HH; Cheng, CY; Kwan, HY; Yu, H; Zhu, GY; Wu, YC; Fong, WF; Yu, ZL				Tse, Anfernee Kai-Wing; Chow, Ka-Yu; Cao, Hui-Hui; Cheng, Chi-Yan; Kwan, Hiu-Yee; Yu, Hua; Zhu, Guo-Yuan; Wu, Yiu-Cheong; Fong, Wang-Fun; Yu, Zhi-Ling			The Herbal Compound Cryptotanshinone Restores Sensitivity in Cancer Cells That Are Resistant to the Tumor Necrosis Factor-related Apoptosis-inducing Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; KAPPA-B; MEDIATED APOPTOSIS; KILLER/DR5 GENE; TANSHINONE IIA; UP-REGULATION; ER-STRESS; RECEPTOR; EXPRESSION; MELANOMA	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis and kills cancer cells but not normal cells. However, TRAIL resistance due to low level of TRAIL receptor expression is widely found in cancer cells and hampers its development for cancer treatment. Thus, the agents that can sensitize the tumor cells to TRAIL-mediated apoptosis are urgently needed. We investigated whether tanshinones, the major bioactive compounds of Salvia miltiorrhiza (danshen), can up-regulate TRAIL receptor expression. Among the major tanshinones being tested, cryptotanshinone (CT) showed the best ability to induce TRAIL receptor 2 (DR5) expression. We further showed that CT was capable of promoting TRAIL-induced cell death and apoptosis in A375 melanoma cells. CT-induced DR5 induction was not cell type-specific, as DR5 induction was observed in other cancer cell types. DR5 knockdown abolished the enhancing effect of CT on TRAIL responses. Mechanistically, induction of the DR5 by CT was found to be p53-independent but dependent on the induction of CCAAT/enhancer-binding protein-homologous protein (CHOP). Knockdown of CHOP abolished CT-induced DR5 expression and the associated potentiation of TRAIL-mediated cell death. In addition, CT-induced ROS production preceded up-regulation of CHOP and DR5 and consequent sensitization of cells to TRAIL. Interestingly, CT also converted TRAIL-resistant lung A549 cancer cells into TRAIL-sensitive cells. Taken together, our results indicate that CT can potentiate TRAIL-induced apoptosis through up-regulation of DR5.	[Tse, Anfernee Kai-Wing; Chow, Ka-Yu; Cao, Hui-Hui; Cheng, Chi-Yan; Kwan, Hiu-Yee; Yu, Hua; Zhu, Guo-Yuan; Wu, Yiu-Cheong; Fong, Wang-Fun; Yu, Zhi-Ling] Hong Kong Baptist Univ, Sch Chinese Med, Ctr Canc & Inflammat Res, Kowloon Tong, Hong Kong, Peoples R China	Hong Kong Baptist University	Yu, ZL (corresponding author), Sch Chinese Med, Jockey Club Sch Chinese Med Bldg,7 Baptist Univ R, Kowloon Tong, Hong Kong, Peoples R China.	zlyu@hkbu.edu.hk	Yu, Hua/B-8854-2012; Zhu, Guo-Yuan/AAG-7914-2019	Yu, Hua/0000-0003-0737-9925; Zhu, Guo-Yuan/0000-0002-4355-894X; KWAN, Hiu Yee/0000-0002-6088-7323; Tse, Kai Wing/0000-0002-0046-9808; Yu, Zhiling/0000-0002-2979-9608; CHENG, Brian Chi-yan/0000-0002-2447-6893	Hong Kong Baptist University [HKBU 38-40-076, FRG1/11-12/053, FRG2/11-12/057, FRG1/13-14/002]; University Grants Committee of Hong Kong [HKBU 262512]	Hong Kong Baptist University; University Grants Committee of Hong Kong	This work was supported by Hong Kong Baptist University Grants HKBU 38-40-076, FRG1/11-12/053, FRG2/11-12/057, and FRG1/13-14/002 and the University Grants Committee of Hong Kong Grant HKBU 262512.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Aydin C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-584; Cheng CY, 2010, MOL MED REP, V3, P645, DOI 10.3892/mmr_00000310; Chiu TL, 2010, INT J MOL MED, V25, P231, DOI 10.3892/ijmm_00000335; Dimberg LY, 2013, ONCOGENE, V32, P1341, DOI 10.1038/onc.2012.164; Eigentler TK, 2003, LANCET ONCOL, V4, P748, DOI 10.1016/S1470-2045(03)01280-4; Griffith TS, 1998, J IMMUNOL, V161, P2833; Julia F, 2012, DERMATOL THER, V25, P452, DOI 10.1111/j.1529-8019.2012.01487.x; KASTRINAKIS WV, 1995, ONCOGENE, V11, P647; Kim JH, 2011, APOPTOSIS, V16, P696, DOI 10.1007/s10495-011-0605-1; Kim YH, 2008, FREE RADICAL BIO MED, V44, P1055, DOI 10.1016/j.freeradbiomed.2007.12.001; Lee WYW, 2009, CANCER LETT, V285, P46, DOI 10.1016/j.canlet.2009.04.040; Liu AH, 2006, J PHARM PHARM SCI, V9, P1; Mellier G, 2012, FREE RADICAL RES, V46, P996, DOI 10.3109/10715762.2012.690514; Meng RD, 2001, EXP CELL RES, V262, P154, DOI 10.1006/excr.2000.5073; Moon DO, 2011, BIOCHEM PHARMACOL, V82, P1641, DOI 10.1016/j.bcp.2011.08.019; Nguyen T, 2001, CLIN CANCER RES, V7, p966S; OConnor PM, 1997, CANCER RES, V57, P4285; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Park IJ, 2012, APOPTOSIS, V17, P248, DOI 10.1007/s10495-011-0680-3; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Russo M, 2010, BIOCHEM PHARMACOL, V80, P674, DOI 10.1016/j.bcp.2010.03.011; Seol JY, 2003, CANCER GENE THER, V10, P540, DOI 10.1038/sj.cgt.7700597; Sheikh MS, 1998, CANCER RES, V58, P1593; Siegelin MD, 2012, EXPERT OPIN THER TAR, V16, P801, DOI 10.1517/14728222.2012.703655; Su CC, 2012, EXP THER MED, V3, P555, DOI 10.3892/etm.2011.441; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; The State Pharmacopoeia Commission of China, 2005, CHIN PHARM, P528; Tse AKW, 2005, BIOCHEM PHARMACOL, V70, P1443, DOI 10.1016/j.bcp.2005.08.011; Tse AKW, 2010, MOL IMMUNOL, V47, P1728, DOI 10.1016/j.molimm.2010.03.004; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; YAGINUMA Y, 1992, CANCER RES, V52, P4196; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang Y, 2011, ONCOGENE, V30, P2207, DOI 10.1038/onc.2010.600; Ye YT, 2012, MOL CELL BIOCHEM, V363, P191, DOI 10.1007/s11010-011-1171-0; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200; Zhang Y, 2012, INT J MOL SCI, V13, P13621, DOI 10.3390/ijms131013621; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	38	37	41	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29923	29933		10.1074/jbc.M113.483909	http://dx.doi.org/10.1074/jbc.M113.483909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23986445	Green Published, hybrid			2022-12-28	WOS:000330615300065
J	Cottingham, C; Lu, RJ; Jiao, K; Wang, Q				Cottingham, Christopher; Lu, Roujian; Jiao, Kai; Wang, Qin			Cross-talk from beta-Adrenergic Receptors Modulates alpha(2A)-Adrenergic Receptor Endocytosis in Sympathetic Neurons via Protein Kinase A and Spinophilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adrenergic Receptor; Endocytosis; G Protein-coupled receptors (GPCR); Neurons; Protein Kinase A (PKA); Cross-talk; Spinophilin	CHRONIC EPINEPHRINE TREATMENT; CEREBRAL CORTICAL MEMBRANES; DENDRITIC SPINES; ALPHA-2-ADRENERGIC RECEPTORS; SUBCELLULAR-DISTRIBUTION; HIPPOCAMPAL-NEURONS; SURFACE EXPRESSION; COUPLED RECEPTORS; BINDING-PROTEIN; DOWN-REGULATION	Inter-regulation of adrenergic receptors (ARs) via cross-talk is a long appreciated but mechanistically unclear physiological phenomenon. Evidence from the AR literature and our own extensive studies on regulation of (2A)ARs by the scaffolding protein spinophilin have illuminated a potential novel mechanism for cross-talk from to (2)ARs. In the present study, we have characterized a mode of endogenous AR cross-talk in native adrenergic neurons whereby canonical AR-mediated signaling modulates spinophilin-regulated (2A)AR endocytosis through PKA. Our findings demonstrate that co-activation of and (2A)ARs, either by application of endogenous agonist or by simultaneous stimulation with distinct selective agonists, results in acceleration of endogenous (2A)AR endocytosis in native neurons. We show that receptor-independent PKA activation by forskolin is sufficient to accelerate (2A)AR endocytosis and that (2A)AR stimulation alone drives accelerated endocytosis in spinophilin-null neurons. Endocytic response acceleration by /(2A)AR co-activation is blocked by PKA inhibition and lost in spinophilin-null neurons, consistent with our previous finding that spinophilin is a substrate for phosphorylation by PKA that disrupts its interaction with (2A)ARs. Importantly, we show that (2)AR agonist-mediated (2A)AR/spinophilin interaction is blocked by AR co-activation in a PKA-dependent fashion. We therefore propose a novel mechanism for cross-talk from to (2)ARs, whereby canonical AR-mediated signaling coupled to PKA activation results in phosphorylation of spinophilin, disrupting its interaction with (2A)ARs and accelerating (2A)AR endocytic responses. This mechanism of cross-talk has significant implications for endogenous adrenergic physiology and for therapeutic targeting of and (2A)ARs.	[Cottingham, Christopher; Wang, Qin] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Jiao, Kai] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Lu, Roujian] China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, Q (corresponding author), 986 MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.	qinwang@uab.edu		Jiao, Kai/0000-0002-5415-9020; Wang, Qin/0000-0002-1079-5914; jiao, kai/0000-0002-1901-8329	National Institutes of Health [MH081917]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH081917 (to Q. W.).	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Apparsundaram S, 1996, J PHARMACOL EXP THER, V278, P862; ATKINSON BN, 1992, MOL PHARMACOL, V41, P688; Baucum AJ, 2010, MOL CELL PROTEOMICS, V9, P1243, DOI 10.1074/mcp.M900387-MCP200; Bawa T, 2003, BRIT J PHARMACOL, V138, P921, DOI 10.1038/sj.bjp.0705127; Bawa-Khalfe Tasneem, 2007, BMC Pharmacology, V7, P16, DOI 10.1186/1471-2210-7-16; Biaggioni I, 2012, BASIC CLIN PHARM; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Brady AE, 2003, J BIOL CHEM, V278, P32405, DOI 10.1074/jbc.M304195200; Brady AE, 2005, MOL PHARMACOL, V67, P1690, DOI 10.1124/mol.104.005215; Brum PC, 2006, NEUROPHARMACOLOGY, V51, P397, DOI 10.1016/j.neuropharm.2006.03.032; Cottingham C, 2012, NEUROPHARMACOLOGY, V62, P2354, DOI 10.1016/j.neuropharm.2012.02.011; Cottingham C, 2011, J BIOL CHEM, V286, P36063, DOI 10.1074/jbc.M111.261578; Desai AN, 2004, J PHARMACOL EXP THER, V311, P794, DOI 10.1124/jpet.104.069674; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; GLASS DB, 1989, J BIOL CHEM, V264, P8802; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harris TE, 1997, BIOCHEM BIOPH RES CO, V232, P648, DOI 10.1006/bbrc.1997.6344; Hsieh-Wilson LC, 2003, J BIOL CHEM, V278, P1186, DOI 10.1074/jbc.M205754200; Knollman, 2011, GOODMAN GILMANS PHAR; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Kreider ML, 2004, BRAIN RES BULL, V62, P305, DOI 10.1016/j.brainresbull.2003.09.017; Lu R, 2010, MOL PHARMACOL, V78, P279, DOI 10.1124/mol.110.065300; Lu RJ, 2009, J BIOL CHEM, V284, P13233, DOI 10.1074/jbc.M807535200; MAGGI A, 1980, SCIENCE, V207, P645, DOI 10.1126/science.6101510; Molinoff P. B., 2011, GOODMAN GILMANS PHAR; Muly EC, 2004, J COMP NEUROL, V469, P185, DOI 10.1002/cne.11001; NAKAMURA T, 1991, BRAIN RES, V542, P181, DOI 10.1016/0006-8993(91)91564-H; NOMURA Y, 1984, BRAIN RES, V302, P101, DOI 10.1016/0006-8993(84)91289-7; NORTHAM WJ, 1985, EUR J PHARMACOL, V113, P153, DOI 10.1016/0014-2999(85)90363-2; Ouimet CC, 2004, J COMP NEUROL, V479, P374, DOI 10.1002/cne.20313; Pedarzani P, 1996, EUR J NEUROSCI, V8, P2098, DOI 10.1111/j.1460-9568.1996.tb00731.x; PEDARZANI P, 1993, NEURON, V11, P1023, DOI 10.1016/0896-6273(93)90216-E; Prinster SC, 2006, J PHARMACOL EXP THER, V318, P974, DOI 10.1124/jpet.106.106526; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Robertson D., 2012, BASIC CLIN PHARM; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; von Zastrow M, 2012, NEURON, V76, P22, DOI 10.1016/j.neuron.2012.09.022; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Westfall TC., 2011, GOODMAN GILMANS PHAR, V12th ed; Xu JG, 2003, J BIOL CHEM, V278, P10770, DOI 10.1074/jbc.M207968200; Xu JM, 2008, J BIOL CHEM, V283, P14516, DOI 10.1074/jbc.M710340200; YAMAUCHI A, 1973, J ANAT, V114, P271	47	9	9	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29193	29205		10.1074/jbc.M113.469494	http://dx.doi.org/10.1074/jbc.M113.469494			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23965992	hybrid, Green Published			2022-12-28	WOS:000330298800072
J	Lukina, MV; Popov, AV; Koval, VV; Vorobjev, YN; Fedorova, OS; Zharkov, DO				Lukina, Maria V.; Popov, Alexander V.; Koval, Vladimir V.; Vorobjev, Yuri N.; Fedorova, Olga S.; Zharkov, Dmitry O.			DNA Damage Processing by Human 8-Oxoguanine-DNA Glycosylase Mutants with the Occluded Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; DNA Repair; Enzyme Kinetics; Enzyme Mutation; Molecular Modeling; Presteady-state Kinetics; 8-Oxoguanine; OGG1; Abasic Site; Substrate Recognition	SUBSTRATE RECOGNITION; MOLECULAR-DYNAMICS; REPAIR ENZYME; LESION RECOGNITION; FREE-ENERGY; EXCISION; CATALYSIS; SPECIFICITY; MECHANISM; OXIDATION	8-Oxoguanine-DNA glycosylase (OGG1) removes premutagenic lesion 8-oxoguanine (8-oxo-G) from DNA and then nicks the nascent abasic (apurinic/apyrimidinic) site by -elimination. Although the structure of OGG1 bound to damaged DNA is known, the dynamic aspects of 8-oxo-G recognition are not well understood. To comprehend the mechanisms of substrate recognition and processing, we have constructed OGG1 mutants with the active site occluded by replacement of Cys-253, which forms a wall of the base-binding pocket, with bulky leucine or isoleucine. The conformational dynamics of OGG1 mutants were characterized by single-turnover kinetics and stopped-flow kinetics with fluorescent detection. Additionally, the conformational mobility of wild type and the mutant OGG1 substrate complex was assessed using molecular dynamics simulations. Although pocket occlusion distorted the active site and greatly decreased the catalytic activity of OGG1, it did not fully prevent processing of 8-oxo-G and apurinic/apyrimidinic sites. Both mutants were notably stimulated in the presence of free 8-bromoguanine, indicating that this base can bind to the distorted OGG1 and facilitate -elimination. The results agree with the concept of enzyme plasticity, suggesting that the active site of OGG1 is flexible enough to compensate partially for distortions caused by mutation.	[Lukina, Maria V.; Popov, Alexander V.; Koval, Vladimir V.; Vorobjev, Yuri N.; Fedorova, Olga S.; Zharkov, Dmitry O.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, 8 Lavrentieva Ave, Novosibirsk 630090, Russia; [Lukina, Maria V.; Koval, Vladimir V.; Vorobjev, Yuri N.; Fedorova, Olga S.; Zharkov, Dmitry O.] Novosibirsk State Univ, Dept Mol Biol, Fac Nat Sci, Novosibirsk 630090, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University	Fedorova, OS (corresponding author), Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, 8 Lavrentieva Ave, Novosibirsk 630090, Russia.	fedorova@niboch.nsc.ru; dzharkov@niboch.nsc.ru	Fedorova, Olga S./E-1291-2013; Lukina, Maria/M-5820-2017; Popov, Alexander/E-3169-2013; Zharkov, Dmitry/K-2158-2012; Fedorova, Olga/ABE-6637-2020; Koval, Vladimir/G-3489-2013	Fedorova, Olga S./0000-0002-4001-7187; Zharkov, Dmitry/0000-0001-5013-0194; Fedorova, Olga/0000-0002-4001-7187; Koval, Vladimir/0000-0002-2577-2184; Lukina, Maria/0000-0001-9185-4287	National Institutes of Health from NCI [CA017395]; Presidium of the Russian Academy of Sciences [6.11, 6.12]; Russian Foundation for Basic Research [11-04-00807, 12-04-00135, 13-04-00013]; Russian Ministry of Education and Science [SS-64.2012.4, 8092, 8473]; Russian Government [11.G34.31.0045]; Siberian Branch of the Russian Academy of Sciences; NATIONAL CANCER INSTITUTE [R01CA017395, R37CA017395] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Russian Government; Siberian Branch of the Russian Academy of Sciences(Russian Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA017395 from NCI. This work was also supported by Presidium of the Russian Academy of Sciences Grants 6.11 and 6.12, Russian Foundation for Basic Research Grants 11-04-00807, 12-04-00135, and 13-04-00013, Russian Ministry of Education and Science Grants SS-64.2012.4, 8092, and 8473, Russian Government Grant to Leading Scientists 11.G34.31.0045, and funds from the Siberian Branch of the Russian Academy of Sciences.	Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P15020, DOI 10.1073/pnas.0603644103; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Bialkowski K, 1996, Z NATURFORSCH C, V51, P119; Bjoras M, 2002, J MOL BIOL, V317, P171, DOI 10.1006/jmbi.2002.5400; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Chung SJ, 2004, CHEM BIOL, V11, P1643, DOI 10.1016/j.chembiol.2004.09.014; Crenshaw CM, 2012, J BIOL CHEM, V287, P24916, DOI 10.1074/jbc.M111.316497; Dalhus B, 2011, STRUCTURE, V19, P117, DOI 10.1016/j.str.2010.09.023; DeLano W.L, PYMOL MOL GRAPHICS S; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; Fersht A., 1985, ENZYME STRUCTURE MEC; Fromme JC, 2003, NAT STRUCT BIOL, V10, P204, DOI 10.1038/nsb902; Gedik CM, 2005, FASEB J, V19, P82, DOI 10.1096/fj.04-1767fje; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Hamm ML, 2007, J AM CHEM SOC, V129, P7724, DOI 10.1021/ja0716453; Jensen A, 2003, J BIOL CHEM, V278, P19541, DOI 10.1074/jbc.M301504200; Kokkinidis M, 2012, ADV PROTEIN CHEM STR, V87, P181, DOI 10.1016/B978-0-12-398312-1.00007-X; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuznetsov NA, 2005, NUCLEIC ACIDS RES, V33, P3919, DOI 10.1093/nar/gki694; Kuznetsov NA, 2007, J BIOL CHEM, V282, P1029, DOI 10.1074/jbc.M605788200; Kuznetsov NA, 2007, BIOCHEMISTRY-US, V46, P424, DOI 10.1021/bi060787r; Kuznetsov NA, 2012, NUCLEIC ACIDS RES, V40, P7384, DOI 10.1093/nar/gks423; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lee S, 2008, J AM CHEM SOC, V130, P7784, DOI 10.1021/ja800821t; Manuel RC, 2004, J BIOL CHEM, V279, P46930, DOI 10.1074/jbc.M403944200; McKibbin PL, 2012, J AM CHEM SOC, V134, P1653, DOI 10.1021/ja208510m; Nash HM, 1997, CHEM BIOL, V4, P693, DOI 10.1016/S1074-5521(97)90225-8; Norman DPG, 2003, BIOCHEMISTRY-US, V42, P1564, DOI 10.1021/bi026823d; Norman DPG, 2001, J AM CHEM SOC, V123, P359, DOI 10.1021/ja003144m; Peracchi A, 2001, TRENDS BIOCHEM SCI, V26, P497, DOI 10.1016/S0968-0004(01)01911-9; Perlow-Poehnelt RA, 2004, BIOCHEMISTRY-US, V43, P16092, DOI 10.1021/bi048747f; Popov AV, 2010, MOL BIOL+, V44, P648, DOI 10.1134/S0026893310040217; Popov AV, 2013, J COMPUT CHEM, V34, P319, DOI 10.1002/jcc.23135; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Radom CT, 2007, J BIOL CHEM, V282, P9182, DOI 10.1074/jbc.M608989200; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Sidorenko VS, 2007, DNA REPAIR, V6, P317, DOI 10.1016/j.dnarep.2006.10.022; Sonntag von C., 2006, FREE RADICAL INDUCED, P377; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Vorobjev Y. N., 2005, MOL BIOL, V39, P777; Vorobjev YN, 2011, ADV PROTEIN CHEM STR, V85, P281, DOI 10.1016/B978-0-12-386485-7.00008-9; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200; Zharkov DO, 2005, MUTAT RES-FUND MOL M, V577, P24, DOI 10.1016/j.mrfmmm.2005.03.011	47	22	23	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28936	28947		10.1074/jbc.M113.487322	http://dx.doi.org/10.1074/jbc.M113.487322			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23955443	Green Published, hybrid			2022-12-28	WOS:000330298800045
J	Masuda, I; Sakaguchi, R; Liu, CP; Gamper, H; Hou, YM				Masuda, Isao; Sakaguchi, Reiko; Liu, Cuiping; Gamper, Howard; Hou, Ya-Ming			The Temperature Sensitivity of a Mutation in the Essential tRNA Modification Enzyme tRNA Methyltransferase D (TrmD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Protein Folding; RNA Methyltransferase; RNA Modification; Transfer RNA (tRNA); TrmD; m1G37-tRNA Modification; Methyl Transfer; Trefoil Knot Fold	TRANSFER RNA(M1G)METHYLTRANSFERASE; STRUCTURAL ALTERATIONS; GENE TRMD; TRANSLATION; DETERMINANTS; RECOGNITION; INSIGHTS	Conditional temperature-sensitive (ts) mutations are important reagents to study essential genes. Although it is commonly assumed that the ts phenotype of a specific mutation arises from thermal denaturation of the mutant enzyme, the possibility also exists that the mutation decreases the enzyme activity to a certain level at the permissive temperature and aggravates the negative effect further upon temperature upshifts. Resolving these possibilities is important for exploiting the ts mutation for studying the essential gene. The trmD gene is essential for growth in bacteria, encoding the enzyme for converting G37 to m(1)G37 on the 3 side of the tRNA anticodon. This conversion involves methyl transfer from S-adenosyl methionine and is critical to minimize tRNA frameshift errors on the ribosome. Using the ts-S88L mutation of Escherichia coli trmD as an example, we show that although the mutation confers thermal lability to the enzyme, the effect is relatively minor. In contrast, the mutation decreases the catalytic efficiency of the enzyme to 1% at the permissive temperature, and at the nonpermissive temperature, it renders further deterioration of activity to 0.1%. These changes are accompanied by losses of both the quantity and quality of tRNA methylation, leading to the potential of cellular pleiotropic effects. This work illustrates the principle that the ts phenotype of an essential gene mutation can be closely linked to the catalytic defect of the gene product and that such a mutation can provide a useful tool to study the mechanism of catalytic inactivation.	[Masuda, Isao; Sakaguchi, Reiko; Liu, Cuiping; Gamper, Howard; Hou, Ya-Ming] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Hou, YM (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St,BLSB 220, Philadelphia, PA 19107 USA.	ya-ming.hou@jefferson.edu	Masuda, Isao/X-8797-2019	Masuda, Isao/0000-0001-9385-4424; Hou, Ya-Ming/0000-0001-6546-2597	National Institutes of Health [GM081601]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM108972, R01GM108972, R01GM081601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081601 (to Y.M.H.).	Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269; Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Bjork GR, 2003, J BACTERIOL, V185, P750, DOI 10.1128/JB.185.3.750-759.2003; BJORK GR, 1989, SCIENCE, V244, P986, DOI 10.1126/science.2471265; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; BYSTROM AS, 1982, MOL GEN GENET, V188, P447, DOI 10.1007/BF00330047; BYSTROM AS, 1982, MOL GEN GENET, V188, P440, DOI 10.1007/BF00330046; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Chen R, 2008, MOL BIOTECHNOL, V40, P224, DOI 10.1007/s12033-008-9078-z; Christian T, 2004, J MOL BIOL, V339, P707, DOI 10.1016/j.jmb.2004.04.025; Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010; Christian T, 2010, J MOL BIOL, V400, P204, DOI 10.1016/j.jmb.2010.05.003; CLARK DJ, 1988, EMBO J, V7, P69, DOI 10.1002/j.1460-2075.1988.tb02784.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Bie LGS, 2003, J BACTERIOL, V185, P3238, DOI 10.1128/JB.185.10.3238-3243.2003; Elkins PA, 2003, J MOL BIOL, V333, P931, DOI 10.1016/j.jmb.2003.09.011; Guisbert E, 2004, GENE DEV, V18, P2812, DOI 10.1101/gad.1219204; HAGERVALL TG, 1993, J MOL BIOL, V232, P756, DOI 10.1006/jmbi.1993.1429; Hou YM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj018; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Li JN, 1999, RNA, V5, P395, DOI 10.1017/S1355838299980834; Nasvall SJ, 2009, J MOL BIOL, V385, P350, DOI 10.1016/j.jmb.2008.10.069; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; O'Dwyer K, 2004, J BACTERIOL, V186, P2346, DOI 10.1128/JB.186.8.2346-2354.2004; Patil A, 2012, CELL CYCLE, V11, P3656, DOI 10.4161/cc.21919; Qian Q, 1997, J MOL BIOL, V273, P978, DOI 10.1006/jmbi.1997.1363; Redlak M, 1997, BIOCHEMISTRY-US, V36, P8699, DOI 10.1021/bi9701538; Sakaguchi R, 2012, RNA, V18, P1687, DOI 10.1261/rna.032029.111; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; WIKSTROM PM, 1988, J BACTERIOL, V170, P3025, DOI 10.1128/jb.170.7.3025-3031.1988; Yi CQ, 2011, ACCOUNTS CHEM RES, V44, P1380, DOI 10.1021/ar200057m; Yokogawa T, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1182	38	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28987	28996		10.1074/jbc.M113.485797	http://dx.doi.org/10.1074/jbc.M113.485797			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23986443	Green Published, hybrid			2022-12-28	WOS:000330298800053
J	Qiu, JY; Ashkenazi, A; Liu, SW; Shai, Y				Qiu, Jiayin; Ashkenazi, Avraham; Liu, Shuwen; Shai, Yechiel			Structural and Functional Properties of the Membranotropic HIV-1 Glycoprotein gp41 Loop Region Are Modulated by Its Intrinsic Hydrophobic Core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; HIV-1; Membrane Fusion; Membrane Proteins; Peptide Conformation; Peptide-Membrane Interaction; Viral Fusion Protein	IMMUNODEFICIENCY-VIRUS TYPE-1; 2 IMMUNODOMINANT DOMAINS; ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION; CELL FUSION; ECTODOMAIN; PEPTIDE; PROTEIN; MODEL; ANTIBODIES	The gp41 disulfide loop region switches from a soluble state to a membrane-bound state during the human immunodeficiency virus type 1 (HIV-1) envelope-mediated membrane fusion process. The loop possesses a hydrophobic core at the center of the region with an unusual basic residue (Lys-601). Furthermore, two loop core mutations, K601A and L602A, are found to inhibit HIV-1 infectivity while keeping wild type-like levels of the envelope, implying that they exert an inhibitory effect on gp41 during the membrane fusion event. Here, we investigated the mode of action of these mutations on the loop region. We show that the K601A mutation, but not the L602A mutation, abolished the binding of a loop-specific monoclonal antibody to a loop domain peptide. Additionally, the K601A, but not the L602A, impaired disulfide bond formation in the peptides. This was correlated with changes in the circular dichroism spectrum imposed by the K601A mutation. In the membrane, however, the L602A, but not the K601A, reduced the lipid mixing ability of the loop peptides, which was correlated with decreased -helical content of the L602A mutant. The results suggest that the Lys-601 residue provides a moderate hydrophobicity level within the gp41 loop core that contributes to the proper structure and function of the loop inside and outside the membrane. Because basic residues are found between the loop Cys residues of several lentiviral fusion proteins, the findings may contribute to understanding the fusion mechanism of other viruses as well.	[Qiu, Jiayin; Ashkenazi, Avraham; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Qiu, Jiayin; Liu, Shuwen] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou 510515, Guangdong, Peoples R China	Weizmann Institute of Science; Southern Medical University - China	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Yechiel.Shai@weizmann.ac.il		Ashkenazi, Avraham/0000-0002-1253-497X; Liu, Shuwen/0000-0001-6346-5006	Israel Science Foundation [988/09]; Science region is the existence of a basic residue (Lys-601) at the center and Technology Planning Project of Guangdong Province, China [2011B050200006]; Oversea Study Program of Guangzhou Elite Project, China	Israel Science Foundation(Israel Science Foundation); Science region is the existence of a basic residue (Lys-601) at the center and Technology Planning Project of Guangdong Province, China; Oversea Study Program of Guangzhou Elite Project, China	This work was supported by the Israel Science Foundation (988/09), Science region is the existence of a basic residue (Lys-601) at the center and Technology Planning Project of Guangdong Province, China (2011B050200006), and by the Oversea Study Program of Guangzhou Elite Project, China (a fellowship to J. Q.).	Ashkenazi A, 2013, BLOOD, V121, P2244, DOI 10.1182/blood-2012-11-468900; Ashkenazi A, 2012, BIOCHEMISTRY-US, V51, P6981, DOI 10.1021/bi300868f; Ashkenazi A, 2011, FASEB J, V25, P2156, DOI 10.1096/fj.10-175752; Bar S, 2004, J VIROL, V78, P811, DOI 10.1128/JVI.78.2.811-820.2004; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Caffrey M, 2001, BBA-MOL BASIS DIS, V1536, P116, DOI 10.1016/S0925-4439(01)00042-4; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Earl PL, 1997, J VIROL, V71, P2674, DOI 10.1128/JVI.71.4.2674-2684.1997; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; FREED EO, 1990, P NATL ACAD SCI USA, V87, P4650, DOI 10.1073/pnas.87.12.4650; GALLAHER WR, 1989, AIDS RES HUM RETROV, V5, P431, DOI 10.1089/aid.1989.5.431; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Granseth E, 2005, J MOL BIOL, V346, P377, DOI 10.1016/j.jmb.2004.11.036; Jacobs A, 2005, J BIOL CHEM, V280, P27284, DOI 10.1074/jbc.M414411200; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Lev N, 2007, J MOL BIOL, V374, P220, DOI 10.1016/j.jmb.2007.09.008; Maerz AL, 2001, J VIROL, V75, P6635, DOI 10.1128/JVI.75.14.6635-6644.2001; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; Meers P, 2000, BBA-BIOMEMBRANES, V1467, P227, DOI 10.1016/S0005-2736(00)00224-8; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; Moreno MR, 2006, BBA-BIOMEMBRANES, V1758, P111, DOI 10.1016/j.bbamem.2006.01.007; Pascual R, 2005, J VIROL, V79, P5142, DOI 10.1128/JVI.79.8.5142-5152.2005; Peisajovich SG, 2003, J MOL BIOL, V326, P1489, DOI 10.1016/S0022-2836(03)00040-8; Poranen MM, 2002, ANNU REV MICROBIOL, V56, P521, DOI 10.1146/annurev.micro.56.012302.160643; ROBINSON WE, 1991, J VIROL, V65, P4169, DOI 10.1128/JVI.65.8.4169-4176.1991; SCHULZ TF, 1992, AIDS RES HUM RETROV, V8, P1571, DOI 10.1089/aid.1992.8.1571; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; SYU WJ, 1991, J VIROL, V65, P6349, DOI 10.1128/JVI.65.11.6349-6352.1991; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wexler-Cohen Y, 2010, FASEB J, V24, P4196, DOI 10.1096/fj.09-151704; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	37	4	4	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29143	29150		10.1074/jbc.M113.496646	http://dx.doi.org/10.1074/jbc.M113.496646			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23960077	Green Published, hybrid			2022-12-28	WOS:000330298800067
J	Kong, RCK; Petrie, EJ; Mohanty, B; Ling, J; Lee, JCY; Gooley, PR; Bathgate, RAD				Kong, Roy C. K.; Petrie, Emma J.; Mohanty, Biswaranjan; Ling, Jason; Lee, Jeremy C. Y.; Gooley, Paul R.; Bathgate, Ross A. D.			The Relaxin Receptor (RXFP1) Utilizes Hydrophobic Moieties on a Signaling Surface of Its N-terminal Low Density Lipoprotein Class A Module to Mediate Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR-7; FAMILY PEPTIDE RECEPTORS; TORSION ANGLE DYNAMICS; PREGNANCY HORMONE; NMR ASSIGNMENT; HEART-FAILURE; RICH REPEAT; BINDING; LGR8; INSULIN-LIKE-PEPTIDE-3	The peptide hormone relaxin is showing potential as a treatment for acute heart failure. Although it is known that relaxin mediates its actions through the G protein-coupled receptor relaxin family peptide receptor 1 (RXFP1), little is known about the molecular mechanisms by which relaxin binding results in receptor activation. Previous studies have highlighted that the unique N-terminal low density lipoprotein class A (LDLa) module of RXFP1 is essential for receptor activation, and it has been hypothesized that this module is the true "ligand" of the receptor that directs the conformational changes necessary for G protein coupling. In this study, we confirmed that an RXFP1 receptor lacking the LDLa module binds ligand normally but cannot signal through any characterized G protein-coupled receptor signaling pathway. Furthermore, we comprehensively examined the contributions of amino acids in the LDLa module to RXFP1 activity using both gain-of-function and loss-of-function mutational analysis together with NMR structural analysis of recombinant LDLa modules. Gain-of-function studies with an inactive RXFP1 chimera containing the LDLa module of the human LDL receptor (LB2) demonstrated two key N-terminal regions of the module that were able to rescue receptor signaling. Loss-of-function mutations of residues in these regions demonstrated that Leu-7, Tyr-9, and Lys-17 all contributed to the ability of the LDLa module to drive receptor activation, and judicious amino acid substitutions suggested this involves hydrophobic interactions. Our results demonstrate that these key residues contribute to interactions driving the active receptor conformation, providing further evidence of a unique mode of G protein-coupled receptor activation.	[Kong, Roy C. K.; Bathgate, Ross A. D.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Kong, Roy C. K.; Bathgate, Ross A. D.] Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Kong, Roy C. K.; Petrie, Emma J.; Ling, Jason; Lee, Jeremy C. Y.; Gooley, Paul R.; Bathgate, Ross A. D.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Petrie, Emma J.; Ling, Jason; Lee, Jeremy C. Y.; Gooley, Paul R.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Mohanty, Biswaranjan] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Mohanty, Biswaranjan] Monash Univ, Australian Res Council, Ctr Excellence Coherent Xray Sci, Parkville, Vic 3052, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Monash University; Monash University	Bathgate, RAD (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.	bathgate@florey.edu.au	Bathgate, Ross/ABE-6471-2020; Mohanty, Biswaranjan/E-2080-2018	Bathgate, Ross/0000-0001-6301-861X; Mohanty, Biswaranjan/0000-0002-6921-343X; Petrie, Emma/0000-0002-9827-3378; Gooley, Paul/0000-0002-0323-449X; Kong, Roy Chze Khai/0000-0002-7881-9847	National Health and Medical Research Council of Australia [628427, 1043750]; Victorian Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported in part by National Health and Medical Research Council of Australia Project Grants 628427 and 1043750 (to R.A.D.B. and P.R.G.) and by the Victorian Government Operational Infrastructure Support Program.	Bani D, 1998, HYPERTENSION, V31, P1240, DOI 10.1161/01.HYP.31.6.1240; BANISACCHI T, 1995, BRIT J PHARMACOL, V116, P1589, DOI 10.1111/j.1476-5381.1995.tb16377.x; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Bathgate R. A. D., 2006, PHYSL REPROD, P679; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate RAD, 2006, BIOCHEMISTRY-US, V45, P1043, DOI 10.1021/bi052233e; Bieri S, 1998, BIOCHEMISTRY-US, V37, P10994, DOI 10.1021/bi980452c; Bogatcheva NV, 2007, AM J PHYSIOL-ENDOC M, V292, pE138, DOI 10.1152/ajpendo.00228.2006; Bullesbach EE, 2005, J BIOL CHEM, V280, P14051, DOI 10.1074/jbc.M500030200; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Cepko C., 2001, CURR PROTOC MOL BIOL; Dagil R, 2013, J BIOL CHEM, V288, P4424, DOI 10.1074/jbc.M112.434159; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; Dschietzig T, 2003, CIRC RES, V92, P32, DOI 10.1161/01.RES.0000051884.27117.7E; EVANS BA, 1994, J ENDOCRINOL, V140, P385, DOI 10.1677/joe.0.1400385; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fiorito F, 2008, J BIOMOL NMR, V42, P23, DOI 10.1007/s10858-008-9259-x; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Halls ML, 2007, J PHARMACOL EXP THER, V320, P281, DOI 10.1124/jpet.106.113225; Hartley BJ, 2009, ANN NY ACAD SCI, V1160, P67, DOI 10.1111/j.1749-6632.2009.03949.x; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hiller S, 2005, P NATL ACAD SCI USA, V102, P10876, DOI 10.1073/pnas.0504818102; Hopkins EJ, 2005, ANN NY ACAD SCI, V1041, P27, DOI 10.1196/annals.1282.006; Hopkins EJ, 2007, J BIOL CHEM, V282, P4172, DOI 10.1074/jbc.M609526200; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Hsu SYT, 2003, TRENDS ENDOCRIN MET, V14, P303, DOI 10.1016/S1043-2760(03)00106-1; Kern A, 2007, ENDOCRINOLOGY, V148, P1181, DOI 10.1210/en.2006-1086; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Scott DJ, 2007, MOL ENDOCRINOL, V21, P1699, DOI 10.1210/me.2007-0097; Scott DJ, 2012, MOL ENDOCRINOL, V26, P1896, DOI 10.1210/me.2012-1188; Scott DJ, 2006, J BIOL CHEM, V281, P34942, DOI 10.1074/jbc.M602728200; Segal MS, 2012, BLOOD, V119, P629, DOI 10.1182/blood-2011-04-346007; Svendsen AM, 2008, ENDOCRINOLOGY, V149, P1113, DOI 10.1210/en.2007-0412; Svendsen AM, 2008, MOL CELL ENDOCRINOL, V296, P10, DOI 10.1016/j.mce.2008.07.014; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Volk J, 2008, J BIOMOL NMR, V41, P127, DOI 10.1007/s10858-008-9243-5; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; Yan Y, 2008, BIOCHEMISTRY-US, V47, P6953, DOI 10.1021/bi800535b; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	43	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28138	28151		10.1074/jbc.M113.499640	http://dx.doi.org/10.1074/jbc.M113.499640			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23926099	Green Published, hybrid			2022-12-28	WOS:000330612800038
J	Akiyama, K; Noguchi, J; Hirose, M; Kajita, S; Katayama, K; Khalaj, M; Tsuji, T; Fairfield, H; Byers, C; Reinholdt, L; Ogura, A; Kunieda, T				Akiyama, Kouyou; Noguchi, Junko; Hirose, Michiko; Kajita, Shimpei; Katayama, Kentaro; Khalaj, Maryam; Tsuji, Takehito; Fairfield, Heather; Byers, Candice; Reinholdt, Laura; Ogura, Atsuo; Kunieda, Tetsuo			A Mutation in the Nuclear Pore Complex Gene Tmem48 Causes Gametogenesis Defects in Skeletal Fusions with Sterility (sks) Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXONIC SPLICING ENHANCERS; SPINDLE POLE BODIES; SACCHAROMYCES-CEREVISIAE; MOUSE SPERMATOCYTES; GERM-CELLS; IN-VITRO; MEIOSIS; NUCLEOPORIN; YEAST; NDC1	Skeletal fusions with sterility (sks) is an autosomal recessive mutation of mouse that results in male and female sterility because of defects in gametogenesis. The mutants also have skeletal malformations with fused vertebrae and ribs. We examined testicular phenotypes of sks/sks mice to investigate the defects in spermatogenesis. Histological and immunocytochemical analyses and expression analyses of the marker genes demonstrated that spermatogenesis is arrested at mid to late pachytene stage of meiotic prophase with defective synapsis of the homologous chromosomes. Next, we determined the precise chromosomal localization of the sks locus on a 0.3-Mb region of mouse chromosome 4 by linkage analysis. By sequencing the positional candidate genes in this region and whole exome sequencing, we found a GG to TT nucleotide substitution in exon 6 of the Tmem48 gene that encodes a putative transmembrane protein with six transmembrane domains. The nucleotide substitution causes aberrant splicing, which deletes exon 6 of the Tmem48 transcript. Specific expression of TMEM48 was observed in germ cells of males and females. Furthermore, the phenotypes of the sks mutant were completely rescued by the transgenesis of a genomic fragment containing the wild-type Tmem48 gene. These findings indicate that the Tmem48 mutation is responsible for the gametogenesis defects and skeletal malformations in the sks mice. The TMEM48 protein is a nuclear membrane protein comprising the nuclear pore complex; its exact function in the nuclear pore complex is still unknown. Our finding suggested that the nuclear pore complex plays an important role in mammalian gametogenesis and skeletal development.	[Akiyama, Kouyou; Tsuji, Takehito; Kunieda, Tetsuo] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Kajita, Shimpei; Katayama, Kentaro; Khalaj, Maryam] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Noguchi, Junko] Natl Inst Agrobiol Sci, Div Anim Sci, Tsukuba, Ibaraki 9058602, Japan; [Hirose, Michiko; Ogura, Atsuo] RIKEN Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan; [Fairfield, Heather; Byers, Candice; Reinholdt, Laura] Jackson Lab, Bar Harbor, ME 04609 USA	Okayama University; Okayama University; National Institute of Agrobiological Sciences - Japan; RIKEN; Jackson Laboratory	Kunieda, T (corresponding author), Okayama Univ, Grad Sch Environm & Life Sci, 1-1-1 Tsushima Naka, Okayama 7008530, Japan.	tkunieda@cc.okayama-u.ac.jp	Katayama, Kentaro/O-5296-2019; Ogura, Atsuo/J-3916-2014	Katayama, Kentaro/0000-0002-2859-0423; Ogura, Atsuo/0000-0003-0447-1988; Byers, Candice/0000-0003-2526-2843	Japan Science Society [18-130]; Japan Society for the Promotion of Science; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010972] Funding Source: NIH RePORTER	Japan Science Society; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by Sasakawa Scientific Research Grant 18-130 from the Japan Science Society and grants from the Japan Society for the Promotion of Science.	Akiyama K, 2008, J REPROD DEVELOP, V54, P122, DOI 10.1262/jrd.19186; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; BYERS B, 1978, J CELL SCI, V30, P331; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chatel G, 2011, CELL SIGNAL, V23, P1555, DOI 10.1016/j.cellsig.2011.05.023; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; Dix DJ, 1997, DEVELOPMENT, V124, P4595; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Fairfield H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r86; Gigliotti S, 1998, J CELL BIOL, V142, P1195, DOI 10.1083/jcb.142.5.1195; HANDEL MA, 1988, GAMETE RES, V21, P409, DOI 10.1002/mrd.1120210409; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; HYAMS JS, 1978, J CELL BIOL, V78, P401, DOI 10.1083/jcb.78.2.401; La Salle S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095752; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Noguchi J, 2008, J REPROD DEVELOP, V54, P203, DOI 10.1262/jrd.19158; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Scherthan H, 2001, NAT REV MOL CELL BIO, V2, P621, DOI 10.1038/35085086; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Sun FY, 2010, DEVELOPMENT, V137, P1699, DOI 10.1242/dev.043125; THOMAS JH, 1986, CELL, V44, P65, DOI 10.1016/0092-8674(86)90485-X; Vuillaumier-Barrot S, 1999, Hum Mutat, V14, P543, DOI 10.1002/(SICI)1098-1004(199912)14:6<543::AID-HUMU17>3.0.CO;2-S; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; WINEY M, 1993, J CELL BIOL, V122, P743, DOI 10.1083/jcb.122.4.743; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	31	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31830	31841		10.1074/jbc.M113.492306	http://dx.doi.org/10.1074/jbc.M113.492306			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045954	hybrid, Green Published			2022-12-28	WOS:000330596200033
J	Ferreyra, MLF; Rodriguez, E; Casas, MI; Labadie, G; Grotewold, E; Casati, P				Falcone Ferreyra, Maria Lorena; Rodriguez, Eduardo; Casas, Maria Isabel; Labadie, Guillermo; Grotewold, Erich; Casati, Paula			Identification of a Bifunctional Maize C- and O-Glucosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYL FLAVONOID PHYTOALEXINS; QUANTITATIVE TRAIT LOCI; UV-B; CRYSTAL-STRUCTURES; GLYCOSYLTRANSFERASES; EXPRESSION; LEAVES; MAYSIN; YEAST; L.	Flavonoids accumulate in plant vacuoles usually as O-glycosylated derivatives, but several species can also synthesize flavonoid C-glycosides. Recently, we demonstrated that a flavanone 2-hydroxylase (ZmF2H1, CYP93G5) converts flavanones to the corresponding 2-hydroxy derivatives, which are expected to serve as substrates for C-glycosylation. Here, we isolated ac DNA encoding a UDP-dependent glycosyltransferase (UGT708A6), and its activity was characterized by in vitro and in vivo bioconversion assays. In vitro assays using 2-hydroxyflavanones as substrates and in vivo activity assays in yeast co-expressing ZmF2H1 and UGT708A6 show the formation of the flavones C-glycosides. UGT708A6 can also O-glycosylate flavanones in bioconversion assays in Escherichia coli as well as by in vitro assays with the purified recombinant protein. Thus, UGT708A6 is a bifunctional glycosyltransferase that can produce both C-and O-glycosidated flavonoids, a property not previously described for any other glycosyltransferase.	[Falcone Ferreyra, Maria Lorena; Casati, Paula] Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim, RA-2000 Rosario, Santa Fe, Argentina; [Rodriguez, Eduardo] Univ Nacl Rosario, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Labadie, Guillermo] Univ Nacl Rosario, Inst Quim Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Casas, Maria Isabel] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [Casas, Maria Isabel; Grotewold, Erich] Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA; [Grotewold, Erich] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Grotewold, Erich] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA	National University of Rosario; National University of Rosario; National University of Rosario; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Casati, P (corresponding author), Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim, S2002LRK, RA-2000 Rosario, Santa Fe, Argentina.	casati@cefobi-conicet.gov.ar	Casas, Maria/M-2393-2016; Labadie, Guillermo/I-1401-2015	Casas, Maria/0000-0002-1395-9646; Labadie, Guillermo/0000-0003-2467-1573; Grotewold, Erich/0000-0002-4720-7290; Falcone Ferreyra, Maria Lorena/0000-0001-5235-3252	United States Department of Agriculture [2010-65115-20408]; National Science Foundation [IOS-1125620]; Fondo para la Investigacion Cientifica y Tecnologica [PICT-2006-00957, PICT-2010-00105]; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Excellence in Plant Molecular Biology/Biotechnology graduate fellowship	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Fondo para la Investigacion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Excellence in Plant Molecular Biology/Biotechnology graduate fellowship	This work was supported in part by United States Department of Agriculture Grant 2010-65115-20408 and National Science Foundation Grant IOS-1125620 (to E. G.), Fondo para la Investigacion Cientifica y Tecnologica Grants PICT-2006-00957 and PICT-2010-00105 (to P. C. and E. G.), and grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (to L. F. F.).; Supported by an Excellence in Plant Molecular Biology/Biotechnology graduate fellowship.	Abad-Garcia B, 2008, RAPID COMMUN MASS SP, V22, P1834, DOI 10.1002/rcm.3560; Akashi T, 1998, FEBS LETT, V431, P287, DOI 10.1016/S0014-5793(98)00781-9; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Bowles D, 2010, ENCY LIFE SCI ELS, DOI [10.1002/9780470015902.a0021537, DOI 10.1002/9780470015902.A0021537]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Brazier-Hicks M, 2013, METAB ENG, V16, P11, DOI 10.1016/j.ymben.2012.11.004; Brazier-Hicks M, 2009, J BIOL CHEM, V284, P17926, DOI 10.1074/jbc.M109.009258; Byrne PF, 1996, P NATL ACAD SCI USA, V93, P8820, DOI 10.1073/pnas.93.17.8820; Caasi-Lit MT, 2007, PHOTOCHEM PHOTOBIOL, V83, P1167, DOI 10.1111/j.1751-1097.2007.00125.x; Caputi L, 2012, PLANT J, V69, P1030, DOI 10.1111/j.1365-313X.2011.04853.x; Casati P, 2005, PLANT CELL ENVIRON, V28, P788, DOI 10.1111/j.1365-3040.2005.01329.x; Du YG, 2010, PLANT PHYSIOL, V154, P324, DOI 10.1104/pp.110.161042; Durr C, 2004, ANGEW CHEM INT EDIT, V43, P2962, DOI 10.1002/anie.200453758; El-Alfy Taha S, 2011, Sci Pharm, V79, P963, DOI 10.3797/scipharm.1108-19; Eveland AL, 2010, PLANT PHYSIOL, V154, P1024, DOI 10.1104/pp.110.159673; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Francisco RM, 2013, PLANT CELL, V25, P1840, DOI 10.1105/tpc.112.102152; FURTEK D, 1988, PLANT MOL BIOL, V11, P473, DOI 10.1007/BF00039028; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Gueldner R. C., 1989, 197 198 NAT M AM CHE, P251; Harborne, 1993, FLAVONOIDS INSECTS; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; KERSCHER F, 1988, J PLANT PHYSIOL, V132, P110, DOI 10.1016/S0176-1617(88)80193-7; KROON J, 1994, PLANT J, V5, P69, DOI 10.1046/j.1365-313X.1994.5010069.x; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee EM, 2010, MOLECULES, V15, P8251, DOI 10.3390/molecules15118251; Markham KR, 1998, PHYTOCHEMISTRY, V49, P1913, DOI 10.1016/S0031-9422(98)00438-5; McMullen MD, 2004, J HERED, V95, P225, DOI 10.1093/jhered/esh042; McMullen MD, 1998, P NATL ACAD SCI USA, V95, P1996, DOI 10.1073/pnas.95.5.1996; McNally DJ, 2003, PHYSIOL MOL PLANT P, V63, P293, DOI 10.1016/j.pmpp.2004.03.005; McNally DJ, 2003, J NAT PROD, V66, P1280, DOI 10.1021/np030150y; Morohashi K, 2012, PLANT CELL, V24, P2745, DOI 10.1105/tpc.112.098004; Nichenametla SN, 2006, CRIT REV FOOD SCI, V46, P161, DOI 10.1080/10408390591000541; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Patil BS, 2009, J AGR FOOD CHEM, V57, P8142, DOI 10.1021/jf9000132; Payyavula RS, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-151; Peiru S, 2005, APPL ENVIRON MICROB, V71, P2539, DOI 10.1128/AEM.71.5.2539-2547.2005; RALSTON EJ, 1988, GENETICS, V119, P185; Rozen S, 2000, Methods Mol Biol, V132, P365; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schreiber SL, 2007, NAT CHEM BIOL, V3, P352, DOI 10.1038/nchembio0707-352; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; SNOOK ME, 1995, J AGR FOOD CHEM, V43, P2740, DOI 10.1021/jf00058a036; SNOOK ME, 1989, J CHROMATOGR, V477, P439, DOI 10.1016/S0021-9673(01)89654-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tapas AR, 2008, TROP J PHARM RES, V7, P1089; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Vaistij FE, 2009, PLANT-DERIVED NATURAL PRODUCTS: SYNTHESIS, FUNCTION, AND APPLICATION, P209, DOI 10.1007/978-0-387-85498-4_10; Zhang JA, 2007, PLANT PHYSIOL, V144, P741, DOI 10.1104/pp.106.095018	55	91	96	1	61	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31678	31688		10.1074/jbc.M113.510040	http://dx.doi.org/10.1074/jbc.M113.510040			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045947	Green Published, hybrid			2022-12-28	WOS:000330596200026
J	Ferrero, JJ; Alvarez, AM; Ramirez-Franco, J; Godino, MC; Bartolome-Martin, D; Aguado, C; Torres, M; Lujan, R; Ciruela, F; Sanchez-Prieto, J				Ferrero, Jose J.; Alvarez, Ana M.; Ramirez-Franco, Jorge; Godino, Maria C.; Bartolome-Martin, David; Aguado, Carolina; Torres, Magdalena; Lujan, Rafael; Ciruela, Francisco; Sanchez-Prieto, Jose			beta-Adrenergic Receptors Activate Exchange Protein Directly Activated by cAMP (Epac), Translocate Munc13-1, and Enhance the Rab3A-RIM1 alpha Interaction to Potentiate Glutamate Release at Cerebrocortical Nerve Terminals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; PHOSPHOLIPASE-C; RIM PROTEINS; KINASE-C; METABOTROPIC GLUTAMATE-RECEPTOR-7; NEUROTRANSMITTER RELEASE; PYRAMIDAL NEURONS	The adenylyl cyclase activator forskolin facilitates synaptic transmission presynaptically via cAMP-dependent protein kinase (PKA). In addition, cAMP also increases glutamate release via PKA-independent mechanisms, although the downstream presynaptic targets remain largely unknown. Here, we describe the isolation of a PKA-independent component of glutamate release in cerebrocortical nerve terminals after blocking Na+ channels with tetrodotoxin. We found that 8-pCPT-2 '-O-Me- cAMP, a specific activator of the exchange protein directly activated by cAMP (Epac), mimicked and occluded forskolin-induced potentiation of glutamate release. This Epac-mediated increase in glutamate release was dependent on phospholipase C, and it increased the hydrolysis of phosphatidylinositol 4,5-bisphosphate. Moreover, the potentiation of glutamate release by Epac was independent of protein kinase C, although it was attenuated by the diacylglycerol-binding site antagonist calphostin C. Epac activation translocated the active zone protein Munc13-1 from soluble to particulate fractions; it increased the association between Rab3A and RIM1 alpha and redistributed synaptic vesicles closer to the presynaptic membrane. Furthermore, these responses were mimicked by the beta-adrenergic receptor (beta AR) agonist isoproterenol, consistent with the immunoelectron microscopy and immunocytochemical data demonstrating presynaptic expression of beta ARs in a subset of glutamatergic synapses in the cerebral cortex. Based on these findings, we conclude that beta ARs couple to a cAMP/Epac/PLC/Munc13/Rab3/RIM-dependent pathway to enhance glutamate release at cerebrocortical nerve terminals.	[Ferrero, Jose J.; Alvarez, Ana M.; Ramirez-Franco, Jorge; Godino, Maria C.; Bartolome-Martin, David; Torres, Magdalena; Sanchez-Prieto, Jose] Univ Complutense, Fac Vet, Dept Bioquim, E-28040 Madrid, Spain; [Aguado, Carolina; Lujan, Rafael] Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, Albacete 02006, Spain; [Ciruela, Francisco] Univ Barcelona, Fac Med, IDIBELL, Dept Patol & Terapeut Expt,Unitat Farmacol, Barcelona 08907, Spain	Complutense University of Madrid; Universidad de Castilla-La Mancha; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Sanchez-Prieto, J (corresponding author), Univ Complutense, Fac Vet, Dept Bioquim, E-28040 Madrid, Spain.	jsprieto@vet.ucm.es	Lujan, Rafael/G-2555-2015; Ramirez-Franco, Jorge/J-1082-2018; Martín, David Bartolomé/AAX-5855-2020; Torres, Magdalena/E-6150-2017; Ciruela, F./A-5096-2013; Aguado, Carolina CA/G-3067-2015	Ramirez-Franco, Jorge/0000-0002-2426-6140; Martín, David Bartolomé/0000-0003-0258-7477; Torres, Magdalena/0000-0002-3893-8569; Ciruela, F./0000-0003-0832-3739; Aguado, Carolina CA/0000-0003-0265-8124; Ferrero Lopez, Jose J/0000-0002-4043-3906; Sanchez-Prieto, Jose/0000-0002-8513-3501; Lujan Miras, Rafael/0000-0003-2001-9545	Spanish Ministerio de Educacion y Ciencia [BFU2010-16947, SAF2011-24779, CSD2008-00005]; CONSOLIDER [CSD2008-00005]; Instituto de Salud Carlos III [RD06/0026, RD12/0014]; Comunidad de Madrid [CAM-I2M2 2011-BMD-2349]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by Spanish Ministerio de Educacion y Ciencia Grants BFU2010-16947 (to J.S.-P.) and SAF2011-24779 and CSD2008-00005 (to F. C.) and CONSOLIDER (CSD2008-00005) (to R. L. and F. C.), Instituto de Salud Carlos III Grants RD06/0026 and RD12/0014, and Comunidad de Madrid Grant CAM-I2M2 2011-BMD-2349 (to J.S.-P. and M.T.).	AOKI C, 1989, BRAIN RES, V493, P331, DOI 10.1016/0006-8993(89)91168-2; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; CHEN TC, 1995, J BIOL CHEM, V270, P7750, DOI 10.1074/jbc.270.13.7750; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; Dulubova I, 2005, EMBO J, V24, P2839, DOI 10.1038/sj.emboj.7600753; Dzhura I, 2011, ISLETS, V3, P121, DOI 10.4161/isl.3.3.15507; FYKSE EM, 1995, J NEUROSCI, V15, P2385, DOI 10.1523/JNEUROSCI.15-03-02385.1995; Gekel I, 2008, J NEUROSCI, V28, P7991, DOI 10.1523/JNEUROSCI.0268-08.2008; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; HELL JW, 1995, EMBO J, V14, P3036, DOI 10.1002/j.1460-2075.1995.tb07306.x; HERRERO I, 1991, NEUROSCI LETT, V126, P41, DOI 10.1016/0304-3940(91)90366-2; Herrero I, 1996, J BIOL CHEM, V271, P30554, DOI 10.1074/jbc.271.48.30554; Huang CC, 2006, MOL PHARMACOL, V69, P846, DOI 10.1124/mol.105.018093; Huang CC, 1996, J NEUROSCI, V16, P1026; Hurley JH, 1997, PROTEIN SCI, V6, P477; Ji XH, 2008, CEREB CORTEX, V18, P1506, DOI 10.1093/cercor/bhm177; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kalla S, 2006, J NEUROSCI, V26, P13054, DOI 10.1523/JNEUROSCI.4330-06.2006; Kaneko M, 2004, J NEUROSCI, V24, P5202, DOI 10.1523/JNEUROSCI.0999-04.2004; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kobayashi M, 2009, SYNAPSE, V63, P269, DOI 10.1002/syn.20604; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Leenders AGM, 2001, MOL BIOL CELL, V12, P3095, DOI 10.1091/mbc.12.10.3095; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Lou XL, 2008, J NEUROSCI, V28, P8257, DOI 10.1523/JNEUROSCI.0550-08.2008; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; Martin R, 2011, J NEUROCHEM, V116, P476, DOI 10.1111/j.1471-4159.2010.07134.x; Martin R, 2010, J BIOL CHEM, V285, P17907, DOI 10.1074/jbc.M109.080838; Millan C, 2003, J NEUROCHEM, V87, P1101, DOI 10.1046/j.1471-4159.2003.02065.x; Millan C, 2003, J BIOL CHEM, V278, P23955, DOI 10.1074/jbc.M211471200; Millan C, 2002, J BIOL CHEM, V277, P14092, DOI 10.1074/jbc.M109044200; MURPHY BJ, 1993, J BIOL CHEM, V268, P27355; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Park JH, 2012, ENDOCRINOLOGY, V153, P574, DOI 10.1210/en.2011-0259; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rodriguez-Castaneda F, 2010, EMBO J, V29, P680, DOI 10.1038/emboj.2009.373; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Shen N, 2005, BIOCHEMISTRY-US, V44, P1089, DOI 10.1021/bi0476127; Simsek-Duran F, 2004, NAT NEUROSCI, V7, P1296, DOI 10.1038/nn1348; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Trinquet E, 2006, ANAL BIOCHEM, V358, P126, DOI 10.1016/j.ab.2006.08.002; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2003, GENOMICS, V81, P126, DOI 10.1016/S0888-7543(02)00024-1; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Yang Y, 2012, NEURON, V73, P774, DOI 10.1016/j.neuron.2012.02.003; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang CL, 2009, SCIENCE, V325, P607, DOI 10.1126/science.1172256; Zhong N, 2005, J NEUROSCI, V25, P208, DOI 10.1523/JNEUROSCI.3703-04.2005	70	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31370	31385		10.1074/jbc.M113.463877	http://dx.doi.org/10.1074/jbc.M113.463877			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24036110	Green Published, hybrid			2022-12-28	WOS:000330778900054
J	Mao, XM; Sun, N; Wang, F; Luo, S; Zhou, Z; Feng, WH; Huang, FL; Li, YQ				Mao, Xu-Ming; Sun, Ning; Wang, Feng; Luo, Shuai; Zhou, Zhan; Feng, Wei-Hong; Huang, Fang-Liang; Li, Yong-Quan			Dual Positive Feedback Regulation of Protein Degradation of an Extra-cytoplasmic Function sigma Factor for Cell Differentiation in Streptomyces coelicolor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; MYCOBACTERIUM-TUBERCULOSIS; ANTIBIOTIC BIOSYNTHESIS; OXIDATIVE STRESS; GENE-EXPRESSION; TRANSCRIPTION; PROTEOLYSIS; SYSTEM; A3(2); ACTINORHODIN	Here we report that in Streptomyces coelicolor, the protein stability of an ECF sigma factor SigT, which is involved in the negative regulation of cell differentiation, was completely dependent on its cognate anti-sigma factor RstA. The degradation of RstA caused a ClpP/SsrA-dependent degradation of SigT during cell differentiation. This was consistent with the delayed morphological development or secondary metabolism in the Delta clpP background after rstA deletion or sigT overexpression. Meanwhile, SigT negatively regulated clpP/ssrA expression by directly binding to the clpP promoter (clpPp). The SigT-clpPp interaction could be disrupted by secondary metabolites, giving rise to the stabilized SigT protein and retarded morphological development in a non-antibiotic-producing mutant. Thus a novel regulatory mechanism was revealed that the protein degradation of the ECF sigma factor was initiated by the degradation of its anti-sigma factor, and was accelerated in a dual positive feedback manner, through regulation by secondary metabolites, to promote rapid and irreversible development of the secondary metabolism. This ingenious cooperation of intracellular components can ensure economical and exquisite control of the ECF sigma factor protein level for the proper cell differentiation in Streptomyces.	[Mao, Xu-Ming; Sun, Ning; Wang, Feng; Luo, Shuai; Zhou, Zhan; Feng, Wei-Hong; Huang, Fang-Liang; Li, Yong-Quan] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Mao, Xu-Ming; Sun, Ning; Wang, Feng; Luo, Shuai; Zhou, Zhan; Feng, Wei-Hong; Huang, Fang-Liang; Li, Yong-Quan] Key Lab Microbial Biochem & Metab Engn Zhejiang P, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Li, YQ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	lyq@zju.edu.cn	Zhou, Zhan/I-2372-2013; Mao, Xu-Ming/AAI-4212-2020	Zhou, Zhan/0000-0002-2730-5483; 	National Basic Research Program of China (973 Program) [2012CB721005]; National Science Foundation of China [31070040]; National High Technology Research and Development Program of China (863 Program) [2012AA02A706]; National Science and Technology Major Projects for "Major New Drugs Innovation and Development" Grant [2011ZX09202-101-11]; Specialized Research Fund for the Doctoral Program of Higher Education Grant [20120101110143]; Chinese Scholarship Council [201208330062]; Zhejiang University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science and Technology Major Projects for "Major New Drugs Innovation and Development" Grant; Specialized Research Fund for the Doctoral Program of Higher Education Grant; Chinese Scholarship Council(China Scholarship Council); Zhejiang University	This work was supported by National Basic Research Program of China (973 Program) Grant 2012CB721005, National Science Foundation of China Grant 31070040, National High Technology Research and Development Program of China (863 Program) Grant 2012AA02A706, National Science and Technology Major Projects for "Major New Drugs Innovation and Development" Grant 2011ZX09202-101-11 and Specialized Research Fund for the Doctoral Program of Higher Education Grant 20120101110143. This work was also supported by fellowships from Chinese Scholarship Council (201208330062) and New Star Project from Zhejiang University.	Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bibb MJ, 2012, MOL MICROBIOL, V84, P1033, DOI 10.1111/j.1365-2958.2012.08070.x; Bibb MJ, 2003, J BACTERIOL, V185, P2338, DOI 10.1128/JB.185.7.2338-2345.2003; Dalton KA, 2007, MOL MICROBIOL, V64, P719, DOI 10.1111/j.1365-2958.2007.05684.x; Damron FH, 2011, J BACTERIOL, V193, P286, DOI 10.1128/JB.01132-10; de Crecy-Lagard V, 1999, MOL MICROBIOL, V32, P505, DOI 10.1046/j.1365-2958.1999.01364.x; Feng WH, 2011, APPL MICROBIOL BIOT, V92, P1009, DOI 10.1007/s00253-011-3619-2; Gehring AM, 2001, J BACTERIOL, V183, P5991, DOI 10.1128/JB.183.20.5991-5996.2001; Gomez-Escribano JP, 2011, MICROB BIOTECHNOL, V4, P207, DOI 10.1111/j.1751-7915.2010.00219.x; Gomez-Santos N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002106; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Heinrich J, 2006, MOL MICROBIOL, V62, P566, DOI 10.1111/j.1365-2958.2006.05391.x; Heinrich J, 2009, MOL MICROBIOL, V74, P1412, DOI 10.1111/j.1365-2958.2009.06940.x; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Ho TD, 2012, CURR OPIN MICROBIOL, V15, P182, DOI 10.1016/j.mib.2012.01.001; Ho TD, 2011, J BACTERIOL, V193, P6215, DOI 10.1128/JB.05467-11; Hong HJ, 2002, MOL MICROBIOL, V44, P1199, DOI 10.1046/j.1365-2958.2002.02960.x; Huang JQ, 2001, GENE DEV, V15, P3183, DOI 10.1101/gad.943401; Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim MS, 2009, MOL MICROBIOL, V73, P815, DOI 10.1111/j.1365-2958.2009.06824.x; Li QL, 2013, J BACTERIOL, V195, P2232, DOI 10.1128/JB.00054-13; Liu JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040885; Mao XM, 2013, J BACTERIOL, V195, P2072, DOI 10.1128/JB.00040-13; Mao XM, 2009, FEBS LETT, V583, P3145, DOI 10.1016/j.febslet.2009.09.025; Mo S, 2008, CHEM BIOL, V15, P137, DOI 10.1016/j.chembiol.2007.11.015; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Paget MSB, 1998, EMBO J, V17, P5776, DOI 10.1093/emboj/17.19.5776; Paget MSB, 2001, MOL MICROBIOL, V39, P1036, DOI 10.1046/j.1365-2958.2001.02298.x; SAMBROOK J, 2000, MOL CLONING LAB MANU; Sklar JG, 2010, MOL MICROBIOL, V77, P605, DOI 10.1111/j.1365-2958.2010.07232.x; Sola-Landa A, 2013, NUCLEIC ACIDS RES, V41, P1767, DOI 10.1093/nar/gks1203; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Sun JH, 1999, MICROBIOL-UK, V145, P2221, DOI 10.1099/00221287-145-9-2221; Tahlan K, 2007, MOL MICROBIOL, V63, P951, DOI 10.1111/j.1365-2958.2006.05559.x; Thackray PD, 2003, J BACTERIOL, V185, P3491, DOI 10.1128/JB.185.12.3491-3498.2003; Wang LQ, 2009, P NATL ACAD SCI USA, V106, P8617, DOI 10.1073/pnas.0900592106; Willems AR, 2008, J MOL BIOL, V376, P1377, DOI 10.1016/j.jmb.2007.12.061; Xu GM, 2010, J BIOL CHEM, V285, P27440, DOI 10.1074/jbc.M110.143081; Yang CZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004459; Yeh HY, 2011, NUCLEIC ACIDS RES, V39, P913, DOI 10.1093/nar/gkq911; Zianni Michael, 2006, J Biomol Tech, V17, P103	47	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31217	31228		10.1074/jbc.M113.491498	http://dx.doi.org/10.1074/jbc.M113.491498			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24014034	Green Published, hybrid			2022-12-28	WOS:000330778900038
J	Michau, A; Guillemain, G; Grosfeld, A; Vuillaumier-Barrot, S; Grand, T; Keck, M; L'Hoste, S; Chateau, D; Serradas, P; Teulon, J; De Lonlay, P; Scharfmann, R; Brot-Laroche, E; Leturque, A; Le Gall, M				Michau, Aurelien; Guillemain, Ghislaine; Grosfeld, Alexandra; Vuillaumier-Barrot, Sandrine; Grand, Teddy; Keck, Mathilde; L'Hoste, Sebastien; Chateau, Danielle; Serradas, Patricia; Teulon, Jacques; De Lonlay, Pascale; Scharfmann, Raphael; Brot-Laroche, Edith; Leturque, Armelle; Le Gall, Maude			Mutations in SLC2A2 Gene Reveal hGLUT2 Function in Pancreatic beta Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; GLUCOSE TRANSPORTERS; INSULIN-SECRETION; GLUT2 MUTATIONS; EXPRESSION; GLUCOKINASE; IDENTIFICATION; POLYMORPHISMS; ERYTHROCYTE; MECHANISM	The structure-function relationships of sugar transporter-receptor hGLUT2 coded by SLC2A2 and their impact on insulin secretion and beta cell differentiation were investigated through the detailed characterization of a panel of mutations along the protein. We studied naturally occurring SLC2A2 variants or mutants: two single-nucleotide polymorphisms and four proposed inactivating mutations associated to Fanconi-Bickel syndrome. We also engineered mutations based on sequence alignment and conserved amino acids in selected domains. The single-nucleotide polymorphisms P68L and T110I did not impact on sugar transport as assayed in Xenopus oocytes. All the Fanconi-Bickel syndrome-associated mutations invalidated glucose transport by hGLUT2 either through absence of protein at the plasma membrane (G20D and S242R) or through loss of transport capacity despite membrane targeting (P417L and W444R), pointing out crucial amino acids for hGLUT2 transport function. In contrast, engineered mutants were located at the plasma membrane and able to transport sugar, albeit with modified kinetic parameters. Notably, these mutations resulted in gain of function. G20S and L368P mutations increased insulin secretion in the absence of glucose. In addition, these mutants increased insulin-positive cell differentiation when expressed in cultured rat embryonic pancreas. F295Y mutation induced beta cell differentiation even in the absence of glucose, suggesting that mutated GLUT2, as a sugar receptor, triggers a signaling pathway independently of glucose transport and metabolism. Our results describe the first gain of function mutations for hGLUT2, revealing the importance of its receptor versus transporter function in pancreatic beta cell development and insulin secretion.	[Michau, Aurelien; Grosfeld, Alexandra; Grand, Teddy; Keck, Mathilde; L'Hoste, Sebastien; Chateau, Danielle; Serradas, Patricia; Teulon, Jacques; Brot-Laroche, Edith; Leturque, Armelle; Le Gall, Maude] Univ Paris 06, INSERM, UMRS872, Cordeliers Res Ctr, F-75006 Paris, France; [Guillemain, Ghislaine; Scharfmann, Raphael] Univ Paris 05, INSERM U845, Res Ctr Growth & Signalling, Sorbonne Paris Cite,Fac Med,Hop Necker, F-75006 Paris, France; [Vuillaumier-Barrot, Sandrine] Hop Xavier Bichat Claude Bernard, Unite Fonct Genet, CHU Paris Nord Val de Seine, F-75018 Paris, France; [De Lonlay, Pascale] Hop Necker Enfants Malad, Reference Ctr Metab Dis, F-75006 Paris, France; [Brot-Laroche, Edith; Leturque, Armelle] Inst CardioMetab & Nutr ICAN, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Le Gall, M (corresponding author), Univ Paris 07, INSERM U773, Fac Med, Site Bichat,16 Rue Henri Huchard, F-75890 Paris 18, France.	maude.le-gall@inserm.fr	Grosfeld, Alexandra/AAH-3510-2020; Guillemain, Ghislaine/P-7740-2017; Keck, Mathilde/Q-4574-2017; Leturque, Armelle/Q-9437-2017; Serradas, Patricia/R-2185-2017; scharfmann, raphael/L-3296-2017; Grosfeld, Alexandra/R-1404-2017; Le Gall, Maude/W-2593-2019; Le Gall, Maude/C-3917-2017	Keck, Mathilde/0000-0003-4717-3446; Leturque, Armelle/0000-0001-6570-6387; Serradas, Patricia/0000-0002-6652-9746; Grosfeld, Alexandra/0000-0002-9508-036X; Le Gall, Maude/0000-0002-5372-4585; Le Gall, Maude/0000-0002-5372-4585; Scharfmann, Raphael/0000-0001-7619-337X; Guillemain, Ghislaine/0000-0002-8256-9545	Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Pierre & Marie Curie Paris 6 (UMPC); Universite Rene Descartes Paris 5; Centre National de la Recherche Scientifique (CNRS); European Union; UPMC Paris 6	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre & Marie Curie Paris 6 (UMPC); Universite Rene Descartes Paris 5; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Union(European Commission); UPMC Paris 6	The work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Universite Pierre & Marie Curie Paris 6 (UMPC) and Universite Rene Descartes Paris 5, Centre National de la Recherche Scientifique (CNRS), and the 6th European Union Framework Program (Beta-Cell Therapy Integrated Project) (to R. S.).; Recipient of a doctoral fellowship from UPMC Paris 6.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ANTOINE B, 1992, EXP CELL RES, V200, P175, DOI 10.1016/S0014-4827(05)80086-2; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Burgdorf KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015813; Carruthers A, 2009, AM J PHYSIOL-ENDOC M, V297, pE836, DOI 10.1152/ajpendo.00496.2009; Cassany A, 2004, TRAFFIC, V5, P10, DOI 10.1046/j.1398-9219.2003.0143.x; Clark SA, 1997, DIABETES, V46, P958, DOI 10.2337/diabetes.46.6.958; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Eny KM, 2008, PHYSIOL GENOMICS, V33, P355, DOI 10.1152/physiolgenomics.00148.2007; Ganesh R, 2009, CLIN PEDIATR, V48, P271, DOI 10.1177/0009922808324950; Ge Q, 2011, J BIOL CHEM, V286, P28119, DOI 10.1074/jbc.M111.237016; Giurgea I, 2006, HORM RES, V66, P289, DOI 10.1159/000095938; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; Grand T, 2011, HUM MUTAT, V32, P476, DOI 10.1002/humu.21467; Grunert SC, 2012, MOL GENET METAB, V105, P433, DOI 10.1016/j.ymgme.2011.11.200; Guillemain G, 2004, BIOCHEM J, V378, P219, DOI 10.1042/BJ20031549; Guillemain G, 2000, J CELL SCI, V113, P841; Guillemain G, 2002, BIOCHEM J, V364, P201, DOI 10.1042/bj3640201; Guillemain G, 2007, J BIOL CHEM, V282, P15228, DOI 10.1074/jbc.M610986200; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; HUGHES SD, 1993, J BIOL CHEM, V268, P15205; Igl W, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000798; JANSSEN RC, 1994, DIABETES, V43, P558, DOI 10.2337/diabetes.43.4.558; Laukkanen O, 2005, DIABETES, V54, P2256, DOI 10.2337/diabetes.54.7.2256; Le Gall M, 2007, J CELL PHYSIOL, V213, P834, DOI 10.1002/jcp.21245; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Levy S, 2011, SCIENCE, V334, P1408, DOI 10.1126/science.1207154; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Moller AM, 2001, J CLIN ENDOCR METAB, V86, P2181, DOI 10.1210/jc.86.5.2181; MUECKLER M, 1994, J BIOL CHEM, V269, P17765; PANG K, 1994, P NATL ACAD SCI USA, V91, P9559, DOI 10.1073/pnas.91.20.9559; Pena L, 2011, AM J MED GENET A, V155A, P415, DOI 10.1002/ajmg.a.33822; Richardson CC, 2007, DIABETOLOGIA, V50, P1000, DOI 10.1007/s00125-007-0644-x; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Sansbury FH, 2012, DIABETOLOGIA, V55, P2381, DOI 10.1007/s00125-012-2595-0; Santer R., 2002, Current Molecular Medicine (Hilversum), V2, P213, DOI 10.2174/1566524024605743; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; Soggia A, 2012, DIABETOLOGIA, V55, P2713, DOI 10.1007/s00125-012-2623-0; Stolarczyk E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001288; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Taha D, 2008, J PEDIATR ENDOCR MET, V21, P581; THORENS B, 1990, DIABETES CARE, V13, P209, DOI 10.2337/diacare.13.3.209; Tsatsos NG, 2008, BIOCHEM J, V411, P261, DOI 10.1042/BJ20071156; Willer CJ, 2007, DIABETES, V56, P256, DOI 10.2337/db06-0461; Yang H, 2011, ANN NEUROL, V70, P996, DOI 10.1002/ana.22640	47	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31080	31092		10.1074/jbc.M113.469189	http://dx.doi.org/10.1074/jbc.M113.469189			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	23986439	Green Published, hybrid			2022-12-28	WOS:000330778900027
J	Yuan, XW; Wang, DM; Hu, Y; Tang, YN; Shi, WW; Guo, XJ; Song, JG				Yuan, Xin-Wang; Wang, Dong-Mei; Hu, Ying; Tang, Yun-Neng; Shi, Wei-Wei; Guo, Xiao-Jie; Song, Jian-Guo			Hepatocyte Nuclear Factor 6 Suppresses the Migration and Invasive Growth of Lung Cancer Cells through p53 and the Inhibition of Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONECUT TRANSCRIPTION FACTORS; PANCREATIC-CANCER; TUMOR PROGRESSION; DNA-BINDING; E-CADHERIN; EXPRESSION; CARCINOMA; MORPHOGENESIS; METASTASIS; HNF-6	Epithelial-mesenchymal transition plays an important role in many patho-physiological processes, including cancer invasion and metastatic progression. Hepatocyte nuclear factor 6 (HNF6) has been known to be an important factor for both physiological and pathological functions in liver and pancreas. However, its role in EMT and lung cancer progression remains unidentified. We observed that HNF6 level can be down-regulated by TGF-beta 1 in human lung cancer cells. Knockdown of HNF6 induced EMT and increased cell migration. In contrast, ectopically expression of HNF6 inhibited cell migration and attenuated TGF-beta 1-induced EMT. The data suggest that HNF6 plays a role in maintaining epithelial phenotype, which suppresses EMT. HNF6 also inhibits both colony formation and proliferation of lung cancer cells. It pronouncedly reduced the formation of tumor xenografts in nude mice. In addition, HNF6 can activate the promoter activity of p53 by directly binding to a specific region of its promoter and therefore increase the protein level of tumor suppressor p53. p53 knockdown induced EMT and increased cell migration, whereas the opposite effect was generated by p53 overexpression. p53 knockdown also inhibited the effect of HNF6 on EMT and cell migration, indicating that p53 is required for the functions of HNF6 herein. Moreover, there is a high positive correlation among the expression levels of HNF6, p53, and E-cadherinin human lung cancer cells and tissues. The data suggest that HNF6 inhibits EMT, cell migration, and invasive growth through a mechanism involving the transcriptional activation of p53.	[Yuan, Xin-Wang; Wang, Dong-Mei; Hu, Ying; Tang, Yun-Neng; Shi, Wei-Wei; Guo, Xiao-Jie; Song, Jian-Guo] Chinese Acad Sci, Shanghai Inst Biol Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, JG (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Mol Cell Biol Lab, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	jgsong@sibcb.ac.cn			Chinese Ministry of Science and Technology [2011CB966200]; Natural Science Foundation of China [30730023]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese Ministry of Science and Technology (2011CB966200) and Natural Science Foundation of China (30730023).	Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Clotman F, 2002, DEVELOPMENT, V129, P1819; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Holterman AXL, 2002, HEPATOLOGY, V35, P1392, DOI 10.1053/jhep.2002.33680; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jiang XH, 2008, ONCOL REP, V19, P157; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Lannoy VJ, 1998, J BIOL CHEM, V273, P13552, DOI 10.1074/jbc.273.22.13552; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Prudkin L, 2009, MODERN PATHOL, V22, P668, DOI 10.1038/modpathol.2009.19; Rausa FM, 2003, MOL CELL BIOL, V23, P437, DOI 10.1128/MCB.23.2.437-449.2003; Rosenau J, 2002, TRANSPLANTATION, V73, P386, DOI 10.1097/00007890-200202150-00012; Rothberg BEG, 2006, BREAST CANCER RES TR, V100, P139, DOI 10.1007/s10549-006-9248-2; Samadani U, 1996, MOL CELL BIOL, V16, P6273; Schubert J, 2011, CELL RES, V21, P705, DOI 10.1038/cr.2011.62; Shi J, 2009, CANCER RES, V69, P7180, DOI 10.1158/0008-5472.CAN-08-4470; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Takenaka C, 2010, EXP HEMATOL, V38, P154, DOI 10.1016/j.exphem.2009.11.003; Tan YJ, 2006, GASTROENTEROLOGY, V130, P1283, DOI 10.1053/j.gastro.2006.01.010; Tang YN, 2011, CELL RES, V21, P316, DOI 10.1038/cr.2010.126; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Vanhorenbeeck V, 2007, DEV BIOL, V305, P685, DOI 10.1016/j.ydbio.2007.02.027; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang KW, 2012, CELL SIGNAL, V24, P9, DOI 10.1016/j.cellsig.2011.08.009; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yue HY, 2010, GUT, V59, P236, DOI 10.1136/gut.2008.174904; Zhang KH, 2009, CANCER RES, V69, P5340, DOI 10.1158/0008-5472.CAN-09-0112	35	25	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31206	31216		10.1074/jbc.M113.480285	http://dx.doi.org/10.1074/jbc.M113.480285			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24022481	Green Published, hybrid			2022-12-28	WOS:000330778900037
J	Ishizaki, Y; Hayashi, C; Inoue, K; Igarashi, M; Takahashi, Y; Pujari, V; Crick, DC; Brennan, PJ; Nomoto, A				Ishizaki, Yoshimasa; Hayashi, Chigusa; Inoue, Kunio; Igarashi, Masayuki; Takahashi, Yoshiaki; Pujari, Venugopal; Crick, Dean C.; Brennan, Patrick J.; Nomoto, Akio			Inhibition of the First Step in Synthesis of the Mycobacterial Cell Wall Core, Catalyzed by the GlcNAc-1-phosphate Transferase WecA, by the Novel Caprazamycin Derivative CPZEN-45	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics Action; Bacillus; Cell Wall; Teichoic Acid; Tuberculosis; CPZEN-45; TagO; WecA; Caprazamycin B; Mycolylarabinogalactan	TEICHOIC-ACID; BACILLUS-SUBTILIS; NUCLEOSIDE ANTIBIOTICS; BIOSYNTHESIS; MUTANTS; TRANSFORMATION; SMEGMATIS; GROWTH; GENES; LEAD	Because tuberculosis is one of the most prevalent and serious infections, countermeasures against it are urgently required. We isolated the antitubercular agents caprazamycins from the culture of an actinomycete strain and created CPZEN-45 as the most promising derivative of the caprazamycins. Herein, we describe the mode of action of CPZEN-45 first against Bacillus subtilis. Unlike the caprazamycins, CPZEN-45 strongly inhibited incorporation of radiolabeled glycerol into growing cultures and showed antibacterial activity against caprazamycin-resistant strains, including a strain overexpressing translocase-I (MraY, involved in the biosynthesis of peptidoglycan), the target of the caprazamycins. By contrast, CPZEN-45 was not effective against a strain overexpressing undecaprenyl-phosphate-GlcNAc-1-phosphate transferase (TagO, involved in the biosynthesis of teichoic acid), and a mutation was found in the tagO gene of the spontaneous CPZEN-45-resistant strain. This suggested that the primary target of CPZEN-45 in B. subtilis is TagO, which is a different target from that of the parent caprazamycins. This suggestion was confirmed by evaluation of the activities of these enzymes. Finally, we showed that CPZEN-45 was effective against WecA (Rv1302, also called Rfe) of Mycobacterium tuberculosis, the ortholog of TagO and involved in the biosynthesis of the mycolylarabinogalactan of the cell wall of M. tuberculosis. The outlook for WecA as a promising target for the development of antituberculous drugs as a countermeasure of drug resistant tuberculosis is discussed.	[Ishizaki, Yoshimasa; Hayashi, Chigusa; Inoue, Kunio; Igarashi, Masayuki; Nomoto, Akio] Inst Microbial Chem BIKAKEN, Shinagawa Ku, Tokyo, Japan; [Takahashi, Yoshiaki] Inst Microbial Chem BIKAKEN, Nakahara Ku, Kawasaki, Kanagawa, Japan; [Pujari, Venugopal; Crick, Dean C.; Brennan, Patrick J.] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Ishizaki, Y (corresponding author), Inst Microbial Chem BIKAKEN, Shinagawa Ku, 3-14-23 Kamiosaki, Tokyo, Japan.	ishizakiy@bikaken.or.jp	Crick, Dean/H-8251-2017; Brennan, Patrick J/G-6896-2017; Igarashi, Masayuki/AAG-1628-2020	Crick, Dean/0000-0001-9281-7058; 	National Institutes of Health from NIAID [AI049151, AI018357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI049151, R01AI018357, R01AI049151, R22AI018357, R37AI018357] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI049151 and AI018357 from NIAID.	Al-Dabbagh B, 2008, J BACTERIOL, V190, P7141, DOI 10.1128/JB.00676-08; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Bhavsar AP, 2006, MOL MICROBIOL, V60, P1077, DOI 10.1111/j.1365-2958.2006.05169.x; Brotz-Oesterhelt H, 2008, CURR OPIN PHARMACOL, V8, P564, DOI 10.1016/j.coph.2008.06.008; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; Denapaite D, 2012, MICROB DRUG RESIST, V18, P344, DOI 10.1089/mdr.2012.0026; Engohang-Ndong J, 2012, EXPERT OPIN INV DRUG, V21, P1789, DOI 10.1517/13543784.2012.724397; Galamba A, 2001, MICROBIOL-SGM, V147, P3281, DOI 10.1099/00221287-147-12-3281; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hashimoto-Gotoh T, 2000, GENE, V241, P185, DOI 10.1016/S0378-1119(99)00434-5; Hashizume H, 2011, ANTIMICROB AGENTS CH, V55, P3821, DOI 10.1128/AAC.00443-11; Igarahi M, 2003, J ANTIBIOT, V56, P580, DOI 10.7164/antibiotics.56.580; Igarashi M, 2005, J ANTIBIOT, V58, P327, DOI 10.1038/ja.2005.41; ISONO F, 1991, ANTIMICROB AGENTS CH, V35, P234, DOI 10.1128/AAC.35.2.234; ISONO K, 1985, J ANTIBIOT, V38, P1617, DOI 10.7164/antibiotics.38.1617; Jin Y, 2010, FEMS MICROBIOL LETT, V310, P54, DOI 10.1111/j.1574-6968.2010.02045.x; KARAMATA D, 1970, MOL GEN GENET, V108, P277, DOI 10.1007/BF00283358; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lechartier B, 2012, ANTIMICROB AGENTS CH, V56, P5790, DOI 10.1128/AAC.01476-12; McDonald LA, 2002, J AM CHEM SOC, V124, P10260, DOI 10.1021/ja017748h; Mikusova K, 1996, J BIOL CHEM, V271, P7820, DOI 10.1074/jbc.271.13.7820; Muramatsu Y, 2003, J ANTIBIOT, V56, P253, DOI 10.7164/antibiotics.56.253; Phillips L, 2013, NATURE, V493, P14, DOI 10.1038/493014a; Plinke C, 2010, J ANTIMICROB CHEMOTH, V65, P1359, DOI 10.1093/jac/dkq120; Pooley HM, 2000, MICROBIOL-SGM, V146, P797, DOI 10.1099/00221287-146-4-797; Price NP, 2005, GLYCOBIOLOGY, V15, p29R, DOI 10.1093/glycob/cwi065; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sawa R, 2012, CHEM-EUR J, V18, P15772, DOI 10.1002/chem.201202645; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Soldo B, 2002, MICROBIOL-SGM, V148, P2079, DOI 10.1099/00221287-148-7-2079; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Takahashi Y, 2013, J ANTIBIOT, V66, P171, DOI 10.1038/ja.2013.9; TAKAYAMA K, 1975, J LIPID RES, V16, P308; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301	39	101	109	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30309	30319		10.1074/jbc.M113.492173	http://dx.doi.org/10.1074/jbc.M113.492173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986448	Green Published, hybrid			2022-12-28	WOS:000329868100028
J	Reardon, PN; Mueller, KT				Reardon, Patrick N.; Mueller, Karl T.			Structure of the Type IVa Major Pilin from the Electrically Conductive Bacterial Nanowires of Geobacter sulfurreducens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR ELECTRON-TRANSFER; MICROBIAL NANOWIRES; PILUS STRUCTURE; REDUCTION; SYSTEM; CRYSTALLOGRAPHY; RESTRAINTS; TRANSPORT; DATABASE; FE(III)	Several species of delta proteobacteria are capable of reducing insoluble metal oxides as well as other extracellular electron acceptors. These bacteria play a critical role in the cycling of minerals in subsurface environments, sediments, and ground-water. In some species of bacteria such as Geobacter sulfurreducens, the transport of electrons is proposed to be facilitated by filamentous fibers that are referred to as bacterial nanowires. These nanowires are polymeric assemblies of proteins belonging to the type IVa family of pilin proteins and are mainly comprised of one subunit protein, PilA. Here, we report the high resolution solution NMR structure of the PilA protein from G. sulfurreducens determined in detergent micelles. The protein is > 85% alpha-helical and exhibits similar architecture to the N-terminal regions of other non-conductive type IVa pilins. The detergent micelle interacts with the first 21 amino acids of the protein, indicating that this region likely associates with the bacterial inner membrane prior to fiber formation. A model of the G. sulfurreducens pilus fiber is proposed based on docking of this structure into the fiber model of the type IVa pilin from Neisseria gonorrhoeae. This model provides insight into the organization of aromatic amino acids that are important for electrical conduction.	[Reardon, Patrick N.; Mueller, Karl T.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99354 USA; [Mueller, Karl T.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Reardon, PN (corresponding author), Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99354 USA.	Patrick.reardon@pnnl.gov	Mueller, Karl/A-3637-2010	Reardon, Patrick/0000-0002-6858-0086	William Wiley Post-Doctoral Fellowship from the Environmental Molecular Sciences Laboratory; Department of Energy's Office of Biological and Environmental Research	William Wiley Post-Doctoral Fellowship from the Environmental Molecular Sciences Laboratory; Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was supported by the William Wiley Post-Doctoral Fellowship from the Environmental Molecular Sciences Laboratory. All data were collected at the Environmental Molecular Sciences Laboratory, a national scientific user facility supported by the Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory.	Arts J, 2007, J BACTERIOL, V189, P2069, DOI 10.1128/JB.01236-06; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Biais N, 2010, P NATL ACAD SCI USA, V107, P11358, DOI 10.1073/pnas.0911328107; Bond DR, 2012, CHEMSUSCHEM, V5, P1099, DOI 10.1002/cssc.201100748; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brutinel ED, 2012, APPL MICROBIOL BIOT, V93, P41, DOI 10.1007/s00253-011-3653-0; Calderone TL, 1996, J MOL BIOL, V262, P407, DOI 10.1006/jmbi.1996.0524; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Eyre TA, 2004, PROTEIN ENG DES SEL, V17, P613, DOI 10.1093/protein/gzh072; Feliciano GT, 2012, J PHYS CHEM A, V116, P8023, DOI 10.1021/jp302232p; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Goddard T. D, 2009, SPARKY 3; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gray HB, 2010, BBA-BIOENERGETICS, V1797, P1563, DOI 10.1016/j.bbabio.2010.05.001; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hartung S, 2011, J BIOL CHEM, V286, P44254, DOI 10.1074/jbc.M111.297242; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Lovley DR, 2012, BIOCHEM SOC T, V40, P1186, DOI 10.1042/BST20120131; LOVLEY DR, 1991, NATURE, V350, P413, DOI 10.1038/350413a0; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; Lovley DR, 2001, SCIENCE, V293, P1444, DOI 10.1126/science.1063294; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; Lovley DR, 2004, ADV MICROB PHYSIOL, V49, P219, DOI 10.1016/S0065-2911(04)49005-5; Malvankar NS, 2012, CHEMSUSCHEM, V5, P1039, DOI 10.1002/cssc.201100733; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; NUNN DN, 1991, P NATL ACAD SCI USA, V88, P3281, DOI 10.1073/pnas.88.8.3281; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Reguera G, 2006, APPL ENVIRON MICROB, V72, P7345, DOI 10.1128/AEM.01444-06; Shi L, 2007, MOL MICROBIOL, V65, P12, DOI 10.1111/j.1365-2958.2007.05783.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Strycharz-Glaven SM, 2011, ENERG ENVIRON SCI, V4, P4366, DOI 10.1039/c1ee01753e; Vargas M, 2013, MBIO, V4, DOI 10.1128/mBio.00105-13; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; YANSURA DG, 1990, METHOD ENZYMOL, V185, P161	43	83	90	1	67	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29260	29266		10.1074/jbc.M113.498527	http://dx.doi.org/10.1074/jbc.M113.498527			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23965997	Green Published, hybrid			2022-12-28	WOS:000330615300006
J	Cabrera, M; Ungermann, C				Cabrera, Margarita; Ungermann, Christian			Guanine Nucleotide Exchange Factors (GEFs) Have a Critical but Not Exclusive Role in Organelle Localization of Rab GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Guanine Nucleotide Exchange Factor (GEF); Membrane Fusion; Rab; Rab Proteins; Subcellular Organelles; GAP; GDF	GDP-DISSOCIATION INHIBITOR; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; DISPLACEMENT FACTOR; ESCORT PROTEIN; COMPLEX; FUSION; YEAST; IDENTIFICATION; PRENYLATION	Membrane fusion at eukaryotic organelles is initiated by Rab GTPases and tethering factors. Rabs in their GDP-bound form are kept soluble in the cytoplasm by the GDP dissociation inhibitor (GDI) chaperone. Guanine nucleotide exchange factors (GEFs) are found at organelles and are critical for Rab function. Here, we surveyed the overall role of GEFs in Rab localization. We show that GEFs, but none of the proposed GDI displacement factors, are essential for the correct membrane localization of yeast Rabs. In the absence of the GEF, Rabs lost their primary localization to the target organelle. Several Rabs, such as vacuolar Ypt7, were found at the endoplasmic reticulum and thus were still membrane-bound. Surprisingly, a Ypt7 mutant that undergoes facilitated nucleotide exchange localized to vacuoles independently of its GEF Mon1-Ccz1 and rescued vacuole morphology. In contrast, wild-type Ypt7 required its GEF for localization and to counteract the extraction by GDI. Our data agree with the emerging model that GEFs are critical for Rab localization but raise the possibility that additional factors can contribute to this process.	[Cabrera, Margarita; Ungermann, Christian] Univ Osnabruck, Biochem Sect, Dept Biol Chem, D-49076 Osnabruck, Germany	University Osnabruck	Cabrera, M (corresponding author), Dept Biol Chem, Biochem Sect, Barbarastr 13, D-49076 Osnabruck, Germany.	margarita.cabrera@biologie.uni-osnabrueck.de	Cabrera, Margarita/F-3306-2016; Cabrera, Margarita/Y-1225-2019	Cabrera, Margarita/0000-0002-2978-8255; Cabrera, Margarita/0000-0002-2978-8255	Hans-Muhlenhoff Foundation;  [Sonderforschungsbereich (SFB) 944 (Project P11)]	Hans-Muhlenhoff Foundation; 	This work was supported by Sonderforschungsbereich (SFB) 944 (Project P11) and by the Hans-Muhlenhoff Foundation (to C. U.).	Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Barrowman J, 2003, J BIOL CHEM, V278, P19878, DOI 10.1074/jbc.M302406200; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Brocker C, 2010, CURR BIOL, V20, pR943, DOI 10.1016/j.cub.2010.09.015; Cabrera M, 2013, J BIOL CHEM, V288, P5166, DOI 10.1074/jbc.M112.431536; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Calero M, 2003, MOL BIOL CELL, V14, P1852, DOI 10.1091/mbc.E02-11-0707; Calero M, 2002, FEBS LETT, V515, P89, DOI 10.1016/S0014-5793(02)02442-0; Chen CZ, 2004, GENETICS, V168, P1827, DOI 10.1534/genetics.104.032888; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; Geng JM, 2005, EUKARYOT CELL, V4, P1166, DOI 10.1128/EC.4.7.1166-1174.2005; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Heidtman M, 2003, J CELL BIOL, V163, P57, DOI 10.1083/jcb.200306118; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Itzen A, 2011, SEMIN CELL DEV BIOL, V22, P48, DOI 10.1016/j.semcdb.2010.10.003; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Kucharczyk R, 2001, J CELL SCI, V114, P3137; Lachmann Jens, 2011, Small GTPases, V2, P182; Lachmann J, 2012, MOL BIOL CELL, V23, P2516, DOI 10.1091/mbc.E11-12-1030; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Nickerson DP, 2012, TRAFFIC, V13, P1411, DOI 10.1111/j.1600-0854.2012.01390.x; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Paulsel AL, 2013, J BIOL CHEM, V288, P18162, DOI 10.1074/jbc.M113.457069; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Puig O, 1998, YEAST, V14, P1139; Pusapati GV, 2012, J BIOL CHEM, V287, P42129, DOI 10.1074/jbc.M112.414565; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Shen F, 1996, J BIOL CHEM, V271, P3692; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; SMELAND TE, 1994, P NATL ACAD SCI USA, V91, P10712, DOI 10.1073/pnas.91.22.10712; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x; Suh HY, 2010, EMBO J, V29, P496, DOI 10.1038/emboj.2009.347; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Yang XP, 1998, EMBO J, V17, P4954, DOI 10.1093/emboj/17.17.4954; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107	53	47	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28704	28712		10.1074/jbc.M113.488213	http://dx.doi.org/10.1074/jbc.M113.488213			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23979137	Green Published, hybrid			2022-12-28	WOS:000330298800024
J	Korekane, H; Park, JY; Matsumoto, A; Nakajima, K; Takamatsu, S; Ohtsubo, K; Miyamoto, Y; Hanashima, S; Kanekiyo, K; Kitazume, S; Yamaguchi, Y; Matsuo, I; Taniguchi, N				Korekane, Hiroaki; Park, Jong Yi; Matsumoto, Akio; Nakajima, Kazuki; Takamatsu, Shinji; Ohtsubo, Kazuaki; Miyamoto, Yasuhide; Hanashima, Shinya; Kanekiyo, Kenji; Kitazume, Shinobu; Yamaguchi, Yoshiki; Matsuo, Ichiro; Taniguchi, Naoyuki			Identification of Ectonucleotide Pyrophosphatase/Phosphodiesterase 3 (ENPP3) as a Regulator of N-Acetylglucosaminyltransferase GnT-IX (GnT-Vb)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN GLYCOSYLATION; NUCLEOSIDE DIPHOSPHATASE; FUNCTIONAL ASSOCIATION; RAT-LIVER; PURIFICATION; EXPRESSION; GLYCAN; GLCNAC; DIFFERENTIATION; CLONING	Our previous studies on a beta 1,6-N-acetylglucosaminyltransferase, GnT-IX (GnT-Vb), a homolog of GnT-V, indicated that the enzyme has a broad GlcNAc transfer activity toward N-linked and O-mannosyl glycan core structures and that its brain-specific gene expression is regulated by epigenetic histone modifications. In this study, we demonstrate the existence of an endogenous inhibitory factor for GnT-IX that functions as a key regulator for GnT-IX enzymatic activity in Neuro2a (N2a) cells. We purified this factor from N2a cells and found that it is identical to ectonucleotide pyrophosphatase/phosphodiesterase 3 (ENPP3), as evidenced by mass spectrometry and by the knockdown and overexpression of ENPP3 in cultured cells. Kinetic analyses revealed that the mechanism responsible for the inhibition of GnT-IX caused by ENPP3 is the ENPP3-mediated hydrolysis of the nucleotide sugar donor substrate, UDP-GlcNAc, with the resulting generation of UMP, a potent and competitive inhibitor of GnT-IX. Indeed, ENPP3 knockdown cells had significantly increased levels of intracellular nucleotide sugars and displayed changes in the total cellular glycosylation profile. In addition to chaperones or other known regulators of glycosyltransferases, the ENPP3-mediated hydro-lysis of nucleotide sugars would have widespread and significant impacts on glycosyltransferase activities and would be responsible for altering the total cellular glycosylation profile and modulating cellular functions.	[Korekane, Hiroaki; Nakajima, Kazuki; Takamatsu, Shinji; Ohtsubo, Kazuaki; Hanashima, Shinya; Kanekiyo, Kenji; Kitazume, Shinobu; Yamaguchi, Yoshiki; Taniguchi, Naoyuki] RIKEN Global Res Cluster, RIKEN Adv Sci Inst, Dept Biol Chem, Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Korekane, Hiroaki; Ohtsubo, Kazuaki; Kanekiyo, Kenji; Kitazume, Shinobu; Yamaguchi, Yoshiki; Taniguchi, Naoyuki] RIKEN Global Res Cluster, RIKEN MAX Planck Joint Res Ctr, Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Korekane, Hiroaki; Park, Jong Yi; Matsumoto, Akio; Nakajima, Kazuki; Takamatsu, Shinji; Ohtsubo, Kazuaki; Taniguchi, Naoyuki] Osaka Univ, Alliance Lab, Inst Sci & Ind Res, Dept Dis Glyc, Osaka 5670047, Japan; [Miyamoto, Yasuhide] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Immunol, Higashinari Ku, Osaka 5378511, Japan; [Matsuo, Ichiro] Gunma Univ, Dept Chem & Chem Biol, Kiryu, Gunma 3768515, Japan	RIKEN; RIKEN; Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Gunma University	Taniguchi, N (corresponding author), RIKEN Global Res Cluster, RIKEN MAX Planck Joint Res Ctr, Syst Glycobiol Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tani52@wd5.so-net.ne.jp	Taniguchi, Naoyuki/I-4182-2014; Yamaguchi, Yoshiki/N-5246-2015; Hanashima, Shinya/AGN-0921-2022; Taniguchi, Naoyuki/A-7086-2016	Taniguchi, Naoyuki/0000-0001-5889-5968; Yamaguchi, Yoshiki/0000-0003-0100-5439; Hanashima, Shinya/0000-0003-3102-7890; Matsumoto, Akio/0000-0002-3402-6992	Global Centers of Excellence Program of Osaka University; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan; RIKEN;  [20249018]; Grants-in-Aid for Scientific Research [24659111] Funding Source: KAKEN	Global Centers of Excellence Program of Osaka University; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan; RIKEN; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research (A) 20249018 (to N. T.) and the Global Centers of Excellence Program of Osaka University (to N. T.) funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Program for Promotion of Fundamental Studies in Health Science (to N. T.) of the National Institute of Biomedical Innovation, Japan. This work was also supported by incentive research projects (to H. K.) of RIKEN.	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; BlassKampmann S, 1997, J NEUROSCI RES, V48, P95, DOI 10.1002/(SICI)1097-4547(19970415)48:2<95::AID-JNR2>3.0.CO;2-7; DEISSLER H, 1995, J BIOL CHEM, V270, P9849, DOI 10.1074/jbc.270.17.9849; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Fang M, 2010, CELL, V143, P711, DOI 10.1016/j.cell.2010.10.010; Gijsbers R, 2001, J BIOL CHEM, V276, P1361, DOI 10.1074/jbc.M007552200; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Huang HH, 2010, J CELL BIOL, V190, P893, DOI 10.1083/jcb.201004102; Inamori K, 2004, J BIOL CHEM, V279, P2337, DOI 10.1074/jbc.C300480200; Inamori K, 2003, J BIOL CHEM, V278, P43102, DOI 10.1074/jbc.M308255200; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kanekiyo K, 2013, J NEUROSCI, V33, P10037, DOI 10.1523/JNEUROSCI.3137-12.2013; Kaneko M, 2003, FEBS LETT, V554, P515, DOI 10.1016/S0014-5793(03)01234-1; KELLY SJ, 1975, BIOCHEM BIOPH RES CO, V66, P316, DOI 10.1016/S0006-291X(75)80330-5; Kizuka Y, 2006, J BIOL CHEM, V281, P13644, DOI 10.1074/jbc.M601453200; Kizuka Y, 2011, J BIOL CHEM, V286, P31875, DOI 10.1074/jbc.M111.251173; Kouno T, 2011, J BIOL CHEM, V286, P31337, DOI 10.1074/jbc.M111.233353; Kurihara T, 2007, ANAL CHEM, V79, P8694, DOI 10.1021/ac071140v; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee JK, 2012, J BIOL CHEM, V287, P28526, DOI 10.1074/jbc.M112.367565; Levesque SA, 2007, BRIT J PHARMACOL, V152, P141, DOI 10.1038/sj.bjp.0707361; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Min JZ, 2005, ANAL CHIM ACTA, V550, P173, DOI 10.1016/j.aca.2005.06.052; Misonou Y, 2009, J PROTEOME RES, V8, P2990, DOI 10.1021/pr900092r; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nakahara S, 2006, FASEB J, V20, P2451, DOI 10.1096/fj.05-5066com; Nakajima K, 2010, GLYCOBIOLOGY, V20, P865, DOI 10.1093/glycob/cwq044; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Natsuka S, 1998, METH MOL B, V76, P101; Natsuka S, 2011, FEBS J, V278, P452, DOI 10.1111/j.1742-4658.2010.07966.x; Noda K, 2003, CANCER RES, V63, P6282; OHKUBO I, 1982, INT J BIOCHEM, V14, P1075; OHKUBO I, 1980, EUR J BIOCHEM, V112, P111, DOI 10.1111/j.1432-1033.1980.tb04992.x; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; REBBE NF, 1991, P NATL ACAD SCI USA, V88, P5192, DOI 10.1073/pnas.88.12.5192; Rucker B, 2007, MOL CELL BIOCHEM, V306, P247, DOI 10.1007/s11010-007-9576-5; Sasai K, 2003, J BIOL CHEM, V278, P25295, DOI 10.1074/jbc.M301913200; Sasai K, 2002, FEBS LETT, V522, P151, DOI 10.1016/S0014-5793(02)02916-2; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; Seifert J, 2000, GLYCOCONJUGATE J, V17, P407, DOI 10.1023/A:1007112232131; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; Smith PL, 2002, J CELL BIOL, V158, P801, DOI 10.1083/jcb.200203125; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Stefan Cristiana, 2006, Purinergic Signal, V2, P361, DOI 10.1007/s11302-005-5303-4; Sugimoto I, 2007, J BIOL CHEM, V282, P34896, DOI 10.1074/jbc.M704766200; Taniguchi N., 2002, HDB GLYCOSYLTRANSFER; Taniguchi N, 2006, CURR OPIN STRUC BIOL, V16, P561, DOI 10.1016/j.sbi.2006.08.011; Taniguchi N, 2007, NAT CHEM BIOL, V3, P307, DOI 10.1038/nchembio0607-307; Taniguchi N, 2009, J BIOL CHEM, V284, P34469, DOI 10.1074/jbc.X109.023150; Traynor AJ, 1996, J MED CHEM, V39, P2894, DOI 10.1021/jm960175c; WALDMAN BC, 1990, BIOCHEMISTRY-US, V29, P44, DOI 10.1021/bi00453a006; YANAGISAWA K, 1990, J BIOL CHEM, V265, P19351; Zimmermann H, 2006, PFLUG ARCH EUR J PHY, V452, P573, DOI 10.1007/s00424-006-0067-4	60	23	24	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27912	27926		10.1074/jbc.M113.474304	http://dx.doi.org/10.1074/jbc.M113.474304			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23960081	Green Published, hybrid			2022-12-28	WOS:000330612800019
J	Hannedouche, S; Beck, V; Leighton-Davies, J; Beibel, M; Roma, G; Oakeley, EJ; Lannoy, V; Bernard, J; Hamon, J; Barbieri, S; Preuss, I; Lasbennes, MC; Sailer, AW; Suply, T; Seuwen, K; Parker, CN; Bassilana, F				Hannedouche, Sebastien; Beck, Valerie; Leighton-Davies, Juliet; Beibel, Martin; Roma, Guglielmo; Oakeley, Edward J.; Lannoy, Vincent; Bernard, Jerome; Hamon, Jacques; Barbieri, Samuel; Preuss, Inga; Lasbennes, Marie-Christine; Sailer, Andreas W.; Suply, Thomas; Seuwen, Klaus; Parker, Christian N.; Bassilana, Frederic			Identification of the C3a Receptor (C3AR1) as the Target of the VGF-derived Peptide TLQP-21 in Rodent Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; RNA-SEQ; IN-VITRO; ANAPHYLATOXIN; COMPLEMENT; MICE; VIVO; RAT; TRANSCRIPTOMICS; RESISTANCE	TLQP-21, a peptide derived from VGF (non-acronymic) by proteolytic processing, has been shown to modulate energy metabolism, differentiation, and cellular response to stress. Although extensively investigated, the receptor for this endogenous peptide has not previously been described. This study describes the use of a series of studies that show G protein-coupled receptor-mediated biological activity of TLQP-21 signaling in CHO-K1 cells. Unbiased genome-wide sequencing of the transcriptome from responsive CHO-K1 cells identified a prioritized list of possible G protein-coupled receptors bringing about this activity. Further experiments using a series of defined receptor antagonists and siRNAs led to the identification of complement C3a receptor-1 (C3AR1) as a target for TLQP-21 in rodents. We have not been able to demonstrate so far that this finding is translatable to the human receptor. Our results are in line with a large number of physiological observations in rodent models of food intake and metabolic control, where TLQP-21 shows activity. In addition, the sensitivity of TLQP-21 signaling to pertussis toxin is consistent with the known signaling pathway of C3AR1. The binding of TLQP-21 to C3AR1 not only has effects on signaling but also modulates cellular functions, as TLQP-21 was shown to have a role in directing migration of mouse RAW264.7 cells.	[Beck, Valerie; Leighton-Davies, Juliet; Beibel, Martin; Roma, Guglielmo; Oakeley, Edward J.; Hamon, Jacques; Barbieri, Samuel; Preuss, Inga; Lasbennes, Marie-Christine; Sailer, Andreas W.; Suply, Thomas; Seuwen, Klaus; Parker, Christian N.; Bassilana, Frederic] Novartis AG, CH-4056 Basel, Switzerland; [Hannedouche, Sebastien; Lannoy, Vincent; Bernard, Jerome] Euroscreen SA, B-6041 Gosselies, Belgium	Novartis	Bassilana, F (corresponding author), Novartis AG, NIBR, Dev & Mol Pathways,Novartis Campus,Fabrikstr 22, CH-4056 Basel, Switzerland.	frederic.bassilana@novartis.com	; Sailer, Andreas/M-9913-2016	Bassilana, Frederic/0000-0003-2063-8450; Hannedouche, Sebastien/0000-0001-5909-242X; Sailer, Andreas/0000-0002-9015-7946				Aguilar E, 2013, NEUROENDOCRINOLOGY, V98, P38, DOI 10.1159/000350323; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ames RS, 2001, J IMMUNOL, V166, P6341, DOI 10.4049/jimmunol.166.10.6341; Bartolomucci A, 2007, GROWTH HORM IGF RES, V17, P342, DOI 10.1016/j.ghir.2007.02.002; Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; Bartolomucci A, 2009, GENES NUTR, V4, P49, DOI 10.1007/s12263-009-0110-0; Benard M, 2008, MOL IMMUNOL, V45, P3767, DOI 10.1016/j.molimm.2008.05.027; Brancia C, 2010, J ENDOCRINOL, V207, P329, DOI 10.1677/JOE-10-0189; Cassina V, 2013, BBA-BIOMEMBRANES, V1828, P455, DOI 10.1016/j.bbamem.2012.10.023; Ferri GL, 2011, J CHEM NEUROANAT, V42, P249, DOI 10.1016/j.jchemneu.2011.05.007; Francis K, 2003, FASEB J, V17, P2266, DOI 10.1096/fj.02-1103fje; Gao JM, 2003, J BIOL CHEM, V278, P37902, DOI 10.1074/jbc.M306061200; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; Hahm S, 2002, J NEUROSCI, V22, P6929; Jethwa PH, 2007, ENDOCRINOLOGY, V148, P4044, DOI 10.1210/en.2007-0038; Jimenez-Guri E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-123; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEVI A, 1985, SCIENCE, V229, P393, DOI 10.1126/science.3839317; Lim J, 2013, FASEB J, V27, P822, DOI 10.1096/fj.12-220582; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Martin U, 1997, J EXP MED, V186, P199, DOI 10.1084/jem.186.2.199; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Passeri PP, 2013, NEUROENDOCRINOLOGY, V97, P212, DOI 10.1159/000339855; Petrella C, 2012, PEPTIDES, V36, P133, DOI 10.1016/j.peptides.2012.03.035; Pinilla L, 2011, AM J PHYSIOL-ENDOC M, V300, pE837, DOI 10.1152/ajpendo.00598.2010; Possenti R, 2012, BIOCHEM J, V441, P511, DOI 10.1042/BJ20111165; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Razzoli M, 2012, BEHAV BRAIN RES, V229, P333, DOI 10.1016/j.bbr.2012.01.038; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Rosethorne EM, 2004, N-S ARCH PHARMACOL, V370, P64, DOI 10.1007/s00210-004-0932-7; Settmacher B, 2003, EUR J IMMUNOL, V33, P920, DOI 10.1002/eji.200323293; Severini C, 2009, BRIT J PHARMACOL, V157, P984, DOI 10.1111/j.1476-5381.2009.00192.x; Sibilia V, 2012, AMINO ACIDS, V42, P1261, DOI 10.1007/s00726-010-0818-6; Stephens SB, 2012, CELL METAB, V16, P33, DOI 10.1016/j.cmet.2012.05.011; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Winden AWJOV, 2012, BREAST CANCER RES TR, V134, P1, DOI 10.1007/s10549-011-1907-2; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932	41	72	72	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27434	27443		10.1074/jbc.M113.497214	http://dx.doi.org/10.1074/jbc.M113.497214			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23940034	Green Published, hybrid			2022-12-28	WOS:000330597300039
J	Dhruv, H; Loftus, JC; Narang, P; Petit, JL; Fameree, M; Burton, J; Tchegho, G; Chow, D; Yin, H; Al-Abed, Y; Berens, ME; Tran, NL; Meurice, N				Dhruv, Harshil; Loftus, Joseph C.; Narang, Pooja; Petit, Joachim L.; Fameree, Maureen; Burton, Julien; Tchegho, Giresse; Chow, Donald; Yin, Holly; Al-Abed, Yousef; Berens, Michael E.; Tran, Nhan L.; Meurice, Nathalie			Structural Basis and Targeting of the Interaction between Fibroblast Growth Factor-inducible 14 and Tumor Necrosis Factor-like Weak Inducer of Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cell Signaling; Cell Surface Receptor; Docking; Drug Development; Drug Discovery; Drug Screening; Protein-Protein Interactions	CYSTEINE-RICH DOMAIN; SMALL-MOLECULE INHIBITION; TWEAK/FN14 PATHWAY; KAPPA-B; MULTIFUNCTIONAL CYTOKINE; CELL MIGRATION; FN14; RECEPTOR; PROTEIN; TNF	Deregulation of the TNF-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling pathway is observed in many diseases, including inflammation, autoimmune diseases, and cancer. Activation of Fn14 signaling by TWEAK binding triggers cell invasion and survival and therefore represents an attractive pathway for therapeutic intervention. Based on structural studies of the TWEAK-binding cysteine-rich domain of Fn14, several homology models of TWEAK were built to investigate plausible modes of TWEAK-Fn14 interaction. Two promising models, centered on different anchoring residues of TWEAK (tyrosine 176 and tryptophan 231), were prioritized using a data-driven strategy. Site-directed mutagenesis of TWEAK at Tyr(176), but not Trp(231), resulted in the loss of TWEAK binding to Fn14 substantiating Tyr(176) as the anchoring residue. Importantly, mutation of TWEAK at Tyr(176) did not disrupt TWEAK trimerization but failed to induce Fn14-mediated nuclear factor -light chain enhancer of activated B cell (NF-B) signaling. The validated structural models were utilized in a virtual screen to design a targeted library of small molecules predicted to disrupt the TWEAK-Fn14 interaction. 129 small molecules were screened iteratively, with identification of molecules producing up to 37% inhibition of TWEAK-Fn14 binding. In summary, we present a data-driven in silico study revealing key structural elements of the TWEAK-Fn14 interaction, followed by experimental validation, serving as a guide for the design of small molecule inhibitors of the TWEAK-Fn14 ligand-receptor interaction. Our results validate the TWEAK-Fn14 interaction as a chemically tractable target and provide the foundation for further exploration utilizing chemical biology approaches focusing on validating this system as a therapeutic target in invasive cancers.	[Dhruv, Harshil; Fameree, Maureen; Burton, Julien; Tchegho, Giresse; Chow, Donald; Yin, Holly; Berens, Michael E.; Tran, Nhan L.] Translat Genom Res Inst, Phoenix, AZ 85004 USA; [Loftus, Joseph C.; Narang, Pooja; Petit, Joachim L.; Meurice, Nathalie] Mayo Clin, Scottsdale, AZ 85259 USA; [Al-Abed, Yousef] Feinstein Inst Med Res, Ctr Mol Innovat, Manhasset, NY 11030 USA	Translational Genomics Research Institute; Mayo Clinic; Mayo Clinic Phoenix; Northwell Health	Tran, NL (corresponding author), Translat Genom Res Inst, 445 N 5th St, Phoenix, AZ 85004 USA.	ntran@tgen.org; meurice.nathalie@mayo.edu			National Institutes of Health from NIEHS [ES06694]; NCI [CA023074]; BIO5 Institute of the University of Arizona; NATIONAL CANCER INSTITUTE [R01CA130940, P50CA108961, P30CA023074, P30CA015083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH090878] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BIO5 Institute of the University of Arizona; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. Gerald M. Maggiora for fruitful discussions and Dr. Jeffrey Winkles (University of Maryland) for the HEK293-Fn14-NF kappa B luciferase cells. Surface plasmon resonance data were acquired by the Arizona Proteomics Consortium supported by National Institutes of Health Grant ES06694 from NIEHS to the Southwest Environmental Health Sciences Center and Grant CA023074 from NCI to the Arizona Cancer Center, and by the BIO5 Institute of the University of Arizona.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Benicchi T, 2012, J BIOMOL SCREEN, V17, P933, DOI 10.1177/1087057112447873; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhatnagar S, 2012, CURR MOL MED, V12, P3, DOI 10.2174/156652412798376107; Bhattacharjee M., 2012, J SIGNAL TRANSDUCT, V2012; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brockmann MA, 2003, NEUROSURGERY, V52, P1391, DOI 10.1227/01.NEU.0000064806.87785.AB; Brown SAN, 2006, BIOCHEM J, V397, P297, DOI 10.1042/BJ20051362; Brown SAN, 2010, J BIOL CHEM, V285, P17432, DOI 10.1074/jbc.M110.131979; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Dixon SL, 2006, CHEM BIOL DRUG DES, V67, P370, DOI 10.1111/j.1747-0285.2006.00384.x; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Frostell-Karlsson A, 2000, J MED CHEM, V43, P1986, DOI 10.1021/jm991174y; Han HY, 2002, CANCER RES, V62, P2890; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; He F, 2009, PROTEIN SCI, V18, P650, DOI 10.1002/pro.49; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hymowitz SG, 2005, J BIOL CHEM, V280, P7218, DOI 10.1074/jbc.M411714200; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; Kolfschoten GA, 2003, BIOCHEM PHARMACOL, V66, P1427, DOI 10.1016/S0006-2952(03)00493-3; Kolzsch J, 1990, Z Arztl Fortbild (Jena), V84, P1199; Lammens A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062697; Lamszus K, 1998, INT J CANCER, V75, P19, DOI 10.1002/(SICI)1097-0215(19980105)75:1<19::AID-IJC4>3.0.CO;2-4; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Meireles LMC, 2010, NUCLEIC ACIDS RES, V38, pW407, DOI 10.1093/nar/gkq502; Molecular Operating Environment, 2010, MOL OP ENV VERS 2010; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; Pellegrini M, 2013, FEBS J, V280, P1818, DOI 10.1111/febs.12206; Polek TC, 2003, J BIOL CHEM, V278, P32317, DOI 10.1074/jbc.M302518200; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Silvian LF, 2011, ACS CHEM BIOL, V6, P636, DOI 10.1021/cb2000346; Tansey MG, 2009, DRUG DISCOV TODAY, V14, P1082, DOI 10.1016/j.drudis.2009.10.002; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; Watts GS, 2007, INT J CANCER, V121, P2132, DOI 10.1002/ijc.22898; Watts KS, 2010, J CHEM INF MODEL, V50, P534, DOI 10.1021/ci100015j; Whitsett TG, 2012, AM J PATHOL, V181, P111, DOI 10.1016/j.ajpath.2012.03.026; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yoriki R, 2011, EXP THER MED, V2, P103, DOI 10.3892/etm.2010.181; Zheng TS, 2008, J LEUKOCYTE BIOL, V84, P338, DOI 10.1189/jlb.0308165	50	17	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32261	32276		10.1074/jbc.M113.493536	http://dx.doi.org/10.1074/jbc.M113.493536			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24056367	Green Published, hybrid			2022-12-28	WOS:000328681700014
J	Kapoor, K; Bhatnagar, J; Chufan, EE; Ambudkar, SV				Kapoor, Khyati; Bhatnagar, Jaya; Chufan, Eduardo E.; Ambudkar, Suresh V.			Mutations in Intracellular Loops 1 and 3 Lead to Misfolding of Human P-glycoprotein (ABCB1) That Can Be Rescued by Cyclosporine A, Which Reduces Its Association with Chaperone Hsp70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Drug Resistance; Molecular Chaperone; Multidrug Transporters; Protein Misfolding; Chemical Chaperones; P-glycoprotein	TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; MULTIDRUG TRANSPORTER; PHARMACOLOGICAL CHAPERONES; CATALYTIC CYCLE; ATP HYDROLYSIS; MONOCLONAL-ANTIBODIES; MAMMALIAN-CELLS; PROTEIN; ABCG2	P-glycoprotein (P-gp) is an ATP binding cassette transporter that effluxes a variety of structurally diverse compounds including anticancer drugs. Computational models of human P-gp in the apo- and nucleotide-bound conformation show that the adenine group of ATP forms hydrogen bonds with the conserved Asp-164 and Asp-805 in intracellular loops 1 and 3, respectively, which are located at the interface between the nucleotide binding domains and transmembrane domains. We investigated the role of Asp-164 and Asp-805 residues by substituting them with cysteine in a cysteine-less background. It was observed that the D164C/D805C mutant, when expressed in HeLa cells, led to misprocessing of P-gp, which thus failed to transport the drug substrates. The misfolded protein could be rescued to the cell surface by growing the cells at a lower temperature (27 degrees C) or by treatment with substrates (cyclosporine A, FK506), modulators (tariquidar), or small corrector molecules. We also show that short term (4-6 h) treatment with 15 m cyclosporine A or FK506 rescues the pre-formed immature protein trapped in the endoplasmic reticulum in an immunophilin-independent pathway. The intracellularly trapped misprocessed protein associates more with chaperone Hsp70, and the treatment with cyclosporine A reduces the association of mutant P-gp, thus allowing it to be trafficked to the cell surface. The function of rescued cell surface mutant P-gp is similar to that of wild-type protein. These data demonstrate that the Asp-164 and Asp-805 residues are not important for ATP binding, as proposed earlier, but are critical for proper folding and maturation of a functional transporter.	[Kapoor, Khyati; Bhatnagar, Jaya; Chufan, Eduardo E.; Ambudkar, Suresh V.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ambudkar, SV (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	ambudkar@mail.nih.gov	Ambudkar, Suresh V/L-1317-2016		Research Program of the National Institutes of Health, Center for Cancer Research, NCI Grant [ZIA BC010030-13]; NATIONAL CANCER INSTITUTE [ZIABC010030] Funding Source: NIH RePORTER	Research Program of the National Institutes of Health, Center for Cancer Research, NCI Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Research Program of the National Institutes of Health, Center for Cancer Research, NCI Grant ZIA BC010030-13.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; Banasavadi-Siddegowda YK, 2011, J BIOL CHEM, V286, P43071, DOI 10.1074/jbc.M111.269993; Becker JP, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-3; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Cheepala SB, 2013, J BIOL CHEM, V288, P22207, DOI 10.1074/jbc.M113.476218; Chen ZS, 2011, FEBS J, V278, P3226, DOI 10.1111/j.1742-4658.2011.08235.x; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Gautherot J, 2012, J BIOL CHEM, V287, P5070, DOI 10.1074/jbc.M111.275438; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; HAMADA H, 1986, P NATL ACAD SCI USA, V83, P7785, DOI 10.1073/pnas.83.20.7785; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Loo TW, 2006, J BIOL CHEM, V281, P29436, DOI 10.1074/jbc.C600209200; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2005, J BIOENERG BIOMEMBR, V37, P501, DOI 10.1007/s10863-005-9499-3; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1994, J BIOL CHEM, V269, P28683; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; Ozvegy-Laczka C, 2005, J BIOL CHEM, V280, P4219, DOI 10.1074/jbc.M411338200; Pajeva IK, 2013, CHEMMEDCHEM, V8, P748, DOI 10.1002/cmdc.201200491; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; SAEKI T, 1993, J BIOL CHEM, V268, P6077; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; Sauna ZE, 2007, MOL CANCER THER, V6, P13, DOI 10.1158/1535-7163.MCT-06-0155; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Shukla S, 2012, DRUG METAB DISPOS, V40, P304, DOI 10.1124/dmd.111.042721; Silverton Latoya, 2011, Drug Metabolism and Drug Interactions, V26, P169, DOI 10.1515/DMDI.2011.027; TANAKA S, 1990, BIOCHEM BIOPH RES CO, V166, P180, DOI 10.1016/0006-291X(90)91928-L; Tiberghien F, 1996, ANTI-CANCER DRUG, V7, P568, DOI 10.1097/00001813-199607000-00012; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wolf SJ, 2011, PHARMACOGENOMICS J, V11, P315, DOI 10.1038/tpj.2011.16; Woodward OM, 2013, P NATL ACAD SCI USA, V110, P5223, DOI 10.1073/pnas.1214530110; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Wu GS, 2010, PLANT CELL, V22, P3295, DOI 10.1105/tpc.110.078360; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	43	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32622	32636		10.1074/jbc.M113.498980	http://dx.doi.org/10.1074/jbc.M113.498980			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24064216	Green Published, hybrid			2022-12-28	WOS:000328681700044
J	Okada, S; Zhou, XR; Damcevski, K; Gibb, N; Wood, C; Hamberg, M; Haritos, VS				Okada, Shoko; Zhou, Xue-Rong; Damcevski, Katherine; Gibb, Nerida; Wood, Craig; Hamberg, Mats; Haritos, Victoria S.			Diversity of Delta 12 Fatty Acid Desaturases in Santalaceae and Their Role in Production of Seed Oil Acetylenic Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Gene Expression; Lipids; Membrane Enzymes; Phylogenetics; Polyunsaturated Fatty Acids	OMEGA-6 DESATURASE; MOLECULAR-CLONING; GENE; FAD2; POLYACETYLENES; IDENTIFICATION; DERIVATIVES; OLACACEAE; L.	Plants in the Santalaceae family, including the native cherry Exocarpos cupressiformis and sweet quandong Santalum acuminatum, accumulate ximenynic acid (trans-11-octadecen-9-ynoic acid) in their seed oil and conjugated polyacetylenic fatty acids in root tissue. Twelve full-length genes coding for microsomal 12 fatty acid desaturases (FADs) from the two Santalaceae species were identified by degenerate PCR. Phylogenetic analysis of the predicted amino acid sequences placed five Santalaceae FADs with 12 FADs, which include Arabidopsis thaliana FAD2. When expressed in yeast, the major activity of these genes was 12 desaturation of oleic acid, but unusual activities were also observed: i.e. 15 desaturation of linoleic acid as well as trans-12 and trans-11 desaturations of stearolic acid (9-octadecynoic acid). The trans-12-octadecen-9-ynoic acid product was also detected in quandong seed oil. The two other FAD groups (FADX and FADY) were present in both species; in a phylogenetic tree of microsomal FAD enzymes, FADX and FADY formed a unique clade, suggesting that are highly divergent. The FADX group enzymes had no detectable 12 FAD activity but instead catalyzed cis-13 desaturation of stearolic acid when expressed in yeast. No products were detected for the FADY group when expressed recombinantly. Quantitative PCR analysis showed that the FADY genes were expressed in leaf rather than developing seed of the native cherry. FADs with promiscuous and unique activities have been identified in Santalaceae and explain the origin of some of the unusual lipids found in this plant family.	[Okada, Shoko; Damcevski, Katherine; Gibb, Nerida; Haritos, Victoria S.] CSIRO Ecosyst Sci, Canberra, ACT 2601, Australia; [Zhou, Xue-Rong; Wood, Craig] CSIRO Plant Ind, Canberra, ACT 2601, Australia; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Karolinska Institutet	Haritos, VS (corresponding author), CSIRO Ecosyst Sci, 343 Royal Pde, Parkville, Vic 3052, Australia.	victoria.haritos@csiro.au	Wood, Craig C/B-5792-2009; Okada, Shoko/B-6167-2009; Zhou, Xue-Rong/D-4706-2009	Okada, Shoko/0000-0002-1759-2677; Zhou, Xue-Rong/0000-0003-3717-2984; Haritos, Victoria/0000-0003-4630-9647; Hamberg, Mats/0000-0002-8910-7810	CSIRO Grains Research Development Corporation Crop Biofactories Initiative	CSIRO Grains Research Development Corporation Crop Biofactories Initiative(Grains R&D Corp)	This work was supported by the CSIRO Grains Research Development Corporation Crop Biofactories Initiative.	Blacklock BJ, 2010, J BIOL CHEM, V285, P28442, DOI 10.1074/jbc.M110.151498; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; BULOCK JD, 1963, PHYTOCHEMISTRY, V2, P289, DOI 10.1016/S0031-9422(00)85116-X; Cahoon EB, 1999, P NATL ACAD SCI USA, V96, P12935, DOI 10.1073/pnas.96.22.12935; Cahoon EB, 2004, J BIOL CHEM, V279, P12495, DOI 10.1074/jbc.M314329200; Cahoon EB, 2003, PLANT J, V34, P671, DOI 10.1046/j.1365-313X.2003.01757.x; Cantrell CL, 2010, CHEM BIODIVERS, V7, P1681, DOI 10.1002/cbdv.201000031; Cao SJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-5; Dembitsky VM, 2006, LIPIDS, V41, P883, DOI 10.1007/s11745-006-5044-3; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; HARVEY DJ, 1982, BIOMED MASS SPECTROM, V9, P33, DOI 10.1002/bms.1200090107; HATT HH, 1959, AUST J CHEM, V12, P190, DOI 10.1071/CH9590190; HATT HH, 1960, AUST J CHEM, V13, P488, DOI 10.1071/CH9600488; Heppard EP, 1996, PLANT PHYSIOL, V110, P311, DOI 10.1104/pp.110.1.311; Hernandez ML, 2005, PHYTOCHEMISTRY, V66, P1417, DOI 10.1016/j.phytochem.2005.04.004; Horne I, 2010, GENE, V468, P41, DOI 10.1016/j.gene.2010.08.003; Jin UH, 2001, PLANT SCI, V161, P935, DOI 10.1016/S0168-9452(01)00489-7; Khadake RM, 2009, MOL BIOTECHNOL, V42, P168, DOI 10.1007/s12033-009-9150-3; Lee M, 1998, SCIENCE, V280, P915, DOI 10.1126/science.280.5365.915; Lei N, 2010, BIOL PLANTARUM, V54, P41, DOI 10.1007/s10535-010-0006-2; Li XC, 2008, ANTIMICROB AGENTS CH, V52, P2442, DOI 10.1128/AAC.01297-07; Liu YD, 1997, J SCI FOOD AGR, V75, P27, DOI 10.1002/(SICI)1097-0010(199709)75:1&lt;27::AID-JSFA832&gt;3.0.CO;2-5; Minto RE, 2008, PROG LIPID RES, V47, P233, DOI 10.1016/j.plipres.2008.02.002; MORRIS LJ, 1966, CHEM IND-LONDON, P460; Naim F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052717; Niu B, 2007, BIOTECHNOL LETT, V29, P959, DOI 10.1007/s10529-007-9325-6; Panthama N, 2010, J NAT PROD, V73, P1366, DOI 10.1021/np1001913; Qiu X, 2001, PLANT PHYSIOL, V125, P847, DOI 10.1104/pp.125.2.847; Rawat R, 2012, J BIOL CHEM, V287, P16230, DOI 10.1074/jbc.M111.325316; Sperling P, 2000, EUR J BIOCHEM, V267, P3801, DOI 10.1046/j.1432-1327.2000.01418.x; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wood CC, 2009, PLANT BIOTECHNOL J, V7, P914, DOI 10.1111/j.1467-7652.2009.00453.x	33	10	13	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32405	32413		10.1074/jbc.M113.511931	http://dx.doi.org/10.1074/jbc.M113.511931			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24062307	Green Published, hybrid			2022-12-28	WOS:000328681700025
J	Wang, WJ; Hou, HF; Du, Q; Zhang, W; Liu, GF; Shtykova, EV; Xu, JH; Liu, P; Dong, YH				Wang, Wenjia; Hou, Haifeng; Du, Qian; Zhang, Wen; Liu, Guangfeng; Shtykova, Eleonora V.; Xu, Jianhua; Liu, Peng; Dong, Yuhui			Solution Small Angle X-ray Scattering (SAXS) Studies of RecQ from Deinococcus radiodurans and Its Complexes with Junction DNA Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Helicase; Homologous Recombination; Junctions; Molecular Modeling; X-ray Scattering; RecQ; SAXS	SYNDROME GENE-PRODUCT; RESOLUTION STRUCTURE; CRYSTAL-STRUCTURE; BRANCH MIGRATION; PROTEIN; HELICASE; RECOMBINATION; ENZYME; DOMAIN	RecQ helicases, essential enzymes for maintaining genome integrity, possess the capability to participate in a wide variety of DNA metabolisms. They can initiate the homologous recombination repair pathway by unwinding damaged dsDNA and suppress hyper-recombination by promoting Holliday junction (HJ) migration. To learn how DrRecQ participates in the homologous recombination repair pathway, solution structures of Deinococcus radiodurans RecQ (DrRecQ) and its complexes with DNA substrates were investigated by small angle x-ray scattering. We found that the catalytic core and the most N-terminal HRDC (helicase and RNase D C-terminal) domain (HRDC1) undergo a conformational change to a compact state upon binding to a junction DNA. Furthermore, models of DrRecQ in complexes with two kinds of junction DNA (fork junction and HJ) were built based on the small angle x-ray scattering data, and together with the EMSA results, possible binding sites were proposed. It is demonstrated that two DrRecQ molecules bind to the opposite arms of HJ. This architecture is similar to the RuvAB complex and is hypothesized to be highly conserved in the other HJ migration proteins. This work provides us new clues to understand the roles DrRecQ plays in the RecFOR pathway.	[Wang, Wenjia; Hou, Haifeng; Liu, Guangfeng; Xu, Jianhua; Liu, Peng; Dong, Yuhui] Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 100049, Peoples R China; [Du, Qian] Univ Connecticut, Dept Plant Sci, Coll Agr & Nat Resources, Storrs, CT 06269 USA; [Zhang, Wen] Univ Hong Kong, Dept Physiol, Hong Kong 999077, Hong Kong, Peoples R China; [Shtykova, Eleonora V.] Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	Chinese Academy of Sciences; Institute of High Energy Physics, CAS; University of Connecticut; University of Hong Kong; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Liu, P (corresponding author), Chinese Acad Sci, Inst High Energy Phys, 19B YuquanLu, Beijing 100049, Peoples R China.	liup@ihep.ac.cn; dongyh@ihep.ac.cn	Du, Qian/AAF-1111-2019; Shtykova, Eleonora V./G-6241-2013	Shtykova, Eleonora V./0000-0003-4347-7266; hou, Haifeng/0000-0002-0808-3459; Du, Qian/0000-0001-7438-9838; Dong, Yuhui/0000-0002-4422-4685	National Basic Research Program of China [2012CB917203]; National Natural Science Foundation of China [10979005]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Basic Research Program of China (2012CB917203) and the National Natural Science Foundation of China (10979005).	Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bentchikou E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000774; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Bernstein DA, 2005, STRUCTURE, V13, P1173, DOI 10.1016/j.str.2005.04.018; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cox MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000815; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Killoran MP, 2008, NUCLEIC ACIDS RES, V36, P3139, DOI 10.1093/nar/gkn143; Killoran MP, 2006, J BIOL CHEM, V281, P12849, DOI 10.1074/jbc.M600097200; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LeRoy G, 2005, NUCLEIC ACIDS RES, V33, P6251, DOI 10.1093/nar/gki929; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Rafferty JB, 1996, SCIENCE, V274, P415, DOI 10.1126/science.274.5286.415; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; STASIAK A, 1994, P NATL ACAD SCI USA, V91, P7618, DOI 10.1073/pnas.91.16.7618; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; UMEZU K, 1990, P NATL ACAD SCI USA, V87, P5363, DOI 10.1073/pnas.87.14.5363; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	37	4	4	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32414	32423		10.1074/jbc.M113.502112	http://dx.doi.org/10.1074/jbc.M113.502112			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24068706	Green Published, hybrid			2022-12-28	WOS:000328681700026
J	Kam, RKT; Shi, WL; Chan, SO; Chen, YL; Xu, G; Lau, CBS; Fung, KP; Chan, WY; Zhao, H				Kam, Richard Kin Ting; Shi, Weili; Chan, Sun On; Chen, Yonglong; Xu, Gang; Lau, Clara Bik-San; Fung, Kwok Pui; Chan, Wood Yee; Zhao, Hui			Dhrs3 Protein Attenuates Retinoic Acid Signaling and Is Required for Early Embryonic Patterning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-EMBRYOS; GASTRULATION MOVEMENTS; ZEBRAFISH PRONEPHROS; CELL MOVEMENTS; GENE XLIM-1; EXPRESSION; MESODERM; INDUCTION; SPECIFICATION; LAEVIS	All-trans-retinoic acid (atRA) is an important morphogen involved in many developmental processes, including neural differentiation, body axis formation, and organogenesis. During early embryonic development, atRA is synthesized from all-trans-retinal (atRAL) in an irreversible reaction mainly catalyzed by retinal dehydrogenase 2 (aldh1a2), whereas atRAL is converted from all-trans-retinol via reversible oxidation by retinol dehydrogenases, members of the short-chain dehydrogenase/reductase family. atRA is degraded by cytochrome P450, family 26 (cyp26). We have previously identified a short-chain dehydrogenase/reductase 3 (dhrs3), which showed differential expression patterns in Xenopus embryos. We show here that the expression of dhrs3 was induced by atRA treatment and overexpression of Xenopus nodal related 1 (xnr1) in animal cap assay. Overexpression of dhrs3 enhanced the phenotype of excessive cyp26a1. In embryos overexpressing aldh1a2 or retinol dehydrogenase 10 (rdh10) in the presence of their respective substrates, Dhrs3 counteracted the action of Aldh1a2 or Rdh10, indicating that retinoic acid signaling is attenuated. Knockdown of Dhrs3 by antisense morpholino oligonucleotides resulted in a phenotype of shortened anteroposterior axis, reduced head structure, and perturbed somitogenesis, which were also found in embryos treated with an excess of atRA. Examination of the expression of brachyury, not, goosecoid, and papc indicated that convergent extension movement was defective in Dhrs3 morphants. Taken together, these studies suggest that dhrs3 participates in atRA metabolism by reducing atRAL levels and is required for proper anteroposterior axis formation, neuroectoderm patterning, and somitogenesis.	[Kam, Richard Kin Ting; Fung, Kwok Pui; Zhao, Hui] Chinese Univ Hong Kong, Minist Educ, Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Sun On; Chan, Wood Yee] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Chen, Yonglong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China; [Zhao, Hui] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518057, Peoples R China; [Shi, Weili; Xu, Gang] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Lau, Clara Bik-San] Chinese Univ Hong Kong, Inst Chinese Med, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, WY (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	wy-chan@cuhk.edu.hk; zhaohui@cuhk.edu.hk	Chan, Sun-On/R-6547-2018; Zhao, Hui/B-8429-2016; Fung, Kwok Pui/R-9708-2018; Lau, Clara Bik-San/AAF-3989-2020; Chan, Wood Yee/R-6692-2018	Chan, Sun-On/0000-0002-3221-3786; Zhao, Hui/0000-0001-8160-6415; Fung, Kwok Pui/0000-0001-6214-5123; Lau, Clara Bik-San/0000-0002-7409-1270; Chan, Wood Yee/0000-0002-7114-1463	Research Grants Council of Hong Kong [CUHK480709, N_CUHK413/12]; Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-YW-R-083]; National Natural Science Foundation of China [81270438]; Chinese University of Hong Kong	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported in part by Grants CUHK480709 and N_CUHK413/12 from the Research Grants Council of Hong Kong (to H. Z.), in part by Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences Grant KSCX2-YW-R-083 (to Y. L. C.), and National Natural Science Foundation of China Grant 81270438 (to G. X.).; Supported by graduate studentships from the Chinese University of Hong Kong.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; Brent AE, 2004, DEVELOPMENT, V131, P3885, DOI 10.1242/dev.01275; Caneparo L, 2007, GENE DEV, V21, P465, DOI 10.1101/gad.406007; Cartry J, 2006, DEV BIOL, V299, P35, DOI 10.1016/j.ydbio.2006.06.047; Cerignoli F, 2002, CANCER RES, V62, P1196; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Chen Y, 2003, MECH DEVELOP, V120, P277, DOI 10.1016/S0925-4773(02)00460-4; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; CHEN YP, 1994, DEV BIOL, V161, P70, DOI 10.1006/dbio.1994.1008; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Duester Gregg, 2007, Birth Defects Research, V81, P84, DOI 10.1002/bdrc.20092; Esteban-Pretel G, 2010, J NUTR BIOCHEM, V21, P227, DOI 10.1016/j.jnutbio.2008.12.007; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Harada Y, 2007, BIOCHEM BIOPH RES CO, V358, P968, DOI 10.1016/j.bbrc.2007.04.208; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HARVEY RP, 1992, MECH DEVELOP, V37, P141, DOI 10.1016/0925-4773(92)90076-V; Hollemann T, 1998, EMBO J, V17, P7361, DOI 10.1093/emboj/17.24.7361; Hukriede NA, 2003, DEV CELL, V4, P83, DOI 10.1016/S1534-5807(02)00398-2; ISAACS HV, 1994, EMBO J, V13, P4469, DOI 10.1002/j.1460-2075.1994.tb06769.x; Ishibashi H, 2008, MECH DEVELOP, V125, P58, DOI 10.1016/j.mod.2007.10.005; Janssens S, 2010, INT J DEV BIOL, V54, P1435, DOI 10.1387/ijdb.092985sj; JONES CM, 1995, DEVELOPMENT, V121, P3651; Kam RKT, 2010, INT J DEV BIOL, V54, P1355, DOI 10.1387/ijdb.092984rk; Kam RKT, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-11; Kim SH, 1998, DEVELOPMENT, V125, P4681; Kolm PJ, 1997, DEV BIOL, V192, P1, DOI 10.1006/dbio.1997.8754; KOLM PJ, 1995, DEV BIOL, V167, P34, DOI 10.1006/dbio.1995.1005; Kuroda H, 2002, DEV BIOL, V244, P267, DOI 10.1006/dbio.2002.0589; Latinkic BV, 1997, GENE DEV, V11, P3265, DOI 10.1101/gad.11.23.3265; Lee SJ, 2010, MECH DEVELOP, V127, P49, DOI 10.1016/j.mod.2009.11.001; Lee YM, 2008, J BIOL CHEM, V283, P33969, DOI 10.1074/jbc.M804469200; Luxardi G, 2010, DEVELOPMENT, V137, P417, DOI 10.1242/dev.039735; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mic FA, 2002, DEVELOPMENT, V129, P2271; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ryckebusch L, 2008, P NATL ACAD SCI USA, V105, P2913, DOI 10.1073/pnas.0712344105; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Strate I, 2009, DEVELOPMENT, V136, P461, DOI 10.1242/dev.024901; Tada M, 2012, DEVELOPMENT, V139, P3897, DOI 10.1242/dev.073007; TAIRA M, 1994, DEVELOPMENT, V120, P1525; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; Tanibe M, 2008, INT J DEV BIOL, V52, P893, DOI 10.1387/ijdb.082683mt; Uehara M, 2009, GENE DEV, V23, P1689, DOI 10.1101/gad.1776209; Wessely O, 2002, NEURON, V33, P489, DOI 10.1016/S0896-6273(02)00596-2; White RJ, 2008, DEV DYNAM, V237, P2775, DOI 10.1002/dvdy.21695; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Zhao H, 2001, INT J DEV BIOL, V45, P817	56	39	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31477	31487		10.1074/jbc.M113.514984	http://dx.doi.org/10.1074/jbc.M113.514984			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24045938	hybrid, Green Published			2022-12-28	WOS:000330596200007
J	Perdomo-Morales, R; Montero-Alejo, V; Corzo, G; Besada, V; Vega-Hurtado, Y; Gonzalez-Gonzalez, Y; Perera, E; Porto-Verdecia, M				Perdomo-Morales, Rolando; Montero-Alejo, Vivian; Corzo, Gerardo; Besada, Vladimir; Vega-Hurtado, Yamile; Gonzalez-Gonzalez, Yamile; Perera, Erick; Porto-Verdecia, Marlene			The Trypsin Inhibitor Panulirin Regulates the Prophenoloxidase-activating System in the Spiny Lobster Panulirus argus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANDUCA-SEXTA SERPIN-4; BLACK TIGER SHRIMP; SERINE PROTEINASE; PHENOLOXIDASE ACTIVITY; PROTEASE INHIBITORS; OXIDASE ACTIVATION; PROTEOLYTIC-ENZYMES; CATIONIC PEPTIDE; CDNA CLONING; ACTIVE-SITE	The melanization reaction promoted by the prophenoloxidase- activating system is an essential defense response in invertebrates subjected to regulatory mechanisms that are still not fully understood. We report here the finding and characterization of a novel trypsin inhibitor, named panulirin, isolated from the hemocytes of the spiny lobster Panulirus argus with regulatory functions on the melanization cascade. Panulirin is a cationic peptide (pI 9.5) composed of 48 amino acid residues (5.3 kDa), with six cysteine residues forming disulfide bridges. Its primary sequence was determined by combining Edman degradation/N-terminal sequencing and electrospray ionization-MS/MS spectrometry. The low amino acid sequence similarity with known proteins indicates that it represents a new family of peptidase inhibitors. Panulirin is a competitive and reversible tight-binding inhibitor of trypsin (K-i = 8.6 nM) with a notable specificity because it does not inhibit serine peptidases such as subtilisin, elastase, chymotrypsin, thrombin, and plasmin. The removal of panulirin from the lobster hemocyte lysate leads to an increase in phenoloxidase response to LPS. Likewise, the addition of increasing concentrations of panulirin to a lobster hemocyte lysate, previously depleted of trypsin-inhibitory activity, decreased the phenoloxidase response to LPS in a concentration-dependent fashion. These results indicate that panulirin is implicated in the regulation of the melanization cascade in P. argus by inhibiting peptidase(s) in the pathway toward the activation of the prophenoloxidase enzyme.	[Perdomo-Morales, Rolando; Montero-Alejo, Vivian; Vega-Hurtado, Yamile; Porto-Verdecia, Marlene] Ctr Pharmaceut Res & Dev, Dept Biochem, Havana 10400, Cuba; [Corzo, Gerardo] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62250, Morelos, Mexico; [Besada, Vladimir] Ctr Genet Engn & Biotechnol, Dept Prote, Havana 10600, Cuba; [Gonzalez-Gonzalez, Yamile] Univ Fed Sao Paulo, Dept Biochem, BR-04044020 Sao Paulo, Brazil; [Perera, Erick] Univ Havana, Ctr Marine Res, Havana 11300, Cuba	Universidad Nacional Autonoma de Mexico; Centro de Ingenieria Genetica y Biotecnologia; Universidade Federal de Sao Paulo (UNIFESP); Universidad de la Habana	Perdomo-Morales, R (corresponding author), Ctr Pharmaceut Res & Dev, Dept Biochem, Ave 26 1605 E Ave 51 & Boyeros, Havana 10400, Cuba.	rolando.perdomo@infomed.sld.cu	Perera, Erick/F-2917-2012; Perera, Erick/E-9908-2018; Corzo, Gerardo/B-3778-2014; Montero-Alejo, Vivian/AAY-1316-2020; Perdomo-Morales, Rolando/AAC-8280-2020	Perera, Erick/0000-0001-6108-1340; Perera, Erick/0000-0001-6108-1340; Corzo, Gerardo/0000-0002-9513-1622; Montero-Alejo, Vivian/0000-0002-0089-7925; Perdomo-Morales, Rolando/0000-0001-5598-6864; Besada, Vladimir/0000-0003-3584-7714				An CJ, 2010, INSECT BIOCHEM MOLEC, V40, P683, DOI 10.1016/j.ibmb.2010.07.001; Corral-Rodriguez MA, 2009, INSECT BIOCHEM MOLEC, V39, P579, DOI 10.1016/j.ibmb.2009.07.003; Apostoluk W, 1998, PROTEINS, V32, P459, DOI 10.1002/(SICI)1097-0134(19980901)32:4<459::AID-PROT5>3.0.CO;2-B; ASHIDA M, 1984, COMP BIOCHEM PHYS B, V77, P21, DOI 10.1016/0305-0491(84)90217-7; ASPAN A, 1990, INSECT BIOCHEM, V20, P485, DOI 10.1016/0020-1790(90)90030-X; ASPAN A, 1991, INSECT BIOCHEM, V21, P363, DOI 10.1016/0020-1790(91)90002-V; Ballin JD, 2004, NUCLEIC ACIDS RES, V32, P3271, DOI 10.1093/nar/gkh646; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Breugelmans B, 2009, PEPTIDES, V30, P622, DOI 10.1016/j.peptides.2008.07.026; Cardenas W, 1997, FISH SHELLFISH IMMUN, V7, P283, DOI 10.1006/fsim.1997.0083; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Cerenius L, 2010, J INVERTEBR PATHOL, V103, P21, DOI 10.1016/j.jip.2009.09.006; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Christeller JT, 2005, FEBS J, V272, P5710, DOI 10.1111/j.1742-4658.2005.04975.x; Copeland R. A., 2000, PRACTICAL INTRO STRU, P305; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Franssens V, 2008, PEPTIDES, V29, P235, DOI 10.1016/j.peptides.2007.07.032; Gai YC, 2008, FISH SHELLFISH IMMUN, V25, P657, DOI 10.1016/j.fsi.2008.08.013; Garcia-Molina F, 2007, J AGR FOOD CHEM, V55, P9739, DOI 10.1021/jf0712301; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Grzesiak A, 2000, J MOL BIOL, V301, P205, DOI 10.1006/jmbi.2000.3935; Gubb D, 2010, BIOCHIMIE, V92, P1749, DOI 10.1016/j.biochi.2010.09.004; HANSPAL JS, 1983, ANAL BIOCHEM, V132, P288, DOI 10.1016/0003-2697(83)90010-6; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; HERGENHAHN HG, 1987, BIOCHEM J, V248, P223, DOI 10.1042/bj2480223; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kelly CA, 2005, PROTEIN PEPTIDE LETT, V12, P465, DOI 10.2174/0929866054395383; Krowarsch D, 2005, PROTEIN PEPTIDE LETT, V12, P403, DOI 10.2174/0929866054395275; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; LABOUESSE J, 1967, EUR J BIOCHEM, V2, P215, DOI 10.1111/j.1432-1033.1967.tb00127.x; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Laskowski Jr. M., 2000, PROTEIN PROTEIN RECO, P228; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Laskowski M Jr, 1986, Adv Exp Med Biol, V199, P1; Liang ZC, 1997, P NATL ACAD SCI USA, V94, P6682, DOI 10.1073/pnas.94.13.6682; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu ZQ, 2007, INSECT BIOCHEM MOLEC, V37, P478, DOI 10.1016/j.ibmb.2007.02.004; Montero-Alejo V, 2012, FISH SHELLFISH IMMUN, V33, P872, DOI 10.1016/j.fsi.2012.07.013; Nagase H., 2001, FINDING PURIFICATION, V2nd ed., P131; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; OHTA T, 1994, J MOL EVOL, V39, P614, DOI 10.1007/BF00160406; Otlewski J, 2005, EMBO J, V24, P1303, DOI 10.1038/sj.emboj.7600611; Perazzolo LM, 1997, DEV COMP IMMUNOL, V21, P385, DOI 10.1016/S0145-305X(97)00022-0; Perdomo-Morales R, 2007, FISH SHELLFISH IMMUN, V23, P1187, DOI 10.1016/j.fsi.2007.04.001; Perdomo-Morales R, 2008, BBA-GEN SUBJECTS, V1780, P652, DOI 10.1016/j.bbagen.2008.01.001; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Pisuttharachai D, 2009, DEV COMP IMMUNOL, V33, P434, DOI 10.1016/j.dci.2008.11.007; Pisuttharachai D, 2009, FISHERIES SCI, V75, P195, DOI 10.1007/s12562-008-0027-3; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rawlings ND, 2010, BIOCHIMIE, V92, P1463, DOI 10.1016/j.biochi.2010.04.013; Rimphanitchayakit V, 2010, DEV COMP IMMUNOL, V34, P377, DOI 10.1016/j.dci.2009.12.004; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Simonet G, 2003, PEPTIDES, V24, P1633, DOI 10.1016/j.peptides.2003.07.014; Simonet G, 2002, COMP BIOCHEM PHYS B, V132, P247, DOI 10.1016/S1096-4959(01)00530-9; SMITH VJ, 1991, DEV COMP IMMUNOL, V15, P251, DOI 10.1016/0145-305X(91)90018-T; Soderhall I, 2009, J BIOL CHEM, V284, P6301, DOI 10.1074/jbc.M806764200; SODERHALL K, 1984, BIOCHIM BIOPHYS ACTA, V797, P99, DOI 10.1016/0304-4165(84)90387-8; Somnuk S, 2012, FISH SHELLFISH IMMUN, V33, P332, DOI 10.1016/j.fsi.2012.05.005; Sritunyalucksana K, 1999, DEV COMP IMMUNOL, V23, P179, DOI 10.1016/S0145-305X(99)00005-1; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Sugumaran M, 2000, BIOCHEM BIOPH RES CO, V268, P379, DOI 10.1006/bbrc.2000.2138; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Tong YR, 2005, J BIOL CHEM, V280, P14923, DOI 10.1074/jbc.M500531200; TSUKAMOTO T, 1992, BIOCHEM BIOPH RES CO, V184, P86, DOI 10.1016/0006-291X(92)91161-I; Wang SY, 2012, FISH SHELLFISH IMMUN, V32, P331, DOI 10.1016/j.fsi.2011.11.025; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zhang W, 1996, P NATL ACAD SCI USA, V93, P2511, DOI 10.1073/pnas.93.6.2511; Zhao MY, 2005, J BIOL CHEM, V280, P24744, DOI 10.1074/jbc.M504173200; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200; Zou Z, 2005, J BIOL CHEM, V280, P14341, DOI 10.1074/jbc.M500570200	82	6	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31867	31879		10.1074/jbc.M113.464297	http://dx.doi.org/10.1074/jbc.M113.464297			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047891	Green Published, hybrid			2022-12-28	WOS:000330596200036
J	Prigozhin, DM; Mavrici, D; Huizar, JP; Vansell, HJ; Alber, T				Prigozhin, Daniil M.; Mavrici, Daniela; Huizar, John P.; Vansell, Hilary J.; Alber, Tom			Structural and Biochemical Analyses of Mycobacterium tuberculosis N-Acetylmuramyl-L-alanine Amidase Rv3717 Point to a Role in Peptidoglycan Fragment Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; BACTERIAL-GROWTH; CELL-DIVISION; ENZYMES; RECOGNITION; HYDROLASES; WALLS; SUITE	Peptidoglycan hydrolases are key enzymes in bacterial cell wall homeostasis. Understanding the substrate specificity and biochemical activity of peptidoglycan hydrolases in Mycobacterium tuberculosis is of special interest as it can aid in the development of new cell wall targeting therapeutics. In this study, we report biochemical and structural characterization of the mycobacterial N-acetylmuramyl-L-alanine amidase, Rv3717. The crystal structure of Rv3717 in complex with a dipeptide product shows that, compared with previously characterized peptidoglycan amidases, the enzyme contains an extra disulfide-bonded beta-hairpin adjacent to the active site. The structure of two intermediates in assembly reveal that Zn2+ binding rearranges active site residues, and disulfide formation promotes folding of the beta-hairpin. Although Zn2+ is required for hydrolysis of muramyl dipeptide, disulfide oxidation is not required for activity on this substrate. The orientation of the product in the active site suggests a role for a conserved glutamate (Glu-200) in catalysis; mutation of this residue abolishes activity. The product binds at the head of a closed tunnel, and the enzyme showed no activity on polymerized peptidoglycan. These results point to a potential role for Rv3717 in peptidoglycan fragment recycling.	[Prigozhin, Daniil M.; Mavrici, Daniela; Huizar, John P.; Vansell, Hilary J.; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Alber, T (corresponding author), 156 Stanley Hall, Berkeley, CA 94720 USA.	tom@ucxray.berkeley.edu		Prigozhin, Daniil M/0000-0003-2075-0231	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI095208] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Ksenia V. Krasileva for assistance with phylogenetic analysis and critical reading of the manuscript. Weare grateful to James Holton, George Meigs, and Jane Tanamachi for assistance with Beamline 8.3.1 at the Lawrence Berkeley National Laboratory Advanced Light Source. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC02-05CH11231.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Both D, 2011, J MOL BIOL, V413, P247, DOI 10.1016/j.jmb.2011.08.014; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; Deng LL, 2005, BBA-PROTEINS PROTEOM, V1747, P57, DOI 10.1016/j.bbapap.2004.09.021; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Kana BD, 2010, FEMS IMMUNOL MED MIC, V58, P39, DOI 10.1111/j.1574-695X.2009.00606.x; Korndorfer IP, 2006, J MOL BIOL, V364, P678, DOI 10.1016/j.jmb.2006.08.069; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Mayer MJ, 2011, J BACTERIOL, V193, P5477, DOI 10.1128/JB.00439-11; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reith J, 2011, APPL MICROBIOL BIOT, V92, P1, DOI 10.1007/s00253-011-3486-x; ROGERS HJ, 1984, J GEN MICROBIOL, V130, P2395; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; van Heijenoort J, 2011, MICROBIOL MOL BIOL R, V75, P636, DOI 10.1128/MMBR.00022-11; Wyckoff TJ, 2012, TRENDS MICROBIOL, V20, P540, DOI 10.1016/j.tim.2012.08.003; Yang DC, 2012, MOL MICROBIOL, V85, P768, DOI 10.1111/j.1365-2958.2012.08138.x; YOUNG FE, 1966, J BIOL CHEM, V241, P3462; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	26	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31549	31555		10.1074/jbc.M113.510792	http://dx.doi.org/10.1074/jbc.M113.510792			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24019530	Green Published, hybrid			2022-12-28	WOS:000330596200014
J	Fan, J; Kamphorst, JJ; Rabinowitz, JD; Shlomi, T				Fan, Jing; Kamphorst, Jurre J.; Rabinowitz, Joshua D.; Shlomi, Tomer			Fatty Acid Labeling from Glutamine in Hypoxia Can Be Explained by Isotope Exchange without Net Reductive Isocitrate Dehydrogenase (IDH) Flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KREBS CYCLE; METABOLOMIC ANALYSIS; CELLS; CONVERSION; GROWTH; GLUCONEOGENESIS; CARBOXYLATION; CARBOHYDRATE; LIPOGENESIS; EXPRESSION	Acetyl-CoA is an important anabolic precursor for lipid biosynthesis. In the conventional view of mammalian metabolism, acetyl-CoA is primarily derived by the oxidation of glucose-derived pyruvate in mitochondria. Recent studies have employed isotope tracers to show that in cancer cells grown in hypoxia or with defective mitochondria, a major fraction of acetyl-CoA is produced via another route, reductive carboxylation of glutamine- derived alpha-ketoglutarate (catalyzed by reverse flux through isocitrate dehydrogenase, IDH). Here, we employ a quantitative flux model to show that in hypoxia and in cells with defective mitochondria, oxidative IDH flux persists and may exceed the reductive flux. Therefore, IDH flux may not be a net contributor to acetyl-CoA production, although we cannot rule out net reductive IDH flux in some compartments. Instead of producing large amounts of net acetyl-CoA reductively, the cells adapt by reducing their demand for acetyl-CoA by importing rather than synthesizing fatty acids. Thus, fatty acid labeling from glutamine in hypoxia can be explained by spreading of label without net reductive IDH flux.	[Fan, Jing; Kamphorst, Jurre J.; Rabinowitz, Joshua D.; Shlomi, Tomer] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Rabinowitz, Joshua D.] Princeton Univ, Dept Chem & Mol Biol, Princeton, NJ 08544 USA; [Rabinowitz, Joshua D.] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel	Princeton University; Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Technion Israel Institute of Technology	Shlomi, T (corresponding author), Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel.	tomersh@cs.technion.ac.il	Rabinowitz, Joshua/GPP-4019-2022; damiani, chiara/R-4256-2016	Rabinowitz, Joshua/0000-0002-1247-4727; Kamphorst, Jurre/0000-0002-2042-5474; Fan, Jing/0000-0002-5326-5358	NATIONAL CANCER INSTITUTE [R01CA163591] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA163591] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAILEY JW, 1990, AM J PHYSIOL, V258, pE850, DOI 10.1152/ajpendo.1990.258.5.E850; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Comte B, 2002, AM J PHYSIOL-HEART C, V283, pH1505, DOI 10.1152/ajpheart.00287.2002; DESROSIERS C, 1994, J BIOL CHEM, V269, P27179; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; KHARROUBI AT, 1992, AM J PHYSIOL, V263, pE667, DOI 10.1152/ajpendo.1992.263.4.E667; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; KOSUGI K, 1986, J BIOL CHEM, V261, P3179; Krebs H A, 1972, Essays Biochem, V8, P1; KREBS HA, 1966, BIOCHEM J, V101, P242, DOI 10.1042/bj1010242; LANDAU BR, 1992, METABOLISM, V41, P457, DOI 10.1016/0026-0495(92)90199-K; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; McBrian MA, 2013, MOL CELL, V49, P310, DOI 10.1016/j.molcel.2012.10.025; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; SCHUMANN WC, 1991, J BIOL CHEM, V266, P6985; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; SPENCER A, 1964, BIOCHEM J, V93, P378, DOI 10.1042/bj0930378; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; WEINMAN EO, 1957, PHYSIOL REV, V37, P252, DOI 10.1152/physrev.1957.37.2.252; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang LL, 2008, J BIOL CHEM, V283, P21988, DOI 10.1074/jbc.M803455200; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	31	51	51	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31363	31369		10.1074/jbc.M113.502740	http://dx.doi.org/10.1074/jbc.M113.502740			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24030823	Green Published, hybrid			2022-12-28	WOS:000330778900053
J	Gadepalli, R; Kotla, S; Heckle, MR; Verma, SK; Singh, NK; Rao, GN				Gadepalli, Ravisekhar; Kotla, Sivareddy; Heckle, Mark R.; Verma, Shailendra K.; Singh, Nikhlesh K.; Rao, Gadiparthi N.			RETRACTED: Novel Role for p21-activated Kinase 2 in Thrombin-induced Monocyte Migration (Retracted article. See vol. 298, 2022)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							PROTEASE-ACTIVATED RECEPTORS; TYROSINE PHOSPHATASE SHP2; RHO-GTPASES; SCAFFOLDING PROTEIN; CELL-MIGRATION; DNA-SYNTHESIS; IN-VITRO; GAB1; RAC; MACROPHAGES	To understand the role of thrombin in inflammation, we tested its effects on migration of THP-1 cells, a human monocytic cell line. Thrombin induced THP-1 cell migration in a dose-dependent manner. Thrombin induced tyrosine phosphorylation of Pyk2, Gab1, and p115 RhoGEF, leading to Rac1- and RhoA-dependent Pak2 activation. Downstream to Pyk2, Gab1 formed a complex with p115 RhoGEF involving their pleckstrin homology domains. Furthermore, inhibition or depletion of Pyk2, Gab1, p115 RhoGEF, Rac1, RhoA, or Pak2 levels substantially attenuated thrombin-induced THP-1 cell F-actin cytoskeletal remodeling and migration. Inhibition or depletion of PAR1 also blocked thrombin-induced activation of Pyk2, Gab1, p115 RhoGEF, Rac1, RhoA, and Pak2, resulting in diminished THP-1 cell F-actin cytoskeletal remodeling and migration. Similarly, depletion of G alpha(12) negated thrombin-induced Pyk2, Gab1, p115 RhoGEF, Rac1, RhoA, and Pak2 activation, leading to attenuation of THP-1 cell F-actin cytoskeletal remodeling and migration. These novel observations reveal that thrombin induces monocyte/macrophage migration via PAR1-G alpha 12-dependent Pyk2-mediated Gab1 and p115 RhoGEF interactions, leading to Rac1- and RhoA-targeted Pak2 activation. Thus, these findings provide mechanistic evidence for the role of thrombin and its receptor PAR1 in inflammation.	[Gadepalli, Ravisekhar; Kotla, Sivareddy; Heckle, Mark R.; Verma, Shailendra K.; Singh, Nikhlesh K.; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Singh, Nikhlesh/AAA-4253-2020; Gadepalli, Ravisekhar/AAU-2636-2020	kotla, sivareddy/0000-0001-7516-7647; Singh, Nikhlesh/0000-0002-3665-6023	National Institutes of Health [HL103575, HL069908]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069908, R01HL103575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL103575 and HL069908 (to G. N. R.).	Ahn HS, 2003, CURR PHARM DESIGN, V9, P2349, DOI 10.2174/1381612033453884; BADIMON L, 1991, BLOOD, V78, P423; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cambien B, 2001, BLOOD, V97, P359, DOI 10.1182/blood.V97.2.359; Cao HQ, 2006, AM J PHYSIOL-CELL PH, V290, pC172, DOI 10.1152/ajpcell.00284.2005; Chen Z, 2012, J BIOL CHEM, V287, P25490, DOI 10.1074/jbc.M111.333716; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Dance M, 2006, J BIOL CHEM, V281, P23285, DOI 10.1074/jbc.M600987200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gadepalli R, 2012, ARTERIOSCL THROM VAS, V32, P2652, DOI 10.1161/ATVBAHA.112.253112; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hart MJ, 1996, J BIOL CHEM, V271, P25452, DOI 10.1074/jbc.271.41.25452; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Ishimi Y, 2003, J BIOL CHEM, V278, P24644, DOI 10.1074/jbc.M213252200; JOSEPH S, 1992, BIOCHEM J, V286, P945, DOI 10.1042/bj2860945; Kaplanski G, 1998, BLOOD, V92, P1259, DOI 10.1182/blood.V92.4.1259.416k11_1259_1267; Katsume A, 2011, ARTERIOSCL THROM VAS, V31, P1084, DOI 10.1161/ATVBAHA.110.221804; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Kong TQ, 2009, MOL BIOL CELL, V20, P4596, DOI 10.1091/mbc.E09-03-0220; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lock LS, 2002, MOL BIOL CELL, V13, P2132, DOI 10.1091/mbc.02-02-0031; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Maggio N, 2008, J NEUROSCI, V28, P732, DOI 10.1523/JNEUROSCI.3665-07.2008; Mansilla S, 2008, ARTERIOSCL THROM VAS, V28, P1844, DOI 10.1161/ATVBAHA.108.171389; Mantuano E, 2010, J BIOL CHEM, V285, P14259, DOI 10.1074/jbc.M109.085126; Marin V, 2001, BLOOD, V98, P667, DOI 10.1182/blood.V98.3.667; Maroun CR, 2003, MOL BIOL CELL, V14, P1691, DOI 10.1091/mbc.E02-06-0352; Maroun CR, 1999, MOL CELL BIOL, V19, P1784; Martorell L, 2008, THROMB HAEMOSTASIS, V99, P305, DOI 10.1160/TH07-08-0481; Mikelis CM, 2013, J BIOL CHEM, V288, P12232, DOI 10.1074/jbc.M112.428599; Nakaoka Y, 2003, CIRC RES, V93, P221, DOI 10.1161/01.RES.0000085562.48906.4A; NELKEN NA, 1992, J CLIN INVEST, V90, P1614, DOI 10.1172/JCI116031; O'Brien PJ, 2001, ONCOGENE, V20, P1570, DOI 10.1038/sj.onc.1204194; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Okkenhaug K, 1998, J BIOL CHEM, V273, P21194, DOI 10.1074/jbc.273.33.21194; Paliouras GN, 2009, MOL CELL BIOL, V29, P3018, DOI 10.1128/MCB.01286-08; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Parrini MC, 2009, J BIOL CHEM, V284, P24133, DOI 10.1074/jbc.M109.015271; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Seasholtz TM, 1999, CIRC RES, V84, P1186, DOI 10.1161/01.RES.84.10.1186; Shi CS, 2000, J BIOL CHEM, V275, P24470, DOI 10.1074/jbc.M908449199; Shi XL, 2004, MOL CANCER RES, V2, P395; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Simoncini S, 2009, CIRC RES, V104, P943, DOI 10.1161/CIRCRESAHA.108.183285; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Suire S, 2012, EMBO J, V31, P3118, DOI 10.1038/emboj.2012.167; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Tang Y, 1999, MOL CELL BIOL, V19, P1881; Timmerman I, 2012, MOL BIOL CELL, V23, P4212, DOI 10.1091/mbc.E12-01-0038; Trejo J, 2003, J PHARMACOL EXP THER, V307, P437, DOI 10.1124/jpet.103.052100; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Wan QW, 2012, MOL BIOL CELL, V23, P2076, DOI 10.1091/mbc.E11-11-0940; Wang D, 2009, CIRC RES, V104, P1066, DOI 10.1161/CIRCRESAHA.109.196691; Weiss-Haljiti C, 2004, J BIOL CHEM, V279, P43273, DOI 10.1074/jbc.M402924200; Whitman SC, 2000, J BIOL CHEM, V275, P35807, DOI 10.1074/jbc.M001797200; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; YIN HL, 1988, J CELL SCI, P169; Zeng HY, 2002, J BIOL CHEM, V277, P46791, DOI 10.1074/jbc.M206133200; Zigler M, 2011, CANCER RES, V71, P6561, DOI 10.1158/0008-5472.CAN-11-1432	66	30	31	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30815	30831		10.1074/jbc.M113.463414	http://dx.doi.org/10.1074/jbc.M113.463414			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24025335	Green Published, hybrid			2022-12-28	WOS:000330778900003
J	Hu, SL; Wang, MR; Cai, GP; He, MY				Hu, Shaoliang; Wang, Mingrong; Cai, Guoping; He, Mingyue			Genetic Code-guided Protein Synthesis and Folding in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							USAGE BIAS; EXPRESSION; TRANSLATION; RATES	Universal genetic codes are degenerated with 61 codons specifying 20 amino acids, thus creating synonymous codons for a single amino acid. Synonymous codons have been shown to affect protein properties in a given organism. To address this issue and explore how Escherichia coli selects its "codon-preferred" DNA template(s) for synthesis of proteins with required properties, we have designed synonymous codon libraries based on an antibody (scFv) sequence and carried out bacterial expression and screening for variants with altered properties. As a result, 342 codon variants have been identified, differing significantly in protein solubility and functionality while retaining the identical original amino acid sequence. The soluble expression level varied from completely insoluble aggregates to a soluble yield of similar to 2.5 mg/liter, whereas the antigen-binding activity changed from no binding at all to a binding affinity of > 10(-8) M. Not only does our work demonstrate the involvement of genetic codes in regulating protein synthesis and folding but it also provides a novel screening strategy for producing improved proteins without the need to substitute amino acids.	[Hu, Shaoliang; Cai, Guoping] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Hu, Shaoliang; Cai, Guoping] Tsinghua Univ, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China; [Wang, Mingrong; He, Mingyue] Chengdu Inst Biol Prod, Recombinant Prot Therapeut, Chengdu 610023, Sichuan, Peoples R China	Tsinghua University; Tsinghua University; University Town of Shenzhen	He, MY (corresponding author), Chengdu Inst Biol Prod, Recombinant Prot Therapeut, Chengdu 610023, Sichuan, Peoples R China.	mingyuehe2001@yahoo.com			SinoPharm and national "12.5" Scheme (Beijing, China) [2011ZX09506-005]; SinoPharm, Beijing, China	SinoPharm and national "12.5" Scheme (Beijing, China); SinoPharm, Beijing, China	This work was supported by SinoPharm and national "12.5" Scheme (2011ZX09506-005) (Beijing, China) to Chengdu Institute of Biological Products. The Recombinant Protein Therapeutics Laboratory is supported by SinoPharm, Beijing, China.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Angov E, 2011, METHODS MOL BIOL, V705, P1, DOI 10.1007/978-1-61737-967-3_1; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Frenkel-Morgenstern M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.3; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Huang Y, 2009, NUCLEIC ACIDS RES, V37, P6799, DOI 10.1093/nar/gkp712; Kaiser CM, 2011, SCIENCE, V334, P1723, DOI 10.1126/science.1209740; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Satapathy SS, 2012, J MOL EVOL, V75, P34, DOI 10.1007/s00239-012-9524-1; Saunders R, 2010, NUCLEIC ACIDS RES, V38, P6719, DOI 10.1093/nar/gkq495; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Tao H, 2010, BIOTECHNIQUES, V48, P61, DOI 10.2144/000113304; Thanaraj TA, 1996, PROTEIN SCI, V5, P1973, DOI 10.1002/pro.5560051003; Wang MR, 2011, MABS-AUSTIN, V3, P495, DOI 10.4161/mabs.3.5.16087; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	28	30	32	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30855	30861		10.1074/jbc.M113.467977	http://dx.doi.org/10.1074/jbc.M113.467977			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24003234	hybrid, Green Published			2022-12-28	WOS:000330778900006
J	Singh, BK; Sinha, RA; Zhou, J; Xie, SY; You, SH; Gauthier, K; Yen, PM				Singh, Brijesh Kumar; Sinha, Rohit Anthony; Zhou, Jin; Xie, Sherwin Ying; You, Seo-Hee; Gauthier, Karine; Yen, Paul Michael			FoxO1 Deacetylation Regulates Thyroid Hormone-induced Transcription of Key Hepatic Gluconeogenic Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						FoxO; Gene Regulation; Gene Transcription; Gluconeogenesis; Phosphoenolpyruvate Carboxykinase; Sirt1; Thyroid Hormone	RESPONSE ELEMENT; IN-VIVO; TR-BETA; METABOLISM; EXPRESSION; PROMOTER; LIVER; ACETYLATION; DISEASE; SIRT1	Hepatic gluconeogenesis is a concerted process that integrates transcriptional regulation with hormonal signals. A major regulator is thyroid hormone (TH), which acts through its nuclear receptor (TR) to induce the expression of the hepatic gluconeogenic genes, phosphoenolpyruvate carboxykinase (PCK1) and glucose-6-phosphatase (G6PC). Forkhead transcription factor FoxO1 also is an important regulator of these genes; however, its functional interactions with TR are not known. Here, we report that TR-mediated transcriptional activation of PCK1 and G6PC in human hepatic cells and mouse liver was FoxO1-dependent and furthermore required FoxO1 deacetylation by the NAD(+)-dependent deacetylase, SirT1. siRNA knockdown of FoxO1 decreased, whereas overexpression of FoxO1 increased, TH-dependent transcriptional activation of PCK1 and G6PC in cultured hepatic cells. FoxO1 siRNA knockdown also decreased TH-mediated transcription in vivo. Additionally, TH was unable to induce FoxO1 deacetylation or hepatic PCK1 gene expression in TH receptor -null (TR-/-) mice. Moreover, TH stimulated FoxO1 recruitment to the PCK1 and G6PC gene promoters in a SirT1-dependent manner. In summary, our results show that TH-dependent deacetylation of a second metabolically regulated transcription factor represents a novel mechanism for transcriptional integration of nuclear hormone action with cellular energy status.	[Singh, Brijesh Kumar; Sinha, Rohit Anthony; Zhou, Jin; Xie, Sherwin Ying; Yen, Paul Michael] Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Lab Hormonal Regulat, Singapore 169857, Singapore; [You, Seo-Hee] Univ Penn, Sch Med, Dept Med,Perelman Sch Med, Div Endocrinol Diabet & Metab,Inst Diabet Obes &, Philadelphia, PA 19104 USA; [Gauthier, Karine] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, Ecole Normale Super Lyon, F-69364 Lyon 07, France	National University of Singapore; University of Pennsylvania; Pennsylvania Medicine; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Yen, PM (corresponding author), Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Lab Hormonal Regulat, 8 Coll Rd, Singapore 169857, Singapore.	paul.yen@duke-nus.edu.sg	Singh, Brijesh K/C-1093-2009; Sinha, Rohit/GXV-2427-2022; Yen, Paul M/V-9857-2019	Singh, Brijesh K/0000-0003-4615-3988; /0000-0002-6840-9502; Yen, Paul/0000-0002-3790-8114	Duke-NUS Graduate Medical School Faculty Funds; Ministry of Health; Ministry of Education and Ministry of Trade, Singapore; A*StaR Singapore; Singapore National Medical Research Council (NMRC) [(EDG)/1044/2011]; Singapore NMRC [1340/2012]; American Diabetes Association mentored research fellowship;  [NMRC/CIRG/1340/2012]	Duke-NUS Graduate Medical School Faculty Funds; Ministry of Health; Ministry of Education and Ministry of Trade, Singapore(Ministry of Education, Singapore); A*StaR Singapore(Agency for Science Technology & Research (A*STAR)); Singapore National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Singapore NMRC(National Medical Research Council, Singapore); American Diabetes Association mentored research fellowship(American Diabetes Association); 	This work was supported by Duke-NUS Graduate Medical School Faculty Funds (to P. M. Y.) sponsored by the Ministry of Health, Ministry of Education and Ministry of Trade, Singapore, and A*StaR Singapore; Singapore National Medical Research Council (NMRC) Early Development Grant (EDG)/1044/2011; Singapore NMRC Clinical Investigator Research Grant 1340/2012; and NMRC/CIRG/1340/2012 grants. This work also was supported by an American Diabetes Association mentored research fellowship (to S. H. Y. and M. A. Lazar).	Aub JC, 1929, J CLIN INVEST, V7, P97, DOI 10.1172/JCI100223; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chan IH, 2009, MOL ENDOCRINOL, V23, P1758, DOI 10.1210/me.2009-0025; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gauthier K, 1999, EMBO J, V18, P623, DOI 10.1093/emboj/18.3.623; Gauthier K, 2010, J BIOL CHEM, V285, P28156, DOI 10.1074/jbc.M110.146241; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Nasrin N, 2000, P NATL ACAD SCI USA, V97, P10412, DOI 10.1073/pnas.190326997; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; PARK EA, 1995, BIOCHEM J, V309, P913, DOI 10.1042/bj3090913; Schilling MM, 2006, NATURE, V443, pE10, DOI 10.1038/nature05288; Sinha RA, 2012, J CLIN INVEST, V122, P2428, DOI 10.1172/JCI60580; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Thakran S, 2013, J BIOL CHEM, V288, P807, DOI 10.1074/jbc.M112.437970; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Webb AE, 2013, NAT CELL BIOL, V15, P444, DOI 10.1038/ncb2749; Yabaluri N, 2010, J BIOSCIENCES, V35, P473, DOI 10.1007/s12038-010-0052-0; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030; You SH, 2010, MOL ENDOCRINOL, V24, P1359, DOI 10.1210/me.2009-0501; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527	31	40	43	4	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30365	30372		10.1074/jbc.M113.504845	http://dx.doi.org/10.1074/jbc.M113.504845			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23995837	Green Published, hybrid			2022-12-28	WOS:000329868100033
J	Giganti, D; Alegre-Cebollada, J; Urresti, S; Albesa-Jove, D; Rodrigo-Unzueta, A; Comino, N; Kachala, M; Lopez-Fernandez, S; Svergun, DI; Fernandez, JM; Guerin, ME				Giganti, David; Alegre-Cebollada, Jorge; Urresti, Saioa; Albesa-Jove, David; Rodrigo-Unzueta, Ane; Comino, Natalia; Kachala, Michael; Lopez-Fernandez, Sonia; Svergun, Dmitri I.; Fernandez, Julio M.; Guerin, Marcelo E.			Conformational Plasticity of the Essential Membrane-associated Mannosyltransferase PimA from Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE FORCE SPECTROSCOPY; SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; SINGLE-MOLECULE; GLYCOGEN-SYNTHASE; CRYSTAL-STRUCTURE; RETAINING GLYCOSYLTRANSFERASES; BIOLOGICAL MACROMOLECULES; BETA-GLUCOSYLTRANSFERASE; SPECTRIN REPEATS	Phosphatidyl-myo-inositol mannosyltransferase A (PimA) is an essential glycosyltransferase (GT) that initiates the biosynthetic pathway of phosphatidyl-myo-inositol mannosides, lipomannan, and lipoarabinomannan, which are key glycolipids/lipoglycans of the mycobacterial cell envelope. PimA belongs to a large family of peripheral membrane-associated GTs for which the understanding of the molecular mechanism and conformational changes that govern substrate/membrane recognition and catalysis remains a major challenge. Here we used single molecule force spectroscopy techniques to study the mechanical and conformational properties of PimA. In our studies, we engineered a polyprotein containing PimA flanked by four copies of the well characterized I27 protein, which provides an unambiguous mechanical fingerprint. We found that PimA exhibits weak mechanical stability albeit displaying beta-sheet topology expected to unfold at much higher forces. Notably, PimA unfolds following heterogeneous multiple step mechanical unfolding pathways at low force akin to molten globule states. Interestingly, the ab initio low resolution envelopes obtained from small angle x-ray scattering of the unliganded PimA and the PimA.GDP complexed forms clearly demonstrate that not only the "open" and "closed" conformations of the GT-B enzyme are largely present in solution, but in addition, PimA experiences remarkable flexibility that undoubtedly corresponds to the N-terminal "Rossmann fold" domain, which has been proved to participate in protein-membrane interactions. Based on these results and on our previous experimental data, we propose a model wherein the conformational transitions are important for the mannosyltransferase to interact with the donor and acceptor substrates/membrane.	[Giganti, David; Urresti, Saioa; Albesa-Jove, David; Rodrigo-Unzueta, Ane; Comino, Natalia; Lopez-Fernandez, Sonia; Guerin, Marcelo E.] Univ Basque Country, CSIC, Unidad Biofis, Euskal Herriko Unibertsitatea, Leioa 48940, Bizkaia, Spain; [Giganti, David; Urresti, Saioa; Albesa-Jove, David; Rodrigo-Unzueta, Ane; Comino, Natalia; Lopez-Fernandez, Sonia; Guerin, Marcelo E.] Univ Basque Country, Dept Bioquim, Leioa 48940, Bizkaia, Spain; [Giganti, David; Alegre-Cebollada, Jorge; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Kachala, Michael; Svergun, Dmitri I.] Deutsch Elektronen Synchrotron DESY, Hamburg Outstn, European Mol Biol Lab, D-22603 Hamburg, Germany; [Guerin, Marcelo E.] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Columbia University; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Basque Foundation for Science	Fernandez, JM (corresponding author), Columbia Univ, Dept Biol Sci, Northwest Corner Bldg,550 West 120 St, New York, NY 10027 USA.	jfernandez@columbia.edu; mrcguerin@gmail.com	Albesa-Jové, David/O-3822-2019; Alegre-Cebollada, Jorge/I-4301-2014; Guerin, Marcelo M/N-7245-2016; Albesa-Jové, David/F-5683-2016	Albesa-Jové, David/0000-0003-2904-8203; Alegre-Cebollada, Jorge/0000-0003-0542-0170; Guerin, Marcelo M/0000-0001-9524-3184; Albesa-Jové, David/0000-0003-2904-8203; Kachala, Mikhail/0000-0002-6189-1105; Urresti, Saioa/0000-0002-8678-8358; Svergun, Dmitri/0000-0003-0830-5696; Giganti, David/0000-0001-5735-5679; Comino, Natalia/0000-0001-8924-8819	National Institutes of Health [HL61228/HL66030]; European Commission [LSHP-CT-2005-018923, HEALTH-F3-2011-260872]; Spanish Ministry of Science and Innovation [SAF2010-19096]; IKERBASQUE; Basque Government; Fundacion Ibercaja (Zaragoza, Spain); Fundacion Biofisica Bizkaia; European Commission (the 7th Framework Programme) Marie Curie Grant IDPbyNMR [264257]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066030, R01HL061228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); IKERBASQUE; Basque Government(Basque Government); Fundacion Ibercaja (Zaragoza, Spain); Fundacion Biofisica Bizkaia; European Commission (the 7th Framework Programme) Marie Curie Grant IDPbyNMR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL61228/HL66030 (to J. M. F.). This work was also supported by European Commission Contracts LSHP-CT-2005-018923 and HEALTH-F3-2011-260872, Spanish Ministry of Science and Innovation Contract SAF2010-19096, and IKERBASQUE and the Basque Government (to M.E.G.).; Supported by Fundacion Ibercaja (Zaragoza, Spain).; Supported by Fundacion Biofisica Bizkaia.; Supported by European Commission (the 7th Framework Programme) Marie Curie Grant IDPbyNMR (Contract 264257).	Abdian PL, 2000, J BIOL CHEM, V275, P40568, DOI 10.1074/jbc.M007496200; Agasoster AV, 2003, J BIOL CHEM, V278, P21790, DOI 10.1074/jbc.M211466200; Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P18961, DOI 10.1074/jbc.R109.011932; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Ardevol A, 2011, ANGEW CHEM INT EDIT, V50, P10897, DOI 10.1002/anie.201104623; ARTYMIUK PJ, 1995, NAT STRUCT BIOL, V2, P117, DOI 10.1038/nsb0295-117; BARFORD D, 1989, NATURE, V340, P609, DOI 10.1038/340609a0; Baskaran S, 2010, P NATL ACAD SCI USA, V107, P17563, DOI 10.1073/pnas.1006340107; Blanchet CE, 2013, ANNU REV PHYS CHEM, V64, P37, DOI 10.1146/annurev-physchem-040412-110132; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cala-De Paepe D, 2012, J BIOL CHEM, V287, P31494, DOI 10.1074/jbc.M112.386300; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Elms PJ, 2012, P NATL ACAD SCI USA, V109, P3796, DOI 10.1073/pnas.1115519109; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10534, DOI 10.1073/pnas.0901213106; Gomez H, 2012, J AM CHEM SOC, V134, P4743, DOI 10.1021/ja210490f; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2010, J BIOL CHEM, V285, P33577, DOI 10.1074/jbc.R110.168328; Guerin ME, 2009, J BIOL CHEM, V284, P25687, DOI 10.1074/jbc.M109.030593; Guerin ME, 2009, J BIOL CHEM, V284, P21613, DOI 10.1074/jbc.M109.003947; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Hu YN, 2002, CHEM BIOL, V9, P1287, DOI 10.1016/S1074-5521(02)00295-8; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Larson MH, 2011, MOL CELL, V41, P249, DOI 10.1016/j.molcel.2011.01.008; Law R, 2003, BIOPHYS J, V84, P533, DOI 10.1016/S0006-3495(03)74872-3; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098; Liu RC, 2009, BIOPHYS J, V96, P3810, DOI 10.1016/j.bpj.2009.01.043; Mishra AK, 2012, J BIOL CHEM, V287, P44173, DOI 10.1074/jbc.M112.402396; Monegal A, 2006, J AM CHEM SOC, V128, P16030, DOI 10.1021/ja0659931; Morita YS, 2011, BBA-GEN SUBJECTS, V1810, P630, DOI 10.1016/j.bbagen.2011.03.017; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Rini J., 2009, ESSENTIALS GLYCOBIOL, P63; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Soya N, 2011, GLYCOBIOLOGY, V21, P547, DOI 10.1093/glycob/cwq190; Surade S, 2012, CHEM BIOL, V19, P42, DOI 10.1016/j.chembiol.2011.12.013; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thoren KL, 2009, P NATL ACAD SCI USA, V106, P21555, DOI 10.1073/pnas.0905880106; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Valbuena A, 2009, P NATL ACAD SCI USA, V106, P13791, DOI 10.1073/pnas.0813093106; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; VRIELINK A, 1994, EMBO J, V13, P3413, DOI 10.1002/j.1460-2075.1994.tb06646.x; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151; Wriggers W, 2012, ACTA CRYSTALLOGR D, V68, P344, DOI 10.1107/S0907444911049791	66	24	25	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29797	29808		10.1074/jbc.M113.462705	http://dx.doi.org/10.1074/jbc.M113.462705			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23963451	Green Published, hybrid			2022-12-28	WOS:000330615300054
J	Leunissen, EHP; Nair, AV; Bull, C; Lefeber, DJ; van Delft, FL; Bindels, RJM; Hoenderop, JGJ				Leunissen, Elizabeth H. P.; Nair, Anil V.; Bull, Christian; Lefeber, Dirk J.; van Delft, Floris L.; Bindels, Ren J. M.; Hoenderop, Joost G. J.			The Epithelial Calcium Channel TRPV5 Is Regulated Differentially by Klotho and Sialidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNEL; N-GLYCANS; GALECTIN-1; EXPRESSION; BINDING; CELLS; PROTEIN; FAMILY	The transient receptor potential vanilloid type 5 (TRPV5) Ca2+ channel facilitates transcellular Ca2+ transport in the distal convoluted tubule (DCT) of the kidney. The channel is glycosylated with a complex type N-glycan and it has been postulated that hydrolysis of the terminal sialic acid(s) stimulate TRPV5 activity. The present study delineates the role of the N-glycan in TRPV5 activity using biochemical assays in Human Embryonic Kidney 293 cells expressing TRPV5, isoelectric focusing and total internal reflection fluorescent microscopy. The anti-aging hormone klotho and other glycosidases stimulate TRPV5-dependent Ca2+ uptake. Klotho was found to increase the plasma membrane stability of TRPV5, via the TRPV5 N-glycan. Sialidase mimicked this stimulatory action. However, this effect was independent of the N-glycosylation state of TRPV5, since the N-glycosylation mutant (TRPV5N358Q) was activated to the same extent. We showed that the increased TRPV5 activity after sialidase treatment is caused by inhibition of lipid raft-mediated internalization. In addition, sialidase modified the N-glycan of transferrin, a model glycoprotein, differently from klotho. Previous studies showed that after klotho treatment, galectin-1 binds the TRPV5 N-glycan and thereby increases TRPV5 activity. However, galectin-3, but not galectin-1, was expressed in the DCT. Furthermore, an increase in TRPV5-mediated Ca2 + uptake was detected after galectin-3 treatment. In conclusion, two distinct TRPV5 stimulatory mechanisms were demonstrated; a klotho-mediated effect that is dependent on the N-glycan of TRPV5 and a sialidase-mediated stimulation that is lipid raft-dependent and independent of the N-glycan of TRPV5.	[Leunissen, Elizabeth H. P.; Nair, Anil V.; Bull, Christian; Bindels, Ren J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Physiol, NL-6500 HB Nijmegen, Netherlands; [Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Lab Med, NL-6500 HB Nijmegen, Netherlands; [van Delft, Floris L.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	J.Hoenderop@fysiol.umcn.nl	Bindels, René JM/B-9824-2013; Lefeber, Dirk DJ/A-2146-2014; Hoenderop, Joost G.J./H-8047-2014; Büll, Christian/AAN-1946-2021; Büll, Christian/L-9417-2013	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544; Büll, Christian/0000-0001-7785-2920; Büll, Christian/0000-0001-7785-2920	Nijmegen Centre for Molecular membrane; Dutch Kidney Foundation [C06.2170, CP10.11]; Netherlands Organization for Scientific Research [NWO-CW 700.55.302]; European Union [305608]; Life Sciences (NCMLS)	Nijmegen Centre for Molecular membrane; Dutch Kidney Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union(European Commission); Life Sciences (NCMLS)	This work was supported by grants from the Nijmegen Centre for Molecular membrane and therefore, the Ca<SUP>2+</SUP> reabsorption. Life Sciences (NCMLS) (to J.G.H.), the Dutch Kidney Foundation (C06.2170, CP10.11), the Netherlands Organization for Scientific Research (NWO-CW 700.55.302), and EURenOmics funding from the European Union Seventh Framework Programme (FP7/2007-2013, agreement no 305608).	Burger A, 1996, KIDNEY INT, V50, P754, DOI 10.1038/ki.1996.373; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; CHO MJ, 1995, J BIOL CHEM, V270, P5198, DOI 10.1074/jbc.270.10.5198; Coddeville B, 2000, BBA-GEN SUBJECTS, V1475, P321, DOI 10.1016/S0304-4165(00)00083-0; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; Dimke H, 2011, J AM SOC NEPHROL, V22, P508, DOI 10.1681/ASN.2010060606; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hoenderop JGJ, 2000, AM J PHYSIOL-RENAL, V278, pF352, DOI 10.1152/ajprenal.2000.278.3.F352; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Hoenderop JGJ, 2008, PHYSIOLOGY, V23, P32, DOI 10.1152/physiol.00039.2007; Huang CL, 2011, PFLUG ARCH EUR J PHY, V462, P185, DOI 10.1007/s00424-011-0950-5; Kawamura S, 2012, CELL DEATH DIFFER, V19, P170, DOI 10.1038/cdd.2011.83; Kikuchi Y, 2004, NEPHROL DIAL TRANSPL, V19, P602, DOI 10.1093/ndt/gfg603; Kohno T, 2002, FASEB J, V16, P983, DOI 10.1096/fj.01-0809com; Lu P, 2008, NEPHROL DIAL TRANSPL, V23, P3397, DOI 10.1093/ndt/gfn291; Meyer AH, 2002, J NEUROSCI, V22, P7055; Miller RL, 2006, AM J PHYSIOL-RENAL, V291, pF236, DOI 10.1152/ajprenal.00273.2005; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Moen A, 2011, GLYCOBIOLOGY, V21, P1416, DOI 10.1093/glycob/cwr069; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Singh RD, 2010, TRAFFIC, V11, P348, DOI 10.1111/j.1600-0854.2009.01022.x; SPIK G, 1985, FEBS LETT, V183, P65, DOI 10.1016/0014-5793(85)80955-8; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Suzuki Y, 2008, ANNU REV PHYSIOL, V70, P257, DOI 10.1146/annurev.physiol.69.031905.161003; Takahashi M, 2008, BBA-GEN SUBJECTS, V1780, P520, DOI 10.1016/j.bbagen.2007.10.019; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; Toomre D, 2010, ANNU REV CELL DEV BI, V26, P285, DOI 10.1146/annurev-cellbio-100109-104048; van de Graaf SFJ, 2007, REV PHYSIOL BIOCH P, V158, P77, DOI 10.1007/11220060607; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; VANEIJK HG, 1992, ELECTROPHORESIS, V13, P354, DOI 10.1002/elps.1150130173; Varki A., 2009, ESSENTIALS GLYCOBIOL; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Winyard PJD, 1997, J AM SOC NEPHROL, V8, P1647; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	38	33	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29238	29246		10.1074/jbc.M113.473520	http://dx.doi.org/10.1074/jbc.M113.473520			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23970553	Green Published, hybrid			2022-12-28	WOS:000330615300003
J	Liu, HB; Thaker, YR; Stagg, L; Schneider, H; Ladbury, JE; Rudd, CE				Liu, Hebin; Thaker, Youg Raj; Stagg, Loren; Schneider, Helga; Ladbury, John E.; Rudd, Christopher E.			SLP-76 Sterile alpha Motif (SAM) and Individual H5 alpha Helix Mediate Oligomer Formation for Microclusters and T-cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING LEUKOCYTE PHOSPHOPROTEIN; ADAPTER PROTEIN SLP-76; SIGNAL-TRANSDUCTION; INTERLEUKIN-2 TRANSCRIPTION; RECEPTOR; DOMAIN; BINDING; PHOSPHORYLATION; PLC-GAMMA-1; COMPLEX	Despite the importance of the immune adaptor SLP-76 in T-cell immunity, it has been unclear whether SLP-76 directly self-associates to form higher order oligomers for T-cell activation. In this study, we show that SLP-76 self-associates in response to T-cell receptor ligation as mediated by the N-terminal sterile alpha motif (SAM) domain. SLP-76 co-precipitated alternately tagged SLP-76 in response to anti-CD3 ligation. Dynamic light scattering and fluorescent microscale thermophoresis of the isolated SAM domain (residues 1-78) revealed evidence of dimers and tetramers. Consistently, deletion of the SAM region eliminated SLP-76 co-precipitation of itself, concurrent with a loss of microcluster formation, nuclear factor of activated T-cells (NFAT) transcription, and interleukin-2 production in Jurkat or primary T-cells. Furthermore, the H5 alpha helix within the SAM domain contributed to self-association. Retention of H5 in the absence of H1-4 sufficed to support SLP-76 self-association with smaller microclusters that nevertheless enhancedanti-CD3-drivenAP1/NFAT transcription and IL-2 production. By contrast, deletion of the H5 alpha helix impaired self-association and anti-CD3 induced AP1/NFAT transcription. Our data identified for the first time a role for the SAM domain in mediating SLP-76 self-association for T-cell function.	[Liu, Hebin; Thaker, Youg Raj; Schneider, Helga; Rudd, Christopher E.] Univ Cambridge, Cell Signalling Sect, Dept Pathol, Cambridge CB2 1QP, England; [Liu, Hebin] Xian Jiaotong Liverpool Univ, Dept Biol Sci, Suzhou Ind Pk 215123, Jiangsu, Peoples R China; [Stagg, Loren; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Cambridge; Xi'an Jiaotong-Liverpool University; University of Texas System; UTMD Anderson Cancer Center	Liu, HB (corresponding author), Xian Jiaotong Liverpool Univ, Dept Biol Sci, 111 Renai Rd, Sip Suzhou 215123, Jiangsu, Peoples R China.	Hebin.liu@xjtlu.edu.cn; cer51@cam.ac.uk	Rudd, Christopher E/ABF-7259-2021; Rudd, Christopher E/GOH-2021-2022; Thaker, Youg/K-6083-2016	Rudd, Christopher E/0000-0001-5295-9019; Thaker, Youg/0000-0002-6496-1017; Ladbury, John/0000-0002-6328-7200	Wellcome Trust (London)	Wellcome Trust (London)(Wellcome Trust)	This work was supported by a grant from the Wellcome Trust (London).	Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Baker RG, 2009, MOL CELL BIOL, V29, P5578, DOI 10.1128/MCB.00283-09; Barda-Saad M, 2010, EMBO J, V29, P2315, DOI 10.1038/emboj.2010.133; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; Bhattacharjya S, 2005, PROTEIN SCI, V14, P828, DOI 10.1110/ps.041122105; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Di Bartolo V, 2007, J EXP MED, V204, P681, DOI 10.1084/jem.20062066; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Graham LJ, 2003, ONCOGENE, V22, P2493, DOI 10.1038/sj.onc.1206318; Grasis JA, 2010, MOL CELL BIOL, V30, P3596, DOI 10.1128/MCB.01657-09; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Ishiai M, 2000, J EXP MED, V192, P847, DOI 10.1084/jem.192.6.847; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; Liu HB, 2010, P NATL ACAD SCI USA, V107, P10166, DOI 10.1073/pnas.0909112107; Meruelo AD, 2009, PROTEINS, V74, P1, DOI 10.1002/prot.22232; Musci MA, 1997, J IMMUNOL, V159, P1639; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Purbhoo MA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000645; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Raab M, 1999, J BIOL CHEM, V274, P21170, DOI 10.1074/jbc.274.30.21170; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Raab M, 2011, J BIOL CHEM, V286, P29663, DOI 10.1074/jbc.M111.222661; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sanzenbacher R, 1999, J IMMUNOL, V163, P3143; Sauer K, 2001, J BIOL CHEM, V276, P45207, DOI 10.1074/jbc.M106811200; Schneider H, 2000, J BIOL CHEM, V275, P3835, DOI 10.1074/jbc.275.6.3835; Schneider H, 2008, EUR J IMMUNOL, V38, P40, DOI 10.1002/eji.200737423; Schultz J, 1997, PROTEIN SCI, V6, P249; Sela M, 2011, EMBO J, V30, P3160, DOI 10.1038/emboj.2011.213; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Shen SD, 2009, BLOOD, V114, P74, DOI 10.1182/blood-2008-09-177832; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Singer AL, 2004, J BIOL CHEM, V279, P15481, DOI 10.1074/jbc.M313339200; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Tran Hoang H, 2002, BMC Struct Biol, V2, P5, DOI 10.1186/1472-6807-2-5; Valk E, 2006, IMMUNITY, V25, P807, DOI 10.1016/j.immuni.2006.08.024; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wang HY, 2008, TRENDS CELL BIOL, V18, P486, DOI 10.1016/j.tcb.2008.07.005; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Weiss A, 2009, J IMMUNOL, V183, P4821, DOI 10.4049/jimmunol.0990083; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Yablonski D, 2001, MOL CELL BIOL, V21, P4208, DOI 10.1128/MCB.21.13.4208-4218.2001; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yoder J, 2001, SCIENCE, V291, P1987, DOI 10.1126/science.1057176; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	61	18	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29539	29549		10.1074/jbc.M112.424846	http://dx.doi.org/10.1074/jbc.M112.424846			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23935094	Green Published, hybrid			2022-12-28	WOS:000330615300030
J	Maussang, D; Mujic-Delic, A; Descamps, FJ; Stortelers, C; Vanlandschoot, P; Stigter-van Walsum, M; Vischer, HF; van Roy, M; Vosjan, M; Gonzalez-Pajuelo, M; van Dongen, GAMS; Merchiers, P; van Rompaey, P; Smit, MJ				Maussang, David; Mujic-Delic, Azra; Descamps, Francis J.; Stortelers, Catelijne; Vanlandschoot, Peter; Stigter-van Walsum, Marijke; Vischer, Henry F.; van Roy, Maarten; Vosjan, Maria; Gonzalez-Pajuelo, Maria; van Dongen, Guus A. M. S.; Merchiers, Pascal; van Rompaey, Philippe; Smit, Martine J.			Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-GROWTH; ANGIOGENESIS; EXPRESSION; MIGRATION; BREAST; SDF-1/CXCL12; INHIBITION; SURVIVAL; CXCL12; RDC1	The chemokine receptor CXCR7, belonging to the membrane-bound G protein-coupled receptor superfamily, is expressed in several tumor types. Inhibition of CXCR7 with either small molecules or small interference (si) RNA has shown promising therapeutic benefits in several tumor models. With the increased interest and effectiveness of biologicals inhibiting membrane-bound receptors we made use of the "Nanobody platform" to target CXCR7. Previously we showed that Nanobodies, i.e. immunoglobulin single variable domains derived from naturally occurring heavy chain-only camelids antibodies, represent new biological tools to efficiently tackle difficult drug targets such as G protein-coupled receptors. In this study we developed and characterized highly selective and potent Nanobodies against CXCR7. Interestingly, the CXCR7-targeting Nanobodies displayed antagonistic properties in contrast with previously reported CXCR7-targeting agents. Several high affinity CXCR7-specific Nanobodies potently inhibited CXCL12-induced beta-arrestin2 recruitment in vitro. A wide variety of tumor biopsies was profiled, showing for the first time high expression of CXCR7 in head and neck cancer. Using a patient-derived CXCR7-expressing head and neck cancer xenograft model in nude mice, tumor growth was inhibited by CXCR7-targeting Nanobody therapy. Mechanistically, CXCR7-targeting Nanobodies did not inhibit cell cycle progression but instead reduced secretion of the angiogenic chemokine CXCL1 from head and neck cancer cells in vitro, thus acting here as inverse agonists, and subsequent angiogenesis in vivo. Hence, with this novel class of CXCR7 inhibitors, we further substantiate the therapeutic relevance of targeting CXCR7 in head and neck cancer.	[Maussang, David; Mujic-Delic, Azra; Vischer, Henry F.; Smit, Martine J.] Vrije Univ Amsterdam, Div Med Chem, Amsterdam Inst Mol Med & Syst, Fac Sci, NL-1081 HV Amsterdam, Netherlands; [Descamps, Francis J.; Stortelers, Catelijne; Vanlandschoot, Peter; van Roy, Maarten; Gonzalez-Pajuelo, Maria; Merchiers, Pascal; van Rompaey, Philippe] Ablynx NV, B-9052 Ghent, Belgium; [Stigter-van Walsum, Marijke; Vosjan, Maria; van Dongen, Guus A. M. S.] Vrije Univ Amsterdam Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Smit, MJ (corresponding author), Vrije Univ Amsterdam, Div Med Chem, Amsterdam Inst Mol Med & Syst, De Boelelaan 1083, NL-1081 HV Amsterdam, Netherlands.	mj.smit@vu.nl	Vosjan, Maria/AAV-4987-2021	Smit, Martine/0000-0003-2713-0238				[Anonymous], 2012, Drug Discov Today Technol, V9, pe227, DOI 10.1016/j.ddtec.2012.05.003; Arenberg DA, 1997, J LEUKOCYTE BIOL, V62, P554, DOI 10.1002/jlb.62.5.554; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Behdani M, 2012, MOL IMMUNOL, V50, P35, DOI 10.1016/j.molimm.2011.11.013; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Gahan JC, 2012, J UROLOGY, V187, P827, DOI 10.1016/j.juro.2011.10.150; Hao MG, 2012, BIOCHEM PHARMACOL, V84, P204, DOI 10.1016/j.bcp.2012.04.007; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Helman EE, 2010, CANCER BIOL THER, V10, P166, DOI 10.4161/cbt.10.2.12164; Huang L, 2008, MOL IMAGING BIOL, V10, P167, DOI 10.1007/s11307-008-0133-8; Jahnichen S, 2010, P NATL ACAD SCI USA, V107, P20565, DOI 10.1073/pnas.1012865107; Kollmar O, 2010, INT J CANCER, V126, P1302, DOI 10.1002/ijc.24956; Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006; Lane BR, 2002, J VIROL, V76, P11570, DOI 10.1128/JVI.76.22.11570-11583.2002; Lansford CGR, 2002, HUM CELL CULTURE, V2, P185; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059750; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Maussang D, 2006, P NATL ACAD SCI USA, V103, P13068, DOI 10.1073/pnas.0604433103; Maussang D, 2009, METHOD ENZYMOL, V460, P151, DOI 10.1016/S0076-6879(09)05207-0; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Omidfar K, 2004, TUMOR BIOL, V25, P296, DOI 10.1159/000081395; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Schrevel M, 2012, BRIT J CANCER, V106, P1520, DOI 10.1038/bjc.2012.110; Senkal CE, 2006, J PHARMACOL EXP THER, V317, P1188, DOI 10.1124/jpet.106.101949; Shimizu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020680; Shintani S, 2004, ONCOLOGY-BASEL, V66, P316, DOI 10.1159/000078333; Singh RK, 2011, CANCER RES, V71, P3268, DOI 10.1158/0008-5472.CAN-10-2769; Smith Victoria, 2008, Cancer Genomics & Proteomics, V5, P263; Tijink BM, 2008, MOL CANCER THER, V7, P2288, DOI 10.1158/1535-7163.MCT-07-2384; Vaneycken I, 2011, CURR OPIN BIOTECH, V22, P877, DOI 10.1016/j.copbio.2011.06.009; Vaneycken I, 2011, FASEB J, V25, P2433, DOI 10.1096/fj.10-180331; Vosjan MJWD, 2012, MOL CANCER THER, V11, P1017, DOI 10.1158/1535-7163.MCT-11-0891; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wijtmans M, 2012, EUR J MED CHEM, V51, P184, DOI 10.1016/j.ejmech.2012.02.041; Xia J, 2011, J MOL HISTOL, V42, P175, DOI 10.1007/s10735-011-9322-x; Xu HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027399; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Zabel BA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-73; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zheng K, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-31	50	109	129	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29562	29572		10.1074/jbc.M113.498436	http://dx.doi.org/10.1074/jbc.M113.498436			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979133	Green Published, hybrid			2022-12-28	WOS:000330615300032
J	Das, AK; Kumar, VA; Sevalkar, RR; Bansal, R; Sarkar, D				Das, Arijit Kumar; Kumar, Vijjamarri Anil; Sevalkar, Ritesh Rajesh; Bansal, Roohi; Sarkar, Dibyendu			Unique N-terminal Arm of Mycobacterium tuberculosis PhoP Protein Plays an Unusual Role in Its Regulatory Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; Gene Regulation; Protein-DNA Interaction; Transcription Regulation; Tuberculosis	SIGNAL-TRANSDUCTION; RESPONSE REGULATORS; LIPID BIOSYNTHESIS; RECEIVER DOMAIN; VIRULENCE; GENE; PHOSPHORYLATION; SYSTEM; RECOGNITION; EXPRESSION	Mycobacterium tuberculosis PhoP, a master regulator involved in complex lipid biosynthesis and expression of unknown virulence determinants, is composed of an N-terminal receiver domain and a C-terminal effector domain. The two experimentally characterized PhoP orthologs, from Escherichia coli and Salmonella enterica, display vastly different regulatory capabilities. Here, we demonstrate that the 20-residue-long N-terminal arm unique to M. tuberculosis PhoP plays an essential role in the expanded regulatory capabilities of this important regulator. Although the arm is not required for overall structural stability and/or phosphorylation of the PhoP N-domain, strikingly it is essential for phosphorylation-coupled transcription regulation of target genes. Consistent with this view, arm truncation of PhoP is accompanied by a conformational change of the effector domain, presenting a block in activation subsequent to phosphorylation. These results suggest that presence of the arm, unique to this regulator that shares an otherwise highly conserved domain structure with members of the protein family, contributes to the mechanism of inter-domain interactions. Thus, we propose that the N-terminal arm is an adaptable structural feature of M. tuberculosis PhoP, which evolved to fine-tune regulatory capabilities of the transcription factor in response to the changing physiology of the bacilli within its host.	[Das, Arijit Kumar; Kumar, Vijjamarri Anil; Sevalkar, Ritesh Rajesh; Bansal, Roohi; Sarkar, Dibyendu] CSIR Inst Microbial Technol, Sect 39A, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Sarkar, D (corresponding author), CSIR Inst Microbial Technol, Sect 39A, Chandigarh 160036, India.	dibyendu@imtech.res.in		Sevalkar, Ritesh/0000-0002-1694-8854	Supra Institutional Project on Infectious Disease; Council of Scientific and Industrial Research; Department of Biotechnology, Government of India; University Grants Commission	Supra Institutional Project on Infectious Disease; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission(University Grants Commission, India)	This work was supported in part by Supra Institutional Project on Infectious Disease by the Council of Scientific and Industrial Research and by research grants (to D. S.) from the Department of Biotechnology, Government of India.; Supported in part by funding from Council of Scientific and Industrial Research and the Department of Biotechnology, Government of India. Present address: Sainsbury Laboratory, University of Cambridge, Cambridge CB2 1LR, United Kingdom.; Recipients of predoctoral research fellowships from the Council of Scientific and Industrial Research.; Supported by predoctoral research fellowship from the University Grants Commission.	Allen MP, 2001, J BACTERIOL, V183, P2204, DOI 10.1128/JB.183.7.2204-2211.2001; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Av-Gay Y, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P359; Bretl DJ, 2011, MICROBIOL MOL BIOL R, V75, P566, DOI 10.1128/MMBR.05004-11; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Das AK, 2010, J MOL BIOL, V398, P647, DOI 10.1016/j.jmb.2010.03.056; DeLano W.L, PYMOL MOL GRAPHICS S; Dubey VS, 2002, MOL MICROBIOL, V45, P1451, DOI 10.1046/j.1365-2958.2002.03119.x; Dussurget O, 1999, J BACTERIOL, V181, P3402, DOI 10.1128/JB.181.11.3402-3408.1999; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Goyal R, 2011, J BIOL CHEM, V286, P45197, DOI 10.1074/jbc.M111.307447; Gupta S, 2006, FEBS LETT, V580, P5328, DOI 10.1016/j.febslet.2006.09.004; Gupta S, 2009, J BACTERIOL, V191, P7466, DOI 10.1128/JB.00669-09; Jeon Y, 2001, J BIOL CHEM, V276, P40873, DOI 10.1074/jbc.M104855200; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Lejona S, 2004, J BACTERIOL, V186, P2476, DOI 10.1128/JB.186.8.2476-2480.2004; Ludwiczak P, 2002, MICROBIOL-SGM, V148, P3029, DOI 10.1099/00221287-148-10-3029; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x; Menon S, 2011, BIOCHEMISTRY-US, V50, P5948, DOI 10.1021/bi2005575; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; Pathak A, 2010, J BIOL CHEM, V285, P34309, DOI 10.1074/jbc.M110.135822; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Ryndak M, 2008, TRENDS MICROBIOL, V16, P528, DOI 10.1016/j.tim.2008.08.006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sinha A, 2008, J BACTERIOL, V190, P1317, DOI 10.1128/JB.01074-07; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; TIMM JL, 1994, J BACTERIOL, V176, P6749, DOI 10.1128/JB.176.21.6749-6753.1994; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Walthers D, 2003, J BACTERIOL, V185, P317, DOI 10.1128/JB.185.1.317-324.2003; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a	37	6	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29182	29192		10.1074/jbc.M113.499905	http://dx.doi.org/10.1074/jbc.M113.499905			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23963455	hybrid, Green Published			2022-12-28	WOS:000330298800071
J	Humbard, MA; Surkov, S; De Donatis, GM; Jenkins, LM; Maurizi, MR				Humbard, Matthew A.; Surkov, Serhiy; De Donatis, Gian Marco; Jenkins, Lisa M.; Maurizi, Michael R.			The N-degradome of Escherichia coli LIMITED PROTEOLYSIS IN VIVO GENERATES A LARGE POOL OF PROTEINS BEARING N-DEGRONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Proteins; ATP-dependent Protease; Protein Degradation; Protein Processing; Proteomics; Aat; ClpA; ClpS; END Site; N-end Rule	END RULE SUBSTRATE; CLPAP PROTEASE; CLPXP PROTEASE; RECOGNITION; DEGRADATION; MACHINE; ADAPTER; PATHWAY; TRANSLOCATION; STABILITY	The N-end rule is a conserved mechanism found in Gram-negative bacteria and eukaryotes for marking proteins to be degraded by ATP-dependent proteases. Specific N-terminal amino acids (N-degrons) are sufficient to target a protein to the degradation machinery. In Escherichia coli, the adaptor ClpS binds an N-degron and delivers the protein to ClpAP for degradation. As ClpS recognizes N-terminal Phe, Trp, Tyr, and Leu, which are not found at the N terminus of proteins translated and processed by the canonical pathway, proteins must be post-translationally modified to expose an N-degron. One modification is catalyzed by Aat, an enzyme that adds leucine or phenylalanine to proteins with N-terminal lysine or arginine; however, such proteins are also not generated by the canonical protein synthesis pathway. Thus, the mechanisms producing N-degrons in proteins and the frequency of their occurrence largely remain a mystery. To address these issues, we used a ClpS affinity column to isolate interacting proteins from E. coli cell lysates under non-denaturing conditions. We identified more than 100 proteins that differentially bound to a column charged with wild-type ClpS and eluted with a peptide bearing an N-degron. Thirty-two of 37 determined N-terminal peptides had N-degrons. Most of the proteins were N-terminally truncated by endoproteases or exopeptidases, and many were further modified by Aat. The identities of the proteins point to possible physiological roles for the N-end rule in cell division, translation, transcription, and DNA replication and reveal widespread proteolytic processing of cellular proteins to generate N-end rule substrates.	[Humbard, Matthew A.; Surkov, Serhiy; De Donatis, Gian Marco; Maurizi, Michael R.] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Jenkins, Lisa M.] NCI, Collaborat Prot Technol Resource, Cell Biol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Maurizi, MR (corresponding author), NCI, NIH, Bldg 37,Rm 2128,37 Convent Dr,MSC4256, Bethesda, MD 20892 USA.	mmaurizi@helix.nih.gov	Jenkins, Lisa/AAI-2490-2021		National Institutes of Health Intramural Research Program of the Center for Cancer Research, NCI; NATIONAL CANCER INSTITUTE [ZICBC011430, ZIABC005597] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the Center for Cancer Research, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the Center for Cancer Research, NCI.	Abdelhakim AH, 2010, P NATL ACAD SCI USA, V107, P2437, DOI 10.1073/pnas.0910905106; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Bjornsson A, 1998, METH MOL B, V77, P75; De Donatis GM, 2010, J BIOL CHEM, V285, P8771, DOI 10.1074/jbc.M109.053736; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gonzalez M, 2000, EMBO J, V19, P5251, DOI 10.1093/emboj/19.19.5251; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Guo FS, 2002, J BIOL CHEM, V277, P46753, DOI 10.1074/jbc.M208104200; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Link AJ, 1997, ELECTROPHORESIS, V18, P1259, DOI 10.1002/elps.1150180807; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Muffler A, 1996, EMBO J, V15, P1333, DOI 10.1002/j.1460-2075.1996.tb00475.x; Ninnis RL, 2009, EMBO J, V28, P1732, DOI 10.1038/emboj.2009.134; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Pratt LA, 1996, P NATL ACAD SCI USA, V93, P2488, DOI 10.1073/pnas.93.6.2488; Roman-Hernandez G, 2011, MOL CELL, V43, P217, DOI 10.1016/j.molcel.2011.06.009; Roman-Hernandez G, 2009, P NATL ACAD SCI USA, V106, P8888, DOI 10.1073/pnas.0903614106; Schmidt R, 2009, MOL MICROBIOL, V72, P506, DOI 10.1111/j.1365-2958.2009.06666.x; Schuenemann VJ, 2009, EMBO REP, V10, P508, DOI 10.1038/embor.2009.62; Seyfried NT, 2012, J PROTEOME RES, V11, P2721, DOI 10.1021/pr2010814; SHRADER TE, 1993, J BACTERIOL, V175, P4364, DOI 10.1128/JB.175.14.4364-4374.1993; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Surkov S, 2010, FEBS J, V277, P2428, DOI 10.1111/j.1742-4658.2010.07657.x; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Wang KH, 2008, J BIOL CHEM, V283, P24600, DOI 10.1074/jbc.M802213200; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	37	32	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28913	28924		10.1074/jbc.M113.492108	http://dx.doi.org/10.1074/jbc.M113.492108			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23960079	Green Published, hybrid			2022-12-28	WOS:000330298800043
J	Schulz, EM; Wilder, T; Chowdhury, SAK; Sheikh, HN; Wolska, BM; Solaro, RJ; Wieczorek, DF				Schulz, Emily M.; Wilder, Tanganyika; Chowdhury, Shamim A. K.; Sheikh, Hajer N.; Wolska, Beata M.; Solaro, R. John; Wieczorek, David F.			Decreasing Tropomyosin Phosphorylation Rescues Tropomyosin-induced Familial Hypertrophic Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Cardiac Hypertrophy; Muscle; Phosphorylation; Transgenic Mice; Tropomyosin	KINASE C-EPSILON; COMPENSATED CARDIAC-HYPERTROPHY; STRIATED-MUSCLE TROPOMYOSIN; ALPHA-TROPOMYOSIN; PROTEIN-KINASE; HEART-FAILURE; TRANSGENIC MICE; MOUSE MODEL; DILATED CARDIOMYOPATHY; GENE-EXPRESSION	Studies indicate that tropomyosin (Tm) phosphorylation status varies in different mouse models of cardiac disease. Investigation of basal and acute cardiac function utilizing a mouse model expressing an -Tm protein that cannot be phosphorylated (S283A) shows a compensated hypertrophic phenotype with significant increases in SERCA2a expression and phosphorylation of phospholamban Ser-16 (Schulz, E. M., Correll, R. N., Sheikh, H. N., Lofrano-Alves, M. S., Engel, P. L., Newman, G., Schultz Jel, J., Molkentin, J. D., Wolska, B. M., Solaro, R. J., and Wieczorek, D. F. (2012) J. Biol. Chem. 287, 44478-44489). With these results, we hypothesized that decreasing -Tm phosphorylation may be beneficial in the context of a chronic, intrinsic stressor. To test this hypothesis, we utilized the familial hypertrophic cardiomyopathy (FHC) -Tm E180G model (Prabhakar, R., Boivin, G. P., Grupp, I. L., Hoit, B., Arteaga, G., Solaro, R. J., and Wieczorek, D. F. (2001) J. Mol. Cell. Cardiol. 33, 1815-1828). These FHC hearts are characterized by increased heart:body weight ratios, fibrosis, increased myofilament Ca2+ sensitivity, and contractile defects. The FHC mice die by 6-8 months of age. We generated mice expressing both the E180G and S283A mutations and found that the hypertrophic phenotype was rescued in the -Tm E180G/S283A double mutant transgenic animals; these mice exhibited no signs of cardiac hypertrophy and displayed improved cardiac function. These double mutant transgenic hearts showed increased phosphorylation of phospholamban Ser-16 and Thr-17 compared with the -Tm E180G mice. This is the first study to demonstrate that decreasing phosphorylation of tropomyosin can rescue a hypertrophic cardiomyopathic phenotype.	[Schulz, Emily M.; Sheikh, Hajer N.; Wieczorek, David F.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Wilder, Tanganyika; Chowdhury, Shamim A. K.; Wolska, Beata M.; Solaro, R. John] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Wolska, Beata M.] Univ Illinois, Cardiol Sect, Dept Med, Ctr Cardiovasc Res, Chicago, IL 60612 USA	University of Cincinnati; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wieczorek, DF (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	David.Wieczorek@uc.edu		Sheikh, Hajer/0000-0002-6411-5259	National Institutes of Health [RO1 HL-081680, RO1 HL-064035, PO1 HL-062426, T32 HL-07382, T32 HL-07692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692, R01HL081680, T32HL007382, R01HL064035, P01HL062426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL-081680 (to D. F. W.), RO1 HL-064035 (to R. J. S. and B. M. W.), PO1 HL-062426 (to R. J. S.), T32 HL-07382 (to E. M. S.), and T32 HL-07692 (to T. W.).	Abraham WT, 2002, MOL MED, V8, P750, DOI 10.1007/BF03402039; Al Moamen NJ, 2011, J MOL CELL CARDIOL, V50, P137, DOI 10.1016/j.yjmcc.2010.10.028; Biesiadecki BJ, 2010, J BIOL CHEM, V285, P19688, DOI 10.1074/jbc.M109.086892; Brittsan AG, 2000, J BIOL CHEM, V275, P12129, DOI 10.1074/jbc.275.16.12129; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Coutu P, 2004, CIRC RES, V94, P1235, DOI 10.1161/01.RES.0000126923.46786.FD; DEBELLE I, 1987, BIOCHIM BIOPHYS ACTA, V925, P17, DOI 10.1016/0304-4165(87)90143-7; del Monte F, 2001, CIRC RES, V88, pE66, DOI 10.1161/hh1101.092004; Evans CC, 2000, AM J PHYSIOL-HEART C, V279, pH2414, DOI 10.1152/ajpheart.2000.279.5.H2414; Force T, 2010, CIRCULATION, V122, P1130, DOI 10.1161/CIRCULATIONAHA.110.950089; Gaffin RD, 2011, J MOL CELL CARDIOL, V51, P812, DOI 10.1016/j.yjmcc.2011.07.026; Gollapudi SK, 2013, J MOL BIOL, V425, P1565, DOI 10.1016/j.jmb.2013.01.028; Hamilton M, 2001, J BIOL CHEM, V276, P29079, DOI 10.1074/jbc.M102001200; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Hoshijima M, 2002, NAT MED, V8, P864, DOI 10.1038/nm739; Jagatheesan G, 2003, J BIOL CHEM, V278, P23204, DOI 10.1074/jbc.M303073200; Jagatheesan G, 2007, AM J PHYSIOL-HEART C, V293, pH949, DOI 10.1152/ajpheart.01341.2006; Jagatheesan G, 2010, J MUSCLE RES CELL M, V31, P227, DOI 10.1007/s10974-010-9228-3; Jin JP, 2010, ARCH BIOCHEM BIOPHYS, V500, P144, DOI 10.1016/j.abb.2010.06.001; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Li XC, 2012, BIOCHEM BIOPH RES CO, V424, P493, DOI 10.1016/j.bbrc.2012.06.141; Li YJ, 2010, J MOL CELL CARDIOL, V49, P402, DOI 10.1016/j.yjmcc.2010.04.017; Ling SK, 2012, CIRCULATION, V126, P3028, DOI 10.1161/CIRCULATIONAHA.112.102780; Loong CKP, 2012, FEBS LETT, V586, P3503, DOI 10.1016/j.febslet.2012.08.005; Ly S, 2012, BIOCHEMISTRY-US, V51, P6413, DOI 10.1021/bi3006835; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; MAK A, 1978, P NATL ACAD SCI USA, V75, P3588, DOI 10.1073/pnas.75.8.3588; Mamidi R., 2013, FASEB J, V10; MONTGOMERY K, 1984, J BIOL CHEM, V259, P5555; Muthu P, 2012, J CELL MOL MED, V16, P911, DOI 10.1111/j.1582-4934.2011.01371.x; Muthuchamy M, 1999, CIRC RES, V85, P47; MUTHUCHAMY M, 1993, MOL CELL BIOL, V13, P3311, DOI 10.1128/MCB.13.6.3311; Muthuchamy M, 1995, J BIOL CHEM, V270, P30593, DOI 10.1074/jbc.270.51.30593; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nixon BR, 2013, ARCH BIOCHEM BIOPHYS, V535, P30, DOI 10.1016/j.abb.2012.11.010; Pena JR, 2010, J MOL CELL CARDIOL, V49, P993, DOI 10.1016/j.yjmcc.2010.09.010; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prabhakar R, 2003, MOL CELL BIOCHEM, V251, P33, DOI 10.1023/A:1025409227350; Prabhakar R, 2001, J MOL CELL CARDIOL, V33, P1815, DOI 10.1006/jmcc.2001.1445; Prekeris R, 1998, J BIOL CHEM, V273, P26790, DOI 10.1074/jbc.273.41.26790; Rajan S., 2010, AHA BASIC CARDIOVASC; Rajan S, 2010, CIRCULATION, V121, P410, DOI 10.1161/CIRCULATIONAHA.109.889725; REDDY YS, 1973, J MOL CELL CARDIOL, V5, P461, DOI 10.1016/0022-2828(73)90016-3; Robia SL, 2001, BIOPHYS J, V80, P2140, DOI 10.1016/S0006-3495(01)76187-5; Schevzov G, 2008, J BIOL CHEM, V283, P275, DOI 10.1074/jbc.M704392200; Schmidt U, 1999, AM J PHYSIOL-HEART C, V277, pH474, DOI 10.1152/ajpheart.1999.277.2.H474; Schulz EM, 2012, J BIOL CHEM, V287, P44478, DOI 10.1074/jbc.M112.402040; Sheikh H. N., 2009, THESIS U CINCINNATI; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Tardiff JC, 2011, CIRC RES, V108, P765, DOI 10.1161/CIRCRESAHA.110.224170; Warren CM, 2008, PROTEOMICS, V8, P100, DOI 10.1002/pmic.200700772; Wieczorek DF, 2008, ADV EXP MED BIOL, V644, P132; Wu SC, 2007, J BIOL CHEM, V282, P30691, DOI 10.1074/jbc.M703670200; Yuan C, 2008, PROTEOM CLIN APPL, V2, P788, DOI 10.1002/prca.200780076; Zhou C.C., 2012, PLOS ONE, V7	57	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28925	28935		10.1074/jbc.M113.466466	http://dx.doi.org/10.1074/jbc.M113.466466			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23960072	hybrid, Green Published			2022-12-28	WOS:000330298800044
J	Chaumont, S; Andre, C; Perrais, D; Boue-Grabot, E; Taly, A; Garret, M				Chaumont, Severine; Andre, Caroline; Perrais, David; Boue-Grabot, Eric; Taly, Antoine; Garret, Maurice			Agonist-dependent Endocytosis of gamma-Aminobutyric Acid Type A (GABA(A)) Receptors Revealed by a gamma 2(R43Q) Epilepsy Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHILDHOOD ABSENCE EPILEPSY; NICOTINIC ACETYLCHOLINE-RECEPTORS; CELL-SURFACE EXPRESSION; CYS-LOOP RECEPTOR; FEBRILE SEIZURES; STATUS EPILEPTICUS; BINDING-SITE; AP2 COMPLEX; SUBUNIT; TRAFFICKING	GABA-gated chloride channels (GABA(A)Rs) trafficking is involved in the regulation of fast inhibitory transmission. Here, we took advantage of a gamma 2(R43Q) subunit mutation linked to epilepsy in humans that considerably reduces the number of GABA(A)Rs on the cell surface to better understand the trafficking of GABA(A)Rs. Using recombinant expression in cultured rat hippocampal neurons and COS-7 cells, we showed that receptors containing gamma 2(R43Q) were addressed to the cell membrane but underwent clathrin-mediated dynamin-dependent endocytosis. The gamma 2(R43Q)-dependent endocytosis was reduced by GABA(A)R antagonists. These data, in addition to a new homology model, suggested that a conformational change in the extracellular domain of gamma 2(R43Q)-containing GABA(A)Rs increased their internalization. This led us to show that endogenous and recombinant wild-type GABA(A)R endocytosis in both cultured neurons and COS-7 cells can be amplified by their agonists. These findings revealed not only a direct relationship between endocytosis of GABA(A)Rs and a genetic neurological disorder but also that trafficking of these receptors can be modulated by their agonist.	[Chaumont, Severine; Andre, Caroline; Garret, Maurice] Univ Bordeaux, INCIA, UMR 5287, F-33000 Bordeaux, France; [Chaumont, Severine; Andre, Caroline; Garret, Maurice] CNRS, UMR 5287, INCIA, F-33000 Bordeaux, France; [Perrais, David] Univ Bordeaux, Inst Interdisciplinary Neurosci IINS, UMR 5297, F-33000 Bordeaux, France; [Perrais, David] CNRS, UMR 5297, IINS, F-33000 Bordeaux, France; [Boue-Grabot, Eric] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, F-33000 Bordeaux, France; [Boue-Grabot, Eric] CNRS, UMR 5293, Inst Malad Neurodegenerat, F-33000 Bordeaux, France; [Taly, Antoine] CNRS, UPR 9080, Inst Biol Physicochim, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Garret, M (corresponding author), Univ Bordeaux 2, CNRS, UMR 5287, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	maurice.garret@u-bordeaux2.fr	Taly, Antoine/B-3339-2008; Perrais, David/W-9360-2019; Boué-Grabot, Eric/AAQ-2061-2020	Taly, Antoine/0000-0001-5109-0091; Perrais, David/0000-0002-5878-5408; Boué-Grabot, Eric/0000-0003-2187-9037; Chaumont-Dubel, Severine/0000-0001-6860-6891	CNRS, Universite de Bordeaux, Conseil Regional Aquitaine; Federation de la Recherche sur le Cerveau	CNRS, Universite de Bordeaux, Conseil Regional Aquitaine; Federation de la Recherche sur le Cerveau	This work was supported by CNRS, Universite de Bordeaux, Conseil Regional Aquitaine, and Federation de la Recherche sur le Cerveau.	Bailey MES, 1999, MAMM GENOME, V10, P839, DOI 10.1007/s003359901101; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; Barnes EM, 1996, INT REV NEUROBIOL, V39, P53, DOI 10.1016/S0074-7742(08)60663-7; Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615; Bianchi MT, 2002, J NEUROSCI, V22, P5321; Boileau AJ, 2002, J BIOL CHEM, V277, P2931, DOI 10.1074/jbc.M109334200; Boue-Grabot E, 2004, J BIOL CHEM, V279, P52517, DOI 10.1074/jbc.M410223200; Boue-Grabot E, 2004, J BIOL CHEM, V279, P6967, DOI 10.1074/jbc.M307772200; Bouthour W, 2012, CEREB CORTEX, V22, P1542, DOI 10.1093/cercor/bhr225; Bowser DN, 2002, P NATL ACAD SCI USA, V99, P15170, DOI 10.1073/pnas.212320199; Bradley CA, 2008, J BIOL CHEM, V283, P22043, DOI 10.1074/jbc.M801708200; Changeux JP, 2008, TRENDS MOL MED, V14, P93, DOI 10.1016/j.molmed.2008.01.001; Charych EI, 2009, NEUROPHARMACOLOGY, V57, P481, DOI 10.1016/j.neuropharm.2009.07.027; Chen GJ, 2006, J NEUROSCI, V26, P2513, DOI 10.1523/JNEUROSCI.4712-05.2006; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Cossart R, 2005, TRENDS NEUROSCI, V28, P108, DOI 10.1016/j.tins.2004.11.011; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Ding L, 2010, J BIOL CHEM, V285, P26390, DOI 10.1074/jbc.M110.142299; Eugene E, 2007, J NEUROSCI, V27, P14108, DOI 10.1523/JNEUROSCI.2618-07.2007; Everitt AB, 2009, FASEB J, V23, P4361, DOI 10.1096/fj.09-137042; Fache MP, 2004, J CELL BIOL, V166, P571, DOI 10.1083/jcb.200312155; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Frugier G, 2007, J BIOL CHEM, V282, P3819, DOI 10.1074/jbc.M608910200; Galanopoulou AS, 2010, PFLUG ARCH EUR J PHY, V460, P505, DOI 10.1007/s00424-010-0816-2; Goldschen-Ohm MP, 2010, MOL PHARMACOL, V77, P35, DOI 10.1124/mol.109.058289; Gonzalez C, 2012, J NEUROSCI, V32, P17874, DOI 10.1523/JNEUROSCI.2535-12.2012; Goodkin HP, 2008, J NEUROSCI, V28, P2527, DOI 10.1523/JNEUROSCI.3426-07.2008; Hales TG, 2005, MOL CELL NEUROSCI, V29, P120, DOI 10.1016/j.mcn.2005.01.002; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Huyghe D, 2011, J NEUROSCI, V31, P11645, DOI 10.1523/JNEUROSCI.2206-11.2011; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Kang JQ, 2006, J NEUROSCI, V26, P2590, DOI 10.1523/JNEUROSCI.4243-05.2006; Kang JQ, 2004, J NEUROSCI, V24, P8672, DOI 10.1523/JNEUROSCI.2717-04.2004; Kittler JT, 2008, P NATL ACAD SCI USA, V105, P3616, DOI 10.1073/pnas.0707920105; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Krishek BJ, 1996, NEUROPHARMACOLOGY, V35, P1289, DOI 10.1016/S0028-3908(96)00089-5; Le Novere N, 1999, NUCLEIC ACIDS RES, V27, P340, DOI 10.1093/nar/27.1.340; Leidenheimer Nancy J., 2008, V44, P1, DOI 10.1007/400_2007_039; Li HF, 2006, NEUROPHARMACOLOGY, V51, P121, DOI 10.1016/j.neuropharm.2006.03.003; Liang J, 2007, J NEUROSCI, V27, P12367, DOI 10.1523/JNEUROSCI.2786-07.2007; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Meldrum BS, 2007, NEUROTHERAPEUTICS, V4, P18, DOI 10.1016/j.nurt.2006.11.010; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mondin M, 2010, J BIOL CHEM, V285, P40060, DOI 10.1074/jbc.M110.140442; Naylor DE, 2005, J NEUROSCI, V25, P7724, DOI 10.1523/JNEUROSCI.4944-04.2005; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Peters JA, 2010, J PHYSIOL-LONDON, V588, P587, DOI 10.1113/jphysiol.2009.183137; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Ragozzino D, 2005, P NATL ACAD SCI USA, V102, P15219, DOI 10.1073/pnas.0507339102; Roy S, 2011, MOL ENDOCRINOL, V25, P1961, DOI 10.1210/me.2011-0018; Saito M, 2009, J NEUROSCI RES, V87, P3120, DOI 10.1002/jnr.22141; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saliba RS, 2012, EMBO J, V31, P2937, DOI 10.1038/emboj.2012.109; Sancar F, 2004, J BIOL CHEM, V279, P47034, DOI 10.1074/jbc.M403388200; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smith KR, 2012, J NEUROSCI, V32, P2485, DOI 10.1523/JNEUROSCI.1622-11.2011; Smith KR, 2010, CURR OPIN NEUROBIOL, V20, P550, DOI 10.1016/j.conb.2010.06.001; STEIN BS, 1984, J BIOL CHEM, V259, P4762; Taly A, 2006, P NATL ACAD SCI USA, V103, P16965, DOI 10.1073/pnas.0607477103; Tan HO, 2007, P NATL ACAD SCI USA, V104, P17536, DOI 10.1073/pnas.0708440104; Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758; Tierney ML, 2011, BBA-BIOMEMBRANES, V1808, P667, DOI 10.1016/j.bbamem.2010.11.022; Torres VI, 2002, J BIOL CHEM, V277, P43741, DOI 10.1074/jbc.M202007200; Toulme E, 2006, MOL PHARMACOL, V69, P576, DOI 10.1124/mol.105.018812; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Tsetlin V, 2011, J NEUROCHEM, V116, P734, DOI 10.1111/j.1471-4159.2010.07060.x; Ueno S, 1997, J NEUROSCI, V17, P625; Uusi-Oukari M, 2010, PHARMACOL REV, V62, P97, DOI 10.1124/pr.109.002063; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264	76	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28254	28265		10.1074/jbc.M113.470807	http://dx.doi.org/10.1074/jbc.M113.470807			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23935098	hybrid, Green Published			2022-12-28	WOS:000330612800047
J	Feng, YB; Yu, WY; Li, XX; Lin, SY; Zhou, Y; Hu, JJ; Liu, XQ				Feng, Yanbin; Yu, Wenying; Li, Xinxin; Lin, Shaoyu; Zhou, Ying; Hu, Junjie; Liu, Xinqi			Structural Insight into Golgi Membrane Stacking by GRASP65 and GRASP55 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCONVENTIONAL SECRETION; CISTERNAL STACKING; CELL-DIVISION; PDZ LIGAND; ULTRACENTRIFUGATION; PHOSPHORYLATION; SUGGESTS; PATHWAY; GM130; ACB1	The stacking of Golgi cisternae involves GRASP65 and GRASP55. The oligomerization of the N-terminal GRASP domain of these proteins, which consists of two tandem PDZ domains, is required to tether the Golgi membranes. However, the molecular basis for GRASP assembly is unclear. Here, we determined the crystal structures of the GRASP domain of GRASP65 and GRASP55. The structures reveal similar homotypic interactions: the GRASP domain forms a dimer in which the peptide-binding pockets of the two neighboring PDZ2 domains face each other, and the dimers are further connected by the C-terminal tail of one GRASP domain inserting into the binding pocket of the PDZ1 domain in another dimer. Biochemical analysis suggests that both types of contacts are relatively weak but are needed in combination for GRASP-mediated Golgi stacking. Our results unveil a novel mode of membrane tethering by GRASP proteins and provide insight into the mechanism of Golgi stacking.	[Feng, Yanbin; Li, Xinxin; Liu, Xinqi] Nankai Univ, Coll Life Sci, Dept Biochem & Mol Biol, Tianjin 300071, Peoples R China; [Feng, Yanbin; Li, Xinxin; Liu, Xinqi] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Yu, Wenying; Lin, Shaoyu; Zhou, Ying; Hu, Junjie] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China; [Yu, Wenying; Lin, Shaoyu; Zhou, Ying; Hu, Junjie] Nankai Univ, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University	Hu, JJ (corresponding author), Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China.	huj@nankai.edu.cn; liu2008@nankai.edu.cn			National Basic Research Program of China 973 Program [2010CB911800, 2010CB833702]; National S&T Major Project on Major Infectious Diseases Grants from the Ministry of Science and Technology of China [2012ZX10001006-002, 2012ZX10001-008]; National Science Foundation of China [31225006]; International Early Career Scientist grant from the Howard Hughes Medical Institute	National Basic Research Program of China 973 Program(National Basic Research Program of China); National S&T Major Project on Major Infectious Diseases Grants from the Ministry of Science and Technology of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by National Basic Research Program of China 973 Program Grant 2010CB911800 and National S&T Major Project on Major Infectious Diseases Grants 2012ZX10001006-002 and 2012ZX10001-008 from the Ministry of Science and Technology of China (to X. L.) and by National Basic Research Program of China 973 Program Grant 2010CB833702, National Science Foundation of China Grant 31225006, and an International Early Career Scientist grant from the Howard Hughes Medical Institute (to J. H.).	Bachert C, 2010, J BIOL CHEM, V285, P16294, DOI 10.1074/jbc.M110.116129; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Bernstein A, 2008, TRENDS MICROBIOL, V16, P553, DOI 10.1016/j.tim.2008.08.009; CLUETT EB, 1992, J CELL SCI, V103, P773; Craig RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046778; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; FARQUHAR MG, 1985, ANNU REV CELL BIOL, V1, P447, DOI 10.1146/annurev.cb.01.110185.002311; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Jesch SA, 2001, MOL BIOL CELL, V12, P1811, DOI 10.1091/mbc.12.6.1811; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; Pfeffer SR, 2001, J CELL BIOL, V155, P873, DOI 10.1083/jcb.200109095; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; RAMBOURG A, 1990, EUR J CELL BIOL, V51, P189; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sengupta D, 2010, J BIOL CHEM, V285, P39994, DOI 10.1074/jbc.M110.189449; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; Tang DM, 2010, TRAFFIC, V11, P827, DOI 10.1111/j.1600-0854.2010.01055.x; Truschel ST, 2011, J BIOL CHEM, V286, P20125, DOI 10.1074/jbc.C111.245324; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; Wu YH, 2011, NATURE, V475, P510, DOI 10.1038/nature10183; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132; Zhang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044241	35	36	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28418	28427		10.1074/jbc.M113.478024	http://dx.doi.org/10.1074/jbc.M113.478024			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940043	Green Published, hybrid			2022-12-28	WOS:000330612800069
J	Pham, D; Walline, CC; Hollister, K; Dent, AL; Blum, JS; Firulli, AB; Kaplan, MH				Duy Pham; Walline, Crystal C.; Hollister, Kristin; Dent, Alexander L.; Blum, Janice S.; Firulli, Anthony B.; Kaplan, Mark H.			The Transcription Factor Twist1 Limits T Helper 17 and T Follicular Helper Cell Development by Repressing the Gene Encoding the Interleukin-6 Receptor alpha Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENIC T(H)17 CELLS; CYTOKINE GM-CSF; ROR-GAMMA; LINEAGE DIFFERENTIATION; REGULATORY NETWORK; T-H-17 CELLS; FACTOR E2A; TGF-BETA; INFLAMMATION; EXPRESSION	Cytokine responsiveness is a critical component of the ability of cells to respond to the extracellular milieu. Transcription factor-mediated regulation of cytokine receptor expression is a common mode of altering responses to the external environment. We identify the transcription factor Twist1 as a component of a STAT3-induced feedback loop that controls IL-6 signals by directly repressing Il6ra. Human and mouse T cells lacking Twist1 have an increased ability to differentiate into Th17 cells. Mice with a T cell-specific deletion of Twist1 demonstrate increased Th17 and T follicular helper cell development, early onset experimental autoimmune encephalomyelitis, and increased antigen-specific antibody responses. Thus, Twist1 has a critical role in limiting both cell-mediated and humoral immunity.	[Duy Pham; Hollister, Kristin; Dent, Alexander L.; Firulli, Anthony B.; Kaplan, Mark H.] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Duy Pham; Walline, Crystal C.; Blum, Janice S.; Kaplan, Mark H.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Kaplan, MH (corresponding author), Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, 1044 West Walnut St,Rm 202, Indianapolis, IN 46202 USA.	mkaplan2@iupui.edu	Walline, Crystal/M-8815-2019; Walline, Crystal/H-9514-2018	Walline, Crystal/0000-0002-0116-7991; Kaplan, Mark/0000-0002-2923-8245	Riley Children's Foundation; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI099825, T32AI060519, R01AI079065, R01AI045515, P01AI056097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090948] Funding Source: NIH RePORTER	Riley Children's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support for the Herman B Wells Center was provided in part by the Riley Children's Foundation.	Barnes RM, 2009, INT J DEV BIOL, V53, P909, DOI 10.1387/ijdb.082747rb; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Castanon I, 2001, DEVELOPMENT, V128, P3145; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Pham D, 2012, J IMMUNOL, V189, P832, DOI 10.4049/jimmunol.1200854; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hayashi M, 2007, J CELL SCI, V120, P1350, DOI 10.1242/jcs.000067; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Liu XD, 2013, IMMUNOL REV, V252, P139, DOI 10.1111/imr.12040; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Mathur AN, 2006, BLOOD, V108, P1595, DOI 10.1182/blood-2006-04-015016; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Mo CQ, 2008, J IMMUNOL, V181, P5681, DOI 10.4049/jimmunol.181.8.5681; Niesner U, 2008, J EXP MED, V205, P1889, DOI 10.1084/jem.20072468; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Pierson E, 2012, IMMUNOL REV, V248, P205, DOI 10.1111/j.1600-065X.2012.01126.x; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; TEMPLE L, 1993, FUND APPL TOXICOL, V21, P412, DOI 10.1006/faat.1993.1116; Thieu VT, 2008, IMMUNITY, V29, P679, DOI 10.1016/j.immuni.2008.08.017; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vincentz JW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003405; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	52	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27423	27433		10.1074/jbc.M113.497248	http://dx.doi.org/10.1074/jbc.M113.497248			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23935104	Green Published, hybrid			2022-12-28	WOS:000330597300038
J	Tan, EP; Caro, S; Potnis, A; Lanza, C; Slawson, C				Tan, Ee Phie; Caro, Sarah; Potnis, Anish; Lanza, Christopher; Slawson, Chad			O-Linked N-Acetylglucosamine Cycling Regulates Mitotic Spindle Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-B KINASE; CELL-CYCLE; CHROMOSOME CONDENSATION; HISTONE H3; CENP-A; PHOSPHORYLATION; GLCNAC; ACTIVATION; COMPLEX; MECHANISM	Any defects in the correct formation of the mitotic spindle will lead to chromosomal segregation errors, mitotic arrest, or aneuploidy. We demonstrate that O-linked N-acetylglucosamine (O-GlcNAc), a post-translational modification of serine and threonine residues in nuclear and cytoplasmic proteins, regulates spindle function. In O-GlcNAc transferase or O-GlcNAcase gain of function cells, the mitotic spindle is incorrectly assembled. Chromosome condensation and centrosome assembly is impaired in these cells. The disruption in spindle architecture is due to a reduction in histone H3 phosphorylation by Aurora kinase B. However, gain of function cells treated with the O-GlcNAcase inhibitor Thiamet-G restored the assembly of the spindle and partially rescued histone phosphorylation. Together, these data suggest that the coordinated addition and removal of O-GlcNAc, termed O-GlcNAc cycling, regulates mitotic spindle organization and provides a potential new perspective on how O-GlcNAc regulates cellular events.	[Tan, Ee Phie; Caro, Sarah; Potnis, Anish; Lanza, Christopher; Slawson, Chad] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, MO 64108 USA; [Slawson, Chad] Univ Kansas, Med Ctr, KUMC Canc Ctr, Kansas City, MO 64108 USA; [Slawson, Chad] Univ Kansas, Med Ctr, Inst Reprod Hlth & Regenerat Med, Kansas City, MO 64108 USA	University of Kansas; University of Kansas; University of Kansas	Slawson, C (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, MO 64108 USA.	cslawson@kumc.edu	Tan, Ee Phie/AAC-8378-2021		Institutional Development Award (IDeA) from the NIGMS of the National Institutes of Health [P20GM12345]	Institutional Development Award (IDeA) from the NIGMS of the National Institutes of Health	This work was supported, in whole or in part, by an Institutional Development Award (IDeA) from the NIGMS of the National Institutes of Health under Grant Number P20GM12345.	Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; CLARKE PR, 1993, MOL BIOL CELL, V4, P397, DOI 10.1091/mbc.4.4.397; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Fisher D, 2012, J CELL SCI, V125, P4703, DOI 10.1242/jcs.106351; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540; Hayama S, 2007, CANCER RES, V67, P4113, DOI 10.1158/0008-5472.CAN-06-4705; Heng YW, 2012, J CELL SCI, V125, P1579, DOI 10.1242/jcs.096818; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Loncarek J, 2007, NATURE, V450, P745, DOI 10.1038/nature06344; Macauley MS, 2010, CHEM BIOL, V17, P937, DOI 10.1016/j.chembiol.2010.07.006; Macauley MS, 2008, J BIOL CHEM, V283, P34687, DOI 10.1074/jbc.M804525200; Meunier S, 2012, J CELL SCI, V125, P2805, DOI 10.1242/jcs.092429; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ozlu N, 2010, MOL CELL PROTEOMICS, V9, P336, DOI 10.1074/mcp.M900308-MCP200; Petsalaki E, 2011, J CELL BIOL, V195, P449, DOI 10.1083/jcb.201104023; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; Qi GY, 2010, ORAL ONCOL, V46, P263, DOI 10.1016/j.oraloncology.2010.01.004; Rahal R, 2008, GENE DEV, V22, P1534, DOI 10.1101/gad.1638308; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Seshan A, 2004, CURR OPIN CELL BIOL, V16, P41, DOI 10.1016/j.ceb.2003.11.003; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Tong Y, 2008, ONCOGENE, V27, P6385, DOI 10.1038/onc.2008.234; Tseng BS, 2010, DEV CELL, V18, P903, DOI 10.1016/j.devcel.2010.05.018; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Yang J, 2009, BIOCHEM J, V417, P355, DOI 10.1042/BJ20081365; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885	51	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27085	27099		10.1074/jbc.M113.470187	http://dx.doi.org/10.1074/jbc.M113.470187			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23946484	Green Published, hybrid			2022-12-28	WOS:000330597300009
J	Penrose, HM; Marchelletta, RR; Krishnan, M; McCole, DF				Penrose, Harrison M.; Marchelletta, Ronald R.; Krishnan, Moorthy; McCole, Declan F.			Spermidine Stimulates T Cell Protein-tyrosine Phosphatase-mediated Protection of Intestinal Epithelial Barrier Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epithelial Cell; Interferon; Permeability; STAT Transcription Factor; Tight Junctions	TIGHT JUNCTION PROTEINS; INTERFERON-GAMMA; IFN-GAMMA; POLYAMINES; INCREASES; DISEASE; PERMEABILITY; MODULATION; MECHANISM; OCCLUDIN	The gene locus encoding protein-tyrosine phosphatase non-receptor type 2 (PTPN2) has been associated with inflammatory bowel disease. Expression of the PTPN2 gene product, T cell protein-tyrosine phosphatase (TCPTP), in intestinal epithelial cells has been shown to play an important role in the protection of epithelial barrier function during periods of inflammation by acting as a negative regulator of the proinflammatory cytokine IFN-. Therefore, agents that increase the activity of TCPTP are of general interest as modifiers of inflammatory signaling events. A previous study demonstrated that the small molecule spermidine is a selective activator of TCPTP in vitro. The aim of this study was to investigate whether activation of TCPTP by spermidine was capable of alleviating IFN--induced, proinflammatory signaling and barrier dysfunction in human intestinal epithelial cells. Studies revealed that treatment of T-84 and HT29/cl.19A colonocytes with spermidine increased both TCPTP protein levels and enzymatic activity, correlating with a decrease in the phosphorylation of the signal transducers and activators of transcription 1 and 3, downstream mediators of IFN- signaling, upon coadministration of spermidine to IFN--treated cells. On a functional level, spermidine protected barrier function in the setting of inflammation, restricting the decrease in transepithelial electrical resistance and the increase in epithelial permeability induced by IFN- in coincubation experiments. These data implicate spermidine as a potential therapeutic agent to treat conditions associated with elevated IFN- signaling and a faulty mucosal barrier.	[Krishnan, Moorthy; McCole, Declan F.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Penrose, Harrison M.; Marchelletta, Ronald R.] Univ Calif San Diego, Sch Med, Div Gastroenterol, La Jolla, CA 92093 USA	University of California System; University of California Riverside; University of California System; University of California San Diego	McCole, DF (corresponding author), Univ Calif Riverside, Div Biomed Sci, 307 Sch Med Res Bldg,900 Univ Ave, Riverside, CA 92521 USA.	declan.mccole@ucr.edu	McCole, Declan/AAL-2454-2020	Penrose, Harrison/0000-0001-7957-5066	National Institutes of Health [R01DK091281]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, R01DK091281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in whole or in part, by National Institutes of Health Grant R01DK091281 (to D.F.M.).	ADAMS RB, 1993, J IMMUNOL, V150, P2356; AUGERON C, 1984, CANCER RES, V44, P3961; Beaurepaire C, 2009, J INTERF CYTOK RES, V29, P133, DOI 10.1089/jir.2008.0057; Boivin MA, 2009, J INTERF CYTOK RES, V29, P45, DOI 10.1089/jir.2008.0128; Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com; Cafferata EG, 2000, BBA-MOL BASIS DIS, V1500, P241, DOI 10.1016/S0925-4439(99)00105-2; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Festen EAM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001283; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Guo X, 2005, AM J PHYSIOL-GASTR L, V288, pG1159, DOI 10.1152/ajpgi.00407.2004; Guo X, 2003, AM J PHYSIOL-CELL PH, V285, pC1174, DOI 10.1152/ajpcell.00015.2003; Hao LN, 1997, J BIOL CHEM, V272, P29322, DOI 10.1074/jbc.272.46.29322; Heinonen KM, 2004, BLOOD, V103, P3457, DOI 10.1182/blood-2003-09-3153; Hoet PHM, 2000, AM J PHYSIOL-LUNG C, V278, pL417, DOI 10.1152/ajplung.2000.278.3.L417; Johnson LR, 1999, NEWS PHYSIOL SCI, V14, P12; Ma TY, 1999, AM J PHYSIOL-GASTR L, V276, pG965, DOI 10.1152/ajpgi.1999.276.4.G965; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Mattila E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-7; McKay DM, 2007, J PHARMACOL EXP THER, V320, P1013, DOI 10.1124/jpet.106.113639; Moinard C, 2005, CLIN NUTR, V24, P184, DOI 10.1016/j.clnu.2004.11.001; OTSUKA H, 1971, J CELL SCI, V9, P71; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Scharl M, 2010, INFLAMM BOWEL DIS, V16, P2055, DOI 10.1002/ibd.21325; Scharl M, 2009, GASTROENTEROLOGY, V137, P2030, DOI 10.1053/j.gastro.2009.07.078; Scharl M, 2009, J BIOL CHEM, V284, P27952, DOI 10.1074/jbc.M109.046292; Seiler N, 1996, INT J BIOCHEM CELL B, V28, P843, DOI 10.1016/1357-2725(96)00021-0; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tiganis T, 1999, J BIOL CHEM, V274, P27768, DOI 10.1074/jbc.274.39.27768; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Watson CJ, 2005, J CELL SCI, V118, P5221, DOI 10.1242/jcs.02630; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; Youakim A, 1999, AM J PHYSIOL-GASTR L, V276, pG1279, DOI 10.1152/ajpgi.1999.276.5.G1279	40	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32651	32662		10.1074/jbc.M113.475962	http://dx.doi.org/10.1074/jbc.M113.475962			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24022492	Green Published, hybrid			2022-12-28	WOS:000328681700050
J	Ishikawa, Y; Bachinger, HP				Ishikawa, Yoshihiro; Baechinger, Hans Peter			An Additional Function of the Rough Endoplasmic Reticulum Protein Complex Prolyl 3-Hydroxylase 1.Cartilage-associated Protein.Cyclophilin B THE CXXXC MOTIF REVEALS DISULFIDE ISOMERASE ACTIVITY IN VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE OSTEOGENESIS IMPERFECTA; BASEMENT-MEMBRANE COLLAGEN; CHICK TENDON COLLAGEN; CIS-TRANS-ISOMERASE; CYCLOPHILIN-B; TRIPLE-HELIX; STRUCTURAL BASIS; BOND FORMATION; MUTATIONS; PROCOLLAGEN	Collagen biosynthesis occurs in the rough endoplasmic reticulum, and many molecular chaperones and folding enzymes are involved in this process. The folding mechanism of type I procollagen has been well characterized, and protein disulfide isomerase (PDI) has been suggested as a key player in the formation of the correct disulfide bonds in the noncollagenous carboxyl-terminal and amino-terminal propeptides. Prolyl 3-hydroxylase 1 (P3H1) forms a hetero-trimeric complex with cartilage-associated protein and cyclophilin B (CypB). This complex is a multifunctional complex acting as a prolyl 3-hydroxylase, a peptidyl prolyl cis-trans isomerase, and a molecular chaperone. Two major domains are predicted from the primary sequence of P3H1: an amino-terminal domain and a carboxyl-terminal domain corresponding to the 2-oxoglutarate-and iron-dependent dioxygenase domains similar to the alpha-subunit of prolyl 4-hydroxylase and lysyl hydroxylases. The amino-terminal domain contains four CXXXC sequence repeats. The primary sequence of cartilage-associated protein is homologous to the amino-terminal domain of P3H1 and also contains four CXXXC sequence repeats. However, the function of the CXXXC sequence repeats is not known. Several publications have reported that short peptides containing a CXC or a CXXC sequence show oxido-reductase activity similar to PDI in vitro. We hypothesize that CXXXC motifs have oxido-reductase activity similar to the CXXC motif in PDI. We have tested the enzyme activities on model substrates in vitro using a GCRALCG peptide and the P3H1 complex. Our results suggest that this complex could function as a disulfide isomerase in the rough endoplasmic reticulum.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA	Oregon Health & Science University	Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org		Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospitals for Children	Shriners Hospitals for Children	This work was supported by grants from Shriners Hospitals for Children (to H. P. B.).	Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; BACHINGER HP, 1978, EUR J BIOCHEM, V90, P605, DOI 10.1111/j.1432-1033.1978.tb12641.x; Bachinger HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P469; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bottomley MJ, 2001, CURR BIOL, V11, P1114, DOI 10.1016/S0960-9822(01)00317-7; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Cabrele C, 2002, CHEM BIOL, V9, P731, DOI 10.1016/S1074-5521(02)00152-7; Castagnola P, 1997, J CELL SCI, V110, P1351; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ettema TJG, 2003, TRENDS BIOCHEM SCI, V28, P170, DOI 10.1016/S0968-0004(03)00037-9; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; GRYDER RM, 1975, J BIOL CHEM, V250, P2470; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; HAWKINS HC, 1991, BIOCHEM J, V275, P335, DOI 10.1042/bj2750335; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; Horibe T, 2004, J BIOL CHEM, V279, P4604, DOI 10.1074/jbc.M310922200; Horibe T, 2002, J BIOCHEM, V132, P401, DOI 10.1093/oxfordjournals.jbchem.a003236; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Ishikawa Y, 2012, J BIOL CHEM, V287, P22253, DOI 10.1074/jbc.M111.333336; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; JIMENEZ S, 1973, BIOCHEM BIOPH RES CO, V52, P106, DOI 10.1016/0006-291X(73)90960-1; JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x; KEFALIDES NA, 1975, J INVEST DERMATOL, V65, P85, DOI 10.1111/1523-1747.ep12598062; Kikuchi M, 2002, J BIOCHEM, V132, P451, DOI 10.1093/oxfordjournals.jbchem.a003242; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Klappa P, 2000, J BIOL CHEM, V275, P13213, DOI 10.1074/jbc.275.18.13213; Koehler CM, 2006, ANTIOXID REDOX SIGN, V8, P813, DOI 10.1089/ars.2006.8.813; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Koide T, 2005, TOP CURR CHEM, V247, P85, DOI 10.1007/b103820; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; KRESINA TF, 1979, BIOCHEMISTRY-US, V18, P3089, DOI 10.1021/bi00581a028; LAMBERT N, 1983, BIOCHEM J, V213, P225, DOI 10.1042/bj2130225; LAMBERT N, 1983, BIOCHEM J, V213, P235, DOI 10.1042/bj2130235; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Mokranjac D, 2009, BBA-MOL CELL RES, V1793, P33, DOI 10.1016/j.bbamcr.2008.06.021; MOORE EC, 1964, J BIOL CHEM, V239, P3453; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Ochs RL, 1996, MOL BIOL CELL, V7, P1015, DOI 10.1091/mbc.7.7.1015; Pirneskoski A, 2001, J BIOL CHEM, V276, P11287, DOI 10.1074/jbc.M010656200; Pyott SM, 2011, HUM MOL GENET, V20, P1595, DOI 10.1093/hmg/ddr037; ROSENBLO.J, 1973, ARCH BIOCHEM BIOPHYS, V158, P478, DOI 10.1016/0003-9861(73)90539-0; Sato Y, 2012, FEBS J, V279, P2262, DOI 10.1111/j.1742-4658.2012.08593.x; Satoh M, 2005, CELL STRESS CHAPERON, V10, P211, DOI 10.1379/CSC-109R.1; SIEDLER F, 1993, BIOCHEMISTRY-US, V32, P7488, DOI 10.1021/bi00080a021; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Takagi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036809; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Valli M, 2012, CLIN GENET, V82, P453, DOI 10.1111/j.1399-0004.2011.01794.x; Van Dijk FS, 2009, EUR J HUM GENET, V17, P1560, DOI 10.1038/ejhg.2009.75; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; Wagner K, 2009, BBA-MOL CELL RES, V1793, P52, DOI 10.1016/j.bbamcr.2008.05.026; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; Woycechowsky KJ, 1999, CHEM BIOL, V6, P871, DOI 10.1016/S1074-5521(00)80006-X; Woycechowsky KJ, 2003, BIOCHEMISTRY-US, V42, P5387, DOI 10.1021/bi026993q; Zito E, 2012, MOL CELL, V48, P39, DOI 10.1016/j.molcel.2012.08.010	80	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31437	31446		10.1074/jbc.M113.498063	http://dx.doi.org/10.1074/jbc.M113.498063			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043621	Green Published, hybrid			2022-12-28	WOS:000330596200003
J	Liu, WJ; Li, XL; Zhao, YS; Meng, XM; Wan, C; Yang, BX; Lan, HY; Lin, HY; Xia, Y				Liu, Wenjing; Li, Xiaoling; Zhao, Yueshui; Meng, Xiao-Ming; Wan, Chao; Yang, Baoxue; Lan, Hui-Yao; Lin, Herbert Y.; Xia, Yin			Dragon (Repulsive Guidance Molecule RGMb) Inhibits E-cadherin Expression and Induces Apoptosis in Renal Tubular Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOGENETIC PROTEIN CORECEPTOR; REGULATES HEPCIDIN EXPRESSION; FIBROSIS; KIDNEY; NEOGENIN; INJURY; RECEPTORS; INFLAMMATION; TRANSITION; MECHANISMS	Dragon is one of the three members of the repulsive guidance molecule (RGM) family, i.e. RGMa, RGMb (Dragon), and RGMc (hemojuvelin). We previously identified the RGM members as bone morphogenetic protein (BMP) co-receptors that enhance BMP signaling. Our previous studies found that Dragon is highly expressed in the tubular epithelial cells of mouse kidneys. However, the roles of Dragon in renal epithelial cells are yet to be defined. We now show that overexpression of Dragon increased cell death induced by hypoxia in association with increased cleaved poly(ADP-ribose) polymerase and cleaved caspase-3 levels in mouse inner medullary collecting duct (IMCD3) cells. Dragon also inhibited E-cadherin expression but did not affect epithelial-to-mesenchymal transition induced by TGF-beta in IMCD3 cells. Previous studies suggest that the three RGM members can function as ligands for the receptor neogenin. Interestingly, our present study demonstrates that the Dragon actions on apoptosis and E-cadherin expression in IMCD3 cells were mediated by the neogenin receptor but not through the BMP pathway. Dragon expression in the kidney was up-regulated by unilateral ureteral obstruction in mice. Compared with wild-type mice, heterozygous Dragon knock-out mice exhibited 45-66% reduction in Dragon mRNA expression, decreased epithelial apoptosis, and increased tubular E-cadherin expression and had attenuated tubular injury after unilateral ureteral obstruction. Our results suggest that Dragon may impair tubular epithelial integrity and induce epithelial apoptosis both in vitro and in vivo.	[Liu, Wenjing; Li, Xiaoling; Zhao, Yueshui; Wan, Chao; Xia, Yin] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Key Lab Regenerat Med,Minist Educ, Hong Kong, Hong Kong, Peoples R China; [Wan, Chao; Xia, Yin] Chinese Univ Hong Kong, Shenzhen Res Inst, Sch Biomed Sci Core Lab, Shenzhen 518057, Peoples R China; [Lin, Herbert Y.] Harvard Univ, Ctr Syst Biol,Med Sch, Massachusetts Gen Hosp,Program Membrane Biol, Program Anemia Signaling Res,Div Nephrol,Dept Med, Boston, MA 02114 USA; [Meng, Xiao-Ming; Lan, Hui-Yao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Meng, Xiao-Ming; Lan, Hui-Yao] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Yang, Baoxue] Peking Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing 100191, Peoples R China; [Yang, Baoxue] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Harvard University; Harvard Medical School; Massachusetts General Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Peking University	Lin, HY (corresponding author), Richard B Simches Res Ctr, Program Membrane Biol, 185 Cambridge St,CPZN-8216, Boston, MA 02114 USA.	Lin.Herbert@mgh.harvard.edu; Xia.Yin@cuhk.edu.hk	Liu, Wenjing/ACS-5787-2022; Wan, Chao/J-9277-2013; Lan, Hui Yao/C-9734-2015; Xia, Yin/M-5440-2018	Wan, Chao/0000-0001-6780-2006; Lan, Hui Yao/0000-0003-4283-9755; Xia, Yin/0000-0003-0315-7532; ZHAO, YUESHUI/0000-0002-1972-6130; Meng, Xiao-ming/0000-0002-1166-561X	Hong Kong Research Grant Council (RGC) [N_CUHK432/12, 81261160507]; National Natural Science Foundation of China (NSFC) [N_CUHK432/12, 81261160507]; Chinese University of Hong Kong; RGC/General Research Fund (GRF) [CUHK477311]; CUHK [2041603, 2041747]; Shenzhen Science and Technology Research and Development Funding [SZRI-C.02.12.006]; National Institute of Health [RO1 DK-069533, RO1 DK-071837]; Chinese University of Hong Kong postgraduate scholarships; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069533, R01DK071837] Funding Source: NIH RePORTER	Hong Kong Research Grant Council (RGC)(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese University of Hong Kong(Chinese University of Hong Kong); RGC/General Research Fund (GRF); CUHK(Chinese University of Hong Kong); Shenzhen Science and Technology Research and Development Funding; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese University of Hong Kong postgraduate scholarships; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Hong Kong Research Grant Council (RGC) and National Natural Science Foundation of China (NSFC) joint grants N_CUHK432/12 and 81261160507 (to Y. X. and B. Y.), the startup fund offered by The Chinese University of Hong Kong (to Y. X.), RGC/General Research Fund (GRF) grant CUHK477311 (to Y. X.), CUHK direct grants 2041603 and 2041747 (to Y. X.), Shenzhen Science and Technology Research and Development Funding SZRI-C.02.12.006 (to Y. X.), and National Institute of Health Grants RO1 DK-069533 and RO1 DK-071837 (to H. Y. L.).; Supported by Chinese University of Hong Kong postgraduate scholarships.	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Bell CH, 2013, SCIENCE, V341, P77, DOI 10.1126/science.1232322; Cain JE, 2008, DIFFERENTIATION, V76, P831, DOI 10.1111/j.1432-0436.2008.00265.x; Chung ACK, 2011, J AM SOC NEPHROL, V22, P802, DOI 10.1681/ASN.2010050510; Conrad S, 2010, MOL CELL NEUROSCI, V43, P222, DOI 10.1016/j.mcn.2009.11.003; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; Dendooven A, 2011, AM J PATHOL, V178, P1069, DOI 10.1016/j.ajpath.2010.12.005; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Gould SE, 2002, KIDNEY INT, V61, P51, DOI 10.1046/j.1523-1755.2002.00103.x; Hotter G, 2004, LAB INVEST, V84, P213, DOI 10.1038/labinvest.3700026; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Khan S, 1999, LAB INVEST, V79, P1089; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Li VSW, 2009, GASTROENTEROLOGY, V137, P176, DOI 10.1053/j.gastro.2009.03.005; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Meng XM, 2013, CLIN SCI, V124, P243, DOI 10.1042/CS20120252; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Shin GJ, 2008, J MOL HISTOL, V39, P105, DOI 10.1007/s10735-007-9138-x; Truong LD, 1996, KIDNEY INT, V50, P200, DOI 10.1038/ki.1996.303; Wang WW, 2009, AM J NEPHROL, V30, P186, DOI 10.1159/000213503; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Xia Y, 2011, J IMMUNOL, V186, P1369, DOI 10.4049/jimmunol.1002047; Xia Y, 2010, J AM SOC NEPHROL, V21, P666, DOI 10.1681/ASN.2009050511; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yang YL, 2009, ENDOCRINOLOGY, V150, P727, DOI 10.1210/en.2008-0090; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616	38	17	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31528	31539		10.1074/jbc.M113.517573	http://dx.doi.org/10.1074/jbc.M113.517573			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052264	Green Published, hybrid			2022-12-28	WOS:000330596200012
J	Muller, I; Schnberger, T; Schneider, M; Borst, O; Ziegler, M; Seizer, P; Leder, C; Muller, K; Lang, M; Appenzeller, F; Lunov, O; Buchele, B; Fahrleitner, M; Olbrich, M; Langer, H; Geisler, T; Lang, F; Chatterjee, M; de Boer, JF; Tietge, UJF; Bernhagen, J; Simmet, T; Gawaz, M				Mueller, Iris; Schnberger, Tanja; Schneider, Martina; Borst, Oliver; Ziegler, Melanie; Seizer, Peter; Leder, Christoph; Mueller, Karin; Lang, Michael; Appenzeller, Florian; Lunov, Oleg; Buechele, Berthold; Fahrleitner, Manuela; Olbrich, Marcus; Langer, Harald; Geisler, Tobias; Lang, Florian; Chatterjee, Madhumita; de Boer, Jan Freark; Tietge, Uwe J. F.; Bernhagen, Juergen; Simmet, Thomas; Gawaz, Meinrad			Gremlin-1 Is an Inhibitor of Macrophage Migration Inhibitory Factor and Attenuates Atherosclerotic Plaque Growth in ApoE(-/-) Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN; GLYCOPROTEIN-VI; I-TASSER; ANTAGONIST GREMLIN-1; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; EXPRESSION; MONOCYTE; DOCKING; GENE	Monocyte infiltration and macrophage formation are pivotal steps in atherosclerosis and plaque vulnerability. Gremlin-1/Drm is crucial in embryo-/organogenesis and has been shown to be expressed in the adult organism at sites of arterial injury and to inhibit monocyte migration. The purpose of the present study was to evaluate and characterize the role of Gremlin-1 in atherosclerosis. Here we report that Gremlin-1 is highly expressed primarily by monocytes/macrophages in aortic atherosclerotic lesions of ApoE(-/-) mice and is secreted from activated monocytes and during macrophage development in vitro. Gremlin-1 reduces macrophage formation by inhibiting macrophage migration inhibitory factor (MIF), a cytokine critically involved in atherosclerotic plaque progression and vulnerability. Gremlin-1 binds with high affinity to MIF (K-D = 54 nM), as evidenced by surface plasmon resonance analysis and co-immunoprecipitation, and reduces MIF-induced release of TNF-alpha from macrophages. Treatment of ApoE(-/-) mice with a dimeric recombinant fusion protein, (m)Gremlin1-Fc, but not with equimolar control Fc or inactivated (m)Gremlin1-Fc, reduced TNF-alpha expression, the content of monocytes/macrophages of atherosclerotic lesions, and attenuated atheroprogression. The present data disclose that Gremlin-1 is an endogenous antagonist of MIF and define a role for Gremlin-1/MIF interaction in atherosclerosis.	[Mueller, Iris; Schnberger, Tanja; Schneider, Martina; Borst, Oliver; Ziegler, Melanie; Seizer, Peter; Leder, Christoph; Mueller, Karin; Lang, Michael; Appenzeller, Florian; Fahrleitner, Manuela; Olbrich, Marcus; Langer, Harald; Geisler, Tobias; Chatterjee, Madhumita; Gawaz, Meinrad] Univ Tubingen, Med Klin Kardiol & Kreislauferkrankungen 3, D-72076 Tubingen, Germany; [Lunov, Oleg; Buechele, Berthold; Simmet, Thomas] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89081 Ulm, Germany; [Lang, Florian] Univ Tubingen, Inst Physiol, D-72076 Tubingen, Germany; [de Boer, Jan Freark; Tietge, Uwe J. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, NL-9713 Groningen, Netherlands; [Bernhagen, Juergen] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, D-52074 Aachen, Germany	Eberhard Karls University of Tubingen; Ulm University; Eberhard Karls University of Tubingen; University of Groningen; RWTH Aachen University	Gawaz, M (corresponding author), Univ Tubingen, Otfried Muller Str 10, D-72076 Tubingen, Germany.	meinrad.gawaz@med.uni-tuebingen.de	Lunov, Oleg/H-1387-2014; Chatterjee, Madhumita/AAJ-1802-2020; Sauter, Manuela/AAU-5685-2021; Geisler, Tobias/AAO-4472-2020; Stefanadis, Christodoulos/ABH-2232-2020	Lunov, Oleg/0000-0003-2922-8896; Chatterjee, Madhumita/0000-0002-3428-4107; Sauter, Manuela/0000-0002-6411-5697; Syrovets, Tatiana/0000-0002-6751-2233; Stefanadis, Christodoulos/0000-0001-5974-6454; Ziegler, Melanie/0000-0002-6229-5698; Borst, Oliver/0000-0003-4002-4085	Deutsche Forschungsgemeinschaft (DFG) [Transregio-SFB-19, Klinische Forschergruppe KFO-274]; DFG [MU 2928/2-1]; University of Tubingen (Iris Muller Fortune Research Program); University of Tubingen (Interdisciplinary Center for Clinical Research (IZKF)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); University of Tubingen (Iris Muller Fortune Research Program); University of Tubingen (Interdisciplinary Center for Clinical Research (IZKF)	This study was supported in part by grants from the Deutsche Forschungsgemeinschaft (DFG) (Transregio-SFB-19 and Klinische Forschergruppe KFO-274, "Platelets-Molecular Mechanisms and Translational Implications") and by DFG Grant MU 2928/2-1 to Iris Muller, the University of Tubingen (Iris Muller Fortune Research Program; H. L. Interdisciplinary Center for Clinical Research (IZKF)).	Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Boers W, 2006, J BIOL CHEM, V281, P16289, DOI 10.1074/jbc.M600711200; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Chang K, 2007, CIRCULATION, V116, P1258, DOI 10.1161/CIRCULATIONAHA.106.683227; Chen B, 2004, J IMMUNOL, V173, P5914, DOI 10.4049/jimmunol.173.10.5914; Chiodelli P, 2011, ARTERIOSCL THROM VAS, V31, pE116, DOI 10.1161/ATVBAHA.111.235184; Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497; Daub K, 2006, FASEB J, V20, P2559, DOI 10.1096/fj.06-6265fje; Daub K, 2010, J MOL MED, V88, P909, DOI 10.1007/s00109-010-0629-y; Diecke S, 2008, CELLS TISSUES ORGANS, V188, P52, DOI 10.1159/000121282; Dolan V, 2005, AM J KIDNEY DIS, V45, P1034, DOI 10.1053/j.ajkd.2005.03.014; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Hanlon AD, 2010, BIOPHYS J, V98, P297, DOI 10.1016/j.bpj.2009.09.061; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Kane R, 2005, BRIT J OPHTHALMOL, V89, P1638, DOI 10.1136/bjo.2005.069591; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Maciel TT, 2008, J MOL CELL CARDIOL, V44, P370, DOI 10.1016/j.yjmcc.2007.10.021; Massberg S, 2003, FASEB J, V17, P397, DOI 10.1096/f.03-0464.fje; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Merk M, 2009, J IMMUNOL, V182, P6896, DOI 10.4049/jimmunol.0803710; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Namkoong H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-74; Nijstad N, 2011, BBA-MOL CELL BIOL L, V1811, P294, DOI 10.1016/j.bbalip.2011.01.008; Ritchie DW, 2008, BIOINFORMATICS, V24, P1865, DOI 10.1093/bioinformatics/btn334; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schmidt R, 2006, CIRCULATION, V113, P834, DOI 10.1161/CIRCULATIONAHA.105.568162; Schonberger T, 2008, CARDIOVASC RES, V80, P131, DOI 10.1093/cvr/cvn169; Schulz C, 2007, CIRCULATION, V116, P764, DOI 10.1161/CIRCULATIONAHA.107.695189; Seizer P, 2010, SEMIN THROMB HEMOST, V36, P157, DOI 10.1055/s-0030-1251499; Shi W, 2001, AM J PHYSIOL-LUNG C, V280, pL1030, DOI 10.1152/ajplung.2001.280.5.L1030; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Stellos K, 2010, ARTERIOSCL THROM VAS, V30, P1127, DOI 10.1161/ATVBAHA.110.204370; Sugimoto H, 1996, FEBS LETT, V389, P145, DOI 10.1016/0014-5793(96)00553-4; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; THISSE C, 1993, DEVELOPMENT, V119, P1203; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Topol LZ, 2000, J BIOL CHEM, V275, P8785, DOI 10.1074/jbc.275.12.8785; Topol LZ, 1997, MOL CELL BIOL, V17, P4801, DOI 10.1128/MCB.17.8.4801; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Zeibig S, 2011, CIRC RES, V108, P695, DOI 10.1161/CIRCRESAHA.111.240515; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	57	45	46	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31635	31645		10.1074/jbc.M113.477745	http://dx.doi.org/10.1074/jbc.M113.477745			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24003215	Green Published, hybrid			2022-12-28	WOS:000330596200022
J	Lewrenz, I; Rietzschel, N; Guiard, B; Lill, R; van der Laan, M; Voos, W				Lewrenz, Ilka; Rietzschel, Nicole; Guiard, Bernard; Lill, Roland; van der Laan, Martin; Voos, Wolfgang			The Functional Interaction of Mitochondrial Hsp70s with the Escort Protein Zim17 Is Critical for Fe/S Biogenesis and Substrate Interaction at the Inner Membrane Preprotein Translocase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S CLUSTER BIOGENESIS; MOLECULAR CHAPERONES; SACCHAROMYCES-CEREVISIAE; INTERDOMAIN LINKER; ATPASE ACTIVITY; IMPORT MOTOR; IN-VIVO; SCAFFOLD; DNAJ; BINDING	The yeast protein Zim17 belongs to a unique class of co-chaperones that maintain the solubility of Hsp70 proteins in mitochondria and plastids of eukaryotic cells. However, little is known about the functional cooperation between Zim17 and mitochondrial Hsp70 proteins in vivo. To analyze the effects of a loss of Zim17 function in the authentic environment, we introduced novel conditional mutations within the ZIM17 gene of the model organism Saccharomyces cerevisiae that allowed a recovery of temperature-sensitive but respiratory competent zim17 mutant cells. On fermentable growth medium, the mutant cells were prone to acquire respiratory deficits and showed a strong aggregation of the mitochondrial Hsp70 Ssq1 together with a concomitant defect in Fe/S protein biogenesis. In contrast, under respiring conditions, the mitochondrial Hsp70s Ssc1 and Ssq1 exhibited only a partial aggregation. We show that the induction of the zim17 mutant phenotype leads to strong import defects for Ssc1-dependent matrix-targeted precursor proteins that correlate with a significantly reduced binding of newly imported substrate proteins to Ssc1. We conclude that Zim17 is not only required for the maintenance of mtHsp70 solubility but also directly assists the functional interaction of mtHsp70 with substrate proteins in a J-type co-chaperone-dependent manner.	[Lewrenz, Ilka; Voos, Wolfgang] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Rietzschel, Nicole; Lill, Roland] Univ Marburg, Inst Zytobiol & Zytopathol, D-35032 Marburg, Germany; [Guiard, Bernard] Univ Paris 06, CNRS, Lab Propre, Ctr Genet Mol, F-91190 Gif Sur Yvette, France; [van der Laan, Martin] Univ Freiburg, Inst Biochem & Mol Biol ZBMZ, D-79104 Freiburg, Germany; [van der Laan, Martin] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Bonn; Philipps University Marburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Freiburg; University of Freiburg	Voos, W (corresponding author), Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	wolfgang.voos@uni-bonn.de		Lill, Roland/0000-0002-8345-6518; van der Laan, Martin/0000-0003-0789-9912	Deutsche Forschungsgemeinschaft [VO657/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant VO657/5-1 (to W. V.).	Andrew AJ, 2006, J BIOL CHEM, V281, P14580, DOI 10.1074/jbc.M600842200; Andrew AJ, 2008, MOL BIOL CELL, V19, P5259, DOI 10.1091/mbc.E08-06-0622; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Becker D, 2009, J BIOL CHEM, V284, P2934, DOI 10.1074/jbc.M803557200; Bender T, 2011, MOL BIOL CELL, V22, P541, DOI 10.1091/mbc.E10-08-0718; Blamowska M, 2012, J CELL BIOL, V199, P125, DOI 10.1083/jcb.201205012; Blamowska M, 2010, J BIOL CHEM, V285, P4423, DOI 10.1074/jbc.M109.061697; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Burri L, 2004, J BIOL CHEM, V279, P50243, DOI 10.1074/jbc.M409194200; Ciesielski SJ, 2012, J MOL BIOL, V417, P1, DOI 10.1016/j.jmb.2012.01.022; Dutkiewicz R, 2006, J BIOL CHEM, V281, P7801, DOI 10.1074/jbc.M513301200; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hausmann A, 2008, J BIOL CHEM, V283, P8318, DOI 10.1074/jbc.M705570200; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kelley WL, 1999, CURR BIOL, V9, pR305, DOI 10.1016/S0960-9822(99)80185-7; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Linke K, 2003, J BIOL CHEM, V278, P44457, DOI 10.1074/jbc.M307491200; LORENZ MC, 1995, GENE, V158, P113, DOI 10.1016/0378-1119(95)00144-U; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Momose T, 2007, EMBO REP, V8, P664, DOI 10.1038/sj.embor.7400990; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Westermann B, 1996, MOL CELL BIOL, V16, P7063; Willmund F, 2008, J BIOL CHEM, V283, P16363, DOI 10.1074/jbc.M708431200; Yamamoto H, 2005, FEBS LETT, V579, P507, DOI 10.1016/j.febslet.2004.12.018; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhai P, 2008, J BIOL CHEM, V283, P26098, DOI 10.1074/jbc.M803475200; Zhai P, 2011, BIOCHEM BIOPH RES CO, V408, P589, DOI 10.1016/j.bbrc.2011.04.066	41	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30931	30943		10.1074/jbc.M113.465997	http://dx.doi.org/10.1074/jbc.M113.465997			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24030826	Green Published, hybrid			2022-12-28	WOS:000330778900013
J	Shea, ME; Juarez, O; Cho, J; Barquera, B				Shea, Michael E.; Juarez, Oscar; Cho, Jonathan; Barquera, Blanca			Aspartic Acid 397 in Subunit B of the Na+-pumping NADH:Quinone Oxidoreductase from Vibrio cholerae Forms Part of a Sodium-binding Site, Is Involved in Cation Selectivity, and Affects Cation-binding Site Cooperativity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING NADH; QUINONE OXIDOREDUCTASE; UBIQUINONE OXIDOREDUCTASE; ALGINOLYTICUS; TRANSPORT; PROGRESS; DRIVEN; STEPS; CYCLE	The Na+-pumping NADH: quinone complex is found in Vibrio cholerae and other marine and pathogenic bacteria. NADH: ubiquinone oxidoreductase oxidizes NADH and reduces ubiquinone, using the free energy released by this reaction to pump sodium ions across the cell membrane. In a previous report, a conserved aspartic acid residue in the NqrB subunit at position 397, located in the cytosolic face of this protein, was proposed to be involved in the capture of sodium. Here, we studied the role of this residue through the characterization of mutant enzymes in which this aspartic acid was substituted by other residues that change charge and size, such as arginine, serine, lysine, glutamic acid, and cysteine. Our results indicate that NqrB-Asp-397 forms part of one of the at least two sodium-binding sites and that both size and charge at this position are critical for the function of the enzyme. Moreover, we demonstrate that this residue is involved in cation selectivity, has a critical role in the communication between sodium-binding sites, by promoting cooperativity, and controls the electron transfer step involved in sodium uptake (2Fe-2S -> FMNC).	Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Barquera, B (corresponding author), Rensselaer Polytech Inst, Rm 2239 CBIS, Troy, NY 12180 USA.	barqub@rpi.edu		Cho, Jonathan/0000-0001-6280-9030; Juarez, Oscar/0000-0002-2915-8413				Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Bogachev AV, 2009, J BIOL CHEM, V284, P5533, DOI 10.1074/jbc.M808984200; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; Dashper SG, 2001, J BACTERIOL, V183, P4142, DOI 10.1128/JB.183.14.4142-4148.2001; DIBROV PA, 1986, BIOCHIM BIOPHYS ACTA, V850, P458, DOI 10.1016/0005-2728(86)90114-3; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Kojima S, 1999, J BACTERIOL, V181, P1927, DOI 10.1128/JB.181.6.1927-1930.1999; Neehaubl Y, 2013, BIOCHEMISTRY-US, V52, P3085, DOI 10.1021/bi4000386; Neehaul Y, 2012, BIOCHEMISTRY-US, V51, P4072, DOI 10.1021/bi300343u; Roitel O, 1999, BIOCHEMISTRY-US, V38, P16084, DOI 10.1021/bi9912802; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; Steuber J, 1997, EUR J BIOCHEM, V249, P770, DOI 10.1111/j.1432-1033.1997.t01-2-00770.x	19	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31241	31249		10.1074/jbc.M113.510776	http://dx.doi.org/10.1074/jbc.M113.510776			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24030824	Green Published, hybrid			2022-12-28	WOS:000330778900040
J	Li, SL; Du, LL; Zhang, L; Hu, Y; Xia, WC; Wu, J; Zhu, J; Chen, LL; Zhu, FQ; Li, CX; Yang, SJ				Li, Shali; Du, Leilei; Zhang, Lu; Hu, Yue; Xia, Wenchun; Wu, Jia; Zhu, Jing; Chen, Lingling; Zhu, Fengqi; Li, Chunxian; Yang, SiJun			Cathepsin B Contributes to Autophagy-related 7 (Atg7)-induced Nod-like Receptor 3 (NLRP3)-dependent Proinflammatory Response and Aggravates Lipotoxicity in Rat Insulinoma Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Cytokine; Glucose Metabolism; Inflammation; Insulin Resistance; Pancreatic Islets	ENDOPLASMIC-RETICULUM STRESS; NLRP3 INFLAMMASOME; PALMITIC ACID; PROTEIN-KINASE; ACTIVATION; APOPTOSIS; MATURATION; IL-1-BETA; PATHWAY; GLUCOSE	Background: Previous studies show that autophagy deficiency leads to inflammasome activation. Results: Excessive autophagy activation induces a proinflammatory response. Conclusion: Our findings provide new insights into the release mechanisms of proinflammatory cytokines regulated by autophagy. Significance: That autophagy may play a deleterious role in pathogenesis in T2D is a novel finding. Impairment of glucose-stimulated insulin secretion caused by the lipotoxicity of palmitate was found in -cells. Recent studies have indicated that defects in autophagy contribute to pathogenesis in type 2 diabetes. Here, we report that autophagy-related 7 (Atg7) induced excessive autophagic activation in INS-1(823/13) cells exposed to saturated fatty acids. Atg7-induced cathepsin B (CTSB) overexpression resulted in an unexpected significant increase in proinflammatory chemokine and cytokine production levels of IL-1, monocyte chemotactic protein-1, IL-6, and TNF-. Inhibition of receptor-interacting protein did not affect the inflammatory response, ruling out involvement of necrosis. CTSB siRNA suppressed the inflammatory response but did not affect apoptosis significantly, suggesting that CTSB was a molecular linker between autophagy and the proinflammatory response. Blocking caspase-3 suppressed apoptosis but did not affect the inflammatory response, suggesting that CTSB induced inflammatory effects independently of apoptosis. Silencing of Nod-like receptor 3 (NLRP3) completely abolished both IL-1 secretion and the down-regulation effects of Atg7-induced CTSB overexpression on glucose-stimulated insulin secretion impairment, thus identifying the NLRP3 inflammasome as an autophagy-responsive element in the pancreatic INS-1(823/13) cell line. Combined together, our results indicate that CTSB contributed to the Atg7-induced NLRP3-dependent proinflammatory response, resulting in aggravation of lipotoxicity, independently of apoptosis in the pancreatic INS-1(823/13) cell line.	[Li, Shali; Du, Leilei; Zhang, Lu; Hu, Yue; Xia, Wenchun; Wu, Jia; Zhu, Jing; Chen, Lingling; Zhu, Fengqi; Li, Chunxian; Yang, SiJun] Nanjing Normal Univ, Dept Cell Biol, Coll Life Sci, Nanjing 210046, Jiangsu, Peoples R China	Nanjing Normal University	Yang, SJ (corresponding author), Nanjing Normal Univ, Dept Cell Biol, Coll Life Sci, Nanjing 210046, Jiangsu, Peoples R China.	08275@njnu.edu.cn	Chen, Ling-Ling/AAY-3547-2021					Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Caglic D, 2011, BIOORGAN MED CHEM, V19, P1055, DOI 10.1016/j.bmc.2010.10.028; Cao LZ, 2004, DIABETES, V53, P3168, DOI 10.2337/diabetes.53.12.3168; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Deretic V, 2009, CURR OPIN IMMUNOL, V21, P53, DOI 10.1016/j.coi.2009.02.002; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Khan MJ, 2012, J BIOL CHEM, V287, P21110, DOI 10.1074/jbc.M111.319129; Kolattukudy PE, 2012, CIRC RES, V110, P174, DOI 10.1161/CIRCRESAHA.111.243212; Komatsu M, 2012, J BIOCHEM, V152, P5, DOI 10.1093/jb/mvs059; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liang HS, 2011, IN VIVO, V25, P711; Lightfoot YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020617; Martino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036188; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Orlichenko L, 2012, J BIOL CHEM, V287, P24284, DOI 10.1074/jbc.M111.328815; Osborn O, 2008, CYTOKINE, V44, P141, DOI 10.1016/j.cyto.2008.07.004; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Shao SY, 2010, J CELL BIOCHEM, V111, P634, DOI 10.1002/jcb.22750; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Song MK, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/323784; Sun L, 2012, J NEUROSCI, V32, P11330, DOI 10.1523/JNEUROSCI.0677-12.2012; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	39	44	48	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30094	30104		10.1074/jbc.M113.494286	http://dx.doi.org/10.1074/jbc.M113.494286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986436	Green Published, hybrid			2022-12-28	WOS:000329868100010
J	Loiarro, M; Volpe, E; Ruggiero, V; Gallo, G; Furlan, R; Maiorino, C; Battistini, L; Sette, C				Loiarro, Maria; Volpe, Elisabetta; Ruggiero, Vito; Gallo, Grazia; Furlan, Roberto; Maiorino, Chiara; Battistini, Luca; Sette, Claudio			Mutational Analysis Identifies Residues Crucial for Homodimerization of Myeloid Differentiation Factor 88 (MyD88) and for Its Function in Immune Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellular Immune Response; Mutagenesis; MyD88; Signal Transduction; Toll IL-1 Receptor (TIR) Domain; Toll-like Receptor (TLR)	NF-KAPPA-B; FAST INTERACTION REFINEMENT; RECEPTOR TIR DOMAIN; TOLL-LIKE RECEPTORS; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; INTERACTION SITES; STRUCTURAL BASIS; ADAPTER PROTEIN; MOLECULAR-BASIS	Background: MyD88 is an adaptor protein that plays a crucial role in the immune response. Results: We identified residues within the TIR domain of MyD88 required for protein self-association. Conclusion: Interference with the surface of homodimerization identified by these residues inhibits MyD88 function. Significance: The inhibition of MyD88 activity could be a good therapeutic strategy for inflammatory and autoimmune diseases. Myeloid differentiation factor 88 (MyD88) is an adaptor protein that transduces intracellular signaling pathways evoked by the Toll-like receptors (TLRs) and interleukin-1 receptors (IL-1Rs). MyD88 is composed of an N-terminal death domain (DD) and a C-terminal Toll/IL-1 receptor (TIR) domain, separated by a short region. Upon ligand binding, TLR/IL-1Rs hetero- or homodimerize and recruit MyD88 through their respective TIR domains. Then, MyD88 oligomerizes via its DD and TIR domain and interacts with the interleukin-1 receptor-associated kinases (IRAKs) to form the Myddosome complex. We performed site-directed mutagenesis of conserved residues that are located in exposed regions of the MyD88-TIR domain and analyzed the effect of the mutations on MyD88 signaling. Our studies revealed that mutation of Glu(183), Ser(244), and Arg(288) impaired homodimerization of the MyD88-TIR domain, recruitment of IRAKs, and activation of NF-B. Moreover, overexpression of two green fluorescent protein (GFP)-tagged MyD88 mini-proteins (GFP-MyD88(151-189) and GFP-MyD88(168-189)), comprising the Glu(183) residue, recapitulated these effects. Importantly, expression of these dominant negative MyD88 mini-proteins competed with the function of endogenous MyD88 and interfered with TLR2/4-mediated responses in a human monocytic cell line (THP-1) and in human primary monocyte-derived dendritic cells. Thus, our studies identify novel residues of the TIR domain that are crucially involved in MyD88 homodimerization and TLR signaling in immune cells.	[Loiarro, Maria; Sette, Claudio] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy; [Loiarro, Maria; Sette, Claudio] Santa Lucia Fdn, Lab Neuroembryol, I-00143 Rome, Italy; [Volpe, Elisabetta; Battistini, Luca] Santa Lucia Fdn, Lab Neuroimmunol, I-00143 Rome, Italy; [Ruggiero, Vito; Gallo, Grazia] Res & Dev Sigma Tau SpA, I-00040 Rome, Italy; [Furlan, Roberto; Maiorino, Chiara] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia; IRCCS Santa Lucia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Sette, C (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy.	claudio.sette@uniroma2.it	Furlan, Roberto/J-9177-2016; Battistini, luca/ABE-1882-2021; Volpe, Elisabetta/J-8589-2016; Sette, Claudio/S-4307-2019; Furlan, Roberto/N-5224-2019; Battistini, Luca/D-6920-2014	Furlan, Roberto/0000-0001-7376-9425; Sette, Claudio/0000-0003-2864-8266; Furlan, Roberto/0000-0001-7376-9425; Battistini, Luca/0000-0002-6488-4891; Volpe, Elisabetta/0000-0001-7985-2422	Fondazione Italiana Sclerosi Multipla (FISM); Association for International Cancer Research (AICR); Italian Ministry of Health (Progetto Giovani Ricercatori); Worldwide Cancer Research [12-0150] Funding Source: researchfish	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Association for International Cancer Research (AICR); Italian Ministry of Health (Progetto Giovani Ricercatori)(Ministry of Health, Italy); Worldwide Cancer Research	This work was supported by grants from Fondazione Italiana Sclerosi Multipla (FISM), Association for International Cancer Research (AICR) (to C. S.), and the Italian Ministry of Health (Progetto Giovani Ricercatori) (to E. V.).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bartfai T, 2003, P NATL ACAD SCI USA, V100, P7971, DOI 10.1073/pnas.0932746100; Basith S, 2012, ARCH PHARM RES, V35, P1297, DOI 10.1007/s12272-012-0802-7; Bovijn C, 2013, J BIOL CHEM, V288, P12054, DOI 10.1074/jbc.M112.415810; Bovijn C, 2012, J BIOL CHEM, V287, P4088, DOI 10.1074/jbc.M111.282350; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Capolunghi F, 2010, RHEUMATOLOGY, V49, P2281, DOI 10.1093/rheumatology/keq226; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Fekonja O, 2012, CURR PROTEIN PEPT SC, V13, P776, DOI 10.2174/138920312804871148; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Hardiman G, 1996, ONCOGENE, V13, P2467; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Li CS, 2005, J BIOL CHEM, V280, P26152, DOI 10.1074/jbc.M503262200; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Loiarro M, 2013, CL LYMPH MYELOM LEUK, V13, P222, DOI 10.1016/j.clml.2013.02.003; Loiarro M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/674363; Loiarro M, 2009, J BIOL CHEM, V284, P28093, DOI 10.1074/jbc.M109.004465; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nada M, 2012, MOL IMMUNOL, V52, P108, DOI 10.1016/j.molimm.2012.05.003; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ohnishi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038423; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Radons JR, 2003, J BIOL CHEM, V278, P49145, DOI 10.1074/jbc.M306077200; Remer KA, 2006, J IMMUNOL METHODS, V313, P1, DOI 10.1016/j.jim.2005.07.026; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sasai M, 2013, INT REV IMMUNOL, V32, P116, DOI 10.3109/08830185.2013.774391; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Verstak B, 2007, INFLAMM RES, V56, P1, DOI 10.1007/s00011-007-6093-7; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	53	38	40	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30210	30222		10.1074/jbc.M113.490946	http://dx.doi.org/10.1074/jbc.M113.490946			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24019529	hybrid, Green Published			2022-12-28	WOS:000329868100020
J	Haldiman, T; Kim, C; Cohen, Y; Chen, W; Blevins, J; Qing, LT; Cohen, ML; Langeveld, J; Telling, GC; Kong, QZ; Safar, JG				Haldiman, Tracy; Kim, Chae; Cohen, Yvonne; Chen, Wei; Blevins, Janis; Qing, Liuting; Cohen, Mark L.; Langeveld, Jan; Telling, Glenn C.; Kong, Qingzhong; Safar, Jiri G.			Co-existence of Distinct Prion Types Enables Conformational Evolution of Human PrPSc by Competitive Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; TRANSMISSIBLE MINK ENCEPHALOPATHY; CHRONIC WASTING DISEASE; STRAIN VARIATION; MOLECULAR-BASIS; PROTEIN; MICE; CLASSIFICATION; INTERFERENCE; COOCCURRENCE	The unique phenotypic characteristics of mammalian prions are thought to be encoded in the conformation of pathogenic prion proteins (PrPSc). The molecular mechanism responsible for the adaptation, mutation, and evolution of prions observed in cloned cells and upon crossing the species barrier remains unsolved. Using biophysical techniques and conformation-dependent immunoassays in tandem, we isolated two distinct populations of PrPSc particles with different conformational stabilities and aggregate sizes, which frequently co-exist in the most common human prion disease, sporadic Creutzfeldt-Jakob disease. The protein misfolding cyclic amplification replicates each of the PrPSc particle types independently and leads to the competitive selection of those with lower initial conformational stability. In serial propagation with a nonglycosylated mutant PrPC substrate, the dominant PrPSc conformers are subject to further evolution by natural selection of the subpopulation with the highest replication rate due to its lowest stability. Cumulatively, the data show that sporadic Creutzfeldt-Jakob disease PrPSc is not a single conformational entity but a dynamic collection of two distinct populations of particles. This implies the co-existence of different prions, whose adaptation and evolution are governed by the selection of progressively less stable, faster replicating PrPSc conformers.	[Haldiman, Tracy; Kim, Chae; Cohen, Yvonne; Chen, Wei; Blevins, Janis; Qing, Liuting; Cohen, Mark L.; Kong, Qingzhong; Safar, Jiri G.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Kong, Qingzhong; Safar, Jiri G.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Cohen, Yvonne; Chen, Wei; Blevins, Janis; Cohen, Mark L.; Safar, Jiri G.] Case Western Reserve Univ, Sch Med, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA; [Langeveld, Jan] Cent Vet Inst Wageningen UR, NL-8200 AB Lelystad, Netherlands; [Telling, Glenn C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Wageningen University & Research; Colorado State University	Safar, JG (corresponding author), Case Western Reserve Univ, Dept Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	jiri.safar@case.edu	Telling, Glenn C/G-1217-2019	Telling, Glenn C/0000-0002-6294-1805	National Institutes of Health [NS074317]; Centers for Disease Control and Prevention [UR8/CCU515004]; Charles S. Britton Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040334, R01NS074317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Charles S. Britton Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS074317. This work was also supported by Centers for Disease Control and Prevention Grant UR8/CCU515004 and the Charles S. Britton Fund.	Bartz JC, 2007, J VIROL, V81, P689, DOI 10.1128/JVI.01751-06; Bellon A, 2003, J GEN VIROL, V84, P1921, DOI 10.1099/vir.0.18996-0; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Bishop MT, 2010, P NATL ACAD SCI USA, V107, P12005, DOI 10.1073/pnas.1004688107; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Choi EM, 2009, LAB INVEST, V89, P624, DOI 10.1038/labinvest.2009.30; Choi YP, 2011, J GEN VIROL, V92, P727, DOI 10.1099/vir.0.026948-0; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Collins SJ, 2006, BRAIN, V129, P2278, DOI 10.1093/brain/awl159; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Geschwind MD, 2008, ANN NEUROL, V64, P97, DOI 10.1002/ana.21430; Ghaemmaghami S, 2013, AM J PATHOL, V182, P866, DOI 10.1016/j.ajpath.2012.11.038; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kim C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002835; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; Kobayashi A, 2011, AM J PATHOL, V178, P1309, DOI 10.1016/j.ajpath.2010.11.069; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Makarava N, 2013, J BIOL CHEM, V288, P33, DOI 10.1074/jbc.M112.419531; Manuelidis L, 2003, P NATL ACAD SCI USA, V100, P5360, DOI 10.1073/pnas.0931192100; McCutcheon S, 2005, J IMMUNOL METHODS, V298, P119, DOI 10.1016/j.jim.2005.01.012; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; Oelschlegel AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003158; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Piro JR, 2009, J VIROL, V83, P5321, DOI 10.1128/JVI.02502-08; Pocchiari M, 2004, BRAIN, V127, P2348, DOI 10.1093/brain/awh249; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Puoti G, 2012, LANCET NEUROL, V11, P618, DOI 10.1016/S1474-4422(12)70063-7; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar J. G., 2012, PRIONS DIS, P161; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Safar JG, 2006, P NATL ACAD SCI USA, V103, P11312, DOI 10.1073/pnas.0604021103; Safar JG, 2012, PRION, V6, P108, DOI 10.4161/pri.18666; Safer J, 1998, PROG BRAIN RES, V117, P421; Schoch G, 2006, PLOS MED, V3, P236, DOI 10.1371/journal.pmed.0030014; Scott Michael, 2004, VVolume 41, P435; Scott MR, 2005, J VIROL, V79, P5259, DOI 10.1128/JVI.79.9.5259-5271.2005; Shikiya RA, 2010, J VIROL, V84, P5706, DOI 10.1128/JVI.00243-10; Steensgaard J., 1992, PREPARATIVE CENTRIFU, P187; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; Uro-Coste E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000029; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; WHO, 1999, WHO LAB MAN EX HUM S, P1; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812	65	37	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29846	29861		10.1074/jbc.M113.500108	http://dx.doi.org/10.1074/jbc.M113.500108			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23974118	Green Published, hybrid			2022-12-28	WOS:000330615300058
J	Karunakaran, V; Wickner, W				Karunakaran, Vidya; Wickner, William			Fusion Proteins and Select Lipids Cooperate as Membrane Receptors for the Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (SNARE) Vam7p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fusion Protein; Lipids; Membrane Fusion; SNARE; Yeast; Vacuole	HOMOTYPIC VACUOLE FUSION; YEAST VACUOLE; T-SNARE; REGULATORY LIPIDS; ALPHA-SNAP; V-SNARES; IN-VITRO; DOCKING; COMPLEX; RAB	Vam7p, the vacuolar soluble Q(c)-SNARE, is essential for yeast vacuole fusion. The large tethering complex, homotypic fusion and vacuole protein sorting complex (HOPS), and phosphoinositides, which interact with the Vam7p PX domain, have each been proposed to serve as its membrane receptors. Studies with the isolated organelle cannot determine whether these receptor elements suffice and whether ligands or mutations act directly or indirectly on Vam7p binding to the membrane. Using pure components that are active in reconstituted vacuolar fusion, we now find that Vam7p binds to membranes through its combined affinities for several vacuolar membrane constituents: HOPS, phosphatidylinositol 3-phosphate, SNAREs, and acidic phospholipids. Acidic lipids allow low concentrations of Vam7p to suffice for fusion; without acidic lipids, the block to fusion is partially bypassed by high concentrations of Vam7p.	[Karunakaran, Vidya; Wickner, William] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Wickner, W (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, 7200 Vail Bldg, Hanover, NH 03755 USA.	william.wickner@dartmouth.edu			National Institutes of Health [R01 GM23377-37]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM23377-37.	Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; COMPTON SJ, 1985, ANAL BIOCHEM, V151, P369, DOI 10.1016/0003-2697(85)90190-3; Eitzen G, 2000, EMBO J, V19, P6713, DOI 10.1093/emboj/19.24.6713; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Grosshans BL, 2006, J CELL BIOL, V172, P55, DOI 10.1083/jcb.200510016; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Hickey CM, 2009, J BIOL CHEM, V284, P16118, DOI 10.1074/jbc.M109.000737; Jahn R, 2006, SCIENCE, V312, P540, DOI 10.1126/science.1127236; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; Jun Y, 2006, EMBO J, V25, P5260, DOI 10.1038/sj.emboj.7601413; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Scott BL, 2004, J CELL BIOL, V167, P75, DOI 10.1083/jcb.200405018; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; TSUKAMOTO Y, 1988, J BIOL CHEM, V263, P16225; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Wang L, 2000, J BIOL CHEM, V275, P22862, DOI 10.1074/jbc.M001447200; Zucchi PC, 2011, MOL BIOL CELL, V22, P4635, DOI 10.1091/mbc.E11-08-0680	42	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28557	28566		10.1074/jbc.M113.484410	http://dx.doi.org/10.1074/jbc.M113.484410			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23955338	Green Published, hybrid			2022-12-28	WOS:000330298800013
J	Lawson, KA; Teteak, CJ; Zou, JH; Hacquebord, J; Ghatan, A; Zielinska-Kwiatkowska, A; Fernandes, RJ; Chansky, HA; Yang, L				Lawson, Kevin A.; Teteak, Colin J.; Zou, Junhui; Hacquebord, Jacques; Ghatan, Andrew; Zielinska-Kwiatkowska, Anna; Fernandes, Russell J.; Chansky, Howard A.; Yang, Liu			Mesenchyme-specific Knockout of ESET Histone Methyltransferase Causes Ectopic Hypertrophy and Terminal Differentiation of Articular Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arthritis; Articular cartilage; Cartilage biology; Chondrocytes; Differentiation; Epigenetics; Gene Knockout; Histone methylation	CELL NUCLEAR ANTIGEN; ALKALINE-PHOSPHATASE; OSTEOARTHRITIC CARTILAGE; DNA FRAGMENTATION; GROWTH-PLATE; MOUSE LIMB; EXPRESSION; JOINT; APOPTOSIS; GENE	The exact molecular mechanisms governing articular chondrocytes remain unknown in skeletal biology. In this study, we have found that ESET (an ERG-associated protein with a SET domain, also called SETDB1) histone methyltransferase is expressed in articular cartilage. To test whether ESET regulates articular chondrocytes, we carried out mesenchyme-specific deletion of the ESET gene in mice. ESET knock-out did not affect generation of articular chondrocytes during embryonic development. Two weeks after birth, there was minimal qualitative difference at the knee joints between wild-type and ESET knock-out animals. At 1 month, ectopic hypertrophy, proliferation, and apoptosis of articular chondrocytes were seen in the articular cartilage of ESET-null animals. At 3 months, additional signs of terminal differentiation such as increased alkaline phosphatase activity and an elevated level of matrix metalloproteinase (MMP)-13 were found in ESET-null cartilage. Staining for type II collagen and proteoglycan revealed that cartilage degeneration became progressively worse from 2 weeks to 12 months at the knee joints of ESET knock-out mutants. Analysis of over 14 pairs of age- and sex-matched wild-type and knock-out mice indicated that the articular chondrocyte phenotype in ESET-null mutants is 100% penetrant. Our results demonstrate that expression of ESET plays an essential role in the maintenance of articular cartilage by preventing articular chondrocytes from terminal differentiation and may have implications in joint diseases such as osteoarthritis.	[Lawson, Kevin A.; Teteak, Colin J.; Zou, Junhui; Hacquebord, Jacques; Ghatan, Andrew; Zielinska-Kwiatkowska, Anna; Fernandes, Russell J.; Chansky, Howard A.; Yang, Liu] Univ Washington, Dept Orthoped & Sports Med, Seattle, WA 98108 USA; [Chansky, Howard A.; Yang, Liu] Vet Affairs Puget Sound Hlth Care Syst, Res & Dev Program, Seattle, WA 98108 USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Yang, L (corresponding author), Univ Washington, Dept Orthoped & Sports Med, 1660 S Columbian Way,GMR 151, Seattle, WA 98108 USA.	lyang@u.washington.edu		Lawson, Kevin/0000-0002-2931-5263; , jacques/0000-0003-1829-1195	National Institutes of Health [RO1 AR051455, RO1 AR057025]; Merit Review Award from the United States Department of Veterans Affairs, Office of Research and Development Biomedical Laboratory Research Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057025, R01AR051455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review Award from the United States Department of Veterans Affairs, Office of Research and Development Biomedical Laboratory Research Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health Grant RO1 AR051455 (to L. Y.). This work was also supported by a Merit Review Award from the United States Department of Veterans Affairs, Office of Research and Development Biomedical Laboratory Research Program (to H. A. C.).; Supported by National Institutes of Health Grant RO1 AR057025.	AYDELOTTE MB, 1988, CONNECT TISSUE RES, V18, P205, DOI 10.3109/03008208809016808; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Blackburn ML, 2003, BBA-GENE STRUCT EXPR, V1629, P8, DOI 10.1016/S0167-4781(03)00155-6; Chen CG, 2012, ARTHRITIS RHEUM-US, V64, P3278, DOI 10.1002/art.34566; Dy P, 2010, DEV BIOL, V341, P346, DOI 10.1016/j.ydbio.2010.02.024; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403; Hyde G, 2007, DEV BIOL, V304, P825, DOI 10.1016/j.ydbio.2007.01.026; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Iwamoto M, 2007, DEV BIOL, V305, P40, DOI 10.1016/j.ydbio.2007.01.037; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kouzarides T, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.005; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Miao DS, 2002, J HISTOCHEM CYTOCHEM, V50, P333, DOI 10.1177/002215540205000305; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Pfander D, 2001, AM J PATHOL, V159, P1777, DOI 10.1016/S0002-9440(10)63024-6; Pitsillides AA, 2011, NAT REV RHEUMATOL, V7, P654, DOI 10.1038/nrrheum.2011.129; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Quinn TM, 2005, OSTEOARTHR CARTILAGE, V13, P672, DOI 10.1016/j.joca.2005.04.011; Rodova M, 2011, J BONE MINER RES, V26, P1974, DOI 10.1002/jbmr.397; van der Kraan PM, 2012, OSTEOARTHR CARTILAGE, V20, P223, DOI 10.1016/j.joca.2011.12.003; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; Weng JJ, 2013, BBA-GEN SUBJECTS, V1830, P2839, DOI 10.1016/j.bbagen.2012.12.021; Xia Y, 2002, OSTEOARTHR CARTILAGE, V10, P370, DOI 10.1053/joca.2002.0523; Yang CL, 1997, EXP CELL RES, V235, P370, DOI 10.1006/excr.1997.3692; Yang L, 2013, DEV BIOL, V380, P99, DOI 10.1016/j.ydbio.2013.04.031	28	16	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32119	32125		10.1074/jbc.M113.473827	http://dx.doi.org/10.1074/jbc.M113.473827			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24056368	Green Published, hybrid			2022-12-28	WOS:000328681700002
J	Simon, BR; Parlee, SD; Learman, BS; Mori, H; Scheller, EL; Cawthorn, WP; Ning, XM; Gallagher, K; Tyrberg, B; Assadi-Porter, FM; Evans, CR; MacDougald, OA				Simon, Becky R.; Parlee, Sebastian D.; Learman, Brian S.; Mori, Hiroyuki; Scheller, Erica L.; Cawthorn, William P.; Ning, Xiaomin; Gallagher, Katherine; Tyrberg, Bjoern; Assadi-Porter, Fariba M.; Evans, Charles R.; MacDougald, Ormond A.			Artificial Sweeteners Stimulate Adipogenesis and Suppress Lipolysis Independently of Sweet Taste Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipogenesis; Akt; G Protein-coupled Receptors (GPCR); Lipolysis; Metabolism; Acesulfame K; Saccharin; T1R2; T1R3	BITTER TASTE; T1R3 TASTE; ADIPOCYTE DIFFERENTIATION; CYCLASE ACTIVITY; MAMMALIAN SWEET; ADIPOSE-TISSUE; SACCHARIN; EXPRESSION; GLUCOSE; SUBUNITS	G protein-coupled receptors mediate responses to a myriad of ligands, some of which regulate adipocyte differentiation and metabolism. The sweet taste receptors T1R2 and T1R3 are G protein-coupled receptors that function as carbohydrate sensors in taste buds, gut, and pancreas. Here we report that sweet taste receptors T1R2 and T1R3 are expressed throughout adipogenesis and in adipose tissues. Treatment of mouse and human precursor cells with artificial sweeteners, saccharin and acesulfame potassium, enhanced adipogenesis. Saccharin treatment of 3T3-L1 cells and primary mesenchymal stem cells rapidly stimulated phosphorylation of Akt and downstream targets with functions in adipogenesis such as cAMP-response element-binding protein and FOXO1; however, increased expression of peroxisome proliferator-activated receptor and CCAAT/enhancer-binding protein was not observed until relatively late in differentiation. Saccharin-stimulated Akt phosphorylation at Thr-308 occurred within 5 min, was phosphatidylinositol 3-kinase-dependent, and occurred in the presence of high concentrations of insulin and dexamethasone; phosphorylation of Ser-473 occurred more gradually. Surprisingly, neither saccharin-stimulated adipogenesis nor Thr-308 phosphorylation was dependent on expression of T1R2 and/or T1R3, although Ser-473 phosphorylation was impaired in T1R2/T1R3 double knock-out precursors. In mature adipocytes, artificial sweetener treatment suppressed lipolysis even in the presence of forskolin, and lipolytic responses were correlated with phosphorylation of hormone-sensitive lipase. Suppression of lipolysis by saccharin in adipocytes was also independent of T1R2 and T1R3. These results suggest that some artificial sweeteners have previously uncharacterized metabolic effects on adipocyte differentiation and metabolism and that effects of artificial sweeteners on adipose tissue biology may be largely independent of the classical sweet taste receptors, T1R2 and T1R3.	[Simon, Becky R.; MacDougald, Ormond A.] Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48105 USA; [Parlee, Sebastian D.; Learman, Brian S.; Mori, Hiroyuki; Scheller, Erica L.; Cawthorn, William P.; Ning, Xiaomin; Evans, Charles R.; MacDougald, Ormond A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48105 USA; [Gallagher, Katherine] Univ Michigan, Dept Surg, Ann Arbor, MI 48105 USA; [MacDougald, Ormond A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48105 USA; [Cawthorn, William P.] Lilly Res Labs, Musculoskeletal Res, Indianapolis, IN 46285 USA; [Tyrberg, Bjoern] MedImmune LLC, Cardiovasc & Metab Dis, Gaithersburg Headquarters, Gaithersburg, MD 20878 USA; [Assadi-Porter, Fariba M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Tyrberg, Bjoern] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Eli Lilly; AstraZeneca; Medimmune; University of Wisconsin System; University of Wisconsin Madison; Sanford Burnham Prebys Medical Discovery Institute	MacDougald, OA (corresponding author), Univ Michigan, 6313 Brehm Tower, Ann Arbor, MI 48105 USA.	macdouga@umich.edu	Cawthorn, William P./Y-2115-2019; Scheller, Erica L/H-6993-2019	Cawthorn, William P./0000-0001-7832-5057; Scheller, Erica L/0000-0002-1551-3816; MacDougald, Ormond/0000-0001-6907-7960; Evans, Charles/0000-0001-6698-5330; Tyrberg, Bjorn/0000-0003-0976-1220	National Institutes of Health [R01-DK062876, R01-DK095705, T32-GM007315]; Cellular and Molecular Biology Program training grant [T32-HD007505]; Training Program in Organogenesis grant; Fulbright scholar's award; American Diabetes Association; Royal Commission for the Exhibition of 1851 (United Kingdom); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503, P30DK020572, R01DK095705, R01DK062876, U24DK097153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Biology Program training grant; Training Program in Organogenesis grant; Fulbright scholar's award; American Diabetes Association(American Diabetes Association); Royal Commission for the Exhibition of 1851 (United Kingdom); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK062876 and R01-DK095705 (to O.A.M.) and T32-GM007315 (to B.R.S.), a Cellular and Molecular Biology Program training grant, and T32-HD007505, a Training Program in Organogenesis grant (to B.R.S. and S.D.P.). This work was also supported by a Fulbright scholar's award (to O.A.M.).; Supported by a mentor-based postdoctoral fellowship from the American Diabetes Association.; Supported by a Lilly Innovation Fellowship award with previous support from a postdoctoral research fellowship from the Royal Commission for the Exhibition of 1851 (United Kingdom).	Ahmed K, 2009, TRENDS PHARMACOL SCI, V30, P557, DOI 10.1016/j.tips.2009.09.001; Anderson GH, 2012, J NUTR, V142, p1163S, DOI 10.3945/jn.111.149617; Andrabi S, 2007, P NATL ACAD SCI USA, V104, P19011, DOI 10.1073/pnas.0706696104; BARTOSHUK LM, 1979, SCIENCE, V205, P934, DOI 10.1126/science.472717; Blackburn GL, 1997, AM J CLIN NUTR, V65, P409, DOI 10.1093/ajcn/65.2.409; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; COLBURN WA, 1981, CLIN PHARMACOL THER, V30, P558, DOI 10.1038/clpt.1981.203; COLBURN WA, 1981, J CLIN PHARMACOL, V21, P147, DOI 10.1002/j.1552-4604.1981.tb05692.x; Cypess AM, 2011, ENDOCRINOLOGY, V152, P3680, DOI 10.1210/en.2011-1229; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Dergance JM, 2005, J AM GERIATR SOC, V53, P1240, DOI 10.1111/j.1532-5415.2005.53363.x; Dib K, 1996, INT J OBESITY, V20, P15; Dib K, 1997, CELL SIGNAL, V9, P431, DOI 10.1016/S0898-6568(97)00033-8; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; Elliott RA, 2011, J UROLOGY, V186, P2455, DOI 10.1016/j.juro.2011.07.083; Geraedts MCP, 2012, AM J PHYSIOL-ENDOC M, V303, pE464, DOI 10.1152/ajpendo.00163.2012; Gotoh C, 2007, BIOCHEM BIOPH RES CO, V354, P591, DOI 10.1016/j.bbrc.2007.01.028; Hemati N, 1997, J BIOL CHEM, V272, P25913, DOI 10.1074/jbc.272.41.25913; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Kim SP, 2010, BIOCHEM BIOPH RES CO, V399, P55, DOI 10.1016/j.bbrc.2010.07.038; Klemm DJ, 2001, J BIOL CHEM, V276, P28430, DOI 10.1074/jbc.M103382200; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Kyriazis GA, 2012, P NATL ACAD SCI USA, V109, pE524, DOI 10.1073/pnas.1115183109; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Lund TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058945; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Magun R, 1996, ENDOCRINOLOGY, V137, P3590, DOI 10.1210/en.137.8.3590; Maitrepierre E, 2012, PROTEIN EXPRES PURIF, V83, P75, DOI 10.1016/j.pep.2012.03.006; MARKUS HB, 1969, BIOCHIM BIOPHYS ACTA, V187, P486, DOI 10.1016/0005-2760(69)90045-9; Masubuchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054500; Masuda K., 2012, PLOS ONE, V7; Menghini R, 2005, CIRCULATION, V111, P1946, DOI 10.1161/01.CIR.0000161814.02942.B2; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Nie YL, 2006, CHEM SENSES, V31, P505, DOI 10.1093/chemse/bjj053; PANTAROTTO C, 1981, TOXICOL LETT, V9, P367, DOI 10.1016/0378-4274(81)90012-6; PORIKOS KP, 1988, APPETITE, V11, P12, DOI 10.1016/0195-6663(88)90037-2; Ren N, 2009, J LIPID RES, V50, P908, DOI 10.1194/jlr.M800625-JLR200; Ren XY, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.012.2009; RENWICK AG, 1986, XENOBIOTICA, V16, P1057, DOI 10.3109/00498258609038983; Rim JS, 2005, FASEB J, V19, P1205, DOI 10.1096/fj.04-3204fje; RODIN J, 1990, AM J CLIN NUTR, V51, P428, DOI 10.1093/ajcn/51.3.428; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Slack JP, 2010, CURR BIOL, V20, P1104, DOI 10.1016/j.cub.2010.04.043; STRIEM BJ, 1990, LIFE SCI, V46, P803, DOI 10.1016/0024-3205(90)90068-3; SWEATMAN TW, 1979, SCIENCE, V205, P1019, DOI 10.1126/science.472722; SWEATMAN TW, 1981, XENOBIOTICA, V11, P531, DOI 10.3109/00498258109045864; Swithers SE, 2008, BEHAV NEUROSCI, V122, P161, DOI 10.1037/0735-7044.122.1.161; Swithers SE, 2010, PHYSIOL BEHAV, V100, P55, DOI 10.1016/j.physbeh.2009.12.021; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Treesukosol Y, 2009, AM J PHYSIOL-REG I, V296, pR855, DOI 10.1152/ajpregu.90869.2008; Venkitakrishnan Rani Parvathy, 2012, Methods Mol Biol, V914, P47, DOI 10.1007/978-1-62703-023-6_4; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zukerman S, 2009, AM J PHYSIOL-REG I, V296, pR866, DOI 10.1152/ajpregu.90870.2008	68	70	75	5	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32475	32489		10.1074/jbc.M113.514034	http://dx.doi.org/10.1074/jbc.M113.514034			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24068707	Green Published, hybrid			2022-12-28	WOS:000328681700032
J	Samanta, S; Martin, CT				Samanta, Satamita; Martin, Craig T.			Insights into the Mechanism of Initial Transcription in Escherichia coli RNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAC UV5 PROMOTER; ABORTIVE INITIATION; STRUCTURAL BASIS; IN-VITRO; DNA HYBRID; OPEN COMPLEX; ANGSTROM RESOLUTION; T7-RNA POLYMERASE; SIGMA(70) SUBUNIT; CLEAVAGE FACTORS	It has long been known that during initial transcription of the first 8-10 bases of RNA, complexes are relatively unstable, leading to the release of short abortive RNA transcripts. An early "stressed intermediate" model led to a more specific mechanistic model proposing "scrunching" stress as the basis for the instability. Recent studies in the single subunit T7 RNA polymerase have argued against scrunching as the energetic driving force and instead argue for a model in which pushing of the RNA-DNA hybrid against a protein element associated with promoter binding, while likely driving promoter release, reciprocally leads to instability of the hybrid. In this study, we test these models in the structurally unrelated multisubunit bacterial RNA polymerase. Via the targeted introduction of mismatches and nicks in the DNA, we demonstrate that neither downstream bubble collapse nor compaction/scrunching of either the single-stranded template or nontemplate strands is a major force driving abortive instability (although collapse from the downstream end of the bubble does contribute significantly to the instability of artificially halted complexes). In contrast, pushing of the hybrid against a mobile protein element (sigma(3.2) in the bacterial enzyme) results in substantially increased abortive instability and is likely the primary energetic contributor to abortive cycling. The results suggest that abortive instability is a by-product of the mechanistic need to couple the energy of nucleotide addition (RNA chain growth) to driving the timed release of promoter contacts during initial transcription.	[Samanta, Satamita; Martin, Craig T.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Martin, CT (corresponding author), Univ Massachusetts, Dept Chem, 710 N Pleasant St,LGRT 104, Amherst, MA 01003 USA.	cmartin@chem.umass.edu	Martin, Craig T/L-3596-2013	Martin, Craig T/0000-0003-1029-5239	National Institutes of Health [1RO1 GM55002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1 GM55002.	BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Cashel M, 2003, J BIOL CHEM, V278, P5539, DOI 10.1074/jbc.M211430200; Chander M, 2007, BIOCHEMISTRY-US, V46, P12687, DOI 10.1021/bi701236f; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1998, COLD SPRING HARB SYM, V63, P263, DOI 10.1101/sqb.1998.63.263; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; DEUSCHLE U, 1986, EMBO J, V5, P2987, DOI 10.1002/j.1460-2075.1986.tb04596.x; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Gong P, 2006, J BIOL CHEM, V281, P23533, DOI 10.1074/jbc.M604023200; GRALLA JD, 1980, BIOCHEMISTRY-US, V19, P5864, DOI 10.1021/bi00566a031; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Hernandez VJ, 1996, J BIOL CHEM, V271, P18775, DOI 10.1074/jbc.271.31.18775; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Hsu LM, 2006, BIOCHEMISTRY-US, V45, P8841, DOI 10.1021/bi060247u; Hsu LM, 2009, METHODS, V47, P25, DOI 10.1016/j.ymeth.2008.10.010; Hsu LLM, 2003, BIOCHEMISTRY-US, V42, P3777, DOI 10.1021/bi026954e; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; JIN DJ, 1994, J MOL BIOL, V236, P72, DOI 10.1006/jmbi.1994.1119; KAMMERER W, 1986, EMBO J, V5, P2995, DOI 10.1002/j.1460-2075.1986.tb04597.x; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kireeva ML, 2000, J MOL BIOL, V299, P325, DOI 10.1006/jmbi.2000.3755; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Li XY, 1998, J BIOL CHEM, V273, P23558, DOI 10.1074/jbc.273.36.23558; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Marr MT, 2001, P NATL ACAD SCI USA, V98, P8972, DOI 10.1073/pnas.161253298; Martin CT, 2005, PROG NUCLEIC ACID RE, V80, P323, DOI 10.1016/S0079-6603(05)80008-X; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; MASLAK M, 1993, BIOCHEMISTRY-US, V32, P4281, DOI 10.1021/bi00067a017; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Mekler V, 2011, J BIOL CHEM, V286, P22600, DOI 10.1074/jbc.M111.247080; Mekler V, 2011, J BIOL CHEM, V286, P270, DOI 10.1074/jbc.M110.174102; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MINKLEY EG, 1973, J MOL BIOL, V77, P255, DOI 10.1016/0022-2836(73)90335-5; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Ramirez-Tapia LE, 2012, J BIOL CHEM, V287, P37352, DOI 10.1074/jbc.M112.370643; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Santangelo TJ, 2007, J MOL BIOL, V367, P344, DOI 10.1016/j.jmb.2006.12.069; Sen R, 1998, J BIOL CHEM, V273, P9872, DOI 10.1074/jbc.273.16.9872; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; Toulokhonov I, 2006, J MOL BIOL, V361, P644, DOI 10.1016/j.jmb.2006.06.071; Ujvari A, 1996, BIOCHEMISTRY-US, V35, P14574, DOI 10.1021/bi961165g; Vahia AV, 2011, BIOCHEMISTRY-US, V50, P7015, DOI 10.1021/bi200620q; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	56	25	26	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31993	32003		10.1074/jbc.M113.497669	http://dx.doi.org/10.1074/jbc.M113.497669			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047893	Green Published, hybrid			2022-12-28	WOS:000330596200052
J	Tsutsui, Y; Ramakrishnan, B; Qasba, PK				Tsutsui, Yuko; Ramakrishnan, Boopathy; Qasba, Pradman K.			Crystal Structures of beta-1,4-Galactosyltransferase 7 Enzyme Reveal Conformational Changes and Substrate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; HEPARAN-SULFATE; COMPLEX; PROTEOGLYCANS; RECOGNITION; SNAPSHOTS; DONOR	The beta-1,4-galactosyltransferase 7 (beta 4GalT7) enzyme is involved in proteoglycan synthesis. In the presence of a manganese ion, it transfers galactose from UDP-galactose to xylose on a proteoglycan acceptor substrate. We present here the crystal structures of human beta 4GalT7 in open and closed conformations. A comparison of these crystal structures shows that, upon manganese and UDP or UDP-Gal binding, the enzyme undergoes conformational changes involving a small and a long loop. We also present the crystal structures of Drosophila wild-type beta 4GalT7 and D211N beta 4GalT7 mutant enzymes in the closed conformation in the presence of the acceptor substrate xylobiose and the donor substrate UDP-Gal, respectively. To understand the catalytic mechanism, we have crystallized the ternary complex of D211N beta 4GalT7 mutant enzyme in the presence of manganese with the donor and the acceptor substrates together in the same crystal structure. The galactose moiety of the bound UDP-Gal molecule forms seven hydrogen bonds with the protein molecule. The nonreducing end of the xylose moiety of xylobiose binds to the hydrophobic acceptor sugar binding pocket created by the conformational changes, whereas its extended xylose moiety forms hydrophobic interactions with a Tyr residue. In the ternary complex crystal structure, the nucleophile O4 oxygen atom of the xylose molecule is found in close proximity to the C1 and O5 atoms of the galactose moiety. This is the first time that a Michaelis complex of a glycosyltransferase has been described, and it clearly suggests an S(N)2 type catalytic mechanism for the beta 4GalT7 enzyme.	NCI, Struct Glycobiol Sect, NIH, Frederick, MD 21702 USA; NCI, Basic Res Program, SAIC Frederick Inc, Nanobiol Program,Ctr Canc Res,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Qasba, PK (corresponding author), Frederick Natl Lab Canc Res, Struct Glycobiol Sect, Bldg 469,Rm 221,POB B, Frederick, MD 21702 USA.	qasba@helix.nih.gov			National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the National Institutes of Health, NCI, National Institutes of Health	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the National Institutes of Health, NCI, National Institutes of Health	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E (to P. K. Q.). This research was supported (in part) by the Intramural Research Program of the National Institutes of Health, NCI, National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Chiodoni C, 2010, CANCER METAST REV, V29, P295, DOI 10.1007/s10555-010-9221-8; Daligault F, 2009, BIOCHEM J, V418, P605, DOI 10.1042/BJ20081093; DeLano WL, 2010, PYMOL MOL GRAPH SYST; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; Garcia-Garcia JF, 2011, MOL BIOSYST, V7, P1312, DOI 10.1039/c0mb00206b; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Gunasekaran K, 2003, BIOCHEMISTRY-US, V42, P3674, DOI 10.1021/bi034046r; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krupicka M, 2009, J PHYS CHEM B, V113, P11314, DOI 10.1021/jp904716t; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; LUGEMWA FN, 1991, J BIOL CHEM, V266, P6674; Okajima T, 1999, J BIOL CHEM, V274, P28841, DOI 10.1074/jbc.274.41.28841; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasek M, 2010, BIOCHEM BIOPH RES CO, V394, P679, DOI 10.1016/j.bbrc.2010.03.051; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rahuel-Clermont S, 2010, BIOCHEM J, V432, P303, DOI 10.1042/BJ20100921; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Ramakrishnan B, 2004, BIOCHEMISTRY-US, V43, P12513, DOI 10.1021/bi049007+; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Ramakrishnan B, 2010, CURR OPIN STRUC BIOL, V20, P536, DOI 10.1016/j.sbi.2010.07.004; Ramakrishnan B, 2010, J BIOL CHEM, V285, P15619, DOI 10.1074/jbc.M109.099564; Raman K, 2011, BIOCHEM BIOPH RES CO, V404, P86, DOI 10.1016/j.bbrc.2010.11.069; Ramasamy V, 2003, J MOL BIOL, V331, P1065, DOI 10.1016/S0022-2836(03)00790-3; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Talhaoui I, 2010, J BIOL CHEM, V285, P37342, DOI 10.1074/jbc.M110.151951; Tremblay LV, 2010, BIOCHEMISTRY-US, V49, P9685, DOI 10.1021/bi1015088; Varki A., 1999, ESSENTIALS GLYCOBIOL	37	31	32	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31963	31970		10.1074/jbc.M113.509984	http://dx.doi.org/10.1074/jbc.M113.509984			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052259	Green Published, hybrid			2022-12-28	WOS:000330596200049
J	Wolny, M; Colegrave, M; Colman, L; White, E; Knight, PJ; Peckham, M				Wolny, Marcin; Colegrave, Melanie; Colman, Lucy; White, Ed; Knight, Peter J.; Peckham, Michelle			Cardiomyopathy Mutations in the Tail of beta-Cardiac Myosin Modify the Coiled-coil Structure and Affect Integration into Thick Filaments in Muscle Sarcomeres in Adult Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN GENE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; REGULATORY PHOSPHORYLATION SITE; CONTRACTILE KINETICS; MOLECULAR-BASIS; BINDING-SITE; AMINO-ACID; SKELETAL; DOMAIN; PROTEIN	It is unclear why mutations in the filament-forming tail of myosin heavy chain (MHC) cause hypertrophic or dilated cardiomyopathy as these mutations should not directly affect contraction. To investigate this, we first investigated the impact of five hypertrophic cardiomyopathy-causing (N1327K, E1356K, R1382W, E1555K, and R1768K) and one dilated cardiomyopathy-causing (R1500W) tail mutations on their ability to incorporate into muscle sarcomeres in vivo. We used adenoviral delivery to express full-length wild type or mutant enhanced GFP-MHC in isolated adult cardiomyocytes. Three mutations (N1327K, E1356K, and E1555K) reduced enhanced GFP-MHC incorporation into muscle sarcomeres, whereas the remainder had no effect. No mutations significantly affected contraction. Fluorescence recovery after photobleaching showed that fluorescence recovery for the mutation that incorporated least well (N1327K) was significantly faster than that of WT with half-times of 25.1 +/- 1.8 and 32.2 +/- 2.5 min (mean +/- S.E.), respectively. Next, we determined the effects of each mutation on the helical properties of wild type and seven mutant peptides (7, 11, or 15 heptads long) from the myosin tail by circular dichroism. R1382W and E1768K slightly increased the alpha-helical nature of peptides. The remaining mutations reduced alpha-helical content, with N1327K showing the greatest reduction. Only peptides containing residues 1301-1329 were highly alpha-helical suggesting that this region helps in initiation of coiled coil. These results suggest that small effects of mutations on helicity translate into a reduced ability to incorporate into sarcomeres, which may elicit compensatory hypertrophy.	[Wolny, Marcin; Colegrave, Melanie; Colman, Lucy; Knight, Peter J.; Peckham, Michelle] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [White, Ed] Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [White, Ed] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds	Peckham, M (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Miall Bldg, Leeds LS2 9JT, W Yorkshire, England.	m.peckham@leeds.ac.uk	Colegrave, Melanie/AAB-1590-2020; Peckham, Michelle/J-4991-2015	Peckham, Michelle/0000-0002-3754-2028	British Heart Foundation [PG/07/061/23277]; Biotechnology and Biological Sciences Research Council [BB/I007423/1]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/I007423/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by British Heart Foundation Grant PG/07/061/23277 and Biotechnology and Biological Sciences Research Council Grant BB/I007423/1 (to M. P., P. J. K., and M. W.).; Recipient of a Biotechnology and Biological Sciences Research Council-funded studentship. Present address: Karus Therapeutics Ltd., Abingdon, Oxfordshire OX14 4RZ, United Kingdom.	Armel TZ, 2010, J MOL CELL CARDIOL, V48, P1007, DOI 10.1016/j.yjmcc.2009.10.011; Armel TZ, 2010, BIOCHEM BIOPH RES CO, V391, P352, DOI 10.1016/j.bbrc.2009.11.062; ATKINSON SJ, 1992, J MOL BIOL, V226, P7, DOI 10.1016/0022-2836(92)90118-4; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Becker KD, 1997, J CELL BIOL, V137, P131, DOI 10.1083/jcb.137.1.131; Blair E, 2002, CIRC RES, V90, P263, DOI 10.1161/hh0302.104532; Buvoli M, 2012, J MOL BIOL, V415, P807, DOI 10.1016/j.jmb.2011.11.042; Cohen C, 1998, J STRUCT BIOL, V122, P180, DOI 10.1006/jsbi.1998.3983; CRAIG R, 1976, J MOL BIOL, V102, P325, DOI 10.1016/S0022-2836(76)80057-5; Flashman E, 2007, BIOCHEM J, V401, P97, DOI 10.1042/BJ20060500; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Herron TJ, 2007, CIRC RES, V100, P1182, DOI 10.1161/01.RES.0000264102.00706.4e; Ho CY, 2012, CIRCULATION, V125, P1432, DOI 10.1161/CIRCULATIONAHA.110.017277; Hougs L, 2005, EUR J HUM GENET, V13, P161, DOI 10.1038/sj.ejhg.5201310; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Karkkainen S, 2004, EUR J HEART FAIL, V6, P861, DOI 10.1016/j.ejheart.2004.04.017; Leach RN, 2005, CELL CALCIUM, V38, P515, DOI 10.1016/j.ceca.2005.07.006; Lee DL, 2001, J MOL BIOL, V306, P539, DOI 10.1006/jmbi.2000.4351; Locher MR, 2011, AM J PHYSIOL-HEART C, V300, pH869, DOI 10.1152/ajpheart.00452.2010; Maggs AM, 2000, J MUSCLE RES CELL M, V21, P101, DOI 10.1023/A:1005639229497; Maron Barry J, 2010, Am J Cardiol, V105, P1164, DOI 10.1016/j.amjcard.2009.12.021; Maron BJ, 2009, CIRC-CARDIOVASC GENE, V2, P81, DOI 10.1161/CIRCGENETICS.108.788703; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2004, CIRCULATION, V109, P2807, DOI 10.1161/01.CIR.0000128363.85581.E1; McCrossan ZA, 2004, CARDIOVASC RES, V63, P283, DOI 10.1016/j.cardiores.2004.04.013; MCLACHLAN AD, 1982, NATURE, V299, P226, DOI 10.1038/299226a0; McNally EM, 2002, CIRC RES, V90, P246, DOI 10.1161/res.90.3.246; Meredith C, 2004, AM J HUM GENET, V75, P703, DOI 10.1086/424760; Miller G, 2003, J PHYSIOL-LONDON, V548, P167, DOI 10.1113/jphysiol.2002.031922; Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211; Obermann WMJ, 1998, MOL BIOL CELL, V9, P829, DOI 10.1091/mbc.9.4.829; OFFER G, 1990, J MOL BIOL, V216, P213, DOI 10.1016/S0022-2836(05)80309-2; OFFER G, 1995, J MOL BIOL, V249, P967, DOI 10.1006/jmbi.1995.0352; Papageorgopoulos C, 2002, ANAL BIOCHEM, V309, P1, DOI 10.1016/S0003-2697(02)00253-1; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; Perrot A, 2005, J MOL MED-JMM, V83, P468, DOI 10.1007/s00109-005-0635-7; Picard B, 2011, ELECTROPHORESIS, V32, P1804, DOI 10.1002/elps.201100118; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Sanger JW, 2009, CELL MOTIL CYTOSKEL, V66, P556, DOI 10.1002/cm.20365; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Taylor MRG, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-27; Van der Ven PFM, 1999, J MUSCLE RES CELL M, V20, P569, DOI 10.1023/A:1005569225773; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P602, DOI 10.1016/j.jacc.2004.04.039; Vandenboom R, 2011, AM J PHYSIOL-HEART C, V300, pH574, DOI 10.1152/ajpheart.00786.2009; Waldmuller S, 2002, HUM MUTAT, V19, P560, DOI 10.1002/humu.10074; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; WENDEROTH MP, 1987, J CELL BIOL, V105, P2771, DOI 10.1083/jcb.105.6.2771; Willis MS, 2013, NEW ENGL J MED, V368, P455, DOI 10.1056/NEJMra1106180; Xu Q, 2010, J MOL CELL CARDIOL, V48, P899, DOI 10.1016/j.yjmcc.2010.03.005	53	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31952	31962		10.1074/jbc.M113.513291	http://dx.doi.org/10.1074/jbc.M113.513291			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24047955	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000330596200047
J	Lofgren, M; Koutmos, M; Banerjee, R				Lofgren, Michael; Koutmos, Markos; Banerjee, Ruma			Autoinhibition and Signaling by the Switch II Motif in the G-protein Chaperone of a Radical B-12 Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLMALONYL-COA MUTASE; GTP HYDROLYSIS; ATP-COB(I)ALAMIN ADENOSYLTRANSFERASE; COMPLEMENTATION GROUP; STRUCTURAL BASIS; BINDING PROTEIN; COMPLEX; GENE; IDENTIFICATION; TRANSDUCTION	MeaB is an accessory GTPase protein involved in the assembly, protection, and reactivation of 5'-deoxyadenosyl cobalamin-dependent methylmalonyl-CoA mutase (MCM). Mutations in the human ortholog of MeaB result in methylmalonic aciduria, an inborn error of metabolism. G-proteins typically utilize conserved switch I and II motifs for signaling to effector proteins via conformational changes elicited by nucleotide binding and hydrolysis. Our recent discovery that MeaB utilizes an unusual switch III region for bidirectional signaling with MCM raised questions about the roles of the switch I and II motifs in MeaB. In this study, we addressed the functions of conserved switch II residues by performing alanine-scanning mutagenesis. Our results demonstrate that the GTPase activity of MeaB is autoinhibited by switch II and that this loop is important for coupling nucleotide-sensitive conformational changes in switch III to elicit the multiple chaperone functions of MeaB. Furthermore, we report the structure of MeaB center dot GDP crystallized in the presence of AlFx- to form the putative transition state analog, GDP center dot AlF4-. The resulting crystal structure and its comparison with related G-proteins support the conclusion that the catalytic site of MeaB is incomplete in the absence of the GTPase-activating protein MCM and therefore unable to stabilize the transition state analog. Favoring an inactive conformation in the absence of the client MCM protein might represent a strategy for suppressing the intrinsic GTPase activity of MeaB in which the switch II loop plays an important role.	[Lofgren, Michael; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Koutmos, Markos] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA	University of Michigan System; University of Michigan; Uniformed Services University of the Health Sciences - USA	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 4320C MSRB III,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu		Koutmos, Markos/0000-0003-0933-6312	National Institutes of Health [DK45776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45776.	Anand B, 2013, BIOCHEMISTRY-US, V52, P1122, DOI 10.1021/bi3014054; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; Bohm A, 1997, CURR OPIN BIOTECH, V8, P480, DOI 10.1016/S0958-1669(97)80072-9; Chan KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030547; Chen YB, 2001, J BIOL CHEM, V276, P45751, DOI 10.1074/jbc.M107191200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Day PW, 2004, J BIOL CHEM, V279, P53643, DOI 10.1074/jbc.M401438200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dempsey-Nunez L, 2012, MOL GENET METAB, V107, P363, DOI 10.1016/j.ymgme.2012.09.012; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Lanzilotta WN, 1997, J BIOL CHEM, V272, P4157, DOI 10.1074/jbc.272.7.4157; Leal NA, 2004, J BIOL CHEM, V279, P47536, DOI 10.1074/jbc.M405449200; Leal NA, 2003, J BIOL CHEM, V278, P9227, DOI 10.1074/jbc.M212739200; LEDLEY FD, 1988, P NATL ACAD SCI USA, V85, P3518, DOI 10.1073/pnas.85.10.3518; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Li QB, 1997, J BIOL CHEM, V272, P21673, DOI 10.1074/jbc.272.35.21673; Lofgren M, 2013, NAT CHEM BIOL, V9, P535, DOI [10.1038/NCHEMBIO.1298, 10.1038/nchembio.1298]; Lofgren M, 2011, BIOCHEMISTRY-US, V50, P5790, DOI 10.1021/bi2006306; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natochin M, 2002, BIOCHEMISTRY-US, V41, P258, DOI 10.1021/bi015708k; Padovani D, 2006, BIOCHEMISTRY-US, V45, P2951, DOI 10.1021/bi051742d; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; REY L, 1994, J BACTERIOL, V176, P6066, DOI 10.1128/jb.176.19.6066-6073.1994; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STOUTEN PFW, 1993, FEBS LETT, V320, P1, DOI 10.1016/0014-5793(93)81644-F; Takahashi-Iniguez T, 2011, BIOCHEM BIOPH RES CO, V404, P443, DOI 10.1016/j.bbrc.2010.11.141; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Warner DR, 1997, MOL ENDOCRINOL, V11, P1718, DOI 10.1210/me.11.11.1718; Wittinghofer A, 1998, BIOL CHEM, V379, P933; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Wittinghofer F, 1998, NATURE, V394, P317, DOI 10.1038/28492; Zambelli B, 2005, J BIOL CHEM, V280, P4684, DOI 10.1074/jbc.M408483200	52	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30980	30989		10.1074/jbc.M113.499970	http://dx.doi.org/10.1074/jbc.M113.499970			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	23996001	Green Published, hybrid			2022-12-28	WOS:000330778900017
J	Muromoto, R; Nakajima, M; Hirashima, K; Hirao, T; Kon, S; Shimoda, K; Oritani, K; Matsuda, T				Muromoto, Ryuta; Nakajima, Maiko; Hirashima, Koki; Hirao, Toru; Kon, Shigeyuki; Shimoda, Kazuya; Oritani, Kenji; Matsuda, Tadashi			Jun Activation Domain-binding Protein 1 (JAB1) Is Required for the Optimal Response to Interferons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULLIN UBIQUITIN LIGASES; COP9 SIGNALOSOME CSN; KAPPA-B-ALPHA; NEDD8-ACTIVATING ENZYME; FUNCTIONAL INTERACTIONS; NEDD8 MODIFICATION; DOWN-REGULATION; RECEPTOR; MOTIF; CELLS	Degradation of IFN receptor (IFNR) protein is one of the mechanisms to limit the extent of cellular responses to interferons. Tyrosine kinase 2 (TYK2), a JAK family kinase, has been reported to bind to and stabilize IFNR, indicating that TYK2 is a fundamental component of IFNR complex. Herein, we identified Jun activation domain-binding protein 1 (JAB1) as a new TYK2 binding partner and investigated its role in the regulation of IFN responses. siRNA knockdown of JAB1 resulted in suppression of IFN-induced phosphorylation of STAT proteins and their transcriptional activation. Importantly, JAB1 knockdown induced the activation of SCF ubiquitin ligase complex containing Cullin 1 (CUL1), as judged by the enhancement of covalent modification of CUL1 with the ubiquitin-like protein NEDD8, and markedly reduced the basal protein level of IFNR. In contrast, NEDD8 knockdown or inhibition of NEDD8 modification by NEDD8-activating enzyme inhibitor resulted in increased IFNR protein concomitantly with a reduction of NEDD8-modified CUL1. Furthermore, NEDD8-activating enzyme inhibitor treatment enhanced the susceptibility to IFN-alpha in HeLa cells. These data suggest that the NEDD8 modification pathway is involved in the proteolysis of IFNR and that JAB1 acts as a positive regulator of IFN responses by stabilizing IFNR through antagonizing the NEDD8 pathway.	[Muromoto, Ryuta; Nakajima, Maiko; Hirashima, Koki; Hirao, Toru; Kon, Shigeyuki; Matsuda, Tadashi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Shimoda, Kazuya] Miyazaki Univ, Fac Med, Dept Gastroenterol & Hematol, Miyazaki 8891692, Japan; [Oritani, Kenji] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan	Hokkaido University; University of Miyazaki; Osaka University	Matsuda, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tmatsuda@pharm.hokudai.ac.jp	Matsuda, Tadashi/A-3835-2012; Muromoto, Ryuta/E-4203-2012	Matsuda, Tadashi/0000-0002-3089-3757; Muromoto, Ryuta/0000-0002-7474-493X	Japan Society for the Promotion of Science; Northern Advancement Center for Science and Technology by the Takeda Science Foundation; Uehara Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Northern Advancement Center for Science and Technology by the Takeda Science Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported in part by Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science, by the Northern Advancement Center for Science and Technology by the Takeda Science Foundation and by the Uehara Memorial Foundation.	Ahmed CM, 2013, J NEUROIMMUNOL, V254, P101, DOI 10.1016/j.jneuroim.2012.10.006; Bhattacharya S, 2010, J BIOL CHEM, V285, P2318, DOI 10.1074/jbc.M109.071498; Blank JL, 2013, CANCER RES, V73, P225, DOI 10.1158/0008-5472.CAN-12-1729; Bush KT, 1997, J BIOL CHEM, V272, P9086; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; CONSTANTINESCU SN, 1994, P NATL ACAD SCI USA, V91, P9602, DOI 10.1073/pnas.91.20.9602; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Haro T, 2004, J IMMUNOL, V173, P1151, DOI 10.4049/jimmunol.173.2.1151; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kumar KGS, 2008, J BIOL CHEM, V283, P18566, DOI 10.1074/jbc.M800991200; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2003, EMBO J, V22, P5480; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122; Minakshi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008342; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Muromoto R, 2006, FEBS LETT, V580, P93, DOI 10.1016/j.febslet.2005.11.057; Muromoto R, 2004, J IMMUNOL, V172, P2985, DOI 10.4049/jimmunol.172.5.2985; Muromoto R, 2006, J IMMUNOL, V177, P1160, DOI 10.4049/jimmunol.177.2.1160; Pearce C, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-31; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ragimbeau J, 2001, J BIOL CHEM, V276, P30812, DOI 10.1074/jbc.M103559200; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schwechheimer C, 2004, BBA-MOL CELL RES, V1695, P45, DOI 10.1016/j.bbamcr.2004.09.023; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Soucy TA, 2009, CLIN CANCER RES, V15, P3912, DOI 10.1158/1078-0432.CCR-09-0343; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Welteke V, 2009, EMBO REP, V10, P642, DOI 10.1038/embor.2009.64; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Yamakami M, 2003, J BIOL CHEM, V278, P52865, DOI 10.1074/jbc.M306740200	54	6	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30969	30979		10.1074/jbc.M113.485847	http://dx.doi.org/10.1074/jbc.M113.485847			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24043623	Green Published, hybrid			2022-12-28	WOS:000330778900016
J	Smadja-Lamere, N; Shum, M; Deleris, P; Roux, PP; Abe, J; Marette, A				Smadja-Lamere, Nicolas; Shum, Michael; Deleris, Paul; Roux, Philippe P.; Abe, Jun-ichi; Marette, Andre			Insulin Activates RSK (p90 Ribosomal S6 Kinase) to Trigger a New Negative Feedback Loop That Regulates Insulin Signaling for Glucose Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; RECEPTOR SUBSTRATE-1; SERINE PHOSPHORYLATION; TUBEROUS SCLEROSIS; PROTEIN-KINASES; MICE LACKING; AMINO-ACID; IN-VITRO; RESISTANCE; EXPRESSION	We previously demonstrated that the mTORC1/S6K1 pathway is activated by insulin and nutrient overload (e.g. amino acids (AA)), which leads to the inhibition of the PI3K/Akt pathway via the inhibitory serine phosphorylation of IRS-1, notably on serine 1101 (Ser-1101). However, even in the absence of AA, insulin can still promote IRS-1 Ser-1101 phosphorylation by other kinases that remain to be fully characterized. Here, we describe a new negative regulator of IRS-1, the p90 ribosomal S6 kinase (RSK). Computational analyses revealed that Ser-1101 within IRS-1 falls into the consensus motif of RSK. Moreover, recombinant RSK phosphorylated IRS-1 C-terminal fragment on Ser-1101, which was prevented by mutations of this site or when a kinase-inactive mutant of RSK was used. Using antibodies directed toward the phosphorylation sites located in the activation segment of RSK (Ser-221 or Ser-380), we found that insulin activates RSK in L6 myocytes in the absence of AA overload. Inhibition of RSK using either the pharmacological inhibitor BI-D1870 or after adenoviral expression of a dominant negative RSK1 mutant (RSK1-DN) showed that RSK selectively phosphorylates IRS-1 on Ser-1101. Accordingly, expression of the RSK1-DN mutant in L6 myocytes and FAO hepatic cells improved insulin action on glucose uptake and glucose production, respectively. Furthermore, RSK1 inhibition prevented insulin resistance in L6 myocytes chronically exposed to high glucose and high insulin. These results show that RSK is a novel regulator of insulin signaling and glucose metabolism and a potential mediator of insulin resistance, notably through the negative phosphorylation of IRS-1 on Ser-1101.	[Smadja-Lamere, Nicolas; Shum, Michael; Marette, Andre] Univ Laval, Quebec Heart & Lung Inst, Ste Foy, PQ G1V 4G5, Canada; [Deleris, Paul; Roux, Philippe P.] Univ Montreal, IRIC, Fac Med, Montreal, PQ H3C 3J7, Canada; [Roux, Philippe P.] Univ Montreal, Dept Pathol & Cell Biol, Fac Med, Montreal, PQ H3C 3J7, Canada; [Abe, Jun-ichi] Univ Rochester, Med Ctr, ACVRI, Rochester, NY 14642 USA	Laval University; Quebec Heart & Lung Institute; Universite de Montreal; Universite de Montreal; University of Rochester	Marette, A (corresponding author), Hop Laval, Dept Med, Fac Med, Quebec Heart & Lung Inst, Pavillon Marguerite dYouville,Room Y4308, Ste Foy, PQ G1V 4G5, Canada.	andre.marette@criucpq.ulaval.ca	Roux, Philippe P./J-3996-2012	Roux, Philippe P./0000-0002-5962-0250; Marette, Andre/0000-0003-3950-5973; Shum, Michael/0000-0001-8784-9928	Canadian Institutes of Health Research (CIHR) [FRN-57878]; CIHR; National Science and Engineering Research Council (NSERC); obesity training program	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); obesity training program	This work was funded by Grant FRN-57878 from the Canadian Institutes of Health Research (CIHR) (to A. M.) and in part by grants from the CIHR and the National Science and Engineering Research Council (NSERC).; Supported by a postdoctoral scholarship from the obesity training program funded by CIHR.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Barthel A, 2001, BIOCHEM BIOPH RES CO, V285, P897, DOI 10.1006/bbrc.2001.5261; Bedard S, 1997, BIOCHEM J, V325, P487, DOI 10.1042/bj3250487; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; CHANG PY, 1995, J BIOL CHEM, V270, P29928; Chen S, 2009, CELL SIGNAL, V21, P1984, DOI 10.1016/j.cellsig.2009.09.009; Cieslik KA, 2005, J BIOL CHEM, V280, P18411, DOI 10.1074/jbc.M410017200; Dardevet D, 1999, J ENDOCRINOL, V162, P77, DOI 10.1677/joe.0.1620077; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; Draznin B, 2006, DIABETES, V55, P2392, DOI 10.2337/db06-0391; Drummond MJ, 2008, CLIN NUTR, V27, P447, DOI 10.1016/j.clnu.2008.01.012; Dufresne SD, 2001, MOL CELL BIOL, V21, P81, DOI 10.1128/MCB.21.1.81-87.2001; El-Haschimi K, 2003, DIABETES, V52, P1340, DOI 10.2337/diabetes.52.6.1340; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Huang C, 2002, DIABETES, V51, P2090, DOI 10.2337/diabetes.51.7.2090; Jager J, 2011, DIABETOLOGIA, V54, P180, DOI 10.1007/s00125-010-1944-0; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Maekawa N, 2006, CIRCULATION, V113, P2516, DOI 10.1161/CIRCULATIONAHA.105.563486; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; OBRIEN RM, 1990, SCIENCE, V249, P533, DOI 10.1126/science.2166335; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Pilon G., PLOS ONE, V5; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Streeper RS, 1997, J BIOL CHEM, V272, P11698, DOI 10.1074/jbc.272.18.11698; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Ueno M, 2005, DIABETOLOGIA, V48, P506, DOI 10.1007/s00125-004-1662-6; Veilleux A, 2010, MOL ENDOCRINOL, V24, P766, DOI 10.1210/me.2009-0328; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zheng YB, 2009, J ENDOCRINOL, V203, P337, DOI 10.1677/JOE-09-0181	49	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31165	31176		10.1074/jbc.M113.474148	http://dx.doi.org/10.1074/jbc.M113.474148			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24036112	Green Published, hybrid			2022-12-28	WOS:000330778900034
J	Edye, ME; Lopez-Castejon, G; Allan, SM; Brough, D				Edye, Michelle E.; Lopez-Castejon, Gloria; Allan, Stuart M.; Brough, David			Acidosis Drives Damage-associated Molecular Pattern (DAMP)-induced Interleukin-1 Secretion via a Caspase-1-independent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acidosis; Caspase; Glia; Inflammation; Innate Immunity; Interleukin; Stroke	STERILE INFLAMMATORY RESPONSE; RECEPTOR ANTAGONIST; NLRP3 INFLAMMASOME; DEFICIENT MICE; IL-1-BETA; CELLS; PH; IL-1-ALPHA; ARTHRITIS; ISCHEMIA	The proinflammatory cytokine IL-1 is a key mediator of inflammatory responses that contribute to and exacerbate brain injury. IL-1 is synthesized by microglia in the brain as an inactive precursor (pro-IL-1). Cleavage of pro-IL-1 to a mature form is stimulated by damage-associated molecular patterns (DAMPs). These DAMPs are sensed by a pattern recognition receptor called NLRP3, which forms an inflammasome, resulting in the activation of caspase-1 and cleavage of pro-IL-1. To date, regulation of the inflammasome in culture has been studied under normal culture conditions, and it is not known how DAMPs signal under disease relevant conditions such as acidosis. Given the presence of acidosis in pathological states, our objective was to test the hypothesis that acidic conditions modify DAMP-induced IL-1 release from cultured primary mouse glial cells. When LPS-primed glial cells were stimulated with DAMPs under acidic conditions (pH 6.2), the predominant IL-1 form secreted was the 20-kDa rather than the 17-kDa caspase-1-dependent species. Lactic acidosis, induced by the addition of 25 mm lactic acid, also induced the release of 20-kDa IL-1. This 20-kDa product was produced independently of NLRP3 and caspase-1 but was inhibited by the cathepsin D inhibitor pepstatin A. These data suggest that under disease relevant acidosis, DAMPs and lactic acid induce the secretion of IL-1 independently of the inflammasome. Therapeutic strategies directed to the inhibition of IL-1 processing should therefore consider alternative processing of IL-1 in addition to caspase-1-dependent processing.	[Edye, Michelle E.; Lopez-Castejon, Gloria; Allan, Stuart M.; Brough, David] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Allan, SM (corresponding author), Univ Manchester, Fac Life Sci, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	stuart.allan@manchester.ac.uk	Lopez-Castejon, Gloria/F-6985-2015; Allan, Stuart/AAL-1245-2020	Lopez-Castejon, Gloria/0000-0002-8585-3381; Edye, Michelle/0000-0003-0727-8366; Brough, David/0000-0002-2250-2381; Allan, Stuart/0000-0001-9646-4456	Wellcome Trust; Medical Research Council; Neusentis UK; Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [1118598] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Neusentis UK; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust (to D. B. and G. L.-C.), the Medical Research Council (to S. M. A.), and Neusentis UK and the Biotechnology and Biological Sciences Research Council (BBSRC; to M. E. E.).	Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Angell SY, 2012, SCIENCE, V337, P1456, DOI 10.1126/science.1228293; Bouchard L, 2002, J IMMUNOL, V168, P5310, DOI 10.4049/jimmunol.168.10.5310; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Dinarello CA, 2011, J INTERN MED, V269, P16, DOI 10.1111/j.1365-2796.2010.02313.x; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; Fantuzzi G, 1997, J IMMUNOL, V158, P1818; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Greenhalgh AD, 2012, DIS MODEL MECH, V5, P823, DOI 10.1242/dmm.008557; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; GUERNE PA, 1989, ARTHRITIS RHEUM-US, V32, P1443, DOI 10.1002/anr.1780321114; HAZUDA DJ, 1991, J BIOL CHEM, V266, P7081; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Luheshi NM, 2009, BRIT J PHARMACOL, V157, P1318, DOI 10.1111/j.1476-5381.2009.00331.x; Luheshi NM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-186; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; NEMOTO EM, 1981, STROKE, V12, P77, DOI 10.1161/01.STR.12.1.77; Rajamaki K, 2013, J BIOL CHEM, V288, P13410, DOI 10.1074/jbc.M112.426254; Reardon S, 2011, SCIENCE, V333, P558, DOI 10.1126/science.333.6042.558; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Savage CD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00288; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Stehlik C, 2009, ARTHRITIS RHEUM-US, V60, P3524, DOI 10.1002/art.24961; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sun PZ, 2011, J CEREBR BLOOD F MET, V31, P1743, DOI 10.1038/jcbfm.2011.23; Takenouchi T, 2011, J NEUROCHEM, V117, P712, DOI 10.1111/j.1471-4159.2011.07240.x; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	33	45	45	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30485	30494		10.1074/jbc.M113.478941	http://dx.doi.org/10.1074/jbc.M113.478941			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24022484	hybrid, Green Published			2022-12-28	WOS:000329868100044
J	Li, LB; Zhang, WL; Liu, QS; Gao, Y; Gao, Y; Wang, Y; Wang, DZ; Li, ZG; Wang, T				Li, Lianbo; Zhang, Weili; Liu, Qisong; Gao, Yu; Gao, Ying; Wang, Yun; Wang, David Zhigang; Li, Zigang; Wang, Tao			Structural Insights on the Bacteriolytic and Self-protection Mechanism of Muramidase Effector Tse3 in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Peptidoglycan; Protein Complexes; Pseudomonas aeruginosa; Toxins; Antitoxins; Immune Protein Tsi3; Muramidase Effector Tse3; Type VI Secretion System	VI SECRETION SYSTEM; CRYSTAL-STRUCTURE; COMPLEX; INHIBITION; REVEALS	The warfare among microbial species as well as between pathogens and hosts is fierce, complicated, and continuous. In Pseudomonas aeruginosa, the muramidase effector Tse3 (Type VI secretion exported 3) can be injected into the periplasm of neighboring bacterial competitors by a Type VI secretion apparatus, eventually leading to cell lysis and death. However, P. aeruginosa protects itself from lysis by expressing immune protein Tsi3 (Type six secretion immunity 3). Here, we report the crystal structure of the Tse3-Tsi3 complex at 1.8 resolution, revealing that Tse3 possesses one open accessible, goose-type lysozyme-like domain with peptidoglycan hydrolysis activity. Calcium ions bind specifically in the Tse3 active site and are identified to be crucial for its bacteriolytic activity. In combination with biochemical studies, the structural basis of self-protection mechanism of Tsi3 is also elucidated, thus providing an understanding and new insights into the effectors of Type VI secretion system.	[Li, Lianbo; Zhang, Weili; Gao, Yu; Gao, Ying; Wang, Yun; Wang, Tao] Peking Univ, Shenzhen Grad Sch, Lab Computat Chem & Drug Design, Shenzhen 518055, Peoples R China; [Liu, Qisong; Wang, David Zhigang; Li, Zigang] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Key Lab Chem Genom, Shenzhen 518055, Peoples R China	Peking University; University Town of Shenzhen; Peking University; University Town of Shenzhen	Wang, DZ (corresponding author), Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Key Lab Chem Genom, Shenzhen 518055, Peoples R China.	dzw@pkusz.edu.cn; lizg@pkusz.edu.cn; tau@pku.edu.cn	Li, Lianbo/H-1152-2011	Li, Lianbo/0000-0003-0107-7125	Ministry of Science and Technology (MOST) of China [2013CB911501, NSFC31300600]; Shenzhen Science and Technology Innovation (SZSTI) Program [ZDSY20120614144410389, JCYJ20120614150904060]; PKUSZ; SZSTI Program [SW201110060, SW201110018]; Peacock Program [KQTD201103]; MOST of China [2012CB722602]; SZSTI "Shuang Bai Project";  [NSFC21102007];  [NSFC20872004];  [NSFC20972008];  [NSFC21290180]	Ministry of Science and Technology (MOST) of China(Ministry of Science and Technology, China); Shenzhen Science and Technology Innovation (SZSTI) Program; PKUSZ; SZSTI Program; Peacock Program; MOST of China(Ministry of Science and Technology, China); SZSTI "Shuang Bai Project"; ; ; ; 	This work was supported by Ministry of Science and Technology (MOST) of China 2013CB911501 and NSFC31300600, Shenzhen Science and Technology Innovation (SZSTI) Program ZDSY20120614144410389 and JCYJ20120614150904060, and a startup fund from PKUSZ (to T. W.); NSFC21102007, SZSTI Program SW201110060 and SW201110018, and Peacock Program KQTD201103 (to Z. L.); and MOST of China 2012CB722602, NSFC20872004, NSFC20972008, and NSFC21290180 and SZSTI "Shuang Bai Project" (to D. Z. W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Artola-Recolons C, 2011, BIOCHEMISTRY-US, V50, P2384, DOI 10.1021/bi200085y; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Benz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067362; Benz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040453; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; Ding JJ, 2012, J BIOL CHEM, V287, P26911, DOI 10.1074/jbc.M112.368043; Dong C, 2013, BIOCHEM J, V454, P59, DOI 10.1042/BJ20130193; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Helland R, 2009, CELL MOL LIFE SCI, V66, P2585, DOI 10.1007/s00018-009-0063-x; Holland IB, 2010, METHODS MOL BIOL, V619, P1, DOI 10.1007/978-1-60327-412-8_1; Jackson SA, 2012, BBA-BIOENERGETICS, V1817, P1331, DOI 10.1016/j.bbabio.2012.02.032; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Li M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002613; LOLL PJ, 1989, PROTEINS, V5, P183, DOI 10.1002/prot.340050302; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shang GJ, 2012, BIOCHEM J, V448, P201, DOI 10.1042/BJ20120668; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Steiner RA, 2001, ACTA CRYSTALLOGR D, V57, P516, DOI 10.1107/S0907444901002530; Stewart M, 2000, J MOL BIOL, V299, P213, DOI 10.1006/jmbi.2000.3733; Strynadka N C, 1996, EXS, V75, P185; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013; WEAVER LH, 1985, J MOL EVOL, V21, P97, DOI 10.1007/BF02100084; Zhang H, 2013, J BIOL CHEM, V288, P5928, DOI 10.1074/jbc.M112.434357; Zhang H, 2012, FEBS LETT, V586, P3193, DOI 10.1016/j.febslet.2012.06.036; Zou TT, 2012, J MOL BIOL, V417, P351, DOI 10.1016/j.jmb.2012.01.040	41	22	24	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30607	30613		10.1074/jbc.C113.506097	http://dx.doi.org/10.1074/jbc.C113.506097			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24025333	Green Published, hybrid			2022-12-28	WOS:000329868100061
J	Wiegmann, EM; Westendorf, E; Kalus, I; Pringle, TH; Lubke, T; Dierks, T				Wiegmann, Elena Marie; Westendorf, Eva; Kalus, Ina; Pringle, Thomas H.; Luebke, Torben; Dierks, Thomas			Arylsulfatase K, a Novel Lysosomal Sulfatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Enzyme Processing; Lysosomal Glycoproteins; Lysosomal Storage Disease; Lysosomes; Protein Sorting; ARSK; Arylsulfatase K; Sulfatase	FORMYLGLYCINE-GENERATING ENZYME; MOLECULAR CHARACTERIZATION; CRYSTAL-STRUCTURE; DEFICIENCY; PROTEINS; MICE; IDENTIFICATION; CONVERSION; MUTATIONS; MECHANISM	Background: Human sulfatases play key roles in physiology and cause numerous pathological conditions upon deficiency/misregulation. Results: ARSK is ubiquitously expressed, localizes to lysosomes, and shows arylsulfatase activity at acidic pH. Conclusion: ARSK is a novel lysosomal sulfatase acting on a ubiquitous substrate. Significance: ARSK functions in lysosomal degradation, possibly of glycosaminoglycans, and, in all probability, is associated with a non-classified lysosomal storage disorder. The human sulfatase family has 17 members, 13 of which have been characterized biochemically. These enzymes specifically hydrolyze sulfate esters in glycosaminoglycans, sulfolipids, or steroid sulfates, thereby playing key roles in cellular degradation, cell signaling, and hormone regulation. The loss of sulfatase activity has been linked to severe pathophysiological conditions such as lysosomal storage disorders, developmental abnormalities, or cancer. A novel member of this family, arylsulfatase K (ARSK), was identified bioinformatically through its conserved sulfatase signature sequence directing posttranslational generation of the catalytic formylglycine residue in sulfatases. However, overall sequence identity of ARSK with other human sulfatases is low (18-22%). Here we demonstrate that ARSK indeed shows desulfation activity toward arylsulfate pseudosubstrates. When expressed in human cells, ARSK was detected as a 68-kDa glycoprotein carrying at least four N-glycans of both the complex and high-mannose type. Purified ARSK turned over p-nitrocatechol and p-nitrophenyl sulfate. This activity was dependent on cysteine 80, which was verified to undergo conversion to formylglycine. Kinetic parameters were similar to those of several lysosomal sulfatases involved in degradation of sulfated glycosaminoglycans. An acidic pH optimum (approximate to 4.6) and colocalization with LAMP1 verified lysosomal functioning of ARSK. Further, it carries mannose 6-phosphate, indicating lysosomal sorting via mannose 6-phosphate receptors. ARSK mRNA expression was found in all tissues tested, suggesting a ubiquitous physiological substrate and a so far non-classified lysosomal storage disorder in the case of ARSK deficiency, as shown before for all other lysosomal sulfatases.	[Wiegmann, Elena Marie; Westendorf, Eva; Kalus, Ina; Luebke, Torben; Dierks, Thomas] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany; [Pringle, Thomas H.] Sperling Fdn, Eugene, OR 97405 USA	University of Bielefeld	Dierks, T (corresponding author), Univ Bielefeld, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany.	thomas.dierks@uni-bielefeld.de	Dierks, Thomas/A-3596-2012; Lübke, Torben/B-6019-2012	Dierks, Thomas/0000-0001-6426-1339; Lubke, Torben/0000-0002-3342-0090	Deutsche Forschungsgemeinschaft; Shire Human Genetic Therapies Inc. (Lexington, MA)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Shire Human Genetic Therapies Inc. (Lexington, MA)	This work was supported by the Deutsche Forschungsgemeinschaft and Shire Human Genetic Therapies Inc. (Lexington, MA).	Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Chruszcz M, 2003, J INORG BIOCHEM, V96, P386, DOI 10.1016/S0162-0134(03)00176-4; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Dierks T, 1999, EMBO J, V18, P2084, DOI 10.1093/emboj/18.8.2084; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Dierks T, 2009, BBA-MOL CELL RES, V1793, P710, DOI 10.1016/j.bbamcr.2008.11.015; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; FRANCO B, 1995, CELL, V81, P15, DOI 10.1016/0092-8674(95)90367-4; Frese MA, 2008, J BIOL CHEM, V283, P11388, DOI 10.1074/jbc.M709917200; GIESELMANN V, 1983, J CELL BIOL, V97, P1, DOI 10.1083/jcb.97.1.1; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; HASILIK A, 1992, EXPERIENTIA, V48, P130, DOI 10.1007/BF01923507; Hopwood JJ, 2001, METABOLIC MOL BASES, P3725; KOBAYASHI T, 1992, BIOCHIM BIOPHYS ACTA, V1159, P243, DOI 10.1016/0167-4838(92)90051-E; Kollmann K, 2005, PROTEOMICS, V5, P3966, DOI 10.1002/pmic.200401247; Kollmann K, 2009, FEBS J, V276, P1356, DOI 10.1111/j.1742-4658.2009.06877.x; Koppe G., 1978, ARCH DIS CHILD, V53, P803; Kowalewski B, 2012, P NATL ACAD SCI USA, V109, P10310, DOI 10.1073/pnas.1202071109; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Mullerr-Loennies S, 2010, AM J PATHOL, V177, P240, DOI 10.2353/ajpath.2010.090954; Obaya AJ, 2006, GENE, V372, P110, DOI 10.1016/j.gene.2005.12.023; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; Qian MQ, 2008, MOL CELL PROTEOMICS, V7, P58, DOI 10.1074/mcp.M700217-MCP200; Sardiello M, 2005, HUM MOL GENET, V14, P3203, DOI 10.1093/hmg/ddi351; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Sleat DE, 2008, J PROTEOME RES, V7, P3010, DOI 10.1021/pr800135v; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P686, DOI 10.1074/mcp.M500343-MCP200; von Bulow R, 2001, J MOL BIOL, V305, P269, DOI 10.1006/jmbi.2000.4297; Waldow A, 1999, J BIOL CHEM, V274, P12284, DOI 10.1074/jbc.274.18.12284	37	13	15	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30019	30028		10.1074/jbc.M113.499541	http://dx.doi.org/10.1074/jbc.M113.499541			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986440	Green Published, hybrid			2022-12-28	WOS:000329868100003
J	Tao, RY; Xiong, XW; DePinho, RA; Deng, CX; Dong, XC				Tao, Rongya; Xiong, Xiwen; DePinho, Ronald A.; Deng, Chu-Xia; Dong, X. Charlie			FoxO3 Transcription Factor and Sirt6 Deacetylase Regulate Low Density Lipoprotein (LDL)-cholesterol Homeostasis via Control of the Proprotein Convertase Subtilisin/Kexin Type 9 (Pcsk9) Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; MONOCLONAL-ANTIBODY; HUMAN LONGEVITY; CHOLESTEROL-BIOSYNTHESIS; RECEPTOR EXPRESSION; RANDOMIZED-TRIAL; LDL CHOLESTEROL; HEPATIC PCSK9; DOUBLE-BLIND; HEPG2 CELLS	Elevated LDL-cholesterol is a risk factor for the development of cardiovascular disease. Thus, proper control of LDL-cholesterol homeostasis is critical for organismal health. Genetic analysis has identified PCSK9 (proprotein convertase subtilisin/kexin type 9) as a crucial gene in the regulation of LDL-cholesterol via control of LDL receptor degradation. Although biochemical characteristics and clinical implications of PCSK9 have been extensively investigated, epigenetic regulation of this gene is largely unknown. In this work we have discovered that Sirt6, an NAD(+)-dependent histone deacetylase, plays a critical role in the regulation of the Pcsk9 gene expression in mice. Hepatic Sirt6 deficiency leads to elevated Pcsk9 gene expression and LDL-cholesterol as well. Mechanistically, we have demonstrated that Sirt6 can be recruited by forkhead transcription factor FoxO3 to the proximal promoter region of the Pcsk9 gene and deacetylates histone H3 at lysines 9 and 56, thereby suppressing the gene expression. Also remarkably, overexpression of Sirt6 in high fat diet-fed mice lowers LDL-cholesterol. Overall, our data suggest that FoxO3 and Sirt6, two longevity genes, can reduce LDL-cholesterol levels through regulation of the Pcsk9 gene.	[Tao, Rongya; Xiong, Xiwen; Dong, X. Charlie] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	Indiana University System; Indiana University Bloomington; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dong, XC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr,MS1021D, Indianapolis, IN 46202 USA.	xcdong@iu.edu	deng, chuxia/N-6713-2016; tao, rongya/B-8042-2014; Xiong, Xiwen/GSN-0686-2022	tao, rongya/0000-0002-3316-5587; DePinho, Ronald/0000-0002-5625-577X	National Institutes of Health (NIDDK) [R00DK077505, R01DK091592]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091592, R00DK077505] Funding Source: NIH RePORTER	National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R00DK077505 and R01DK091592 (NIDDK; to X.C.D.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Ai D, 2012, J CLIN INVEST, V122, P1262, DOI 10.1172/JCI61919; Anselmi CV, 2009, REJUV RES, V12, P95, DOI 10.1089/rej.2008.0827; Browning JD, 2010, J LIPID RES, V51, P3359, DOI 10.1194/jlr.P009860; Bulbulia R, 2012, CURR OPIN LIPIDOL, V23, P265, DOI 10.1097/MOL.0b013e3283556c1b; Cameron J, 2008, ATHEROSCLEROSIS, V201, P266, DOI 10.1016/j.atherosclerosis.2008.02.004; Cao AQ, 2011, J LIPID RES, V52, P518, DOI 10.1194/jlr.M010603; Costet P, 2006, J BIOL CHEM, V281, P6211, DOI 10.1074/jbc.M508582200; Denis M, 2012, CIRCULATION, V125, P894, DOI 10.1161/CIRCULATIONAHA.111.057406; Dias CS, 2012, J AM COLL CARDIOL, V60, P1888, DOI 10.1016/j.jacc.2012.08.986; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Dong B, 2010, J LIPID RES, V51, P1486, DOI 10.1194/jlr.M003566; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Duan YJ, 2012, J BIOL CHEM, V287, P23667, DOI 10.1074/jbc.M112.350181; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Koren MJ, 2012, LANCET, V380, P1995, DOI 10.1016/S0140-6736(12)61771-1; Kourimate S, 2008, J BIOL CHEM, V283, P9666, DOI 10.1074/jbc.M705831200; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lalanne F, 2005, J LIPID RES, V46, P1312, DOI 10.1194/jlr.M400396-JLR200; Lambert G, 2012, J LIPID RES, V53, P2515, DOI 10.1194/jlr.R026658; Langhi C, 2008, FEBS LETT, V582, P949, DOI 10.1016/j.febslet.2008.02.038; Li H, 2012, BIOCHEM J, V443, P757, DOI 10.1042/BJ20111645; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Luo Y, 2009, J LIPID RES, V50, P1581, DOI 10.1194/jlr.M800542-JLR200; Marais DA, 2012, CURR OPIN LIPIDOL, V23, P511, DOI 10.1097/MOL.0b013e3283587563; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Niesen M, 2008, ARCH BIOCHEM BIOPHYS, V470, P111, DOI 10.1016/j.abb.2007.11.009; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Persson L, 2010, ARTERIOSCL THROM VAS, V30, P2666, DOI 10.1161/ATVBAHA.110.214130; Persson L, 2009, ENDOCRINOLOGY, V150, P1140, DOI 10.1210/en.2008-1281; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Schmidt RJ, 2008, BIOCHEM BIOPH RES CO, V370, P634, DOI 10.1016/j.bbrc.2008.04.004; Soerensen M, 2010, AGING CELL, V9, P1010, DOI 10.1111/j.1474-9726.2010.00627.x; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Sullivan D, 2012, JAMA-J AM MED ASSOC, V308, P2497, DOI 10.1001/jama.2012.25790; Tao RY, 2013, J LIPID RES, V54, P2745, DOI 10.1194/jlr.M039339; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; van der Wulp MYM, 2013, MOL CELL ENDOCRINOL, V368, P1, DOI 10.1016/j.mce.2012.06.007; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wu MH, 2012, ATHEROSCLEROSIS, V224, P401, DOI 10.1016/j.atherosclerosis.2012.08.012; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	59	116	123	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29252	29259		10.1074/jbc.M113.481473	http://dx.doi.org/10.1074/jbc.M113.481473			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23974119	Green Published, hybrid			2022-12-28	WOS:000330615300005
J	Arapulisamy, O; Mannangatti, P; Jayanthi, LD				Arapulisamy, Obulakshmi; Mannangatti, Padmanabhan; Jayanthi, Lankupalle D.			Regulated Norepinephrine Transporter Interaction with the Neurokinin-1 Receptor Establishes Transporter Subcellular Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Catecholamines; G Protein-coupled Receptors (GPCR); Monoamine Transporters; Plasma Membrane; Protein-protein Interactions; Internalization; Lipid Rafts; Regulation	SUBSTANCE-P; NK1 RECEPTOR; LIPID RAFTS; PHARMACOLOGICAL BLOCKADE; MEMBRANE MICRODOMAINS; SEROTONIN TRANSPORTER; UP-REGULATION; PHOSPHORYLATION; ANTIDEPRESSANT; TRAFFICKING	Neurokinin-1 receptor (NK1R) mediates down-regulation of human norepinephrine (NE) transporter (hNET) via protein kinase C (PKC). However, native NET regulation by NK1R and the mechanism by which NK1R targets NET among other potential effectors are unknown. Effect of NK1R activation on native NET regulation and NET/NK1R interaction were studied using rat brain synaptosomes expressing native NET and NK1R as well as human placental trophoblast (HTR) cells coexpressing WT-hNET or NK1R/PKC-resistant hNET-T258A,S259A double mutant (NET-DM) and hNK1R. The selective NK1R agonist, GR73632, and Substance-P (SP) inhibited NE transport and reduced plasma membrane expression of NET and NK1R. Pretreatment with the NK1R antagonist, EMEND (aprepitant) prevented these NK1R-mediated effects. Immunoprecipitation experiments showed that NET forms stable complexes with NK1R. In HTR cells, combined biotinylation and immunoprecipitation studies revealed plasma membrane localization of NETNK1R complexes. Receptor activation resulted in the internalization of NETNK1R complexes. Lipid raft and immunoprecipitation analyses revealed the presence of NETNK1R complexes exclusively in non-raft membrane fractions under basal/unstimulated conditions. However, NK1R activation led to translocation of NETNK1R complexes to raft-rich membrane fractions. Importantly, PKC was found in association with raft-localized NET following SP treatment. Similar to WT-NET, PKC-resistant NET-DM was found in association with NK1R exclusively in non-raft fractions. However, SP treatment failed to translocate NET-DMNK1R complexes from non-raft fractions to raft fractions. Collectively, these results suggest that NK1R forms physical complexes with NET and that the receptor-mediated Thr(258) + Ser(259) motif-dependent translocation of NETNK1R complexes into raft-rich microdomains facilitates NET/NK1R interaction with PKC to coordinate spatially restricted NET regulation.	[Arapulisamy, Obulakshmi; Mannangatti, Padmanabhan; Jayanthi, Lankupalle D.] Med Univ S Carolina, Div Neurosci Res, Dept Neurosci, Charleston, SC 29425 USA; [Mannangatti, Padmanabhan; Jayanthi, Lankupalle D.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA	Medical University of South Carolina; Virginia Commonwealth University	Jayanthi, LD (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23219 USA.	ljayanthi@vcu.edu			National Institutes of Health from the NIGMS [R01-GM081054]; Virginia Commonwealth University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081054] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Virginia Commonwealth University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM081054 from the NIGMS and the start up fund from Virginia Commonwealth University (to L. D. J.).	Annamalai B, 2012, MOL PHARMACOL, V81, P73, DOI 10.1124/mol.111.073171; Annamalai B, 2010, J NEUROCHEM, V115, P23, DOI 10.1111/j.1471-4159.2010.06898.x; Apparsundaram S, 1998, J PHARMACOL EXP THER, V287, P733; Bauman AL, 2000, J NEUROSCI, V20, P7571; Becher A, 2001, J NEUROCHEM, V79, P787, DOI 10.1046/j.1471-4159.2001.00614.x; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Brocco M, 2008, EUR NEUROPSYCHOPHARM, V18, P729, DOI 10.1016/j.euroneuro.2008.06.002; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Chen R, 2010, FUTUR NEUROL, V5, P123, DOI 10.2217/FNL.09.76; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Fisher AS, 2007, EUR J NEUROSCI, V25, P1195, DOI 10.1111/j.1460-9568.2007.05369.x; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Garcia-Olivares J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059788; Ghisi V, 2009, CELL SIGNAL, V21, P87, DOI 10.1016/j.cellsig.2008.09.011; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; Jasmin L, 2002, P NATL ACAD SCI USA, V99, P1029, DOI 10.1073/pnas.012598599; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Jayanthi LD, 2002, BRIT J PHARMACOL, V135, P1927, DOI 10.1038/sj.bjp.0704658; Jeannotte AM, 2007, EUR J NEUROSCI, V26, P1509, DOI 10.1111/j.1460-9568.2007.05757.x; Johnson LA, 2005, J BIOL CHEM, V280, P10914, DOI 10.1074/jbc.M413887200; Kreibich AS, 2008, J NEUROSCI, V28, P6516, DOI 10.1523/JNEUROSCI.0390-08.2008; Lee FJS, 2007, EMBO J, V26, P2127, DOI 10.1038/sj.emboj.7601656; Lin Z, 2006, HANDB EXP PHARM, V175, P327; Mannangatti P, 2011, J BIOL CHEM, V286, P20239, DOI 10.1074/jbc.M111.226811; Matthies HJG, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-65; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Min MY, 2009, MOL CELL NEUROSCI, V42, P56, DOI 10.1016/j.mcn.2009.05.006; Miyano K, 2010, NEUROCHEM INT, V57, P923, DOI 10.1016/j.neuint.2010.09.012; Monastyrskaya K, 2005, J BIOL CHEM, V280, P7135, DOI 10.1074/jbc.M405806200; Mounir S, 2002, NEUROSCI RES, V44, P71, DOI 10.1016/S0168-0102(02)00087-1; Murphy JE, 2011, AM J PHYSIOL-CELL PH, V301, pC780, DOI 10.1152/ajpcell.00096.2011; Phenna S, 1996, BRIT J PHARMACOL, V119, P315, DOI 10.1111/j.1476-5381.1996.tb15988.x; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Ramnath RD, 2008, AM J PHYSIOL-CELL PH, V294, pC683, DOI 10.1152/ajpcell.00360.2007; Rupniak NMJ, 2001, BEHAV PHARMACOL, V12, P497, DOI 10.1097/00008877-200111000-00011; Rupniak NMJ, 2000, NEUROPHARMACOLOGY, V39, P1413, DOI 10.1016/S0028-3908(00)00052-6; Sager JJ, 2011, BIOCHEMISTRY-US, V50, P7295, DOI 10.1021/bi200405c; Samuvel DJ, 2008, J PHARMACOL EXP THER, V325, P293, DOI 10.1124/jpet.107.130534; Schmidlin F, 2001, J BIOL CHEM, V276, P25427, DOI 10.1074/jbc.M101688200; SCHOMIG E, 1989, N-S ARCH PHARMACOL, V340, P502; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Steiner JA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-26; Sung U, 2005, BIOCHEM BIOPH RES CO, V333, P671, DOI 10.1016/j.bbrc.2005.05.165; Sung U, 2003, J NEUROSCI, V23, P1697; Sung U, 2007, MOL CELL NEUROSCI, V34, P251, DOI 10.1016/j.mcn.2006.11.007; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; TRENDELENBURG U, 1991, TRENDS PHARMACOL SCI, V12, P334; Wang YM, 1999, BIOL PSYCHIAT, V46, P1124, DOI 10.1016/S0006-3223(99)00245-0; Yan TC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/0269881108100255; Yan TC, 2009, NEUROPHARMACOLOGY, V57, P627, DOI 10.1016/j.neuropharm.2009.08.021; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; Zhu CB, 2011, MOL PHARMACOL, V80, P458, DOI 10.1124/mol.111.071399	54	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28599	28610		10.1074/jbc.M113.472878	http://dx.doi.org/10.1074/jbc.M113.472878			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23979140	Green Published, hybrid			2022-12-28	WOS:000330298800016
J	Peth, A; Nathan, JA; Goldberg, AL				Peth, Andreas; Nathan, James A.; Goldberg, Alfred L.			The ATP Costs and Time Required to Degrade Ubiquitinated Proteins by the 26 S Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; ATPases; Proteasome; Protein Degradation; Ubiquitin; 26 S Proteasome; AAA-ATPases; ATP Hydrolysis; Ubiquitin Conjugates	REGULATORY PARTICLE; DEPENDENT PROTEASE; 20S PROTEASOME; AAA-ATPASE; BINDING; ACTIVATE; GATE; POLYUBIQUITIN; RECOGNITION; PROTEOLYSIS	The degradation of ubiquitinated proteins by 26 S proteasomes requires ATP hydrolysis. To investigate if the six proteasomal ATPases function independently or in a cyclic manner, as proposed recently, we used yeast mutants that prevent ATP binding to Rpt3, Rpt5, or Rpt6. Although proteasomes contain six ATPase subunits, each of these single mutations caused a 66% reduction in basal ATP hydrolysis, and each blocked completely the 2-3-fold stimulation of ATPase activity induced by ubiquitinated substrates. Therefore, the ATPase subunits must function in a ordered manner, in which each is required for the stimulation of ATPase activity by substrates. Although ATP is essential for multiple steps in proteasome function, when the rate of ATP hydrolysis was reduced incrementally, the degradation of Ub(5)-DHFR (where Ub is ubiquitin and DHFR is dihydrofolate reductase) decreased exactly in parallel. This direct proportionality implies that a specific number of ATPs is consumed in degrading a ubiquitinated protein. When the ubiquitinated DHFR was more tightly folded (upon addition of the ligand folate), the rate of ATP hydrolysis was unchanged, but the time to degrade a Ub(5)-DHFR molecule (approximate to 13 s) and the energy expenditure (50-80 ATPs/Ub(5)-DHFR) both increased by 2-fold. With a mutation in the ATPase C terminus that reduced gate opening into the 20 S proteasome, the energy costs and time required for conjugate degradation also increased. Thus, different ubiquitin conjugates activate similarly the ATPase subunit cycle that drives proteolysis, but polypeptide structure determines the time required for degradation and thus the energy cost.	[Peth, Andreas; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Nathan, James A.] Univ Cambridge, Dept Med, Cambridge Inst Med Res, Natl Inst Hlth Res,Cambridge Biomed Res Ctr, Cambridge CB2 0XY, England	Harvard University; Harvard Medical School; University of Cambridge	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	alfred_goldberg@hms.harvard.edu		Nathan, James Alexander/0000-0002-0248-1632	National Institutes of Health from NIGMS [R01 GM051923-17]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER; MRC [G0802822] Funding Source: UKRI; Medical Research Council [G0802822] Funding Source: researchfish	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM051923-17 from NIGMS.	Bar-Nun S, 2012, BBA-MOL CELL RES, V1823, P67, DOI 10.1016/j.bbamcr.2011.07.009; Bech-Otschir D, 2009, NAT STRUCT MOL BIOL, V16, P219, DOI 10.1038/nsmb.1547; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim YC, 2013, J BIOL CHEM, V288, P3334, DOI 10.1074/jbc.M112.424788; Lam YA, 2005, METHOD ENZYMOL, V398, P379, DOI 10.1016/S0076-6879(05)98031-2; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li XH, 2009, BIOCHEM J, V421, P397, DOI 10.1042/BJ20090528; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; WAXMAN L, 1986, SCIENCE, V232, P500, DOI 10.1126/science.2938257; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021	33	86	87	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29215	29222		10.1074/jbc.M113.482570	http://dx.doi.org/10.1074/jbc.M113.482570			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23965995	Green Published, hybrid			2022-12-28	WOS:000330298800074
J	Anastassiadis, T; Duong-Ly, KC; Deacon, SW; Lafontant, A; Ma, HC; Devarajan, K; Dunbrack, RL; Wu, JH; Peterson, JR				Anastassiadis, Theonie; Duong-Ly, Krisna C.; Deacon, Sean W.; Lafontant, Alec; Ma, Haiching; Devarajan, Karthik; Dunbrack, Roland L., Jr.; Wu, Jinhua; Peterson, Jeffrey R.			Highly Selective Dual Insulin Receptor (IR)/Insulin-like Growth Factor 1 Receptor (IGF-1R) Inhibitor Derived from an Extracellular Signal-regulated Kinase (ERK) Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TYROSINE KINASE; I RECEPTOR; CANCER; IDENTIFICATION; DISCOVERY; DESIGN; FEATURES; COMPLEX	Dual inhibitors of the closely related receptor tyrosine kinases insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (IR) are promising therapeutic agents in cancer. Here, we report an unusually selective class of dual inhibitors of IGF-1R and IR identified in a parallel screen of known kinase inhibitors against a panel of 300 human protein kinases. Biochemical and structural studies indicate that this class achieves its high selectivity by binding to the ATP-binding pocket of inactive, unphosphorylated IGF-1R/IR and stabilizing the activation loop in a native-like inactive conformation. One member of this compound family was originally reported as an inhibitor of the serine/threonine kinase ERK, a kinase that is distinct in the structure of its unphosphorylated/inactive form from IR/IGF-1R. Remarkably, this compound binds to the ATP-binding pocket of ERK in an entirely different conformation to that of IGF-1R/IR, explaining the potency against these two structurally distinct kinase families. These findings suggest a novel approach to polypharmacology in which two or more unrelated kinases are inhibited by a single compound that targets different conformations of each target kinase.	[Anastassiadis, Theonie; Duong-Ly, Krisna C.; Peterson, Jeffrey R.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Deacon, Sean W.; Ma, Haiching] React Biol Corp, Malvern, PA 19355 USA; [Lafontant, Alec; Dunbrack, Roland L., Jr.; Wu, Jinhua] Fox Chase Canc Ctr, Dev Therapeut Program, Philadelphia, PA 19111 USA; [Devarajan, Karthik] Fox Chase Canc Ctr, Dept Biostat & Bioinformat, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center	Peterson, JR (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave,Rm P3165, Philadelphia, PA 19111 USA.	Jeffrey.Peterson@fccc.edu	Dunbrack, Roland/ABG-7141-2020	Dunbrack, Roland/0000-0001-7674-6667; Duong-Ly, Krisna/0000-0002-4593-8145; Peterson, Jeffrey/0000-0002-0604-718X; Lafontant, Alec/0000-0003-3669-0114	National Institutes of Health [GM083025, T32 CA009035-36, P30 CA006927]; W.W. Smith Charitable Trust Award; FCCC Keystone Program in Head and Neck Cancer; NATIONAL CANCER INSTITUTE [P30CA006927, T32CA009035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083025, R01GM084453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.W. Smith Charitable Trust Award; FCCC Keystone Program in Head and Neck Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grants GM083025 (to J.R.P.), T32 CA009035-36 (to K.C.D.), and P30 CA006927 (to the Fox Chase Cancer Center) and by a W.W. Smith Charitable Trust Award. This work was also supported by the FCCC Keystone Program in Head and Neck Cancer.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; [Anonymous], 2010, R LANG ENV STAT COMP; Buchanan JL, 2011, BIOORG MED CHEM LETT, V21, P2394, DOI 10.1016/j.bmcl.2011.02.075; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Chamberlain SD, 2009, BIOORG MED CHEM LETT, V19, P360, DOI 10.1016/j.bmcl.2008.11.077; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Fidler MJ, 2012, THER ADV MED ONCOL, V4, P51, DOI 10.1177/1758834011427576; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Hari SB, 2013, CHEM BIOL, V20, P806, DOI 10.1016/j.chembiol.2013.05.005; Hartog H, 2007, EUR J CANCER, V43, P1895, DOI 10.1016/j.ejca.2007.05.021; Heinrich T, 2010, ACS MED CHEM LETT, V1, P199, DOI 10.1021/ml100044h; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Jin MZ, 2012, FUTURE MED CHEM, V4, P315, DOI [10.4155/FMC.11.180, 10.4155/fmc.11.180]; Katayama N, 2008, PROTEINS, V73, P795, DOI 10.1002/prot.22207; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lesuisse D, 2011, BIOORG MED CHEM LETT, V21, P2224, DOI 10.1016/j.bmcl.2011.03.003; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Mayer SC, 2008, BIOORG MED CHEM LETT, V18, P3641, DOI 10.1016/j.bmcl.2008.04.044; Miller BS, 2005, CANCER RES, V65, P10123, DOI 10.1158/0008-5472.CAN-05-2752; Miller LM, 2009, BIOORG MED CHEM LETT, V19, P62, DOI 10.1016/j.bmcl.2008.11.037; Mulvihill MJ, 2009, FUTURE MED CHEM, V1, P1153, DOI 10.4155/FMC.09.89; Munshi S, 2003, ACTA CRYSTALLOGR D, V59, P1725, DOI 10.1107/S0907444903015415; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemecek C, 2010, CHEM BIOL DRUG DES, V76, P100, DOI 10.1111/j.1747-0285.2010.00991.x; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parang K, 2001, NAT STRUCT BIOL, V8, P37; Patnaik S, 2009, BIOORG MED CHEM LETT, V19, P3136, DOI 10.1016/j.bmcl.2008.12.110; Sampognaro AJ, 2010, BIOORG MED CHEM LETT, V20, P5027, DOI 10.1016/j.bmcl.2010.07.045; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van der Loo M. P., 2010, EXTREMEVALUES PACKAG; Velaparthi U, 2007, BIOORG MED CHEM LETT, V17, P2317, DOI 10.1016/j.bmcl.2007.01.102; Vincent EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066963; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wittman MD, 2009, J MED CHEM, V52, P7360, DOI 10.1021/jm900786r; Wu JH, 2008, EMBO J, V27, P1985, DOI 10.1038/emboj.2008.116; Wu JH, 2008, NAT STRUCT MOL BIOL, V15, P251, DOI 10.1038/nsmb.1388; Yee TW, 2010, J STAT SOFTW, V32, P1	44	9	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28068	28077		10.1074/jbc.M113.505032	http://dx.doi.org/10.1074/jbc.M113.505032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23935097	Green Published, hybrid			2022-12-28	WOS:000330612800032
J	Martinkova, M; Kitanishi, K; Shimizu, T				Martinkova, Marketa; Kitanishi, Kenichi; Shimizu, Toru			Heme-based Globin-coupled Oxygen Sensors: Linking Oxygen Binding to Functional Regulation of Diguanylate Cyclase, Histidine Kinase, and Methyl-accepting Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SOLUBLE GUANYLATE-CYCLASE; COLI EC DOS; BRADYRHIZOBIUM-JAPONICUM FIXL; RESONANCE RAMAN-SPECTROSCOPY; SENSING TRANSCRIPTION FACTOR; TRANSDUCER PROTEIN HEMAT; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; SIGNAL-TRANSDUCTION; BACILLUS-SUBTILIS	An emerging class of novel heme-based oxygen sensors containing a globin fold binds and senses environmental O-2 via a heme iron complex. Structure-function relationships of oxygen sensors containing a heme-bound globin fold are different from those containing heme-bound PAS and GAF folds. It is thus worth reconsidering from an evolutionary perspective how heme-bound proteins with a globin fold similar to that of hemoglobin and myoglobin could act as O-2 sensors. Here, we summarize the molecular mechanisms of heme-based oxygen sensors containing a globin fold in an effort to shed light on the O-2-sensing properties and O-2-stimulated catalytic enhancement observed for these proteins.	[Martinkova, Marketa; Shimizu, Toru] Charles Univ Prague, Fac Sci, Dept Biochem, Prague 12843 2, Czech Republic; [Kitanishi, Kenichi] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Shimizu, Toru] Natl Inst Adv Ind Sci & Technol, Res Ctr Compact Chem Syst, Sendai, Miyagi 9838551, Japan	Charles University Prague; University of Michigan System; University of Michigan; National Institute of Advanced Industrial Science & Technology (AIST)	Martinkova, M (corresponding author), Charles Univ Prague, Fac Sci, Dept Biochem, Prague 12843 2, Czech Republic.	marketa.martinkova@natur.cuni.cz; shimizu@tagen.tohoku.ac.jp	Kitanishi, Kenichi/I-3323-2014; Martinkova, Marketa/E-3748-2012	Kitanishi, Kenichi/0000-0002-2110-8104; Martinkova, Marketa/0000-0002-0865-8785; Shimizu, Toru/0000-0002-3950-5554	Japan Society for the Promotion of Science;  [UNCE 204025/2012]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported in part by Grant-in-aid UNCE 204025/2012 from Charles University in Prague.; Supported in part by a postdoctoral fellowship for research abroad from the Japan Society for the Promotion of Science.	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; Aono S, 2012, ANTIOXID REDOX SIGN, V16, P678, DOI 10.1089/ars.2011.4248; Benabbas A, 2012, J BIOL CHEM, V287, P21729, DOI 10.1074/jbc.M112.345090; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Clark RW, 2007, J BIOL INORG CHEM, V12, P139, DOI 10.1007/s00775-006-0168-8; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Derbyshire ER, 2011, BIOCHEMISTRY-US, V50, P4281, DOI 10.1021/bi200341b; Dunham CM, 2003, BIOCHEMISTRY-US, V42, P7701, DOI 10.1021/bi0343370; El-Mashtoly SF, 2012, J BIOL CHEM, V287, P19973, DOI 10.1074/jbc.M112.357855; Farhana A, 2012, ANTIOXID REDOX SIGN, V17, P1232, DOI 10.1089/ars.2012.4613; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Freitas TAK, 2004, P NATL ACAD SCI USA, V101, P6675, DOI 10.1073/pnas.0308657101; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Gilles-Gonzalez MA, 2006, J MOL BIOL, V360, P80, DOI 10.1016/j.jmb.2006.04.054; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Gong WM, 2000, BIOCHEMISTRY-US, V39, P3955, DOI 10.1021/bi992346w; Gonzalez G, 1998, BIOCHEMISTRY-US, V37, P10188, DOI 10.1021/bi980529x; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; Hao B, 2002, BIOCHEMISTRY-US, V41, P12952, DOI 10.1021/bi020144l; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Ibrahim M, 2006, J BIOL CHEM, V281, P29165, DOI 10.1074/jbc.M605568200; Igarashi J, 2011, HANDB PORPHYR SCI, V15, P399; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Ioanoviciu A, 2009, BIOCHEMISTRY-US, V48, P5839, DOI 10.1021/bi802309y; Ishitsuka Y, 2008, BIOCHEMISTRY-US, V47, P8874, DOI 10.1021/bi800248c; Kitanishi K, 2011, J BIOL CHEM, V286, P35522, DOI 10.1074/jbc.M111.274811; Kitanishi K, 2010, BIOCHEMISTRY-US, V49, P10381, DOI 10.1021/bi100733q; Kobayashi K, 2010, J BIOCHEM, V148, P693, DOI 10.1093/jb/mvq103; Komori H, 2007, J MOL BIOL, V367, P864, DOI 10.1016/j.jmb.2007.01.043; Kubo M, 2006, J BIOL CHEM, V281, P11271, DOI 10.1074/jbc.M513261200; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Lechauve C, 2009, J BIOL CHEM, V284, P36146, DOI 10.1074/jbc.M109.066811; Lee AJ, 2009, BIOCHEMISTRY-US, V48, P6585, DOI 10.1021/bi801827j; Liu N, 2012, BIOCHEMISTRY-US, V51, P2087, DOI 10.1021/bi201753f; Makino R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177576; Miyatake H, 2000, J MOL BIOL, V301, P415, DOI 10.1006/jmbi.2000.3954; Mujoo K, 2008, P NATL ACAD SCI USA, V105, P18924, DOI 10.1073/pnas.0810230105; Muralidharan S, 2012, J AM CHEM SOC, V134, P2044, DOI 10.1021/ja211576b; Murray JW, 2005, P NATL ACAD SCI USA, V102, P17320, DOI 10.1073/pnas.0506599102; Nakajima K, 2012, J INORG BIOCHEM, V108, P163, DOI 10.1016/j.jinorgbio.2011.09.019; Nakamura H, 2004, P NATL ACAD SCI USA, V101, P2742, DOI 10.1073/pnas.0305795101; Nardini M, 2008, EMBO REP, V9, P157, DOI 10.1038/sj.embor.7401153; Nuernberger P, 2011, J AM CHEM SOC, V133, P17110, DOI 10.1021/ja204549n; Ohta T, 2004, J AM CHEM SOC, V126, P15000, DOI 10.1021/ja046896f; Park HJ, 2004, BIOCHEMISTRY-US, V43, P2738, DOI 10.1021/bi035980p; Pesce A, 2011, J BIOL CHEM, V286, P5347, DOI 10.1074/jbc.M110.169045; Pesce A, 2009, J MOL BIOL, V386, P246, DOI 10.1016/j.jmb.2008.12.023; Pinakoulaki E, 2006, P NATL ACAD SCI USA, V103, P14796, DOI 10.1073/pnas.0604248103; Pinakoulaki E, 2006, BIOCHEMISTRY-US, V45, P7763, DOI 10.1021/bi0604072; Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Roberts GP, 2004, MICROBIOL MOL BIOL R, V68, P453, DOI 10.1128/MMBR.68.3.453-473.2004; Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525; Sasakura Y, 2002, J BIOL CHEM, V277, P23821, DOI 10.1074/jbc.M202738200; Sawai H, 2012, CHEM COMMUN, V48, P6523, DOI 10.1039/c2cc32549g; Sawai H, 2010, BBA-PROTEINS PROTEOM, V1804, P166, DOI 10.1016/j.bbapap.2009.09.028; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Shimizu T, 2013, BIOSENSORS-BASEL, V3, P211, DOI 10.3390/bios3020211; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Stranzl GR, 2011, J BIOL CHEM, V286, P8448, DOI 10.1074/jbc.M110.207126; Taguchi S, 2004, J BIOL CHEM, V279, P3340, DOI 10.1074/jbc.M301013200; Tanaka A, 2007, J BIOL CHEM, V282, P21301, DOI 10.1074/jbc.M701920200; Tanaka A, 2008, BIOCHEMISTRY-US, V47, P13438, DOI 10.1021/bi8012017; Thijs L, 2007, J BIOL CHEM, V282, P37325, DOI 10.1074/jbc.M705541200; Tsai AL, 2012, ANTIOXID REDOX SIGN, V17, P1246, DOI 10.1089/ars.2012.4564; Tsai AL, 2012, BIOCHEMISTRY-US, V51, P172, DOI 10.1021/bi2015629; Tuckerman JR, 2009, BIOCHEMISTRY-US, V48, P9764, DOI 10.1021/bi901409g; Uchida T, 2005, ACCOUNTS CHEM RES, V38, P662, DOI 10.1021/ar030267d; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; Vinogradov SN, 2013, BBA-PROTEINS PROTEOM, V1834, P1789, DOI 10.1016/j.bbapap.2013.03.021; Voet D, 2011, BIOCHEMISTRY-US, P323; Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6; Vos MH, 2012, BIOCHEMISTRY-US, V51, P159, DOI 10.1021/bi201467c; Wan XH, 2009, J MOL BIOL, V388, P262, DOI 10.1016/j.jmb.2009.03.015; Watts KJ, 2011, MOL MICROBIOL, V79, P686, DOI 10.1111/j.1365-2958.2010.07477.x; Winter MB, 2011, P NATL ACAD SCI USA, V108, pE881, DOI 10.1073/pnas.1114038108; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Yamada S, 2009, STRUCTURE, V17, P1333, DOI 10.1016/j.str.2009.07.016; Yamashita T, 2008, J BIOL CHEM, V283, P2344, DOI 10.1074/jbc.M708123200; YANG J, 1995, P NATL ACAD SCI USA, V92, P4224, DOI 10.1073/pnas.92.10.4224; Yazawa S, 2006, J BIOL CHEM, V281, P21763, DOI 10.1074/jbc.M508983200; Yoshimura H, 2006, BIOCHEMISTRY-US, V45, P8301, DOI 10.1021/bi060315c; Youn H, 2004, J BIOL CHEM, V279, P45744, DOI 10.1074/jbc.M404336200; Yukl ET, 2008, BIOCHEMISTRY-US, V47, P12532, DOI 10.1021/bi801234w; Yukl ET, 2009, J AM CHEM SOC, V131, P7234, DOI 10.1021/ja9026924; Zhang W, 2005, BIOPHYS J, V88, P2801, DOI 10.1529/biophysj.104.047936; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	98	61	61	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27702	27711		10.1074/jbc.R113.473249	http://dx.doi.org/10.1074/jbc.R113.473249			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23928310	Green Published, hybrid			2022-12-28	WOS:000330612800001
J	Kulkarni, A; Oza, J; Yao, M; Sohail, H; Ginjala, V; Tomas-Loba, A; Horejsi, Z; Tan, AR; Boulton, SJ; Ganesan, S				Kulkarni, Atul; Oza, Jay; Yao, Ming; Sohail, Honeah; Ginjala, Vasudeva; Tomas-Loba, Antonia; Horejsi, Zuzana; Tan, Antoinette R.; Boulton, Simon J.; Ganesan, Shridar			Tripartite Motif-containing 33 (TRIM33) Protein Functions in the Poly(ADP-ribose) Polymerase (PARP)-dependent DNA Damage Response through Interaction with Amplified in Liver Cancer 1 (ALC1) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Cancer Biology; Cell Signaling; Chromatin; DNA Damage Response; ALC1; PARP; TRIM33	TUMOR-SUPPRESSOR; ADP-RIBOSYLATION; APLF C2ORF13; CHROMATIN; RECRUITMENT; TIF1-GAMMA; REPAIR; GLYCOHYDROLASE; COFACTORS; PARP-1	Activation of poly(ADP-ribose) polymerase (PARP) near sites of DNA breaks facilitates recruitment of DNA repair proteins and promotes chromatin relaxation in part through the action of chromatin-remodeling enzyme Amplified in Liver Cancer 1 (ALC1). Through proteomic analysis we find that ALC1 interacts after DNA damage with Tripartite Motif-containing 33 (TRIM33), a multifunctional protein implicated in transcriptional regulation, TGF- signaling, and tumorigenesis. We demonstrate that TRIM33 is dynamically recruited to DNA damage sites in a PARP1- and ALC1-dependent manner. TRIM33-deficient cells show enhanced sensitivity to DNA damage and prolonged retention of ALC1 at sites of DNA breaks. Conversely, overexpression of TRIM33 alleviates the DNA repair defects conferred by ALC1 overexpression. Thus, TRIM33 plays a role in PARP-dependent DNA damage response and regulates ALC1 activity by promoting its timely removal from sites of DNA damage.	[Kulkarni, Atul; Oza, Jay; Yao, Ming; Sohail, Honeah; Ginjala, Vasudeva; Tan, Antoinette R.; Ganesan, Shridar] Rutgers State Univ, Dept Med, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Tomas-Loba, Antonia; Horejsi, Zuzana; Boulton, Simon J.] London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Ganesan, S (corresponding author), Rutgers State Univ, Dept Med, Rutgers Canc Inst New Jersey, 195 Little Albany St, New Brunswick, NJ 08903 USA.	ganesash@umdnj.edu	Loba, Antonia Tomas/AAB-6814-2019; Ginjala, Vasudeva/E-5869-2019; Tomas-Loba, Antonia/N-6828-2016; Oza, Jay/ABG-8272-2021	Tomas-Loba, Antonia/0000-0002-6440-3373; Licenikova Horejsi, Zuzana/0000-0002-9943-1649; Oza, Jay/0000-0001-6050-1913	National Institutes of Health; New Jersey Commission for Cancer Research; Department of Defense; Rutgers Cancer Institute of New Jersey (CINJ) Foundation; Cancer Research UK; Royal Society; Cancer Research UK [11581] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission for Cancer Research; Department of Defense(United States Department of Defense); Rutgers Cancer Institute of New Jersey (CINJ) Foundation; Cancer Research UK(Cancer Research UK); Royal Society(Royal Society of London); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health (to S. G.). This work was also supported by the New Jersey Commission for Cancer Research (to A. K., J. O., and S. G.), by the Department of Defense (to J. O. and S. G.), and by the Rutgers Cancer Institute of New Jersey (CINJ) Foundation (to S. G.). The laboratory of S. J. B. was funded by Cancer Research UK.; A Royal Society Research Merit Award holder.	Agricola E, 2011, MOL CELL, V43, P85, DOI 10.1016/j.molcel.2011.05.020; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Aucagne R, 2011, M S-MED SCI, V27, P696, DOI 10.1051/medsci/2011278006; Aucagne R, 2011, J CLIN INVEST, V121, P2361, DOI 10.1172/JCI45213; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Doisne JM, 2009, J EXP MED, V206, P1365, DOI 10.1084/jem.20090127; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Goodarzi AA, 2009, BIOCHEM SOC T, V37, P569, DOI 10.1042/BST0370569; Gottschalk AJ, 2012, J BIOL CHEM, V287, P43527, DOI 10.1074/jbc.M112.401141; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Herquel B, 2011, TRANSCR-AUSTIN, V2, P231, DOI 10.4161/trns.2.5.17725; Herquel B, 2011, P NATL ACAD SCI USA, V108, P8212, DOI 10.1073/pnas.1101544108; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Howard PW, 2010, BIOCHEM BIOPH RES CO, V396, P674, DOI 10.1016/j.bbrc.2010.04.160; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; Kubota Y, 2009, DNA REPAIR, V8, P953, DOI 10.1016/j.dnarep.2009.06.003; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Lonn P, 2010, MOL CELL, V40, P521, DOI 10.1016/j.molcel.2010.10.029; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; Min W, 2010, CARCINOGENESIS, V31, P2058, DOI 10.1093/carcin/bgq205; Morsut L, 2010, DEVELOPMENT, V137, P2571, DOI 10.1242/dev.053801; Palma JP, 2008, ANTICANCER RES, V28, P2625; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; Pines A, 2012, J CELL BIOL, V199, P235, DOI 10.1083/jcb.201112132; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Rapizzi E, 2004, MOL PHARMACOL, V66, P890, DOI 10.1124/mol.104.000968; REALINI CA, 1992, J BIOL CHEM, V267, P18858; Rulten SL, 2008, MOL CELL BIOL, V28, P4620, DOI 10.1128/MCB.02243-07; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Vincent DF, 2012, AM J PATHOL, V180, P2214, DOI 10.1016/j.ajpath.2012.02.006; Vincent DF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000575; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	53	45	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32357	32369		10.1074/jbc.M113.459164	http://dx.doi.org/10.1074/jbc.M113.459164			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	23926104	hybrid, Green Published			2022-12-28	WOS:000328681700021
J	Sabit, H; Mallajosyula, SS; MacKerell, AD; Swaan, PW				Sabit, Hairat; Mallajosyula, Sairam S.; MacKerell, Alexander D., Jr.; Swaan, Peter W.			Transmembrane Domain II of the Human Bile Acid Transporter SLC10A2 Coordinates Sodium Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Transport; Membrane Proteins; Membrane Transport; Site-directed Mutagenesis; Transporters	MOLECULAR-DYNAMICS SIMULATIONS; SUBSTRATE TRANSLOCATION; ASBT SLC10A2; HASBT; MUTAGENESIS; INHIBITORS; TOPOLOGY; PROTEINS; RESIDUES; PATHWAY	Human apical sodium-dependent bile acid transporter (hASBT, SLC10A2) is responsible for intestinal reabsorption of bile acids and plays a key role in cholesterol homeostasis. We used a targeted and systematic approach to delineate the role of highly conserved transmembrane helix 2 on the expression and function of hASBT. Cysteine mutation significantly depressed transport activity for >60% of mutants without affecting cell surface localization of the transporter. All mutants were inaccessible toward chemical modification by membrane-impermeant MTSET reagent, strongly suggesting that transmembrane 2 (TM2) plays an indirect role in bile acid substrate translocation. Both bile acid uptake and sodium dependence of TM2 mutants revealed a distinct -helical periodicity. Kinetic studies with conservative and non-conservative mutants of sodium sensitive residues further underscored the importance of Gln(75), Phe(76), Met(79), Gly(83), Leu(86), Phe(90), and Asp(91) in hASBT function. Computational analysis indicated that Asp(91) may coordinate with sodium during the transport cycle. Combined, our data propose that a consortium of sodium-sensitive residues along with previously reported residues (Thr(134), Leu(138), and Thr(149)) from TM3 may form the sodium binding and translocation pathway. Notably, residues Gln(75), Met(79), Thr(82), and Leu(86) from TM2 are highly conserved in TM3 of a putative remote bacterial homologue (ASBT(NM)), suggesting a universal mechanism for the SLC10A transporter family.	[Sabit, Hairat; Mallajosyula, Sairam S.; MacKerell, Alexander D., Jr.; Swaan, Peter W.] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Swaan, PW (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 Penn St, Baltimore, MD 21201 USA.	pswaan@rx.umaryland.edu	MacKerell, Alex/Y-2469-2019; MacKerell, Alex/AAA-2560-2020	MacKerell, Alex/0000-0001-8287-6804; Swaan, Peter/0000-0003-1767-1487	National Science Foundation [OCI-1053575]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061425] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Tatiana Claro da Silva for excellent advice during the course of this work. We also thank Dr. Robyn Moore for critical reading of the manuscript. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation Grant OCI-1053575. We also acknowledge the use of computational facilities at computer aided drug design (CADD), University of Maryland Baltimore.	Balakrishnan A, 2006, MOL PHARMACEUT, V3, P223, DOI 10.1021/mp060022d; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P943, DOI 10.1021/bi052202j; Banerjee A, 2005, BIOCHEMISTRY-US, V44, P8908, DOI 10.1021/bi050553s; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; da Silva TC, 2011, J BIOL CHEM, V286, P27322, DOI 10.1074/jbc.M110.217802; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dawson PA, 2011, HANDB EXP PHARMACOL, V201, P169, DOI 10.1007/978-3-642-14541-4_4; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Gibbs N, 1997, BIOPHYS J, V72, P2490, DOI 10.1016/S0006-3495(97)78893-3; Gonzalez PM, 2012, PHARM RES-DORDR, V29, P1821, DOI 10.1007/s11095-012-0706-8; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hussainzada N, 2008, J BIOL CHEM, V283, P20653, DOI 10.1074/jbc.M802885200; Hussainzada N, 2008, MOL PHARMACOL, V73, P305, DOI 10.1124/mol.107.041640; Hussainzada N, 2006, MOL PHARMACOL, V70, P1565, DOI 10.1124/mol.106.028647; Hussainzada N, 2009, BIOCHEMISTRY-US, V48, P8528, DOI 10.1021/bi900616w; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Khantwal CM, 2008, BIOCHEMISTRY-US, V47, P3606, DOI 10.1021/bi702498w; Kitayama K, 2006, EUR J PHARMACOL, V539, P89, DOI 10.1016/j.ejphar.2006.04.005; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lionarons DA, 2012, J LIPID RES, V53, P1535, DOI 10.1194/jlr.M025726; LOO TW, 1993, J BIOL CHEM, V268, P3143; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Moore RH, 2013, BIOCHEMISTRY-US, V52, P5117, DOI 10.1021/bi400028q; Rais R, 2011, J PHARM SCI-US, V100, P1184, DOI 10.1002/jps.22332; Ray A, 2006, BIOORG MED CHEM LETT, V16, P1473, DOI 10.1016/j.bmcl.2005.12.050; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Tremont SJ, 2005, J MED CHEM, V48, P5837, DOI 10.1021/jm040215+; Weinman SA, 1998, J BIOL CHEM, V273, P34691, DOI 10.1074/jbc.273.52.34691; Zhang EY, 2004, BIOCHEMISTRY-US, V43, P11380, DOI 10.1021/bi049270a	34	7	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32394	32404		10.1074/jbc.M113.518555	http://dx.doi.org/10.1074/jbc.M113.518555			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24045943	hybrid, Green Published			2022-12-28	WOS:000328681700024
J	Schafer, KN; Cisek, K; Huseby, CJ; Chang, E; Kuret, J				Schafer, Kelsey N.; Cisek, Katryna; Huseby, Carol J.; Chang, Edward; Kuret, Jeff			Structural Determinants of Tau Aggregation Inhibitor Potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aggregation; Alzheimer Disease; Chemical biology; Protein Structure; Tau	PAIRED HELICAL FILAMENTS; TAUOPATHIC NEURODEGENERATIVE DISEASES; SMALL-MOLECULE INHIBITORS; E-STATE INDEXES; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; IN-VITRO; FRONTOTEMPORAL DEMENTIA; MECHANISTIC BASIS; BINDING-AFFINITY	Small-molecule Tau aggregation inhibitors are under investigation as potential therapeutic agents against Alzheimer disease. Many such inhibitors have been identified in vitro, but their potency-driving features, and their molecular targets in the Tau aggregation pathway, have resisted identification. Previously we proposed ligand polarizability, a measure of electron delocalization, as a candidate descriptor of inhibitor potency. Here we tested this hypothesis by correlating the ground state polarizabilities of cyanine, phenothiazine, and arylmethine derivatives calculated using ab initio quantum methods with inhibitory potency values determined in the presence of octadecyl sulfate inducer under reducing conditions. A series of rhodanine analogs was analyzed as well using potency values disclosed in the literature. Results showed that polarizability and inhibitory potency directly correlated within all four series. To identify putative binding targets, representative members of the four chemotypes were added to aggregation reactions, where they were found to stabilize soluble, but SDS-resistant Tau species at the expense of filamentous aggregates. Using SDS resistance as a secondary assay, and a library of Tau deletion and missense mutants as targets, interaction with cyanine was localized to the microtubule binding repeat region. Moreover, the SDS-resistant phenotype was completely dependent on the presence of octadecyl sulfate inducer, but not intact PHF6/PH6* hexapeptide motifs, indicating that cyanine interacted with a species in the aggregation pathway prior to nucleus formation. Together the data suggest that flat, highly polarizable ligands inhibit Tau aggregation by interacting with folded species in the aggregation pathway and driving their assembly into soluble but highly stable Tau oligomers.	[Schafer, Kelsey N.; Cisek, Katryna; Huseby, Carol J.; Chang, Edward; Kuret, Jeff] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Kuret, J (corresponding author), 1060 Carmack Rd, Columbus, OH 43210 USA.	kuret.3@osu.edu		Cisek, Katryna/0000-0002-2888-9943; Huseby, Carol/0000-0002-9558-5560	National Institutes of Health [AG14452]; Alzheimer's Disease Drug Discovery Foundation [281205]; Ohio Supercomputer Center [PAS0453]; NATIONAL INSTITUTE ON AGING [R01AG014452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Disease Drug Discovery Foundation; Ohio Supercomputer Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG14452, Alzheimer's Disease Drug Discovery Foundation Grant 281205, and an allocation of computing time from the Ohio Supercomputer Center (PAS0453).	Abraha A, 2000, J CELL SCI, V113, P3737; Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Akoury E, 2013, ANGEW CHEM INT EDIT, V52, P3511, DOI 10.1002/anie.201208290; Akoury E, 2013, J AM CHEM SOC, V135, P2853, DOI 10.1021/ja312471h; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Bulic B, 2007, ANGEW CHEM INT EDIT, V46, P9215, DOI 10.1002/anie.200704051; Bulic B, 2010, NEUROPHARMACOLOGY, V59, P276, DOI 10.1016/j.neuropharm.2010.01.016; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chang E, 2008, J NEUROCHEM, V107, P1113, DOI 10.1111/j.1471-4159.2008.05692.x; Chang E, 2009, J MED CHEM, V52, P3539, DOI 10.1021/jm900116d; Chirita C, 2004, BIOCHEMISTRY-US, V43, P2879, DOI 10.1021/bi036094h; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; Cisek K, 2012, BIOPHYS CHEM, V170, P25, DOI 10.1016/j.bpc.2012.09.001; Cisek K, 2012, BIOORGAN MED CHEM, V20, P1434, DOI 10.1016/j.bmc.2011.12.062; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Congdon EE, 2008, J ALZHEIMERS DIS, V14, P453; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Congdon EE, 2009, J BIOL CHEM, V284, P20830, DOI 10.1074/jbc.M109.016089; Consonni V., 2000, HDB MOL DESCRIPTORS; Crowe A, 2007, BIOCHEM BIOPH RES CO, V358, P1, DOI 10.1016/j.bbrc.2007.03.056; Crowe A, 2013, J BIOL CHEM, V288, P11024, DOI 10.1074/jbc.M112.436006; DAHNE S, 1978, SCIENCE, V199, P1163, DOI 10.1126/science.199.4334.1163; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P14203, DOI 10.1021/bi001876l; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Hong DP, 2008, J MOL BIOL, V383, P214, DOI 10.1016/j.jmb.2008.08.039; Honson NS, 2008, J ALZHEIMERS DIS, V14, P417; Honson NS, 2007, NEUROBIOL DIS, V28, P251, DOI 10.1016/j.nbd.2007.07.018; Jacquemin D, 2009, ACCOUNTS CHEM RES, V42, P326, DOI 10.1021/ar800163d; Jensen JR, 2011, J ALZHEIMERS DIS, V26, P147, DOI 10.3233/JAD-2011-0003; Jensen JR, 2011, BIOORGAN MED CHEM, V19, P5147, DOI 10.1016/j.bmc.2011.07.016; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; Konovalov DA, 2008, J CHEM INF MODEL, V48, P2081, DOI 10.1021/ci800209k; Kuret J, 2005, MICROSC RES TECHNIQ, V67, P141, DOI 10.1002/jemt.20187; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Kuret J., 2007, PROTEIN FOLDING DIS, P287; Kurunczi L, 2007, INT J QUANTUM CHEM, V107, P2057, DOI 10.1002/qua.21384; Lamberto GR, 2009, P NATL ACAD SCI USA, V106, P21057, DOI 10.1073/pnas.0902603106; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; Li WK, 2009, J NEUROCHEM, V110, P1339, DOI 10.1111/j.1471-4159.2009.06224.x; Liu XR, 2004, DRUG METAB DISPOS, V32, P132, DOI 10.1124/dmd.32.1.132; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; Masuda M, 2009, FEBS LETT, V583, P787, DOI 10.1016/j.febslet.2009.01.037; Mauri A, 2006, MATCH-COMMUN MATH CO, V56, P237; Metivier-Pignon H, 2007, CHEMOSPHERE, V66, P887, DOI 10.1016/j.chemosphere.2006.06.032; Necula M, 2005, BIOCHEMISTRY-US, V44, P10227, DOI 10.1021/bi050387o; Necula M, 2005, FEBS LETT, V579, P1453, DOI 10.1016/j.febslet.2005.01.047; Necula M, 2004, ANAL BIOCHEM, V333, P205, DOI 10.1016/j.ab.2004.05.044; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Rao JN, 2008, BIOCHEMISTRY-US, V47, P4651, DOI 10.1021/bi8002378; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Ryan AJ, 2003, J MED CHEM, V46, P3448, DOI 10.1021/jm0340896; Schafer KN, 2011, BIOORG MED CHEM LETT, V21, P3273, DOI 10.1016/j.bmcl.2011.04.039; SELKOE DJ, 1982, SCIENCE, V215, P1243, DOI 10.1126/science.6120571; Smith MC, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.10; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Tetko IV, 2001, J CHEM INF COMP SCI, V41, P1488, DOI 10.1021/ci000392t; Tetko IV, 2001, J CHEM INF COMP SCI, V41, P1407, DOI 10.1021/ci010368v; Tomoo K, 2005, J BIOCHEM, V138, P413, DOI 10.1093/jb/mvi142; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Verhaar HJM, 2000, CHEMOSPHERE, V40, P875, DOI 10.1016/S0045-6535(99)00317-3; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wischik C. M., 2005, U. S. Patent, Patent No. [6,953,794, 6953794]; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; WISCHIK CM, 2008, 11 INT C ALZH DIS CH	76	35	35	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32599	32611		10.1074/jbc.M113.503474	http://dx.doi.org/10.1074/jbc.M113.503474			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072703	Green Published, hybrid			2022-12-28	WOS:000328681700042
J	Subrini, O; Sotomayor-Perez, AC; Hessel, A; Spiaczka-Karst, J; Selwa, E; Sapay, N; Veneziano, R; Pansieri, J; Chopineau, J; Ladant, D; Chenal, A				Subrini, Orso; Sotomayor-Perez, Ana-Cristina; Hessel, Audrey; Spiaczka-Karst, Johanna; Selwa, Edithe; Sapay, Nicolas; Veneziano, Remi; Pansieri, Jonathan; Chopineau, Joel; Ladant, Daniel; Chenal, Alexandre			Characterization of a Membrane-active Peptide from the Bordetella pertussis CyaA Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenylate Cyclase (Adenylyl Cyclase); Bacterial Toxins; Circular Dichroism (CD); Infrared Spectroscopy; Membrane; Molecular Dynamics; Peptide Conformation; Phospholipid Vesicle	ADENYLATE-CYCLASE TOXIN; CELL-PENETRATING PEPTIDES; TRANSFORM INFRARED-SPECTROSCOPY; ANTIGEN-PRESENTING CELLS; COARSE-GRAINED MODEL; PARTICLE MESH EWALD; MAGAININ 2 AMIDE; ESCHERICHIA-COLI; DIPHTHERIA-TOXIN; T-DOMAIN	Bordetella pertussis, the pathogenic bacteria responsible for whooping cough, secretes several virulence factors, among which is the adenylate cyclase toxin (CyaA) that plays a crucial role in the early stages of human respiratory tract colonization. CyaA invades target cells by translocating its catalytic domain directly across the plasma membrane and overproduces cAMP, leading to cell death. The molecular process leading to the translocation of the catalytic domain remains largely unknown. We have previously shown that the catalytic domain per se, AC384, encompassing residues 1-384 of CyaA, did not interact with lipid bilayer, whereas a longer polypeptide, AC489, spanning residues 1-489, binds to membranes and permeabilizes vesicles. Moreover, deletion of residues 375-485 within CyaA abrogated the translocation of the catalytic domain into target cells. Here, we further identified within this region a peptidic segment that exhibits membrane interaction properties. A synthetic peptide, P454, corresponding to this sequence (residues 454-485 of CyaA) was characterized by various biophysical approaches. We found that P454 (i) binds to membranes containing anionic lipids, (ii) adopts an -helical structure oriented in plane with respect to the lipid bilayer, and (iii) permeabilizes vesicles. We propose that the region encompassing the helix 454-485 of CyaA may insert into target cell membrane and induce a local destabilization of the lipid bilayer, thus favoring the translocation of the catalytic domain across the plasma membrane.	[Subrini, Orso; Sotomayor-Perez, Ana-Cristina; Hessel, Audrey; Spiaczka-Karst, Johanna; Ladant, Daniel; Chenal, Alexandre] Inst Pasteur, CNRS UMR 3528, Dept Biol Struct & Chim, Unite Biochim Interact Macromol, F-75724 Paris 15, France; [Selwa, Edithe] Inst Pasteur, CNRS UMR 3528, Dept Biol Struct & Chim, Unite Bioinformat Struct, F-75724 Paris 15, France; [Sapay, Nicolas] CEA Grenoble, Inst Rech Technol & Sci Vivant, Lab Chim & Biol Met, Direct Sci Vie,CEA, F-38054 Grenoble, France; [Veneziano, Remi; Pansieri, Jonathan; Chopineau, Joel] Inst Charles Gerhardt, UMR CNRS ENSCM UM2 UM1 5253, Equipe Mat Avances Catalyse & Sante, UFR Sci Pharmaceut & Biol, F-34093 Montpellier 05, France; [Chopineau, Joel] Univ Nimes, F-30021 Nimes, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Nimes	Ladant, D (corresponding author), Inst Pasteur, CNRS UMR 3528, Dept Biol Struct & Chim, Unite Biochim Interact Macromol, 28 Rue Dr Roux, F-75724 Paris 15, France.	daniel.ladant@pasteur.fr; alexandre.chenal@pasteur.fr	chopineau, joel/J-6674-2015; Chenal, Alexandre/C-2240-2009	chopineau, joel/0000-0001-8307-0167; Chenal, Alexandre/0000-0002-4959-1003; Veneziano, Remi/0000-0002-2726-3770; Pansieri, Jonathan/0000-0001-8918-9943; LADANT, Daniel/0000-0003-1955-548X	Institut Pasteur (Projet Transversal de Recherche) [PTR374]; CNRS [UMR 3528]; Agence Nationale de la Recherche, program Jeunes Chercheurs [ANR-09-JCJC-0012]	Institut Pasteur (Projet Transversal de Recherche); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche, program Jeunes Chercheurs(French National Research Agency (ANR))	This work was supported by the Institut Pasteur (Projet Transversal de Recherche, PTR374), CNRS (UMR 3528, Biologie Structurale et Agents Infectieux), and the Agence Nationale de la Recherche, program Jeunes Chercheurs (Grant ANR-09-JCJC-0012).	Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Basler M, 2007, J BIOL CHEM, V282, P12419, DOI 10.1074/jbc.M611226200; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Bechinger B, 1999, BIOPHYS J, V76, P552, DOI 10.1016/S0006-3495(99)77223-1; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Beven L, 2001, BIOCHEMISTRY-US, V40, P8152, DOI 10.1021/bi010188e; Bobone S, 2011, J PEPT SCI, V17, P335, DOI 10.1002/psc.1340; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Caesar CEB, 2006, BIOCHEMISTRY-US, V45, P7682, DOI 10.1021/bi052095t; Chenal A, 2005, J MOL BIOL, V349, P890, DOI 10.1016/j.jmb.2005.04.036; Chenal A, 2002, J TOXICOL-TOXIN REV, V21, P321, DOI 10.1081/TXR-120014408; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; Chenal A, 2009, J MOL BIOL, V391, P872, DOI 10.1016/j.jmb.2009.06.061; Chenal A, 2009, J BIOL CHEM, V284, P1781, DOI 10.1074/jbc.M807312200; Chiantia S, 2012, BIOPHYS J, V103, P2311, DOI 10.1016/j.bpj.2012.10.033; Chiantia S, 2012, BBA-BIOMEMBRANES, V1818, P1284, DOI 10.1016/j.bbamem.2012.02.005; COOTE JG, 1992, FEMS MICROBIOL LETT, V88, P137, DOI 10.1016/0378-1097(92)90688-K; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Diamond G, 2009, CURR PHARM DESIGN, V15, P2377, DOI 10.2174/138161209788682325; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Falnes PO, 2000, CURR OPIN CELL BIOL, V12, P407, DOI 10.1016/S0955-0674(00)00109-5; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; Galloux M, 2008, J BIOL CHEM, V283, P27668, DOI 10.1074/jbc.M802557200; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GLASER P, 1988, MOL MICROBIOL, V2, P19, DOI 10.1111/j.1365-2958.1988.tb00003.x; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; Goormaghtigh E, 1994, Subcell Biochem, V23, P329; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; Guermonprez P, 2002, EUR J IMMUNOL, V32, P3071, DOI 10.1002/1521-4141(200211)32:11<3071::AID-IMMU3071>3.0.CO;2-A; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; Guo Q, 2005, EMBO J, V24, P3190, DOI 10.1038/sj.emboj.7600800; Guo Q, 2008, J BIOL CHEM, V283, P23836, DOI 10.1074/jbc.M802168200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holubova J, 2012, INFECT IMMUN, V80, P1181, DOI 10.1128/IAI.05711-11; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeppesen B, 2008, J BIOL CHEM, V283, P6126, DOI 10.1074/jbc.M707637200; Johnson RM, 2011, METHODS MOL BIOL, V683, P535, DOI 10.1007/978-1-60761-919-2_38; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Karst JC, 2012, J BIOL CHEM, V287, P9200, DOI 10.1074/jbc.M111.316166; Karst JC, 2010, BIOCHEMISTRY-US, V49, P318, DOI 10.1021/bi9016389; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LADANT D, 1989, J BIOL CHEM, V264, P4015; LADANT D, 1986, J BIOL CHEM, V261, P6264; LeCoutre J, 1997, P NATL ACAD SCI USA, V94, P10167, DOI 10.1073/pnas.94.19.10167; Lindgren M, 2011, METHODS MOL BIOL, V683, P3, DOI 10.1007/978-1-60761-919-2_1; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Marsh D, 1999, BIOPHYS J, V77, P2630, DOI 10.1016/S0006-3495(99)77096-7; Martin C, 2004, J BACTERIOL, V186, P3760, DOI 10.1128/JB.186.12.3760-3765.2004; MASURE HR, 1990, BIOCHEMISTRY-US, V29, P140, DOI 10.1021/bi00453a017; Montagner C, 2007, BIOCHEMISTRY-US, V46, P1878, DOI 10.1021/bi602381z; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nakase I, 2013, MOL BIOSYST, V9, P855, DOI 10.1039/c2mb25467k; Osickova A, 1999, J BIOL CHEM, V274, P37644; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; Reig N, 2006, FEBS LETT, V580, P5572, DOI 10.1016/j.febslet.2006.08.033; ROSE T, 1995, J BIOL CHEM, V270, P26370, DOI 10.1074/jbc.270.44.26370; Roy MO, 2001, J MOL RECOGNIT, V14, P72, DOI 10.1002/1099-1352(200101/02)14:1<72::AID-JMR519>3.0.CO;2-2; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; Sandvig K, 2013, HISTOCHEM CELL BIOL, V140, P317, DOI 10.1007/s00418-013-1111-z; Sotomayor Perez AC, 2010, J MOL BIOL, V397, P534, DOI 10.1016/j.jmb.2010.01.031; Sotomayor-Perez Ana Cristina, 2012, Methods Mol Biol, V896, P331, DOI 10.1007/978-1-4614-3704-8_22; Sotomayor-Perez AC, 2011, J BIOL CHEM, V286, P16997, DOI 10.1074/jbc.M110.210393; Sotomayor-Perez AC, 2013, J AM CHEM SOC, V135, P11929, DOI 10.1021/ja404790f; Szilvay GR, 2009, BIOCHEMISTRY-US, V48, P11273, DOI 10.1021/bi901447j; Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375; Tatulian Suren A, 2013, Methods Mol Biol, V974, P177, DOI 10.1007/978-1-62703-275-9_9; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Tiriveedhi V, 2007, BIOCHEMISTRY-US, V46, P3888, DOI 10.1021/bi602527t; Tolokh IS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031911; Trabulo S, 2013, CURR PHARM DESIGN, V19, P2895; Uribe K. B., 2013, PLOS ONE, V8; Vinchurkar MS, 2004, BIOCHEMISTRY-US, V43, P13283, DOI 10.1021/bi049016i; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Wadhwani P, 2012, BIOPHYS J, V103, P265, DOI 10.1016/j.bpj.2012.06.004; Watson P, 2006, ADV DRUG DELIVER REV, V58, P1581, DOI 10.1016/j.addr.2006.09.016; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n; Westrop GD, 1996, GENE, V180, P91, DOI 10.1016/S0378-1119(96)00412-X; White SH, 1998, METHOD ENZYMOL, V295, P62; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wieprecht T, 2000, BIOPHYS CHEM, V85, P187, DOI 10.1016/S0301-4622(00)00120-4; Ziegler A, 2008, BIOPHYS J, V94, P2142, DOI 10.1529/biophysj.107.113472	94	39	41	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32585	32598		10.1074/jbc.M113.508838	http://dx.doi.org/10.1074/jbc.M113.508838			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24064217	Green Published, hybrid			2022-12-28	WOS:000328681700041
J	El Khouri, E; Le Pavec, G; Toledano, MB; Delaunay-Moisan, A				El Khouri, Elma; Le Pavec, Gwenaelle; Toledano, Michel B.; Delaunay-Moisan, Agnes			RNF185 Is a Novel E3 Ligase of Endoplasmic Reticulum-associated Degradation (ERAD) That Targets Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; CELL-RECEPTOR SUBUNITS; UBIQUITIN-LIGASE; QUALITY-CONTROL; MEMBRANE-PROTEIN; PROTEASOMAL DEGRADATION; ALPHA(1)-ANTITRYPSIN Z; MISFOLDED PROTEINS; ANTIGEN RECEPTOR; RING FINGER	In the endoplasmic reticulum (ER), misfolded or improperly assembled proteins are exported to the cytoplasm and degraded by the ubiquitin-proteasome pathway through a process called ER-associated degradation (ERAD). ER-associated E3 ligases, which coordinate substrate recognition, export, and proteasome targeting, are key components of ERAD. Cystic fibrosis transmembrane conductance regulator (CFTR) is one ERAD substrate targeted to co-translational degradation by the E3 ligase RNF5/RMA1. RNF185 is a RING domain-containing polypeptide homologous to RNF5. We show that RNF185 controls the stability of CFTR and of the CFTR Delta F508 mutant in a RING- and proteasome-dependent manner but does not control that of other classical ERAD model substrates. Reciprocally, its silencing stabilizes CFTR proteins. Turnover analyses indicate that, as RNF5, RNF185 targets CFTR to co-translational degradation. Importantly, however, simultaneous depletion of RNF5 and RNF185 profoundly blocks CFTR Delta F508 degradation not only during translation but also after synthesis is complete. Our data thus identify RNF185 and RNF5 as a novel E3 ligase module that is central to the control of CFTR degradation.	[El Khouri, Elma; Le Pavec, Gwenaelle; Toledano, Michel B.; Delaunay-Moisan, Agnes] CEA Saclay, Lab Stress Oxydant & Canc, Serv Biol Integrat & Genet Mol SBiGeM, Inst Biol & Technol Saclay IBiTec S, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Delaunay-Moisan, A (corresponding author), CEA Saclay, Lab Stress Oxydant & Canc, SBiGEM, IBiTec S, F-91191 Gif Sur Yvette, France.	agnes.delaunay-moisan@cea.fr	El Khouri, Elma/GRN-8601-2022		Ligue Contre le Cancer, Vaincre la Mucoviscidose; Fondation pour la Recherche Medicale; Agence Nationale pour la Recherche	Ligue Contre le Cancer, Vaincre la Mucoviscidose; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the Ligue Contre le Cancer, Vaincre la Mucoviscidose, the Fondation pour la Recherche Medicale, and Agence Nationale pour la Recherche (Project ERRed to M. B. T. and A. D. M.).	Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; Carroll SM, 2010, J BIOL CHEM, V285, P5146, DOI 10.1074/jbc.M109.067876; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Delaunay A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001609; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fanen P, 1999, FEBS LETT, V452, P371, DOI 10.1016/S0014-5793(99)00647-X; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Iida Y, 2011, J BIOL CHEM, V286, P16929, DOI 10.1074/jbc.M110.215871; Iioka H, 2007, NAT CELL BIOL, V9, P813, DOI 10.1038/ncb1607; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kny M, 2011, J BIOL CHEM, V286, P5151, DOI 10.1074/jbc.M110.134551; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kuang E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003007; Lenk U, 2002, J CELL SCI, V115, P3007; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu Y, 1997, J BIOL CHEM, V272, P7946, DOI 10.1074/jbc.272.12.7946; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rosser MFN, 2008, MOL BIOL CELL, V19, P4570, DOI 10.1091/mbc.E08-04-0357; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; Tcherpakov M, 2009, J BIOL CHEM, V284, P12099, DOI 10.1074/jbc.M808222200; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V278, pG39, DOI 10.1152/ajpgi.2000.278.1.G39; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Zhang Q, 2012, BIOCHEM J, V447, P261, DOI 10.1042/BJ20120598; Zhong B, 2010, J IMMUNOL, V184, P6249, DOI 10.4049/jimmunol.0903748; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	71	54	57	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31177	31191		10.1074/jbc.M113.470500	http://dx.doi.org/10.1074/jbc.M113.470500			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24019521	Green Published, hybrid			2022-12-28	WOS:000330778900035
J	Walker, R; Gissot, M; Huot, L; Alayi, TD; Hot, D; Marot, G; Schaeffer-Reiss, C; Van Dorsselaer, A; Kim, K; Tomavo, S				Walker, Robert; Gissot, Mathieu; Huot, Ludovic; Alayi, Tchilabalo Dilezitoko; Hot, David; Marot, Guillemette; Schaeffer-Reiss, Christine; Van Dorsselaer, Alain; Kim, Kami; Tomavo, Stanislas			Toxoplasma Transcription Factor TgAP2XI-5 Regulates the Expression of Genes Involved in Parasite Virulence and Host Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; PLASMODIUM-FALCIPARUM; MALARIA PARASITES; GONDII; DIMERIZATION; APICOMPLEXA; CYST	Gene regulation in apicomplexan parasites, a phylum containing important protozoan parasites such as Plasmodium and Toxoplasma, is poorly understood. The life cycle of Toxoplasma gondii is complex, with multiple proliferation and differentiation steps, of which tachyzoite proliferation is the most relevant to pathogenesis in humans and animals. Tachyzoites express invasion and virulence factors that are crucial for their survival and manipulation of host cell functions. The expression of those factors is tightly controlled during the tachyzoite cell cycle to permit their correct packaging in newly formed apical secretory organelles named micronemes and rhoptries in the daughter cells. However, little is known about the factors that control the expression of genes encoding the virulence factors present in these parasite-specific secretory organelles. We report that the plant-like nuclear factor TgAP2XI-5 targets more than 300 gene promoters and actively controls the transcription of these genes. Most of these target genes, including those that are essential for parasite virulence, showed a peak of expression in the S and M phases of the cell cycle. Furthermore, we identified the cis-regulatory element recognized by TgAP2XI-5 and demonstrated its ability to actively drive gene transcription. Our results demonstrated that TgAP2XI-5 is a novel DNA sequence-specific transcription factor associated with promoter activation. TgAP2XI-5 may regulate gene transcription of crucial virulence factors in T. gondii.	[Walker, Robert; Gissot, Mathieu; Huot, Ludovic; Hot, David; Van Dorsselaer, Alain; Tomavo, Stanislas] Univ Lille Nord France, Ctr Infect & Immun Lille, CNRS UMR 8204, Inst Pasteur Lille,INSERM 1019, F-59000 Lille, France; [Alayi, Tchilabalo Dilezitoko; Schaeffer-Reiss, Christine] Univ Strasbourg, Lab Spectrometrie Masse Bioorgan, IPHC, CNRS UMR 7178, F-67087 Strasbourg, France; [Marot, Guillemette] INRIA MODAL Team, F-59650 Villeneuve Dascq, France; [Kim, Kami] Albert Einstein Coll Med, Dept Med & Microbiol & Immunol, Bronx, NY 10461 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Yeshiva University; Albert Einstein College of Medicine	Tomavo, S (corresponding author), Univ Lille Nord France, Ctr Infect & Immun Lille, CNRS UMR 8204, Inst Pasteur Lille,INSERM 1019, F-59000 Lille, France.	Stan.Tomavo@pasteur-lille.fr	Walker, Robert/C-3202-2013; Marot, Guillemette/O-6525-2014; Gissot, Mathieu/AFN-3127-2022; Alayi, Tchilabalo Dilezitoko/X-7191-2018; Hot, David/M-6775-2016	Walker, Robert/0000-0003-0032-9925; Marot, Guillemette/0000-0002-7437-8239; Gissot, Mathieu/0000-0003-0047-8189; Alayi, Tchilabalo Dilezitoko/0000-0002-7291-531X; Hot, David/0000-0002-2361-0616; Kim, Kami/0000-0003-3384-152X	National Institutes of Health [R01AI087625, RC4AI092801]; CNRS; INSERM; French National Research Agency [ANR-09-MIEN-002-01]; National Agency for Research [ANR-11-LABX-0024]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC4AI092801, R01AI087625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French National Research Agency(French National Research Agency (ANR)); National Agency for Research(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI087625 and RC4AI092801. (to K. K.). This work was also supported by the CNRS, INSERM, French National Research Agency Grant ANR-09-MIEN-002-01 (BradyToxoFT), and Grant ANR-11-LABX-0024 from the National Agency for Research to the Laboratoire d'Excellence ParaFrap.	Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Boyle JP, 2008, EUKARYOT CELL, V7, P1403, DOI 10.1128/EC.00073-08; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Gissot M, 2009, INT J PARASITOL, V39, P145, DOI 10.1016/j.ijpara.2008.10.002; Gissot M, 2007, PLOS PATHOG, V3, P709, DOI 10.1371/journal.ppat.0030077; Gissot M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032671; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Iwanaga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047557; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lindner SE, 2010, J MOL BIOL, V395, P558, DOI 10.1016/j.jmb.2009.11.004; Naguleswaran A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001232; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Radke JB, 2013, P NATL ACAD SCI USA, V110, P6871, DOI 10.1073/pnas.1300059110; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Toedling J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000227; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Walker R, 2013, MOL MICROBIOL, V87, P641, DOI 10.1111/mmi.12121; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	27	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31127	31138		10.1074/jbc.M113.486589	http://dx.doi.org/10.1074/jbc.M113.486589			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24025328	hybrid, Green Published			2022-12-28	WOS:000330778900031
J	Bunce, MW; Bos, MHA; Krishnaswamy, S; Camire, RM				Bunce, Matthew W.; Bos, Mettine H. A.; Krishnaswamy, Sriram; Camire, Rodney M.			Restoring the Procofactor State of Factor Va-like Variants by Complementation with B-domain Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Coagulation Factors; Enzyme Mechanisms; Hemostasis; Protein Engineering; Recombinant Protein Expression; Autoinhibition; Factor V; Factor Va; Prothrombinase	FACTOR PATHWAY INHIBITOR; COAGULATION-FACTOR-V; FACTOR XA-BINDING; BOVINE FACTOR-V; THROMBIN-CATALYZED ACTIVATION; CLOTTING FACTOR-V; ELECTRON-MICROSCOPY; BLOOD-COAGULATION; COFACTOR FUNCTION; PROTHROMBINASE COMPLEX	Background: B-domain fragments of factor V (FV) were used to assess the mechanism by which it is maintained as a procofactor. Results: A basic region fragment binds to FV containing an intact acidic region and inhibits FXa binding. Conclusion: B-domain sequences function as cis- and trans-acting elements to suppress FV(a) procoagulant function. Significance: The results provide mechanistic insight into FV autoinhibition and activation. Coagulation factor V (FV) circulates as an inactive procofactor and is activated to FVa by proteolytic removal of a large inhibitory B-domain. Conserved basic and acidic sequences within the B-domain appear to play an important role in keeping FV as an inactive procofactor. Here, we utilized recombinant B-domain fragments to elucidate the mechanism of this FV autoinhibition. We show that a fragment encoding the basic region (BR) of the B-domain binds with high affinity to cofactor-like FV(a) variants that harbor an intact acidic region. Furthermore, the BR inhibits procoagulant function of the variants, thereby restoring the procofactor state. The BR competes with FXa for binding to FV(a), and limited proteolysis of the B-domain, specifically at Arg(1545), ablates BR binding to promote high affinity association between FVa and FXa. These results provide new insight into the mechanism by which the B-domain stabilizes FV as an inactive procofactor and reveal how limited proteolysis of FV progressively destabilizes key regulatory regions of the B-domain to produce an active form of the molecule.	[Bunce, Matthew W.; Bos, Mettine H. A.; Krishnaswamy, Sriram; Camire, Rodney M.] Univ Penn, Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram; Camire, Rodney M.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Camire, RM (corresponding author), Childrens Hosp Philadelphia, Colket Translat Res Ctr 5018, 3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	rcamire@mail.med.upenn.edu	Bos, Mettine/S-5317-2016; Krishnaswamy, Sriram/Z-4380-2019	Bos, Mettine/0000-0002-8164-817X; 	National Institutes of Health [R01 HL88010, P01 HL74124]; NHLBI [T32 HL-07439]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124, R01HL108933, T32HL007439, R01HL088010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL88010 and P01 HL74124 (Project 2; to R. M. C.) and Grant T32 HL-07439 from NHLBI (to M. W. B.).	Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bevington P. R., 1992, DATA REDUCTION ERROR, P141; Bos MHA, 2012, J BIOL CHEM, V287, P26342, DOI 10.1074/jbc.M112.377168; Broze GJ, 2012, FRONT BIOSCI-LANDMRK, V17, P262, DOI 10.2741/3926; Buddai SK, 2010, J BIOL CHEM, V285, P5212, DOI 10.1074/jbc.M109.049833; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Camire RM, 1998, BIOCHEMISTRY-US, V37, P11896, DOI 10.1021/bi980520v; DENNIS S, 1990, EUR J BIOCHEM, V188, P61, DOI 10.1111/j.1432-1033.1990.tb15371.x; Duckers C, 2008, BLOOD, V112, P3615, DOI 10.1182/blood-2008-06-162453; Duckers C, 2010, BLOOD, V115, P879, DOI 10.1182/blood-2009-08-237719; ESMON CT, 1979, J BIOL CHEM, V254, P964; ESMON CT, 1973, BIOCHIM BIOPHYS ACTA, V310, P289, DOI 10.1016/0005-2795(73)90034-2; FOSTER WB, 1983, J BIOL CHEM, V258, P3970; FOWLER WE, 1990, P NATL ACAD SCI USA, V87, P7648, DOI 10.1073/pnas.87.19.7648; Gale AJ, 2007, J BIOL CHEM, V282, P21848, DOI 10.1074/jbc.M702192200; Gould WR, 2004, J BIOL CHEM, V279, P2383, DOI 10.1074/jbc.M308600200; Heeb MJ, 1996, PROTEIN SCI, V5, P1883, DOI 10.1002/pro.5560050914; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; Kalafatis M, 2003, J BIOL CHEM, V278, P33550, DOI 10.1074/jbc.M303153200; KANE WH, 1990, BIOCHEMISTRY-US, V29, P6762, DOI 10.1021/bi00481a003; KANE WH, 1981, J BIOL CHEM, V256, P1002; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; KELLER FG, 1995, BIOCHEMISTRY-US, V34, P4118, DOI 10.1021/bi00012a030; Khan AR, 1998, PROTEIN SCI, V7, P815; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LAMPE PD, 1984, J BIOL CHEM, V259, P9959; LAUE TM, 1984, BIOCHEMISTRY-US, V23, P1339, DOI 10.1021/bi00302a001; Mann K G, 1976, Methods Enzymol, V45, P123; MANN KG, 1981, METHOD ENZYMOL, V80, P286; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; MANN KG, 1990, BLOOD, V76, P1; Maroney SA, 2007, BLOOD, V109, P1931, DOI 10.1182/blood-2006-07-037283; Mast AE, 1996, BLOOD, V87, P1845; Mast Alan E, 2011, Front Biosci (Schol Ed), V3, P1457; MOSESSON MW, 1985, BLOOD, V65, P1158; MOSESSON MW, 1990, J BIOL CHEM, V265, P8863; Ndonwi M, 2012, J THROMB HAEMOST, V10, P1944, DOI 10.1111/j.1538-7836.2012.04834.x; NESHEIM ME, 1979, J BIOL CHEM, V254, P508; NESHEIM ME, 1979, J BIOL CHEM, V254, P1326; NESHEIM ME, 1984, J BIOL CHEM, V259, P3187; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NOVOTNY WF, 1988, BLOOD, V72, P2020; OTTO A, 1991, EUR J BIOCHEM, V202, P67, DOI 10.1111/j.1432-1033.1991.tb16345.x; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; Segers K, 2006, PROTEINS, V64, P968, DOI 10.1002/prot.21051; Siigur J, 2001, HAEMOSTASIS, V31, P123; SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2010, BLOOD, V116, P4353, DOI 10.1182/blood-2010-01-266791; Steen M, 2002, J BIOL CHEM, V277, P50022, DOI 10.1074/jbc.M205609200; Steen M, 2002, J BIOL CHEM, V277, P38424, DOI 10.1074/jbc.M204972200; Steen M, 2008, J BIOL CHEM, V283, P20805, DOI 10.1074/jbc.M802703200; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; STRAUME M, 1992, METHOD ENZYMOL, V210, P87; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; Thorelli E, 1998, THROMB HAEMOSTASIS, V80, P92, DOI 10.1055/s-0037-1615145; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; Toso R, 2008, J BIOL CHEM, V283, P18627, DOI 10.1074/jbc.M802205200; Yun TH, 2009, J CELL MOL MED, V13, P4146, DOI 10.1111/j.1582-4934.2009.00884.x; Zhu H, 2007, J BIOL CHEM, V282, P15033, DOI 10.1074/jbc.M701315200	68	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30151	30160		10.1074/jbc.M113.506840	http://dx.doi.org/10.1074/jbc.M113.506840			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014022	Green Published, hybrid			2022-12-28	WOS:000329868100015
J	Dave, JM; Kang, HJ; Abbey, CA; Maxwell, SA; Bayless, KJ				Dave, Jui M.; Kang, Hojin; Abbey, Colette A.; Maxwell, Steve A.; Bayless, Kayla J.			Proteomic Profiling of Endothelial Invasion Revealed Receptor for Activated C Kinase 1 (RACK1) Complexed with Vimentin to Regulate Focal Adhesion Kinase (FAK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Collagen; Endothelial Cell; Focal Adhesion Kinase; Morphogenesis; RACK1; Vimentin	SCAFFOLDING PROTEIN; INTERMEDIATE-FILAMENTS; CONDITIONAL KNOCKOUT; EXTRACELLULAR-MATRIX; INTERACTING PROTEIN; MEDIATED REGULATION; LUMEN FORMATION; AKT ACTIVATION; CELL-MIGRATION; IN-VITRO	Angiogenesis is critical for many physiological and pathological processes. To identify molecules relevant to angiogenesis, we performed a proteomic screen comparing invading versus non-invading endothelial cells in three-dimensional collagen matrices. We found up-regulated levels of receptor for activated C kinase 1 (RACK1) and the intermediate filament protein vimentin that correlated with increased endothelial cell invasion. Because both RACK1 and vimentin have been linked to focal adhesion kinase (FAK), we investigated whether this pathway regulated invasion. RACK1 depletion reduced invasion responses, and this was associated with attenuated activation of FAK. Knockdown of vimentin significantly decreased levels of phosphorylated and total FAK. Treatment with a pharmacological inhibitor of FAK dose-dependently reduced invasion, indicating a crucial role for FAK activity during invasion. Because RACK1 and vimentin were both up-regulated with sphingosine 1-phosphate treatment, required for invasion, and regulated FAK, we tested whether they complexed together. RACK1 complexed with vimentin, and growth factors enhanced this interaction. In addition, RACK1, vimentin, and FAK formed an intermolecular complex in invading endothelial cultures in three dimensions in response to stimulation by sphingosine 1-phosphate and growth factors. Moreover, depletion of RACK1 decreased the association of vimentin and FAK, suggesting that RACK1 was required for stabilizing vimentin-FAK interactions during sprouting. Silencing of vimentin and RACK1 decreased cell adhesion and focal contact formation. Taken together, these results demonstrate that proangiogenic signals converge to enhance expression and association of RACK1 and vimentin, which regulated FAK, resulting in successful endothelial sprout formation in three-dimensional collagen matrices.	[Dave, Jui M.; Kang, Hojin; Abbey, Colette A.; Maxwell, Steve A.; Bayless, Kayla J.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Bayless, KJ (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, 440 Reynolds Med Bldg, College Stn, TX 77843 USA.	kbayless@medicine.tamhsc.edu		Dave, Jui/0000-0002-5448-4798	National Institutes of Health, Public Health Service from NHLBI [HL-095786]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095786] Funding Source: NIH RePORTER	National Institutes of Health, Public Health Service from NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-095786, a Public Health Service grant from the NHLBI (to K. J. B.).	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Al-Reefy S, 2010, BREAST CANCER RES TR, V123, P911, DOI 10.1007/s10549-010-1020-y; Alfonso P, 2005, PROTEOMICS, V5, P2602, DOI 10.1002/pmic.200401196; Arold ST, 2011, CURR OPIN STRUC BIOL, V21, P808, DOI 10.1016/j.sbi.2011.09.008; Bayless KJ, 2009, NAT PROTOC, V4, P1888, DOI 10.1038/nprot.2009.221; Bayless KJ, 1997, PROTEIN EXPRES PURIF, V9, P309, DOI 10.1006/prep.1996.0699; Berns H, 2000, FASEB J, V14, P2549, DOI 10.1096/fj.99-1038com; BERSHADSKY AD, 1987, CELL MOTIL CYTOSKEL, V8, P274, DOI 10.1002/cm.970080308; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Burgstaller G, 2010, MOL BIOL CELL, V21, P3362, DOI 10.1091/mbc.E10-02-0094; Burridge K, 1997, TRENDS CELL BIOL, V7, P342, DOI 10.1016/S0962-8924(97)01127-6; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cao XX, 2010, BREAST CANCER RES TR, V123, P375, DOI 10.1007/s10549-009-0657-x; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chen JG, 2006, J EXP BOT, V57, P2697, DOI 10.1093/jxb/erl035; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Egginton S, 2003, MICROCIRCULATION, V10, P45, DOI 10.1038/sj.mn.7800174; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85; Guan JL, 2010, IUBMB LIFE, V62, P268, DOI 10.1002/iub.303; Guo JJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-108; Hakim ZS, 2007, MOL CELL BIOL, V27, P5352, DOI 10.1128/MCB.00068-07; Helfand BT, 2005, TRENDS CELL BIOL, V15, P568, DOI 10.1016/j.tcb.2005.09.009; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Ili D, 1995, NATURE, V377, P539, DOI 10.1038/377539a07566154; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Kiely PA, 2008, J BIOL CHEM, V283, P22952, DOI 10.1074/jbc.M800802200; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Koehler JA, 2001, BIOCHEM BIOPH RES CO, V283, P888, DOI 10.1006/bbrc.2001.4889; Kwak HI, 2012, ANGIOGENESIS, V15, P287, DOI 10.1007/s10456-012-9262-4; Lee HS, 2002, OSTEOARTHR CARTILAGE, V10, P890, DOI 10.1053/joca.2002.0842; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Martin GM, 1996, JPN J CANC RES, P87; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Montesano R, 1992, EXS, V61, P129; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nicosia RF, 1999, INT REV CYTOL, V185, P1; Onishi I, 2007, CELL SIGNAL, V19, P194, DOI 10.1016/j.cellsig.2006.06.011; Oriolo AS, 2007, EXP CELL RES, V313, P2255, DOI 10.1016/j.yexcr.2007.02.030; Owens LV, 1996, ANN SURG ONCOL, V3, P100, DOI 10.1007/BF02409059; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Peters SLM, 2007, CURR OPIN PHARMACOL, V7, P186, DOI 10.1016/j.coph.2006.09.008; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Rigas AC, 2003, J BIOL CHEM, V278, P46087, DOI 10.1074/jbc.M306219200; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Serrels A, 2011, CELL ADHES MIGR, V5, P360, DOI 10.4161/cam.5.4.17290; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Singh S, 2003, CANCER RES, V63, P2306; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Su SC, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M110.157271; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Tremblay L, 1996, INT J CANCER, V68, P164, DOI 10.1002/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Usacheva A, 2003, J IMMUNOL, V171, P2989, DOI 10.4049/jimmunol.171.6.2989; VERNON RB, 1995, AM J PATHOL, V147, P873; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Zhao J, 2009, CELL SIGNAL, V21, P1945, DOI 10.1016/j.cellsig.2009.09.002	73	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30720	30733		10.1074/jbc.M113.512467	http://dx.doi.org/10.1074/jbc.M113.512467			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24005669	Green Published, hybrid			2022-12-28	WOS:000329868100072
J	Huysmans, GHM; Guilvout, I; Pugsley, AP				Huysmans, Gerard H. M.; Guilvout, Ingrid; Pugsley, Anthony P.			Sequential Steps in the Assembly of the Multimeric Outer Membrane Secretin PulD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Kinetics; Membrane Proteins; Phospholipid Vesicle; Protein Self-assembly; Protein Synthesis; Secretin; Type II Secretion	ESCHERICHIA-COLI; LIPID-BILAYERS; PORE FORMATION; IN-VITRO; PSEUDOMONAS-AERUGINOSA; STRUCTURAL INSIGHTS; TRANSITION-STATE; PROTEIN PAGP; MECHANISM; CHAPERONE	Investigations into protein folding are largely dominated by studies on monomeric proteins. However, the transmembrane domain of an important group of membrane proteins is only formed upon multimerization. Here, we use in vitro translation-coupled folding and insertion into artificial liposomes to investigate kinetic steps in the assembly of one such protein, the outer membrane secretin PulD of the bacterial type II secretion system. Analysis of the folding kinetics, measured by the acquisition of distinct determinants of the native state, provides unprecedented evidence for a sequential multistep process initiated by membrane-driven oligomerization. The effects of varying the lipid composition of the liposomes indicate that PulD first forms a prepore structure that attains the native state via a conformational switch.	[Pugsley, Anthony P.] Inst Pasteur, Mol Genet Unit, Dept Microbiol, F-75724 Paris 15, France; [Pugsley, Anthony P.] Inst Pasteur, Dept Struct Biol & Chem, F-75724 Paris 15, France; Inst Pasteur, CNRS, ERL3526, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Pugsley, AP (corresponding author), Inst Pasteur, Mol Genet Unit, Dept Microbiol, Rue Dr Roux, F-75724 Paris 15, France.	max@pasteur.fr	Huysmans, Gerard/AAJ-6285-2020		French National Research Agency Agence Nationale de la Recherche [09-BLAN-0291]; Marie Curie Intra-European Fellowship [PIEF-GA-2010-272611]	French National Research Agency Agence Nationale de la Recherche(French National Research Agency (ANR)); Marie Curie Intra-European Fellowship(European Commission)	This work was supported in part by the French National Research Agency Agence Nationale de la Recherche Grant 09-BLAN-0291. This work was also supported by Marie Curie Intra-European Fellowship PIEF-GA-2010-272611 (to G. H. M. H.).	Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; BLANTON MP, 1992, BIOCHEMISTRY-US, V31, P3738, DOI 10.1021/bi00130a003; Bondar AN, 2012, BBA-BIOMEMBRANES, V1818, P942, DOI 10.1016/j.bbamem.2011.11.035; Bowie JU, 2011, CURR OPIN STRUC BIOL, V21, P42, DOI 10.1016/j.sbi.2010.10.003; Burgess NK, 2008, J BIOL CHEM, V283, P26748, DOI 10.1074/jbc.M802754200; Cao Z, 2012, P NATL ACAD SCI USA, V109, P8121, DOI 10.1073/pnas.1201298109; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Clarke OB, 2012, ADV EXP MED BIOL, V747, P122, DOI 10.1007/978-1-4614-3229-6_8; Collin S, 2007, MOL MICROBIOL, V64, P1350, DOI 10.1111/j.1365-2958.2007.05743.x; Collin S, 2013, RES MICROBIOL, V164, P390, DOI 10.1016/j.resmic.2013.03.023; Collin S, 2011, MOL MICROBIOL, V80, P655, DOI 10.1111/j.1365-2958.2011.07596.x; Curnow P, 2007, P NATL ACAD SCI USA, V104, P18970, DOI 10.1073/pnas.0705067104; Curnow P, 2011, P NATL ACAD SCI USA, V108, P14133, DOI 10.1073/pnas.1012594108; Cymer F, 2012, BIOL CHEM, V393, P1215, DOI 10.1515/hsz-2012-0231; Cymer F, 2010, BIOCHEMISTRY-US, V49, P279, DOI 10.1021/bi901660t; Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x; Dewald AH, 2011, BIOPHYS J, V100, P2131, DOI 10.1016/j.bpj.2011.03.025; Dowd KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002787; Dunstone MA, 2012, CURR OPIN STRUC BIOL, V22, P342, DOI 10.1016/j.sbi.2012.04.008; Fiedler S, 2010, CELL MOL LIFE SCI, V67, P1779, DOI 10.1007/s00018-010-0259-0; Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999; Guilvout I, 2008, J MOL BIOL, V382, P13, DOI 10.1016/j.jmb.2008.06.055; Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402; Guilvout I, 2011, RES MICROBIOL, V162, P180, DOI 10.1016/j.resmic.2011.01.006; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; Hong HD, 2004, P NATL ACAD SCI USA, V101, P4065, DOI 10.1073/pnas.0400358101; Hong H, 2011, J AM CHEM SOC, V133, P11389, DOI 10.1021/ja204524c; Hong H, 2010, P NATL ACAD SCI USA, V107, P19802, DOI 10.1073/pnas.1010348107; Huysmans GHM, 2012, J MOL BIOL, V416, P453, DOI 10.1016/j.jmb.2011.12.039; Huysmans GHM, 2010, P NATL ACAD SCI USA, V107, P4099, DOI 10.1073/pnas.0911904107; Junge F, 2011, NEW BIOTECHNOL, V28, P262, DOI 10.1016/j.nbt.2010.07.002; Kalli AC, 2011, P NATL ACAD SCI USA, V108, P11890, DOI 10.1073/pnas.1104505108; Kleinschmidt JH, 1996, BIOCHEMISTRY-US, V35, P12993, DOI 10.1021/bi961478b; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Lieberman JA, 2012, J BACTERIOL, V194, P1646, DOI 10.1128/JB.06330-11; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Masi M, 2009, MICROBIOL-SGM, V155, P1847, DOI 10.1099/mic.0.027219-0; McLaughlin LS, 2012, CURR OPIN STRUC BIOL, V22, P208, DOI 10.1016/j.sbi.2012.02.005; McMorran LM, 2013, J MOL BIOL, V425, P3178, DOI 10.1016/j.jmb.2013.06.017; Meng GY, 2009, MOL MEMBR BIOL, V26, P136, DOI 10.1080/09687680802712422; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108; Nickerson NN, 2012, J BACTERIOL, V194, P4951, DOI 10.1128/JB.00798-12; Nickerson NN, 2011, J BIOL CHEM, V286, P38833, DOI 10.1074/jbc.M111.279851; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Patel GJ, 2009, BIOCHEMISTRY-US, V48, P10235, DOI 10.1021/bi901403c; PERIDES G, 1987, J BIOL CHEM, V262, P13742; RODIONOVA NA, 1995, BIOCHEMISTRY-US, V34, P1921, DOI 10.1021/bi00006a013; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; SMITH DP, 1981, BIOCHEMISTRY-US, V20, P2417, DOI 10.1021/bi00512a008; Stanley AM, 2006, J MOL BIOL, V358, P120, DOI 10.1016/j.jmb.2006.01.033; Tan AE, 2010, MACROMOL BIOSCI, V10, P763, DOI 10.1002/mabi.200900479; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; TOMITA T, 1992, J BIOL CHEM, V267, P13391; Van der Meeren R, 2013, J BIOL CHEM, V288, P1214, DOI 10.1074/jbc.M112.432096; Wallace LA, 2002, BIOPHYS CHEM, V101, P113, DOI 10.1016/S0301-4622(02)00155-2; Wang XH, 2012, J BIOL CHEM, V287, P19082, DOI 10.1074/jbc.M112.346338	60	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30700	30707		10.1074/jbc.M113.489112	http://dx.doi.org/10.1074/jbc.M113.489112			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24019525	hybrid, Green Published			2022-12-28	WOS:000329868100070
J	Macdonald-Obermann, JL; Adak, S; Landgraf, R; Piwnica-Worms, D; Pike, LJ				Macdonald-Obermann, Jennifer L.; Adak, Sangeeta; Landgraf, Ralf; Piwnica-Worms, David; Pike, Linda J.			Dynamic Analysis of the Epidermal Growth Factor (EGF) Receptor-ErbB2-ErbB3 Protein Network by Luciferase Fragment Complementation Imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Epidermal Growth Factor (EGF); Epidermal Growth Factor Receptor (EGFR); Growth Factors; Receptor Tyrosine Kinase; ErbB2; ErbB3	FACTOR RECEPTOR EGFR; KINASE DOMAIN; BREAST-CANCER; SIGNAL-TRANSDUCTION; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; DIMER FORMATION; ERBB RECEPTORS; ACTIVATION; DIMERIZATION	Background: The EGF receptor, ErbB2, and ErbB3 can interact to form dimers. Results: Analyses of these interactions show that ErbB3 interacts strongly with ErbB2 but weakly with the EGF receptor. All ErbB receptor interactions are enhanced by erlotinib and lapatinib. Conclusion: ErbB3 binds and is functionally affected by tyrosine kinase inhibitors. Significance: Tyrosine kinase inhibitors restructure the network of ErbB interactions. ErbB3 is a member of the ErbB family of receptor tyrosine kinases. It is unique because it is the only member of the family whose kinase domain is defective. As a result, it is obliged to form heterodimers with other ErbB receptors to signal. In this study, we characterized the interaction of ErbB3 with the EGF receptor and ErbB2 and assessed the effects of Food and Drug Administration-approved therapeutic agents on these interactions. Our findings support the concept that ErbB3 exists in preformed clusters that can be dissociated by NRG-1 and that it interacts with other ErbB receptors in a distinctly hierarchical fashion. Our study also shows that all pairings of the EGF receptor, ErbB2, and ErbB3 form ligand-independent dimers/oligomers. The small-molecule tyrosine kinase inhibitors erlotinib and lapatinib differentially enhance the dimerization of the various ErbB receptor pairings, with the EGFR/ErbB3 heterodimer being particularly sensitive to the effects of erlotinib. The data suggest that the physiological effects of these drugs may involve not only inhibition of tyrosine kinase activity but also a dynamic restructuring of the entire network of receptors.	[Macdonald-Obermann, Jennifer L.; Adak, Sangeeta; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Bridging Res Imaging Genom & High Throughput Tech, St Louis, MO 63110 USA; [Landgraf, Ralf] Univ Miami, Dept Biochem & Mol Biol, Miami, FL 33101 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Miami	Pike, LJ (corresponding author), 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu		ADAK, SANGEETA/0000-0003-3855-9099	National Institutes of Health [R01GM082824, P50 CA94056]; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM082824 (to L. J. P.) and P50 CA94056 (to D. P. W.).	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Blakely BT, 2000, NAT BIOTECHNOL, V18, P218, DOI 10.1038/72686; Bublil EM, 2010, FASEB J, V24, P4744, DOI 10.1096/fj.10-166199; Carter P, 2000, Breast Dis, V11, P103; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Chen CHB, 2003, P NATL ACAD SCI USA, V100, P9226, DOI 10.1073/pnas.1332660100; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Graham J, 2004, NAT REV DRUG DISCOV, V3, P549, DOI 10.1038/nrd1445; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kani K, 2005, J BIOL CHEM, V280, P8238, DOI 10.1074/jbc.M410944200; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Landgraf R, 2000, BIOCHEMISTRY-US, V39, P8503, DOI 10.1021/bi000953+; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Li Y, 2012, J BIOL CHEM, V287, P31116, DOI 10.1074/jbc.M112.373647; Lichtner RB, 2001, CANCER RES, V61, P5790; Lu CF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414391; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Macdonald-Obermann JL, 2012, P NATL ACAD SCI USA, V109, P137, DOI 10.1073/pnas.1111316109; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415, DOI 10.1016/S0006-3495(02)75585-9; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Park E, 2008, BIOCHEMISTRY-US, V47, P11992, DOI 10.1021/bi8004208; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Walker F, 2004, J BIOL CHEM, V279, P22387, DOI 10.1074/jbc.M401244200; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yang KS, 2010, J BIOL CHEM, V285, P24014, DOI 10.1074/jbc.M110.103317; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; Yang S, 2007, J CELL SCI, V120, P2763, DOI 10.1242/jcs.007658; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zhang Q, 2012, P NATL ACAD SCI USA, V109, P13237, DOI 10.1073/pnas.1200105109; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	49	29	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30773	30784		10.1074/jbc.M113.489534	http://dx.doi.org/10.1074/jbc.M113.489534			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014028	Green Published, hybrid			2022-12-28	WOS:000329868100077
J	Shinya, S; Ohnuma, T; Yamashiro, R; Kimoto, H; Kusaoke, H; Anbazhagan, P; Juffer, AH; Fukamizo, T				Shinya, Shoko; Ohnuma, Takayuki; Yamashiro, Reina; Kimoto, Hisashi; Kusaoke, Hideo; Anbazhagan, Padmanabhan; Juffer, Andre H.; Fukamizo, Tamo			The First Identification of Carbohydrate Binding Modules Specific to Chitosan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate-binding Protein; Docking; Isothermal Titration Calorimetry; NMR; Oligosaccharide	DICTYOSTELIUM-DISCOIDEUM; FUNCTIONAL-ANALYSIS; AUTOMATED DOCKING; CHITIN-BINDING; PROTEIN; RECOGNITION; TITRATION; AFFINITY; DOMAIN; OLIGOSACCHARIDES	Background: Carbohydrate binding modules (CBMs) specific to chitosan have yet to be identified. Results: Two CBMs located at the C terminus of a chitosanase from Paenibacillus sp. IK-5 specifically bound chitosan oligosaccharides. Conclusion: Individual CBMs can accommodate at least two glucosamine units at loops extruded from the core -sandwich. Significance: The synergistic action of the two CBMs appears to facilitate chitosan hydrolysis. Two carbohydrate binding modules (DD1 and DD2) belonging to CBM32 are located at the C terminus of a chitosanase from Paenibacillus sp. IK-5. We produced three proteins, DD1, DD2, and tandem DD1/DD2 (DD1+DD2), and characterized their binding ability. Transition temperature of thermal unfolding (T-m) of each protein was elevated by the addition of cello-, laminari-, chitin-, or chitosan-hexamer (GlcN)(6). The T-m elevation (T-m) in DD1 was the highest (10.3 degrees C) upon the addition of (GlcN)(6) and was markedly higher than that in DD2 (1.0 degrees C). A synergistic effect was observed (T-m = 13.6 degrees C), when (GlcN)(6) was added to DD1+DD2. From isothermal titration calorimetry experiments, affinities to DD1 were not clearly dependent upon chain length of (GlcN)(n); G(r)degrees values were -7.8 (n = 6), -7.6 (n = 5), -7.6 (n = 4), -7.6 (n = 3), and -7.1 (n = 2) kcal/mol, and the value was not obtained for GlcN due to the lowest affinity. DD2 bound (GlcN)(n) with the lower affinities (G(r)degrees = -5.0 (n = 3) approximate to -5.2 (n = 6) kcal/mol). Isothermal titration calorimetry profiles obtained for DD1+DD2 exhibited a better fit when the two-site model was used for analysis and provided greater affinities to (GlcN)(6) for individual DD1 and DD2 sites (G(r)degrees = -8.6 and -6.4 kcal/mol, respectively). From NMR titration experiments, (GlcN)(n) (n = 2 approximate to 6) were found to bind to loops extruded from the core -sandwich of individual DD1 and DD2, and the interaction sites were similar to each other. Taken together, DD1+DD2 is specific to chitosan, and individual modules synergistically interact with at least two GlcN units, facilitating chitosan hydrolysis.	[Shinya, Shoko; Ohnuma, Takayuki; Yamashiro, Reina; Fukamizo, Tamo] Kinki Univ, Dept Adv Biosci, Nara 6318505, Japan; [Kimoto, Hisashi] Fukui Prefectural Univ, Dept Biosci, Fukui 9101195, Japan; [Kusaoke, Hideo] Fukui Univ Technol, Dept Environm & Biotechnol Frontier Engn, Fukui 9108505, Japan; [Anbazhagan, Padmanabhan; Juffer, Andre H.] Univ Oulu, Bioctr Oulu, FI-90074 Oulu, Finland; [Anbazhagan, Padmanabhan; Juffer, Andre H.] Univ Oulu, Dept Biochem, FI-90074 Oulu, Finland	Kindai University (Kinki University); Fukui Prefectural University; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu	Fukamizo, T (corresponding author), Kinki Univ, Dept Adv Biosci, 3327-204 Nakamachi, Nara 6318505, Japan.	fukamizo@nara.kindai.ac.jp	OHNUMA, Takayuki/T-8839-2019; Fukamizo, Tamo/AAY-7251-2020	Juffer, Andre/0000-0003-3533-0520	Strategic Project to Support the Formation of Research Bases at Private Universities; MEXT (Ministry of Education, Culture, Sports, Science, and Technology) [S1101035]; Japan Society for the Promotion of Science [25-3639]	Strategic Project to Support the Formation of Research Bases at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT (Ministry of Education, Culture, Sports, Science, and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Strategic Project to Support the Formation of Research Bases at Private Universities and a Matching Fund Subsidy from MEXT (Ministry of Education, Culture, Sports, Science, and Technology), 2011-2015 (S1101035).; Supported by a Research Fellowship for Young Scientists from Japan Society for the Promotion of Science (25-3639).	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; Akagi K, 2006, J BIOCHEM, V139, P483, DOI 10.1093/jb/mvj062; Aragao KS, 2008, PROTEINS, V73, P43, DOI 10.1002/prot.22038; Araki Y, 2010, BIOSCI BIOTECH BIOCH, V74, P802, DOI 10.1271/bbb.90845; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Boraston AB, 2006, J BIOL CHEM, V281, P587, DOI 10.1074/jbc.M509958200; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caspi J, 2009, APPL ENVIRON MICROB, V75, P7335, DOI 10.1128/AEM.01241-09; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dvortsov IA, 2012, MOL BIOL+, V46, P817, DOI 10.1134/S0026893312060039; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Garcia-Hernandez E, 2003, PROTEIN SCI, V12, P135, DOI 10.1110/ps.0222503; Goddard T.D., 2004, SPARKY 3; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Kezuka Y, 2006, J MOL BIOL, V358, P472, DOI 10.1016/j.jmb.2006.02.013; Kiedzierska A, 2007, BBA-PROTEINS PROTEOM, V1774, P1069, DOI 10.1016/j.bbapap.2007.07.007; Kimoto H, 2002, J BIOL CHEM, V277, P14695, DOI 10.1074/jbc.M108660200; Kimoto H, 2010, J MOL MICROB BIOTECH, V18, P14, DOI 10.1159/000274308; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Mathieu SV, 2010, J MOL BIOL, V400, P540, DOI 10.1016/j.jmb.2010.05.042; Mizutani K, 2012, APPL ENVIRON MICROB, V78, P4781, DOI 10.1128/AEM.07457-11; MONAGHAN RL, 1973, NATURE-NEW BIOL, V245, P78, DOI 10.1038/newbio245078a0; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Newstead SL, 2005, ACTA CRYSTALLOGR D, V61, P1483, DOI 10.1107/S0907444905026132; Ohnuma T, 2011, FEBS J, V278, P3991, DOI 10.1111/j.1742-4658.2011.08301.x; Onaga S, 2008, GLYCOBIOLOGY, V18, P414, DOI 10.1093/glycob/cwn018; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SIMPSON DL, 1974, BIOCHEMISTRY-US, V13, P3487, DOI 10.1021/bi00714a011; Simpson HD, 1999, J BACTERIOL, V181, P4611, DOI 10.1128/JB.181.15.4611-4616.1999; Synowiecki J, 2003, CRIT REV FOOD SCI, V43, P145, DOI 10.1080/10408690390826473; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSUKADA S, 1981, CARBOHYD RES, V88, P19, DOI 10.1016/S0008-6215(00)84598-X; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; van Bueren AL, 2009, J MOL BIOL, V385, P131, DOI 10.1016/j.jmb.2008.10.031; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VARUM KM, 1991, CARBOHYD RES, V217, P19, DOI 10.1016/0008-6215(91)84113-S; Vazana Y, 2010, APPL ENVIRON MICROB, V76, P3236, DOI 10.1128/AEM.00009-10; Vijayasarathy C, 2007, INVEST OPHTH VIS SCI, V48, P991, DOI 10.1167/iovs.06-0915; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	50	16	17	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30042	30053		10.1074/jbc.M113.503243	http://dx.doi.org/10.1074/jbc.M113.503243			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986450	Green Published, hybrid			2022-12-28	WOS:000329868100005
J	Demers-Giroux, PO; Bourdin, B; Sauve, R; Parent, L				Demers-Giroux, Pierre-Olivier; Bourdin, Benoite; Sauve, Remy; Parent, Lucie			Cooperative Activation of the T-type Ca(V)3.2 Channel INTERACTION BETWEEN DOMAINS II AND III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNEL; CALCIUM-CHANNELS; CRYSTAL-STRUCTURE; STRUCTURAL DETERMINANTS; CA2+ CHANNELS; MOLECULAR DETERMINANTS; VOLTAGE SENSORS; S4-S5 LINKER; INACTIVATION; MUTATIONS	T-type Ca(V)3 channels are important mediators of Ca2+ entry near the resting membrane potential. Little is known about the molecular mechanisms responsible for channel activation. Homology models based upon the high-resolution structure of bacterial Na-V channels predict interaction between the S4-S5 helix of Domain II (IIS4-S5) and the distal S6 pore region of Domain II (IIS6) and Domain III (IIIS6). Functional intra-and inter-domain interactions were investigated with a double mutant cycle analysis. Activation gating and channel kinetics were measured for 47 single mutants and 20 pairs of mutants. Significant coupling energies (Delta Delta G(interact) >= 1.5 kcal mol(-1)) were measured for 4 specific pairs of mutants introduced between IIS4-S5 and IIS6 and between IIS4-S5 and IIIS6. In agreement with the computer based models, Thr-911 in IIS4-S5 was functionally coupled with Ile-1013 in IIS6 during channel activation. The interaction energy was, however, found to be stronger between Val-907 in IIS4-S5 and Ile-1013 in IIS6. In addition Val-907 was significantly coupled with Asn-1548 in IIIS6 but not with Asn-1853 in IVS6. Altogether, our results demonstrate that the S4-S5 and S6 helices from adjacent domains are energetically coupled during the activation of a low voltage-gated T-type Ca(V)3 channel.	[Demers-Giroux, Pierre-Olivier; Bourdin, Benoite; Sauve, Remy; Parent, Lucie] Univ Montreal, Dept Physiol, Membrane Prot Res Grp, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Parent, L (corresponding author), POB 6128, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca						Amaral C, 2012, P NATL ACAD SCI USA, V109, P21336, DOI 10.1073/pnas.1218087109; Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Autret L, 2005, J PHYSIOL-LONDON, V567, P67, DOI 10.1113/jphysiol.2005.089342; Batulan Z, 2010, J BIOL CHEM, V285, P14005, DOI 10.1074/jbc.M109.097717; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; Berrou L, 2005, J BIOL CHEM, V280, P494, DOI 10.1074/jbc.M410859200; Berrou L, 2001, BIOPHYS J, V80, P215, DOI 10.1016/S0006-3495(01)76008-0; Beyl S, 2012, PFLUG ARCH EUR J PHY, V464, P391, DOI 10.1007/s00424-012-1144-5; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166; Bourdin B, 2010, J BIOL CHEM, V285, P22851, DOI 10.1074/jbc.M110.111062; Cao YQ, 2005, P NATL ACAD SCI USA, V102, P2590, DOI 10.1073/pnas.0409896102; Carbone E, 2006, CELL CALCIUM, V40, P147, DOI 10.1016/j.ceca.2006.04.019; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CARL SL, 1995, J CELL BIOL, V129, P673, DOI 10.1083/jcb.129.3.673; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Hans M, 1999, J NEUROSCI, V19, P1610; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hohaus A, 2005, J BIOL CHEM, V280, P38471, DOI 10.1074/jbc.M507013200; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Karmazinova M, 2011, PFLUG ARCH EUR J PHY, V461, P461, DOI 10.1007/s00424-011-0937-2; Karmazinova M, 2010, PFLUG ARCH EUR J PHY, V460, P1015, DOI 10.1007/s00424-010-0874-5; Khosravani H, 2006, PHYSIOL REV, V86, P941, DOI 10.1152/physrev.00002.2006; Klockner U, 1999, EUR J NEUROSCI, V11, P4171, DOI 10.1046/j.1460-9568.1999.00849.x; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Kurejova M, 2007, PFLUG ARCH EUR J PHY, V455, P527, DOI 10.1007/s00424-007-0302-7; Kusch J, 2010, BIOPHYS J, V99, P2488, DOI 10.1016/j.bpj.2010.07.041; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Marksteiner R, 2001, J PHYSIOL-LONDON, V537, P27, DOI 10.1111/j.1469-7793.2001.0027k.x; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Nelson MT, 2006, CURR PHARM DESIGN, V12, P2189, DOI 10.2174/138161206777585184; Nilius B, 2006, CELL CALCIUM, V40, P81, DOI 10.1016/j.ceca.2006.04.011; Olcese R, 1996, J PHYSIOL-LONDON, V497, P675, DOI 10.1113/jphysiol.1996.sp021799; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Randall A, 1999, MOL CELL NEUROSCI, V14, P255, DOI 10.1006/mcne.1999.0795; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Raybaud A, 2007, J BIOL CHEM, V282, P27944, DOI 10.1074/jbc.M703895200; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; Shakeri B, 2012, J BIOL CHEM, V287, P32835, DOI 10.1074/jbc.M112.387233; Singh Baljinder, 2007, Hum Mutat, V28, P524, DOI 10.1002/humu.9491; Siwek M, 2012, ADV EXP MED BIOL, V740, P1219, DOI 10.1007/978-94-007-2888-2_55; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; Staes M, 2001, J PHYSIOL-LONDON, V530, P35, DOI 10.1111/j.1469-7793.2001.0035m.x; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Talavera K, 2006, PFLUG ARCH EUR J PHY, V453, P189, DOI 10.1007/s00424-006-0129-7; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Wall-Lacelle S, 2011, J BIOL CHEM, V286, P27197, DOI 10.1074/jbc.M111.237412; Yang Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2184; ZHANG JF, 1993, NEUROPHARMACOLOGY, V32, P1075, DOI 10.1016/0028-3908(93)90003-L; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	66	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29281	29293		10.1074/jbc.M113.500975	http://dx.doi.org/10.1074/jbc.M113.500975			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23970551	hybrid, Green Published			2022-12-28	WOS:000330615300008
J	Wang, F; Xu, ZW; Zhou, J; Lo, WS; Lau, CF; Nangle, LA; Yang, XL; Zhang, MJ; Schimmel, P				Wang, Feng; Xu, Zhiwen; Zhou, Jie; Lo, Wing-Sze; Lau, Ching-Fun; Nangle, Leslie A.; Yang, Xiang-Lei; Zhang, Mingjie; Schimmel, Paul			Regulated Capture by Exosomes of mRNAs for Cytoplasmic tRNA Synthetases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TRANSLATION; CELLS; MICRORNAS; MECHANISM; PATHWAY; COMPLEX	Although tRNA synthetases are enzymes that catalyze the first step of translation in the cytoplasm, surprising functions unrelated to translation have been reported. These studies, and the demonstration of novel activities of splice variants, suggest a far broader reach of tRNA synthetases into cell biology than previously recognized. Here we show that mRNAs for most tRNA synthetases can be detected in exosomes. Also detected in exosomes was an mRNA encoding a unique splice variant that others had associated with prostate cancer. The exosomal mRNAs encoding the native synthetase and its cancer-associated splice variant could be translated in vitro and in mammalian cells into stable proteins. Other results showed that selection by exosomes of the splice variant mRNA could be regulated by an external stimulus. Thus, a broad and diverse regulated pool of tRNA synthetase-derived mRNAs is packaged for genetic exchange.	[Wang, Feng; Xu, Zhiwen; Zhou, Jie; Lo, Wing-Sze; Zhang, Mingjie; Schimmel, Paul] HKUST, Inst Adv Study, IAS HKUST Scripps R&D Lab, Kowloon, Hong Kong, Peoples R China; [Zhang, Mingjie] HKUST, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Wang, Feng; Xu, Zhiwen; Zhou, Jie; Lo, Wing-Sze; Lau, Ching-Fun] Pangu Biopharma, Hong Kong, Hong Kong, Peoples R China; [Nangle, Leslie A.] aTyr Pharma, San Diego, CA 92121 USA; [Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, La Jolla, CA 92037 USA	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Scripps Research Institute	Schimmel, P (corresponding author), HKUST, Inst Adv Study, IAS HKUST Scripps R&D Lab, Kowloon, Hong Kong, Peoples R China.	schimmel@scripps.edu	Yang, Xiang-Lei/AAR-7107-2020; Lo, Cario Wing Sze/DGZ-8810-2022	Zhang, Mingjie/0000-0001-9404-0190; Yang, Xiang-Lei/0000-0003-2554-084X	Innovation and Technology Fund of Hong Kong [UIM181, UIM192, UIM199]; NCI [CA092577]; National Institutes of Health [GM 088278]; aTyr Pharma; National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278] Funding Source: NIH RePORTER	Innovation and Technology Fund of Hong Kong; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); aTyr Pharma; National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Innovation and Technology Fund of Hong Kong (UIM181, UIM192, and UIM199), Grant CA092577 from the NCI (to P. S.) and Grant GM 088278 from the National Institutes of Health (to Y.-X.L.), aTyr Pharma, and by a fellowship from the National Foundation for Cancer Research. Professors Mingjie Zhang, Xiang-Lei Yang, and Paul Schimmel have a financial benefit from aTyr Pharma in the form of compensation or stock ownership or both. The partial support of this work by aTyr Pharma is stated in this footnote. The rest of the authors have affiliations that are annotated, and these affiliations include aTyr Pharma and Pangu Biopharma.	Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Del Prete MJ, 2007, RNA, V13, P414, DOI 10.1261/rna.79407; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; King RW, 1997, SCIENCE, V277, P973, DOI 10.1126/science.277.5328.973; LEDBETTER JA, 1987, MOL CELL BIOL, V7, P650, DOI 10.1128/MCB.7.2.650; Leygue Etienne, 2007, Nucl Recept Signal, V5, pe006; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; PERONA JJ, 1993, BIOCHEMISTRY-US, V32, P8758, DOI 10.1021/bi00085a006; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Xu XL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1686; Xu ZW, 2012, STRUCTURE, V20, P1470, DOI 10.1016/j.str.2012.08.001; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhu HY, 2011, AM J CARDIOVASC DIS, V1, P138	33	10	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29223	29228		10.1074/jbc.C113.490599	http://dx.doi.org/10.1074/jbc.C113.490599			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24003230	Green Published, hybrid			2022-12-28	WOS:000330615300001
J	Xu, GQ; Jiang, XG; Jaffrey, SR				Xu, Guoqiang; Jiang, Xiaogang; Jaffrey, Samie R.			A Mental Retardation-linked Nonsense Mutation in Cereblon Is Rescued by Proteasome Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MESSENGER-RNA; UBIQUITIN LIGASE; BINDING-PROTEIN; DEGRADATION; GENE; AUTOUBIQUITINATION; THALIDOMIDE; ABUNDANCE; MOUSE; IDENTIFICATION	A nonsense mutation in cereblon (CRBN) causes autosomal recessive nonsyndromic mental retardation. Cereblon is a substrate receptor for the Cullin-RING E3 ligase complex and couples the ubiquitin ligase to specific ubiquitination targets. The CRBN nonsense mutation (R419X) results in a protein lacking 24 amino acids at its C terminus. Although this mutation has been linked to mild mental retardation, the mechanism by which the mutation affects CRBN function is unknown. Here, we used biochemical and mass spectrometric approaches to explore the function of this mutant. We show that the protein retains its ability to assemble into a Cullin-RING E3 ligase complex and catalyzes the ubiquitination of CRBN-target proteins. However, we find that this mutant exhibits markedly increased levels of autoubiquitination and is more readily degraded by the proteasome than the wild type protein. We also show that the level of the mutant protein can be restored by a treatment of cells with a clinically utilized proteasome inhibitor, suggesting that this agent may be useful for the treatment of mental retardation associated with the CRBN R419X mutation. These data demonstrate that enhanced autoubiquitination and degradation account for the defect in CRBN activity that leads to mental retardation.	[Xu, Guoqiang; Jiang, Xiaogang] Soochow Univ, Dept Pharmacol, Coll Pharmaceut Sci, Jiangsu Key Lab Translat Res Neuropsychodis, Suzhou 215123, Jiangsu, Peoples R China; [Xu, Guoqiang; Jaffrey, Samie R.] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10065 USA	Soochow University - China; Cornell University	Xu, GQ (corresponding author), Soochow Univ, Dept Pharmacol, Coll Pharmaceut Sci, Suzhou 215123, Jiangsu, Peoples R China.	gux2002@suda.edu.cn; srj2003@med.cornell.edu		Jaffrey, Samie/0000-0003-3615-6958; Xu, Guoqiang/0000-0002-4753-4769	National Institutes of Health [RR19355, RR22615]; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019355, S10RR022615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Columbia University). The full-length and dominant negative CUL4As and His6-ubiquitin plasmids were from Pengbo Zhou (Weill Medical College of Cornell University). Weare grateful to Michael S. Cohen and Alessia Deglincerti for assistance in molecular biology and plasmid transfection and Steven S. Gross (Weill Medical College) and Yuliang Ma (Weill Medical College) for helpful discussions in MS/ MS analysis. The mass spectrometry work was performed at the Weill Medical College of Cornell University mass spectrometry core facility using instrumentation supported by National Institutes of Health Grants RR19355 and RR22615.	Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BAUMANN B, 1985, EMBO J, V4, P351, DOI 10.1002/j.1460-2075.1985.tb03636.x; BELGRADER P, 1994, MOL CELL BIOL, V14, P6326, DOI 10.1128/MCB.14.9.6326; Bhat KP, 2010, J BIOL CHEM, V285, P25893, DOI 10.1074/jbc.M110.127746; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P61; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; CHENG J, 1994, MOL CELL BIOL, V14, P6317, DOI 10.1128/MCB.14.9.6317; Damaj G, 2003, LEUKEMIA, V17, P1914, DOI 10.1038/sj.leu.2403058; Ehninger D, 2005, NAT NEUROSCI, V8, P548, DOI 10.1038/nn0505-548; ENSSLE J, 1993, P NATL ACAD SCI USA, V90, P10091, DOI 10.1073/pnas.90.21.10091; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Haberland J, 1997, J BIOL CHEM, V272, P24717, DOI 10.1074/jbc.272.39.24717; Higgins JJ, 2000, NEUROLOGY, V55, P335, DOI 10.1212/WNL.55.3.335; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Hohberger B, 2009, FEBS LETT, V583, P633, DOI 10.1016/j.febslet.2009.01.018; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jo S, 2005, J NEUROCHEM, V94, P1212, DOI 10.1111/j.1471-4159.2005.03344.x; Lai ZH, 2002, P NATL ACAD SCI USA, V99, P14734, DOI 10.1073/pnas.212428599; Lee KM, 2012, BIOCHEM BIOPH RES CO, V427, P618, DOI 10.1016/j.bbrc.2012.09.108; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; Lin GY, 1998, VIROLOGY, V249, P189, DOI 10.1006/viro.1998.9317; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Ren HG, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-40; Silva AJ, 2009, J NEURODEV DISORD, V1, P150, DOI 10.1007/s11689-009-9018-7; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wu FQ, 2011, MED MICROBIOL IMMUN, V200, P203, DOI 10.1007/s00430-011-0196-z; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zeier Z, 2009, GENE THER, V16, P1122, DOI 10.1038/gt.2009.83; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	47	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29573	29585		10.1074/jbc.M113.472092	http://dx.doi.org/10.1074/jbc.M113.472092			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23983124	Green Published, hybrid			2022-12-28	WOS:000330615300033
J	Hammer, JA; Wagner, W				Hammer, John A., III; Wagner, Wolfgang			Functions of Class V Myosins in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Cell Polarity; Endoplasmic Reticulum (ER); Ionotropic Glutamate Receptors (AMPA; NMDA); mRNA; Myosin; Neurons; PTEN; Rab Proteins; Receptor Recycling; Synaptic Plasticity	LONG-TERM DEPRESSION; RECYCLING ENDOSOMES; DENDRITIC SPINES; AMPA RECEPTORS; IN-VIVO; INTERACTING PROTEIN; GLUTAMATE-RECEPTOR; EPITHELIAL-CELLS; PURKINJE-CELLS; MOTOR COMPLEX	This minireview focuses on recent studies implicating class V myosins in organelle and macromolecule transport within neurons. These studies reveal that class V myosins play important roles in a wide range of fundamental processes occurring within neurons, including the transport into dendritic spines of organelles that support synaptic plasticity, the establishment of neuronal shape, the specification of polarized cargo transport, and the subcellular localization of mRNA.	[Hammer, John A., III] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA; [Wagner, Wolfgang] Univ Med Ctr Hamburg Eppendorf UKE, Dept Mol Neurogenet, Ctr Mol Neurobiol Hamburg ZMNH, D-20251 Hamburg, Germany	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Hamburg; University Medical Center Hamburg-Eppendorf	Hammer, JA (corresponding author), NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	hammerj@nhlbi.nih.gov		Wagner, Wolfgang/0000-0003-1187-2990; Hammer, John/0000-0002-2496-5179	Marie Curie FP7 Integration Grant within the Seventh European Union Framework Programme [GA-2012-321905]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000514] Funding Source: NIH RePORTER	Marie Curie FP7 Integration Grant within the Seventh European Union Framework Programme; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Marie Curie FP7 Integration Grant PCIG11-GA-2012-321905 within the Seventh European Union Framework Programme (to W. W.).	Alami NH, 2009, J NEUROSCI, V29, P6625, DOI 10.1523/JNEUROSCI.3829-08.2009; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Bittins CM, 2010, CELL MOL NEUROBIOL, V30, P369, DOI 10.1007/s10571-009-9459-2; Bittins CM, 2009, CELL MOL NEUROBIOL, V29, P597, DOI 10.1007/s10571-009-9352-z; Bridgman PC, 2009, RESULTS PROBL CELL D, V48, P91, DOI 10.1007/400_2009_10; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Brozzi F, 2012, TRAFFIC, V13, P54, DOI 10.1111/j.1600-0854.2011.01301.x; Chen YG, 2013, PSYCHIAT RES, V207, P13, DOI 10.1016/j.psychres.2013.02.026; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hartmann J., 2011, COLD SPRING HARB PER, V3; Heym RG, 2012, CELL MOL LIFE SCI, V69, P1843, DOI 10.1007/s00018-011-0902-4; Huang JD, 1998, GENETICS, V148, P1963; Jedlicka P, 2008, BEHAV BRAIN RES, V192, P12, DOI 10.1016/j.bbr.2008.02.033; Kano M, 2008, PHILOS T R SOC B, V363, P2173, DOI 10.1098/rstb.2008.2270; Kapitein LC, 2011, MOL CELL NEUROSCI, V46, P9, DOI 10.1016/j.mcn.2010.08.015; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; Kogel T, 2010, BIOCHEM SOC T, V38, P199, DOI 10.1042/BST0380199; Lalli G, 2003, J CELL SCI, V116, P4639, DOI 10.1242/jcs.00727; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Lise MF, 2009, J CELL SCI, V122, P3810, DOI 10.1242/jcs.050344; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Liu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3005; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; McCaffrey MW, 2012, BIOCHEM SOC T, V40, P1416, DOI 10.1042/BST20120172; Menasche G, 2002, AM J HUM GENET, V71, P1237, DOI 10.1086/344140; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; Miyata M, 2011, J NEUROSCI, V31, P6067, DOI 10.1523/JNEUROSCI.5651-10.2011; Muller T, 2008, NAT GENET, V40, P1163, DOI 10.1038/ng.225; Nalavadi VC, 2012, J NEUROSCI, V32, P15133, DOI 10.1523/JNEUROSCI.2006-12.2012; Nelson SR, 2009, BIOPHYS J, V97, P509, DOI 10.1016/j.bpj.2009.04.052; Oke OA, 2010, P NATL ACAD SCI USA, V107, P2509, DOI 10.1073/pnas.0906907107; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Pathak D, 2010, J NEUROSCI, V30, P8984, DOI 10.1523/JNEUROSCI.1621-10.2010; Provance DW, 2004, P NATL ACAD SCI USA, V101, P1868, DOI 10.1073/pnas.0305895101; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Rodriguez OC, 2002, J CELL SCI, V115, P991; Roder IV, 2010, P NATL ACAD SCI USA, V107, P2031, DOI 10.1073/pnas.0914087107; Roder IV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003871; Rudolf R, 2011, J NEUROCHEM, V116, P177, DOI 10.1111/j.1471-4159.2010.07110.x; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Schonewille M, 2011, NEURON, V70, P43, DOI 10.1016/j.neuron.2011.02.044; Sellers JR, 2008, BIOCHEM BIOPH RES CO, V369, P176, DOI 10.1016/j.bbrc.2007.11.109; Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014; Shin SM, 2012, NAT NEUROSCI, V15, P1655, DOI 10.1038/nn.3259; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sloane JA, 2007, J NEUROSCI, V27, P11366, DOI 10.1523/JNEUROSCI.2326-07.2007; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Takagishi Y, 1996, NEUROSCI LETT, V215, P169, DOI 10.1016/S0304-3940(96)12967-0; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Tilelli CQ, 2003, NEUROSCIENCE, V121, P573, DOI 10.1016/S0306-4522(03)00546-3; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852; van Diepen MT, 2009, NAT CELL BIOL, V11, P1191, DOI 10.1038/ncb1961; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Wagner W, 2011, NAT CELL BIOL, V13, P40, DOI 10.1038/ncb2132; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yoshii A, 2013, J NEUROSCI, V33, P8472, DOI 10.1523/JNEUROSCI.4585-12.2013; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826	69	34	34	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28428	28434		10.1074/jbc.R113.514497	http://dx.doi.org/10.1074/jbc.R113.514497			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23990471	hybrid, Green Published			2022-12-28	WOS:000330298800001
J	Murasawa, Y; Watanabe, K; Yoneda, M; Zako, M; Kimata, K; Sakai, LY; Isogai, Z				Murasawa, Yusuke; Watanabe, Ken; Yoneda, Masahiko; Zako, Masahiro; Kimata, Koji; Sakai, Lynn Y.; Isogai, Zenzo			Homotypic Versican G1 Domain Interactions Enhance Hyaluronan Incorporation into Fibrillin Microfibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM ADAMTS; Extracellular Matrix; Fibrillin; Hyaluronate; Proteoglycan; Dermis; Versican	CHONDROITIN SULFATE PROTEOGLYCAN; LINK PROTEIN; EXTRACELLULAR MICROFIBRILS; ADAMTS METALLOPROTEASES; BINDING PROTEINS; IN-VIVO; AGGRECAN; TISSUES; SKIN; PROLIFERATION	Versican G1 domain-containing fragments (VG1Fs) have been identified in extracts from the dermis in which hyaluronan (HA)-versican-fibrillin complexes are found. However, the molecular assembly of VG1Fs in the HA-versican-microfibril macrocomplex has not yet been elucidated. Here, we clarify the role of VG1Fs in the extracellular macrocomplex, specifically in mediating the recruitment of HA to microfibrils. Sequential extraction studies suggested that the VG1Fs were not associated with dermal elements through HA binding properties alone. Overlay analyses of dermal tissue sections using the recombinant versican G1 domain, rVN, showed that rVN deposited onto the elastic fiber network. In solid-phase binding assays, rVN bound to isolated nondegraded microfibrils. rVN specifically bound to authentic versican core protein produced by dermal fibroblasts. Furthermore, rVN bound to VG1Fs extracted from the dermis and to nondenatured versican but not to fibrillin-1. Homotypic binding of rVN was also seen. Consistent with these binding properties, macroaggregates containing VG1Fs were detected in high molecular weight fractions of sieved dermal extracts and visualized by electron microscopy, which revealed localization to microfibrils at the microscopic level. Importantly, exogenous rVN enhanced HA recruitment both to isolated microfibrils and to microfibrils in tissue sections in a dose-dependent manner. From these data, we propose that cleaved VG1Fs can be recaptured by microfibrils through VG1F homotypical interactions to enhance HA recruitment to microfibrils.	[Murasawa, Yusuke; Isogai, Zenzo] Natl Ctr Geriatr & Gerontol, Dept Adv Med, Obu, Aichi 4748511, Japan; [Watanabe, Ken] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Obu, Aichi 4748511, Japan; [Yoneda, Masahiko] Aichi Prefectural Univ, Sch Nursing & Hlth, Nagoya, Aichi 4638502, Japan; [Zako, Masahiro] Aichi Med Univ, Dept Ophthalmol, Nagakute, Aichi 4801195, Japan; [Kimata, Koji] Aichi Med Univ, Nagakute, Aichi 4801195, Japan; [Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97239 USA; [Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology; Aichi Medical University; Aichi Medical University; Oregon Health & Science University; Oregon Health & Science University	Isogai, Z (corresponding author), 35 Gengo,Morioka Cho, Obu, Aichi 4748511, Japan.	zenzo@ncgg.go.jp	Isogai, Zenzo/AAD-3690-2022; Watanabe, Ken/I-3960-2013	Watanabe, Ken/0000-0003-0664-3915	Ministry of Health, Labor, and Welfare of Japan; Mizutani Foundation; Shriners Hospital for Children	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Mizutani Foundation; Shriners Hospital for Children	This work was supported by grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan (to Z. I., K. W., and M. Y.), by a grant from the Mizutani Foundation (to Z. I.), and by a grant from Shriners Hospital for Children (to L. Y. S.).	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Aspberg A, 1999, J BIOL CHEM, V274, P20444, DOI 10.1074/jbc.274.29.20444; BERNSTEIN EF, 1995, LAB INVEST, V72, P662; BINETTE F, 1994, J BIOL CHEM, V269, P19116; BodeLesniewska B, 1996, J HISTOCHEM CYTOCHEM, V44, P303, DOI 10.1177/44.4.8601689; Carrino DA, 2011, GLYCOBIOLOGY, V21, P257, DOI 10.1093/glycob/cwq162; Cattaruzza S, 2004, FASEB J, V18, P779, DOI 10.1096/fj.03-0660fje; Charbonneau NL, 2010, J BIOL CHEM, V285, P24943, DOI 10.1074/jbc.M110.130021; CRESTFIELD AM, 1963, J BIOL CHEM, V238, P622; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Enomoto H, 2010, DEVELOPMENT, V137, P4029, DOI 10.1242/dev.050591; Feinberg T, 2009, DEV CELL, V17, P584, DOI 10.1016/j.devcel.2009.10.020; GIBSON MA, 1986, J BIOL CHEM, V261, P1429; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; Handford PA, 2000, MATRIX BIOL, V19, P457, DOI 10.1016/S0945-053X(00)00100-1; Hasegawa K, 2007, J INVEST DERMATOL, V127, P1657, DOI 10.1038/sj.jid.5700754; Hattori N, 2011, J BIOL CHEM, V286, P34298, DOI 10.1074/jbc.M111.254938; Inoue Y, 2006, J BIOL CHEM, V281, P10381, DOI 10.1074/jbc.M508161200; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Isogai Z, 1996, CANCER RES, V56, P3902; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P441, DOI 10.1177/39.4.2005373; Kenagy RD, 2009, J HISTOCHEM CYTOCHEM, V57, P889, DOI 10.1369/jhc.2009.953901; KIMATA K, 1986, J BIOL CHEM, V261, P3517; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; Matsumoto K, 2003, J BIOL CHEM, V278, P41205, DOI 10.1074/jbc.M305060200; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; Murasawa Y, 2008, EXP CELL RES, V314, P3638, DOI 10.1016/j.yexcr.2008.08.024; NEAME PJ, 1985, J BIOL CHEM, V260, P2402; Ohno-Jinno A, 2008, INVEST OPHTH VIS SCI, V49, P2870, DOI 10.1167/iovs.07-1488; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; PERIDES G, 1989, J BIOL CHEM, V264, P5981; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Seyfried NT, 2005, J BIOL CHEM, V280, P5435, DOI 10.1074/jbc.M411297200; Shi SL, 2004, J BIOL CHEM, V279, P12060, DOI 10.1074/jbc.M310091200; Sorrell JM, 1999, ANAT EMBRYOL, V199, P45, DOI 10.1007/s004290050208; Watanabe H, 1998, J BIOCHEM, V124, P687, DOI 10.1093/oxfordjournals.jbchem.a022166; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x; ZIMMERMANN DR, 1994, J CELL BIOL, V124, P817, DOI 10.1083/jcb.124.5.817	45	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29170	29181		10.1074/jbc.M113.456947	http://dx.doi.org/10.1074/jbc.M113.456947			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23963449	Green Published, hybrid			2022-12-28	WOS:000330298800070
J	Voak, AA; Gobalakrishnapillai, V; Seifert, K; Balczo, E; Hu, LQ; Hall, BS; Wilkinson, SR				Voak, Andrew A.; Gobalakrishnapillai, Vithurshaa; Seifert, Karin; Balczo, Edina; Hu, Longqin; Hall, Belinda S.; Wilkinson, Shane R.			An Essential Type I Nitroreductase from Leishmania major Can Be Used to Activate Leishmanicidal Prodrugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Discovery; Drug Screening; Oxidation-Reduction; Parasite; Trypanosoma brucei; Trypanosome	ESCHERICHIA-COLI; DRUG CANDIDATE; RESPIRATORY-CHAIN; PURIFICATION; NIFURTIMOX; RAT; CARCINOGENESIS; FEXINIDAZOLE; NITAZOXANIDE; BENZNIDAZOLE	Nitroaromatic prodrugs are used to treat a range of microbial infections with selectivity achieved by specific activation reactions. For trypanosomatid parasites, this is mediated by type I nitroreductases. Here, we demonstrate that the causative agent of leishmaniasis, Leishmania major, expresses an FMN-containing nitroreductase (LmNTR) that metabolizes a wide range of substrates, and based on electron donor and acceptor preferences, it may function as an NADH:quinone oxidoreductase. Using gene deletion approaches, we demonstrate that this activity is essential to L. major promastigotes, the parasite forms found in the insect vector. Intriguingly, LmNTR(+/-) heterozygote promastigote parasites could readily differentiate into infectious metacyclic cells but these were unable to establish infections in cultured mammalian cells and caused delayed pathology in mice. Furthermore, we exploit the LmNTR activity evaluating a library of nitrobenzylphosphoramide mustards using biochemical and phenotypic screens. We identify a subset of compounds that display significant growth inhibitory properties against the intracellular parasite form found in the mammalian hosts. The leishmanicidal activity was shown to be LmNTR-specific as the LmNTR(+/-) heterozygote promastigotes displayed resistance to the most potent mustards. We conclude that LmNTR can be targeted for drug development by exploiting its prodrug activating property or by designing specific inhibitors to block its endogenous function.	[Voak, Andrew A.; Gobalakrishnapillai, Vithurshaa; Balczo, Edina; Hall, Belinda S.; Wilkinson, Shane R.] Queen Mary Univ London, Sch Biol & Chem Sci, Queen Mary Preclin Drug Discovery Grp, London E1 4NS, England; [Seifert, Karin] Univ London London Sch Hyg & Trop Med, Immunol & Infect Dept, London WC1E 7HT, England; [Hu, Longqin] Rutgers State Univ, Dept Med Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA	University of London; Queen Mary University London; University of London; London School of Hygiene & Tropical Medicine; Rutgers State University New Brunswick	Wilkinson, SR (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Queen Mary Preclin Drug Discovery Grp, Mile End Rd, London E1 4NS, England.	s.r.wilkinson@qmul.ac.uk	Hu, Longqin/AAR-7076-2021; Hall, Belinda/AGU-6214-2022	Hu, Longqin/0000-0002-1799-5652; Voak, Andrew/0000-0002-1010-4781; Hall, Belinda/0000-0002-3753-1978	Queen Mary University of London Graduate Training Studentship	Queen Mary University of London Graduate Training Studentship	Recipient of a Queen Mary University of London Graduate Training Studentship. Present address: Immunology and Infection Dept., London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom.	Adagu IS, 2002, J ANTIMICROB CHEMOTH, V49, P103, DOI 10.1093/jac/49.1.103; Arya SC, 2009, BJU INT, V103, P994, DOI [10.1111/j.1464-410X.2009.08510_1.x, 10.1111/j.1464-410X.2009.08510_2.x]; Balasegaram M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000234; BRYANT C, 1991, J BIOL CHEM, V266, P4119; Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081; Chen S, 1997, J BIOL CHEM, V272, P1437, DOI 10.1074/jbc.272.3.1437; Chen Y, 2009, MED RES REV, V29, P29, DOI 10.1002/med.20137; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Cruz I, 2002, LANCET, V359, P1124, DOI 10.1016/S0140-6736(02)08160-6; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; de Oliveira IM, 2007, BIOCHEM BIOPH RES CO, V355, P919, DOI 10.1016/j.bbrc.2007.02.049; Denny WA, 2003, J BIOMED BIOTECHNOL, P48; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; GRUNBERG E, 1973, ANNU REV MICROBIOL, V27, P317, DOI 10.1146/annurev.mi.27.100173.001533; Hall BS, 2012, ANTIMICROB AGENTS CH, V56, P5821, DOI 10.1128/AAC.01227-12; Hall BS, 2012, ANTIMICROB AGENTS CH, V56, P115, DOI 10.1128/AAC.05135-11; Hall BS, 2011, J BIOL CHEM, V286, P13088, DOI 10.1074/jbc.M111.230847; Hall BS, 2010, ANTIMICROB AGENTS CH, V54, P1193, DOI 10.1128/AAC.01213-09; HART DT, 1981, MOL BIOCHEM PARASIT, V4, P39, DOI 10.1016/0166-6851(81)90027-X; Hiraku Y, 2004, CANCER LETT, V215, P141, DOI 10.1016/j.canlet.2004.05.016; Hu LQ, 2011, BIOORG MED CHEM LETT, V21, P3986, DOI 10.1016/j.bmcl.2011.05.009; Hu LQ, 2003, J MED CHEM, V46, P4818, DOI 10.1021/jm034133h; Jiang YY, 2008, BIOORG MED CHEM LETT, V18, P4059, DOI 10.1016/j.bmcl.2008.05.099; Jiang YY, 2006, J MED CHEM, V49, P4333, DOI 10.1021/jm051246n; Kaiser M, 2011, ANTIMICROB AGENTS CH, V55, P5602, DOI 10.1128/AAC.00246-11; Korba BE, 2008, ANTIVIR RES, V77, P56, DOI 10.1016/j.antiviral.2007.08.005; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; MCCALLA DR, 1983, ENVIRON MUTAGEN, V5, P745, DOI 10.1002/em.2860050512; MORENO SNJ, 1984, J BIOL CHEM, V259, P6298; Opperdoes FR, 2008, TRENDS PARASITOL, V24, P310, DOI 10.1016/j.pt.2008.03.013; Pal D, 2009, ANTIMICROB AGENTS CH, V53, P458, DOI 10.1128/AAC.00909-08; Pavli A, 2010, INT J INFECT DIS, V14, pE1032, DOI 10.1016/j.ijid.2010.06.019; PETERSON FJ, 1979, J BIOL CHEM, V254, P4009; Race PR, 2007, J MOL BIOL, V368, P481, DOI 10.1016/j.jmb.2007.02.012; ROVERA G, 1979, SCIENCE, V204, P868, DOI 10.1126/science.286421; Santhamma KR, 1995, MOL BIOCHEM PARASIT, V75, P43, DOI 10.1016/0166-6851(95)02510-3; Sholler GLS, 2006, J PEDIAT HEMATOL ONC, V28, P693, DOI 10.1097/01.mph.0000212994.56812.f2; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Takahashi M, 2000, CANCER LETT, V156, P177, DOI 10.1016/S0304-3835(00)00459-6; Trunz BB, 2011, EUR J MED CHEM, V46, P1524, DOI 10.1016/j.ejmech.2011.01.071; Tweats D, 2012, MUTAGENESIS, V27, P523, DOI 10.1093/mutage/ges015; VanHellemond JJ, 1997, MOL BIOCHEM PARASIT, V85, P135, DOI 10.1016/S0166-6851(97)02828-4; Watanabe M, 1998, J BIOL CHEM, V273, P23922, DOI 10.1074/jbc.273.37.23922; Wilkinson SR, 2008, P NATL ACAD SCI USA, V105, P5022, DOI 10.1073/pnas.0711014105; Wyllie S, 2013, ANTIMICROB AGENTS CH, V57, P901, DOI 10.1128/AAC.01788-12; Wyllie S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003326; Zenno S, 1996, J BIOCHEM-TOKYO, V120, P736	50	22	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28466	28476		10.1074/jbc.M113.494781	http://dx.doi.org/10.1074/jbc.M113.494781			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946481	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000330298800005
J	Yoon, S; Baik, JH				Yoon, Sehyoun; Baik, Ja-Hyun			Dopamine D2 Receptor-mediated Epidermal Growth Factor Receptor Transactivation through a Disintegrin and Metalloprotease Regulates Dopaminergic Neuron Development via Extracellular Signal-related Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; ADAMTS; Dopamine Receptors; Epidermal Growth Factor Receptor (EGFR); ERK; Signal Transduction; Dopaminergic Neuron Development	PARKINSONS-DISEASE; EGF RECEPTOR; HB-EGF; SURVIVAL; EXPRESSION; GENERATION; ADAM10; NURR1	Dopamine D2 receptor (D2R)-mediated extracellular signal-regulated kinase (ERK) activation plays an important role in the development of dopaminergic mesencephalic neurons. Here, we demonstrate that D2R induces the shedding of heparin-binding epidermal growth factor (EGF) through the activation of a disintegrin and metalloprotease (ADAM) 10 or 17, leading to EGF receptor transactivation, downstream ERK activation, and ultimately an increase in the number of dopaminergic neurons and their neurite length in primary mesencephalic cultures from wild-type mice. These outcomes, however, were not observed in cultures from D2R knock-out mice. Our findings show that D2R-mediated ERK activation regulates mesencephalic dopaminergic neuron development via EGF receptor transactivation through ADAM10/17.	[Yoon, Sehyoun; Baik, Ja-Hyun] Korea Univ, Coll Life Sci & Biotechnol, Mol Neurobiol Lab, Seoul 136701, South Korea	Korea University	Baik, JH (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Mol Neurobiol Lab, Seoul 136701, South Korea.	jahyunb@korea.ac.kr		Yoon, Sehyoun/0000-0001-6545-3615	Brain Research Center of the 21st Century Frontier Research Program [2011K000273]; National Research Foundation of Korea [2011-0015678]; Korea government (MEST); Seoul RBD Program [ST100079]; Korean Ministry of Education; Seoul Scholarship Foundation	Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Seoul RBD Program(Seoul RBD program); Korean Ministry of Education(Ministry of Education (MOE), Republic of Korea); Seoul Scholarship Foundation	This work was supported by Research Grants 2011K000273 from the Brain Research Center of the 21st Century Frontier Research Program, 2011-0015678 from the National Research Foundation of Korea, funded by the Korea government (MEST), and ST100079 from the Seoul R&BD Program.; Recipient of a Brain Korea 21 Program grant from the Korean Ministry of Education and the Hi Seoul Science (Humanities) Fellowship from the Seoul Scholarship Foundation.	Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Diaz J, 1997, J NEUROSCI, V17, P4282; Farkas LM, 2002, J NEURAL TRANSM, V109, P267, DOI 10.1007/s007020200022; Futamura T, 2002, MOL PSYCHIATR, V7, P673, DOI 10.1038/sj.mp.4001081; GOLDSTEIN M, 1992, FASEB J, V6, P2413, DOI 10.1096/fasebj.6.7.1348713; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; Iwakura Y, 2005, J NEUROCHEM, V93, P974, DOI 10.1111/j.1471-4159.2005.03073.x; Iwakura Y, 2011, J NEUROCHEM, V118, P45, DOI 10.1111/j.1471-4159.2011.07287.x; Iwakura Y, 2011, J NEUROCHEM, V118, P57, DOI 10.1111/j.1471-4159.2011.07295.x; Kim SJ, 2004, MOL ENDOCRINOL, V18, P640, DOI 10.1210/me.2003-0066; Kim SY, 2008, EXP NEUROL, V214, P69, DOI 10.1016/j.expneurol.2008.07.014; Kim SY, 2006, J NEUROSCI, V26, P4567, DOI 10.1523/JNEUROSCI.5236-05.2006; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; Moses D, 2006, EXP NEUROL, V199, P209, DOI 10.1016/j.expneurol.2006.02.120; O'Keeffe GC, 2009, P NATL ACAD SCI USA, V106, P8754, DOI 10.1073/pnas.0803955106; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Oyagi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007461; Perlmann T, 2004, CELL TISSUE RES, V318, P45, DOI 10.1007/s00441-004-0974-7; Perrone-Capano C, 2000, NEUROSCI BIOBEHAV R, V24, P119, DOI 10.1016/S0149-7634(99)00054-8; Riddle R, 2003, DEV BRAIN RES, V147, P3, DOI 10.1016/j.devbrainres.2003.09.010; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Simon HH, 2003, ANN NY ACAD SCI, V991, P36; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Wang CH, 2005, J NEUROCHEM, V93, P899, DOI 10.1111/j.1471-4159.2005.03055.x; Yan YB, 2002, J CELL BIOL, V158, P221, DOI 10.1083/jcb.200112026; Yoon S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.188078	29	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28435	28446		10.1074/jbc.M113.461202	http://dx.doi.org/10.1074/jbc.M113.461202			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23955337	Green Published, hybrid			2022-12-28	WOS:000330298800002
J	Wang, ZL; Weitzmann, MN; Sangadala, S; Hutton, WC; Yoon, ST				Wang, Zili; Weitzmann, M. Neale; Sangadala, Sreedhara; Hutton, William C.; Yoon, S. Tim			Link Protein N-terminal Peptide Binds to Bone Morphogenetic Protein (BMP) Type II Receptor and Drives Matrix Protein Expression in Rabbit Intervertebral Disc Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARTILAGE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; NUCLEUS PULPOSUS; GROWTH; SOX9; BIOSYNTHESIS; DEGENERATION; INHIBITOR; AGGRECAN; REPAIR	Intervertebral disc (IVD) degeneration and associated spinal disorders are leading sources of morbidity, and they can be responsible for chronic low back pain. Treatments for degenerative disc diseases continue to be a challenge. Intensive research is now focusing on promoting regeneration of degenerated discs by stimulating production of the disc matrix. Link protein N-terminal peptide (LPP) is a proteolytic fragment of link protein, an important cross-linker and stabilizer of the major structural components of cartilage, aggrecan and hyaluronan. In this study we investigated LPP action in rabbit primary intervertebral disc cells cultured ex vivo in a three-dimensional alginate matrix. Our data reveal that LPP promotes disc matrix production, which was evidenced by increased expression of the chondrocyte-specific transcription factor SOX9 and the extracellular matrix macromolecules aggrecan and collagen II. Using colocalization and pulldown studies we further document a noggin-insensitive direct peptide-protein association between LPP and BMP-RII. This association mediated Smad signaling that converges on BMP genes leading to expression of BMP-4 and BMP-7. Furthermore, through a cell-autonomous loop BMP-4 and BMP-7 intensified Smad 1/5 signaling though a feedforward circuit involving BMP-RI, ultimately promoting expression of SOX9 and downstream aggrecan and collagen II genes. Our data define a complex regulatory signaling cascade initiated by LPP and suggest that LPP may be a useful therapeutic substitute for direct BMP administration to treat IVD degeneration and to ameliorate IVD-associated chronic low back pain.	[Wang, Zili; Weitzmann, M. Neale; Sangadala, Sreedhara; Hutton, William C.; Yoon, S. Tim] Vet Affairs Med Ctr, Atlanta Dept, Decatur, GA 30033 USA; [Wang, Zili; Sangadala, Sreedhara; Hutton, William C.; Yoon, S. Tim] Emory Univ, Sch Med, Emory Spine Ctr, Atlanta, GA 30322 USA; [Weitzmann, M. Neale] Emory Univ, Sch Med, Dept Med, Div Endocrinol & Metab & Lipids, Atlanta, GA 30322 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Emory University; Emory University	Wang, ZL (corresponding author), Atlanta VA Med Ctr, Res Bldg,Rm 4A-189,1670 Clairmont Rd, Decatur, GA 30033 USA.	zwang084@gmail.com			Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development [5I01BX000105]; National Institutes of Health through the NIAMS [R01AR059364]; National Institutes of Health through the NIA [R01AG040013]	Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development; National Institutes of Health through the NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health through the NIA	This work was supported by Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center (to S.T.Y.).; Supported by Grant 5I01BX000105 from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development and National Institutes of Health Awards R01AR059364 through the NIAMS and R01AG040013 through the NIA.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; An HS, 2005, SPINE, V30, P25, DOI 10.1097/01.brs.0000148002.68656.4d; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bogduk N, 1991, Neurosurg Clin N Am, V2, P791; Boswell Mark V, 2007, Pain Physician, V10, P7; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Cohen EEW, 2009, CANCER RES, V69, P65, DOI 10.1158/0008-5472.CAN-08-0377; Colombini A, 2008, INT J BIOCHEM CELL B, V40, P837, DOI 10.1016/j.biocel.2007.12.011; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; FALTZ LL, 1979, J BIOL CHEM, V254, P1381; Fassett DR, 2009, J SPINAL DISORD TECH, V22, P297, DOI 10.1097/BSD.0b013e31816d5f64; Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; HARDINGHAM TE, 1979, BIOCHEM J, V177, P237, DOI 10.1042/bj1770237; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hsiao CJ, 2010, CTR DIS CONTROL PREV, V27, P1; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Karppinen J, 2011, ORTHOP CLIN N AM, V42, P513, DOI 10.1016/j.ocl.2011.07.009; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kepler CK, 2011, J AM ACAD ORTHOP SUR, V19, P543, DOI 10.5435/00124635-201109000-00005; KIMURA JH, 1980, J BIOL CHEM, V255, P7134; Kishi S, 2011, J BIOL CHEM, V286, P32162, DOI 10.1074/jbc.M111.244541; Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652, DOI 10.1042/BST0350652; Li Jun, 2003, J Orthop Sci, V8, P829, DOI 10.1007/s00776-003-0719-6; Liu H., 1997, BIOCHEM SOC T, V25, p427S; Liu HX, 1999, BBA-GEN SUBJECTS, V1428, P191, DOI 10.1016/S0304-4165(99)00074-4; Masuda K, 2003, J ORTHOP RES, V21, P922, DOI 10.1016/S0736-0266(03)00037-8; Masuda K, 2008, EUR SPINE J, V17, pS441, DOI 10.1007/s00586-008-0749-z; McKenna LA, 1998, ARTHRITIS RHEUM, V41, P157, DOI 10.1002/1529-0131(199801)41:1<157::AID-ART19>3.0.CO;2-J; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; MORGELIN M, 1988, BIOCHEM J, V253, P175; Mwale F, 2003, J CELL BIOCHEM, V88, P1202, DOI 10.1002/jcb.10479; Petit A, 2011, TISSUE ENG PT A, V17, P899, DOI [10.1089/ten.tea.2010.0494, 10.1089/ten.TEA.2010.0494]; Roughley P, 2006, EUR CELLS MATER, V11, P1; Roughley PJ, 2002, BIOCHEM SOC T, V30, P869, DOI 10.1042/BST0300869; Seyfried NT, 2005, J BIOL CHEM, V280, P5435, DOI 10.1074/jbc.M411297200; Wan DC, 2007, J BIOL CHEM, V282, P26450, DOI 10.1074/jbc.M703282200; Yoon ST, 2006, EUR SPINE J, V15, pS379, DOI 10.1007/s00586-006-0155-3; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	42	29	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28243	28253		10.1074/jbc.M113.451948	http://dx.doi.org/10.1074/jbc.M113.451948			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940040	Green Published, hybrid			2022-12-28	WOS:000330612800046
J	Ahmed, AH; Ptak, CP; Fenwick, MK; Hsieh, CL; Weiland, GA; Oswald, RE				Ahmed, Ahmed H.; Ptak, Christopher P.; Fenwick, Michael K.; Hsieh, Ching-Lin; Weiland, Gregory A.; Oswald, Robert E.			Dynamics of Cleft Closure of the GluA2 Ligand-binding Domain in the Presence of Full and Partial Agonists Revealed by Hydrogen-Deuterium Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-RECEPTOR; AMPA RECEPTOR; KAINATE RECEPTORS; NMR-SPECTROSCOPY; ACTIVATION; DESENSITIZATION; MECHANISMS; WILLARDIINE; DERIVATIVES; COMPLEXES	The majority of excitatory neurotransmission in the CNS is mediated by tetrameric AMPA receptors. Channel activation begins with a series of interactions with an agonist that binds to the cleft between the two lobes of the ligand-binding domain of each subunit. Binding leads to a series of conformational transitions, including the closure of the two lobes of the binding domain around the ligand, culminating in ion channel opening. Although a great deal has been learned from crystal structures, determining the molecular details of channel activation, deactivation, and desensitization requires measures of dynamics and stabilities of hydrogen bonds that stabilize cleft closure. The use of hydrogen-deuterium exchange at low pH provides a measure of the variation of stability of specific hydrogen bonds among agonists of different efficacy. Here, we used NMR measurements of hydrogen-deuterium exchange to determine the stability of hydrogen bonds in the GluA2 (AMPA receptor) ligand-binding domain in the presence of several full and partial agonists. The results suggest that the stabilization of hydrogen bonds between the two lobes of the binding domain is weaker for partial than for full agonists, and efficacy is correlated with the stability of these hydrogen bonds. The closure of the lobes around the agonists leads to a destabilization of the hydrogen bonding in another portion of the lobe interface, and removing an electrostatic interaction in Lobe 2 can relieve the strain. These results provide new details of transitions in the binding domain that are associated with channel activation and desensitization.	[Ahmed, Ahmed H.; Ptak, Christopher P.; Weiland, Gregory A.; Oswald, Robert E.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Fenwick, Michael K.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Hsieh, Ching-Lin] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Oswald, RE (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	reo1@cornell.edu	Ptak, Christopher/I-3126-2012; Ptak, Christopher/AAP-7763-2021; Hsieh, Ching-Lin/ABA-6461-2021; Hsieh, Ching-Lin/K-4139-2018; HSIEH, CHING-LIN/G-6057-2011	Ptak, Christopher/0000-0003-2752-0367; Ptak, Christopher/0000-0003-2752-0367; Hsieh, Ching-Lin/0000-0002-3665-5717; HSIEH, CHING-LIN/0000-0001-9468-9969	National Institutes of Health [R01 GM068935]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM068935 (to R. E. O.).	Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; Ahmed AH, 2011, J BIOL CHEM, V286, P35257, DOI 10.1074/jbc.M111.269001; Ahmed AH, 2010, BIOCHEMISTRY-US, V49, P2843, DOI 10.1021/bi1000678; Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed AH, 2007, J BIOL CHEM, V282, P12773, DOI 10.1074/jbc.M610077200; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; BERGER ARIEH, 1957, ARCH BIOCHEM AND BIOPHYS, V69, P106, DOI 10.1016/0003-9861(57)90478-2; Carbone AL, 2012, NEURON, V74, P845, DOI 10.1016/j.neuron.2012.04.020; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; Fenwick MK, 2007, BIOMOL NMR ASSIGN, V1, P241, DOI 10.1007/s12104-007-9067-3; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Fenwick MK, 2010, J BIOL CHEM, V285, P12334, DOI 10.1074/jbc.M109.086371; Goddard T. D., SPARKY 3; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Lidak M. Y., 1972, CHEM HETEROCYCL COMP, V8, P644; Madden DR, 2000, EUR J BIOCHEM, V267, P4281; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Maltsev AS, 2010, J BIOL CHEM, V285, P10154, DOI 10.1074/jbc.M109.088641; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PATNEAU DK, 1992, J NEUROSCI, V12, P595; PATNEAU DK, 1991, NEURON, V6, P785, DOI 10.1016/0896-6273(91)90175-Y; Poon K, 2011, MOL PHARMACOL, V80, P49, DOI 10.1124/mol.111.071688; Sekiguchi M, 1997, J NEUROSCI, V17, P5760; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; WEMPEN I, 1964, J AM CHEM SOC, V86, P2474, DOI 10.1021/ja01066a034	32	22	23	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27658	27666		10.1074/jbc.M113.495564	http://dx.doi.org/10.1074/jbc.M113.495564			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23940029	Green Published, hybrid			2022-12-28	WOS:000330597300059
J	Ladeveze, S; Tarquis, L; Cecchini, DA; Bercovici, J; Andre, I; Topham, CM; Morel, S; Laville, E; Monsan, P; Lombard, V; Henrissat, B; Potocki-Veronese, G				Ladeveze, Simon; Tarquis, Laurence; Cecchini, Davide A.; Bercovici, Juliette; Andre, Isabelle; Topham, Christopher M.; Morel, Sandrine; Laville, Elisabeth; Monsan, Pierre; Lombard, Vincent; Henrissat, Bernard; Potocki-Veronese, Gabrielle			Role of Glycoside Phosphorylases in Mannose Foraging by Human Gut Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Metabolism; Enzyme Mechanisms; Glycoprotein; Intestinal Epithelium; Phosphorylase; GH130; N-Glycan; Human Gut	ENDO-BETA-MANNOSIDASE; SUBSTRATE-SPECIFICITY; N-GLYCAN; BACTEROIDES-THETAIOTAOMICRON; DISACCHARIDE PHOSPHORYLASES; CHEMOENZYMATIC SYNTHESIS; TREHALOSE PHOSPHORYLASE; MOLECULAR-CLONING; METABOLISM; MANNAN	To metabolize both dietary fiber constituent carbohydrates and host glycans lining the intestinal epithelium, gut bacteria produce a wide range of carbohydrate-active enzymes, of which glycoside hydrolases are the main components. In this study, we describe the ability of phosphorylases to participate in the breakdown of human N-glycans, from an analysis of the substrate specificity of UhgbMP, a mannoside phosphorylase of the GH130 protein family discovered by functional metagenomics. UhgbMP is found to phosphorolyze -d-Manp-1,4--d-GlcpNAc-1,4-d-GlcpNAc and is also a highly efficient enzyme to catalyze the synthesis of this precious N-glycan core oligosaccharide by reverse phosphorolysis. Analysis of sequence conservation within family GH130, mapped on a three-dimensional model of UhgbMP and supported by site-directed mutagenesis results, revealed two GH130 subfamilies and allowed the identification of key residues responsible for catalysis and substrate specificity. The analysis of the genomic context of 65 known GH130 sequences belonging to human gut bacteria indicates that the enzymes of the GH130_1 subfamily would be involved in mannan catabolism, whereas the enzymes belonging to the GH130_2 subfamily would rather work in synergy with glycoside hydrolases of the GH92 and GH18 families in the breakdown of N-glycans. The use of GH130 inhibitors as therapeutic agents or functional foods could thus be considered as an innovative strategy to inhibit N-glycan degradation, with the ultimate goal of protecting, or restoring, the epithelial barrier.	[Ladeveze, Simon; Tarquis, Laurence; Cecchini, Davide A.; Bercovici, Juliette; Andre, Isabelle; Topham, Christopher M.; Morel, Sandrine; Laville, Elisabeth; Monsan, Pierre; Potocki-Veronese, Gabrielle] Univ Toulouse, Inst Natl Sci Appl, Univ Toulouse 3, Lab Ingn Syst Biol & Proc,Inst Natl Polytech, F-31077 Toulouse, France; [Ladeveze, Simon; Tarquis, Laurence; Cecchini, Davide A.; Bercovici, Juliette; Andre, Isabelle; Topham, Christopher M.; Morel, Sandrine; Laville, Elisabeth; Monsan, Pierre; Potocki-Veronese, Gabrielle] CNRS, UMR5504, F-31400 Toulouse, France; [Ladeveze, Simon; Tarquis, Laurence; Cecchini, Davide A.; Bercovici, Juliette; Andre, Isabelle; Topham, Christopher M.; Morel, Sandrine; Laville, Elisabeth; Monsan, Pierre; Potocki-Veronese, Gabrielle] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Lombard, Vincent; Henrissat, Bernard] Aix Marseille Univ, CNRS UMR 7257, F-13288 Marseille, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Potocki-Veronese, G (corresponding author), Inst Natl Rech Agron UMR792, CNRS UMR5504, Inst Natl Sci Appl, Lab Ingn Syst Biol & Proc, 135 Ave Rangueil, F-31077 Toulouse, France.	veronese@insa-toulouse.fr	Veronese, Gabrielle/GTF-3473-2022; Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Topham, Christopher/0000-0002-9147-0184; Lombard, Vincent/0000-0002-9684-7067	Region Midi-Pyrenees; European Regional Development Fund; SICOVAL; Infrastructures en Biologie Sante et Agronomie (IBiSa, France); CNRS; Institut National de la Recherche Agronomique	Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); European Regional Development Fund(European Commission); SICOVAL; Infrastructures en Biologie Sante et Agronomie (IBiSa, France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique	We cordially thank Nelly Monties for technical assistance. MetaToul (Metabolomics & Fluxomics Facitilies, Toulouse, France) is gratefully acknowledged for access to NMR facilities. MetaToul is supported by grants from the Region Midi-Pyrenees, the European Regional Development Fund, the SICOVAL, the Infrastructures en Biologie Sante et Agronomie (IBiSa, France), the CNRS, and the Institut National de la Recherche Agronomique.	Aerts D, 2011, CARBOHYD RES, V346, P1860, DOI 10.1016/j.carres.2011.06.024; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Brett C. T., 1996, PHYSL BIOCH PLANT CE, P222; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Desmet T, 2012, PROCESS BIOCHEM, V47, P11, DOI 10.1016/j.procbio.2011.10.039; DEY PM, 1978, ADV CARBOHYD CHEM BI, V35, P341; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Dilokpimol A, 2011, BBA-PROTEINS PROTEOM, V1814, P1720, DOI 10.1016/j.bbapap.2011.08.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eneyskaya EV, 2009, BIOCHIMIE, V91, P632, DOI 10.1016/j.biochi.2009.03.009; Englyst KN, 2005, BRIT J NUTR, V94, P1, DOI 10.1079/BJN20051457; Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gloster TM, 2008, CHEM BIOL, V15, P1058, DOI 10.1016/j.chembiol.2008.09.005; Han SE, 2003, PROTEIN EXPRES PURIF, V30, P194, DOI 10.1016/S1046-5928(03)00104-9; Heinken A, 2013, GUT MICROBES, V4, P28, DOI 10.4161/gmic.22370; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hu L, 2011, INT J CHEM INT J QUA, V3, P68; Hughes CV, 2003, ORAL MICROBIOL IMMUN, V18, P309, DOI 10.1034/j.1399-302X.2003.00091.x; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ishimizu T, 2004, J BIOL CHEM, V279, P38555, DOI 10.1074/jbc.M406886200; Kawahara R, 2012, J BIOL CHEM, V287, P42389, DOI 10.1074/jbc.M112.390336; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Luley-Goedl C, 2010, BIOTECHNOL J, V5, P1324, DOI 10.1002/biot.201000217; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Motomura K, 2011, FEMS MICROBIOL LETT, V320, P25, DOI 10.1111/j.1574-6968.2011.02285.x; Murata T, 1997, BIOSCI BIOTECH BIOCH, V61, P1059, DOI 10.1271/bbb.61.1059; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Nakajima M, 2008, APPL ENVIRON MICROB, V74, P6333, DOI 10.1128/AEM.02846-07; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rathore RS, 2009, CRIT REV BIOTECHNOL, V29, P214, DOI 10.1080/07388550902926063; Revers L, 1999, BBA-GEN SUBJECTS, V1428, P88, DOI 10.1016/S0304-4165(99)00048-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salinardi TC, 2010, J NUTR, V140, P1943, DOI 10.3945/jn.110.128207; Sasaki A, 2005, J BIOCHEM, V137, P87, DOI 10.1093/jb/mvi008; Segel, 1975, ENZYME KINETICS BEHA, P274; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Thompson AJ, 2012, P NATL ACAD SCI USA, V109, P781, DOI 10.1073/pnas.1111482109; USUI T, 1994, GLYCOCONJUGATE J, V11, P105, DOI 10.1007/BF00731150; Van der Borght J, 2011, APPL ENVIRON MICROB, V77, P6939, DOI 10.1128/AEM.05190-11; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Zhao YX, 1999, CARBOHYD RES, V319, P184, DOI 10.1016/S0008-6215(99)00116-0; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	59	35	37	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32370	32383		10.1074/jbc.M113.483628	http://dx.doi.org/10.1074/jbc.M113.483628			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24043624	Green Published, hybrid			2022-12-28	WOS:000328681700022
J	Zhang, XR; Zhu, J; Li, YM; Lin, T; Siclari, VA; Chandra, A; Candela, EM; Koyama, E; Enomoto-Iwamoto, M; Qin, L				Zhang, Xianrong; Zhu, Ji; Li, Yumei; Lin, Tiao; Siclari, Valerie A.; Chandra, Abhishek; Candela, Elena M.; Koyama, Eiki; Enomoto-Iwamoto, Motomi; Qin, Ling			Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Epiphyseal Cartilage Development through beta-Catenin-dependent and -independent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-Catenin; Cartilage Biology; Epidermal Growth Factor Receptor (EGFR); Extracellular Matrix; Matrix Metalloproteinase (MMP); Cartilage Matrix Degradation; Secondary Ossification Center	MATRIX METALLOPROTEINASES; TRANSCRIPTIONAL ACTIVITY; CHONDROCYTE MATURATION; BONE-DEVELOPMENT; MICE LACKING; EXPRESSION; TRANSACTIVATION; PROLIFERATION; OSSIFICATION; ANGIOGENESIS	The epidermal growth factor receptor (EGFR) is an essential player in the development of multiple organs during embryonic and postnatal stages. To understand its role in epiphyseal cartilage development, we generated transgenic mice with conditionally inactivated EGFR in chondrocytes. Postnatally, these mice exhibited a normal initiation of cartilage canals at the perichondrium, but the excavation of these canals into the cartilage was strongly suppressed, resulting in a delay in the formation of the secondary ossification center (SOC). This delay was accompanied by normal chondrocyte hypertrophy but decreased mineralization and apoptosis of hypertrophic chondrocytes and reduced osteoclast number at the border of marrow space. Immunohistochemical analyses demonstrated that inactivation of chondrocyte-specific EGFR signaling reduced the amounts of matrix metalloproteinases (MMP9, -13, and -14) and RANKL (receptor activator of NF-B ligand) in the hypertrophic chondrocytes close to the marrow space and decreased the cartilage matrix degradation in the SOC. Analyses of EGFR downstream signaling pathways in primary epiphyseal chondrocytes revealed that up-regulation of MMP9 and RANKL by EGFR signaling was partially mediated by the canonical Wnt/-catenin pathway, whereas EGFR-enhanced MMP13 expression was not. Further biochemical studies suggested that EGFR signaling stimulates the phosphorylation of LRP6, increases active -catenin level, and induces its nuclear translocation. In line with these in vitro studies, deficiency in chondrocyte-specific EGFR activity reduced -catenin amount in hypertrophic chondrocytes in vivo. In conclusion, our work demonstrates that chondrocyte-specific EGFR signaling is an important regulator of cartilage matrix degradation during SOC formation and epiphyseal cartilage development and that its actions are partially mediated by activating the -catenin pathway.	[Zhang, Xianrong; Zhu, Ji; Li, Yumei; Lin, Tiao; Siclari, Valerie A.; Chandra, Abhishek; Koyama, Eiki; Enomoto-Iwamoto, Motomi; Qin, Ling] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Zhang, Xianrong] Wuhan Univ, Sch Basic Med Sci, Dept Physiol, Wuhan 430072, Hubei Province, Peoples R China; [Li, Yumei] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Shanghai 201203, Peoples R China; [Lin, Tiao; Candela, Elena M.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthopaed Surg, Hangzhou 310009, Zhejiang, Peoples R China; [Koyama, Eiki; Enomoto-Iwamoto, Motomi] Childrens Hosp Philadelphia, Dept Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Wuhan University; Shanghai University of Traditional Chinese Medicine; Zhejiang University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Qin, L (corresponding author), Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, 424 Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA.	qinling@mail.med.upenn.edu	Chandra, Abhishek/AAG-8781-2020		National Institutes of Health [AR060991, AR062908]; Penn Center for Musculoskeletal Disorders [P30AR050950]; American Society for Bone and Mineral Research (ASBMR) Research Career Enhancement Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062908, P30AR050950, R03AR060991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Center for Musculoskeletal Disorders; American Society for Bone and Mineral Research (ASBMR) Research Career Enhancement Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR060991 (to L. Q.) and AR062908 (to M. E. I.) and Penn Center for Musculoskeletal Disorders Grant P30AR050950. This study was also supported by American Society for Bone and Mineral Research (ASBMR) Research Career Enhancement Award (to L. Q.).	Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Alvarez J, 2005, CELL TISSUE RES, V320, P501, DOI 10.1007/s00441-004-1034-z; Alvarez J, 2005, J BONE MINER RES, V20, P1011, DOI 10.1359/JBMR.050204; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Blumer MJF, 2008, ANN ANAT, V190, P305, DOI 10.1016/j.aanat.2008.02.004; Blumer MJF, 2012, MECH DEVELOP, V129, P162, DOI 10.1016/j.mod.2012.04.003; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; Civenni G, 2003, EMBO REP, V4, P166, DOI 10.1038/sj.embor.embor735; Dao DY, 2012, J BONE MINER RES, V27, P1680, DOI 10.1002/jbmr.1639; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Edwards JR, 2011, NAT REV RHEUMATOL, V7, P235, DOI 10.1038/nrrheum.2011.23; Enomoto-Iwamoto M, 2002, DEV BIOL, V251, P142, DOI 10.1006/dbio.2002.0802; Fosang AJ, 2013, OSTEOARTHR CARTILAGE, V21, P401, DOI 10.1016/j.joca.2012.11.013; Guo XZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006067; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-64; Lee D, 2004, MAMM GENOME, V15, P525, DOI 10.1007/s00335-004-2384-2; Lee ER, 2001, DEV DYNAM, V222, P52, DOI 10.1002/dvdy.1168; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003; Ortega N, 2010, DIS MODEL MECH, V3, P224, DOI 10.1242/dmm.004226; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Renkiewicz R, 2003, ARTHRITIS RHEUM, V48, P1742, DOI 10.1002/art.11030; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Schneider MR, 2009, TRENDS ENDOCRIN MET, V20, P517, DOI 10.1016/j.tem.2009.06.008; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Usmani SE, 2012, BONE, V51, P131, DOI 10.1016/j.bone.2012.04.012; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wuelling M, 2011, ENDOCR DEV, V21, P1, DOI 10.1159/000328081; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yasuhara R, 2011, LAB INVEST, V91, P1739, DOI 10.1038/labinvest.2011.144; Zhang XR, 2011, J BONE MINER RES, V26, P2622, DOI 10.1002/jbmr.502; Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	50	47	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32229	32240		10.1074/jbc.M113.463554	http://dx.doi.org/10.1074/jbc.M113.463554			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24047892	hybrid, Green Published			2022-12-28	WOS:000328681700011
J	Kikkawa, Y; Ogawa, T; Sudo, R; Yamada, Y; Katagiri, F; Hozumi, K; Nomizu, M; Miner, JH				Kikkawa, Yamato; Ogawa, Takaho; Sudo, Ryo; Yamada, Yuji; Katagiri, Fumihiko; Hozumi, Kentaro; Nomizu, Motoyoshi; Miner, Jeffrey H.			The Lutheran/Basal Cell Adhesion Molecule Promotes Tumor Cell Migration by Modulating Integrin-mediated Cell Attachment to Laminin-511 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP GLYCOPROTEIN; IMMUNOGLOBULIN SUPERFAMILY; BINDING-SITE; IN-VIVO; EXPRESSION; RECEPTOR; SPECTRIN; LAMININ-ALPHA-5; ALPHA-3-BETA-1; IDENTIFICATION	Cell-matrix interactions are critical for tumor cell migration. Lutheran (Lu), also known as basal cell adhesion molecule (B-CAM), competes with integrins for binding to laminin alpha 5, a subunit of LM-511, a major component of basement membranes. Here we show that the preferential binding of Lu/B-CAM to laminin alpha 5 promotes tumor cell migration. The attachment of Lu/B-CAM transfectants to LM-511 was slightly weaker than that of control cells, and this was because Lu/B-CAM disturbed integrin binding to laminin alpha 5. Lu/B-CAM induced a spindle cell shape with pseudopods and promoted cell migration on LM-511. In addition, blocking with an anti-Lu/B-CAM antibody led to a flat cell shape and inhibited migration on LM-511, similar to the effects of an activating integrin beta 1 antibody. We conclude that tumor cell migration on LM-511 requires that Lu/B-CAM competitively modulates cell attachment through integrins. We suggest that this competitive interaction is involved in a balance between static and migratory cell behaviors.	[Kikkawa, Yamato; Ogawa, Takaho; Yamada, Yuji; Katagiri, Fumihiko; Hozumi, Kentaro; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Hachioji, Tokyo 1920392, Japan; [Sudo, Ryo] Keio Univ, Sch Integrated Design Engn, Dept Syst Design Engn, Yokohama, Kanagawa 2238522, Japan; [Miner, Jeffrey H.] Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA	Tokyo University of Pharmacy & Life Sciences; Keio University; Washington University (WUSTL)	Kikkawa, Y (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Hachioji, Tokyo 1920392, Japan.	kikkawa@toyaku.ac.jp	Kikkawa, Yamato/D-1503-2010; Sudo, Ryo/D-2319-2010	Hozumi, Kentaro/0000-0002-6671-4386; Sudo, Ryo/0000-0002-1053-9662; Yamada, Yuji/0000-0003-2338-6906	National Institutes of Health [R01DK078314]; Ministry of Education, Sciences Sports and Culture, Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078314] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25249018] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Sciences Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK078314 (to J. H. M.). This work was also supported by Ministry of Education, Sciences Sports and Culture, Japan grants (to Y. K.).	Alais S, 2001, J CELL SCI, V114, P1847; An XL, 2008, BLOOD, V112, P5212, DOI 10.1182/blood-2008-03-146068; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Burton NM, 2008, BLOOD CELL MOL DIS, V40, P446, DOI 10.1016/j.bcmd.2008.01.004; CAMPBELL IG, 1994, CANCER RES, V54, P5761; Collec E, 2011, BIOCHEM J, V436, P699, DOI 10.1042/BJ20101717; De Grandis M, 2013, BLOOD, V121, P658, DOI 10.1182/blood-2012-07-440487; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; El Nemer W, 1998, J BIOL CHEM, V273, P16686; El Nemer W, 1999, J BIOL CHEM, V274, P31903, DOI 10.1074/jbc.274.45.31903; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; Gauthier E, 2005, J BIOL CHEM, V280, P30055, DOI 10.1074/jbc.M503293200; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Kikkawa Y, 2002, J BIOL CHEM, V277, P44864, DOI 10.1074/jbc.M208731200; Kikkawa Y, 1998, J BIOL CHEM, V273, P15854, DOI 10.1074/jbc.273.25.15854; Kikkawa Y, 2000, J CELL SCI, V113, P869; Kikkawa Y, 2008, EXP CELL RES, V314, P2579, DOI 10.1016/j.yexcr.2008.05.021; Kikkawa Y, 2007, J BIOL CHEM, V282, P14853, DOI 10.1074/jbc.M611706200; Kikkawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023329; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Kroviarski Y, 2004, BRIT J HAEMATOL, V126, P255, DOI 10.1111/j.1365-2141.2004.05010.x; Mankelow T, 2007, BLOOD, V110, P3398, DOI 10.1182/blood-2007-06-094748; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Moulson CL, 2001, DEV DYNAM, V222, P101, DOI 10.1002/dvdy.1169; Nishimune H, 2008, J CELL BIOL, V182, P1201, DOI 10.1083/jcb.200805095; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; PARSONS SF, 1995, P NATL ACAD SCI USA, V92, P5496, DOI 10.1073/pnas.92.12.5496; Pouliot N, 2013, CELL ADHES MIGR, V7, P142, DOI 10.4161/cam.22125; Rahuel C, 2008, AM J PHYSIOL-RENAL, V294, pF393, DOI 10.1152/ajprenal.00315.2007; Richard M, 2006, TRANSFUSION, V46, P1011, DOI 10.1111/j.1537-2995.2006.00836.x; Ritie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037710; Shannon MB, 2006, J AM SOC NEPHROL, V17, P1913, DOI 10.1681/ASN.2005121298; Shimizu H, 1999, J BIOL CHEM, V274, P11995, DOI 10.1074/jbc.274.17.11995; Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668; Spenle C, 2013, CELL ADHES MIGR, V7, P90, DOI 10.4161/cam.22236; Tanimizu N, 2012, J BIOL CHEM, V287, P28586, DOI 10.1074/jbc.M112.350488; Udani M, 1998, J CLIN INVEST, V101, P2550, DOI 10.1172/JCI1204	38	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30990	31001		10.1074/jbc.M113.486456	http://dx.doi.org/10.1074/jbc.M113.486456			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24036115	hybrid, Green Published			2022-12-28	WOS:000330778900018
J	Breyton, C; Flayhan, A; Gabel, F; Lethier, M; Durand, G; Boulanger, P; Chami, M; Ebel, C				Breyton, Cecile; Flayhan, Ali; Gabel, Frank; Lethier, Mathilde; Durand, Gregory; Boulanger, Pascale; Chami, Mohamed; Ebel, Christine			Assessing the Conformational Changes of pb5, the Receptor-binding Protein of Phage T5, upon Binding to Its Escherichia coli Receptor FhuA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; Biophysics; Electron Microscopy (EM); Membrane Proteins; Viral Protein; Fluorinated Surfactant; Small Angle Neutron Scattering	LOW-RESOLUTION STRUCTURE; OUTER-MEMBRANE PROTEIN; TAIL FIBER PROTEIN; X-RAY; BACTERIOPHAGE-LAMBDA; NEUTRON-SCATTERING; STRUCTURAL-CHANGES; SURFACTANTS; HOST; PURIFICATION	Background: Little is known about the very first steps of infection of bacterial viruses. Results: We specifically access the structure of phage T5 receptor-binding protein bound to its membrane receptor using specific techniques in small angle neutron scattering. Conclusion: There are no large conformational changes. Significance: Signal transduction within T5 appears different from that of phages binding cell wall saccharides. Within tailed bacteriophages, interaction of the receptor-binding protein (RBP) with the target cell triggers viral DNA ejection into the host cytoplasm. In the case of phage T5, the RBP pb5 and the receptor FhuA, an outer membrane protein of Escherichia coli, have been identified. Here, we use small angle neutron scattering and electron microscopy to investigate the FhuA-pb5 complex. Specific deuteration of one of the partners allows the complete masking in small angle neutron scattering of the surfactant and unlabeled proteins when the complex is solubilized in the fluorinated surfactant F-6-DigluM. Thus, individual structures within a membrane protein complex can be described. The solution structure of FhuA agrees with its crystal structure; that of pb5 shows an elongated shape. Neither displays significant conformational changes upon interaction. The mechanism of signal transduction within phage T5 thus appears different from that of phages binding cell wall saccharides, for which structural information is available.	[Breyton, Cecile; Flayhan, Ali; Gabel, Frank; Lethier, Mathilde; Ebel, Christine] Univ Grenoble Alpes, IBS, F-38027 Grenoble, France; [Breyton, Cecile; Flayhan, Ali; Gabel, Frank; Lethier, Mathilde; Ebel, Christine] CNRS, IBS, UMR5075, F-38027 Grenoble, France; [Breyton, Cecile; Flayhan, Ali; Gabel, Frank; Lethier, Mathilde; Ebel, Christine] CEA, DSV, IBS, F-38027 Grenoble, France; [Durand, Gregory] Univ Avignon, Equipe Chim Bioorgan & Syst Amphiphiles, F-84029 Avignon, France; [Durand, Gregory] Inst Biomol Max Mousseron, UMR 5247, F-34093 Montpellier, France; [Boulanger, Pascale] Univ Paris 11, UMR CNRS 8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France; [Chami, Mohamed] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, CH-4058 Basel, Switzerland	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Avignon Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; UDICE-French Research Universities; Universite Paris Saclay; University of Basel	Breyton, C (corresponding author), Inst Biol Struct, 41 Rue Jules Horowitz, F-38027 Grenoble 01, France.	Cecile.Breyton@ibs.fr		Durand, Gregory/0000-0001-6680-2821; Gabel, Frank/0000-0003-3446-2601; Ebel, Christine/0000-0002-6912-500X	FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]	FRISBI; GRAL	We are grateful to H. Stahlberg (Center for Cellular Imaging and NanoAnalytics) for support. We thank A. Le Roy (IBS) for performing AUC experiments and S. Raynal (University of Avignon) for the synthesis of F<INF>6</INF>-DigluM. We also thank the Laue-Langevin Institute for BAG beamtime on D22, P. Callow and G. Zaccai for local contacting, and the European Synchrotron Radiation Facility for BAG beamtime on ID14-3. This work used the Analytical Ultracentrifugation, Surface Plasmon Resonance, Mass Spectrometry, and Membrane Protein Purification platforms of the Grenoble Instruct Centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB).	Abla M, 2008, J ORG CHEM, V73, P8142, DOI 10.1021/jo801379e; Abla M, 2012, J FLUORINE CHEM, V134, P63, DOI 10.1016/j.jfluchem.2011.05.015; Basit H, 2012, CHEM COMMUN, V48, P6037, DOI 10.1039/c2cc31107k; Blesneac I, 2012, BBA-BIOMEMBRANES, V1818, P798, DOI 10.1016/j.bbamem.2011.12.016; Bohm J, 2001, CURR BIOL, V11, P1168, DOI 10.1016/S0960-9822(01)00349-9; Boulanger P, 1996, BIOCHEMISTRY-US, V35, P14216, DOI 10.1021/bi9608673; Braun V, 2009, J BACTERIOL, V191, P3431, DOI 10.1128/JB.00106-09; Breyton C, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13071-6; Breyton C, 2010, METHODS MOL BIOL, V601, P219, DOI 10.1007/978-1-60761-344-2_14; Breyton C, 2009, BIOPHYS J, V97, P1077, DOI 10.1016/j.bpj.2009.05.053; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Chang JT, 2010, J MOL BIOL, V402, P731, DOI 10.1016/j.jmb.2010.07.058; Cho KH, 2013, CHEMBIOCHEM, V14, P452, DOI 10.1002/cbic.201200759; Clifton LA, 2012, J BIOL CHEM, V287, P337, DOI 10.1074/jbc.M111.302901; Compton ELR, 2011, J BIOL CHEM, V286, P27058, DOI 10.1074/jbc.M111.244533; Dai W, 2010, P NATL ACAD SCI USA, V107, P4347, DOI 10.1073/pnas.0915008107; Ebel C, 2011, METHODS, V54, P56, DOI 10.1016/j.ymeth.2010.11.003; Ferguson AD, 1998, PROTEIN SCI, V7, P1636, DOI 10.1002/pro.5560070719; Flayhan A, 2012, BIOCHIMIE, V94, P1982, DOI 10.1016/j.biochi.2012.05.021; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Ghosh R., 2006, COMPUTING GUIDE SMAL, P35; Goulet A, 2011, J BIOL CHEM, V286, P25397, DOI 10.1074/jbc.M111.243360; HELLER KJ, 1984, J VIROL, V49, P20, DOI 10.1128/JVI.49.1.20-25.1984; JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maura D, 2011, APPL MICROBIOL BIOT, V90, P851, DOI 10.1007/s00253-011-3227-1; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; MONTAG D, 1989, J BACTERIOL, V171, P4378, DOI 10.1128/JB.171.8.4378-4384.1989; Nehme R, 2010, BBA-BIOMEMBRANES, V1798, P1100, DOI 10.1016/j.bbamem.2010.02.015; Plancon L, 2002, J MOL BIOL, V318, P557, DOI 10.1016/S0022-2836(02)00089-X; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; ROESSNER CA, 1983, J BIOL CHEM, V258, P643; Salvay AG, 2007, J BIOL PHYS, V33, P399, DOI 10.1007/s10867-008-9058-3; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107; Soto CM, 2010, CURR OPIN BIOTECH, V21, P426, DOI 10.1016/j.copbio.2010.07.004; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Stone R, 2002, SCIENCE, V298, P730, DOI 10.1126/science.298.5594.730; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Talbot JC, 2009, J BIOENERG BIOMEMBR, V41, P349, DOI 10.1007/s10863-009-9235-5; TIMMINS PA, 1988, EUR BIOPHYS J BIOPHY, V15, P257, DOI 10.1007/BF00256476; Udho E, 2012, BIOCHEMISTRY-US, V51, P6753, DOI 10.1021/bi300493u; Veesler D, 2012, P NATL ACAD SCI USA, V109, P8954, DOI 10.1073/pnas.1200966109; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; Vinga I, 2012, MOL MICROBIOL, V83, P289, DOI 10.1111/j.1365-2958.2011.07931.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang J, 2000, J BACTERIOL, V182, P508, DOI 10.1128/JB.182.2.508-512.2000; Zoued A, 2013, J BIOL CHEM, V288, P27031, DOI 10.1074/jbc.M113.499772	54	31	32	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30763	30772		10.1074/jbc.M113.501536	http://dx.doi.org/10.1074/jbc.M113.501536			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014030	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000329868100076
J	Morada, M; Pendyala, L; Wu, G; Merali, S; Yarlett, N				Morada, Mary; Pendyala, Lakhsmi; Wu, Gang; Merali, Salim; Yarlett, Nigel			Cryptosporidium parvum Induces an Endoplasmic Stress Response in the Intestinal Adenocarcinoma HCT-8 Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Endoplasmic Reticulum Stress; Host-Pathogen Interactions; Parasitology; Polyamines; Unfolded Protein Response; C; parvum; SSAT	SPERMIDINE SPERMINE N1-ACETYLTRANSFERASE; ER STRESS; N-1-ACETYLTRANSFERASE; RETICULUM; CATABOLISM; APOPTOSIS; PROTEIN; UBIQUITINATION; TRANSCRIPTION; PURIFICATION	Invasion of human intestinal epithelial cells (HCT-8) by Cryptosporidium parvum resulted in a rapid induction of host cell spermidine/spermine N-1-acetyltransferase 1 (hSSAT-1) mRNA, causing a 4-fold increase in SSAT-1 enzyme activity after 24 h of infection. In contrast, host cell SSAT-2, spermine oxidase, and acetylpolyamine oxidase (hAPAO) remained unchanged during this period. Intracellular polyamine levels of C. parvum-infected human epithelial cells were determined, and it was found that spermidine remained unchanged and putrescine increased by 2.5-fold after 15 h and then decreased after 24 h, whereas spermine decreased by 3.9-fold after 15 h. Concomitant with these changes, N-1-acetylspermine and N-1-acetylspermidine both increased by 115- and 24-fold, respectively. Increased SSAT-1 has previously been shown to be involved in the endoplasmic reticulum (ER) stress response leading to apoptosis. Several stress response proteins were increased in HCT-8 cells infected with C. parvum, including calreticulin, a major calcium-binding chaperone in the ER; GRP78/BiP, a prosurvival ER chaperone; and Nrf2, a transcription factor that binds to antioxidant response elements, thus activating them. However, poly(ADP-ribose) polymerase, a protein involved in DNA repair and programmed cell death, was decreased. Cumulatively, these results suggest that the invasion of HCT-8 cells by C. parvum results in an ER stress response by the host cell that culminates in overexpression of host cell SSAT-1 and elevated N-1-acetylpolyamines, which can be used by a parasite that lacks ornithine decarboxylase.	[Morada, Mary; Wu, Gang; Yarlett, Nigel] Pace Univ, Haskins Labs, New York, NY 10038 USA; [Yarlett, Nigel] Pace Univ, Dept Chem & Phys Sci, New York, NY 10038 USA; [Pendyala, Lakhsmi] Roswell Pk Canc Res Inst, Buffalo, NY 14263 USA; [Merali, Salim] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [Merali, Salim] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA	Pace University; Pace University; Roswell Park Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Yarlett, N (corresponding author), Pace Univ, Haskins Labs, 41 Pk Row, New York, NY 10038 USA.	nyarlett@pace.edu	Yarlett, Nigel/B-3523-2009		National Institutes of Health from the National Cooperative Drug Discovery/Development Groups (NCDDG) [AI40320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI040320] Funding Source: NIH RePORTER	National Institutes of Health from the National Cooperative Drug Discovery/Development Groups (NCDDG)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI40320 from the National Cooperative Drug Discovery/Development Groups (NCDDG; to N. Y.).	ARROWOOD MJ, 1987, J PARASITOL, V73, P314, DOI 10.2307/3282084; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bhardwaj N, 2005, INT J PARASITOL, V35, P75, DOI 10.1016/j.ijpara.2004.10.018; CAI J, 1992, BIOCHIM BIOPHYS ACTA, V1131, P317, DOI 10.1016/0167-4781(92)90032-U; Chen XM, 2005, J IMMUNOL, V175, P7447, DOI 10.4049/jimmunol.175.11.7447; Coleman CS, 1997, J BIOL CHEM, V272, P12164, DOI 10.1074/jbc.272.18.12164; Coleman CS, 1996, BIOCHEM J, V316, P697, DOI 10.1042/bj3160697; Coleman CS, 2001, BIOCHEM J, V358, P137, DOI 10.1042/0264-6021:3580137; Cook T, 2007, MICROBIOL-SGM, V153, P1123, DOI 10.1099/mic.0.2006/001768-0; Crowley-Weber CL, 2003, CHEM-BIOL INTERACT, V145, P53, DOI 10.1016/S0009-2797(02)00162-X; Fayer Ronald, 2007, P1, DOI 10.1201/9781420052275.ch1; GAJADHAR AA, 1991, MOL BIOCHEM PARASIT, V45, P147, DOI 10.1016/0166-6851(91)90036-6; Gass JN, 2008, MOL IMMUNOL, V45, P1035, DOI 10.1016/j.molimm.2007.07.029; GERNER EW, 1993, BIOCHEM J, V294, P491, DOI 10.1042/bj2940491; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Hector S, 2004, MOL CANCER THER, V3, P813; Ishii M, 2000, DIGEST DIS SCI, V45, P93, DOI 10.1023/A:1005413511320; Ishii M, 2002, INT J BIOCHEM CELL B, V34, P1134, DOI 10.1016/S1357-2725(02)00033-X; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; JANNE J, 1971, J BIOL CHEM, V246, P1725; JOHNSON AM, 1990, INT J PARASITOL, V20, P141, DOI 10.1016/0020-7519(90)90093-3; Keithly JS, 1997, MOL BIOCHEM PARASIT, V88, P35, DOI 10.1016/S0166-6851(97)00063-7; KILANI RT, 1987, AM J TROP MED HYG, V36, P505, DOI 10.4269/ajtmh.1987.36.505; Kincaid MM, 2007, MOL BIOL CELL, V18, P455, DOI 10.1091/mbc.E06-08-0696; Kohno K, 2007, ANTIOXID REDOX SIGN, V9, P2295, DOI 10.1089/ars.2007.1819; LIBBY PR, 1991, ARCH BIOCHEM BIOPHYS, V284, P238, DOI 10.1016/0003-9861(91)90291-P; LOUIE E, 1987, CLIN IMMUNOL IMMUNOP, V44, P329, DOI 10.1016/0090-1229(87)90077-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo R, 2008, J CELL BIOCHEM, V104, P1708, DOI 10.1002/jcb.21736; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Marverti G, 2001, EUR J CANCER, V37, P281, DOI 10.1016/S0959-8049(00)00389-0; OLEMOIYOI OK, 1995, SCIENCE, V267, P834, DOI 10.1126/science.7846527; Pallepati P, 2011, BBA-MOL CELL RES, V1813, P1987, DOI 10.1016/j.bbamcr.2011.07.021; Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008; Perez-Leal O, 2012, MOL CELL BIOL, V32, P1453, DOI 10.1128/MCB.06444-11; Pichyangkul S, 1997, AM J TROP MED HYG, V57, P383, DOI 10.4269/ajtmh.1997.57.383; Seabra SH, 2004, J PARASITOL, V90, P455, DOI 10.1645/GE-179R; SEILER N, 1981, MED BIOL, V59, P334; Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z; SEILER N, 1987, CAN J PHYSIOL PHARM, V65, P2024, DOI 10.1139/y87-317; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang YL, 2001, BIOCHEM J, V355, P45, DOI 10.1042/0264-6021:3550045; Wang YL, 2001, CANCER RES, V61, P5370; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yarlett N, 2007, MOL BIOCHEM PARASIT, V152, P170, DOI 10.1016/j.molbiopara.2007.01.004; Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200	47	14	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30356	30364		10.1074/jbc.M113.459735	http://dx.doi.org/10.1074/jbc.M113.459735			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23986438	hybrid, Green Published			2022-12-28	WOS:000329868100032
J	Woods, NK; Padmanabhan, J				Woods, Neha Kabra; Padmanabhan, Jaya			Inhibition of Amyloid Precursor Protein Processing Enhances Gemcitabine-mediated Cytotoxicity in Pancreatic Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM ADAMTS; Amyloid Precursor Protein; Pancreatic Cancer; Protein Secretion; Secretases	ALPHA-SECRETASE CLEAVAGE; DISINTEGRIN METALLOPROTEASE; PLUS GEMCITABINE; PHASE-III; EXPRESSION; ADAM10; ADAM-10; PROLIFERATION; PATHOGENESIS; SURVIVAL	Background: Amyloid precursor protein (APP) and ADAM10, main -secretase involved in generation of secreted APP (sAPP), are overexpressed in pancreatic cancer. Results: Inhibition of APP processing by ADAM10 prevents anchorage independent growth and survival of cancer cells. Conclusion: Inhibition of sAPP generation enhances chemotherapeutic potential of gemcitabine. Significance: Supplementing established pancreatic cancer therapy regimen with sAPP inhibition will significantly improve the efficacy of treatment. Pancreatic adenocarcinoma or pancreatic cancer is often diagnosed at a very late stage at which point treatment options are minimal. Current chemotherapeutic interventions prolong survival marginally, thereby emphasizing the acute need for better treatment options to effectively manage this disease. Studies from different laboratories have shown that the Alzheimer disease-associated amyloid precursor protein (APP) is overexpressed in various cancers but its significance is not known. Here we sought to determine the role of APP in pancreatic cancer cell survival and proliferation. Our results show that pancreatic cancer cells secrete high levels of sAPP, the -secretase cleaved ectodomain fragment of APP, as compared with normal non-cancerous cells. Treatment of cells with batimastat or GI254023X, inhibitors of the -secretase ADAM10, prevented sAPP generation and reduced cell survival. Additionally, inhibition of sAPP significantly reduced anchorage independent growth of the cancer cells. The effect of batimastat on cell survival and colony formation was enhanced when sAPP downregulation was combined with gemcitabine treatment. Moreover, treatment of batimastat-treated cells with recombinant sAPP reversed the inhibitory effect of the drug thereby indicating that sAPP can indeed induce proliferation of cancer cells. Down-regulation of APP and ADAM10 brought about similar results, as did batimastat treatment, thereby confirming that APP processing is important for growth and proliferation of these cells. These results suggest that inhibition of sAPP generation might enhance the effectiveness of the existing chemotherapeutic regimen for a better outcome.	[Woods, Neha Kabra; Padmanabhan, Jaya] USF Hlth Byrd Alzheimers Inst, Tampa, FL 33613 USA; [Woods, Neha Kabra; Padmanabhan, Jaya] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Padmanabhan, J (corresponding author), Univ S Florida, Dept Mol Med, USF Hlth Byrd Alzheimers Inst, 4001 E Fletcher Ave, Tampa, FL 33613 USA.	jpadmana@health.usf.edu	Padmanabhan, Jaya/A-4226-2012	Padmanabhan, Jaya/0000-0003-2019-5135	NIA, National Institutes of Health [1R21AG031429-01A2]; Alzheimer's Association [IIRG-08-90842]; NATIONAL INSTITUTE ON AGING [R21AG031429] Funding Source: NIH RePORTER	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by NIA, National Institutes of Health Grant 1R21AG031429-01A2 and Alzheimer's Association Grant IIRG-08-90842 (to J. P.)	Arima T, 2007, CANCER SCI, V98, P1720, DOI 10.1111/j.1349-7006.2007.00601.x; Berlin JD, 2002, J CLIN ONCOL, V20, P3270, DOI 10.1200/JCO.2002.11.149; Berlin J, 2010, NAT REV CLIN ONCOL, V7, P135, DOI 10.1038/nrclinonc.2010.16; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; De Strooper B, 2000, J CELL SCI, V113, P1857; Demars MP, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt77; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gaida MM, 2010, INT J MOL MED, V26, P281, DOI 10.3892/ijmm_00000463; GANDY S, 1994, NEUROBIOL AGING, V15, P253, DOI 10.1016/0197-4580(94)90125-2; Hansel DE, 2003, CANCER RES, V63, P7032; Hundhausen Christian, 2003, Blood, V102, P1186; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LEWIS DA, 1988, P NATL ACAD SCI USA, V85, P1691, DOI 10.1073/pnas.85.5.1691; Lima CMR, 2004, J CLIN ONCOL, V22, P3776, DOI 10.1200/JCO.2004.12.082; Lopez-Perez E, 2001, J NEUROCHEM, V76, P1532, DOI 10.1046/j.1471-4159.2001.00180.x; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; McCulloch DR, 2004, CLIN CANCER RES, V10, P314, DOI 10.1158/1078-0432.CCR-0846-3; Oettle H, 2005, ANN ONCOL, V16, P1639, DOI 10.1093/annonc/mdi309; PERRY G, 1988, LANCET, V2, P746; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prinzen C, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-66; Schmitz A, 2002, HISTOCHEM CELL BIOL, V117, P171, DOI 10.1007/s00418-001-0351-5; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1949, DOI 10.1200/JCO.2006.09.4664; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Venkataramani V, 2010, J BIOL CHEM, V285, P10678, DOI 10.1074/jbc.M109.057836; Vincent B, 2011, J ALZHEIMERS DIS, V24, P75, DOI 10.3233/JAD-2011-110218; Zimmermann M, 2004, J NEUROCHEM, V90, P1489, DOI 10.1111/j.1471-4159.2004.02680.x	36	24	25	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30114	30124		10.1074/jbc.M113.459255	http://dx.doi.org/10.1074/jbc.M113.459255			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24022491	Green Published, hybrid			2022-12-28	WOS:000329868100012
J	Zheng, F; Quiocho, FA				Zheng, Fei; Quiocho, Florante A.			New Structural Insights into Phosphorylation-free Mechanism for Full Cyclin-dependent Kinase (CDK)-Cyclin Activity and Substrate Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDK (Cyclin-dependent Kinase); Crystal Structure; Cyclins; Phosphorylation; Protein Structure; CDK-Cyclin; Pho85-Pcl CDK-Cyclin Superfamily	FUNCTIONAL HOMOLOG; PROTEIN-KINASE; PHO85 KINASE; CDK; ACTIVATION; SPECIFICITY; PHO80-PHO85; INHIBITOR; COMPLEX	Pho85 is a versatile cyclin-dependent kinase (CDK) found in budding yeast that regulates a myriad of eukaryotic cellular functions in concert with 10 cyclins (called Pcls). Unlike cell cycle CDKs that require phosphorylation of a serine/threonine residue by a CDK-activating kinase (CAK) for full activation, Pho85 requires no phosphorylation despite the presence of an equivalent residue. The Pho85-Pcl10 complex is a key regulator of glycogen metabolism by phosphorylating the substrate Gsy2, the predominant, nutritionally regulated form of glycogen synthase. Here we report the crystal structures of Pho85-Pcl10 and its complex with the ATP analog, ATPS. The structure solidified the mechanism for bypassing CDK phosphorylation to achieve full catalytic activity. An aspartate residue, invariant in all Pcls, acts as a surrogate for the phosphoryl adduct of the phosphorylated, fully activated CDK2, the prototypic cell cycle CDK, complexed with cyclin A. Unlike the canonical recognition motif, SPX(K/R), of phosphorylation sites of substrates of several cell cycle CDKs, the motif in the Gys2 substrate of Pho85-Pcl10 is SPXX. CDK5, an important signal transducer in neural development and the closest known functional homolog of Pho85, does not require phosphorylation either, and we found that in its crystal structure complexed with p25 cyclin a water/hydroxide molecule remarkably plays a similar role to the phosphoryl or aspartate group. Comparison between Pho85-Pcl10, phosphorylated CDK2-cyclin A, and CDK5-p25 complexes reveals the convergent structural characteristics necessary for full kinase activity and the variations in the substrate recognition mechanism.	[Zheng, Fei; Quiocho, Florante A.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine	Quiocho, FA (corresponding author), Baylor Coll Med, Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	faq@bcm.edu			Welch Foundation [Q-0581]	Welch Foundation(The Welch Foundation)	This work was supported by The Welch Foundation (Q-0581; to F. A. Q.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friesen H, 2003, MOL BIOL CELL, V14, P3027, DOI 10.1091/mbc.E02-09-0613; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Huang DQ, 1999, P NATL ACAD SCI USA, V96, P14445, DOI 10.1073/pnas.96.25.14445; Huang DQ, 1998, MOL CELL BIOL, V18, P3289, DOI 10.1128/MCB.18.6.3289; Huang K, 2007, MOL CELL, V28, P614, DOI 10.1016/j.molcel.2007.09.013; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nishizawa M, 1999, J BIOL CHEM, V274, P33859, DOI 10.1074/jbc.274.48.33859; Nishizawa M, 1998, MOL BIOL CELL, V9, P2393, DOI 10.1091/mbc.9.9.2393; Nishizawa M, 1999, GENES CELLS, V4, P627, DOI 10.1046/j.1365-2443.1999.00290.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poon RYC, 1997, J BIOL CHEM, V272, P5703, DOI 10.1074/jbc.272.9.5703; QI Z, 1995, J BIOL CHEM, V270, P10847, DOI 10.1074/jbc.270.18.10847; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Shemer R, 2002, MOL CELL BIOL, V22, P5395, DOI 10.1128/MCB.22.15.5395-5404.2002; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277; Sopko R, 2007, EMBO J, V26, P4487, DOI 10.1038/sj.emboj.7601847; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Tan YSH, 2003, J BIOL CHEM, V278, P147, DOI 10.1074/jbc.M208058200; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; Wagner MV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004300; Wanke V, 2005, EMBO J, V24, P4271, DOI 10.1038/sj.emboj.7600889; Wilson WA, 1999, MOL CELL BIOL, V19, P7020; Yang ZF, 2010, MOL CELL, V38, P250, DOI 10.1016/j.molcel.2010.02.033	32	5	5	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30682	30692		10.1074/jbc.M113.502773	http://dx.doi.org/10.1074/jbc.M113.502773			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24022486	Green Published, hybrid			2022-12-28	WOS:000329868100068
J	Johnson, A; Wu, RH; Peetz, M; Gygi, SP; Moazed, D				Johnson, Aaron; Wu, Ronghu; Peetz, Matthew; Gygi, Steven P.; Moazed, Danesh			Heterochromatic Gene Silencing by Activator Interference and a Transcription Elongation Barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Chromatin Modification; Gene Silencing; Heterochromatin; Transcription; Sir Proteins	RNA-POLYMERASE; SIR COMPLEX; CHROMATIN; YEAST; NUCLEOSOMES; BINDING; RECONSTITUTION; MECHANISM; DOMAIN; BLOCK	Heterochromatin silences transcription, contributing to development, differentiation, and genome stability in eukaryotic organisms. Budding yeast heterochromatic silencing is strictly dependent on the silent information regulator (SIR) complex composed of the Sir2 histone deacetylase and the chromatin-interacting proteins Sir3 and Sir4. We use reconstituted SIR heterochromatin to characterize the steps in transcription that are disrupted to achieve silencing. Transcriptional activator binding is permitted before and after heterochromatin assembly. A comprehensive proteomic approach identified heterochromatin-mediated disruption of activator interactions with coactivator complexes. We also find that if RNA polymerase II (Pol II) is allowed to initiate transcription, the SIR complex blocks elongation on chromatin while maintaining Pol II in a halted conformation. This Pol II elongation barrier functions for even one nucleosome, is more effective when assembled with multiple nucleosomes, and is sensitive to a histone mutation that is known to disrupt silencing. This dual mechanism of silencing suggests a conserved principle of heterochromatin in assembling a specific structure that targets multiple steps to achieve repression.	[Johnson, Aaron; Wu, Ronghu; Gygi, Steven P.; Moazed, Danesh] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Johnson, Aaron; Peetz, Matthew] Univ Colorado, Dept Biochem & Mol Genet, Sch Med, Aurora, CO 80045 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus	Johnson, A (corresponding author), Univ Colorado, Dept Biochem & Mol Genet, Sch Med, 12801 E 17th Ave, Aurora, CO 80045 USA.	aaron.m.johnson@ucdenver.edu			National Institutes of Health [K99/R00 GM094291, HG3456, GM67945, RO1 GM061641]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945, R01GM061641, K99GM094291, R00GM094291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Pathway to Independence Award K99/R00 GM094291 (to A. J.), National Institutes of Health Grants HG3456 and GM67945 (to S. P. G.), and National Institutes of Health Grant RO1 GM061641 (to D. M.).	Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Bhaumik SR, 2011, BBA-GENE REGUL MECH, V1809, P97, DOI 10.1016/j.bbagrm.2010.08.009; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2009, CHROMOSOMA, V118, P141, DOI 10.1007/s00412-008-0195-z; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Chen LY, 2004, BIOCHEM CELL BIOL, V82, P413, DOI 10.1139/O04-035; Chen LY, 2005, CELL, V120, P37, DOI 10.1016/j.cell.2004.11.030; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Fitzgerald DP, 2001, MOL CELL BIOL, V21, P6585, DOI 10.1128/MCB.21.19.6585-6597.2001; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gao L, 2008, MOL CELL BIOL, V28, P3979, DOI 10.1128/MCB.00019-08; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hoppe GJ, 2002, MOL CELL BIOL, V22, P4167, DOI 10.1128/MCB.22.12.4167-4180.2002; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Johnson A, 2009, MOL CELL, V35, P769, DOI 10.1016/j.molcel.2009.07.030; Keogh MC, 2002, MOL CELL BIOL, V22, P1288, DOI 10.1128/MCB.22.5.1288-1297.2002; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; Kitada T, 2012, GENE DEV, V26, P2443, DOI 10.1101/gad.201095.112; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lehmann L, 2012, J BIOL CHEM, V287, P35784, DOI 10.1074/jbc.M112.397430; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009; Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42; Rudner AD, 2005, MOL CELL BIOL, V25, P4514, DOI 10.1128/MCB.25.11.4514-4528.2005; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Sikorski TW, 2012, J BIOL CHEM, V287, P35397, DOI 10.1074/jbc.M112.391581; Sinha M, 2009, CELL, V138, P1109, DOI 10.1016/j.cell.2009.07.013; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wang F, 2013, P NATL ACAD SCI USA, V110, P8495, DOI 10.1073/pnas.1300126110; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; WOONTNER M, 1991, MOL CELL BIOL, V11, P4555, DOI 10.1128/MCB.11.9.4555; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	43	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28771	28782		10.1074/jbc.M113.460071	http://dx.doi.org/10.1074/jbc.M113.460071			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940036	Green Published, hybrid			2022-12-28	WOS:000330298800030
J	Zuehlke, AD; Wren, N; Tenge, V; Johnson, JL				Zuehlke, Abbey D.; Wren, Nicholas; Tenge, Victoria; Johnson, Jill L.			Interaction of Heat Shock Protein 90 and the Co-chaperone Cpr6 with Ura2, a Bifunctional Enzyme Required for Pyrimidine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRATRICOPEPTIDE REPEAT DOMAIN; HSP90 MOLECULAR CHAPERONE; SACCHAROMYCES-CEREVISIAE; GLUCOCORTICOID-RECEPTOR; MUTATIONAL ANALYSIS; SUBSTRATE-BINDING; ATPASE ACTIVITY; CYCLOPHILIN; HSP70; COMPLEXES	The molecular chaperone heat shock protein 90 (Hsp90) is an essential protein required for the activity and stability of multiple proteins termed clients. Hsp90 cooperates with a set of cochaperone proteins that modulate Hsp90 activity and/or target clients to Hsp90 for folding. Many of the Hsp90 co-chaperones, including Cpr6 and Cpr7, contain tetratricopeptide repeat (TPR) domains that bind a common acceptor site at the carboxyl terminus of Hsp90. We found that Cpr6 and Hsp90 interacted with Ura2, a protein critical for pyrimidine biosynthesis. Mutation or inhibition of Hsp90 resulted in decreased accumulation of Ura2, indicating it is an Hsp90 client. Cpr6 interacted with Ura2 in the absence of stable Cpr6-Hsp90 interaction, suggesting a direct interaction. However, loss of Cpr6 did not alter the Ura2-Hsp90 interaction or Ura2 accumulation. The TPR domain of Cpr6 was required for Ura2 interaction, but other TPR containing co-chaperones, including Cpr7, failed to interact with Ura2 or rescue CPR6-dependent growth defects. Further analysis suggests that the carboxyl-terminal 100 amino acids of Cpr6 and Cpr7 are critical for specifying their unique functions, providing new information about this important class of Hsp90 co-chaperones.	[Zuehlke, Abbey D.; Wren, Nicholas; Tenge, Victoria; Johnson, Jill L.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA	Idaho; University of Idaho	Johnson, JL (corresponding author), 875 Perimeter Dr MS3051, Moscow, ID 83844 USA.	jilljohn@uidaho.edu		Zuehlke, Abbey/0000-0003-0432-8823; Tenge, Victoria/0000-0002-9429-7161	National Science Foundation [MCB-0744522]; Direct For Biological Sciences [0744522] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB-0744522 ( to J.L.J.).	Antonelli R, 1998, FEBS LETT, V422, P170, DOI 10.1016/S0014-5793(98)00010-6; Armstrong H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049322; Barent RL, 1998, MOL ENDOCRINOL, V12, P342, DOI 10.1210/me.12.3.342; Carrello A, 2004, CELL STRESS CHAPERON, V9, P167, DOI 10.1379/CSC-26R.1; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; DENISDUPHIL M, 1989, BIOCHEM CELL BIOL, V67, P612, DOI 10.1139/o89-094; Dolinski KJ, 1998, MOL CELL BIOL, V18, P7344, DOI 10.1128/MCB.18.12.7344; Duina AA, 1996, YEAST, V12, P943, DOI 10.1002/(SICI)1097-0061(199608)12:10<943::AID-YEA997>3.0.CO;2-3; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Flom G, 2006, GENETICS, V172, P41, DOI 10.1534/genetics.105.045815; Flom G, 2007, BIOCHEM J, V404, P159, DOI 10.1042/BJ20070084; Flom GA, 2012, CURR GENET, V58, P149, DOI 10.1007/s00294-012-0373-7; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Johnson JL, 2007, MOL CELL BIOL, V27, P768, DOI 10.1128/MCB.01034-06; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kwapisz M, 2008, EMBO J, V27, P2411, DOI 10.1038/emboj.2008.165; Leach MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003069; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; Li J, 2013, NAT STRUCT MOL BIOL, V20, P326, DOI 10.1038/nsmb.2502; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li J, 2011, NAT STRUCT MOL BIOL, V18, P61, DOI 10.1038/nsmb.1965; Lin JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002491; Mandal AK, 2010, MOL BIOL CELL, V21, P1439, DOI 10.1091/mbc.E09-09-0779; Marsh JA, 1998, MOL CELL BIOL, V18, P7353, DOI 10.1128/MCB.18.12.7353; Mayr C, 2000, J BIOL CHEM, V275, P34140, DOI 10.1074/jbc.M005251200; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mok D, 2006, FEBS LETT, V580, P2761, DOI 10.1016/j.febslet.2006.04.039; Mollapour M, 2010, MOL CELL, V37, P333, DOI 10.1016/j.molcel.2010.01.005; Morishima Y, 2000, J BIOL CHEM, V275, P6894, DOI 10.1074/jbc.275.10.6894; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Ratajczak T, 1996, J BIOL CHEM, V271, P2961, DOI 10.1074/jbc.271.6.2961; RATAJCZAK T, 1993, J BIOL CHEM, V268, P13187; Richter K, 2011, STRUCTURE, V19, P445, DOI 10.1016/j.str.2011.03.007; Riggs DL, 2004, CRIT REV BIOCHEM MOL, V39, P279, DOI 10.1080/10409230490892513; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Silverstein AM, 1999, J BIOL CHEM, V274, P36980, DOI 10.1074/jbc.274.52.36980; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Taylor P, 2001, STRUCTURE, V9, P431, DOI 10.1016/S0969-2126(01)00603-7; Tesic M, 2003, J BIOL CHEM, V278, P32692, DOI 10.1074/jbc.M304315200; Thiebaut M, 2008, MOL CELL, V31, P671, DOI 10.1016/j.molcel.2008.08.010; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Ward BK, 2002, J BIOL CHEM, V277, P40799, DOI 10.1074/jbc.M207097200; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006; Zuehlke AD, 2012, GENETICS, V191, P805, DOI 10.1534/genetics.112.140319	59	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27406	27414		10.1074/jbc.M113.504142	http://dx.doi.org/10.1074/jbc.M113.504142			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23926110	Green Published, hybrid			2022-12-28	WOS:000330597300036
J	Genz, C; Fundakowski, J; Hermesh, O; Schmid, M; Jansen, RP				Genz, Christian; Fundakowski, Julia; Hermesh, Orit; Schmid, Maria; Jansen, Ralf-Peter			Association of the Yeast RNA-binding Protein She2p with the Tubular Endoplasmic Reticulum Depends on Membrane Curvature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Membrane; RNA Binding Protein; RNA Transport; Yeast	ASH1 MESSENGER-RNA; ASYMMETRIC LOCALIZATION; SUBCELLULAR MEMBRANES; TRANSLATIONAL CONTROL; INHERITANCE; MYO4P; TRANSLOCATION; TRANSPORT; REVEALS; DOMAINS	Localization of mRNAs contributes to the generation and maintenance of cellular asymmetry in a wide range of organisms. In Saccharomyces cerevisiae, the so-called locasome complex with its core components Myo4p, She2p, and She3p localizes more than 30 mRNAs to the yeast bud tip. A significant fraction of these mRNAs encodes membrane or secreted proteins. Their localization requires, besides the locasome, a functional segregation apparatus of the cortical endoplasmic reticulum (ER), including the machinery that is involved in the movement of ER tubules into the bud. Colocalization of RNA-containing particles with these tubules suggests a coordinated transport of localized mRNAs and the cortical ER to the bud. Association of localized mRNAs to the ER requires the presence of the locasome component She2p. Here we report that She2p is not only an RNA-binding protein but can specifically bind to ER-derived membranes in a membrane curvature-dependent manner in vitro. Although it does not contain any known curvature recognizing motifs, the protein shows a binding preference for liposomes with a diameter resembling that of yeast ER tubules. In addition, membrane binding depends on tetramerization of She2p. In an in vivo membrane-tethering assay, She2p can target a viral peptide GFP fusion protein to the cortical ER, indicating that a fraction of She2p associates with the ER in vivo. Combining RNA- and membrane-binding features makes She2p an ideal coordinator of ER tubule and mRNA cotransport.	[Genz, Christian; Fundakowski, Julia; Hermesh, Orit; Jansen, Ralf-Peter] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Schmid, Maria] Univ Munich, Gene Ctr, D-81377 Munich, Germany	Eberhard Karls University of Tubingen; University of Munich	Jansen, RP (corresponding author), IFIB, Hoppe Seyler Str 4, D-72076 Tubingen, Germany.	ralf.jansen@uni-tuebingen.de			Deutsche Forschungsgesellschaft [DFG JA696/7-1]	Deutsche Forschungsgesellschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgesellschaft Grant DFG JA696/7-1 (to R. P. J.).	Aronov S, 2007, MOL CELL BIOL, V27, P3441, DOI 10.1128/MCB.01643-06; Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Bohl F, 2000, EMBO J, V19, P5514, DOI 10.1093/emboj/19.20.5514; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; BROUILLETTE CG, 1982, BIOCHEMISTRY-US, V21, P4569, DOI 10.1021/bi00262a009; Colomina N, 2008, J BIOL CHEM, V283, P28670, DOI 10.1074/jbc.M804604200; Cui XYA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001336; DAUM G, 1982, J BIOL CHEM, V257, P3075; Deshler JO, 1998, CURR BIOL, V8, P489, DOI 10.1016/S0960-9822(98)70200-3; Du TG, 2008, EMBO REP, V9, P781, DOI 10.1038/embor.2008.112; Du TG, 2007, SEMIN CELL DEV BIOL, V18, P171, DOI 10.1016/j.semcdb.2007.01.010; Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286; Estrada P, 2003, J CELL BIOL, V163, P1255, DOI 10.1083/jcb.200304030; Frey S, 2001, J BIOL CHEM, V276, P15905, DOI 10.1074/jbc.M009430200; Fundakowski J, 2012, TRAFFIC, V13, P1642, DOI 10.1111/tra.12011; Graham J. M., 2001, PURIFICATION CRUDE M; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Hermesh O, 2013, BBA-MOL CELL RES, V1833, P2519, DOI 10.1016/j.bbamcr.2013.01.013; Heuck A, 2010, J CELL BIOL, V189, P497, DOI 10.1083/jcb.201002076; Hodges AR, 2008, J BIOL CHEM, V283, P6906, DOI 10.1074/jbc.M708865200; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Irie K, 2002, EMBO J, V21, P1158, DOI 10.1093/emboj/21.5.1158; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kraut-Cohen J, 2010, TRENDS BIOCHEM SCI, V35, P459, DOI 10.1016/j.tibs.2010.02.006; Lang BD, 2001, NUCLEIC ACIDS RES, V29, P2567, DOI 10.1093/nar/29.12.2567; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Long RM, 2001, J CELL BIOL, V153, P307, DOI 10.1083/jcb.153.2.307; Long RM, 2000, EMBO J, V19, P6592, DOI 10.1093/emboj/19.23.6592; Madsen KL, 2010, FEBS LETT, V584, P1848, DOI 10.1016/j.febslet.2010.01.053; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Merklinger E, 2012, BIOCHEM J, V442, P381, DOI 10.1042/BJ20111363; Muller M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000611; Muller M, 2009, RNA, V15, P2002, DOI 10.1261/rna.1753309; Niessing D, 2004, CELL, V119, P491, DOI 10.1016/j.cell.2004.10.018; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Peabody DS, 1996, NUCLEIC ACIDS RES, V24, P2352, DOI 10.1093/nar/24.12.2352; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Qbadou S, 2003, J CELL SCI, V116, P837, DOI 10.1242/jcs.00291; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; ROTHBLATT JA, 1986, CELL, V44, P619, DOI 10.1016/0092-8674(86)90271-0; Schmid M, 2006, CURR BIOL, V16, P1538, DOI 10.1016/j.cub.2006.06.025; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Shen ZF, 2010, GENE DEV, V24, P1914, DOI 10.1101/gad.1937510; Shen Z, 2009, MOL BIOL CELL, V20, P2265, DOI 10.1091/mbc.E08-11-1151; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Tuller G, 1999, YEAST, V15, P1555, DOI 10.1002/(SICI)1097-0061(199910)15:14<1555::AID-YEA479>3.0.CO;2-Z; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Waizengger T, 2005, EMBO REP, V6, P57, DOI 10.1038/sj.embor.7400318; Wang C, 2008, PLANT J, V55, P443, DOI 10.1111/j.1365-313X.2008.03516.x; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Wu CH, 2011, J CELL BIOL, V193, P521, DOI 10.1083/jcb.201006023	54	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32384	32393		10.1074/jbc.M113.486431	http://dx.doi.org/10.1074/jbc.M113.486431			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24056370	Green Published, hybrid			2022-12-28	WOS:000328681700023
J	Caillat, C; Pefani, DE; Gillespie, PJ; Taraviras, S; Blow, JJ; Lygerou, Z; Perrakis, A				Caillat, Christophe; Pefani, Dafni-Eleftheria; Gillespie, Peter J.; Taraviras, Stavros; Blow, J. Julian; Lygerou, Zoi; Perrakis, Anastassis			The Geminin and Idas Coiled Coils Preferentially Form a Heterodimer That Inhibits Geminin Function in DNA Replication Licensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLE REGULATOR GEMININ; CELL-CYCLE; RE-REPLICATION; FACTOR CDT1; STRUCTURAL BASIS; NEURAL PLATE; S-PHASE; PROTEIN; DIFFERENTIATION; CHROMATIN	Geminin is an important regulator of proliferation and differentiation in metazoans, which predominantly inhibits the DNA replication licensing factor Cdt1, preventing genome over-replication. We show that Geminin preferentially forms stable coiled-coil heterodimers with its homologue, Idas. In contrast to Idas-Geminin heterodimers, Idas homodimers are thermodynamically unstable and are unlikely to exist as a stable macromolecule under physiological conditions. The crystal structure of the homology regions of Idas in complex with Geminin showed a tight head-to-head heterodimeric coiled-coil. This Idas-Geminin heterodimer binds Cdt1 less strongly than Geminin-Geminin, still with high affinity (similar to 30 nM), but with notably different thermodynamic properties. Consistently, in Xenopus egg extracts, Idas-Geminin is less active in licensing inhibition compared with a Geminin-Geminin homodimer. In human cultured cells, ectopic expression of Idas leads to limited over-replication, which is counteracted by Geminin co-expression. The properties of the Idas-Geminin complex suggest it as the functional form of Idas and provide a possible mechanism to modulate Geminin activity.	[Caillat, Christophe; Perrakis, Anastassis] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Pefani, Dafni-Eleftheria; Lygerou, Zoi] Univ Patras, Sch Med, Biol Lab, Patras 26505, Greece; [Gillespie, Peter J.; Blow, J. Julian] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Taraviras, Stavros] Univ Patras, Sch Med, Physiol Lab, Patras 26505, Greece	Netherlands Cancer Institute; University of Patras; University of Dundee; University of Patras	Perrakis, A (corresponding author), Netherlands Canc Inst, Div Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.perrakis@nki.nl	Blow, J. Julian/B-3977-2009; Taraviras, Stavros/AAJ-4690-2020; Perrakis, Anastassis/E-8704-2013	Blow, J. Julian/0000-0002-9524-5849; Taraviras, Stavros/0000-0002-7455-647X; Perrakis, Anastassis/0000-0002-1151-6227; christophe, caillat/0000-0003-2959-1871	European Molecular Biology Organization long term fellowship [EMBO ALTF 102-2010]; European Research Council [ERC281851_DYNACOM]; European Molecular Biology Organization short term fellowship; Biotechnology and Biological Sciences Research Council (Swindon, UK) [BB/H013024/1]; Cancer Research UK [C303/A7399]; Wellcome Trust [083524/Z/07/Z]; BBSRC [BB/H013024/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H013024/1] Funding Source: researchfish; Cancer Research UK [14301] Funding Source: researchfish	European Molecular Biology Organization long term fellowship(European Molecular Biology Organization (EMBO)); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization short term fellowship; Biotechnology and Biological Sciences Research Council (Swindon, UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	This work supported by a European Molecular Biology Organization long term fellowship (EMBO ALTF 102-2010; to C. C.).; Supported by the European Research Council (ERC281851_DYNACOM) and a European Molecular Biology Organization short term fellowship (to E.-D. P.).; Supported by Biotechnology and Biological Sciences Research Council (Swindon, UK) Grant BB/H013024/1, Cancer Research UK Grant C303/A7399, and Wellcome Trust Grant 083524/Z/07/Z.	Acharya A, 2006, BIOCHEMISTRY-US, V45, P11324, DOI 10.1021/bi060822u; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bricogne G., 2011, BUSTER VERSION 2 8 0; Caillat Christophe, 2012, Subcell Biochem, V62, P71, DOI 10.1007/978-94-007-4572-8_5; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; De Marco V, 2009, P NATL ACAD SCI USA, V106, P19807, DOI 10.1073/pnas.0905281106; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; DePamphilis ML, 2006, CURR OPIN CELL BIOL, V18, P231, DOI 10.1016/j.ceb.2006.04.001; Diffley JFX, 2010, COLD SH Q B, V75, P135, DOI 10.1101/sqb.2010.75.062; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferenbach A, 2005, NUCLEIC ACIDS RES, V33, P316, DOI 10.1093/nar/gki176; Gillespie PJ, 2012, METHODS, V57, P203, DOI 10.1016/j.ymeth.2012.03.029; Joosten RP, 2011, BIOINFORMATICS, V27, P3392, DOI 10.1093/bioinformatics/btr590; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karamitros D, 2010, CELL CYCLE, V9, P3181, DOI 10.4161/cc.9.16.12554; Kearsey SE, 2003, MOL CELL, V12, P1067, DOI 10.1016/S1097-2765(03)00441-6; Kisielewska J, 2012, DEVELOPMENT, V139, P63, DOI 10.1242/dev.068676; Klotz-Noack K, 2012, J CELL SCI, V125, P2436, DOI 10.1242/jcs.100883; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Kroll KL, 2007, FRONT BIOSCI, V12, P1395, DOI 10.2741/2156; Kulartz M, 2003, BIOCHEM BIOPH RES CO, V305, P412, DOI 10.1016/S0006-291X(03)00773-3; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Luna-Vargas MPA, 2011, J STRUCT BIOL, V175, P113, DOI 10.1016/j.jsb.2011.03.017; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; Markey M, 2004, J BIOL CHEM, V279, P29255, DOI 10.1074/jbc.M313482200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Papanayotou C, 2008, PLOS BIOL, V6, P109, DOI 10.1371/journal.pbio.0060002; Pefani DE, 2011, J BIOL CHEM, V286, P23234, DOI 10.1074/jbc.M110.207688; Roukos V, 2007, J BIOL CHEM, V282, P9346, DOI 10.1074/jbc.M611643200; Roukos V, 2011, J CELL SCI, V124, P422, DOI 10.1242/jcs.074229; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Spella M, 2007, NEUROSCIENCE, V147, P373, DOI 10.1016/j.neuroscience.2007.03.050; Spella M, 2011, STEM CELLS, V29, P1269, DOI 10.1002/stem.678; Stiff T, 2013, PLOS GENET, V9, DOI [10.1371/journal.pgen.1003360, 10.1371/journal.pone.0058239]; Stubbs JL, 2012, NAT CELL BIOL, V14, P140, DOI 10.1038/ncb2406; Symeonidou IE, 2012, FEBS LETT, V586, P2803, DOI 10.1016/j.febslet.2012.07.042; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Thepaut M, 2004, J MOL BIOL, V342, P275, DOI 10.1016/j.jmb.2004.06.065; Truong LN, 2011, J MOL CELL BIOL, V3, P13, DOI 10.1093/jmcb/mjq052; Varma D, 2012, NAT CELL BIOL, V14, P593, DOI 10.1038/ncb2489; Wei Z, 2010, J BIOL CHEM, V285, P12469, DOI 10.1074/jbc.C109.094599; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wong PG, 2010, CELL CYCLE, V9, P4351, DOI 10.4161/cc.9.21.13596; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; Yellajoshyula D, 2011, P NATL ACAD SCI USA, V108, P3294, DOI 10.1073/pnas.1012053108; Zhou B, 2012, P NATL ACAD SCI USA, V109, P8931, DOI 10.1073/pnas.1200874109; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	57	15	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31624	31634		10.1074/jbc.M113.491928	http://dx.doi.org/10.1074/jbc.M113.491928			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24064211	Green Published, hybrid			2022-12-28	WOS:000330596200021
J	Deakyne, JS; Huang, F; Negri, J; Tolliday, N; Cocklin, S; Mazin, AV				Deakyne, Julianna S.; Huang, Fei; Negri, Joseph; Tolliday, Nicola; Cocklin, Simon; Mazin, Alexander V.			Analysis of the Activities of RAD54, a SWI2/SNF2 Protein, Using a Specific Small-molecule Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; ANTITUMOR ANTIBIOTIC STREPTONIGRIN; CHROMATIN-REMODELING ENZYME; RECOMBINATION FACTORS RAD51; HOMOLOGOUS RECOMBINATION; NUCLEOPROTEIN FILAMENT; SACCHAROMYCES-CEREVISIAE; HOLLIDAY JUNCTION; GENOMIC STABILITY; BRANCH MIGRATION	RAD54, an important homologous recombination protein, is a member of the SWI2/SNF2 family of ATPase-dependent DNA translocases. In vitro, RAD54 stimulates RAD51-mediated DNA strand exchange and promotes branch migration of Holliday junctions. It is thought that an ATPase-dependent DNA translocation is required for both of these RAD54 activities. Here we identified, by high-throughput screening, a specific RAD54 inhibitor, streptonigrin (SN), and used it to investigate the mechanisms of RAD54 activities. We found that SN specifically targets the RAD54 ATPase, but not DNA binding, through direct interaction with RAD54 and generation of reactive oxygen species. Consistent with the dependence of branch migration (BM) on the ATPase-dependent DNA translocation of RAD54, SN inhibited RAD54 BM. Surprisingly, the ability of RAD54 to stimulate RAD51 DNA strand exchange was not significantly affected by SN, indicating a relatively smaller role of RAD54 DNA translocation in this process. Thus, the use of SN enabled us to identify important differences in the effect of the RAD54 ATPase and DNA translocation on two major activities of RAD54, BM of Holliday junctions and stimulation of DNA pairing.	[Deakyne, Julianna S.; Huang, Fei; Cocklin, Simon; Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Negri, Joseph; Tolliday, Nicola] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA	Drexel University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Mazin, AV (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA.	amazin@drexelmed.edu			National Institutes of Health [CA100839, DA033981, MH097512, 1R21AI087388]; KECK Foundation; Leukemia and Lymphoma Society Scholar Award [1054-09]; NATIONAL CANCER INSTITUTE [R56CA100839, R01CA100839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH097512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KECK Foundation(W.M. Keck Foundation); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants CA100839, DA033981, and MH097512 (to A. V. M.) and 1R21AI087388 (to S. C.). This work was also supported by a KECK Foundation award and by Leukemia and Lymphoma Society Scholar Award 1054-09 (to A. V. M.).	Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Anderberg PI, 2004, J INORG BIOCHEM, V98, P720, DOI 10.1016/j.jinorgbio.2003.10.011; Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; Bolzan AD, 2001, MUTAT RES-REV MUTAT, V488, P25, DOI 10.1016/S1383-5742(00)00062-4; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Bugreev D. V., 2006, NAT PROTOC, DOI [10.1038/nprot.2006.217, DOI 10.1038/NPR0T.2006.217]; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; Bugreev DV, 2009, J BIOL CHEM, V284, P26349, DOI 10.1074/jbc.M109.029371; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; CAPRANICO G, 1994, J BIOL CHEM, V269, P25004; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; Clever B, 1997, EMBO J, V16, P2535, DOI 10.1093/emboj/16.9.2535; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Firman K, 2000, EMBO J, V19, P2094, DOI 10.1093/emboj/19.9.2094; GAME JC, 1993, SEMIN CANCER BIOL, V4, P73; Godson GN, 2000, BIOCHEMISTRY-US, V39, P332, DOI 10.1021/bi9916628; Golub EI, 1997, NUCLEIC ACIDS RES, V25, P4106, DOI 10.1093/nar/25.20.4106; Goulart MOF, 2003, BIOELECTROCHEMISTRY, V59, P85, DOI 10.1016/S1567-5394(03)00005-7; HAJDU J, 1981, J AM CHEM SOC, V103, P232, DOI 10.1021/ja00391a061; HARRIS MN, 1965, CANCER, V18, P49, DOI 10.1002/1097-0142(196501)18:1<49::AID-CNCR2820180109>3.0.CO;2-#; Haseltine CA, 2009, NUCLEIC ACIDS RES, V37, P2757, DOI 10.1093/nar/gkp068; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; IYPE LE, 1994, J BIOL CHEM, V269, P24967; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; Kowalczykowski SC, 2008, NATURE, V453, P463, DOI 10.1038/453463a; KREMER WILLIAM B., 1967, CANCER CHEMOTHER REP, V51, P19; LATUASAN HE, 1961, BIOCHIM BIOPHYS ACTA, V52, P502, DOI 10.1016/0006-3002(61)90408-5; Liu YL, 2004, NAT REV MOL CELL BIO, V5, P937, DOI 10.1038/nrm1502; Long GV, 1997, ANTI-CANCER DRUG DES, V12, P453; LOWN JW, 1983, MOL CELL BIOCHEM, V55, P17, DOI 10.1007/BF00229240; Matsuda M, 1999, ONCOGENE, V18, P3427, DOI 10.1038/sj.onc.1202692; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; Mazina OM, 2007, J BIOL CHEM, V282, P21068, DOI 10.1074/jbc.M701992200; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; MILLER DS, 1967, CANCER RES, V27, P632; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; PITTILLO RF, 1974, ANTIMICROB AGENTS CH, V5, P82, DOI 10.1128/AAC.5.1.82; POWIS G, 1989, FREE RADICAL BIO MED, V6, P63, DOI 10.1016/0891-5849(89)90162-7; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Rossi MJ, 2010, METHODS, V51, P336, DOI 10.1016/j.ymeth.2010.02.010; Sanchez-Cruz P, 2009, CHEM RES TOXICOL, V22, P818, DOI 10.1021/tx800392j; Schmuckli-Maurer J, 2003, NUCLEIC ACIDS RES, V31, P1013, DOI 10.1093/nar/gkg190; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; SMITH GMR, 1967, BRIT J CANCER, V21, P295, DOI 10.1038/bjc.1967.32; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Solinger JA, 2001, J MOL BIOL, V307, P1207, DOI 10.1006/jmbi.2001.4555; SUGIURA Y, 1984, BIOCHIM BIOPHYS ACTA, V782, P254, DOI 10.1016/0167-4781(84)90060-5; SULLIVAN RD, 1963, CANCER CHEMOTH REP, P27; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tan TLR, 1999, CURR BIOL, V9, P325, DOI 10.1016/S0960-9822(99)80142-0; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027; Wolner B, 2005, J BIOL CHEM, V280, P10855, DOI 10.1074/jbc.M414388200; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; YAMASHITA Y, 1990, CANCER RES, V50, P5841	70	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31567	31580		10.1074/jbc.M113.502195	http://dx.doi.org/10.1074/jbc.M113.502195			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24043618	Green Published, hybrid			2022-12-28	WOS:000330596200016
J	Jamshidiha, M; Ishida, H; Sutherland, C; Gifford, JL; Walsh, MP; Vogel, HJ				Jamshidiha, Mostafa; Ishida, Hiroaki; Sutherland, Cindy; Gifford, Jessica L.; Walsh, Michael P.; Vogel, Hans J.			Structural Analysis of a Calmodulin Variant from Rice THE C-TERMINAL EXTENSION OF OsCaM61 REGULATES ITS CALCIUM BINDING AND ENZYME ACTIVATION PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; SWISS-MODEL WORKSPACE; LIGHT-CHAIN KINASE; NMR-SPECTROSCOPY; BINDING PROTEINS; RELAXATION MEASUREMENTS; ARABIDOPSIS-THALIANA; SECONDARY STRUCTURE; PRENYLATION STATUS; PLASMA-MEMBRANE	OsCaM61 is one of five calmodulins known to be present in Oryza sativa that relays the increase of cytosolic [Ca2+] to down-stream targets. OsCaM61 bears a unique C-terminal extension with a prenylation site. Using nuclear magnetic resonance (NMR) spectroscopy we studied the behavior of the calmodulin (CaM) domain and the C-terminal extension of OsCaM61 in the absence and presence of Ca2+. NMR dynamics data for OsCaM61 indicate that the two lobes of the CaM domain act together unlike the independent behavior of the lobes seen in mammalian CaM and soybean CaM4. Also, data demonstrate that the positively charged nuclear localization signal region in the tail in apo-OsCaM61 is helical, whereas it becomes flexible in the Ca2+-saturated protein. The extra helix in apo-OsCaM61 provides additional interactions in the C-lobe and increases the structural stability of the closed apo conformation. This leads to a decrease in the Ca2+ binding affinity of EF-hands III and IV in OsCaM61. In Ca2+-OsCaM61, the basic nuclear localization signal cluster adopts an extended conformation, exposing the C-terminal extension for prenylation or enabling OsCaM61 to be transferred to the nucleus. Moreover, Ser(172) and Ala(173), residues in the tail, interact with different regions of the protein. These interactions affect the ability of OsCaM61 to activate different target proteins. Altogether, our data show that the tail is not simply a linker between the prenyl group and the protein but that it also provides a new regulatory mechanism that some plants have developed to fine-tune Ca2+ signaling events.	[Jamshidiha, Mostafa; Ishida, Hiroaki; Gifford, Jessica L.; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Sutherland, Cindy; Walsh, Michael P.] Univ Calgary, Dept Biochem & Mol Biol, Smooth Muscle Res Grp, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Struct Biol Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca			Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an operating grant from the Natural Science and Engineering Research Council of Canada.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Batistic O, 2012, BBA-GEN SUBJECTS, V1820, P1283, DOI 10.1016/j.bbagen.2011.10.012; Benjamins R, 2003, PLANT PHYSIOL, V132, P1623, DOI 10.1104/pp.103.019943; Biekofsky RR, 1998, FEBS LETT, V439, P101, DOI 10.1016/S0014-5793(98)01349-0; Boonburapong B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-4; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong AW, 2002, PLANT MOL BIOL, V48, P203, DOI 10.1023/A:1013380814919; FISCHER R, 1988, J BIOL CHEM, V263, P17055; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Hashimoto K, 2011, BIOCHIMIE, V93, P2054, DOI 10.1016/j.biochi.2011.05.019; Huang H, 2011, J BIOL CHEM, V286, P17181, DOI 10.1074/jbc.M110.179028; Hwang YS, 1999, PLANT MOL BIOL, V40, P911, DOI 10.1023/A:1006241811136; Ishida H, 2008, J BIOL CHEM, V283, P14619, DOI 10.1074/jbc.M801398200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Katou S, 2007, PLANT CELL PHYSIOL, V48, P332, DOI 10.1093/pcp/pcm007; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Koo SC, 2009, MOL CELLS, V27, P563, DOI 10.1007/s10059-009-0081-4; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SH, 2000, BIOCHEM J, V350, P299, DOI 10.1042/0264-6021:3500299; Li DF, 2006, FEBS LETT, V580, P4325, DOI 10.1016/j.febslet.2006.06.090; Liao BR, 1996, ARCH BIOCHEM BIOPHYS, V327, P53, DOI 10.1006/abbi.1996.0092; Magnan F, 2008, PLANT J, V56, P575, DOI 10.1111/j.1365-313X.2008.03622.x; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; NGAI PK, 1984, BIOCHEM J, V218, P863, DOI 10.1042/bj2180863; Oravecz A, 2006, PLANT CELL, V18, P1975, DOI 10.1105/tpc.105.040097; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PATO MD, 1983, J BIOL CHEM, V258, P7047; Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i; Rodriguez-Concepcion M, 1999, EMBO J, V18, P1996, DOI 10.1093/emboj/18.7.1996; Rodriguez-Concepcion M, 1999, PLANT MOL BIOL, V39, P865, DOI 10.1023/A:1006170020836; Rodriguez-Concepcion M, 2000, PLANT J, V24, P775, DOI 10.1046/j.1365-313x.2000.00924.x; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; SCOTTWOO GC, 1988, BIOCHEM J, V252, P463, DOI 10.1042/bj2520463; Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Tsai YC, 2007, PLANT SIGNAL BEHAV, V2, P446, DOI 10.4161/psb.2.6.4695; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; VOGEL HJ, 1983, FEBS LETT, V157, P241, DOI 10.1016/0014-5793(83)80554-7; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; Walsh Michael P, 2002, Methods Mol Biol, V173, P339; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Xiao C, 1999, DNA Res, V6, P179, DOI 10.1093/dnares/6.3.179; Yamniuk AP, 2006, J BIOL CHEM, V281, P26455, DOI 10.1074/jbc.M603963200; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Ye SF, 2009, PLANT MOL BIOL, V70, P311, DOI 10.1007/s11103-009-9475-0; Zielinski RE, 2002, PLANTA, V214, P446, DOI 10.1007/s004250100636; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697; Zweckstetter M, 2002, J BIOMOL NMR, V23, P127, DOI 10.1023/A:1016316415261	56	3	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					32036	32049		10.1074/jbc.M113.491076	http://dx.doi.org/10.1074/jbc.M113.491076			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052265	Green Published, hybrid			2022-12-28	WOS:000330596200055
J	Hahn, A; Stevanovic, M; Mirus, O; Lytvynenko, I; Pos, KM; Schleiff, E				Hahn, Alexander; Stevanovic, Mara; Mirus, Oliver; Lytvynenko, Iryna; Pos, Klaas Martinus; Schleiff, Enrico			The Outer Membrane TolC-like Channel HgdD Is Part of Tripartite Resistance-Nodulation-Cell Division (RND) Efflux Systems Conferring Multiple-drug Resistance in the Cyanobacterium Anabaena sp PCC7120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEXA-MEXB-OPRM; ESCHERICHIA-COLI; HETEROCYST-DIFFERENTIATION; PSEUDOMONAS-AERUGINOSA; I SECRETION; PROTEIN; TOLERANCE; EXPORT; PUMPS; PATS	The TolC-like protein HgdD of the filamentous, heterocyst-forming cyanobacterium Anabaena sp. PCC 7120 is part of multiple three-component "AB-D" systems spanning the inner and outer membranes and is involved in secretion of various compounds, including lipids, metabolites, antibiotics, and proteins. Several components of HgdD-dependent tripartite transport systems have been identified, but the diversity of inner membrane energizing systems is still unknown. Here we identified six putative resistance-nodulation-cell division (RND) type factors. Four of them are expressed during late exponential and stationary growth phase under normal growth conditions, whereas the other two are induced upon incubation with erythromycin or ethidium bromide. The constitutively expressed RND component Alr4267 has an atypical predicted topology, and a mutant strain (I-alr4267) shows a reduction in the content of monogalactosyldiacylglycerol as well as an altered filament shape. An insertion mutant of the ethidium bromide-induced all7631 did not show any significant phenotypic alteration under the conditions tested. Mutants of the constitutively expressed all3143 and alr1656 exhibited a Fox(-) phenotype. The phenotype of the insertion mutant I-all3143 parallels that of the I-hgdD mutant with respect to antibiotic sensitivity, lipid profile, and ethidium efflux. In addition, expression of the RND genes all3143 and all3144 partially complements the capability of Escherichia coli Delta acrAB to transport ethidium. We postulate that the RND transporter All3143 and the predicted membrane fusion protein All3144, as homologs of E. coli AcrB and AcrA, respectively, are major players for antibiotic resistance in Anabaena sp. PCC 7120.	[Hahn, Alexander; Stevanovic, Mara; Mirus, Oliver; Schleiff, Enrico] Goethe Univ Frankfurt, Dept Biosci Mol Cell Biol Plants, D-60439 Frankfurt, Germany; [Lytvynenko, Iryna; Pos, Klaas Martinus] Goethe Univ Frankfurt, Inst Biochem, D-60439 Frankfurt, Germany; [Pos, Klaas Martinus; Schleiff, Enrico] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, D-60439 Frankfurt, Germany; [Pos, Klaas Martinus; Schleiff, Enrico] Goethe Univ Frankfurt, Ctr Membrane Prote, D-60439 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Schleiff, E (corresponding author), Goethe Univ Frankfurt, Dept Biosci Mol Cell Biol Plants, Max von Laue Str 9, D-60438 Frankfurt, Germany.	schleiff@bio.uni-frankfurt.de	Schleiff, Enrico/C-5105-2017	Schleiff, Enrico/0000-0002-0518-3489; Hahn, Alexander/0000-0003-4118-5438	Centre of Membrane Proteomics (Goethe University Frankfurt); Deutsche Forschungsgemeinschaft-EXC115 (Cluster of Excellence Macromolecular Complexes); Deutsche Forschungsgemeinschaft [DFG SCHL 585/2, SFB 807]; Innovative Medicine Initiative (IMI) Project TRANSLOCATION	Centre of Membrane Proteomics (Goethe University Frankfurt); Deutsche Forschungsgemeinschaft-EXC115 (Cluster of Excellence Macromolecular Complexes); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Innovative Medicine Initiative (IMI) Project TRANSLOCATION	This work was supported by the Centre of Membrane Proteomics (Goethe University Frankfurt) (to A. H.), Deutsche Forschungsgemeinschaft-EXC115 (Cluster of Excellence Macromolecular Complexes) (to E. S. and K. M. P.), Deutsche Forschungsgemeinschaft Grants DFG SCHL 585/2 (to E. S.) and SFB 807 (to K. M. P. and E. S.), and Innovative Medicine Initiative (IMI) Project TRANSLOCATION (to K. M. P.).	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Awram P, 1998, J BACTERIOL, V180, P3062, DOI 10.1128/JB.180.12.3062-3069.1998; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; Bohnert JA, 2007, J ANTIMICROB CHEMOTH, V59, P1216, DOI 10.1093/jac/dkl426; Bolhuis H, 1997, FEMS MICROBIOL REV, V21, P55, DOI 10.1016/S0168-6445(97)00051-X; Borthakur PB, 2005, MOL MICROBIOL, V57, P111, DOI 10.1111/j.1365-2958.2005.04678.x; Bundschuh FA, 2009, J BIOL CHEM, V284, P25735, DOI 10.1074/jbc.M109.040295; CHRASTIL J, 1993, COMPUT CHEM, V17, P103, DOI 10.1016/0097-8485(93)80035-C; Corrales-Guerrero L, 2013, MOL MICROBIOL, V88, P1093, DOI 10.1111/mmi.12244; Coudeyras S, 2008, INFECT IMMUN, V76, P4633, DOI 10.1128/IAI.00356-08; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; Ermakova M, 2013, FEBS LETT, V587, P82, DOI 10.1016/j.febslet.2012.11.006; Feldmann EA, 2012, BIOCHEMISTRY-US, V51, P2436, DOI 10.1021/bi300228n; FELMLEE T, 1985, J BACTERIOL, V163, P94, DOI 10.1128/JB.163.1.94-105.1985; Fetar H, 2011, ANTIMICROB AGENTS CH, V55, P508, DOI 10.1128/AAC.00830-10; Fiedler G, 1998, MOL MICROBIOL, V27, P1193, DOI 10.1046/j.1365-2958.1998.00762.x; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Goldberg M, 1999, J BIOL CHEM, V274, P26065, DOI 10.1074/jbc.274.37.26065; Hahn A, 2012, J BIOL CHEM, V287, P41126, DOI 10.1074/jbc.M112.396010; Huang F, 2004, MOL CELL PROTEOMICS, V3, P586, DOI 10.1074/mcp.M300137-MCP200; Huang H, 2004, ACTA BOT SIN, V46, P1186; Kang HJ, 2005, APPL ENVIRON MICROB, V71, P5056, DOI 10.1128/AEM.71.9.5056-5065.2005; Kieboom J, 2001, MICROBIOL-SGM, V147, P43, DOI 10.1099/00221287-147-1-43; Kobayashi A, 2006, J BACTERIOL, V188, P5693, DOI 10.1128/JB.00217-06; Kohler T, 1997, MOL MICROBIOL, V23, P345, DOI 10.1046/j.1365-2958.1997.2281594.x; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Li XZ, 1998, J BACTERIOL, V180, P2987, DOI 10.1128/JB.180.11.2987-2991.1998; LIESEGANG H, 1993, J BACTERIOL, V175, P767, DOI 10.1128/JB.175.3.767-778.1993; LOMOVSKAYA O, 1992, P NATL ACAD SCI USA, V89, P8938, DOI 10.1073/pnas.89.19.8938; MA D, 1993, J BACTERIOL, V175, P6299, DOI 10.1128/JB.175.19.6299-6313.1993; Masi M, 2005, J BACTERIOL, V187, P3894, DOI 10.1128/JB.187.11.3894-3897.2005; Mirus O, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P175, DOI 10.1007/978-3-642-05062-6_6; Mirus O, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-68; Moslavac S, 2007, J BACTERIOL, V189, P7887, DOI 10.1128/JB.00750-07; Murakami S, 2004, J BIOL CHEM, V279, P3743, DOI 10.1074/jbc.M308893200; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Newton SM, 2010, J BIOL CHEM, V285, P17488, DOI 10.1074/jbc.M109.100206; Nicolaisen K, 2010, BBA-BIOMEMBRANES, V1798, P2131, DOI 10.1016/j.bbamem.2010.07.008; Nicolaisen K, 2009, MOL MICROBIOL, V74, P58, DOI 10.1111/j.1365-2958.2009.06850.x; Nicolalsen K, 2009, J BASIC MICROB, V49, P5, DOI 10.1002/jobm.200800300; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; Ocaktan A, 1997, J BIOL CHEM, V272, P21964, DOI 10.1074/jbc.272.35.21964; OMATA T, 1983, PLANT CELL PHYSIOL, V24, P1101; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Pernil R, 2008, MOL MICROBIOL, V67, P1067, DOI 10.1111/j.1365-2958.2008.06107.x; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 1996, MOL MICROBIOL, V21, P713, DOI 10.1046/j.1365-2958.1996.281397.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pos KM, 2009, BBA-PROTEINS PROTEOM, V1794, P782, DOI 10.1016/j.bbapap.2008.12.015; Provence David L., 1994, P317; Ramos JL, 1998, J BACTERIOL, V180, P3323, DOI 10.1128/JB.180.13.3323-3329.1998; Rensing C, 1997, J BACTERIOL, V179, P6871, DOI 10.1128/jb.179.22.6871-6879.1997; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rosenberg EY, 2000, J BACTERIOL, V182, P1754, DOI 10.1128/JB.182.6.1754-1756.2000; Staron P, 2011, J BIOL CHEM, V286, P38202, DOI 10.1074/jbc.M111.269332; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Tian T, 2010, MICROBIOL-SGM, V156, P39, DOI 10.1099/mic.0.031161-0; Tikhonova EB, 2009, P NATL ACAD SCI USA, V106, P16416, DOI 10.1073/pnas.0906601106; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Valladares A, 2011, J BACTERIOL, V193, P1172, DOI 10.1128/JB.01202-10; Wilk L, 2011, CELL MICROBIOL, V13, P1744, DOI 10.1111/j.1462-5822.2011.01655.x; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Xue LG, 2011, CURR MICROBIOL, V62, P1253, DOI 10.1007/s00284-010-9850-8; Zhang YL, 2011, J BIOL CHEM, V286, P26576, DOI 10.1074/jbc.M111.243261	80	20	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31192	31205		10.1074/jbc.M113.495598	http://dx.doi.org/10.1074/jbc.M113.495598			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24014018	hybrid, Green Published			2022-12-28	WOS:000330778900036
J	Snider, NT; Park, H; Omary, MB				Snider, Natasha T.; Park, Haewon; Omary, M. Bishr			A Conserved Rod Domain Phosphotyrosine That Is Targeted by the Phosphatase PTP1B Promotes Keratin 8 Protein Insolubility and Filament Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENTS; ALEXANDER-DISEASE; TYROSINE PHOSPHORYLATION; CULTURED-CELLS; STRESS; TISSUE; MICE; GFAP; MIGRATION; VIMENTIN	Post-translational modifications are important functional determinants for intermediate filament (IF) proteins. Phosphorylation of IF proteins regulates filament organization, solubility, and cell-protective functions. Most known IF protein phosphorylation sites are serines localized in the variable "head" and "tail" domain regions. By contrast, little is known about site-specific tyrosine phosphorylation or its implications on IF protein function. We used available proteomic data from large scale studies to narrow down potential phospho-tyrosine sites on the simple epithelial IF protein keratin 8 (K8). Validation of the predicted sites using a pan-phosphotyrosine and a site-specific antibody, which we generated, revealed that the highly conserved Tyr-267 in the K8 "rod" domain was basally phosphorylated. The charge at this site was critically important, as demonstrated by altered filament organization of site-directed mutants, Y267F and Y267D, the latter exhibiting significantly diminished solubility. Pharmacological inhibition of the protein-tyrosine phosphatase PTP1B increased K8 Tyr-267 phosphorylation, decreased solubility, and increased K8 filament bundling, whereas PTP1B overexpression had the opposite effects. Furthermore, there was significant co-localization between K8 and a "substrate-trapping" mutant of PTP1B (D181A). Because K8 Tyr-267 is conserved in many IFs (QYE motif), we tested the effect of the paralogous Tyr in glial fibrillary acidic protein (GFAP), which is mutated in Alexander disease (Y242D). Similar to K8, Y242D GFAP exhibited highly irregular filament organization and diminished solubility. Our results implicate the rod domain QYE motif tyrosine as an important determinant of IF assembly and solubility properties that can be dynamically modulated by phosphorylation.	[Snider, Natasha T.; Park, Haewon; Omary, M. Bishr] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Snider, NT (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	nsnider@umich.edu		Omary, Bishr/0000-0002-8624-2347	National Institutes of Health [R01 DK52951, K01 DK093776]; Department of Veterans Affairs Merit Review Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052951, K01DK093776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK52951 (to M. B. O.) and K01 DK093776 (to N. T. S.). This work was also supported by a Department of Veterans Affairs Merit Review Award (to M. B. O.).	Angelastro JM, 1998, J NEUROCHEM, V70, P540; Artemenko KA, 2011, ANALYST, V136, P1971, DOI 10.1039/c0an00649a; Charest A, 2006, CANCER RES, V66, P7473, DOI 10.1158/0008-5472.CAN-06-1193; Chung BM, 2012, J BIOL CHEM, V287, P7573, DOI 10.1074/jbc.M111.301549; Ding SJ, 2007, EXPERT REV PROTEOMIC, V4, P13, DOI 10.1586/14789450.4.1.13; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Felkl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045280; Feng L, 1999, J CELL SCI, V112, P2081; Ferrari E, 2011, J BIOL CHEM, V286, P4173, DOI 10.1074/jbc.M110.157420; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Gorospe JR, 2002, NEUROLOGY, V58, P1494, DOI 10.1212/WNL.58.10.1494; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Haj FG, 2005, J BIOL CHEM, V280, P15038, DOI 10.1074/jbc.M413240200; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hsiao VC, 2005, J CELL SCI, V118, P2057, DOI 10.1242/jcs.02339; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Ku NO, 2007, HEPATOLOGY, V46, P1639, DOI 10.1002/hep.21976; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Kwan R, 2012, FASEB J, V26, P2318, DOI 10.1096/fj.11-198580; Li B, 2010, P NATL ACAD SCI USA, V107, P1408, DOI 10.1073/pnas.0907907107; Liao J, 1997, J BIOL CHEM, V272, P17565, DOI 10.1074/jbc.272.28.17565; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; Lind SB, 2011, CELL SIGNAL, V23, P1387, DOI 10.1016/j.cellsig.2011.03.021; Majumder A, 2011, BIOCHEMISTRY-US, V50, P7774, DOI 10.1021/bi200847n; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Pan XO, 2011, J BIOL CHEM, V286, P42403, DOI 10.1074/jbc.M111.302042; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rotty JD, 2012, J CELL BIOL, V197, P381, DOI 10.1083/jcb.201107078; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Snider NT, 2013, J CELL BIOL, V200, P241, DOI 10.1083/jcb.201209028; Snider NT, 2011, J BIOL CHEM, V286, P2273, DOI 10.1074/jbc.M110.171314; Stuible M, 2008, J BIOL CHEM, V283, P15740, DOI 10.1074/jbc.M710534200; Stuible M, 2010, TRENDS CELL BIOL, V20, P672, DOI 10.1016/j.tcb.2010.08.013; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Toivola DM, 2002, MOL BIOL CELL, V13, P1857, DOI 10.1091/mbc.01-12-0591; Utermark T, 2005, NEUROBIOL DIS, V19, P1, DOI 10.1016/j.nbd.2004.11.015; Valgeirsdottir S, 1998, J CELL SCI, V111, P1973; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Zhou Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013538	51	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31329	31337		10.1074/jbc.M113.502724	http://dx.doi.org/10.1074/jbc.M113.502724			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24003221	hybrid, Green Published			2022-12-28	WOS:000330778900049
J	Yuan, G; Ma, B; Yuan, W; Zhang, ZQ; Chen, P; Ding, XJ; Feng, L; Shen, XH; Chen, S; Li, GH; Zhu, B				Yuan, Gang; Ma, Ben; Yuan, Wen; Zhang, Zhuqiang; Chen, Ping; Ding, Xiaojun; Feng, Li; Shen, Xiaohua; Chen, She; Li, Guohong; Zhu, Bing			Histone H2A Ubiquitination Inhibits the Enzymatic Activity of H3 Lysine 36 Methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCOMB GROUP PROTEINS; DROSOPHILA-MELANOGASTER; RESPONSE ELEMENTS; CROSS-TALK; CHROMATIN; METHYLATION; COMPLEX; GENES; TRITHORAX; TRIMETHYLATION	Histone H3 lysine 27 (H3K27) methylation and H2A monoubiquitination (ubH2A) are two closely related histone modifications that regulate Polycomb silencing. Previous studies reported that H3K27 trimethylation (H3K27me3) rarely coexists with H3K36 di- or tri-methylation (H3K36me2/3) on the same histone H3 tails, which is partially controlled by the direct inhibition of the enzymatic activity of H3K27-specific methyltransferase PRC2. By contrast, H3K27 methylation does not affect the catalytic activity of H3K36-specific methyltransferases, suggesting other Polycomb mechanism(s) may negatively regulate the H3K36-specific methyltransferase(s). In this study, we established a simple protocol to purify milligram quantities of ubH2A from mammalian cells, which were used to reconstitute nucleosome substrates with fully ubiquitinated H2A. A number of histone methyltransferases were then tested on these nucleosome substrates. Notably, all of the H3K36-specific methyltransferases, including ASH1L, HYPB, NSD1, and NSD2 were inhibited by ubH2A, whereas the other histone methyltransferases, including PRC2, G9a, and Pr-Set7 were not affected by ubH2A. Together with previous reports, these findings collectively explain the mutual repulsion of H3K36me2/3 and Polycomb modifications.	[Yuan, Gang] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Yuan, Gang; Ma, Ben; Yuan, Wen; Zhang, Zhuqiang; Ding, Xiaojun; Feng, Li; Chen, She; Zhu, Bing] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Chen, Ping; Li, Guohong] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China; [Shen, Xiaohua] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China	Beijing Normal University; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS; Tsinghua University	Zhu, B (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	zhubing@nibs.ac.cn	Zhang, Zhuqiang/P-7329-2019	Zhang, Zhuqiang/0000-0001-6513-2854	Chinese Ministry of Science and Technology [2011CB812700, 2011CB965300]; Howard Hughes Medical Institute International Early Career Scientist Program	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Howard Hughes Medical Institute International Early Career Scientist Program	This work was supported by Chinese Ministry of Science and Technology Grants 2011CB812700 and 2011CB965300 (to B. Z.) and the Howard Hughes Medical Institute International Early Career Scientist Program (to B. Z.).	An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; BOHM L, 1980, EUR J BIOCHEM, V106, P525, DOI 10.1111/j.1432-1033.1980.tb04599.x; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brockdorff N, 2013, RNA, V19, P429, DOI 10.1261/rna.037598.112; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chen XZ, 2011, EMBO REP, V12, P244, DOI 10.1038/embor.2011.6; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fierz B, 2012, J AM CHEM SOC, V134, P19548, DOI 10.1021/ja308908p; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; HUNTER AJ, 1985, ANAL BIOCHEM, V150, P394, DOI 10.1016/0003-2697(85)90527-5; Jia GS, 2009, CELL RES, V19, P1217, DOI 10.1038/cr.2009.110; Kallin EM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000506; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; LEVINGER L, 1980, P NATL ACAD SCI-BIOL, V77, P3244, DOI 10.1073/pnas.77.6.3244; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Lucio-Eterovic AK, 2010, P NATL ACAD SCI USA, V107, P16952, DOI 10.1073/pnas.1002653107; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; SHEARN A, 1989, GENETICS, V121, P517; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Tanaka Y, 2007, GENE, V397, P161, DOI 10.1016/j.gene.2007.04.027; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y., 2004, NOVART FDN SYMP, V259, P3; Wang Y, 2004, NOVART FDN SYMP, V259, P17; Wang Yanming, 2004, Novartis Found Symp, V259, P3; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Whitcomb SJ, 2012, J BIOL CHEM, V287, P23718, DOI 10.1074/jbc.M112.361824; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; Young NL, 2009, MOL CELL PROTEOMICS, V8, P2266, DOI 10.1074/mcp.M900238-MCP200; Yuan W, 2012, SCIENCE, V337, P971, DOI 10.1126/science.1225237; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	71	43	48	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					30832	30842		10.1074/jbc.M113.475996	http://dx.doi.org/10.1074/jbc.M113.475996			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24019522	hybrid, Green Published			2022-12-28	WOS:000330778900004
J	Liu, Y; Liu, H; Meyer, C; Li, J; Nadalin, S; Konigsrainer, A; Weng, HL; Dooley, S; ten Dijke, P				Liu, Yan; Liu, Heng; Meyer, Christoph; Li, Jun; Nadalin, Silvio; Koenigsrainer, Alfred; Weng, Honglei; Dooley, Steven; ten Dijke, Peter			Transforming Growth Factor-beta (TGF-beta)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ERK; Jak Kinase; Jun N-terminal Kinase (JNK); MAP Kinases (MAPKs); PI 3-kinase (PI3K); SMAD Transcription Factor; Liver Fibrosis	LIVER FIBROSIS; TGF-BETA; RAT; PROTEIN; TRANSDIFFERENTIATION; FIBROGENESIS; PROGRESSION; INHIBITION; RECEPTOR; MEDIATOR	In fibrotic liver, connective tissue growth factor (CTGF) is constantly expressed in activated hepatic stellate cells (HSCs) and acts downstream of TGF- to modulate extracellular matrix production. Distinct from other cell types in which Smad signaling plays major role in regulating CTGF production, TGF- stimulated CTGF expression in activated HSCs is only in part dependent on Smad3. Other signaling molecules like MAPKs and PI3Ks may also participate in this process, and the underlying mechanisms have yet to be clarified. In this study, we report involvement of Stat3 activation in modulating CTGF production upon TGF- challenge in activated HSCs. Stat3 is phosphorylated via JAK1 and acts as a critical ALK5 (activin receptor-like kinase 5) downstream signaling molecule to mediate CTGF expression. This process requires de novo gene transcription and is additionally modulated by MEK1/2, JNK, and PI3K pathways. Cell-specific knockdown of Smad3 partially decreases CTGF production, whereas it has no significant influence on Stat3 activation. The total CTGF production induced by TGF- in activated HSCs is therefore, to a large extent, dependent on the balance and integration of the canonical Smad3 and Stat3 signaling pathways.	[Liu, Yan; Liu, Heng; Meyer, Christoph; Weng, Honglei; Dooley, Steven] Heidelberg Univ, Med Fac Mannheim, Sect Mol Hepatol, Dept Med 2, D-68167 Mannheim, Germany; [Liu, Yan; ten Dijke, Peter] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Canc Genom Ctr Netherlands, NL-2300 RC Leiden, Netherlands; [Liu, Yan; ten Dijke, Peter] Leiden Univ, Med Ctr, Ctr Biomed Genet, NL-2300 RC Leiden, Netherlands; [Liu, Heng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Gastroenterol, Shanghai 200080, Peoples R China; [Li, Jun; Nadalin, Silvio; Koenigsrainer, Alfred] Univ Tubingen Hosp, Dept Gen Visceral Surg & Transplantat, D-72076 Tubingen, Germany; [Li, Jun] Univ Med Ctr Hamburg Eppendorf, Dept Hepatobiliary Surg & Visceral Transplantat, D-20246 Hamburg, Germany	Ruprecht Karls University Heidelberg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Shanghai Jiao Tong University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Dooley, S (corresponding author), Heidelberg Univ, Med Fac Mannheim, Sect Mol Hepatol, Dept Med 2, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	steven.dooley@medma.uni-heidelberg.de; p.ten_dijke@lumc.nl	Dooley, Steven/T-6491-2018; Dijke, Peter ten/AAG-4660-2021	Dooley, Steven/0000-0002-4840-6240; Dijke, Peter ten/0000-0002-7234-342X	Marie Curie Initial Training Network (ITN) IT-Liver grant; Netherlands Institute for Regenerative Medicine and Cancer Genomics Centre Netherlands, Centre for Biomedical Genetics; German Research Foundation [SFB TRR77, Do373/8-1]; Federal Ministry of Education and Research	Marie Curie Initial Training Network (ITN) IT-Liver grant; Netherlands Institute for Regenerative Medicine and Cancer Genomics Centre Netherlands, Centre for Biomedical Genetics; German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by a Marie Curie Initial Training Network (ITN) IT-Liver grant; the Netherlands Institute for Regenerative Medicine and Cancer Genomics Centre Netherlands, Centre for Biomedical Genetics; German Research Foundation Programs "SFB TRR77 Liver Cancer" and "Do373/8-1"; and Federal Ministry of Education and Research grants "The Virtual Liver" and "Cell Therapy in Liver Regeneration."	Abou-Shady M, 2000, LIVER, V20, P296, DOI 10.1034/j.1600-0676.2000.020004296.x; Brigstock DR, 2009, J CELL COMMUN SIGNAL, V3, P5, DOI 10.1007/s12079-009-0043-9; Chen L, 2011, J HEPATOL, V55, P399, DOI 10.1016/j.jhep.2010.11.025; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dooley S, 2003, GASTROENTEROLOGY, V125, P178, DOI 10.1016/S0016-5085(03)00666-8; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Frias MA, 2007, CARDIOVASC RES, V73, P57, DOI 10.1016/j.cardiores.2006.09.016; Gao RP, 2003, HEPATOL RES, V27, P214, DOI 10.1016/S1386-6346(03)00241-9; George J, 2007, GENE THER, V14, P790, DOI 10.1038/sj.gt.3302929; GREENWEL P, 1991, LAB INVEST, V65, P644; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; Gressner OA, 2007, J HEPATOL, V47, P699, DOI 10.1016/j.jhep.2007.05.015; Gressner OA, 2011, WORLD J GASTROENTERO, V17, P151, DOI 10.3748/wjg.v17.i2.151; Hayashi N, 2002, HEPATO-GASTROENTEROL, V49, P133; Herrmann J, 2007, J CELL MOL MED, V11, P704, DOI 10.1111/j.1582-4934.2007.00060.x; Hora C, 2008, LIVER INT, V28, P370, DOI 10.1111/j.1478-3231.2007.01608.x; Huang GC, 2012, FRONT BIOSCI-LANDMRK, V17, P2495, DOI 10.2741/4067; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/j.gastro.2003.08.029; Kobayashi H, 2005, PEDIATR SURG INT, V21, P12, DOI 10.1007/s00383-004-1254-z; Lakner AM, 2010, WORLD J GASTROENTERO, V16, P5047, DOI 10.3748/wjg.v16.i40.5047; Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leask A, 2008, J CELL COMMUN SIGNAL, V2, P49, DOI 10.1007/s12079-008-0029-z; Li GM, 2006, J GENE MED, V8, P889, DOI 10.1002/jgm.894; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Liu Y, 2011, J IMMUNOL, V187, P2814, DOI 10.4049/jimmunol.1003260; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Ng DCH, 2001, J BIOL CHEM, V276, P29490, DOI 10.1074/jbc.M100699200; Paradis V, 2001, HEPATOLOGY, V34, P738, DOI 10.1053/jhep.2001.28055; Paradis V, 2002, LAB INVEST, V82, P767, DOI 10.1097/01.LAB.0000017365.18894.D3; Paradis V, 1999, HEPATOLOGY, V30, P968, DOI 10.1002/hep.510300425; Sarkozi R, 2012, BIOCHEM BIOPH RES CO, V424, P801, DOI 10.1016/j.bbrc.2012.07.042; Schnabl B, 2002, LAB INVEST, V82, P323, DOI 10.1038/labinvest.3780426; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sedlaczek N, 2001, AM J PATHOL, V158, P1239, DOI 10.1016/S0002-9440(10)64074-6; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Sun K, 2006, ACTA PHARMACOL SIN, V27, P715, DOI 10.1111/j.1745-7254.2006.00299.x; Tache D, 2011, ROM J MORPHOL EMBRYO, V52, P409; Vogt PK, 2011, CANCER DISCOV, V1, P481, DOI 10.1158/2159-8290.CD-11-0218; Weng HL, 2009, HEPATOLOGY, V50, P230, DOI 10.1002/hep.22934; Wiercinska E, 2006, HEPATOLOGY, V43, P1032, DOI 10.1002/hep.21135; Williams EJ, 2000, J HEPATOL, V32, P754, DOI 10.1016/S0168-8278(00)80244-5	44	140	147	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30708	30719		10.1074/jbc.M113.478685	http://dx.doi.org/10.1074/jbc.M113.478685			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24005672	Green Published, hybrid			2022-12-28	WOS:000329868100071
J	Chen, C; Krishnan, V; Macon, K; Manne, K; Narayana, SVL; Schneewind, O				Chen, Chen; Krishnan, Vengadesan; Macon, Kevin; Manne, Kartik; Narayana, Sthanam V. L.; Schneewind, Olaf			Secreted Proteases Control Autolysin-mediated Biofilm Growth of Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; BINDING PROTEIN-A; L-ALANINE AMIDASE; MUREIN HYDROLASE; BACTERIAL BIOFILMS; SERINE-PROTEASE; MOLECULAR-BASIS; REPEAT DOMAINS; NASAL CARRIAGE; CROSS-WALL	Staphylococcus epidermidis, a commensal of humans, secretes Esp protease to prevent Staphylococcus aureus biofilm formation and colonization. Blocking S. aureus colonization may reduce the incidence of invasive infectious diseases; however, the mechanism whereby Esp disrupts biofilms is unknown. We show here that Esp cleaves autolysin (Atl)-derived murein hydrolases and prevents staphylococcal release of DNA, which serves as extracellular matrix in biofilms. The three-dimensional structure of Esp was revealed by x-ray crystallography and shown to be highly similar to that of S. aureus V8 (SspA). Both atl and sspA are necessary for biofilm formation, and purified SspA cleaves Atl-derived murein hydrolases. Thus, S. aureus biofilms are formed via the controlled secretion and proteolysis of autolysin, and this developmental program appears to be perturbed by the Esp protease of S. epidermidis.	[Chen, Chen; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Krishnan, Vengadesan] Biotech Sci Cluster, Reg Ctr Biotechnol, Gurgaon 122016, Haryana, India; [Macon, Kevin; Manne, Kartik; Narayana, Sthanam V. L.] Univ Alabama Birmingham, Sch Optometry, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA	University of Chicago; Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; University of Alabama System; University of Alabama Birmingham	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu	Manne, Kartik/AAC-9511-2021; krishnan, vengadesan/F-8069-2011	Manne, Kartik/0000-0002-7218-4852; krishnan, vengadesan/0000-0002-8083-0121	National Institutes of Health [AI38897, AI52474]; National Institutes of Health through membership in the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium [1-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052474, R01AI038897, U54AI057153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through membership in the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI38897 and AI52474 (to O.S.). This work was also supported by National Institutes of Health Award 1-U54-AI-057153 through membership in the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (to O.S.).	Ahn JS, 2006, MOL MICROBIOL, V62, P1158, DOI 10.1111/j.1365-2958.2006.05433.x; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Bose JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042244; BROWDER HP, 1965, BIOCHEM BIOPH RES CO, V19, P383, DOI 10.1016/0006-291X(65)90473-0; Burian M, 2010, J INFECT DIS, V201, P1414, DOI 10.1086/651619; Cavarelli J, 1997, STRUCTURE, V5, P813, DOI 10.1016/S0969-2126(97)00235-9; CHARNEY J, 1947, J BIOL CHEM, V171, P501; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DRAPEAU GR, 1972, J BIOL CHEM, V247, P6720; DRAPEAU GR, 1978, J BACTERIOL, V136, P607, DOI 10.1128/JB.136.2.607-613.1978; Dubin G, 2001, BIOL CHEM, V382, P1575, DOI 10.1515/BC.2001.192; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frankel MB, 2012, J BIOL CHEM, V287, P10460, DOI 10.1074/jbc.M111.336404; Frankel MB, 2011, J BIOL CHEM, V286, P32593, DOI 10.1074/jbc.M111.258863; Geoghegan JA, 2013, J BACTERIOL, V195, P2675, DOI 10.1128/JB.02128-12; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; HOLM L, 1994, NUCLEIC ACIDS RES, V22, P3600; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; HOUMARD J, 1972, P NATL ACAD SCI USA, V69, P3506, DOI 10.1073/pnas.69.12.3506; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Johnson M, 2008, INFECT IMMUN, V76, P1756, DOI 10.1128/IAI.01635-07; Kaplan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00198-12; Klevens RM, 2008, CLIN INFECT DIS, V47, P927, DOI 10.1086/591698; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Krismer B, 2011, FUTURE MICROBIOL, V6, P489, DOI [10.2217/fmb.11.37, 10.2217/FMB.11.37]; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Lower SK, 2011, P NATL ACAD SCI USA, V108, P18372, DOI 10.1073/pnas.1109071108; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCGRATH ME, 1992, BIOCHEMISTRY-US, V31, P3059, DOI 10.1021/bi00127a005; Moon JL, 2001, BIOL CHEM, V382, P1095, DOI 10.1515/BC.2001.138; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemoto TK, 2008, FEBS J, V275, P573, DOI 10.1111/j.1742-4658.2007.06224.x; Nemoto TK, 2009, BIOL CHEM, V390, P277, DOI 10.1515/BC.2009.027; Ono T, 2010, BIOL CHEM, V391, P1221, DOI 10.1515/BC.2010.116; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Otto M, 2012, SEMIN IMMUNOPATHOL, V34, P201, DOI 10.1007/s00281-011-0296-2; Papageorgiou AC, 2000, PROTEIN SCI, V9, P610; Park DW, 2011, BMB REP, V44, P279, DOI 10.5483/BMBRep.2011.44.4.279; PERONA JJ, 1995, BIOCHEMISTRY-US, V34, P1489, DOI 10.1021/bi00005a004; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Prasad L, 2004, ACTA CRYSTALLOGR D, V60, P256, DOI 10.1107/S090744490302599X; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rouf SMA, 2012, INDIAN J BIOCHEM BIO, V49, P421; RUHLMANN A, 1973, J MOL BIOL, V77, P417, DOI 10.1016/0022-2836(73)90448-8; Sadykov MR, 2012, CURR OPIN MICROBIOL, V15, P211, DOI 10.1016/j.mib.2011.12.010; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Scriba TJ, 2008, INFECT IMMUN, V76, P2164, DOI 10.1128/IAI.01699-07; Shaw L, 2004, MICROBIOL-SGM, V150, P217, DOI 10.1099/mic.0.26634-0; Stec-Niemczyk J, 2009, BIOCHEM J, V419, P555, DOI 10.1042/BJ20081351; Sugai M, 1997, J BACTERIOL, V179, P2958, DOI 10.1128/jb.179.9.2958-2962.1997; SUGAI M, 1995, J BACTERIOL, V177, P1491, DOI 10.1128/jb.177.6.1491-1496.1995; Sugimoto S, 2013, J BACTERIOL, V195, P1645, DOI 10.1128/JB.01672-12; Thompson KM, 2010, FEMS MICROBIOL LETT, V305, P143, DOI 10.1111/j.1574-6968.2010.01918.x; Vengadesan K, 2013, ACTA CRYSTALLOGR F, V69, P49, DOI 10.1107/S1744309112047124; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Volanakis JE, 1996, PROTEIN SCI, V5, P553; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; Zoll S, 2012, J BACTERIOL, V194, P3789, DOI 10.1128/JB.00331-12	76	70	73	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29440	29452		10.1074/jbc.M113.502039	http://dx.doi.org/10.1074/jbc.M113.502039			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23970550	Green Published, hybrid			2022-12-28	WOS:000330615300022
J	Cui, XYA; Zhang, YJ; Hong, SJ; Palazzo, AF				Cui, Xianying A.; Zhang, Yangjing; Hong, Seo Jung; Palazzo, Alexander F.			Identification of a Region within the Placental Alkaline Phosphatase mRNA That Mediates p180-dependent Targeting to the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TRANSLOCATION; MEMBRANE-PROTEINS; NUCLEAR EXPORT; TRANSLATION; LOCALIZATION; RIBOSOMES; RECEPTOR; MODEL	In both eukaryotic and prokaryotic cells, it has been recently established that mRNAs encoding secreted and membrane proteins can be localized to the surface of membranes via both translation-dependent and RNA element-mediated mechanisms. Previously, we showed that the placental alkaline phosphatase (ALPP) mRNA can be localized to the ER membrane independently of translation, and this localization is mediated by p180, an mRNA receptor present in the ER. In this article, we aimed to identify the cis-acting RNA element in ALPP. Using chimera constructs containing fragments of the ALPP mRNA, we demonstrate that the ER-localizing RNA element is present within the 3' end of the open reading frame and codes for a transmembrane domain. In addition, we show that this region requires p180 for efficient ER anchoring. Taken together, we provide the first insight into the nature of cis-acting ER-localizing RNA elements responsible for localizing mRNAs on the ER in mammalian cells.	[Cui, Xianying A.; Zhang, Yangjing; Hong, Seo Jung; Palazzo, Alexander F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto	Palazzo, AF (corresponding author), Univ Toronto, Dept Biochem, 1 Kings Coll Circle,Med Sci Bldg,Rm 5336, Toronto, ON M5S 1A8, Canada.	alex.palazzo@utoronto.ca	Palazzo, Alexander/B-1270-2013	Palazzo, Alexander/0000-0002-9700-1995; Zhang, Yangjing/0000-0003-3762-0767	National Science and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a graduate fellowship (to X. A. C.), summer student fellowships (to Y. Z. and S. J. H.), and a grant (to A. F. P.) all from the National Science and Engineering Research Council of Canada.	AMTHAUER R, 1992, CLIN CHEM, V38, P2510; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Bibi E, 2011, BBA-BIOMEMBRANES, V1808, P841, DOI 10.1016/j.bbamem.2010.07.025; Cenik C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001366; Cui X. A., 2012, JOVE-J VIS EXP, V70; Cui XYA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001336; Dejgaard K, 2010, J PROTEOME RES, V9, P1763, DOI 10.1021/pr900900x; FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; GORLICH D, 1990, J CELL BIOL, V111, P2283, DOI 10.1083/jcb.111.6.2283; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Gueroussov Serge, 2010, J Vis Exp, DOI 10.3791/2387; Kraut-Cohen J, 2013, MOL BIOL CELL, V24, P3069, DOI 10.1091/mbc.E13-01-0038; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403; Loya A, 2008, RNA, V14, P1352, DOI 10.1261/rna.867208; Mahadevan K, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001545; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; Palazzo AF, 2013, WIRES RNA, V4, P523, DOI 10.1002/wrna.1176; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prilusky J, 2009, P NATL ACAD SCI USA, V106, P6662, DOI 10.1073/pnas.0902029106; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Ueno T, 2012, NUCLEIC ACIDS RES, V40, P3006, DOI 10.1093/nar/gkr1197; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	29	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29633	29641		10.1074/jbc.M113.482505	http://dx.doi.org/10.1074/jbc.M113.482505			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	24019514	hybrid, Green Published			2022-12-28	WOS:000330615300039
J	Fredenburgh, JC; Leslie, BA; Stafford, AR; Lim, T; Chan, HH; Weitz, JI				Fredenburgh, James C.; Leslie, Beverly A.; Stafford, Alan R.; Lim, Teresa; Chan, Howard H.; Weitz, Jeffrey I.			Zn2+ Mediates High Affinity Binding of Heparin to the alpha C Domain of Fibrinogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE-RICH GLYCOPROTEIN; SURFACE-PLASMON RESONANCE; PLATELET FACTOR-IV; ZINC IONS; PLASMINOGEN-ACTIVATOR; EQUILIBRIUM DIALYSIS; PROTECTS THROMBIN; BOUND THROMBIN; TISSUE FACTOR; COFACTOR-II	The nonspecific binding of heparin to plasma proteins compromises its anticoagulant activity by reducing the amount of heparin available to bind antithrombin. In addition, interaction of heparin with fibrin promotes formation of a ternary heparin-thrombin-fibrin complex that protects fibrin-bound thrombin from inhibition by the heparin-antithrombin complex. Previous studies have shown that heparin binds the E domain of fibrinogen. The current investigation examines the role of Zn2+ in this interaction because Zn2+ is released locally by platelets and both heparin and fibrinogen bind the cation, resulting in greater protection from inhibition by antithrombin. Zn2+ promotes heparin binding to fibrinogen, as determined by chromatography, fluorescence, and surface plasmon resonance. Compared with intact fibrinogen, there is reduced heparin binding to fragment X, a clottable plasmin degradation product of fibrinogen. A monoclonal antibody directed against a portion of the fibrinogen alpha C domain removed by plasmin attenuates binding of heparin to fibrinogen and a peptide analog of this region binds heparin in a Zn2+-dependent fashion. These results indicate that the alpha C domain of fibrinogen harbors a Zn2+-dependent heparin binding site. As a consequence, heparin-catalyzed inhibition of factor Xa by antithrombin is compromised by fibrinogen to a greater extent when Zn2+ is present. These results reveal the mechanism by which Zn2+ augments the capacity of fibrinogen to impair the anticoagulant activity of heparin.	[Fredenburgh, James C.; Leslie, Beverly A.; Stafford, Alan R.; Lim, Teresa; Chan, Howard H.; Weitz, Jeffrey I.] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada; [Fredenburgh, James C.; Leslie, Beverly A.; Stafford, Alan R.; Lim, Teresa; Chan, Howard H.; Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON L8L 2X2, Canada; [Weitz, Jeffrey I.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8L 2X2, Canada	McMaster University; McMaster University; McMaster University	Weitz, JI (corresponding author), Thrombosis & Atherosclerosis Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	weitzj@taari.ca	Weitz, Jeffrey/AAD-1929-2019	Weitz, Jeffrey/0000-0002-1092-7550	Canadian Institutes of Health Research [FRN 3992, MOP 102735, CTP 79846]; Heart and Stroke Foundation of Ontario [T4729, T4730]; Ontario Research and Development Challenge Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Research and Development Challenge Fund(General Electric)	This work was supported in part by grants from the Canadian Institutes of Health Research (FRN 3992, MOP 102735, and CTP 79846), the Heart and Stroke Foundation of Ontario (T4729 and T4730), and the Ontario Research and Development Challenge Fund.	Bajaj SP, 2006, J BIOL CHEM, V281, P24873, DOI 10.1074/jbc.M509971200; Becker DL, 1999, J BIOL CHEM, V274, P6226, DOI 10.1074/jbc.274.10.6226; Becker DL, 1997, ADV EXP MED BIOL, V425, P55; BJORK I, 1989, BIOCHEMISTRY-US, V28, P1213; Boehm T, 1998, BIOCHEM BIOPH RES CO, V252, P190, DOI 10.1006/bbrc.1998.9617; Borza DB, 1998, J BIOL CHEM, V273, P5493, DOI 10.1074/jbc.273.10.5493; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chan HH, 2012, BIOCHEMISTRY-US, V51, P7964, DOI 10.1021/bi301046b; De Caterina R, 2007, EUR HEART J, V28, P880, DOI 10.1093/eurheartj/ehl492; Eckert R, 2003, FEBS LETT, V541, P121, DOI 10.1016/S0014-5793(03)00322-3; EHRLICH PH, 1983, BIOCHEMISTRY-US, V22, P4184, DOI 10.1021/bi00287a004; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Galanakis DK, 2010, BLOOD COAGUL FIBRIN, V21, P135, DOI 10.1097/MBC.0b013e3283358163; Gestwicki JE, 2001, ANAL CHEM, V73, P5732, DOI 10.1021/ac0105888; Gonzalez-Iglesias R, 2002, J MOL BIOL, V319, P527, DOI 10.1016/S0022-2836(02)00341-8; GUTHANS SL, 1982, ARCH BIOCHEM BIOPHYS, V218, P320, DOI 10.1016/0003-9861(82)90350-2; Heeb MJ, 2009, FASEB J, V23, P2244, DOI 10.1096/fj.08-123174; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; HOGG PJ, 1990, J BIOL CHEM, V265, P241; KAZAMA Y, 1992, THROMB HAEMOSTASIS, V67, P50; Kluszynski BA, 1997, J BIOL CHEM, V272, P13541, DOI 10.1074/jbc.272.21.13541; Krezel A, 2011, INORG CHEM, V50, P72, DOI 10.1021/ic101212y; LANE DA, 1986, J BIOL CHEM, V261, P3980; LEUNG LLK, 1983, BLOOD, V62, P1016; LIJNEN HR, 1983, THROMB RES, V29, P443, DOI 10.1016/0049-3848(83)90248-7; MARX G, 1988, ARCH BIOCHEM BIOPHYS, V266, P285, DOI 10.1016/0003-9861(88)90260-3; Mcrae SJ, 2007, BIOCHEMISTRY-US, V46, P4195, DOI 10.1021/bi0617299; Mohri, 1994, J Thromb Thrombolysis, V1, P49, DOI 10.1007/BF01061996; NESHEIM M, 1990, J BIOL CHEM, V265, P21541; Odrljin TM, 1996, BLOOD, V88, P2050, DOI 10.1182/blood.V88.6.2050.bloodjournal8862050; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2; PARRISH RF, 1981, BIOCHEM J, V193, P407, DOI 10.1042/bj1930407; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Rich JD, 2007, J THROMB THROMBOLYS, V23, P93, DOI 10.1007/s11239-006-9049-9; Rydengard V, 2006, FEBS J, V273, P2399, DOI 10.1111/j.1742-4658.2006.05246.x; Schaefer AVL, 2006, BIOCHEMISTRY-US, V45, P4257, DOI 10.1021/bi0525730; SCULLY MF, 1982, BIOCHIM BIOPHYS ACTA, V700, P130, DOI 10.1016/0167-4838(82)90301-6; SMITH JW, 1990, J BIOL CHEM, V265, P12267; Syme CD, 2006, BBA-PROTEINS PROTEOM, V1764, P246, DOI 10.1016/j.bbapap.2005.09.012; Thompson LC, 2011, PROTEIN SCI, V20, P366, DOI 10.1002/pro.567; Tubek S, 2008, BIOL TRACE ELEM RES, V121, P1, DOI 10.1007/s12011-007-8038-y; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Vu TT, 2013, THROMB HAEMOSTASIS, V109, P421, DOI 10.1160/TH12-07-0465; WOODHEAD NE, 1986, BIOCHEM J, V237, P281, DOI 10.1042/bj2370281; Yakovlev S, 2003, BIOCHEMISTRY-US, V42, P7709, DOI 10.1021/bi0344073; YOUNG E, 1993, THROMB HAEMOSTASIS, V70, P625	50	19	19	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29394	29402		10.1074/jbc.M113.469916	http://dx.doi.org/10.1074/jbc.M113.469916			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23990470	Green Published, hybrid			2022-12-28	WOS:000330615300018
J	Pham, P; Landolph, A; Mendez, C; Li, N; Goodman, MF				Phuong Pham; Landolph, Alice; Mendez, Carlos; Li, Nancy; Goodman, Myron F.			A Biochemical Analysis Linking APOBEC3A to Disparate HIV-1 Restriction and Skin Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSINE DEAMINASE; CYTIDINE DEAMINATION; FOREIGN DNA; NUCLEAR-DNA; HYPERMUTATION; PROTEINS; VIRUS; AID; EXPRESSION; MUTATIONS	Human deoxycytidine deaminase APOBEC3A (Apo3A) acts as an HIV-1 restriction factor in cells of myeloid lineage yet functions separately as a potent mutator for genomic DNA. Apo3A activity and C motif deamination specificity exhibit a striking dependence on pH that reflects these two distinct biological processes. Upon infection of macrophages, HIV-1 induces the formation of autophagosomes, and requires autophagosomes for replication, whereas inhibiting lysosomal fusion indicative of late stage autophagy. Here we show that Apo3A has optimal activity and a strict 5 '-YYCR motif specificity in the pH 5.8-6.1 range, characteristic of enclosed autophagosomal membrane compartments, and reflective of the mutation pattern of HIV-1. In contrast to the high activity and narrow specificity of Apo3A at acid pH, a 13-30-fold reduction in specific activity is accompanied by relaxed C deamination specificity at pH 7.4-8. Notably, Apo3A is also expressed in keratinocytes, and is up-regulated in skin lesions. AtpH7.9, we show that Apo3A generates transcription-dependent CC -> TT tandem mutations on the non-transcribed strand, a hallmark signature of skin cancer. The biochemical data taken in conjunction with the biological up-regulation of Apo3A in skin lesions suggests that enzyme-catalyzed deaminations at adjacent C sites followed by normal replication generating CC -> TT mutations provides an alternative molecular basis for the initiation events in skin cancer in contrast to well established pathways in which CC dimers formed in response to UV radiation either undergo nonenzymatic spontaneous deaminations or aberrant replication.	[Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; Univ So Calif, Dept Chem, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA.	mgoodman@usc.edu		MENDEZ-DORANTES, CARLOS/0000-0002-8190-8568	National Institutes of Health [GM21422, ES013192]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES013192, R01ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021422, R37GM021422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM21422 and ES013192.	Aynaud MM, 2012, J BIOL CHEM, V287, P39182, DOI 10.1074/jbc.M112.372722; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bulliard Y, 2011, J VIROL, V85, P1765, DOI 10.1128/JVI.01651-10; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Cheney KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013521; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Doehle BP, 2005, J VIROL, V79, P8201, DOI 10.1128/JVI.79.13.8201-8207.2005; Espert L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005787; Giglia-Mari G, 2003, HUM MUTAT, V21, P217, DOI 10.1002/humu.10179; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Harjes S, 2013, J VIROL, V87, P7008, DOI 10.1128/JVI.03173-12; Jaszczur M, 2013, CELL MOL LIFE SCI, V70, P3089, DOI 10.1007/s00018-012-1212-1; Jiang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048672; Killian MS, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-16; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Koning FA, 2011, J VIROL, V85, P13448, DOI 10.1128/JVI.00775-11; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Lackey L, 2013, CELL CYCLE, V12, P762, DOI 10.4161/cc.23713; Lada AG, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-47; Land AM, 2013, J BIOL CHEM, V288, P17253, DOI 10.1074/jbc.M113.458661; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Love RP, 2012, J BIOL CHEM, V287, P30812, DOI 10.1074/jbc.M112.393181; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; Madsen P, 1999, J INVEST DERMATOL, V113, P162, DOI 10.1046/j.1523-1747.1999.00682.x; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mu YX, 2012, J BIOL CHEM, V287, P28007, DOI 10.1074/jbc.M112.370189; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Peng W, 1996, BIOCHEMISTRY-US, V35, P10172, DOI 10.1021/bi960001x; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2007, DNA REPAIR, V6, P689, DOI 10.1016/j.dnarep.2007.01.001; Pham P, 2011, J BIOL CHEM, V286, P24931, DOI 10.1074/jbc.M111.241208; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Seksek O, 1996, J CELL SCI, V109, P257; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Skinner AM, 2008, PHOTOCHEM PHOTOBIOL, V84, P222, DOI 10.1111/j.1751-1097.2007.00224.x; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Trivedi NR, 2006, J INVEST DERMATOL, V126, P1071, DOI 10.1038/sj.jid.5700213; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Wiegand HL, 2007, J VIROL, V81, P13694, DOI 10.1128/JVI.01646-07; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836	62	36	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29294	29304		10.1074/jbc.M113.504175	http://dx.doi.org/10.1074/jbc.M113.504175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23979356	hybrid, Green Published			2022-12-28	WOS:000330615300009
J	Hoggatt, AM; Kim, JR; Ustiyan, V; Ren, XM; Kalin, TV; Kalinichenko, VV; Herring, BP				Hoggatt, April M.; Kim, Ju-Ryoung; Ustiyan, Vladimir; Ren, Xiaomeng; Kalin, Tanya V.; Kalinichenko, Vladimir V.; Herring, B. Paul			The Transcription Factor Foxf1 Binds to Serum Response Factor and Myocardin to Regulate Gene Transcription in Visceral Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Knockout; Gene Regulation; Gene Transcription; Smooth Muscle; Transcription; Developmental Factors; Forkhead Factors; telokin	MOUSE FORKHEAD-BOX-F1 GENE; MASTER REGULATOR; EXPRESSION; TARGET; LUNG; SRF; HAPLOINSUFFICIENCY; PROLIFERATION; OBSTRUCTION; ACTIVATION	Smooth muscle cells (SMCs) modulate their phenotype from a quiescent contractile state to a dedifferentiated, proliferative and migratory state during the pathogenesis of many diseases, including intestinal pseudoobstruction. Understanding how smooth muscle gene expression is regulated in these different phenotypic states is critical for unraveling the pathogenesis of these diseases. In the current study we examined the specific roles of Foxf1 in visceral SMC differentiation. Data show that Foxf1 is specifically required for expression of several contractile and regulatory proteins such as telokin, smooth muscle -actin, and Cav1.2b in visceral SMCs. Mechanistically, Foxf1 directly binds to and activates the telokin promoter. Foxf1 also directly binds to serum response factor (SRF) and myocardin-related transcription factors (MRTFs). Unlike Foxo4 and Foxq1, which bind to MRTFs and block their interaction with SRF, Foxf1 acts synergistically with these proteins to regulate telokin expression. Knock-out of Foxf1 specifically in SMCs results in neonatal lethality, with mice exhibiting GI tract abnormalities. Mice heterozygous for Foxf1 in SMC exhibited impaired colonic contractility and decreased expression of contractile proteins. These studies together with previous studies, suggest that different forkhead proteins can regulate gene expression in SMCs through modulating the activity of the SRF-myocardin axis to either promote or inhibit differentiation and proliferation thereby altering gastrointestinal contractility and development.	[Hoggatt, April M.; Kim, Ju-Ryoung; Herring, B. Paul] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Ustiyan, Vladimir; Ren, Xiaomeng; Kalin, Tanya V.; Kalinichenko, Vladimir V.] Cincinnati Childrens Res Fdn, Div Pulm Biol, Perinatal Inst, Cincinnati, OH 45229 USA	Indiana University System; Indiana University Bloomington; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Herring, BP (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	pherring@iupui.edu	Ren, Xiaomeng/U-1751-2019		National Institutes of Health [DK61130, HL 84151]; NATIONAL CANCER INSTITUTE [R01CA142724] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK61130 (to B. P. H.) and HL 84151 (to V. V. K.).	Abid MR, 2005, J BIOL CHEM, V280, P29864, DOI 10.1074/jbc.M502149200; Adachi M, 2007, GASTROENTEROLOGY, V132, P1434, DOI 10.1053/j.gastro.2007.01.033; Allard D, 2008, J BIOL CHEM, V283, P19739, DOI 10.1074/jbc.M710098200; Angstenberger M, 2007, GASTROENTEROLOGY, V133, P1948, DOI 10.1053/j.gastro.2007.08.078; Chen J, 2008, NEUROGASTROENT MOTIL, V20, P829, DOI 10.1111/j.1365-2982.2008.01149.x; Clemens RA, 2007, J IMMUNOL, V178, P4606, DOI 10.4049/jimmunol.178.7.4606; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Freddie CT, 2007, NUCLEIC ACIDS RES, V35, P5203, DOI 10.1093/nar/gkm528; Fukuyama K, 2006, ARTERIOSCL THROM VAS, V26, P2049, DOI 10.1161/01.ATV.0000233358.87583.01; Herring BP, 2001, J BIOL CHEM, V276, P14482, DOI 10.1074/jbc.M011585200; Hoggatt AM, 2000, J BIOL CHEM, V275, P31162, DOI 10.1074/jbc.M005595200; Kalinichenko VV, 2002, J BIOL CHEM, V277, P12369, DOI 10.1074/jbc.M112162200; Kalinichenko VV, 2002, AM J PHYSIOL-LUNG C, V282, pL1253, DOI 10.1152/ajplung.00463.2001; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Kumar MS, 2003, CIRC RES, V92, P840, DOI 10.1161/01.RES.0000069031.55281.7C; Li H, 2007, MOL CELL BIOL, V27, P2676, DOI 10.1128/MCB.01748-06; Lim L, 2002, AM J PHYSIOL-LUNG C, V282, pL1012, DOI 10.1152/ajplung.00371.2001; Littlewood TD, 2007, CIRC RES, V100, P302, DOI 10.1161/01.RES.0000259101.39931.d3; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Mericskay M, 2007, GASTROENTEROLOGY, V133, P1960, DOI 10.1053/j.gastro.2007.09.010; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Peterson RS, 1997, MECH DEVELOP, V69, P53, DOI 10.1016/S0925-4773(97)00153-6; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Stankiewicz P, 2009, AM J HUM GENET, V84, P780, DOI 10.1016/j.ajhg.2009.05.005; Touw K, 2012, AM J PHYSIOL-GASTR L, V302, pG66, DOI 10.1152/ajpgi.00183.2011; Ustiyan V, 2009, DEV BIOL, V336, P266, DOI 10.1016/j.ydbio.2009.10.007; Varenne O, 1999, HUM GENE THER, V10, P1105, DOI 10.1089/10430349950018102; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhang M, 2011, MOL CELL BIOL, V31, P2618, DOI 10.1128/MCB.01338-10; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200	42	38	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28477	28487		10.1074/jbc.M113.478974	http://dx.doi.org/10.1074/jbc.M113.478974			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946491	Green Published, hybrid			2022-12-28	WOS:000330298800006
J	Karki, P; Webb, A; Smith, K; Lee, K; Son, DS; Aschner, M; Lee, E				Karki, Pratap; Webb, Anton; Smith, Keisha; Lee, Kyuwon; Son, Deok-Soo; Aschner, Michael; Lee, Eunsook			cAMP Response Element-binding Protein (CREB) and Nuclear Factor kappa B Mediate the Tamoxifen-induced Up-regulation of Glutamate Transporter 1 (GLT-1) in Rat Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Astrocytes; CREB; Glutamate; NF-B; TGF-); EAAT2; Tamoxifen	CEREBRAL-ARTERY OCCLUSION; ESTROGEN-RECEPTOR MODULATORS; REDUCES INFARCT VOLUME; COUPLED RECEPTOR; ISCHEMIC TOLERANCE; GENE-EXPRESSION; BREAST-CANCER; NEUROPROTECTION; EAAT2; GPR30	Tamoxifen (TX), a selective estrogen receptor modulator, exerts antagonistic effects on breast tissue and is used to treat breast cancer. Recent evidence also suggests that it may act as an agonist in brain tissue. We reported previously that TX enhanced the expression and function of glutamate transporter 1 (GLT-1) in rat astrocytes, an effect that was mediated by TGF-. To gain further insight into the mechanisms that mediate TX-induced up-regulation of GLT-1 (EAAT2 in humans), we investigated its effect on GLT-1 at the transcriptional level. TX phosphorylated the cAMP response element-binding protein (CREB) and recruited CREB to the GLT-1 promoter consensus site. The effect of TX on astrocytic GLT-1 was attenuated by the inhibition of PKA, the upstream activator of the CREB pathway. In addition, the effect of TX on GLT-1 promoter activity was abolished by the inhibition of the NF-B pathway. Furthermore, TX recruited the NF-B subunits p65 and p50 to the NF-B binding domain of the GLT-1 promoter. Mutation of NF-B (triple, -583/-282/-251) or CRE (-308) sites on the GLT-1 promoter led to significant repression of the promoter activity, but neither mutant completely abolished the TX-induced GLT-1 promoter activity. Mutation of both the NF-B (-583/-282/-251) and CRE (-308) sites led to a complete abrogation of the effect of TX on GLT-1 promoter activity. Taken together, our findings establish that TX regulates GLT-1 via the CREB and NF-B pathways.	[Karki, Pratap; Webb, Anton; Smith, Keisha; Son, Deok-Soo; Lee, Eunsook] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA; [Aschner, Michael] Vanderbilt Univ, Dept Pediat, Nashville, TN 37212 USA; [Lee, Kyuwon] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Meharry Medical College; Vanderbilt University; Harvard University	Lee, E (corresponding author), Meharry Med Coll, Dept Physiol, 1005 DB Todd Jr Blvd, Nashville, TN 37208 USA.	elee@mmc.edu		Smith, Keisha/0000-0001-7655-7997	NIGMS, National Institutes of Health [SC1 089630]; NIAID, National Institutes of Health [SC1 I089073]; NIEHS, National Institutes of Health [R01 10563]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM089630] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS, National Institutes of Health Grant SC1 089630; NIAID, National Institutes of Health Grant SC1 I089073; and NIEHS, National Institutes of Health Grant R01 10563.	Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Arevalo MA, 2011, J MOL ENDOCRINOL, V46, pR1, DOI 10.1677/JME-10-0122; ASCHNER M, 1992, J NEUROCHEM, V58, P730, DOI 10.1111/j.1471-4159.1992.tb09778.x; Bell KFS, 2013, J NEUROCHEM, V126, P274, DOI 10.1111/jnc.12176; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Cechinel-Recco K, 2012, J PSYCHOPHARMACOL, V26, P1594, DOI 10.1177/0269881112463124; Chakrabarti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052357; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Danbolt NC, 1998, PROG BRAIN RES, V116, P23, DOI 10.1016/S0079-6123(08)60428-8; Dhandapani KM, 2005, ENDOCRINOLOGY, V146, P2749, DOI 10.1210/en.2005-0014; Dluzen DE, 2001, J NEUROENDOCRINOL, V13, P618, DOI 10.1046/j.1365-2826.2001.00675.x; Du BT, 2004, J ENDOCRINOL, V183, P605, DOI 10.1677/joe.1.05775; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Ganel R, 2006, NEUROBIOL DIS, V21, P556, DOI 10.1016/j.nbd.2005.08.014; Ghosh M, 2011, J NEUROSCI, V31, P9159, DOI 10.1523/JNEUROSCI.0302-11.2011; Gillessen T, 2002, ADV EXP MED BIOL, V513, P3; Guo H, 2003, HUM MOL GENET, V12, P2519, DOI 10.1093/hmg/ddg267; Hara T, 2003, J NEUROCHEM, V86, P805, DOI 10.1046/j.1471-4159.2003.01847.x; Ignatov A, 2010, BREAST CANCER RES TR, V123, P87, DOI 10.1007/s10549-009-0624-6; Justicia C, 1999, J CEREBR BLOOD F MET, V19, P128, DOI 10.1097/00004647-199902000-00002; Justicia C, 2001, J CEREBR BLOOD F MET, V21, P1097, DOI 10.1097/00004647-200109000-00007; Kim K, 2011, J CELL PHYSIOL, V226, P2484, DOI 10.1002/jcp.22609; Kimelberg HK, 2000, NEUROREPORT, V11, P2675, DOI 10.1097/00001756-200008210-00014; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Koeberle PD, 2008, CELL DEATH DIFFER, V15, P471, DOI 10.1038/sj.cdd.4402281; Lappano R, 2012, CURR CANCER DRUG TAR, V12, P531, DOI 10.2174/156800912800673284; Lappano R., 2013, J STEROID BIOCH MOL, DOI S0960-0760(13)00054-X; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lee ESY, 2009, J NEUROCHEM, V110, P530, DOI 10.1111/j.1471-4159.2009.06105.x; Lee E, 2012, J BIOL CHEM, V287, P26817, DOI 10.1074/jbc.M112.341867; Lee E, 2012, GLIA, V60, P1024, DOI 10.1002/glia.22329; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mehta SH, 2003, NEUROENDOCRINOLOGY, V77, P44, DOI 10.1159/000068332; Merchenthaler I, 2003, ANN NY ACAD SCI, V1007, P89, DOI 10.1196/annals.1286.009; MILLER S, 1995, J NEUROSCI, V15, P6103; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; Osuka K, 2001, J NEUROCHEM, V76, P1842, DOI 10.1046/j.1471-4159.2001.00198.x; Pawlak J, 2005, MOL BRAIN RES, V138, P1, DOI 10.1016/j.molbrainres.2004.10.043; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Sattler R, 2006, HANDB EXP PHARM, V175, P277; Sawka CA, 1997, BREAST CANCER RES TR, V44, P211, DOI 10.1023/A:1005895813401; Schluter K, 2002, EUR J NEUROSCI, V16, P836, DOI 10.1046/j.1460-9568.2002.02130.x; Shao B, 2012, CURR DRUG TARGETS, V13, P188, DOI 10.2174/138945012799201702; Sharma K, 2008, BRAIN RES, V1204, P1, DOI 10.1016/j.brainres.2008.01.080; Sharma K, 2007, BRAIN RES, V1132, P10, DOI 10.1016/j.brainres.2006.11.027; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; Stice JP, 2012, SHOCK, V38, P128, DOI 10.1097/SHK.0b013e31825da754; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Su ZZ, 2003, P NATL ACAD SCI USA, V100, P1955, DOI 10.1073/pnas.0136555100; Vermeiren C, 2005, J NEUROCHEM, V94, P405, DOI 10.1111/j.1471-4159.2005.03216.x; Wang DY, 1997, J BIOL CHEM, V272, P14244, DOI 10.1074/jbc.272.22.14244; Wisman LAB, 2003, NEUROREPORT, V14, P1967, DOI 10.1097/00001756-200310270-00017; Zelenaia O, 2000, MOL PHARMACOL, V57, P667, DOI 10.1124/mol.57.4.667; Zhang YH, 2005, EXP NEUROL, V196, P41, DOI 10.1016/j.expneurol.2005.07.002; Zhang YH, 2007, EXP NEUROL, V204, P819, DOI 10.1016/j.expneurol.2007.01.015	61	64	65	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28975	28986		10.1074/jbc.M113.483826	http://dx.doi.org/10.1074/jbc.M113.483826			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23955341	Green Published, hybrid			2022-12-28	WOS:000330298800052
J	Lee, JJ; Kim, DG; Kim, DH; Simborio, HL; Min, W; Lee, HJ; Her, M; Jung, SC; Watarai, M; Kim, S				Lee, Jin Ju; Kim, Dae Geun; Kim, Dong Hyeok; Simborio, Hannah Leah; Min, Wongi; Lee, Hu Jang; Her, Moon; Jung, Suk Chan; Watarai, Masahisa; Kim, Suk			Interplay between Clathrin and Rab5 Controls the Early Phagocytic Trafficking and Intracellular Survival of Brucella abortus within HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; DEPENDENT ENDOCYTOSIS; CONTAINING PHAGOSOMES; DYNAMIN; ACTIN; INTERNALIZATION; MATURATION; MEMBRANE; RECEPTOR; CHOLESTEROL	Lipid raft-associated clathrin is essential for host-pathogen interactions during infection. Brucella abortus is an intracellular pathogen that circumvents host defenses, but little is known about the precise infection mechanisms that involve interaction with lipid raft-associated mediators. The aim of this study was to elucidate the clathrin-mediated phagocytic mechanisms of B. abortus. The clathrin dependence of B. abortus infection in HeLa cells was investigated using an infection assay and immunofluorescence microscopy. The redistribution of clathrin in the membrane and in phagosomes was investigated using sucrose gradient fractionation of lipid rafts and the isolation of B. abortus-containing vacuoles, respectively. Clathrin and dynamin were concentrated into lipid rafts during B. abortus infection, and the entry and intracellular survival of B. abortus within HeLa cells were abrogated by clathrin inhibition. Clathrin disruption decreased actin polymerization and the colocalization of B. abortus-containing vacuoles with clathrin and Rab5 but not lysosome-associated membrane protein 1 (LAMP-1). Thus, our data demonstrate that clathrin plays a fundamental role in the entry and intracellular survival of B. abortus via interaction with lipid rafts and actin rearrangement. This process facilitates the early intracellular trafficking of B. abortus to safe replicative vacuoles.	[Lee, Jin Ju; Kim, Dae Geun; Kim, Dong Hyeok; Simborio, Hannah Leah; Min, Wongi; Lee, Hu Jang; Kim, Suk] Gyeongsang Natl Univ, Coll Vet Med, Jinju 660701, South Korea; [Her, Moon; Jung, Suk Chan] Anim Plant & Fisheries Quarantine & Inspect Agcy, Anyang 430824, Gyeonggi Do, South Korea; [Watarai, Masahisa] Yamaguchi Univ, Fac Agr, Dept Vet Publ Hlth, Yamaguchi 7538515, Japan; [Kim, Suk] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea	Gyeongsang National University; Animal & Plant Quarantine Agency; Yamaguchi University; Gyeongsang National University	Kim, S (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Jinju 660701, South Korea.	kimsuk@gnu.ac.kr			National Research Foundation of Korea (NRF) [20121032, 2010-0009080]; Ministry of Education, Science and Technology; National Veterinary Research and Quarantine Service [0468-2010002]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Veterinary Research and Quarantine Service	This work was supported by Basic Science Research Program Grants 20121032 and 2010-0009080 through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology and by National Veterinary Research and Quarantine Service Grant 0468-2010002.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; AlvarezDominguez C, 1996, J BIOL CHEM, V271, P13834, DOI 10.1074/jbc.271.23.13834; Anitei M, 2012, NAT CELL BIOL, V14, P11, DOI 10.1038/ncb2409; Baldeon ME, 2001, CELL MICROBIOL, V3, P473, DOI 10.1046/j.1462-5822.2001.00130.x; Baldwin C L, 1994, Immunol Ser, V60, P363; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chaves-Olarte E, 2002, CELL MICROBIOL, V4, P663, DOI 10.1046/j.1462-5822.2002.00221.x; Clemente R, 2009, J VIROL, V83, P10406, DOI 10.1128/JVI.00990-09; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; DETILLEUX PG, 1990, INFECT IMMUN, V58, P2320, DOI 10.1128/IAI.58.7.2320-2328.1990; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Garnham P. C. C., 1958, Journal of Tropical Medicine and Hygiene, V61, P92; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Gopaldass N, 2012, TRAFFIC, V13, P120, DOI 10.1111/j.1600-0854.2011.01296.x; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hernaez B, 2010, J VIROL, V84, P2100, DOI 10.1128/JVI.01557-09; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Holtta-Vuori M, 2012, CIRC RES, V110, P450, DOI 10.1161/CIRCRESAHA.111.256842; Kim S, 2004, MICROB PATHOGENESIS, V37, P11, DOI 10.1016/j.micpath.2004.04.002; Kim S, 2002, MICROB PATHOGENESIS, V33, P225, DOI 10.1006/mpat.2002.0531; Lafont F, 2004, CURR OPIN MICROBIOL, V7, P4, DOI 10.1016/j.mib.2003.12.007; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Luhrmann A, 2000, Methods Cell Sci, V22, P329, DOI 10.1023/A:1017963401560; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Naroeni A, 2002, INFECT IMMUN, V70, P1640, DOI 10.1128/IAI.70.3.1640-1644.2002; Nicoziani P, 2000, MOL BIOL CELL, V11, P481, DOI 10.1091/mbc.11.2.481; Perskvist N, 2002, J CELL SCI, V115, P1321; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Shen-Tu G, 2010, LAB INVEST, V90, P266, DOI 10.1038/labinvest.2009.131; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Triantafilou M, 2002, J CELL SCI, V115, P2603; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; Veiga E, 2006, TRENDS CELL BIOL, V16, P499, DOI 10.1016/j.tcb.2006.08.005; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wang M, 2008, CELL MICROBIOL, V10, P2029, DOI 10.1111/j.1462-5822.2008.01185.x; Watarai M, 2002, CELL MICROBIOL, V4, P341, DOI 10.1046/j.1462-5822.2002.00195.x; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774	50	21	22	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28049	28057		10.1074/jbc.M113.491555	http://dx.doi.org/10.1074/jbc.M113.491555			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940042	Green Published, hybrid			2022-12-28	WOS:000330612800030
J	Lee, S; Gaspar, ML; Aregullin, MA; Jesch, SA; Henry, SA				Lee, Sojin; Gaspar, Maria L.; Aregullin, Manuel A.; Jesch, Stephen A.; Henry, Susan A.			Activation of Protein Kinase C-Mitogen-activated Protein Kinase Signaling in Response to Inositol Starvation Triggers Sir2p-dependent Telomeric Silencing in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONOLOGICAL LIFE-SPAN; CALORIE RESTRICTION EXTENDS; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-METABOLISM; GENE-EXPRESSION; SPHINGOLIPID METABOLISM; SIR2 FAMILY; PATHWAY; BIOSYNTHESIS; NICOTINAMIDE	Depriving wild type yeast of inositol, a soluble precursor for phospholipid, phosphoinositide, and complex sphingolipid synthesis, activates the protein kinase C (PKC)-MAPK signaling pathway, which plays a key role in the activation of NAD(+)-dependent telomeric silencing. We now report that triggering PKC-MAPK signaling by inositol deprivation or by blocking inositol-containing sphingolipid synthesis with aureobasidin A results in increased telomeric silencing regulated by the MAPK, Slt2p, and the NAD(+)-dependent deacetylase, Sir2p. Consistent with the dependence on NAD(+) in Sir2p-regulated silencing, we found that inositol depletion induces the expression of BNA2, which is required for the de novo synthesis of NAD(+). Moreover, telomeric silencing is greatly reduced in bna2 Delta and npt1 Delta mutants, which are defective in de novo and salvage pathways for NAD(+) synthesis, respectively. Surprisingly, however, omitting nicotinic acid from the growth medium, which reduces cellular NAD(+) levels, leads to increased telomeric silencing in the absence of inositol and/or at high temperature. This increase in telomeric silencing in response to inositol starvation is correlated to chronological life span extension but is Sir2p-independent. We conclude that activation of the PKC-MAPK signaling by interruption of inositol sphingolipid synthesis leads to increased Sir2p-dependent silencing and is dependent upon the de novo and salvage pathways for NAD(+) synthesis but is not correlated with cellular NAD(+) levels.	[Lee, Sojin; Gaspar, Maria L.; Aregullin, Manuel A.; Jesch, Stephen A.; Henry, Susan A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Henry, SA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 245 Biotechnol Bldg, Ithaca, NY 14853 USA.	sah42@cornell.edu	Henry, Susan/K-5464-2014		National Institutes of Health [GM-19629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019629, R37GM019629, R01GM019629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-19629 (to S. A. H.). This study is taken in part from the Ph.D. thesis of Sojin Lee, Cornell University, 2009.	Aerts AM, 2006, FEBS LETT, V580, P1903, DOI 10.1016/j.febslet.2006.02.061; Ai WD, 2002, MOL CELL, V10, P1295, DOI 10.1016/S1097-2765(02)00695-0; Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Ashrafi K, 2000, GENE DEV, V14, P1872; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; BECKER GW, 1977, J BIOL CHEM, V252, P8684; Bedalov A, 2003, MOL CELL BIOL, V23, P7044, DOI 10.1128/MCB.23.19.7044-7054.2003; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bi X, 2004, J MOL BIOL, V344, P893, DOI 10.1016/j.jmb.2004.10.002; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; Chang HJ, 2002, GENETICS, V162, P29; CORNELL NW, 1983, ANAL BIOCHEM, V132, P418, DOI 10.1016/0003-2697(83)90029-5; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Craven RJ, 2000, MOL CELL BIOL, V20, P2378, DOI 10.1128/MCB.20.7.2378-2384.2000; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Endo M, 1997, ANTIMICROB AGENTS CH, V41, P672, DOI 10.1128/AAC.41.3.672; Evans Charles, 2010, BMC Chemical Biology, V10, P2, DOI 10.1186/1472-6769-10-2; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; HANSON BA, 1980, J LIPID RES, V21, P309; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Huang XH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002493; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jesch SA, 2010, J BIOL CHEM, V285, P41947, DOI 10.1074/jbc.M110.188607; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Li MG, 2010, MOL CELL BIOL, V30, P3329, DOI 10.1128/MCB.01590-09; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Moazed D, 1996, CELL, V86, P667, DOI 10.1016/S0092-8674(00)80139-7; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Ray A, 2003, NAT GENET, V33, P522, DOI 10.1038/ng1132; RINE J, 1987, GENETICS, V116, P9; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sandmeier JJ, 2002, GENETICS, V160, P877; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Shears Stephen B, 2012, Subcell Biochem, V59, P389, DOI 10.1007/978-94-007-3015-1_13; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 2002, METHOD ENZYMOL, V353, P282; Sporty JL, 2008, J SEP SCI, V31, P3202, DOI 10.1002/jssc.200800238; Stone EM, 1996, J CELL BIOL, V135, P571, DOI 10.1083/jcb.135.3.571; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Ye CQ, 2013, J BIOL CHEM, V288, P24898, DOI 10.1074/jbc.M113.493353	68	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27861	27871		10.1074/jbc.M113.493072	http://dx.doi.org/10.1074/jbc.M113.493072			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23943620	Green Published, hybrid			2022-12-28	WOS:000330612800014
J	Matitau, AE; Gabor, TV; Gill, RM; Scheid, MP				Matitau, Adi E.; Gabor, Timothy V.; Gill, R. Montgomery; Scheid, Michael P.			MEKK2 Kinase Association with 14-3-3 Protein Regulates Activation of c-Jun N-terminal Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; TOLL-LIKE RECEPTOR; SIGNALING PATHWAY; GENE-EXPRESSION; JNK ACTIVATION; PB1 DOMAIN; MAST-CELLS; ERK KINASE; PHOSPHORYLATION; ALPHA	MEKK2 (MAP/ERK kinase kinase-2) is a serine/threonine kinase that belongs to the MEKK/STE11 family of MAP kinase kinase kinases (MAP(3) Ks). MEKK2 integrates stress and mitogenic signals to the activation of NF-kappa B, JNK1/2, p38, and ERK5 pathways. We have found that MEKK2 is regulated through a phosphorylation-dependent association with 14-3-3, a group of adapters that modulate dimerization and association between proteins. We found that MEKK2 was phosphorylated at Thr-283, which resulted in decreased activation loop phosphorylation at Ser-519 and consequently reduced activity. Mechanistically, we found that MEKK2 associated with inactive MEKK2 in the absence of 14-3-3 binding, which led to trans-autophosphorylation of Ser-519. Enforced binding with 14-3-3 reduced Ser-519 trans-autophosphorylation. Expression of T283A MEKK2 within a MEKK2(-/-) background enhanced stress-activated c-Jun N-terminal kinase activity while elevating IL-6 expression, but also reduced ERK activation with a corresponding reduced proliferation rate. These results indicate that Thr-283 phosphorylation is an important regulatory mechanism for MEKK2 activation.	[Matitau, Adi E.; Gabor, Timothy V.; Gill, R. Montgomery; Scheid, Michael P.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	York University - Canada	Scheid, MP (corresponding author), York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	mscheid@yorku.ca			Canadian Institute of Health Research (CIHR)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institute of Health Research (CIHR) (to M.P.S.).	Black EJ, 2002, ONCOGENE, V21, P6540, DOI 10.1038/sj.onc.1205851; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; Blonska M, 2004, MOL CELL BIOL, V24, P10757, DOI 10.1128/MCB.24.24.10757-10765.2004; Chao TH, 1999, J BIOL CHEM, V274, P36035, DOI 10.1074/jbc.274.51.36035; Chayama K, 2001, P NATL ACAD SCI USA, V98, P4599, DOI 10.1073/pnas.081021898; Cheng J, 2005, MOL CELL BIOL, V25, P5955, DOI 10.1128/MCB.25.14.5955-5964.2005; Cheng JK, 2005, J BIOL CHEM, V280, P13477, DOI 10.1074/jbc.M414258200; Cheng JK, 2000, MOL CELL BIOL, V20, P2334, DOI 10.1128/MCB.20.7.2334-2342.2000; Deacon K, 1999, J BIOL CHEM, V274, P16604, DOI 10.1074/jbc.274.23.16604; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Fritz A, 2006, J BIOL CHEM, V281, P6236, DOI 10.1074/jbc.M509249200; Garner AP, 2002, ONCOGENE, V21, P8089, DOI 10.1038/sj.onc.1206000; Garrington TP, 2000, EMBO J, V19, P5387, DOI 10.1093/emboj/19.20.5387; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Matitau AE, 2008, J BIOL CHEM, V283, P13261, DOI 10.1074/jbc.M801474200; Nakamura K, 2006, MOL CELL BIOL, V26, P2065, DOI 10.1128/MCB.26.6.2065-2079.2006; Nakamura K, 2003, J BIOL CHEM, V278, P36989, DOI 10.1074/jbc.C300313200; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Qin JZ, 2006, J BIOL CHEM, V281, P21013, DOI 10.1074/jbc.M512908200; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; Shen Y, 2001, P NATL ACAD SCI USA, V98, P13613, DOI 10.1073/pnas.231499098; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Su B, 2001, J BIOL CHEM, V276, P14784, DOI 10.1074/jbc.M010134200; Sun WY, 2000, J BIOL CHEM, V275, P24421, DOI 10.1074/jbc.M003148200; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	32	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28293	28302		10.1074/jbc.M113.511352	http://dx.doi.org/10.1074/jbc.M113.511352			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23963453	hybrid, Green Published			2022-12-28	WOS:000330612800050
J	Brouwers, B; Pruniau, VPEG; Cauwelier, EJG; Schuit, F; Lerut, E; Ectors, N; Declercq, J; Creemers, JWM				Brouwers, Bas; Pruniau, Vincent P. E. G.; Cauwelier, Elisa J. G.; Schuit, Frans; Lerut, Evelyne; Ectors, Nadine; Declercq, Jeroen; Creemers, John W. M.			Phlorizin Pretreatment Reduces Acute Renal Toxicity in a Mouse Model for Diabetic Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE KIDNEY INJURY; DES-ACYL GHRELIN; DIALYSIS PATIENTS; GASTRIC-MOTILITY; DESACYL GHRELIN; HEPATIC-CHANGES; MOTOR-ACTIVITY; IN-VIVO; STREPTOZOTOCIN; FAILURE	Streptozotocin (STZ) is widely used as diabetogenic agent in animal models for diabetic nephropathy (DN). However, it is also directly cytotoxic to kidneys, making it difficult to distinguish between DN-related and STZ-induced nephropathy. Therefore, an improved protocol to generate mice for DN studies, with a quick and robust achievement of the diabetic state, without direct kidney toxicity is required. To investigate the mechanism leading to STZ-induced nephropathy, kidney damage was induced with a high dose of STZ. This resulted in delayed gastric emptying, at least partially caused by impaired desacyl ghrelin clearance. STZ uptake in the kidneys is to a large extent mediated by the sodium/glucose cotransporters (Sglts) because the Sglt inhibitor phlorizin could reduce STZ uptake in the kidneys. Consequently, the direct toxic effects in the kidney and the gastric dilatation were resolved without interfering with the beta-cell toxicity. Furthermore, pancreatic STZ uptake was increased, hereby decreasing the threshold for beta-cell toxicity, allowing for single low non-nephrotoxic STZ doses (70 mg/kg). In conclusion, this study provides novel insights into the mechanism of STZ toxicity in kidneys and suggests a more efficient regime to induce DN with little or no toxic side effects.	[Brouwers, Bas; Pruniau, Vincent P. E. G.; Cauwelier, Elisa J. G.; Declercq, Jeroen; Creemers, John W. M.] Katholieke Univ Leuven, Dept Human Genet, Biochem Neuroendocrinol Lab, B-3000 Louvain, Belgium; [Schuit, Frans] Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, B-3000 Louvain, Belgium; [Lerut, Evelyne; Ectors, Nadine] Univ Hosp Gasthuisberg, Dept Pathol, B-3000 Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven	Declercq, J (corresponding author), Katholieke Univ Leuven VIB, Dept Human Genet, Lab Biochem Neuroendocrinol, O&N1,Herestr 49 Bus 602, B-3000 Louvain, Belgium.	jeroen.declercq@med.kuleuven.be	Brouwers, Bas/C-3996-2015	Brouwers, Bas/0000-0001-6541-4835	Fonds Wetenschappelijk Onderzoek (FWO); "Geconcerteerde Onderzoeksacties" (GOA) [GOA/12/016]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); "Geconcerteerde Onderzoeksacties" (GOA)	This work was supported in part by grants from the Fonds Wetenschappelijk Onderzoek (FWO) and "Geconcerteerde Onderzoeksacties" (GOA) (GOA/12/016).	Asakawa A, 2005, GUT, V54, P18, DOI 10.1136/gut.2004.038737; Aygen B, 2009, J INT MED RES, V37, P757, DOI 10.1177/147323000903700319; Barcelona S, 2012, AM J PHYSIOL-CELL PH, V302, pC1073, DOI 10.1152/ajpcell.00436.2011; Belangero Vera Maria Santoro, 1998, Arquivos de Gastroenterologia, V35, P278; Bolzan AD, 2002, MUTAT RES-REV MUTAT, V512, P121, DOI 10.1016/S1383-5742(02)00044-3; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Campanile N, 2007, XENOTRANSPLANTATION, V14, P265, DOI 10.1111/j.1399-3089.2007.00406.x; De Schoenmakere G, 2001, NEPHROL DIAL TRANSPL, V16, P1850, DOI 10.1093/ndt/16.9.1850; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Fu YC, 2004, BLOOD CELL MOL DIS, V32, P182, DOI 10.1016/j.bcmd.2003.09.002; Fujimiya M, 2012, DIGESTION, V85, P90, DOI 10.1159/000334654; Fujimiya M, 2011, PEPTIDES, V32, P2348, DOI 10.1016/j.peptides.2011.07.020; Fujino K, 2003, J PHYSIOL-LONDON, V550, P227, DOI 10.1113/jphysiol.2003.040600; Garcia A., 2001, COMPARATIVE MED, V51, P262; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hirako M, 2005, J GASTROENTEROL, V40, P1116, DOI 10.1007/s00535-005-1709-6; Janssen P, 2011, ALIMENT PHARM THER, V33, P880, DOI 10.1111/j.1365-2036.2011.04609.x; Jarkovska Z, 2005, GROWTH HORM IGF RES, V15, P369, DOI 10.1016/j.ghir.2005.07.004; Johnston APW, 2007, AM J PHYSIOL-CELL PH, V292, pC1033, DOI 10.1152/ajpcell.00338.2006; KARUNANAYAKE EH, 1976, DIABETOLOGIA, V12, P483, DOI 10.1007/BF01219512; Kim EM, 1999, AM J PHYSIOL-REG I, V276, pR1320, DOI 10.1152/ajpregu.1999.276.5.R1320; Kinne RKH, 2011, HANDB EXP PHARMACOL, V203, P105, DOI 10.1007/978-3-642-17214-4_5; Ko GJ, 2010, AM J PHYSIOL-RENAL, V298, pF1472, DOI 10.1152/ajprenal.00619.2009; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kraynak AR, 1995, TOXICOL APPL PHARM, V135, P279, DOI 10.1006/taap.1995.1234; Kume E, 2004, EXP TOXICOL PATHOL, V55, P467, DOI 10.1078/0940-2993-00351; KUME E, 1994, EXP TOXICOL PATHOL, V46, P368, DOI 10.1016/S0940-2993(11)80119-3; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Marks J, 2003, J PHYSIOL-LONDON, V553, P137, DOI 10.1113/jphysiol.2003.046268; Martindale W., 1989, MARTINDALE EXTRA PHA, P649; Mather A, 2010, NAT REV NEPHROL, V6, P307, DOI 10.1038/nrneph.2010.38; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P4551, DOI 10.1210/en.140.10.4551; Muller YD, 2011, DIABETES, V60, P2331, DOI 10.2337/db11-0159; Palm F, 2004, DIABETES-METAB RES, V20, P452, DOI 10.1002/dmrr.472; Ravelli AM, 1995, PEDIATR NEPHROL, V9, P756, DOI 10.1007/BF00868736; RERUP C C, 1970, Pharmacological Reviews, V22, P485; Ross EA, 1998, AM J KIDNEY DIS, V31, P62, DOI 10.1053/ajkd.1998.v31.pm9428453; Santer R, 2010, CLIN J AM SOC NEPHRO, V5, P133, DOI 10.2215/CJN.04010609; SCHNEDL WJ, 1994, DIABETES, V43, P1326, DOI 10.2337/diabetes.43.11.1326; Silang R, 2001, AM J KIDNEY DIS, V37, P287, DOI 10.1053/ajkd.2001.21291; Stanley WC, 1997, CARDIOVASC RES, V33, P243, DOI 10.1016/S0008-6363(96)00245-3; Strid H, 2004, SCAND J GASTROENTERO, V39, P516, DOI 10.1080/00365520410004505; Tal MG, 2004, RADIOLOGY, V230, P163, DOI 10.1148/radiol.2301021413; Tay YC, 2005, KIDNEY INT, V68, P391, DOI 10.1111/j.1523-1755.2005.00405.x; Tesch GH, 2007, NEPHROLOGY, V12, P261, DOI 10.1111/j.1440-1797.2007.00796.x; Urbschat A, 2011, BIOMARKERS, V16, pS22, DOI 10.3109/1354750X.2011.587129; Waring WS, 2011, CLIN TOXICOL, V49, P720, DOI 10.3109/15563650.2011.615319; WEISS RB, 1982, CANCER TREAT REP, V66, P427; Wold LE, 2004, BIOCHEM BIOPH RES CO, V318, P1066, DOI 10.1016/j.bbrc.2004.04.138; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10; Yoshikawa T, 2011, HISTOCHEM CELL BIOL, V135, P183, DOI 10.1007/s00418-011-0779-1; Yoshimoto A, 2002, J AM SOC NEPHROL, V13, P2748, DOI 10.1097/01.ASN.0000032420.12455.74; Zhang RX, 2011, NEUROGASTROENT MOTIL, V23, pE356, DOI 10.1111/j.1365-2982.2011.01753.x	54	30	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27200	27207		10.1074/jbc.M113.469486	http://dx.doi.org/10.1074/jbc.M113.469486			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23940028	Green Published, hybrid			2022-12-28	WOS:000330597300018
J	Sontag, JM; Nunbhakdi-Craig, V; Sontag, E				Sontag, Jean-Marie; Nunbhakdi-Craig, Viyada; Sontag, Estelle			Leucine Carboxyl Methyltransferase 1 (LCMT1)-dependent Methylation Regulates the Association of Protein Phosphatase 2A and Tau Protein with Plasma Membrane Microdomains in Neuroblastoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; ALZHEIMERS-DISEASE; DOWN-REGULATION; MOUSE-BRAIN; IN-VITRO; PHOSPHORYLATION; CAVEOLAE; DOMAINS; DEPHOSPHORYLATION; MICROTUBULES	Down-regulation of protein phosphatase 2A (PP2A) methylation occurs in Alzheimer disease (AD). However, the regulation of PP2A methylation remains poorly understood. We have reported that altered leucine carboxyl methyltransferase (LCMT1)-dependent PP2A methylation is associated with down-regulation of PP2A holoenzymes containing the B alpha subunit (PP2A/B alpha) and subsequent accumulation of phosphorylated Tau in N2a cells, in vivo and in AD. Here, we show that pools of LCMT1, methylated PP2A, and PP2A/B alpha are co-enriched in cholesterol-rich plasma membrane microdomains/rafts purified from N2a cells. In contrast, demethylated PP2A is preferentially distributed in non-rafts wherein small amounts of the PP2A methylesterase PME-1 are exclusively present. A methylation-incompetent PP2A mutant is excluded from rafts. Enhanced methylation of PP2A promotes the association of PP2A and Tau with the plasma membrane. Altered PP2A methylation following expression of a catalytically inactive LCMT1 mutant, knockdown of LCMT1, or alterations in one-carbon metabolism all result in a loss of plasma membrane-associated PP2A and Tau in N2a cells. This correlates with accumulation of soluble phosphorylated Tau, a hallmark of AD and other tauopathies. Thus, our findings reveal a distinct compartmentalization of PP2A and PP2A regulatory enzymes in plasma membrane microdomains and identify a novel methylation-dependent mechanism involved in modulating the targeting of PP2A, and its substrate Tau, to the plasma membrane. We propose that alterations in the membrane localization of PP2A and Tau following down-regulation of LCMT1 may lead to PP2A and Tau dysfunction in AD.	[Sontag, Jean-Marie; Sontag, Estelle] Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth & Med, Callaghan, NSW 2308, Australia; [Nunbhakdi-Craig, Viyada] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Newcastle; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sontag, E (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth & Med, Callaghan, NSW 2308, Australia.	Estelle.Sontag@newcastle.edu.au	SONTAG, ESTELLE/AAE-9805-2020		National Health and Medical Research Council (NHMRC) Australia	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported in part by a National Health and Medical Research Council (NHMRC) Australia grant (to E. S. and J. M. S.).	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Arrasate M, 2000, NEUROCHEM RES, V25, P43, DOI 10.1023/A:1007583214722; Berrou E, 2009, EXP CELL RES, V315, P836, DOI 10.1016/j.yexcr.2008.12.002; Bottiglieri T, 2012, J NEUROSCI, V32, P9173, DOI 10.1523/JNEUROSCI.0125-12.2012; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Chadwick W., 2010, INT J ALZHEIMERS DIS, V2010, DOI [10.4061/2010/604792, DOI 10.4061/2010/604792]; Chen DH, 2004, J BIOCHEM, V136, P371, DOI 10.1093/jb/mvh131; Eidenmuller J, 2001, BIOCHEM J, V357, P759, DOI 10.1042/0264-6021:3570759; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Fowler Brian, 2005, Semin Vasc Med, V5, P77; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Gentry MS, 2005, EUKARYOT CELL, V4, P1029, DOI 10.1128/EC.4.6.1029-1040.2005; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; Hernandez P, 2009, J ALZHEIMERS DIS, V16, P149, DOI 10.3233/JAD-2009-0933; Hiraga A, 2000, BIOCHEM J, V346, P433, DOI 10.1042/0264-6021:3460433; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Lee G, 1998, J CELL SCI, V111, P3167; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Longin S, 2008, EXP CELL RES, V314, P68, DOI 10.1016/j.yexcr.2007.07.030; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Nunbhakdi-Craig V, 2007, J NEUROCHEM, V101, P959, DOI 10.1111/j.1471-4159.2007.04503.x; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pooler AM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.005; Pooler AM, 2010, BIOCHEM SOC T, V38, P1012, DOI 10.1042/BST0381012; PORTER CW, 1984, BIOCHEM BIOPH RES CO, V122, P350, DOI 10.1016/0006-291X(84)90482-0; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Schild A, 2006, BIOCHEM BIOPH RES CO, V343, P1171, DOI 10.1016/j.bbrc.2006.03.066; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Sontag JM, 2008, J NEUROSCI, V28, P11477, DOI 10.1523/JNEUROSCI.2816-08.2008; Sontag JM, 2012, J BIOL CHEM, V287, P14984, DOI 10.1074/jbc.M111.338681; Sontag JM, 2010, J NEUROCHEM, V115, P1455, DOI 10.1111/j.1471-4159.2010.07049.x; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Swingle Mark, 2007, V365, P23; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Usardi A, 2011, FEBS J, V278, P2927, DOI 10.1111/j.1742-4658.2011.08218.x; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Williamson R, 2011, CURR ALZHEIMER RES, V8, P213, DOI 10.2174/156720511795256008; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	56	35	38	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27396	27405		10.1074/jbc.M113.490102	http://dx.doi.org/10.1074/jbc.M113.490102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23943618	Green Published, hybrid			2022-12-28	WOS:000330597300035
J	Du, YT; Zhang, HH; Zhang, X; Lu, J; Holmgren, A				Du, Yatao; Zhang, Huihui; Zhang, Xu; Lu, Jun; Holmgren, Arne			Thioredoxin 1 Is Inactivated Due to Oxidation Induced by Peroxiredoxin under Oxidative Stress and Reactivated by the Glutaredoxin System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hydrogen Peroxide; Oxidative Stress; Peroxiredoxin; Redox Signaling; Thiol; Thioredoxin	ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; INTERACTING PROTEIN; HYDROGEN-PEROXIDE; SULFHYDRYL-GROUPS; CELL-DEATH; DISULFIDE; REDUCTASE; IDENTIFICATION; GLUTATHIONE	The mammalian cytosolic thioredoxin system, comprising thioredoxin (Trx), Trx reductase, and NADPH, is the major protein-disulfide reductase of the cell and has numerous functions. Besides the active site thiols, human Trx1 contains three non-active site cysteine residues at positions 62, 69, and 73. A two-disulfide form of Trx1, containing an active site disulfide between Cys-32 and Cys-35 and a non-active site disulfide between Cys-62 and Cys-69, is inactive either as a disulfide reductase or as a substrate for Trx reductase. This could possibly provide a structural switch affecting Trx1 function during oxidative stress and redox signaling. We found that two-disulfide Trx1 was generated in A549 cells under oxidative stress. In vitro data showed that two-disulfide Trx1 was generated from oxidation of Trx1 catalyzed by peroxiredoxin 1 in the presence of H2O2. The redox Western blot data indicated that the glutaredoxin system protected Trx1 in HeLa cells from oxidation caused by ebselen, a superfast oxidant for Trx1. Our results also showed that physiological concentrations of glutathione, NADPH, and glutathione reductase reduced the non-active site disulfide in vitro. This reaction was stimulated by glutaredoxin 1 via the so-called monothiol mechanism. In conclusion, reversible oxidation of the non-active site disulfide of Trx1 is suggested to play an important role in redox regulation and cell signaling via temporal inhibition of its protein-disulfide reductase activity for the transmission of oxidative signals under oxidative stress.	[Du, Yatao; Zhang, Huihui; Zhang, Xu; Lu, Jun; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden	Karolinska Institutet	Holmgren, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, SE-17177 Stockholm, Sweden.	arne.holmgren@ki.se	Lu, Jun/E-9701-2017; zhang, hui/GXH-6098-2022; Zhang, Xu/F-4324-2018; Zhang, Hui/HHN-8494-2022	Lu, Jun/0000-0002-1699-8835; Du, Yatao/0000-0002-6881-0080	Swedish Cancer Society [961]; Swedish Research Council Medicine [13X-3529]; K&A Wallenberg Foundation; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council Medicine(Swedish Research Council); K&A Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Cancer Society (961), the Swedish Research Council Medicine (13X-3529), the K&A Wallenberg Foundation, and grants from Karolinska Institutet.	Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Cheng ZY, 2011, CHEM REV, V111, P5768, DOI 10.1021/cr100006x; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dominy Clifford N, 2003, Methods Mol Biol, V235, P209; Du YT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392225; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Gelhaye E, 2003, FEBS LETT, V555, P443, DOI 10.1016/S0014-5793(03)01301-2; Gitler C, 2002, BIOCHEM BIOPH RES CO, V290, P624, DOI 10.1006/bbrc.2001.6214; Gough DR, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.96; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1968, EUR J BIOCHEM, V6, P475, DOI 10.1111/j.1432-1033.1968.tb00470.x; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Japelaghi RH, 2012, MOL BIOL REP, V39, P3683, DOI 10.1007/s11033-011-1143-1; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Koh CS, 2008, J BIOL CHEM, V283, P23062, DOI 10.1074/jbc.M802093200; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Masutani H, 2012, J CLIN BIOCHEM NUTR, V50, P23, DOI 10.3164/jcbn.11-36SR; Meng L, 2010, P NATL ACAD SCI USA, V107, P3900, DOI 10.1073/pnas.0913759107; Meyer Y, 2012, ANTIOXID REDOX SIGN, V17, P1124, DOI 10.1089/ars.2011.4327; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Niso-Santano M, 2010, FREE RADICAL BIO MED, V48, P1370, DOI 10.1016/j.freeradbiomed.2010.02.024; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; ROTHWARF DM, 1992, P NATL ACAD SCI USA, V89, P7944, DOI 10.1073/pnas.89.17.7944; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TAKAHASHI N, 1990, ANAL BIOCHEM, V188, P359, DOI 10.1016/0003-2697(90)90621-F; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Veal E, 2011, ANTIOXID REDOX SIGN, V15, P147, DOI 10.1089/ars.2011.3968; Watson WH, 2004, TOXICOL SCI, V78, P3, DOI 10.1093/toxsci/kfh050; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Yoshihara E, 2010, METHOD ENZYMOL, V474, P67, DOI 10.1016/S0076-6879(10)74005-2; Yoshioka J, 2004, CIRCULATION, V109, P2581, DOI 10.1161/01.CIR.0000129771.32215.44; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	51	72	75	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32241	32247		10.1074/jbc.M113.495150	http://dx.doi.org/10.1074/jbc.M113.495150			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24062305	Green Published, hybrid			2022-12-28	WOS:000328681700012
J	Gartner, F; Seidel, T; Schulz, U; Gummert, J; Milting, H				Gaertner, Florian; Seidel, Thorsten; Schulz, Uwe; Gummert, Jan; Milting, Hendrik			Desensitization and Internalization of Endothelin Receptor A IMPACT OF G PROTEIN-COUPLED RECEPTOR KINASE 2 (GRK2)-MEDIATED PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelin; G Protein-coupled Receptor (GPCR); Phosphorylation; Receptor Desensitization; Receptor Endocytosis; Receptor Regulation	INTRACELLULAR TRAFFICKING PATHWAYS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; BETA-ARRESTIN TRANSLOCATION; PROTEIN-COUPLED RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; PHOSPHORYLATION SITES; MOLECULAR CHARACTERIZATION; KINASE; BINDING; RHODOPSIN	Endothelin receptor A (ETA), a G protein-coupled receptor, mediates endothelin signaling, which is regulated by GRK2. Three Ser and seven Thr residues recently proven to be phosphoacceptor sites are located in the C-terminal extremity (CTE) of the receptor following its palmitoylation site. We created various phosphorylation-deficient ETA mutants. The phospholipase C activity of mutant receptors in HEK-293 cells was analyzed during continuous endothelin stimulation to investigate the impact of phosphorylation sites on ETA desensitization. Total deletion of phosphoacceptor sites in the CTE affected proper receptor regulation. However, proximal and distal phosphoacceptor sites both turned out to be sufficient to induce WT-like desensitization. Overexpression of the G(q) coupling-deficient mutant GRK2-D110A suppressed ETA-WT signaling but failed to decrease phospholipase C activity mediated by the phosphorylation-deficient mutant ETA-6PD. In contrast, GRK2-WT acted on both receptors, whereas the kinase-inactive mutant GRK2-D110A/K220R failed to inhibit signaling of ETA-WT and ETA-6PD. This demonstrates that ETA desensitization involves at least two autonomous GRK2-mediated components: 1) a phosphorylation-independent signal decrease mediated by blocking of G(q) and 2) a mechanism involving phosphorylation of Ser and Thr residues in the CTE of the receptor in a redundant fashion, able to incorporate either proximal or distal phosphoacceptor sites. High level transfection of GRK2 variants influenced signaling of ETA-WT and ETA-6PD and hints at an additional phosphorylation-independent regulatory mechanism. Furthermore, internalization of mRuby-tagged receptors was observed with ETA-WT and the phosphorylation-deficient mutant ETA-14PD (lacking 14 phosphoacceptor sites) and turned out to be based on a phosphorylation-independent mechanism.	[Gaertner, Florian; Schulz, Uwe; Gummert, Jan; Milting, Hendrik] Ruhr Univ Bochum, Heart & Diabet Ctr NRW, Clin Thorac & Cardiovasc Surg, E&H Klessmann Inst Cardiovasc Res & Dev, D-32545 Bad Oeynhausen, Germany; [Seidel, Thorsten] Univ Bielefeld, Fac Biol, D-33501 Bielefeld, Germany	Ruhr University Bochum; University of Bielefeld	Milting, H (corresponding author), Ruhr Univ Bochum, Heart & Diabet Ctr NRW, Clin Thorac & Cardiovasc Surg, E&H Klessmann Inst Cardiovasc Res & Dev, D-32545 Bad Oeynhausen, Germany.	hmilting@hdz-nrw.de			Actelion Pharmaceuticals (Allschwil, Switzerland); Erich and Hanna Klessmann Foundation (Gutersloh, Germany)	Actelion Pharmaceuticals (Allschwil, Switzerland); Erich and Hanna Klessmann Foundation (Gutersloh, Germany)	This work was supported by Actelion Pharmaceuticals (Allschwil, Switzerland) and the Erich and Hanna Klessmann Foundation (Gutersloh, Germany) (to F. G. and H. M.).	Bremnes T, 2000, J BIOL CHEM, V275, P17596, DOI 10.1074/jbc.M000142200; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Christophe T, 2000, J BIOL CHEM, V275, P1656, DOI 10.1074/jbc.275.3.1656; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; ELSHOURBAGY NA, 1993, J BIOL CHEM, V268, P3873; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; HAJNOCZKY G, 1994, NATURE, V370, P474, DOI 10.1038/370474a0; Hamdan FF, 2007, J BIOL CHEM, V282, P29089, DOI 10.1074/jbc.M700577200; Huang CC, 2011, J BIOL CHEM, V286, P7715, DOI 10.1074/jbc.R109.051847; Jala VR, 2005, J BIOL CHEM, V280, P4880, DOI 10.1074/jbc.M409821200; Klenk C, 2010, J BIOL CHEM, V285, P30355, DOI 10.1074/jbc.M110.114900; KONG GH, 1994, J BIOL CHEM, V269, P13084; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; Liu Q, 2008, MOL PHARMACOL, V73, P292, DOI 10.1124/mol.107.038570; Luttrell LM, 2002, J CELL SCI, V115, P455; Maestri-El Kouhen O, 2000, J BIOL CHEM, V275, P36659, DOI 10.1074/jbc.M006788200; MASAKI T, 1993, ENDOCR REV, V14, P256, DOI 10.1210/er.14.3.256; MOENCH SJ, 1994, BIOCHEMISTRY-US, V33, P5791, DOI 10.1021/bi00185a017; Morris GE, 2010, CARDIOVASC RES, V85, P424, DOI 10.1093/cvr/cvp310; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; Paasche JD, 2001, J BIOL CHEM, V276, P34041, DOI 10.1074/jbc.M103243200; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pao Christina S, 2002, Sci STKE, V2002, ppe42, DOI 10.1126/stke.2002.153.pe42; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reiner S, 2009, MOL PHARMACOL, V76, P1162, DOI 10.1124/mol.109.060467; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Richardson MD, 2003, J NEUROCHEM, V84, P854, DOI 10.1046/j.1471-4159.2003.01577.x; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SAKURAI T, 1992, TRENDS PHARMACOL SCI, V13, P103; Seibold A, 2000, MOL PHARMACOL, V58, P1162, DOI 10.1124/mol.58.5.1162; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Stannard C, 2003, BIOCHEMISTRY-US, V42, P13909, DOI 10.1021/bi0354132; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; WAGGONER WG, 1992, LIFE SCI, V51, P1869, DOI 10.1016/0024-3205(92)90038-Q; Wang JH, 2000, J CARDIOVASC PHARM, V36, pS61; Willets JM, 2003, TRENDS PHARMACOL SCI, V24, P626, DOI 10.1016/j.tips.2003.10.003; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhang LR, 1997, J BIOL CHEM, V272, P14762, DOI 10.1074/jbc.272.23.14762	47	12	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32138	32148		10.1074/jbc.M113.461566	http://dx.doi.org/10.1074/jbc.M113.461566			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24064210	hybrid, Green Published			2022-12-28	WOS:000328681700004
J	Razinia, Z; Baldassarre, M; Cantelli, G; Calderwood, DA				Razinia, Ziba; Baldassarre, Massimiliano; Cantelli, Gaia; Calderwood, David A.			ASB2 alpha, an E3 Ubiquitin Ligase Specificity Subunit, Regulates Cell Spreading and Triggers Proteasomal Degradation of Filamins by Targeting the Filamin Calponin Homology 1 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING DOMAIN; LEUKEMIA-CELLS; ALPHA-ACTININ; MUTATIONS; DIFFERENTIATION; MIGRATION; PROTEIN; DIMERIZATION; MYOPATHY; HEMATOPOIESIS	Filamins are actin-binding and cross-linking proteins that organize the actin cytoskeleton and anchor transmembrane proteins to the cytoskeleton and scaffold signaling pathways. During hematopoietic cell differentiation, transient expression of ASB2 alpha, the specificity subunit of an E3-ubiquitin ligase complex, triggers acute proteasomal degradation of filamins. This led to the proposal that ASB2 alpha regulates hematopoietic cell differentiation by modulating cell adhesion, spreading, and actin remodeling through targeted degradation of filamins. Here, we show that the calponin homology domain 1 (CH1), within the filamin A (FLNa) actin-binding domain, is the minimal fragment sufficient for ASB2 alpha-mediated degradation. Combining an in-depth flow cytometry analysis with mutagenesis of lysine residues within CH1, we find that arginine substitution at each of a cluster of three lysines (Lys-42, Lys-43, and Lys-135) renders FLNa resistant to ASB2 alpha-mediated degradation without altering ASB2 alpha binding. These lysines lie within previously predicted actin-binding sites, and the ASB2 alpha-resistant filamin mutant is defective in targeting to F-actin-rich structures in cells. However, by swapping CH1 with that of alpha-actinin1, which is resistant to ASB2 alpha-mediated degradation, we generated an ASB2 alpha-resistant chimeric FLNa with normal subcellular localization. Notably, this chimera fully rescues the impaired cell spreading induced by ASB2 alpha expression. Our data therefore reveal ubiquitin acceptor sites in FLNa and establish that ASB2 alpha-mediated effects on cell spreading are due to loss of filamins.	[Razinia, Ziba; Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Baldassarre, Massimiliano; Cantelli, Gaia; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Calderwood, David A.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Calderwood, DA (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,SHM B395C, New Haven, CT 06520 USA.	david.calderwood@yale.edu	Calderwood, David A/AAC-6954-2019; Baldassarre, Massimiliano/E-6236-2011; Baldassarre, Massimiliano/AAI-6581-2021	Calderwood, David A/0000-0002-0791-4142; Baldassarre, Massimiliano/0000-0002-2498-4767; Baldassarre, Massimiliano/0000-0002-2498-4767; Cantelli, Gaia/0000-0003-2650-6280	National Institutes of Health [RO1 GM-068600]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM-068600 (to D. A. C.). This work was also supported by an award from the American Heart Association (to Z. R.).	Baldassarre M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007830; Bello NF, 2009, CELL DEATH DIFFER, V16, P921, DOI 10.1038/cdd.2009.27; Bicknell LS, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029967; Carugo KD, 1997, NAT STRUCT BIOL, V4, P175, DOI 10.1038/nsb0397-175; Chiba N, 1997, ONCOGENE, V14, P2543, DOI 10.1038/sj.onc.1201109; Clark AR, 2009, HUM MOL GENET, V18, P4791, DOI 10.1093/hmg/ddp442; Coffman JA, 2003, CELL BIOL INT, V27, P315, DOI 10.1016/S1065-6995(03)00018-0; Connelly JT, 2008, J CELL PHYSIOL, V217, P145, DOI 10.1002/jcp.21484; Duff RM, 2011, AM J HUM GENET, V88, P729, DOI 10.1016/j.ajhg.2011.04.021; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Guibal FC, 2002, J BIOL CHEM, V277, P218, DOI 10.1074/jbc.M108476200; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157; Kley RA, 2007, BRAIN, V130, P3250, DOI 10.1093/brain/awm271; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Kohroki J, 2001, FEBS LETT, V505, P223, DOI 10.1016/S0014-5793(01)02829-0; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; Lamsoul I, 2013, BLOOD, V122, P533, DOI 10.1182/blood-2012-11-466649; Lamsoul I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043798; Lamsoul I, 2011, J BIOL CHEM, V286, P30571, DOI 10.1074/jbc.M111.220921; Lu J, 2007, HUM MOL GENET, V16, P1661, DOI 10.1093/hmg/ddm114; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; MCGOUGH A, 1994, J CELL BIOL, V126, P433, DOI 10.1083/jcb.126.2.433; Nakamura A, 2005, BIOCHEM BIOPH RES CO, V328, P838, DOI 10.1016/j.bbrc.2005.01.035; Nie L, 2011, CELL RES, V21, P754, DOI 10.1038/cr.2010.165; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Okuda T, 2001, INT J HEMATOL, V74, P252, DOI 10.1007/BF02982057; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Razinia Z, 2012, ANNU REV BIOPHYS, V41, P227, DOI 10.1146/annurev-biophys-050511-102252; Razinia Z, 2011, J CELL SCI, V124, P2631, DOI 10.1242/jcs.084343; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; Ruskamo S, 2009, ACTA CRYSTALLOGR D, V65, P1217, DOI 10.1107/S0907444909037330; Sarkisian MR, 2008, TRENDS NEUROSCI, V31, P54, DOI 10.1016/j.tins.2007.11.009; Sawyer GM, 2009, J MOL BIOL, V390, P1030, DOI 10.1016/j.jmb.2009.06.009; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959; Wang JY, 2012, BLOOD, V119, P1151, DOI 10.1182/blood-2011-06-362079; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; WINDER SJ, 1995, J CELL SCI, V108, P63; Wu W, 2011, J BIOL CHEM, V286, P41153, DOI 10.1074/jbc.M111.273755; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005; Zheng L, 2007, J CELL BIOL, V178, P121, DOI 10.1083/jcb.200703113; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; Zhou X, 2007, TRENDS CARDIOVAS MED, V17, P222, DOI 10.1016/j.tcm.2007.08.001	52	14	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					32093	32105		10.1074/jbc.M113.496604	http://dx.doi.org/10.1074/jbc.M113.496604			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052262	Green Published, hybrid			2022-12-28	WOS:000330596200059
J	Wakabayashi, H; Fay, PJ				Wakabayashi, Hironao; Fay, Philip J.			Replacing the Factor VIII C1 Domain with a Second C2 Domain Reduces Factor VIII Stability and Affinity for Factor IXa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-PROTEIN-C; WILLEBRAND FACTOR-BINDING; RESONANCE ENERGY-TRANSFER; COFACTOR ACTIVITY; MEMBRANE-BINDING; LIGHT-CHAIN; PHOSPHOLIPID-BINDING; BLOOD-COAGULATION; CHARGED RESIDUES; INTERACTIVE SITE	Factor VIII (FVIII) consists of a heavy chain (A1(a1)A2(a2)B domains) and light chain ((a3)A3C1C2 domains). To gain insights into a role of the FVIII C domains, we eliminated the C1 domain by replacing it with the homologous C2 domain. FVIII stability of the mutant (FVIIIC2C2) as measured by thermal decay at 55 degrees C of FVIII activity was markedly reduced (similar to 11-fold), whereas the decay rate of FVIIIa due to A2 subunit dissociation was similar to WT FVIIIa. The binding affinity of FVIIIC2C2 for phospholipid membranes as measured by fluorescence resonance energy transfer was modestly lower (similar to 2.8-fold) than that for WT FVIII. Among several anti-FVIII antibodies tested (anti-C1 (GMA8011), anti-C2 (ESH4 and ESH8), and anti-A3 (2D2) antibody), only ESH4 inhibited membrane binding of both WT FVIII and FVIIIC2C2. FVIIIa cofactor activity measured in the presence of each of the above antibodies was examined by FXa generation assays. The activity of WT FVIIIa was inhibited by both GMA8011 and ESH4, whereas the activity of FVIIIC2C2 was inhibited by both the anti-C2 antibodies, ESH4 and ESH8. Interestingly, factor IXa (FIXa) binding affinity for WT FVIIIa was significantly reduced in the presence of GMA8011 (similar to 10-fold), whereas the anti-C2 antibodies reduced FIXa binding affinity of FVIIIC2C2 variant (similar to 4-fold). Together, the reduced stability plus impaired FIXa interaction of FVIIIC2C2 suggest that the C1 domain resides in close proximity to FIXa in the FXase complex and contributes a critical role to FVIII structure and function.	[Wakabayashi, Hironao; Fay, Philip J.] Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), Univ Rochester, Dept Biochem & Biophys, POB 712,601 Elmwood Ave, Rochester, NY 14642 USA.	philip_fay@urmc.rochester.edu			National Institutes of Health [HL38199]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL38199 (to P. J. F.).	Ahmad SS, 2005, BIOCHEMISTRY-US, V44, P13858, DOI 10.1021/bi0511033; Albert T, 2008, THROMB HAEMOSTASIS, V99, P634, DOI 10.1160/TH07-06-0400; Ansong C, 2006, BIOCHEMISTRY-US, V45, P13140, DOI 10.1021/bi061202w; DeAngelis JP, 2012, J BIOL CHEM, V287, P15409, DOI 10.1074/jbc.M111.333948; Doering CB, 2002, THROMB HAEMOSTASIS, V88, P450; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; GILBERT GE, 1993, BIOCHEMISTRY-US, V32, P9577, DOI 10.1021/bi00088a009; Gilbert GE, 1996, J BIOL CHEM, V271, P11120, DOI 10.1074/jbc.271.19.11120; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; Griffiths AE, 2013, J BIOL CHEM, V288, P15057, DOI 10.1074/jbc.M113.456467; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; Lewis DA, 2003, THROMB HAEMOSTASIS, V89, P795, DOI 10.1055/s-0037-1613464; Liu Z, 2010, J BIOL CHEM, V285, P8824, DOI 10.1074/jbc.M109.080168; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; Lu JH, 2011, BLOOD, V117, P3181, DOI 10.1182/blood-2010-08-301663; Matsumoto T, 2012, THROMB HAEMOSTASIS, V107, P288, DOI 10.1160/TH11-05-0331; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Novakovic VA, 2011, BIOCHEM J, V435, P187, DOI 10.1042/BJ20101797; OVER J, 1984, SCAND J HAEMATOL, V33, P13; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; SCANDELLA D, 1995, BLOOD, V86, P1811, DOI 10.1182/blood.V86.5.1811.bloodjournal8651811; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Takeyama M, 2013, THROMB HAEMOSTASIS, V109, P187, DOI 10.1160/TH12-08-0561; Varfaj F, 2006, BIOCHEM J, V396, P355, DOI 10.1042/BJ20060117; Wakabayashi H, 2005, BIOCHEMISTRY-US, V44, P10298, DOI 10.1021/bi050638t; Wakabayashi H, 2001, BIOCHEMISTRY-US, V40, P10293, DOI 10.1021/bi010353q; Wakabayashi H, 2004, J BIOL CHEM, V279, P12677, DOI 10.1074/jbc.M311042200; Wakabayashi H, 2002, BIOCHEMISTRY-US, V41, P8485, DOI 10.1021/bi025589o; Wakabayashi H, 2009, J THROMB HAEMOST, V7, P438, DOI 10.1111/j.1538-7836.2008.03256.x; Wakabayashi H, 2008, BLOOD, V112, P2761, DOI 10.1182/blood-2008-02-142158; Wakabayashi H, 2008, J BIOL CHEM, V283, P11645, DOI 10.1074/jbc.M710252200; Wakabayashi H, 2013, BIOCHEMISTRY-US, V52, P3921, DOI 10.1021/bi400295x; Wakabayashi H, 2013, BIOCHEM J, V452, P293, DOI 10.1042/BJ20130025; Wakabayashi H, 2011, J BIOL CHEM, V286, P25748, DOI 10.1074/jbc.M111.241109; Wakabayashi H, 2010, J BIOL CHEM, V285, P25176, DOI 10.1074/jbc.M110.106906; Yegneswaran S, 1997, J BIOL CHEM, V272, P25013, DOI 10.1074/jbc.272.40.25013	37	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31289	31297		10.1074/jbc.M113.497289	http://dx.doi.org/10.1074/jbc.M113.497289			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24030831	Green Published, hybrid			2022-12-28	WOS:000330778900045
J	Hsieh, YC; Chen, MC; Hsu, CC; Chan, SI; Yang, YS; Chen, CJ				Hsieh, Yin-Cheng; Chen, Mei-Chun; Hsu, Ching-Chen; Chan, Sunney I.; Yang, Yuh-Shyong; Chen, Chun-Jung			Crystal Structures of Vertebrate Dihydropyrimidinase and Complexes from Tetraodon nigroviridis with Lysine Carbamylation METAL AND STRUCTURAL REQUIREMENTS FOR POST-TRANSLATIONAL MODIFICATION AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Crystallography; Metalloenzymes; Post-translational Modification; Protein Carboxylation; Protein Complexes	D-HYDANTOINASE; ESCHERICHIA-COLI; BETA-LACTAMASES; POSTTRANSLATIONAL MODIFICATIONS; AMIDOHYDROLASE SUPERFAMILY; SUBSTRATE-SPECIFICITY; PYRUVATE-CARBOXYLASE; CATALYTIC MECHANISM; MOLECULAR-STRUCTURE; PROTEIN	Lysine carbamylation, a post-translational modification, facilitates metal coordination for specific enzymatic activities. We have determined structures of the vertebrate dihydropyrimidinase from Tetraodon nigroviridis (TnDhp) in various states: the apoenzyme as well as two forms of the holoenzyme with one and two metals at the catalytic site. The essential active-site structural requirements have been identified for the possible existence of four metal-mediated stages of lysine carbamylation. Only one metal is sufficient for stabilizing lysine carbamylation; however, the post-translational lysine carbamylation facilitates additional metal coordination for the regulation of specific enzymatic activities through controlling the conformations of two dynamic loops, Ala(69)-Arg(74) and Met(158)-Met(165), located in the tunnel for the substrate entrance. The substrate/product tunnel is in the open form in the apo-TnDhp, in the intermediate state in the monometal TnDhp, and in the closed form in the dimetal TnDhp structure, respectively. Structural comparison also suggests that the C-terminal tail plays a role in the enzymatic function through interactions with the Ala(69)-Arg(74) dynamic loop. In addition, the structures of the dimetal TnDhp in complexes with hydantoin, N-carbamyl--alanine, and N-carbamyl--amino isobutyrate as well as apo-TnDhp in complex with a product analog, N-(2-acetamido)-iminodiacetic acid, have been determined. These structural results illustrate how a protein exploits unique lysines and the metal distribution to accomplish lysine carbamylation as well as subsequent enzymatic functions.	[Hsieh, Yin-Cheng; Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Sci Res Div, Life Sci Grp, Hsinchu 30076, Taiwan; [Chen, Mei-Chun; Hsu, Ching-Chen; Yang, Yuh-Shyong] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30010, Taiwan; [Chan, Sunney I.] Acad Sinica, Inst Chem, Taipei 11529, Taiwan; [Chan, Sunney I.] CALTECH, Div Chem & Chem Engn, Pasadena, CA USA; [Chen, Chun-Jung] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30043, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan 701, Taiwan	National Synchrotron Radiation Research Center; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; California Institute of Technology; National Tsing Hua University; National Cheng Kung University; National Cheng Kung University	Yang, YS (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30010, Taiwan.	ysyang@mail.nctu.edu.tw; cjchen@nsrrc.org.tw	Chen, Chun-Jung/A-6880-2011; Yang, Yuh-Shyong/L-7401-2019	Chen, Chun-Jung/0000-0002-5157-4288; Yang, Yuh-Shyong/0000-0003-0177-473X	National Science Council (NSC) [NSC 98-2311-B-213-MY3, NSC 101-2628-B-213-MY4]; National Synchrotron Radiation Center [1003RSB02, 1013RSB02]; NSC [NSC 99-2311-B-009-004-MY3]; Aiming for the Top University and Elite Research Center Development Plan of Ministry of Education (MOE-ATU Plan)	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Synchrotron Radiation Center; NSC(Ministry of Science and Technology, Taiwan); Aiming for the Top University and Elite Research Center Development Plan of Ministry of Education (MOE-ATU Plan)	This work was supported in part by National Science Council (NSC) Grants NSC 98-2311-B-213-MY3 and NSC 101-2628-B-213-MY4 and National Synchrotron Radiation Center Grants 1003RSB02 and 1013RSB02 (to C. J. C.) and NSC Grant NSC 99-2311-B-009-004-MY3 and the Aiming for the Top University and Elite Research Center Development Plan of Ministry of Education (MOE-ATU Plan) (to Y. S. Y.).	Altenbuchner J, 2001, CURR OPIN BIOTECH, V12, P559, DOI 10.1016/S0958-1669(01)00263-4; An Woojin, 2007, Subcell Biochem, V41, P351; BENNING MM, 1995, BIOCHEMISTRY-US, V34, P7973, DOI 10.1021/bi00025a002; BROOKS KP, 1983, ARCH BIOCHEM BIOPHYS, V226, P469, DOI 10.1016/0003-9861(83)90316-8; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bush K, 1998, ADV EXP MED BIOL, V456, P71; Bush K, 2001, CLIN INFECT DIS, V32, P1085, DOI 10.1086/319610; Che T, 2012, J AM CHEM SOC, V134, P11206, DOI 10.1021/ja303168n; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheon YH, 2004, BIOCHEMISTRY-US, V43, P7413, DOI 10.1021/bi036330o; Cheon YH, 2002, BIOCHEMISTRY-US, V41, P9410, DOI 10.1021/bi0201567; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewing S. P., 1980, J AM CHEM SOC, V102, P3071; Gaucher SP, 2008, J PROTEOME RES, V7, P2320, DOI 10.1021/pr700772s; Gojkovic Z, 2003, NUCLEIC ACIDS RES, V31, P1683, DOI 10.1093/nar/gkg258; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Ha NC, 2001, NAT STRUCT BIOL, V8, P505, DOI 10.1038/88563; Hall PR, 2004, EMBO J, V23, P3621, DOI 10.1038/sj.emboj.7600373; Huang CY, 2009, J BIOL INORG CHEM, V14, P111, DOI 10.1007/s00775-008-0428-x; Huq MDM, 2009, J PROTEOME RES, V8, P1156, DOI 10.1021/pr800569c; JAHNKE K, 1993, BIOCHEMISTRY-US, V32, P5160, DOI 10.1021/bi00070a027; KAUTZ J, 1989, EUR J BIOCHEM, V181, P431, DOI 10.1111/j.1432-1033.1989.tb14743.x; KIKUGAWA M, 1994, EUR J BIOCHEM, V219, P393, DOI 10.1111/j.1432-1033.1994.tb19951.x; Kim GJ, 1998, BIOCHEM BIOPH RES CO, V243, P96, DOI 10.1006/bbrc.1997.8037; Kim K, 2009, J MOL BIOL, V387, P1067, DOI 10.1016/j.jmb.2009.02.041; Kishan KVR, 2005, J MOL BIOL, V347, P95, DOI 10.1016/j.jmb.2005.01.025; Kotra L P., 2002, BACTERIAL RESISTANCE, P123; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lee M, 2007, BIOCHEMISTRY-US, V46, P10538, DOI 10.1021/bi701098e; Liaw SH, 2003, J BIOL CHEM, V278, P4957, DOI 10.1074/jbc.M210795200; Lohkamp B, 2006, J BIOL CHEM, V281, P13762, DOI 10.1074/jbc.M513266200; LORIMER GH, 1983, TRENDS BIOCHEM SCI, V8, P65, DOI 10.1016/0968-0004(83)90393-6; Martinez-Rodriguez S, 2010, J STRUCT BIOL, V169, P200, DOI 10.1016/j.jsb.2009.10.013; Martinez-Rodriguez S, 2009, BIOPHYS CHEM, V139, P42, DOI 10.1016/j.bpc.2008.10.003; Niu LX, 2007, BIOTECHNOL LETT, V29, P303, DOI 10.1007/s10529-006-9238-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Su TM, 2000, PROTEIN EXPRES PURIF, V19, P289, DOI 10.1006/prep.2000.1250; Syldatk C, 1999, APPL MICROBIOL BIOT, V51, P293, DOI 10.1007/s002530051395; Taylor TC, 2001, J BIOL CHEM, V276, P48159, DOI 10.1074/jbc.M107765200; Thoden JB, 2001, BIOCHEMISTRY-US, V40, P6989, DOI 10.1021/bi010682i; Vagin J., 1997, J APPL CRYSTALLOGR, V30, P1022; van Kuilenburg ABP, 2010, BBA-MOL BASIS DIS, V1802, P639, DOI 10.1016/j.bbadis.2010.03.013; WALLACH DP, 1957, J BIOL CHEM, V226, P277; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang D., 2009, GENEREVIEWS; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xiang DF, 2009, BIOCHEMISTRY-US, V48, P3730, DOI 10.1021/bi900111q; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q; Zhang XY, 2008, APPL BIOCHEM BIOTECH, V144, P237, DOI 10.1007/s12010-007-8004-3	55	21	22	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30645	30658		10.1074/jbc.M113.496778	http://dx.doi.org/10.1074/jbc.M113.496778			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24005677	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000329868100065
J	Wu, CY; Martel, J; Cheng, WY; He, CC; Ojcius, DM; Young, JD				Wu, Cheng-Yeu; Martel, Jan; Cheng, Wei-Yun; He, Chao-Chih; Ojcius, David M.; Young, John D.			Membrane Vesicles Nucleate Mineralo-organic Nanoparticles and Induce Carbonate Apatite Precipitation in Human Body Fluids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atherosclerosis; Biomineralization; Calcification; Calcium; Phosphatidylserine; Ectopic Calcification; Membrane Vesicles; Nanobacteria	AMORPHOUS CALCIUM-CARBONATE; FETUIN-A; IN-VITRO; HUMAN BLOOD; NANOBACTERIA; PROTEIN; SERUM; HYDROXYAPATITE; PHOSPHATE; PHOSPHATIDYLSERINE	Recent studies indicate that membrane vesicles (MVs) secreted by various cells are associated with human diseases, including arthritis, atherosclerosis, cancer, and chronic kidney disease. The possibility that MVs may induce the formation of mineralo-organic nanoparticles (NPs) and ectopic calcification has not been investigated so far. Here, we isolated MVs ranging in size between 20 and 400 nm from human serum and FBS using ultracentrifugation and sucrose gradient centrifugation. The MV preparations consisted of phospholipid-bound vesicles containing the serum proteins albumin, fetuin-A, and apolipoprotein A1; the mineralization-associated enzyme alkaline phosphatase; and the exosome proteins TNFR1 and CD63. Notably, we observed that MVs induced mineral precipitation following inoculation and incubation in cell culture medium. The mineral precipitates consisted of round, mineralo-organic NPs containing carbonate hydroxyapatite, similar to previous descriptions of the so-called nanobacteria. Annexin V-immunogold staining revealed that the calcium-binding lipid phosphatidylserine (PS) was exposed on the external surface of serum MVs. Treatment of MVs with an anti-PS antibody significantly decreased their mineral seeding activity, suggesting that PS may provide nucleating sites for calcium phosphate deposition on the vesicles. These results indicate that MVs may represent nucleating agents that induce the formation of mineral NPs in body fluids. Given that mineralo-organic NPs represent precursors of calcification in vivo, our results suggest that MVs may initiate ectopic calcification in the human body.	[Wu, Cheng-Yeu; Martel, Jan; Cheng, Wei-Yun; He, Chao-Chih; Young, John D.] Chang Gung Univ, Lab Nanomat, Tao Yuan 333, Taiwan; [Wu, Cheng-Yeu; Martel, Jan; Cheng, Wei-Yun; He, Chao-Chih; Ojcius, David M.; Young, John D.] Chang Gung Univ, Ctr Mol & Clin Immunol, Tao Yuan 333, Taiwan; [Wu, Cheng-Yeu] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Tao Yuan 333, Taiwan; [Ojcius, David M.] Univ Calif, Hlth Sci Res Inst, Merced, CA 95343 USA; [Young, John D.] Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA; [Young, John D.] Ming Chi Univ Technol, Biochem Engn Res Ctr, Taipei 24301, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; University of California System; University of California Merced; Rockefeller University; Ming Chi University of Technology	Young, JD (corresponding author), Chang Gung Univ, Lab Nanomat, Tao Yuan 333, Taiwan.	dingeyoung@hotmail.com	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495; Martel, Jan/0000-0003-0879-109X	Primordia Institute of New Sciences and Medicine and Chang Gung University [QZRPD88E]; Ming Chi University of Technology [0XB0]; Ministry of Education of Taiwan, Republic of China [EMRPD1B0471]; National Science Council of Taiwan [101-2632-B-182-001-MY3]	Primordia Institute of New Sciences and Medicine and Chang Gung University; Ming Chi University of Technology; Ministry of Education of Taiwan, Republic of China(Ministry of Education, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Primordia Institute of New Sciences and Medicine and Chang Gung University Grant QZRPD88E; Ming Chi University of Technology Grant 0XB0; Ministry of Education of Taiwan, Republic of China, Grant EMRPD1B0471; and National Science Council of Taiwan Grant 101-2632-B-182-001-MY3.	Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Aizenberg J, 1996, ADV MATER, V8, P222, DOI 10.1002/adma.19960080307; Anderson HC, 2010, LAB INVEST, V90, P1549, DOI 10.1038/labinvest.2010.152; Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576; Ayman A, 2008, EUR PHYS J-SPEC TOP, V153, P497, DOI 10.1140/epjst/e2008-00493-5; Barr SC, 2003, AM J VET RES, V64, P176, DOI 10.2460/ajvr.2003.64.176; Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C; Barrere F, 2006, INT J NANOMED, V1, P317; Bonucci E, 2002, J BONE MINER METAB, V20, P249, DOI 10.1007/s007740200037; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994; Chen CW, 2004, J MATER CHEM, V14, P2425, DOI 10.1039/b315095j; Chen JY, 2009, J APPL TOXICOL, V29, P330, DOI 10.1002/jat.1414; Ciftcioglu N, 2006, J INVEST MED, V54, P385, DOI 10.2310/6650.2006.06018; Cisar JO, 2000, P NATL ACAD SCI USA, V97, P11511, DOI 10.1073/pnas.97.21.11511; Daniel L, 2008, NEPHROL DIAL TRANSPL, V23, P2129, DOI 10.1093/ndt/gfn029; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Donaldson K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-5; Drancourt M, 2003, J CLIN MICROBIOL, V41, P368, DOI 10.1128/JCM.41.1.368-372.2003; Evan AP, 2010, PEDIATR NEPHROL, V25, P831, DOI 10.1007/s00467-009-1116-y; Evan AP, 2005, KIDNEY INT, V68, P145, DOI 10.1111/j.1523-1755.2005.00388.x; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Garimella Rama, 2004, Biol Proced Online, V6, P263, DOI 10.1251/bpo97; GIROTTI AW, 1984, BIOCHEM BIOPH RES CO, V118, P474, DOI 10.1016/0006-291X(84)91327-5; Golub EE., 2007, CURR OPIN ORTHOP, V18, P444, DOI [10.1097/BCO.0b013e3282630851, 10.1084/jem.93.5.415, DOI 10.1084/JEM.93.5.415]; Golub EE, 2011, SEMIN IMMUNOPATHOL, V33, P409, DOI 10.1007/s00281-010-0230-z; Golub EE, 2009, BBA-GEN SUBJECTS, V1790, P1592, DOI 10.1016/j.bbagen.2009.09.006; Grandjean-Laquerriere A, 2005, BIOMATERIALS, V26, P2361, DOI 10.1016/j.biomaterials.2004.07.036; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Hess D. J., 1997, CAN BACTERIA CAUSE C, P7; Hohling H J, 1997, Adv Dent Res, V11, P462; HUBER R, 1990, FEBS LETT, V275, P15, DOI 10.1016/0014-5793(90)81428-Q; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Hunter LW, 2011, ACTA BIOMATER, V7, P1339, DOI 10.1016/j.actbio.2010.10.027; Jahnen-Dechent W., 2005, BIOMINERALISATION, P243; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; Kajander EO, 1997, P SOC PHOTO-OPT INS, V3111, P420, DOI 10.1117/12.278796; Kajander EO, 2003, UROL RES, V31, P47, DOI 10.1007/s002440-003-0304-7; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Kajander EO, 2001, CURR OPIN NEPHROL HY, V10, P445, DOI 10.1097/00041552-200105000-00023; Kajander EO, 1999, PROC SPIE, V3755, P106, DOI 10.1117/12.375068; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kim BYS, 2010, NEW ENGL J MED, V363, P2434, DOI 10.1056/NEJMra0912273; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Mahamid J, 2010, P NATL ACAD SCI USA, V107, P6316, DOI 10.1073/pnas.0914218107; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; Martel J, 2012, ANNU REV EARTH PL SC, V40, P167, DOI 10.1146/annurev-earth-042711-105401; Martel J, 2011, ANAL BIOCHEM, V418, P111, DOI 10.1016/j.ab.2011.06.018; Martel J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010343; Matsui I, 2009, KIDNEY INT, V75, P915, DOI 10.1038/ki.2008.700; McLaughlin RW, 2002, J CLIN MICROBIOL, V40, P4771, DOI 10.1128/JCM.40.12.4771-4775.2002; Merolli A, 2009, MOLECULES, V14, P5367, DOI 10.3390/molecules14125367; Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2; Nadra I, 2008, ATHEROSCLEROSIS, V196, P98, DOI 10.1016/j.atherosclerosis.2007.02.005; Nieuwland R, 2010, THROMB RES, V125, pS49, DOI 10.1016/j.thromres.2010.01.037; Nomura S, 2008, THROMB RES, V123, P8, DOI 10.1016/j.thromres.2008.06.006; Peng HH, 2013, SMALL, V9, P2297, DOI 10.1002/smll.201202270; Peng HH, 2011, NANOMEDICINE-UK, V6, P643, DOI [10.2217/nnm.11.24, 10.2217/NNM.11.24]; Price PA, 2002, J BIOL CHEM, V277, P3926, DOI 10.1074/jbc.M106366200; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Raz S, 2002, BIOL BULL-US, V203, P269, DOI 10.2307/1543569; Robinson C, 2004, J MATER CHEM, V14, P2242, DOI 10.1039/b401154f; Samoylov AM, 2005, CELLS TISSUES ORGANS, V179, P115, DOI 10.1159/000085003; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schlieper G, 2010, J AM SOC NEPHROL, V21, P689, DOI 10.1681/ASN.2009080829; Shanahan CM, 2007, CIRCULATION, V116, P2782, DOI 10.1161/CIRCULATIONAHA.107.749655; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Vali H, 2001, GEOCHIM COSMOCHIM AC, V65, P63, DOI 10.1016/S0016-7037(00)00525-1; Vallet-Regi M, 2000, CHEM MATER, V12, P961, DOI 10.1021/cm991110b; Wainwright Milton, 2010, Science Progress, V93, P393, DOI 10.3184/003685010X12871628232041; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008058; Young J, 2009, BRIT J CRIMINOL, V49, P4, DOI 10.1093/bjc/azn074; Young JD, 2010, SCI AM, V302, P52, DOI 10.1038/scientificamerican0110-52; Young JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004417; Yuana Y, 2011, THROMB HAEMOSTASIS, V105, P396, DOI 10.1160/TH10-09-0595; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	87	27	27	0	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30571	30584		10.1074/jbc.M113.492157	http://dx.doi.org/10.1074/jbc.M113.492157			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23990473	hybrid, Green Published			2022-12-28	WOS:000329868100058
J	Cheng, XW; Guo, S; Liu, Y; Chu, H; Hakimi, P; Berger, NA; Hanson, RW; Kao, HY				Cheng, Xiwen; Guo, Shuang; Liu, Yu; Chu, Hao; Hakimi, Parvin; Berger, Nathan A.; Hanson, Richard W.; Kao, Hung-Ying			Ablation of Promyelocytic Leukemia Protein (PML) Re-patterns Energy Balance and Protects Mice from Obesity Induced by a Western Diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; ALPHA TNF-ALPHA; INSULIN-RESISTANCE; SKELETAL-MUSCLE; NUCLEAR-BODIES; RAR-ALPHA; METABOLISM; TRANSLOCATION; TRANSCRIPTION; SUMOYLATION	The promyelocytic leukemia protein is a well known tumor suppressor, but its role in metabolism is largely unknown. Mice with a deletion in the gene for PML (KO mice) exhibit altered gene expression in liver, adipose tissue, and skeletal muscle, an accelerated rate of fatty acid metabolism, abnormal glucose metabolism, constitutive AMP-activating kinase (AMPK) activation, and insulin resistance in skeletal muscle. Last, an increased rate of energy expenditure protects PML KO mice from the effects of obesity induced by a Western diet. Collectively, our study uncovers a previously unappreciated role of PML in the regulation of metabolism and energy balance in mice.	[Cheng, Xiwen; Guo, Shuang; Liu, Yu; Hakimi, Parvin; Hanson, Richard W.; Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Berger, Nathan A.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Chu, Hao] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Kao, HY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	hxk43@cwru.edu	Hakimi, Parvin/AAB-1643-2021; Cheng, Xiwen/B-8385-2014	Cheng, Xiwen/0000-0001-7398-1522	National Institutes of Health [HL093269, DK078965, P20 CA103736, U54 CA116867]; Ellison Foundation [AG-SS-2420-10]; NATIONAL CANCER INSTITUTE [P20CA103736, U54CA116867] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093269 and DK078965 (to H.-Y. K.) and P20 CA103736 and U54 CA116867 (Case Comprehensive Cancer Center Program in Aging and Energy Balance, NCI; to N. A. B.). This work was also supported by The Ellison Foundation Senior Scholars Award AG-SS-2420-10 (to R. W. H.).	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; BALLARD FJ, 1969, BIOCHEM J, V112, P195, DOI 10.1042/bj1120195; Blagih J, 2012, IMMUNOL REV, V249, P59, DOI 10.1111/j.1600-065X.2012.01157.x; Buchner DA, 2008, PHYSIOL GENOMICS, V35, P116, DOI 10.1152/physiolgenomics.00033.2008; Carracedo A, 2012, J CLIN INVEST, V122, P3088, DOI 10.1172/JCI62129; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Cheng Xiwen, 2012, Front Oncol, V2, P210, DOI 10.3389/fonc.2012.00210; Cheng XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-453; Cheng XW, 2012, J BIOL CHEM, V287, P23356, DOI 10.1074/jbc.M112.340505; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Gao CZ, 2008, MOL BIOL CELL, V19, P3020, DOI 10.1091/mbc.E07-11-1203; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; HimmsHagen J, 1997, SCIENCE, V276, P1132, DOI 10.1126/science.276.5315.1132; Hoover-Plow Jane, 2006, BMC Blood Disord, V6, P6, DOI 10.1186/1471-2326-6-6; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kim MK, 2011, AM J PHYSIOL-ENDOC M, V301, pE1130, DOI 10.1152/ajpendo.00092.2011; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kokkotou E, 2005, AM J PHYSIOL-REG I, V289, pR117, DOI 10.1152/ajpregu.00861.2004; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lim JH, 2011, J BIOL CHEM, V286, P44403, DOI 10.1074/jbc.M111.289512; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; McCabe BJ, 2006, ANAL BIOCHEM, V350, P171, DOI 10.1016/j.ab.2006.01.020; McCabe BJ, 2004, METAB ENG, V6, P25, DOI 10.1016/j.ymben.2003.09.003; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Muratani M, 2002, NAT CELL BIOL, V4, P106, DOI 10.1038/ncb740; Nadeau JH, 2005, NEW ENGL J MED, V352, P1598, DOI 10.1056/NEJMe058054; RANDLE PJ, 1963, LANCET, V1, P785; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Reineke EL, 2009, INT J BIOL SCI, V5, P366; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Westerterp Klaas R., 1993, American Journal of Clinical Nutrition, V57, p759S, DOI 10.1093/ajcn/57.5.759S; Wu WS, 2003, J BIOL CHEM, V278, P12294, DOI 10.1074/jbc.M211849200; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	50	21	21	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29746	29759		10.1074/jbc.M113.487595	http://dx.doi.org/10.1074/jbc.M113.487595			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23986437	Green Published, hybrid			2022-12-28	WOS:000330615300050
J	Pan, WW; Zhou, JJ; Yu, C; Xu, Y; Guo, LJ; Zhang, HY; Zhou, DW; Song, FZ; Fan, HY				Pan, Wei-Wei; Zhou, Jian-Jie; Yu, Chao; Xu, Ying; Guo, Lian-Jun; Zhang, Hai-Yi; Zhou, Dawang; Song, Fang-Zhou; Fan, Heng-Yu			Ubiquitin E3 Ligase CRL4(CDT2/DCAF2) as a Potential Chemotherapeutic Target for Ovarian Surface Epithelial Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MLN4924 INDUCES AUTOPHAGY; CULLIN-RING LIGASES; NEDD8-ACTIVATING ENZYME; CELLS; INHIBITOR; DDB1; REPLICATION; INDUCTION; APOPTOSIS; DELETION	Cullin-RING ubiquitin ligases (CRLs) are the largest family of E3 ligases and require cullin neddylation for their activation. The NEDD8-activating enzyme inhibitor MLN4924 reportedly blocked cullin neddylation and inactivated CRLs, which resulted in apoptosis induction and tumor suppression. However, CRL roles in ovarian cancer cell survival and the ovarian tumor repressing effects of MLN4924 are unknown. We show here that CRL4 components are highly expressed in human epithelial ovarian cancer tissues. MLN4924-induced DNA damage, cell cycle arrest, and apoptosis in ovarian cancer cells in a time- and dose-dependent manner. In addition, MLN4924 sensitized ovarian cancer cells to other chemotherapeutic drug treatments. Depletion of CRL4 components Roc1/2, Cul4a, and DDB1 had inhibitory effects on ovarian cancer cells similar to MLN4924 treatment, which suggested that CRL4 inhibition contributed to the chemotherapeutic effect of MLN4924 in ovarian cancers. We also investigated for key CRL4 substrate adaptors required for ovarian cancer cells. Depleting Vprbp/Dcaf1 did not significantly affect ovarian cancer cell growth, even though it was expressed by ovarian cancer tissues. However, depleting Cdt2/Dcaf2 mimicked the pharmacological effects of MLN4924 and caused the accumulation of its substrate, CDT1, both in vitro and in vivo. MLN4924-induced DNA damage and apoptosis were partially rescued by Cdt1 depletion, suggesting that CRL4(CDT2) repression and CDT1 accumulation were key biochemical events contributing to the genotoxic effects of MLN4924 in ovarian cancer cells. Taken together, these results indicate that CRL4CDT2 is a potential drug target in ovarian cancers and that MLN4924 may be an effective anticancer agent for targeted ovarian cancer therapy.	[Pan, Wei-Wei; Yu, Chao; Zhang, Hai-Yi; Fan, Heng-Yu] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Pan, Wei-Wei; Song, Fang-Zhou] Chongqing Med Univ, Mol Med & Canc Res Ctr, Chongqing 400016, Peoples R China; [Zhou, Jian-Jie; Zhou, Dawang] Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen 361102, Peoples R China; [Pan, Wei-Wei; Xu, Ying; Guo, Lian-Jun] Jiaxing Univ, Sch Med, Jiaxing 314001, Peoples R China	Zhejiang University; Chongqing Medical University; Xiamen University; Jiaxing University	Song, FZ (corresponding author), Chongqing Med Univ, Mol Med & Canc Res Ctr, Chongqing 400016, Peoples R China.	fzsongcq@163.com; hyfan@zju.edu.cn	Xu, Ying/A-3009-2013; Xu, Ying/AAF-3081-2019	Xu, Ying/0000-0002-6689-7768; Xu, Ying/0000-0002-6689-7768; Zhou, Dawang/0000-0002-9053-5249	National Basic Research Program of China [2011CB944504, 2012CB944403]; National Natural Science Foundation of China [81172473]; Zhejiang University [2011QN81001]; Natural Science Foundation of Zhejiang Province [LQ13H160020]; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University [SKLCSB2013KF001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang University; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University	This work was supported by National Basic Research Program of China Grants 2011CB944504 and 2012CB944403, National Natural Science Foundation of China Grant 81172473, Basic Scientific Research Funding of Zhejiang University Grant 2011QN81001 (to H. Y. F.), and Natural Science Foundation of Zhejiang Province Grant LQ13H160020 (to W. W. P.). This project was also supported by the Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University Grant SKLCSB2013KF001.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2004, ONCOGENE, V23, P6997, DOI 10.1038/sj.onc.1207925; Ali AY, 2012, ONCOGENE, V31, P2175, DOI 10.1038/onc.2011.399; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Endo Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031846; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jia L, 2011, CURR CANCER DRUG TAR, V11, P347, DOI 10.2174/156800911794519734; Jia LJ, 2011, NEOPLASIA, V13, P561, DOI 10.1593/neo.11420; Jia LJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-16; Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671; Kim Y, 2007, MOL CELL BIOL, V27, P1394, DOI 10.1128/MCB.00736-06; Kopanja D, 2011, DEV BIOL, V352, P278, DOI 10.1016/j.ydbio.2011.01.028; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Liu LR, 2012, CELL RES, V22, P1258, DOI 10.1038/cr.2012.48; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Luo ZG, 2012, AUTOPHAGY, V8, P1677, DOI 10.4161/auto.21484; Luo ZG, 2012, CANCER RES, V72, P3360, DOI 10.1158/0008-5472.CAN-12-0388; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; McCall CM, 2008, MOL CELL BIOL, V28, P5621, DOI 10.1128/MCB.00232-08; Mullany LK, 2011, ONCOGENE, V30, P3522, DOI 10.1038/onc.2011.70; Mullany LK, 2012, ENDOCRINOLOGY, V153, P1638, DOI 10.1210/en.2011-2131; Mullany LK, 2012, ENDOCRINOLOGY, V153, P1585, DOI 10.1210/en.2011-2121; Pines A, 2009, DNA REPAIR, V8, P153, DOI 10.1016/j.dnarep.2008.09.011; Richards JS, 2012, ONCOGENE, V31, P1504, DOI 10.1038/onc.2011.341; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Wei DP, 2012, TRANSL ONCOL, V5, P305, DOI 10.1593/tlo.12229; Xu H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001132; Yamaji S, 2010, P NATL ACAD SCI USA, V107, P22237, DOI 10.1073/pnas.1015793108; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034079; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Yoon T, 2005, ONCOGENE, V24, P469, DOI 10.1038/sj.onc.1208211; Zhao Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.125; Zhao YC, 2013, CURR PHARM DESIGN, V19, P3215, DOI 10.2174/13816128113199990300	37	58	61	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29680	29691		10.1074/jbc.M113.495069	http://dx.doi.org/10.1074/jbc.M113.495069			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23995842	Green Published, hybrid			2022-12-28	WOS:000330615300043
J	Soysa, R; Wilson, ZN; Elferich, J; Forquer, I; Shinde, U; Riscoe, MK; Yates, PA; Ullman, B				Soysa, Radika; Wilson, Zachary N.; Elferich, Johannes; Forquer, Isaac; Shinde, Ujwal; Riscoe, Michael K.; Yates, Phillip A.; Ullman, Buddy			Substrate Inhibition of Uracil Phosphoribosyltransferase by Uracil Can Account for the Uracil Growth Sensitivity of Leishmania donovani Pyrimidine Auxotrophs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; GENE AMPLIFICATION; TRYPANOSOMA-BRUCEI; HAMSTER-CELLS; UMP SYNTHESIS; BIOSYNTHESIS; GENOME; OLIGOMERIZATION; OVERPRODUCTION; PURIFICATION	The pathogenic protozoan parasite Leishmania donovani is capable of both de novo pyrimidine biosynthesis and salvage of pyrimidines from the host milieu. Genetic analysis has authenticated L. donovani uracil phosphoribosyltransferase (LdUPRT), an enzyme not found in mammalian cells, as the focal enzyme of pyrimidine salvage because all exogenous pyrimidines that can satisfy the requirement of the parasite for pyrimidine nucleotides are funneled to uracil and then phosphoribosylated to UMP in the parasite by LdUPRT. To characterize this unique parasite enzyme, LdUPRT was expressed in Escherichia coli, and the recombinant enzyme was purified to homogeneity. Kinetic analysis revealed apparent K-m values of 20 and 99 mu M for the natural substrates uracil and phosphoribosylpyrophosphate, respectively, as well as apparent K-m values 6 and 7 mu M for the pyrimidine analogs 5-fluorouracil and 4-thiouracil, respectively. Size exclusion chromatography revealed the native LdUPRT to be tetrameric and retained partial structure and activity in high concentrations of urea. L. donovani mutants deficient in de novo pyrimidine biosynthesis, which require functional LdUPRT for growth, are hypersensitive to high concentrations of uracil, 5-fluorouracil, and 4-thiouracil in the growth medium. This hypersensitivity can be explained by the observation that LdUPRT is substrate-inhibited by uracil and 4-thiouracil, but 5-fluorouracil toxicity transpires via an alternative mechanism. This substrate inhibition of LdUPRT provides a protective mechanism for the parasite by facilitating purine and pyrimidine nucleotide pool balance and by sparing phosphoribosylpyrophosphate for consumption by the nutritionally indispensable purine salvage process.	[Soysa, Radika; Wilson, Zachary N.; Elferich, Johannes; Shinde, Ujwal; Yates, Phillip A.; Ullman, Buddy] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Forquer, Isaac; Riscoe, Michael K.] Vet Affairs Med Ctr, Expt Chemotherapy Lab, Portland, OR 97239 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ullman, B (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol L224, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	ullmanb@ohsu.edu		Wilson, Zachary/0000-0003-4269-4058; Elferich, Johannes/0000-0002-9911-706X	National Institutes of Health [AI023682]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023682, R01AI023682] Funding Source: NIH RePORTER; Direct For Biological Sciences [0746589] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grant AI023682 (to B.U.).	Ali JAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058034; Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Boitz JM, 2006, J BIOL CHEM, V281, P16084, DOI 10.1074/jbc.M600188200; Carter D, 1997, MOL BIOCHEM PARASIT, V87, P137, DOI 10.1016/S0166-6851(97)00058-3; CARTER NS, 2003, MOL MED PARASITOLOGY, P197; Cleary MD, 2005, NAT BIOTECHNOL, V23, P232, DOI 10.1038/nbt1061; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; French JB, 2011, J BIOL CHEM, V286, P20930, DOI 10.1074/jbc.M111.228213; HAMMOND DJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P1, DOI 10.1016/0304-4165(82)90002-2; Hashimoto M, 2012, BIOCHEM BIOPH RES CO, V417, P1002, DOI 10.1016/j.bbrc.2011.12.073; HASSAN HF, 1986, COMP BIOCHEM PHYS B, V84, P217, DOI 10.1016/0305-0491(86)90209-9; ILTZSCH MH, 1994, BIOCHEM PHARMACOL, V48, P781, DOI 10.1016/0006-2952(94)90057-4; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Mikus Judith, 2000, Parasitology International, V48, P265, DOI 10.1016/S1383-5769(99)00020-3; NATALINI P, 1979, J BIOL CHEM, V254, P1558; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; OPPERDOES FR, 1988, TRENDS BIOCHEM SCI, V13, P255, DOI 10.1016/0968-0004(88)90158-2; PETERS GJ, 1986, CANCER RES, V46, P20; PFEFFERKORN ER, 1977, J PROTOZOOL, V24, P449, DOI 10.1111/j.1550-7408.1977.tb04774.x; Schumacher MA, 2002, P NATL ACAD SCI USA, V99, P78, DOI 10.1073/pnas.012399599; Schumacher MA, 1998, EMBO J, V17, P3219, DOI 10.1093/emboj/17.12.3219; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; Shoemaker Laura K, 2004, Cancer Control, V11, P46; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; SUTTLE DP, 1979, J BIOL CHEM, V254, P4602; WAHL GM, 1979, J BIOL CHEM, V254, P8679; Wilson ZN, 2012, J BIOL CHEM, V287, P12759, DOI 10.1074/jbc.M112.346502; Zeiner Gusti M., 2008, V419, P135, DOI 10.1007/978-1-59745-033-1_9	31	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29954	29964		10.1074/jbc.M113.478826	http://dx.doi.org/10.1074/jbc.M113.478826			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23986453	Green Published, hybrid			2022-12-28	WOS:000330615300068
J	Lue, NF; Chan, JM				Lue, Neal F.; Chan, Jamie			Duplication and Functional Specialization of the Telomere-capping Protein Cdc13 in Candida Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromosomes; Chromosomes; Non-histone Chromosomal Proteins; DNA-Protein Interaction; Telomerase; Telomeres; CST; Cdc13; OB Fold; Dimerization	CHROMOSOME END PROTECTION; DNA-BINDING; YEAST; ALBICANS; DIMERIZATION; COMPLEX; LENGTH; CONSTRUCTION; SUBUNIT; STN1	The budding yeast G-tail binding complex CST (Cdc13-Stn1-Ten1) is crucial for both telomere protection and replication. Previous studies revealed a family of Cdc13 orthologues (Cdc13A) in Candida species that are unusually small but are nevertheless responsible for G-tail binding and the regulation of telomere lengths and structures. Here we report the identification and characterization of a second family of Cdc13-like proteins in the Candida clade, named Cdc13B. Phylogenetic analysis and sequence alignment indicate that Cdc13B probably arose through gene duplication prior to Candida speciation. Like Cdc13A, Cdc13B appears to be essential. Deleting one copy each of the CDC13A and CDC13B genes caused a synergistic effect on aberrant telomere elongation and t-circle accumulation, suggesting that the two paralogues mediate overlapping and nonredundant functions in telomere regulation. Interestingly, Cdc13B utilizes its C-terminal OB-fold domain (OB4) to mediate self-association and binding to Cdc13A. Moreover, the stability of the heterodimer is evidently greater than that of either homodimer. Both the Cdc13 A/A homodimer and A/B heterodimer, but not the B/B homodimer, recognized the telomere G-tail repeat with high affinity and sequence specificity. Our results reveal novel evolutionary elaborations of the G-tail-binding protein in Saccharomycotina yeast, suggesting a drastic remodeling of CDC13 that entails gene duplication, fusion, and functional specialization. The repeated and independent duplication of G-tail-binding proteins such as Cdc13 and Pot1 hints at the evolutionary advantage of having multiple G-tail-binding proteins.	[Lue, Neal F.; Chan, Jamie] Cornell Univ, Weill Med Coll, WR Hearst Microbiol Res Ctr, Dept Microbiol & Immunol, New York, NY 10065 USA	Cornell University	Lue, NF (corresponding author), Cornell Univ, Weill Med Coll, WR Hearst Microbiol Res Ctr, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10065 USA.	nflue@med.cornell.edu	Lue, Neal/AAO-6759-2020	Lue, Neal/0000-0001-9700-6895	National Institutes of Health [GM062631]; National Science Foundation [MCB-1157305]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM062631. This work was also supported by National Science Foundation Grant MCB-1157305.	Chan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000236; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Enloe B, 2000, J BACTERIOL, V182, P5730, DOI 10.1128/JB.182.20.5730-5736.2000; FONZI WA, 1993, GENETICS, V134, P717; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Giraud-Panis MJ, 2010, MOL CELL, V39, P665, DOI 10.1016/j.molcel.2010.08.024; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Lue NF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003145; Lue NF, 2010, TRENDS BIOCHEM SCI, V35, P8, DOI 10.1016/j.tibs.2009.08.006; Lundblad V, 2006, COLD SPRING HARB MON, V45, P345; Mandell EK, 2011, BIOCHEMISTRY-US, V50, P6289, DOI 10.1021/bi2005448; Mason M, 2013, STRUCTURE, V21, P109, DOI 10.1016/j.str.2012.10.012; Mitchell MT, 2010, MOL CELL BIOL, V30, P5325, DOI 10.1128/MCB.00515-10; Mitton-Fry RM, 2004, J MOL BIOL, V338, P241, DOI 10.1016/j.jmb.2004.01.063; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Petreaca RC, 2006, NAT CELL BIOL, V8, P748, DOI 10.1038/ncb1430; Pickett HA, 2009, EMBO J, V28, P799, DOI 10.1038/emboj.2009.42; Puglisi A, 2008, EMBO J, V27, P2328, DOI 10.1038/emboj.2008.158; Raices M, 2008, CELL, V132, P745, DOI 10.1016/j.cell.2007.12.039; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SANTOS MAS, 1993, EMBO J, V12, P607, DOI 10.1002/j.1460-2075.1993.tb05693.x; Shakirov EV, 2005, MOL CELL BIOL, V25, P7725, DOI 10.1128/MCB.25.17.7725-7733.2005; Sun J, 2011, CELL RES, V21, P258, DOI 10.1038/cr.2010.138; Sun J, 2009, GENE DEV, V23, P2900, DOI 10.1101/gad.1851909; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wu Y, 2011, P NATL ACAD SCI USA, V108, P20362, DOI 10.1073/pnas.1100281108; Yu EY, 2012, MOL CELL BIOL, V32, P186, DOI 10.1128/MCB.05875-11; Yu EY, 2010, MOL CELL BIOL, V30, P1254, DOI 10.1128/MCB.00986-09	31	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29115	29123		10.1074/jbc.M113.506519	http://dx.doi.org/10.1074/jbc.M113.506519			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23965999	hybrid, Green Published			2022-12-28	WOS:000330298800064
J	Hatoum-Aslan, A; Samai, P; Maniv, I; Jiang, WY; Marraffini, LA				Hatoum-Aslan, Asma; Samai, Poulami; Maniv, Inbal; Jiang, Wenyan; Marraffini, Luciano A.			A Ruler Protein in a Complex for Antiviral Defense Determines the Length of Small Interfering CRISPR RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL IMMUNE-SYSTEM; CAS SYSTEMS; GENE-EXPRESSION; SEED SEQUENCE; DNA; PROKARYOTES; RESISTANCE; EVOLUTION; ENDONUCLEASE; MECHANISM	Small RNAs undergo maturation events that precisely determine the length and structure required for their function. CRISPRs (clustered regularly interspaced short palindromic repeats) encode small RNAs (crRNAs) that together with CRISPR-associated (cas) genes constitute a sequence-specific prokaryotic immune system for anti-viral and anti-plasmid defense. crRNAs are subject to multiple processing events during their biogenesis, and little is known about the mechanism of the final maturation step. We show that in the Staphylococcus epidermidis type III CRISPR-Cas system, mature crRNAs are measured in a Cas10.Csm ribonucleoprotein complex to yield discrete lengths that differ by 6-nucleotide increments. We looked for mutants that impact this crRNA size pattern and found that an alanine substitution of a conserved aspartate residue of Csm3 eliminates the 6-nucleotide increments in the length of crRNAs. In vitro, recombinant Csm3 binds RNA molecules at multiple sites, producing gel-shift patterns that suggest that each protein binds 6 nucleotides of substrate. In vivo, changes in the levels of Csm3 modulate the crRNA size distribution without disrupting the 6-nucleotide periodicity. Our data support a model in which multiple Csm3 molecules within the Cas10.Csm complex bind the crRNA with a 6-nucleotide periodicity to function as a ruler that measures the extent of crRNA maturation.	[Hatoum-Aslan, Asma; Samai, Poulami; Maniv, Inbal; Jiang, Wenyan; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10065 USA	Rockefeller University	Marraffini, LA (corresponding author), Rockefeller Univ, Bacteriol Lab, 1230 York Ave, New York, NY 10065 USA.	marraffini@rockefeller.edu			Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University; Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; National Institutes of Health Director's New Innovator Award [1DP2AI104556-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104556] Funding Source: NIH RePORTER	Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University; Searle Scholars Program; Rita Allen Scholars Program; Irma T. Hirschl Award; National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by a Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University.; Supported by the Searle Scholars Program, the Rita Allen Scholars Program, an Irma T. Hirschl Award, and National Institutes of Health Director's New Innovator Award 1DP2AI104556-01.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaltwasser M, 2002, APPL ENVIRON MICROB, V68, P2624, DOI 10.1128/AEM.68.5.2624-2628.2002; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	37	87	93	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27888	27897		10.1074/jbc.M113.499244	http://dx.doi.org/10.1074/jbc.M113.499244			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23935102	hybrid, Green Published			2022-12-28	WOS:000330612800017
J	Madison, DL; Wirz, JA; Siess, D; Lundblad, JR				Madison, Dana L.; Wirz, Jacqueline A.; Siess, Don; Lundblad, James R.			Nicotinamide Adenine Dinucleotide-induced Multimerization of the Co-repressor CtBP1 Relies on a Switching Tryptophan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL-BINDING-PROTEIN; ADENOVIRUS E1A; TRANSCRIPTIONAL COREPRESSOR; GENE-EXPRESSION; CLEFT REGION; DEHYDROGENASE; COMPLEX; SITE; NADH; DIMERIZATION	The transcriptional co-repressor C-terminal binding protein (CtBP) interacts with a number of repressor proteins and chromatin modifying enzymes. How the biochemical properties including binding of dinucleotide, oligomerization, and dehydrogenase domains of CtBP1 direct the assembly of a functional co-repressor to influence gene expression is not well understood. In the current study we demonstrate that CtBP1 assembles into a tetramer in a NAD(H)-dependent manner, proceeding through a dimeric intermediate. We find that NAD-dependent oligomerization correlates with NAD(+) binding affinity and that the carboxyl terminus is required for assembly of a dimer of dimers. Mutant CtBP1 proteins that abrogate dinucleotide-binding retain wild type affinity for the PXDLS motif, but do not self-associate either in vitro or in vivo. CtBP1 proteins with mutations in the dehydrogenase domain still retain the ability to self-associate and bind target proteins. Both co-immunoprecipitation and mammalian two-hybrid experiments demonstrate that CtBP1 self-association occurs within the nucleus, and depends on dinucleotide binding. Repression of transcription does not depend on dinucleotide binding or an intact dehydrogenase domain, but rather depends on the amino-terminal domain that recruits PXDLS containing targets. We show that tryptophan 318 (Trp(318)) is a critical residue for tetramer assembly and likely functions as a switch for effective dimerization following NAD(+) binding. These results suggest that dinucleotide binding permits CtBP1 to form an intranuclear homodimer through a Trp(318) switch, creating a nucleation site for multimerization through the C-terminal domain for tetramerization to form an effective repression complex.	[Madison, Dana L.; Siess, Don; Lundblad, James R.] Oregon Hlth & Sci Univ, Div Endocrinol, Portland, OR 97201 USA; [Wirz, Jacqueline A.] Oregon Hlth & Sci Univ, Dept Biochem, Portland, OR 97201 USA; [Madison, Dana L.] Oregon Hlth & Sci Univ, Dept Otolaryngol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Madison, DL (corresponding author), Oregon Hlth & Sci Univ, Div Endocrinol, L-607,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	madisond@ohsu.edu			National Institutes of Health from the NIDDK [K08CA109158, R01DK060133]; NATIONAL CANCER INSTITUTE [K08CA109158] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060133] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08CA109158 (to D. L. M.) and R01DK060133 from the NIDDK (to J. R. L.).	Balasubramanian P, 2003, FEBS LETT, V537, P157, DOI 10.1016/S0014-5793(03)00119-4; Bhambhani C, 2011, EMBO J, V30, P2031, DOI 10.1038/emboj.2011.100; BIRKTOFT JJ, 1983, J BIOL CHEM, V258, P472; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Di LJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2438; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; FRISCH SM, 1990, ONCOGENE, V5, P75; Grant GA, 2000, ARCH BIOCHEM BIOPHYS, V375, P171, DOI 10.1006/abbi.1999.1652; Grant GA, 2002, J BIOL CHEM, V277, P39548, DOI 10.1074/jbc.M208019200; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; LUNDBLAD JR, 2006, CTBP FAMILY PROTEINS, P83; Madison DL, 2010, ONCOGENE, V29, P6027, DOI 10.1038/onc.2010.338; Madison DL, 2002, J BIOL CHEM, V277, P38755, DOI 10.1074/jbc.M207512200; Mani-Telang P, 2007, FEBS LETT, V581, P5241, DOI 10.1016/j.febslet.2007.10.011; Molloy DP, 1998, J BIOL CHEM, V273, P20867, DOI 10.1074/jbc.273.33.20867; Nadauld LD, 2006, J BIOL CHEM, V281, P37828, DOI 10.1074/jbc.M602119200; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Nardini M, 2009, BIOCHEM BIOPH RES CO, V381, P70, DOI 10.1016/j.bbrc.2009.02.010; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Phippen TM, 2000, J BIOL CHEM, V275, P37628, DOI 10.1074/jbc.M004234200; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8202, DOI 10.1128/MCB.00445-06; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Straza MW, 2010, CELL CYCLE, V9, P3740, DOI 10.4161/cc.9.18.12936; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Thillainadesan G, 2008, MOL CELL BIOL, V28, P6066, DOI 10.1128/MCB.00246-08; Thio SSC, 2004, NUCLEIC ACIDS RES, V32, P1836, DOI 10.1093/nar/gkh344; Ueda J, 2006, J BIOL CHEM, V281, P20120, DOI 10.1074/jbc.M603087200; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang YW, 2011, MOL CELL BIOL, V31, P375, DOI 10.1128/MCB.00772-10; Zhao LJ, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-89	38	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27836	27848		10.1074/jbc.M113.493569	http://dx.doi.org/10.1074/jbc.M113.493569			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23940047	Green Published, hybrid			2022-12-28	WOS:000330612800012
J	Perlson, E; Hendricks, AG; Lazarus, JE; Ben-Yaakov, K; Gradus, T; Tokito, M; Holzbaur, ELF				Perlson, Eran; Hendricks, Adam G.; Lazarus, Jacob E.; Ben-Yaakov, Keren; Gradus, Tal; Tokito, Mariko; Holzbaur, Erika L. F.			Dynein Interacts with the Neural Cell Adhesion Molecule (NCAM180) to Tether Dynamic Microtubules and Maintain Synaptic Density in Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROMUSCULAR-JUNCTIONS; CYTOPLASMIC DYNEIN; DEFICIENT MICE; N-CAM; DYNACTIN COMPLEX; MOTOR-NEURONS; PLUS ENDS; IN-VIVO; ORGANIZATION; GROWTH	Cytoplasmic dynein is well characterized as an organelle motor, but dynein also acts to tether and stabilize dynamic microtubule plus-ends in vitro. Here we identify a novel and direct interaction between dynein and the 180-kDa isoform of the neural cell adhesion molecule( NCAM). Optical trapping experiments indicate that dynein bound to beads via the NCAM180 interaction domain can tether projecting microtubule plus-ends. Live cell assays indicate that the NCAM180-dependent recruitment of dynein to the cortex leads to the selective stabilization of microtubules projecting to NCAM180 patches at the cell periphery. The dynein-NCAM180 interaction also enhances cell-cell adhesion in heterologous cell assays. Dynein and NCAM180 co-precipitate from mouse brain extract and from synaptosomal fractions, consistent with an endogenous interaction in neurons. Thus, we examined microtubule dynamics and synaptic density in primary cortical neurons. We find that depletion of NCAM, inhibition of the dynein-NCAM180 interaction, or dampening of microtubule dynamics with low dose nocodazole all result in significantly decreased in synaptic density. Based on these observations, we propose a working model for the role of dynein at the synapse, in which the anchoring of the motor to the cortex via binding to an adhesion molecule mediates the tethering of dynamic microtubule plus-ends to potentiate synaptic stabilization.	[Perlson, Eran; Ben-Yaakov, Keren; Gradus, Tal] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Perlson, Eran; Ben-Yaakov, Keren; Gradus, Tal] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Hendricks, Adam G.; Lazarus, Jacob E.; Tokito, Mariko; Holzbaur, Erika L. F.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Hendricks, Adam G.; Lazarus, Jacob E.; Tokito, Mariko; Holzbaur, Erika L. F.] Univ Penn, Perelman Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Holzbaur, ELF (corresponding author), Univ Penn, Perelman Sch Med, Dept Physiol, 630 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	holzbaur@mail.med.upenn.edu	; Hendricks, Adam/B-3692-2009	Lazarus, Jacob/0000-0001-9286-3548; Hendricks, Adam/0000-0003-3635-1577; Perlson, Eran/0000-0001-6047-9613	National Institutes of Health (NIH) [NS060698]; NIH postdoctoral fellowship; NIH predoctoral fellowship; Muscular Dystrophy Association Postdoctoral Fellowship; Israel Science Foundation [060116480]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060698, R37NS060698] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association Postdoctoral Fellowship(Muscular Dystrophy Association); Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant NS060698 (to E. L. F. H.), an NIH postdoctoral fellowship (to A. G. H.), and an NIH predoctoral fellowship (to J. E. L.). This work was also supported by a Muscular Dystrophy Association Postdoctoral Fellowship and Israel Science Foundation Grant 060116480 (to E. P.).	Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Beffert U, 2012, J NEUROSCI, V32, P13906, DOI 10.1523/JNEUROSCI.2108-12.2012; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chevalier-Larsen ES, 2008, HUM MOL GENET, V17, P1946, DOI 10.1093/hmg/ddn092; Chipman PH, 2010, EUR J NEUROSCI, V31, P238, DOI 10.1111/j.1460-9568.2009.07049.x; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Courchesne Stephanie L, 2011, PLoS One, V6, pe16753, DOI 10.1371/journal.pone.0016753; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DICHTER MA, 1978, BRAIN RES, V149, P279, DOI 10.1016/0006-8993(78)90476-6; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Eaton BA, 2002, NEURON, V34, P729, DOI 10.1016/S0896-6273(02)00721-3; Faire K, 1999, J CELL SCI, V112, P4243; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Goellner B, 2012, DEV NEUROBIOL, V72, P111, DOI 10.1002/dneu.20892; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Graf ER, 2011, J NEUROSCI, V31, P15026, DOI 10.1523/JNEUROSCI.2024-11.2011; Gray E G, 1975, Proc R Soc Lond B Biol Sci, V190, P367; GRAY EG, 1976, J NEUROCYTOL, V5, P361, DOI 10.1007/BF01175121; GRAY EG, 1978, PROC R SOC SER B-BIO, V203, P219, DOI 10.1098/rspb.1978.0102; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; Hata K, 2007, J NEUROSCI, V27, P14481, DOI 10.1523/JNEUROSCI.3847-07.2007; Heil-Chapdelaine RA, 2000, J CELL BIOL, V151, P1337, DOI 10.1083/jcb.151.6.1337; Hendricks AG, 2012, CURR BIOL, V22, P632, DOI 10.1016/j.cub.2012.02.023; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Hu XD, 2008, J NEUROSCI, V28, P13094, DOI 10.1523/JNEUROSCI.3074-08.2008; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Jaworski J, 2008, INT J BIOCHEM CELL B, V40, P619, DOI 10.1016/j.biocel.2007.10.015; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Kochlamazashvili G, 2012, J NEUROSCI, V32, P2263, DOI 10.1523/JNEUROSCI.5103-11.2012; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Leshchyns'ka I, 2011, J BIOL CHEM, V286, P23397, DOI 10.1074/jbc.M111.252098; Levy JR, 2007, DEV CELL, V12, P320, DOI 10.1016/j.devcel.2007.02.012; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Ligon LA, 2007, TRAFFIC, V8, P808, DOI 10.1111/j.1600-0854.2007.00574.x; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Markus SM, 2011, DEV CELL, V20, P639, DOI 10.1016/j.devcel.2011.04.011; Merriam EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027688; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Moore JK, 2010, SEMIN CELL DEV BIOL, V21, P283, DOI 10.1016/j.semcdb.2010.01.020; Moscoso LM, 1998, J NEUROSCI, V18, P1465; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Nahm M, 2013, NEURON, V77, P680, DOI 10.1016/j.neuron.2012.12.015; Nyarko A, 2012, J BIOL CHEM, V287, P24884, DOI 10.1074/jbc.M112.376038; Orso G, 2005, J CLIN INVEST, V115, P3026, DOI 10.1172/JCI24694; Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; PERSOHN E, 1990, J NEUROCYTOL, V19, P807, DOI 10.1007/BF01186812; PERSOHN E, 1989, J COMP NEUROL, V288, P92, DOI 10.1002/cne.902880108; Polo-Parada L, 2005, NEURON, V46, P917, DOI 10.1016/j.neuron.2005.05.018; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Rafuse VF, 2000, J NEUROSCI, V20, P6529, DOI 10.1523/JNEUROSCI.20-17-06529.2000; Rawson JM, 2012, AGING CELL, V11, P418, DOI 10.1111/j.1474-9726.2012.00799.x; ROGERS SW, 1991, J NEUROSCI, V11, P2713; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Suter DM, 1998, J CELL BIOL, V141, P227, DOI 10.1083/jcb.141.1.227; Sytnyk V, 2006, J CELL BIOL, V174, P1071, DOI 10.1083/jcb.200604145; Tanaka H, 2012, NEUROCHEM INT, V61, P240, DOI 10.1016/j.neuint.2012.05.008; ten Hoopen R, 2012, CURR BIOL, V22, P1075, DOI 10.1016/j.cub.2012.04.059; Teuling E, 2008, HUM MOL GENET, V17, P2849, DOI 10.1093/hmg/ddn182; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Toba S, 2004, CELL MOTIL CYTOSKEL, V58, P281, DOI 10.1002/cm.20018; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973	73	31	32	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27812	27824		10.1074/jbc.M113.465088	http://dx.doi.org/10.1074/jbc.M113.465088			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23960070	hybrid, Green Published			2022-12-28	WOS:000330612800010
J	Randak, CO; Dong, Q; Heul, ARV; Elcock, AH; Welsh, MJ				Randak, Christoph O.; Dong, Qian; Heul, Amanda R. Ver; Elcock, Adrian H.; Welsh, Michael J.			ATP and AMP Mutually Influence Their Interaction with the ATP-binding Cassette (ABC) Adenylate Kinase Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) at Separate Binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MOLECULAR-BASIS; BAKERS-YEAST; SWISS-MODEL; NUCLEOTIDE; TRANSPORTER; DOMAIN; CHANNEL; PROTEIN; PHOSPHOTRANSFERASE	Cystic fibrosis transmembrane conductance regulator (CFTR) is an anion channel in the ATP-binding cassette (ABC) transporter protein family. In the presence of ATP and physiologically relevant concentrations of AMP, CFTR exhibits adenylate kinase activity (ATP + AMP reversible arrow 2 ADP). Previous studies suggested that the interaction of nucleotide triphosphate with CFTR at ATP-binding site 2 is required for this activity. Two other ABC proteins, Rad50 and a structural maintenance of chromosome protein, also have adenylate kinase activity. All three ABC adenylate kinases bind and hydrolyze ATP in the absence of other nucleotides. However, little is known about how an ABC adenylate kinase interacts with ATP and AMP when both are present. Based on data from non-ABC adenylate kinases, we hypothesized that ATP and AMP mutually influence their interaction with CFTR at separate binding sites. We further hypothesized that only one of the two CFTR ATP-binding sites is involved in the adenylate kinase reaction. We found that 8-azidoadenosine 5'-triphosphate (8-N-3-ATP) and 8-azidoadenosine 5'-monophosphate (8-N-3-AMP) photolabeled separate sites in CFTR. Labeling of the AMP-binding site with 8-N-3-AMP required the presence of ATP. Conversely, AMP enhanced photolabeling with 8-N-3-ATP at ATP-binding site 2. The adenylate kinase active center probe P-1,P-5-di(adenosine-5') pentaphosphate interacted simultaneously with an AMP-binding site and ATP-binding site 2. These results show that ATP and AMP interact with separate binding sites but mutually influence their interaction with the ABC adenylate kinase CFTR. They further indicate that the active center of the adenylate kinase comprises ATP-binding site 2.	[Randak, Christoph O.; Dong, Qian; Heul, Amanda R. Ver] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Elcock, Adrian H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Randak, CO (corresponding author), Univ Iowa, Dept Pediat, 500 EMRB, Iowa City, IA 52242 USA.	chris-toph-randak@uiowa.edu		Randak, Christoph/0000-0003-3264-4137; Welsh, Michael/0000-0002-1646-6206; Elcock, Adrian/0000-0003-2820-1376	National Institutes of Health [K08HL097071, HL51670, HL091842]; Cystic Fibrosis Foundation [RANDAK09Q0]; Harry Shwachman Cystic Fibrosis Clinical Investigator Award; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091842, K08HL097071, P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Harry Shwachman Cystic Fibrosis Clinical Investigator Award; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants K08HL097071 (to C. O. R.) and HL51670 and HL091842 (to M. J. W.). This work was also supported by Cystic Fibrosis Foundation Grant RANDAK09Q0.; The recipient of a Harry Shwachman Cystic Fibrosis Clinical Investigator Award and of a Parker B. Francis Fellowship.	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; AMES GF, 1992, ADV ENZYMOL RAMB, V65, P1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Berry MB, 2006, PROTEINS, V62, P555, DOI 10.1002/prot.20699; BERRY MB, 1994, PROTEINS, V19, P183, DOI 10.1002/prot.340190304; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Bianchet MA, 1997, J BIOENERG BIOMEMBR, V29, P503, DOI 10.1023/A:1022443209010; Bilderback T, 1996, BIOCHEMISTRY-US, V35, P6100, DOI 10.1021/bi951833i; Brandt BW, 2008, NUCLEIC ACIDS RES, V36, pW255, DOI 10.1093/nar/gkn237; Callebaut I, 2004, CELL MOL LIFE SCI, V61, P230, DOI 10.1007/s00018-003-3386-z; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cheung JC, 2008, ARCH BIOCHEM BIOPHYS, V476, P95, DOI 10.1016/j.abb.2008.03.033; CHUAN H, 1989, J BIOL CHEM, V264, P7981; Criswell AR, 2003, J MOL BIOL, V330, P1087, DOI 10.1016/S0022-2836(03)00655-7; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dong Q, 2008, BIOPHYS J, V95, P5178, DOI 10.1529/biophysj.108.140897; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; Gross CH, 2006, J BIOL CHEM, V281, P4058, DOI 10.1074/jbc.M511113200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hanrahan JW, 2003, ABC PROTEINS BACTERI, P589; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; ITO Y, 1980, EUR J BIOCHEM, V105, P85, DOI 10.1111/j.1432-1033.1980.tb04477.x; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Lammens A, 2010, J MOL BIOL, V401, P265, DOI 10.1016/j.jmb.2010.06.029; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; OSTEDGAARD LS, 1992, J BIOL CHEM, V267, P26142; Polshakov D, 2005, BIOCHEMISTRY-US, V44, P11241, DOI 10.1021/bi050859z; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; Ramjeesingh M, 2008, BIOCHEM J, V412, P315, DOI 10.1042/BJ20071719; Randak C, 2003, CELL, V115, P837, DOI 10.1016/S0092-8674(03)00983-8; Randak CO, 2012, J BIOL CHEM, V287, P36105, DOI 10.1074/jbc.M112.408450; Randak CO, 2005, P NATL ACAD SCI USA, V102, P2216, DOI 10.1073/pnas.0409787102; SALVUCCI ME, 1992, BIOCHEMISTRY-US, V31, P4479, DOI 10.1021/bi00133a014; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schulz G. E., 1992, FARADAY DISCUSS, V93, P858; SHYAMALA V, 1991, J BIOL CHEM, V266, P18714; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Szabo K, 1999, J BIOL CHEM, V274, P12209, DOI 10.1074/jbc.274.18.12209; TOMASSELLI AG, 1980, EUR J BIOCHEM, V103, P481, DOI 10.1111/j.1432-1033.1980.tb05972.x; TOMASSELLI AG, 1979, EUR J BIOCHEM, V93, P263, DOI 10.1111/j.1432-1033.1979.tb12819.x; TOMASSELLI AG, 1983, EUR J BIOCHEM, V132, P109, DOI 10.1111/j.1432-1033.1983.tb07333.x; TRAVIS SM, 1993, J BIOL CHEM, V268, P15336; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Yan HG, 1999, ADV ENZYMOL RAMB, V73, P103, DOI 10.1002/9780470123195.ch4; YAZAWA M, 1976, J BIOL CHEM, V251, P3021	62	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27692	27701		10.1074/jbc.M113.479675	http://dx.doi.org/10.1074/jbc.M113.479675			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23921386	Green Published, hybrid			2022-12-28	WOS:000330597300062
J	Burska, UL; Harle, VJ; Coffey, K; Darby, S; Ramsey, H; O'Neill, D; Logan, IR; Gaughan, L; Robson, CN				Burska, Urszula L.; Harle, Victoria J.; Coffey, Kelly; Darby, Steven; Ramsey, Hollie; O'Neill, Daniel; Logan, Ian R.; Gaughan, Luke; Robson, Craig N.			Deubiquitinating Enzyme Usp12 Is a Novel Co-activator of the Androgen Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Androgen; Androgen Receptor; Chromatin Immunoprecipitation (ChIP); Deubiquitination; Prostate Cancer; uaf-1; usp12; wdr20	HISTONE DEACETYLASE-1; PROTEIN; DEGRADATION; TIP60	The androgen receptor (AR), a member of the nuclear receptor family, is a transcription factor involved in prostate cell growth, homeostasis, and transformation. AR is a key protein in growth and development of both normal and malignant prostate, making it a common therapeutic target in prostate cancer. AR is regulated by an interplay of multiple post-translational modifications including ubiquitination. We and others have shown that the AR is ubiquitinated by a number of E3 ubiquitin ligases, including MDM2, CHIP, and NEDD4, which can result in its proteosomal degradation or enhanced transcriptional activity. As ubiquitination of AR causes a change in AR activity or stability and impacts both survival and growth of prostate cancer cells, deubiquitination of these sites has an equally important role. Hence, deubiquitinating enzymes could offer novel therapeutic targets. We performed an siRNA screen to identify deubiquitinating enzymes that regulate AR; in that screen ubiquitin-specific protease 12 (Usp12) was identified as a novel positive regulator of AR. Usp12 is a poorly characterized protein with few known functions and requires the interaction with two cofactors, Uaf-1 and WDR20, for its enzymatic activity. In this report we demonstrate that Usp12, in complex with Uaf-1 and WDR20, deubiquitinates the AR to enhance receptor stability and transcriptional activity. Our data show that Usp12 acts in a pro-proliferative manner by stabilizing AR and enhancing its cellular function.	[Burska, Urszula L.; Harle, Victoria J.; Coffey, Kelly; Darby, Steven; Ramsey, Hollie; O'Neill, Daniel; Logan, Ian R.; Gaughan, Luke; Robson, Craig N.] Newcastle Univ, Sch Med, Solid Tumour Target Discovery Lab, Newcastle Canc Ctr,Northern Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Robson, CN (corresponding author), Newcastle Univ, Sch Med, Solid Tumour Target Discovery Lab, Newcastle Canc Ctr,Northern Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	c.n.robson@ncl.ac.uk	Coffey, Kelly/AAZ-4433-2020	Coffey, Kelly/0000-0003-0502-2914; darby, steven/0000-0002-7226-8634; McClurg, Urszula/0000-0003-2631-4174	Prostate Cancer United Kingdom, Cancer Research UK; Medical Research Council; Cancer Research UK [12415] Funding Source: researchfish; Medical Research Council [G0800889, G0900871, G0601123] Funding Source: researchfish; National Institute for Health Research [ACF-2012-01-002] Funding Source: researchfish; Prostate Cancer UK [G2011/14, PG09-23] Funding Source: researchfish; MRC [G0601123, G0900871, G0800889] Funding Source: UKRI	Prostate Cancer United Kingdom, Cancer Research UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Prostate Cancer UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Prostate Cancer United Kingdom, Cancer Research UK, and the Medical Research Council.	Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Cardozo CP, 2003, ARCH BIOCHEM BIOPHYS, V410, P134, DOI 10.1016/S0003-9861(02)00680-X; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen SY, 2009, J BIOL CHEM, V284, P25576, DOI 10.1074/jbc.M109.043133; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Coffey K, 2013, NUCLEIC ACIDS RES, V41, P4433, DOI 10.1093/nar/gkt106; Coffey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045539; Coffey K, 2012, J ENDOCRINOL, V215, P221, DOI 10.1530/JOE-12-0238; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Culig Z, 2003, UROLOGY, V62, P21, DOI 10.1016/S0090-4295(03)00698-8; Dirac AMG, 2010, MOL CANCER RES, V8, P844, DOI 10.1158/1541-7786.MCR-09-0424; Draker R, 2011, NUCLEIC ACIDS RES, V39, P3529, DOI 10.1093/nar/gkq1352; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; Joo HY, 2011, J BIOL CHEM, V286, P7190, DOI 10.1074/jbc.M110.158311; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Kouranti I, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000471; Li HY, 2008, J BIOL CHEM, V283, P28988, DOI 10.1074/jbc.M710528200; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Logan IR, 2006, MOL CELL BIOL, V26, P6502, DOI 10.1128/MCB.00147-06; Logan IR, 2009, NUCLEIC ACIDS RES, V37, P2962, DOI 10.1093/nar/gkp180; Lu S, 1999, ENDOCRINOLOGY, V140, P5054, DOI 10.1210/en.140.11.5054; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109; Ryan CJ, 2006, UROLOGY, V68, P834, DOI 10.1016/j.urology.2006.04.016; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021	32	59	60	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32641	32650		10.1074/jbc.M113.485912	http://dx.doi.org/10.1074/jbc.M113.485912			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24056413	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000328681700049
J	McCarthy, DA; Clark, RR; Bartling, TR; Trebak, M; Melendez, JA				McCarthy, Donald A.; Clark, Ryan R.; Bartling, Toni R.; Trebak, Mohamed; Melendez, J. Andres			Redox Control of the Senescence Regulator Interleukin-1 alpha and the Secretory Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antioxidants; Calcium; Calpain; Cell Invasion; Cellular Senescence; Epithelial-Mesenchymal Transition; Hydrogen Peroxide; Interleukin; Redox Regulation	EPITHELIAL-MESENCHYMAL TRANSITION; DIPLOID FIBROBLAST CELLS; ENDOTHELIAL-CELLS; BOUND IL-1-ALPHA; OXYGEN-TENSION; EXPRESSION; INDUCE; IL-8; TRANSCRIPTION; INVASIVENESS	Senescent cells accumulate in aged tissue and are causally linked to age-associated tissue degeneration. These non-dividing, metabolically active cells are highly secretory and alter tissue homeostasis, creating an environment conducive to metastatic disease progression. IL-1 is a key senescence-associated (SA) proinflammatory cytokine that acts as a critical upstream regulator of the SA secretory phenotype (SASP). We established that SA shifts in steady-state H2O2 and intracellular Ca2+ levels caused an increase in IL-1 expression and processing. The increase in intracellular Ca2+ promoted calpain activation and increased the proteolytic cleavage of IL-1. Antioxidants and low oxygen tension prevented SA IL-1 expression and restricted expression of SASP components IL-6 and IL-8. Ca2+ chelation or calpain inhibition prevented SA processing of IL-1 and its ability to induce downstream cytokine expression. Conditioned medium from senescent cells treated with antioxidants or Ca2+ chelators or cultured in low oxygen markedly reduced the invasive capacity of proximal metastatic cancer cells. In this paracrine fashion, senescent cells promoted invasion by inducing an epithelial-mesenchymal transition, actin reorganization, and cellular polarization of neighboring cancer cells. Collectively, these findings demonstrate how SA alterations in the redox state and Ca2+ homeostasis modulate the inflammatory phenotype through the regulation of the SASP initiator IL-1, creating a microenvironment permissive to tumor invasion.	[McCarthy, Donald A.; Clark, Ryan R.; Bartling, Toni R.; Trebak, Mohamed; Melendez, J. Andres] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute	Melendez, JA (corresponding author), SUNY Albany, Coll Nanoscale Sci & Engn, 257 Fuller Rd, Albany, NY 12203 USA.	jmelendez@albany.edu	Trebak, Mohamed/E-7405-2014	Melendez, Juan/0000-0001-8021-3097	National Institutes of Health [NIH R01 AG031067]; NATIONAL INSTITUTE ON AGING [R01AG031067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant NIH R01 AG031067 (to J. A. M.).	Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Ahn JK, 2008, RHEUMATOLOGY, V47, P834, DOI 10.1093/rheumatology/ken086; Badugu R, 2008, J BIOL CHEM, V283, P3409, DOI 10.1074/jbc.M706851200; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bates RC, 2004, EXP CELL RES, V299, P315, DOI 10.1016/j.yexcr.2004.05.033; BURDSAL CA, 1993, DEVELOPMENT, V118, P829; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cane G, 2010, CELL MICROBIOL, V12, P640, DOI 10.1111/j.1462-5822.2009.01422.x; Canino C, 2012, ONCOGENE, V31, P3148, DOI 10.1038/onc.2011.485; Chander H, 2013, ONCOGENE, V32, P3080, DOI 10.1038/onc.2012.317; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cohen I, 2010, P NATL ACAD SCI USA, V107, P2574, DOI 10.1073/pnas.0915018107; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Dasgupta J, 2010, J CELL PHYSIOL, V225, P52, DOI 10.1002/jcp.22193; Dewamitta SR, 2010, INFECT IMMUN, V78, P1884, DOI 10.1128/IAI.01143-09; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Galan C, 2010, MOLECULES, V15, P7167, DOI 10.3390/molecules15107167; GARFINKEL S, 1994, P NATL ACAD SCI USA, V91, P1559, DOI 10.1073/pnas.91.4.1559; Genetos DC, 2010, J MOL NEUROSCI, V40, P360, DOI 10.1007/s12031-009-9326-0; Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Guikema BJ, 2005, FREE RADICAL BIO MED, V38, P597, DOI 10.1016/j.freeradbiomed.2004.11.022; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; KUMAR S, 1992, P NATL ACAD SCI USA, V89, P4683, DOI 10.1073/pnas.89.10.4683; Law ME, 2013, ONCOGENE, V32, P1316, DOI 10.1038/onc.2012.138; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Mariotti Massimo, 2006, Immun Ageing, V3, P4, DOI 10.1186/1742-4933-3-4; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Reichert M, 2000, J BIOL CHEM, V275, P9492, DOI 10.1074/jbc.275.13.9492; SAITO H, 1995, EXP CELL RES, V217, P272, DOI 10.1006/excr.1995.1087; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Stevenson FT, 1997, P NATL ACAD SCI USA, V94, P508, DOI 10.1073/pnas.94.2.508; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Trebak M, 2010, ANTIOXID REDOX SIGN, V12, P657, DOI 10.1089/ars.2009.2842; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262	40	55	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32149	32159		10.1074/jbc.M113.493841	http://dx.doi.org/10.1074/jbc.M113.493841			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24062309	Green Published, hybrid			2022-12-28	WOS:000328681700005
J	Chu, BCH; DeWolf, T; Vogel, HJ				Chu, Byron C. H.; DeWolf, Timothy; Vogel, Hans J.			Role of the Two Structural Domains from the Periplasmic Escherichia coli Histidine-binding Protein HisJ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-TYPHIMURIUM; NMR-SPECTROSCOPY; LIGAND-BINDING; CRYSTAL-STRUCTURE; TRANSPORT-SYSTEM; CONFORMATIONAL PLASTICITY; CASSETTE TRANSPORTERS; MULTIDIMENSIONAL NMR; MALTOSE TRANSPORTER; BACKBONE DYNAMICS	Escherichia coli HisJ is a type II periplasmic binding protein that functions to reversibly capture histidine and transfer it to its cognate inner membrane ABC permease. Here, we used NMR spectroscopy to determine the structure of apo-HisJ (26.5 kDa) in solution. HisJ is a bilobal protein in which domain 1 (D1) is made up of two noncontiguous subdomains, and domain 2 (D2) is expressed as the inner domain. To better understand the roles of D1 and D2, we have isolated and characterized each domain separately. Structurally, D1 closely resembles its homologous domain in apo- and holo-HisJ, whereas D2 is more similar to the holo-form. NMR relaxation experiments reveal that HisJ becomes more ordered upon ligand binding, whereas isolated D2 experiences a significant reduction in slower (millisecond to microsecond) motions compared with the homologous domain in apo-HisJ. NMR titrations reveal that D1 is able to bind histidine in a similar manner as full-length HisJ, albeit with lower affinity. Unexpectedly, isolated D1 and D2 do not interact with each other in the presence or absence of histidine, which indicates the importance of intact interdomain-connecting elements (i.e. hinge regions) for HisJ functioning. Our results shed light on the binding mechanism of type II periplasmic binding proteins where ligand is initially bound by D1, and D2 plays a supporting role in this dynamic process.	[Chu, Byron C. H.; DeWolf, Timothy; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Biochem Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca		DeWolf, Timothy/0000-0002-0510-3602	Canadian Institutes of Health Research (Novel Alternatives to Antibiotics Program); Alberta Innovates Health Solutions	Canadian Institutes of Health Research (Novel Alternatives to Antibiotics Program)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions	This work was supported in part by an operating grant from the Canadian Institutes of Health Research (Novel Alternatives to Antibiotics Program).; Recipient of a scientist award from Alberta Innovates Health Solutions. To whom correspondence should be addressed: Biochemistry Research Group, Dept. of Biological Sciences, University of Calgary, 2500 University Dr. NW, Calgary, Alberta T2N 1N4, Canada. Tel.: 403-220-6006; Fax: 403-289-9311; E-mail: vogel@ucalgary.ca.	AMES GFL, 1972, J BIOL CHEM, V247, P4309; AMES GFL, 1970, P NATL ACAD SCI USA, V66, P1096, DOI 10.1073/pnas.66.4.1096; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bermejo GA, 2010, BIOCHEMISTRY-US, V49, P1893, DOI 10.1021/bi902045p; Bermejo GA, 2009, J AM CHEM SOC, V131, P9532, DOI 10.1021/ja902436g; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bohm S, 2013, P NATL ACAD SCI USA, V110, P5492, DOI 10.1073/pnas.1217745110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN KD, 1970, J BACTERIOL, V104, P177, DOI 10.1128/JB.104.1.177-188.1970; Bucher D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002034; CEDEL TE, 1984, BIOPHYS CHEM, V19, P279, DOI 10.1016/0301-4622(84)87011-8; Chou JJ, 2000, J BIOMOL NMR, V18, P217, DOI 10.1023/A:1026563923774; Chu BCH, 2014, PROTEINS, V82, P386, DOI 10.1002/prot.24396; Chu BCH, 2011, BIOL CHEM, V392, P39, DOI 10.1515/BC.2011.012; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; Daus ML, 2009, J BACTERIOL, V191, P754, DOI 10.1128/JB.01439-08; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DOIGE CA, 1993, ANNU REV MICROBIOL, V47, P291, DOI 10.1146/annurev.micro.47.1.291; Eckey V, 2010, J BACTERIOL, V192, P2150, DOI 10.1128/JB.00809-09; Eletsky A, 2001, J BIOMOL NMR, V20, P177, DOI 10.1023/A:1011265430149; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Felder CB, 1999, AAPS PHARMSCI, V1; FERROLUZZIAMES G, 1976, P NATL ACAD SCI USA, V73, P1877, DOI 10.1073/pnas.73.6.1877; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Gardner KH, 1997, BIOCHEMISTRY-US, V36, P1389, DOI 10.1021/bi9624806; Gifford JL, 2011, J BIOMOL NMR, V50, P71, DOI 10.1007/s10858-011-9495-3; Goddard T. D., 2003, SPARKY 3 VERSION 3 1; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; Huang Hao, 2013, Methods Mol Biol, V963, P99, DOI 10.1007/978-1-62703-230-8_7; Huang H, 2012, J AM CHEM SOC, V134, P3864, DOI 10.1021/ja2111306; Igarashi S, 2010, BIOMOL NMR ASSIGN, V4, P17, DOI 10.1007/s12104-009-9200-6; Jacso T, 2012, J BIOL CHEM, V287, P17040, DOI 10.1074/jbc.M112.340679; Jacso T, 2009, BIOCHEMISTRY-US, V48, P2216, DOI 10.1021/bi801376m; KANG CH, 1991, J BIOL CHEM, V266, P23893; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Krewulak K. D., 2004, PERIPLASMIC BINDING, P113; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; LEVER JE, 1972, ANAL BIOCHEM, V50, P73, DOI 10.1016/0003-2697(72)90487-3; Liu CE, 1999, J BIOL CHEM, V274, P739, DOI 10.1074/jbc.274.2.739; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Loria JP, 1999, J BIOMOL NMR, V15, P151, DOI 10.1023/A:1008355631073; MILLER DM, 1983, J BIOL CHEM, V258, P3665; Mosteller F., 1977, DATA ANAL REGRESSION, P133; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; NIKAIDO K, 1992, J BIOL CHEM, V267, P20706; NOSSAL NG, 1966, J BIOL CHEM, V241, P3055; OH BH, 1993, J BIOL CHEM, V268, P11348; OH BH, 1994, J BIOL CHEM, V269, P4135; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653; Ortega G, 2012, J AM CHEM SOC, V134, P19869, DOI 10.1021/ja3092938; Otten R, 2010, J AM CHEM SOC, V132, P2952, DOI 10.1021/ja907706a; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pistolesi Sara, 2011, Biomol Concepts, V2, P53, DOI 10.1515/bmc.2011.005; POST JFM, 1984, J MOL BIOL, V179, P729, DOI 10.1016/0022-2836(84)90164-5; PROSSNITZ E, 1991, J BIOL CHEM, V266, P9673; PROSSNITZ E, 1988, J BIOL CHEM, V263, P17917; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Schneider E, 2012, EUR J CELL BIOL, V91, P311, DOI 10.1016/j.ejcb.2011.02.008; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Silva DA, 2011, PROTEINS, V79, P2097, DOI 10.1002/prot.23030; Sobolev V, 2005, NUCLEIC ACIDS RES, V33, pW39, DOI 10.1093/nar/gki398; Stockner T, 2005, BIOPHYS J, V89, P3362, DOI 10.1529/biophysj.105.069443; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732; TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279; Trakhanov S, 2005, BIOCHEMISTRY-US, V44, P6597, DOI 10.1021/bi047302o; Tugarinov V, 2005, P NATL ACAD SCI USA, V102, P622, DOI 10.1073/pnas.0407792102; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Venters RA, 1996, J MOL BIOL, V264, P1101, DOI 10.1006/jmbi.1996.0699; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WOLF A, 1994, J BIOL CHEM, V269, P23051; WOLF A, 1995, J BIOL CHEM, V270, P16097, DOI 10.1074/jbc.270.27.16097; Wolf A, 1996, J BIOL CHEM, V271, P21243, DOI 10.1074/jbc.271.35.21243; YAO NH, 1994, BIOCHEMISTRY-US, V33, P4769, DOI 10.1021/bi00182a004; Zhu G, 1999, J BIOMOL NMR, V13, P77, DOI 10.1023/A:1008398227519; ZUKIN RS, 1986, BIOPHYS J, V49, P1229, DOI 10.1016/S0006-3495(86)83752-3; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	92	16	17	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					31409	31422		10.1074/jbc.M113.490441	http://dx.doi.org/10.1074/jbc.M113.490441			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24036119	hybrid, Green Published			2022-12-28	WOS:000330596200001
J	Zhu, L; Zhong, MH; Zhao, JY; Rhee, H; Caesar, I; Knight, EM; Volpicelli-Daley, L; Bustos, V; Netzer, W; Liu, LJ; Lucast, L; Ehrlich, ME; Robakis, NK; Gandy, SE; Cai, DM				Zhu, Li; Zhong, Minghao; Zhao, Jiaying; Rhee, Hannah; Caesar, Ina; Knight, Elysse M.; Volpicelli-Daley, Laura; Bustos, Victor; Netzer, William; Liu, Lijuan; Lucast, Louise; Ehrlich, Michelle E.; Robakis, Nikolaos K.; Gandy, Samuel E.; Cai, Dongming			Reduction of Synaptojanin 1 Accelerates A beta Clearance and Attenuates Cognitive Deterioration in an Alzheimer Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-PRECURSOR-PROTEIN; GAMMA-SECRETASE; IN-VIVO; PRESENILIN-MUTATIONS; EARLY ENDOSOMES; DOWN-SYNDROME; DISEASE; METABOLISM; MICE; PHOSPHORYLATION	Recent studies link synaptojanin 1 (synj1), the main phosphoinositol (4,5)-biphosphate phosphatase (PI(4,5)P-2-degrading enzyme) in the brain and synapses, to Alzheimer disease. Here we report a novel mechanism by which synj1 reversely regulates cellular clearance of amyloid-beta (A beta). Genetic down-regulation of synj1 reduces both extracellular and intracellular A beta levels in N2a cells stably expressing the Swedish mutant of amyloid precursor protein (APP). Moreover, synj1 haploinsufficiency in an Alzheimer disease transgenic mouse model expressing the Swedish mutant APP and the presenilin-1 mutant Delta E9 reduces amyloid plaque load, as well as A beta(40) and A beta(42) levels in hippocampus of 9-month-old animals. Reduced expression of synj1 attenuates cognitive deficits in these transgenic mice. However, reduction of synj1 does not affect levels of full-length APP and the C-terminal fragment, suggesting that A beta generation by beta- and gamma-secretase cleavage is not affected. Instead, synj1 knockdown increases A beta uptake and cellular degradation through accelerated delivery to lysosomes. These effects are partially dependent upon elevated PI(4,5)P-2 with synj1 down-regulation. In summary, our data suggest a novel mechanism by which reduction of a PI(4,5)P-2-degrading enzyme, synj1, improves amyloid-induced neuropathology and behavior deficits through accelerating cellular A beta clearance.	[Zhu, Li; Zhao, Jiaying; Rhee, Hannah; Caesar, Ina; Knight, Elysse M.; Ehrlich, Michelle E.; Gandy, Samuel E.; Cai, Dongming] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Zhu, Li; Zhao, Jiaying; Rhee, Hannah; Caesar, Ina; Knight, Elysse M.; Ehrlich, Michelle E.; Gandy, Samuel E.; Cai, Dongming] Icahn Sch Med Mt Sinai, Alzheimers Dis Res Ctr, New York, NY 10029 USA; [Robakis, Nikolaos K.] Icahn Sch Med Mt Sinai, Dept Psychiat Neurosci & Expt Therapeut, New York, NY 10029 USA; [Zhu, Li; Zhao, Jiaying; Rhee, Hannah; Caesar, Ina; Knight, Elysse M.; Ehrlich, Michelle E.; Gandy, Samuel E.; Cai, Dongming] James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA; [Zhong, Minghao] New York Med Coll, Dept Pathol, Vahalla, NY 10595 USA; [Volpicelli-Daley, Laura; Liu, Lijuan; Lucast, Louise] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06519 USA; [Volpicelli-Daley, Laura; Liu, Lijuan; Lucast, Louise] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06519 USA; [Bustos, Victor; Netzer, William] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; New York Medical College; Yale University; Yale University; Rockefeller University	Cai, DM (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.	dongming.cai@mssm.edu	Robakis, Nikolaos/AAA-1838-2021	Cai, Dongming/0000-0002-0601-6826; knight, Elysse/0000-0001-8372-1214	National Institutes of Health [NS047229]; Department of Neurology and Friedman Brain Institute of Icahn Mount Sinai School of Medicine; Ellison Foundation; National Institutes of Health-National Cancer Institute Shared Resources Grant [5R24CA095823-04]; National Science Foundation Major Research Instrumentation Grant [DBI-9724504]; National Institutes of Health Shared Instrumentation Grant [1S10RR09145-01]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Neurology and Friedman Brain Institute of Icahn Mount Sinai School of Medicine; Ellison Foundation(Lawrence Ellison Foundation); National Institutes of Health-National Cancer Institute Shared Resources Grant; National Science Foundation Major Research Instrumentation Grant(National Science Foundation (NSF)); National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS047229 (to N.R.). This work was also supported by a seed fund provided to Dongming Cai by the Department of Neurology and Friedman Brain Institute of Icahn Mount Sinai School of Medicine, funds from the Ellison Foundation (to P.D.), National Institutes of Health-National Cancer Institute Shared Resources Grant 5R24CA095823-04, National Science Foundation Major Research Instrumentation Grant DBI-9724504, and National Institutes of Health Shared Instrumentation Grant 1S10RR09145-01.	ABRAHAMS JP, 1993, EMBO J, V12, P1775, DOI 10.1002/j.1460-2075.1993.tb05825.x; Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v; Barthet G, 2012, PROG NEUROBIOL, V98, P166, DOI 10.1016/j.pneurobio.2012.05.006; Berg I, 2010, NAT PROTOC, V5, P935, DOI 10.1038/nprot.2010.41; Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; Calhoun ME, 1998, NEUROBIOL AGING, V19, P599, DOI 10.1016/S0197-4580(98)00098-0; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Chaufty J, 2012, J NEUROSCI, V32, P9613, DOI 10.1523/JNEUROSCI.0602-12.2012; Cherra SJ, 2010, NEUROPATH APPL NEURO, V36, P125, DOI [10.1111/j.1365-2990.2009.01062.x, 10.1111/j.1365-2990.2010.01062.x]; Cossec JC, 2012, HUM MOL GENET, V21, P3156, DOI 10.1093/hmg/dds142; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Frere Samuel G, 2012, Subcell Biochem, V59, P131, DOI 10.1007/978-94-007-3015-1_5; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; Ihara Y, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006361; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim ML, 2008, J NEUROSCI, V28, P12052, DOI 10.1523/JNEUROSCI.2913-08.2008; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lane RF, 2010, J NEUROSCI, V30, P13110, DOI 10.1523/JNEUROSCI.3872-10.2010; Lanz TA, 2003, J PHARMACOL EXP THER, V305, P864, DOI 10.1124/jpet.102.048280; Lee S, 2011, AUTOPHAGY, V7, P1562, DOI 10.4161/auto.7.12.17956; Li J, 2012, J BIOL CHEM, V287, P44593, DOI 10.1074/jbc.M112.420224; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McIntire LBJ, 2012, J NEUROSCI, V32, P15271, DOI 10.1523/JNEUROSCI.2034-12.2012; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Nixon RA, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P277; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Shamir L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000974; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Vieira SI, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-40; Vingtdeux V, 2012, J NEUROCHEM, V120, P34, DOI 10.1111/j.1471-4159.2011.07477.x; Voronov SV, 2008, P NATL ACAD SCI USA, V105, P9415, DOI 10.1073/pnas.0803756105; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045033; Zinchuk Vadim, 2011, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s52	48	49	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2013	288	44					32050	32063		10.1074/jbc.M113.504365	http://dx.doi.org/10.1074/jbc.M113.504365			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HX	24052255	Green Published, hybrid			2022-12-28	WOS:000330596200056
J	MacDiarmid, CW; Taggart, J; Kerdsomboon, K; Kubisiak, M; Panascharoen, S; Schelble, K; Eide, DJ				MacDiarmid, Colin W.; Taggart, Janet; Kerdsomboon, Kittikhun; Kubisiak, Michael; Panascharoen, Supawee; Schelble, Katherine; Eide, David J.			Peroxiredoxin Chaperone Activity Is Critical for Protein Homeostasis in Zinc-deficient Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; THIOL-PEROXIDASE; THIOREDOXIN REDUCTASE; SUPEROXIDE-DISMUTASE; GENE DISRUPTION; GLOBAL ANALYSIS; LOCALIZATION; EXPRESSION	Zinc is required for the folding and function of many proteins. In Saccharomyces cerevisiae, homeostatic and adaptive responses to zinc deficiency are regulated by the Zap1 transcription factor. One Zap1 target gene encodes the Tsa1 peroxiredoxin, a protein with both peroxidase and protein chaperone activities. Consistent with its regulation, Tsa1 is critical for growth under low zinc conditions. We previously showed that Tsa1's peroxidase function decreases the oxidative stress that occurs in zinc deficiency. In this report, we show that Tsa1 chaperone, and not peroxidase, activity is the more critical function in zinc-deficient cells. Mutations restoring growth to zinc-deficient tsa1 cells inactivated TRR1, encoding thioredoxin reductase. Because Trr1 is required for oxidative stress tolerance, this result implicated the Tsa1 chaperone function in tolerance to zinc deficiency. Consistent with this hypothesis, the tsa1 Delta zinc requirement was complemented by a Tsa1 mutant allele that retained only chaperone function. Additionally, growth of tsa1 Delta was also restored by overexpression of holdase chaperones Hsp26 and Hsp42, which lack peroxidase activity, and the Tsa1 paralog Tsa2 contributed to suppression by trr1 Delta, even though trr1 Delta inactivates Tsa2 peroxidase activity. The essentiality of the Tsa1 chaperone suggested that zinc-deficient cells experience a crisis of disrupted protein folding. Consistent with this model, assays of protein homeostasis suggested that zinc-limited tsa1 Delta mutants accumulated unfolded proteins and induced a corresponding stress response. These observations demonstrate a clear physiological role for a peroxiredoxin chaperone and reveal a novel and unexpected role for protein homeostasis in tolerating metal deficiency.	[MacDiarmid, Colin W.; Taggart, Janet; Kubisiak, Michael; Panascharoen, Supawee; Schelble, Katherine; Eide, David J.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Kerdsomboon, Kittikhun] Mahidol Univ, Fac Sci, Dept Biol, Bangkok 10400, Thailand	University of Wisconsin System; University of Wisconsin Madison; Mahidol University	Eide, DJ (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	eide@nutrisci.wisc.edu	MacDiarmid, Colin/AAV-5920-2021	MacDiarmid, Colin/0000-0001-8578-5756	National Institutes of Health [GM56285]; Office of Commission on Higher Education Thailand; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Commission on Higher Education Thailand(Office of Higher Education Commission (OHEC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56285 (to D. E.). This work was also supported by a grant from the Office of Commission on Higher Education Thailand (to K. K.).	Amoros M, 2001, MOL MICROBIOL, V39, P1523, DOI 10.1046/j.1365-2958.2001.02339.x; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Andreini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026325; Andreini C, 2009, BIOINFORMATICS, V25, P2088, DOI 10.1093/bioinformatics/btp256; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Birkeland SR, 2010, GENETICS, V186, P1127, DOI 10.1534/genetics.110.123232; Boisnard S, 2009, EUKARYOT CELL, V8, P1429, DOI 10.1128/EC.00106-09; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; Carmel-Harel O, 2001, MOL MICROBIOL, V39, P595, DOI 10.1046/j.1365-2958.2001.02255.x; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; CHEN JJ, 1993, J BIOL CHEM, V268, P7442; Coleman ST, 1999, MOL CELL BIOL, V19, P8302; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Eide DJ, 2011, METALLOMICS, V3, P1124, DOI 10.1039/c1mt00064k; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Frey AG, 2011, J BIOL CHEM, V286, P6844, DOI 10.1074/jbc.M110.203927; Geiler-Samerotte KA, 2011, P NATL ACAD SCI USA, V108, P680, DOI 10.1073/pnas.1017570108; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2004, EMBO J, V23, P638, DOI 10.1038/sj.emboj.7600080; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Hong SK, 2002, J BIOL CHEM, V277, P12109, DOI 10.1074/jbc.M111341200; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kawai R, 1999, CELL STRESS CHAPERON, V4, P46, DOI 10.1054/csac.1999.0076; Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; Liu IC, 2012, MOL BIOL CELL, V23, P1231, DOI 10.1091/mbc.E11-09-0752; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Makmura L, 2001, ANTIOXID REDOX SIGN, V3, P1105, DOI 10.1089/152308601317203611; Molin M, 2011, MOL CELL, V43, P823, DOI 10.1016/j.molcel.2011.07.027; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Moon JC, 2013, BIOCHEM BIOPH RES CO, V432, P291, DOI 10.1016/j.bbrc.2013.01.114; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; Munhoz DC, 2004, J BIOL CHEM, V279, P35219, DOI 10.1074/jbc.M313773200; North M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002699; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Pearson GD, 1998, J BIOL CHEM, V273, P5431, DOI 10.1074/jbc.273.10.5431; Pisat NP, 2009, GENETICS, V183, P873, DOI 10.1534/genetics.109.106419; Powell SR, 2000, J NUTR, V130, p1447S, DOI 10.1093/jn/130.5.1447S; Qiao W, 2006, P NATL ACAD SCI USA, V103, P8674, DOI 10.1073/pnas.0600928103; Qiao W, 2009, MOL MICROBIOL, V72, P320, DOI 10.1111/j.1365-2958.2009.06644.x; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Wang YY, 2012, MOL BIOL CELL, V23, P3290, DOI 10.1091/mbc.E12-06-0447; WEMMIE JA, 1994, J BIOL CHEM, V269, P32592; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wong CM, 2003, FREE RADICAL BIO MED, V34, P585, DOI 10.1016/S0891-5849(02)01354-0; Wotton D, 1996, J BIOL CHEM, V271, P2717, DOI 10.1074/jbc.271.5.2717; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007061; Wu CY, 2009, J BIOL CHEM, V284, P27544, DOI 10.1074/jbc.M109.042036; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	84	43	43	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	2013	288	43					31313	31327		10.1074/jbc.M113.512384	http://dx.doi.org/10.1074/jbc.M113.512384			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA0IN	24022485	hybrid, Green Published			2022-12-28	WOS:000330778900048
J	Chacon, MG; Fournier, AE; Tran, F; Dittrich-Domergue, F; Pulsifer, IP; Domergue, F; Rowland, O				Chacon, Micaela G.; Fournier, Ashley E.; Tran, Frances; Dittrich-Domergue, Franziska; Pulsifer, Ian P.; Domergue, Frederic; Rowland, Owen			Identification of Amino Acids Conferring Chain Length Substrate Specificities on Fatty Alcohol-forming Reductases FAR5 and FAR8 from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Structure; Lipid Metabolism; Plant Biochemistry; Protein Engineering; Site-directed Mutagenesis; Fatty Acyl Reductase; Fatty Alcohol	ACYL-COENZYME; WAX BIOSYNTHESIS; YEAST; GENE; ACYLTRANSFERASE; PURIFICATION; EXPRESSION; ENCODES; SUBERIN; FAMILY	Fatty alcohols play a variety of biological roles in all kingdoms of life. Fatty acyl reductase (FAR) enzymes catalyze the reduction of fatty acyl-coenzyme A (CoA) or fatty acyl-acyl carrier protein substrates to primary fatty alcohols. FAR enzymes have distinct substrate specificities with regard to chain length and degree of saturation. FAR5 (At3g44550) and FAR8 (At3g44560) from Arabidopsis thaliana are 85% identical at the amino acid level and are of equal length, but they possess distinct specificities for 18:0 or 16:0 acyl chain length, respectively. We used Saccharomyces cerevisiae as a heterologous expression system to assess FAR substrate specificity determinants. We identified individual amino acids that affect protein levels or 16:0-CoA versus 18:0-CoA specificity by expressing in yeast FAR5 and FAR8 domain-swap chimeras and site-specific mutants. We found that a threonine at position 347 and a serine at position 363 were important for high FAR5 and FAR8 protein accumulation in yeast and thus are likely important for protein folding and stability. Amino acids at positions 355 and 377 were important for dictating 16:0-CoA versus 18:0-CoA chain length specificity. Simultaneously converting alanine 355 and valine 377 of FAR5 to the corresponding FAR8 residues, leucine and methionine, respectively, almost fully converted FAR5 specificity from 18:0-CoA to 16:0-CoA. The reciprocal amino acid conversions, L355A and M377V, made in the active FAR8-S363P mutant background converted its specificity from 16:0-CoA to 18:0-CoA. This study is an important advancement in the engineering of highly active FAR proteins with desired specificities for the production of fatty alcohols with industrial value.	[Chacon, Micaela G.; Fournier, Ashley E.; Tran, Frances; Pulsifer, Ian P.; Rowland, Owen] Carleton Univ, Inst Biochem, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Dittrich-Domergue, Franziska; Domergue, Frederic] Univ Bordeaux Segalen, CNRS UMR 5200, Lab Biogenese Membranaire, F-33883 Villenave Dornon, France	Carleton University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Rowland, O (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	owen_rowland@carleton.ca	Rowland, Owen/ABH-2744-2021	Rowland, Owen/0000-0002-2752-2584; Domergue, Frederic/0000-0002-0183-7000	Natural Sciences and Engineering Research Council of Canada; France-Canada Research Fund grant from the Embassy of France in Canada; European Commission	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); France-Canada Research Fund grant from the Embassy of France in Canada; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada (to O. R.), by a France-Canada Research Fund grant from the Embassy of France in Canada (to F. D. and O. R.), and by European Commission Framework 7 Project entitled "Industrial Crops Producing Added Value Oils for Novel Chemicals" (ICON).	Aarts MGM, 1997, PLANT J, V12, P615, DOI 10.1046/j.1365-313X.1997.00615.x; ANTIA NJ, 1974, J PROTOZOOL, V21, P768, DOI 10.1111/j.1550-7408.1974.tb03749.x; Chen WW, 2011, PLANT PHYSIOL, V157, P842, DOI 10.1104/pp.111.181693; CHEN Z, 1993, BIOCHEMISTRY-US, V32, P3342, DOI 10.1021/bi00064a017; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Doan TTP, 2012, BBA-MOL CELL BIOL L, V1821, P1244, DOI 10.1016/j.bbalip.2011.10.019; Doan TTP, 2009, J PLANT PHYSIOL, V166, P787, DOI 10.1016/j.jplph.2008.10.003; Domergue F, 2003, J BIOL CHEM, V278, P35115, DOI 10.1074/jbc.M305990200; Domergue F, 2010, PLANT PHYSIOL, V153, P1539, DOI 10.1104/pp.110.158238; Fujimoto K, 2001, CHEM-BIOL INTERACT, V130, P825, DOI 10.1016/S0009-2797(00)00238-6; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hajra A. K., 1983, ETHER LIPIDS, P85; Hellenbrand J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-64; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Khannoon ER, 2011, CHEMOECOLOGY, V21, P143, DOI 10.1007/s00049-011-0076-4; KOLATTUK.PE, 1970, BIOCHEMISTRY-US, V9, P1095, DOI 10.1021/bi00807a007; Kosma DK, 2012, PLANT PHYSIOL, V160, P237, DOI 10.1104/pp.112.201822; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LABESSE G, 1994, BIOCHEM J, V304, P95, DOI 10.1042/bj3040095; Lardizabal KD, 2000, PLANT PHYSIOL, V122, P645, DOI 10.1104/pp.122.3.645; Lassance JM, 2010, NATURE, V466, P486, DOI 10.1038/nature09058; Lienard MA, 2010, P NATL ACAD SCI USA, V107, P10955, DOI 10.1073/pnas.1000823107; Metz JG, 2000, PLANT PHYSIOL, V122, P635, DOI 10.1104/pp.122.3.635; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; POLLARD MR, 1979, LIPIDS, V14, P651, DOI 10.1007/BF02533451; Pulsifer IP, 2012, PLANT PHYSIOL BIOCH, V51, P31, DOI 10.1016/j.plaphy.2011.10.003; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Rowland O, 2012, PLANT SCI, V193, P28, DOI 10.1016/j.plantsci.2012.05.002; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; SPENCER GF, 1979, J AM OIL CHEM SOC, V56, P642, DOI 10.1007/BF02679341; Teerawanichpan P, 2010, INSECT BIOCHEM MOLEC, V40, P641, DOI 10.1016/j.ibmb.2010.06.004; Teerawanichpan P, 2010, LIPIDS, V45, P263, DOI 10.1007/s11745-010-3395-2; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107	35	15	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30345	30355		10.1074/jbc.M113.499715	http://dx.doi.org/10.1074/jbc.M113.499715			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24005667	hybrid, Green Published			2022-12-28	WOS:000329868100031
J	Khodai-Kalaki, M; Aubert, DF; Valvano, MA				Khodai-Kalaki, Maryam; Aubert, Daniel F.; Valvano, Miguel A.			Characterization of the AtsR Hybrid Sensor Kinase Phosphorelay Pathway and Identification of Its Response Regulator in Burkholderia cenocepacia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Protein Kinases; Cystic Fibrosis; Histidine Kinases; Macrophages; Phosphorylation; Protease; Transcription Regulation; Virulence Factors	VI SECRETION SYSTEM; QUORUM-SENSING SYSTEM; ESCHERICHIA-COLI; PHOSPHATASE-ACTIVITY; IN-VITRO; VIRULENCE; COMPLEX; PROTEIN; PHOSPHORYLATION; BACTERIA	AtsR is a membrane-bound hybrid sensor kinase of Burkholderia cenocepacia that negatively regulates quorum sensing and virulence factors such as biofilm production, type 6-secretion, and protease secretion. Here we elucidate the mechanism of AtsR phosphorelay by site-directed mutagenesis of predicted histidine and aspartic acid phosphoacceptor residues. We demonstrate by in vitro phosphorylation that histidine 245 and aspartic acid 536 are conserved sites of phosphorylation in AtsR, and we also identify the cytosolic response regulator AtsT (BCAM0381) as a key component of the AtsR phosphorelay pathway. Monitoring the function of AtsR and its derivatives in vivo by measuring extracellular protease activity and swarming motility confirmed the in vitro phosphorylation results. Together we find that the AtsR receiver domain plays a fine-tuning role in determining the levels of phosphotransfer from its sensor kinase domain to the AtsT response regulator.	[Khodai-Kalaki, Maryam; Aubert, Daniel F.; Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, Ctr Human Immunol, Schulich Sch Med, London, ON N6A 5C1, Canada; [Valvano, Miguel A.] Queens Univ Belfast, Ctr Infect & Immun, Belfast BT9 5GZ, Antrim, North Ireland	Western University (University of Western Ontario); Queens University Belfast	Valvano, MA (corresponding author), Queens Univ Belfast, Ctr Infect & Immun, 97 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland.	m.valvano@qub.ac.uk	Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada.	Aubert D, 2010, J BIOL CHEM, V285, P35988, DOI 10.1074/jbc.M110.120402; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Aubert DF, 2013, ENVIRON MICROBIOL, V15, P372, DOI 10.1111/j.1462-2920.2012.02828.x; Baldwin A, 2004, INFECT IMMUN, V72, P1537, DOI 10.1128/IAI.72.3.1537-1547.2004; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bevivino A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-228; BURKHOLDER WH, 1950, PHYTOPATHOLOGY, V40, P115; Castelli ME, 2000, J BIOL CHEM, V275, P22948, DOI 10.1074/jbc.M909335199; Chang CH, 1996, J BACTERIOL, V178, P4710, DOI 10.1128/jb.178.15.4710-4716.1996; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; CRAIG FF, 1989, J GEN MICROBIOL, V135, P2885; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Flannagan RS, 2008, ENVIRON MICROBIOL, V10, P1652, DOI 10.1111/j.1462-2920.2008.01576.x; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Georgellis D, 1997, J BACTERIOL, V179, P5429, DOI 10.1128/jb.179.17.5429-5435.1997; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Hamad MA, 2012, MOL MICROBIOL, V85, P962, DOI 10.1111/j.1365-2958.2012.08154.x; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; Jourlin C, 1997, J MOL BIOL, V267, P770, DOI 10.1006/jmbi.1997.0919; Kooi C, 2006, INFECT IMMUN, V74, P4083, DOI 10.1128/IAI.00297-06; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Kwon O, 2000, J BACTERIOL, V182, P3858, DOI 10.1128/JB.182.13.3858-3862.2000; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamothe J, 2004, CELL MICROBIOL, V6, P1127, DOI 10.1111/j.1462-5822.2004.00424.x; Lamothe J, 2007, CELL MICROBIOL, V9, P40, DOI 10.1111/j.1462-5822.2006.00766.x; Laskowski MA, 2004, MOL MICROBIOL, V54, P1090, DOI 10.1111/j.1365-2958.2004.04331.x; Lee YA, 2007, PHYTOPATHOLOGY, V97, P195, DOI 10.1094/PHYTO-97-2-0195; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Malott RJ, 2009, J BACTERIOL, V191, P2447, DOI 10.1128/JB.01746-08; Malott RJ, 2005, INFECT IMMUN, V73, P4982, DOI 10.1128/IAI.73.8.4982-4992.2005; McNeely D, 2009, INT J ENVIRON HEAL R, V19, P157, DOI 10.1080/09603120802392876; Perez JM, 2008, MOL MICROBIOL, V70, P1424, DOI 10.1111/j.1365-2958.2008.06490.x; Perraud AL, 1998, MOL MICROBIOL, V27, P875, DOI 10.1046/j.1365-2958.1998.00716.x; Rosales-Reyes R, 2012, CELL MICROBIOL, V14, P255, DOI 10.1111/j.1462-5822.2011.01716.x; Sambrook J., 2006, CONDENSED PROTOCOLS; Sokol PA, 2003, MICROBIOL-SGM, V149, P3649, DOI 10.1099/mic.0.26540-0; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; UHL MA, 1994, P NATL ACAD SCI USA, V91, P1163, DOI 10.1073/pnas.91.3.1163; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Vergunst AC, 2010, INFECT IMMUN, V78, P1495, DOI 10.1128/IAI.00743-09; Wolanin PM, 2002, GENOME BIOL, V3; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200	46	11	11	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30473	30484		10.1074/jbc.M113.489914	http://dx.doi.org/10.1074/jbc.M113.489914			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	24014026	Green Published, hybrid			2022-12-28	WOS:000329868100043
J	Rubin, J; Khosravi, H; Bruce, KL; Lydon, ME; Behrens, SH; Chernoff, YO; Bommarius, AS				Rubin, Jonathan; Khosravi, Hasan; Bruce, Kathryn L.; Lydon, Megan E.; Behrens, Sven H.; Chernoff, Yury O.; Bommarius, Andreas S.			Ion-specific Effects on Prion Nucleation and Strain Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Protein Aggregation; Protein Conformation; Translation Release Factors; Yeast; Chaotrope; Hofmeister Series; Kosmotrope	YEAST PRION; FIBRIL FORMATION; PROTEIN AGGREGATION; SACCHAROMYCES-CEREVISIAE; AMYLOID FORMATION; PSI+; DISEASES; TRANSMISSION; INHERITANCE; VARIANTS	Ordered, fibrous, self-seeding aggregates of misfolded proteins known as amyloids are associated with important diseases in mammals and control phenotypic traits in fungi. A given protein may adopt multiple amyloid conformations, known as variants or strains, each of which leads to a distinct disease pattern or phenotype. Here, we study the effect of Hofmeister ions on amyloid nucleation and strain generation by the prion domain-containing fragment (Sup35NM) of a yeast protein Sup35p. Strongly hydrated anions (kosmotropes) initiate nucleation quickly and cause rapid fiber elongation, whereas poorly hydrated anions (chaotropes) delay nucleation and mildly affect the elongation rate. For the first time, we demonstrate that kosmotropes favor formation of amyloid strains that are characterized by lower thermostability and higher frangibility in vitro and stronger phenotypic and proliferation patterns effectively in vivo as compared with amyloids formed in chaotropes. These phenomena point to inherent differences in the biochemistry of Hofmeister ions. Our work shows that the ionic composition of a solution not only influences the kinetics of amyloid nucleation but also determines the amyloid strain that is preferentially formed.	[Rubin, Jonathan; Behrens, Sven H.; Bommarius, Andreas S.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Rubin, Jonathan; Khosravi, Hasan; Bruce, Kathryn L.; Behrens, Sven H.; Chernoff, Yury O.; Bommarius, Andreas S.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Khosravi, Hasan; Lydon, Megan E.; Bommarius, Andreas S.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Bruce, Kathryn L.; Chernoff, Yury O.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Chernoff, YO (corresponding author), Georgia Inst Technol, Sch Biol, 310 Ferst Dr, Atlanta, GA 30332 USA.	yury.chernoff@biology.gatech.edu; andreas.bommarius@chbe.gatech.edu	Chernoff, Yury O/J-2833-2014	Behrens, Sven/0000-0002-3528-4053; Chernoff, Yury/0000-0002-8934-9051	National Institutes of Health [R01GM093294]; National Science Foundation (NSF) [MCB-1024854]; NSF Industry/University Cooperative Research Centers (I/UCRC) Program Center for Pharmaceutical Development (CPD) [0969003]; United States Department of Education; Medtronics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Industry/University Cooperative Research Centers (I/UCRC) Program Center for Pharmaceutical Development (CPD)(National Science Foundation (NSF)); United States Department of Education(US Department of Education); Medtronics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the subaward (to Y. O. C.) on National Institutes of Health Grant R01GM093294. This work was also supported by National Science Foundation (NSF) Grant MCB-1024854 (to Y. O. C.), NSF Industry/University Cooperative Research Centers (I/UCRC) Program Center for Pharmaceutical Development (CPD) Grant 0969003 (to A. S. B. and S. H. B.), the Graduate Assistance in Areas of National Need (GAANN) fellowship through the United States Department of Education (to J. R. and K. L B.), and the Petite Undergraduate Scholar program through Medtronics (to H. K.).	Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Bailleul PA, 1999, GENETICS, V153, P81; Baynes BM, 2004, BIOPHYS J, V87, P1631, DOI 10.1529/biophysj.104.042473; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Bruce KL, 2011, SEMIN CELL DEV BIOL, V22, P444, DOI 10.1016/j.semcdb.2011.03.005; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen BX, 2007, P NATL ACAD SCI USA, V104, P2791, DOI 10.1073/pnas.0611158104; Chen BX, 2010, MOL MICROBIOL, V76, P1483, DOI 10.1111/j.1365-2958.2010.07177.x; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; Derkatch IL, 1996, GENETICS, V144, P1375; Diaz-Espinoza R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031678; Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Halfmann R., 2008, J VIS EXP, P838; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; Kim AY, 2000, LANGMUIR, V16, P2101, DOI 10.1021/la990841n; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lodderstedt G, 2008, BIOCHEMISTRY-US, V47, P2181, DOI 10.1021/bi701322g; Peula-Garcia JM, 2010, J PHYS CHEM C, V114, P11133, DOI 10.1021/jp912035v; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Munishkina LA, 2004, BIOCHEMISTRY-US, V43, P3289, DOI 10.1021/bi034938r; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; Pegram LM, 2008, J PHYS CHEM B, V112, P9428, DOI 10.1021/jp800816a; Pegram LM, 2010, P NATL ACAD SCI USA, V107, P7716, DOI 10.1073/pnas.0913376107; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ross ED, 2010, PRION, V4, DOI 10.4161/pri.4.2.12190; Rubin J, 2010, J PHYS CHEM B, V114, P4383, DOI 10.1021/jp912126w; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Sorci M, 2009, PROTEINS, V77, P62, DOI 10.1002/prot.22417; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Tessier PM, 2009, NAT STRUCT MOL BIOL, V16, P598, DOI 10.1038/nsmb.1617; Toombs JA, 2012, P NATL ACAD SCI USA, V109, P6519, DOI 10.1073/pnas.1119366109; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Tuite MF, 2006, METHODS, V39, P9, DOI 10.1016/j.ymeth.2006.04.001; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Verges KJ, 2011, NAT STRUCT MOL BIOL, V18, P493, DOI 10.1038/nsmb.2030; Walters RH, 2012, J MOL BIOL, V421, P329, DOI 10.1016/j.jmb.2012.03.017; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wickner RB, 2011, PRION, V5, P258, DOI [10.4161/pri.5.4.17748, 10.4161/pri.17748]; Wickner RB, 2007, PRION, V1, P94, DOI 10.4161/pri.1.2.4664; Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107; Yeh V, 2010, PROTEIN SCI, V19, P47, DOI 10.1002/pro.281	61	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 18	2013	288	42					30300	30308		10.1074/jbc.M113.467829	http://dx.doi.org/10.1074/jbc.M113.467829			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YF	23990463	Green Published, hybrid			2022-12-28	WOS:000329868100027
J	Murphy, CM; Michael, WM				Murphy, Christopher M.; Michael, W. Matthew			Control of DNA Replication by the Nucleus/Cytoplasm Ratio in Xenopus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; DROSOPHILA MIDBLASTULA TRANSITION; CELL-CYCLE; EGG EXTRACTS; CHECKPOINT; ATR; INITIATION; EMBRYOS; CHK1; DAMAGE	The nucleus/cytoplasm (N/C) ratio controls S phase dynamics in many biological systems, most notably the abrupt remodeling of the cell cycle that occurs at the midblastula transition in early Xenopus laevis embryos. After an initial series of rapid cleavage cycles consisting only of S and M phases, a critical N/C ratio is reached, which causes a sharp increase in the length of S phase as the cell cycle is reconfigured to resemble somatic cell cycles. How the N/C ratio determines the length of S phase has been a longstanding problem in developmental biology. Using Xenopus egg extracts, we show that DNA replication at high N/C ratio is restricted by one or more limiting substances. We report here that the protein phosphatase PP2A, in conjunction with its B55 alpha regulatory subunit, becomes limiting for replication origin firing at high N/C ratio, and this in turn leads to reduced origin activation and an increase in the time required to complete S phase. Increasing the levels of PP2A catalytic subunit or B55 alpha experimentally restores rapid DNA synthesis at high N/C ratio. Inversely, reduction of PP2A or B55 alpha levels sharply extends S phase even in low N/C extracts. These results identify PP2A-B55 alpha as a link between DNA replication and N/C ratio in egg extracts and suggest a mechanism that may influence the onset of the midblastula transition in vivo.	[Murphy, Christopher M.; Michael, W. Matthew] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; [Murphy, Christopher M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of Southern California; Harvard University	Michael, WM (corresponding author), Univ So Calif, Dept Biol Sci, RRI 104B,1050 Childs Way, Los Angeles, CA 90089 USA.	mattm@usc.edu	McDermott, Michael Francis/GZM-5330-2022		National Institutes of Health [GM067735]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067735 (to W.M.M.).	Anderson JA, 1997, MOL BIOL CELL, V8, P1195, DOI 10.1091/mbc.8.7.1195; BRANDT H, 1975, J BIOL CHEM, V250, P8038; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clute P, 1997, DEV BIOL, V185, P1, DOI 10.1006/dbio.1997.8540; Di Talia S, 2013, CURR BIOL, V23, P127, DOI 10.1016/j.cub.2012.11.029; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; Farrell JA, 2013, CURR BIOL, V23, P118, DOI 10.1016/j.cub.2012.11.036; Finkielstein CV, 2001, P NATL ACAD SCI USA, V98, P1006, DOI 10.1073/pnas.98.3.1006; Gotoh T, 2011, DEV BIOL, V353, P302, DOI 10.1016/j.ydbio.2011.03.002; GRAHAM CF, 1966, DEV BIOL, V14, P439, DOI 10.1016/0012-1606(66)90024-8; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; Ikehara T, 2006, PROTEIN EXPRES PURIF, V45, P150, DOI 10.1016/j.pep.2005.06.002; Iwao Y, 2005, DEV GROWTH DIFFER, V47, P283; KANE DA, 1993, DEVELOPMENT, V119, P447; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; Krasinska L, 2011, MOL CELL, V44, P437, DOI 10.1016/j.molcel.2011.10.007; Lin XH, 1998, P NATL ACAD SCI USA, V95, P14693, DOI 10.1073/pnas.95.25.14693; Luciani MG, 2004, J CELL SCI, V117, P6019, DOI 10.1242/jcs.01400; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Marheineke Kathrin, 2009, V521, P575, DOI [10.1007/978-1-60327-817-5_33, 10.1007/978-1-60327-815-7_33]; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; NEWPORT J, 1989, J CELL SCI, P149; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Petersen P, 2006, MOL CELL BIOL, V26, P1997, DOI 10.1128/MCB.26.5.1997-2011.2006; R Core Team, 2020, R LANG ENV STAT COMP; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Stokes MP, 2002, J CELL BIOL, V158, P863, DOI 10.1083/jcb.200204127; Sung HW, 2013, CURR BIOL, V23, P133, DOI 10.1016/j.cub.2012.12.013; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takada S, 2007, DEVELOPMENT, V134, P1737, DOI 10.1242/dev.02831; Vastag Livia, 2011, PLoS One, V6, pe16881, DOI 10.1371/journal.pone.0016881; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Walter J, 1999, PRACT APPROACH SER, V199, P201	41	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29382	29393		10.1074/jbc.M113.499012	http://dx.doi.org/10.1074/jbc.M113.499012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23986447	Green Published, hybrid			2022-12-28	WOS:000330615300017
J	Wan, W; Bian, W; McDonald, M; Kijac, A; Wemmer, DE; Stubbs, G				Wan, William; Bian, Wen; McDonald, Michele; Kijac, Aleksandra; Wemmer, David E.; Stubbs, Gerald			Heterogeneous Seeding of a Prion Structure by a Generic Amyloid Form of the Fungal Prion-forming Domain HET-s(218-289)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HET-S PRION; RAY FIBER DIFFRACTION; PODOSPORA-ANSERINA; PROTEIN; FIBRILS; MODEL; CORE; MICROSCOPY; AGGREGATE; MECHANISM	The fungal prion-forming domain HET-s(218-289) forms infectious amyloid fibrils at physiological pH that were shown by solid-state NMR to be assemblies of a two-rung beta-solenoid structure. Under acidic conditions, HET-s(218-289) has been shown to form amyloid fibrils that have very low infectivity in vivo, but structural information about these fibrils has been very limited. Weshow by x-ray fiber diffraction that the HET-s(218289) fibrils formed under acidic conditions have a stacked beta-sheet architecture commonly found in short amyloidogenic peptides and denatured protein aggregates. At physiological pH, stacked beta-sheet fibrils nucleate the formation of the infectious beta-solenoid prions in a process of heterogeneous seeding, but do so with kinetic profiles distinct from those of spontaneous or homogeneous (seeded with infectious beta-solenoid fibrils) fibrillization. Several serial passages of stacked beta-sheet-seeded solutions lead to fibrillization kinetics similar to homogeneously seeded solutions. Our results directly show that structural mutation can occur between substantially different amyloid architectures, lending credence to the suggestion that the processes of strain adaptation and crossing species barriers are facilitated by structural mutation.	[Wan, William; Bian, Wen; McDonald, Michele; Stubbs, Gerald] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Wan, William; Bian, Wen; McDonald, Michele; Stubbs, Gerald] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Kijac, Aleksandra; Wemmer, David E.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kijac, Aleksandra; Wemmer, David E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Kijac, Aleksandra] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA	Vanderbilt University; Vanderbilt University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Stubbs, G (corresponding author), Vanderbilt Univ, Dept Biol Sci, 1210 MRB 3,465 21st Ave South, Nashville, TN 37232 USA.	gerald.stubbs@vanderbilt.edu		Wan, William/0000-0003-2497-3010	Department of Energy; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM111072, P41GM103543, T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002132, F31AG040947] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the staff of beamline 4-2 at the Stanford Synchrotron Radiation Lightsource (SSRL) and BioCAT at the Advanced Photon Source (APS), Amy Kendall for discussions and assistance with data collection, Xi Meng for purification of the labeled HET-s protein, and Jochem Struppe of Bruker Biospin for help with pulse sequence implementation. The SSRL is a national user facility operated by Stanford University on behalf of the Department of Energy. The SSRL Structural Molecular Biology Program is supported by the Department of Energy and National Institutes of Health. The APS is supported by the Department of Energy. BioCAT and BioCARS are supported by the National Institutes of Health.	ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2004, J BIOL CHEM, V279, P7671, DOI 10.1074/jbc.M310594200; Benkemoun L, 2011, MOL MICROBIOL, V82, P1392, DOI 10.1111/j.1365-2958.2011.07893.x; Bian W, 2006, J APPL CRYSTALLOGR, V39, P752, DOI 10.1107/S0021889806025386; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Debets AJM, 2012, P NATL ACAD SCI USA, V109, P10432, DOI 10.1073/pnas.1205333109; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; FRASER RDB, 1976, J APPL CRYSTALLOGR, V9, P81, DOI 10.1107/S0021889876010674; Geddes A. J., 1968, J MOL BIOL, V32, P343; GONZALEZ A, 1995, ACTA CRYSTALLOGR D, V51, P792, DOI 10.1107/S0907444995003027; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hetz C, 2003, TRENDS MOL MED, V9, P237, DOI 10.1016/S1471-4914(03)00069-8; Holmes BB, 2012, CURR OPIN NEUROL, V25, P721, DOI 10.1097/WCO.0b013e32835a3ee0; HOLMES KC, 1974, ACTA CRYSTALLOGR A, VA 30, P635, DOI 10.1107/S0567739474001537; HOLMES KC, 1958, VIROLOGY, V6, P328, DOI 10.1016/0042-6822(58)90086-2; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; KLUG A, 1958, ACTA CRYSTALLOGR, V11, P199, DOI 10.1107/S0365110X58000517; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Makarava N, 2012, J BIOL CHEM, V287, P30205, DOI 10.1074/jbc.M112.392985; Makarava N, 2012, J NEUROSCI, V32, P7345, DOI 10.1523/JNEUROSCI.6351-11.2012; Makarava N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002419; McDonald M, 2008, J APPL CRYSTALLOGR, V41, P206, DOI 10.1107/S0021889807060803; McGlinchey RP, 2009, P NATL ACAD SCI USA, V106, P13731, DOI 10.1073/pnas.0906509106; Mizuno N, 2011, P NATL ACAD SCI USA, V108, P3252, DOI 10.1073/pnas.1011342108; Ostapchenko VG, 2010, J MOL BIOL, V400, P908, DOI 10.1016/j.jmb.2010.05.051; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; PRUSINER SB, 2007, FIELDS VIROLOGY, P3059; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Rhodes G., 2006, CRYSTALLOGRAPHY MADE, P211; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Rudall K. M., 1946, S FIBROUS PROTEINS, P15; Sabate R, 2007, J MOL BIOL, V370, P768, DOI 10.1016/j.jmb.2007.05.014; Saupe SJ, 2011, SEMIN CELL DEV BIOL, V22, P460, DOI 10.1016/j.semcdb.2011.02.019; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sen A, 2007, J BIOL CHEM, V282, P5545, DOI 10.1074/jbc.M611464200; Shewmaker F, 2008, BIOCHEMISTRY-US, V47, P4000, DOI 10.1021/bi7024589; Siemer AB, 2006, J BIOMOL NMR, V34, P75, DOI 10.1007/s10858-005-5582-7; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Wan W, 2012, BIOPHYS J, V102, P2339, DOI [10.1016/j.bpj.2012.04.011, 10.1016/j.bpj.2012.04.01]; Wasmer C, 2008, ANGEW CHEM INT EDIT, V47, P5839, DOI 10.1002/anie.200704896; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wasmer C, 2010, J MOL BIOL, V402, P311, DOI 10.1016/j.jmb.2010.06.053; Wickner RB, 1999, MICROBIOL MOL BIOL R, V63, P844, DOI 10.1128/MMBR.63.4.844-861.1999; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106	53	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 11	2013	288	41					29604	29612		10.1074/jbc.M113.505511	http://dx.doi.org/10.1074/jbc.M113.505511			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OT	23986444	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000330615300036
J	Buitrago, L; Bhavanasi, D; Dangelmaier, C; Manne, BK; Badolia, R; Borgognone, A; Tsygankov, AY; McKenzie, SE; Kunapuli, SP				Buitrago, Lorena; Bhavanasi, Dheeraj; Dangelmaier, Carol; Manne, Bhanu Kanth; Badolia, Rachit; Borgognone, Alessandra; Tsygankov, Alexander Y.; McKenzie, Steven E.; Kunapuli, Satya P.			Tyrosine Phosphorylation on Spleen Tyrosine Kinase (Syk) Is Differentially Regulated in Human and Murine Platelets by Protein Kinase C Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Phosphotyrosine Signaling; Platelets; Protein Kinase C (PKC); Protein Phosphorylation; Protein-tyrosine Kinase (Tyrosine Kinase); GPVI; Syk	RECEPTOR GLYCOPROTEIN VI; COLLAGEN RECEPTOR; FUNCTIONAL-RESPONSES; GAMMA-CHAIN; ACTIVATION; DELTA; GPVI; THETA; PKC; ASSOCIATION	Protein kinase C (PKC) isoforms differentially regulate platelet functional responses downstream of glycoprotein VI (GPVI) signaling, but the role of PKCs regulating upstream effectors such as Syk is not known. We investigated the role of PKC on Syk tyrosine phosphorylation using the pan-PKC inhibitor GF109203X (GFX). GPVI-mediated phosphorylation on Syk Tyr-323, Tyr-352, and Tyr-525/526 was rapidly dephosphorylated, but GFX treatment inhibited this dephosphorylation on Tyr-525/526 in human platelets but not in wild type murine platelets. GFX treatment did not affect tyrosine phosphorylation on FcR chain or Src family kinases. Phosphorylation of Lat Tyr-191 and PLC2 Tyr-759 was also increased upon treatment with GFX. We evaluated whether secreted ADP is required for such dephosphorylation. Exogenous addition of ADP to GFX-treated platelets did not affect tyrosine phosphorylation on Syk. FcRIIA- or CLEC-2-mediated Syk tyrosine phosphorylation was also potentiated with GFX in human platelets. Because potentiation of Syk phosphorylation is not observed in murine platelets, PKC-deficient mice cannot be used to identify the PKC isoform regulating Syk phosphorylation. We therefore used selective inhibitors of PKC isoforms. Only PKC inhibition resulted in Syk hyperphosphorylation similar to that in platelets treated with GFX. This result indicates that PKC is the isoform responsible for Syk negative regulation in human platelets. In conclusion, we have elucidated a novel pathway of Syk regulation by PKC in human platelets.	[Buitrago, Lorena; Bhavanasi, Dheeraj; Manne, Bhanu Kanth; Badolia, Rachit; Kunapuli, Satya P.] Temple Univ, Dept Physiol, Philadelphia, PA 19140 USA; [Bhavanasi, Dheeraj; Dangelmaier, Carol; Manne, Bhanu Kanth; Badolia, Rachit; Tsygankov, Alexander Y.; Kunapuli, Satya P.] Temple Univ, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Tsygankov, Alexander Y.] Temple Univ, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Tsygankov, Alexander Y.] Temple Univ, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [Borgognone, Alessandra] Univ Birmingham, Inst Biomed Res, Coll Med & Dent Sci, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [McKenzie, Steven E.] Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Birmingham; Jefferson University	Kunapuli, SP (corresponding author), Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA.	spk@temple.edu	Tsygankov, Alexander Y/K-6205-2017	McKenzie, Steven/0000-0003-2654-8560	National Institutes of Health Research [HL 93231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093231, R01HL118593] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Research Grant HL 93231 (to S. P. K.).	Bhavanasi D, 2011, BIOCHEM PHARMACOL, V82, P720, DOI 10.1016/j.bcp.2011.06.032; Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200; BLOCKMANS D, 1995, BLOOD REV, V9, P143, DOI 10.1016/0268-960X(95)90020-9; Boylan B, 2008, BLOOD, V112, P2780, DOI 10.1182/blood-2008-02-142125; Buitrago L, 2011, BLOOD, V118, P5631, DOI 10.1182/blood-2011-01-328807; Chari R, 2009, BLOOD, V114, P3056, DOI 10.1182/blood-2008-11-188516; Chari R, 2009, ARTERIOSCL THROM VAS, V29, P699, DOI 10.1161/ATVBAHA.109.184010; Dangelmaier CA, 2005, BLOOD, V105, P3918, DOI 10.1182/blood-2004-09-3689; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Gilio K, 2010, J BIOL CHEM, V285, P23408, DOI 10.1074/jbc.M110.136176; Harper MT, 2010, J BIOL CHEM, V285, P19865, DOI 10.1074/jbc.M109.085654; Harper MT, 2009, BLOOD, V114, P489, DOI 10.1182/blood-2009-03-208454; Kasirer-Friede A, 2007, IMMUNOL REV, V218, P247, DOI 10.1111/j.1600-065X.2007.00532.x; Kim S, 2009, J BIOL CHEM, V284, P33763, DOI 10.1074/jbc.M109.048553; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Kronfeld I, 2000, J BIOL CHEM, V275, P35491, DOI 10.1074/jbc.M005991200; Manne BK, 2013, J BIOL CHEM, V288, P7717, DOI 10.1074/jbc.M112.424473; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Nieswandt B, 2001, BLOOD, V97, P3829, DOI 10.1182/blood.V97.12.3829; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Pasquet JM, 2000, J BIOL CHEM, V275, P28526, DOI 10.1074/jbc.M001531200; Pears CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003793; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Pula G, 2005, J BIOL CHEM, V280, P7194, DOI 10.1074/jbc.M409212200; Quinter PG, 2007, J THROMB HAEMOST, V5, P362, DOI 10.1111/j.1538-7836.2007.02309.x; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Severin S, 2011, J BIOL CHEM, V286, P4107, DOI 10.1074/jbc.M110.167502; Suzuki-Inoue K, 2002, J BIOL CHEM, V277, P21561, DOI 10.1074/jbc.M201012200; Thomas DH, 2010, BLOOD, V116, P2570, DOI 10.1182/blood-2010-02-268136; Violin JD, 2003, IUBMB LIFE, V55, P653, DOI 10.1080/152165401310001642216; Watson SP, 2010, J THROMB HAEMOST, V8, P1457, DOI 10.1111/j.1538-7836.2010.03875.x; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x	36	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29160	29169		10.1074/jbc.M113.464107	http://dx.doi.org/10.1074/jbc.M113.464107			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23960082	hybrid, Green Published			2022-12-28	WOS:000330298800069
J	Dudakovic, A; Evans, JM; Li, Y; Middha, S; McGee-Lawrence, ME; van Wijnen, AJ; Westendorf, JJ				Dudakovic, Amel; Evans, Jared M.; Li, Ying; Middha, Sumit; McGee-Lawrence, Meghan E.; van Wijnen, Andre J.; Westendorf, Jennifer J.			Histone Deacetylase Inhibition Promotes Osteoblast Maturation by Altering the Histone H4 Epigenome and Reduces Akt Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Bone; Corepressor Transcription; Epigenetics; Osteoblasts; Nherf1; Slc9a3r1; HDAC; Histone H4; Vorinostat	SUBEROYLANILIDE HYDROXAMIC ACID; ELEMENT ANNOTATION SYSTEM; MESENCHYMAL STEM-CELLS; LARGE GENE LISTS; OSTEOGENIC DIFFERENTIATION; SODIUM-BUTYRATE; TRICHOSTATIN-A; IN-VITRO; EXPRESSION; RUNX2	Bone has remarkable regenerative capacity, but this ability diminishes during aging. Histone deacetylase inhibitors (HDIs) promote terminal osteoblast differentiation and extracellular matrix production in culture. The epigenetic events altered by HDIs in osteoblasts may hold clues for the development of new anabolic treatments for osteoporosis and other conditions of low bone mass. To assess how HDIs affect the epigenome of committed osteoblasts, MC3T3 cells were treated with suberoylanilide hydroxamic acid (SAHA) and subjected to microarray gene expression profiling and high-throughput ChIP-Seq analysis. As expected, SAHA induced differentiation and matrix calcification of osteoblasts in vitro. ChIP-Seq analysis revealed that SAHA increased histone H4 acetylation genome-wide and in differentially regulated genes, except for the 500 bp upstream of transcriptional start sites. Pathway analysis indicated that SAHA increased the expression of insulin signaling modulators, including Slc9a3r1. SAHA decreased phosphorylation of insulin receptor , Akt, and the Akt substrate FoxO1, resulting in FoxO1 stabilization. Thus, SAHA induces genome-wide H4 acetylation and modulates the insulin/Akt/FoxO1 signaling axis, whereas it promotes terminal osteoblast differentiation in vitro.	[Dudakovic, Amel; McGee-Lawrence, Meghan E.; Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Evans, Jared M.; Li, Ying; Middha, Sumit] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [van Wijnen, Andre J.; Westendorf, Jennifer J.] Mayo Clin, Ctr Regenerat Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Westendorf, JJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu	van Wijnen, Andre J./AAG-3578-2019	van Wijnen, Andre J./0000-0002-4458-0946; Middha, Sumit/0000-0003-4135-6268; McGee-Lawrence, Meghan/0000-0002-2728-5849; Dudakovic, Amel/0000-0002-8850-3977	National Institutes of Health [R01 AR048147, R01 DE020194, AR049069, AR60140]; Mayo Clinic Center for Individualized Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, F32AR060140, R01AR048147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Individualized Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR048147 and R01 DE020194 (to J. J. W.), Grant AR049069 (to A. J. v. W.), and Grant AR60140 (to M. E. M.-L.). This work was also supported by the Mayo Clinic Center for Individualized Medicine.	Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; Ballman KV, 2004, BIOINFORMATICS, V20, P2778, DOI 10.1093/bioinformatics/bth327; Bradley EW, 2013, J BIOL CHEM, V288, P9572, DOI 10.1074/jbc.M112.423723; Di Bernardo G, 2009, STEM CELLS DEV, V18, P573, DOI 10.1089/scd.2008.0172; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; Haberland M, 2010, J BIOL CHEM, V285, P14663, DOI 10.1074/jbc.M109.081679; Hu XQ, 2013, STEM CELLS DEV, V22, P248, DOI 10.1089/scd.2012.0105; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; IWAMI K, 1993, INT J BIOCHEM, V25, P1631, DOI 10.1016/0020-711X(93)90522-G; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim HN, 2011, J BONE MINER RES, V26, P2161, DOI 10.1002/jbmr.426; Kim HJ, 2011, AM J TRANSL RES, V3, P166; LaBonte MJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-67; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu L, 2012, J BIOL CHEM, V287, P43312, DOI 10.1074/jbc.M112.422766; Maroni P, 2012, BIOCHEM BIOPH RES CO, V428, P271, DOI 10.1016/j.bbrc.2012.10.044; Marrocco DL, 2007, MOL CANCER THER, V6, P51, DOI 10.1158/1535-7163.MCT-06-0144; McGee-Lawrence ME, 2013, J BIOL CHEM, V288, P5291, DOI 10.1074/jbc.M112.414995; McGee-Lawrence ME, 2011, GENE, V474, P1, DOI 10.1016/j.gene.2010.12.003; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Rada-Iglesias A, 2007, GENOME RES, V17, P708, DOI 10.1101/gr.5540007; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Sadeh R, 2011, CELL, V147, P263, DOI 10.1016/j.cell.2011.09.042; Schroeder TM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-362; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Wightman F, 2012, IMMUNOL CELL BIOL, V90, P47, DOI 10.1038/icb.2011.95; Yi T, 2007, EXP MOL MED, V39, P213, DOI 10.1038/emm.2007.24; Yin D, 2007, CLIN CANCER RES, V13, P1045, DOI 10.1158/1078-0432.CCR-06-1261; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	62	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28783	28791		10.1074/jbc.M113.489732	http://dx.doi.org/10.1074/jbc.M113.489732			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23940046	Green Published, hybrid			2022-12-28	WOS:000330298800031
J	Farrow, SC; Facchini, PJ				Farrow, Scott C.; Facchini, Peter J.			Dioxygenases Catalyze O-Demethylation and O,O-Demethylenation with Widespread Roles in Benzylisoquinoline Alkaloid Metabolism in Opium Poppy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dioxygenase; Gene Silencing; Mass Spectrometry (MS); Metabolic Regulation; Plant Biochemistry; Plant Physiology; Secondary Metabolism	TANDEM MASS-SPECTROMETRY; MOLECULAR-CLONING; MORPHINE BIOSYNTHESIS; CELL-CULTURES; KEY ENZYME; DEMETHYLENATION; METHYLTRANSFERASE; DISCOVERY; RHOEADINE; TETRAHYDROPROTOBERBERINE	In opium poppy, the antepenultimate and final steps in morphine biosynthesis are catalyzed by the 2-oxoglutarate/Fe(II)-dependent dioxygenases, thebaine 6-O-demethylase (T6ODM) and codeine O-demethylase (CODM). Further investigation into the biochemical functions of CODM and T6ODM revealed extensive and unexpected roles for such enzymes in the metabolism of protopine, benzo[c]phenanthridine, and rhoeadine alkaloids. When assayed with a wide range of benzylisoquinoline alkaloids, CODM, T6ODM, and the functionally unassigned paralog DIOX2, renamed protopine O-dealkylase, showed novel and efficient dealkylation activities, including regio- and substrate-specific O-demethylation and O,O-demethylenation. Enzymes catalyzing O,O-demethylenation, which cleave a methylenedioxy bridge leaving two hydroxyl groups, have previously not been reported in plants. Similar cleavage of methylenedioxy bridges on substituted amphetamines is catalyzed by heme-dependent cytochromes P450 in mammals. Preferred substrates for O,O-demethylenation by CODM and protopine O-dealkylase were protopine alkaloids that serve as intermediates in the biosynthesis of benzo[c]phenanthridine and rhoeadine derivatives. Virus-induced gene silencing used to suppress the abundance of CODM and/or T6ODM transcripts indicated a direct physiological role for these enzymes in the metabolism of protopine alkaloids, and they revealed their indirect involvement in the formation of the antimicrobial benzo[c]phenanthridine sanguinarine and certain rhoeadine alkaloids in opium poppy.	[Farrow, Scott C.; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Facchini, PJ (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca		Farrow, Scott/0000-0001-7106-8924	Genome Canada; Genome Alberta; Government of Alberta; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation-Leaders Opportunity Fund; Alberta Innovates Technology Futures	Genome Canada(Genome Canada); Genome Alberta; Government of Alberta; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation-Leaders Opportunity Fund; Alberta Innovates Technology Futures	This work was supported in part by funding from Genome Canada, Genome Alberta, the Government of Alberta, the Natural Sciences and Engineering Research Council of Canada, and the Canada Foundation for Innovation-Leaders Opportunity Fund.; Recipient of scholarships from the Natural Sciences and Engineering Research Council of Canada and Alberta Innovates Technology Futures.	BAHADUR S, 1983, J NAT PROD, V46, P454, DOI 10.1021/np50028a002; Beaudoin GAW, 2013, BIOCHEM BIOPH RES CO, V431, P597, DOI 10.1016/j.bbrc.2012.12.129; Chavez MLD, 2011, ARCH BIOCHEM BIOPHYS, V507, P186, DOI 10.1016/j.abb.2010.11.016; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dang TTT, 2012, METHOD ENZYMOL, V515, P231, DOI 10.1016/B978-0-12-394290-6.00011-2; Dang TTT, 2012, PLANT PHYSIOL, V159, P618, DOI 10.1104/pp.112.194886; Decker G, 2000, ELECTROPHORESIS, V21, P3500, DOI 10.1002/1522-2683(20001001)21:16<3500::AID-ELPS3500>3.0.CO;2-O; Desgagne-Penix I, 2012, PLANT J, V72, P331, DOI 10.1111/j.1365-313X.2012.05084.x; Desgagne-Penix I, 2012, PLANT MOL BIOL, V79, P295, DOI 10.1007/s11103-012-9913-2; DOLEJS L, 1967, TETRAHEDRON, V23, P2997, DOI 10.1016/S0040-4020(01)83354-8; Farrow SC, 2012, PHYTOCHEMISTRY, V77, P79, DOI 10.1016/j.phytochem.2012.02.014; FUKUTO JM, 1991, J MED CHEM, V34, P2871, DOI 10.1021/jm00113a028; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Hagel JM, 2012, J BIOL CHEM, V287, P42972, DOI 10.1074/jbc.M112.420414; Hagel JM, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00014; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Ibragimova M.U, 1974, CHEM NAT COMPD+, V10, P481, DOI [10.1007/BF00563813, DOI 10.1007/BF00563813]; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; Kametani T., 1968, CHEM ISOQUINOLINE AL; Kametani T, 1974, CHEM ISOQUINOLINE AL, V2; Lassakaya O. E., 1978, CHEM NAT COMPD, V44, P650; LIN LY, 1992, CHEM RES TOXICOL, V5, P401, DOI 10.1021/tx00027a013; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liu CJ, 2001, PLANT CELL, V13, P2643, DOI 10.1105/tpc.13.12.2643; Liu YT, 2009, J PHARM SCI-US, V98, P4391, DOI 10.1002/jps.21721; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Manoj K. M., 2010, PLOS ONE, V5; Martin-Hernandez AM, 2008, J VIROL, V82, P4064, DOI 10.1128/JVI.02438-07; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; Meyer MR, 2008, DRUG METAB DISPOS, V36, P2345, DOI 10.1124/dmd.108.021543; Meyer MR, 2009, TOXICOL LETT, V190, P54, DOI 10.1016/j.toxlet.2009.06.866; MONTGOMERY CT, 1983, J NAT PROD, V46, P441, DOI 10.1021/np50028a001; Morishige T, 2002, EUR J BIOCHEM, V269, P5659, DOI 10.1046/j.1432-1033.2002.03275.x; Paul LD, 2004, EUR J PHARMACOL, V485, P69, DOI 10.1016/j.ejphar.2003.11.051; Purpero V, 2007, J BIOL INORG CHEM, V12, P587, DOI 10.1007/s00775-007-0231-0; RONSCH H, 1977, PHYTOCHEMISTRY, V16, P691, DOI 10.1016/S0031-9422(00)89233-X; Runguphan W, 2012, CHEM BIOL, V19, P674, DOI 10.1016/j.chembiol.2012.04.017; Samanani N, 2004, PLANT J, V40, P302, DOI 10.1111/j.1365-313X.2004.02210.x; Schmidt J, 2005, EUR J MASS SPECTROM, V11, P325, DOI 10.1255/ejms.745; Schmidt J, 2007, PHYTOCHEMISTRY, V68, P189, DOI 10.1016/j.phytochem.2006.10.003; TANI C, 1977, YAKUGAKU ZASSHI, V97, P93, DOI 10.1248/yakushi1947.97.1_93; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; Tracy Timothy S, 2006, Drugs R D, V7, P349, DOI 10.2165/00126839-200607060-00004; TUCKER GT, 1994, BIOCHEM PHARMACOL, V47, P1151, DOI 10.1016/0006-2952(94)90386-7; Wijekoon CP, 2012, PLANT J, V69, P1052, DOI 10.1111/j.1365-313X.2011.04855.x; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757; Zhu W, 2008, MED SCI MONITOR, V14, pSC15; Ziegler J, 2009, J BIOL CHEM, V284, P26758, DOI 10.1074/jbc.M109.030957; Zulak KG, 2007, PLANTA, V225, P1085, DOI 10.1007/s00425-006-0419-5	50	40	49	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28997	29012		10.1074/jbc.M113.488585	http://dx.doi.org/10.1074/jbc.M113.488585			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23928311	Green Published, hybrid			2022-12-28	WOS:000330298800054
J	Francisco, T; Rodrigues, TA; Freitas, MO; Grou, CP; Carvalho, AF; Sa-Miranda, C; Pinto, MP; Azevedo, JE				Francisco, Tania; Rodrigues, Tony A.; Freitas, Marta O.; Grou, Claudia P.; Carvalho, Andreia F.; Sa-Miranda, Clara; Pinto, Manuel P.; Azevedo, Jorge E.			A Cargo-centered Perspective on the PEX5 Receptor-mediated Peroxisomal Protein Import Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Peroxisomes; Protein Sorting; Protein Translocation; Subcellular Organelles; Ubiquitination; PEX5; PTS1 Protein; In Vitro Import Assays	TARGETING SIGNAL-1 RECOGNITION; HUMAN PTS1 RECEPTOR; ACYL-COA OXIDASE; CYCLING RECEPTOR; SACCHAROMYCES-CEREVISIAE; STEROL-CARRIER; YARROWIA-LIPOLYTICA; EXPORT MACHINERY; RAT-LIVER; MEMBRANE	Peroxisomal matrix proteins are synthesized on cytosolic ribosomes and post-translationally targeted to the organelle by PEX5, the peroxisomal shuttling receptor. The pathway followed by PEX5 during this process is known with reasonable detail. After recognizing cargo proteins in the cytosol, the receptor interacts with the peroxisomal docking/translocation machinery, where it gets inserted; PEX5 is then monoubiquitinated, extracted back to the cytosol and, finally, deubiquitinated. However, despite this information, the exact step of this pathway where cargo proteins are translocated across the organelle membrane is still ill-defined. In this work, we used an in vitro import system to characterize the translocation mechanism of a matrix protein possessing a type 1 targeting signal. Our results suggest that translocation of proteins across the organelle membrane occurs downstream of a reversible docking step and upstream of the first cytosolic ATP-dependent step (i.e. before ubiquitination of PEX5), concomitantly with the insertion of the receptor into the docking/translocation machinery.	[Francisco, Tania; Rodrigues, Tony A.; Freitas, Marta O.; Grou, Claudia P.; Carvalho, Andreia F.; Pinto, Manuel P.; Azevedo, Jorge E.] Univ Porto, Organelle Biogenesis & Funct Grp, IBMC, P-4150180 Oporto, Portugal; [Sa-Miranda, Clara] Univ Porto, Lysosome & Peroxisome Biol Unit, IBMC, P-4150180 Oporto, Portugal; [Francisco, Tania; Rodrigues, Tony A.; Freitas, Marta O.; Azevedo, Jorge E.] Univ Porto, ICBAS, P-4050313 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Azevedo, JE (corresponding author), IBMC, Organelle Biogenesis & Funct Grp, R Campo Alegre 823, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	Grou, Claudia P/K-5472-2013; Francisco, Tânia FAG/K-5545-2013; Azevedo, Jorge E/A-4113-2008; Rodrigues, Tony A. Q./K-1141-2014; Francisco, Tânia/AAK-9920-2020; Carvalho, Andreia/J-9013-2015; Freitas, Marta/J-8699-2013; Sa Miranda, Maria Clara Pereira/K-3920-2013; Pinto, Manuel/K-6425-2013	Grou, Claudia P/0000-0001-5197-2270; Francisco, Tânia FAG/0000-0003-3571-5164; Azevedo, Jorge E/0000-0001-7714-5302; Rodrigues, Tony A. Q./0000-0003-2311-8258; Francisco, Tânia/0000-0003-3571-5164; Carvalho, Andreia/0000-0001-8781-5680; Freitas, Marta/0000-0001-5779-2289; Sa Miranda, Maria Clara Pereira/0000-0003-0123-5525; Pinto, Manuel/0000-0001-9778-2093	Fundo Europeu de Desenvolvimento Regional (FEDER) through the Operational Competitiveness Programme (COMPETE); Fundacao para a Ciencia e a Tecnologia (FCT) [FCOMP-01-0124-FEDER-022718 (PEst-C/SAU/LA0002/2011), FCOMP-01-0124-FEDER-007044 (PTDC/BIA-BCM/64771/2006), FCOMP-01-0124-FEDER-019731 (PTDC/BIA-BCM/118577/2010)]; Fundacao para a Ciencia e a Tecnologia; Programa Operacional Potencial Humano do Quadro de Referencia Estrategica Nacional (QREN); Fundo Social Europeu; Programa Ciencia; Programa Operacional Potencial Humano do QREN; Tipologia 4.2; Promocao do Emprego Cientifico; Ministerio da Ciencia, Tecnologia e Ensino Superior	Fundo Europeu de Desenvolvimento Regional (FEDER) through the Operational Competitiveness Programme (COMPETE); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Potencial Humano do Quadro de Referencia Estrategica Nacional (QREN); Fundo Social Europeu; Programa Ciencia(Spanish Government); Programa Operacional Potencial Humano do QREN; Tipologia 4.2; Promocao do Emprego Cientifico; Ministerio da Ciencia, Tecnologia e Ensino Superior	This work was funded by Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the Operational Competitiveness Programme (COMPETE) and by national funds through the Fundacao para a Ciencia e a Tecnologia (FCT) under the projects FCOMP-01-0124-FEDER-022718 (PEst-C/SAU/LA0002/2011), FCOMP-01-0124-FEDER-007044 (PTDC/BIA-BCM/64771/2006), and FCOMP-01-0124-FEDER-019731 (PTDC/BIA-BCM/118577/2010).; Supported by Fundacao para a Ciencia e a Tecnologia, Programa Operacional Potencial Humano do Quadro de Referencia Estrategica Nacional (QREN), and Fundo Social Europeu.; Supported by Programa Ciencia, funded by Programa Operacional Potencial Humano do QREN, Tipologia 4.2, Promocao do Emprego Cientifico, by Fundo Social Europeu and by national funds from Ministerio da Ciencia, Tecnologia e Ensino Superior.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; Azevedo JE, 2004, CELL BIOCHEM BIOPHYS, V41, P451, DOI 10.1385/CBB:41:3:451; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; De Nys K, 2001, BBA-MOL CELL BIOL L, V1533, P66, DOI 10.1016/S1388-1981(01)00141-X; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Dodt G, 2001, J BIOL CHEM, V276, P41769, DOI 10.1074/jbc.M106932200; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; Freitas MO, 2011, J BIOL CHEM, V286, P40509, DOI 10.1074/jbc.M111.287201; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Galland N, 2007, BBA-MOL CELL RES, V1773, P521, DOI 10.1016/j.bbamcr.2007.01.006; Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7; Gatto GJ, 2000, PROTEINS, V38, P241, DOI 10.1002/(SICI)1097-0134(20000215)38:3<241::AID-PROT1>3.0.CO;2-1; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Grou CP, 2009, CELL MOL LIFE SCI, V66, P254, DOI 10.1007/s00018-008-8415-5; Grou CP, 2012, J BIOL CHEM, V287, P12815, DOI 10.1074/jbc.M112.340158; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Gunkel K, 2004, MOL BIOL CELL, V15, P1347, DOI 10.1091/mbc.E03-04-0258; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; HARTL FU, 1985, ARCH BIOCHEM BIOPHYS, V237, P124, DOI 10.1016/0003-9861(85)90261-9; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; HWANG ST, 1989, P NATL ACAD SCI USA, V86, P8432, DOI 10.1073/pnas.86.21.8432; Klein ATJ, 2002, J BIOL CHEM, V277, P25011, DOI 10.1074/jbc.M203254200; Kunze M, 2011, J BIOL CHEM, V286, P45048, DOI 10.1074/jbc.M111.301853; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Liu XQ, 2012, CURR OPIN CELL BIOL, V24, P484, DOI 10.1016/j.ceb.2012.05.003; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; Oeljeklaus S, 2012, J PROTEOME RES, V11, P2567, DOI 10.1021/pr3000333; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Oliveira MEM, 2002, BBA-BIOMEMBRANES, V1567, P13, DOI 10.1016/S0005-2736(02)00635-1; Oshima Y, 2008, PLANT CELL PHYSIOL, V49, P671, DOI 10.1093/pcp/pcn038; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Pinto MP, 2006, J BIOL CHEM, V281, P34492, DOI 10.1074/jbc.M607183200; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2013, CELL MOL LIFE SCI, V70, P1393, DOI 10.1007/s00018-012-1136-9; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; SEEDORF U, 1994, J BIOL CHEM, V269, P21277; SEEDORF U, 1993, GENE, V123, P165, DOI 10.1016/0378-1119(93)90120-R; Shiozawa K, 2009, J BIOL CHEM, V284, P25334, DOI 10.1074/jbc.M109.002311; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Szilard RK, 2000, BIOCHEM J, V346, P177, DOI 10.1042/0264-6021:3460177; Titorenko VI, 2002, J CELL BIOL, V156, P481, DOI 10.1083/jcb.200111075; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422	62	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					29151	29159		10.1074/jbc.M113.487140	http://dx.doi.org/10.1074/jbc.M113.487140			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23963456	hybrid, Green Published			2022-12-28	WOS:000330298800068
J	Kobayashi, H; Hirata, M; Saito, T; Itoh, S; Chung, U; Kawaguchi, H				Kobayashi, Hiroshi; Hirata, Makoto; Saito, Taku; Itoh, Shozo; Chung, Ung-il; Kawaguchi, Hiroshi			Transcriptional Induction of ADAMTS5 Protein by Nuclear Factor-kappa B (NF-kappa B) Family Member RelA/p65 in Chondrocytes during Osteoarthritis Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM ADAMTS; Articular Cartilage; Cartilage; Cartilage Biology; Chondrocytes; NF-kappa B (NF-KB); Osteoarthritis; Transcription; ADAMTS5; RelA; p65	HUMAN ARTICULAR CHONDROCYTES; GENE-EXPRESSION; MATRIX METALLOPROTEINASE-3; ENDOCHONDRAL OSSIFICATION; MOUSE CARTILAGE; MICE LACKING; ACTIVATION; INTERLEUKIN-1; AGGRECANASE; ARTHRITIS	Here we sought to identify transcription factors that induce ADAMTS5, a crucial proteinase for osteoarthritis development. Exhaustive comparison of the genomic sequences of human, macaque, and mouse ADAMTS5 genes revealed that the proximal 1.4 kb of the 5-end-flanking regions containing several consensus motifs was highly conserved. Among putative transcription factors for these motifs, NF-B family member RelA/p65 most strongly stimulated the promoter activity. In the ADAMTS5 gene, there were three NF-B binding motifs, in which deletion, mutagenesis, and tandem repeat analyses of the luciferase assay identified the core responsive elements of RelA/p65 to be -896/-887 and -424/-415 bp with specific bindings. The endogenous Adamts5 expression in ATDC5 cells was increased by RelA/p65 overexpression and decreased by knockdown through its siRNA. The expression was also inhibited by the Rela deletion through Cre transfection in primary articular chondrocytes from Rela(fl/fl) mice. In the ex vivo culture of femoral head cartilage from mesenchymal cell-specific Rela knock-out (Prx1-Cre;Rela(fl/fl)) mice, aggrecanolysis was significantly lower than that in the Rela(fl/fl) cartilage. Finally, in the experimental mouse osteoarthritis model, ADAMTS5 and RelA were co-localized in chondrocytes of degraded articular cartilage. We conclude that RelA/p65 is a potent transcriptional activator of ADAMTS5 in chondrocytes during osteoarthritis development.	[Kobayashi, Hiroshi; Hirata, Makoto; Itoh, Shozo; Kawaguchi, Hiroshi] Univ Tokyo, Dept Sensory & Motor Syst Med, Bunkyo Ku, Tokyo 1138655, Japan; [Saito, Taku] Univ Tokyo, Dept Bone & Cartilage Regenerat Med, Bunkyo Ku, Tokyo 1138655, Japan; [Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Kawaguchi, H (corresponding author), Univ Tokyo, Dept Sensory & Motor Syst Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kawaguchi-ort@h.u-tokyo.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [24592253, 22659266, 24659663]; Grants-in-Aid for Scientific Research [25293316, 24592253] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 24592253, 22659266, and 24659663 from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barthel KKB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002184; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bondeson J, 2007, J RHEUMATOL, V34, P523; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brophy RH, 2012, J BONE JOINT SURG AM, V94A, P385, DOI 10.2106/JBJS.K.00919; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Echtermeyer F, 2009, NAT MED, V15, P1072, DOI 10.1038/nm.1998; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Han ZN, 1998, AUTOIMMUNITY, V28, P197, DOI 10.3109/08916939808995367; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Itoh S, 2012, J BIOL CHEM, V287, P29227, DOI 10.1074/jbc.M112.372086; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li QT, 2005, TRENDS IMMUNOL, V26, P318, DOI 10.1016/j.it.2005.04.003; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Lianxu C, 2006, OSTEOARTHR CARTILAGE, V14, P367, DOI 10.1016/j.joca.2005.10.009; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Makihira S, 2003, ENDOCRINOLOGY, V144, P2480, DOI 10.1210/en.2002-220746; Malfait AM, 2008, ARCH BIOCHEM BIOPHYS, V478, P43, DOI 10.1016/j.abb.2008.07.012; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Park M, 2007, NAT CELL BIOL, V9, P287, DOI 10.1038/ncb1538; Pratta MA, 2003, ARTHRITIS RHEUM, V48, P119, DOI 10.1002/art.10726; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Sitcheran R, 2003, GENE DEV, V17, P2368, DOI 10.1101/gad.1114503; Souslova V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009902; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stanton H, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.179; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Thirunavukkarasu K, 2007, MOL BIOL REP, V34, P225, DOI 10.1007/s11033-006-9037-3; Tsushima H, 2012, ANN RHEUM DIS, V71, P99, DOI 10.1136/annrheumdis-2011-200061; Ushita M, 2009, OSTEOARTHR CARTILAGE, V17, P1065, DOI 10.1016/j.joca.2009.02.003; Verma P, 2011, J CELL BIOCHEM, V112, P3507, DOI 10.1002/jcb.23298; Yamada T, 2006, NAT MED, V12, P665, DOI 10.1038/nm1409; Yamanishi Y, 2002, J IMMUNOL, V168, P1405, DOI 10.4049/jimmunol.168.3.1405; Young DA, 2005, ARTHRITIS RES THER, V7, pR503, DOI 10.1186/ar1702; Zhang ZQ, 2010, ARTHRITIS RHEUM-US, V62, P1993, DOI 10.1002/art.27473	54	50	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28620	28629		10.1074/jbc.M113.452169	http://dx.doi.org/10.1074/jbc.M113.452169			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23963448	Green Published, hybrid			2022-12-28	WOS:000330298800018
J	Weber, BW; Kimani, SW; Varsani, A; Cowan, DA; Hunter, R; Venter, GA; Gumbart, JC; Sewell, BT				Weber, Brandon W.; Kimani, Serah W.; Varsani, Arvind; Cowan, Donald A.; Hunter, Roger; Venter, Gerhard A.; Gumbart, James C.; Sewell, B. Trevor			The Mechanism of the Amidases MUTATING THE GLUTAMATE ADJACENT TO THE CATALYTIC TRIAD INACTIVATES THE ENZYME DUE TO SUBSTRATE MISPOSITIONING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemical Biology; Enzyme Mechanisms; Enzyme Structure; Quantum Chemistry; X-ray Crystallography; Amidase	GEOBACILLUS-PALLIDUS RAPC8; AMINO ACID AMIDOHYDROLASE; AMBER FORCE-FIELD; NITRILASE SUPERFAMILY; ALIPHATIC AMIDASE; CRYSTAL-STRUCTURE; DENSITY; ENERGIES; ONIOM; SIMULATIONS	All known nitrilase superfamily amidase and carbamoylase structures have an additional glutamate that is hydrogen bonded to the catalytic lysine in addition to the Glu, Lys, Cys catalytic triad. In the amidase from Geobacillus pallidus, mutating this glutamate (Glu-142) to a leucine or aspartate renders the enzyme inactive. X-ray crystal structure determination shows that the structural integrity of the enzyme is maintained despite the mutation with the catalytic cysteine (Cys-166), lysine (Lys-134), and glutamate (Glu-59) in positions similar to those of the wild-type enzyme. In the case of the E142L mutant, a chloride ion is located in the position occupied by Glu-142 O-E1 in the wild-type enzyme and interacts with the active site lysine. In the case of the E142D mutant, this site is occupied by Asp-142 O-1. In neither case is an atom located at the position of Glu-142 O-E2 in the wild-type enzyme. The active site cysteine of the E142L mutant was found to form a Michael adduct with acrylamide, which is a substrate of the wild-type enzyme, due to an interaction that places the double bond of the acrylamide rather than the amide carbonyl carbon adjacent to the active site cysteine. Our results demonstrate that in the wild-type active site a crucial role is played by the hydrogen bond between Glu-142 O-E2 and the substrate amino group in positioning the substrate with the correct stereoelectronic alignment to enable the nucleophilic attack on the carbonyl carbon by the catalytic cysteine.	[Weber, Brandon W.; Kimani, Serah W.; Varsani, Arvind; Sewell, B. Trevor] Univ Cape Town, Struct Biol Res Unit, Div Med Biochem, Dept Clin Lab Sci, ZA-7925 Observatory, Western Cape, South Africa; [Sewell, B. Trevor] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Observatory, Western Cape, South Africa; [Kimani, Serah W.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, Western Cape, South Africa; [Varsani, Arvind] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Varsani, Arvind] Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Cowan, Donald A.] Univ Western Cape, Inst Microbial Biotechnol & Metagen, Dept Biotechnol, ZA-7535 Cape Town, South Africa; [Cowan, Donald A.] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Hunter, Roger; Venter, Gerhard A.] Univ Cape Town, Dept Chem, Sci Comp Res Unit, ZA-7700 Rondebosch, South Africa; [Gumbart, James C.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA	University of Cape Town; University of Cape Town; University of Cape Town; University of Canterbury; University of Canterbury; University of the Western Cape; University of Pretoria; University of Cape Town; University System of Georgia; Georgia Institute of Technology	Sewell, BT (corresponding author), Univ Cape Town, Struct Biol Res Unit, Dept Clin Lab Sci, Inst Infect Dis & Mol Med, ZA-7925 Observatory, Western Cape, South Africa.	Trevor.Sewell@uct.ac.za	Cowan, Donald A/E-3991-2012; Venter, Gerhard/GQI-1207-2022	Cowan, Donald A/0000-0001-8059-861X; Venter, Gerhard/0000-0003-3993-1198; Varsani, Arvind/0000-0003-4111-2415; Sewell, Bryan Trevor/0000-0002-6701-2394; Hunter, Roger/0000-0001-8775-083X	National Research Foundation; Carnegie Corporation of New York; National Institutes of Health [K22-AI100927]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI100927] Funding Source: NIH RePORTER	National Research Foundation; Carnegie Corporation of New York; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Research Foundation and the Carnegie Corporation of New York.; Supported by Grant K22-AI100927 from the National Institutes of Health.	Agarkar VB, 2006, ACTA CRYSTALLOGR F, V62, P1174, DOI 10.1107/S1744309106043855; Andrade J, 2007, J BIOL CHEM, V282, P19598, DOI 10.1074/jbc.M701039200; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BORK P, 1994, PROTEIN SCI, V3, P1344, DOI 10.1002/pro.5560030821; Cameron RA, 2005, BBA-GEN SUBJECTS, V1725, P35, DOI 10.1016/j.bbagen.2005.03.019; Chen CY, 2003, J BIOL CHEM, V278, P26194, DOI 10.1074/jbc.M302384200; Chien CH, 2012, J BIOL CHEM, V287, P25715, DOI 10.1074/jbc.M111.259119; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes BCM, 2006, ADV SYNTH CATAL, V348, P2597, DOI 10.1002/adsc.200600269; Frisch M. J., 2009, GAUSSIAN 09 REVISION; HORN DB, 1966, CLIN CHIM ACTA, V14, P185, DOI 10.1016/0009-8981(66)90085-4; Hung CL, 2007, J BIOL CHEM, V282, P12220, DOI 10.1074/jbc.M609134200; Jandhyala DM, 2005, APPL MICROBIOL BIOT, V68, P327, DOI 10.1007/s00253-005-1903-8; Kimani SW, 2007, ACTA CRYSTALLOGR D, V63, P1048, DOI 10.1107/S090744490703836X; Krasnikov BF, 2009, BIOCHIMIE, V91, P1072, DOI 10.1016/j.biochi.2009.07.003; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee MC, 2004, PROTEINS, V55, P620, DOI 10.1002/prot.10470; MAESTRACCI M, 1986, AGR BIOL CHEM TOKYO, V50, P2237, DOI 10.1080/00021369.1986.10867736; Makhongela HS, 2007, APPL MICROBIOL BIOT, V75, P801, DOI 10.1007/s00253-007-0883-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 2000, STRUCTURE, V8, P729, DOI 10.1016/S0969-2126(00)00160-X; Nel AJM, 2011, APPL ENVIRON MICROB, V77, P3696, DOI 10.1128/AEM.02726-10; Pace HC, 2001, GENOME BIOL, V2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Piotrowski M, 2008, PHYTOCHEMISTRY, V69, P2655, DOI 10.1016/j.phytochem.2008.08.020; Raczynska JE, 2011, J STRUCT BIOL, V173, P294, DOI 10.1016/j.jsb.2010.11.017; Soriano-Maldonado P, 2011, APPL ENVIRON MICROB, V77, P5761, DOI 10.1128/AEM.00312-11; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; STEVENSON DE, 1990, FEBS LETT, V277, P112, DOI 10.1016/0014-5793(90)80821-Y; Tao P, 2010, J COMPUT CHEM, V31, P2363, DOI 10.1002/jcc.21524; Thuku RN, 2009, J APPL MICROBIOL, V106, P703, DOI 10.1111/j.1365-2672.2008.03941.x; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Vreven T, 2006, J CHEM THEORY COMPUT, V2, P815, DOI 10.1021/ct050289g; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	40	23	23	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28514	28523		10.1074/jbc.M113.503284	http://dx.doi.org/10.1074/jbc.M113.503284			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23946488	Green Published, hybrid			2022-12-28	WOS:000330298800009
J	You, CJ; Swanson, AL; Dai, XX; Yuan, BF; Wang, JS; Wang, YS				You, Changjun; Swanson, Ashley L.; Dai, Xiaoxia; Yuan, Bifeng; Wang, Jianshuang; Wang, Yinsheng			Translesion Synthesis of 8,5 '-Cyclopurine-2 '-deoxynucleosides by DNA Polymerases eta, iota, and zeta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; DNA Polymerase; DNA Replication; Mutagenesis Site Specific; Oxygen Radicals	NUCLEOTIDE EXCISION-REPAIR; FREE REPLICATIVE BYPASS; NF-KAPPA-B; HUMAN-CELLS; ERROR-FREE; MAMMALIAN-CELLS; IN-VITRO; 2-POLYMERASE MECHANISMS; ESCHERICHIA-COLI; LESIONS	Reactive oxygen species can give rise to a battery of DNA damage products including the 8,5-cyclo-2-deoxyadenosine (cdA) and 8,5-cyclo-2-deoxyguanosine (cdG) tandem lesions. The 8,5-cyclopurine-2-deoxynucleosides are quite stable lesions and are valid and reliable markers of oxidative DNA damage. However, it remains unclear how these lesions compromise DNA replication in mammalian cells. Previous in vitro biochemical assays have suggested a role for human polymerase (Pol) in the insertion step of translesion synthesis (TLS) across the (5S) diastereomers of cdA and cdG. Using in vitro steady-state kinetic assay, herein we showed that human Pol and a two-subunit yeast Pol complex (REV3/REV7) could function efficiently in the insertion and extension steps, respectively, of TLS across S-cdA and S-cdG; human Pol and Pol could also extend past these lesions, albeit much less efficiently. Results from a quantitative TLS assay showed that, in human cells, S-cdA and S-cdG inhibited strongly DNA replication and induced substantial frequencies of mutations at the lesion sites. Additionally, Pol , Pol , and Pol , but not Pol , had important roles in promoting replication through S-cdA and S-cdG in human cells. Based on these results, we propose a model for TLS across S-cdA and S-cdG in human cells, where Pol and/or Pol carries out nucleotide insertion opposite the lesion, whereas Pol executes the extension step.	[You, Changjun; Dai, Xiaoxia; Yuan, Bifeng; Wang, Jianshuang; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Swanson, Ashley L.; Wang, Yinsheng] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Yuan, Bi-Feng/K-5803-2013	Yuan, Bi-Feng/0000-0001-5223-4659; You, Changjun/0000-0003-4301-2098; Dai, Xiaoxia/0000-0002-3514-5061	National Institutes of Health [R01 CA101864]; National Research Service Award T32 Training Grant [T32 ES018827]; NATIONAL CANCER INSTITUTE [R01CA101864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES018827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award T32 Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA101864.; Supported by an National Research Service Award T32 Training Grant T32 ES018827.	Abraham J, 2011, ENVIRON MOL MUTAGEN, V52, P287, DOI 10.1002/em.20619; Andersen N, 2012, CHEM RES TOXICOL, V25, P2523, DOI 10.1021/tx300325q; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Brooks PJ, 2008, DNA REPAIR, V7, P1168, DOI 10.1016/j.dnarep.2008.03.016; Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200; Burns JA, 2010, NUCLEIC ACIDS RES, V38, P8178, DOI 10.1093/nar/gkq706; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Chatgilialoglu C, 2011, CHEM SOC REV, V40, P1368, DOI 10.1039/c0cs00061b; de Feraudy S, 2007, ONCOGENE, V26, P5713, DOI 10.1038/sj.onc.1210385; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Jaruga P, 2008, DNA REPAIR, V7, P1413, DOI 10.1016/j.dnarep.2008.06.005; Jasti VP, 2011, BIOCHEMISTRY-US, V50, P3862, DOI 10.1021/bi2004944; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Kuraoka I, 2000, P NATL ACAD SCI USA, V97, P3832, DOI 10.1073/pnas.070471597; Kuraoka I, 2001, J BIOL CHEM, V276, P49283, DOI 10.1074/jbc.M107779200; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Levine RL, 2000, CANCER RES, V60, P4098; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Livneh Z, 2010, CELL CYCLE, V9, P729, DOI 10.4161/cc.9.4.10727; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Marietta C, 2002, DNA REPAIR, V1, P967, DOI 10.1016/S1568-7864(02)00148-9; Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020; Masuda Y, 2003, J BIOL CHEM, V278, P12356, DOI 10.1074/jbc.M211765200; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Pande P, 2012, DNA REPAIR, V11, P926, DOI 10.1016/j.dnarep.2012.09.002; Romieu A, 1999, CHEM RES TOXICOL, V12, P412, DOI 10.1021/tx9802668; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; SANCHEZ JA, 1992, J CELL SCI, V103, P907; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Shaked H, 2012, P NATL ACAD SCI USA, V109, P14007, DOI 10.1073/pnas.1211509109; Swanson AL, 2012, CHEM RES TOXICOL, V25, P1682, DOI 10.1021/tx3001576; Taylor E, 2003, J FOREST, V101, P1; Thakur M, 2001, GENE CHROMOSOME CANC, V32, P222, DOI 10.1002/gcc.1186; Wang J, 2012, AGING CELL, V11, P714, DOI 10.1111/j.1474-9726.2012.00828.x; Wang J, 2011, ANAL CHEM, V83, P2201, DOI 10.1021/ac103099s; Wang YS, 2008, CHEM RES TOXICOL, V21, P276, DOI 10.1021/tx700411g; Yang IY, 2002, CHEM RES TOXICOL, V15, P160, DOI 10.1021/tx010123c; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; You CJ, 2012, J BIOL CHEM, V287, P40915, DOI 10.1074/jbc.M112.418681; You CJ, 2012, NAT CHEM BIOL, V8, P817, DOI 10.1038/NCHEMBIO.1046; Yuan BF, 2011, NUCLEIC ACIDS RES, V39, P5945, DOI 10.1093/nar/gkr159; Yuan BF, 2011, J BIOL CHEM, V286, P17503, DOI 10.1074/jbc.M111.232835; Ziegler K, 2004, J VIROL METHODS, V122, P123, DOI 10.1016/j.jviromet.2004.08.012; Ziv O, 2009, P NATL ACAD SCI USA, V106, P11552, DOI 10.1073/pnas.0812548106	53	60	59	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 4	2013	288	40					28548	28556		10.1074/jbc.M113.480459	http://dx.doi.org/10.1074/jbc.M113.480459			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	298BL	23965998	Green Published, hybrid			2022-12-28	WOS:000330298800012
J	Cochran, JC; Thompson, ME; Kull, FJ				Cochran, Jared C.; Thompson, Morgan E.; Kull, F. Jon			Metal Switch-controlled Myosin II from Dictyostelium discoideum Supports Closure of Nucleotide Pocket during ATP Binding Coupled to Detachment from Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; X-RAY STRUCTURES; MOTOR DOMAIN; KINETIC CHARACTERIZATION; CRYSTAL-STRUCTURE; MOLECULAR MOTOR; ION CATALYSIS; F-ACTIN; ACTOMYOSIN SUBFRAGMENT-1; ADENOSINE-TRIPHOSPHATASE	G-proteins, kinesins, and myosins are hydrolases that utilize a common protein fold and divalent metal cofactor (typically Mg2+) to coordinate purine nucleotide hydrolysis. The nucleoside triphosphorylase activities of these enzymes are activated through allosteric communication between the nucleotide-binding site and the activator/effector/polymer interface to convert the free energy of nucleotide hydrolysis into molecular switching (G-proteins) or force generation (kinesins and myosin). We have investigated the ATPase mechanisms of wild-type and the S237C mutant of non-muscle myosin II motor from Dictyostelium discoideum. The S237C substitution occurs in the conserved metal-interacting switch-1, and we show that this substitution modulates the actomyosin interaction based on the divalent metal present in solution. Surprisingly, S237C shows rapid basal steady-state Mg2+- or Mn2+ -ATPase kinetics, but upon binding actin, its MgATPase is inhibited. This actin inhibition is relieved by Mn2+, providing a direct and experimentally reversible linkage of switch-1 and the actin-binding cleft through the swapping of divalent metals in the reaction. Using pyrenyl-labeled F-actin, we demonstrate that acto center dot S237C undergoes slow and weak MgATP binding, which limits the rate of steady-state catalysis. Mn2+ rescues this effect to near wildtype activity. 2'(3')-O-(N-Methylanthraniloyl)-ADP release experiments show the need for switch-1 interaction with the metal cofactor for tight ADP binding. Our results are consistent with strong reciprocal coupling of nucleoside triphosphate and F-actin binding and provide additional evidence for the allosteric communication pathway between the nucleotide-binding site and the filament-binding region.	[Cochran, Jared C.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Thompson, Morgan E.; Kull, F. Jon] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Kull, F. Jon] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Indiana University System; Indiana University Bloomington; Dartmouth College; Dartmouth College	Cochran, JC (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Simon Hall,Rm 405C,212 S Hawthorne Dr, Bloomington, IN 47405 USA.	jcc6@indiana.edu			National Institutes of Health [R01 GM097079]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM097079 (to F. J. K.).	Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Allingham JS, 1999, J MOL BIOL, V289, P1195, DOI 10.1006/jmbi.1999.2837; BAGSHAW CR, 1974, BIOCHEM J, V141, P331, DOI 10.1042/bj1410331; Bobkov AA, 1997, J MUSCLE RES CELL M, V18, P563, DOI 10.1023/A:1018667319386; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Conibear PB, 2004, BIOCHEMISTRY-US, V43, P15404, DOI 10.1021/bi048338j; Conibear PB, 2003, NAT STRUCT BIOL, V10, P831, DOI 10.1038/nsb986; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Frederiksen JK, 2009, METHODS, V49, P148, DOI 10.1016/j.ymeth.2009.07.005; FREY MN, 1973, ACTA CRYSTALLOGR B, VB 29, P876, DOI 10.1107/S0567740873003481; Frye JJ, 2010, BIOCHEMISTRY-US, V49, P4897, DOI 10.1021/bi1001344; FURUKAWA KI, 1980, J BIOCHEM-TOKYO, V88, P1629, DOI 10.1093/oxfordjournals.jbchem.a133139; Gao K, 2004, J VIROL, V78, P6715, DOI 10.1128/JVI.78.13.6715-6722.2004; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; Gollub J, 1999, BIOCHEMISTRY-US, V38, P10107, DOI 10.1021/bi990267e; Gulick AM, 1997, BIOCHEMISTRY-US, V36, P11619, DOI 10.1021/bi9712596; Hannemann DE, 2005, BIOCHEMISTRY-US, V44, P8826, DOI 10.1021/bi0473509; HE JJ, 1991, SCIENCE, V251, P1479, DOI 10.1126/science.1900953; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Himmel DM, 2002, P NATL ACAD SCI USA, V99, P12645, DOI 10.1073/pnas.202476799; HIRATSUKA T, 1994, J BIOL CHEM, V269, P27251; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; IKEBE M, 1980, J BIOCHEM-TOKYO, V88, P1653, DOI 10.1093/oxfordjournals.jbchem.a133141; INOUE A, 1980, J BIOCHEM-TOKYO, V88, P1663, DOI 10.1093/oxfordjournals.jbchem.a133142; ITAKURA S, 1993, BIOCHEM BIOPH RES CO, V196, P1504, DOI 10.1006/bbrc.1993.2422; JAFFE EK, 1979, J BIOL CHEM, V254, P839; JOHN J, 1993, J BIOL CHEM, V268, P923; Johnson K. A., 1992, ENZYMES, P1; JOHNSON KA, 1978, BIOCHEMISTRY-US, V17, P3432, DOI 10.1021/bi00610a002; KERR KA, 1975, ACTA CRYSTALLOGR B, V31, P2022, DOI 10.1107/S0567740875006772; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; KISTENMACHER TJ, 1974, ACTA CRYSTALLOGR B, V30, P2573, DOI 10.1107/S0567740874007618; Kliche W, 2001, EMBO J, V20, P40, DOI 10.1093/emboj/20.1.40; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kull FJ, 2004, TRENDS BIOCHEM SCI, V29, P103, DOI 10.1016/j.tibs.2004.01.001; Kull FJ, 2002, J CELL SCI, V115, P15; Kull FJ, 1998, J MUSCLE RES CELL M, V19, P877, DOI 10.1023/A:1005489907021; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Kurzawa SE, 1996, J MUSCLE RES CELL M, V17, P669, DOI 10.1007/BF00154061; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Malnasi-Csizmadia A, 2005, J MUSCLE RES CELL M, V26, P31, DOI 10.1007/s10974-005-9004-y; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; Malnasi-Csizmadia A., 2001, J BIOL CHEM, V276, P19483; MANSTEIN DJ, 1995, J MUSCLE RES CELL M, V16, P325, DOI 10.1007/BF00121141; Marx A, 2005, ADV PROTEIN CHEM, V71, P299, DOI 10.1016/S0065-3233(04)71008-6; Minehardt TJ, 2001, BIOPHYS J, V80, P1151, DOI 10.1016/S0006-3495(01)76092-4; Naber N, 2003, BIOPHYS J, V84, P3190, DOI 10.1016/S0006-3495(03)70043-5; Naber N, 2003, SCIENCE, V300, P798, DOI 10.1126/science.1082374; Naber N, 2010, J MOL BIOL, V396, P937, DOI 10.1016/j.jmb.2009.12.035; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Ovchinnikov V, 2010, J MOL BIOL, V395, P815, DOI 10.1016/j.jmb.2009.10.029; PICCIRILLI JA, 1993, NATURE, V361, P85, DOI 10.1038/361085a0; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Purcell TJ, 2011, J MOL BIOL, V407, P79, DOI 10.1016/j.jmb.2010.11.053; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; Rosenfeld SS, 2000, J BIOL CHEM, V275, P25418, DOI 10.1074/jbc.M002685200; Sack S, 1999, EUR J BIOCHEM, V262, P1, DOI 10.1046/j.1432-1327.1999.00341.x; Sarnovsky RJ, 1996, EMBO J, V15, P6348, DOI 10.1002/j.1460-2075.1996.tb01024.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shih WM, 2000, CELL, V102, P683, DOI 10.1016/S0092-8674(00)00090-8; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Sontheimer EJ, 1999, GENE DEV, V13, P1729, DOI 10.1101/gad.13.13.1729; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Woodward SKA, 1995, BIOCHEMISTRY-US, V34, P16056, DOI 10.1021/bi00049a020; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017; Yang YT, 2007, STRUCTURE, V15, P553, DOI 10.1016/j.str.2007.03.010; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u; Zheng WJ, 2010, PROTEINS, V78, P638, DOI 10.1002/prot.22594	89	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28312	28323		10.1074/jbc.M113.466045	http://dx.doi.org/10.1074/jbc.M113.466045			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23960071	Green Published, hybrid			2022-12-28	WOS:000330612800060
J	de Oliveira, GAP; Pereira, EG; Ferretti, GDS; Valente, AP; Cordeiro, Y; Silva, JL				de Oliveira, Guilherme A. P.; Pereira, Elen G.; Ferretti, Giulia D. S.; Valente, Ana Paula; Cordeiro, Yraima; Silva, Jerson L.			Intramolecular Dynamics within the N-Cap-SH3-SH2 Regulatory Unit of the c-Abl Tyrosine Kinase Reveal Targeting to the Cellular Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; BCR-ABL; TRANSFORMING ACTIVITY; PROTEIN; LEUKEMIA; INSIGHTS; MYRISTOYLATION; AUTOINHIBITION; CONFORMATION; INHIBITORS	c-Abl is a key regulator of cell signaling and is under strict control via intramolecular interactions. In this study, we address changes in the intramolecular dynamics coupling within the c-Abl regulatory unit by presenting its N-terminal segment (N-Cap) with an alternative function in the cell as c-Abl becomes activated. Using small angle x-ray scattering, nuclear magnetic resonance, and confocal microscopy, we demonstrate that the N-Cap and the Src homology (SH) 3 domain acquire mu s-ms motions upon N-Cap association with the SH2-L domain, revealing a stabilizing synergy between these segments. The N-Cap-myristoyl tether likely triggers the protein to anchor to the membrane because of these flip-flop dynamics, which occur in the mu s-ms time range. This segment not only presents the myristate during c-Abl inhibition but may also trigger protein localization inside the cell in a functional and stability-dependent mechanism that is lost in Bcr-Abl(+) cells, which underlie chronic myeloid leukemia. This loss of intramolecular dynamics and binding to the cellular membrane is a potential therapeutic target.	[de Oliveira, Guilherme A. P.; Pereira, Elen G.; Ferretti, Giulia D. S.; Valente, Ana Paula; Silva, Jerson L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Nacl Biol Estrutural & Bioimagem, Programa Biol Estrutural,Inst Bioquim Med, BR-21941902 Rio De Janeiro, RJ, Brazil; [Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, BR-21941902 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Nacl Biol Estrutural & Bioimagem, Programa Biol Estrutural,Inst Bioquim Med, BR-21941902 Rio De Janeiro, RJ, Brazil.	jerson@bioqmed.ufrj.br	SILVA, JERSON Lima/GRF-1442-2022; de Oliveira, Guilherme A. P./O-1192-2013; Silva, Jerson/J-8984-2014; Valente, Ana Paula/J-3010-2017; Cordeiro, Yraima/J-7619-2012; Gomes Pereira, Elen/H-9585-2013	SILVA, JERSON Lima/0000-0001-9523-9441; de Oliveira, Guilherme A. P./0000-0002-0063-5888; Silva, Jerson/0000-0001-9523-9441; Valente, Ana Paula/0000-0001-7219-1123; Cordeiro, Yraima/0000-0003-4278-212X; Diniz da Silva Ferretti, Giulia/0000-0002-1205-6090; Gomes Pereira, Elen/0000-0001-8073-7931	Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Ministerio da Saude (MS/DECIT); Financiadora de Estudos e Projetos (FINEP) of Brazil	Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Ministerio da Saude (MS/DECIT); Financiadora de Estudos e Projetos (FINEP) of Brazil(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by grants from the Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Ministerio da Saude (MS/DECIT), and Financiadora de Estudos e Projetos (FINEP) of Brazil.	Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; de Oliveira GAP, 2013, BIOCHEMISTRY-US, V52, P28, DOI 10.1021/bi301139d; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fushman D, 1999, BIOCHEMISTRY-US, V38, P10225, DOI 10.1021/bi990897g; Grebien F, 2011, CELL, V147, P306, DOI 10.1016/j.cell.2011.08.046; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hantschel O, 2012, CANCER RES, V72, P4890, DOI 10.1158/0008-5472.CAN-12-1276; Heisterkamp N, 2002, ONCOGENE, V21, P8536, DOI 10.1038/sj.onc.1206080; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nam HJ, 1996, STRUCTURE, V4, P1105, DOI 10.1016/S0969-2126(96)00116-5; NOWELL PC, 1960, SCIENCE, V132, P1497; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Taniguchi H, 1999, BIOPHYS CHEM, V82, P129, DOI 10.1016/S0301-4622(99)00112-X; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Urist M, 2004, CANCER CELL, V5, P515, DOI 10.1016/j.ccr.2004.06.001; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Zhu JY, 1996, MOL CELL BIOL, V16, P7054	38	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28331	28345		10.1074/jbc.M113.500926	http://dx.doi.org/10.1074/jbc.M113.500926			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23928308	Green Published, hybrid			2022-12-28	WOS:000330612800062
J	Harling, JD; Deakin, AM; Campos, S; Grimley, R; Chaudry, L; Nye, C; Polyakova, O; Bessant, CM; Barton, N; Somers, D; Barrett, J; Graves, RH; Hanns, L; Kerr, WJ; Solari, R				Harling, John D.; Deakin, Angela M.; Campos, Sebastien; Grimley, Rachel; Chaudry, Laiq; Nye, Catherine; Polyakova, Oxana; Bessant, Christina M.; Barton, Nick; Somers, Don; Barrett, John; Graves, Rebecca H.; Hanns, Laura; Kerr, William J.; Solari, Roberto			Discovery of Novel Irreversible Inhibitors of Interleukin (IL)-2-inducible Tyrosine Kinase (Itk) by Targeting Cysteine 442 in the ATP Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL KINASE; GROWTH-FACTOR RECEPTOR; TEC FAMILY KINASE; MICE LACKING; CYTOKINE PRODUCTION; ALLERGIC-ASTHMA; CUTTING EDGE; IFN-GAMMA; RESPONSES; RLK	IL-2-inducible tyrosine kinase (Itk) plays a key role in antigen receptor signaling in T cells and is considered an important target for anti-inflammatory drug discovery. In order to generate inhibitors with the necessary potency and selectivity, a compound that targeted cysteine 442 in the ATP binding pocket and with an envisaged irreversible mode of action was designed. We incorporated a high degree of molecular recognition and specific design features making the compound suitable for inhaled delivery. This study confirms the irreversible covalent binding of the inhibitor to the kinase by x-ray crystallography and enzymology while demonstrating potency, selectivity, and prolonged duration of action in in vitro biological assays. The biosynthetic turnover of the kinase was also examined as a critical factor when designing irreversible inhibitors for extended duration of action. The exemplified Itk inhibitor demonstrated inhibition of both T-H1 and T-H2 cytokines, was additive with fluticasone propionate, and inhibited cytokine release from human lung fragments. Finally, we describe an in vivo pharmacodynamic assay that allows rapid preclinical development without animal efficacy models.	[Harling, John D.; Deakin, Angela M.; Campos, Sebastien; Bessant, Christina M.; Barrett, John; Graves, Rebecca H.; Hanns, Laura; Solari, Roberto] GlaxoSmithKline, Allerg Inflammat Discovery Performance Unit, Stevenage SG1 2NY, Herts, England; [Grimley, Rachel; Chaudry, Laiq; Nye, Catherine; Polyakova, Oxana; Barton, Nick; Somers, Don] GlaxoSmithKline, Platform Technol Sci, Stevenage SG1 2NY, Herts, England; [Kerr, William J.] Univ Strathclyde, Dept Pure & Appl Chem, WestCHEM, Glasgow G1 1XL, Lanark, Scotland	GlaxoSmithKline; GlaxoSmithKline; University of Strathclyde	Solari, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Infect Sect, Norfolk Pl, London W2 1PG, England.	roberto.2.solari@gsk.com		Campos, Sebastien/0000-0003-1717-5918; Buckley, Catherine/0000-0003-2105-0456; Kerr, William/0000-0002-1332-785X				Alder CM, 2013, ACS MED CHEM LETT, V4, P948, DOI 10.1021/ml400206q; Alexander DJ, 2008, INHAL TOXICOL, V20, P1179, DOI [10.1080/08958370802207318, 10.1080/08958370802207318 ]; Atherly LO, 2006, J IMMUNOL, V176, P1571, DOI 10.4049/jimmunol.176.3.1571; Au-Yeung BB, 2007, J IMMUNOL, V179, P111, DOI 10.4049/jimmunol.179.1.111; Au-Yeung BB, 2006, J IMMUNOL, V176, P3895, DOI 10.4049/jimmunol.176.7.3895; August A, 2012, INT REV IMMUNOL, V31, P155, DOI 10.3109/08830185.2012.668981; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOCHNER BS, 1987, J IMMUNOL, V139, P2303; Carpenter RL, 2012, J THORAC DIS, V4, P639, DOI 10.3978/j.issn.2072-1439.2012.10.09; Charrier JD, 2011, J MED CHEM, V54, P2341, DOI 10.1021/jm101499u; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Das J, 2006, BIOORG MED CHEM LETT, V16, P3706, DOI 10.1016/j.bmcl.2006.04.060; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, DATA COLLECTION PROC, P114; Felices M, 2008, J IMMUNOL, V180, P3007, DOI 10.4049/jimmunol.180.5.3007; Ferrara TJ, 2006, J ALLERGY CLIN IMMUN, V117, P780, DOI 10.1016/j.jaci.2005.12.1330; Forssell J, 2005, AM J RESP CELL MOL, V32, P511, DOI 10.1165/rcmb.2004-0348OC; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Fry DW, 1998, P NATL ACAD SCI USA, V95, P12022, DOI 10.1073/pnas.95.20.12022; Guimond DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063645; Herdemann M, 2011, BIOORG MED CHEM LETT, V21, P1852, DOI 10.1016/j.bmcl.2011.01.035; Holmes AM, 2011, DRUG DISCOV TODAY, V16, P659, DOI 10.1016/j.drudis.2011.05.014; Iyer AS, 2008, J IMMUNOL, V180, P7869, DOI 10.4049/jimmunol.180.12.7869; Kannan AK, 2013, J ALLERGY CLIN IMMUN, V132, P811, DOI 10.1016/j.jaci.2013.04.033; KATO M, 1994, LUNG, V172, P113; Khurana D, 2007, J IMMUNOL, V178, P3575, DOI 10.4049/jimmunol.178.6.3575; KITZ R, 1962, J BIOL CHEM, V237, P3245; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li CR, 2005, J IMMUNOL, V174, P4475, DOI 10.4049/jimmunol.174.8.4475; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Lin TA, 2004, BIOCHEMISTRY-US, V43, P11056, DOI 10.1021/bi049428r; Linka RM, 2012, LEUKEMIA, V26, P963, DOI 10.1038/leu.2011.371; Lowenberg M, 2007, TRENDS MOL MED, V13, P158, DOI 10.1016/j.molmed.2007.02.001; McLean LR, 2012, BIOORG MED CHEM LETT, V22, P3296, DOI 10.1016/j.bmcl.2012.03.016; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; Mueller C, 2003, J IMMUNOL, V170, P5056, DOI 10.4049/jimmunol.170.10.5056; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pan ZY, 2007, CHEMMEDCHEM, V2, P58, DOI 10.1002/cmdc.200600221; Rice LV, 2013, EUR J PHARMACOL, V704, P49, DOI 10.1016/j.ejphar.2013.02.022; Riether D, 2009, BIOORG MED CHEM LETT, V19, P1588, DOI 10.1016/j.bmcl.2009.02.012; Sahu N, 2008, J IMMUNOL, V180, P3833, DOI 10.4049/jimmunol.180.6.3833; Sanofi-aventis, 2005, Patent No. [W02005026175, 2005026175]; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Singleton KL, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001821; Tsou HR, 2001, J MED CHEM, V44, P2719, DOI 10.1021/jm0005555; Van Laethem F, 2001, J EXP MED, V193, P803, DOI 10.1084/jem.193.7.803; Zapf CW, 2012, J MED CHEM, V55, P10047, DOI 10.1021/jm301190s	49	24	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					28195	28206		10.1074/jbc.M113.474114	http://dx.doi.org/10.1074/jbc.M113.474114			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23935099	Green Published, hybrid			2022-12-28	WOS:000330612800042
J	Jakobsson, ME; Moen, A; Bousset, L; Egge-Jacobsen, W; Kernstock, S; Melki, R; Falnes, PO				Jakobsson, Magnus E.; Moen, Anders; Bousset, Luc; Egge-Jacobsen, Wolfgang; Kernstock, Stefan; Melki, Ronald; Falnes, Pal O.			Identification and Characterization of a Novel Human Methyltransferase Modulating Hsp70 Protein Function through Lysine Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; ALPHA-SYNUCLEIN; BINDING; SET; HEAT-SHOCK-PROTEIN-70; PHOSPHORYLATION; ACTIVATION; SUBSTRATE; DISEASE; HSC70	Hsp70 proteins constitute an evolutionarily conserved protein family of ATP-dependent molecular chaperones involved in a wide range of biological processes. Mammalian Hsp70 proteins are subject to various post-translational modifications, including methylation, but for most of these, a functional role has not been attributed. In this study, we identified the methyltransferase METTL21A as the enzyme responsible for trimethylation of a conserved lysine residue found in several human Hsp70 (HSPA) proteins. This enzyme, denoted by us as HSPA lysine (K) methyltransferase (HSPA-KMT), was found to catalyze trimethylation of various Hsp70 family members both in vitro and in vivo, and the reaction was stimulated by ATP. Furthermore, we show that HSPA-KMT exclusively methylates 70-kDa proteins in mammalian protein extracts, demonstrating that it is a highly specific enzyme. Finally, we show that trimethylation of HSPA8 (Hsc70) has functional consequences, as it alters the affinity of the chaperone for both the monomeric and fibrillar forms of the Parkinson disease-associated protein alpha-synuclein.	[Jakobsson, Magnus E.; Moen, Anders; Egge-Jacobsen, Wolfgang; Kernstock, Stefan; Falnes, Pal O.] Univ Oslo, Dept Biosci, Fac Math & Nat Sci, N-0316 Oslo, Norway; [Bousset, Luc; Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	University of Oslo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Falnes, PO (corresponding author), Univ Oslo, Dept Biosci, Fac Math & Nat Sci, N-0316 Oslo, Norway.	pal.falnes@ibv.uio.no	Falnes, Pål Ø./AAA-4581-2020	bousset, luc/0000-0002-0433-4337; Falnes, Pal/0000-0001-8114-6025	University of Oslo; Norwegian Cancer Society; Research Council of Norway; Agence Nationale pour la Recherche [ANR-09-MNPS-013-01]; CNRS; Human Frontier Science Program; Fondation Bettencourt Schueller	University of Oslo; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Agence Nationale pour la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Human Frontier Science Program(Human Frontier Science Program); Fondation Bettencourt Schueller	The work performed in the Falnes laboratory was supported by the University of Oslo and by grants from the Norwegian Cancer Society and the Research Council of Norway.; Supported by Agence Nationale pour la Recherche Grant ANR-09-MNPS-013-01, CNRS, the Human Frontier Science Program, and the Fondation Bettencourt Schueller.	Abe Miyako, 2004, Clin Prostate Cancer, V3, P49, DOI 10.3816/CGC.2004.n.013; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Birtas-Atesoglu E, 2008, CLIN EXP RHEUMATOL, V26, pS96; Cho HS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2074; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Dakappagari N, 2010, BIOMARKERS, V15, P31, DOI 10.3109/13547500903261347; Del Rizzo PA, 2011, EPIGENETICS-US, V6, P1059, DOI 10.4161/epi.6.9.16069; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Gao XC, 2012, J BIOL CHEM, V287, P6044, DOI 10.1074/jbc.M111.294728; Ghee M, 2005, FEBS J, V272, P4023, DOI 10.1111/j.1742-4658.2005.04776.x; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gribaldo S, 1999, J BACTERIOL, V181, P434, DOI 10.1128/JB.181.2.434-443.1999; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang L, 2001, MOL CELL BIOL, V21, P8575, DOI 10.1128/MCB.21.24.8575-8591.2001; Kahali S, 2010, NEOPLASIA, V12, P80, DOI 10.1593/neo.91422; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; Kernstock S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2041; Knowlton AA, 2000, AM J PHYSIOL-HEART C, V278, pH2143, DOI 10.1152/ajpheart.2000.278.6.H2143; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Pehar M, 2012, J BIOL CHEM, V287, P22436, DOI 10.1074/jbc.C112.362871; Pemberton S, 2011, J BIOL CHEM, V286, P34690, DOI 10.1074/jbc.M111.261321; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Redeker V, 2012, J BIOL CHEM, V287, P32630, DOI 10.1074/jbc.M112.387530; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; WANG C, 1982, J BIOL CHEM, V257, P8356; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	41	82	96	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27752	27763		10.1074/jbc.M113.483248	http://dx.doi.org/10.1074/jbc.M113.483248			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23921388	Green Published, hybrid			2022-12-28	WOS:000330612800005
J	Qian, C; Qian, L; Yu, YZ; An, HZ; Guo, ZH; Han, YM; Chen, YJ; Bai, Y; Wang, QQ; Cao, XT				Qian, Cheng; Qian, Li; Yu, Yizhi; An, Huazhang; Guo, Zhenhong; Han, Yanmei; Chen, Yongjian; Bai, Yi; Wang, Qingqing; Cao, Xuetao			Fas Signal Promotes the Immunosuppressive Function of Regulatory Dendritic Cells via the ERK/beta-Catenin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; T-CELLS; TOLEROGENIC RESPONSES; IMMUNE-RESPONSES; EXPRESSION; TOLERANCE; ACTIVATION; DIFFERENTIATION; INNATE	Dendritic cells (DCs) play important roles in the initiation of immune response and also in the maintenance of immune tolerance. Now, many kinds of regulatory DCs with different phenotypes have been identified to suppress immune response and contribute to the control of autoimmune diseases. However, the mechanisms by which regulatory DCs can be regulated to exert the immunosuppressive function in the immune microenvironment remain to be fully investigated. In addition, how T cells, once activated, can feedback affect the function of regulatory DCs during immune response needs to be further identified. We previously identified a unique subset of CD11b(hi)Ia(low) regulatory DCs, differentiated from mature DCs or hematopoietic stem cells under a stromal microenvironment in spleen and liver, which can negatively regulate immune response in a feedback way. Here, we show that CD11b(hi)Ia(low) regulatory DCs expressed high level of Fas, and endothelial stromal cell-derived TGF-beta could induce high expression of Fas on regulatory DCs via ERK activation. Fas ligation could promote regulatory DCs to inhibit CD4(+) T cell proliferation more significantly. Furthermore, Fas ligation preferentially induced regulatory DCs to produce IL-10 and IP-10 via ERK-mediated inactivation of GSK-3 and subsequent up-regulation of beta-catenin. Interestingly, activated T cells could promote regulatory DCs to secrete more IL-10 and IP-10 partially through FasL. Therefore, our results demonstrate that Fas signal, at least from the activated T cells, can promote the immunosuppressive function of Fas-expressing regulatory DCs, providing a new manner for the regulatory DCs to regulate adaptive immunity.	[Qian, Cheng; Qian, Li; Yu, Yizhi; An, Huazhang; Guo, Zhenhong; Han, Yanmei; Chen, Yongjian; Bai, Yi; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Qian, Cheng; Qian, Li; Yu, Yizhi; An, Huazhang; Guo, Zhenhong; Han, Yanmei; Chen, Yongjian; Bai, Yi; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Wang, Qingqing; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Beijing 100730, Peoples R China	Naval Medical University; Naval Medical University; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College	Cao, XT (corresponding author), Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.	caoxt@immunol.org	Guo, Zhenhong/HGB-4912-2022; Han, Yanmei/D-8995-2016; yu, yizhi/ADP-7854-2022		Shanghai Rising-Star Program (A type) Grant [12QA1404100]; National Natural Science Foundation of China [30972704, 81230074, 81123006]; National Key Basic Research Program of China [2013CB530500]; Foundation for the Authors of National Excellent Doctoral Dissertations of China [201180]; Training Program Foundation for Excellent Young Teachers of Colleges and Universities of Shanghai	Shanghai Rising-Star Program (A type) Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Foundation for the Authors of National Excellent Doctoral Dissertations of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Training Program Foundation for Excellent Young Teachers of Colleges and Universities of Shanghai	This work was supported by Shanghai Rising-Star Program (A type) Grant 12QA1404100; National Natural Science Foundation of China Grants 30972704, 81230074, and 81123006; National Key Basic Research Program of China Grant 2013CB530500; Foundation for the Authors of National Excellent Doctoral Dissertations of China Grant 201180; and the Training Program Foundation for Excellent Young Teachers of Colleges and Universities of Shanghai.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Askenasy N, 2005, BLOOD, V105, P1396, DOI 10.1182/blood-2004-06-2364; Bai Y, 2012, J IMMUNOL, V188, P5293, DOI 10.4049/jimmunol.1102371; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Collin M, 2011, NAT REV IMMUNOL, V11, P575, DOI 10.1038/nri3046; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Feigelson SW, 2011, BLOOD, V117, P7042, DOI 10.1182/blood-2010-12-322859; Guo ZH, 2005, BLOOD, V106, P2033, DOI 10.1182/blood-2004-12-4831; Guo ZH, 2003, BLOOD, V102, P4441, DOI 10.1182/blood-2002-11-3420; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Hartmann K, 1997, J IMMUNOL, V159, P4006; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Kalas W, 2002, LEUKEMIA LYMPHOMA, V43, P1469, DOI 10.1080/1042819022386815; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Letellier E, 2010, IMMUNITY, V32, P240, DOI 10.1016/j.immuni.2010.01.011; Li XR, 1999, J BIOL CHEM, V274, P35203, DOI 10.1074/jbc.274.49.35203; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Lucas JA, 2008, J IMMUNOL, V181, P2513, DOI 10.4049/jimmunol.181.4.2513; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mohammadzadeh A, 2012, RHEUMATOL INT, V32, P2833, DOI 10.1007/s00296-011-2065-x; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Qian C, 2007, BLOOD, V109, P3308, DOI 10.1182/blood-2006-08-040337; Qian C, 2006, BLOOD, V108, P2307, DOI 10.1182/blood-2006-03-005595; Qian C, 2012, EUR J IMMUNOL, V42, P1388, DOI 10.1002/eji.201242632; Qian L, 2012, BLOOD, V120, P581, DOI 10.1182/blood-2011-08-377242; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; Roozendaal R, 2011, ANNU REV IMMUNOL, V29, P23, DOI 10.1146/annurev-immunol-031210-101357; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Strobl H, 1996, J IMMUNOL, V157, P1499; Takahashi-Yanaga F, 2004, BIOCHEM BIOPH RES CO, V316, P411, DOI 10.1016/j.bbrc.2004.02.061; Tang H, 2006, BLOOD, V108, P1189, DOI 10.1182/blood-2006-01-007187; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Xia S, 2008, BLOOD, V112, P3175, DOI 10.1182/blood-2008-05-159921; Xu S, 2012, NAT IMMUNOL, V13, P551, DOI 10.1038/ni.2283; Xu XF, 2011, BLOOD, V117, P1218, DOI 10.1182/blood-2010-05-285494; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130	53	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 27	2013	288	39					27825	27835		10.1074/jbc.M112.425751	http://dx.doi.org/10.1074/jbc.M112.425751			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302OB	23943615	Green Published, hybrid			2022-12-28	WOS:000330612800011
J	Kryndushkin, D; Pripuzova, N; Burnett, BG; Shewmaker, F				Kryndushkin, Dmitry; Pripuzova, Natalia; Burnett, Barrington G.; Shewmaker, Frank			Non-targeted Identification of Prions and Amyloid-forming Proteins from Yeast and Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENT; GLOBAL ANALYSIS; SUP35 POLYMERS; PSI+; HUNTINGTIN; LOCALIZATION; INHERITANCE; EXPRESSION; MODEL; MAINTENANCE	The formation of amyloid aggregates is implicated both as a primary cause of cellular degeneration in multiple human diseases and as a functional mechanism for providing extraordinary strength to large protein assemblies. The recent identification and characterization of several amyloid proteins from diverse organisms argues that the amyloid phenomenon is widespread in nature. Yet identifying new amyloid-forming proteins usually requires a priori knowledge of specific candidates. Amyloid fibers can resist heat, pressure, proteolysis, and denaturation by reagents such as urea or sodium dodecyl sulfate. Here we show that these properties can be exploited to identify naturally occurring amyloid-forming proteins directly from cell lysates. This proteomic-based approach utilizes a novel purification of amyloid aggregates followed by identification by mass spectrometry without the requirement for special genetic tools. We have validated this technique by blind identification of three amyloid-based yeast prions from laboratory and wild strains and disease-related polyglutamine proteins expressed in both yeast and mammalian cells. Furthermore, we found that polyglutamine aggregates specifically recruit some stress granule components, revealing a possible mechanism of toxicity. Therefore, core amyloid-forming proteins as well as strongly associated proteins can be identified directly from cells of diverse origin.	[Kryndushkin, Dmitry; Shewmaker, Frank] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [Burnett, Barrington G.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Pripuzova, Natalia] US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; US Food & Drug Administration (FDA)	Kryndushkin, D (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	dkrynd@yahoo.com; frank.shewmaker@usuhs.edu			National Institutes of Health [1R03DA035194]; Uniformed Services University of the Health Sciences [RO75QF, CS75QF]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA035194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uniformed Services University of the Health Sciences; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant 1R03DA035194. This work was also supported by Uniformed Services University of the Health Sciences Grants RO75QF and CS75QF.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bagriantsev SN, 2008, MOL BIOL CELL, V19, P2433, DOI 10.1091/mbc.E08-01-0078; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Bateman DA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003257; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Dong JJ, 2010, NAT STRUCT MOL BIOL, V17, P1422, DOI 10.1038/nsmb.1954; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kelly AC, 2012, P NATL ACAD SCI USA, V109, pE2683, DOI 10.1073/pnas.1213449109; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kryndushkin D, 2012, MOL MICROBIOL, V86, P1531, DOI 10.1111/mmi.12075; Kryndushkin DS, 2008, EMBO J, V27, P2725, DOI 10.1038/emboj.2008.198; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lopez N, 2003, MOL BIOL CELL, V14, P1172, DOI 10.1091/mbc.E02-09-0593; MacLea KS, 2011, PRION, V5, P263, DOI [10.4161/pri.5.4.17918, 10.4161/pri.17918]; MacPhee CE, 2000, J MOL BIOL, V297, P1203, DOI 10.1006/jmbi.2000.3600; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; Manogaran AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001386; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Newby GA, 2013, TRENDS CELL BIOL, V23, P251, DOI 10.1016/j.tcb.2013.01.007; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Nucifora FC, 2003, J BIOL CHEM, V278, P13047, DOI 10.1074/jbc.M211224200; Nubling G, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-35; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Ratovitski T, 2012, CELL CYCLE, V11, P2006, DOI 10.4161/cc.20423; Resende CG, 2003, MOL MICROBIOL, V49, P1005, DOI 10.1046/j.1365-2958.2003.03608.x; Romanova NV, 2009, PROTEIN PEPTIDE LETT, V16, P598, DOI 10.2174/092986609788490078; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; Toombs JA, 2012, P NATL ACAD SCI USA, V109, P6519, DOI 10.1073/pnas.1119366109; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; Urakov VN, 2010, PRION, V4, P45, DOI 10.4161/pri.4.1.11074; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195; Wang Y, 2007, PRION, V1, P128, DOI 10.4161/pri.1.2.4440; Wickner RB, 2008, BIOESSAYS, V30, P955, DOI 10.1002/bies.20821; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Xu GL, 2013, HUM MOL GENET, V22, P2765, DOI 10.1093/hmg/ddt121; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	70	46	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27100	27111		10.1074/jbc.M113.485359	http://dx.doi.org/10.1074/jbc.M113.485359			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23926098	Green Published, hybrid			2022-12-28	WOS:000330597300010
J	Orabi, AI; Muili, KA; Javed, TA; Jin, SQ; Jayaraman, T; Lund, FE; Husain, SZ				Orabi, Abrahim I.; Muili, Kamaldeen A.; Javed, Tanveer A.; Jin, Shunqian; Jayaraman, Thottala; Lund, Frances E.; Husain, Sohail Z.			Cluster of Differentiation 38 (CD38) Mediates Bile Acid-induced Acinar Cell Injury and Pancreatitis through Cyclic ADP-ribose and Intracellular Calcium Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE RECEPTORS; ADENINE-DINUCLEOTIDE PHOSPHATE; CERULEIN-INDUCED PANCREATITIS; CA2+-INDUCED CA2+ RELEASE; RYANODINE-RECEPTORS; INSULIN-SECRETION; ENDOPLASMIC-RETICULUM; PROTEASE ACTIVATION; SURFACE-MOLECULE; IP3 RECEPTORS	Aberrant Ca2+ signals within pancreatic acinar cells are an early and critical feature in acute pancreatitis, yet it is unclear how these signals are generated. An important mediator of the aberrant Ca2+ signals due to bile acid exposure is the intracellular Ca2+ channel ryanodine receptor. One putative activator of the ryanodine receptor is the nucleotide second messenger cyclic ADP-ribose (cADPR), which is generated by an ectoenzyme ADP-ribosyl cyclase, CD38. In this study, we examined the role of CD38 and cADPR in acinar cell Ca2+ signals and acinar injury due to bile acids using pharmacologic inhibitors of CD38 and cADPR as well as mice deficient in Cd38 (Cd38(-/-)). Cytosolic Ca2+ signals were imaged using live time-lapse confocal microscopy in freshly isolated mouse acinar cells during perifusion with the bile acid taurolithocholic acid 3-sulfate (TLCS; 500 mu M). To focus on intracellular Ca2+ release and to specifically exclude Ca2+ influx, cells were perifused in Ca2+-free medium. Cell injury was assessed by lactate dehydrogenase leakage and propidium iodide uptake. Pretreatment with either nicotinamide (20 mM) or the cADPR antagonist 8-Br-cADPR (30 mu M) abrogated TLCS-induced Ca2+ signals and cell injury. TLCS-induced Ca2+ release and cell injury were reduced by 30 and 95%, respectively, in Cd38-deficient acinar cells compared with wild-type cells (p < 0.05). Cd38-deficient mice were protected against a model of bile acid infusion pancreatitis. In summary, these data indicate that CD38-cADPR mediates bile acid-induced pancreatitis and acinar cell injury through aberrant intracellular Ca2+ signaling.	[Orabi, Abrahim I.; Muili, Kamaldeen A.; Javed, Tanveer A.; Jin, Shunqian; Husain, Sohail Z.] Univ Pittsburgh, Sch Med, UPMC, Childrens Hosp Pittsburgh,Dept Pediat, Pittsburgh, PA 15224 USA; [Jayaraman, Thottala] Univ Pittsburgh, Sch Med, UPMC, Childrens Hosp Pittsburgh,Dept Internal Med, Pittsburgh, PA 15224 USA; [Lund, Frances E.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham	Husain, SZ (corresponding author), UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	sohail.husain@chp.edu		Husain, Sohail Z/0000-0003-3012-1308	National Institutes of Health [DK083327, DK093491]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083327, R01DK093491, T32DK007017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK083327 and DK093491 (to S. Z. H.).	Bai HX, 2011, J PEDIATR GASTR NUTR, V52, P262, DOI 10.1097/MPG.0b013e3182061d75; Bottino R., 2012, J TRANSPLANT, V2012; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Burdakov D, 2001, CELL CALCIUM, V29, P211, DOI 10.1054/ceca.2000.0188; Cancela JM, 1998, PFLUG ARCH EUR J PHY, V435, P746, DOI 10.1007/s004240050578; Chaudhuri A, 2007, AM J PHYSIOL-GASTR L, V292, pG1403, DOI 10.1152/ajpgi.00478.2005; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; Criddle DN, 2004, P NATL ACAD SCI USA, V101, P10738, DOI 10.1073/pnas.0403431101; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; De Flora A, 1997, INT J BIOCHEM CELL B, V29, P1149, DOI 10.1016/S1357-2725(97)00062-9; Fukushi Y, 2001, J BIOL CHEM, V276, P649, DOI 10.1074/jbc.M004469200; Gale E A, 1996, Horm Res, V45 Suppl 1, P39; GALIONE A, 1993, NATURE, V365, P456, DOI 10.1038/365456a0; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Gerasimenko JV, 2011, P NATL ACAD SCI USA, V108, P5873, DOI 10.1073/pnas.1016534108; Gerasimenko JV, 2009, P NATL ACAD SCI USA, V106, P10758, DOI 10.1073/pnas.0904818106; Gerasimenko JV, 2006, J BIOL CHEM, V281, P40154, DOI 10.1074/jbc.M606402200; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Gobel A, 2001, CELL CALCIUM, V29, P29, DOI 10.1054/ceca.2000.0154; Higashida H, 2007, NEUROCHEM INT, V51, P192, DOI 10.1016/j.neuint.2007.06.023; HOFMANN AF, 1984, J LIPID RES, V25, P1477; Husain SZ, 2012, AM J PHYSIOL-GASTR L, V302, pG1423, DOI 10.1152/ajpgi.00546.2011; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; ITOH M, 1994, BIOCHEM BIOPH RES CO, V203, P1309, DOI 10.1006/bbrc.1994.2325; KAISHO T, 1994, P NATL ACAD SCI USA, V91, P5325, DOI 10.1073/pnas.91.12.5325; Kajimoto Y, 1996, BIOCHEM BIOPH RES CO, V219, P941, DOI 10.1006/bbrc.1996.0327; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Kim JY, 2002, GASTROENTEROLOGY, V122, P1941, DOI 10.1053/gast.2002.33617; Kim MS, 2011, GASTROENTEROLOGY, V140, P2107, DOI 10.1053/j.gastro.2011.02.052; Kim MS, 2009, GASTROENTEROLOGY, V137, P1509, DOI 10.1053/j.gastro.2009.07.042; Krause E, 2002, J BIOL CHEM, V277, P11696, DOI 10.1074/jbc.M107794200; Kruger B, 2000, AM J PATHOL, V157, P43, DOI 10.1016/S0002-9440(10)64515-4; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; LEE HC, 1995, J BIOL CHEM, V270, P9060, DOI 10.1074/jbc.270.16.9060; LEE HC, 1994, NATURE, V370, P307, DOI 10.1038/370307a0; LEE HC, 1993, J BIOL CHEM, V268, P293; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Leite MF, 1999, BIOCHEM J, V337, P305, DOI 10.1042/0264-6021:3370305; Leite MF, 2002, GASTROENTEROLOGY, V122, P415, DOI 10.1053/gast.2002.30982; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Mooren FC, 2003, J BIOL CHEM, V278, P9361, DOI 10.1074/jbc.M207454200; Muili KA, 2013, J BIOL CHEM, V288, P21065, DOI 10.1074/jbc.M113.471425; Muili KA, 2013, J BIOL CHEM, V288, P570, DOI 10.1074/jbc.M112.428896; Orabi AI, 2011, J BIOL CHEM, V286, P14090, DOI 10.1074/jbc.M110.196832; Orabi AI, 2010, AM J PHYSIOL-GASTR L, V299, pG196, DOI 10.1152/ajpgi.00498.2009; Pandol SJ, 1999, GASTROENTEROLOGY, V117, P706, DOI 10.1016/S0016-5085(99)70465-8; Parekh AB, 2000, P NATL ACAD SCI USA, V97, P12933, DOI 10.1073/pnas.97.24.12933; Perides G, 2010, NAT PROTOC, V5, P335, DOI 10.1038/nprot.2009.243; Perides G, 2010, GASTROENTEROLOGY, V138, P715, DOI 10.1053/j.gastro.2009.10.052; Petersen OH, 2005, CELL CALCIUM, V38, P171, DOI 10.1016/j.ceca.2005.06.024; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Ricordi C., 1995, METHODS CELL TRANSPL; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Siegel C, 2011, ACTA PHYSIOL, V203, P225, DOI 10.1111/j.1748-1716.2010.02229.x; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; TANAKA Y, 1995, P NATL ACAD SCI USA, V92, P3244, DOI 10.1073/pnas.92.8.3244; THORN P, 1994, EMBO J, V13, P2038, DOI 10.1002/j.1460-2075.1994.tb06478.x; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Voronina S, 2002, J PHYSIOL-LONDON, V540, P49, DOI 10.1113/jphysiol.2002.017525; Voronina SG, 2004, J BIOL CHEM, V279, P27327, DOI 10.1074/jbc.M311698200; Voronina SG, 2010, GASTROENTEROLOGY, V138, P1976, DOI 10.1053/j.gastro.2010.01.037; Wildi S, 2007, GUT, V56, P685, DOI 10.1136/gut.2006.105833; Williams JA, 2001, ANNU REV PHYSIOL, V63, P77, DOI 10.1146/annurev.physiol.63.1.77; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200	68	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 20	2013	288	38					27128	27137		10.1074/jbc.M113.494534	http://dx.doi.org/10.1074/jbc.M113.494534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IG	23940051	hybrid, Green Published			2022-12-28	WOS:000330597300012
